<?xml version='1.0' encoding='utf-8'?>
<PubmedArticleSet>
  <PubmedArticle>
    <ArticleTitle>The Conundrum of the PFOA human half-life, an international collaboration.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/35537634</pubmedLink>
    <Year>2022</Year>
    <DOI>S0273-2300(22)00072-1</DOI>
    <AuthorList>
      <Author>
        <Name>Jerry Campbell</Name>
        <Affiliation>Ramboll, US Corporation, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Harvey Clewell</Name>
        <Affiliation>Ramboll, US Corporation, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Tony Cox</Name>
        <Affiliation>Cox Associates, Colorado, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Michael Dourson</Name>
        <Affiliation>Toxicology Excellence for Risk Assessment, Ohio, USA. Electronic address: dourson@tera.org.</Affiliation>
      </Author>
      <Author>
        <Name>Shannon Ethridge</Name>
        <Affiliation>International Association of Plumbing and Mechanical Officials, California, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Norman Forsberg</Name>
        <Affiliation>Arcadis U.S. Inc, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Bernard Gadagbui</Name>
        <Affiliation>Toxicology Excellence for Risk Assessment, Ohio, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Ali Hamade</Name>
        <Affiliation>Oregon Health Authority, Oregon, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Ravi Naidu</Name>
        <Affiliation>CRC CARE, Callaghan, Australia.</Affiliation>
      </Author>
      <Author>
        <Name>Nathan Pechacek</Name>
        <Affiliation>Ecolab, Minnesota, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Tiago Severo Peixe</Name>
        <Affiliation>State University of Londrina, Parana, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Robyn Prueitt</Name>
        <Affiliation>Gradient, Massachusetts, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Mahesh Rachamalla</Name>
        <Affiliation>Department of Biology, University of Saskatchewan, Saskatoon, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Lorenz Rhomberg</Name>
        <Affiliation>Gradient, Massachusetts, USA.</Affiliation>
      </Author>
      <Author>
        <Name>James Smith</Name>
        <Affiliation>Navy and Marine Corps Public Health Center, Virginia, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Nitin Verma</Name>
        <Affiliation>Chitkara University, School of Pharmacy, Himachal Pradesh, India.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Comparison of toxicological effects and exposure levels between triclosan and its structurally similar chemicals using in vitro tests for read-across case study.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/35526779</pubmedLink>
    <Year>2022</Year>
    <DOI>S0273-2300(22)00068-X</DOI>
    <KeywordList>
      <Keywords>Hepatotoxicity</Keywords>
      <Keywords>Quantitative chemical risk assessment</Keywords>
      <Keywords>Read-across</Keywords>
      <Keywords>Toxicogenomics</Keywords>
      <Keywords>Triclosan</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Shota Nakagawa</Name>
        <Affiliation>Kao Corporation, Safety Science Research, 2606, Akabane, Ichikai-Machi, Haga-Gun Tochigi, 321-3497, Japan. Electronic address: nakagawa.shouta@kao.com.</Affiliation>
      </Author>
      <Author>
        <Name>Akane Hayashi</Name>
        <Affiliation>Kao Corporation, Safety Science Research, 2606, Akabane, Ichikai-Machi, Haga-Gun Tochigi, 321-3497, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Yuko Nukada</Name>
        <Affiliation>Kao Corporation, Safety Science Research, 2606, Akabane, Ichikai-Machi, Haga-Gun Tochigi, 321-3497, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Masayuki Yamane</Name>
        <Affiliation>Kao Corporation, Safety Science Research, 2606, Akabane, Ichikai-Machi, Haga-Gun Tochigi, 321-3497, Japan.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Read-across and new approach methodologies applied in a 10-step framework for cosmetics safety assessment - A case study with parabens.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/35508214</pubmedLink>
    <Year>2022</Year>
    <DOI>S0273-2300(22)00048-4</DOI>
    <KeywordList>
      <Keywords>Butylparaben</Keywords>
      <Keywords>Ethylparaben</Keywords>
      <Keywords>Methylparaben</Keywords>
      <Keywords>New approach methodologies (NAM)</Keywords>
      <Keywords>Next generation risk assessment (NGRA)</Keywords>
      <Keywords>Physiologically based kinetic (PBK) modelling</Keywords>
      <Keywords>Propylparaben</Keywords>
      <Keywords>Read-across (RAX)</Keywords>
      <Keywords>Systemic toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Gladys Ouedraogo</Name>
        <Affiliation>L'Oréal, Research &amp; Innovation, 1 Avenue Eugène Schueller, Aulnay Sous-Bois, France.</Affiliation>
      </Author>
      <Author>
        <Name>Camilla Alexander-White</Name>
        <Affiliation>MKTox &amp; Co Ltd, 36 Fairford Crescent, Downhead Park, Milton Keynes, Buckinghamshire, MK15 9AQ, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Dagmar Bury</Name>
        <Affiliation>L'Oréal, Research &amp; Innovation, 9 rue Pierre Dreyfus, 92110, Clichy, France.</Affiliation>
      </Author>
      <Author>
        <Name>Harvey J. Clewell</Name>
        <Affiliation>Ramboll Health Sciences, 3107 Armand Street, Monroe, LA, 71201, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Mark Cronin</Name>
        <Affiliation>School of Pharmacy and Biomolecular Sciences, Liverpool John Moores University, Byrom Street, Liverpool, L3 AF, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Tom Cull</Name>
        <Affiliation>Unilever, Safety &amp; Environmental Assurance Centre, Colworth House, Sharnbrook, Bedfordshire, MK44 1ET, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Matthew Dent</Name>
        <Affiliation>Unilever, Safety &amp; Environmental Assurance Centre, Colworth House, Sharnbrook, Bedfordshire, MK44 1ET, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Bertrand Desprez</Name>
        <Affiliation>Cosmetics Europe, 40 Avenue Hermann-Debroux, Brussels, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Ann Detroyer</Name>
        <Affiliation>L'Oréal, Research &amp; Innovation, 1 Avenue Eugène Schueller, Aulnay Sous-Bois, France.</Affiliation>
      </Author>
      <Author>
        <Name>Corie Ellison</Name>
        <Affiliation>The Procter &amp; Gamble Company, Cincinnati, OH, 45040, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Stefania Giammanco</Name>
        <Affiliation>Creme Global, 4th Floor, The Design Tower, Trinity Technology &amp; Enterprise Campus, Grand Canal Quay, Dublin 2, Ireland.</Affiliation>
      </Author>
      <Author>
        <Name>Eric Hack</Name>
        <Affiliation>ScitoVation, Research Triangle Park, Durham, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Nicola J. Hewitt</Name>
        <Affiliation>SWS, Wingertstrasse 25, 64390, Erzhausen, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Gerry Kenna</Name>
        <Affiliation>2 Farmfield Drive, Macclesfield, Cheshire, SK10 2TJ, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Martina Klaric</Name>
        <Affiliation>Cosmetics Europe, 40 Avenue Hermann-Debroux, Brussels, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Reinhard Kreiling</Name>
        <Affiliation>Clariant Produkte (Deutschland) GmbH, Am Unisys-Park 1, 65843, Sulzbach, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Cathy Lester</Name>
        <Affiliation>Procter &amp; Gamble Technical Centres Ltd, Reading, RG2 0RX, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Catherine Mahony</Name>
        <Affiliation>Procter &amp; Gamble Technical Centres Ltd, Reading, RG2 0RX, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Enrico Mombelli</Name>
        <Affiliation>Institut National de l'Environnement Industriel et des Risques (INERIS), Parc ALATA BP2, 60550, Verneuil en Halatte, France.</Affiliation>
      </Author>
      <Author>
        <Name>Jorge Naciff</Name>
        <Affiliation>The Procter &amp; Gamble Company, Cincinnati, OH, 45040, USA.</Affiliation>
      </Author>
      <Author>
        <Name>John O'Brien</Name>
        <Affiliation>Creme Global, 4th Floor, The Design Tower, Trinity Technology &amp; Enterprise Campus, Grand Canal Quay, Dublin 2, Ireland.</Affiliation>
      </Author>
      <Author>
        <Name>Andreas Schepky</Name>
        <Affiliation>Beiersdorf, Unnastrasse 48, 20253, Hamburg, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Sarah Tozer</Name>
        <Affiliation>Procter &amp; Gamble Technical Centres Ltd, Reading, RG2 0RX, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Bart van der Burg</Name>
        <Affiliation>BDS, Science Park 406, 1098XH, Amsterdam, the Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Barbara van Vugt</Name>
        <Affiliation>BDS, Science Park 406, 1098XH, Amsterdam, the Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Sharon Stuard</Name>
        <Affiliation>The Procter &amp; Gamble Company, Cincinnati, OH, 45040, USA.</Affiliation>
      </Author>
      <Author>
        <Name> Cosmetics Europe</Name>
        <Affiliation>Cosmetics Europe, 40 Avenue Hermann-Debroux, Brussels, Belgium. Electronic address: cosmeticseurope@cosmeticseurope.eu.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Results from two-year rodent oral carcinogenicity studies of cizolirtine, a substance-P and calcitonin gene-related peptide release modulator.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/35490976</pubmedLink>
    <Year>2022</Year>
    <DOI>S0273-2300(22)00069-1</DOI>
    <KeywordList>
      <Keywords>Calcitonin gene-related peptide</Keywords>
      <Keywords>Carcinogenicity</Keywords>
      <Keywords>Cizolirtine</Keywords>
      <Keywords>Mouse</Keywords>
      <Keywords>Rat</Keywords>
      <Keywords>Substance P</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Antonio Guzmán</Name>
        <Affiliation>Toxicology Department, Welab, Barcelona, Spain. Electronic address: aguzman@welab.barcelona.</Affiliation>
      </Author>
      <Author>
        <Name>Araceli Tortajada</Name>
        <Affiliation>Toxicology Department, Welab, Barcelona, Spain.</Affiliation>
      </Author>
      <Author>
        <Name>Ana Paz Marín</Name>
        <Affiliation>Toxicology Department, Welab, Barcelona, Spain.</Affiliation>
      </Author>
      <Author>
        <Name>Cristina Vila</Name>
        <Affiliation>Toxicology Department, Welab, Barcelona, Spain.</Affiliation>
      </Author>
      <Author>
        <Name>Gregorio Encina</Name>
        <Affiliation>Development-DMPK Department, Welab, Barcelona, Spain.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interestsThe authors (except for Cristina Vila) were full time employees of Esteve Pharmaceuticals at the time when the reported studies were conducted. At the current time, the authors have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>TSCA risk evaluation-directed characterization of occupational exposures during formaldehyde manufacturing, use as an intermediate, and compounding of formaldehyde-based polymers.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/35483541</pubmedLink>
    <Year>2022</Year>
    <DOI>S0273-2300(22)00060-5</DOI>
    <KeywordList>
      <Keywords>EPA</Keywords>
      <Keywords>Exposure data</Keywords>
      <Keywords>Formaldehyde</Keywords>
      <Keywords>Lautenberg act</Keywords>
      <Keywords>OSHA PEL</Keywords>
      <Keywords>Occupational non-users</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>James H. Sherman</Name>
        <Affiliation>Celanese Corp, 222 W. Las Colinas Blvd, Irving, TX, 75039, USA. Electronic address: james.sherman@celanese.com.</Affiliation>
      </Author>
      <Author>
        <Name>Gary M. Rowen</Name>
        <Affiliation>Celanese Corp, 222 W. Las Colinas Blvd, Irving, TX, 75039, USA. Electronic address: gary.rowen_contractor@celanese.com.</Affiliation>
      </Author>
      <Author>
        <Name>J. Tyler Tanniehill</Name>
        <Affiliation>Celanese Ltd., 9502 Bayport Blvd, Houston, TX, 77507, USA. Electronic address: Jordan.Tanniehill@celanese.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Corrigendum to a cross-industry collaboration to assess if acute toxicity (Q)SAR models are fit-for-purpose for GHS classification and labelling. Regulatory toxicology and pharmacology (2021) 104843.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/35474000</pubmedLink>
    <Year>2022</Year>
    <DOI>S0273-2300(22)00052-6</DOI>
    <AuthorList>
      <Author>
        <Name>Joel Bercu</Name>
        <Affiliation>Gilead Sciences, 333 Lakeside Drive, Foster City, CA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Melisa J. Masuda Herrera</Name>
        <Affiliation>Gilead Sciences, 333 Lakeside Drive, Foster City, CA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Alejandra Trejo-Martin</Name>
        <Affiliation>Gilead Sciences, 333 Lakeside Drive, Foster City, CA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Catrin Hasselgren</Name>
        <Affiliation>Genentech, Inc., 1 DNA Way, South San Francisco, CA, 94080, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jean Lord</Name>
        <Affiliation>Ultragenyx, 60 Leveroni Court, Novato, CA, 94949, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jessica Graham</Name>
        <Affiliation>Bristol Myers Squibb, Drug Safety Evaluation, 1 Squibb Dr, New Brunswick, NJ, 08903, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Matthew Schmitz</Name>
        <Affiliation>AbbVie Inc., North Chicago, IL, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Lawrence Milchak</Name>
        <Affiliation>3M Company, 3M Center, St. Paul, MN, 55144-1000, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Colin Owens</Name>
        <Affiliation>3M Company, 3M Center, St. Paul, MN, 55144-1000, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Surya Hari Lal</Name>
        <Affiliation>Syngenta Crop Protection, Product Safety Department, Jealott's Hill International Research Centre, Bracknell, Berkshire, RG42 6EY, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Richard Marchese Robinson</Name>
        <Affiliation>Syngenta Crop Protection, Product Safety Department, Jealott's Hill International Research Centre, Bracknell, Berkshire, RG42 6EY, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Sarah Whalley</Name>
        <Affiliation>Syngenta Crop Protection, Product Safety Department, Jealott's Hill International Research Centre, Bracknell, Berkshire, RG42 6EY, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Phillip Bellion</Name>
        <Affiliation>DSM Nutritional Products, Kaiseraugst, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Anna Vuorinen</Name>
        <Affiliation>DSM Nutritional Products, Kaiseraugst, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Kamila Gromek</Name>
        <Affiliation>Galapagos SASU, 102 Avenue Gaston Roussel, 93230, Romainville, France.</Affiliation>
      </Author>
      <Author>
        <Name>William A. Hawkins</Name>
        <Affiliation>GlaxoSmithKline, Park Road, Ware, Hertfordshire, SG12 0DP, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Iris Van de Gevel</Name>
        <Affiliation>Janssen Pharmaceutical Companies of Johnson &amp; Johnson, 2340, Beerse, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Kathleen Vriens</Name>
        <Affiliation>Janssen Pharmaceutical Companies of Johnson &amp; Johnson, 2340, Beerse, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Raymond Kemper</Name>
        <Affiliation>Vertex Pharmaceuticals Inc., Discovery and Investigative Toxicology, 50 Northern Ave, Boston, MA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Russell Naven</Name>
        <Affiliation>Vertex Pharmaceuticals Inc., Discovery and Investigative Toxicology, 50 Northern Ave, Boston, MA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Pierre Ferrer</Name>
        <Affiliation>Department of Veterinary Physiology and Pharmacology, Interdisciplinary Faculty of Toxicology Program, Texas A&amp;M University, 4466 TAMU, College Station, TX, 77843-4466, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Glenn J. Myatt</Name>
        <Affiliation>Leadscope (an Instem Company), 1393 Dublin Rd, Columbus, OH, 43215, USA. Electronic address: glenn.myatt@instem.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Review of air concentrations of pesticides for estimating exposure to vapour in European risk assessments.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/35469931</pubmedLink>
    <Year>2022</Year>
    <DOI>S0273-2300(22)00059-9</DOI>
    <AuthorList>
      <Author>
        <Name>Edgars Felkers</Name>
        <Affiliation>ADAMA Deutschland GmbH, Cologne, Germany. Electronic address: edgars.felkers@adama.com.</Affiliation>
      </Author>
      <Author>
        <Name>Felix M. Kluxen</Name>
        <Affiliation>ADAMA Deutschland GmbH, Cologne, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Sarah Adham</Name>
        <Affiliation>Corteva Agriscience, Abingdon, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Anne Kim Vinck</Name>
        <Affiliation>Bayer SAS, Crop Science Division, Lyon, France.</Affiliation>
      </Author>
      <Author>
        <Name>Neil Morgan</Name>
        <Affiliation>Syngenta, Jealott's Hill International Research Centre, Bracknell, United Kingdom.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Characterization of population variability of 1,3-butadiene derived protein adducts in humans and mice.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/35469930</pubmedLink>
    <GrantList>
      <Grant>P42 ES027704</Grant>
      <Grant>R01 ES029911</Grant>
      <Grant>R21 ES019684</Grant>
      <Grant>R21 ES023046</Grant>
    </GrantList>
    <Year>2022</Year>
    <DOI>S0273-2300(22)00058-7</DOI>
    <AuthorList>
      <Author>
        <Name>Gunnar Boysen</Name>
        <Affiliation>Department of Environmental and Occupational Health, The Winthrop P. Rockefeller Cancer Institute at the University of Arkansas for Medical Sciences, Little Rock, AR, USA. Electronic address: gboysen@uams.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Ivan Rusyn</Name>
        <Affiliation>Department of Veterinary Physiology and Pharmacology, Texas A&amp;M University, College Station, TX, USA. Electronic address: irusyn@tamu.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Weihsueh A. Chiu</Name>
        <Affiliation>Department of Veterinary Physiology and Pharmacology, Texas A&amp;M University, College Station, TX, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Fred A. Wright</Name>
        <Affiliation>Depts of Statistics and Biological Sciences, Bioinformatics Research Center, North Carolina State University, Raleigh, NC, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Residue depletion profiles and withdrawal interval estimations of meloxicam in eggs and ovarian follicles following intravenous (Meloxicam solution for injection) and oral (Meloxidyl®) administration in domestic chickens (Gallus domesticus).</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/35460801</pubmedLink>
    <Year>2022</Year>
    <DOI>S0273-2300(22)00057-5</DOI>
    <KeywordList>
      <Keywords>Drug residue</Keywords>
      <Keywords>Egg withdrawal time</Keywords>
      <Keywords>Meloxicam</Keywords>
      <Keywords>Pharmacokinetics</Keywords>
      <Keywords>Tissue residue depletion</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Long Yuan</Name>
        <Affiliation>Department of Environmental and Global Health, College of Public Health and Health Professions, University of Florida, Gainesville, FL, United States; Center for Environmental and Human Toxicology, University of Florida, Gainesville, FL, United States. Electronic address: yuanlong123@ufl.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Zhoumeng Lin</Name>
        <Affiliation>Department of Environmental and Global Health, College of Public Health and Health Professions, University of Florida, Gainesville, FL, United States; Center for Environmental and Human Toxicology, University of Florida, Gainesville, FL, United States. Electronic address: linzhoumeng@ufl.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Rachel S. Dutch</Name>
        <Affiliation>Department of Medicine and Epidemiology, School of Veterinary Medicine, University of California-Davis, Davis, CA, United States. Electronic address: rachelsdutch@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Emily D. Richards</Name>
        <Affiliation>Department of Medicine and Epidemiology, School of Veterinary Medicine, University of California-Davis, Davis, CA, United States. Electronic address: edrichards@ucdavis.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Maaike O. Clapham</Name>
        <Affiliation>Department of Medicine and Epidemiology, School of Veterinary Medicine, University of California-Davis, Davis, CA, United States. Electronic address: moclapham@ucdavis.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Nathaniel Burmas</Name>
        <Affiliation>Department of Medicine and Epidemiology, School of Veterinary Medicine, University of California-Davis, Davis, CA, United States. Electronic address: nburmas@ucdavis.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Scott E. Wetzlich</Name>
        <Affiliation>Department of Medicine and Epidemiology, School of Veterinary Medicine, University of California-Davis, Davis, CA, United States. Electronic address: sewetzlich@ucdavis.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Lisa A. Tell</Name>
        <Affiliation>Department of Medicine and Epidemiology, School of Veterinary Medicine, University of California-Davis, Davis, CA, United States. Electronic address: latell@ucdavis.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Expansion of the Cosmetics Europe skin sensitisation database with new substances and PPRA data.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/35447229</pubmedLink>
    <Year>2022</Year>
    <DOI>S0273-2300(22)00056-3</DOI>
    <KeywordList>
      <Keywords>Database</Keywords>
      <Keywords>Human reference data</Keywords>
      <Keywords>LLNA</Keywords>
      <Keywords>New approach methodologies</Keywords>
      <Keywords>Next generation risk assessment</Keywords>
      <Keywords>Skin sensitisation</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Sebastian Hoffmann</Name>
        <Affiliation>seh consulting + services, Stembergring 15, 33106, Paderborn, Germany. Electronic address: sebastian.hoffmann@seh-cs.com.</Affiliation>
      </Author>
      <Author>
        <Name>Nathalie Alépée</Name>
        <Affiliation>L'Oréal, Research &amp; Innovation, Aulnay-sous-Bois, France. Electronic address: nathalie.alepee@rd.loreal.com.</Affiliation>
      </Author>
      <Author>
        <Name>Nicola Gilmour</Name>
        <Affiliation>Unilever, Colworth Science Park, Bedford, MK44 1LQ, United Kingdom. Electronic address: Nicola.Gilmour@Unilever.com.</Affiliation>
      </Author>
      <Author>
        <Name>Petra S. Kern</Name>
        <Affiliation>Procter &amp; Gamble Services NV/SA, Temselaan/ Boechoutlaan, 1853, Strombeek-Bever, Belgium. Electronic address: kern.ps@pg.com.</Affiliation>
      </Author>
      <Author>
        <Name>Erwin van Vliet</Name>
        <Affiliation>Innovitox Consulting &amp; Services, Regentenland 35, 3994TZ, Houten, the Netherlands. Electronic address: vanvliete@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Fanny Boislève</Name>
        <Affiliation>Chanel, 135 Avenue Charles de Gaulle, 92521, Neuilly, France. Electronic address: fanny.boisleve@chanel.com.</Affiliation>
      </Author>
      <Author>
        <Name>Dagmar Bury</Name>
        <Affiliation>L'Oréal, Research &amp; Innovation, Clichy, France. Electronic address: dagmar.bury@rd.loreal.com.</Affiliation>
      </Author>
      <Author>
        <Name>Elodie Cloudet</Name>
        <Affiliation>Pierre Fabre, 3 Avenue Hubert Curien, 31100, Toulouse, France.</Affiliation>
      </Author>
      <Author>
        <Name>Martina Klaric</Name>
        <Affiliation>Cosmetics Europe, 40 Avenue Hermann-Debroux, 1160, Brussels, Belgium. Electronic address: martina_klaric@huntsman.com.</Affiliation>
      </Author>
      <Author>
        <Name>Jochen Kühnl</Name>
        <Affiliation>Beiersdorf AG, Unnastraße 48, 20245, Hamburg, Germany. Electronic address: Jochen.Kuehnl@Beiersdorf.com.</Affiliation>
      </Author>
      <Author>
        <Name>Jon F. Lalko</Name>
        <Affiliation>Estee Lauder Companies, 155 Pinelawn Road, Suite 300 South, Melville, NY, 11747, USA. Electronic address: jlalko@estee.com.</Affiliation>
      </Author>
      <Author>
        <Name>Karsten Mewes</Name>
        <Affiliation>Henkel, Henkelstraße 67, 40589, Düsseldorf, Germany. Electronic address: Karsten.Mewes@henkel.com.</Affiliation>
      </Author>
      <Author>
        <Name>Masaaki Miyazawa</Name>
        <Affiliation>Kao Corporation, 2606 Akabane, Ichikai, Haga, Tochigi, 321-3497, Japan. Electronic address: miyazawa.masaaki@kao.com.</Affiliation>
      </Author>
      <Author>
        <Name>Hayato Nishida</Name>
        <Affiliation>Shiseido Global Innovation Center, 1-2-11, Takashima, Nishi-ku, Yokohama-shi, Kanagawa, 220-0011, Japan. Electronic address: hayato.nishida@shiseido.com.</Affiliation>
      </Author>
      <Author>
        <Name>Mai Thanh Tam Brami</Name>
        <Affiliation>LVMH, 185 Avenue de Verdun, 45804, St Jean de Braye, France. Electronic address: mttbrami@research.lvmh-pc.com.</Affiliation>
      </Author>
      <Author>
        <Name>Mustafa Varçin</Name>
        <Affiliation>Cosmetics Europe, 40 Avenue Hermann-Debroux, 1160, Brussels, Belgium. Electronic address: mustafa.varcin@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Anne Marie Api</Name>
        <Affiliation>Research Institute for Fragrance Materials, Inc, Woodcliff Lake, NJ, USA. Electronic address: amapi@rifm.org.</Affiliation>
      </Author>
      <Author>
        <Name>Cosmetics Europe</Name>
        <Affiliation>Cosmetics Europe, 40 Avenue Hermann-Debroux, 1160, Brussels, Belgium. Electronic address: cosmeticseurope@cosmeticseurope.eu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Prenatal developmental toxicity study of 2,4-dichlorobenzyl alcohol in rats.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/35430291</pubmedLink>
    <Year>2022</Year>
    <DOI>S0273-2300(22)00055-1</DOI>
    <KeywordList>
      <Keywords>2,4-dichlorobenzyl alcohol</Keywords>
      <Keywords>Embryo-fetal development</Keywords>
      <Keywords>Pregnant rats</Keywords>
      <Keywords>Sore throat lozenges</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Kyeong Nang Moon</Name>
        <Affiliation>Developmental and Reproductive Toxicology Research Group, Korea Institute of Toxicology, Daejeon, Republic of Korea; OliX Pharmaceuticals, Inc., Suwon, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Sang Ki Baek</Name>
        <Affiliation>Developmental and Reproductive Toxicology Research Group, Korea Institute of Toxicology, Daejeon, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Woojin Kim</Name>
        <Affiliation>Toxicological Pathology Research Group, Korea Institute of Toxicology, Daejeon, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Ji Seong Jeong</Name>
        <Affiliation>Developmental and Reproductive Toxicology Research Group, Korea Institute of Toxicology, Daejeon, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Byoung Seok Lee</Name>
        <Affiliation>Toxicological Pathology Research Group, Korea Institute of Toxicology, Daejeon, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Yixian Quah</Name>
        <Affiliation>Developmental and Reproductive Toxicology Research Group, Korea Institute of Toxicology, Daejeon, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Jinsoo Lee</Name>
        <Affiliation>Developmental and Reproductive Toxicology Research Group, Korea Institute of Toxicology, Daejeon, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Sang Yun Kim</Name>
        <Affiliation>Developmental and Reproductive Toxicology Research Group, Korea Institute of Toxicology, Daejeon, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Seung Jin Lee</Name>
        <Affiliation>Developmental and Reproductive Toxicology Research Group, Korea Institute of Toxicology, Daejeon, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Kyu Bong Kim</Name>
        <Affiliation>College of Pharmacy, Dankook University, Cheonan, Chungnam, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Wook Joon Yu</Name>
        <Affiliation>Developmental and Reproductive Toxicology Research Group, Korea Institute of Toxicology, Daejeon, Republic of Korea. Electronic address: yuwj@kitox.re.kr.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Integration of toxicodynamic and toxicokinetic new approach methods into a weight-of-evidence analysis for pesticide developmental neurotoxicity assessment: A case-study with DL- and L-glufosinate.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/35413399</pubmedLink>
    <Year>2022</Year>
    <DOI>S0273-2300(22)00054-X</DOI>
    <AuthorList>
      <Author>
        <Name>Sarah Dobreniecki</Name>
        <Affiliation>Office of Pesticide Programs USEPA, Washington, DC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Elizabeth Mendez</Name>
        <Affiliation>Office of Pesticide Programs USEPA, Washington, DC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Anna Lowit</Name>
        <Affiliation>Office of Pesticide Programs USEPA, Washington, DC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Theresa M. Freudenrich</Name>
        <Affiliation>Center for Computational Toxicology and Exposure, Office of Research and Development. US Environmental Protection Agency, Research Triangle Park, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Kathleen Wallace</Name>
        <Affiliation>Center for Computational Toxicology and Exposure, Office of Research and Development. US Environmental Protection Agency, Research Triangle Park, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Amy Carpenter</Name>
        <Affiliation>Oak Ridge Institute for Science and Education (ORISE), Oak Ridge, TN, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Barbara A. Wetmore</Name>
        <Affiliation>Center for Computational Toxicology and Exposure, Office of Research and Development. US Environmental Protection Agency, Research Triangle Park, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Anna Kreutz</Name>
        <Affiliation>Oak Ridge Institute for Science and Education (ORISE), Oak Ridge, TN, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Evgenia Korol-Bexell</Name>
        <Affiliation>Oak Ridge Institute for Science and Education (ORISE), Oak Ridge, TN, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Katie Paul Friedman</Name>
        <Affiliation>Center for Computational Toxicology and Exposure, Office of Research and Development. US Environmental Protection Agency, Research Triangle Park, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Timothy J. Shafer</Name>
        <Affiliation>Center for Computational Toxicology and Exposure, Office of Research and Development. US Environmental Protection Agency, Research Triangle Park, NC, USA. Electronic address: shafer.tim@epa.gov.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Preclinical safety assessment of toxicity and biodistribution of oncolytic virus HSV-1 expressing human PD-1 antibody in mice.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/35405296</pubmedLink>
    <Year>2022</Year>
    <DOI>S0273-2300(22)00053-8</DOI>
    <KeywordList>
      <Keywords>Biodistribution</Keywords>
      <Keywords>Herpes simplex virus type-1</Keywords>
      <Keywords>Oncolytic virus</Keywords>
      <Keywords>PD-1 antibody</Keywords>
      <Keywords>Preclinical study</Keywords>
      <Keywords>Repeat-dose toxicity</Keywords>
      <Keywords>Single-dose toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Xin Wang</Name>
        <Affiliation>National Center for Safety Evaluation of Drugs, National Institute for Food and Drug Control, Beijing, 100176, China.</Affiliation>
      </Author>
      <Author>
        <Name>Chao Wang</Name>
        <Affiliation>National Center for Safety Evaluation of Drugs, National Institute for Food and Drug Control, Beijing, 100176, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhe Qu</Name>
        <Affiliation>National Center for Safety Evaluation of Drugs, National Institute for Food and Drug Control, Beijing, 100176, China.</Affiliation>
      </Author>
      <Author>
        <Name>Chao Tian</Name>
        <Affiliation>Beijing WellGene Company Ltd., Beijing, 100085, China.</Affiliation>
      </Author>
      <Author>
        <Name>Tiantian Wang</Name>
        <Affiliation>Beijing WellGene Company Ltd., Beijing, 100085, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yufa Miao</Name>
        <Affiliation>National Center for Safety Evaluation of Drugs, National Institute for Food and Drug Control, Beijing, 100176, China.</Affiliation>
      </Author>
      <Author>
        <Name>Hua Jiang</Name>
        <Affiliation>National Center for Safety Evaluation of Drugs, National Institute for Food and Drug Control, Beijing, 100176, China.</Affiliation>
      </Author>
      <Author>
        <Name>Lulu Li</Name>
        <Affiliation>National Center for Safety Evaluation of Drugs, National Institute for Food and Drug Control, Beijing, 100176, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jiajia Liu</Name>
        <Affiliation>Beijing WellGene Company Ltd., Beijing, 100085, China.</Affiliation>
      </Author>
      <Author>
        <Name>Rui Zhao</Name>
        <Affiliation>Beijing WellGene Company Ltd., Beijing, 100085, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaopeng Li</Name>
        <Affiliation>Beijing WellGene Company Ltd., Beijing, 100085, China. Electronic address: patricklee@genevec.com.</Affiliation>
      </Author>
      <Author>
        <Name>Xingchao Geng</Name>
        <Affiliation>National Center for Safety Evaluation of Drugs, National Institute for Food and Drug Control, Beijing, 100176, China. Electronic address: gengxch@nifdc.org.cn.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Report on investigation of ISO 10993-12 extraction conditions.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/35381323</pubmedLink>
    <Year>2022</Year>
    <DOI>S0273-2300(22)00051-4</DOI>
    <AuthorList>
      <Author>
        <Name>Theodore Heise</Name>
        <Affiliation>MED Institute, West Lafayette, IN, 47906, United States. Electronic address: theise@medinstitute.com.</Affiliation>
      </Author>
      <Author>
        <Name>Anita Y. Sawyer</Name>
        <Affiliation>Anita Sawyer Consulting, Raleigh, NC, 27615, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Toshiyuki Hirai</Name>
        <Affiliation>Terumo Corporation, Kanagawa, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Sandi Schaible</Name>
        <Affiliation>WuXi AppTec Medical Device Testing, Minneapolis, MN, 55120, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Harmony Sy</Name>
        <Affiliation>North American Science Associates, LLC, Bowling Green, OH, 43619, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Samanthi Wickramasekara</Name>
        <Affiliation>Center for Devices and Radiological Health, Food and Drug Administration, Silver Spring, MD, 20993, United States.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Characterization of false positive, contaminant-driven mutagenicity in impurities associated with the sotorasib drug substance.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/35331777</pubmedLink>
    <Year>2022</Year>
    <DOI>S0273-2300(22)00049-6</DOI>
    <KeywordList>
      <Keywords>AMG 510</Keywords>
      <Keywords>Contaminants</Keywords>
      <Keywords>Drug substance</Keywords>
      <Keywords>Impurity</Keywords>
      <Keywords>Mutagenicity</Keywords>
      <Keywords>QSAR</Keywords>
      <Keywords>Root cause analysis</Keywords>
      <Keywords>Sotorasib</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Aldo Coppi</Name>
        <Affiliation>Amgen Research, Translational Safety and Bioanalytical Sciences, Amgen Inc, Thousand Oaks, CA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Rhian Davies</Name>
        <Affiliation>Amgen Research, Translational Safety and Bioanalytical Sciences, Amgen Inc, Thousand Oaks, CA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Teresa Wegesser</Name>
        <Affiliation>Amgen Research, Translational Safety and Bioanalytical Sciences, Amgen Inc, Thousand Oaks, CA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Katsu Ishida</Name>
        <Affiliation>Amgen Research, Translational Safety and Bioanalytical Sciences, Amgen Inc, Thousand Oaks, CA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jamie Karmel</Name>
        <Affiliation>Amgen Research, Translational Safety and Bioanalytical Sciences, Amgen Inc, Thousand Oaks, CA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jun Han</Name>
        <Affiliation>Process Development, Amgen Inc., Thousand Oaks, CA, 91320, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Frankie Aiello</Name>
        <Affiliation>Process Development, Amgen Inc., Thousand Oaks, CA, 91320, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Yong Xie</Name>
        <Affiliation>Process Development, Amgen Inc., Thousand Oaks, CA, 91320, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Michael T. Corbett</Name>
        <Affiliation>Process Development, Amgen Inc., Thousand Oaks, CA, 91320, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Andrew T. Parsons</Name>
        <Affiliation>Process Development, Amgen Inc., Thousand Oaks, CA, 91320, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Thomas M. Monticello</Name>
        <Affiliation>Amgen Research, Translational Safety and Bioanalytical Sciences, Amgen Inc, Thousand Oaks, CA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Sheroy Minocherhomji</Name>
        <Affiliation>Amgen Research, Translational Safety and Bioanalytical Sciences, Amgen Inc, Thousand Oaks, CA, USA. Electronic address: sheroy.minocherhomji@amgen.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Applicability of nanomaterial-specific guidelines within long-term Daphnia magna toxicity assays: A case study on multigenerational effects of nTiO</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/35321839</pubmedLink>
    <Year>2022</Year>
    <DOI>S0273-2300(22)00043-5</DOI>
    <KeywordList>
      <Keywords>Chronic effects</Keywords>
      <Keywords>Environmental risk assessment</Keywords>
      <Keywords>Standard operating procedure</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Tom A. P. Nederstigt</Name>
        <Affiliation>Institute of Environmental Sciences, University of Leiden, Leiden, the Netherlands. Electronic address: t.a.p.nederstigt@cml.leidenuniv.nl.</Affiliation>
      </Author>
      <Author>
        <Name>Willie J. G. M. Peijnenburg</Name>
        <Affiliation>Institute of Environmental Sciences, University of Leiden, Leiden, the Netherlands; National Institute for Public Health and the Environment, Bilthoven, the Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Eric A. J. Bleeker</Name>
        <Affiliation>National Institute for Public Health and the Environment, Bilthoven, the Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Martina G. Vijver</Name>
        <Affiliation>Institute of Environmental Sciences, University of Leiden, Leiden, the Netherlands.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Absence of developmental or reproductive toxicity in rats for MB-102, a fluorescent tracer agent for point-of-care measurement of glomerular filtration rate.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/35318092</pubmedLink>
    <Year>2022</Year>
    <DOI>S0273-2300(22)00045-9</DOI>
    <KeywordList>
      <Keywords>Fetal/skeletal variations or malformations</Keywords>
      <Keywords>Fluorescence</Keywords>
      <Keywords>GFR</Keywords>
      <Keywords>Organogenesis</Keywords>
      <Keywords>Renal function</Keywords>
      <Keywords>Toxicokinetics</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Joseph E. Bugaj</Name>
        <Affiliation>MediBeacon Inc, 425 N. New Ballas Road, St. Louis, Missouri, 63141, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Richard B. Dorshow</Name>
        <Affiliation>MediBeacon Inc, 425 N. New Ballas Road, St. Louis, Missouri, 63141, USA. Electronic address: rbdorshow@medibeacon.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Next generation risk assessment for skin allergy: Decision making using new approach methodologies.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/35311660</pubmedLink>
    <Year>2022</Year>
    <DOI>S0273-2300(22)00046-0</DOI>
    <KeywordList>
      <Keywords>Case study</Keywords>
      <Keywords>Decision making</Keywords>
      <Keywords>NAM</Keywords>
      <Keywords>Next generation risk assessment</Keywords>
      <Keywords>Non-animal test methods</Keywords>
      <Keywords>Skin allergy risk assessment</Keywords>
      <Keywords>Uncertainty</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>N. Gilmour</Name>
        <Affiliation>Unilever Safety and Environmental Assurance Centre, Colworth Science Park, Sharnbrook, Bedfordshire, MK44 1LQ, UK. Electronic address: Nicola.gilmour@unilever.com.</Affiliation>
      </Author>
      <Author>
        <Name>J. Reynolds</Name>
        <Affiliation>Unilever Safety and Environmental Assurance Centre, Colworth Science Park, Sharnbrook, Bedfordshire, MK44 1LQ, UK.</Affiliation>
      </Author>
      <Author>
        <Name>K. Przybylak</Name>
        <Affiliation>Unilever Safety and Environmental Assurance Centre, Colworth Science Park, Sharnbrook, Bedfordshire, MK44 1LQ, UK.</Affiliation>
      </Author>
      <Author>
        <Name>M. Aleksic</Name>
        <Affiliation>Unilever Safety and Environmental Assurance Centre, Colworth Science Park, Sharnbrook, Bedfordshire, MK44 1LQ, UK.</Affiliation>
      </Author>
      <Author>
        <Name>N. Aptula</Name>
        <Affiliation>Unilever Safety and Environmental Assurance Centre, Colworth Science Park, Sharnbrook, Bedfordshire, MK44 1LQ, UK.</Affiliation>
      </Author>
      <Author>
        <Name>M. T. Baltazar</Name>
        <Affiliation>Unilever Safety and Environmental Assurance Centre, Colworth Science Park, Sharnbrook, Bedfordshire, MK44 1LQ, UK.</Affiliation>
      </Author>
      <Author>
        <Name>R. Cubberley</Name>
        <Affiliation>Unilever Safety and Environmental Assurance Centre, Colworth Science Park, Sharnbrook, Bedfordshire, MK44 1LQ, UK.</Affiliation>
      </Author>
      <Author>
        <Name>R. Rajagopal</Name>
        <Affiliation>Unilever Safety and Environmental Assurance Centre, Colworth Science Park, Sharnbrook, Bedfordshire, MK44 1LQ, UK.</Affiliation>
      </Author>
      <Author>
        <Name>G. Reynolds</Name>
        <Affiliation>Unilever Safety and Environmental Assurance Centre, Colworth Science Park, Sharnbrook, Bedfordshire, MK44 1LQ, UK.</Affiliation>
      </Author>
      <Author>
        <Name>S. Spriggs</Name>
        <Affiliation>Unilever Safety and Environmental Assurance Centre, Colworth Science Park, Sharnbrook, Bedfordshire, MK44 1LQ, UK.</Affiliation>
      </Author>
      <Author>
        <Name>C. Thorpe</Name>
        <Affiliation>Unilever Safety and Environmental Assurance Centre, Colworth Science Park, Sharnbrook, Bedfordshire, MK44 1LQ, UK.</Affiliation>
      </Author>
      <Author>
        <Name>S. Windebank</Name>
        <Affiliation>Unilever Safety and Environmental Assurance Centre, Colworth Science Park, Sharnbrook, Bedfordshire, MK44 1LQ, UK.</Affiliation>
      </Author>
      <Author>
        <Name>G. Maxwell</Name>
        <Affiliation>Unilever Safety and Environmental Assurance Centre, Colworth Science Park, Sharnbrook, Bedfordshire, MK44 1LQ, UK.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Rethinking chronic toxicity and carcinogenicity assessment for agrochemicals project (ReCAAP): A reporting framework to support a weight of evidence safety assessment without long-term rodent bioassays.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/35311659</pubmedLink>
    <Year>2022</Year>
    <DOI>S0273-2300(22)00047-2</DOI>
    <KeywordList>
      <Keywords>Carcinogenicity</Keywords>
      <Keywords>Chronic toxicity</Keywords>
      <Keywords>Hazard classification</Keywords>
      <Keywords>Integrated approach to testing and assessment (IATA)</Keywords>
      <Keywords>Mode of action (MoA)</Keywords>
      <Keywords>New approach methodology (NAM)</Keywords>
      <Keywords>Reporting framework</Keywords>
      <Keywords>Risk assessment</Keywords>
      <Keywords>Rodent bioassay</Keywords>
      <Keywords>Weight of evidence (WoE)</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Gina M. Hilton</Name>
        <Affiliation>PETA Science Consortium International e.V., Stuttgart, Germany. Electronic address: GinaH@thepsci.eu.</Affiliation>
      </Author>
      <Author>
        <Name>Catherine Adcock</Name>
        <Affiliation>Health Canada, Pest Management Regulatory Agency, Ottawa, Ontario, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Gregory Akerman</Name>
        <Affiliation>United States Environmental Protection Agency, Office of Pesticide Programs, Washington DC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>James Baldassari</Name>
        <Affiliation>FMC Corporation, Newark, DE, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Michael Battalora</Name>
        <Affiliation>FMC Corporation, Newark, DE, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Warren Casey</Name>
        <Affiliation>Division of the National Toxicology Program, National Institute of Environmental Health Sciences, Research Triangle Park, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Amy J. Clippinger</Name>
        <Affiliation>PETA Science Consortium International e.V., Stuttgart, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Rhian Cope</Name>
        <Affiliation>Australian Pesticides and Veterinary Medicines Authority, Armidale, New South Wales, Australia.</Affiliation>
      </Author>
      <Author>
        <Name>Amber Goetz</Name>
        <Affiliation>Syngenta Crop Protection, LLC, Greensboro, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>A. Wallace Hayes</Name>
        <Affiliation>University of South Florida College of Public Health, Tampa, FL, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Sabitha Papineni</Name>
        <Affiliation>Labcorp Early Development Laboratories Inc, Greenfield, IN, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Richard C. Peffer</Name>
        <Affiliation>Rich Peffer Toxicology Consulting, LLC, Greensboro, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Deborah Ramsingh</Name>
        <Affiliation>Health Canada, Pest Management Regulatory Agency, Ottawa, Ontario, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Brandy Williamson Riffle</Name>
        <Affiliation>BASF Corporation, Research Triangle Park, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Mitscheli Sanches da Rocha</Name>
        <Affiliation>BASF Corporation, Research Triangle Park, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Natalia Ryan</Name>
        <Affiliation>Syngenta Crop Protection, LLC, Greensboro, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Edward Scollon</Name>
        <Affiliation>Valent U.S.A. LLC, San Ramon, CA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Nicolo Visconti</Name>
        <Affiliation>Bayer CropScience LP, St. Louis, Missouri, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Douglas C. Wolf</Name>
        <Affiliation>Syngenta Crop Protection, LLC, Greensboro, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Zhongyu Yan</Name>
        <Affiliation>Corteva Agriscience™, Indianapolis, IN, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Anna Lowit</Name>
        <Affiliation>United States Environmental Protection Agency, Office of Pesticide Programs, Washington DC, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A framework to mitigate the risk of chemical leukoderma: Consumer products.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/35292310</pubmedLink>
    <Year>2022</Year>
    <DOI>S0273-2300(22)00044-7</DOI>
    <KeywordList>
      <Keywords>Hydroquinone</Keywords>
      <Keywords>Leukoderma</Keywords>
      <Keywords>Melanocyte toxicity</Keywords>
      <Keywords>Quinone</Keywords>
      <Keywords>Rhododendrol</Keywords>
      <Keywords>SAR read-Across</Keywords>
      <Keywords>Tyrosinase</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Donald L. Bjerke</Name>
        <Affiliation>The Procter &amp; Gamble Company, Mason Business Center, 8700 Mason-Montgomery Road, Mason, OH, 45040, USA. Electronic address: bjerke.dl@pg.com.</Affiliation>
      </Author>
      <Author>
        <Name>Shengde Wu</Name>
        <Affiliation>The Procter &amp; Gamble Company, Mason Business Center, 8700 Mason-Montgomery Road, Mason, OH, 45040, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Kazumasa Wakamatsu</Name>
        <Affiliation>Institute for Melanin Chemistry, Fujita Health University, Toyoake, Aichi, 470-1192, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Shosuke Ito</Name>
        <Affiliation>Institute for Melanin Chemistry, Fujita Health University, Toyoake, Aichi, 470-1192, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Jiazhen Wang</Name>
        <Affiliation>The Procter &amp; Gamble Company, Mason Business Center, 8700 Mason-Montgomery Road, Mason, OH, 45040, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Timothy Laughlin</Name>
        <Affiliation>The Procter &amp; Gamble Company, Mason Business Center, 8700 Mason-Montgomery Road, Mason, OH, 45040, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Tomohiro Hakozaki</Name>
        <Affiliation>The Procter &amp; Gamble Company, Mason Business Center, 8700 Mason-Montgomery Road, Mason, OH, 45040, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Isoflucypram: Combining in vivo and NAMs data in a weight of evidence approach to demonstrate the human non-relevance of the mode of action leading to the subtle thyroid effects observed in the rat.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/35276315</pubmedLink>
    <Year>2022</Year>
    <DOI>S0273-2300(22)00041-1</DOI>
    <KeywordList>
      <Keywords>Endocrine disruption</Keywords>
      <Keywords>Human</Keywords>
      <Keywords>In vitro comparison</Keywords>
      <Keywords>In vivo</Keywords>
      <Keywords>Liver</Keywords>
      <Keywords>Liver enzyme induction</Keywords>
      <Keywords>New approach methods (NAMs)</Keywords>
      <Keywords>Rat</Keywords>
      <Keywords>T-modality</Keywords>
      <Keywords>Thyroid</Keywords>
      <Keywords>UDPGT-T4</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>H. Tinwell</Name>
        <Affiliation>Bayer SAS, 16 rue Jean-Marie Leclair, 69009, Lyon, France. Electronic address: helen.tinwell@bayer.com.</Affiliation>
      </Author>
      <Author>
        <Name>R. Bars</Name>
        <Affiliation>Bayer SAS, 16 rue Jean-Marie Leclair, 69009, Lyon, France.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A scoping review of infant and children health effects associated with cadmium exposure.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/35257832</pubmedLink>
    <Year>2022</Year>
    <DOI>S0273-2300(22)00042-3</DOI>
    <KeywordList>
      <Keywords>Cadmium</Keywords>
      <Keywords>Cd</Keywords>
      <Keywords>Children</Keywords>
      <Keywords>Exposure</Keywords>
      <Keywords>Food</Keywords>
      <Keywords>Infant</Keywords>
      <Keywords>Maternal neurodevelopment</Keywords>
      <Keywords>Pregnant</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Brenna M. Flannery</Name>
        <Affiliation>Contaminant Assessment Branch, Division of Risk and Decision Analysis, US Food and Drug Administration, Center for Food Safety and Applied Nutrition, College Park, MD, United States. Electronic address: Brenna.flannery@fda.hhs.gov.</Affiliation>
      </Author>
      <Author>
        <Name>Heather R. Schaefer</Name>
        <Affiliation>Contaminant Assessment Branch, Division of Risk and Decision Analysis, US Food and Drug Administration, Center for Food Safety and Applied Nutrition, College Park, MD, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Karlyn B. Middleton</Name>
        <Affiliation>Contaminant Assessment Branch, Division of Risk and Decision Analysis, US Food and Drug Administration, Center for Food Safety and Applied Nutrition, College Park, MD, United States.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>R-ODAF: Omics data analysis framework for regulatory application.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/35247516</pubmedLink>
    <Year>2022</Year>
    <DOI>S0273-2300(22)00030-7</DOI>
    <KeywordList>
      <Keywords>DEGs</Keywords>
      <Keywords>Data analysis</Keywords>
      <Keywords>RNA-Seq</Keywords>
      <Keywords>Statistical analysis</Keywords>
      <Keywords>Statistics</Keywords>
      <Keywords>Transcriptomics</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Marcha Ct Verheijen</Name>
        <Affiliation>Department of Toxicogenomics, School of Oncology and Developmental Biology (GROW), Maastricht University, Maastricht, the Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Matthew J. Meier</Name>
        <Affiliation>Environmental Health Science and Research Bureau, Health Canada, Ottawa, Ontario, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Juan Ochoteco Asensio</Name>
        <Affiliation>Department of Toxicogenomics, School of Oncology and Developmental Biology (GROW), Maastricht University, Maastricht, the Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Timothy W. Gant</Name>
        <Affiliation>Public Health England (PHE), Centre for Radiation, Chemical and Environmental Hazards, Harwell Science and Innovation Campus, Oxfordshire, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Weida Tong</Name>
        <Affiliation>National Center for Toxicological Research, U.S. Food and Drug Administration (FDA), Jefferson, AR, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Carole L. Yauk</Name>
        <Affiliation>Department of Biology, University of Ottawa, Ottawa, Ontario, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Florian Caiment</Name>
        <Affiliation>Department of Toxicogenomics, School of Oncology and Developmental Biology (GROW), Maastricht University, Maastricht, the Netherlands. Electronic address: florian.caiment@maastrichtuniversity.nl.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Human exposure to toxic elements through facial cosmetic products: Dermal risk assessment.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/35219764</pubmedLink>
    <Year>2022</Year>
    <DOI>S0273-2300(22)00032-0</DOI>
    <KeywordList>
      <Keywords>Chronic daily intake</Keywords>
      <Keywords>Facial cosmetics</Keywords>
      <Keywords>Margin of safety</Keywords>
      <Keywords>Risk characterization</Keywords>
      <Keywords>Systematic exposure dose</Keywords>
      <Keywords>Toxic elements</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Asma Akhtar</Name>
        <Affiliation>National Centre of Excellence in Analytical Chemistry, University of Sindh, Jamshoro, 76080, Pakistan. Electronic address: 2k10chem21@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Tasneem Gul Kazi</Name>
        <Affiliation>National Centre of Excellence in Analytical Chemistry, University of Sindh, Jamshoro, 76080, Pakistan.</Affiliation>
      </Author>
      <Author>
        <Name>Hassan Imran Afridi</Name>
        <Affiliation>National Centre of Excellence in Analytical Chemistry, University of Sindh, Jamshoro, 76080, Pakistan.</Affiliation>
      </Author>
      <Author>
        <Name>Mustafa Khan</Name>
        <Affiliation>School of Chemistry and Material Sciences, University of Science and Technology, Hefei, China.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>"From Protein Toxins to Applied Toxicological Testing" virtual workshop identifies the need for a bioinformatic framework to assess novel food protein safety.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/35219763</pubmedLink>
    <Year>2022</Year>
    <DOI>S0273-2300(22)00033-2</DOI>
    <KeywordList>
      <Keywords>Bioinformatics</Keywords>
      <Keywords>Mechanism of toxicity</Keywords>
      <Keywords>Protein toxin</Keywords>
      <Keywords>Safety assessment</Keywords>
      <Keywords>Toxin database</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Patricia A. Bauman</Name>
        <Affiliation>Syngenta Crop Protection, LLC, 9 Davis Drive, Research Triangle Park, NC, 27709, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Andrew C. Doxey</Name>
        <Affiliation>University of Waterloo, Department of Biology, 200 University Ave. W, Ontario, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Ivano Eberini</Name>
        <Affiliation>Dipartimento di Scienze Farmacologiche e Biomolecolari, Università degli Studi di Milano, Via Balzaretti 9, 20133, Milano, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Emir Islamovic</Name>
        <Affiliation>BASF Corporation, 407 Davis Drive Tech 3, Morrisville, NC, 27560, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Florence Jungo</Name>
        <Affiliation>SIB Swiss Institute of Bioinformatics - Swiss-Prot Group, 1 rue Michel Servet - CH 1211 Geneva 4, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Colton Kessenich</Name>
        <Affiliation>Bayer Crop Science, 700 Chesterfield Parkway West, Chesterfield, MO, 63017, USA.</Affiliation>
      </Author>
      <Author>
        <Name>John Kough</Name>
        <Affiliation>US Environmental Protection Agency, Office of Pesticides Program, 1200 Pennsylvania Avenue, NW, Washington DC, 20460, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Mansi Krishan</Name>
        <Affiliation>Becton, Dickinson, and Company (BD), 21 Davis Drive, Research Triangle Park, NC, 27709, USA; Society of Toxicology (SOT) Food Safety Specialty Section, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Luca Palazzolo</Name>
        <Affiliation>Dipartimento di Scienze Farmacologiche e Biomolecolari, Università degli Studi di Milano, Via Balzaretti 9, 20133, Milano, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Laura Privalle</Name>
        <Affiliation>BASF Corporation, 407 Davis Drive Tech 3, Morrisville, NC, 27560, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Chester E. Rodriguez</Name>
        <Affiliation>Society of Toxicology (SOT) Food Safety Specialty Section, USA; Duke University Toxicology Program, Division of Occupational and Environmental Medicine, 2200 West Main Street, Durham, NC, 27705, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Karla J. F. Satchell</Name>
        <Affiliation>Northwestern University Feinberg School of Medicine, 303 E. Chicago Avenue, Ward 6-205, Chicago, IL, 60611, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Andre Silvanovich</Name>
        <Affiliation>Bayer Crop Science, 700 Chesterfield Parkway West, Chesterfield, MO, 63017, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Lucilia Pereira Mouriès</Name>
        <Affiliation>Health &amp; Environmental Sciences Institute (HESI), 740 15th Street NW, Suite 600, Washington, DC, 20005, USA. Electronic address: lmouries@hesiglobal.org.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Standardization, in-silico and in-vivo safety assessment of methanol extract of Ziziphus mauritiana Lam leaves.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/35218873</pubmedLink>
    <Year>2022</Year>
    <DOI>S0273-2300(22)00031-9</DOI>
    <KeywordList>
      <Keywords>Biochemical</Keywords>
      <Keywords>Hematology</Keywords>
      <Keywords>Histopathology</Keywords>
      <Keywords>Toxicity</Keywords>
      <Keywords>Ziziphus mauritiana Lam</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Mohan Kumar Ramar</Name>
        <Affiliation>Laboratory of Pulmonary Research, National Facility for Drug Development (NFDD) for Academia, Pharmaceutical and Allied Industries, Bharathidasan Institute of Technology, Anna University, Tiruchirappalli, 620024, Tamil Nadu, India; Department of Pharmaceutical Technology, Centre for Excellence in Nanobio Translational REsearch (CENTRE), Bharathidasan Institute of Technology, Anna University, Tiruchirappalli, 620024, Tamil Nadu, India. Electronic address: mkumar.rx@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Kumarappan Chidambaram</Name>
        <Affiliation>Department of Pharmacology &amp; Toxicology, School of Pharmacy, King Khalid University, Abha, 68589, Saudi Arabia. Electronic address: ctkumarrx@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Balakumar Chandrasekaran</Name>
        <Affiliation>Department of Pharmaceutical Chemistry, School of Pharmacy, ITM University, Gwalior 475001, Mathya Pradesh, India. Electronic address: dhillbalu@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Ruckmani Kandasamy</Name>
        <Affiliation>Laboratory of Pulmonary Research, National Facility for Drug Development (NFDD) for Academia, Pharmaceutical and Allied Industries, Bharathidasan Institute of Technology, Anna University, Tiruchirappalli, 620024, Tamil Nadu, India; Department of Pharmaceutical Technology, Centre for Excellence in Nanobio Translational REsearch (CENTRE), Bharathidasan Institute of Technology, Anna University, Tiruchirappalli, 620024, Tamil Nadu, India. Electronic address: ruckmani@aubit.edu.in.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Use of in vitro metabolism and biokinetics assays to refine predicted in vivo and in vitro internal exposure to the cosmetic ingredient, phenoxyethanol, for use in risk assessment.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/35217105</pubmedLink>
    <Year>2022</Year>
    <DOI>S0273-2300(22)00019-8</DOI>
    <KeywordList>
      <Keywords>IVIVE</Keywords>
      <Keywords>In vitro biokinetics</Keywords>
      <Keywords>In vitro models</Keywords>
      <Keywords>Phenoxyethanol</Keywords>
      <Keywords>Safety assessment</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Nicola J. Hewitt</Name>
        <Affiliation>Cosmetics Europe, Avenue Herrmann-Debroux 40, 1160, Auderghem, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>John Troutman</Name>
        <Affiliation>The Procter &amp; Gamble Company, Cincinnati, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Julia Przibilla</Name>
        <Affiliation>Pharmacelsus GmbH, Science Park 2, D-66123, Saarbrücken, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Andreas Schepky</Name>
        <Affiliation>Beiersdorf AG, Hamburg, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Gladys Ouédraogo</Name>
        <Affiliation>L'Oréal, Research &amp; Innovation, 9 rue Pierre Dreyfus, 92110, Clichy, France.</Affiliation>
      </Author>
      <Author>
        <Name>Catherine Mahony</Name>
        <Affiliation>Procter &amp; Gamble Technical Centres Ltd, Reading, RG2 0RX, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Gerry Kenna</Name>
        <Affiliation>Drug Safety Consultant, 2 Farmfield Drive, Macclesfield, Cheshire, SK10 2TJ, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Mustafa Varçin</Name>
        <Affiliation>Cosmetics Europe, Avenue Herrmann-Debroux 40, 1160, Auderghem, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Mathew P. Dent</Name>
        <Affiliation>Unilever Safety and Environmental Assurance Centre, Colworth Science Park, Sharnbrook, Bedfordshire, MK44 1LQ, UK.</Affiliation>
      </Author>
      <Author>
        <Name> </Name>
        <Affiliation>The Personal Care Association, Avenue Herrmann-Debroux, 401160, Brussels, Belgium.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The underlying mode of action for lung tumors in a tiered approach to the assessment of inhaled cobalt compounds.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/35158000</pubmedLink>
    <Year>2022</Year>
    <DOI>S0273-2300(22)00027-7</DOI>
    <KeywordList>
      <Keywords>Adverse outcome</Keywords>
      <Keywords>Animal carcinogen</Keywords>
      <Keywords>Mechanism</Keywords>
      <Keywords>Pathway</Keywords>
      <Keywords>Predictive toxicology testing</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Ruth Danzeisen</Name>
        <Affiliation>Cobalt Institute, 18 Jeffries Passage, Guildford, GU1 4AP, UK. Electronic address: rdanzeisen@cobaltinstitute.org.</Affiliation>
      </Author>
      <Author>
        <Name>Gerd Rüdiger Jänig</Name>
        <Affiliation>Dr. Gerd-Rüdiger Jänig, Toxicological Consulting, 12524, Berlin, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Arne Burzlaff</Name>
        <Affiliation>EBRC Consulting GmbH, Raffaelstr. 4, 30177, Hannover, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Steven Verberckmoes</Name>
        <Affiliation>BeTechnic Studios, 9150 Bazel, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Janine Adam</Name>
        <Affiliation>EBRC Consulting GmbH, Raffaelstr. 4, 30177, Hannover, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Vanessa Viegas</Name>
        <Affiliation>Cobalt Institute, 18 Jeffries Passage, Guildford, GU1 4AP, UK.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Successful regulatory agency interaction - A nonclinical regulatory strategist's perspective.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/35131340</pubmedLink>
    <Year>2022</Year>
    <DOI>S0273-2300(22)00017-4</DOI>
    <KeywordList>
      <Keywords>CTA</Keywords>
      <Keywords>IND</Keywords>
      <Keywords>MAA</Keywords>
      <Keywords>Marketing applications</Keywords>
      <Keywords>NDA</Keywords>
      <Keywords>Nonclinical</Keywords>
      <Keywords>Post-marketing strategy</Keywords>
      <Keywords>Regulatory agency meetings</Keywords>
      <Keywords>Regulatory submissions</Keywords>
      <Keywords>Toxicology</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Paul Baldrick</Name>
        <Affiliation>Product Development and Market Access Consulting, Clinical Development &amp; Commercialisation Services, Labcorp Drug Development Inc. (formerly Covance), Harrogate, North Yorkshire, HG3 1PY, United Kingdom. Electronic address: paul.baldrick@covance.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Derivation of thresholds for inhaled chemically reactive irritants: Searching for substance-specific common denominators for read-across prediction.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/35124139</pubmedLink>
    <Year>2022</Year>
    <DOI>S0273-2300(22)00018-6</DOI>
    <KeywordList>
      <Keywords>Acute exposure guideline levels</Keywords>
      <Keywords>Carbonyl chloride</Keywords>
      <Keywords>Chloroformates</Keywords>
      <Keywords>Phosgene</Keywords>
      <Keywords>Regional inhalation dosimetry</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Juergen Pauluhn</Name>
        <Affiliation>Covestro Deutschland AG, Global Phosgene Steering Group, 51365, Leverkusen, Germany. Electronic address: juergen.pauluhn@covestro.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A tiered approach to investigate the inhalation toxicity of cobalt substances. Tier 4: Effects from a 28-day inhalation toxicity study with tricobalt tetraoxide in rats.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/35124138</pubmedLink>
    <Year>2022</Year>
    <DOI>S0273-2300(22)00016-2</DOI>
    <KeywordList>
      <Keywords>Lung</Keywords>
      <Keywords>Metal compounds</Keywords>
      <Keywords>Metals</Keywords>
      <Keywords>Poorly soluble particle (PSP)</Keywords>
      <Keywords>Solubility</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Arne Burzlaff</Name>
        <Affiliation>EBRC Consulting GmbH, Raffaelstr. 4, 30177, Hannover, Germany. Electronic address: a.burzlaff@ebrc.de.</Affiliation>
      </Author>
      <Author>
        <Name>Otto Creutzenberg</Name>
        <Affiliation>Fraunhofer Institute for Toxicology and Experimental Medicine (Fh-ITEM), Nikolai Fuchs Strasse 1, 30625, Hannover, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Dirk Schaudien</Name>
        <Affiliation>Fraunhofer Institute for Toxicology and Experimental Medicine (Fh-ITEM), Nikolai Fuchs Strasse 1, 30625, Hannover, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Vanessa Viegas</Name>
        <Affiliation>Cobalt Institute, 18 Jeffries Passage, Guildford, GU1 4AP, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Ruth Danzeisen</Name>
        <Affiliation>Cobalt Institute, 18 Jeffries Passage, Guildford, GU1 4AP, UK. Electronic address: rdanzeisen@cobaltinstitute.org.</Affiliation>
      </Author>
      <Author>
        <Name>David Warheit</Name>
        <Affiliation>Warheit Scientific LLC, Wilmington, DE, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A tiered approach to investigate the inhalation toxicity of cobalt substances. Tier 3: Inflammatory response following acute inhalation exposure correlates with lower tier data.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/35124137</pubmedLink>
    <Year>2022</Year>
    <DOI>S0273-2300(22)00014-9</DOI>
    <KeywordList>
      <Keywords>Biomarker</Keywords>
      <Keywords>Cancer</Keywords>
      <Keywords>Inflammation</Keywords>
      <Keywords>Lung</Keywords>
      <Keywords>Metals</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Vanessa Viegas</Name>
        <Affiliation>Cobalt Institute, 18 Jeffries Passage, Guildford, GU1 4AP, UK. Electronic address: vviegas@cobaltinstitute.org.</Affiliation>
      </Author>
      <Author>
        <Name>Arne Burzlaff</Name>
        <Affiliation>EBRC Consulting GmbH, Raffaelstraße 4, 30177, Hannover, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Thomas O. Brock</Name>
        <Affiliation>Duke Occupational &amp; Environmental Medicine, DUMC 3834, Durham, NC, 27710, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Ruth Danzeisen</Name>
        <Affiliation>Cobalt Institute, 18 Jeffries Passage, Guildford, GU1 4AP, UK. Electronic address: rdanzeisen@cobaltinstitute.org.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Acute dose toxicity evaluation of the food supplement calcium 3-hydroxy-3-methylbutyrate (HMB) in female Sprague Dawley rats.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/35122888</pubmedLink>
    <Year>2022</Year>
    <DOI>S0273-2300(22)00020-4</DOI>
    <KeywordList>
      <Keywords>HMB</Keywords>
      <Keywords>Preclinical study</Keywords>
      <Keywords>Rodents</Keywords>
      <Keywords>Safety</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>John C. Fuller</Name>
        <Affiliation>Metabolic Technologies, LLC, Missoula, MT, 59802, USA. Electronic address: Fuller@mti-hmb.com.</Affiliation>
      </Author>
      <Author>
        <Name>John A. Rathmacher</Name>
        <Affiliation>MTI Biotech, Inc, Ames, IA, 50010, USA; Department of Animal Science, Iowa State University, Ames, IA, 50010, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Benchmarking performance of SENS-IS assay against weight of evidence skin sensitization potency categories.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/35104615</pubmedLink>
    <Year>2022</Year>
    <DOI>S0273-2300(22)00015-0</DOI>
    <KeywordList>
      <Keywords>Animal alternative</Keywords>
      <Keywords>Fragrance materials</Keywords>
      <Keywords>In vitro assay</Keywords>
      <Keywords>Potency prediction</Keywords>
      <Keywords>Skin sensitization</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Mihwa Na</Name>
        <Affiliation>Research Institute for Fragrance Materials, Inc., 50 Tice Blvd., Woodcliff Lake, NJ, USA. Electronic address: mna@rifm.org.</Affiliation>
      </Author>
      <Author>
        <Name>Devin O'Brien</Name>
        <Affiliation>Research Institute for Fragrance Materials, Inc., 50 Tice Blvd., Woodcliff Lake, NJ, USA.</Affiliation>
      </Author>
      <Author>
        <Name>G. Frank Gerberick</Name>
        <Affiliation>GF3 Consultancy, LLC, West Chester, OH, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Petra S. Kern</Name>
        <Affiliation>Procter &amp; Gamble Services NV, Strombeek-Bever, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Maura Lavelle</Name>
        <Affiliation>Research Institute for Fragrance Materials, Inc., 50 Tice Blvd., Woodcliff Lake, NJ, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Isabelle Lee</Name>
        <Affiliation>Research Institute for Fragrance Materials, Inc., 50 Tice Blvd., Woodcliff Lake, NJ, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Rahul Parakhia</Name>
        <Affiliation>Research Institute for Fragrance Materials, Inc., 50 Tice Blvd., Woodcliff Lake, NJ, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Cindy Ryan</Name>
        <Affiliation>ToxTech Solutions, LLC, Milan, IN, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Anne Marie Api</Name>
        <Affiliation>Research Institute for Fragrance Materials, Inc., 50 Tice Blvd., Woodcliff Lake, NJ, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A tiered approach to investigate the inhalation toxicity of cobalt substances. Tier 1: Bioaccessibility testing.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/35093462</pubmedLink>
    <Year>2022</Year>
    <DOI>S0273-2300(22)00011-3</DOI>
    <KeywordList>
      <Keywords>Bioelution</Keywords>
      <Keywords>Lung</Keywords>
      <Keywords>Metal compounds</Keywords>
      <Keywords>Metals</Keywords>
      <Keywords>Solubility</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Violaine Verougstraete</Name>
        <Affiliation>Eurometaux, 168 Avenue de Tervueren Box 13, 1150, Brussels, Belgium. Electronic address: verougstraete@eurometaux.be.</Affiliation>
      </Author>
      <Author>
        <Name>Ruth Danzeisen</Name>
        <Affiliation>Cobalt Institute, 18 Jeffries Passage, Guildford, GU1 4AP, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Vanessa Viegas</Name>
        <Affiliation>Cobalt Institute, 18 Jeffries Passage, Guildford, GU1 4AP, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Paul Marsh</Name>
        <Affiliation>Cobalt Institute, 18 Jeffries Passage, Guildford, GU1 4AP, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Adriana Oller</Name>
        <Affiliation>NiPERA Inc, 2525 Meridian Parkway suite 240, Durham, NC, 27713, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Review of regulatory reference values and background levels for heavy metals in the human diet.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/35090957</pubmedLink>
    <Year>2022</Year>
    <DOI>S0273-2300(22)00009-5</DOI>
    <KeywordList>
      <Keywords>Arsenic</Keywords>
      <Keywords>Cadmium</Keywords>
      <Keywords>Chromium</Keywords>
      <Keywords>Dietary exposure</Keywords>
      <Keywords>Lead</Keywords>
      <Keywords>Mercury</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Candace Wong</Name>
        <Affiliation>University of Rochester, Department of Environmental Medicine, Toxicology Program, 601 Elmwood Ave., Box 850, Rochester, NY, 14642, USA. Electronic address: candacewong888@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Stephen M. Roberts</Name>
        <Affiliation>University of Florida, Center for Environmental and Human Toxicology, 2187 Mowry Road, Gainesville, FL, 32611, USA. Electronic address: smroberts@ufl.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Imad Neal Saab</Name>
        <Affiliation>Institute for Advancement of Food and Nutrition Sciences (IAFNS), 740 15th St. NW, Ste 600, Washington, DC, 20005, USA. Electronic address: nsaab@iafns.org.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A tiered approach to investigate the inhalation toxicity of cobalt substances. Introduction: Cobalt's essential role in nature and technology.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/35085603</pubmedLink>
    <Year>2022</Year>
    <DOI>S0273-2300(22)00012-5</DOI>
    <KeywordList>
      <Keywords>Chemicals' regulation</Keywords>
      <Keywords>Demand</Keywords>
      <Keywords>Metals</Keywords>
      <Keywords>Occurrence</Keywords>
      <Keywords>REACH</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Ruth Danzeisen</Name>
        <Affiliation>Cobalt Institute, 18 Jeffries Passage, Guildford, GU1 4AP, UK. Electronic address: rdanzeisen@cobaltinstitute.org.</Affiliation>
      </Author>
      <Author>
        <Name>David Weight</Name>
        <Affiliation>Cobalt Institute, 18 Jeffries Passage, Guildford, GU1 4AP, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Michael Blakeney</Name>
        <Affiliation>Cobalt Institute, 18 Jeffries Passage, Guildford, GU1 4AP, UK.</Affiliation>
      </Author>
      <Author>
        <Name>David Boyle</Name>
        <Affiliation>Cobalt Institute, 18 Jeffries Passage, Guildford, GU1 4AP, UK.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Safety assessment of Asterarcys quadricellulare, a microalga, with applications in poultry and livestock feed.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/35065094</pubmedLink>
    <Year>2022</Year>
    <DOI>S0273-2300(22)00013-7</DOI>
    <KeywordList>
      <Keywords>Asterarcys quadricellulare</Keywords>
      <Keywords>Eye irritation</Keywords>
      <Keywords>Feed safety</Keywords>
      <Keywords>Microalgae</Keywords>
      <Keywords>Mutagenicity</Keywords>
      <Keywords>Oral toxicity</Keywords>
      <Keywords>Skin irritation</Keywords>
      <Keywords>Skin sensitisation</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>S. Mustafa</Name>
        <Affiliation>Alltech Ireland, Sarney, Summerhill Road, Dunboyne, Co Meath, Ireland.</Affiliation>
      </Author>
      <Author>
        <Name>G. P. Dillon</Name>
        <Affiliation>Alltech Ireland, Sarney, Summerhill Road, Dunboyne, Co Meath, Ireland.</Affiliation>
      </Author>
      <Author>
        <Name>C. A. Moran</Name>
        <Affiliation>Alltech France SARL, Rue Charles Amand, 14500, Vire, France. Electronic address: cmoran@alltech.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The purity of tattoo inks, screening substances of high concern.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/35065093</pubmedLink>
    <Year>2022</Year>
    <DOI>S0273-2300(22)00010-1</DOI>
    <KeywordList>
      <Keywords>Ink</Keywords>
      <Keywords>Primary aromatic amines</Keywords>
      <Keywords>Risk assessment</Keywords>
      <Keywords>Screening</Keywords>
      <Keywords>Tattoo</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>B. Desmedt</Name>
        <Affiliation>Medicines and Health Products, Scientific Direction Physical and Chemical Health Risks, Sciensano, Juliette Wytsmanstraat 14, 1050, Brussels, Belgium. Electronic address: Bart.desmedt@sciensano.be.</Affiliation>
      </Author>
      <Author>
        <Name>M. Vanhamme</Name>
        <Affiliation>Medicines and Health Products, Scientific Direction Physical and Chemical Health Risks, Sciensano, Juliette Wytsmanstraat 14, 1050, Brussels, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>E. Deconinck</Name>
        <Affiliation>Medicines and Health Products, Scientific Direction Physical and Chemical Health Risks, Sciensano, Juliette Wytsmanstraat 14, 1050, Brussels, Belgium.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A tiered approach to investigate the inhalation toxicity of cobalt substances. Tier 2a: Grouping cobalt compounds based on their capacity to stabilize HIF-1α in human alveolar epithelial cells in vitro.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/35063568</pubmedLink>
    <Year>2022</Year>
    <DOI>S0273-2300(22)00008-3</DOI>
    <KeywordList>
      <Keywords>Cytotoxicity</Keywords>
      <Keywords>Hypoxia</Keywords>
      <Keywords>Lung</Keywords>
      <Keywords>Metals</Keywords>
      <Keywords>Solubility</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Sybille van den Brule</Name>
        <Affiliation>Louvain centre for Toxicology and Applied Pharmacology, Institut de Recherche Expérimentale et Clinique, UCLouvain, Avenue Hippocrate 57/B1.57.06, 1200, Brussels, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Saloua Ibouraadaten</Name>
        <Affiliation>Louvain centre for Toxicology and Applied Pharmacology, Institut de Recherche Expérimentale et Clinique, UCLouvain, Avenue Hippocrate 57/B1.57.06, 1200, Brussels, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Lisa Brombin</Name>
        <Affiliation>Louvain centre for Toxicology and Applied Pharmacology, Institut de Recherche Expérimentale et Clinique, UCLouvain, Avenue Hippocrate 57/B1.57.06, 1200, Brussels, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Dominique Lison</Name>
        <Affiliation>Louvain centre for Toxicology and Applied Pharmacology, Institut de Recherche Expérimentale et Clinique, UCLouvain, Avenue Hippocrate 57/B1.57.06, 1200, Brussels, Belgium. Electronic address: dominique.lison@uclouvain.be.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A tiered approach to investigate the inhalation toxicity of cobalt substances. Tier 2 b: Reactive cobalt substances induce oxidative stress in ToxTracker and activate hypoxia target genes.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/35038485</pubmedLink>
    <Year>2022</Year>
    <DOI>S0273-2300(22)00007-1</DOI>
    <KeywordList>
      <Keywords>Biomarker</Keywords>
      <Keywords>Cancer</Keywords>
      <Keywords>Genotoxicity</Keywords>
      <Keywords>Metal</Keywords>
      <Keywords>Solubility</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Remco Derr</Name>
        <Affiliation>Toxys, Leiden Bio Science Park, De Limes 7, 2342 DH, Oegstgeest, the Netherlands. Electronic address: r.derr@toxys.com.</Affiliation>
      </Author>
      <Author>
        <Name>Nynke Moelijker</Name>
        <Affiliation>Toxys, Leiden Bio Science Park, De Limes 7, 2342 DH, Oegstgeest, the Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Giel Hendriks</Name>
        <Affiliation>Toxys, Leiden Bio Science Park, De Limes 7, 2342 DH, Oegstgeest, the Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Inger Brandsma</Name>
        <Affiliation>Toxys, Leiden Bio Science Park, De Limes 7, 2342 DH, Oegstgeest, the Netherlands.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Evaluation of the safety of ethanolic extract from Piper amalago L. (Piperaceae) leaves in vivo: Subacute toxicity and genotoxicity studies.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/35038484</pubmedLink>
    <Year>2022</Year>
    <DOI>S0273-2300(22)00005-8</DOI>
    <KeywordList>
      <Keywords>Genotoxicity</Keywords>
      <Keywords>Hemato-biochemical alterations</Keywords>
      <Keywords>Hepatotoxicity</Keywords>
      <Keywords>Mice</Keywords>
      <Keywords>Piper amalago</Keywords>
      <Keywords>Piperaceae</Keywords>
      <Keywords>Rats</Keywords>
      <Keywords>Safety</Keywords>
      <Keywords>Subacute toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Julia Stein</Name>
        <Affiliation>Department of Structural and Functional Biology, Institute of Biosciences of Botucatu, UNESP - Univ. Estadual Paulista - Botucatu, São Paulo State, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Bárbara Campos Jorge</Name>
        <Affiliation>Department of Structural and Functional Biology, Institute of Biosciences of Botucatu, UNESP - Univ. Estadual Paulista - Botucatu, São Paulo State, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Ana Carolina Casali Reis</Name>
        <Affiliation>Department of Structural and Functional Biology, Institute of Biosciences of Botucatu, UNESP - Univ. Estadual Paulista - Botucatu, São Paulo State, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Joyce Alencar Santos Radai</Name>
        <Affiliation>School of Health Sciences, University Center of Grande Dourados, UNIGRAN, Dourados, Mato Grosso do Sul State, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Suyane da Silva Moreira</Name>
        <Affiliation>Department of Structural and Functional Biology, Institute of Biosciences of Botucatu, UNESP - Univ. Estadual Paulista - Botucatu, São Paulo State, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Thiago Leite Fraga</Name>
        <Affiliation>School of Health Sciences, University Center of Grande Dourados, UNIGRAN, Dourados, Mato Grosso do Sul State, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Jonas da Silva Mota</Name>
        <Affiliation>Mato Grosso do Sul State University, UEMS, Dourados, Mato Grosso do Sul State, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Rodrigo Juliano Oliveira</Name>
        <Affiliation>Federal University of Mato Grosso do Sul, UFMS, Campo Grande, Mato Grosso do Sul State, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Cândida Aparecida Leite Kassuya</Name>
        <Affiliation>School of Health Sciences, Federal University of Grande Dourados, UFGD, Dourados, Mato Grosso do Sul State, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Arielle Cristina Arena</Name>
        <Affiliation>Department of Structural and Functional Biology, Institute of Biosciences of Botucatu, UNESP - Univ. Estadual Paulista - Botucatu, São Paulo State, Brazil. Electronic address: arielle.arena@unesp.br.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Effects of glucokinase activator, DS-7309, on embryo-fetal developmental toxicity in rats and rabbits.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/35031383</pubmedLink>
    <Year>2022</Year>
    <DOI>S0273-2300(22)00006-X</DOI>
    <KeywordList>
      <Keywords>Developmental toxicity</Keywords>
      <Keywords>Embryo-fetal development</Keywords>
      <Keywords>Eye anomaly</Keywords>
      <Keywords>Glucokinase activator</Keywords>
      <Keywords>Hypoglycemia</Keywords>
      <Keywords>Rabbit</Keywords>
      <Keywords>Rat</Keywords>
      <Keywords>Skeleton anomaly</Keywords>
      <Keywords>Teratogenicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Chiharu Kuwata</Name>
        <Affiliation>Medicinal Safety Research Laboratories, Daiichi Sankyo Co., Ltd., 1-16-13 Kita-Kasai, Edogawa-ku, Tokyo, 134-8630, Japan. Electronic address: kuwata.chiharu.ah@daiichisankyo.co.jp.</Affiliation>
      </Author>
      <Author>
        <Name>Toshiki Matsuoka</Name>
        <Affiliation>Translational Science, Daiichi Sankyo Co., Ltd., 1-2-58 Hiromachi, Shinagawa-ku, Tokyo, 140-8710, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Yoshiko Ohshima</Name>
        <Affiliation>Medicinal Safety Research Laboratories, Daiichi Sankyo Co., Ltd., 1-16-13 Kita-Kasai, Edogawa-ku, Tokyo, 134-8630, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Satoko Yahagi</Name>
        <Affiliation>Medicinal Safety Research Laboratories, Daiichi Sankyo Co., Ltd., 1-16-13 Kita-Kasai, Edogawa-ku, Tokyo, 134-8630, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Toshiyuki Watanabe</Name>
        <Affiliation>R&amp;D &amp; PV Quality Assurance Department, Daiichi Sankyo Co., Ltd., 1-2-58 Hiromachi, Shinagawa-ku, Tokyo, 140-8710, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Yoshimi Tsuchiya</Name>
        <Affiliation>Medicinal Safety Research Laboratories, Daiichi Sankyo Co., Ltd., 1-16-13 Kita-Kasai, Edogawa-ku, Tokyo, 134-8630, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Kazuhiro Shimomura</Name>
        <Affiliation>Vaccine Research Laboratories, Daiichi Sankyo Co., Ltd., 1-16-13 Kita-Kasai, Edogawa-ku, Tokyo, 134-8630, Japan.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>De-risking in Tier I CNS safety assessments is the primary function of study design and technical training of laboratory staff observers.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/35017023</pubmedLink>
    <Year>2022</Year>
    <DOI>S0273-2300(22)00003-4</DOI>
    <KeywordList>
      <Keywords>Functional observational battery</Keywords>
      <Keywords>Neurotoxicology</Keywords>
      <Keywords>Nonclinical screening</Keywords>
      <Keywords>Safety assessment</Keywords>
      <Keywords>Tier I testing</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>David V. Gauvin</Name>
        <Affiliation>Neurobehavioral Sciences, Charles River Laboratories, Mattawan, 49071, MI, USA. Electronic address: david.gauvin@crl.com.</Affiliation>
      </Author>
      <Author>
        <Name>Zachary J. Zimmermann</Name>
        <Affiliation>Neurobehavioral Sciences, Charles River Laboratories, Mattawan, 49071, MI, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jill A. Dalton</Name>
        <Affiliation>Neurobehavioral Sciences, Charles River Laboratories, Mattawan, 49071, MI, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Sub-structure-based category formation for the prioritisation of genotoxicity hazard assessment for pesticide residues: Sulphonyl ureas.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/35017022</pubmedLink>
    <Year>2022</Year>
    <DOI>S0273-2300(22)00002-2</DOI>
    <KeywordList>
      <Keywords>Category formation</Keywords>
      <Keywords>Metabolism</Keywords>
      <Keywords>Mutagenicity</Keywords>
      <Keywords>Read-across</Keywords>
      <Keywords>Sulphonyl urea</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>S. J. Enoch</Name>
        <Affiliation>School of Pharmacy and Biomolecular Sciences, Liverpool John Moores University, Liverpool, England, UK. Electronic address: s.j.enoch@ljmu.ac.uk.</Affiliation>
      </Author>
      <Author>
        <Name>Z. Hasarova</Name>
        <Affiliation>School of Pharmacy and Biomolecular Sciences, Liverpool John Moores University, Liverpool, England, UK.</Affiliation>
      </Author>
      <Author>
        <Name>M. T. D. Cronin</Name>
        <Affiliation>School of Pharmacy and Biomolecular Sciences, Liverpool John Moores University, Liverpool, England, UK.</Affiliation>
      </Author>
      <Author>
        <Name>K. Bridgwood</Name>
        <Affiliation>Syngenta, Bracknell, England, UK.</Affiliation>
      </Author>
      <Author>
        <Name>S. Rao</Name>
        <Affiliation>Gowan Company, Yuma, AZ, USA.</Affiliation>
      </Author>
      <Author>
        <Name>F. M. Kluxen</Name>
        <Affiliation>ADAMA Deutschland GmbH, Cologne, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>M. Frericks</Name>
        <Affiliation>BASF, Limburgerhof, Germany.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>In silico predictions of absorption of MDI substances after dermal or inhalation exposures to support a category based read-across assessment.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/35017021</pubmedLink>
    <Year>2022</Year>
    <DOI>S0273-2300(22)00004-6</DOI>
    <KeywordList>
      <Keywords>Absorption</Keywords>
      <Keywords>Dermal</Keywords>
      <Keywords>In silico</Keywords>
      <Keywords>Inhalation</Keywords>
      <Keywords>Modeling</Keywords>
      <Keywords>Read-across</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Michael Bartels</Name>
        <Affiliation>ToxMetrics.com LLC, Midland, Michigan, USA. Electronic address: mjbartels@toxmetrics.com.</Affiliation>
      </Author>
      <Author>
        <Name>William van Osdol</Name>
        <Affiliation>Simulations Plus, Lancaster, CA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Maxime Le Merdy</Name>
        <Affiliation>Simulations Plus, Lancaster, CA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Anne Chappelle</Name>
        <Affiliation>International Isocyanate Institute, Mountain Lakes, NJ, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Adam Kuhl</Name>
        <Affiliation>Huntsman LLC, The Woodlands, Texas, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Robert West</Name>
        <Affiliation>International Isocyanate Institute, Mountain Lakes, NJ, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Acute and subacute oral toxicity of artemisinin-hydroxychloroquine sulfate tablets in rats.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/35007669</pubmedLink>
    <Year>2022</Year>
    <DOI>S0273-2300(22)00001-0</DOI>
    <KeywordList>
      <Keywords>Acute toxicity</Keywords>
      <Keywords>Artemisinin</Keywords>
      <Keywords>Evaluation</Keywords>
      <Keywords>Hydroxychloroquine sulfate</Keywords>
      <Keywords>Rats</Keywords>
      <Keywords>Safety</Keywords>
      <Keywords>Subacute toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Xiaobo Li</Name>
        <Affiliation>Artemisinin Research Center, Guangzhou University of Chinese Medicine, Guangzhou, 510405, China; Sci-tech Industrial Park, Guangzhou University of Chinese Medicine, Guangzhou, 510445, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xingcheng Liao</Name>
        <Affiliation>Artemisinin Research Center, Guangzhou University of Chinese Medicine, Guangzhou, 510405, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiufang Yan</Name>
        <Affiliation>Artemisinin Research Center, Guangzhou University of Chinese Medicine, Guangzhou, 510405, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yueming Yuan</Name>
        <Affiliation>Artemisinin Research Center, Guangzhou University of Chinese Medicine, Guangzhou, 510405, China; Sci-tech Industrial Park, Guangzhou University of Chinese Medicine, Guangzhou, 510445, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zheng Yuan</Name>
        <Affiliation>Sci-tech Industrial Park, Guangzhou University of Chinese Medicine, Guangzhou, 510445, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ruidong Liu</Name>
        <Affiliation>Sci-tech Industrial Park, Guangzhou University of Chinese Medicine, Guangzhou, 510445, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhiyong Xu</Name>
        <Affiliation>Sci-tech Industrial Park, Guangzhou University of Chinese Medicine, Guangzhou, 510445, China.</Affiliation>
      </Author>
      <Author>
        <Name>Qi Wang</Name>
        <Affiliation>Artemisinin Research Center, Guangzhou University of Chinese Medicine, Guangzhou, 510405, China; Sci-tech Industrial Park, Guangzhou University of Chinese Medicine, Guangzhou, 510445, China; Guangzhou Chest Hospital, Guangzhou, 510095, China.</Affiliation>
      </Author>
      <Author>
        <Name>Qin Xu</Name>
        <Affiliation>Artemisinin Research Center, Guangzhou University of Chinese Medicine, Guangzhou, 510405, China; The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, 510405, China.</Affiliation>
      </Author>
      <Author>
        <Name>Li Ru</Name>
        <Affiliation>Artemisinin Research Center, Guangzhou University of Chinese Medicine, Guangzhou, 510405, China; Sci-tech Industrial Park, Guangzhou University of Chinese Medicine, Guangzhou, 510445, China. Electronic address: ruli119105@163.com.</Affiliation>
      </Author>
      <Author>
        <Name>Jianping Song</Name>
        <Affiliation>Artemisinin Research Center, Guangzhou University of Chinese Medicine, Guangzhou, 510405, China; The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, 510405, China. Electronic address: songjp@gzucm.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A 10-step framework for use of read-across (RAX) in next generation risk assessment (NGRA) for cosmetics safety assessment.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34990780</pubmedLink>
    <Year>2022</Year>
    <DOI>S0273-2300(21)00235-X</DOI>
    <KeywordList>
      <Keywords>Caffeine</Keywords>
      <Keywords>Cosmetics safety assessment</Keywords>
      <Keywords>New approach methodology (NAM)</Keywords>
      <Keywords>Next generation read-across (RAX)</Keywords>
      <Keywords>Next generation risk assessment (NGRA)</Keywords>
      <Keywords>Parabens</Keywords>
      <Keywords>Physiologically-based biokinetic modelling (PBK)</Keywords>
      <Keywords>Systemic toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Camilla Alexander-White</Name>
        <Affiliation>MKTox &amp; Co Ltd, 36 Fairford Crescent, Downhead Park, Milton Keynes, Buckinghamshire, MK15 9AQ, UK. Electronic address: ckaw@mktoxconsult.com.</Affiliation>
      </Author>
      <Author>
        <Name>Dagmar Bury</Name>
        <Affiliation>L'Oreal Research &amp; Innovation, 9 Rue Pierre Dreyfus, 92110, Clichy, France.</Affiliation>
      </Author>
      <Author>
        <Name>Mark Cronin</Name>
        <Affiliation>School of Pharmacy and Biomolecular Sciences, Liverpool John Moores University, Byrom Street, Liverpool L3 AF, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Matthew Dent</Name>
        <Affiliation>Unilever, Safety &amp; Environmental Assurance Centre, Colworth House, Sharnbrook, Bedfordshire, MK44 1ET, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Eric Hack</Name>
        <Affiliation>ScitoVation, Research Triangle Park, Durham, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Nicola J. Hewitt</Name>
        <Affiliation>Cosmetics Europe, 40 Avenue Hermann-Debroux, 1160, Brussels, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Gerry Kenna</Name>
        <Affiliation>Cosmetics Europe, 40 Avenue Hermann-Debroux, 1160, Brussels, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Jorge Naciff</Name>
        <Affiliation>The Procter &amp; Gamble Company, Cincinnati, OH, 45040, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Gladys Ouedraogo</Name>
        <Affiliation>L'Oreal Research &amp; Innovation, 1 Avenue Eugène Schueller, Aulnay sous bois, France.</Affiliation>
      </Author>
      <Author>
        <Name>Andreas Schepky</Name>
        <Affiliation>Beiersdorf, Unnastrasse 48, 20253, Hamburg, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Catherine Mahony</Name>
        <Affiliation>Procter &amp; Gamble Technical Centres Ltd, Reading, RG2 0RX, UK. Electronic address: mahony.c@pg.com.</Affiliation>
      </Author>
      <Author>
        <Name>Cosmetics Europe</Name>
        <Affiliation>Cosmetics Europe, 40 Avenue Hermann-Debroux, 1160, Brussels, Belgium. Electronic address: cosmeticseurope@cosmeticseurope.eu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Ethylene oxide derived glycol ethers: A review of the alkyl glycol ethers potential to cause endocrine disruption.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34974128</pubmedLink>
    <Year>2022</Year>
    <DOI>S0273-2300(21)00254-3</DOI>
    <KeywordList>
      <Keywords>E series</Keywords>
      <Keywords>Endocrine disruption</Keywords>
      <Keywords>Endocrine disruptor</Keywords>
      <Keywords>Glycol ethers</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jeffrey R. Kelsey</Name>
        <Affiliation>Chemsage Ltd, PO Box 431, Fleet, Hampshire, GU51 9BP, UK. Electronic address: kelsey@chemsage.co.uk.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Enzymes and sensitization via skin exposure: A critical analysis.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34973388</pubmedLink>
    <Year>2022</Year>
    <DOI>S0273-2300(21)00253-1</DOI>
    <KeywordList>
      <Keywords>Cutaneous immune responses</Keywords>
      <Keywords>Enzymes</Keywords>
      <Keywords>Sensitization of the respiratory tract</Keywords>
      <Keywords>Skin sensitization</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>David A. Basketter</Name>
        <Affiliation>DABMEB Consultancy Ltd, Kingswood, Gloucestershire GL12 8RN, UK. Electronic address: dabmebconsultancyltd@me.com.</Affiliation>
      </Author>
      <Author>
        <Name>Ian Kimber</Name>
        <Affiliation>Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Clearly weighing the evidence in read-across can improve assessments of data-poor chemicals.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34973387</pubmedLink>
    <Year>2022</Year>
    <DOI>S0273-2300(21)00252-X</DOI>
    <KeywordList>
      <Keywords>Analogy</Keywords>
      <Keywords>DDD</Keywords>
      <Keywords>DDT</Keywords>
      <Keywords>Evidence integration</Keywords>
      <Keywords>Read-across</Keywords>
      <Keywords>Weight of evidence</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Glenn W. Suter</Name>
        <Affiliation>Office of Research and Development, Emeritus, U.S. Environmental Protection Agency, 26 W. Martin L. King Drive, Cincinnati, OH, 45268, USA. Electronic address: suterpro@earthlink.net.</Affiliation>
      </Author>
      <Author>
        <Name>Lucina E. Lizarraga</Name>
        <Affiliation>Center for Public Health and Environmental Assessment, U.S. Environmental Protection Agency, 26 W. Martin L. King Drive, Cincinnati, OH, 45268, USA. Electronic address: Lizarraga.Lucina@epa.gov.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Evaluation of the predictivity of Acute Oral Toxicity (AOT) structure-activity relationship models.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34968630</pubmedLink>
    <Year>2022</Year>
    <DOI>S0273-2300(21)00250-6</DOI>
    <KeywordList>
      <Keywords>(Q)SAR In silico</Keywords>
      <Keywords>3Rs</Keywords>
      <Keywords>Acute oral toxicity (AOT)</Keywords>
      <Keywords>CLP/GHS</Keywords>
      <Keywords>Classification and labelling</Keywords>
      <Keywords>Hazard assessment</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Kamila Gromek</Name>
        <Affiliation>GlaxoSmithKline, Gunnels Wood Road Stevenage Herts SG1 2NY, United Kingdom. Electronic address: kamila.x.gromek@gsk.com.</Affiliation>
      </Author>
      <Author>
        <Name>William Hawkins</Name>
        <Affiliation>GlaxoSmithKline, Gunnels Wood Road Stevenage Herts SG1 2NY, United Kingdom. Electronic address: william.a.hawkins@gsk.com.</Affiliation>
      </Author>
      <Author>
        <Name>Zoe Dunn</Name>
        <Affiliation>GlaxoSmithKline, Gunnels Wood Road Stevenage Herts SG1 2NY, United Kingdom. Electronic address: zoe.x.dunn@gsk.com.</Affiliation>
      </Author>
      <Author>
        <Name>Maciej Gawlik</Name>
        <Affiliation>Department of Medicinal Chemistry, Medical University of Lublin, Poland. Electronic address: maciejgawlik@umlub.pl.</Affiliation>
      </Author>
      <Author>
        <Name>Davide Ballabio</Name>
        <Affiliation>Chemometrics and QSAR Research Group, Department of Earth and Environmental Sciences, University of Milano-Bicocca, Italy. Electronic address: davide.ballabio@unimib.it.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Randomized, triple-blind, placebo-controlled study to evaluate the safety of 6'-Sialyllactose in healthy adults.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34958861</pubmedLink>
    <Year>2022</Year>
    <DOI>S0273-2300(21)00251-8</DOI>
    <KeywordList>
      <Keywords>6′-sialyllactose</Keywords>
      <Keywords>Adverse reactions</Keywords>
      <Keywords>Human</Keywords>
      <Keywords>Human milk oligosaccharide</Keywords>
      <Keywords>Safety</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Ji Hyun Kim</Name>
        <Affiliation>Department of Rehabilitation Medicine, Yonsei University Wonju College of Medicine, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Sang Yeol Yong</Name>
        <Affiliation>Department of Rehabilitation Medicine, Yonsei University Wonju College of Medicine, Republic of Korea; IOC Research Centre Korea, Republic of Korea. Electronic address: rehsyyong@yonsei.ac.kr.</Affiliation>
      </Author>
      <Author>
        <Name>Sung Hoon Kim</Name>
        <Affiliation>Department of Rehabilitation Medicine, Yonsei University Wonju College of Medicine, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Ahreum Baek</Name>
        <Affiliation>Department of Rehabilitation Medicine, Yonsei University Wonju College of Medicine, Republic of Korea; Department and Research Institute of Rehabilitation Medicine, Yonsei University College of Medicine, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Tae Hwa Go</Name>
        <Affiliation>Department of Biostatistics, Yonsei University Wonju College of Medicine, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Dae Ryong Kang</Name>
        <Affiliation>Department of Biostatistics, Yonsei University Wonju College of Medicine, Republic of Korea; Department of Precision Medicine, Yonsei University Wonju College of Medicine, Republic of Korea.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Use of alternative test methods in a tiered testing approach to address photoirritation potential of fragrance materials.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34953932</pubmedLink>
    <Year>2022</Year>
    <DOI>S0273-2300(21)00239-7</DOI>
    <KeywordList>
      <Keywords>Dermal toxicity</Keywords>
      <Keywords>Fragrance</Keywords>
      <Keywords>Photoirritation</Keywords>
      <Keywords>Photosafety</Keywords>
      <Keywords>Risk assessment</Keywords>
      <Keywords>Safety</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Gretchen Ritacco</Name>
        <Affiliation>Research Institute for Fragrance Materials, Inc., 50 Tice Blvd., Woodcliff Lake, NJ, 07660, USA. Electronic address: gritacco@rifm.org.</Affiliation>
      </Author>
      <Author>
        <Name>Allison Hilberer</Name>
        <Affiliation>Institute for In Vitro Sciences, Inc., 30 W. Watkins Mill Road, Suite 100, Gaithersburg, MD, 20878, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Maura Lavelle</Name>
        <Affiliation>Research Institute for Fragrance Materials, Inc., 50 Tice Blvd., Woodcliff Lake, NJ, 07660, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Anne Marie Api</Name>
        <Affiliation>Research Institute for Fragrance Materials, Inc., 50 Tice Blvd., Woodcliff Lake, NJ, 07660, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Physiologically based pharmacokinetic (PBPK) modeling of perfluorohexane sulfonate (PFHxS) in humans.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34933042</pubmedLink>
    <Year>2022</Year>
    <DOI>S0273-2300(21)00240-3</DOI>
    <KeywordList>
      <Keywords>National Health and Nutrition Examination Survey (NHANES)</Keywords>
      <Keywords>Perfluorohexane sulfonate (PFHxS)</Keywords>
      <Keywords>Physiologically based pharmacokinetic (PBPK) model</Keywords>
      <Keywords>per- and polyfluoroalkyl substances (PFAS)</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Lisa M. Sweeney</Name>
        <Affiliation>UES, Inc., Beavercreek, Ohio Contractor Assigned to the U.S. Air Force Research Laboratory 711th Human Performance Wing, Wright Patterson AFB, OH, USA. Electronic address: LMS29@case.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A proposed approach to confirm heroin administration - Regional differences in heroin purity is a major factor.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34902532</pubmedLink>
    <Year>2022</Year>
    <DOI>S0273-2300(21)00238-5</DOI>
    <KeywordList>
      <Keywords>Brown mixture</Keywords>
      <Keywords>Cough medicine</Keywords>
      <Keywords>Herbal medicine</Keywords>
      <Keywords>Liquid chromatography–mass spectrometry</Keywords>
      <Keywords>Poppy seed</Keywords>
      <Keywords>Street heroin</Keywords>
      <Keywords>Thebaine</Keywords>
      <Keywords>Urine</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Wei Ru Chen</Name>
        <Affiliation>Graduate Institute of Toxicology, College of Medicine, National Taiwan University, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Po Hsin Kong</Name>
        <Affiliation>Department and Graduate Institute of Forensic Medicine, College of Medicine, National Taiwan University, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Christoph Sauer</Name>
        <Affiliation>Department Forensic Toxicology &amp; Drug Analysis, SYNLAB, Weiden, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Huei Wen Chen</Name>
        <Affiliation>Graduate Institute of Toxicology, College of Medicine, National Taiwan University, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Hsiang Yu Chan</Name>
        <Affiliation>Graduate Institute of Toxicology, College of Medicine, National Taiwan University, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Da Peng Yang</Name>
        <Affiliation>Graduate Institute of Toxicology, College of Medicine, National Taiwan University, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Yung Cheng Jair</Name>
        <Affiliation>Graduate Institute of Toxicology, College of Medicine, National Taiwan University, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Hsin Tung Liu</Name>
        <Affiliation>Graduate Institute of Toxicology, College of Medicine, National Taiwan University, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Tsang Yaw Lin</Name>
        <Affiliation>Tsao-Tun Psychiatric Center, Ministry of Health and Welfare, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Muh Yong Yen</Name>
        <Affiliation>Department of Disease Control and Prevention, Taipei City Hospital, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Yung Feng Yen</Name>
        <Affiliation>Department of Disease Control and Prevention, Taipei City Hospital, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Sheng Huang Chang</Name>
        <Affiliation>Tsao-Tun Psychiatric Center, Ministry of Health and Welfare, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Lan Hui Li</Name>
        <Affiliation>Department of Disease Control and Prevention, Taipei City Hospital, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Claire George</Name>
        <Affiliation>Alere Toxicology Plc, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Ya Chi Chang</Name>
        <Affiliation>Graduate Institute of Toxicology, College of Medicine, National Taiwan University, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Yi Hsin Wu</Name>
        <Affiliation>Graduate Institute of Toxicology, College of Medicine, National Taiwan University, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Hsiao Lin Hwa</Name>
        <Affiliation>Department and Graduate Institute of Forensic Medicine, College of Medicine, National Taiwan University, Taiwan; Forensic and Clinical Toxicology Center, National Taiwan University, College of Medicine, National Taiwan University Hospital, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Chia Yang Chen</Name>
        <Affiliation>Institute of Environmental Health, National Taiwan University, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Jung Hsuan Chen</Name>
        <Affiliation>Graduate Institute of Toxicology, College of Medicine, National Taiwan University, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Andrew T. Kicman</Name>
        <Affiliation>Analytical and Environmental Sciences &amp; Institute of Pharmaceutical Science, King's College London, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Hans H. Maurer</Name>
        <Affiliation>Department of Experimental and Clinical Toxicology, Institute of Experimental and Clinical Pharmacology and Toxicology, Saarland University, Homburg, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Pai Shan Chen</Name>
        <Affiliation>Graduate Institute of Toxicology, College of Medicine, National Taiwan University, Taiwan. Electronic address: paishanchen@ntu.edu.tw.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Site-specific cancer risk following cobalt exposure via orthopedic implants or in occupational settings: A systematic review and meta-analysis.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34896478</pubmedLink>
    <Year>2022</Year>
    <DOI>S0273-2300(21)00237-3</DOI>
    <KeywordList>
      <Keywords>Cobalt</Keywords>
      <Keywords>Joint prosthesis</Keywords>
      <Keywords>Meta-analysis</Keywords>
      <Keywords>Neoplasms</Keywords>
      <Keywords>Occupational exposure</Keywords>
      <Keywords>Risk</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Chantal E. Holy</Name>
        <Affiliation>Johnson &amp; Johnson, 410 George St, New Brunswick, NJ, 08901, United States. Electronic address: choly1@its.jnj.com.</Affiliation>
      </Author>
      <Author>
        <Name>Shumin Zhang</Name>
        <Affiliation>Johnson &amp; Johnson, 410 George St, New Brunswick, NJ, 08901, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Laura E. Perkins</Name>
        <Affiliation>Abbott Vascular, 3200 Lakeside Dr, Santa Clara, CA, 95054, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Philippe Hasgall</Name>
        <Affiliation>Zimmer Biomet, Sulzerallee 8, CH-8404, Winterthur, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Laurence B. Katz</Name>
        <Affiliation>LifeScan Global Corporation, 20 Valley Stream Parkway, Malvern, PA, 19355, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Jason R. Brown</Name>
        <Affiliation>Medtronic PLC, 8200 Coral Sea St NE, Minneapolis, MN, 55112, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Luca Orlandini</Name>
        <Affiliation>Smith and Nephew, Oberneuhofstasse 10D, 6340, Baar, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Gion Fessel</Name>
        <Affiliation>Smith and Nephew, Oberneuhofstasse 10D, 6340, Baar, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Behrooz Nasseri-Aghbosh</Name>
        <Affiliation>Stryker, Elstree, Borehamwood, WD6 3SG, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Gary Eichenbaum</Name>
        <Affiliation>Johnson &amp; Johnson, 410 George St, New Brunswick, NJ, 08901, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Natalie S. Egnot</Name>
        <Affiliation>Cardno ChemRisk, 20 Stanwix St, Pittsburgh, PA, 15222, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Stephen Marcello</Name>
        <Affiliation>Ethicon, A J&amp;J Company, Cincinnati, OH, 45242, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Paul M. Coplan</Name>
        <Affiliation>Johnson &amp; Johnson, 410 George St, New Brunswick, NJ, 08901, United States; University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, 19104, United States.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>PDE concept for controlling cleaning agent residues in pharmaceuticals- A critical analysis.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34890761</pubmedLink>
    <Year>2022</Year>
    <DOI>S0273-2300(21)00236-1</DOI>
    <KeywordList>
      <Keywords>Builders</Keywords>
      <Keywords>Cleaning agents (CAs)</Keywords>
      <Keywords>Cross-contamination</Keywords>
      <Keywords>Mode of action reasoning</Keywords>
      <Keywords>Oxidizers</Keywords>
      <Keywords>Permitted daily exposure (PDE)</Keywords>
      <Keywords>Read-across</Keywords>
      <Keywords>Residues</Keywords>
      <Keywords>Surfactants</Keywords>
      <Keywords>pH modifiers</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>S. Araya</Name>
        <Affiliation>Lonza, Switzerland. Electronic address: selene.araya@lonza.com.</Affiliation>
      </Author>
      <Author>
        <Name>T. Pfister</Name>
        <Affiliation>F. Hoffmann-La Roche, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>K. Gromek</Name>
        <Affiliation>GlaxoSmithKline, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>W. Hawkins</Name>
        <Affiliation>SafeBridge Europe Ltd., United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>S. T. Thomsen</Name>
        <Affiliation>Novo Nordisk, Denmark.</Affiliation>
      </Author>
      <Author>
        <Name>N. Clemann</Name>
        <Affiliation>F. Hoffmann-La Roche, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>S. Faltermann</Name>
        <Affiliation>F. Hoffmann-La Roche, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>L. Wiesner</Name>
        <Affiliation>Lonza, Switzerland.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Safe- and sustainable-by-design: The case of Smart Nanomaterials. A perspective based on a European workshop.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34864125</pubmedLink>
    <Year>2022</Year>
    <DOI>S0273-2300(21)00234-8</DOI>
    <KeywordList>
      <Keywords>European Union policy</Keywords>
      <Keywords>Regulatory requirements</Keywords>
      <Keywords>Safe- and Sustainable-by-Design</Keywords>
      <Keywords>Safe-by-Design</Keywords>
      <Keywords>Smart nanomaterial</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Agnieszka Mech</Name>
        <Affiliation>European Commission, Joint Research Centre (JRC), Ispra, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Stefania Gottardo</Name>
        <Affiliation>European Commission, Joint Research Centre (JRC), Ispra, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Valeria Amenta</Name>
        <Affiliation>European Commission, Joint Research Centre (JRC), Ispra, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Alessia Amodio</Name>
        <Affiliation>European Commission, Directorate-General Research and Innovation (DG RTD), Brussels, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Susanne Belz</Name>
        <Affiliation>European Commission, Joint Research Centre (JRC), Ispra, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Søren Bøwadt</Name>
        <Affiliation>European Commission, Directorate-General Research and Innovation (DG RTD), Brussels, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Jana Drbohlavová</Name>
        <Affiliation>European Commission, Directorate-General Research and Innovation (DG RTD), Brussels, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Lucian Farcal</Name>
        <Affiliation>European Commission, Joint Research Centre (JRC), Ispra, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Paula Jantunen</Name>
        <Affiliation>European Commission, Joint Research Centre (JRC), Ispra, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Aleksandra Małyska</Name>
        <Affiliation>European Commission, Directorate-General Research and Innovation (DG RTD), Brussels, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Kirsten Rasmussen</Name>
        <Affiliation>European Commission, Joint Research Centre (JRC), Ispra, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Juan Riego Sintes</Name>
        <Affiliation>European Commission, Joint Research Centre (JRC), Ispra, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Hubert Rauscher</Name>
        <Affiliation>European Commission, Joint Research Centre (JRC), Ispra, Italy. Electronic address: hubert.rauscher@ec.europa.eu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The Botanical Safety Consortium: A public-private partnership to enhance the botanical safety toolkit.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34863907</pubmedLink>
    <Year>2022</Year>
    <DOI>S0273-2300(21)00231-2</DOI>
    <KeywordList>
      <Keywords>Botanicals</Keywords>
      <Keywords>Dietary supplements</Keywords>
      <Keywords>Mixtures</Keywords>
      <Keywords>New approach methodologies</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Constance A. Mitchell</Name>
        <Affiliation>Health and Environmental Sciences Institute, Washington, DC, USA. Electronic address: cmitchell@hesiglobal.org.</Affiliation>
      </Author>
      <Author>
        <Name>Joseph T. Dever</Name>
        <Affiliation>NSF International, Ann Arbor, MI, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Stefan Gafner</Name>
        <Affiliation>American Botanical Council, Austin, TX, USA.</Affiliation>
      </Author>
      <Author>
        <Name>James C. Griffiths</Name>
        <Affiliation>Council for Responsible Nutrition, Washington, DC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Daniel S. Marsman</Name>
        <Affiliation>Procter &amp; Gamble Health Care, Cincinnati, OH, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Cynthia Rider</Name>
        <Affiliation>Division of the National Toxicology Program, National Institute of Environmental Health Sciences, Research Triangle Park, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Cara Welch</Name>
        <Affiliation>US Food and Drug Administration, Silver Spring, MD, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Michelle R. Embry</Name>
        <Affiliation>Health and Environmental Sciences Institute, Washington, DC, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Integrating toxicokinetics into toxicology studies and the human health risk assessment process for chemicals: Reduced uncertainty, better health protection.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34863906</pubmedLink>
    <Year>2022</Year>
    <DOI>S0273-2300(21)00233-6</DOI>
    <KeywordList>
      <Keywords>Regulatory toxicology</Keywords>
      <Keywords>Risk assessment</Keywords>
      <Keywords>Toxicokinetics</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Terry Claire</Name>
        <Affiliation>Corteva Agriscience, 9330 Zionsville Road, Indianapolis, IN, 46032, United States. Electronic address: claire.terry@corteva.com.</Affiliation>
      </Author>
      <Author>
        <Name>Hays Sean</Name>
        <Affiliation>Corteva Agriscience, 9330 Zionsville Road, Indianapolis, IN, 46032, United States.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Safety assessment of phytase transgenic maize 11TPY050 in Sprague-Dawley rats by 90-day feeding study.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34863905</pubmedLink>
    <Year>2022</Year>
    <DOI>S0273-2300(21)00232-4</DOI>
    <KeywordList>
      <Keywords>90-Day feeding study</Keywords>
      <Keywords>Phytase transgenic maize</Keywords>
      <Keywords>Rats</Keywords>
      <Keywords>Safety assessment</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Nana Sun</Name>
        <Affiliation>NHC Key Laboratory of Food Safety Assessment, Chinese Academy of Medical Science Research Unit (2019RU014), China National Center for Food Safety Risk Assessment, Beijing 100021, China.</Affiliation>
      </Author>
      <Author>
        <Name>Chunlai Liang</Name>
        <Affiliation>NHC Key Laboratory of Food Safety Assessment, Chinese Academy of Medical Science Research Unit (2019RU014), China National Center for Food Safety Risk Assessment, Beijing 100021, China.</Affiliation>
      </Author>
      <Author>
        <Name>Qiannan Zhang</Name>
        <Affiliation>NHC Key Laboratory of Food Safety Assessment, Chinese Academy of Medical Science Research Unit (2019RU014), China National Center for Food Safety Risk Assessment, Beijing 100021, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xue Geng</Name>
        <Affiliation>NHC Key Laboratory of Food Safety Assessment, Chinese Academy of Medical Science Research Unit (2019RU014), China National Center for Food Safety Risk Assessment, Beijing 100021, China.</Affiliation>
      </Author>
      <Author>
        <Name>Haibo Liu</Name>
        <Affiliation>NHC Key Laboratory of Food Safety Assessment, Chinese Academy of Medical Science Research Unit (2019RU014), China National Center for Food Safety Risk Assessment, Beijing 100021, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yongquan Feng</Name>
        <Affiliation>NHC Key Laboratory of Food Safety Assessment, Chinese Academy of Medical Science Research Unit (2019RU014), China National Center for Food Safety Risk Assessment, Beijing 100021, China.</Affiliation>
      </Author>
      <Author>
        <Name>Hui Yang</Name>
        <Affiliation>NHC Key Laboratory of Food Safety Assessment, Chinese Academy of Medical Science Research Unit (2019RU014), China National Center for Food Safety Risk Assessment, Beijing 100021, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhou Yu</Name>
        <Affiliation>NHC Key Laboratory of Food Safety Assessment, Chinese Academy of Medical Science Research Unit (2019RU014), China National Center for Food Safety Risk Assessment, Beijing 100021, China. Electronic address: yuzhou@cfsa.net.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Xudong Jia</Name>
        <Affiliation>NHC Key Laboratory of Food Safety Assessment, Chinese Academy of Medical Science Research Unit (2019RU014), China National Center for Food Safety Risk Assessment, Beijing 100021, China. Electronic address: jiaxudong@cfsa.net.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>RespiraTox - Development of a QSAR model to predict human respiratory irritants.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34861320</pubmedLink>
    <GrantList>
      <Grant>MR/S003991/1</Grant>
    </GrantList>
    <Year>2022</Year>
    <DOI>S0273-2300(21)00230-0</DOI>
    <KeywordList>
      <Keywords>Human respiratory irritation</Keywords>
      <Keywords>In silico</Keywords>
      <Keywords>Machine learning</Keywords>
      <Keywords>QSAR</Keywords>
      <Keywords>Read-across</Keywords>
      <Keywords>Web application</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Matthias M. Wehr</Name>
        <Affiliation>Fraunhofer Institute for Toxicology and Experimental Medicine - ITEM, Hannover, Germany. Electronic address: matthias.wehr@item.fraunhofer.de.</Affiliation>
      </Author>
      <Author>
        <Name>Satinder S. Sarang</Name>
        <Affiliation>Shell International, Shell Health, Houston, TX, USA. Electronic address: Satinder.Sarang@Shell.Com.</Affiliation>
      </Author>
      <Author>
        <Name>Martijn Rooseboom</Name>
        <Affiliation>Shell International, Shell Health, The Hague, Netherlands. Electronic address: Martijn.Rooseboom@shell.com.</Affiliation>
      </Author>
      <Author>
        <Name>Peter J. Boogaard</Name>
        <Affiliation>Shell International, Shell Health, The Hague, Netherlands; Wageningen University &amp; Research, Wageningen, Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Andreas Karwath</Name>
        <Affiliation>University of Birmingham, Birmingham, United Kingdom. Electronic address: A.Karwath@bham.ac.uk.</Affiliation>
      </Author>
      <Author>
        <Name>Sylvia E. Escher</Name>
        <Affiliation>Fraunhofer Institute for Toxicology and Experimental Medicine - ITEM, Hannover, Germany. Electronic address: sylvia.escher@item.fraunhofer.de.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Assessment of black cumin (Nigella sativa L.) as a food ingredient and putative therapeutic agent.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34838871</pubmedLink>
    <Year>2022</Year>
    <DOI>S0273-2300(21)00229-4</DOI>
    <AuthorList>
      <Author>
        <Name>George A. Burdock</Name>
        <Affiliation>Burdock Group, 859 Outer Road, Orlando, FL, 3814, USA. Electronic address: gburdock@burdockgroup.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Liver biomarkers in adults: Evaluation of associations with reported green tea consumption and use of green tea supplements in U.S. NHANES.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34826597</pubmedLink>
    <Year>2022</Year>
    <DOI>S0273-2300(21)00228-2</DOI>
    <KeywordList>
      <Keywords>Green tea</Keywords>
      <Keywords>Green tea extracts</Keywords>
      <Keywords>Hepatic function</Keywords>
      <Keywords>Liver toxicity</Keywords>
      <Keywords>National Health and Nutrition Examination Survey</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Shafagh Fallah</Name>
        <Affiliation>Intertek Health Sciences Inc., Mississauga, Ontario, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Kathy Musa-Veloso</Name>
        <Affiliation>Intertek Health Sciences Inc., Mississauga, Ontario, Canada. Electronic address: kathy.musa-veloso@intertek.com.</Affiliation>
      </Author>
      <Author>
        <Name>Joyce Cao</Name>
        <Affiliation>Herbalife Nutrition, Torrance, CA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Carolina Venditti</Name>
        <Affiliation>Intertek Health Sciences Inc., Mississauga, Ontario, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Han Youl Lee</Name>
        <Affiliation>Intertek Health Sciences Inc., Mississauga, Ontario, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Samer Hamamji</Name>
        <Affiliation>Intertek Health Sciences Inc., Mississauga, Ontario, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Jiang Hu</Name>
        <Affiliation>Herbalife Nutrition, Torrance, CA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Kristy Appelhans</Name>
        <Affiliation>Herbalife Nutrition, Torrance, CA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Vasilios Frankos</Name>
        <Affiliation>Herbalife Nutrition, Torrance, CA, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Fluoride concentrations in drinking water and health risk assessment in the south of Algeria.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34822942</pubmedLink>
    <Year>2022</Year>
    <DOI>S0273-2300(21)00227-0</DOI>
    <KeywordList>
      <Keywords>Africa</Keywords>
      <Keywords>Dental fluorosis</Keywords>
      <Keywords>Drinking water</Keywords>
      <Keywords>Fluoride</Keywords>
      <Keywords>Northern</Keywords>
      <Keywords>Risk assessment</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Mohamed Amine Kerdoun</Name>
        <Affiliation>Department of Medicine, Faculty of Medical Sciences, Kasdi Merbah University, Ouargla, 30000, Algeria; Mohamed Boudiaf Public Hospital, Ouargla, 30000, Algeria; Ouargla Technical Platform of the Center for Scientific and Technical Research in Physico-Chemical Analysis (PT-CRAPC), 30000, Ouargla, Algeria. Electronic address: aminekerdoun@hotmail.fr.</Affiliation>
      </Author>
      <Author>
        <Name>Sabah Mekhloufi</Name>
        <Affiliation>Annex of the National Toxicology Center, Ouargla, 30000, Algeria.</Affiliation>
      </Author>
      <Author>
        <Name>Oum El Kheir Adjaine</Name>
        <Affiliation>Annex of the National Toxicology Center, Ouargla, 30000, Algeria.</Affiliation>
      </Author>
      <Author>
        <Name>Zineb Bechki</Name>
        <Affiliation>Annex of the National Toxicology Center, Ouargla, 30000, Algeria.</Affiliation>
      </Author>
      <Author>
        <Name>Mohamed Gana</Name>
        <Affiliation>Laboratory for Development and Valorization of Plant Genetic Resources, Department of Biology and Plant Ecology, S.N.V Faculty, University of the Brothers Mentouri Constantine 1, Algeria.</Affiliation>
      </Author>
      <Author>
        <Name>Hakim Belkhalfa</Name>
        <Affiliation>Ouargla Technical Platform of the Center for Scientific and Technical Research in Physico-Chemical Analysis (PT-CRAPC), 30000, Ouargla, Algeria.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Six-well plate-based colony-forming efficacy assay and Co-Culture application to assess toxicity of metal oxide nanoparticles.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34800565</pubmedLink>
    <Year>2022</Year>
    <DOI>S0273-2300(21)00226-9</DOI>
    <KeywordList>
      <Keywords>CFE assay</Keywords>
      <Keywords>Cytotoxicity</Keywords>
      <Keywords>Interference</Keywords>
      <Keywords>Nanomaterial</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Seong Han Lee</Name>
        <Affiliation>Lab of Toxicology, Department of Health Sciences, The Graduate School of Dong-A University, 37, Nakdong-daero 550 Beon-gil, Saha-gu, Busan, 49315, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Hansol Won</Name>
        <Affiliation>Division of Toxicological Research, National Institute of Food and Drug Safety Evaluation, Ministry of Food and Drug Safety, Osong, Cheongju, 28159, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Sung Hyun Kim</Name>
        <Affiliation>Division of Toxicological Research, National Institute of Food and Drug Safety Evaluation, Ministry of Food and Drug Safety, Osong, Cheongju, 28159, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Soyeon Jeon</Name>
        <Affiliation>Lab of Toxicology, Department of Health Sciences, The Graduate School of Dong-A University, 37, Nakdong-daero 550 Beon-gil, Saha-gu, Busan, 49315, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Jiyoung Jeong</Name>
        <Affiliation>Lab of Toxicology, Department of Health Sciences, The Graduate School of Dong-A University, 37, Nakdong-daero 550 Beon-gil, Saha-gu, Busan, 49315, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Dong Keun Lee</Name>
        <Affiliation>Lab of Toxicology, Department of Health Sciences, The Graduate School of Dong-A University, 37, Nakdong-daero 550 Beon-gil, Saha-gu, Busan, 49315, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Jun Young Yang</Name>
        <Affiliation>Division of Toxicological Research, National Institute of Food and Drug Safety Evaluation, Ministry of Food and Drug Safety, Osong, Cheongju, 28159, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Ji Hyeun Seok</Name>
        <Affiliation>Division of Toxicological Research, National Institute of Food and Drug Safety Evaluation, Ministry of Food and Drug Safety, Osong, Cheongju, 28159, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Kikyung Jung</Name>
        <Affiliation>Division of Toxicological Research, National Institute of Food and Drug Safety Evaluation, Ministry of Food and Drug Safety, Osong, Cheongju, 28159, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Jae Ho Oh</Name>
        <Affiliation>Division of Toxicological Research, National Institute of Food and Drug Safety Evaluation, Ministry of Food and Drug Safety, Osong, Cheongju, 28159, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Jin Hee Lee</Name>
        <Affiliation>Division of Toxicological Research, National Institute of Food and Drug Safety Evaluation, Ministry of Food and Drug Safety, Osong, Cheongju, 28159, Republic of Korea. Electronic address: tod98@korea.kr.</Affiliation>
      </Author>
      <Author>
        <Name>Wan Seob Cho</Name>
        <Affiliation>Lab of Toxicology, Department of Health Sciences, The Graduate School of Dong-A University, 37, Nakdong-daero 550 Beon-gil, Saha-gu, Busan, 49315, Republic of Korea. Electronic address: wcho@dau.ac.kr.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Threshold of Toxicological Concern: Extending the chemical space by inclusion of a highly curated dataset for organosilicon compounds.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34757112</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(21)00215-4</DOI>
    <KeywordList>
      <Keywords>Organosilicon</Keywords>
      <Keywords>Silane</Keywords>
      <Keywords>Siloxane</Keywords>
      <Keywords>TTC</Keywords>
      <Keywords>Threshold of toxicological concern</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Barbara G. Schmitt</Name>
        <Affiliation>Evonik Operations GmbH, Goldschmidtstr. 100, D-45127 Essen, Germany. Electronic address: barbara1.schmitt@evonik.com.</Affiliation>
      </Author>
      <Author>
        <Name>Elke Jensen</Name>
        <Affiliation>The Dow Chemical Company, 1803 Building, Midland, MI, 48674, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Michael C. Laufersweiler</Name>
        <Affiliation>The Procter &amp; Gamble Company, Mason Business Center | 8700 Mason Montgomery Rd. | Mason, Ohio, 45040, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jane L. Rose</Name>
        <Affiliation>The Procter &amp; Gamble Company, Mason Business Center | 8700 Mason Montgomery Rd. | Mason, Ohio, 45040, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Conceptual model for the evaluation of attractiveness, addictiveness and toxicity of tobacco and related products: The example of JUUL e-cigarettes.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34748878</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(21)00218-X</DOI>
    <KeywordList>
      <Keywords>Addictiveness</Keywords>
      <Keywords>Attractiveness</Keywords>
      <Keywords>Health effect evaluation</Keywords>
      <Keywords>Tobacco and related products</Keywords>
      <Keywords>Toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Yvonne Staal</Name>
        <Affiliation>Centre for Health Protection, National Institute for Public Health and the Environment (RIVM), Antonie van Leeuwenhoeklaan 9, 3721, MA, Bilthoven, the Netherlands. Electronic address: Yvonne.staal@rivm.nl.</Affiliation>
      </Author>
      <Author>
        <Name>Anne Havermans</Name>
        <Affiliation>Centre for Health Protection, National Institute for Public Health and the Environment (RIVM), Antonie van Leeuwenhoeklaan 9, 3721, MA, Bilthoven, the Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Lotte van Nierop</Name>
        <Affiliation>Centre for Health Protection, National Institute for Public Health and the Environment (RIVM), Antonie van Leeuwenhoeklaan 9, 3721, MA, Bilthoven, the Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Wouter Visser</Name>
        <Affiliation>Centre for Health Protection, National Institute for Public Health and the Environment (RIVM), Antonie van Leeuwenhoeklaan 9, 3721, MA, Bilthoven, the Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Susan Wijnhoven</Name>
        <Affiliation>Centre for Safety of Substances and Products, National Institute for Public Health and the Environment (RIVM), Antonie van Leeuwenhoeklaan 9, 3721, MA, Bilthoven, the Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Wieneke Bil</Name>
        <Affiliation>Centre for Safety of Substances and Products, National Institute for Public Health and the Environment (RIVM), Antonie van Leeuwenhoeklaan 9, 3721, MA, Bilthoven, the Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Reinskje Talhout</Name>
        <Affiliation>Centre for Health Protection, National Institute for Public Health and the Environment (RIVM), Antonie van Leeuwenhoeklaan 9, 3721, MA, Bilthoven, the Netherlands.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Incorporating human exposure information in a weight of evidence approach to inform design of repeated dose animal studies.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34743952</pubmedLink>
    <GrantList>
      <Grant>EPA999999</Grant>
    </GrantList>
    <Year>2021</Year>
    <DOI>S0273-2300(21)00214-2</DOI>
    <KeywordList>
      <Keywords>Exposure</Keywords>
      <Keywords>Study design</Keywords>
      <Keywords>Toxicokinetics</Keywords>
      <Keywords>Weight of evidence</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Kelly Lowe</Name>
        <Affiliation>U.S. Environmental Protection Agency, Office of Pesticide Programs, Washington, DC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jeffrey Dawson</Name>
        <Affiliation>U.S. Environmental Protection Agency, Office of Chemical Safety and Pollution Prevention, Washington, DC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Katherine Phillips</Name>
        <Affiliation>U.S. Environmental Protection Agency, Office of Research &amp; Development, Durham, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jeffrey Minucci</Name>
        <Affiliation>U.S. Environmental Protection Agency, Office of Research &amp; Development, Durham, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>John F. Wambaugh</Name>
        <Affiliation>U.S. Environmental Protection Agency, Office of Research &amp; Development, Durham, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Hua Qian</Name>
        <Affiliation>ExxonMobil Biomedical Sciences, Inc., Annandale, NJ, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Tharacad Ramanarayanan</Name>
        <Affiliation>Syngenta Ltd., Greensboro, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Peter Egeghy</Name>
        <Affiliation>U.S. Environmental Protection Agency, Office of Research &amp; Development, Durham, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Brandall Ingle</Name>
        <Affiliation>U.S. Environmental Protection Agency, Office of Pesticide Program, Durham, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Rachel Brunner</Name>
        <Affiliation>U.S. Environmental Protection Agency, Office of Pesticide Program, Durham, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Elizabeth Mendez</Name>
        <Affiliation>U.S. Environmental Protection Agency, Office of Pesticide Programs, Washington, DC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Michelle Embry</Name>
        <Affiliation>Health and Environmental Sciences Institute, Washington, DC, USA. Electronic address: membry@hesiglobal.org.</Affiliation>
      </Author>
      <Author>
        <Name>Yu Mei Tan</Name>
        <Affiliation>U.S. Environmental Protection Agency, Office of Pesticide Program, Durham, NC, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Iron oxide nanoparticles exert inhibitory effects on N-Bis(2-hydroxypropyl)nitrosamine (DHPN)-induced lung tumorigenesis in rats.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34742869</pubmedLink>
    <Year>2022</Year>
    <DOI>S0273-2300(21)00213-0</DOI>
    <KeywordList>
      <Keywords>DHPN</Keywords>
      <Keywords>Fischer 344 rat</Keywords>
      <Keywords>Iron oxide nanoparticles</Keywords>
      <Keywords>Lung tumorigenesis</Keywords>
      <Keywords>Magnetite</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Yukie Tada</Name>
        <Affiliation>Department of Pharmaceutical and Environmental Sciences, Tokyo Metropolitan Institute of Public Health, 3-24-1 Hyakunincho, Shin'juku, Tokyo, 169-0073, Japan. Electronic address: Yukie_Tada@member.metro.tokyo.jp.</Affiliation>
      </Author>
      <Author>
        <Name>Motoki Hojo</Name>
        <Affiliation>Department of Pharmaceutical and Environmental Sciences, Tokyo Metropolitan Institute of Public Health, 3-24-1 Hyakunincho, Shin'juku, Tokyo, 169-0073, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Katsuhiro Yuzawa</Name>
        <Affiliation>Department of Pharmaceutical and Environmental Sciences, Tokyo Metropolitan Institute of Public Health, 3-24-1 Hyakunincho, Shin'juku, Tokyo, 169-0073, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Akemichi Nagasawa</Name>
        <Affiliation>Department of Pharmaceutical and Environmental Sciences, Tokyo Metropolitan Institute of Public Health, 3-24-1 Hyakunincho, Shin'juku, Tokyo, 169-0073, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Jin Suzuki</Name>
        <Affiliation>Department of Pharmaceutical and Environmental Sciences, Tokyo Metropolitan Institute of Public Health, 3-24-1 Hyakunincho, Shin'juku, Tokyo, 169-0073, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Akiko Inomata</Name>
        <Affiliation>Department of Pharmaceutical and Environmental Sciences, Tokyo Metropolitan Institute of Public Health, 3-24-1 Hyakunincho, Shin'juku, Tokyo, 169-0073, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Takako Moriyasu</Name>
        <Affiliation>Department of Pharmaceutical and Environmental Sciences, Tokyo Metropolitan Institute of Public Health, 3-24-1 Hyakunincho, Shin'juku, Tokyo, 169-0073, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Dai Nakae</Name>
        <Affiliation>Department of Nutritional Science and Food Safety, Faculty of Applied Bioscience, Tokyo University of Agriculture, 1-1-1 Sakura-ga-Oka, Setagaya, Tokyo, 156-8502, Japan. Electronic address: dn201223@nodai.ac.jp.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A 90-day subchronic toxicity study of Myrrh in F344 rats.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34742868</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(21)00217-8</DOI>
    <KeywordList>
      <Keywords>F344 rats</Keywords>
      <Keywords>Flavoring agent</Keywords>
      <Keywords>Food additive</Keywords>
      <Keywords>Myrrh</Keywords>
      <Keywords>Subchronic toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Tatsuya Mitsumoto</Name>
        <Affiliation>Division of Pathology, National Institute of Health Sciences, 3-25-26 Tonomachi, Kawasaki-ku, Kawasaki-shi, Kanagawa, 210-9501, Japan; Faculty of Animal Health Technology, Yamazaki University of Animal Health Technology, 4-7-2, Minami-osawa, Hachihoji, Tokyo, 192-0364, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Yuji Ishii</Name>
        <Affiliation>Division of Pathology, National Institute of Health Sciences, 3-25-26 Tonomachi, Kawasaki-ku, Kawasaki-shi, Kanagawa, 210-9501, Japan. Electronic address: y-ishii@nihs.go.jp.</Affiliation>
      </Author>
      <Author>
        <Name>Moeka Namiki</Name>
        <Affiliation>Division of Pathology, National Institute of Health Sciences, 3-25-26 Tonomachi, Kawasaki-ku, Kawasaki-shi, Kanagawa, 210-9501, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Kenji Nakamura</Name>
        <Affiliation>Division of Pathology, National Institute of Health Sciences, 3-25-26 Tonomachi, Kawasaki-ku, Kawasaki-shi, Kanagawa, 210-9501, Japan; Laboratory of Veterinary Pathology, Tokyo University of Agriculture and Technology, 3-5-8 Saiwai-cho, Fuchu-shi, Tokyo, 183-8509, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Shinji Takasu</Name>
        <Affiliation>Division of Pathology, National Institute of Health Sciences, 3-25-26 Tonomachi, Kawasaki-ku, Kawasaki-shi, Kanagawa, 210-9501, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Kumiko Ogawa</Name>
        <Affiliation>Division of Pathology, National Institute of Health Sciences, 3-25-26 Tonomachi, Kawasaki-ku, Kawasaki-shi, Kanagawa, 210-9501, Japan.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Employing an adverse outcome pathway framework for weight-of-evidence assessment with application to the ICH S1B guidance addendum.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34737134</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(21)00212-9</DOI>
    <KeywordList>
      <Keywords>AOP</Keywords>
      <Keywords>IATA</Keywords>
      <Keywords>ICHS1</Keywords>
      <Keywords>WoE</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Susanne A. Stalford</Name>
        <Affiliation>Lhasa Limited, Granary Wharf House, 2 Canal Wharf, Leeds, LS11 5PS, United Kingdom. Electronic address: Susanne.stalford@lhasalimited.org.</Affiliation>
      </Author>
      <Author>
        <Name>Alex N. Cayley</Name>
        <Affiliation>Lhasa Limited, Granary Wharf House, 2 Canal Wharf, Leeds, LS11 5PS, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Antonio Anax F. de Oliveira</Name>
        <Affiliation>Lhasa Limited, Granary Wharf House, 2 Canal Wharf, Leeds, LS11 5PS, United Kingdom.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A hypothetical skin sensitisation next generation risk assessment for coumarin in cosmetic products.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34728330</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(21)00216-6</DOI>
    <KeywordList>
      <Keywords>Allergic contact dermatitis</Keywords>
      <Keywords>Consumer exposure</Keywords>
      <Keywords>Decision making</Keywords>
      <Keywords>Metabolism</Keywords>
      <Keywords>New approach methodologies</Keywords>
      <Keywords>Next generation risk assessment</Keywords>
      <Keywords>Non-animal alternatives</Keywords>
      <Keywords>Skin sensitisation</Keywords>
      <Keywords>Uncertainty analysis</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>G. Reynolds</Name>
        <Affiliation>Unilever Safety and Environmental Assurance Centre, Colworth Science Park, Sharnbrook, Bedfordshire, MK44 1LQ, UK. Electronic address: georgia.reynolds@unilever.com.</Affiliation>
      </Author>
      <Author>
        <Name>J. Reynolds</Name>
        <Affiliation>Unilever Safety and Environmental Assurance Centre, Colworth Science Park, Sharnbrook, Bedfordshire, MK44 1LQ, UK.</Affiliation>
      </Author>
      <Author>
        <Name>N. Gilmour</Name>
        <Affiliation>Unilever Safety and Environmental Assurance Centre, Colworth Science Park, Sharnbrook, Bedfordshire, MK44 1LQ, UK.</Affiliation>
      </Author>
      <Author>
        <Name>R. Cubberley</Name>
        <Affiliation>Unilever Safety and Environmental Assurance Centre, Colworth Science Park, Sharnbrook, Bedfordshire, MK44 1LQ, UK.</Affiliation>
      </Author>
      <Author>
        <Name>S. Spriggs</Name>
        <Affiliation>Unilever Safety and Environmental Assurance Centre, Colworth Science Park, Sharnbrook, Bedfordshire, MK44 1LQ, UK.</Affiliation>
      </Author>
      <Author>
        <Name>A. Aptula</Name>
        <Affiliation>Unilever Safety and Environmental Assurance Centre, Colworth Science Park, Sharnbrook, Bedfordshire, MK44 1LQ, UK.</Affiliation>
      </Author>
      <Author>
        <Name>K. Przybylak</Name>
        <Affiliation>Unilever Safety and Environmental Assurance Centre, Colworth Science Park, Sharnbrook, Bedfordshire, MK44 1LQ, UK.</Affiliation>
      </Author>
      <Author>
        <Name>S. Windebank</Name>
        <Affiliation>Unilever Safety and Environmental Assurance Centre, Colworth Science Park, Sharnbrook, Bedfordshire, MK44 1LQ, UK.</Affiliation>
      </Author>
      <Author>
        <Name>G. Maxwell</Name>
        <Affiliation>Unilever Safety and Environmental Assurance Centre, Colworth Science Park, Sharnbrook, Bedfordshire, MK44 1LQ, UK.</Affiliation>
      </Author>
      <Author>
        <Name>M. T. Baltazar</Name>
        <Affiliation>Unilever Safety and Environmental Assurance Centre, Colworth Science Park, Sharnbrook, Bedfordshire, MK44 1LQ, UK. Electronic address: maria.baltazar@unilever.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Potential implications of new information concerning manganese Ohio community health effects studies.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34718075</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(21)00210-5</DOI>
    <KeywordList>
      <Keywords>Community studies</Keywords>
      <Keywords>Manganese</Keywords>
      <Keywords>Neurological effects</Keywords>
      <Keywords>Respirable particulates</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Lisa A. Bailey</Name>
        <Affiliation>Gradient, One Beacon Street, Boston, MA, 02108, USA. Electronic address: lbailey@gradientcorp.com.</Affiliation>
      </Author>
      <Author>
        <Name>Steven R. Boomhower</Name>
        <Affiliation>Gradient, One Beacon Street, Boston, MA, 02108, USA; Harvard Division of Continuing Education, Harvard University, Cambridge, MA, 02138, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Opportunities and challenges related to saturation of toxicokinetic processes: Implications for risk assessment.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34718074</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(21)00211-7</DOI>
    <KeywordList>
      <Keywords>Dose selection</Keywords>
      <Keywords>KMD</Keywords>
      <Keywords>Toxicokinetics</Keywords>
      <Keywords>Weight of evidence</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Yu Mei Tan</Name>
        <Affiliation>U.S. Environmental Protection Agency, Office of Pesticide Programs, Durham, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Hugh A. Barton</Name>
        <Affiliation>Independent Consultant, Mystic, CT, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Alan Boobis</Name>
        <Affiliation>Imperial College London, London, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Rachel Brunner</Name>
        <Affiliation>U.S. Environmental Protection Agency, Office of Pesticide Programs, Durham, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Harvey Clewell</Name>
        <Affiliation>Ramboll US Consulting, Inc., Monroe, LA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Rhian Cope</Name>
        <Affiliation>Australian Pesticides and Veterinary Medicines Authority, Sydney, NSW, Australia.</Affiliation>
      </Author>
      <Author>
        <Name>Jeffrey Dawson</Name>
        <Affiliation>U.S. Environmental Protection Agency, Office of Chemical Safety and Pollution Prevention, Washington, DC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jeanne Domoradzki</Name>
        <Affiliation>Corteva Agriscience, Indianapolis, IN, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Peter Egeghy</Name>
        <Affiliation>U.S. Environmental Protection Agency, Office of Research &amp; Development, Durham, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Pankaj Gulati</Name>
        <Affiliation>Australian Pesticides and Veterinary Medicines Authority, Sydney, NSW, Australia.</Affiliation>
      </Author>
      <Author>
        <Name>Brandall Ingle</Name>
        <Affiliation>U.S. Environmental Protection Agency, Office of Pesticide Programs, Durham, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Nicole Kleinstreuer</Name>
        <Affiliation>National Toxicology Program, Interagency Center for the Evaluation of Alternative Toxicological Methods, Research Triangle Park, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Kelly Lowe</Name>
        <Affiliation>U.S. Environmental Protection Agency, Office of Pesticide Programs, Washington, DC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Anna Lowit</Name>
        <Affiliation>U.S. Environmental Protection Agency, Office of Pesticide Programs, Washington, DC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Elizabeth Mendez</Name>
        <Affiliation>U.S. Environmental Protection Agency, Office of Pesticide Programs, Washington, DC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>David Miller</Name>
        <Affiliation>U.S. Environmental Protection Agency, Office of Pesticide Programs, Washington, DC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jeffrey Minucci</Name>
        <Affiliation>U.S. Environmental Protection Agency, Office of Research &amp; Development, Durham, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>James Nguyen</Name>
        <Affiliation>U.S. Environmental Protection Agency, Office of Pesticide Programs, Washington, DC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Alicia Paini</Name>
        <Affiliation>European Commission, Joint Research Centre, Ispra, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Monique Perron</Name>
        <Affiliation>U.S. Environmental Protection Agency, Office of Pesticide Programs, Washington, DC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Katherine Phillips</Name>
        <Affiliation>U.S. Environmental Protection Agency, Office of Research &amp; Development, Durham, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Hua Qian</Name>
        <Affiliation>ExxonMobil Biomedical Sciences, Inc., Annandale, NJ, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Tharacad Ramanarayanan</Name>
        <Affiliation>Syngenta, Ltd., Greensboro, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Fiona Sewell</Name>
        <Affiliation>National Centre for the Replacement, Refinement, and Reduction of Animals in Research, London, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Philip Villanueva</Name>
        <Affiliation>U.S. Environmental Protection Agency, Office of Pesticide Programs, Washington, DC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>John Wambaugh</Name>
        <Affiliation>U.S. Environmental Protection Agency, Office of Research &amp; Development, Durham, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Michelle Embry</Name>
        <Affiliation>Health and Environmental Sciences Institute, Washington DC, USA. Electronic address: membry@hesiglobal.org.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A reproductive and developmental toxicity screening study of 1,3-butadiene in Sprague-Dawley rats.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34699959</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(21)00207-5</DOI>
    <KeywordList>
      <Keywords>1,3 butadiene</Keywords>
      <Keywords>OECD 421</Keywords>
      <Keywords>Reproductive toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>M. Sue Marty</Name>
        <Affiliation>The Dow Chemical Company, Toxicology &amp; Environmental Research &amp; Consulting, Midland, MI, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Neeraja Erraguntla</Name>
        <Affiliation>American Chemistry Council, Washington, DC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Colin North</Name>
        <Affiliation>Exxon Mobil, Annandale, NJ, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Wade T. Barranco</Name>
        <Affiliation>Lyondell Chemical Company, Houston, TX, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Christopher R. Kirman</Name>
        <Affiliation>Summit Toxicology, Bozeman, MT, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Stuart Cagen</Name>
        <Affiliation>Shell Oil Company, Houston, TX, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Erik K. Rushton</Name>
        <Affiliation>Lyondell Chemical Company, Houston, TX, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Hua Shen</Name>
        <Affiliation>Shell Oil Company, Houston, TX, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Matthew W. Koehler</Name>
        <Affiliation>The Dow Chemical Company, Toxicology &amp; Environmental Research &amp; Consulting, Midland, MI, USA. Electronic address: Koehler2@dow.com.</Affiliation>
      </Author>
      <Author>
        <Name>Robert Budinsky</Name>
        <Affiliation>The Dow Chemical Company, Toxicology &amp; Environmental Research &amp; Consulting, Midland, MI, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Levels of mercury in Moroccan breast milk and the affecting factors: CONTAMILK study.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34687771</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(21)00206-3</DOI>
    <KeywordList>
      <Keywords>Associated factors</Keywords>
      <Keywords>Breast milk</Keywords>
      <Keywords>Mercury levels</Keywords>
      <Keywords>Morocco</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Abha Cherkani-Hassani</Name>
        <Affiliation>Unit of Training and Research in Nutrition and Food Science, Faculty of Medicine and Pharmacy, University Mohammed V, Rabat, Morocco; Laboratory of Analytical Chemistry and Food Science, Faculty of Medicine and Pharmacy, University Mohammed V Rabat, Morocco. Electronic address: abha.cher@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Meriem Slaoui</Name>
        <Affiliation>University Mohammed V Rabat, Morocco. Electronic address: slaouimeriem@yahoo.fr.</Affiliation>
      </Author>
      <Author>
        <Name>Imane Ghanname</Name>
        <Affiliation>Faculty of Health Sciences, International University of Casablanca, Morocco. Electronic address: imane.ghanname@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Brahim Mojemmi</Name>
        <Affiliation>Laboratory of Analytical Chemistry and Food Science, Faculty of Medicine and Pharmacy, University Mohammed V Rabat, Morocco. Electronic address: brahimpharma@hotmail.fr.</Affiliation>
      </Author>
      <Author>
        <Name>Abdelilah Belhaj</Name>
        <Affiliation>Laboratory of Quality Control of Waters, National Office of Electricity and Drinking Water (ONEE), Rabat, Morocco. Electronic address: abdbelhaj@onee.ma.</Affiliation>
      </Author>
      <Author>
        <Name>Brahim Kers</Name>
        <Affiliation>Laboratory of Quality Control of Waters, National Office of Electricity and Drinking Water (ONEE), Rabat, Morocco. Electronic address: bkers@onee.ma.</Affiliation>
      </Author>
      <Author>
        <Name>Majda Flayou</Name>
        <Affiliation>Laboratory of Quality Control of Waters, National Office of Electricity and Drinking Water (ONEE), Rabat, Morocco. Electronic address: mflayou@onee.ma.</Affiliation>
      </Author>
      <Author>
        <Name>Nezha Mouane</Name>
        <Affiliation>Unit of Training and Research in Nutrition and Food Science, Faculty of Medicine and Pharmacy, University Mohammed V, Rabat, Morocco; Department of Pediatric, Hepatology, Gastroenterology and Nutrition PIII-Children's Hospital, Rabat, Morocco. Electronic address: nezhamouane@hotmail.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Rethinking agrochemical safety assessment: A perspective.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34678328</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(21)00209-9</DOI>
    <KeywordList>
      <Keywords>3Rs</Keywords>
      <Keywords>Acute toxicity</Keywords>
      <Keywords>Agrochemicals</Keywords>
      <Keywords>Carcinogenicity</Keywords>
      <Keywords>Repeat dose toxicity</Keywords>
      <Keywords>Risk assessment</Keywords>
      <Keywords>Safety assessment</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Fiona Sewell</Name>
        <Affiliation>National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs), Gibbs Building, 215 Euston Road, London, NW1 2BE, UK. Electronic address: fiona.sewell@nc3rs.org.uk.</Affiliation>
      </Author>
      <Author>
        <Name>Dick Lewis</Name>
        <Affiliation>Syngenta Ltd., Jealott's Hill International Research Centre, Bracknell, Berkshire, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Jyotigna Mehta</Name>
        <Affiliation>ADAMA Agricultural Solutions Ltd, Reading, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Claire Terry</Name>
        <Affiliation>Corteva Agriscience, 9330 Zionsville Road, Indianapolis, IN, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Ian Kimber</Name>
        <Affiliation>Faculty of Biology, Medicine and Health, University of Manchester, Manchester, M20 9BX, UK.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Assessing biological oxidative damage induced by graphene-based materials: An asset for grouping approaches using the FRAS assay.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34678327</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(21)00208-7</DOI>
    <KeywordList>
      <Keywords>Biological oxidative damage</Keywords>
      <Keywords>FRAS</Keywords>
      <Keywords>Graphene-based materials</Keywords>
      <Keywords>Grouping</Keywords>
      <Keywords>Oxidative stress</Keywords>
      <Keywords>Screening</Keywords>
      <Keywords>Surface reactivity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Salma Achawi</Name>
        <Affiliation>Manufacture Française des Pneumatiques Michelin, Place des Carmes Déchaux, 63040, Clermont-Ferrand, Cedex 9, France; Mines Saint-Etienne, Univ Lyon, Univ Jean Monnet, INSERM, U1059, Sainbiose, Centre CIS, F-42023, Saint-Etienne, France.</Affiliation>
      </Author>
      <Author>
        <Name>Bruno Feneon</Name>
        <Affiliation>Manufacture Française des Pneumatiques Michelin, Place des Carmes Déchaux, 63040, Clermont-Ferrand, Cedex 9, France.</Affiliation>
      </Author>
      <Author>
        <Name>Jérémie Pourchez</Name>
        <Affiliation>Mines Saint-Etienne, Univ Lyon, Univ Jean Monnet, INSERM, U1059, Sainbiose, Centre CIS, F-42023, Saint-Etienne, France.</Affiliation>
      </Author>
      <Author>
        <Name>Valérie Forest</Name>
        <Affiliation>Mines Saint-Etienne, Univ Lyon, Univ Jean Monnet, INSERM, U1059, Sainbiose, Centre CIS, F-42023, Saint-Etienne, France. Electronic address: vforest@emse.fr.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Nonclinical safety assessment of engineered T cell therapies.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34656748</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(21)00205-1</DOI>
    <KeywordList>
      <Keywords>CAR-T cells</Keywords>
      <Keywords>Engineered T cells</Keywords>
      <Keywords>Nonclinical</Keywords>
      <Keywords>Safety</Keywords>
      <Keywords>TCR-T cells</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Herve Lebrec</Name>
        <Affiliation>Amgen, South San Francisco, CA, United States. Electronic address: hlebrec@sonomabio.com.</Affiliation>
      </Author>
      <Author>
        <Name>Curtis C. Maier</Name>
        <Affiliation>GlaxoSmithKline, Collegeville, PA, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Kazushige Maki</Name>
        <Affiliation>Pharmaceutical and Medical Device Agency, Tokyo, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Rafael Ponce</Name>
        <Affiliation>Shape Therapeutics Incorporated, Seattle, WA, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Jacintha Shenton</Name>
        <Affiliation>Janssen Research and Development, Spring House, PA, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Shon Green</Name>
        <Affiliation>Umoja Biopharma Incorporated, Seattle, WA, United States.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Minimum reporting standards based on a comprehensive review of the zebrafish embryo teratogenicity assay.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34653553</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(21)00195-1</DOI>
    <KeywordList>
      <Keywords>Alternative methods</Keywords>
      <Keywords>Danio rerio</Keywords>
      <Keywords>Developmental toxicity</Keywords>
      <Keywords>New approach methodologies</Keywords>
      <Keywords>Protocol</Keywords>
      <Keywords>Standardization</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Carolina Di Paolo</Name>
        <Affiliation>Shell Health, Shell International, B.V. Carel van Bylandtlaan 16, 2596, HR, The Hague, the Netherlands. Electronic address: carolina.dipaolo@shell.com.</Affiliation>
      </Author>
      <Author>
        <Name>Sebastian Hoffmann</Name>
        <Affiliation>Seh Consulting + Services, Stembergring 15, 33106, Paderborn, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Hilda Witters</Name>
        <Affiliation>Flemish Institute for Technological Research (VITO), Unit Health, Boeretang 200, B-2400, Mol, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Juan Carlos Carrillo</Name>
        <Affiliation>Shell Health, Shell International, B.V. Carel van Bylandtlaan 16, 2596, HR, The Hague, the Netherlands.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The SCCS Notes of Guidance for the testing of cosmetic ingredients and their safety evaluation, 11th revision, 30-31 March 2021, SCCS/1628/21.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34653552</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(21)00193-8</DOI>
    <KeywordList>
      <Keywords>11th revision</Keywords>
      <Keywords>Alternative method</Keywords>
      <Keywords>Cosmetics</Keywords>
      <Keywords>Guidance</Keywords>
      <Keywords>NAM</Keywords>
      <Keywords>NGRA</Keywords>
      <Keywords>New approach methodology</Keywords>
      <Keywords>Next generation risk assessment</Keywords>
      <Keywords>Risk assessment</Keywords>
      <Keywords>SCCS</Keywords>
      <Keywords>SCCS Notes of Guidance for the testing of cosmetic ingredients and their safety evaluation</Keywords>
      <Keywords>SCCS/1628/21</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name> </Name>
      </Author>
      <Author>
        <Name> </Name>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Correlation between dietary and dislodgeable foliar (DFR) crop residues decline data; A proposed approach to refine non-dietary risk assessment.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34619289</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(21)00190-2</DOI>
    <KeywordList>
      <Keywords>DFR</Keywords>
      <Keywords>DT(50)</Keywords>
      <Keywords>Dietary residue</Keywords>
      <Keywords>Dietary risk assessment</Keywords>
      <Keywords>Dislodgeable foliar residue</Keywords>
      <Keywords>Half-lives</Keywords>
      <Keywords>Non dietary risk assessment</Keywords>
      <Keywords>PPDB</Keywords>
      <Keywords>Residue decline</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Mohamed H. Badawy</Name>
        <Affiliation>University of Hertfordshire, School of Life and Medical Sciences, Hatfield, Herts, AL10 9AB, United Kingdom. Electronic address: moh.mma@hotmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Neil Morgan</Name>
        <Affiliation>Syngenta, Jealott's Hill International Research Centre, Bracknell, Berkshire, RG42 6EY, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Kathleen A. Lewis</Name>
        <Affiliation>University of Hertfordshire, School of Life and Medical Sciences, Hatfield, Herts, AL10 9AB, United Kingdom.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Nonclinical evaluation of abuse liability of the dual orexin receptor antagonist lemborexant.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34619288</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(21)00194-X</DOI>
    <KeywordList>
      <Keywords>Abuse potential</Keywords>
      <Keywords>Drug dependence</Keywords>
      <Keywords>Drug discrimination</Keywords>
      <Keywords>Insomnia</Keywords>
      <Keywords>Lemborexant</Keywords>
      <Keywords>Orexin receptor antagonist</Keywords>
      <Keywords>Physical dependence</Keywords>
      <Keywords>Self-administration</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Shoji Asakura</Name>
        <Affiliation>Eisai Co, Ltd, Tsukuba, Japan. Electronic address: s-asakura@hhc.eisai.co.jp.</Affiliation>
      </Author>
      <Author>
        <Name>Motohiro Shiotani</Name>
        <Affiliation>Eisai Co, Ltd, Tsukuba, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>David V. Gauvin</Name>
        <Affiliation>MPI Research (A Charles River Company), Mattawan, MI, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Atsushi Fujiwara</Name>
        <Affiliation>INA Research Inc, Nagano, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Takashi Ueno</Name>
        <Affiliation>Eisai Co, Ltd, Tsukuba, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Nancy Bower</Name>
        <Affiliation>Eisai Inc, Woodcliff Lake, NJ, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Carsten T. Beuckmann</Name>
        <Affiliation>Eisai Co, Ltd, Tsukuba, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Margaret Moline</Name>
        <Affiliation>Eisai Inc, Woodcliff Lake, NJ, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Exploring the utility of the Threshold of Toxicological Concern (TTC) as a screening approach for complex substances.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34614434</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(21)00192-6</DOI>
    <KeywordList>
      <Keywords>Chemical mixtures</Keywords>
      <Keywords>Combined exposures</Keywords>
      <Keywords>Complex substances</Keywords>
      <Keywords>Human health risk assessment</Keywords>
      <Keywords>Multiple chemicals</Keywords>
      <Keywords>Screening of toxic chemicals</Keywords>
      <Keywords>Threshold of toxicological concern</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>R. Zaleski</Name>
        <Affiliation>ExxonMobil Biomedical Sciences Inc, 1545 Route 22 East, Annandale, NJ, 08801, USA. Electronic address: rzaleski10@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>M. Embry</Name>
        <Affiliation>Health and Environmental Sciences Institute, 740 15th Street NW, Suite 600, Washington, DC, 20005, USA. Electronic address: membry@hesiglobal.org.</Affiliation>
      </Author>
      <Author>
        <Name>R. McKee</Name>
        <Affiliation>ExxonMobil Biomedical Sciences Inc, 1545 Route 22 East, Annandale, NJ, 08801, USA; Hillsborough, NJ, USA. Electronic address: richardmckee3@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>L. K. Teuschler</Name>
        <Affiliation>LK Teuschler &amp; Associates, 6634 Tenth Avenue Terr So, St. Petersburg, FL, 33707, USA. Electronic address: lindateuschler@gmail.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>28-Day oral (gavage) and 13-week (dietary) toxicity studies of DHA canola oil and DHA canola meal in rats.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34610366</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(21)00191-4</DOI>
    <KeywordList>
      <Keywords>Canola oil</Keywords>
      <Keywords>Docosahexaenoic acid</Keywords>
      <Keywords>Food safety</Keywords>
      <Keywords>Toxicity in vivo study</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Genoveva Murillo</Name>
        <Affiliation>Toxicology Division, IIT Research Institute, Chicago, IL, 60616, USA. Electronic address: gmurillo@iitri.org.</Affiliation>
      </Author>
      <Author>
        <Name>Thomas Horn</Name>
        <Affiliation>Toxicology Division, IIT Research Institute, Chicago, IL, 60616, USA.</Affiliation>
      </Author>
      <Author>
        <Name>William D. Johnson</Name>
        <Affiliation>Toxicology Division, IIT Research Institute, Chicago, IL, 60616, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Susan MacIntosh</Name>
        <Affiliation>Nuseed Nutritional US Ltd., 990 Riverside Parkway, West Sacramento, CA, 95605, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Occupational exposure to hexavalent chromium. Part I. Hazard assessment of non-cancer health effects.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34563613</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(21)00189-6</DOI>
    <KeywordList>
      <Keywords>Chromium</Keywords>
      <Keywords>Hazard assessment</Keywords>
      <Keywords>Hexavalent chromium</Keywords>
      <Keywords>Occupational exposure</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Ellen V. S. Hessel</Name>
        <Affiliation>National Institute for Public Health and the Environment (RIVM), P.O. Box 1, 3720 BA, Bilthoven, the Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Yvonne C. M. Staal</Name>
        <Affiliation>National Institute for Public Health and the Environment (RIVM), P.O. Box 1, 3720 BA, Bilthoven, the Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Aldert H. Piersma</Name>
        <Affiliation>National Institute for Public Health and the Environment (RIVM), P.O. Box 1, 3720 BA, Bilthoven, the Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Shalenie P. den Braver-Sewradj</Name>
        <Affiliation>National Institute for Public Health and the Environment (RIVM), P.O. Box 1, 3720 BA, Bilthoven, the Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Janine Ezendam</Name>
        <Affiliation>National Institute for Public Health and the Environment (RIVM), P.O. Box 1, 3720 BA, Bilthoven, the Netherlands. Electronic address: Janine.Ezendam@rivm.nl.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The SCCS scientific advice on the safety of nanomaterials in cosmetics.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34560169</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(21)00187-2</DOI>
    <KeywordList>
      <Keywords>Cosmetics</Keywords>
      <Keywords>Nanomaterials</Keywords>
      <Keywords>SCCS</Keywords>
      <Keywords>Safety concerns</Keywords>
      <Keywords>Scientific advice</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name> </Name>
      </Author>
      <Author>
        <Name>Ulrike Bernauer</Name>
        <Affiliation>Federal Institute for Risk Assessment (BfR), Berlin, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Laurent Bodin</Name>
        <Affiliation>Alternative Energies and Atomic Energy Commission (CEA), Saclay, France.</Affiliation>
      </Author>
      <Author>
        <Name>Qasim Chaudhry</Name>
        <Affiliation>University of Chester, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Pieter Jan Coenraads</Name>
        <Affiliation>University Medical Center Groningen, Groningen, the Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Maria Dusinska</Name>
        <Affiliation>Norwegian Institute for Air Research (NILU), Kjeller, Norway.</Affiliation>
      </Author>
      <Author>
        <Name>Eric Gaffet</Name>
        <Affiliation>Institute Jean Lamour (UMR 7198 CNRS Université de Lorraine), Nancy, France.</Affiliation>
      </Author>
      <Author>
        <Name>Eirini Panteri</Name>
        <Affiliation>National and Kapodistrian University of Athens, School of Pharmacy, Division of Pharmaceutical Chemistry, Athens, Greece.</Affiliation>
      </Author>
      <Author>
        <Name>Vera Rogiers</Name>
        <Affiliation>Vrije Universiteit, Brussels, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Christophe Rousselle</Name>
        <Affiliation>French Agency for Food, Environmental and Occupational Health &amp; Safety (ANSES), Maisons-Alfort, France.</Affiliation>
      </Author>
      <Author>
        <Name>Maciej Stepnik</Name>
        <Affiliation>Qsar Lab Ltd., Gdańsk, Poland.</Affiliation>
      </Author>
      <Author>
        <Name>Tamara Vanhaecke</Name>
        <Affiliation>Vrije Universiteit, Brussels, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Susan Wijnhoven</Name>
        <Affiliation>National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name> </Name>
      </Author>
      <Author>
        <Name>Natalie von Goetz</Name>
        <Affiliation>Federal Office of Public Health (FOPH), Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Wim H. de Jong</Name>
        <Affiliation>Formerly Centre for Health Protection, National Institute for Public Health (RIVM), Bilthoven, the Netherlands.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A systematic assessment of the epidemiologic literature regarding an association between acetaminophen exposure and cancer.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34517075</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(21)00184-7</DOI>
    <KeywordList>
      <Keywords>Acetaminophen</Keywords>
      <Keywords>Bias</Keywords>
      <Keywords>Carcinogenicity</Keywords>
      <Keywords>Epidemiology</Keywords>
      <Keywords>Hazard identification</Keywords>
      <Keywords>Systematic review</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Rachel Weinstein</Name>
        <Affiliation>Janssen Research and Development, Titusville, NJ, USA. Electronic address: RWeinst1@its.jnj.com.</Affiliation>
      </Author>
      <Author>
        <Name>Amisha M. Parikh-Das</Name>
        <Affiliation>Johnson &amp; Johnson Consumer Products US, Fort Washington, PA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Raymark Salonga</Name>
        <Affiliation>ClinChoice Inc., Pasig City, Philippines.</Affiliation>
      </Author>
      <Author>
        <Name>Martijn Schuemie</Name>
        <Affiliation>Janssen Research and Development, Titusville, NJ, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Patrick B. Ryan</Name>
        <Affiliation>Janssen Research and Development, Titusville, NJ, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Evren Atillasoy</Name>
        <Affiliation>Johnson &amp; Johnson Consumer Products US, Fort Washington, PA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Anne Hermanowski-Vosatka</Name>
        <Affiliation>Johnson &amp; Johnson Consumer Products US, Skillman, NJ, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Gary Eichenbaum</Name>
        <Affiliation>Johnson &amp; Johnson, New Brunswick, NJ, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jesse A. Berlin</Name>
        <Affiliation>Johnson &amp; Johnson, Titusville, NJ, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>In silico assessment of genotoxicity. Combinations of sensitive structural alerts minimize false negative predictions for all genotoxicity endpoints and can single out chemicals for which experimentation can be avoided.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34506881</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(21)00183-5</DOI>
    <KeywordList>
      <Keywords>Genotoxicity</Keywords>
      <Keywords>In silico</Keywords>
      <Keywords>Predictive toxicology</Keywords>
      <Keywords>QSAR</Keywords>
      <Keywords>Regulation</Keywords>
      <Keywords>Structure-activity relationships</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Romualdo Benigni</Name>
        <Affiliation>Alpha-Pretox, Rome, Italy. Electronic address: romualdo.benigni@gmail.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Occupational exposure to hexavalent chromium. Part II. Hazard assessment of carcinogenic effects.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34506880</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(21)00186-0</DOI>
    <KeywordList>
      <Keywords>Chromium</Keywords>
      <Keywords>Hazard assessment</Keywords>
      <Keywords>Hexavalent chromium</Keywords>
      <Keywords>occupational exposure</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Shalenie P. den Braver-Sewradj</Name>
        <Affiliation>National Institute for Public Health and the Environment (RIVM), P.O. Box 1, 3720BA Bilthoven, the Netherlands. Electronic address: shalenie.den.braver@rivm.nl.</Affiliation>
      </Author>
      <Author>
        <Name>Jan van Benthem</Name>
        <Affiliation>National Institute for Public Health and the Environment (RIVM), P.O. Box 1, 3720BA Bilthoven, the Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Yvonne C. M. Staal</Name>
        <Affiliation>National Institute for Public Health and the Environment (RIVM), P.O. Box 1, 3720BA Bilthoven, the Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Janine Ezendam</Name>
        <Affiliation>National Institute for Public Health and the Environment (RIVM), P.O. Box 1, 3720BA Bilthoven, the Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Aldert H. Piersma</Name>
        <Affiliation>National Institute for Public Health and the Environment (RIVM), P.O. Box 1, 3720BA Bilthoven, the Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Ellen V. S. Hessel</Name>
        <Affiliation>National Institute for Public Health and the Environment (RIVM), P.O. Box 1, 3720BA Bilthoven, the Netherlands.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Inter-laboratory performance of ICE histopathology scoring to identify UN GHS Category 1 surfactants and non-extreme pH detergents.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34506879</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(21)00185-9</DOI>
    <KeywordList>
      <Keywords>Detergent products</Keywords>
      <Keywords>Histopathology</Keywords>
      <Keywords>Isolated chicken eye test</Keywords>
      <Keywords>OECD TG 438</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Chantra Eskes</Name>
        <Affiliation>SeCAM Services and Consultation on Alternative Methods, Magliaso, Switzerland. Electronic address: chantra.eskes@secam-ce.eu.</Affiliation>
      </Author>
      <Author>
        <Name>Marcel V. W. Wijnands</Name>
        <Affiliation>TNO Triskelion, Zeist, the Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Martina Hermann</Name>
        <Affiliation>Henkel AG &amp; Co. KGaA, Duesseldorf, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Menk Prinsen</Name>
        <Affiliation>TNO Triskelion, Zeist, the Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Caroline Bertein</Name>
        <Affiliation>A.I.S.E., Brussels, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Dominic Byrne</Name>
        <Affiliation>A.I.S.E., Brussels, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Robert Kreutzer</Name>
        <Affiliation>Anapath Services GmbH, Liestal, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Vasanthi Mowat</Name>
        <Affiliation>Envigo, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Ian Taylor</Name>
        <Affiliation>Envigo, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Erwin van Vliet</Name>
        <Affiliation>SeCAM Services and Consultation on Alternative Methods, Magliaso, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Klaus Weber</Name>
        <Affiliation>Anapath Services GmbH, Liestal, Switzerland.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>An evolution of risk assessment for potential carcinogens in food: Scientific session proceedings.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34506878</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(21)00188-4</DOI>
    <KeywordList>
      <Keywords>Carcinogenic risk assessment</Keywords>
      <Keywords>Food safety</Keywords>
      <Keywords>Modern carcinogenic frameworks</Keywords>
      <Keywords>Rodent bioassay</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>G. Craig Llewellyn</Name>
        <Affiliation>SafeBridge® Regulatory and Life Sciences Group, A Trinity Consultants Inc. Company, USA. Electronic address: craig.llewellyn@safebridge.com.</Affiliation>
      </Author>
      <Author>
        <Name>Marisa O. Rihner</Name>
        <Affiliation>SafeBridge® Regulatory and Life Sciences Group, A Trinity Consultants Inc. Company, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Paul R. Hanlon</Name>
        <Affiliation>Abbott Nutrition, Columbus, OH, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Ability of mathematical models to predict human in vivo percutaneous penetration of steroids.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34499979</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(21)00182-3</DOI>
    <KeywordList>
      <Keywords>Aqueous solubility</Keywords>
      <Keywords>Human</Keywords>
      <Keywords>Hydrogen bonds</Keywords>
      <Keywords>In vivo</Keywords>
      <Keywords>Octanol water partition coefficient</Keywords>
      <Keywords>Percutaneous penetration</Keywords>
      <Keywords>Permeability constant</Keywords>
      <Keywords>Potts and Guy model</Keywords>
      <Keywords>Steroids</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Anuk Burli</Name>
        <Affiliation>Department of Dermatology, University of California, San Francisco, 2340 Sutter Street N461, San Francisco, CA, 94115, USA; University of Rochester School of Medicine and Dentistry, 601 Elmwood Ave, Rochester, NY, 14642, USA. Electronic address: burlianuk@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Rebecca M. Law</Name>
        <Affiliation>Department of Dermatology, University of California, San Francisco, 2340 Sutter Street N461, San Francisco, CA, 94115, USA; Memorial University of Newfoundland School of Pharmacy H3440, 300 Prince Phillip Drive, St. John's, NL, A1B 3V6, Canada. Electronic address: rlaw@mun.ca.</Affiliation>
      </Author>
      <Author>
        <Name>Howard I. Maibach</Name>
        <Affiliation>Department of Dermatology, University of California, San Francisco, 2340 Sutter Street N461, San Francisco, CA, 94115, USA. Electronic address: howard.maibach@ucsf.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Post-market surveillance of consumer products: Framework for adverse event management.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34481892</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(21)00169-0</DOI>
    <KeywordList>
      <Keywords>Adverse event</Keywords>
      <Keywords>Association assessment</Keywords>
      <Keywords>Consumer products</Keywords>
      <Keywords>Correlation</Keywords>
      <Keywords>Outcome</Keywords>
      <Keywords>Pharmacovigilance</Keywords>
      <Keywords>Poison control</Keywords>
      <Keywords>Post-market surveillance system</Keywords>
      <Keywords>Scoring system</Keywords>
      <Keywords>Spontaneous reports</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>R. Kingston</Name>
        <Affiliation>SafetyCall International, LLC, 3600 American Blvd W #725, Minneapolis, MN, 55431, USA; University of Minnesota, Division of Professional Education, College of Pharmacy, 308 Harvard St SE, Minneapolis, MN, 55455, USA; University of Minnesota, Department of Experimental and Clinical Pharmacology (ECP), College of Pharmacy, 308 Harvard St SE, Minneapolis, MN, 55455, USA.</Affiliation>
      </Author>
      <Author>
        <Name>K. Sioris</Name>
        <Affiliation>SafetyCall International, LLC, 3600 American Blvd W #725, Minneapolis, MN, 55431, USA; University of Minnesota, Department of Experimental and Clinical Pharmacology (ECP), College of Pharmacy, 308 Harvard St SE, Minneapolis, MN, 55455, USA.</Affiliation>
      </Author>
      <Author>
        <Name>J. Gualtieri</Name>
        <Affiliation>SafetyCall International, LLC, 3600 American Blvd W #725, Minneapolis, MN, 55431, USA; University of Minnesota, Department of Experimental and Clinical Pharmacology (ECP), College of Pharmacy, 308 Harvard St SE, Minneapolis, MN, 55455, USA.</Affiliation>
      </Author>
      <Author>
        <Name>A. Brutlag</Name>
        <Affiliation>SafetyCall International, LLC, 3600 American Blvd W #725, Minneapolis, MN, 55431, USA; University of Minnesota, College of Veterinary Medicine, 1365 Gortner Ave, St Paul, MN, 55108, USA.</Affiliation>
      </Author>
      <Author>
        <Name>W. Droege</Name>
        <Affiliation>Science Strategies, LLC, 1001 East Market St, Suite 202, Charlottesville, VA, 22902, USA.</Affiliation>
      </Author>
      <Author>
        <Name>T. G. Osimitz</Name>
        <Affiliation>Science Strategies, LLC, 1001 East Market St, Suite 202, Charlottesville, VA, 22902, USA. Electronic address: tom@sciencestrategies.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Appraisal of the human health related toxicological information available on dicyclopentadiene (DCPD) in view of assessing the substance's potential to cause endocrine disruption.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34478800</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(21)00181-1</DOI>
    <KeywordList>
      <Keywords>DCPD</Keywords>
      <Keywords>Developmental toxicity</Keywords>
      <Keywords>Dicyclopentadiene</Keywords>
      <Keywords>Endocrine</Keywords>
      <Keywords>Mode of action</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Francesca Tencalla</Name>
        <Affiliation>ToxMinds BVBA, Brussels, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Neslihan Aygun Kocabas</Name>
        <Affiliation>TotalEnergies Refining &amp; Chemicals, Seneffe, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Martijn Rooseboom</Name>
        <Affiliation>Shell International BV, Den Haag, the Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Erik Rushton</Name>
        <Affiliation>LyondellBasell Industries, Rotterdam, the Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Nicholas Synhaeve</Name>
        <Affiliation>ExxonMobil Petroleum &amp; Chemical BVBA, Machelen, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Thomas Petry</Name>
        <Affiliation>ToxMinds BVBA, Brussels, Belgium.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Species selection for nonclinical safety assessment of drug candidates: Examples of current industry practice.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34455009</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(21)00170-7</DOI>
    <KeywordList>
      <Keywords>Biologics</Keywords>
      <Keywords>Drug development</Keywords>
      <Keywords>NCEs</Keywords>
      <Keywords>Non-rodent</Keywords>
      <Keywords>Nonclinical</Keywords>
      <Keywords>Rodent</Keywords>
      <Keywords>Safety assessment</Keywords>
      <Keywords>Species selection</Keywords>
      <Keywords>Toxicology</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Rostam Namdari</Name>
        <Affiliation>Xenon Pharmaceuticals Inc, Burnaby, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Keith Jones</Name>
        <Affiliation>CFMD Ltd, Peterborough, UK. Electronic address: kjones.cfmd@btinternet.com.</Affiliation>
      </Author>
      <Author>
        <Name>Samuel S. Chuang</Name>
        <Affiliation>Charles River Laboratories, Wilmington, MA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Steven Van Cruchten</Name>
        <Affiliation>University of Antwerp, Wilrijk, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Zuhal Dincer</Name>
        <Affiliation>Labcorp Early Development Laboratories Ltd, Harrogate, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Noel Downes</Name>
        <Affiliation>Sequani Ltd, Ledbury, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Lars Friis Mikkelsen</Name>
        <Affiliation>Ellegaard Göttingen Minipigs, Dalmose, Denmark.</Affiliation>
      </Author>
      <Author>
        <Name>Joanna Harding</Name>
        <Affiliation>R&amp;D, AstraZeneca, Cambridge, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Sven Jäckel</Name>
        <Affiliation>Merck KGaA, Darmstadt, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Björn Jacobsen</Name>
        <Affiliation>Roche Pharmaceutical Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Jacqueline Kinyamu-Akunda</Name>
        <Affiliation>Janssen Research &amp; Development, Spring House, PA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Andréanne Lortie</Name>
        <Affiliation>Ipsen, Les Ulis, France.</Affiliation>
      </Author>
      <Author>
        <Name>Sofiene Mhedhbi</Name>
        <Affiliation>Bracco Suisse SA, Plan-les-Ouates, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Susanne Mohr</Name>
        <Affiliation>Roche Pharmaceutical Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Michael W. Schmitt</Name>
        <Affiliation>Merck KGaA, Darmstadt, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Helen Prior</Name>
        <Affiliation>National Centre for the Replacement Refinement &amp; Reduction of Animals in Research (NC3Rs), London, UK.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Safety evaluation of food enzymes produced by a safe strain lineage of Bacillussubtilis.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34455008</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(21)00171-9</DOI>
    <KeywordList>
      <Keywords>Bacillus subtilis</Keywords>
      <Keywords>Classical mutagenesis</Keywords>
      <Keywords>Enzyme safety</Keywords>
      <Keywords>Safe strain lineage</Keywords>
      <Keywords>Targeted genetic engineering</Keywords>
      <Keywords>Toxicity studies</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Melina Galano</Name>
        <Affiliation>DSM Food Specialties B.V., Alexander Fleminglaan 1, 2613 AX, Delft, the Netherlands. Electronic address: melina.galano@dsm.com.</Affiliation>
      </Author>
      <Author>
        <Name>Myrthe W. van den Dungen</Name>
        <Affiliation>DSM Food Specialties B.V., Alexander Fleminglaan 1, 2613 AX, Delft, the Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Tjeerd van Rij</Name>
        <Affiliation>DSM Food Specialties B.V., Alexander Fleminglaan 1, 2613 AX, Delft, the Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Hanna E. Abbas</Name>
        <Affiliation>DSM Food Specialties B.V., Alexander Fleminglaan 1, 2613 AX, Delft, the Netherlands.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Perspectives on the elimination of animal assays in the assessment of carcinogenicity.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34437954</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(21)00172-0</DOI>
    <KeywordList>
      <Keywords>Animal assay</Keywords>
      <Keywords>Carcinogenicity assessment</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Akiyoshi Nishikawa</Name>
        <Affiliation>Division of Pathology, National Institute of Health Sciences, 3-25-26 Tonomachi, Kawasaki, Kanagawa, 210-9501, Japan; Division of Diagnostic Pathology, Saiseikai Utsunomiya Hospital, Takebayashi-machi 911-1, Utsunomiya, 321-0974, Japan. Electronic address: nishikaw@nihs.go.jp.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The safety of a Kluyveromyces lactis strain lineage for enzyme production.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34428516</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(21)00168-9</DOI>
    <KeywordList>
      <Keywords>Classical mutagenesis</Keywords>
      <Keywords>Fermentation produced enzymes</Keywords>
      <Keywords>Genetic engineering</Keywords>
      <Keywords>Genotoxicity</Keywords>
      <Keywords>Kluyveromyces lactis, yeast</Keywords>
      <Keywords>Microbial enzymes</Keywords>
      <Keywords>Safe strain lineage</Keywords>
      <Keywords>Safety</Keywords>
      <Keywords>Subchronic oral toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Myrthe W. van den Dungen</Name>
        <Affiliation>DSM Food Specialties B.V, Alexander Fleminglaan 1, 2613 AX, Delft, the Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Rémon Boer</Name>
        <Affiliation>DSM Food Specialties B.V, Alexander Fleminglaan 1, 2613 AX, Delft, the Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Lonneke C. Wilms</Name>
        <Affiliation>DSM Food Specialties B.V, Alexander Fleminglaan 1, 2613 AX, Delft, the Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Yulia Efimova</Name>
        <Affiliation>DSM Food Specialties B.V, Alexander Fleminglaan 1, 2613 AX, Delft, the Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Hanna E. Abbas</Name>
        <Affiliation>DSM Food Specialties B.V, Alexander Fleminglaan 1, 2613 AX, Delft, the Netherlands. Electronic address: hanna.abbas@dsm.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The Dilemma of perfluorooctanoate (PFOA) human half-life.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34400261</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(21)00166-5</DOI>
    <KeywordList>
      <Keywords>Half-life</Keywords>
      <Keywords>Human clinical study</Keywords>
      <Keywords>Human observational studies</Keywords>
      <Keywords>PFOA</Keywords>
      <Keywords>Safe dose</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Michael Dourson</Name>
        <Affiliation>Toxicology Excellence for Risk Assessment (TERA), Cincinnati, OH, USA. Electronic address: dourson@tera.org.</Affiliation>
      </Author>
      <Author>
        <Name>Bernard Gadagbui</Name>
        <Affiliation>Toxicology Excellence for Risk Assessment (TERA), Cincinnati, OH, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Paving the way for application of next generation risk assessment to safety decision-making for cosmetic ingredients.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34389358</pubmedLink>
    <GrantList>
      <Grant>EPA999999</Grant>
    </GrantList>
    <Year>2021</Year>
    <DOI>S0273-2300(21)00167-7</DOI>
    <KeywordList>
      <Keywords>In silico</Keywords>
      <Keywords>In vitro</Keywords>
      <Keywords>Next generation risk assessment</Keywords>
      <Keywords>Non-animal approaches</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>M. P. Dent</Name>
        <Affiliation>Unilever Safety and Environmental Assurance Centre, Sharnbrook, Bedfordshire, MK44 1LQ, UK. Electronic address: matthew.dent@unilever.com.</Affiliation>
      </Author>
      <Author>
        <Name>E. Vaillancourt</Name>
        <Affiliation>Health Canada, Healthy Environments and Consumer Safety Branch, 269 Laurier Ave. W., Ottawa, ON K1A 0K9, Canada. Electronic address: eric.vaillancourt@canada.ca.</Affiliation>
      </Author>
      <Author>
        <Name>R. S. Thomas</Name>
        <Affiliation>Center for Computational Toxicology and Exposure, U.S. Environmental Protection Agency, Research, Triangle Park, NC, 27711, USA. Electronic address: thomas.russell@epa.gov.</Affiliation>
      </Author>
      <Author>
        <Name>P. L. Carmichael</Name>
        <Affiliation>Unilever Safety and Environmental Assurance Centre, Sharnbrook, Bedfordshire, MK44 1LQ, UK. Electronic address: paul.carmichael@unilever.com.</Affiliation>
      </Author>
      <Author>
        <Name>G. Ouedraogo</Name>
        <Affiliation>l'Oréal, Research and Development, Paris, France. Electronic address: gouedraogo@rd.loreal.com.</Affiliation>
      </Author>
      <Author>
        <Name>H. Kojima</Name>
        <Affiliation>National Institute of Health Sciences, 1-18-1 Kamiyoga, Setagaya-ku, 158-8501, Tokyo, Japan. Electronic address: h-kojima@nihs.go.jp.</Affiliation>
      </Author>
      <Author>
        <Name>J. Barroso</Name>
        <Affiliation>European Commission, Joint Research Centre (JRC), Ispra, VA, Italy. Electronic address: joao.barroso@ec.europa.eu.</Affiliation>
      </Author>
      <Author>
        <Name>J. Ansell</Name>
        <Affiliation>US Personal Care Products Council (PCPC), 1620 L St. NW, Suite 1200, Washington, D.C, 20036, USA. Electronic address: ansellj@personalcarecouncil.org.</Affiliation>
      </Author>
      <Author>
        <Name>T. S. Barton-Maclaren</Name>
        <Affiliation>Health Canada, Healthy Environments and Consumer Safety Branch, 269 Laurier Ave. W., Ottawa, ON K1A 0K9, Canada. Electronic address: tara.barton-maclaren@canada.ca.</Affiliation>
      </Author>
      <Author>
        <Name>S. H. Bennekou</Name>
        <Affiliation>National Food Institute, Technical University of Denmark (DTU), Copenhagen, Denmark. Electronic address: shobe@food.dtu.dk.</Affiliation>
      </Author>
      <Author>
        <Name>K. Boekelheide</Name>
        <Affiliation>Department of Pathology and Laboratory Medicine, Brown University, Providence, RI, USA. Electronic address: kim_boekelheide@brown.edu.</Affiliation>
      </Author>
      <Author>
        <Name>J. Ezendam</Name>
        <Affiliation>National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands. Electronic address: janine.ezendam@rivm.nl.</Affiliation>
      </Author>
      <Author>
        <Name>J. Field</Name>
        <Affiliation>Health Canada, Healthy Environments and Consumer Safety Branch, 269 Laurier Ave. W., Ottawa, ON K1A 0K9, Canada. Electronic address: john.field@canada.ca.</Affiliation>
      </Author>
      <Author>
        <Name>S. Fitzpatrick</Name>
        <Affiliation>US Food and Drug Administration (US FDA), Center for Food Safety and Applied Nutrition (CFSAN), 5001 Campus Drive, College Park, MD, 20740, USA. Electronic address: suzanne.fitzpatrick@fda.hhs.gov.</Affiliation>
      </Author>
      <Author>
        <Name>M. Hatao</Name>
        <Affiliation>Japan Cosmetic Industry Association (JCIA), Metro City Kamiyacho 6F, 5-1-5, Toranomon, Minato-ku, Tokyo, 105-0001 Japan. Electronic address: hatao@jcia.org.</Affiliation>
      </Author>
      <Author>
        <Name>R. Kreiling</Name>
        <Affiliation>Clariant Produkte (Deutschland) GmbH, Am Unisyspark 1, 65843, Sulzbach, Germany. Electronic address: reinhard.kreiling@clariant.com.</Affiliation>
      </Author>
      <Author>
        <Name>M. Lorencini</Name>
        <Affiliation>Grupo Boticário, Research &amp; Development, São José dos Pinhais, Brazil. Electronic address: marciolo@grupoboticario.com.br.</Affiliation>
      </Author>
      <Author>
        <Name>C. Mahony</Name>
        <Affiliation>Procter &amp; Gamble Technical Centres Ltd, Reading, RG2 0RX, UK. Electronic address: mahony.c@pg.com.</Affiliation>
      </Author>
      <Author>
        <Name>B. Montemayor</Name>
        <Affiliation>Cosmetics Alliance Canada, 420 Britannia Road East Suite 102, Mississauga, ON L4Z 3L5, Canada. Electronic address: bmontemayor@cosmeticsalliance.ca.</Affiliation>
      </Author>
      <Author>
        <Name>R. Mazaro-Costa</Name>
        <Affiliation>Departament of Pharmacology, Universidade Federal de Goiás, Goiânia, GO, 74.690-900, Brazil. Electronic address: mazaro@ufg.br.</Affiliation>
      </Author>
      <Author>
        <Name>J. Oliveira</Name>
        <Affiliation>Brazilian Health Regulatory Agency (ANVISA), Gerência de Produtos de Higiene, Perfumes, Cosméticos e Saneantes, Setor de Indústria e Abastecimento (SIA), Trecho 5, Área Especial 57, CEP 71205-050, Brasília, DF, Brazil. Electronic address: julcemara.oliveira@anvisa.gov.br.</Affiliation>
      </Author>
      <Author>
        <Name>V. Rogiers</Name>
        <Affiliation>Vrije Universiteit Brussel, Brussels, Belgium. Electronic address: Vera.Rogiers@vub.be.</Affiliation>
      </Author>
      <Author>
        <Name>D. Smegal</Name>
        <Affiliation>US Food and Drug Administration (US FDA), Center for Food Safety and Applied Nutrition (CFSAN), 5001 Campus Drive, College Park, MD, 20740, USA. Electronic address: deborah.smegal@fda.hhs.gov.</Affiliation>
      </Author>
      <Author>
        <Name>R. Taalman</Name>
        <Affiliation>Cosmetics Europe, Avenue Herrmann-Debroux 40, 1160 Auderghem, Belgium. Electronic address: rtaalman@cosmeticseurope.eu.</Affiliation>
      </Author>
      <Author>
        <Name>Y. Tokura</Name>
        <Affiliation>Allergic Disease Research Center, Chutoen General Medical Center, Kakegawa, Japan. Electronic address: tokura@med.uoeh-u.ac.jp.</Affiliation>
      </Author>
      <Author>
        <Name>R. Verma</Name>
        <Affiliation>US Food and Drug Administration (US FDA), Center for Food Safety and Applied Nutrition (CFSAN), 5001 Campus Drive, College Park, MD, 20740, USA. Electronic address: rajeshwar.verma@fda.hhs.gov.</Affiliation>
      </Author>
      <Author>
        <Name>C. Willett</Name>
        <Affiliation>Humane Society International, Washington, DC, USA. Electronic address: kwillett@humanesociety.org.</Affiliation>
      </Author>
      <Author>
        <Name>C. Yang</Name>
        <Affiliation>Taiwan Cosmetic Industry Association (TWCIA), 8F No. 136, Bo'ai Rd., Zhongzheng Dist., Taipei City, 100, Taiwan, ROC. Electronic address: k77982@kao.com.tw.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Using historical control data in bioassays for regulatory toxicology.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34364928</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(21)00165-3</DOI>
    <KeywordList>
      <Keywords>Biological relevance</Keywords>
      <Keywords>Compatibility intervals</Keywords>
      <Keywords>Hazard characterisation</Keywords>
      <Keywords>Hazard identification</Keywords>
      <Keywords>Historical control data</Keywords>
      <Keywords>Relevance thresholds</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Felix M. Kluxen</Name>
        <Affiliation>ADAMA Deutschland GmbH, Cologne, Germany. Electronic address: felix.kluxen@adama.com.</Affiliation>
      </Author>
      <Author>
        <Name>Klaus Weber</Name>
        <Affiliation>Anapath Services GmbH, Liestal, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Christian Strupp</Name>
        <Affiliation>Gowan Crop Protection Ltd., Reading, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Signe M. Jensen</Name>
        <Affiliation>Department of Plant and Efoldnvironmental Sciences, University of Copenhagen, Copenhagen, Denmark.</Affiliation>
      </Author>
      <Author>
        <Name>Ludwig A. Hothorn</Name>
        <Affiliation>Leibniz University of Hannover (retired), Lauenau, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Jean Christophe Garcin</Name>
        <Affiliation>Bayer SAS, Sophia Antipolis, France.</Affiliation>
      </Author>
      <Author>
        <Name>Thomas Hofmann</Name>
        <Affiliation>BASF SE, Ludwigshafen, Germany.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Calculating qualified non-mutagenic impurity levels: Harmonization of approaches.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34363920</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(21)00164-1</DOI>
    <KeywordList>
      <Keywords>Body surface area conversion</Keywords>
      <Keywords>Impurity qualification</Keywords>
      <Keywords>Pharmaceutical impurities</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jessica C. Graham</Name>
        <Affiliation>Bristol Myers Squibb, New Brunswick, NJ, USA. Electronic address: graham.jessica@gene.com.</Affiliation>
      </Author>
      <Author>
        <Name>Mark W. Powley</Name>
        <Affiliation>Merck &amp; Co., Inc., West Point, PA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Erika Udovic</Name>
        <Affiliation>Novartis Pharma AG, Pre-Clinical Safety, Basel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Susanne Glowienke</Name>
        <Affiliation>Novartis Pharma AG, Pre-Clinical Safety, Basel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>John Nicolette</Name>
        <Affiliation>AbbVie Inc., Pre-clinical Safety, North Chicago, IL, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Patricia Parris</Name>
        <Affiliation>Pfizer Global Research &amp; Development, Sandwich, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Michelle Kenyon</Name>
        <Affiliation>Pfizer Global Research &amp; Development, Groton, CT, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Angela White</Name>
        <Affiliation>GlaxoSmithKline R&amp;D, Ware, Hertfordshire, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Ailis Maisey</Name>
        <Affiliation>GlaxoSmithKline R&amp;D, Ware, Hertfordshire, UK.</Affiliation>
      </Author>
      <Author>
        <Name>James Harvey</Name>
        <Affiliation>GlaxoSmithKline R&amp;D, Ware, Hertfordshire, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Elizabeth A. Martin</Name>
        <Affiliation>AstraZeneca, R&amp;D, Cambridge, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Eric Dowdy</Name>
        <Affiliation>Gilead Sciences, Inc., Chemical Development &amp; Manufacturing, Foster City, CA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Melisa Masuda-Herrera</Name>
        <Affiliation>Gilead Sciences, Inc., Nonclinical Safety and Pathobiology, Foster City, CA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Alejandra Trejo-Martin</Name>
        <Affiliation>Gilead Sciences, Inc., Nonclinical Safety and Pathobiology, Foster City, CA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Joel Bercu</Name>
        <Affiliation>Gilead Sciences, Inc., Nonclinical Safety and Pathobiology, Foster City, CA, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>AOP and IATA applied to ocular surface toxicity.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34348128</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(21)00162-8</DOI>
    <KeywordList>
      <Keywords>AOP</Keywords>
      <Keywords>IATA</Keywords>
      <Keywords>OECD</Keywords>
      <Keywords>Ocular surface</Keywords>
      <Keywords>Toxic exposure</Keywords>
      <Keywords>Toxicity-induced dry eye (TIDE)</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Noémie Bonneau</Name>
        <Affiliation>Sorbonne Université, INSERM, CNRS, IHU FOReSight, Institut de La Vision, 75012, Paris, France; HORUS PHARMA, 06700, Saint-Laurent-du-Var, France.</Affiliation>
      </Author>
      <Author>
        <Name>Christophe Baudouin</Name>
        <Affiliation>Sorbonne Université, INSERM, CNRS, IHU FOReSight, Institut de La Vision, 75012, Paris, France; Centre Hospitalier National D'Ophtalmologie des Quinze-Vingts, INSERM-DGOS CIC 1423, IHU FOReSight, 75012, France; Université Versailles-Saint-Quentin-en-Yvelines, Hôpital Ambroise Paré, APHP, F-92100, Boulogne-Billancourt, France.</Affiliation>
      </Author>
      <Author>
        <Name>Françoise Brignole-Baudouin</Name>
        <Affiliation>Sorbonne Université, INSERM, CNRS, IHU FOReSight, Institut de La Vision, 75012, Paris, France; Centre Hospitalier National D'Ophtalmologie des Quinze-Vingts, INSERM-DGOS CIC 1423, IHU FOReSight, 75012, France; Laboratoire d'ophtalmobiologie, Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts, 75012, Paris, France; Université de Paris, Faculté de Pharmacie de Paris, 75006, Paris, France. Electronic address: fbaudouin@15-20.fr.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Evaluation of the toxicity of sodium dodecyl sulphate (SDS) in the MucilAir™ human airway model in vitro.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34333067</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(21)00163-X</DOI>
    <KeywordList>
      <Keywords>3D in vitro model</Keywords>
      <Keywords>Airway epithelium</Keywords>
      <Keywords>Inhalation toxicology</Keywords>
      <Keywords>MucilAir™</Keywords>
      <Keywords>Sodium dodecyl sulphate</Keywords>
      <Keywords>Sodium lauryl sulphate</Keywords>
      <Keywords>Up to 10): respiratory toxicology</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jonathan Welch</Name>
        <Affiliation>Department of In Vitro Toxicology, Charles River Laboratories, Tranent, Edinburgh, EH33 2NE, UK. Electronic address: jonathan.welch@newcellsbiotech.co.uk.</Affiliation>
      </Author>
      <Author>
        <Name>Joanne Wallace</Name>
        <Affiliation>Department of In Vitro Toxicology, Charles River Laboratories, Tranent, Edinburgh, EH33 2NE, UK. Electronic address: Joanne.Wallace@crl.com.</Affiliation>
      </Author>
      <Author>
        <Name>Alison B. Lansley</Name>
        <Affiliation>School of Pharmacy and Biomolecular Sciences, University of Brighton, Brighton, BN2 1GJ, UK. Electronic address: a.lansley@brighton.ac.uk.</Affiliation>
      </Author>
      <Author>
        <Name>Clive Roper</Name>
        <Affiliation>Department of In Vitro Toxicology, Charles River Laboratories, Tranent, Edinburgh, EH33 2NE, UK. Electronic address: Clive@RoperTCL.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Progress towards an OECD reporting framework for transcriptomics and metabolomics in regulatory toxicology.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34333066</pubmedLink>
    <GrantList>
      <Grant>EPA999999</Grant>
      <Grant>MR/S019669/1</Grant>
    </GrantList>
    <Year>2021</Year>
    <DOI>S0273-2300(21)00161-6</DOI>
    <KeywordList>
      <Keywords>MRF</Keywords>
      <Keywords>Metabolomics</Keywords>
      <Keywords>Metabolomics reporting framework</Keywords>
      <Keywords>OECD</Keywords>
      <Keywords>QA/QC</Keywords>
      <Keywords>Regulatory</Keywords>
      <Keywords>TRF</Keywords>
      <Keywords>Toxicology</Keywords>
      <Keywords>Transcriptomics</Keywords>
      <Keywords>Transcriptomics reporting framework</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Joshua A. Harrill</Name>
        <Affiliation>Center for Computational Toxicology and Exposure, Office of Research and Development, U.S. Environmental Protection Agency, Research Triangle Park, NC, 27711, United States. Electronic address: harrill.joshua@epa.gov.</Affiliation>
      </Author>
      <Author>
        <Name>Mark R. Viant</Name>
        <Affiliation>School of Biosciences, University of Birmingham, Edgbaston, Birmingham, B15 2TT, United Kingdom; Michabo Health Science, University of Birmingham Enterprise, Birmingham Research Park, Vincent Drive, Birmingham, B15 2SQ, United Kingdom. Electronic address: m.viant@bham.ac.uk.</Affiliation>
      </Author>
      <Author>
        <Name>Carole L. Yauk</Name>
        <Affiliation>Department of Biology, University of Ottawa, Ottawa, ON, K1N 6N5, Canada. Electronic address: carole.yauk@uottawa.ca.</Affiliation>
      </Author>
      <Author>
        <Name>Magdalini Sachana</Name>
        <Affiliation>Organisation for Economic Co-operation and Development (OECD), Environment Health and Safety Division, Paris, France.</Affiliation>
      </Author>
      <Author>
        <Name>Timothy W. Gant</Name>
        <Affiliation>Centre for Radiation, Chemical and Environmental Hazards (CRCE), Public Health England (PHE), Harwell Science Campus, Oxfordshire, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Scott S. Auerbach</Name>
        <Affiliation>Division of the National Toxicology Program, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Richard D. Beger</Name>
        <Affiliation>National Center for Toxicological Research, U.S. Food and Drug Administration, Jefferson, AR, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Mounir Bouhifd</Name>
        <Affiliation>European Chemicals Agency (ECHA), Helsinki, Finland.</Affiliation>
      </Author>
      <Author>
        <Name>Jason O'Brien</Name>
        <Affiliation>Ecotoxicology and Wildlife Health Division, Environment and Climate Change Canada, Ottawa, ON, K1A 0H3, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Lyle Burgoon</Name>
        <Affiliation>US Army Engineer Research and Development Center, 3909 Halls Ferry Rd, Vicksburg, MS, 39180, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Florian Caiment</Name>
        <Affiliation>Department of Toxicogenomics, Maastricht University, Universiteitssingel 50, 6229, ER, Maastricht, the Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Donatella Carpi</Name>
        <Affiliation>European Commission, Joint Research Centre (JRC), 21027, Ispra, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Tao Chen</Name>
        <Affiliation>National Center for Toxicological Research, U.S. Food and Drug Administration, Jefferson, AR, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Brian N. Chorley</Name>
        <Affiliation>Center for Computational Toxicology and Exposure, Office of Research and Development, U.S. Environmental Protection Agency, Research Triangle Park, NC, 27711, United States.</Affiliation>
      </Author>
      <Author>
        <Name>John Colbourne</Name>
        <Affiliation>School of Biosciences, University of Birmingham, Edgbaston, Birmingham, B15 2TT, United Kingdom; Michabo Health Science, University of Birmingham Enterprise, Birmingham Research Park, Vincent Drive, Birmingham, B15 2SQ, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Raffaella Corvi</Name>
        <Affiliation>European Commission, Joint Research Centre (JRC), 21027, Ispra, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Laurent Debrauwer</Name>
        <Affiliation>Toxalim (Research Centre in Food Toxicology), INRAE UMR 1331, ENVT, INP-Purpan, Paul Sabatier University (UPS), Toulouse, France; MetaToul-AXIOM Platform, MetaboHUB, National Infrastructure for Metabolomics and Fluxomics, Toulouse, France.</Affiliation>
      </Author>
      <Author>
        <Name>Claire O'Donovan</Name>
        <Affiliation>European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Hinxton, Cambridge, CB10 1SD, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Timothy M. D. Ebbels</Name>
        <Affiliation>Division of Systems Medicine, Department of Metabolism, Digestion and Reproduction, Imperial College London, SW7 2AZ, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Drew R. Ekman</Name>
        <Affiliation>Center for Environmental Measurement and Modeling, Office of Research and Development, U.S. Environmental Protection Agency, Athens, GA, 30605, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Frank Faulhammer</Name>
        <Affiliation>BASF SE, Toxicology and Ecology, 67056, Ludwigshafen, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Laura Gribaldo</Name>
        <Affiliation>European Commission, Joint Research Centre (JRC), 21027, Ispra, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Gina M. Hilton</Name>
        <Affiliation>PETA Science Consortium International e.V., Friolzheimer Str. 3, 70499, Stuttgart, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Stephanie P. Jones</Name>
        <Affiliation>Ecotoxicology and Wildlife Health Division, Environment and Climate Change Canada, Ottawa, ON, K1A 0H3, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Aniko Kende</Name>
        <Affiliation>Syngenta Jealott's Hill International Research Centre, Bracknell, RG42 6EY, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Thomas N. Lawson</Name>
        <Affiliation>Michabo Health Science, University of Birmingham Enterprise, Birmingham Research Park, Vincent Drive, Birmingham, B15 2SQ, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Sofia B. Leite</Name>
        <Affiliation>European Commission, Joint Research Centre (JRC), 21027, Ispra, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Pim E. G. Leonards</Name>
        <Affiliation>Department of Environment and Health, Vrije Universiteit Amsterdam, De Boelelaan 1085, 1081HV, Amsterdam, the Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Mirjam Luijten</Name>
        <Affiliation>Centre for Health Protection, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Alberto Martin</Name>
        <Affiliation>European Chemicals Agency (ECHA), Helsinki, Finland.</Affiliation>
      </Author>
      <Author>
        <Name>Laura Moussa</Name>
        <Affiliation>US Food and Drug Administration, Center for Veterinary Medicine, Rockville, MD, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Serge Rudaz</Name>
        <Affiliation>School of Pharmaceutical Sciences, University of Geneva, Geneva, Switzerland; Institute of Pharmaceutical Sciences of Western Switzerland, University of Geneva, Geneva, Switzerland; Swiss Centre for Applied Human Toxicology (SCAHT), Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Oliver Schmitz</Name>
        <Affiliation>BASF Metabolome Solutions, Metabolome Data Science, Tegeler Weg 33, 10589, Berlin, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Tomasz Sobanski</Name>
        <Affiliation>European Chemicals Agency (ECHA), Helsinki, Finland.</Affiliation>
      </Author>
      <Author>
        <Name>Volker Strauss</Name>
        <Affiliation>BASF SE, Toxicology and Ecology, 67056, Ludwigshafen, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Monica Vaccari</Name>
        <Affiliation>Center for Environmental Health and Prevention, Regional Agency for Prevention, Environment and Energy of Emilia-Romagna, Bologna, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Vikrant Vijay</Name>
        <Affiliation>National Center for Toxicological Research, U.S. Food and Drug Administration, Jefferson, AR, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Ralf J. M. Weber</Name>
        <Affiliation>School of Biosciences, University of Birmingham, Edgbaston, Birmingham, B15 2TT, United Kingdom; Michabo Health Science, University of Birmingham Enterprise, Birmingham Research Park, Vincent Drive, Birmingham, B15 2SQ, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Antony J. Williams</Name>
        <Affiliation>Center for Computational Toxicology and Exposure, Office of Research and Development, U.S. Environmental Protection Agency, Research Triangle Park, NC, 27711, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Andrew Williams</Name>
        <Affiliation>Environmental Health Science and Research Bureau, Health Canada, Ottawa, ON, K1A 0K9, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Russell S. Thomas</Name>
        <Affiliation>Center for Computational Toxicology and Exposure, Office of Research and Development, U.S. Environmental Protection Agency, Research Triangle Park, NC, 27711, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Maurice Whelan</Name>
        <Affiliation>European Commission, Joint Research Centre (JRC), 21027, Ispra, Italy.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Screening of different cytotoxicity methods for the assessment of ENDS toxicity relative to tobacco cigarettes.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34314750</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(21)00159-8</DOI>
    <KeywordList>
      <Keywords>Cigarette smoke</Keywords>
      <Keywords>Cytotoxicity</Keywords>
      <Keywords>ENDS</Keywords>
      <Keywords>Electronic cigarette</Keywords>
      <Keywords>Neutral red</Keywords>
      <Keywords>THP</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Massimo Caruso</Name>
        <Affiliation>Department of Biomedical and Biotechnological Sciences, University of Catania, Via S. Sofia, 97, 95123, Catania, Italy; Center of Excellence for the Acceleration of Harm Reduction (CoEHAR), University of Catania, Via S. Sofia, 97, 95123, Catania, Italy. Electronic address: mascaru@unict.it.</Affiliation>
      </Author>
      <Author>
        <Name>Rosalia Emma</Name>
        <Affiliation>Department of Biomedical and Biotechnological Sciences, University of Catania, Via S. Sofia, 97, 95123, Catania, Italy; Center of Excellence for the Acceleration of Harm Reduction (CoEHAR), University of Catania, Via S. Sofia, 97, 95123, Catania, Italy. Electronic address: rosalia.emma@unict.it.</Affiliation>
      </Author>
      <Author>
        <Name>Sonja Rust</Name>
        <Affiliation>Center of Excellence for the Acceleration of Harm Reduction (CoEHAR), University of Catania, Via S. Sofia, 97, 95123, Catania, Italy. Electronic address: sonja.rust@eclatrbc.it.</Affiliation>
      </Author>
      <Author>
        <Name>Alfio Distefano</Name>
        <Affiliation>Department of Biomedical and Biotechnological Sciences, University of Catania, Via S. Sofia, 97, 95123, Catania, Italy. Electronic address: distalfio@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Giuseppe Carota</Name>
        <Affiliation>Department of Biomedical and Biotechnological Sciences, University of Catania, Via S. Sofia, 97, 95123, Catania, Italy. Electronic address: giuseppe-carota@outlook.it.</Affiliation>
      </Author>
      <Author>
        <Name>Roberta Pulvirenti</Name>
        <Affiliation>Department of Biomedical and Biotechnological Sciences, University of Catania, Via S. Sofia, 97, 95123, Catania, Italy. Electronic address: pulvirentiroberta9@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Riccardo Polosa</Name>
        <Affiliation>Center of Excellence for the Acceleration of Harm Reduction (CoEHAR), University of Catania, Via S. Sofia, 97, 95123, Catania, Italy; Department of Clinical and Experimental Medicine, University of Catania, Via S. Sofia, 97, 95123, Catania, Italy. Electronic address: polosa@unict.it.</Affiliation>
      </Author>
      <Author>
        <Name>Giovanni Li Volti</Name>
        <Affiliation>Department of Biomedical and Biotechnological Sciences, University of Catania, Via S. Sofia, 97, 95123, Catania, Italy; Center of Excellence for the Acceleration of Harm Reduction (CoEHAR), University of Catania, Via S. Sofia, 97, 95123, Catania, Italy. Electronic address: livolti@unict.it.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A cross-industry survey on photosafety evaluation of pharmaceuticals after implementation of ICH S10.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34311056</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(21)00158-6</DOI>
    <KeywordList>
      <Keywords>ICH S10</Keywords>
      <Keywords>Pharmaceuticals</Keywords>
      <Keywords>Photosafety</Keywords>
      <Keywords>Phototoxicity</Keywords>
      <Keywords>Safety margins</Keywords>
      <Keywords>Sunlight</Keywords>
      <Keywords>Survey</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Daniel Bauer</Name>
        <Affiliation>Preclinical Safety, Novartis Institutes for BioMedical Research, Basel, Switzerland. Electronic address: daniel_manfred.bauer@novartis.com.</Affiliation>
      </Author>
      <Author>
        <Name>Lorrene A. Buckley</Name>
        <Affiliation>Toxicology and Drug Disposition, Eli Lilly and Company Inc., Indianapolis, IN, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Laure Delafoy</Name>
        <Affiliation>Preclinical Safety - Toxicology, Sanofi R&amp;D, Montpellier, France.</Affiliation>
      </Author>
      <Author>
        <Name>Heidrun Ellinger-Ziegelbauer</Name>
        <Affiliation>Investigational Toxicology, R&amp;D, Pharmaceuticals, Bayer AG, Wuppertal, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Mick D. Fellows</Name>
        <Affiliation>Clinical Pharmacology and Safety Sciences, R&amp;D, AstraZeneca, Cambridge, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Helga H. J. Gerets</Name>
        <Affiliation>Non-clinical Safety Evaluation, UCB BioPharma SRL, Braine L'Alleud, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Jonathan Howe</Name>
        <Affiliation>Genetic Toxicology and Photosafety, GlaxoSmithKline R&amp;D, Park Road, Ware, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Gerry Kaijser</Name>
        <Affiliation>Safety Assessment and Laboratory Animal Resources, MSD, Riom, France.</Affiliation>
      </Author>
      <Author>
        <Name>John Nicolette</Name>
        <Affiliation>Pre-clinical Safety, AbbVie Inc., North Chicago, IL, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Betty A. Pettersen</Name>
        <Affiliation>Drug Safety Research and Development, Pfizer Inc., Cambridge, MA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Brian Schimpf</Name>
        <Affiliation>Translational Research, SeaGen Inc., Bothell, WA, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Development of quantitative model of a local lymph node assay for evaluating skin sensitization potency applying machine learning CatBoost.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34311055</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(21)00160-4</DOI>
    <KeywordList>
      <Keywords>Adverse outcome pathway</Keywords>
      <Keywords>CatBoost</Keywords>
      <Keywords>Integrated approaches to testing and assessment</Keywords>
      <Keywords>Machine learning</Keywords>
      <Keywords>Murine local lymph node assay</Keywords>
      <Keywords>Quantitative model</Keywords>
      <Keywords>Skin sensitization</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Kaori Ambe</Name>
        <Affiliation>Department of Regulatory Science, Graduate School of Pharmaceutical Sciences, Nagoya City University, Nagoya, Japan. Electronic address: ambek@phar.nagoya-cu.ac.jp.</Affiliation>
      </Author>
      <Author>
        <Name>Masaharu Suzuki</Name>
        <Affiliation>Department of Regulatory Science, Graduate School of Pharmaceutical Sciences, Nagoya City University, Nagoya, Japan. Electronic address: c202712@ed.nagoya-cu.ac.jp.</Affiliation>
      </Author>
      <Author>
        <Name>Takao Ashikaga</Name>
        <Affiliation>Division of Risk Assessment, National Institute of Health Sciences, Kawasaki, Japan. Electronic address: takao.ashikaga@nihs.go.jp.</Affiliation>
      </Author>
      <Author>
        <Name>Masahiro Tohkin</Name>
        <Affiliation>Department of Regulatory Science, Graduate School of Pharmaceutical Sciences, Nagoya City University, Nagoya, Japan. Electronic address: tohkin@phar.nagoya-cu.ac.jp.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Application of the 3Rs principles in the development of pharmaceutical generics.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34302895</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(21)00157-4</DOI>
    <KeywordList>
      <Keywords>Animal</Keywords>
      <Keywords>Generic drug</Keywords>
      <Keywords>Impurities</Keywords>
      <Keywords>Regulatory</Keywords>
      <Keywords>Safety</Keywords>
      <Keywords>Toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Abhijit S. Vichare</Name>
        <Affiliation>Global Preclinical &amp; Product Safety, Abbott Healthcare Pvt Ltd., Mumbai, India. Electronic address: abhijit.vichare@abbott.com.</Affiliation>
      </Author>
      <Author>
        <Name>Sushant U. Kamath</Name>
        <Affiliation>Global Preclinical &amp; Product Safety, Abbott Healthcare Pvt Ltd., Mumbai, India.</Affiliation>
      </Author>
      <Author>
        <Name>Marcel Leist</Name>
        <Affiliation>In vitro Toxicology and Biomedicine, University of Konstanz, Konstanz, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>A. Wallace Hayes</Name>
        <Affiliation>The University of South Florida, College of Public Health, Tampa, FL, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Brinda Mahadevan</Name>
        <Affiliation>Brincor Associates, LLC, New Albany, OH, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Performance of the GHS Mixtures Equation for Predicting Acute Oral Toxicity.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34298086</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(21)00148-3</DOI>
    <KeywordList>
      <Keywords>Acute systemic toxicity</Keywords>
      <Keywords>Alternative approaches</Keywords>
      <Keywords>GHS Mixtures equation</Keywords>
      <Keywords>Non-animal methods</Keywords>
      <Keywords>Regulatory requirements</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jon Hamm</Name>
        <Affiliation>ILS, P.O. Box 13501, Research Triangle Park, NC, 27709, USA. Electronic address: jhamm@ils-inc.com.</Affiliation>
      </Author>
      <Author>
        <Name>David Allen</Name>
        <Affiliation>ILS, P.O. Box 13501, Research Triangle Park, NC, 27709, USA. Electronic address: dallen@ils-inc.com.</Affiliation>
      </Author>
      <Author>
        <Name>Patricia Ceger</Name>
        <Affiliation>ILS, P.O. Box 13501, Research Triangle Park, NC, 27709, USA. Electronic address: pceger1@ils-inc.com.</Affiliation>
      </Author>
      <Author>
        <Name>Tara Flint</Name>
        <Affiliation>Office of Pesticide Programs, U.S. Environmental Protection Agency, 1200 Pennsylvania Ave, NW, Washington, DC, 20460, USA. Electronic address: Flint.Tara@epa.gov.</Affiliation>
      </Author>
      <Author>
        <Name>Anna Lowit</Name>
        <Affiliation>Office of Pesticide Programs, U.S. Environmental Protection Agency, 1200 Pennsylvania Ave, NW, Washington, DC, 20460, USA. Electronic address: Lowit.Anna@epa.gov.</Affiliation>
      </Author>
      <Author>
        <Name>Lindsay O'Dell</Name>
        <Affiliation>Office of Pesticide Programs, U.S. Environmental Protection Agency, 1200 Pennsylvania Ave, NW, Washington, DC, 20460, USA. Electronic address: Odell.Lindsay@epa.gov.</Affiliation>
      </Author>
      <Author>
        <Name>Jenny Tao</Name>
        <Affiliation>Office of Pesticide Programs, U.S. Environmental Protection Agency, 1200 Pennsylvania Ave, NW, Washington, DC, 20460, USA. Electronic address: Tao.Jenny@epa.gov.</Affiliation>
      </Author>
      <Author>
        <Name>Nicole Kleinstreuer</Name>
        <Affiliation>National Toxicology Program Interagency Center for the Evaluation of Alternative Toxicological Methods, National Institute of Environmental Health Sciences, P.O. Box 12233, Research Triangle Park, NC, 27709, USA. Electronic address: nicole.kleinstreuer@nih.gov.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Automated read-across workflow for predicting acute oral toxicity: I. The decision scheme in the QSAR toolbox.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34293429</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(21)00156-2</DOI>
    <KeywordList>
      <Keywords>Acute oral toxicity</Keywords>
      <Keywords>Automated workflow</Keywords>
      <Keywords>Decision scheme</Keywords>
      <Keywords>QSAR Toolbox</Keywords>
      <Keywords>Read-across</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Stela Kutsarova</Name>
        <Affiliation>Laboratory of Mathematical Chemistry, Prof. As. Zlatarov University, Bourgas, Bulgaria.</Affiliation>
      </Author>
      <Author>
        <Name>Aycel Mehmed</Name>
        <Affiliation>Laboratory of Mathematical Chemistry, Prof. As. Zlatarov University, Bourgas, Bulgaria.</Affiliation>
      </Author>
      <Author>
        <Name>Daniela Cherkezova</Name>
        <Affiliation>Laboratory of Mathematical Chemistry, Prof. As. Zlatarov University, Bourgas, Bulgaria.</Affiliation>
      </Author>
      <Author>
        <Name>Stoyanka Stoeva</Name>
        <Affiliation>Laboratory of Mathematical Chemistry, Prof. As. Zlatarov University, Bourgas, Bulgaria.</Affiliation>
      </Author>
      <Author>
        <Name>Marin Georgiev</Name>
        <Affiliation>Laboratory of Mathematical Chemistry, Prof. As. Zlatarov University, Bourgas, Bulgaria.</Affiliation>
      </Author>
      <Author>
        <Name>Todor Petkov</Name>
        <Affiliation>Laboratory of Mathematical Chemistry, Prof. As. Zlatarov University, Bourgas, Bulgaria.</Affiliation>
      </Author>
      <Author>
        <Name>Atanas Chapkanov</Name>
        <Affiliation>Laboratory of Mathematical Chemistry, Prof. As. Zlatarov University, Bourgas, Bulgaria.</Affiliation>
      </Author>
      <Author>
        <Name>Terry W. Schultz</Name>
        <Affiliation>The University of Tennessee, College of Veterinary Medicine, Knoxville, TN, 37996-4500, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Ovanes G. Mekenyan</Name>
        <Affiliation>Laboratory of Mathematical Chemistry, Prof. As. Zlatarov University, Bourgas, Bulgaria. Electronic address: omekenya@btu.bg.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Opinion of the Scientific Committee on Consumer Safety (SCCS) - Final Opinion on propylparaben (CAS No 94-13-3, EC No 202-307-7).</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34274358</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(21)00146-X</DOI>
    <KeywordList>
      <Keywords>CAS No 94-13-3</Keywords>
      <Keywords>EC No 202-307-7</Keywords>
      <Keywords>Preservative</Keywords>
      <Keywords>Propylparaben</Keywords>
      <Keywords>Regulation 1223/2009</Keywords>
      <Keywords>SCCS</Keywords>
      <Keywords>SCCS/1623/20</Keywords>
      <Keywords>Scientific opinion</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name> </Name>
      </Author>
      <Author>
        <Name> </Name>
      </Author>
      <Author>
        <Name> </Name>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Assessing the impact of expert knowledge on ICH M7 (Q)SAR predictions. Is expert review still needed?</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34273441</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(21)00147-1</DOI>
    <KeywordList>
      <Keywords>(Q)SAR</Keywords>
      <Keywords>Ames</Keywords>
      <Keywords>Bacterial mutagenicity</Keywords>
      <Keywords>Computational toxicology</Keywords>
      <Keywords>Drug impurities</Keywords>
      <Keywords>Expert review</Keywords>
      <Keywords>ICH M7</Keywords>
      <Keywords>Structure-activity relationship</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>P. Suresh Jayasekara</Name>
        <Affiliation>US Food and Drug Administration, Center for Drug Evaluation and Research, Silver Spring, MD, 20993, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Sophie K. Skanchy</Name>
        <Affiliation>US Food and Drug Administration, Center for Drug Evaluation and Research, Silver Spring, MD, 20993, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Marlene T. Kim</Name>
        <Affiliation>US Food and Drug Administration, Center for Drug Evaluation and Research, Silver Spring, MD, 20993, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Govindaraj Kumaran</Name>
        <Affiliation>US Food and Drug Administration, Center for Drug Evaluation and Research, Silver Spring, MD, 20993, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Benon E. Mugabe</Name>
        <Affiliation>US Food and Drug Administration, Center for Drug Evaluation and Research, Silver Spring, MD, 20993, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Lauren E. Woodard</Name>
        <Affiliation>US Food and Drug Administration, Center for Drug Evaluation and Research, Silver Spring, MD, 20993, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jian Yang</Name>
        <Affiliation>US Food and Drug Administration, Center for Drug Evaluation and Research, Silver Spring, MD, 20993, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Andrew J. Zych</Name>
        <Affiliation>US Food and Drug Administration, Center for Drug Evaluation and Research, Silver Spring, MD, 20993, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Naomi L. Kruhlak</Name>
        <Affiliation>US Food and Drug Administration, Center for Drug Evaluation and Research, Silver Spring, MD, 20993, USA. Electronic address: Naomi.Kruhlak@fda.hhs.gov.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Toxicological assessment method for evaluating the occupational risk of dynamic olfactometry assessors.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34265403</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(21)00144-6</DOI>
    <KeywordList>
      <Keywords>Occupational health</Keywords>
      <Keywords>Occupational risk assessment</Keywords>
      <Keywords>Odorous emissions</Keywords>
      <Keywords>Olfactometric analysis</Keywords>
      <Keywords>Olfactometric examiners</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Elisa Polvara</Name>
        <Affiliation>Department of Chemistry, Materials and Chemical Engineering "Giulio Natta", Politecnico di Milano, Milano, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Andrea Spinazzè</Name>
        <Affiliation>Department of Science and High Technology DiSAT, Università degli Studi dell'Insubria, Como, Italy. Electronic address: andrea.spinazze@uninsubria.it.</Affiliation>
      </Author>
      <Author>
        <Name>Marzio Invernizzi</Name>
        <Affiliation>Department of Chemistry, Materials and Chemical Engineering "Giulio Natta", Politecnico di Milano, Milano, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Andrea Cattaneo</Name>
        <Affiliation>Department of Science and High Technology DiSAT, Università degli Studi dell'Insubria, Como, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Selena Sironi</Name>
        <Affiliation>Department of Chemistry, Materials and Chemical Engineering "Giulio Natta", Politecnico di Milano, Milano, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Domenico Maria Cavallo</Name>
        <Affiliation>Department of Science and High Technology DiSAT, Università degli Studi dell'Insubria, Como, Italy.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>An integrated benefit-risk assessment of cobalt-containing alloys used in medical devices: Implications for regulatory requirements in the European Union.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34256083</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(21)00145-8</DOI>
    <KeywordList>
      <Keywords>Alternatives assessment</Keywords>
      <Keywords>Benefit-risk assessment</Keywords>
      <Keywords>Carcinogenicity</Keywords>
      <Keywords>CoCrMo</Keywords>
      <Keywords>Cobalt</Keywords>
      <Keywords>Cobalt alloy</Keywords>
      <Keywords>Medical devices</Keywords>
      <Keywords>Reproductive toxicity</Keywords>
      <Keywords>Stainless steel</Keywords>
      <Keywords>Weight of evidence</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Gary Eichenbaum</Name>
        <Affiliation>Johnson &amp; Johnson, 410 George St, New Brunswick, NJ, 08901, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jared T. Wilsey</Name>
        <Affiliation>Smith &amp; Nephew, 1450 E Brooks Rd, Memphis, TN, 38116, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Gion Fessel</Name>
        <Affiliation>Smith &amp; Nephew, Oberneuhofstasse 10D, 6340, Baar, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Qing Qing Qiu</Name>
        <Affiliation>Stryker, 2825 Airview Boulevard, Kalamazoo, MI, 49002, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Laura Perkins</Name>
        <Affiliation>Abbott Vascular, 3200 Lakeside Dr, Santa Clara, CA, 95054, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Philippe Hasgall</Name>
        <Affiliation>Zimmer Biomet, Sulzerallee 8, CH-8404 Winterthur, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Andrew Monnot</Name>
        <Affiliation>Cardno ChemRisk, 235 Pine Street Suite 2300, San Francisco, CA, 94104, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Sharlee L. More</Name>
        <Affiliation>Cardno ChemRisk, 6720 S Macadam Ave Suite 150, Portland, OR, 97219, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Natalie Egnot</Name>
        <Affiliation>Cardno ChemRisk, 20 Stanwix Street Suite 505, Pittsburgh, PA, 15222, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jorge Sague</Name>
        <Affiliation>Stryker, 2825 Airview Boulevard, Kalamazoo, MI, 49002, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Stephen Marcello</Name>
        <Affiliation>Ethicon, A J&amp;J Company, Cincinnati, OH, 45242, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Kevin Connor</Name>
        <Affiliation>Boston Scientific, 100 Boston Scientific Way, Marlborough, MA, 01752, USA.</Affiliation>
      </Author>
      <Author>
        <Name>James Scutti</Name>
        <Affiliation>Boston Scientific, 100 Boston Scientific Way, Marlborough, MA, 01752, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Whitney V. Christian</Name>
        <Affiliation>Medtronic Plc, 6743 Southpoint Drive North, Jacksonville, FL, 32216, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Paul M. Coplan</Name>
        <Affiliation>Johnson &amp; Johnson, 410 George St, New Brunswick, NJ, 08901, USA; University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, 19104, USA.</Affiliation>
      </Author>
      <Author>
        <Name>John Wright</Name>
        <Affiliation>Johnson &amp; Johnson, 410 George St, New Brunswick, NJ, 08901, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Bob Hastings</Name>
        <Affiliation>Johnson &amp; Johnson, 410 George St, New Brunswick, NJ, 08901, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Laurence B. Katz</Name>
        <Affiliation>LifeScan Global Corporation, 20 Valley Stream Parkway, Malvern, PA, 19355, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Mark Vreeke</Name>
        <Affiliation>Edwards Lifesciences, One Edwards Way, Irvine, CA, 92614, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Millie Calistri-Yeh</Name>
        <Affiliation>Becton Dickinson, 1 Becton Drive, Franklin Lakes, NJ, 07417, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Brenda Faiola</Name>
        <Affiliation>Becton Dickinson, 1 Becton Drive, Franklin Lakes, NJ, 07417, USA; Rho, Inc., 2635 E NC Hwy 54, Durham, NC, 27713, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Bushan Purushothaman</Name>
        <Affiliation>Medtronic Plc, 8200 Coral Sea St NE, Mounds View, MN, 55112, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jim Nevelos</Name>
        <Affiliation>Stryker, 2825 Airview Boulevard, Kalamazoo, MI, 49002, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Mehran Bashiri</Name>
        <Affiliation>Stryker Neurovascular, 47900 Bayside Parkway, Fremont, CA, 94538, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jesper Bjerg Christensen</Name>
        <Affiliation>Novo Nordisk A/S, Stenager Allé 4, 9800, Hjørring, Denmark.</Affiliation>
      </Author>
      <Author>
        <Name>Michael Kovochich</Name>
        <Affiliation>Cardno ChemRisk, 30 North LaSalle St Suite 3910, Chicago, Illinois, 60602-2590, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Kenneth Unice</Name>
        <Affiliation>Cardno ChemRisk, 20 Stanwix Street Suite 505, Pittsburgh, PA, 15222, USA. Electronic address: Ken.Unice@cardno.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Preclinical screening for antidepressant activity - shifting focus away from the Forced Swim Test to the use of translational biomarkers.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34245825</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(21)00143-4</DOI>
    <KeywordList>
      <Keywords>3Rs</Keywords>
      <Keywords>Antidepressant</Keywords>
      <Keywords>Brain derived neurotrophic factor (BDNF)</Keywords>
      <Keywords>Forced swim test (FST)</Keywords>
      <Keywords>Porsolt test</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Fiona Sewell</Name>
        <Affiliation>National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs), Gibbs Building, 215 Euston Road, London, NW1 2BE, UK. Electronic address: fiona.sewell@nc3rs.org.uk.</Affiliation>
      </Author>
      <Author>
        <Name>Ian Waterson</Name>
        <Affiliation>Medicines and Healthcare Products Regulatory Agency (MHRA), 10 South Colonnade, Canary Wharf, London, E14 4PU, UK.</Affiliation>
      </Author>
      <Author>
        <Name>David Jones</Name>
        <Affiliation>Medicines and Healthcare Products Regulatory Agency (MHRA), 10 South Colonnade, Canary Wharf, London, E14 4PU, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Mark David Tricklebank</Name>
        <Affiliation>Centre for Neuroimaging Sciences, Institute of Psychiatry Psychology and Neuroscience, King's College London, London, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Ian Ragan</Name>
        <Affiliation>National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs), Gibbs Building, 215 Euston Road, London, NW1 2BE, UK.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Evaluation of 28-day repeated oral dose toxicity of SUNACTIVE Zn-P240 in rats.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34242707</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(21)00142-2</DOI>
    <KeywordList>
      <Keywords>NOAEL</Keywords>
      <Keywords>Repeated oral dose toxicity</Keywords>
      <Keywords>SUNACTIVE Zn–P240</Keywords>
      <Keywords>Target organ</Keywords>
      <Keywords>Zinc supplement</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jeong Hyun Lim</Name>
        <Affiliation>National Institute of Agricultural Sciences, Wanju, Jeonbuk, 55365, Republic of Korea; College of Veterinary Medicine, Chonnam National University, Gwangju, 61186, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Myeong Kyu Park</Name>
        <Affiliation>Health Care Institute, Korea Testing and Research Institute, Hwasun, Jeonnam, 58141, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Hyung Seon Baek</Name>
        <Affiliation>Health Care Institute, Korea Testing and Research Institute, Hwasun, Jeonnam, 58141, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Je Oh Lim</Name>
        <Affiliation>College of Veterinary Medicine, Chonnam National University, Gwangju, 61186, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Changjong Moon</Name>
        <Affiliation>College of Veterinary Medicine, Chonnam National University, Gwangju, 61186, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>In Sik Shin</Name>
        <Affiliation>College of Veterinary Medicine, Chonnam National University, Gwangju, 61186, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Jong Choon Kim</Name>
        <Affiliation>College of Veterinary Medicine, Chonnam National University, Gwangju, 61186, Republic of Korea. Electronic address: toxkim@jnu.ac.kr.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Characterization of tea tree oil nanoemulsion and its acute and subchronic toxicity.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34242706</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(21)00140-9</DOI>
    <KeywordList>
      <Keywords>Aqueous solubility</Keywords>
      <Keywords>Nanoemulsion</Keywords>
      <Keywords>Oral toxicity</Keywords>
      <Keywords>Tea tree oil</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>SiMin Wei</Name>
        <Affiliation>School of Veterinary Medicine, Yangzhou University, Yangzhou, 225009, PR China; Jiangsu Co-innovation Center for Prevention and Control of Important Animal Infectious Diseases and Zoonoses, Yangzhou, 225009, PR China; Joint International Research Laboratory of Agriculture and Agri-Product Safety, The Ministry of Education of China, Yangzhou University, Yangzhou, Jiangsu, 225009, China; Postgraduate Research &amp;Practice Innovation Program of Jiangsu Province, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xin Zhao</Name>
        <Affiliation>School of Veterinary Medicine, Yangzhou University, Yangzhou, 225009, PR China; Jiangsu Co-innovation Center for Prevention and Control of Important Animal Infectious Diseases and Zoonoses, Yangzhou, 225009, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Jie Yu</Name>
        <Affiliation>The Affiliated Hospital of Yangzhou University, Yangzhou University, Yangzhou, 225009, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>ShaoJie Yin</Name>
        <Affiliation>School of Veterinary Medicine, Yangzhou University, Yangzhou, 225009, PR China; Jiangsu Co-innovation Center for Prevention and Control of Important Animal Infectious Diseases and Zoonoses, Yangzhou, 225009, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>MingJiang Liu</Name>
        <Affiliation>School of Veterinary Medicine, Yangzhou University, Yangzhou, 225009, PR China; Jiangsu Co-innovation Center for Prevention and Control of Important Animal Infectious Diseases and Zoonoses, Yangzhou, 225009, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>RuoNan Bo</Name>
        <Affiliation>School of Veterinary Medicine, Yangzhou University, Yangzhou, 225009, PR China; Jiangsu Co-innovation Center for Prevention and Control of Important Animal Infectious Diseases and Zoonoses, Yangzhou, 225009, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>JinGui Li</Name>
        <Affiliation>School of Veterinary Medicine, Yangzhou University, Yangzhou, 225009, PR China; Jiangsu Co-innovation Center for Prevention and Control of Important Animal Infectious Diseases and Zoonoses, Yangzhou, 225009, PR China; Joint International Research Laboratory of Agriculture and Agri-Product Safety, The Ministry of Education of China, Yangzhou University, Yangzhou, Jiangsu, 225009, China. Electronic address: jingui_li@163.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Nonclinical genotoxicity and carcinogenicity profile of apremilast, an oral selective inhibitor of PDE4.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34237378</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(21)00126-4</DOI>
    <KeywordList>
      <Keywords>Anti-inflammatory</Keywords>
      <Keywords>Apremilast</Keywords>
      <Keywords>Carcinogenicity</Keywords>
      <Keywords>Genotoxicity</Keywords>
      <Keywords>ICHS2(R1)</Keywords>
      <Keywords>Phosphodiesterase-4 inhibitor</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Teresa Wegesser</Name>
        <Affiliation>Amgen Inc., Thousand Oaks, CA, 91320, USA. Electronic address: wegesser@amgen.com.</Affiliation>
      </Author>
      <Author>
        <Name>Aldo Coppi</Name>
        <Affiliation>Amgen Inc., Thousand Oaks, CA, 91320, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Tod Harper</Name>
        <Affiliation>Amgen Inc., Thousand Oaks, CA, 91320, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Maria Paris</Name>
        <Affiliation>Amgen Inc., Thousand Oaks, CA, 91320, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Sheroy Minocherhomji</Name>
        <Affiliation>Amgen Inc., Thousand Oaks, CA, 91320, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Monitoring and risk assessment of hazardous chemicals in toy-slime and putty in the Netherlands.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34233207</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(21)00141-0</DOI>
    <KeywordList>
      <Keywords>Boron</Keywords>
      <Keywords>Chloromethylisothiazolinone</Keywords>
      <Keywords>Methylisothiazolinone</Keywords>
      <Keywords>N-nitrosodiethanolamine</Keywords>
      <Keywords>Parabens</Keywords>
      <Keywords>Putty</Keywords>
      <Keywords>Risk assessment</Keywords>
      <Keywords>Toy safety</Keywords>
      <Keywords>Toy-slime</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>M. W. den Braver</Name>
        <Affiliation>Office for Risk Assessment &amp; Research, The Netherlands Food and Consumer Product Safety Authority (NVWA), the Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>D. J. Schakel</Name>
        <Affiliation>Chemical &amp; Microbiological Product Safety Laboratory, The Netherlands Food and Consumer Product Safety Authority (NVWA), the Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>H. S. Hendriks</Name>
        <Affiliation>Centre for Safety of Substances and Products, National Institute for Public Health and the Environment (RIVM), the Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>A. G. Schuur</Name>
        <Affiliation>Centre for Safety of Substances and Products, National Institute for Public Health and the Environment (RIVM), the Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>W. Brand</Name>
        <Affiliation>Centre for Safety of Substances and Products, National Institute for Public Health and the Environment (RIVM), the Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>D. T. H. M. Sijm</Name>
        <Affiliation>Office for Risk Assessment &amp; Research, The Netherlands Food and Consumer Product Safety Authority (NVWA), the Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>K. Bouma</Name>
        <Affiliation>Office for Risk Assessment &amp; Research, The Netherlands Food and Consumer Product Safety Authority (NVWA), the Netherlands. Electronic address: k.bouma@nvwa.nl.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Carcinogenic assessment of cobalt-containing alloys in medical devices or cobalt in occupational settings: A systematic review and meta-analysis of overall cancer risk from published epidemiologic studies.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34229014</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(21)00128-8</DOI>
    <KeywordList>
      <Keywords>Cobalt</Keywords>
      <Keywords>Joint prosthesis</Keywords>
      <Keywords>Neoplasms</Keywords>
      <Keywords>Occupational exposure</Keywords>
      <Keywords>Review literature as topic</Keywords>
      <Keywords>Risk</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Shumin Zhang</Name>
        <Affiliation>Johnson &amp; Johnson, 410 George Street, New Brunswick, NJ, 08901, USA. Electronic address: szhan141@its.jnj.com.</Affiliation>
      </Author>
      <Author>
        <Name>Chantal E. Holy</Name>
        <Affiliation>Johnson &amp; Johnson, 410 George Street, New Brunswick, NJ, 08901, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Gary Eichenbaum</Name>
        <Affiliation>Johnson &amp; Johnson, 410 George Street, New Brunswick, NJ, 08901, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Laura E. Perkins</Name>
        <Affiliation>Abbott Vascular, 3200 Lakeside Dr, Santa Clara, CA, 95054, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Philippe Hasgall</Name>
        <Affiliation>Zimmer Biomet, Sulzerallee 8, CH, 8404 Winterthur, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Laurence B. Katz</Name>
        <Affiliation>LifeScan Global Corporation, 20 Valley Stream Parkway, Malvern, PA, 19355, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jason R. Brown</Name>
        <Affiliation>Medtronic, 8200 Coral Sea St NE, Mounds View, MN, 55112, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Luca Orlandini</Name>
        <Affiliation>Smith+Nephew, Oberneuhofstrasse 10D, 6340 Baar, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Gion Fessel</Name>
        <Affiliation>Smith+Nephew, Oberneuhofstrasse 10D, 6340 Baar, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Behrooz Nasseri-Aghbosh</Name>
        <Affiliation>Stryker, Elstree, Borehamwood WD6 3SG, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Natalie S. Egnot</Name>
        <Affiliation>Cardno ChemRisk, 20 Stanwix St, Pittsburgh, PA, 15222, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Meijia Zhou</Name>
        <Affiliation>Johnson &amp; Johnson, 410 George Street, New Brunswick, NJ, 08901, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Richard Beech</Name>
        <Affiliation>Johnson &amp; Johnson, 410 George Street, New Brunswick, NJ, 08901, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Stephen R. Marcello</Name>
        <Affiliation>Johnson &amp; Johnson, 410 George Street, New Brunswick, NJ, 08901, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Paul M. Coplan</Name>
        <Affiliation>Johnson &amp; Johnson, 410 George Street, New Brunswick, NJ, 08901, USA; University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, 19104, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Determination of inorganic arsenic, heavy metals, pesticides and mycotoxins in Indian rice (Oryza sativa) and a probabilistic dietary risk assessment for the population of Saudi Arabia.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34224800</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(21)00127-6</DOI>
    <KeywordList>
      <Keywords>Heavy metal</Keywords>
      <Keywords>Inorganic arsenic</Keywords>
      <Keywords>Mycotoxin</Keywords>
      <Keywords>Pesticide</Keywords>
      <Keywords>Rice</Keywords>
      <Keywords>Risk assessment</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Mohammed Almutairi</Name>
        <Affiliation>Reference Laboratory for Food Chemistry, Saudi Food &amp; Drug Authority (SFDA), Riyadh, 11561, Saudi Arabia.</Affiliation>
      </Author>
      <Author>
        <Name>Turki Alsaleem</Name>
        <Affiliation>Reference Laboratory for Food Chemistry, Saudi Food &amp; Drug Authority (SFDA), Riyadh, 11561, Saudi Arabia.</Affiliation>
      </Author>
      <Author>
        <Name>Hatem Jeperel</Name>
        <Affiliation>Reference Laboratory for Food Chemistry, Saudi Food &amp; Drug Authority (SFDA), Riyadh, 11561, Saudi Arabia.</Affiliation>
      </Author>
      <Author>
        <Name>Mostafa Alsamti</Name>
        <Affiliation>Reference Laboratory for Food Chemistry, Saudi Food &amp; Drug Authority (SFDA), Riyadh, 11561, Saudi Arabia.</Affiliation>
      </Author>
      <Author>
        <Name>Abdullah M. Alowaifeer</Name>
        <Affiliation>Reference Laboratory for Food Chemistry, Saudi Food &amp; Drug Authority (SFDA), Riyadh, 11561, Saudi Arabia. Electronic address: vet.abdullah@gmail.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Classes of organic pigments meet tentative PSLT criteria and lack toxicity in short-term inhalation studies.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34224799</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(21)00129-X</DOI>
    <KeywordList>
      <Keywords>Alveolar macrophage assay</Keywords>
      <Keywords>Dissolution</Keywords>
      <Keywords>In vitro testing</Keywords>
      <Keywords>Inhalation</Keywords>
      <Keywords>Organic pigments</Keywords>
      <Keywords>PSLT</Keywords>
      <Keywords>Surface reactivity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Heidi Stratmann</Name>
        <Affiliation>Department of Product Safety, BASF Schweiz AG, Basel, Switzerland. Electronic address: heidi.stratmann@basf.com.</Affiliation>
      </Author>
      <Author>
        <Name>Wendel Wohlleben</Name>
        <Affiliation>BASF SE, Dept. Experimental Toxicology and Ecology, Dept. Material Physics, 67056, Ludwigshafen, Germany. Electronic address: wendel.wohlleben@basf.com.</Affiliation>
      </Author>
      <Author>
        <Name>Martin Wiemann</Name>
        <Affiliation>IBE R&amp;D Institute for Lung Health GmbH, 48149, Münster, Germany. Electronic address: martin.wiemann@ibe-ms.de.</Affiliation>
      </Author>
      <Author>
        <Name>Antje Vennemann</Name>
        <Affiliation>IBE R&amp;D Institute for Lung Health GmbH, 48149, Münster, Germany. Electronic address: vennemann@ibe-ms.de.</Affiliation>
      </Author>
      <Author>
        <Name>Nicole End</Name>
        <Affiliation>Department of Product Stewardship, BASF Colors &amp; Effects Switzerland AG, Basel, Switzerland. Electronic address: nicole.end@basf.com.</Affiliation>
      </Author>
      <Author>
        <Name>Ulrich Veith</Name>
        <Affiliation>Department of Product Stewardship, BASF Colors &amp; Effects Switzerland AG, Basel, Switzerland. Electronic address: ulrich.veith@basf.com.</Affiliation>
      </Author>
      <Author>
        <Name>Lan Ma-Hock</Name>
        <Affiliation>BASF SE, Dept. Experimental Toxicology and Ecology, Dept. Material Physics, 67056, Ludwigshafen, Germany. Electronic address: lan.ma-hock@basf.com.</Affiliation>
      </Author>
      <Author>
        <Name>Robert Landsiedel</Name>
        <Affiliation>BASF SE, Dept. Experimental Toxicology and Ecology, Dept. Material Physics, 67056, Ludwigshafen, Germany. Electronic address: robert.landsiedel@basf.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Retraction notice to "Proof of concept efficacy study of intranasal stabilized isoamyl nitrite (SIAN) in Rhesus monkeys against acute cyanide poisoning" [Regul. Toxicol. Pharmacol. 123 (2021) 104927].</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34218942</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(21)00124-0</DOI>
    <AuthorList>
      <Author>
        <Name>Yifei Zhong</Name>
        <Affiliation>Charles River (formerly Citoxlab North America), 445 Armand Frappier, Laval, QC, H7V 4B3, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Robert E. Raulli</Name>
        <Affiliation>Biomedical Advanced Research and Development Authority, Office of the Assistant Secretary for Preparedness and Response, US Department of Health and Human Services, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Samir Abtout</Name>
        <Affiliation>Charles River (formerly Citoxlab North America), 445 Armand Frappier, Laval, QC, H7V 4B3, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Simon Authier</Name>
        <Affiliation>Charles River (formerly Citoxlab North America), 445 Armand Frappier, Laval, QC, H7V 4B3, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Alexis Ascah</Name>
        <Affiliation>Charles River (formerly Citoxlab North America), 445 Armand Frappier, Laval, QC, H7V 4B3, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Daniel Lambert</Name>
        <Affiliation>Charles River (formerly Citoxlab North America), 445 Armand Frappier, Laval, QC, H7V 4B3, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Gloria Gutierrez</Name>
        <Affiliation>Southwest Research Institute, 6220 Culebra Road, San Antonio, TX, 78238, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Norma L. Cantú</Name>
        <Affiliation>Southwest Research Institute, 6220 Culebra Road, San Antonio, TX, 78238, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Nadean Gutierrez</Name>
        <Affiliation>Southwest Research Institute, 6220 Culebra Road, San Antonio, TX, 78238, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Larry Cabell</Name>
        <Affiliation>Southwest Research Institute, 6220 Culebra Road, San Antonio, TX, 78238, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Joe McDonough</Name>
        <Affiliation>Southwest Research Institute, 6220 Culebra Road, San Antonio, TX, 78238, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Kelly C. Cakouros</Name>
        <Affiliation>Emergent BioSolutions, Inc., 300 Professional Drive, Gaithersburg, MD, 20879, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Pablo Gurman</Name>
        <Affiliation>Emergent BioSolutions, Inc., 300 Professional Drive, Gaithersburg, MD, 20879, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Vladimir Savransky</Name>
        <Affiliation>Emergent BioSolutions, Inc., 300 Professional Drive, Gaithersburg, MD, 20879, USA. Electronic address: savranskyv@ebsi.com.</Affiliation>
      </Author>
      <Author>
        <Name>John Barry</Name>
        <Affiliation>Emergent BioSolutions, Inc., 300 Professional Drive, Gaithersburg, MD, 20879, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Concordance of 3 alternative teratogenicity assays with results from corresponding in vivo embryo-fetal development studies: Final report from the International Consortium for Innovation and Quality in Pharmaceutical Development (IQ) DruSafe working group 2.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34216694</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(21)00125-2</DOI>
    <KeywordList>
      <Keywords>Embryo-fetal lethality</Keywords>
      <Keywords>Likelihood ratios</Keywords>
      <Keywords>Malformations</Keywords>
      <Keywords>Murine embryonic stem cells</Keywords>
      <Keywords>NPV</Keywords>
      <Keywords>PPV</Keywords>
      <Keywords>Rat whole embryo culture</Keywords>
      <Keywords>Teratogenicity</Keywords>
      <Keywords>Zebrafish embryo culture</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>M. McNerney</Name>
        <Affiliation>Nonclinical Research and Development, Bristol Myers Squibb, New Brunswick, NJ, USA.</Affiliation>
      </Author>
      <Author>
        <Name>D. Potter</Name>
        <Affiliation>Drug Safety R&amp;D, Pfizer Inc., Cambridge, MA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>K. Augustine-Rauch</Name>
        <Affiliation>Nonclinical Research and Development, Bristol Myers Squibb, Lawrenceville, NJ, USA.</Affiliation>
      </Author>
      <Author>
        <Name>P. Barrow</Name>
        <Affiliation>Pharmaceutical Sciences, Roche Pharma Research and Early Development, Basel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>B. Beyer</Name>
        <Affiliation>Preclinical Safety, Sanofi U.S. Inc., Bridgewater, NJ, USA.</Affiliation>
      </Author>
      <Author>
        <Name>K. Brannen</Name>
        <Affiliation>Safety Assessment and Laboratory Animal Resources, Merck &amp; Co., Inc., West Point, PA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>S. Engel</Name>
        <Affiliation>Drug Safety R&amp;D, Pfizer Inc., Groton, CT, USA.</Affiliation>
      </Author>
      <Author>
        <Name>B. P. Enright</Name>
        <Affiliation>Preclinical Safety, Abbvie Inc., North Chicago, IL, USA.</Affiliation>
      </Author>
      <Author>
        <Name>W. S. Nowland</Name>
        <Affiliation>Drug Safety R&amp;D, Pfizer Inc., Groton, CT, USA.</Affiliation>
      </Author>
      <Author>
        <Name>N. Powles-Glover</Name>
        <Affiliation>Clinical Pharmacology and Safety Sciences, AstraZeneca, Cambridge, UK.</Affiliation>
      </Author>
      <Author>
        <Name>S. Powlin</Name>
        <Affiliation>Drug Safety Research and Evaluation, Takeda Pharmaceutical International Co, Cambridge, MA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>M. J. Schneidkraut</Name>
        <Affiliation>Drug Safety Research Laboratories - US, Astellas, Northbrook, IL, USA.</Affiliation>
      </Author>
      <Author>
        <Name>D. Stanislaus</Name>
        <Affiliation>Nonclinical Safety, GlaxoSmithKline, Collegeville, PA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>K. Turner</Name>
        <Affiliation>Nonclinical Safety, Janssen R&amp;D LLC, Spring House, PA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>M. Graziano</Name>
        <Affiliation>Nonclinical Research and Development, Bristol Myers Squibb, New Brunswick, NJ, USA. Electronic address: michael.graziano1@organon.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Final opinion on the safety of breast implants in relation to anaplastic large cell lymphoma: Report of the scientific committee on health, emerging and environmental risks (SCHEER).</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34214611</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(21)00122-7</DOI>
    <KeywordList>
      <Keywords>Anaplastic large cell lymphoma</Keywords>
      <Keywords>BIA-ALCL</Keywords>
      <Keywords>Breast implants</Keywords>
      <Keywords>Cancer</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Wim H. De Jong</Name>
        <Affiliation>Scientific Committee on Health, Environmental and Emerging Risks (SCHEER), European Commission, Luxembourg City, Luxembourg.</Affiliation>
      </Author>
      <Author>
        <Name>Demosthenes Panagiotakos</Name>
        <Affiliation>Scientific Committee on Health, Environmental and Emerging Risks (SCHEER), European Commission, Luxembourg City, Luxembourg.</Affiliation>
      </Author>
      <Author>
        <Name>Ana Proykova</Name>
        <Affiliation>Scientific Committee on Health, Environmental and Emerging Risks (SCHEER), European Commission, Luxembourg City, Luxembourg.</Affiliation>
      </Author>
      <Author>
        <Name>Theodoros Samaras</Name>
        <Affiliation>Scientific Committee on Health, Environmental and Emerging Risks (SCHEER), European Commission, Luxembourg City, Luxembourg.</Affiliation>
      </Author>
      <Author>
        <Name>Mark W. Clemens</Name>
        <Affiliation>The University of Texas MD Anderson Cancer Center, Houston, TX, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Daphne De Jong</Name>
        <Affiliation>Amsterdam UMC, VU University Medical Center, Amsterdam, the Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Ingrid Hopper</Name>
        <Affiliation>Monash University, Melbourne, Australia.</Affiliation>
      </Author>
      <Author>
        <Name>Hinne A. Rakhorst</Name>
        <Affiliation>Medisch Spectrum Twente, Enschede, the Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Fabio Santanelli di Pompeo</Name>
        <Affiliation>Sapienza University of Rome, Rome, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Suzanne D. Turner</Name>
        <Affiliation>University of Cambridge, Cambridge, CB2 0QQ, UK.</Affiliation>
      </Author>
      <Author>
        <Name> </Name>
        <Affiliation>Scientific Committee on Health, Environmental, And Emerging Risks (SCHEER), SCHEER Secretariat, European Commission, DG Health and Food Safety, Directorate C: Public Health, Country Knowledge, Crisis Management, Unit C2: Country Knowledge and Scientific Committees, HTC 03/073, L-2920, Luxembourg.</Affiliation>
      </Author>
      <Author>
        <Name> </Name>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Consumers' lack of understanding of customized cosmetics made on the spot and implications for regulations and controls.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34197870</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(21)00119-7</DOI>
    <KeywordList>
      <Keywords>Consumer survey</Keywords>
      <Keywords>Customized cosmetics</Keywords>
      <Keywords>On the spot</Keywords>
      <Keywords>Regulation</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>H. W. Kim</Name>
        <Affiliation>Department of Biotechnology, College of Life Sciences and Biotechnology, Korea University, Seoul 02841, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Y. S. Seok</Name>
        <Affiliation>Department of Biotechnology, College of Life Sciences and Biotechnology, Korea University, Seoul 02841, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>H. G. Lee</Name>
        <Affiliation>Consumers Union of Korea, Seoul, 04420, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>M. K. Song</Name>
        <Affiliation>Consumers Union of Korea, Seoul, 04420, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>M. S. Rhee</Name>
        <Affiliation>Department of Biotechnology, College of Life Sciences and Biotechnology, Korea University, Seoul 02841, Republic of Korea. Electronic address: rheems@korea.ac.kr.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Toxicological evaluation of S. involucrata culture: Acute, 90-day subchronic and genotoxicity studies.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34186141</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(21)00120-3</DOI>
    <KeywordList>
      <Keywords>Acute study</Keywords>
      <Keywords>Genotoxicity</Keywords>
      <Keywords>S. involucrata culture</Keywords>
      <Keywords>Subchronic toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Lei Han</Name>
        <Affiliation>School of Life Science,Yantai University, Yantai, 264005, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Kaili Chen</Name>
        <Affiliation>School of Life Science,Yantai University, Yantai, 264005, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Ping Liu</Name>
        <Affiliation>School of Life Science,Yantai University, Yantai, 264005, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Lintong Yang</Name>
        <Affiliation>School of Life Science,Yantai University, Yantai, 264005, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Yating Kang</Name>
        <Affiliation>School of Life Science,Yantai University, Yantai, 264005, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Yonglin Gao</Name>
        <Affiliation>School of Life Science,Yantai University, Yantai, 264005, PR China. Electronic address: gylbill@163.com.</Affiliation>
      </Author>
      <Author>
        <Name>Chunmei Li</Name>
        <Affiliation>School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University, Yantai, 264005, PR China. Electronic address: lichunmei@luye.com.</Affiliation>
      </Author>
      <Author>
        <Name>Chengfeng Sun</Name>
        <Affiliation>School of Life Science,Yantai University, Yantai, 264005, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Yanshen Li</Name>
        <Affiliation>School of Life Science,Yantai University, Yantai, 264005, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Wenxia Fan</Name>
        <Affiliation>Dalian Practical Biotechnology Co., Ltd., Dalian, 116001, China.</Affiliation>
      </Author>
      <Author>
        <Name>Hu Hou</Name>
        <Affiliation>College of Food Science and Engineering, Ocean University of China, Qingdao, China.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Chemical interactions and mixtures in public health risk assessment: An analysis of ATSDR's interaction profile database.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34186140</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(21)00121-5</DOI>
    <KeywordList>
      <Keywords>Binary weight of evidence</Keywords>
      <Keywords>Chemical mixtures</Keywords>
      <Keywords>Direction of interactions</Keywords>
      <Keywords>Interaction profiles</Keywords>
      <Keywords>Mechanistic understanding</Keywords>
      <Keywords>Risk assessment</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>J. Przybyla</Name>
        <Affiliation>Agency for Toxic Substances and Disease Registry, US Department of Health and Human Services, Atlanta, GA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>P. R. McClure</Name>
        <Affiliation>SRC, Inc. Syracuse, New York, USA.</Affiliation>
      </Author>
      <Author>
        <Name>K. J. Zaccaria</Name>
        <Affiliation>SRC, Inc. Syracuse, New York, USA.</Affiliation>
      </Author>
      <Author>
        <Name>H. R. Pohl</Name>
        <Affiliation>Agency for Toxic Substances and Disease Registry, US Department of Health and Human Services, Atlanta, GA, USA. Electronic address: hrp1@cdc.gov.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Systemic absorption of benzalkonium chloride after maximal use of a consumer antiseptic wash product.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34174381</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(21)00118-5</DOI>
    <KeywordList>
      <Keywords>Antimicrobial</Keywords>
      <Keywords>Benzalkonium chloride</Keywords>
      <Keywords>Human pharmacokinetic study</Keywords>
      <Keywords>Systemic absorption</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Paul C. DeLeo</Name>
        <Affiliation>Integral Consulting Inc., 200 Harry S. Truman Parkway, Suite 330, Annapolis, MD, 21401, USA. Electronic address: pdeleo@integral-corp.com.</Affiliation>
      </Author>
      <Author>
        <Name>Victoria Tu</Name>
        <Affiliation>Lonza LLC, 412 Mount Kemble Avenue, Morristown, NJ, 07960, USA. Electronic address: victoria.tu@lonza.com.</Affiliation>
      </Author>
      <Author>
        <Name>Janice Fuls</Name>
        <Affiliation>Henkel Corporation, Inc., 200 Elm Street, Stamford, CT, 06902, USA. Electronic address: janice.fuls@henkel.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A systematic approach to evaluate plausible modes of actions for mouse lung tumors in mice exposed to 4-methylimidozole.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34174380</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(21)00117-3</DOI>
    <KeywordList>
      <Keywords>4-Methylimidazole (4-MeI)</Keywords>
      <Keywords>Key characteristics of carcinogens (KCC)</Keywords>
      <Keywords>Mode of action</Keywords>
      <Keywords>Mouse lung tumors</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Susan J. Borghoff</Name>
        <Affiliation>ToxStrategies, Cary, NC, USA. Electronic address: sborghoff@toxstrategies.com.</Affiliation>
      </Author>
      <Author>
        <Name>Seneca E. Fitch</Name>
        <Affiliation>ToxStrategies, Katy, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Michael B. Black</Name>
        <Affiliation>ScitoVation, Research Triangle Park, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Patrick D. McMullen</Name>
        <Affiliation>ScitoVation, Research Triangle Park, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Melvin E. Andersen</Name>
        <Affiliation>ScitoVation, Research Triangle Park, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Grace A. Chappell</Name>
        <Affiliation>ToxStrategies, Asheville, NC, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A toxicological evaluation of lithium orotate.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34146638</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(21)00113-6</DOI>
    <KeywordList>
      <Keywords>Genotoxicity</Keywords>
      <Keywords>Lithium orotate</Keywords>
      <Keywords>NOAEL</Keywords>
      <Keywords>Repeated-dose toxicity</Keywords>
      <Keywords>Safety</Keywords>
      <Keywords>Toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Timothy S. Murbach</Name>
        <Affiliation>AIBMR Life Sciences, Inc., 1425 Broadway, Suite 458, Seattle, WA, 98122, USA. Electronic address: tim@aibmr.com.</Affiliation>
      </Author>
      <Author>
        <Name>Róbert Glávits</Name>
        <Affiliation>Toxi-Coop Zrt., Berlini utca 47-49, H-1045, Budapest, Hungary. Electronic address: glavits.robert.dr@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>John R. Endres</Name>
        <Affiliation>AIBMR Life Sciences, Inc., 1425 Broadway, Suite 458, Seattle, WA, 98122, USA. Electronic address: john@aibmr.com.</Affiliation>
      </Author>
      <Author>
        <Name>Gábor Hirka</Name>
        <Affiliation>Toxi-Coop Zrt., Berlini utca 47-49, H-1045, Budapest, Hungary; Toxi-Coop Zrt., Arácsi út 97, 8230, Balatonfüred, Hungary. Electronic address: gabor.hirka@toxicoop.com.</Affiliation>
      </Author>
      <Author>
        <Name>Adél Vértesi</Name>
        <Affiliation>Toxi-Coop Zrt., Arácsi út 97, 8230, Balatonfüred, Hungary. Electronic address: adel.vertesi@toxicoop.com.</Affiliation>
      </Author>
      <Author>
        <Name>Erzsébet Béres</Name>
        <Affiliation>Toxi-Coop Zrt., Arácsi út 97, 8230, Balatonfüred, Hungary. Electronic address: erzsebet.beres@toxicoop.com.</Affiliation>
      </Author>
      <Author>
        <Name>Ilona Pasics Szakonyiné</Name>
        <Affiliation>Toxi-Coop Zrt., Berlini utca 47-49, H-1045, Budapest, Hungary. Electronic address: ilona.pasics@toxicoop.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A toxicological evaluation of geranylgeraniol.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34144118</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(21)00115-X</DOI>
    <KeywordList>
      <Keywords>Genotoxicity</Keywords>
      <Keywords>Geranylgeraniol</Keywords>
      <Keywords>NOAEL</Keywords>
      <Keywords>Safety</Keywords>
      <Keywords>Toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Kayla Preece</Name>
        <Affiliation>AIBMR Life Sciences, Inc., 1425 Broadway, Suite 458, Seattle, WA, 98373, USA. Electronic address: kayla@aibmr.com.</Affiliation>
      </Author>
      <Author>
        <Name>Róbert Glávits</Name>
        <Affiliation>TOXI-COOP Zrt., Berlini Utca 47-49, H-1045, Budapest, Hungary. Electronic address: glavits.robert.dr@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>John R. Foster</Name>
        <Affiliation>ToxPath Sciences Ltd, 1 Troutbeck Avenue, Congleton, Cheshire, CW12 4JA, United Kingdom. Electronic address: john.foster@regulatoryscience.com.</Affiliation>
      </Author>
      <Author>
        <Name>Timothy Murbach</Name>
        <Affiliation>AIBMR Life Sciences, Inc., 1425 Broadway, Suite 458, Seattle, WA, 98373, USA. Electronic address: tim@aibmr.com.</Affiliation>
      </Author>
      <Author>
        <Name>John R. Endres</Name>
        <Affiliation>AIBMR Life Sciences, Inc., 1425 Broadway, Suite 458, Seattle, WA, 98373, USA. Electronic address: john@aibmr.com.</Affiliation>
      </Author>
      <Author>
        <Name>Gábor Hirka</Name>
        <Affiliation>TOXI-COOP Zrt., Berlini Utca 47-49, H-1045, Budapest, Hungary. Electronic address: gabor.hirka@toxicoop.com.</Affiliation>
      </Author>
      <Author>
        <Name>Adél Vértesi</Name>
        <Affiliation>Toxi-Coop Zrt., Arácsi út 97, 8230, Balatonfüred, Hungary. Electronic address: adel.vertesi@toxicoop.com.</Affiliation>
      </Author>
      <Author>
        <Name>Erzsébet Béres</Name>
        <Affiliation>Toxi-Coop Zrt., Arácsi út 97, 8230, Balatonfüred, Hungary. Electronic address: erzsebet.beres@toxicoop.com.</Affiliation>
      </Author>
      <Author>
        <Name>Ilona Pasics Szakonyiné</Name>
        <Affiliation>TOXI-COOP Zrt., Berlini Utca 47-49, H-1045, Budapest, Hungary. Electronic address: ilona.pasics@toxicoop.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Beyond dermal exposure: The respiratory tract as a target organ in hazard assessments of cosmetic ingredients.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34139277</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(21)00116-1</DOI>
    <KeywordList>
      <Keywords>Alternative methods</Keywords>
      <Keywords>Dermal exposure</Keywords>
      <Keywords>Inhalation exposure</Keywords>
      <Keywords>Irritation</Keywords>
      <Keywords>New approach methodologies</Keywords>
      <Keywords>Sensitisation</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Emanoela Lundgren Thá</Name>
        <Affiliation>Graduate Program in Genetics, Department of Genetics - Federal University of Paraná (UFPR), Curitiba, PR, Brazil. Electronic address: emanoela@ufpr.br.</Affiliation>
      </Author>
      <Author>
        <Name>Andrezza Di Pietro Micali Canavez</Name>
        <Affiliation>Grupo Boticário, Product Safety Management- Q&amp;PP, São José dos Pinhais, PR, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Desiree Cigaran Schuck</Name>
        <Affiliation>Grupo Boticário, Product Safety Management- Q&amp;PP, São José dos Pinhais, PR, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Viviana Stephanie Costa Gagosian</Name>
        <Affiliation>Graduate Program in Genetics, Department of Genetics - Federal University of Paraná (UFPR), Curitiba, PR, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Márcio Lorencini</Name>
        <Affiliation>Grupo Boticário, Product Safety Management- Q&amp;PP, São José dos Pinhais, PR, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Daniela Morais Leme</Name>
        <Affiliation>Department of Genetics - Federal University of Paraná (UFPR), Curitiba, PR, Brazil. Electronic address: daniela.leme@ufpr.br.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Preclinical safety assessment of the crude extract from Sida rhombifolia L. aerial parts in experimental models of acute and repeated-dose 28 days toxicity in rats.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34139276</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(21)00114-8</DOI>
    <KeywordList>
      <Keywords>Antioxidant</Keywords>
      <Keywords>Guanxuma</Keywords>
      <Keywords>Medicinal plant</Keywords>
      <Keywords>Phytochemistry</Keywords>
      <Keywords>Polyphenols</Keywords>
      <Keywords>Toxicology</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Isabel Cristina da Costa Araldi</Name>
        <Affiliation>Universidade Federal de Santa Maria, Santa Maria, RS, Brazil. Electronic address: araldi.isabel@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Thiele Piber de Souza</Name>
        <Affiliation>Universidade Federal de Santa Maria, Santa Maria, RS, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Marina de Souza Vencato</Name>
        <Affiliation>Universidade Federal de Santa Maria, Santa Maria, RS, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Thainara de Andrade Fortes</Name>
        <Affiliation>Universidade Federal de Santa Maria, Santa Maria, RS, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Camila Benaduce Emanuelli Mello</Name>
        <Affiliation>Universidade Federal de Santa Maria, Santa Maria, RS, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Juliana Sorraila de Oliveira</Name>
        <Affiliation>Universidade Federal de Santa Maria, Santa Maria, RS, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Guilherme Lopes Dornelles</Name>
        <Affiliation>Universidade Federal de Santa Maria, Santa Maria, RS, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Cinthia Melazzo de Andrade</Name>
        <Affiliation>Universidade Federal de Santa Maria, Santa Maria, RS, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Roberto Marinho Maciel</Name>
        <Affiliation>Universidade Federal de Santa Maria, Santa Maria, RS, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Cristiane Cademartori Danesi</Name>
        <Affiliation>Universidade Federal de Santa Maria, Santa Maria, RS, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Amanda Leitão Gindri</Name>
        <Affiliation>Universidade Regional Integrada do Alto Uruguai e das Missões, Santiago, RS, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Alencar Kolinski Machado</Name>
        <Affiliation>Universidade Franciscana, Santa Maria, RS, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Liliane de Freitas Bauermann</Name>
        <Affiliation>Universidade Federal de Santa Maria, Santa Maria, RS, Brazil.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Pharmacokinetics of cyadox and its main metabolites in rats, pigs, chickens, and carps following oral administration at three dosage.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34119601</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(21)00111-2</DOI>
    <KeywordList>
      <Keywords>Carp</Keywords>
      <Keywords>Chicken</Keywords>
      <Keywords>Cyadox</Keywords>
      <Keywords>Pharmacokinetics</Keywords>
      <Keywords>Pig</Keywords>
      <Keywords>Rat</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Sechenchogt Harnud</Name>
        <Affiliation>Research Center for Ecotoxicology and Food Safety, Hubei Engineering University, Xiaogan, 432000, PR China; College of Life Science and Technology, Hubei Engineering University, Xiaogan, 432000, PR China. Electronic address: chogt@sina.com.</Affiliation>
      </Author>
      <Author>
        <Name>Shishan Fu</Name>
        <Affiliation>National Reference Laboratory of Veterinary Drug Residues (HZAU), PR China; MAO Key Laboratory for Detection of Veterinary Drug Residues, Wuhan, Hubei, 430070, PR China; MOA Laboratory of Risk Assessment for Quality and Safety of Livestock and Poultry Products, Wuhan, Hubei, 430070, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Yulian Wang</Name>
        <Affiliation>National Reference Laboratory of Veterinary Drug Residues (HZAU), PR China; MAO Key Laboratory for Detection of Veterinary Drug Residues, Wuhan, Hubei, 430070, PR China; MOA Laboratory of Risk Assessment for Quality and Safety of Livestock and Poultry Products, Wuhan, Hubei, 430070, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Yuanhu Pan</Name>
        <Affiliation>National Reference Laboratory of Veterinary Drug Residues (HZAU), PR China; MAO Key Laboratory for Detection of Veterinary Drug Residues, Wuhan, Hubei, 430070, PR China; MOA Laboratory of Risk Assessment for Quality and Safety of Livestock and Poultry Products, Wuhan, Hubei, 430070, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Aiqun Zhang</Name>
        <Affiliation>Research Center for Ecotoxicology and Food Safety, Hubei Engineering University, Xiaogan, 432000, PR China; College of Life Science and Technology, Hubei Engineering University, Xiaogan, 432000, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Lingli Huang</Name>
        <Affiliation>National Reference Laboratory of Veterinary Drug Residues (HZAU), PR China; MAO Key Laboratory for Detection of Veterinary Drug Residues, Wuhan, Hubei, 430070, PR China; MOA Laboratory of Risk Assessment for Quality and Safety of Livestock and Poultry Products, Wuhan, Hubei, 430070, PR China. Electronic address: huanglingli@mail.hzau.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Analysis for data-derived extrapolation factors for procymidone.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34119600</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(21)00112-4</DOI>
    <KeywordList>
      <Keywords>Anogenital distance (AGD)</Keywords>
      <Keywords>Area under the curve (AUC)</Keywords>
      <Keywords>Chemical specific adjustment factors (CSAFs)</Keywords>
      <Keywords>Data-derived extrapolation factors (DDEFs)</Keywords>
      <Keywords>Developmental toxicity</Keywords>
      <Keywords>Hydroxy-procymidone (hydroxy-PCM)</Keywords>
      <Keywords>Hypospadias</Keywords>
      <Keywords>Mode of action (MOA)</Keywords>
      <Keywords>Peak plasma concentrations (cmax)</Keywords>
      <Keywords>Procymidone (PCM)</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Bernard K. Gadagbui</Name>
        <Affiliation>Toxicology Excellence for Risk Assessment, Cincinnati, OH, USA. Electronic address: gadagbui@tera.org.</Affiliation>
      </Author>
      <Author>
        <Name>Raymond G. York</Name>
        <Affiliation>RG York and Associates, LLC, Cincinnati, OH, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Michael L. Dourson</Name>
        <Affiliation>Toxicology Excellence for Risk Assessment, Cincinnati, OH, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Patricia M. McGinnis</Name>
        <Affiliation>Toxicology Excellence for Risk Assessment, Cincinnati, OH, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Rhian B. Cope</Name>
        <Affiliation>Australian Pesticides and Veterinary Medicines Authority, Sydney, Australia.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Refinement of decision tree to assess the consequences of increased serum ALP in dogs: Additional analysis on toxicity studies of pesticides evaluated recently in Japan.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34102240</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(21)00103-3</DOI>
    <KeywordList>
      <Keywords>Adversity</Keywords>
      <Keywords>Alkaline phosphatase</Keywords>
      <Keywords>Decision tree</Keywords>
      <Keywords>Dog</Keywords>
      <Keywords>Hepatotoxicity</Keywords>
      <Keywords>Hypertrophy</Keywords>
      <Keywords>Pesticide</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Yoko Yokoyama</Name>
        <Affiliation>Food Safety Commission of Japan, Tokyo, Japan; Tokyo University of Agriculture and Technology, Tokyo, Japan. Electronic address: yoko.yokoyama.h8w@cao.go.jp.</Affiliation>
      </Author>
      <Author>
        <Name>Atsushi Ono</Name>
        <Affiliation>Okayama University, Okayama, Japan. Electronic address: atsushiono3@okayama-u.ac.jp.</Affiliation>
      </Author>
      <Author>
        <Name>Midori Yoshida</Name>
        <Affiliation>Food Safety Commission of Japan, Tokyo, Japan. Electronic address: midori.yoshida.w2e@cao.go.jp.</Affiliation>
      </Author>
      <Author>
        <Name>Kiyoshi Matsumoto</Name>
        <Affiliation>Shinshu University, Nagano, Japan. Electronic address: kematsu@shinshu-u.ac.jp.</Affiliation>
      </Author>
      <Author>
        <Name>Mikako Saito</Name>
        <Affiliation>Tokyo University of Agriculture and Technology, Tokyo, Japan. Electronic address: mikako@cc.tuat.ac.jp.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Inhalation cancer risk assessment for environmental exposure to hexavalent chromium: Comparison of margin-of-exposure and linear extrapolation approaches.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34089813</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(21)00109-4</DOI>
    <KeywordList>
      <Keywords>Ambient air</Keywords>
      <Keywords>Cancer risk assessment</Keywords>
      <Keywords>Hexavalent chromium</Keywords>
      <Keywords>Inhalation</Keywords>
      <Keywords>Lung cancer</Keywords>
      <Keywords>Margin of exposure</Keywords>
      <Keywords>Mode of action</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Deborah M. Proctor</Name>
        <Affiliation>ToxStrategies, Inc, 27001 La Paz Rd, Suite 260, Mission Viejo, CA, 92691, USA. Electronic address: dproctor@toxstrategies.com.</Affiliation>
      </Author>
      <Author>
        <Name>Virunya Bhat</Name>
        <Affiliation>ToxStrategies, Boston, MA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Mina Suh</Name>
        <Affiliation>ToxStrategies, Inc, 27001 La Paz Rd, Suite 260, Mission Viejo, CA, 92691, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Heidi Reichert</Name>
        <Affiliation>EpidStrategies, Inc, Ann Arbor, MI, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaohui Jiang</Name>
        <Affiliation>EpidStrategies, Inc, Ann Arbor, MI, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Chad M. Thompson</Name>
        <Affiliation>ToxStrategies, Inc, Katy, TX, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Effect of hydrophilic and lipophilic statins on early onset cataract: A nationwide case-control study.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34087384</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(21)00110-0</DOI>
    <KeywordList>
      <Keywords>Early onset cataract</Keywords>
      <Keywords>Observational study</Keywords>
      <Keywords>Statin</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Hsiao Ling Chen</Name>
        <Affiliation>Department of Pharmacy, Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Hsiu Mei Chang</Name>
        <Affiliation>Department of Pharmacy, Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Horng Jiun Wu</Name>
        <Affiliation>Department of Ophthalmology, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Ying Chi Lin</Name>
        <Affiliation>School of Pharmacy, College of Pharmacy, Kaohsiung Medical University, Kaohsiung, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Yu Han Chang</Name>
        <Affiliation>Center of Teaching and Research, Kaohsiung Municipal Hsiao-Kang Hospital, Kaohsiung, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Yong Chieh Chang</Name>
        <Affiliation>Department of Pharmacy, Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Wen Hsien Lee</Name>
        <Affiliation>Division of Cardiology, Department of Internal Medicine, Kaohsiung Municipal Hsiao-Kang Hospital, Kaohsiung, Taiwan; Division of Cardiology, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Ching Tang Chang</Name>
        <Affiliation>Division of Cardiology, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan; Division of Cardiology, Department of Internal Medicine, Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung, Taiwan. Electronic address: cct1118@gmail.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>What happened to quinacrine non-surgical female sterilization?</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34062206</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(21)00108-2</DOI>
    <KeywordList>
      <Keywords>Biological relevance</Keywords>
      <Keywords>Carcinogenicity (CaBio)</Keywords>
      <Keywords>Chronic inflammation</Keywords>
      <Keywords>Contraception</Keywords>
      <Keywords>Maximum tolerated dose (MTD)</Keywords>
      <Keywords>Neoplasm</Keywords>
      <Keywords>Non-surgical sterilization</Keywords>
      <Keywords>Quinacrine</Keywords>
      <Keywords>Tumorigenicity</Keywords>
      <Keywords>Uterus</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Stephen D. Mumford</Name>
        <Affiliation>International Services Assistance Fund, P.O. Box 13067, Research Triangle Park, NC, 27709, USA. Electronic address: smumford@mindspring.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Aloe-emodin, a hydroxyanthracene derivative, is not genotoxic in an in vivo comet test.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34062205</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(21)00107-0</DOI>
    <KeywordList>
      <Keywords>Aloe-emodin</Keywords>
      <Keywords>Colon</Keywords>
      <Keywords>Hydroxyanthracene</Keywords>
      <Keywords>In vivo rodent comet assay</Keywords>
      <Keywords>Kidney</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Corrado L. Galli</Name>
        <Affiliation>Department of Pharmacological and Biomolecular Sciences (DISFeB), Section of Toxicology and Risk Assessment, University of Milan, Milan, Italy. Electronic address: corrado.galli@unimi.it.</Affiliation>
      </Author>
      <Author>
        <Name>Serena Cinelli</Name>
        <Affiliation>European Research Biology Center ERBC, Pomezia, Rome, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Paola Ciliutti</Name>
        <Affiliation>European Research Biology Center ERBC, Pomezia, Rome, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Gloria Melzi</Name>
        <Affiliation>Department of Pharmacological and Biomolecular Sciences (DISFeB), Section of Toxicology and Risk Assessment, University of Milan, Milan, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Marina Marinovich</Name>
        <Affiliation>Department of Pharmacological and Biomolecular Sciences (DISFeB), Section of Toxicology and Risk Assessment, University of Milan, Milan, Italy.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A matched molecular pair (MMP) approach for selecting analogs suitable for structure activity relationship (SAR)-based read across.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34044089</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(21)00106-9</DOI>
    <KeywordList>
      <Keywords>Analog</Keywords>
      <Keywords>Matched molecular pair (MMP)</Keywords>
      <Keywords>Read across</Keywords>
      <Keywords>Source</Keywords>
      <Keywords>Structure activity relationship (SAR)</Keywords>
      <Keywords>Target</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Cathy C. Lester</Name>
        <Affiliation>The Procter &amp; Gamble Company, 8700 Mason Montgomery Rd. Mason, OH, 45040, USA. Electronic address: lester.cc@pg.com.</Affiliation>
      </Author>
      <Author>
        <Name>Gang Yan</Name>
        <Affiliation>The Procter &amp; Gamble Company, 8700 Mason Montgomery Rd. Mason, OH, 45040, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Curing of UV prints - Assessment of possible toxicological hazard for consumers.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34038774</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(21)00105-7</DOI>
    <KeywordList>
      <Keywords>2,4-Diethylthioxanthone</Keywords>
      <Keywords>2/4-Isopropylthioxanthone</Keywords>
      <Keywords>Acrylates</Keywords>
      <Keywords>Ethoxylated trimethylolpropane triacrylate</Keywords>
      <Keywords>PPG-3 glyceryl triacrylate</Keywords>
      <Keywords>Photoinitiators</Keywords>
      <Keywords>Sensitisation</Keywords>
      <Keywords>Toxicological risk assessment</Keywords>
      <Keywords>Trimethylolpropane triacrylate</Keywords>
      <Keywords>UV printing Inks</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Melanie Macherey</Name>
        <Affiliation>Forschungs- und Beratungsinstitut Gefahrstoffe GmbH (FoBiG), Klarastraße 63, 79106, Freiburg, Germany. Electronic address: melanie.macherey@fobig.de.</Affiliation>
      </Author>
      <Author>
        <Name>Ulrike Schuhmacher-Wolz</Name>
        <Affiliation>Forschungs- und Beratungsinstitut Gefahrstoffe GmbH (FoBiG), Klarastraße 63, 79106, Freiburg, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Harry Belz</Name>
        <Affiliation>Bundesverband Druck und Medien e.V. (bvdm), Friedrichstraße 194-199, 10117, Berlin, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Evert H. Delbanco</Name>
        <Affiliation>Siegwerk Druckfarben AG &amp; Co. KGaA, Alfred-Keller-Straße 55, 53721, Siegburg, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Kathrin Mohr</Name>
        <Affiliation>Verband der deutschen Lack- und Druckfarbenindustrie e.V. (VdL), Mainzer Landstraße 55, 60329, Frankfurt, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Thomas Gude</Name>
        <Affiliation>Swiss Quality Testing Services (SQTS), Grünaustrasse 23, 853, Dietikon, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Eva Kaiser</Name>
        <Affiliation>Forschungs- und Beratungsinstitut Gefahrstoffe GmbH (FoBiG), Klarastraße 63, 79106, Freiburg, Germany.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The Threshold of Toxicological Concern (TTC) is a pragmatic tool for the safety assessment: Case studies of cosmetic ingredients with low consumer exposure.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34023455</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(21)00104-5</DOI>
    <KeywordList>
      <Keywords>Cosmetic ingredients</Keywords>
      <Keywords>Safety assessment</Keywords>
      <Keywords>Threshold of toxicological concern (TTC)</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Dagmar Bury</Name>
        <Affiliation>L'Oréal Research &amp; Innovation, 9 Rue Pierre Dreyfus, 92110, Clichy, France. Electronic address: dagmar.bury@rd.loreal.com.</Affiliation>
      </Author>
      <Author>
        <Name>Julia Head</Name>
        <Affiliation>Unilever, Safety &amp; Environmental Assurance Centre, Colworth House, Sharnbrook, Bedfordshire, MK44 1ET, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Detlef Keller</Name>
        <Affiliation>Henkel AG &amp; Co, KGaA, 40191, Düsseldorf, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Martina Klaric</Name>
        <Affiliation>Cosmetics Europe, 40 Avenue Hermann-Debroux, 1160, Brussels, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Jane Rose</Name>
        <Affiliation>Procter &amp; Gamble, Mason, OH, USA.</Affiliation>
      </Author>
      <Author>
        <Name> </Name>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Regulatory safety pharmacology and toxicity assessments of a standardized stem extract of Cassia occidentalis Linn. in rodents.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34022260</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(21)00100-8</DOI>
    <KeywordList>
      <Keywords>Clastogenic</Keywords>
      <Keywords>Genotoxicity</Keywords>
      <Keywords>Histopathology</Keywords>
      <Keywords>Osteogenic</Keywords>
      <Keywords>Safety pharmacology</Keywords>
      <Keywords>Sub chronic toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Madhav Nilakanth Mugale</Name>
        <Affiliation>Toxicology &amp; Experimental Medicine, CSIR-CDRI, Lucknow, 226 031, India. Electronic address: madhav.mugale@cdri.res.in.</Affiliation>
      </Author>
      <Author>
        <Name>Shubha Shukla</Name>
        <Affiliation>Pharmacology, CSIR-CDRI, Lucknow, 226 031, India. Electronic address: shubha_shukla@cdri.res.in.</Affiliation>
      </Author>
      <Author>
        <Name>Manish K. Chourasia</Name>
        <Affiliation>Pharmaceutics &amp; Pharmacokinetics, CSIR-CDRI, Lucknow, 226 031, India. Electronic address: manish_chourasia@cdri.res.in.</Affiliation>
      </Author>
      <Author>
        <Name>Kashif Hanif</Name>
        <Affiliation>Pharmacology, CSIR-CDRI, Lucknow, 226 031, India. Electronic address: k_hanif@cdri.res.in.</Affiliation>
      </Author>
      <Author>
        <Name>Aamir Nazir</Name>
        <Affiliation>Neuroscience &amp; Ageing Biology, CSIR-CDRI, Lucknow, 226 031, India. Electronic address: anazir@cdri.res.in.</Affiliation>
      </Author>
      <Author>
        <Name>Sarika Singh</Name>
        <Affiliation>Toxicology &amp; Experimental Medicine, CSIR-CDRI, Lucknow, 226 031, India. Electronic address: sarika_singh@cdri.res.in.</Affiliation>
      </Author>
      <Author>
        <Name>Jiaur R. Gayen</Name>
        <Affiliation>Pharmaceutics &amp; Pharmacokinetics, CSIR-CDRI, Lucknow, 226 031, India. Electronic address: jr.gayen@cdri.res.in.</Affiliation>
      </Author>
      <Author>
        <Name>Jagavelu Kumaravelu</Name>
        <Affiliation>Pharmacology, CSIR-CDRI, Lucknow, 226 031, India. Electronic address: kumaraveluj@cdri.res.in.</Affiliation>
      </Author>
      <Author>
        <Name>Raj Kamal Tripathi</Name>
        <Affiliation>Toxicology &amp; Experimental Medicine, CSIR-CDRI, Lucknow, 226 031, India. Electronic address: rk_tripathi@cdri.res.in.</Affiliation>
      </Author>
      <Author>
        <Name>Baisakhi Mohrana</Name>
        <Affiliation>Pharmacology, CSIR-CDRI, Lucknow, 226 031, India. Electronic address: b.moharana@cdri.res.in.</Affiliation>
      </Author>
      <Author>
        <Name>Manoj K. Barthwal</Name>
        <Affiliation>Pharmacology, CSIR-CDRI, Lucknow, 226 031, India. Electronic address: manojbarthwal@cdri.res.in.</Affiliation>
      </Author>
      <Author>
        <Name>Akhilesh Kumar</Name>
        <Affiliation>Toxicology &amp; Experimental Medicine, CSIR-CDRI, Lucknow, 226 031, India. Electronic address: akhilcdri@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Deepak Sharma</Name>
        <Affiliation>Pharmaceutics &amp; Pharmacokinetics, CSIR-CDRI, Lucknow, 226 031, India. Electronic address: deepak.vikki@yahoo.com.</Affiliation>
      </Author>
      <Author>
        <Name>Divya Mohan</Name>
        <Affiliation>Pharmacology, CSIR-CDRI, Lucknow, 226 031, India. Electronic address: divstar145@yahoo.com.</Affiliation>
      </Author>
      <Author>
        <Name>Anurag K. Srivastava</Name>
        <Affiliation>Toxicology &amp; Experimental Medicine, CSIR-CDRI, Lucknow, 226 031, India. Electronic address: anuragcdri@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Sheeba Saji Samuel</Name>
        <Affiliation>Pharmacology, CSIR-CDRI, Lucknow, 226 031, India. Electronic address: shebs9179@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Navodayam Kaleti</Name>
        <Affiliation>Toxicology &amp; Experimental Medicine, CSIR-CDRI, Lucknow, 226 031, India. Electronic address: navodayamk@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Sachi Bharti</Name>
        <Affiliation>Pharmacology, CSIR-CDRI, Lucknow, 226 031, India. Electronic address: sachicdri@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Anupama Srivastava</Name>
        <Affiliation>Toxicology &amp; Experimental Medicine, CSIR-CDRI, Lucknow, 226 031, India. Electronic address: anupmacdri@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Divyansh Sharma</Name>
        <Affiliation>Toxicology &amp; Experimental Medicine, CSIR-CDRI, Lucknow, 226 031, India. Electronic address: dvnshsharma08@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Anil Kumar Meena</Name>
        <Affiliation>Toxicology &amp; Experimental Medicine, CSIR-CDRI, Lucknow, 226 031, India. Electronic address: anilhtox@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Ramesh Chandra</Name>
        <Affiliation>Pharmacology, CSIR-CDRI, Lucknow, 226 031, India. Electronic address: rrameshcdri@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Sudhaker Yadav</Name>
        <Affiliation>Toxicology &amp; Experimental Medicine, CSIR-CDRI, Lucknow, 226 031, India. Electronic address: toxisudhaker@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Bharati Bhushan</Name>
        <Affiliation>Pharmacology, CSIR-CDRI, Lucknow, 226 031, India. Electronic address: bbhushancdri@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Sadan K. Pandey</Name>
        <Affiliation>Toxicology &amp; Experimental Medicine, CSIR-CDRI, Lucknow, 226 031, India. Electronic address: sadanway@yahoo.com.</Affiliation>
      </Author>
      <Author>
        <Name>Promod K. Agnihotri</Name>
        <Affiliation>Toxicology &amp; Experimental Medicine, CSIR-CDRI, Lucknow, 226 031, India. Electronic address: promodagnihotri@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Himangsu K. Bora</Name>
        <Affiliation>Laboratory Animals Facility, CSIR-CDRI, Lucknow, 226 031, India. Electronic address: drhkb008@cdri.res.in.</Affiliation>
      </Author>
      <Author>
        <Name>Sanjeev Kanojiya</Name>
        <Affiliation>Sophisticated Analytical Instrument Facility &amp; Research, CSIR-CDRI, Lucknow, 226 031, India. Electronic address: sanjeev_kanojiya@cdri.res.in.</Affiliation>
      </Author>
      <Author>
        <Name>Sharad Sharma</Name>
        <Affiliation>Toxicology &amp; Experimental Medicine, CSIR-CDRI, Lucknow, 226 031, India. Electronic address: s_sharma@cdri.res.in.</Affiliation>
      </Author>
      <Author>
        <Name>Prabhat Ranjan Mishra</Name>
        <Affiliation>Pharmaceutics &amp; Pharmacokinetics, CSIR-CDRI, Lucknow, 226 031, India. Electronic address: prabhat_mishra@cdri.res.in.</Affiliation>
      </Author>
      <Author>
        <Name>Kamal R. Arya</Name>
        <Affiliation>Division of Botany, CSIR-CDRI, Lucknow, 226 031, India. Electronic address: aryakr@rediffmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Naibedya Chattopadhyay</Name>
        <Affiliation>Endocrinology, CSIR-CDRI, Lucknow, 226 031, India. Electronic address: n_chattopadhyay@cdri.res.in.</Affiliation>
      </Author>
      <Author>
        <Name>Srikanta Kumar Rath</Name>
        <Affiliation>Toxicology &amp; Experimental Medicine, CSIR-CDRI, Lucknow, 226 031, India. Electronic address: skrath@cdri.res.in.</Affiliation>
      </Author>
      <Author>
        <Name>Smrati Bhadauria</Name>
        <Affiliation>Toxicology &amp; Experimental Medicine, CSIR-CDRI, Lucknow, 226 031, India. Electronic address: smriti_bhadauria@cdri.res.in.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Active pharmaceutical contaminants in dietary supplements: A tier-based risk assessment approach.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34022259</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(21)00095-7</DOI>
    <KeywordList>
      <Keywords>Active pharmaceutical ingredients (APIs)</Keywords>
      <Keywords>Dietary supplements</Keywords>
      <Keywords>Framework</Keywords>
      <Keywords>Human health</Keywords>
      <Keywords>Nutraceuticals</Keywords>
      <Keywords>Risk assessment</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Suren B. Bandara</Name>
        <Affiliation>Cardno ChemRisk, 235 Pine St #2300, San Francisco, CA, 94104, USA. Electronic address: suren.bandara@cardno.com.</Affiliation>
      </Author>
      <Author>
        <Name>Ania Urban</Name>
        <Affiliation>Cardno ChemRisk, 235 Pine St #2300, San Francisco, CA, 94104, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Lisa G. Liang</Name>
        <Affiliation>Cardno ChemRisk, 235 Pine St #2300, San Francisco, CA, 94104, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jillian Parker</Name>
        <Affiliation>Cardno ChemRisk, 65 Enterprise Suite 150, Aliso Viejo, CA, 92656, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Ernest Fung</Name>
        <Affiliation>Cardno ChemRisk, 65 Enterprise Suite 150, Aliso Viejo, CA, 92656, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Andrew Maier</Name>
        <Affiliation>Cardno ChemRisk, 9999 Carver Road Suite, 125, Cincinnati, OH, 45242, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Afidopyropen: Challenges and impact of a toxicokinetic study designed to identify a point of inflection from dose-proportionality.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34019964</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(21)00102-1</DOI>
    <KeywordList>
      <Keywords>KMD</Keywords>
      <Keywords>Kinetically derived maximum dose</Keywords>
      <Keywords>MTD</Keywords>
      <Keywords>Pharmacokinetics</Keywords>
      <Keywords>Rat</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Anne E. Loccisano</Name>
        <Affiliation>Exponent Inc, Alexandria, VA, 22314, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Elaine Freeman</Name>
        <Affiliation>Exponent Inc, Washington DC, 20036, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Brandy Riffle</Name>
        <Affiliation>BASF Corporation, Research Triangle Park, NC, 27709, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Adriana Doi</Name>
        <Affiliation>BASF Corporation, Research Triangle Park, NC, 27709, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Markus Frericks</Name>
        <Affiliation>BASF SE Experimental Toxicology and Ecology, Ludwigshafen, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Ivana Fegert</Name>
        <Affiliation>BASF SE Experimental Toxicology and Ecology, Ludwigshafen, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Eric Fabian</Name>
        <Affiliation>BASF SE Experimental Toxicology and Ecology, Ludwigshafen, Germany. Electronic address: eric.fabian@basf.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Derivation of an occupational exposure limit for β-glucans.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34019963</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(21)00099-4</DOI>
    <KeywordList>
      <Keywords>Beta-glucan</Keywords>
      <Keywords>Microbial exposure</Keywords>
      <Keywords>Occupational exposure limit</Keywords>
      <Keywords>Risk assessment</Keywords>
      <Keywords>Worker health</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jillian A. Parker</Name>
        <Affiliation>Cardno ChemRisk, Aliso Viejo, CA, USA. Electronic address: jillian.parker@cardno.com.</Affiliation>
      </Author>
      <Author>
        <Name>Corey Boles</Name>
        <Affiliation>Cardno ChemRisk, Cincinnati, OH, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Amanda N. Buerger</Name>
        <Affiliation>Cardno ChemRisk, Cincinnati, OH, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Ernest S. Fung</Name>
        <Affiliation>Cardno ChemRisk, Aliso Viejo, CA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Andrew Maier</Name>
        <Affiliation>Cardno ChemRisk, Cincinnati, OH, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Ethyl acrylate (EA) exposure and thyroid carcinogenicity in rats and mice with relevance to human health.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34015422</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(21)00101-X</DOI>
    <KeywordList>
      <Keywords>Cancer</Keywords>
      <Keywords>Endocrine disruption</Keywords>
      <Keywords>Human relevance</Keywords>
      <Keywords>Thyroid adenoma</Keywords>
      <Keywords>Thyroid carcinoma</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Thomas J. Rosol</Name>
        <Affiliation>Biomedical Sciences, Heritage College of Osteopathic Medicine, Ohio University, Athens, OH, 45701, USA. Electronic address: rosolt@ohio.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Raphael J. Witorsch</Name>
        <Affiliation>Department of Physiology and Biophysics, School of Medicine, Virginia Commonwealth University, Richmond, VA, 23298, USA. Electronic address: raphaelwitorsch@comcast.net.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Corrigendum to Lay people and experts' risk perception of pharmaceuticals in the environment in Southwestern Europe [Regul. Toxicol. Pharmacol. (2020) 104783].</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/34001392</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(21)00097-0</DOI>
    <AuthorList>
      <Author>
        <Name>Sílvia Luís</Name>
        <Affiliation>Instituto Universitário de Lisboa (Iscte), Centro de Investigação e Intervenção Social (CIS-IUL), Portugal; Instituto Superior de Ciências Sociais e Políticas (ISCSP), Centro de Administração e Políticas Públicas (CAPP - ISCSP), Universidade de Lisboa, Portugal. Electronic address: Silvia_luis@iscte-iul.pt.</Affiliation>
      </Author>
      <Author>
        <Name>Maria Luísa Lima</Name>
        <Affiliation>Instituto Universitário de Lisboa (Iscte), Centro de Investigação e Intervenção Social (CIS-IUL), Portugal.</Affiliation>
      </Author>
      <Author>
        <Name>Lucía Poggio</Name>
        <Affiliation>Universidad Complutense de Madrid, Faculdad de Psicologia, Spain.</Affiliation>
      </Author>
      <Author>
        <Name>Juan Ignacio Aragonés</Name>
        <Affiliation>Universidad Complutense de Madrid, Faculdad de Psicologia, Spain.</Affiliation>
      </Author>
      <Author>
        <Name>Audrey Courtier</Name>
        <Affiliation>Université de Nîmes, EA7352, CHROME, France.</Affiliation>
      </Author>
      <Author>
        <Name>Benoit Roig</Name>
        <Affiliation>Université de Nîmes, EA7352, CHROME, France.</Affiliation>
      </Author>
      <Author>
        <Name>Carole Blanchard</Name>
        <Affiliation>Université de Perpignan Via Domitia, Biocapteurs-Analyse-Environnement, 66860, Perpignan, France; Laboratoire de Biodiversité et Biotechnologies Microbiennes, USR 3579 Sorbonne Universités (UPMC) Paris 6 et CNRS Observatoire Océanologique, 66650, Banyuls-sur-Mer, France.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Ni and Cr impurities profile in Valeriana officinalis L., radix-based herbal medicinal product available in polish pharmacies due to ICH Q3D guideline.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33991634</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(21)00085-4</DOI>
    <KeywordList>
      <Keywords>Chromium</Keywords>
      <Keywords>Metal impurities profiling</Keywords>
      <Keywords>Nickel</Keywords>
      <Keywords>Pharmaceutical analysis</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Kamil Jurowski</Name>
        <Affiliation>Institute of Medical Studies, Medical College, Rzeszów University, Al. Mjr. W. Kopisto 2a, 35-959, Rzeszów, Poland. Electronic address: jurowski.tox@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Maria Fołta</Name>
        <Affiliation>Department of Food Chemistry and Nutrition, Medical College, Jagiellonian University, Medyczna 9, 30-688, Kraków, Poland.</Affiliation>
      </Author>
      <Author>
        <Name>Barbara Tatar</Name>
        <Affiliation>Department of Food Chemistry and Nutrition, Medical College, Jagiellonian University, Medyczna 9, 30-688, Kraków, Poland.</Affiliation>
      </Author>
      <Author>
        <Name>Mehmet Berkoz</Name>
        <Affiliation>Department of Biochemistry, Van Yuzuncu Yil University, Faculty of Pharmacy, 65080, Van, Turkey.</Affiliation>
      </Author>
      <Author>
        <Name>Mirosław Krośniak</Name>
        <Affiliation>Department of Food Chemistry and Nutrition, Medical College, Jagiellonian University, Medyczna 9, 30-688, Kraków, Poland.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Case analysis of kinetics investigations in toxicity studies of pesticides to identify the nonlinearity of internal exposure and the influences of nonlinearity on the toxicological interpretation of pesticide residue.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33991633</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(21)00098-2</DOI>
    <KeywordList>
      <Keywords>Kinetic investigation</Keywords>
      <Keywords>Nonlinearity of internal exposure</Keywords>
      <Keywords>Pesticide</Keywords>
      <Keywords>Toxicity study</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Satoshi Machino</Name>
        <Affiliation>Food Safety Commission, Cabinet Office of Japan. Akasaka Park Bld. 22F, 5-2-20 Akasaka, Minato-ku, Tokyo, 107-6122, Japan. Electronic address: satoshi.machino.t9h@cao.go.jp.</Affiliation>
      </Author>
      <Author>
        <Name>Yoko Yokoyama</Name>
        <Affiliation>Food Safety Commission, Cabinet Office of Japan. Akasaka Park Bld. 22F, 5-2-20 Akasaka, Minato-ku, Tokyo, 107-6122, Japan. Electronic address: yoko.yokoyama.h8w@cao.go.jp.</Affiliation>
      </Author>
      <Author>
        <Name>Toyohiro Egawa</Name>
        <Affiliation>Food Safety Commission, Cabinet Office of Japan. Akasaka Park Bld. 22F, 5-2-20 Akasaka, Minato-ku, Tokyo, 107-6122, Japan. Electronic address: toyohiro.egawa.y8i@cao.go.jp.</Affiliation>
      </Author>
      <Author>
        <Name>Hiroshi Satoh</Name>
        <Affiliation>Faculty of Agriculture, Iwate University. 3-18-8 Ueda, Morioka, Iwate, 020-8550, Japan. Electronic address: satohsss@iwate-u.ac.jp.</Affiliation>
      </Author>
      <Author>
        <Name>Katsuhiro Miyajima</Name>
        <Affiliation>Department of Nutritional Science and Food Safety, Faculty of Applied Bio-Science, Tokyo University of Agriculture. 1-1-1 Sakuragaoka, Setagaya-ku, Tokyo, 156-8502, Japan. Electronic address: km206186@nodai.ac.jp.</Affiliation>
      </Author>
      <Author>
        <Name>Midori Yoshida</Name>
        <Affiliation>Food Safety Commission, Cabinet Office of Japan. Akasaka Park Bld. 22F, 5-2-20 Akasaka, Minato-ku, Tokyo, 107-6122, Japan. Electronic address: midori.yoshida.w2e@cao.go.jp.</Affiliation>
      </Author>
      <Author>
        <Name>Satoshi Asano</Name>
        <Affiliation>Department of Pharmaceutical Science, International University of Health and Welfare. 2600-1 Kitakanemaru, Ohtawara, Tochigi, 324-8501, Japan. Electronic address: satoshi.asano@iuhw.ac.jp.</Affiliation>
      </Author>
      <Author>
        <Name>Shogo Ozawa</Name>
        <Affiliation>School of Pharmacy, Iwate Medical University 2-1-1 Nishitokuta, Yahaba-cho, Shiwa-gun, Iwate, 028-3684, Japan. Electronic address: sozawa@iwate-med.ac.jp.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Implementation of the principles of the 3Rs of animal testing at CDER: Past, present and future.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33984412</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(21)00093-3</DOI>
    <KeywordList>
      <Keywords>3Rs</Keywords>
      <Keywords>Alternative methods</Keywords>
      <Keywords>Animal studies</Keywords>
      <Keywords>CDER</Keywords>
      <Keywords>FDA</Keywords>
      <Keywords>Pharmaceutical regulation</Keywords>
      <Keywords>Toxicity testing</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Ronald L. Wange</Name>
        <Affiliation>US Food and Drug Administration, Center for Drug Evaluation and Research, Silver Spring, MD, USA. Electronic address: Ronald.Wange@fda.hhs.gov.</Affiliation>
      </Author>
      <Author>
        <Name>Paul C. Brown</Name>
        <Affiliation>US Food and Drug Administration, Center for Drug Evaluation and Research, Silver Spring, MD, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Karen L. Davis-Bruno</Name>
        <Affiliation>US Food and Drug Administration, Center for Drug Evaluation and Research, Silver Spring, MD, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Egg residue and depletion in Rhode Island Red hens (Gallus gallus domesticus) following multiple oral doses of trimethoprim-sulfamethoxazole.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33984411</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(21)00081-7</DOI>
    <KeywordList>
      <Keywords>Egg</Keywords>
      <Keywords>Hen</Keywords>
      <Keywords>LC-MS</Keywords>
      <Keywords>Sulfamethoxazole</Keywords>
      <Keywords>Trimethoprim</Keywords>
      <Keywords>WDI</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Hiroko Enomoto</Name>
        <Affiliation>Comparative Medicine Institute, North Carolina State University, Raleigh, NC, USA; Department of Population Health and Pathobiology, College of Veterinary Medicine, North Carolina State University, Raleigh, NC, 27607, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Olivia A. Petritz</Name>
        <Affiliation>Department of Clinical Sciences (Petritz, Flammer, Thomson), College of Veterinary Medicine, North Carolina State University, Raleigh, NC, 27607, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Andrea E. Thomson</Name>
        <Affiliation>Department of Clinical Sciences (Petritz, Flammer, Thomson), College of Veterinary Medicine, North Carolina State University, Raleigh, NC, 27607, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Keven Flammer</Name>
        <Affiliation>Department of Clinical Sciences (Petritz, Flammer, Thomson), College of Veterinary Medicine, North Carolina State University, Raleigh, NC, 27607, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Farha Ferdous</Name>
        <Affiliation>Department of Population Health and Pathobiology, College of Veterinary Medicine, North Carolina State University, Raleigh, NC, 27607, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Emma Meyer</Name>
        <Affiliation>Division of Pharmaceutical Sciences and Pharmacology, University of Missouri Kansas City School of Pharmacy, Kansas City, MO, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Lisa A. Tell</Name>
        <Affiliation>Department of Medicine and Epidemiology, School of Veterinary Medicine, University of California, Davis, CA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Ronald E. Baynes</Name>
        <Affiliation>Comparative Medicine Institute, North Carolina State University, Raleigh, NC, USA; Department of Population Health and Pathobiology, College of Veterinary Medicine, North Carolina State University, Raleigh, NC, 27607, USA. Electronic address: Ronald_Baynes@ncsu.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Determination of "fitness-for-purpose" of quantitative structure-activity relationship (QSAR) models to predict (eco-)toxicological endpoints for regulatory use.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33979632</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(21)00096-9</DOI>
    <KeywordList>
      <Keywords>In silico models</Keywords>
      <Keywords>QSAR</Keywords>
      <Keywords>Regulatory use</Keywords>
      <Keywords>Toxicity prediction</Keywords>
      <Keywords>Uncertainty</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Samuel J. Belfield</Name>
        <Affiliation>School of Pharmacy and Biomolecular Sciences, Liverpool John Moores University, Byrom Street, Liverpool, L3 3AF, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Steven J. Enoch</Name>
        <Affiliation>School of Pharmacy and Biomolecular Sciences, Liverpool John Moores University, Byrom Street, Liverpool, L3 3AF, UK.</Affiliation>
      </Author>
      <Author>
        <Name>James W. Firman</Name>
        <Affiliation>School of Pharmacy and Biomolecular Sciences, Liverpool John Moores University, Byrom Street, Liverpool, L3 3AF, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Judith C. Madden</Name>
        <Affiliation>School of Pharmacy and Biomolecular Sciences, Liverpool John Moores University, Byrom Street, Liverpool, L3 3AF, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Terry W. Schultz</Name>
        <Affiliation>University of Tennessee, College of Veterinary Medicine, Knoxville, TN, 37996-4500, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Mark T. D. Cronin</Name>
        <Affiliation>School of Pharmacy and Biomolecular Sciences, Liverpool John Moores University, Byrom Street, Liverpool, L3 3AF, UK. Electronic address: m.t.cronin@ljmu.ac.uk.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The Evolution of SEND at AstraZeneca.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33974947</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(21)00094-5</DOI>
    <KeywordList>
      <Keywords>Analytics</Keywords>
      <Keywords>CDISC</Keywords>
      <Keywords>Data warehousing</Keywords>
      <Keywords>SDTM</Keywords>
      <Keywords>SEND</Keywords>
      <Keywords>Submission</Keywords>
      <Keywords>Toxicology</Keywords>
      <Keywords>US FDA</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Claire Kent</Name>
        <Affiliation>Regulatory Safety, Clinical Pharmacology &amp; Safety Sciences, R&amp;D, AstraZeneca, Cambridge, UK. Electronic address: SEND-Data-Management@astrazeneca.com.</Affiliation>
      </Author>
      <Author>
        <Name>Brett Coupland</Name>
        <Affiliation>Regulatory Safety, Clinical Pharmacology &amp; Safety Sciences, R&amp;D, AstraZeneca, Cambridge, UK. Electronic address: SEND-Data-Management@astrazeneca.com.</Affiliation>
      </Author>
      <Author>
        <Name>Claire Barnard</Name>
        <Affiliation>Regulatory Safety, Clinical Pharmacology &amp; Safety Sciences, R&amp;D, AstraZeneca, Alderley Park, UK. Electronic address: SEND-Data-Management@astrazeneca.com.</Affiliation>
      </Author>
      <Author>
        <Name>Jason Schofield</Name>
        <Affiliation>Data Science &amp; AI, Clinical Pharmacology &amp; Safety Sciences, R&amp;D, AstraZeneca, Cambridge, UK. Electronic address: SEND-Data-Management@astrazeneca.com.</Affiliation>
      </Author>
      <Author>
        <Name>Shameen Afif-Rider</Name>
        <Affiliation>Regulatory Safety, Clinical Pharmacology &amp; Safety Sciences, R&amp;D, AstraZeneca, Gaithersburg, USA. Electronic address: SEND-Data-Management@astrazeneca.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Developing a database of systematic reviews of animal studies.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33964349</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(21)00080-5</DOI>
    <KeywordList>
      <Keywords>Animal studies</Keywords>
      <Keywords>Database</Keywords>
      <Keywords>Systematic reviews</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Miranda W. Langendam</Name>
        <Affiliation>Amsterdam University Medical Centres, University of Amsterdam, Department of Epidemiology and Data Science, Amsterdam Public Health Research Institute, the Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Kristen Magnuson</Name>
        <Affiliation>ICF, Durham, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Ashley R. Williams</Name>
        <Affiliation>ICF, Durham, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Vickie R. Walker</Name>
        <Affiliation>Division of the National Toxicology Program, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Kembra L. Howdeshell</Name>
        <Affiliation>Division of the National Toxicology Program, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Andrew A. Rooney</Name>
        <Affiliation>Division of the National Toxicology Program, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Carlijn R. Hooijmans</Name>
        <Affiliation>Systematic Review Centre for Laboratory Animal Experimentation (SYRCLE), Department for Health Evidence, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, the Netherlands. Electronic address: Carlijn.Hooijmans@radboudumc.nl.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Use of an animal model of disease for toxicology enables identification of a juvenile no observed adverse effect level for cyclocreatine in creatine transporter deficiency.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33961952</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(21)00079-9</DOI>
    <KeywordList>
      <Keywords>Animal models of disease</Keywords>
      <Keywords>Creatine analog</Keywords>
      <Keywords>Creatine transporter deficiency</Keywords>
      <Keywords>Cyclocreatine</Keywords>
      <Keywords>Non-conventional toxicology</Keywords>
      <Keywords>Preclinical toxicity</Keywords>
      <Keywords>SLC6A8</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Minh Ha Thi Do</Name>
        <Affiliation>Lumos Pharma, 4200 Marathon Blvd Suite 200, Austin, TX, 78756, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Joy Cavagnaro</Name>
        <Affiliation>Access Bio, P.O. Box 240, Boyce, VA, 22620, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Mark Butt</Name>
        <Affiliation>Tox Path Specialists, 8420 Gas House Pike Suite G, Frederick, MD, 21701, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Pramod S. Terse</Name>
        <Affiliation>National Center for Advancing Translational Sciences, National Institute of Health, 9800 Medical Center Drive, Rockville, MD, 20850, USA.</Affiliation>
      </Author>
      <Author>
        <Name>John C. McKew</Name>
        <Affiliation>Lumos Pharma, 4200 Marathon Blvd Suite 200, Austin, TX, 78756, USA. Electronic address: jmckew@lumos-pharma.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Support vector machine-based model for toxicity of organic compounds against fish.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33940084</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(21)00082-9</DOI>
    <KeywordList>
      <Keywords>Fish toxicity</Keywords>
      <Keywords>Organic chemicals</Keywords>
      <Keywords>Quantitative structure–toxicity relationship</Keywords>
      <Keywords>Support vector machine</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Xinliang Yu</Name>
        <Affiliation>Hunan Provincial Key Laboratory of Environmental Catalysis &amp; Waste Regeneration, College of Materials and Chemical Engineering, Hunan Institute of Engineering, Fuxing East Road 88#, Xiangtan, Hunan, 411104, China. Electronic address: yxl@hnie.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Fertility and early embryonic development toxicity assessment of naringin in Sprague-Dawley rats.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33933549</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(21)00078-7</DOI>
    <KeywordList>
      <Keywords>Fertility early embryonic development</Keywords>
      <Keywords>Naringin</Keywords>
      <Keywords>Reproductive toxicity</Keywords>
      <Keywords>Sprague-dawley rats</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Yonggang Wang</Name>
        <Affiliation>Guangdong Engineering and Technology Research Center for Quality and Efficacy Re-evaluation of Post-marketed TCM, Guangdong Key Laboratory of Plant Resources, School of Life Sciences, Sun Yat-sen University, Guangzhou, 510275, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Hao Wu</Name>
        <Affiliation>Guangdong Engineering and Technology Research Center for Quality and Efficacy Re-evaluation of Post-marketed TCM, Guangdong Key Laboratory of Plant Resources, School of Life Sciences, Sun Yat-sen University, Guangzhou, 510275, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Pan Chen</Name>
        <Affiliation>Guangdong Engineering and Technology Research Center for Quality and Efficacy Re-evaluation of Post-marketed TCM, Guangdong Key Laboratory of Plant Resources, School of Life Sciences, Sun Yat-sen University, Guangzhou, 510275, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Weiwei Su</Name>
        <Affiliation>Guangdong Engineering and Technology Research Center for Quality and Efficacy Re-evaluation of Post-marketed TCM, Guangdong Key Laboratory of Plant Resources, School of Life Sciences, Sun Yat-sen University, Guangzhou, 510275, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Wei Peng</Name>
        <Affiliation>Guangdong Engineering and Technology Research Center for Quality and Efficacy Re-evaluation of Post-marketed TCM, Guangdong Key Laboratory of Plant Resources, School of Life Sciences, Sun Yat-sen University, Guangzhou, 510275, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Peibo Li</Name>
        <Affiliation>Guangdong Engineering and Technology Research Center for Quality and Efficacy Re-evaluation of Post-marketed TCM, Guangdong Key Laboratory of Plant Resources, School of Life Sciences, Sun Yat-sen University, Guangzhou, 510275, PR China. Electronic address: lipeibo@mail.sysu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Safety evaluation of BPL9K-4 rice in a subchronic rodent feeding study.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33933548</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(21)00083-0</DOI>
    <KeywordList>
      <Keywords>Feeding study</Keywords>
      <Keywords>Rat</Keywords>
      <Keywords>Rice</Keywords>
      <Keywords>Subchronic toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Yuzhe Li</Name>
        <Affiliation>Key Laboratory of Food Safety Risk Assessment, Ministry of Health, China National Center for Food Safety Risk Assessment, Beijing, 100021, China.</Affiliation>
      </Author>
      <Author>
        <Name>Chunlai Liang</Name>
        <Affiliation>Key Laboratory of Food Safety Risk Assessment, Ministry of Health, China National Center for Food Safety Risk Assessment, Beijing, 100021, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jing Hu</Name>
        <Affiliation>Key Laboratory of Food Safety Risk Assessment, Ministry of Health, China National Center for Food Safety Risk Assessment, Beijing, 100021, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xue Geng</Name>
        <Affiliation>Key Laboratory of Food Safety Risk Assessment, Ministry of Health, China National Center for Food Safety Risk Assessment, Beijing, 100021, China.</Affiliation>
      </Author>
      <Author>
        <Name>Haibo Liu</Name>
        <Affiliation>Key Laboratory of Food Safety Risk Assessment, Ministry of Health, China National Center for Food Safety Risk Assessment, Beijing, 100021, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yongquan Feng</Name>
        <Affiliation>Key Laboratory of Food Safety Risk Assessment, Ministry of Health, China National Center for Food Safety Risk Assessment, Beijing, 100021, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yuan Zhi</Name>
        <Affiliation>Key Laboratory of Food Safety Risk Assessment, Ministry of Health, China National Center for Food Safety Risk Assessment, Beijing, 100021, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhou Yu</Name>
        <Affiliation>Key Laboratory of Food Safety Risk Assessment, Ministry of Health, China National Center for Food Safety Risk Assessment, Beijing, 100021, China. Electronic address: yuzhou@cfsa.net.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Comprehensive investigation evaluating the carcinogenic hazard potential of acetaminophen.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33933547</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(21)00084-2</DOI>
    <KeywordList>
      <Keywords>Acetaminophen</Keywords>
      <Keywords>Carcinogenicity</Keywords>
      <Keywords>Epidemiology</Keywords>
      <Keywords>Genotoxicity</Keywords>
      <Keywords>Hazard assessment</Keywords>
      <Keywords>Metabolism</Keywords>
      <Keywords>Weight of evidence</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jay E. Sirois</Name>
        <Affiliation>Consumer Healthcare Products Association, 1625 Eye Street, NW, Suite 600 Washington, DC, 20006, USA. Electronic address: jsirois@chpa.org.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A comprehensive review of mechanistic insights into formaldehyde-induced nasal cavity carcinogenicity.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33905780</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(21)00077-5</DOI>
    <KeywordList>
      <Keywords>Formaldehyde</Keywords>
      <Keywords>Nasal cancer</Keywords>
      <Keywords>Review</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Akiyoshi Nishikawa</Name>
        <Affiliation>Division of Pathology, National Institute of Health Sciences, 3-25-26 Tonomachi, Kawasaki, Kanagawa, 210-9501, Japan; Division of Clinical Pathology, Saiseikai Utsunomiya Hospital, 911-1 Takebayashi, Utsunomiya, Tochigi, 321-0974, Japan. Electronic address: nishikaw@nihs.go.jp.</Affiliation>
      </Author>
      <Author>
        <Name>Kasuke Nagano</Name>
        <Affiliation>Nagano Toxicologic-Pathology Consulting, 467-7 Ojiri, Hadano, Kanagawa, 257-0011, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Hajime Kojima</Name>
        <Affiliation>Division of Risk Assessment, National Institute of Health Sciences, 3-25-26 Tonomachi, Kawasaki, Kanagawa, 210-9501, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Kumiko Ogawa</Name>
        <Affiliation>Division of Pathology, National Institute of Health Sciences, 3-25-26 Tonomachi, Kawasaki, Kanagawa, 210-9501, Japan.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Next generation risk assessment for skin sensitisation: A case study with propyl paraben.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33905779</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(21)00076-3</DOI>
    <KeywordList>
      <Keywords>Defined approaches</Keywords>
      <Keywords>Hazard identification</Keywords>
      <Keywords>New approach methodologies</Keywords>
      <Keywords>Next generation risk assessment</Keywords>
      <Keywords>Parabens</Keywords>
      <Keywords>Risk characterisation</Keywords>
      <Keywords>Skin sensitisation</Keywords>
      <Keywords>Weight of evidence</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Hind Assaf Vandecasteele</Name>
        <Affiliation>L'Oréal, Research &amp; Innovation, Aulnay-sous-Bois, France, L'Oréal, Research &amp; Innovation, Clichy, France. Electronic address: hind.assafvandecasteele@rd.loreal.com.</Affiliation>
      </Author>
      <Author>
        <Name>Françoise Gautier</Name>
        <Affiliation>L'Oréal, Research &amp; Innovation, Aulnay-sous-Bois, France, L'Oréal, Research &amp; Innovation, Clichy, France. Electronic address: francoise.gautier@rd.loreal.com.</Affiliation>
      </Author>
      <Author>
        <Name>Fleur Tourneix</Name>
        <Affiliation>L'Oréal, Research &amp; Innovation, Aulnay-sous-Bois, France, L'Oréal, Research &amp; Innovation, Clichy, France. Electronic address: fleur.tourneix@rd.loreal.com.</Affiliation>
      </Author>
      <Author>
        <Name>Erwin van Vliet</Name>
        <Affiliation>Innovitox Consulting &amp; Services, Regentenland 35, 3994TZ, Houten, the Netherlands. Electronic address: vanvliete@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Dagmar Bury</Name>
        <Affiliation>L'Oréal, Research &amp; Innovation, Aulnay-sous-Bois, France, L'Oréal, Research &amp; Innovation, Clichy, France. Electronic address: dagmar.bury@rd.loreal.com.</Affiliation>
      </Author>
      <Author>
        <Name>Nathalie Alépée</Name>
        <Affiliation>L'Oréal, Research &amp; Innovation, Aulnay-sous-Bois, France, L'Oréal, Research &amp; Innovation, Clichy, France. Electronic address: nathalie.alepee@rd.loreal.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>New framework for a non-animal approach adequately assures the safety of cosmetic ingredients - A case study on caffeine.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33905778</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(21)00071-4</DOI>
    <KeywordList>
      <Keywords>Caffeine</Keywords>
      <Keywords>New approach methodologies</Keywords>
      <Keywords>Next generation risk assessment</Keywords>
      <Keywords>Physiologically-based kinetic modelling</Keywords>
      <Keywords>Read-across</Keywords>
      <Keywords>Systemic toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Dagmar Bury</Name>
        <Affiliation>L'Oréal, Research &amp; Innovation, 9 Rue Pierre Dreyfus, 92110, Clichy, France. Electronic address: dagmar.bury@rd.loreal.com.</Affiliation>
      </Author>
      <Author>
        <Name>Camilla Alexander-White</Name>
        <Affiliation>MKTox &amp; Co Ltd, 36 Fairford Crescent, Downhead Park, Milton Keynes, Buckinghamshire, MK15 9AQ, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Harvey J. Clewell</Name>
        <Affiliation>Ramboll Health Sciences, 3107 Armand Street, Monroe, LA, 71201, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Mark Cronin</Name>
        <Affiliation>School of Pharmacy and Biomolecular Sciences, Liverpool John Moores University, Byrom Street, Liverpool, L3 AF, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Bertrand Desprez</Name>
        <Affiliation>Cosmetics Europe, 40 Avenue Hermann-Debroux, 1160, Brussels, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Ann Detroyer</Name>
        <Affiliation>L'Oréal, Research &amp; Innovation, 1 Avenue Eugène Schueller, Aulnay-sous-Bois, France.</Affiliation>
      </Author>
      <Author>
        <Name>Alina Efremenko</Name>
        <Affiliation>ScitoVation, Research Triangle Park, Durham, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>James Firman</Name>
        <Affiliation>School of Pharmacy and Biomolecular Sciences, Liverpool John Moores University, Byrom Street, Liverpool, L3 AF, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Eric Hack</Name>
        <Affiliation>ScitoVation, Research Triangle Park, Durham, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Nicola J. Hewitt</Name>
        <Affiliation>The Procter &amp; Gamble Co., Cincinnati, OH, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Gerry Kenna</Name>
        <Affiliation>Cosmetics Europe, 40 Avenue Hermann-Debroux, 1160, Brussels, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Martina Klaric</Name>
        <Affiliation>Cosmetics Europe, 40 Avenue Hermann-Debroux, 1160, Brussels, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Cathy Lester</Name>
        <Affiliation>The Procter &amp; Gamble Co., Cincinnati, OH, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Catherine Mahony</Name>
        <Affiliation>Procter &amp; Gamble Technical Centres Ltd, Reading, RG2 0RX, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Gladys Ouedraogo</Name>
        <Affiliation>L'Oréal, Research &amp; Innovation, 1 Avenue Eugène Schueller, Aulnay-sous-Bois, France.</Affiliation>
      </Author>
      <Author>
        <Name>Alicia Paini</Name>
        <Affiliation>European Commission Joint Research Centre, Ispra, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Andreas Schepky</Name>
        <Affiliation>Beiersdorf, Unnastrasse 48, 20253, Hamburg, Germany.</Affiliation>
      </Author>
      <Author>
        <Name> </Name>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A simplified index to quantify the irritation/corrosion potential of chemicals - Part II: Eye.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33901590</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(21)00075-1</DOI>
    <KeywordList>
      <Keywords>Conjunctival redness</Keywords>
      <Keywords>Corneal opacity</Keywords>
      <Keywords>EU CLP</Keywords>
      <Keywords>Eye corrosion</Keywords>
      <Keywords>Eye irritation</Keywords>
      <Keywords>SII(EYE)</Keywords>
      <Keywords>UN GHS</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Carole Charmeau-Genevois</Name>
        <Affiliation>KREATiS, 23 Rue du Creuzat, 38080, L'Isle d'Abeau, France.</Affiliation>
      </Author>
      <Author>
        <Name>Satinder Sarang</Name>
        <Affiliation>Shell International, Shell Health, 150 North Dairy Ashford, Houston, TX, 77079, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Mélissa Perea</Name>
        <Affiliation>KREATiS, 23 Rue du Creuzat, 38080, L'Isle d'Abeau, France.</Affiliation>
      </Author>
      <Author>
        <Name>Nathalie Mayer</Name>
        <Affiliation>KREATiS, 23 Rue du Creuzat, 38080, L'Isle d'Abeau, France.</Affiliation>
      </Author>
      <Author>
        <Name>Charles Eadsforth</Name>
        <Affiliation>Shell International, Shell Health, 150 North Dairy Ashford, Houston, TX, 77079, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Tom Austin</Name>
        <Affiliation>Shell International, Shell Health, 150 North Dairy Ashford, Houston, TX, 77079, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Paul Thomas</Name>
        <Affiliation>KREATiS, 23 Rue du Creuzat, 38080, L'Isle d'Abeau, France. Electronic address: paul.thomas@kreatis.eu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Subchronic oral toxicity study of rhubarb extract in Sprague-Dawley rats.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33894279</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(21)00061-1</DOI>
    <KeywordList>
      <Keywords>No observed adverse effect level</Keywords>
      <Keywords>Rhubarb extract</Keywords>
      <Keywords>Subchronic oral toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Chunxia Liu</Name>
        <Affiliation>Hubei Provincial Key Laboratory for Applied Toxicology, Hubei Provincial Center for Disease Control and Prevention, Wuhan 430079, China. Electronic address: lchx216@163.com.</Affiliation>
      </Author>
      <Author>
        <Name>Ji Liu</Name>
        <Affiliation>Center for Food Evaluation, State Administration for Market Regulation, Beijing 10070, China. Electronic address: liuji@cfe-samr.org.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Yanhua Zheng</Name>
        <Affiliation>Hubei Provincial Key Laboratory for Applied Toxicology, Hubei Provincial Center for Disease Control and Prevention, Wuhan 430079, China. Electronic address: zyh512995587@163.com.</Affiliation>
      </Author>
      <Author>
        <Name>Jingjing Qu</Name>
        <Affiliation>Hubei Provincial Key Laboratory for Applied Toxicology, Hubei Provincial Center for Disease Control and Prevention, Wuhan 430079, China. Electronic address: qujingjing84@126.com.</Affiliation>
      </Author>
      <Author>
        <Name>Wenxiang Yang</Name>
        <Affiliation>Hubei Provincial Key Laboratory for Applied Toxicology, Hubei Provincial Center for Disease Control and Prevention, Wuhan 430079, China. Electronic address: ywx_21@163.com.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaoqiao Tang</Name>
        <Affiliation>Hubei Provincial Key Laboratory for Applied Toxicology, Hubei Provincial Center for Disease Control and Prevention, Wuhan 430079, China. Electronic address: melon_qiao@163.com.</Affiliation>
      </Author>
      <Author>
        <Name>Hong Bai</Name>
        <Affiliation>Center for Food Evaluation, State Administration for Market Regulation, Beijing 10070, China. Electronic address: baihong19640706@sina.com.</Affiliation>
      </Author>
      <Author>
        <Name>Bolin Fan</Name>
        <Affiliation>Hubei Provincial Key Laboratory for Applied Toxicology, Hubei Provincial Center for Disease Control and Prevention, Wuhan 430079, China. Electronic address: 963250015@qq.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Comparisons of PNEC derivation logic flows under example regulatory schemes and implications for ecoTTC.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33891999</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(21)00073-8</DOI>
    <KeywordList>
      <Keywords>Aquatic</Keywords>
      <Keywords>Hazard</Keywords>
      <Keywords>Predicted No Effect concentration</Keywords>
      <Keywords>Statistic</Keywords>
      <Keywords>Threshold of toxicologic concern</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>S. E. Belanger</Name>
        <Affiliation>The Procter &amp; Gamble Company, Cincinnati, OH, USA. Electronic address: sebelang@fuse.net.</Affiliation>
      </Author>
      <Author>
        <Name>A. Beasley</Name>
        <Affiliation>The Dow Chemical Company, Midland, MI, USA. Electronic address: abeasley@dow.com.</Affiliation>
      </Author>
      <Author>
        <Name>J. L. Brill</Name>
        <Affiliation>The Procter &amp; Gamble Company, Cincinnati, OH, USA. Electronic address: brill.jl@g.com.</Affiliation>
      </Author>
      <Author>
        <Name>J. Krailler</Name>
        <Affiliation>The Procter &amp; Gamble Company, Cincinnati, OH, USA. Electronic address: krailler.j@pg.com.</Affiliation>
      </Author>
      <Author>
        <Name>K. A. Connors</Name>
        <Affiliation>The Procter &amp; Gamble Company, Cincinnati, OH, USA. Electronic address: connors.ka@pg.com.</Affiliation>
      </Author>
      <Author>
        <Name>G. J. Carr</Name>
        <Affiliation>The Procter &amp; Gamble Company, Cincinnati, OH, USA. Electronic address: carr.gj@pg.com.</Affiliation>
      </Author>
      <Author>
        <Name>M. Embry</Name>
        <Affiliation>Health and Environmental Sciences Institute, Washington, DC, USA. Electronic address: membry@hesiglobal.com.</Affiliation>
      </Author>
      <Author>
        <Name>M. G. Barron</Name>
        <Affiliation>U.S. EPA, Office of Research &amp; Development, Gulf Breeze, FL, USA. Electronic address: Barron.Mace@epa.gov.</Affiliation>
      </Author>
      <Author>
        <Name>R. Otter</Name>
        <Affiliation>The Data Science Institute, Middle Tennessee State University, Murfreesboro, TN, USA. Electronic address: ryan.otter@mtsu.edu.</Affiliation>
      </Author>
      <Author>
        <Name>A. Kienzler</Name>
        <Affiliation>European Commission, Joint Research Centre, Ispra, Italy. Electronic address: aude.kienzler@efsa.europa.eu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Serial blood sampling effects in rat embryo-fetal development studies for toxicokinetics.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33891998</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(21)00070-2</DOI>
    <KeywordList>
      <Keywords>3Rs</Keywords>
      <Keywords>Pregnant rat</Keywords>
      <Keywords>Regulatory toxicology</Keywords>
      <Keywords>Study design</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jinsoo Lee</Name>
        <Affiliation>Developmental and Reproductive Toxicology Research Group, Korea Institute of Toxicology, Daejeon, Republic of Korea; College of Veterinary Medicine, Chungbuk National University, Cheongju, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Ji Seong Jeong</Name>
        <Affiliation>Developmental and Reproductive Toxicology Research Group, Korea Institute of Toxicology, Daejeon, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Woojin Kim</Name>
        <Affiliation>Toxicological Pathology Research Group, Korea Institute of Toxicology, Daejeon, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Sang Yun Kim</Name>
        <Affiliation>Developmental and Reproductive Toxicology Research Group, Korea Institute of Toxicology, Daejeon, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Seung Jin Lee</Name>
        <Affiliation>Developmental and Reproductive Toxicology Research Group, Korea Institute of Toxicology, Daejeon, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Sang Ki Baek</Name>
        <Affiliation>Developmental and Reproductive Toxicology Research Group, Korea Institute of Toxicology, Daejeon, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Jae Hwan Lee</Name>
        <Affiliation>Developmental and Reproductive Toxicology Research Group, Korea Institute of Toxicology, Daejeon, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Eun Ju Jeong</Name>
        <Affiliation>Chemical Risk Assessment Research Committee, Korea Institute of Toxicology, Daejeon, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Sang Yoon Nam</Name>
        <Affiliation>College of Veterinary Medicine, Chungbuk National University, Cheongju, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Wook Joon Yu</Name>
        <Affiliation>Developmental and Reproductive Toxicology Research Group, Korea Institute of Toxicology, Daejeon, Republic of Korea. Electronic address: yuwj@kitox.re.kr.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Management of bias and conflict of interest among occupational exposure limit expert groups.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33872741</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(21)00069-6</DOI>
    <KeywordList>
      <Keywords>Advisory committees</Keywords>
      <Keywords>Industrial hygiene</Keywords>
      <Keywords>Maximum allowable concentration</Keywords>
      <Keywords>Occupational toxicology</Keywords>
      <Keywords>Threshold limit values</Keywords>
      <Keywords>Vested interest</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Linda Schenk</Name>
        <Affiliation>Integrative Toxicology, Institute of Environmental Medicine, Karolinska Institutet, Box 210, 171 77, Stockholm, Sweden; Department of Philosophy and History, KTH- Royal Institute of Technology, Teknikringen 76, 100 44, Stockholm, Sweden. Electronic address: linda.schenk@ki.se.</Affiliation>
      </Author>
      <Author>
        <Name>Gunnar Johanson</Name>
        <Affiliation>Integrative Toxicology, Institute of Environmental Medicine, Karolinska Institutet, Box 210, 171 77, Stockholm, Sweden. Electronic address: gunnar.johanson@ki.se.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>An orthogonal methods assessment of topical drug concentrations in skin and the impact for risk assessment in the viable epidermis.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33872740</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(21)00074-X</DOI>
    <KeywordList>
      <Keywords>Concentration gradient</Keywords>
      <Keywords>Epidermal toxicity</Keywords>
      <Keywords>Laser capture microdissection</Keywords>
      <Keywords>Mass spectrometry imaging</Keywords>
      <Keywords>Skin concentration</Keywords>
      <Keywords>Stratum basale</Keywords>
      <Keywords>Threshold toxicity</Keywords>
      <Keywords>Topical drug development</Keywords>
      <Keywords>Topical risk assessment</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Brett D. Hollingshead</Name>
        <Affiliation>Pfizer Drug Safety Research and Development, 1 Portland Street, Cambridge, MA, 02139, USA. Electronic address: brett.d.hollingshead@pfizer.com.</Affiliation>
      </Author>
      <Author>
        <Name>Lindsay Tomlinson</Name>
        <Affiliation>Pfizer Drug Safety Research and Development, 1 Portland Street, Cambridge, MA, 02139, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jim Finley</Name>
        <Affiliation>Pfizer Drug Safety Research and Development, Eastern Point Road, Groton, CT, 06340, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Colleen Doshna</Name>
        <Affiliation>Pfizer Drug Safety Research and Development, Eastern Point Road, Groton, CT, 06340, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Casey Ritenour</Name>
        <Affiliation>Pfizer Drug Safety Research and Development, Eastern Point Road, Groton, CT, 06340, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jason Barricklow</Name>
        <Affiliation>Pfizer Pharmacokinetics, Dynamics and Metabolism, Eastern Point Road, Groton, CT, 06340, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Stacey R. Oppenheimer</Name>
        <Affiliation>Pfizer Early Clinical Development, 610 Main Street, Cambridge, MA, 02139, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Shawn P. O'Neil</Name>
        <Affiliation>Pfizer Drug Safety Research and Development, 1 Portland Street, Cambridge, MA, 02139, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jessica L. Moore</Name>
        <Affiliation>Frontier Diagnostics, 345 Hill Ave, Nashville, TN, 37210, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Nathan Heath Patterson</Name>
        <Affiliation>Frontier Diagnostics, 345 Hill Ave, Nashville, TN, 37210, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Sarah P. Nicholson</Name>
        <Affiliation>Frontier Diagnostics, 345 Hill Ave, Nashville, TN, 37210, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jeremy L. Norris</Name>
        <Affiliation>Frontier Diagnostics, 345 Hill Ave, Nashville, TN, 37210, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Richard M. Caprioli</Name>
        <Affiliation>Frontier Diagnostics, 345 Hill Ave, Nashville, TN, 37210, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Kevin Beaumont</Name>
        <Affiliation>Pfizer Pharmacokinetics, Dynamics and Metabolism, 1 Portland Street, Cambridge, MA, 02139, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Amanda J. King-Ahmad</Name>
        <Affiliation>Pfizer Pharmacokinetics, Dynamics and Metabolism, Eastern Point Road, Groton, CT, 06340, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Saurabh Vispute</Name>
        <Affiliation>Pfizer Drug Safety Research and Development, Eastern Point Road, Groton, CT, 06340, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jon C. Cook</Name>
        <Affiliation>Pfizer Drug Safety Research and Development, Eastern Point Road, Groton, CT, 06340, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Zaher Radi</Name>
        <Affiliation>Pfizer Drug Safety Research and Development, 1 Portland Street, Cambridge, MA, 02139, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Maik Schuler</Name>
        <Affiliation>Pfizer Drug Safety Research and Development, Eastern Point Road, Groton, CT, 06340, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A hazard evaluation of the reproductive/developmental toxicity of cobalt in medical devices.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33872739</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(21)00072-6</DOI>
    <KeywordList>
      <Keywords>Clinical</Keywords>
      <Keywords>Cobalt (Co)</Keywords>
      <Keywords>European medical device regulation (MDR)</Keywords>
      <Keywords>Hazard</Keywords>
      <Keywords>Preclinical</Keywords>
      <Keywords>Reproduction</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Andrew D. Monnot</Name>
        <Affiliation>Cardno ChemRisk, 235 Pine Street, Suite 2300, San Francisco, CA, 94104, USA. Electronic address: Andrew.Monnot@cardno.com.</Affiliation>
      </Author>
      <Author>
        <Name>Michael Kovochich</Name>
        <Affiliation>Cardno ChemRisk, 30 North LaSalle Street, Suite 3910, Chicago, IL, 60602, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Suren B. Bandara</Name>
        <Affiliation>Cardno ChemRisk, 235 Pine Street, Suite 2300, San Francisco, CA, 94104, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jared T. Wilsey</Name>
        <Affiliation>Smith &amp; Nephew, 1450 E Brooks Rd, Memphis, TN, 3811, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Whitney V. Christian</Name>
        <Affiliation>Medtronic plc, 6743 Southpoint Drive North, Jacksonville, FL, 32216, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Gary Eichenbaum</Name>
        <Affiliation>Johnson and Johnson, 410 George St, New Brunswick, NJ, 08901, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Laura E. L. Perkins</Name>
        <Affiliation>Abbott, 3200 Lakeside Dr, Santa Clara, CA, 95054, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Philippe Hasgall</Name>
        <Affiliation>Zimmer, Sulzerallee 8, CH-8404 Winterthur, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Maneesh Taneja</Name>
        <Affiliation>Stryker, 47900 Bayside Pkwy, Fremont, CA, 94538, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Kevin Connor</Name>
        <Affiliation>Boston Scientific, 100 Boston Scientific Way, Marlborough, MA, 01752, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jorge Sague</Name>
        <Affiliation>Stryker, 2825 Airview Boulevard, Kalamazoo, MI, 49002, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Behrooz Nasseri-Aghbosh</Name>
        <Affiliation>Stryker, Estree, Borehamwood WD6 3SG, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Stephen Marcello</Name>
        <Affiliation>Johnson and Johnson, 410 George St, New Brunswick, NJ, 08901, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Mark Vreeke</Name>
        <Affiliation>Edwards, One Edwards Way, Irvine, CA, 92614, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Laurence B. Katz</Name>
        <Affiliation>LifeScan Global Corporation, 20 Valley Stream Parkway, Malvern, PA, 19355, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Edward E. Reverdy</Name>
        <Affiliation>Smith &amp; Nephew, 1450 E Brooks Rd, Memphis, TN, 3811, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Herbert Thelen</Name>
        <Affiliation>Biotronik, Woermannkehre 1, 12359, Berlin, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Kenneth Unice</Name>
        <Affiliation>Cardno ChemRisk, 20 Stanwix Street, Suite 505, Pittsburgh, PA, 15222, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Use of less-than-lifetime (LTL) durational limits for nitrosamines: Case study of N-Nitrosodiethylamine (NDEA).</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33862169</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(21)00066-0</DOI>
    <KeywordList>
      <Keywords>Acceptable intake</Keywords>
      <Keywords>Cohort of concern</Keywords>
      <Keywords>Less-than-lifetime</Keywords>
      <Keywords>Mutagenic impurities</Keywords>
      <Keywords>N-Nitrosamine</Keywords>
      <Keywords>NNitrosodiethylamine</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Joel P. Bercu</Name>
        <Affiliation>Gilead Sciences, Nonclinical Safety and Pathobiology (NSP), Foster City, CA, USA. Electronic address: joel.bercu@gilead.com.</Affiliation>
      </Author>
      <Author>
        <Name>Melisa Masuda-Herrera</Name>
        <Affiliation>Gilead Sciences, Nonclinical Safety and Pathobiology (NSP), Foster City, CA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>George Johnson</Name>
        <Affiliation>Institute of Life Science, Swansea University Medical School, Singleton Park, Swansea, SA3 5DE, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Andreas Czich</Name>
        <Affiliation>Sanofi, R&amp;D Preclinical Safety, D-65926, Frankfurt, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Susanne Glowienke</Name>
        <Affiliation>Novartis AG, NIBR, Klybeckstrasse, CH-4057, Basel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Michelle Kenyon</Name>
        <Affiliation>Pfizer Worldwide Research and Development, Genetic Toxicology, Eastern Point Road, Groton, CT, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Rob Thomas</Name>
        <Affiliation>Lhasa Limited, Granary Wharf House, 2 Canal Wharf, Leeds, LS11 5PS, UK.</Affiliation>
      </Author>
      <Author>
        <Name>David J. Ponting</Name>
        <Affiliation>Lhasa Limited, Granary Wharf House, 2 Canal Wharf, Leeds, LS11 5PS, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Angela White</Name>
        <Affiliation>GlaxoSmithKline R&amp;D, Park Road, Ware, Hertfordshire, SG12 0DP, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Kevin Cross</Name>
        <Affiliation>Leadscope Inc. an Instem Company, Columbus, OH, 43215, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Fernanda Waechter</Name>
        <Affiliation>Aché Laboratórios Farmacêuticos S.A., Rodovia Presidente Dutra, km 222,2, Porto da Igreja, 07034-904, Guarulhos, SP, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Maria Augusta C. Rodrigues</Name>
        <Affiliation>Brazilian Health Regulatory Agency, ANVISA, Brasilia, Brazil.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Letter to the editors regarding "Risk assessments for the insect repellents DEET and picaridin".</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33857527</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(21)00068-4</DOI>
    <KeywordList>
      <Keywords>DEET</Keywords>
      <Keywords>Dermal exposure</Keywords>
      <Keywords>Picaridin</Keywords>
      <Keywords>Risk assessment</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Zhaoqing Lyu</Name>
        <Affiliation>Department of Health and Environmental Sciences, Kyoto University Graduate School of Medicine, Yoshida Konoe, Sakyo, Kyoto, 6068501, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Sani Rachman Soleman</Name>
        <Affiliation>Department of Health and Environmental Sciences, Kyoto University Graduate School of Medicine, Yoshida Konoe, Sakyo, Kyoto, 6068501, Japan; Department of Public Health, Faculty of Medicine, Universitas Islam Indonesia, Yogyakarta, 55584, Indonesia.</Affiliation>
      </Author>
      <Author>
        <Name>Meng Li</Name>
        <Affiliation>Department of Health and Environmental Sciences, Kyoto University Graduate School of Medicine, Yoshida Konoe, Sakyo, Kyoto, 6068501, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Kouji H. Harada</Name>
        <Affiliation>Department of Health and Environmental Sciences, Kyoto University Graduate School of Medicine, Yoshida Konoe, Sakyo, Kyoto, 6068501, Japan. Electronic address: kharada-hes@umin.ac.jp.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>RETRACTED: Proof of concept efficacy study of intranasal stabilized isoamyl nitrite (SIAN) in rhesus monkeys against acute cyanide poisoning.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33852946</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(21)00067-2</DOI>
    <AuthorList>
      <Author>
        <Name>Yifei Zhong</Name>
        <Affiliation>Charles River (formerly Citoxlab North America), 445 Armand Frappier, Laval, QC, H7V 4B3, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Robert E. Raulli</Name>
        <Affiliation>Biomedical Advanced Research and Development Authority, Office of the Assistant Secretary for Preparedness and Response, US Department of Health and Human Services, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Samir Abtout</Name>
        <Affiliation>Charles River (formerly Citoxlab North America), 445 Armand Frappier, Laval, QC, H7V 4B3, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Simon Authier</Name>
        <Affiliation>Charles River (formerly Citoxlab North America), 445 Armand Frappier, Laval, QC, H7V 4B3, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Alexis Ascah</Name>
        <Affiliation>Charles River (formerly Citoxlab North America), 445 Armand Frappier, Laval, QC, H7V 4B3, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Daniel Lambert</Name>
        <Affiliation>Charles River (formerly Citoxlab North America), 445 Armand Frappier, Laval, QC, H7V 4B3, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Gloria Gutierrez</Name>
        <Affiliation>Southwest Research Institute, 6220 Culebra Road, San Antonio, TX, 78238, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Norma L. Cantú</Name>
        <Affiliation>Southwest Research Institute, 6220 Culebra Road, San Antonio, TX, 78238, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Nadean Gutierrez</Name>
        <Affiliation>Southwest Research Institute, 6220 Culebra Road, San Antonio, TX, 78238, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Larry Cabell</Name>
        <Affiliation>Southwest Research Institute, 6220 Culebra Road, San Antonio, TX, 78238, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Joe McDonough</Name>
        <Affiliation>Southwest Research Institute, 6220 Culebra Road, San Antonio, TX, 78238, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Kelly C. Cakouros</Name>
        <Affiliation>Emergent BioSolutions, Inc., 300 Professional Drive, Gaithersburg, MD, 20879, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Pablo Gurman</Name>
        <Affiliation>Emergent BioSolutions, Inc., 300 Professional Drive, Gaithersburg, MD, 20879, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Vladimir Savransky</Name>
        <Affiliation>Emergent BioSolutions, Inc., 300 Professional Drive, Gaithersburg, MD, 20879, USA. Electronic address: savranskyv@ebsi.com.</Affiliation>
      </Author>
      <Author>
        <Name>John Barry</Name>
        <Affiliation>Emergent BioSolutions, Inc., 300 Professional Drive, Gaithersburg, MD, 20879, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Classification of chemicals as respiratory allergens based on human data: Requirements and practical considerations.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33831493</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(21)00065-9</DOI>
    <KeywordList>
      <Keywords>Chemical respiratory allergy</Keywords>
      <Keywords>Classification of chemical allergens</Keywords>
      <Keywords>Occupational asthma</Keywords>
      <Keywords>Respiratory irritation</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Mark A. Pemberton</Name>
        <Affiliation>Systox Ltd, UK. Electronic address: markpemberton@systox.com.</Affiliation>
      </Author>
      <Author>
        <Name>Ian Kimber</Name>
        <Affiliation>Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Inhalation toxicity of cyclic semi-volatile methylsiloxanes: Disentangling the conundrum of phase-specific adaptations from adverse outcomes.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33831492</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(21)00063-5</DOI>
    <KeywordList>
      <Keywords>Cyclic methylsiloxanes</Keywords>
      <Keywords>Inhalation toxicology</Keywords>
      <Keywords>Phase-specific toxicity</Keywords>
      <Keywords>Risk characterization</Keywords>
      <Keywords>Semi-volatile aerosol</Keywords>
      <Keywords>Translational toxicology</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Juergen Pauluhn</Name>
        <Affiliation>Hanover Medical School, Hannover, Germany; Bayer HealthCare, Toxicology, Wuppertal, Germany(1). Electronic address: juergen.pauluhn@icloud.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Toxicological evaluation of a glycan preparation from an enzymatic hydrolysis of Saccharomyces cerevisiae.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33831491</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(21)00064-7</DOI>
    <KeywordList>
      <Keywords>Animal feed ingredient</Keywords>
      <Keywords>Saccharomyces cerevisiae</Keywords>
      <Keywords>Safety evaluation</Keywords>
      <Keywords>Toxicology</Keywords>
      <Keywords>Yeast glycan</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>G. P. Dillon</Name>
        <Affiliation>Alltech Ireland, Sarney, Summerhill Road, Dunboyne, Co Meath, Ireland. Electronic address: gdillon@alltech.com.</Affiliation>
      </Author>
      <Author>
        <Name>A. Yiannikouris</Name>
        <Affiliation>Research Department, Alltech Inc., 3031, Catnip Hill Road, Nicholasville, KY, USA.</Affiliation>
      </Author>
      <Author>
        <Name>C. A. Moran</Name>
        <Affiliation>Alltech France SARL, Rue Charles Amand, 14500, Vire, France.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A simplified index to quantify the irritation/corrosion potential of chemicals - Part I: Skin.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33819554</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(21)00062-3</DOI>
    <KeywordList>
      <Keywords>EU CLP/UN GHS</Keywords>
      <Keywords>Erythema</Keywords>
      <Keywords>Oedema</Keywords>
      <Keywords>PII</Keywords>
      <Keywords>SII(SKIN)</Keywords>
      <Keywords>Skin corrosion</Keywords>
      <Keywords>Skin irritation</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Carole Charmeau-Genevois</Name>
        <Affiliation>KREATiS, 23 rue du Creuzat, 38080, L'Isle d'Abeau, France.</Affiliation>
      </Author>
      <Author>
        <Name>Satinder Sarang</Name>
        <Affiliation>Shell International, Shell Health, 150 North Dairy Ashford, Houston, TX, 77079, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Mélissa Perea</Name>
        <Affiliation>KREATiS, 23 rue du Creuzat, 38080, L'Isle d'Abeau, France.</Affiliation>
      </Author>
      <Author>
        <Name>Charles Eadsforth</Name>
        <Affiliation>Shell International, Shell Health, 150 North Dairy Ashford, Houston, TX, 77079, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Tom Austin</Name>
        <Affiliation>Shell International, Shell Health, 150 North Dairy Ashford, Houston, TX, 77079, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Paul Thomas</Name>
        <Affiliation>KREATiS, 23 rue du Creuzat, 38080, L'Isle d'Abeau, France. Electronic address: paul.thomas@kreatis.eu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Analysis of variability in the rabbit skin irritation assay.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33757807</pubmedLink>
    <GrantList>
      <Grant>HHSN273201500010C</Grant>
    </GrantList>
    <Year>2021</Year>
    <DOI>S0273-2300(21)00060-X</DOI>
    <KeywordList>
      <Keywords>Hazard classification</Keywords>
      <Keywords>In vitro</Keywords>
      <Keywords>In vivo</Keywords>
      <Keywords>New approach methodologies</Keywords>
      <Keywords>Reference data</Keywords>
      <Keywords>Skin irritation</Keywords>
      <Keywords>Validation</Keywords>
      <Keywords>Variability</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>John P. Rooney</Name>
        <Affiliation>Integrated Laboratory Systems, LLC, 601 Keystone Park Dr, Suite 800, Morrisville, NC, 27560, USA. Electronic address: jrooney@ils-inc.com.</Affiliation>
      </Author>
      <Author>
        <Name>Neepa Y. Choksi</Name>
        <Affiliation>Integrated Laboratory Systems, LLC, 601 Keystone Park Dr, Suite 800, Morrisville, NC, 27560, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Patricia Ceger</Name>
        <Affiliation>Integrated Laboratory Systems, LLC, 601 Keystone Park Dr, Suite 800, Morrisville, NC, 27560, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Amber B. Daniel</Name>
        <Affiliation>Integrated Laboratory Systems, LLC, 601 Keystone Park Dr, Suite 800, Morrisville, NC, 27560, USA.</Affiliation>
      </Author>
      <Author>
        <Name>James Truax</Name>
        <Affiliation>Integrated Laboratory Systems, LLC, 601 Keystone Park Dr, Suite 800, Morrisville, NC, 27560, USA.</Affiliation>
      </Author>
      <Author>
        <Name>David Allen</Name>
        <Affiliation>Integrated Laboratory Systems, LLC, 601 Keystone Park Dr, Suite 800, Morrisville, NC, 27560, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Nicole Kleinstreuer</Name>
        <Affiliation>National Toxicology Program Interagency Center for the Evaluation of Alternative Toxicological Methods, National Institute of Environmental Health Sciences, Research Triangle Park, NC, 27709, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Qualitative analysis of actual Standard for Exchange of Nonclinical Data (SEND) datasets for Data Domains: Proposition from Japan Pharmaceutical Manufacturers Association SEND Taskforce Team on standardization of nonclinical data.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33753112</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(21)00059-3</DOI>
    <KeywordList>
      <Keywords>AMED</Keywords>
      <Keywords>CDISC</Keywords>
      <Keywords>JPMA</Keywords>
      <Keywords>SEND</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Gen Sato</Name>
        <Affiliation>Non-Clinical Evaluation Expert Committee, Drug Evaluation Committee, Japan Pharmaceutical Manufacturers Association (JPMA), 2-3-11, Nihombashi-honcho, Chuo-ku, Tokyo, 103-0023, Japan; Eisai Co., Ltd., 5-1-3 Tokodai, Tsukuba-shi, Ibaraki, 300-2635, Japan. Electronic address: g-sato@hhc.eisai.co.jp.</Affiliation>
      </Author>
      <Author>
        <Name>Izumi Matsumoto</Name>
        <Affiliation>Non-Clinical Evaluation Expert Committee, Drug Evaluation Committee, Japan Pharmaceutical Manufacturers Association (JPMA), 2-3-11, Nihombashi-honcho, Chuo-ku, Tokyo, 103-0023, Japan; Sumitomo Dainippon Pharma Co., Ltd., 3-1-98 Kasugade-naka, Konohana-ku, Osaka, 554-0022, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Mayumi Watanabe</Name>
        <Affiliation>Non-Clinical Evaluation Expert Committee, Drug Evaluation Committee, Japan Pharmaceutical Manufacturers Association (JPMA), 2-3-11, Nihombashi-honcho, Chuo-ku, Tokyo, 103-0023, Japan; Daiichi Sankyo Co., Ltd., 1-16-13, Kitakasai, Edogawa-ku, Tokyo, 134-8630, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Toshiko Kinomoto</Name>
        <Affiliation>Non-Clinical Evaluation Expert Committee, Drug Evaluation Committee, Japan Pharmaceutical Manufacturers Association (JPMA), 2-3-11, Nihombashi-honcho, Chuo-ku, Tokyo, 103-0023, Japan; ZERIA Pharmaceutical Co., Ltd., 2512-1, Numagami, Oshikiri, Kumagaya-shi, Saitama, 360-0111, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Mikio Nakajima</Name>
        <Affiliation>Non-Clinical Evaluation Expert Committee, Drug Evaluation Committee, Japan Pharmaceutical Manufacturers Association (JPMA), 2-3-11, Nihombashi-honcho, Chuo-ku, Tokyo, 103-0023, Japan; Asahi Kasei Pharma Corporation, 632-1 Mifuku Izunokuni-shi, Shizuoka, 410-2321, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Masakatsu Yamamoto</Name>
        <Affiliation>Non-Clinical Evaluation Expert Committee, Drug Evaluation Committee, Japan Pharmaceutical Manufacturers Association (JPMA), 2-3-11, Nihombashi-honcho, Chuo-ku, Tokyo, 103-0023, Japan; MSD K.K., Urban Ace Kitahama Bldg. 2-3-7 Hiranomachi, Chuo-ku, Osaka-city, Osaka, 541-0046, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Yuki Inoue</Name>
        <Affiliation>Non-Clinical Evaluation Expert Committee, Drug Evaluation Committee, Japan Pharmaceutical Manufacturers Association (JPMA), 2-3-11, Nihombashi-honcho, Chuo-ku, Tokyo, 103-0023, Japan; Otsuka Pharmaceutical Co., Ltd., 463-10 Kagasuno, Kawauchi-cho, Tokushima, 771-0192, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Keita Kobayashi</Name>
        <Affiliation>Non-Clinical Evaluation Expert Committee, Drug Evaluation Committee, Japan Pharmaceutical Manufacturers Association (JPMA), 2-3-11, Nihombashi-honcho, Chuo-ku, Tokyo, 103-0023, Japan; Kowa Company, Ltd., 332-1, OhnoShinden, Fuji-city, Shizuoka, 417-8650, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Takashi Tanaharu</Name>
        <Affiliation>Non-Clinical Evaluation Expert Committee, Drug Evaluation Committee, Japan Pharmaceutical Manufacturers Association (JPMA), 2-3-11, Nihombashi-honcho, Chuo-ku, Tokyo, 103-0023, Japan; Bristol-Myers Squibb K.K., Shinjuku i-Land Tower, 5-1, Nishi-Shinjuku 6-chome, Shinjuku-ku, Tokyo, 163-1327, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Akinori Kiya</Name>
        <Affiliation>Non-Clinical Evaluation Expert Committee, Drug Evaluation Committee, Japan Pharmaceutical Manufacturers Association (JPMA), 2-3-11, Nihombashi-honcho, Chuo-ku, Tokyo, 103-0023, Japan; Shionogi &amp; Co., Ltd., 3-1-1, Futaba-Cho, Toyonaka, Osaka, 561-0825, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Takafumi Yamaguchi</Name>
        <Affiliation>Non-Clinical Evaluation Expert Committee, Drug Evaluation Committee, Japan Pharmaceutical Manufacturers Association (JPMA), 2-3-11, Nihombashi-honcho, Chuo-ku, Tokyo, 103-0023, Japan; Eli Lilly Japan K.K., LILLY PLAZA ONE Bldg., 5-1-28, Isogamidori, Chuo-ku, Kobe, 651-0086, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Hitomi Hayashi</Name>
        <Affiliation>Non-Clinical Evaluation Expert Committee, Drug Evaluation Committee, Japan Pharmaceutical Manufacturers Association (JPMA), 2-3-11, Nihombashi-honcho, Chuo-ku, Tokyo, 103-0023, Japan; Nippon Kayaku Co., Ltd., 31-12, Shimo 3-chome, Kita-ku, Tokyo, 115-0042, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Keiko Motoyama</Name>
        <Affiliation>Non-Clinical Evaluation Expert Committee, Drug Evaluation Committee, Japan Pharmaceutical Manufacturers Association (JPMA), 2-3-11, Nihombashi-honcho, Chuo-ku, Tokyo, 103-0023, Japan; Janssen Pharmaceutical K.K., 3-5-2 Nishi-kanda, Chiyoda-ku, Tokyo, 101-0065, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Mutsumi Suzuki</Name>
        <Affiliation>Non-Clinical Evaluation Expert Committee, Drug Evaluation Committee, Japan Pharmaceutical Manufacturers Association (JPMA), 2-3-11, Nihombashi-honcho, Chuo-ku, Tokyo, 103-0023, Japan; Kyowa Kirin Co., Ltd., 1188, Shimotogari, Nagaizumi-cho, Sunto-gun, Shizuoka, 411-8731, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Kazuto Watanabe</Name>
        <Affiliation>Non-Clinical Evaluation Expert Committee, Drug Evaluation Committee, Japan Pharmaceutical Manufacturers Association (JPMA), 2-3-11, Nihombashi-honcho, Chuo-ku, Tokyo, 103-0023, Japan; Chugai Pharmaceutical Co., Ltd., 1-135 Komakado, Gotemba, Shizuoka, 412-8513, Japan.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Nicotine dosimetry and stability in cambridge filter PADs (CFPs) following different smoking regime protocols and storage conditions.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33744373</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(21)00057-X</DOI>
    <KeywordList>
      <Keywords>Cambridge filter pad</Keywords>
      <Keywords>Electronic cigarette</Keywords>
      <Keywords>Methodology</Keywords>
      <Keywords>Nicotine</Keywords>
      <Keywords>Smoking regimes</Keywords>
      <Keywords>Tobacco constituents</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Pietro Zuccarello</Name>
        <Affiliation>Department of Medical, Surgical Sciences and Advanced Technologies "G.F. Ingrassia", Via S. Sofia, 87, 95123, Catania, Italy. Electronic address: pietro.zuccarello@unict.it.</Affiliation>
      </Author>
      <Author>
        <Name>Sonja Rust</Name>
        <Affiliation>Center of Excellence for the Acceleration of Harm Reduction (CoEHAR), University of Catania, Via S. Sofia, 97, 95123, Catania, Italy. Electronic address: sonja.rust@eclatrbc.it.</Affiliation>
      </Author>
      <Author>
        <Name>Massimo Caruso</Name>
        <Affiliation>Center of Excellence for the Acceleration of Harm Reduction (CoEHAR), University of Catania, Via S. Sofia, 97, 95123, Catania, Italy; Department of Biomedical and Biotechnological Sciences, Via S. Sofia, 97, 95123, Catania, Italy. Electronic address: mascaru@unict.it.</Affiliation>
      </Author>
      <Author>
        <Name>Rosalia Emma</Name>
        <Affiliation>Department of Biomedical and Biotechnological Sciences, Via S. Sofia, 97, 95123, Catania, Italy. Electronic address: rosalia.emma@unict.it.</Affiliation>
      </Author>
      <Author>
        <Name>Roberta Pulvirenti</Name>
        <Affiliation>Department of Biomedical and Biotechnological Sciences, Via S. Sofia, 97, 95123, Catania, Italy. Electronic address: pulvirentiroberta9@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Claudia Favara</Name>
        <Affiliation>Department of Medical, Surgical Sciences and Advanced Technologies "G.F. Ingrassia", Via S. Sofia, 87, 95123, Catania, Italy. Electronic address: favaraclaudia91@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Riccardo Polosa</Name>
        <Affiliation>Center of Excellence for the Acceleration of Harm Reduction (CoEHAR), University of Catania, Via S. Sofia, 97, 95123, Catania, Italy; Department of Clinical and Experimental Medicine, University of Catania, Via S. Sofia, 97, 95123, Catania, Italy. Electronic address: polosa@unict.it.</Affiliation>
      </Author>
      <Author>
        <Name>Giovanni Li Volti</Name>
        <Affiliation>Center of Excellence for the Acceleration of Harm Reduction (CoEHAR), University of Catania, Via S. Sofia, 97, 95123, Catania, Italy; Department of Biomedical and Biotechnological Sciences, Via S. Sofia, 97, 95123, Catania, Italy. Electronic address: livolti@unict.it.</Affiliation>
      </Author>
      <Author>
        <Name>Margherita Ferrante</Name>
        <Affiliation>Department of Medical, Surgical Sciences and Advanced Technologies "G.F. Ingrassia", Via S. Sofia, 87, 95123, Catania, Italy; Center of Excellence for the Acceleration of Harm Reduction (CoEHAR), University of Catania, Via S. Sofia, 97, 95123, Catania, Italy. Electronic address: marfer@unict.it.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Effect of chain length and branching on the in vitro metabolism of a series of parabens in human liver S9, human skin S9, and human plasma.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33741472</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(21)00058-1</DOI>
    <KeywordList>
      <Keywords>Carboxylesterase</Keywords>
      <Keywords>Clearance</Keywords>
      <Keywords>Ester metabolism</Keywords>
      <Keywords>Liver</Keywords>
      <Keywords>Parabens</Keywords>
      <Keywords>Plasma</Keywords>
      <Keywords>Skin</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Cindy Obringer</Name>
        <Affiliation>The Procter &amp; Gamble Co, Cincinnati, USA. Electronic address: Obringer.cm@pg.com.</Affiliation>
      </Author>
      <Author>
        <Name>Shengde Wu</Name>
        <Affiliation>The Procter &amp; Gamble Co, Cincinnati, USA.</Affiliation>
      </Author>
      <Author>
        <Name>John Troutman</Name>
        <Affiliation>The Procter &amp; Gamble Co, Cincinnati, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Michael Karb</Name>
        <Affiliation>The Procter &amp; Gamble Co, Cincinnati, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Cathy Lester</Name>
        <Affiliation>The Procter &amp; Gamble Co, Cincinnati, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Twenty six-week repeat dose oral rat toxicity study of cizolirtine, a substance-P and calcitonin gene-related peptide release modulator.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33711392</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(21)00056-8</DOI>
    <KeywordList>
      <Keywords>Calcitonin gene-related peptide</Keywords>
      <Keywords>Chronic-toxicity</Keywords>
      <Keywords>Cizolirtine</Keywords>
      <Keywords>Rat</Keywords>
      <Keywords>Substance P</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Antonio Guzmán</Name>
        <Affiliation>Toxicology Department, Welab Barcelona and Toxicology Department Esteve Pharmaceuticals, Spain. Electronic address: aguzman@welab.barcelona.</Affiliation>
      </Author>
      <Author>
        <Name>Gregorio Encina</Name>
        <Affiliation>Development PK &amp; Bioanalysis Department WeLab Barcelona and Development PK &amp; Bioanalysis Department, Esteve Pharmaceuticals, Spain.</Affiliation>
      </Author>
      <Author>
        <Name>Antonio R. Fernández de Henestrosa</Name>
        <Affiliation>Toxicology Department, Welab Barcelona and Toxicology Department Esteve Pharmaceuticals, Spain.</Affiliation>
      </Author>
      <Author>
        <Name>Cristina Vila</Name>
        <Affiliation>Toxicology Department, Welab Barcelona and Toxicology Department Esteve Pharmaceuticals, Spain.</Affiliation>
      </Author>
      <Author>
        <Name>Araceli Tortajada</Name>
        <Affiliation>Toxicology Department, Welab Barcelona and Toxicology Department Esteve Pharmaceuticals, Spain.</Affiliation>
      </Author>
      <Author>
        <Name>Ana Paz Marín</Name>
        <Affiliation>Toxicology Department, Welab Barcelona and Toxicology Department Esteve Pharmaceuticals, Spain.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Experimental study for the establishment of a chemotherapy-induced ovarian insufficiency model in rats by using cyclophosphamide combined with busulfan.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33705838</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(21)00055-6</DOI>
    <KeywordList>
      <Keywords>Busulfan</Keywords>
      <Keywords>Chemotherapy</Keywords>
      <Keywords>Cyclophosphamide</Keywords>
      <Keywords>Premature ovarian insufficiency</Keywords>
      <Keywords>Rat model</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Dongyuan Tang</Name>
        <Affiliation>Department of Gynecology and Obstetics, The Second Affiliated Hospital, Chongqing MedicalUniversity, Chongqing, 400010, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiushan Feng</Name>
        <Affiliation>Department of Gynecology and Obstetics, The Second Affiliated Hospital, Chongqing MedicalUniversity, Chongqing, 400010, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Li Ling</Name>
        <Affiliation>Department of Gynecology and Obstetics, The Second Affiliated Hospital, Chongqing MedicalUniversity, Chongqing, 400010, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Wenqian Zhang</Name>
        <Affiliation>Department of Gynecology and Obstetics, The Second Affiliated Hospital, Chongqing MedicalUniversity, Chongqing, 400010, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Yanjing Luo</Name>
        <Affiliation>Department of Gynecology and Obstetics, The Second Affiliated Hospital, Chongqing MedicalUniversity, Chongqing, 400010, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Yaping Wang</Name>
        <Affiliation>Department of Gynecology and Obstetics, The Second Affiliated Hospital, Chongqing MedicalUniversity, Chongqing, 400010, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhengai Xiong</Name>
        <Affiliation>Department of Gynecology and Obstetics, The Second Affiliated Hospital, Chongqing MedicalUniversity, Chongqing, 400010, People's Republic of China. Electronic address: 300534@cqmu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Initial hazard assessment of ethyl(dimethyl)(tetradecyl)ammonium ethyl sulfate: Genotoxicity tests and combined repeated-dose and reproductive/developmental toxicity screening in rats.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33684452</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(21)00054-4</DOI>
    <KeywordList>
      <Keywords>CAS No. 19309-23-0</Keywords>
      <Keywords>Chemical substances control law</Keywords>
      <Keywords>D-value</Keywords>
      <Keywords>Existing chemical substance</Keywords>
      <Keywords>Hazard class</Keywords>
      <Keywords>Quaternary ammonium compound</Keywords>
      <Keywords>Surfactant</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Mariko Matsumoto</Name>
        <Affiliation>Division of Risk Assessment, Biological Safety Research Center, National Institute of Health Sciences, 3-25-26, Tonomachi, Kawasaki-ku, Kawasaki, Kanagawa, 210-9501, Japan. Electronic address: mariko@nihs.go.jp.</Affiliation>
      </Author>
      <Author>
        <Name>Masao Takano</Name>
        <Affiliation>BoZo Research Center Inc., 1284, Kamado, Gotenba, Shizuoka, 412-0039, Japan. Electronic address: takano@bozo.co.jp.</Affiliation>
      </Author>
      <Author>
        <Name>Michihito Takabe</Name>
        <Affiliation>BoZo Research Center Inc., 1-3-11, Hanegi, Setagaya-ku, Tokyo, 156-0042, Japan. Electronic address: takabe-michihito@bozo.co.jp.</Affiliation>
      </Author>
      <Author>
        <Name>Noriko Yamaguchi</Name>
        <Affiliation>BoZo Research Center Inc., 1-3-11, Hanegi, Setagaya-ku, Tokyo, 156-0042, Japan. Electronic address: yamaguchi-noriko@bozo.co.jp.</Affiliation>
      </Author>
      <Author>
        <Name>Takako Iso</Name>
        <Affiliation>Division of Risk Assessment, Biological Safety Research Center, National Institute of Health Sciences, 3-25-26, Tonomachi, Kawasaki-ku, Kawasaki, Kanagawa, 210-9501, Japan. Electronic address: takako.iso@nihs.go.jp.</Affiliation>
      </Author>
      <Author>
        <Name>Yoshiyuki Shigeta</Name>
        <Affiliation>Division of Risk Assessment, Biological Safety Research Center, National Institute of Health Sciences, 3-25-26, Tonomachi, Kawasaki-ku, Kawasaki, Kanagawa, 210-9501, Japan. Electronic address: shigeta@nihs.go.jp.</Affiliation>
      </Author>
      <Author>
        <Name>Yasumasa Murata</Name>
        <Affiliation>Division of Risk Assessment, Biological Safety Research Center, National Institute of Health Sciences, 3-25-26, Tonomachi, Kawasaki-ku, Kawasaki, Kanagawa, 210-9501, Japan. Electronic address: murata_yasumasa@nihs.go.jp.</Affiliation>
      </Author>
      <Author>
        <Name>Nozomu Hirose</Name>
        <Affiliation>Division of Risk Assessment, Biological Safety Research Center, National Institute of Health Sciences, 3-25-26, Tonomachi, Kawasaki-ku, Kawasaki, Kanagawa, 210-9501, Japan. Electronic address: nzmh@nihs.go.jp.</Affiliation>
      </Author>
      <Author>
        <Name>Kaoru Inoue</Name>
        <Affiliation>Division of Risk Assessment, Biological Safety Research Center, National Institute of Health Sciences, 3-25-26, Tonomachi, Kawasaki-ku, Kawasaki, Kanagawa, 210-9501, Japan. Electronic address: k-inoue@nihs.go.jp.</Affiliation>
      </Author>
      <Author>
        <Name>Akihiko Hirose</Name>
        <Affiliation>Division of Risk Assessment, Biological Safety Research Center, National Institute of Health Sciences, 3-25-26, Tonomachi, Kawasaki-ku, Kawasaki, Kanagawa, 210-9501, Japan. Electronic address: hirose@nihs.go.jp.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Carcinogenic hazard assessment of cobalt-containing alloys in medical devices: Review of in vivo studies.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33662479</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(21)00050-7</DOI>
    <KeywordList>
      <Keywords>Carcinogenicity</Keywords>
      <Keywords>CoCrMo</Keywords>
      <Keywords>Cobalt</Keywords>
      <Keywords>Cobalt alloy</Keywords>
      <Keywords>Medical devices</Keywords>
      <Keywords>Stainless steel</Keywords>
      <Keywords>Weight of evidence</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Michael Kovochich</Name>
        <Affiliation>Cardno ChemRisk, 30 North LaSalle St Suite 3910, Chicago, IL, 60602-2590, USA. Electronic address: Michael.Kovochich@cardno.com.</Affiliation>
      </Author>
      <Author>
        <Name>Andrew Monnot</Name>
        <Affiliation>Cardno ChemRisk, 235 Pine Street Suite 2300, San Francisco, CA, 94104, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Daniel G. Kougias</Name>
        <Affiliation>Cardno ChemRisk, 30 North LaSalle St Suite 3910, Chicago, IL, 60602-2590, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Sharlee L. More</Name>
        <Affiliation>Cardno ChemRisk, 6720 S Macadam Ave Suite 150, Portland, OR, 97219, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jared T. Wilsey</Name>
        <Affiliation>Smith &amp; Nephew, 1450 E Brooks Rd, Memphis, TN, 38116, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Qing Qing Qiu</Name>
        <Affiliation>Stryker, 2825 Airview Boulevard, Kalamazoo, MI, 49002, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Laura E. L. Perkins</Name>
        <Affiliation>Abbott Vascular, 3200 Lakeside Dr, Santa Clara, CA, 95054, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Philippe Hasgall</Name>
        <Affiliation>Zimmer Biomet, Sulzerallee 8, CH-8404, Winterthur, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Maneesh Taneja</Name>
        <Affiliation>Stryker, 2825 Airview Boulevard, Kalamazoo, MI, 49002, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Edward E. Reverdy</Name>
        <Affiliation>DePuy Synthes Sports Medicine, A J&amp;J Company, Route 22 West, PO Box 151, Somerville, NJ, 08876, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jorge Sague</Name>
        <Affiliation>Stryker, 2825 Airview Boulevard, Kalamazoo, MI, 49002, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Stephen Marcello</Name>
        <Affiliation>Ethicon, A J&amp;J Company, Cincinnati, OH, 45242, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Kevin Connor</Name>
        <Affiliation>Boston Scientific, 100 Boston Scientific Way, Marlborough, MA, 01752, USA.</Affiliation>
      </Author>
      <Author>
        <Name>James Scutti</Name>
        <Affiliation>Boston Scientific, 100 Boston Scientific Way, Marlborough, MA, 01752, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Whitney V. Christian</Name>
        <Affiliation>Medtronic, plc, 6743 Southpoint Drive North, Jacksonville, FL, 32216, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Paul Coplan</Name>
        <Affiliation>University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, 19104, USA; Johnson &amp; Johnson, 410 George St, New Brunswick, NJ, 08901, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Laurence B. Katz</Name>
        <Affiliation>LifeScan Global Corporation, 20 Valley Stream Parkway, Malvern, PA, 19355, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Mark Vreeke</Name>
        <Affiliation>Edwards Lifesciences, One Edwards Way, Irvine, CA, 92614, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Millie Calistri-Yeh</Name>
        <Affiliation>Becton Dickinson, 1 Becton Drive, Franklin Lakes, NJ, 07417, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Brenda Faiola</Name>
        <Affiliation>Becton Dickinson, 1 Becton Drive, Franklin Lakes, NJ, 07417, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Kenneth Unice</Name>
        <Affiliation>Cardno ChemRisk, 20 Stanwix Street Suite 505, Pittsburgh, PA, 15222, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Gary Eichenbaum</Name>
        <Affiliation>Johnson &amp; Johnson, 410 George St, New Brunswick, NJ, 08901, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Use of nonclinical toxicity studies to support biosimilar antibody development.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33662478</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(21)00052-0</DOI>
    <KeywordList>
      <Keywords>Animal studies</Keywords>
      <Keywords>Biosimilars</Keywords>
      <Keywords>Drug development</Keywords>
      <Keywords>In vivo studies</Keywords>
      <Keywords>Pharmacokinetics/pharmacodynamics</Keywords>
      <Keywords>Regulatory approval</Keywords>
      <Keywords>Toxicokinetics</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Lauren Mihalcik</Name>
        <Affiliation>Amgen Inc., One Amgen Drive, Thousand Oaks, CA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Vincent Chow</Name>
        <Affiliation>Amgen Inc., One Amgen Drive, Thousand Oaks, CA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Monica Ramchandani</Name>
        <Affiliation>Amgen Inc., One Amgen Drive, Thousand Oaks, CA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Beth Hinkle</Name>
        <Affiliation>Amgen Inc., One Amgen Drive, Thousand Oaks, CA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Helen J. McBride</Name>
        <Affiliation>Amgen Inc., One Amgen Drive, Thousand Oaks, CA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Herve Lebrec</Name>
        <Affiliation>Amgen Inc., One Amgen Drive, Thousand Oaks, CA, USA. Electronic address: hlebrec@amgen.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Re: A call for action on the development and implementation of new methodologies for safety assessment of chemical-based products in the EU - A short communication.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33662477</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(21)00051-9</DOI>
    <KeywordList>
      <Keywords>New approach methodology</Keywords>
      <Keywords>Regulatory approval</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Mark Cronin</Name>
        <Affiliation>Chemoinformatics Research Group, School of Pharmacy and Biomolecular Sciences, Liverpool John Moores University, Byrom Street, Liverpool, L3 3AF, UK.</Affiliation>
      </Author>
      <Author>
        <Name>John Doe</Name>
        <Affiliation>Chemoinformatics Research Group, School of Pharmacy and Biomolecular Sciences, Liverpool John Moores University, Byrom Street, Liverpool, L3 3AF, UK. Electronic address: j.e.doe@ljmu.ac.uk.</Affiliation>
      </Author>
      <Author>
        <Name>Marina Pereira</Name>
        <Affiliation>Humane Society International, 1255 23rd St NW, Suite 450, Washington, DC, 20037, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Catherine Willett</Name>
        <Affiliation>Humane Society International, 1255 23rd St NW, Suite 450, Washington, DC, 20037, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Safety evaluation of recycling process used to produce recycled pulp for adult paper diapers.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33652038</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(21)00049-0</DOI>
    <KeywordList>
      <Keywords>Contaminant</Keywords>
      <Keywords>GC-MS</Keywords>
      <Keywords>Recycled pulp</Keywords>
      <Keywords>Recycling process</Keywords>
      <Keywords>Risk assessment</Keywords>
      <Keywords>Surrogate contamination test</Keywords>
      <Keywords>TTC</Keywords>
      <Keywords>Used paper diaper</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Satoko Ishii</Name>
        <Affiliation>Chemicals Evaluation and Research Institute, Japan. Electronic address: ishii-satoko@ceri.jp.</Affiliation>
      </Author>
      <Author>
        <Name>Asako Fukushima</Name>
        <Affiliation>Chemicals Evaluation and Research Institute, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Ritsuko Katagiri</Name>
        <Affiliation>Chemicals Evaluation and Research Institute, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Mayumi Sakunaga</Name>
        <Affiliation>Chemicals Evaluation and Research Institute, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Isamu Kuribara</Name>
        <Affiliation>Chemicals Evaluation and Research Institute, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Takeharu Uchida</Name>
        <Affiliation>Chemicals Evaluation and Research Institute, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Mitsuhiro Wada</Name>
        <Affiliation>Unicharm Corporation, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Shigeo Imai</Name>
        <Affiliation>Unicharm Corporation, Japan.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Derivation of Biomonitoring Equivalents for aluminium for the interpretation of population-level biomonitoring data.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33652037</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(21)00053-2</DOI>
    <KeywordList>
      <Keywords>Aluminium</Keywords>
      <Keywords>Biomarkers of exposure</Keywords>
      <Keywords>Biomonitoring</Keywords>
      <Keywords>Biomonitoring equivalent (BE)</Keywords>
      <Keywords>Health-based guidance values</Keywords>
      <Keywords>Human health risk assessment</Keywords>
      <Keywords>Kinetics</Keywords>
      <Keywords>Metals</Keywords>
      <Keywords>Neurotoxicity</Keywords>
      <Keywords>PK modeling</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Devika Poddalgoda</Name>
        <Affiliation>Health Canada, Ottawa, ON, Canada. Electronic address: devika.poddalgoda@canada.ca.</Affiliation>
      </Author>
      <Author>
        <Name>Sean M. Hays</Name>
        <Affiliation>Summit Toxicology, LLP, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Chris Kirman</Name>
        <Affiliation>Summit Toxicology, LLP, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Natasha Chander</Name>
        <Affiliation>Health Canada, Ottawa, ON, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Andy Nong</Name>
        <Affiliation>Health Canada, Ottawa, ON, Canada.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Extended One-Generation Reproductive Toxicity (EOGRT) study of benzoic acid in Sprague Dawley rats.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33639256</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(21)00037-4</DOI>
    <KeywordList>
      <Keywords>Benzoic acid</Keywords>
      <Keywords>Extended one-generation reproductive toxicology study (EOGRTS)</Keywords>
      <Keywords>OECD 443</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Duncan Turnbull</Name>
        <Affiliation>Ramboll US Consulting, Inc., 4350 North Fairfax Drive, Arlington, VA, 22203, USA. Electronic address: dturnbull@ramboll.com.</Affiliation>
      </Author>
      <Author>
        <Name>Maia M. Jack</Name>
        <Affiliation>American Beverage Association, Science and Regulatory Affairs, 1275 Pennsylvania Ave. NW, Suite 1100, Washington, DC, 20004, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Pragati S. Coder</Name>
        <Affiliation>Charles River Laboratories Ashland Inc., 1407 George Road, Ashland, OH, 44805, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Catherine A. Picut</Name>
        <Affiliation>Charles River Laboratories Inc, 4025 Stirrup Creek Dr. Durham, NC, 27703, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Joseph V. Rodricks</Name>
        <Affiliation>Ramboll US Consulting, Inc., 4350 North Fairfax Drive, Arlington, VA, 22203, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Comprehensive analysis of chronic rodent inhalation toxicity studies for methyl acrylate with attention to test conditions exceeding a maximum tolerated concentration.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33636299</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(21)00040-4</DOI>
    <KeywordList>
      <Keywords>Carcinogenicity</Keywords>
      <Keywords>Inhalation toxicity</Keywords>
      <Keywords>Methyl acrylate</Keywords>
      <Keywords>Nasal cavity</Keywords>
      <Keywords>Regulatory toxicology</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Axel Wibbertmann</Name>
        <Affiliation>Fraunhofer Institute for Toxicology and Experimental Medicine ITEM, Nikolai-Fuchs-Str. 1, 30625, Hannover, Germany. Electronic address: ToxConsulting@t-online.de.</Affiliation>
      </Author>
      <Author>
        <Name>Annette Bitsch</Name>
        <Affiliation>Fraunhofer Institute for Toxicology and Experimental Medicine ITEM, Nikolai-Fuchs-Str. 1, 30625, Hannover, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Christine Frieke Kuper</Name>
        <Affiliation>Haagstraat 13, 3581 SW, Utrecht, the Netherlands.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>How sensitive does chemical characterization of medical devices need to be? Calibration of analytical evaluation thresholds with the carcinogenic potency database.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33621616</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(21)00039-8</DOI>
    <KeywordList>
      <Keywords>Analytical evaluation threshold</Keywords>
      <Keywords>Carcinogenic potency database</Keywords>
      <Keywords>Carcinogenicity</Keywords>
      <Keywords>Chemical characterization</Keywords>
      <Keywords>Combination product</Keywords>
      <Keywords>Extractables</Keywords>
      <Keywords>Genotoxicity</Keywords>
      <Keywords>Medical device</Keywords>
      <Keywords>Threshold of toxicological concern</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Todd A. Kennedy</Name>
        <Affiliation>W.L. Gore &amp; Associates, Inc, P. O. Box 2400, Flagstaff, AZ, 86003-2400, USA. Electronic address: tkennedy@wlgore.com.</Affiliation>
      </Author>
      <Author>
        <Name>Mark J. Spinti</Name>
        <Affiliation>W.L. Gore &amp; Associates, Inc, P. O. Box 2400, Flagstaff, AZ, 86003-2400, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Purification of Bhallathaka (Semecarpus anacardium L.f.) enhanced anti-cancer activity.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33621615</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(21)00038-6</DOI>
    <KeywordList>
      <Keywords>Anti-cancer activity</Keywords>
      <Keywords>Bhallathaka</Keywords>
      <Keywords>LC-MS</Keywords>
      <Keywords>Semecarpus anacardium</Keywords>
      <Keywords>Shodhana</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Sulaiman C. T</Name>
        <Affiliation>Phytochemistry Division, Centre for Medicinal Plants Research, Arya Vaidya Sala, Kottakkal, 676503, Malappuram, Kerala, India. Electronic address: sulaimanct@aryavaidyasala.com.</Affiliation>
      </Author>
      <Author>
        <Name>Deepak M</Name>
        <Affiliation>Phytochemistry Division, Centre for Medicinal Plants Research, Arya Vaidya Sala, Kottakkal, 676503, Malappuram, Kerala, India.</Affiliation>
      </Author>
      <Author>
        <Name>Praveen T. K</Name>
        <Affiliation>Department of Pharmacology, JSS College of Pharmacy, JSS Academy of Higher Education &amp; Research, Ooty, 643001, Tamil Nadu, India.</Affiliation>
      </Author>
      <Author>
        <Name>Lijini K. R</Name>
        <Affiliation>Phytochemistry Division, Centre for Medicinal Plants Research, Arya Vaidya Sala, Kottakkal, 676503, Malappuram, Kerala, India.</Affiliation>
      </Author>
      <Author>
        <Name>Anandan E. M</Name>
        <Affiliation>Product Development Department, Arya Vaidya Sala, Kottakkal, 676503, Malappuram, Kerala, India.</Affiliation>
      </Author>
      <Author>
        <Name>Salman M</Name>
        <Affiliation>Phytochemistry Division, Centre for Medicinal Plants Research, Arya Vaidya Sala, Kottakkal, 676503, Malappuram, Kerala, India.</Affiliation>
      </Author>
      <Author>
        <Name>Indira Balachandran</Name>
        <Affiliation>Phytochemistry Division, Centre for Medicinal Plants Research, Arya Vaidya Sala, Kottakkal, 676503, Malappuram, Kerala, India.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Regulatory landscape of nanotechnology and nanoplastics from a global perspective.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33617940</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(21)00025-8</DOI>
    <KeywordList>
      <Keywords>GSRS</Keywords>
      <Keywords>Harmonisation</Keywords>
      <Keywords>Nanomaterials</Keywords>
      <Keywords>Nanoplastics</Keywords>
      <Keywords>Nanotechnology</Keywords>
      <Keywords>Regulatory science</Keywords>
      <Keywords>Standards</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jacqueline Allan</Name>
        <Affiliation>Joint Institute for Innovation Policy, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Susanne Belz</Name>
        <Affiliation>European Commission, Joint Research Centre (JRC), Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Arnd Hoeveler</Name>
        <Affiliation>European Commission, Joint Research Centre (JRC), Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Marta Hugas</Name>
        <Affiliation>European Food Safety Authority (EFSA), Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Haruhiro Okuda</Name>
        <Affiliation>National Institute of Health Sciences (NIHS), Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Anil Patri</Name>
        <Affiliation>National Center for Toxicological Research (NCTR), Food and Drug Administration (FDA), USA.</Affiliation>
      </Author>
      <Author>
        <Name>Hubert Rauscher</Name>
        <Affiliation>European Commission, Joint Research Centre (JRC), Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Primal Silva</Name>
        <Affiliation>Canadian Food Inspection Agency, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>William Slikker</Name>
        <Affiliation>National Center for Toxicological Research (NCTR), Food and Drug Administration (FDA), USA.</Affiliation>
      </Author>
      <Author>
        <Name>Birgit Sokull-Kluettgen</Name>
        <Affiliation>European Commission, Joint Research Centre (JRC), Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Weida Tong</Name>
        <Affiliation>National Center for Toxicological Research (NCTR), Food and Drug Administration (FDA), USA.</Affiliation>
      </Author>
      <Author>
        <Name>Elke Anklam</Name>
        <Affiliation>European Commission, Joint Research Centre (JRC), Belgium. Electronic address: elke.anklam@ec.europa.eu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Epidemiology of lung cancer among acrylonitrile-exposed study populations: A meta-analysis.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33617939</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(21)00036-2</DOI>
    <KeywordList>
      <Keywords>Acrylonitrile</Keywords>
      <Keywords>Chemical</Keywords>
      <Keywords>Epidemiology</Keywords>
      <Keywords>Lung cancer</Keywords>
      <Keywords>Meta-analysis</Keywords>
      <Keywords>Occupation</Keywords>
      <Keywords>Systematic review</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Dominik D. Alexander</Name>
        <Affiliation>MetaMethod, South Lyon, MI, USA. Electronic address: dalexander@metamethodhealth.com.</Affiliation>
      </Author>
      <Author>
        <Name>Susan T. Pastula</Name>
        <Affiliation>Ann Arbor, MI, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Alexander S. Riordan</Name>
        <Affiliation>Chicago, IL, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Harmonized 3Rs-based non-mutagenic impurity qualification study designs developed using the results of an IQ consortium survey.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33610610</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(21)00035-0</DOI>
    <AuthorList>
      <Author>
        <Name>Mayur S. Mitra</Name>
        <Affiliation>Genentech Inc, Safety Assessment, South San Francisco, CA, USA. Electronic address: mitram2@gene.com.</Affiliation>
      </Author>
      <Author>
        <Name>Kaushik Datta</Name>
        <Affiliation>Bristol-Myers Squibb, Nonclinical Research and Development, NJ, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Richard Hutchinson</Name>
        <Affiliation>Janssen Research &amp; Development, LLC, Spring House, PA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>John J. Nicolette</Name>
        <Affiliation>Abbvie, Inc., Pre-clinical Safety, North Chicago, IL, USA.</Affiliation>
      </Author>
      <Author>
        <Name>John C. Pettersen</Name>
        <Affiliation>Vertex Pharmaceuticals, Pre-clinical Safety Assessment Boston, MA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Teresa C. Wegesser</Name>
        <Affiliation>Amgen, Translational Safety and Bioanalytical Sciences, Thousand Oaks, CA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Joel P. Bercu</Name>
        <Affiliation>Gilead Sciences, Nonclinical Safety and Pathobiology, Foster City, CA, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Metribuzin-induced non-adverse liver changes result in rodent-specific non-adverse thyroid effects via uridine 5'-diphospho-glucuronosyltransferase (UDPGT, UGT) modulation.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33596450</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(21)00024-6</DOI>
    <KeywordList>
      <Keywords>Endocrine disruption</Keywords>
      <Keywords>Human relevance</Keywords>
      <Keywords>IPCS</Keywords>
      <Keywords>Metribuzin</Keywords>
      <Keywords>Mode of action (MOA)</Keywords>
      <Keywords>NOAEL</Keywords>
      <Keywords>Thyroid</Keywords>
      <Keywords>UDPGT</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Werner Bomann</Name>
        <Affiliation>Toxconsult, 9393 W 110th Street, 51 Corporate Woods, Suite 500, Overland Park, KS, 66210, USA. Electronic address: werner.bomann.ext@bayer.com.</Affiliation>
      </Author>
      <Author>
        <Name>Helen Tinwell</Name>
        <Affiliation>Bayer.SAS, 16 rue Jean-Marie Leclair, 69009, Lyon, France.</Affiliation>
      </Author>
      <Author>
        <Name>Peter Jenkinson</Name>
        <Affiliation>CEHTRA Ltd, Nottingham, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Felix M. Kluxen</Name>
        <Affiliation>ADAMA Deutschland GmbH, Cologne, Germany. Electronic address: felix.kluxen@adama.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A comprehensive weight of evidence assessment of published acetaminophen genotoxicity data: Implications for its carcinogenic hazard potential.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33592196</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(21)00032-5</DOI>
    <KeywordList>
      <Keywords>Acetaminophen</Keywords>
      <Keywords>Carcinogenicity</Keywords>
      <Keywords>Clastogenicity</Keywords>
      <Keywords>Genotoxicity</Keywords>
      <Keywords>Mutagenicity</Keywords>
      <Keywords>Weight-of-evidence</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>David Kirkland</Name>
        <Affiliation>Kirkland Consulting, Tadcaster, LS24 0AS, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Michael Kovochich</Name>
        <Affiliation>Cardno ChemRisk, Chicago, IL, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Sharlee L. More</Name>
        <Affiliation>Cardno ChemRisk, Portland, OR, USA.</Affiliation>
      </Author>
      <Author>
        <Name>F. Jay Murray</Name>
        <Affiliation>Murray &amp; Associates, San Jose, CA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Andrew D. Monnot</Name>
        <Affiliation>Cardno ChemRisk, San Francisco, CA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Julie V. Miller</Name>
        <Affiliation>Cardno ChemRisk, Pittsburgh, PA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Hartmut Jaeschke</Name>
        <Affiliation>University of Kansas Medical Center, Kansas City, KS, USA.</Affiliation>
      </Author>
      <Author>
        <Name>David Jacobson-Kram</Name>
        <Affiliation>ToxRox Consulting, McLean, VA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Milind Deore</Name>
        <Affiliation>Johnson &amp; Johnson Consumer, India.</Affiliation>
      </Author>
      <Author>
        <Name>Suresh Kumar Pitchaiyan</Name>
        <Affiliation>Johnson &amp; Johnson Consumer, India.</Affiliation>
      </Author>
      <Author>
        <Name>Kenneth Unice</Name>
        <Affiliation>Cardno ChemRisk, Pittsburgh, PA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Gary Eichenbaum</Name>
        <Affiliation>Johnson &amp; Johnson, New Brunswick, NJ, USA. Electronic address: geichenb@its.jnj.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Preclinical safety evaluation of nafithromycin (WCK 4873) with emphasis on liver safety in rat and dog.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33587936</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(21)00029-5</DOI>
    <KeywordList>
      <Keywords>CYP inhibition</Keywords>
      <Keywords>Hepatic safety</Keywords>
      <Keywords>Mass balance</Keywords>
      <Keywords>Metabolic stability</Keywords>
      <Keywords>Nafithromycin</Keywords>
      <Keywords>Repeat-dose toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Manohar Nandanwar</Name>
        <Affiliation>Wockhardt Research Centre, Chikalthana, Aurangabad, Maharashtra, India. Electronic address: mnandanwar@wockhardt.com.</Affiliation>
      </Author>
      <Author>
        <Name>Rajesh Chavan</Name>
        <Affiliation>Wockhardt Research Centre, Chikalthana, Aurangabad, Maharashtra, India.</Affiliation>
      </Author>
      <Author>
        <Name>Atul Kansagara</Name>
        <Affiliation>Wockhardt Research Centre, Chikalthana, Aurangabad, Maharashtra, India.</Affiliation>
      </Author>
      <Author>
        <Name>Muftedar Ahmed Patel</Name>
        <Affiliation>Wockhardt Research Centre, Chikalthana, Aurangabad, Maharashtra, India.</Affiliation>
      </Author>
      <Author>
        <Name>Anasuya Patel</Name>
        <Affiliation>Wockhardt Research Centre, Chikalthana, Aurangabad, Maharashtra, India.</Affiliation>
      </Author>
      <Author>
        <Name>Ravindra Yeole</Name>
        <Affiliation>Wockhardt Research Centre, Chikalthana, Aurangabad, Maharashtra, India.</Affiliation>
      </Author>
      <Author>
        <Name>Mahesh Patel</Name>
        <Affiliation>Wockhardt Research Centre, Chikalthana, Aurangabad, Maharashtra, India.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Disease area and mode of action as criteria to assign a default occupational exposure limit.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33587935</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(21)00031-3</DOI>
    <KeywordList>
      <Keywords>Drug candidate</Keywords>
      <Keywords>Mode of action</Keywords>
      <Keywords>Occupational exposure limit</Keywords>
      <Keywords>Pharmaceutical development</Keywords>
      <Keywords>Safe handling</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Milica Glogovac</Name>
        <Affiliation>Novartis Pharma AG, Novartis Business Services, Postfach, CH-4002, Basel, Switzerland. Electronic address: milica.glogovac@novartis.com.</Affiliation>
      </Author>
      <Author>
        <Name>Caylee Paulson</Name>
        <Affiliation>Novartis Pharma AG, Novartis Business Services, Postfach, CH-4002, Basel, Switzerland. Electronic address: caylee.paulson@novartis.com.</Affiliation>
      </Author>
      <Author>
        <Name>Amy Lambert</Name>
        <Affiliation>Novartis Institutes for BioMedical Research, Cambridge, USA; Roche Innovation Center Zurich, Wagistrasse 10, CH-8952, Schlieren, Switzerland. Electronic address: amy_letitia.lambert@roche.com.</Affiliation>
      </Author>
      <Author>
        <Name>Gian Christian Winkler</Name>
        <Affiliation>Novartis Pharma AG NIBR, Postfach, CH-4002, Basel, Switzerland; Preclinical Safety Consultant, In den Reben 229, CH-5063, Oberhof, Switzerland. Electronic address: winkgu@vtxnet.ch.</Affiliation>
      </Author>
      <Author>
        <Name>Ester Lovsin Barle</Name>
        <Affiliation>Novartis Pharma AG, Novartis Business Services, Postfach, CH-4002, Basel, Switzerland; Takeda Pharmaceutical Company Limited, Thurgauerstrasse 130, CH-8152, Glattpark (Opfikon), Switzerland. Electronic address: ester.lovsin-barle@takeda.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>In vivo safety testing of Antibody Drug Conjugates.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33587934</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(21)00030-1</DOI>
    <AuthorList>
      <Author>
        <Name>Francesca Pretto</Name>
        <Affiliation>University of Geneva, Faculty of Medicine, Rue Michel-Servet 1, 1206, Genève, Switzerland. Electronic address: francesca_pretto@yahoo.com.</Affiliation>
      </Author>
      <Author>
        <Name>Rex E. FitzGerald</Name>
        <Affiliation>University of Basel, Department of Pharmaceutical Sciences, Swiss Centre for Applied Human Toxicology, SCAHT, Missionsstrasse 64, 4055, Basel, Switzerland. Electronic address: rex.fitzgerald@unibas.ch.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Evaluation of the OECD QSAR toolbox automatic workflow for the prediction of the acute toxicity of organic chemicals to fathead minnow.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33587933</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(21)00033-7</DOI>
    <KeywordList>
      <Keywords>3Rs</Keywords>
      <Keywords>Automated workflow</Keywords>
      <Keywords>Fish toxicity</Keywords>
      <Keywords>OECD QSAR Toolbox</Keywords>
      <Keywords>QSAR</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Enrico Mombelli</Name>
        <Affiliation>Institut National de l'Environnement Industriel et des Risques (INERIS), 60550, Verneuil en Halatte, France. Electronic address: enrico.mombelli@ineris.fr.</Affiliation>
      </Author>
      <Author>
        <Name>Pascal Pandard</Name>
        <Affiliation>Institut National de l'Environnement Industriel et des Risques (INERIS), 60550, Verneuil en Halatte, France.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Probabilistic pharmacokinetic modeling of airborne lead corresponding to toxicologically relevant blood lead levels in workers.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33587932</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(21)00034-9</DOI>
    <AuthorList>
      <Author>
        <Name>Lisa M. Sweeney</Name>
        <Affiliation>UES, Inc., assigned to Air Force Research Laboratory, 711th Human Performance Wing, 4401 Dayton-Xenia Road, Dayton, OH, 45432, USA. Electronic address: LSweeney@ues.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>In vitro skin penetration of bronidox, bronopol and formaldehyde from cosmetics.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33577887</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(21)00028-3</DOI>
    <KeywordList>
      <Keywords>Bronidox</Keywords>
      <Keywords>Bronopol</Keywords>
      <Keywords>DMDM hydantoine</Keywords>
      <Keywords>Formaldehyde</Keywords>
      <Keywords>Franz diffusion cells</Keywords>
      <Keywords>Percutaneous absorption rates</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Lucía López-Sánchez</Name>
        <Affiliation>Department of Pharmacy and Pharmaceutical Technology and Parasitology, Faculty of Pharmacy, University of Valencia, Valencia, Spain; Instituto Interuniversitario de Investigación de Reconocimiento Molecular y Desarrollo Tecnológico (IDM), Universitat Politècnica de València, Universitat de València, Av. Vicent Andrés Estellés s/n, 46100, Burjassot, Valencia, Spain.</Affiliation>
      </Author>
      <Author>
        <Name>Pablo Miralles</Name>
        <Affiliation>Departament of Analytical Chemistry, Faculty of Chemistry. University of Valencia, Valencia, Spain.</Affiliation>
      </Author>
      <Author>
        <Name>Amparo Salvador</Name>
        <Affiliation>Departament of Analytical Chemistry, Faculty of Chemistry. University of Valencia, Valencia, Spain.</Affiliation>
      </Author>
      <Author>
        <Name>Matilde Merino-Sanjuán</Name>
        <Affiliation>Department of Pharmacy and Pharmaceutical Technology and Parasitology, Faculty of Pharmacy, University of Valencia, Valencia, Spain; Instituto Interuniversitario de Investigación de Reconocimiento Molecular y Desarrollo Tecnológico (IDM), Universitat Politècnica de València, Universitat de València, Av. Vicent Andrés Estellés s/n, 46100, Burjassot, Valencia, Spain. Electronic address: matilde.merino@uv.es.</Affiliation>
      </Author>
      <Author>
        <Name>Virginia Merino</Name>
        <Affiliation>Department of Pharmacy and Pharmaceutical Technology and Parasitology, Faculty of Pharmacy, University of Valencia, Valencia, Spain; Instituto Interuniversitario de Investigación de Reconocimiento Molecular y Desarrollo Tecnológico (IDM), Universitat Politècnica de València, Universitat de València, Av. Vicent Andrés Estellés s/n, 46100, Burjassot, Valencia, Spain.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Assessment of the toxicity and toxicokinetics of the novel potent tropomyosin receptor kinase (Trk) inhibitor LPM4870108 in rhesus monkeys.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33556418</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(21)00026-X</DOI>
    <KeywordList>
      <Keywords>LPM4870108</Keywords>
      <Keywords>Oral toxicity study</Keywords>
      <Keywords>Preclinical safety assessment</Keywords>
      <Keywords>Rhesus monkeys</Keywords>
      <Keywords>Toxicokinetics</Keywords>
      <Keywords>Tropomyosin receptor kinase (Trk) inhibitor</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Sijin Duan</Name>
        <Affiliation>School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University, Yantai, 264005, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Lin Dong</Name>
        <Affiliation>State Key Laboratory of Long-acting Targeting Drug Delivery Technologies (Luye Pharma Group Ltd.), Yantai, 264003, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Bingsi Wang</Name>
        <Affiliation>State Key Laboratory of Long-acting Targeting Drug Delivery Technologies (Luye Pharma Group Ltd.), Yantai, 264003, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Shujuan Wei</Name>
        <Affiliation>State Key Laboratory of Long-acting Targeting Drug Delivery Technologies (Luye Pharma Group Ltd.), Yantai, 264003, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaoyan Gong</Name>
        <Affiliation>State Key Laboratory of Long-acting Targeting Drug Delivery Technologies (Luye Pharma Group Ltd.), Yantai, 264003, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Pengfei Yu</Name>
        <Affiliation>School of Public Health and Management, Binzhou Medical University, Yantai, 264003, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Chunmei Li</Name>
        <Affiliation>School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University, Yantai, 264005, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Yonglin Gao</Name>
        <Affiliation>School of Life Science, Yantai University, Yantai, 264005, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Liang Ye</Name>
        <Affiliation>School of Public Health and Management, Binzhou Medical University, Yantai, 264003, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Hongbo Wang</Name>
        <Affiliation>School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University, Yantai, 264005, PR China. Electronic address: hongbowang@ytu.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Jingwei Tian</Name>
        <Affiliation>School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University, Yantai, 264005, PR China. Electronic address: Tianjingwei618@163.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Butylated hydroxyanisole: Carcinogenic food additive to be avoided or harmless antioxidant important to protect food supply?</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33556417</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(21)00027-1</DOI>
    <KeywordList>
      <Keywords>Butylated hydroxyanisole</Keywords>
      <Keywords>Cancer hazard classification</Keywords>
      <Keywords>Cancer risk assessment</Keywords>
      <Keywords>Consumer perception of safety</Keywords>
      <Keywords>Proposition 65</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Susan P. Felter</Name>
        <Affiliation>Procter &amp; Gamble, Central Product Safety, Mason, OH, USA. Electronic address: Felter.sp@pg.com.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaoling Zhang</Name>
        <Affiliation>Procter &amp; Gamble, Central Product Safety, Mason, OH, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Chad Thompson</Name>
        <Affiliation>ToxStrategies, Katy, TX, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Utilisation of parametric methods to improve percentile-based estimates for the carcinogenic potency of nitrosamines.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33556416</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(21)00015-5</DOI>
    <KeywordList>
      <Keywords>Carcinogenicity</Keywords>
      <Keywords>N-Nitrosamine</Keywords>
      <Keywords>Percentile</Keywords>
      <Keywords>TD(50)</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Robert Thomas</Name>
        <Affiliation>Lhasa Limited, Granary Wharf House, Leeds, UK. Electronic address: rob.thomas@lhasalimited.org.</Affiliation>
      </Author>
      <Author>
        <Name>Andrew Thresher</Name>
        <Affiliation>Lhasa Limited, Granary Wharf House, Leeds, UK.</Affiliation>
      </Author>
      <Author>
        <Name>David J. Ponting</Name>
        <Affiliation>Lhasa Limited, Granary Wharf House, Leeds, UK.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Mercury in skin-care products in India and consumer exposure risks.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33493584</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(21)00010-6</DOI>
    <KeywordList>
      <Keywords>Dermal exposure</Keywords>
      <Keywords>Health</Keywords>
      <Keywords>Lightning and fairness</Keywords>
      <Keywords>Mass flows</Keywords>
      <Keywords>Mercury</Keywords>
      <Keywords>Skin-care products</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Supriti Pramanik</Name>
        <Affiliation>Department of Civil Engineering, Indian Institute of Technology (IIT) Hyderabad, Kandi, TS, 502285, India.</Affiliation>
      </Author>
      <Author>
        <Name>Mukesh Kumar</Name>
        <Affiliation>Department of Civil Engineering, Indian Institute of Technology (IIT) Hyderabad, Kandi, TS, 502285, India.</Affiliation>
      </Author>
      <Author>
        <Name>Asif Qureshi</Name>
        <Affiliation>Department of Civil Engineering, Indian Institute of Technology (IIT) Hyderabad, Kandi, TS, 502285, India. Electronic address: asif@ce.iith.ac.in.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Grouping of chemicals based on the potential mechanisms of hepatotoxicity of naphthalene and structurally similar chemicals using in vitro testing for read-across and its validation.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33493583</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(21)00014-3</DOI>
    <KeywordList>
      <Keywords>Hepatotoxicity</Keywords>
      <Keywords>In vitro Toxicogenomics</Keywords>
      <Keywords>Integrated approaches to testing and assessment</Keywords>
      <Keywords>Naphthalene</Keywords>
      <Keywords>Read-across</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Shota Nakagawa</Name>
        <Affiliation>Kao Corporation, Safety Science Research, 2606, Akabane, Ichikai-Machi, Haga-Gun, Tochigi, 321-3497, Japan. Electronic address: nakagawa.shouta@kao.com.</Affiliation>
      </Author>
      <Author>
        <Name>Maiko Okamoto</Name>
        <Affiliation>Kao Corporation, Safety Science Research, 2606, Akabane, Ichikai-Machi, Haga-Gun, Tochigi, 321-3497, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Keita Yoshihara</Name>
        <Affiliation>Kao Corporation, Safety Science Research, 2606, Akabane, Ichikai-Machi, Haga-Gun, Tochigi, 321-3497, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Yuko Nukada</Name>
        <Affiliation>Kao Corporation, Safety Science Research, 2606, Akabane, Ichikai-Machi, Haga-Gun, Tochigi, 321-3497, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Osamu Morita</Name>
        <Affiliation>Kao Corporation, Safety Science Research, 2606, Akabane, Ichikai-Machi, Haga-Gun, Tochigi, 321-3497, Japan.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Toxicity of boric acid, borax and other boron containing compounds: A review.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33485927</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(21)00013-1</DOI>
    <KeywordList>
      <Keywords>Chromosomal aberrations</Keywords>
      <Keywords>Comet assay</Keywords>
      <Keywords>Dermal</Keywords>
      <Keywords>Inhalation</Keywords>
      <Keywords>Micronuclei</Keywords>
      <Keywords>Micronucleus</Keywords>
      <Keywords>Mutation</Keywords>
      <Keywords>Oral</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Niels Hadrup</Name>
        <Affiliation>National Research Centre for the Working Environment, Copenhagen, DK, 2100, Denmark. Electronic address: nih@nfa.dk.</Affiliation>
      </Author>
      <Author>
        <Name>Marie Frederiksen</Name>
        <Affiliation>National Research Centre for the Working Environment, Copenhagen, DK, 2100, Denmark.</Affiliation>
      </Author>
      <Author>
        <Name>Anoop K. Sharma</Name>
        <Affiliation>Division for Risk Assessment and Nutrition, Group for Chemical Risk Assessment and GMO, National Food Institute, Technical University of Denmark, Denmark. Electronic address: aksha@food.dtu.dk.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Classic and evolving approaches to evaluating cross reactivity of mAb and mAb-like molecules - A survey of industry 2008-2019.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33485926</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(21)00012-X</DOI>
    <KeywordList>
      <Keywords>Antibodies</Keywords>
      <Keywords>Arrays</Keywords>
      <Keywords>Cross-reactivity</Keywords>
      <Keywords>IND</Keywords>
      <Keywords>Immunohistochemistry</Keywords>
      <Keywords>Proteome</Keywords>
      <Keywords>Species</Keywords>
      <Keywords>TCR</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Timothy K. MacLachlan</Name>
        <Affiliation>Novartis Institutes for Biomedical Research, Cambridge, MA, 01239, USA. Electronic address: Timothy.maclachlan@novartis.com.</Affiliation>
      </Author>
      <Author>
        <Name>Shari Price</Name>
        <Affiliation>Charles River Laboratories, 15 Worman's Mill Court, Suite I, Frederick, MD, 21701, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Joy Cavagnaro</Name>
        <Affiliation>Access BIO, LC, Boyce, VA, 22620, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Laura Andrews</Name>
        <Affiliation>AbbVie, 100 Research Dr, Worcester, MA, 01520, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Diann Blanset</Name>
        <Affiliation>Boehringer Ingelheim, 900 Ridgebury Road, Ridgefield, CT, 06877, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Mary Ellen Cosenza</Name>
        <Affiliation>MEC Regulatory &amp; Toxicology Consulting, LLC, Moorpark, CA, 93021, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Maggie Dempster</Name>
        <Affiliation>GlaxoSmithKline, 1250 South Collegeville Rd, Collegeville, PA, 19426, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Elizabeth Galbreath</Name>
        <Affiliation>Drug Safety Research and Evaluation, Takeda US, Inc., Cambridge, MA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Anna Maria Giusti</Name>
        <Affiliation>Roche Pharma Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Zurich, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Kathleen Marie Heinz-Taheny</Name>
        <Affiliation>Toxicology and Pathology, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, 46285, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Renaud Fleurance</Name>
        <Affiliation>UCB BioPharma SRL, B-1420, Braine L'Alleud, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Esther Sutter</Name>
        <Affiliation>Novartis Institutes for Biomedical Research, Basel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Michael W. Leach</Name>
        <Affiliation>Drug Safety Research and Development, Pfizer, Inc, 300 Technology Square, Cambridge, MA, 02139, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Expanding the toxicologist's statistical toolbox: Using effect size estimation and dose-response modelling for holistic assessments instead of generic testing.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33485925</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(21)00011-8</DOI>
    <KeywordList>
      <Keywords>Benchmark dose</Keywords>
      <Keywords>Dose-response modelling</Keywords>
      <Keywords>Effect size estimation</Keywords>
      <Keywords>Hazard characterization</Keywords>
      <Keywords>Hazard identification</Keywords>
      <Keywords>Statistical significance</Keywords>
      <Keywords>Statistical testing</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Felix M. Kluxen</Name>
        <Affiliation>ADAMA Deutschland GmbH, Cologne, Germany. Electronic address: felix.kluxen@adama.com.</Affiliation>
      </Author>
      <Author>
        <Name>Signe M. Jensen</Name>
        <Affiliation>Department of Plant and Environmental Sciences, University of Copenhagen, Copenhagen, Denmark.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Human biomonitoring (HBM)-II values for perfluorooctanoic acid (PFOA) and perfluorooctane sulfonic acid (PFOS) - Description, derivation and discussion.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33484797</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(21)00008-8</DOI>
    <KeywordList>
      <Keywords>HBM-II-value</Keywords>
      <Keywords>Human Biomonitoring</Keywords>
      <Keywords>PFAS</Keywords>
      <Keywords>PFOA</Keywords>
      <Keywords>PFOS</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Michael Schümann</Name>
        <Affiliation>Department for Hygiene, Social and Environmental Medicine, MA 1/31, Ruhr-University Bochum, Universitätsstrasse 150, 44801, Bochum, Germany. Electronic address: michael.schuemann@hamburg.de.</Affiliation>
      </Author>
      <Author>
        <Name>Hellmuth Lilienthal</Name>
        <Affiliation>Department for Hygiene, Social and Environmental Medicine, MA 1/31, Ruhr-University Bochum, Universitätsstrasse 150, 44801, Bochum, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Jürgen Hölzer</Name>
        <Affiliation>Department for Hygiene, Social and Environmental Medicine, MA 1/31, Ruhr-University Bochum, Universitätsstrasse 150, 44801, Bochum, Germany.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Nonclinical &amp; clinical interface - extrapolation of nonclinical data to support Phase I clinical studies.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33482290</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(21)00009-X</DOI>
    <KeywordList>
      <Keywords>Clinical study report</Keywords>
      <Keywords>Investigator's brochure</Keywords>
      <Keywords>Maximum recommended starting dose</Keywords>
      <Keywords>Multiple ascending dose</Keywords>
      <Keywords>No observed adverse effect level</Keywords>
      <Keywords>Nonclinical</Keywords>
      <Keywords>Pharmacologically active dose</Keywords>
      <Keywords>Phase I clinical trial</Keywords>
      <Keywords>Single ascending dose</Keywords>
      <Keywords>Treatment emergent adverse event</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Paul Baldrick</Name>
        <Affiliation>Strategic Product Development Consulting, Clinical Development &amp; Commercialization Services, Covance, Harrogate, North Yorkshire, HG3 1PY, United Kingdom. Electronic address: paul.baldrick@covance.com.</Affiliation>
      </Author>
      <Author>
        <Name>Andreas Reichl</Name>
        <Affiliation>Clinical Pharmacology, Medical &amp; Scientific Affairs, Covance, Madison, WI, 53704, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Carcinogenicity and chronic toxicity of acrolein in rats and mice by two-year inhalation study.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33465397</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(21)00003-9</DOI>
    <KeywordList>
      <Keywords>Acrolein</Keywords>
      <Keywords>Carcinogenicity</Keywords>
      <Keywords>Chronic toxicity</Keywords>
      <Keywords>Mice</Keywords>
      <Keywords>Nasal cavity</Keywords>
      <Keywords>Rats</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Michiharu Matsumoto</Name>
        <Affiliation>Japan Bioassay Research Center, Japan Organization of Occupational Health and Safety, Japan. Electronic address: michiharu-matsumoto@jbrc.johas.go.jp.</Affiliation>
      </Author>
      <Author>
        <Name>Shotaro Yamano</Name>
        <Affiliation>Japan Bioassay Research Center, Japan Organization of Occupational Health and Safety, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Hideki Senoh</Name>
        <Affiliation>Japan Bioassay Research Center, Japan Organization of Occupational Health and Safety, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Yumi Umeda</Name>
        <Affiliation>Japan Bioassay Research Center, Japan Organization of Occupational Health and Safety, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Shigeyuki Hirai</Name>
        <Affiliation>Japan Bioassay Research Center, Japan Organization of Occupational Health and Safety, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Arata Saito</Name>
        <Affiliation>Japan Bioassay Research Center, Japan Organization of Occupational Health and Safety, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Tatsuya Kasai</Name>
        <Affiliation>Japan Bioassay Research Center, Japan Organization of Occupational Health and Safety, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Shigetoshi Aiso</Name>
        <Affiliation>Japan Bioassay Research Center, Japan Organization of Occupational Health and Safety, Japan.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Draize human repeat insult patch test (HRIPT): Seven decades of pitfalls and progress.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33460686</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(21)00007-6</DOI>
    <KeywordList>
      <Keywords>Allergic contact dermatitis</Keywords>
      <Keywords>Contact dermatitis</Keywords>
      <Keywords>Draize human repeat insult patch testing</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jordan L. Bormann</Name>
        <Affiliation>University of South Dakota, Sanford School of Medicine, Sioux Falls, SD, 57105, USA. Electronic address: Jordan.bormann@coyotes.usd.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Howard I. Maibach</Name>
        <Affiliation>UCSF, Dermatology Department, San Francisco, CA, 94143-0989, USA. Electronic address: howard.maibach@ucsf.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Quantifying bias in epidemiologic studies evaluating the association between acetaminophen use and cancer.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33454352</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(21)00006-4</DOI>
    <KeywordList>
      <Keywords>Acetaminophen</Keywords>
      <Keywords>Bias</Keywords>
      <Keywords>Cancer</Keywords>
      <Keywords>Negative controls</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Martijn J. Schuemie</Name>
        <Affiliation>Department of Epidemiology, Janssen Research and Development, Titusville, NJ, USA. Electronic address: mschuemi@its.jnj.com.</Affiliation>
      </Author>
      <Author>
        <Name>Rachel Weinstein</Name>
        <Affiliation>Department of Epidemiology, Janssen Research and Development, Titusville, NJ, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Patrick B. Ryan</Name>
        <Affiliation>Department of Epidemiology, Janssen Research and Development, Titusville, NJ, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jesse A. Berlin</Name>
        <Affiliation>Department of Epidemiology, Johnson &amp; Johnson, Titusville, NJ, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Increasing confidence in waiving dermal toxicity studies: A comparison of oral and dermal acute data with alternative approaches for agrochemicals and products.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33453310</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(21)00005-2</DOI>
    <KeywordList>
      <Keywords>Active ingredients</Keywords>
      <Keywords>Acute dermal toxicity</Keywords>
      <Keywords>Acute oral toxicity</Keywords>
      <Keywords>Acute toxicity estimate (ATE) calculations</Keywords>
      <Keywords>Agrochemical plant protection products</Keywords>
      <Keywords>Agrochemicals</Keywords>
      <Keywords>Reduction and refinement of animals</Keywords>
      <Keywords>Replacement</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Sophie van der Kamp</Name>
        <Affiliation>Syngenta Ltd., International Research Centre, Jealott's Hill, Bracknell, Berkshire, RG42 6EY, United Kingdom. Electronic address: sophie.van_der_kamp@syngenta.com.</Affiliation>
      </Author>
      <Author>
        <Name>Claire Elliott</Name>
        <Affiliation>Syngenta Ltd., International Research Centre, Jealott's Hill, Bracknell, Berkshire, RG42 6EY, United Kingdom.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Compounded conservatism in European re-entry worker risk assessment of pesticides.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33450327</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(21)00004-0</DOI>
    <KeywordList>
      <Keywords>Compounded conservatism</Keywords>
      <Keywords>Default values</Keywords>
      <Keywords>Pesticides</Keywords>
      <Keywords>Plant protection products, Non-dietary exposure</Keywords>
      <Keywords>Re-entry</Keywords>
      <Keywords>Risk assessment</Keywords>
      <Keywords>Worker</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Felix M. Kluxen</Name>
        <Affiliation>ADAMA Deutschland GmbH, Cologne, Germany. Electronic address: Felix.Kluxen@adama.com.</Affiliation>
      </Author>
      <Author>
        <Name>Edgars Felkers</Name>
        <Affiliation>ADAMA Deutschland GmbH, Cologne, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Jenny Baumann</Name>
        <Affiliation>Bayer AG, Crop Science Division, Monheim, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Neil Morgan</Name>
        <Affiliation>Syngenta, Bracknell, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Christiane Wiemann</Name>
        <Affiliation>BASF Oesterreich GmbH, Agricultural Solutions, Vienna, Austria.</Affiliation>
      </Author>
      <Author>
        <Name>Franz Stauber</Name>
        <Affiliation>BASF SE, Agricultural Solutions, Ludwigshafen, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Christian Strupp</Name>
        <Affiliation>Gowan Crop Protection, Reading, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Sarah Adham</Name>
        <Affiliation>Corteva Agriscience, Abingdon, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Christian J. Kuster</Name>
        <Affiliation>Bayer AG, Crop Science Division, Monheim, Germany.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Human Biomonitoring (HBM)-I values for perfluorooctanoic acid (PFOA) and perfluorooctane sulfonic acid (PFOS) - Description, derivation and discussion.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33444659</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(21)00002-7</DOI>
    <KeywordList>
      <Keywords>HBM-I-Value</Keywords>
      <Keywords>Human biomonitoring</Keywords>
      <Keywords>PFAS</Keywords>
      <Keywords>PFOA</Keywords>
      <Keywords>PFOS</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jürgen Hölzer</Name>
        <Affiliation>Department for Hygiene, Social and Environmental Medicine, MA 1/31, Ruhr-University Bochum, Universitätsstrasse 150, 44801, Bochum, Germany. Electronic address: juergen.hoelzer@rub.de.</Affiliation>
      </Author>
      <Author>
        <Name>Hellmuth Lilienthal</Name>
        <Affiliation>Department for Hygiene, Social and Environmental Medicine, MA 1/31, Ruhr-University Bochum, Universitätsstrasse 150, 44801, Bochum, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Michael Schümann</Name>
        <Affiliation>Department for Hygiene, Social and Environmental Medicine, MA 1/31, Ruhr-University Bochum, Universitätsstrasse 150, 44801, Bochum, Germany.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Skin immune cell characterization in juvenile and adult Göttingen Minipigs.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33417970</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(21)00001-5</DOI>
    <KeywordList>
      <Keywords>Göttingen minipigs</Keywords>
      <Keywords>Immune system</Keywords>
      <Keywords>Immunotoxicology</Keywords>
      <Keywords>Juvenile</Keywords>
      <Keywords>Skin</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Linda Allais</Name>
        <Affiliation>Charles River, Saint-Germain-Nuelles, France. Electronic address: linda.allais@crl.com.</Affiliation>
      </Author>
      <Author>
        <Name>Elise Brisebard</Name>
        <Affiliation>Charles River, Saint-Germain-Nuelles, France.</Affiliation>
      </Author>
      <Author>
        <Name>Nicolas Ravas</Name>
        <Affiliation>Charles River, Saint-Germain-Nuelles, France.</Affiliation>
      </Author>
      <Author>
        <Name>Jean Paul Briffaux</Name>
        <Affiliation>Charles River, Saint-Germain-Nuelles, France.</Affiliation>
      </Author>
      <Author>
        <Name>Marc Pallardy</Name>
        <Affiliation>Université Paris-Saclay, Inserm, Inflammation, Microbiome and Immunosurveillance, Faculté de Pharmacie, 92290, Châtenay-Malabry, France.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Estimation of toluene exposure in air from BMA (S-benzylmercapturic acid) urinary measures using a reverse dosimetry approach based on physiologically pharmacokinetic modeling.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33406392</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(20)30286-5</DOI>
    <KeywordList>
      <Keywords>And exposure assessment</Keywords>
      <Keywords>Biomonitoring</Keywords>
      <Keywords>PBPK modeling</Keywords>
      <Keywords>Reverse dosimetry</Keywords>
      <Keywords>Toluene</Keywords>
      <Keywords>Uncertainty</Keywords>
      <Keywords>Urinary BMA</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Honesty Tohon</Name>
        <Affiliation>Department of Environmental and Occupational Health, ESPUM, CReSP, Université de Montréal, C.P. 6128 Succ. Centre-ville, Montreal, Qc, H3C 3J7, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Mathieu Valcke</Name>
        <Affiliation>Department of Environmental and Occupational Health, ESPUM, CReSP, Université de Montréal, C.P. 6128 Succ. Centre-ville, Montreal, Qc, H3C 3J7, Canada; Direction de la santé environnementale et de la toxicologie, Institut national de santé publique du Québec, Montréal, Quebec, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Rocio Aranda-Rodriguez</Name>
        <Affiliation>Exposure and Biomonitoring Division, Environmental Health Sciences and Research Bureau, Health Canada, Ottawa, ON, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Andy Nong</Name>
        <Affiliation>Exposure and Biomonitoring Division, Environmental Health Sciences and Research Bureau, Health Canada, Ottawa, ON, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Sami Haddad</Name>
        <Affiliation>Department of Environmental and Occupational Health, ESPUM, CReSP, Université de Montréal, C.P. 6128 Succ. Centre-ville, Montreal, Qc, H3C 3J7, Canada. Electronic address: sami.haddad@umontreal.ca.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Assessment of the biochemical pathways for acetaminophen toxicity: Implications for its carcinogenic hazard potential.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33388367</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(20)30285-3</DOI>
    <KeywordList>
      <Keywords>Acetaminophen</Keywords>
      <Keywords>Carcinogenicity</Keywords>
      <Keywords>Genotoxicity</Keywords>
      <Keywords>Mechanisms</Keywords>
      <Keywords>Metabolism</Keywords>
      <Keywords>Mutagenicity</Keywords>
      <Keywords>Paracetamol</Keywords>
      <Keywords>Toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Hartmut Jaeschke</Name>
        <Affiliation>University of Kansas Medical Center, Department of Pharmacology, Toxicology &amp; Therapeutics, Kansas City, KS, USA.</Affiliation>
      </Author>
      <Author>
        <Name>F. Jay Murray</Name>
        <Affiliation>Murray &amp; Associates, San Jose, CA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Andrew D. Monnot</Name>
        <Affiliation>Cardno ChemRisk, San Fransisco, CA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>David Jacobson-Kram</Name>
        <Affiliation>ToxRox Consulting, McLean, VA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Samuel M. Cohen</Name>
        <Affiliation>University of Nebraska Medical Center, Havlik-Wall Professor of Oncology, Department of Pathology and Microbiology, Omaha, NE, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jerry F. Hardisty</Name>
        <Affiliation>Experimental Pathology Laboratories, Inc., Research Triangle Park, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Evren Atillasoy</Name>
        <Affiliation>Johnson &amp; Johnson Consumer Health, Fort Washington, PA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Anne Hermanowski-Vosatka</Name>
        <Affiliation>Johnson &amp; Johnson Consumer Health, Fort Washington, PA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Edwin Kuffner</Name>
        <Affiliation>Johnson &amp; Johnson Consumer Health, Fort Washington, PA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Daniele Wikoff</Name>
        <Affiliation>ToxStrategies, Asheville, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Grace A. Chappell</Name>
        <Affiliation>ToxStrategies, Asheville, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Suren B. Bandara</Name>
        <Affiliation>Cardno ChemRisk, San Fransisco, CA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Milind Deore</Name>
        <Affiliation>Johnson &amp; Johnson Consumer Products, India.</Affiliation>
      </Author>
      <Author>
        <Name>Suresh Kumar Pitchaiyan</Name>
        <Affiliation>Johnson &amp; Johnson Consumer Products, India.</Affiliation>
      </Author>
      <Author>
        <Name>Gary Eichenbaum</Name>
        <Affiliation>Johnson &amp; Johnson, New Brunswick, NJ, USA. Electronic address: geichenb@its.jnj.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Comparative In vitro metabolism of purified mogrosides derived from monk fruit extracts.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33387567</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(20)30282-8</DOI>
    <KeywordList>
      <Keywords>Anaerobic</Keywords>
      <Keywords>Human safety</Keywords>
      <Keywords>In vitro metabolism</Keywords>
      <Keywords>Mogrol</Keywords>
      <Keywords>Mogrosides</Keywords>
      <Keywords>Monk fruit extracts</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Sachin Bhusari</Name>
        <Affiliation>The Coca-Cola Company, 1 Coca Cola Plaza NW, Atlanta, GA, 30313, USA. Electronic address: sbhusari@coca-cola.com.</Affiliation>
      </Author>
      <Author>
        <Name>Chester Rodriguez</Name>
        <Affiliation>The Coca-Cola Company, 1 Coca Cola Plaza NW, Atlanta, GA, 30313, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Stanley M. Tarka</Name>
        <Affiliation>The Tarka Group Inc., 210 N. Old Stonehouse Road, Carlisle, PA, 17015, USA.</Affiliation>
      </Author>
      <Author>
        <Name>David Kwok</Name>
        <Affiliation>BRI Biopharmaceutical Research Inc., 101-8898 Heather St, Vancouver, BC, V6P 3S8, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>George Pugh</Name>
        <Affiliation>The Coca-Cola Company, 1 Coca Cola Plaza NW, Atlanta, GA, 30313, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jaspreet Gujral</Name>
        <Affiliation>Tate &amp; Lyle, 5450 Prairie Stone Parkway, Hoffman Estates, IL, 60192, USA.</Affiliation>
      </Author>
      <Author>
        <Name>David Tonucci</Name>
        <Affiliation>Tate &amp; Lyle, 5450 Prairie Stone Parkway, Hoffman Estates, IL, 60192, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The use of emerging safety biomarkers in nonclinical and clinical safety assessment - The current and future state: An IQ DruSafe industry survey.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33387566</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(20)30283-X</DOI>
    <KeywordList>
      <Keywords>Clinical</Keywords>
      <Keywords>DruSafe</Keywords>
      <Keywords>Drug development</Keywords>
      <Keywords>Emerging safety biomarkers</Keywords>
      <Keywords>Nonclinical</Keywords>
      <Keywords>Qualification</Keywords>
      <Keywords>Survey</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Tanja S. Zabka</Name>
        <Affiliation>Genentech Inc, 1 DNA Way, South San Francisco, CA, USA. Electronic address: zabka.tanja@gene.com.</Affiliation>
      </Author>
      <Author>
        <Name>John Burkhardt</Name>
        <Affiliation>Pfizer, 1 Eastern Point Road, Groton, CT, USA. Electronic address: john.burkhardt@pfizer.com.</Affiliation>
      </Author>
      <Author>
        <Name>William J. Reagan</Name>
        <Affiliation>Pfizer, 1 Eastern Point Road, Groton, CT, USA. Electronic address: william.j.reagan@pfizer.com.</Affiliation>
      </Author>
      <Author>
        <Name>Jean Charles Gautier</Name>
        <Affiliation>Sanofi, 13, Quai Jules Guesde, Vitry-sur-Seine, France. Electronic address: jcgautier94@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Warren E. Glaab</Name>
        <Affiliation>Merck &amp; Co, 770 Sumneytown Pike, West Point, PA, USA. Electronic address: warren_glaab@merck.com.</Affiliation>
      </Author>
      <Author>
        <Name>Magali Guffroy</Name>
        <Affiliation>AbbVie, 1 North Waukegan Road, North Chicago, IL, USA. Electronic address: magali.guffroy@abbvie.com.</Affiliation>
      </Author>
      <Author>
        <Name>Joanna Harding</Name>
        <Affiliation>AstraZeneca, Da Vinci Building, Melbourn Science Park, Cambridge Road, Melbourn, Royston, Hertfordshire, UK. Electronic address: joanna.harding@astrazeneca.com.</Affiliation>
      </Author>
      <Author>
        <Name>Dominique Brees</Name>
        <Affiliation>Novartis, 4057 Basel, Basel-stadt, Switzerland. Electronic address: dominique.brees@novartis.com.</Affiliation>
      </Author>
      <Author>
        <Name>Eric McDuffie</Name>
        <Affiliation>Janssen, 3210 Merryfield Row, San Diego, CA, USA. Electronic address: jmcduffie@its.jnj.com.</Affiliation>
      </Author>
      <Author>
        <Name>Lila Ramaiah</Name>
        <Affiliation>Pfizer, 401 North Middletown Road, Pearl River, NY, USA. Electronic address: lila.Ramaiah@pfizer.com.</Affiliation>
      </Author>
      <Author>
        <Name>A. Eric Schultze</Name>
        <Affiliation>Lilly Research Laboratories, 893 S Delaware St, Indianapolis, IN, USA. Electronic address: schultze_albert_eric@lilly.com.</Affiliation>
      </Author>
      <Author>
        <Name>James D. Smith</Name>
        <Affiliation>Boehringer Ingelheim, 900 Ridgebury Rd, Ridgefield, CT, USA. Electronic address: James-d.smith@boehringer-ingelheim.com.</Affiliation>
      </Author>
      <Author>
        <Name>Alison Wolfreys</Name>
        <Affiliation>UCB Biopharma, Bath Road, Slough, Berkshire, UK. Electronic address: alison.wolfreys@ucb.com.</Affiliation>
      </Author>
      <Author>
        <Name>Deidre A. Dalmas</Name>
        <Affiliation>GlaxoSmithKline, 1250 S. Collegeville Rd, Collegeville, PA, USA. Electronic address: deidre.a.dalmas@gsk.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Evaluation of the carcinogenicity of dichloromethane in rats, mice, hamsters and humans.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33387565</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(20)30284-1</DOI>
    <KeywordList>
      <Keywords>Carcinogenicity</Keywords>
      <Keywords>Classification and labeling</Keywords>
      <Keywords>Dichloromethane</Keywords>
      <Keywords>Methylene chloride</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Wolfgang Dekant</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Universität Würzburg, Versbacherstr. 9, 97078 Würzburg, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Paul Jean</Name>
        <Affiliation>Olin Corporation, 2205 Ridgewood Dr., Midland, MI, 48642 USA.</Affiliation>
      </Author>
      <Author>
        <Name>Josje Arts</Name>
        <Affiliation>Nouryon Industrial Chemicals, PO Box 60192, 6800 JD Arnhem, the Netherlands. Electronic address: josje.arts@nouryon.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Testing the validity of a proposed dermal cancer slope factor for Benzo[a]pyrene.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33359623</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(20)30278-6</DOI>
    <KeywordList>
      <Keywords>Benzo[a]pyrene</Keywords>
      <Keywords>Dermal</Keywords>
      <Keywords>Polycyclic aromatic hydrocarbons</Keywords>
      <Keywords>Risk assessment</Keywords>
      <Keywords>Skin cancer</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Brian H. Magee</Name>
        <Affiliation>Arcadis U.S., Inc., One Executive Drive, Suite 303, Chelmsford, MA, 01824, United States. Electronic address: brian.magee@arcadis.com.</Affiliation>
      </Author>
      <Author>
        <Name>Norman D. Forsberg</Name>
        <Affiliation>Arcadis U.S., Inc, 855 Route 146, Suite 210, Clifton Park, NY, 12065, United States.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A 13-week subchronic toxicity study of a Dioscorea Rhizome water extract in rats.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33359266</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(20)30270-1</DOI>
    <KeywordList>
      <Keywords>Dioscorea Rhizome</Keywords>
      <Keywords>Herbal medicine</Keywords>
      <Keywords>No-observed-adverse-effect level</Keywords>
      <Keywords>Repeated oral dose toxicity</Keywords>
      <Keywords>Target organ</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Seung Beom Cha</Name>
        <Affiliation>Nonclinical Research Center, ChemOn Inc., Yongin, 17162, Republic of Korea; College of Veterinary Medicine (BK21 Plus Project Team), Chonnam National University, Gwangju, 61186, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Hak Soo Kim</Name>
        <Affiliation>Nonclinical Research Center, ChemOn Inc., Yongin, 17162, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Jin Sook Bae</Name>
        <Affiliation>Nonclinical Research Center, ChemOn Inc., Yongin, 17162, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Si Whan Song</Name>
        <Affiliation>Nonclinical Research Center, ChemOn Inc., Yongin, 17162, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Je Oh Lim</Name>
        <Affiliation>College of Veterinary Medicine (BK21 Plus Project Team), Chonnam National University, Gwangju, 61186, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Jong Choon Kim</Name>
        <Affiliation>College of Veterinary Medicine (BK21 Plus Project Team), Chonnam National University, Gwangju, 61186, Republic of Korea. Electronic address: toxkim@jnu.ac.kr.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Incorporating lines of evidence from New Approach Methodologies (NAMs) to reduce uncertainties in a category based read-across: A case study for repeated dose toxicity.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33359265</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(20)30281-6</DOI>
    <KeywordList>
      <Keywords>New approach methodology</Keywords>
      <Keywords>Read-across</Keywords>
      <Keywords>Read-across assessment framework</Keywords>
      <Keywords>Triazole fungicides</Keywords>
      <Keywords>Uncertainty</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Cynthia B. Pestana</Name>
        <Affiliation>School of Pharmacy and Biomolecular Sciences, Liverpool John Moores University, Byrom Street, Liverpool, L3 3AF, UK.</Affiliation>
      </Author>
      <Author>
        <Name>James W. Firman</Name>
        <Affiliation>School of Pharmacy and Biomolecular Sciences, Liverpool John Moores University, Byrom Street, Liverpool, L3 3AF, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Mark T. D. Cronin</Name>
        <Affiliation>School of Pharmacy and Biomolecular Sciences, Liverpool John Moores University, Byrom Street, Liverpool, L3 3AF, UK. Electronic address: m.t.cronin@ljmu.ac.uk.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Non-dioxin-like polychlorinated biphenyl neurotoxic equivalents found in environmental and human samples.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33346014</pubmedLink>
    <GrantList>
      <Grant>TL4 GM118980</Grant>
      <Grant>RL5 GM118978</Grant>
      <Grant>P42 ES004699</Grant>
      <Grant>SC3 GM132033</Grant>
      <Grant>UL1 GM118979</Grant>
      <Grant>P30 ES023513</Grant>
    </GrantList>
    <Year>2021</Year>
    <DOI>S0273-2300(20)30268-3</DOI>
    <KeywordList>
      <Keywords>Congener</Keywords>
      <Keywords>Equivalency scheme</Keywords>
      <Keywords>NEQ</Keywords>
      <Keywords>Neurotoxicity</Keywords>
      <Keywords>Non-dioxin-like PCBs</Keywords>
      <Keywords>Potency</Keywords>
      <Keywords>TEF</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>E. B. Holland</Name>
        <Affiliation>Department of Biological Sciences, California State University of Long Beach, Long Beach, CA, USA. Electronic address: erika.holland@csulb.edu.</Affiliation>
      </Author>
      <Author>
        <Name>I. N. Pessah</Name>
        <Affiliation>Department of Molecular Biosciences, School of Veterinary Medicine, University of California, Davis, CA, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A cross-industry collaboration to assess if acute oral toxicity (Q)SAR models are fit-for-purpose for GHS classification and labelling.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33340644</pubmedLink>
    <GrantList>
      <Grant>R44 ES026909</Grant>
      <Grant>T32 ES026568</Grant>
    </GrantList>
    <Year>2021</Year>
    <DOI>S0273-2300(20)30269-5</DOI>
    <KeywordList>
      <Keywords>Acute oral Toxicity (Q)SAR</Keywords>
      <Keywords>CLP/GHS GHS</Keywords>
      <Keywords>Classification and labelling</Keywords>
      <Keywords>Expert rule-based Statistical-based model</Keywords>
      <Keywords>In silico 3Rs Expert review</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Joel Bercu</Name>
        <Affiliation>Gilead Sciences, 333 Lakeside Drive, Foster City, CA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Melisa J. Masuda-Herrera</Name>
        <Affiliation>Gilead Sciences, 333 Lakeside Drive, Foster City, CA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Alejandra Trejo-Martin</Name>
        <Affiliation>Gilead Sciences, 333 Lakeside Drive, Foster City, CA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Catrin Hasselgren</Name>
        <Affiliation>Genentech, Inc., 1 DNA Way, South San Francisco, CA, 94080, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jean Lord</Name>
        <Affiliation>Ultragenyx, 60 Leveroni Court, Novato, CA, 94949, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jessica Graham</Name>
        <Affiliation>Bristol Myers Squibb, 1 Squibb Dr, New Brunswick, NJ, 08903, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Matthew Schmitz</Name>
        <Affiliation>AbbVie Inc., North Chicago, IL, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Lawrence Milchak</Name>
        <Affiliation>3M Company, 3M Center, St. Paul, MN, 55144-1000, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Colin Owens</Name>
        <Affiliation>3M Company, 3M Center, St. Paul, MN, 55144-1000, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Surya Hari Lal</Name>
        <Affiliation>Syngenta Crop Protection, Product Safety Department, Jealott's Hill International Research Centre, Bracknell, Berkshire, RG42 6EY, UK(1).</Affiliation>
      </Author>
      <Author>
        <Name>Richard Marchese Robinson</Name>
        <Affiliation>Syngenta Crop Protection, Product Safety Department, Jealott's Hill International Research Centre, Bracknell, Berkshire, RG42 6EY, UK(1).</Affiliation>
      </Author>
      <Author>
        <Name>Sarah Whalley</Name>
        <Affiliation>Syngenta Crop Protection, Product Safety Department, Jealott's Hill International Research Centre, Bracknell, Berkshire, RG42 6EY, UK(1).</Affiliation>
      </Author>
      <Author>
        <Name>Phillip Bellion</Name>
        <Affiliation>DSM Nutritional Products, Kaiseraugst, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Anna Vuorinen</Name>
        <Affiliation>DSM Nutritional Products, Kaiseraugst, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Kamila Gromek</Name>
        <Affiliation>Galapagos SASU, 102 Avenue Gaston Roussel, 93230, Romainville, France.</Affiliation>
      </Author>
      <Author>
        <Name>William A. Hawkins</Name>
        <Affiliation>GlaxoSmithKline, Park Road, Ware, Hertfordshire, SG12 0DP, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Iris van de Gevel</Name>
        <Affiliation>Janssen Pharmaceutical Companies of Johnson &amp; Johnson, 2340, Beerse, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Kathleen Vriens</Name>
        <Affiliation>Janssen Pharmaceutical Companies of Johnson &amp; Johnson, 2340, Beerse, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Raymond Kemper</Name>
        <Affiliation>Vertex Pharmaceuticals Inc., Discovery and Investigative Toxicology, 50 Northern Ave, Boston, MA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Russell Naven</Name>
        <Affiliation>Vertex Pharmaceuticals Inc., Discovery and Investigative Toxicology, 50 Northern Ave, Boston, MA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Pierre Ferrer</Name>
        <Affiliation>Department of Veterinary Physiology and Pharmacology, Interdisciplinary Faculty of Toxicology Program, Texas A&amp;M University, 4466 TAMU, College Station, TX, 77843-4466, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Glenn J. Myatt</Name>
        <Affiliation>Leadscope (an Instem company), 1393 Dublin Rd, Columbus, OH, 43215, USA. Electronic address: gmyatt@leadscope.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Evidence-based regulations for bioinformatic prediction of allergen cross-reactivity are needed.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33333099</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(20)30267-1</DOI>
    <KeywordList>
      <Keywords>Allergens</Keywords>
      <Keywords>Bioinformatics</Keywords>
      <Keywords>Cross-reactive</Keywords>
      <Keywords>Empirical evidence</Keywords>
      <Keywords>Expert opinion</Keywords>
      <Keywords>Genetically engineered crops</Keywords>
      <Keywords>Regulation</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Rod A. Herman</Name>
        <Affiliation>Corteva Agriscience, 9330 Zionsville Road, Indianapolis, IN, 47968, USA. Electronic address: rod.herman@corteva.com.</Affiliation>
      </Author>
      <Author>
        <Name>Ping Song</Name>
        <Affiliation>Corteva Agriscience, 9330 Zionsville Road, Indianapolis, IN, 47968, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Henry P. Mirsky</Name>
        <Affiliation>Corteva Agriscience, 8325 NW 62nd Avenue, Johnston, IA, 50131, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jason M. Roper</Name>
        <Affiliation>Corteva Agriscience, P.O. Box 30 Newark DE, 19714, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Reproductive and developmental toxicity screening study of an acetone extract of rosemary.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33321148</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(20)30266-X</DOI>
    <KeywordList>
      <Keywords>Carnosic acid</Keywords>
      <Keywords>Carnosol</Keywords>
      <Keywords>Developmental toxicity</Keywords>
      <Keywords>Endocrine system</Keywords>
      <Keywords>Food additive</Keywords>
      <Keywords>Reproductive toxicity</Keywords>
      <Keywords>Rosemary extract</Keywords>
      <Keywords>Thyroid hormones</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Kirt R. Phipps</Name>
        <Affiliation>Intertek Health Sciences Inc, Room 1036, Building A8, Cody Technology Park, Ively Road, Farnborough, Hampshire, UK. Electronic address: kirt.phipps@intertek.com.</Affiliation>
      </Author>
      <Author>
        <Name>Barbara Danielewska-Nikiel</Name>
        <Affiliation>Intertek Health Sciences Inc, 2233 Argentia Road, Suite 201, Mississauga, Ontario, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Jessica Mushonganono</Name>
        <Affiliation>Intertek Health Sciences Inc, 2233 Argentia Road, Suite 201, Mississauga, Ontario, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Nigel Baldwin</Name>
        <Affiliation>Intertek Health Sciences Inc, Room 1036, Building A8, Cody Technology Park, Ively Road, Farnborough, Hampshire, UK.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A weight of evidence assessment of the genotoxicity of 2,6-xylidine based on existing and new data, with relevance to safety of lidocaine exposure.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33301869</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(20)30264-6</DOI>
    <KeywordList>
      <Keywords>2,6-Xylidine</Keywords>
      <Keywords>Genotoxicity</Keywords>
      <Keywords>Weight of evidence assessment</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>David J. Kirkland</Name>
        <Affiliation>Kirkland Consulting, P O Box 79, Tadcaster, LS24 0AS, United Kingdom. Electronic address: dkirkland@genetoxconsulting.co.uk.</Affiliation>
      </Author>
      <Author>
        <Name>Meredith L. Sheil</Name>
        <Affiliation>Animal Ethics Pty Ltd., 363 Steeles Road, Yarra Glen, VIC, 3775, Australia.</Affiliation>
      </Author>
      <Author>
        <Name>Michael A. Streicker</Name>
        <Affiliation>Integrated Laboratory Systems, LLC, 635 Davis Drive, Suite 600, Morrisville, NC, 27560, USA.</Affiliation>
      </Author>
      <Author>
        <Name>George E. Johnson</Name>
        <Affiliation>Institute of Life Science, Swansea University Medical School, Singleton Park, Swansea, SA3 5DE, United Kingdom.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Risk assessment of predicted serum concentrations of bisphenol A in children and adults following treatment with dental composite restoratives, dental sealants, or orthodontic adhesives using physiologically based pharmacokinetic modeling.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33301868</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(20)30265-8</DOI>
    <KeywordList>
      <Keywords>Bisphenol A (BPA)</Keywords>
      <Keywords>Bisphenol A glycidyl methacrylate (BisGMA)</Keywords>
      <Keywords>Dental</Keywords>
      <Keywords>Extract</Keywords>
      <Keywords>Orthodontic</Keywords>
      <Keywords>PBPK model</Keywords>
      <Keywords>Serum concentration</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Bradford D. Bagley</Name>
        <Affiliation>3M Corporate Toxicology and Environmental Science, 3M Center, St. Paul, MN, 55144-1000, USA. Electronic address: bdbagley@mmm.com.</Affiliation>
      </Author>
      <Author>
        <Name>Jordan N. Smith</Name>
        <Affiliation>Exposure Science, Pacific Northwest National Laboratory, Richland, WA, 99352, USA; Department of Environmental and Molecular Toxicology, Oregon State University, Corvallis, OR, 93771, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Justin G. Teeguarden</Name>
        <Affiliation>Exposure Science, Pacific Northwest National Laboratory, Richland, WA, 99352, USA; Department of Environmental and Molecular Toxicology, Oregon State University, Corvallis, OR, 93771, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Subchronic toxicity study in rats evaluating herbicide-tolerant soybean DAS-68416-4.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33259869</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(20)30259-2</DOI>
    <KeywordList>
      <Keywords>90-Day feeding test</Keywords>
      <Keywords>Aad-12 gene</Keywords>
      <Keywords>Genetically modified soybean</Keywords>
      <Keywords>Herbicide-tolerant</Keywords>
      <Keywords>Rat</Keywords>
      <Keywords>Subchronic toxicity</Keywords>
      <Keywords>pat gene</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Li Zhang</Name>
        <Affiliation>Department of Toxicology, Tianjin Centers for Disease Control and Prevention, Tianjin, 300011, China.</Affiliation>
      </Author>
      <Author>
        <Name>Shu Fei Li</Name>
        <Affiliation>Department of Toxicology, Tianjin Centers for Disease Control and Prevention, Tianjin, 300011, China.</Affiliation>
      </Author>
      <Author>
        <Name>Qing Hong Zhou</Name>
        <Affiliation>Department of Toxicology, Tianjin Centers for Disease Control and Prevention, Tianjin, 300011, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ying Hua Liu</Name>
        <Affiliation>Department of Toxicology, Tianjin Centers for Disease Control and Prevention, Tianjin, 300011, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jing Zhang</Name>
        <Affiliation>Department of Toxicology, Tianjin Centers for Disease Control and Prevention, Tianjin, 300011, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhi Yong Qian</Name>
        <Affiliation>Department of Toxicology, Tianjin Centers for Disease Control and Prevention, Tianjin, 300011, China. Electronic address: tjcdcdl@163.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A review to support the derivation of a worst-case dermal penetration value for nanoparticles.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33249100</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(20)30262-2</DOI>
    <KeywordList>
      <Keywords>Dermis</Keywords>
      <Keywords>Epidermis</Keywords>
      <Keywords>Nanoparticle</Keywords>
      <Keywords>Penetration</Keywords>
      <Keywords>Skin</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Irene Gimeno-Benito</Name>
        <Affiliation>Leitat Technological Center, Innovació 2, 08225, Terrassa, Spain.</Affiliation>
      </Author>
      <Author>
        <Name>Anna Giusti</Name>
        <Affiliation>German Federal Institute for Risk Assessment (BfR), Department of Chemical and Product Safety, Max- Dohrn- Strasse 8-10, 10589, Berlin, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Susan Dekkers</Name>
        <Affiliation>Rijksinstituut voor Volksgezondheid en Milieu (RIVM), P.O. Box 1, 3720, BA, Bilthoven, the Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Andrea Haase</Name>
        <Affiliation>German Federal Institute for Risk Assessment (BfR), Department of Chemical and Product Safety, Max- Dohrn- Strasse 8-10, 10589, Berlin, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Gemma Janer</Name>
        <Affiliation>Leitat Technological Center, Innovació 2, 08225, Terrassa, Spain. Electronic address: gjaner@leitat.org.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A call for action on the development and implementation of new methodologies for safety assessment of chemical-based products in the EU - A short communication.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33249099</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(20)30263-4</DOI>
    <KeywordList>
      <Keywords>3Rs</Keywords>
      <Keywords>Animal welfare</Keywords>
      <Keywords>Cosmetics</Keywords>
      <Keywords>Food safety</Keywords>
      <Keywords>Medicines</Keywords>
      <Keywords>New approach methods</Keywords>
      <Keywords>Next generation risk assessment</Keywords>
      <Keywords>Non-animal-based testing</Keywords>
      <Keywords>Risk assessment</Keywords>
      <Keywords>Toxicology</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Derek J. Knight</Name>
        <Affiliation>ECHA, Finland.</Affiliation>
      </Author>
      <Author>
        <Name>Hubert Deluyker</Name>
        <Affiliation>Ex-Scientific Advisor EFSA, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Qasim Chaudhry</Name>
        <Affiliation>University of Chester, Parkgate Road, Chester, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Jean Marc Vidal</Name>
        <Affiliation>Consultant toxicologist, London, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Alie de Boer</Name>
        <Affiliation>Food Claims Centre Venlo, Campus Venlo, Maastricht University, the Netherlands. Electronic address: a.deboer@maastrichtuniversity.nl.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Evaluating chemical similarity as a measure to identify potential substances of very high concern.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33227364</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(20)30260-9</DOI>
    <KeywordList>
      <Keywords>Chemical grouping</Keywords>
      <Keywords>Chemical similarity</Keywords>
      <Keywords>Expert elicitation</Keywords>
      <Keywords>Screening and prioritization</Keywords>
      <Keywords>Substances of very high concern</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Pim N. H. Wassenaar</Name>
        <Affiliation>National Institute for Public Health and the Environment (RIVM), P.O. Box 1, 3720BA, Bilthoven, the Netherlands; Institute of Environmental Sciences (CML), Leiden University, P. O. Box 9518, 2300RA, Leiden, the Netherlands. Electronic address: pim.wassenaar@rivm.nl.</Affiliation>
      </Author>
      <Author>
        <Name>Emiel Rorije</Name>
        <Affiliation>National Institute for Public Health and the Environment (RIVM), P.O. Box 1, 3720BA, Bilthoven, the Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Martina G. Vijver</Name>
        <Affiliation>Institute of Environmental Sciences (CML), Leiden University, P. O. Box 9518, 2300RA, Leiden, the Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Willie J. G. M. Peijnenburg</Name>
        <Affiliation>National Institute for Public Health and the Environment (RIVM), P.O. Box 1, 3720BA, Bilthoven, the Netherlands; Institute of Environmental Sciences (CML), Leiden University, P. O. Box 9518, 2300RA, Leiden, the Netherlands.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Simple methodology for ensuring the precision of measuring radioactivity at low concentrations in very small tissues using quantitative whole-body autoradiography.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33227363</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(20)30261-0</DOI>
    <KeywordList>
      <Keywords>Coefficient of variation</Keywords>
      <Keywords>Intensity</Keywords>
      <Keywords>Lower limit of quantification</Keywords>
      <Keywords>Quantitative whole-body autoradiography</Keywords>
      <Keywords>Reliability</Keywords>
      <Keywords>Very small tissue</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Takanori Hironaka</Name>
        <Affiliation>Drug Metabolism and Pharmacokinetics, Research Laboratory for Development, Shionogi &amp; Co., Ltd., Toyonaka, Osaka, Japan; Development of Drug Safety &amp; DMPK, Research Area for Candidate Selection, Shionogi TechnoAdvance Research Co., Ltd., Toyonaka, Osaka, Japan. Electronic address: takanori.hironaka@shionogi.co.jp.</Affiliation>
      </Author>
      <Author>
        <Name>Kazuhiro Inazawa</Name>
        <Affiliation>Drug Metabolism and Pharmacokinetics, Research Laboratory for Development, Shionogi &amp; Co., Ltd., Toyonaka, Osaka, Japan; Development of Drug Safety &amp; DMPK, Research Area for Candidate Selection, Shionogi TechnoAdvance Research Co., Ltd., Toyonaka, Osaka, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Yukari Tanaka</Name>
        <Affiliation>Drug Metabolism and Pharmacokinetics, Research Laboratory for Development, Shionogi &amp; Co., Ltd., Toyonaka, Osaka, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Hiroshi Hasegawa</Name>
        <Affiliation>Drug Metabolism and Pharmacokinetics, Research Laboratory for Development, Shionogi &amp; Co., Ltd., Toyonaka, Osaka, Japan.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Aloe gel-base food products: Chemical, toxicological, and regulatory aspects.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33221425</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(20)30244-0</DOI>
    <KeywordList>
      <Keywords>Aloe gel</Keywords>
      <Keywords>Aloe juice</Keywords>
      <Keywords>Chemical composition</Keywords>
      <Keywords>Developmental toxicity</Keywords>
      <Keywords>Food supplement</Keywords>
      <Keywords>Genotoxicity</Keywords>
      <Keywords>Hydroxyanthracene derivative</Keywords>
      <Keywords>Repeat-dose toxicity</Keywords>
      <Keywords>Reproductive toxicity</Keywords>
      <Keywords>Toxicology</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Alessandra Baldi</Name>
        <Affiliation>Tefarco Innova, National Inter-University Consortium of Innovative Pharmaceutical Technologies, Parco Area delle Scienze 27/A - Campus 43124 Parma, Italy. Electronic address: alessandra.baldi.alimenti@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Eduardo Sommella</Name>
        <Affiliation>Department of Pharmacy, University of Salerno, 84084 Fisciano, SA, Italy. Electronic address: esommella@unisa.it.</Affiliation>
      </Author>
      <Author>
        <Name>Pietro Campiglia</Name>
        <Affiliation>Department of Pharmacy, University of Salerno, 84084 Fisciano, SA, Italy; European Biomedical Research Institute of Salerno, Via De Renzi 50, I-84125 Salerno, Italy. Electronic address: pcampiglia@unisa.it.</Affiliation>
      </Author>
      <Author>
        <Name>Maria Daglia</Name>
        <Affiliation>Department of Pharmacy, University of Napoli Federico II, Via D. Montesano 49, 80131, Naples, Italy; International Research Center for Food Nutrition and Safety, Jiangsu University, Zhenjiang 212013, China. Electronic address: maria.daglia@unina.it.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Genotoxicity and subchronic toxicity studies of supercritical carbon dioxide and acetone extracts of rosemary.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33221424</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(20)30252-X</DOI>
    <KeywordList>
      <Keywords>Carnosic acid</Keywords>
      <Keywords>Carnosol</Keywords>
      <Keywords>Cytochrome P450</Keywords>
      <Keywords>Enzyme induction</Keywords>
      <Keywords>Food additive</Keywords>
      <Keywords>Genotoxicity</Keywords>
      <Keywords>Liver</Keywords>
      <Keywords>Rosemary extract</Keywords>
      <Keywords>Subchronic toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Kirt R. Phipps</Name>
        <Affiliation>Intertek Health Sciences Inc, Room 1036, Building A8, Cody Technology Park, Ively Road, Farnborough, Hampshire, UK. Electronic address: kirt.phipps@intertek.com.</Affiliation>
      </Author>
      <Author>
        <Name>Dayna Lozon</Name>
        <Affiliation>Intertek Health Sciences Inc, 2233 Argentia Road, Suite 201, Mississauga, Ontario, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Nigel Baldwin</Name>
        <Affiliation>Intertek Health Sciences Inc, Room 1036, Building A8, Cody Technology Park, Ively Road, Farnborough, Hampshire, UK.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Antimony release from polyester textiles by artificial sweat solutions: A call for a standardized procedure.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33221423</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(20)30250-6</DOI>
    <KeywordList>
      <Keywords>Antimony</Keywords>
      <Keywords>Clothes</Keywords>
      <Keywords>Mobilization</Keywords>
      <Keywords>Sweat</Keywords>
      <Keywords>Synthetic fibres</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Marc Biver</Name>
        <Affiliation>Bibliothèque Nationale du Luxembourg, 37D, Avenue John F. Kennedy, L-1855, Luxembourg, Luxembourg.</Affiliation>
      </Author>
      <Author>
        <Name>Andrew Turner</Name>
        <Affiliation>School of Geography, Earth and Environmental Sciences, University of Plymouth, Drake Circus, Plymouth, PL4 8AA, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Montserrat Filella</Name>
        <Affiliation>Department F.-A. Forel, University of Geneva, Boulevard Carl-Vogt 66, CH-1205, Geneva, Switzerland. Electronic address: montserrat.filella@unige.ch.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Industry experiences with immune-mediated findings in biotherapeutic nonclinical toxicology studies.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33220389</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(20)30251-8</DOI>
    <KeywordList>
      <Keywords>Adverse</Keywords>
      <Keywords>Allergic reaction</Keywords>
      <Keywords>Antibody</Keywords>
      <Keywords>Autoimmune</Keywords>
      <Keywords>Biotherapeutic</Keywords>
      <Keywords>Hypersensitivity</Keywords>
      <Keywords>Immune complex</Keywords>
      <Keywords>Immune responses</Keywords>
      <Keywords>Immunogenicity</Keywords>
      <Keywords>Non-human primate</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Timothy K. MacLachlan</Name>
        <Affiliation>Department of Preclinical Safety, Novartis Institutes for Biomedical Research, Cambridge, MA, 02139, USA. Electronic address: timothy.maclachlan@novartis.com.</Affiliation>
      </Author>
      <Author>
        <Name>Sven Kronenberg</Name>
        <Affiliation>Roche Pharmaceutical Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, 4070, Basel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Nikki Marshall</Name>
        <Affiliation>Non-Clinical Safety, GlaxoSmithKline, 1250 South Collegeville RD, Collegeville, PA, 19426, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Laura Andrews</Name>
        <Affiliation>Abbvie Preclinical Safety, Worcester, MA, USA, 01605.</Affiliation>
      </Author>
      <Author>
        <Name>Shawn Jay Berens</Name>
        <Affiliation>Investigative Toxicology and Pathology, Lilly Research Laboratories, Lilly Corporate Center, Indianapolis, IN, 46285, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Frederic Brouta</Name>
        <Affiliation>UCB Biopharma SRL, Non-Clinical Safety Evaluation, 1420, Braine-l'Alleud, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Birgit Fogal</Name>
        <Affiliation>Nonclinical Drug Safety, Boehringer Ingelheim Pharmaceuticals Inc, Ridgefield, CT, 06877, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Wendy Freebern</Name>
        <Affiliation>Bristol Myers Squibb, Drug Safety Evaluation, New Brunswick, NJ, 08903, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Danuta Herzyk</Name>
        <Affiliation>Merck Sharp &amp; Dohme Corp., a Subsidiary of Merck &amp; Co., Inc., Kenilworth, NJ, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Cris Kamperschroer</Name>
        <Affiliation>Pfizer Worldwide Research &amp; Development, Groton, CT, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Andrea Kiessling</Name>
        <Affiliation>Department of Preclinical Safety, Novartis Institutes for Biomedical Research, Basel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Marlowe Schneidkraut</Name>
        <Affiliation>Astellas Discovery Science and Management, 1 Astellas Way, N2.103, Northbrook, IL, 60062, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Curtis Maier</Name>
        <Affiliation>Non-Clinical Safety, GlaxoSmithKline, 1250 South Collegeville RD, Collegeville, PA, 19426, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Safety assessment of ethanolic root extract of Zaleya decandra (EEZD) in Wistar rats.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33217502</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(20)30248-8</DOI>
    <KeywordList>
      <Keywords>Acute toxicity</Keywords>
      <Keywords>Chronic toxicity</Keywords>
      <Keywords>Ethanolic root extract</Keywords>
      <Keywords>Safety</Keywords>
      <Keywords>Wistar rat</Keywords>
      <Keywords>Zaleya decandra</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Malarvizhi Deivasigamani</Name>
        <Affiliation>Department of Biochemistry, Karpagam Academy of Higher Education, Eachanari, Coimbatore, 641 021, Tamil Nadu, India.</Affiliation>
      </Author>
      <Author>
        <Name>Nagaraj Kannan</Name>
        <Affiliation>Department of Biochemistry, Karpagam Academy of Higher Education, Eachanari, Coimbatore, 641 021, Tamil Nadu, India.</Affiliation>
      </Author>
      <Author>
        <Name>Nishu Sekar</Name>
        <Affiliation>Department of Biotechnology, Sri Ramakrishna College of Arts and Science, Coimbatore, 641 006, Tamil Nadu, India.</Affiliation>
      </Author>
      <Author>
        <Name>Hariprasath Lakshmanan</Name>
        <Affiliation>Department of Biochemistry, Karpagam Academy of Higher Education, Eachanari, Coimbatore, 641 021, Tamil Nadu, India. Electronic address: hariprasath80@gmail.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Pharmacokinetics and efficacy of atropine sulfate/obidoxime chloride co-formulation against VX in a guinea pig model.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33212192</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(20)30249-X</DOI>
    <KeywordList>
      <Keywords>Atropine sulfate</Keywords>
      <Keywords>Guinea pig</Keywords>
      <Keywords>Nerve agents</Keywords>
      <Keywords>Obidoxime chloride</Keywords>
      <Keywords>Pharmacokinetics</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jiska Kentrop</Name>
        <Affiliation>TNO Defence, Safety &amp; Security, CBRN Protection, Lange Kleiweg 137, NL-2288, GJ Rijswijk, the Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Vladimir Savransky</Name>
        <Affiliation>Emergent BioSolutions Inc, 300 Professional Drive, Gaithersburg, MD, 20879, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Steven D. Klaassen</Name>
        <Affiliation>TNO Defence, Safety &amp; Security, CBRN Protection, Lange Kleiweg 137, NL-2288, GJ Rijswijk, the Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Tomas van Groningen</Name>
        <Affiliation>TNO Defence, Safety &amp; Security, CBRN Protection, Lange Kleiweg 137, NL-2288, GJ Rijswijk, the Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Sara Bohnert</Name>
        <Affiliation>Defense Research and Development Canada - Suffield Research Centre, Casualty Management Section, PO Box 4000 Station Main, Medicine Hat, Alberta, T1A 8K6, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Alex S. Cornelissen</Name>
        <Affiliation>TNO Defence, Safety &amp; Security, CBRN Protection, Lange Kleiweg 137, NL-2288, GJ Rijswijk, the Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Laura Cochrane</Name>
        <Affiliation>Emergent BioSolutions Inc, 300 Professional Drive, Gaithersburg, MD, 20879, USA.</Affiliation>
      </Author>
      <Author>
        <Name>John Barry</Name>
        <Affiliation>Emergent BioSolutions Inc, 300 Professional Drive, Gaithersburg, MD, 20879, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Marloes J. A. Joosen</Name>
        <Affiliation>TNO Defence, Safety &amp; Security, CBRN Protection, Lange Kleiweg 137, NL-2288, GJ Rijswijk, the Netherlands. Electronic address: Marloes.joosen@tno.nl.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A 90-day drinking water study in mice to characterize early events in the cancer mode of action of 1,4-dioxane.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33189748</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(20)30245-2</DOI>
    <KeywordList>
      <Keywords>1,4-Dioxane</Keywords>
      <Keywords>Mitogenesis</Keywords>
      <Keywords>Mode of action</Keywords>
      <Keywords>Mouse liver</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Mark Lafranconi</Name>
        <Affiliation>Environmental Resources Management, Cincinnati, OH, USA. Electronic address: mark.lafranconi@erm.com.</Affiliation>
      </Author>
      <Author>
        <Name>Robert Budinsky</Name>
        <Affiliation>Toxicology and Environmental Research and Consulting, The Dow Chemical Company, Midland, MI, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Lisa Corey</Name>
        <Affiliation>Intertox, Seattle, WA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Joanna Klapacz</Name>
        <Affiliation>Toxicology and Environmental Research and Consulting, The Dow Chemical Company, Midland, MI, USA.</Affiliation>
      </Author>
      <Author>
        <Name>James Crissman</Name>
        <Affiliation>StageBio, Mason, OH, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Matthew LeBaron</Name>
        <Affiliation>Toxicology and Environmental Research and Consulting, The Dow Chemical Company, Midland, MI, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Rachel Golden</Name>
        <Affiliation>Toxicology and Environmental Research and Consulting, The Dow Chemical Company, Midland, MI, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Richard Pleus</Name>
        <Affiliation>Intertox, Seattle, WA, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The activity of methacrylate esters in skin sensitisation test methods II. A review of complementary and additional analyses.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33186628</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(20)30247-6</DOI>
    <KeywordList>
      <Keywords>Direct peptide reactivity assay (DPRA)</Keywords>
      <Keywords>In vitro assays</Keywords>
      <Keywords>Local lymph node assay</Keywords>
      <Keywords>Methacrylates</Keywords>
      <Keywords>Predictive test methods</Keywords>
      <Keywords>QSAR</Keywords>
      <Keywords>Risk assessment</Keywords>
      <Keywords>Skin sensitisation</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Ian Kimber</Name>
        <Affiliation>Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK. Electronic address: ian.kimber@manchester.ac.uk.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Evaluation of dietary dose administration as an alternative to oral gavage in the rodent uterotrophic and Hershberger assays.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33181237</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(20)30246-4</DOI>
    <KeywordList>
      <Keywords>Androgenic</Keywords>
      <Keywords>Endocrine</Keywords>
      <Keywords>Estrogenic</Keywords>
      <Keywords>Hershberger</Keywords>
      <Keywords>Toxicokinetics</Keywords>
      <Keywords>Uterotrophic</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Lauren K. Markell</Name>
        <Affiliation>FMC Corporation, 1090 Elkton Road, Newark, DE, 19711, USA. Electronic address: lauren.markell@fmc.com.</Affiliation>
      </Author>
      <Author>
        <Name>John C. O'Connor</Name>
        <Affiliation>DuPont Haskell Laboratory, 1090 Elkton Road, Newark, DE, 19711, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Ruijuan Luo</Name>
        <Affiliation>FMC Corporation, 1090 Elkton Road, Newark, DE, 19711, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Joseph P. Klems</Name>
        <Affiliation>FMC Corporation, 1090 Elkton Road, Newark, DE, 19711, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Brian C. Sayers</Name>
        <Affiliation>DuPont Haskell Laboratory, 1090 Elkton Road, Newark, DE, 19711, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Robert T. Mingoia</Name>
        <Affiliation>DuPont Haskell Laboratory, 1090 Elkton Road, Newark, DE, 19711, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Assessment of the potential allergenicity and toxicity of Pichia proteins in a novel leghemoglobin preparation.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33171209</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(20)30243-9</DOI>
    <KeywordList>
      <Keywords>Allergenicity</Keywords>
      <Keywords>Bioinformatics</Keywords>
      <Keywords>Leghemoglobin</Keywords>
      <Keywords>Pichia pastoris</Keywords>
      <Keywords>Safety</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Teresa F. Reyes</Name>
        <Affiliation>Impossible Foods Inc., Impossible Foods Inc., 400 Saginaw Drive, Redwood City, CA, 94063, USA. Electronic address: terry.reyes@impossiblefoods.com.</Affiliation>
      </Author>
      <Author>
        <Name>Yiming Chen</Name>
        <Affiliation>Impossible Foods Inc., Impossible Foods Inc., 400 Saginaw Drive, Redwood City, CA, 94063, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Rachel Z. Fraser</Name>
        <Affiliation>Impossible Foods Inc., Impossible Foods Inc., 400 Saginaw Drive, Redwood City, CA, 94063, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Teresa Chan</Name>
        <Affiliation>Impossible Foods Inc., Impossible Foods Inc., 400 Saginaw Drive, Redwood City, CA, 94063, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Xin Li</Name>
        <Affiliation>Impossible Foods Inc., Impossible Foods Inc., 400 Saginaw Drive, Redwood City, CA, 94063, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The performance, reliability and potential application of in silico models for predicting the acute oral toxicity of pharmaceutical compounds.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33166621</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(20)30242-7</DOI>
    <KeywordList>
      <Keywords>Acute oral toxicity</Keywords>
      <Keywords>Alternative test methods</Keywords>
      <Keywords>CATMoS</Keywords>
      <Keywords>Computational models</Keywords>
      <Keywords>Computational toxicology</Keywords>
      <Keywords>Dangerous goods</Keywords>
      <Keywords>In silico</Keywords>
      <Keywords>Leadscope</Keywords>
      <Keywords>QSAR models</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jessica C. Graham</Name>
        <Affiliation>Bristol Myers Squibb, 1 Squibb Drive, New Brunswick, NJ, 08903, USA. Electronic address: jcgraham411@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Maryann Rodas</Name>
        <Affiliation>Bristol Myers Squibb, 1 Squibb Drive, New Brunswick, NJ, 08903, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jedd Hillegass</Name>
        <Affiliation>Bristol Myers Squibb, 1 Squibb Drive, New Brunswick, NJ, 08903, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Gene Schulze</Name>
        <Affiliation>Bristol Myers Squibb, 1 Squibb Drive, New Brunswick, NJ, 08903, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Computational identification of preservatives with potential neuronal cytotoxicity.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33159970</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(20)30241-5</DOI>
    <KeywordList>
      <Keywords>Computational toxicology</Keywords>
      <Keywords>Neuronal cytotoxicity</Keywords>
      <Keywords>Preservatives</Keywords>
      <Keywords>QSAR</Keywords>
      <Keywords>SH-SY5Y</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Hung Lin Kan</Name>
        <Affiliation>Doctoral Degree Program in Toxicology, College of Pharmacy, Kaohsiung Medical University, Kaohsiung, 807, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Chia Chi Wang</Name>
        <Affiliation>Department and Graduate Institute of Veterinary Medicine, School of Veterinary Medicine, National Taiwan University, Taipei, 106, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Ying Chi Lin</Name>
        <Affiliation>Doctoral Degree Program in Toxicology, College of Pharmacy, Kaohsiung Medical University, Kaohsiung, 807, Taiwan; School of Pharmacy, College of Pharmacy, Kaohsiung Medical University, Kaohsiung, 807, Taiwan. Electronic address: yclin@kmu.edu.tw.</Affiliation>
      </Author>
      <Author>
        <Name>Chun Wei Tung</Name>
        <Affiliation>Graduate Institute of Data Science, College of Management, Taipei Medical University, Taipei, 106, Taiwan; National Institute of Environmental Health Sciences, National Health Research Institutes, Miaoli County, 350, Taiwan. Electronic address: cwtung@tmu.edu.tw.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Corrigendum to "28-day somatic gene mutation study of 1-Bromopropane in female big blue® B6C3F1 Mice via whole-Body inhalation: Support for a carcinogenic threshold" [Regul. Toxicol. Pharmacol., 104 (2019) 1-7].</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33158580</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(20)30240-3</DOI>
    <AuthorList>
      <Author>
        <Name>Mark Stelljes</Name>
        <Affiliation>SLR International Corporation, Martinez, CA, USA. Electronic address: mstelljes@slrconsulting.com.</Affiliation>
      </Author>
      <Author>
        <Name>Robert Young</Name>
        <Affiliation>MilliporeSigma, BioReliance® Testing Services, Rockville, MD, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jeff Weinberg</Name>
        <Affiliation>Charles River, Ashland, OH, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Application of the DILIsym® Quantitative Systems Toxicology drug-induced liver injury model to evaluate the carcinogenic hazard potential of acetaminophen.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33153971</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(20)30214-2</DOI>
    <KeywordList>
      <Keywords>Acetaminophen</Keywords>
      <Keywords>Carcinogenicity</Keywords>
      <Keywords>Hazard</Keywords>
      <Keywords>Mechanisms</Keywords>
      <Keywords>Modeling</Keywords>
      <Keywords>Paracetamol</Keywords>
      <Keywords>Safety</Keywords>
      <Keywords>Simulations</Keywords>
      <Keywords>Toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Gary Eichenbaum</Name>
        <Affiliation>Johnson &amp; Johnson, New Brunswick, NJ, 08901, USA. Electronic address: geichenb@its.jnj.com.</Affiliation>
      </Author>
      <Author>
        <Name>Kyunghee Yang</Name>
        <Affiliation>DILIsym Services Inc., Research Triangle Park, NC, 27709, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Yeshitila Gebremichael</Name>
        <Affiliation>DILIsym Services Inc., Research Triangle Park, NC, 27709, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Brett A. Howell</Name>
        <Affiliation>DILIsym Services Inc., Research Triangle Park, NC, 27709, USA.</Affiliation>
      </Author>
      <Author>
        <Name>F. Jay Murray</Name>
        <Affiliation>Murray &amp; Associates, San Jose, CA, 95138, USA.</Affiliation>
      </Author>
      <Author>
        <Name>David Jacobson-Kram</Name>
        <Affiliation>ToxRox Consulting LLC, McLean, VA, 22101, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Hartmut Jaeschke</Name>
        <Affiliation>University of Kansas Medical Center, Kansas City, KS, 66160, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Edwin Kuffner</Name>
        <Affiliation>Johnson &amp; Johnson, New Brunswick, NJ, 08901, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Cathy K. Gelotte</Name>
        <Affiliation>Johnson &amp; Johnson Consumer Products US, Fort Washington, PA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>John C. K. Lai</Name>
        <Affiliation>Johnson &amp; Johnson Consumer Products US, Fort Washington, PA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Daniele Wikoff</Name>
        <Affiliation>ToxStrategies, Inc., Asheville, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Evren Atillasoy</Name>
        <Affiliation>Johnson &amp; Johnson Consumer Products US, Fort Washington, PA, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Considerations for setting occupational exposure limits for novel pharmaceutical modalities.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33144077</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(20)30239-7</DOI>
    <KeywordList>
      <Keywords>Engineered bacteria</Keywords>
      <Keywords>Exposure control band</Keywords>
      <Keywords>Occupational exposure limit</Keywords>
      <Keywords>Occupational health</Keywords>
      <Keywords>Oncolytic virus</Keywords>
      <Keywords>PET Tracer</Keywords>
      <Keywords>Pharmaceutical modalities</Keywords>
      <Keywords>Protein therapeutic</Keywords>
      <Keywords>Vaccine safety</Keywords>
      <Keywords>Worker safety</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jessica C. Graham</Name>
        <Affiliation>Bristol Myers Squibb, 1 Squibb Drive, New Brunswick, NJ, 08903, USA. Electronic address: jcgraham411@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Jedd Hillegass</Name>
        <Affiliation>Bristol Myers Squibb, 1 Squibb Drive, New Brunswick, NJ, 08903, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Gene Schulze</Name>
        <Affiliation>Bristol Myers Squibb, 1 Squibb Drive, New Brunswick, NJ, 08903, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A retrospective study on EU harmonised classifications for carcinogenicity to guide future research.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33129916</pubmedLink>
    <Year>2021</Year>
    <DOI>S0273-2300(20)30226-9</DOI>
    <AuthorList>
      <Author>
        <Name>Claire Terry</Name>
        <Affiliation>Corteva Agriscience, 9330 Zionsville Road, Indianapolis, IN, USA. Electronic address: Claire.terry@corteva.com.</Affiliation>
      </Author>
      <Author>
        <Name>Zhongyu Yan</Name>
        <Affiliation>Corteva Agriscience, 9330 Zionsville Road, Indianapolis, IN, USA. Electronic address: Zhongyu.yan@corteva.com.</Affiliation>
      </Author>
      <Author>
        <Name>Marco Corvaro</Name>
        <Affiliation>Corteva Agriscience, 3B Milton Park Square, OX14 4RN, Abingdon, UK. Electronic address: Marco.corvaro@corteva.com.</Affiliation>
      </Author>
      <Author>
        <Name>Sean C. Gehen</Name>
        <Affiliation>Corteva Agriscience, 9330 Zionsville Road, Indianapolis, IN, USA. Electronic address: Sean.gehen@corteva.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Statistical analysis of in vivo alkaline comet assay data - Comparison of median and geometric mean as centrality measures.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33127357</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(20)30234-8</DOI>
    <KeywordList>
      <Keywords>Comet assay</Keywords>
      <Keywords>Down-turn protected trend test</Keywords>
      <Keywords>Linear model</Keywords>
      <Keywords>Slide summary</Keywords>
      <Keywords>Statistical analysis</Keywords>
      <Keywords>Tail intensity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Timur Tug</Name>
        <Affiliation>Faculty of Statistics, TU Dortmund University, 44221, Dortmund, Germany. Electronic address: tug@statistik.tu-dortmund.de.</Affiliation>
      </Author>
      <Author>
        <Name>Katja Ickstadt</Name>
        <Affiliation>Faculty of Statistics, TU Dortmund University, 44221, Dortmund, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Michael Kunz</Name>
        <Affiliation>Bayer AG, Research &amp; Early Development Statistics, 13342, Berlin, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Andreas Sutter</Name>
        <Affiliation>Bayer AG, Pharmaceuticals, Investigational Toxicology, Müllerstr. 178, 13353 Berlin / Bayer AG, Oncology Development - Program Management, 13342, Berlin, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Bernd Wolfgang Igl</Name>
        <Affiliation>Bayer AG, Research and Clinical Sciences Statistics, 13342 Berlin, Germany / Boehringer Ingelheim Pharma GmbH &amp; Co. KG, Biostatistics + Data Sciences Corp., 88397, Biberach an der Riss, Germany.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The translational value of animal models in orphan medicines designations for rare paediatric neurological diseases.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33122047</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(20)30236-1</DOI>
    <KeywordList>
      <Keywords>Aicardi–Goutières syndrome</Keywords>
      <Keywords>Animal models</Keywords>
      <Keywords>Centronuclear myopathy</Keywords>
      <Keywords>Neurologic diseases</Keywords>
      <Keywords>Orphan medicines designations</Keywords>
      <Keywords>Rare paediatric diseases</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Dinah M. Duarte</Name>
        <Affiliation>INFARMED, Lisboa, Portugal. Electronic address: dinah.duarte@infarmed.pt.</Affiliation>
      </Author>
      <Author>
        <Name>Maria Beatriz da Silva Lima</Name>
        <Affiliation>Universidade de Lisboa, Faculdade de Farmácia, Lisbon, Portugal.</Affiliation>
      </Author>
      <Author>
        <Name>Bruno Sepodes</Name>
        <Affiliation>Universidade de Lisboa, Faculdade de Farmácia, Lisbon, Portugal.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Thirteen-week oral toxicity study of fermented ginseng, GBCK25, in Sprague-Dawley rats.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33122046</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(20)30238-5</DOI>
    <KeywordList>
      <Keywords>13-Week subacute toxicity test</Keywords>
      <Keywords>Fermented ginseng</Keywords>
      <Keywords>No-observed-adverse-effect level</Keywords>
      <Keywords>Safety evaluation</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Kyung Tai Kim</Name>
        <Affiliation>Jeonbuk Branch Institute, Korea Institute of Toxicology, Jeollabuk-Do, 56212, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Doo Wan Cho</Name>
        <Affiliation>Jeonbuk Branch Institute, Korea Institute of Toxicology, Jeollabuk-Do, 56212, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Mi Jin Yang</Name>
        <Affiliation>Jeonbuk Branch Institute, Korea Institute of Toxicology, Jeollabuk-Do, 56212, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Da Hee Kim</Name>
        <Affiliation>Jeonbuk Branch Institute, Korea Institute of Toxicology, Jeollabuk-Do, 56212, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Seung Hyuk Shin</Name>
        <Affiliation>Jeonbuk Branch Institute, Korea Institute of Toxicology, Jeollabuk-Do, 56212, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Jeong Ho Hwang</Name>
        <Affiliation>Jeonbuk Branch Institute, Korea Institute of Toxicology, Jeollabuk-Do, 56212, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Dong Ho Woo</Name>
        <Affiliation>Research Center for Convergence Toxicology, Korea Institute of Toxicology, 141 Gajeong-ro, Yuseong-gu, Daejeon, 34114, South Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Dong Gyu Shin</Name>
        <Affiliation>Research &amp; Development Center of GENERAL BIO Co., Ltd, 254, Yongtusan-ro, Songdong-myeon, Namwon City, Jeollabuk-Do, 55793, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Jeong Hun Seo</Name>
        <Affiliation>Research &amp; Development Center of GENERAL BIO Co., Ltd, 254, Yongtusan-ro, Songdong-myeon, Namwon City, Jeollabuk-Do, 55793, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Young Su Yang</Name>
        <Affiliation>Jeonbuk Branch Institute, Korea Institute of Toxicology, Jeollabuk-Do, 56212, Republic of Korea. Electronic address: ysyang@kitox.re.kr.</Affiliation>
      </Author>
      <Author>
        <Name>Su Cheol Han</Name>
        <Affiliation>Jeonbuk Branch Institute, Korea Institute of Toxicology, Jeollabuk-Do, 56212, Republic of Korea. Electronic address: vethansc@kitox.re.kr.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Safety evaluation of Eucommia ulmoides extract.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33122045</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(20)30237-3</DOI>
    <KeywordList>
      <Keywords>Eucommia ulmoides Oliver</Keywords>
      <Keywords>Genotoxicity</Keywords>
      <Keywords>Nephrotoxicity</Keywords>
      <Keywords>Safety</Keywords>
      <Keywords>Toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Xiaomei Luo</Name>
        <Affiliation>Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences &amp; Peking Union Medical College, Beijing, 100193, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Jiashuo Wu</Name>
        <Affiliation>Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences &amp; Peking Union Medical College, Beijing, 100193, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhuangzhuang Li</Name>
        <Affiliation>Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences &amp; Peking Union Medical College, Beijing, 100193, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Weiyi Jin</Name>
        <Affiliation>Hebei Medical University, Shijiazhuang, 050017, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Fangqing Zhang</Name>
        <Affiliation>Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences &amp; Peking Union Medical College, Beijing, 100193, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Hong Sun</Name>
        <Affiliation>Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences &amp; Peking Union Medical College, Beijing, 100193, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Yue Shi</Name>
        <Affiliation>Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences &amp; Peking Union Medical College, Beijing, 100193, PR China. Electronic address: shiyue1029@126.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Choosing the best for preventing the worst: A structured analysis of the selection of risk management options in REACH restriction dossiers.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33122044</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(20)30235-X</DOI>
    <KeywordList>
      <Keywords>Criteria matrix</Keywords>
      <Keywords>Decision making</Keywords>
      <Keywords>Decision support</Keywords>
      <Keywords>Logistic regression</Keywords>
      <Keywords>Principal component analysis</Keywords>
      <Keywords>REACH</Keywords>
      <Keywords>Restriction process</Keywords>
      <Keywords>Risk management options</Keywords>
      <Keywords>Socio-economic analysis</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Isabel Hilber</Name>
        <Affiliation>Agroscope, Methods Development and Analytics, Environmental Analytics, Reckenholzstrasse 191, 8046, Zurich, Switzerland. Electronic address: isabella.hilber-schoeb@agroscope.admin.ch.</Affiliation>
      </Author>
      <Author>
        <Name>Silke Gabbert</Name>
        <Affiliation>Wageningen University, Department of Social Sciences, Environmental Economics and Natural Resources Group, Hollandseweg 1, 6700, EW Wageningen, the Netherlands; National Institute for Public Health and the Environment (RIVM), Antonie van Leeuwenhoeklaan 9, 3721, MA Bilthoven, the Netherlands.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Rebuttal to the letters to the editors by Terry et al. and Sewell et al. regarding.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33091463</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(20)30229-4</DOI>
    <KeywordList>
      <Keywords>Dose selection</Keywords>
      <Keywords>Kinetically derived maximum dose</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Minne B. Heringa</Name>
        <Affiliation>National Institute for Public Health and the Environment (RIVM), Centre for Safety of Substances and Products (VSP), Bilthoven, the Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Nicole H. P. Cnubben</Name>
        <Affiliation>National Institute for Public Health and the Environment (RIVM), Centre for Safety of Substances and Products (VSP), Bilthoven, the Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Wout Slob</Name>
        <Affiliation>National Institute for Public Health and the Environment (RIVM), Centre for Safety of Substances and Products (VSP), Bilthoven, the Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Marja E. J. Pronk</Name>
        <Affiliation>National Institute for Public Health and the Environment (RIVM), Centre for Safety of Substances and Products (VSP), Bilthoven, the Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Andre Muller</Name>
        <Affiliation>National Institute for Public Health and the Environment (RIVM), Centre for Safety of Substances and Products (VSP), Bilthoven, the Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Marjolijn Woutersen</Name>
        <Affiliation>National Institute for Public Health and the Environment (RIVM), Centre for Safety of Substances and Products (VSP), Bilthoven, the Netherlands. Electronic address: Marjolijn.woutersen@rivm.nl.</Affiliation>
      </Author>
      <Author>
        <Name>Betty C. Hakkert</Name>
        <Affiliation>National Institute for Public Health and the Environment (RIVM), Centre for Safety of Substances and Products (VSP), Bilthoven, the Netherlands.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Updating exposure assessment for skin sensitization quantitative risk assessment for fragrance materials.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33075411</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(20)30231-2</DOI>
    <KeywordList>
      <Keywords>Aggregate exposure</Keywords>
      <Keywords>Fragrance materials</Keywords>
      <Keywords>Quantitative risk assessment (QRA)</Keywords>
      <Keywords>Skin sensitization</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Anne Marie Api</Name>
        <Affiliation>Research Institute for Fragrance Materials, Inc., Woodcliff Lake, NJ, USA. Electronic address: amapi@rifm.org.</Affiliation>
      </Author>
      <Author>
        <Name>David Basketter</Name>
        <Affiliation>Consultant, DABMEB Consultancy Ltd., Sharnbrook, UK.</Affiliation>
      </Author>
      <Author>
        <Name>James Bridges</Name>
        <Affiliation>Member IDEA Supervisory Group, University of Surrey, Guildford, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Peter Cadby</Name>
        <Affiliation>Consultant, Geneva, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Graham Ellis</Name>
        <Affiliation>Firmenich SA, 1 Route des Jeunes, Geneva, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Nicola Gilmour</Name>
        <Affiliation>Unilever Safety &amp; Environmental Assurance Centre, Sharnbrook, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Helmut Greim</Name>
        <Affiliation>Member IDEA Supervisory Group, Technical University of Munich, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Peter Griem</Name>
        <Affiliation>Symrise AG, Holzminden, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Petra Kern</Name>
        <Affiliation>NV Procter &amp; Gamble Services Company SA, Strombeek-Bever, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Alain Khaiat</Name>
        <Affiliation>Member IDEA Supervisory Group, Cosmetics Consultant, Singapore.</Affiliation>
      </Author>
      <Author>
        <Name>John O'Brien</Name>
        <Affiliation>Creme Global, Dublin, Ireland.</Affiliation>
      </Author>
      <Author>
        <Name>Thomas Rustemeyer</Name>
        <Affiliation>Member IDEA Supervisory Group, VU Amsterdam, Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Cindy Ryan</Name>
        <Affiliation>The Procter &amp; Gamble Company, Mason, OH, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Bob Safford</Name>
        <Affiliation>Consultant, B-Safe Toxicology Consulting, Rushden, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Benjamin Smith</Name>
        <Affiliation>Innovations in Food and Chemical Safety Programme, Singapore Institute of Food &amp; Biotechnology Innovation, Agency for Science, Technology &amp; Research, Singapore; School of Chemical &amp; Biomedical Engineering, Nanyang Technological University, Singapore.</Affiliation>
      </Author>
      <Author>
        <Name>Matthias Vey</Name>
        <Affiliation>International Fragrance Association, Brussels, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Ian R. White</Name>
        <Affiliation>Member IDEA Supervisory Group, St. John's Institute of Dermatology, London, UK.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Assessment of veterinary drug residues in food: Considerations when dealing with sub-optimal data.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33058940</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(20)30232-4</DOI>
    <KeywordList>
      <Keywords>Acceptable daily intake (ADI)</Keywords>
      <Keywords>Acute reference dose (ARfD)</Keywords>
      <Keywords>Codex alimentarius commission</Keywords>
      <Keywords>Drug residue</Keywords>
      <Keywords>Joint FAO/WHO Expert committee on food additives (JECFA)</Keywords>
      <Keywords>Maximum residue limit (MRL)</Keywords>
      <Keywords>Risk assessment</Keywords>
      <Keywords>Veterinary drug</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Alan Chicoine</Name>
        <Affiliation>Western College of Veterinary Medicine, University of Saskatchewan, Saskatoon, Canada. Electronic address: al.chicoine@usask.ca.</Affiliation>
      </Author>
      <Author>
        <Name>Holly Erdely</Name>
        <Affiliation>U.S. Food and Drug Administration, Center for Veterinary Medicine, Rockville, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Vittorio Fattori</Name>
        <Affiliation>Food Safety and Quality Unit, Food and Agricultural Organization of the United Nations (FAO), Rome, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Anke Finnah</Name>
        <Affiliation>German Federal Office of Consumer Protection and Food Safety (BVL), Berlin, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Samuel Fletcher</Name>
        <Affiliation>Veterinary Medicines Directorate, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Markus Lipp</Name>
        <Affiliation>Food Safety and Quality Unit, Food and Agricultural Organization of the United Nations (FAO), Rome, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Pascal Sanders</Name>
        <Affiliation>French Agency for Food, Environmental and Occupational Health and Safety, Fougeres, France.</Affiliation>
      </Author>
      <Author>
        <Name>Stefan Scheid</Name>
        <Affiliation>German Federal Office of Consumer Protection and Food Safety (BVL), Berlin, Germany.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Management of pharmaceutical ICH M7 (Q)SAR predictions - The impact of model updates.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33058939</pubmedLink>
    <GrantList>
      <Grant>R43 ES026909</Grant>
      <Grant>R44 ES026909</Grant>
    </GrantList>
    <Year>2020</Year>
    <DOI>S0273-2300(20)30233-6</DOI>
    <KeywordList>
      <Keywords>Computational models</Keywords>
      <Keywords>ICH M7</Keywords>
      <Keywords>Impurities</Keywords>
      <Keywords>Mutagenic</Keywords>
      <Keywords>Pharmaceuticals</Keywords>
      <Keywords>Q)SAR</Keywords>
      <Keywords>Version update</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Catrin Hasselgren</Name>
        <Affiliation>Genentech, Inc., 1 DNA Way, South San Francisco, CA, 94080, USA. Electronic address: hasselgren.catrin@gene.com.</Affiliation>
      </Author>
      <Author>
        <Name>Joel Bercu</Name>
        <Affiliation>Gilead Sciences, 333 Lakeside Drive, Foster City, CA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Alex Cayley</Name>
        <Affiliation>Lhasa Limited, Granary Wharf House, 2 Canal Wharf, Leeds, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Kevin Cross</Name>
        <Affiliation>Leadscope, Inc. an Instem Company, 1393 Dublin Rd, Columbus, OH, 43215, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Susanne Glowienke</Name>
        <Affiliation>Novartis Pharma AG, Pre-Clinical Safety, Werk Klybeck, CH-4057, Basel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Naomi Kruhlak</Name>
        <Affiliation>FDA Center for Drug Evaluation and Research, Silver Spring, MD, 20993, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Wolfgang Muster</Name>
        <Affiliation>Roche Pharmaceutical Research &amp; Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd, Grenzacherstrasse 124, 4070, Basel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>John Nicolette</Name>
        <Affiliation>AbbVie Inc., Pre-clinical Safety, 1 North Waukegan Road, North Chicago, IL, USA.</Affiliation>
      </Author>
      <Author>
        <Name>M. Vijayaraj Reddy</Name>
        <Affiliation>Merck &amp; Co., Inc., West Point, PA, 19486, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Roustem Saiakhov</Name>
        <Affiliation>Multicase Inc., 23811 Chagrin Boulevard, Suite 305, Beachwood, OH, 44122, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Krista Dobo</Name>
        <Affiliation>Pfizer Worldwide Research &amp; Development, 558 Eastern Point Road, Groton, CT, 06340, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A review of clinical pharmacology deficiencies of European centralised drug marketing authorisation applications.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33049309</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(20)30230-0</DOI>
    <KeywordList>
      <Keywords>Clinical pharmacology</Keywords>
      <Keywords>Drug development</Keywords>
      <Keywords>Major objections</Keywords>
      <Keywords>Pharmacodynamics</Keywords>
      <Keywords>Pharmacokinetics</Keywords>
      <Keywords>Regulatory</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Justin L. Hay</Name>
        <Affiliation>Medicines &amp; Healthcare Products Regulatory Agency, London, UK; EMA Modelling and Simulation Working Group, UK. Electronic address: justin.pittaway-hay@mhra.gov.uk.</Affiliation>
      </Author>
      <Author>
        <Name>Jane O'Sullivan</Name>
        <Affiliation>European Medicines Agency, London, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Essam Kerwash</Name>
        <Affiliation>Medicines &amp; Healthcare Products Regulatory Agency, London, UK; EMA Modelling and Simulation Working Group, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Alexandra Roxana Ilie</Name>
        <Affiliation>University College Cork, Ireland.</Affiliation>
      </Author>
      <Author>
        <Name>Susan M. Cole</Name>
        <Affiliation>Medicines &amp; Healthcare Products Regulatory Agency, London, UK; EMA Modelling and Simulation Working Group, UK; EMA Pharmacokinetics Working Party, UK.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A critical review of the acetaminophen preclinical carcinogenicity and tumor promotion data and their implications for its carcinogenic hazard potential.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33039518</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(20)30227-0</DOI>
    <KeywordList>
      <Keywords>Acetaminophen</Keywords>
      <Keywords>Animal model</Keywords>
      <Keywords>Bioassay</Keywords>
      <Keywords>Carcinogenicity</Keywords>
      <Keywords>Metabolite</Keywords>
      <Keywords>Pharmacokinetic</Keywords>
      <Keywords>Tumor</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>F. Jay Murray</Name>
        <Affiliation>Murray &amp; Associates, San Jose, CA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Andrew D. Monnot</Name>
        <Affiliation>Cardno ChemRisk, San Francisco, CA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>David Jacobson-Kram</Name>
        <Affiliation>ToxRox Consulting, McLean, VA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Samuel M. Cohen</Name>
        <Affiliation>Havlik-Wall Professor of Oncology, Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jerry F. Hardisty</Name>
        <Affiliation>Experimental Pathology Laboratories, Inc., Durham, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Suren B. Bandara</Name>
        <Affiliation>Cardno ChemRisk, San Francisco, CA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Michael Kovochich</Name>
        <Affiliation>Cardno ChemRisk, Chicago, IL, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Milind Deore</Name>
        <Affiliation>Johnson &amp; Johnson Consumer, India.</Affiliation>
      </Author>
      <Author>
        <Name>Suresh Kumar Pitchaiyan</Name>
        <Affiliation>Johnson &amp; Johnson Consumer, India.</Affiliation>
      </Author>
      <Author>
        <Name>Cathy K. Gelotte</Name>
        <Affiliation>Johnson &amp; Johnson Consumer Products, USA.</Affiliation>
      </Author>
      <Author>
        <Name>John C. K. Lai</Name>
        <Affiliation>Johnson &amp; Johnson Consumer Products, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Evren Atillasoy</Name>
        <Affiliation>Johnson &amp; Johnson Consumer Products, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Anne Hermanowski-Vosatka</Name>
        <Affiliation>Johnson &amp; Johnson Consumer Products, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Edwin Kuffner</Name>
        <Affiliation>Johnson &amp; Johnson Consumer Products, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Kenneth M. Unice</Name>
        <Affiliation>Cardno ChemRisk, Pittsburgh, PA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Kyunghee Yang</Name>
        <Affiliation>DILIsym Services Inc., Research Triangle Park, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Yeshitila Gebremichael</Name>
        <Affiliation>DILIsym Services Inc., Research Triangle Park, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Brett A. Howell</Name>
        <Affiliation>DILIsym Services Inc., Research Triangle Park, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Gary Eichenbaum</Name>
        <Affiliation>Johnson &amp; Johnson, New Brunswick, NJ, USA. Electronic address: geichenb@its.jnj.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Facilitation of risk assessment with evidence-based methods - A framework for use of systematic mapping and systematic reviews in determining hazard, developing toxicity values, and characterizing uncertainty.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33038430</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(20)30216-6</DOI>
    <KeywordList>
      <Keywords>Critical appraisal</Keywords>
      <Keywords>Mode of action</Keywords>
      <Keywords>Risk assessment</Keywords>
      <Keywords>Systematic review</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Daniele Wikoff</Name>
        <Affiliation>31 College Place, Suite B118, Asheville, NC, 28801, USA. Electronic address: dwikokff@toxstrategies.com.</Affiliation>
      </Author>
      <Author>
        <Name>R. Jeffrey Lewis</Name>
        <Affiliation>ExxonMobil Biomedical Sciences, Inc., 1545 US Highway 22 East, Room CC291, Annandale, NJ, 08801-3059, USA. Electronic address: r.jeffrey.lewis@exxonmobil.com.</Affiliation>
      </Author>
      <Author>
        <Name>Neeraja Erraguntla</Name>
        <Affiliation>American Chemistry Council, 700 2nd St. NE, Washington, DC, 20002, USA. Electronic address: neeraja_erraguntla@americanchemistry.com.</Affiliation>
      </Author>
      <Author>
        <Name>Allison Franzen</Name>
        <Affiliation>ToxStrategies, Inc, 1800 Forsythe Ave., Suite 2 #148, Monroe, LA, 71201, USA. Electronic address: afranzen@toxstrategies.com.</Affiliation>
      </Author>
      <Author>
        <Name>Jennifer Foreman</Name>
        <Affiliation>ExxonMobil Chemical Company, Energy 4, E4.3A.478 22777 Springwoods Village Parkway, Spring, TX, 77389, USA. Electronic address: Jennifer.e.foreman@exxonmobil.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Considerations when deriving compound-specific limits for extractables and leachables from pharmaceutical products: Four case studies.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33038429</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(20)30228-2</DOI>
    <KeywordList>
      <Keywords>BHT</Keywords>
      <Keywords>BPA</Keywords>
      <Keywords>Extractables</Keywords>
      <Keywords>Irgafos® 168</Keywords>
      <Keywords>Irganox® 1010</Keywords>
      <Keywords>Leachables</Keywords>
      <Keywords>PDE</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Patricia Parris</Name>
        <Affiliation>Pfizer Worldwide Research and Development, Sandwich, UK. Electronic address: patricia.parris@pfizer.com.</Affiliation>
      </Author>
      <Author>
        <Name>Elizabeth A. Martin</Name>
        <Affiliation>AstraZeneca, Cambridge, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Brad Stanard</Name>
        <Affiliation>Ultragenyx Pharmaceutical Inc., Novato, CA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Susanne Glowienke</Name>
        <Affiliation>Novartis, Basel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>David G. Dolan</Name>
        <Affiliation>Amgen Inc., Thousand Oaks, CA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Kim Li</Name>
        <Affiliation>Amgen Inc., Thousand Oaks, CA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Ornella Binazon</Name>
        <Affiliation>GlaxoSmithKline, Wavre, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Amanda Giddings</Name>
        <Affiliation>GlaxoSmithKline, Hertfordshire, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Geraldine Whelan</Name>
        <Affiliation>GlaxoSmithKline, Hertfordshire, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Melisa Masuda-Herrera</Name>
        <Affiliation>Gilead Sciences Inc., Foster City, CA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Joel Bercu</Name>
        <Affiliation>Gilead Sciences Inc., Foster City, CA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Thomas Broschard</Name>
        <Affiliation>Merck Healthcare KGaA, Darmstadt, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Uma Bruen</Name>
        <Affiliation>Merck &amp; Co., Inc., Kenilworth, NJ, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Courtney M. Callis</Name>
        <Affiliation>Lilly Research Laboratories, Eli Lilly &amp; Company, Indianapolis, IN, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Cheryl L. M. Stults</Name>
        <Affiliation>C &amp; M Technical Consulting, LLC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Gregory L. Erexson</Name>
        <Affiliation>AbbVie, Inc., North Chicago, IL, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Maureen T. Cruz</Name>
        <Affiliation>Faegre Drinker Biddle &amp; Reath LLP, Washington, DC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Lee M. Nagao</Name>
        <Affiliation>Faegre Drinker Biddle &amp; Reath LLP, Washington, DC, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A comprehensive view on mechanistic approaches for cancer risk assessment of non-genotoxic agrochemicals.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33035627</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(20)30215-4</DOI>
    <KeywordList>
      <Keywords>3Rs</Keywords>
      <Keywords>Alternative approaches to animal testing</Keywords>
      <Keywords>Carcinogenicity</Keywords>
      <Keywords>Human health risk assessment</Keywords>
      <Keywords>Mode of action</Keywords>
      <Keywords>NAMs</Keywords>
      <Keywords>New approach methodologies</Keywords>
      <Keywords>Non-genotoxic carcinogens</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Mirjam Luijten</Name>
        <Affiliation>National Institute for Public Health and the Environment (RIVM), Centre for Health Protection, Bilthoven, the Netherlands. Electronic address: mirjam.luijten@rivm.nl.</Affiliation>
      </Author>
      <Author>
        <Name>Raffaella Corvi</Name>
        <Affiliation>European Commission, Joint Research Centre (JRC), Ispra, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Jyotigna Mehta</Name>
        <Affiliation>ADAMA Agricultural Solutions Ltd., Reading, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Marco Corvaro</Name>
        <Affiliation>Corteva Agriscience, Rome, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Nathalie Delrue</Name>
        <Affiliation>Organisation for Economic Cooperation and Development (OECD), Paris, France.</Affiliation>
      </Author>
      <Author>
        <Name>Susan Felter</Name>
        <Affiliation>Procter &amp; Gamble Company, Mason, OH, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Bodo Haas</Name>
        <Affiliation>Federal Institute for Drugs and Medical Devices, Kurt-Georg-Kiesinger-Allee 3, 53175 Bonn, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Nicola J. Hewitt</Name>
        <Affiliation>SWS, Wingertstrasse 25, 64390 Erzhausen, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Gina Hilton</Name>
        <Affiliation>PETA International Science Consortium Ltd, London, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Thomas Holmes</Name>
        <Affiliation>ADAMA Deutschland GmbH, Cologne, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Miriam N. Jacobs</Name>
        <Affiliation>Centre for Radiation, Chemical and Environmental Hazards (CRCE), Public Health England, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Abigail Jacobs</Name>
        <Affiliation>US Food and Drug Administration (now retired), MD, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Franz Lamplmair</Name>
        <Affiliation>European Commission, DG Internal Market, Industry, Entrepreneurship and SMEs, Brussels, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Dick Lewis</Name>
        <Affiliation>Syngenta Crop Protection, Bracknell, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Federica Madia</Name>
        <Affiliation>European Commission, Joint Research Centre (JRC), Ispra, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Irene Manou</Name>
        <Affiliation>EPAA Industry Secretariat, Brussels, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Stephanie Melching-Kollmuss</Name>
        <Affiliation>BASF SE, Limburgerhof, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Frederic Schorsch</Name>
        <Affiliation>Bayer SAS, Lyon, France.</Affiliation>
      </Author>
      <Author>
        <Name>Katrin Schütte</Name>
        <Affiliation>European Commission, DG Environment, Brussels, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Fiona Sewell</Name>
        <Affiliation>National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs), London, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Christian Strupp</Name>
        <Affiliation>Gowan Crop Protection, Reading, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Jan Willem van der Laan</Name>
        <Affiliation>Medicines Evaluation Board, Utrecht, the Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Douglas C. Wolf</Name>
        <Affiliation>Syngenta Crop Protection, LLC, Greensboro, North Carolina, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Gerrit Wolterink</Name>
        <Affiliation>National Institute for Public Health and the Environment (RIVM), Centre for Nutrition, Prevention and Health Services, Bilthoven, the Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Ruud Woutersen</Name>
        <Affiliation>TNO Innovation for Life, Zeist; Wageningen University and Research, Wageningen, the Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Zvonimir Zvonar</Name>
        <Affiliation>EPAA Industry Secretariat, Brussels, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Harm Heusinkveld</Name>
        <Affiliation>National Institute for Public Health and the Environment (RIVM), Centre for Health Protection, Bilthoven, the Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Hedwig Braakhuis</Name>
        <Affiliation>National Institute for Public Health and the Environment (RIVM), Centre for Health Protection, Bilthoven, the Netherlands.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Toxicological risk assessment of bisphenol a released from dialyzers under simulated-use and exaggerated extraction conditions.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/33011233</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(20)30213-0</DOI>
    <KeywordList>
      <Keywords>BPA</Keywords>
      <Keywords>Bisphenol A</Keywords>
      <Keywords>Dialyzer</Keywords>
      <Keywords>Extractables</Keywords>
      <Keywords>Hemodialysis</Keywords>
      <Keywords>Leachables</Keywords>
      <Keywords>Risk assessment</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Melissa A. Badding</Name>
        <Affiliation>Exponent, Inc, 149 Commonwealth Drive, Menlo Park, CA, 94025, USA. Electronic address: mbadding@exponent.com.</Affiliation>
      </Author>
      <Author>
        <Name>Jessica R. Vargas</Name>
        <Affiliation>Exponent, Inc, 149 Commonwealth Drive, Menlo Park, CA, 94025, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Julian Fortney</Name>
        <Affiliation>Exponent, Inc, 149 Commonwealth Drive, Menlo Park, CA, 94025, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Qiuqiong J. Cheng</Name>
        <Affiliation>Fresenius Medical Care, Ltd, 475, West 13th Street, Ogden, UT, 84404, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Chih Hu Ho</Name>
        <Affiliation>Fresenius Medical Care, Ltd, 475, West 13th Street, Ogden, UT, 84404, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Analysis and reflection on the role of the 90-day oral toxicity study in European chemical risk assessment.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32976858</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(20)30212-9</DOI>
    <KeywordList>
      <Keywords>Chemical safety</Keywords>
      <Keywords>ECHA</Keywords>
      <Keywords>EFSA</Keywords>
      <Keywords>EMA</Keywords>
      <Keywords>Regulatory science</Keywords>
      <Keywords>Risk assessment</Keywords>
      <Keywords>Sub-chronic toxicity</Keywords>
      <Keywords>Toxicology</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Misha Vrolijk</Name>
        <Affiliation>University College Venlo, Campus Venlo, Maastricht University, the Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Hubert Deluyker</Name>
        <Affiliation>Former Scientific Advisor of the European Food Safety Authority (EFSA), the Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Aalt Bast</Name>
        <Affiliation>University College Venlo, Campus Venlo, Maastricht University, the Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Alie de Boer</Name>
        <Affiliation>Food Claims Centre Venlo, Campus Venlo, Maastricht University, the Netherlands. Electronic address: a.deboer@maastrichtuniversity.nl.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Acute and sub-chronic toxicity studies of Benincasa hispida (Thunb.) cogniaux fruit extract in rodents.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32976857</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(20)30211-7</DOI>
    <KeywordList>
      <Keywords>Acute toxicity</Keywords>
      <Keywords>Benincasa hispida</Keywords>
      <Keywords>GC-MS</Keywords>
      <Keywords>Rodents</Keywords>
      <Keywords>Sub-chronic toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Anshul Shakya</Name>
        <Affiliation>Department of Pharmaceutical Sciences, Faculty of Science and Engineering, Dibrugarh University, Dibrugarh, 786 004, Assam, India. Electronic address: anshulshakya@dibru.ac.in.</Affiliation>
      </Author>
      <Author>
        <Name>Sushil Kumar Chaudhary</Name>
        <Affiliation>Faculty of Pharmacy, DIT University, Mussoorie-Diversion Road, Makkawala, Dehradun, 248 009, Uttarakhand, India.</Affiliation>
      </Author>
      <Author>
        <Name>Hans Raj Bhat</Name>
        <Affiliation>Department of Pharmaceutical Sciences, Faculty of Science and Engineering, Dibrugarh University, Dibrugarh, 786 004, Assam, India.</Affiliation>
      </Author>
      <Author>
        <Name>Surajit Kumar Ghosh</Name>
        <Affiliation>Department of Pharmaceutical Sciences, Faculty of Science and Engineering, Dibrugarh University, Dibrugarh, 786 004, Assam, India.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Safety of medicinal comfrey cream preparations (Symphytum officinale s.l.): The pyrrolizidine alkaloid lycopsamine is poorly absorbed through human skin.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32941922</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(20)30210-5</DOI>
    <KeywordList>
      <Keywords>Comfrey</Keywords>
      <Keywords>Lycopsamine</Keywords>
      <Keywords>Pyrrolizidine alkaloids</Keywords>
      <Keywords>Symphytum × uplandicum Nyman</Keywords>
      <Keywords>Transcutaneous absorption</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Kenny Kuchta</Name>
        <Affiliation>Forschungsstelle für Fernöstliche Medizin, Department of Vegetation Analysis and Phytodiversity, Albrecht von Haller Institute of Plant Sciences, Georg August University, Untere Karspüle 2, 37073, Göttingen, Germany. Electronic address: kenny.kuchta@med.uni-goettingen.de.</Affiliation>
      </Author>
      <Author>
        <Name>Mathias Schmidt</Name>
        <Affiliation>Herbresearch Germany, Wartbergweg 15, 86874, Mattsies, Germany. Electronic address: schmidt@herbresearch.de.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Lay people and experts' risk perception of pharmaceuticals in the environment in Southwestern Europe.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32931895</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(20)30209-9</DOI>
    <KeywordList>
      <Keywords>Lay people and experts</Keywords>
      <Keywords>Pharmaceuticals in the environment</Keywords>
      <Keywords>Psychometric paradigm</Keywords>
      <Keywords>Risk management</Keywords>
      <Keywords>Risk perception</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Sílvia Luís</Name>
        <Affiliation>Instituto Universitário de Lisboa (Iscte), Centro de Investigação e Intervenção Social (CIS-IUL), Portugal; Instituto Superior de Ciências Sociais e Políticas (ISCSP), Centro de Administração e Políticas Públicas (CAPP - ISCSP), Portugal. Electronic address: silvia_luis@iscte-iul.pt.</Affiliation>
      </Author>
      <Author>
        <Name>Maria Luísa Lima</Name>
        <Affiliation>Instituto Universitário de Lisboa (Iscte), Centro de Investigação e Intervenção Social (CIS-IUL), Portugal.</Affiliation>
      </Author>
      <Author>
        <Name>Lucía Poggio</Name>
        <Affiliation>Universidad Complutense de Madrid, Faculdad de Psicologia, Spain.</Affiliation>
      </Author>
      <Author>
        <Name>Juan Ignacio Aragonés</Name>
        <Affiliation>Universidad Complutense de Madrid, Faculdad de Psicologia, Spain.</Affiliation>
      </Author>
      <Author>
        <Name>Audrey Courtier</Name>
        <Affiliation>Université de Nîmes, EA7352, CHROME, France.</Affiliation>
      </Author>
      <Author>
        <Name>Benoit Roig</Name>
        <Affiliation>Université de Nîmes, EA7352, CHROME, France.</Affiliation>
      </Author>
      <Author>
        <Name>Carole Blanchard</Name>
        <Affiliation>Université de Perpignan Via Domitia, Biocapteurs-Analyse-Environnement, 66860, Perpignan, France; Laboratoire de Biodiversité et Biotechnologies Microbiennes, USR 3579 Sorbonne Universités (UPMC) Paris 6 et CNRS Observatoire Océanologique, 66650, Banyuls-sur-Mer, France.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Nonclinical safety assessment of epigenetic modulatory drugs: Current status and industry perspective.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32911461</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(20)30172-0</DOI>
    <KeywordList>
      <Keywords>Carcinogenicity</Keywords>
      <Keywords>Drug development</Keywords>
      <Keywords>Drug safety</Keywords>
      <Keywords>Epigenetic</Keywords>
      <Keywords>Epigenetic drugs</Keywords>
      <Keywords>Epigenetic toxicity</Keywords>
      <Keywords>Nonclinical</Keywords>
      <Keywords>Safety pharmacology</Keywords>
      <Keywords>Toxicology</Keywords>
      <Keywords>Transgenerational</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Vincent L. Reynolds</Name>
        <Affiliation>Lilly Research Laboratories, Indianapolis, IN, USA. Electronic address: reynolds_vincent_l@lilly.com.</Affiliation>
      </Author>
      <Author>
        <Name>Paul Butler</Name>
        <Affiliation>Pfizer Inc., San Diego, CA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Matthew M. Abernathy</Name>
        <Affiliation>Lilly Research Laboratories, Indianapolis, IN, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Laura Aschenbrenner</Name>
        <Affiliation>Pfizer Inc., San Diego, CA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Derek D. Best</Name>
        <Affiliation>Lilly Research Laboratories, Indianapolis, IN, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jim Blank</Name>
        <Affiliation>Takeda Pharmaceutical, Cambridge, MA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Meredith Crosby</Name>
        <Affiliation>AbbVie Inc. Global Pharmaceutical Research and Development, Preclinical Safety, 1 North Waukegan Road, North Chicago, IL, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Laura Custer</Name>
        <Affiliation>Bristol-Myers Squibb, Drug Safety Evaluation, 1 Squibb Dr, New Brunswick, NJ, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Patricia A. Escobar</Name>
        <Affiliation>Merck Sharp &amp; Dohme Corp, West Point, PA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Kyle Kolaja</Name>
        <Affiliation>Bristol-Myers Squibb, Drug Safety Evaluation, 1 Squibb Dr, New Brunswick, NJ, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jonathan Moggs</Name>
        <Affiliation>Novartis Institutes for BioMedical Research, Translational Medicine, Basel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Dana Shuey</Name>
        <Affiliation>Incyte Corporation, 1801 Augustine Cutoff, Wilmington, DE, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Chelsea Snyder</Name>
        <Affiliation>Gilead Sciences, Foster City, CA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Terry Van Vleet</Name>
        <Affiliation>AbbVie Inc. Global Pharmaceutical Research and Development, Preclinical Safety, 1 North Waukegan Road, North Chicago, IL, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Junguo Zhou</Name>
        <Affiliation>Nonclinical Safety, Janssen Research and Development LLC., Raritan, NJ, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Timothy K. Hart</Name>
        <Affiliation>GlaxoSmithKline, 1250 S Collegeville Rd, Collegeville, PA, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A toxicological evaluation of monomethylsilanetriol (MMST) stabilized in acacia gum, a novel silicon preparation.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32905813</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(20)30208-7</DOI>
    <KeywordList>
      <Keywords>MMST</Keywords>
      <Keywords>Monomethylsilanetriol</Keywords>
      <Keywords>Mutagenicity</Keywords>
      <Keywords>NOAEL</Keywords>
      <Keywords>Safety</Keywords>
      <Keywords>Silicon</Keywords>
      <Keywords>Toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Kayla E. Preece</Name>
        <Affiliation>AIBMR Life Sciences, Inc, 1425 Broadway, Suite 458, Seattle, WA, 98122, USA. Electronic address: kayla@aibmr.com.</Affiliation>
      </Author>
      <Author>
        <Name>Róbert Glávits</Name>
        <Affiliation>Toxi-Coop Zrt, Magyar Jakobinusok tere 4/B, H-1122, Budapest, Hungary. Electronic address: glavits.robert.dr@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Tim Murbach</Name>
        <Affiliation>AIBMR Life Sciences, Inc, 1425 Broadway, Suite 458, Seattle, WA, 98122, USA. Electronic address: tim@aibmr.com.</Affiliation>
      </Author>
      <Author>
        <Name>John R. Endres</Name>
        <Affiliation>AIBMR Life Sciences, Inc, 1425 Broadway, Suite 458, Seattle, WA, 98122, USA. Electronic address: john@aibmr.com.</Affiliation>
      </Author>
      <Author>
        <Name>Gábor Hirka</Name>
        <Affiliation>Toxi-Coop Zrt, Magyar Jakobinusok tere 4/B, H-1122, Budapest, Hungary. Electronic address: gabor.hirka@toxicoop.com.</Affiliation>
      </Author>
      <Author>
        <Name>Adél Vértesi</Name>
        <Affiliation>Toxi-Coop Zrt, Magyar Jakobinusok tere 4/B, H-1122, Budapest, Hungary. Electronic address: adel.vertesi@toxicoop.com.</Affiliation>
      </Author>
      <Author>
        <Name>Erzsébet Béres</Name>
        <Affiliation>Toxi-Coop Zrt, Magyar Jakobinusok tere 4/B, H-1122, Budapest, Hungary. Electronic address: erzsebet.beres@toxicoop.com.</Affiliation>
      </Author>
      <Author>
        <Name>Ilona Pasics Szakonyiné</Name>
        <Affiliation>Toxi-Coop Zrt, Magyar Jakobinusok tere 4/B, H-1122, Budapest, Hungary. Electronic address: ilona.pasics@toxicoop.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Safety testing of adult novelties using in vitro methods.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32898621</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(20)30206-3</DOI>
    <KeywordList>
      <Keywords>Chemical mixtures safety</Keywords>
      <Keywords>Cytotoxicity</Keywords>
      <Keywords>Endocrine disruption</Keywords>
      <Keywords>In vitro toxicology</Keywords>
      <Keywords>Public health</Keywords>
      <Keywords>Risk assessment</Keywords>
      <Keywords>Sex toy industry</Keywords>
      <Keywords>Skin sensitization</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>L. Svobodova</Name>
        <Affiliation>National Institute of Public Health, Prague, Šrobárova 48/49, 100 00, Prague 10, Czech Republic; Department of Medical Biophysics, Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University in Olomouc, Czech Republic. Electronic address: lada.svobodova@szu.cz.</Affiliation>
      </Author>
      <Author>
        <Name>M. Dvorakova</Name>
        <Affiliation>National Institute of Public Health, Prague, Šrobárova 48/49, 100 00, Prague 10, Czech Republic; Charles University in Prague, Third Faculty of Medicine, Ruská 87, 100 00, Prague 10, Czech Republic. Electronic address: marketa.dvorakova@szu.cz.</Affiliation>
      </Author>
      <Author>
        <Name>M. Rucki</Name>
        <Affiliation>National Institute of Public Health, Prague, Šrobárova 48/49, 100 00, Prague 10, Czech Republic. Electronic address: marian.rucki@szu.cz.</Affiliation>
      </Author>
      <Author>
        <Name>K. Kejlova</Name>
        <Affiliation>National Institute of Public Health, Prague, Šrobárova 48/49, 100 00, Prague 10, Czech Republic. Electronic address: kristina.kejlova@szu.cz.</Affiliation>
      </Author>
      <Author>
        <Name>H. Kandarova</Name>
        <Affiliation>Centre of Experimental Medicine, Slovak Academy of Sciences, Dúbravská Cesta 9, 841 04, Bratislava, Slovakia; Institute of Biochemistry and Microbiology, Faculty of Chemical and Food Technology, Slovak University of Technology in Bratislava, Radlinského 9, 812 37, Bratislava, Slovakia. Electronic address: helena.kandarova@savba.sk.</Affiliation>
      </Author>
      <Author>
        <Name>H. Kolarova</Name>
        <Affiliation>Department of Medical Biophysics, Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University in Olomouc, Czech Republic. Electronic address: hana.kolarova@upol.cz.</Affiliation>
      </Author>
      <Author>
        <Name>M. Mannerstrom</Name>
        <Affiliation>FICAM, Faculty of Medicine and Health Technology, FI-33014 Tampere University, Tampere, Finland. Electronic address: marika.mannerstrom@tuni.fi.</Affiliation>
      </Author>
      <Author>
        <Name>T. Heinonen</Name>
        <Affiliation>FICAM, Faculty of Medicine and Health Technology, FI-33014 Tampere University, Tampere, Finland. Electronic address: tuula.heinonen@tuni.fi.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A 26-week toxicological study of Xuezhikang (XZK), red yeast rice extract, in Beagle dogs with a 4-week recovery period.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32896614</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(20)30207-5</DOI>
    <KeywordList>
      <Keywords>Beagle dog</Keywords>
      <Keywords>Oral toxicity</Keywords>
      <Keywords>Red yeast rice</Keywords>
      <Keywords>Xuezhikang (XZK)</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Chunmei Li</Name>
        <Affiliation>School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University, Yantai, 264005, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Chunyu Su</Name>
        <Affiliation>School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University, Yantai, 264005, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Yu Wang</Name>
        <Affiliation>School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University, Yantai, 264005, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Yonglin Gao</Name>
        <Affiliation>School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University, Yantai, 264005, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Hongbo Wang</Name>
        <Affiliation>School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University, Yantai, 264005, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Jingwei Tian</Name>
        <Affiliation>School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University, Yantai, 264005, PR China. Electronic address: tianjingwei@luye.com.</Affiliation>
      </Author>
      <Author>
        <Name>Fenghua Fu</Name>
        <Affiliation>School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University, Yantai, 264005, PR China. Electronic address: fenghua@luye.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>DP-2Ø2216-6 maize does not adversely affect rats in a 90-day feeding study.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32888975</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(20)30205-1</DOI>
    <KeywordList>
      <Keywords>DP-2Ø2216-6 maize</Keywords>
      <Keywords>Mandatory</Keywords>
      <Keywords>No diet-related effects</Keywords>
      <Keywords>Not scientifically justified</Keywords>
      <Keywords>Subchronic</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Anne B. Carlson</Name>
        <Affiliation>Corteva Agriscience, 8325 NW 62nd Avenue, Johnston, IA, 50131, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Pushkor Mukerji</Name>
        <Affiliation>Corteva Agriscience, Haskell R&amp;D Center, P.O. Box 20, Newark, DE, 19714, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Carey A. Mathesius</Name>
        <Affiliation>Corteva Agriscience, 8325 NW 62nd Avenue, Johnston, IA, 50131, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Emily Huang</Name>
        <Affiliation>Corteva Agriscience, 8325 NW 62nd Avenue, Johnston, IA, 50131, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Rod A. Herman</Name>
        <Affiliation>Corteva Agriscience, 9330 Zionsville Road, Indianapolis, IN, 46268, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Denise Hoban</Name>
        <Affiliation>Corteva Agriscience, Haskell R&amp;D Center, P.O. Box 20, Newark, DE, 19714, USA.</Affiliation>
      </Author>
      <Author>
        <Name>J. Dale Thurman</Name>
        <Affiliation>Corteva Agriscience, Haskell R&amp;D Center, P.O. Box 20, Newark, DE, 19714, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jason M. Roper</Name>
        <Affiliation>Corteva Agriscience, Haskell R&amp;D Center, P.O. Box 20, Newark, DE, 19714, USA. Electronic address: jason.roper-1@corteva.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Letter to the editor regarding Heringa et al. (2020) paper entitled "Use of the Kinetically-derived Maximum Dose concept in selection of top doses for toxicity studies hampers proper hazard assessment and risk management".</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32882312</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(20)30191-4</DOI>
    <AuthorList>
      <Author>
        <Name>Claire Terry</Name>
        <Affiliation>Corteva Agriscience, 9330 Zionsville Road, Indianapolis, IN, 46268, United States. Electronic address: claire.terry@corteva.com.</Affiliation>
      </Author>
      <Author>
        <Name>Jeanne Y. Domoradzki</Name>
        <Affiliation>Corteva Agriscience, 9330 Zionsville Road, Indianapolis, IN, 46268, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Carrie R. Fleming</Name>
        <Affiliation>Corteva Agriscience, 9330 Zionsville Road, Indianapolis, IN, 46268, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Sean C. Gehen</Name>
        <Affiliation>Corteva Agriscience, 9330 Zionsville Road, Indianapolis, IN, 46268, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Robert T. Mingoia</Name>
        <Affiliation>Corteva Agriscience, 9330 Zionsville Road, Indianapolis, IN, 46268, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Lynea A. Murphy</Name>
        <Affiliation>Corteva Agriscience, 9330 Zionsville Road, Indianapolis, IN, 46268, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Michael J. Bartels</Name>
        <Affiliation>ToxMetrics.com LLC, Midland, MI, 48642, United States.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Use of mechanistic information to derive chemical-specific adjustment factors - Refinement of risk assessment.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32871170</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(20)30202-6</DOI>
    <KeywordList>
      <Keywords>Chemical specific assessment factors</Keywords>
      <Keywords>Mechanism based assessment factors</Keywords>
      <Keywords>Risk assessment</Keywords>
      <Keywords>Safety factors</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>C. Smeraldi</Name>
        <Affiliation>European Food Safety Authority, FIP Unit, Parma, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>A. Giarola</Name>
        <Affiliation>European Food Safety Authority, FIP Unit, Parma, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>P. J. Aggett</Name>
        <Affiliation>Emeritus Professor of Child Health and Nutrition, University of Central Lancashire, Preston, UK.</Affiliation>
      </Author>
      <Author>
        <Name>P. Moldeus</Name>
        <Affiliation>Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.</Affiliation>
      </Author>
      <Author>
        <Name>U. Gundert-Remy</Name>
        <Affiliation>Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Institute of Clinical Pharmacology and Toxicology, Berlin, Germany. Electronic address: ursula.gundert-remy@charite.de.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Building confidence in skin sensitisation potency assessment using new approach methodologies: report of the 3rd EPAA Partners Forum, Brussels, 28th October 2019.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32866543</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(20)30193-8</DOI>
    <KeywordList>
      <Keywords>Hazard assessment</Keywords>
      <Keywords>In vitro alternatives</Keywords>
      <Keywords>Potency measurement</Keywords>
      <Keywords>Skin sensitisation</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>D. Basketter</Name>
        <Affiliation>DABMEB Consultancy Ltd, Sharnbrook, UK. Electronic address: dabmebconsultancyltd@me.com.</Affiliation>
      </Author>
      <Author>
        <Name>S. Beken</Name>
        <Affiliation>European Medicines Agency, Amsterdam, the Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>H. Bender</Name>
        <Affiliation>hjb Consulting, Bonn, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>J. Bridges</Name>
        <Affiliation>University of Surrey, Guildford, UK.</Affiliation>
      </Author>
      <Author>
        <Name>S. Casati</Name>
        <Affiliation>European Commission, Joint Research Centre (JRC), Ispra, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>M. Corvaro</Name>
        <Affiliation>Corteva Agrisciences, Rome, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>S. Cuvellier</Name>
        <Affiliation>COSMED, Aix-en-Provence, France.</Affiliation>
      </Author>
      <Author>
        <Name>B. Hubesch</Name>
        <Affiliation>Hubesch Consult BVBA, Sint-Pieters-Leeuw, Belgium; European Chemical Industry Council (Cefic), Brussels, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>A. Irizar</Name>
        <Affiliation>The International Fragrance Association (IFRA), Geneva, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>M. N. Jacobs</Name>
        <Affiliation>Public Health England, Chilton, UK.</Affiliation>
      </Author>
      <Author>
        <Name>P. Kern</Name>
        <Affiliation>Procter and Gamble Services Company NV/SA, Strombeek-Bever, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>F. Lamplmair</Name>
        <Affiliation>European Commission, Brussels, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>I. Manou</Name>
        <Affiliation>European Partnership for Alternative Approaches to Animal Testing (EPAA), Brussels, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>B. P. Müller</Name>
        <Affiliation>Symrise AG, Holzminden, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>R. Roggeband</Name>
        <Affiliation>Procter and Gamble Services Company NV/SA, Strombeek-Bever, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>L. H. Rossi</Name>
        <Affiliation>European Chemicals Agency, Helsinki, Finland.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Iraqi regulatory authority current system and experience with biosimilars.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32861742</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(20)30194-X</DOI>
    <KeywordList>
      <Keywords>Cost savings</Keywords>
      <Keywords>Experience</Keywords>
      <Keywords>Guidelines</Keywords>
      <Keywords>Interchangeability</Keywords>
      <Keywords>Iraq</Keywords>
      <Keywords>Pharmacovigilance</Keywords>
      <Keywords>Regulatory authority</Keywords>
      <Keywords>biosimilars</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Khalid K. Al-Kinani</Name>
        <Affiliation>College of Pharmacy, University of Baghdad, Baghdad, Iraq. Electronic address: khalidalkinani@copharm.uobaghdad.edu.iq.</Affiliation>
      </Author>
      <Author>
        <Name>Mazin J. Ibrahim</Name>
        <Affiliation>College of Medicine, University of Baghdad, Baghdad, Iraq.</Affiliation>
      </Author>
      <Author>
        <Name>Ruaa F. Al-Zubaidi</Name>
        <Affiliation>Directorate of Forensic Medicine, Ministry of Health and Environment, Baghdad, Iraq.</Affiliation>
      </Author>
      <Author>
        <Name>Manal M. Younus</Name>
        <Affiliation>Iraqi Pharmacovigilance Center, Ministry of Health and Environment, Baghdad, Iraq.</Affiliation>
      </Author>
      <Author>
        <Name>Samir H. Ramadhan</Name>
        <Affiliation>National Center for Drug Control and Research, Ministry of Health and Environment, Baghdad, Iraq.</Affiliation>
      </Author>
      <Author>
        <Name>Hussein J. Kadhim</Name>
        <Affiliation>Registration Department, Ministry of Health and Environment, Baghdad, Iraq.</Affiliation>
      </Author>
      <Author>
        <Name>Rodeina Challand</Name>
        <Affiliation>Challand Biosimilar Consulting Ltd, United Kingdom.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Development of peptide therapeutics: A nonclinical safety assessment perspective.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32827570</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(20)30192-6</DOI>
    <KeywordList>
      <Keywords>Drug development</Keywords>
      <Keywords>Genotoxicity</Keywords>
      <Keywords>Immunogenicity</Keywords>
      <Keywords>Impurity qualification</Keywords>
      <Keywords>Non-proteogenic amino acids</Keywords>
      <Keywords>Peptide</Keywords>
      <Keywords>Safety pharmacology</Keywords>
      <Keywords>Toxicology</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Mayur S. Mitra</Name>
        <Affiliation>Genentech Inc, Safety Assessment, 1 DNA Way, South San Francisco, CA, 94080, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Steven DeMarco</Name>
        <Affiliation>PTC Therapeutics, 100 Corporate Court, South Plainfield, NJ, 07080, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Brad Holub</Name>
        <Affiliation>Ra Pharmaceuticals, Cambridge, MA, 02140, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Lakshmanan Thiruneelakantapillai</Name>
        <Affiliation>Ra Pharmaceuticals, Cambridge, MA, 02140, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Evan A. Thackaberry</Name>
        <Affiliation>Ra Pharmaceuticals, Cambridge, MA, 02140, USA. Electronic address: rnethack@gmail.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Repolarization studies using human stem cell-derived cardiomyocytes: Validation studies and best practice recommendations.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32822771</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(20)30182-3</DOI>
    <KeywordList>
      <Keywords>Cardiotoxicity</Keywords>
      <Keywords>Cardiovascular safety assessment</Keywords>
      <Keywords>Cellrhythmias</Keywords>
      <Keywords>CiPA</Keywords>
      <Keywords>Delayed repolarization</Keywords>
      <Keywords>JiCSA</Keywords>
      <Keywords>Nonclinical safety</Keywords>
      <Keywords>Proarrhythmic risk assessment</Keywords>
      <Keywords>Safety pharmacology</Keywords>
      <Keywords>hSC-CM</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Gary Gintant</Name>
        <Affiliation>Department of Integrative Pharmacology, Integrated Sciences and Technology, AbbVie, North Chicago, IL, 60064, USA. Electronic address: gary.gintant@abbvie.com.</Affiliation>
      </Author>
      <Author>
        <Name>Emily Pfeiffer Kaushik</Name>
        <Affiliation>Takeda Pharmaceutical Co, Cambridge, MA, 02139, USA. Electronic address: emily.kaushik@takeda.com.</Affiliation>
      </Author>
      <Author>
        <Name>Tromondae Feaster</Name>
        <Affiliation>Center for Devices and Radiological Health, US Food and Drug Administration, Silver Spring, MD, 20993, USA. Electronic address: tromondae.feaster@fda.hhs.gov.</Affiliation>
      </Author>
      <Author>
        <Name>Sonja Stoelzle-Feix</Name>
        <Affiliation>Nanion Technologies, Munich, Germany. Electronic address: sonja.stoelzle-feix@nanion.de.</Affiliation>
      </Author>
      <Author>
        <Name>Yasunari Kanda</Name>
        <Affiliation>Division of Pharmacology, National Institute of Health Sciences, Kanagawa, Japan. Electronic address: kanda@nihs.go.jp.</Affiliation>
      </Author>
      <Author>
        <Name>Tomoharu Osada</Name>
        <Affiliation>LSI Medience Corporation, Tokyo, Japan. Electronic address: osada.tomoharu@mg.medience.co.jp.</Affiliation>
      </Author>
      <Author>
        <Name>Godfrey Smith</Name>
        <Affiliation>Institute of Cardiovascular and Medical Sciences, University of Glasgow, Scotland, UK; Clyde Biosciences Ltd., Scotland, UK. Electronic address: godfrey.smith@glasgow.ac.uk.</Affiliation>
      </Author>
      <Author>
        <Name>Katherine Czysz</Name>
        <Affiliation>Fujifilm Cellular Dynamics, Inc., Madison, WI, 53711, USA. Electronic address: katherine.czysz@fujifilm.com.</Affiliation>
      </Author>
      <Author>
        <Name>Ralf Kettenhofen</Name>
        <Affiliation>Fraunhofer-Institute for Biomed Engineering IBMT, Sulzbach, Germany. Electronic address: ralf.kettenhofen@ibmt.fraunhofer.de.</Affiliation>
      </Author>
      <Author>
        <Name>Hua Rong Lu</Name>
        <Affiliation>Nonclinical Safety, Johnson &amp; Johnson R&amp;D, Beerse, Belgium. Electronic address: hlu@its.jnj.com.</Affiliation>
      </Author>
      <Author>
        <Name>Beibei Cai</Name>
        <Affiliation>Takeda California, Inc., San Diego, CA, 92121, USA. Electronic address: beibei.cai@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Hong Shi</Name>
        <Affiliation>Bristol-Myers Squibb, New York, NY, 10016, USA. Electronic address: hong.shi@bms.com.</Affiliation>
      </Author>
      <Author>
        <Name>Todd Joseph Herron</Name>
        <Affiliation>Frankel Cardiovascular Regeneration Core Laboratory, University of Michigan, Ann Arbor, MI, 48109, USA. Electronic address: toddherr@umich.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Qianyu Dang</Name>
        <Affiliation>Office of Biostatistics, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, 20993, USA. Electronic address: qianyu.dang@fda.hhs.gov.</Affiliation>
      </Author>
      <Author>
        <Name>Francis Burton</Name>
        <Affiliation>Institute of Cardiovascular and Medical Sciences, University of Glasgow, Scotland, UK; Clyde Biosciences Ltd., Scotland, UK. Electronic address: francis.burton@glasgow.ac.uk.</Affiliation>
      </Author>
      <Author>
        <Name>Li Pang</Name>
        <Affiliation>Division of Systems Biology, National Center for Toxicological Research, US Food and Drug Administration, Jefferson, AR, 72079, USA. Electronic address: li.pang@fda.hhs.gov.</Affiliation>
      </Author>
      <Author>
        <Name>Martin Traebert</Name>
        <Affiliation>Novartis Inst Biomed Res, Switzerland. Electronic address: martin.traebert@novartis.com.</Affiliation>
      </Author>
      <Author>
        <Name>Yama Abassi</Name>
        <Affiliation>Agilent Technologies, San Diego, CA, 92121, USA. Electronic address: yama.abassi@agilent.com.</Affiliation>
      </Author>
      <Author>
        <Name>Jennifer Beck Pierson</Name>
        <Affiliation>Health and Environmental Sciences Institute, Washington, DC, 20005, USA. Electronic address: jpierson@hesiglobal.org.</Affiliation>
      </Author>
      <Author>
        <Name>Ksenia Blinova</Name>
        <Affiliation>Center for Devices and Radiological Health, US Food and Drug Administration, Silver Spring, MD, 20993, USA. Electronic address: ksenia.blinova@fda.hhs.gov.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Effects of an ethanolic extract and fractions from Piper glabratum (Piperaceae) leaves on pain and inflammation.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32805323</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(20)30188-4</DOI>
    <KeywordList>
      <Keywords>Analgesy</Keywords>
      <Keywords>Carrageenan</Keywords>
      <Keywords>Formalin</Keywords>
      <Keywords>Inflammation</Keywords>
      <Keywords>Jaborandi</Keywords>
      <Keywords>Phytol</Keywords>
      <Keywords>Piper glabratum</Keywords>
      <Keywords>Toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Maicon M. Leitão</Name>
        <Affiliation>Faculty of Health Science, Federal University of Grande Dourados, Highway Dourados/Itahum, Km 12 - Unity II, 79, 804-970, Dourados, MS, Brazil. Electronic address: mleitao02@hotmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Joyce A. S. Radai</Name>
        <Affiliation>Faculty of Health Science, Federal University of Grande Dourados, Highway Dourados/Itahum, Km 12 - Unity II, 79, 804-970, Dourados, MS, Brazil. Electronic address: joycealencarr@hotmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Idalina C. Ferrari</Name>
        <Affiliation>Faculty of Health Science, Federal University of Grande Dourados, Highway Dourados/Itahum, Km 12 - Unity II, 79, 804-970, Dourados, MS, Brazil. Electronic address: idalina@uems.br.</Affiliation>
      </Author>
      <Author>
        <Name>Fábio J. Negrão</Name>
        <Affiliation>Faculty of Health Science, Federal University of Grande Dourados, Highway Dourados/Itahum, Km 12 - Unity II, 79, 804-970, Dourados, MS, Brazil. Electronic address: fjnegrao@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Saulo E. Silva-Filho</Name>
        <Affiliation>Faculty of Pharmaceutical Sciences, Food and Nutrition, Federal University of Mato Grosso do Sul, Av. Costa e Silva, University District, 79070-900, Campo Grande, MS, Brazil. Electronic address: saulo.esf@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Rodrigo J. Oliveira</Name>
        <Affiliation>Faculty of Pharmaceutical Sciences, Food and Nutrition, Federal University of Mato Grosso do Sul, Av. Costa e Silva, University District, 79070-900, Campo Grande, MS, Brazil. Electronic address: rjo.rodrigojulianooliveira@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Jonas da S. Mota</Name>
        <Affiliation>Department of Chemistry, State University of Mato Grosso do Sul, University City of Dourados, 79804-97, Dourados, MS, Brazil. Electronic address: js.mota@ig.com.br.</Affiliation>
      </Author>
      <Author>
        <Name>Candida A. L. Kassuya</Name>
        <Affiliation>Faculty of Health Science, Federal University of Grande Dourados, Highway Dourados/Itahum, Km 12 - Unity II, 79, 804-970, Dourados, MS, Brazil. Electronic address: candida2005@gmail.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Read-across can increase confidence in the Next Generation Risk Assessment for skin sensitisation: A case study with resorcinol.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32800849</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(20)30181-1</DOI>
    <KeywordList>
      <Keywords>Defined approaches</Keywords>
      <Keywords>Hazard identification</Keywords>
      <Keywords>New approach methodologies</Keywords>
      <Keywords>Next generation risk assessment</Keywords>
      <Keywords>Read-across</Keywords>
      <Keywords>Risk characterisation</Keywords>
      <Keywords>Skin sensitisation</Keywords>
      <Keywords>Weight of evidence</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Françoise Gautier</Name>
        <Affiliation>L'Oréal, Research &amp; Innovation, Aulnay-sous-Bois, France; L'Oréal, Research &amp; Innovation, Clichy, France. Electronic address: francoise.gautier@rd.loreal.com.</Affiliation>
      </Author>
      <Author>
        <Name>Fleur Tourneix</Name>
        <Affiliation>L'Oréal, Research &amp; Innovation, Aulnay-sous-Bois, France; L'Oréal, Research &amp; Innovation, Clichy, France. Electronic address: fleur.tourneix@rd.loreal.com.</Affiliation>
      </Author>
      <Author>
        <Name>Hind Assaf Vandecasteele</Name>
        <Affiliation>L'Oréal, Research &amp; Innovation, Aulnay-sous-Bois, France; L'Oréal, Research &amp; Innovation, Clichy, France. Electronic address: hind.assafvandecasteele@rd.loreal.com.</Affiliation>
      </Author>
      <Author>
        <Name>Erwin van Vliet</Name>
        <Affiliation>Innovitox Consulting &amp; Services, Regentenland 35, 3994TZ, Houten, the Netherlands. Electronic address: vanvliete@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Dagmar Bury</Name>
        <Affiliation>L'Oréal, Research &amp; Innovation, Aulnay-sous-Bois, France; L'Oréal, Research &amp; Innovation, Clichy, France. Electronic address: dagmar.bury@rd.loreal.com.</Affiliation>
      </Author>
      <Author>
        <Name>Nathalie Alépée</Name>
        <Affiliation>L'Oréal, Research &amp; Innovation, Aulnay-sous-Bois, France; L'Oréal, Research &amp; Innovation, Clichy, France. Electronic address: nathalie.alepee@rd.loreal.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Prenatal developmental toxicity study of an alkaloid-free Ageratum conyzoides extract powder in rats by oral administration.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32800848</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(20)30174-4</DOI>
    <KeywordList>
      <Keywords>Ageratum conyzoides</Keywords>
      <Keywords>Developmental</Keywords>
      <Keywords>Fetal</Keywords>
      <Keywords>Maternal</Keywords>
      <Keywords>NOAEL</Keywords>
      <Keywords>Prenatal</Keywords>
      <Keywords>Safety</Keywords>
      <Keywords>Toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Silma Subah</Name>
        <Affiliation>Gencor Pacific Limited, Unit 3, 1st Floor, Office Building Block 2, Discovery Bay North Plaza, 96 Siena Avenue, Discovery Bay, Lantau Island, Hong Kong. Electronic address: silmah@gencorpacific.com.</Affiliation>
      </Author>
      <Author>
        <Name>Nathasha Bogoda</Name>
        <Affiliation>Gencor Pacific Limited, Unit 3, 1st Floor, Office Building Block 2, Discovery Bay North Plaza, 96 Siena Avenue, Discovery Bay, Lantau Island, Hong Kong. Electronic address: nathasha@gencorpacific.com.</Affiliation>
      </Author>
      <Author>
        <Name>Róbert Glávits</Name>
        <Affiliation>Toxi-Coop Zrt, Berlini utca 47-49, H-1045, Budapest, Hungary. Electronic address: glavits.robert.dr@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Ruchitha Venkatesh</Name>
        <Affiliation>RDC Global, 72 Doggett Street, Newstead, QLD, 4006, Australia. Electronic address: ruchitha@rdcglobal.com.au.</Affiliation>
      </Author>
      <Author>
        <Name>Timothy S. Murbach</Name>
        <Affiliation>AIBMR Life Sciences Inc, 1425 Broadway, Suite 458, Seattle, WA, 98112, USA. Electronic address: tim@aibmr.com.</Affiliation>
      </Author>
      <Author>
        <Name>Kornélia Kolep-Csete</Name>
        <Affiliation>Toxi-Coop Zrt, Arácsi út 97, 8230, Balatonfüred, Hungary. Electronic address: kornelia.kolep@toxicoop.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Weight of Evidence and Human Relevance Evaluation of the Benfluralin Mode of Action in Rats (Part II): Thyroid carcinogenesis.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32798613</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(20)30162-8</DOI>
    <KeywordList>
      <Keywords>Benfluralin</Keywords>
      <Keywords>Human relevance</Keywords>
      <Keywords>Phenobarbital</Keywords>
      <Keywords>Thyroid MOA</Keywords>
      <Keywords>Thyroid carcinogenicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Christian Strupp</Name>
        <Affiliation>Gowan, Highlands House, Basingstoke Road, Spencers Wood Reading, Berkshire, RG7 1NT, United Kingdom. Electronic address: CStrupp@gowanco.com.</Affiliation>
      </Author>
      <Author>
        <Name>Nicolas Quesnot</Name>
        <Affiliation>Charles River Laboratories Evreux, 27005, Evreux Cedex, France. Electronic address: Nicolas.quesnot@crl.com.</Affiliation>
      </Author>
      <Author>
        <Name>Céline Weber-Parmentier</Name>
        <Affiliation>KaLy-Cell, 67115, Plobsheim, France. Electronic address: c.parmentier@kaly-cell.com.</Affiliation>
      </Author>
      <Author>
        <Name>Lysiane Richert</Name>
        <Affiliation>KaLy-Cell, 67115, Plobsheim, France. Electronic address: l.richert@kaly-cell.com.</Affiliation>
      </Author>
      <Author>
        <Name>Werner H. Bomann</Name>
        <Affiliation>ToxConsult®, 9393 W 110th Street, 51 Corporate Woods, Suite 500, Overland Park, KS, 66210, USA. Electronic address: info@tox-consult.com.</Affiliation>
      </Author>
      <Author>
        <Name>Pramila Singh</Name>
        <Affiliation>Charles River Laboratories Evreux, 27005, Evreux Cedex, France. Electronic address: Pramila.singh@crl.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Weight of evidence and human relevance evaluation of the benfluralin mode of action in rodents (Part I): Liver carcinogenesis.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32798612</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(20)30184-7</DOI>
    <KeywordList>
      <Keywords>Benfluralin</Keywords>
      <Keywords>Hepatic carcinogenicity</Keywords>
      <Keywords>Human relevance</Keywords>
      <Keywords>Human safety risk assessment</Keywords>
      <Keywords>Liver MOA</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Christian Strupp</Name>
        <Affiliation>Gowan, Highlands House, Basingstoke Road, Spencers Wood, Reading, Berkshire, RG7 1NT, UK. Electronic address: CStrupp@gowanco.com.</Affiliation>
      </Author>
      <Author>
        <Name>Nicolas Quesnot</Name>
        <Affiliation>Charles River Laboratories Evreux, 27005, Evreux Cedex, France. Electronic address: Nicolas.quesnot@crl.com.</Affiliation>
      </Author>
      <Author>
        <Name>Lysiane Richert</Name>
        <Affiliation>KaLy-Cell, 67115, Plobsheim, France. Electronic address: l.richert@kaly-cell.com.</Affiliation>
      </Author>
      <Author>
        <Name>Joanna Moore</Name>
        <Affiliation>Charles River Laboratories Evreux, 27005, Evreux Cedex, France. Electronic address: Joanna.moore@crl.com.</Affiliation>
      </Author>
      <Author>
        <Name>Werner H. Bomann</Name>
        <Affiliation>ToxConsult®, 9393 W 110th Street, 51 Corporate Woods, Suite 500, Overland Park, KS, 66210, USA. Electronic address: info@tox-consult.com.</Affiliation>
      </Author>
      <Author>
        <Name>Pramila Singh</Name>
        <Affiliation>Charles River Laboratories Evreux, 27005, Evreux Cedex, France. Electronic address: Pramila.singh@crl.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Selecting a minimal set of androgen receptor assays for screening chemicals.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32798611</pubmedLink>
    <GrantList>
      <Grant>EPA999999</Grant>
    </GrantList>
    <Year>2020</Year>
    <DOI>S0273-2300(20)30190-2</DOI>
    <KeywordList>
      <Keywords>Alternative testing methods</Keywords>
      <Keywords>Androgen receptor</Keywords>
      <Keywords>Endocrine disruption</Keywords>
      <Keywords>In vitro</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Richard Judson</Name>
        <Affiliation>U.S. Environmental Protection Agency, RTP, NC, USA. Electronic address: judson.richard@epa.gov.</Affiliation>
      </Author>
      <Author>
        <Name>Keith Houck</Name>
        <Affiliation>U.S. Environmental Protection Agency, RTP, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Katie Paul Friedman</Name>
        <Affiliation>U.S. Environmental Protection Agency, RTP, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jason Brown</Name>
        <Affiliation>U.S. Environmental Protection Agency, RTP, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Patience Browne</Name>
        <Affiliation>OECD, Paris, France.</Affiliation>
      </Author>
      <Author>
        <Name>Paul A. Johnston</Name>
        <Affiliation>Department of Pharmaceutical Sciences, School of Pharmacy, University of Pittsburgh, Pittsburgh, PA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>David A. Close</Name>
        <Affiliation>Department of Pharmaceutical Sciences, School of Pharmacy, University of Pittsburgh, Pittsburgh, PA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Kamel Mansouri</Name>
        <Affiliation>Integrated Laboratory Systems, Inc., Morrisville, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Nicole Kleinstreuer</Name>
        <Affiliation>NTP Interagency Center for the Evaluation of Alternative Toxicological Methods, RTP, NC, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Application of the dermal sensitization threshold concept to chemicals classified as high potency category for skin sensitization assessment of ingredients for consumer products.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32795584</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(20)30158-6</DOI>
    <KeywordList>
      <Keywords>Dermal sensitization threshold (DST)</Keywords>
      <Keywords>High potency category (HPC) chemicals</Keywords>
      <Keywords>Non-animal methods</Keywords>
      <Keywords>Sensitization risk assessment</Keywords>
      <Keywords>Skin sensitization</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Taku Nishijo</Name>
        <Affiliation>Safety Science Research Laboratories, Kao Corporation, 2606 Akabane, Ichikai, Haga, Tochigi 321-3497, Japan. Electronic address: nishijou.taku@kao.com.</Affiliation>
      </Author>
      <Author>
        <Name>Anne Marie Api</Name>
        <Affiliation>Research Institute for Fragrance Materials, Inc., 50 Tice Boulevard, Woodcliff Lake, NJ 07677, United States.</Affiliation>
      </Author>
      <Author>
        <Name>G. Frank Gerberick</Name>
        <Affiliation>GF3 Consultancy, LLC, 6592 Pullman Court, West Chester, OH 45069, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Masaaki Miyazawa</Name>
        <Affiliation>Safety Science Research Laboratories, Kao Corporation, 2606 Akabane, Ichikai, Haga, Tochigi 321-3497, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>David W. Roberts</Name>
        <Affiliation>School of Pharmacy and Biomolecular Sciences, Liverpool John Moores University, Byrom Street, Liverpool, L3 3AF, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Robert J. Safford</Name>
        <Affiliation>B-Safe Toxicology Consulting, 31 Hayway, Rushden, Northants, NN10 6AG, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Hitoshi Sakaguchi</Name>
        <Affiliation>Safety Science Research Laboratories, Kao Corporation, 2606 Akabane, Ichikai, Haga, Tochigi 321-3497, Japan.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Reflections on the OECD guidelines for in vitro skin absorption studies.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32791089</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(20)30178-1</DOI>
    <KeywordList>
      <Keywords>Chemical skin absorption</Keywords>
      <Keywords>Diffusion cell</Keywords>
      <Keywords>In vitro skin permeation tests</Keywords>
      <Keywords>OECD guideline 428</Keywords>
      <Keywords>Percutaneous permeation</Keywords>
      <Keywords>Skin absorption</Keywords>
      <Keywords>Skin permeation</Keywords>
      <Keywords>Skin permeation coefficient</Keywords>
      <Keywords>Time lag</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>N. B. Hopf</Name>
        <Affiliation>Centre for Primary Care and Public Health (Unisante), Department for Occupational and Environmental Health (DSTE), Exposure Science Unit, Switzerland. Electronic address: Nancy.Hopf@unisante.ch.</Affiliation>
      </Author>
      <Author>
        <Name>C. Champmartin</Name>
        <Affiliation>French National Research and Safety Institute for the Prevention of Occupational Accidents and Diseases (INRS), France. Electronic address: catherine.champmartin@inrs.fr.</Affiliation>
      </Author>
      <Author>
        <Name>L. Schenk</Name>
        <Affiliation>Karolinska Institutet, Institute of Environmental Medicine, Unit of Integrative Toxicology, Sweden. Electronic address: linda.schenk@ki.se.</Affiliation>
      </Author>
      <Author>
        <Name>A. Berthet</Name>
        <Affiliation>Centre for Primary Care and Public Health (Unisante), Department for Occupational and Environmental Health (DSTE), Exposure Science Unit, Switzerland. Electronic address: Aurelie.Berthet@unisante.ch.</Affiliation>
      </Author>
      <Author>
        <Name>L. Chedik</Name>
        <Affiliation>French National Research and Safety Institute for the Prevention of Occupational Accidents and Diseases (INRS), France. Electronic address: lisa.chedik@inrs.fr.</Affiliation>
      </Author>
      <Author>
        <Name>J. L. Du Plessis</Name>
        <Affiliation>Occupational Hygiene and Health Research Initiative (OHHRI) North-West University, South Africa. Electronic address: johan.duplessis@nwu.ac.za.</Affiliation>
      </Author>
      <Author>
        <Name>A. Franken</Name>
        <Affiliation>Occupational Hygiene and Health Research Initiative (OHHRI) North-West University, South Africa. Electronic address: anja.franken@nwu.ac.za.</Affiliation>
      </Author>
      <Author>
        <Name>F. Frasch</Name>
        <Affiliation>Occupational Hygiene and Health Research Initiative (OHHRI) North-West University, South Africa. Electronic address: Laurel3417@comcast.net.</Affiliation>
      </Author>
      <Author>
        <Name>S. Gaskin</Name>
        <Affiliation>University of Adelaide, School of Public Health, Health and Medical Sciences, Australia. Electronic address: sharyn.gaskin@adelaide.edu.au.</Affiliation>
      </Author>
      <Author>
        <Name>G. Johanson</Name>
        <Affiliation>Karolinska Institutet, Institute of Environmental Medicine, Unit of Integrative Toxicology, Sweden. Electronic address: gunnar.johanson@ki.se.</Affiliation>
      </Author>
      <Author>
        <Name>A. Julander</Name>
        <Affiliation>Karolinska Institutet, Institute of Environmental Medicine, Unit of Integrative Toxicology, Sweden. Electronic address: anneli.julander@ki.se.</Affiliation>
      </Author>
      <Author>
        <Name>G. Kasting</Name>
        <Affiliation>University of Cincinnati, James L. Winkle College of Pharmacy, USA. Electronic address: Gerald.Kasting@uc.edu.</Affiliation>
      </Author>
      <Author>
        <Name>S. Kilo</Name>
        <Affiliation>Friedrich-Alexander University Erlangen-Nürnberg, Institute and Outpatient Clinic of Occupational, Social and Environmental Medicine, Germany. Electronic address: sonja.kilo@fau.de.</Affiliation>
      </Author>
      <Author>
        <Name>F. Larese Filon</Name>
        <Affiliation>University of Trieste, Clinical Unit of Occupational Medicine, Department of Medical, Surgical and Health Sciences, Italy. Electronic address: larese@units.it.</Affiliation>
      </Author>
      <Author>
        <Name>F. Marquet</Name>
        <Affiliation>French National Research and Safety Institute for the Prevention of Occupational Accidents and Diseases (INRS), France. Electronic address: fabrice.marquet@inrs.fr.</Affiliation>
      </Author>
      <Author>
        <Name>K. Midander</Name>
        <Affiliation>Karolinska Institutet, Institute of Environmental Medicine, Unit of Integrative Toxicology, Sweden. Electronic address: klara.midander@ki.se.</Affiliation>
      </Author>
      <Author>
        <Name>E. Reale</Name>
        <Affiliation>Centre for Primary Care and Public Health (Unisante), Department for Occupational and Environmental Health (DSTE), Exposure Science Unit, Switzerland. Electronic address: Elena.Reale@unisante.ch.</Affiliation>
      </Author>
      <Author>
        <Name>A. L. Bunge</Name>
        <Affiliation>Colorado School of Mines, Chemical and Biological Engineering, USA. Electronic address: abunge@mines.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>"New statistics" in regulatory toxicology?</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32781239</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(20)30189-6</DOI>
    <KeywordList>
      <Keywords>Bechmark dose modelling</Keywords>
      <Keywords>Compatibility intervals</Keywords>
      <Keywords>Hazard identification</Keywords>
      <Keywords>Regulatory toxicology</Keywords>
      <Keywords>Statistics</Keywords>
      <Keywords>Testing vs estimation</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Felix M. Kluxen</Name>
        <Affiliation>ADAMA Deutschland GmbH, Cologne, Germany. Electronic address: felix.kluxen@adama.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Copper alloys' metal migration and bioaccessibility in saliva and gastric fluid.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32777432</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(20)30180-X</DOI>
    <KeywordList>
      <Keywords>Bioelution</Keywords>
      <Keywords>Copper alloys</Keywords>
      <Keywords>Metal migration</Keywords>
      <Keywords>Metals</Keywords>
      <Keywords>Oral bioaccessibility</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Katrien Delbeke</Name>
        <Affiliation>Sint-Jansbergsteenweg 32, B-3040, Loonbeek, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Stijn Baken</Name>
        <Affiliation>European Copper Institute, Tervurenlaan 168, B-1150, Brussels, Belgium. Electronic address: stijn.baken@copperalliance.eu.</Affiliation>
      </Author>
      <Author>
        <Name>Laia Perez Simbor</Name>
        <Affiliation>ETRMA-European Tyre &amp; Rubber Manufacturers' Association, Avenue des Arts 2, box 12, B-1210 Brussels, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Patricio H. Rodriguez</Name>
        <Affiliation>PHR Consulting, Santiago, Chile.</Affiliation>
      </Author>
      <Author>
        <Name>Tony Brouwers</Name>
        <Affiliation>ECTX bvba, Havenstraat 46/0.01, B-3500, Hasselt, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Violaine Verougstraete</Name>
        <Affiliation>Eurometaux, Tervurenlaan 168 box 13, B-1150, Brussels, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Steve Binks</Name>
        <Affiliation>International Lead Association, Bravington House, 2 Bravingtons Walk, London, N1 9AF, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Adriana Oller</Name>
        <Affiliation>NiPERA, Inc., 2525 Meridian Parkway, Suite 240, Durham, NC, 27713, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Ruth Danzeisen</Name>
        <Affiliation>Cobalt Institute, 18 Jeffries Passage, Guildford, GU1 4AP, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Mik Gilles</Name>
        <Affiliation>International Zinc Association, Tervurenlaan 168 box 4, B-1150, Belgium.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Are all nitrosamines concerning? A review of mutagenicity and carcinogenicity data.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32777431</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(20)30175-6</DOI>
    <KeywordList>
      <Keywords>Carcinogenicity</Keywords>
      <Keywords>Mutagenicity</Keywords>
      <Keywords>Nitrosamine</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Andrew Thresher</Name>
        <Affiliation>Lhasa Limited, Granary Wharf House, 2 Canal Wharf, Leeds, West Yorkshire, LS11 5PS, UK. Electronic address: andrew.thresher@lhasalimited.org.</Affiliation>
      </Author>
      <Author>
        <Name>Robert Foster</Name>
        <Affiliation>Lhasa Limited, Granary Wharf House, 2 Canal Wharf, Leeds, West Yorkshire, LS11 5PS, UK.</Affiliation>
      </Author>
      <Author>
        <Name>David J. Ponting</Name>
        <Affiliation>Lhasa Limited, Granary Wharf House, 2 Canal Wharf, Leeds, West Yorkshire, LS11 5PS, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Susanne A. Stalford</Name>
        <Affiliation>Lhasa Limited, Granary Wharf House, 2 Canal Wharf, Leeds, West Yorkshire, LS11 5PS, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Rachael E. Tennant</Name>
        <Affiliation>Lhasa Limited, Granary Wharf House, 2 Canal Wharf, Leeds, West Yorkshire, LS11 5PS, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Robert Thomas</Name>
        <Affiliation>Lhasa Limited, Granary Wharf House, 2 Canal Wharf, Leeds, West Yorkshire, LS11 5PS, UK.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Subchronic (90-Day) repeated dose toxicity study of disodium adenosine-5'-triphosphate in rats.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32771599</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(20)30186-0</DOI>
    <KeywordList>
      <Keywords>ATP</Keywords>
      <Keywords>Disodium adenosine-5′-triphosphate</Keywords>
      <Keywords>Preclinical</Keywords>
      <Keywords>Rodent</Keywords>
      <Keywords>Safety</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Ralf Jäger</Name>
        <Affiliation>Increnovo, LLC, 2138 E Lafayette Pl, Milwaukee, WI, 53202, USA. Electronic address: ralf.jaeger@increnovo.com.</Affiliation>
      </Author>
      <Author>
        <Name>Martin Purpura</Name>
        <Affiliation>Increnovo, LLC, 2138 E Lafayette Pl, Milwaukee, WI, 53202, USA. Electronic address: martin.purpura@increnovo.com.</Affiliation>
      </Author>
      <Author>
        <Name>John C. Fuller</Name>
        <Affiliation>Metabolic Technologies, LLC, 135 W Main St, Suite B, Missoula, MT, 59802, USA. Electronic address: fuller@mti-hmb.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Dose-response assessment for impaired memory from chronic exposure to domoic acid among native American consumers of razor clams.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32768666</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(20)30185-9</DOI>
    <KeywordList>
      <Keywords>Amnesic shellfish poisoning</Keywords>
      <Keywords>Domoic acid</Keywords>
      <Keywords>Domoic acid and memory</Keywords>
      <Keywords>Domoic acid neurotoxicity</Keywords>
      <Keywords>Harmful algal blooms</Keywords>
      <Keywords>Shellfish monitoring</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Leah D. Stuchal</Name>
        <Affiliation>Center for Environmental and Human Toxicology, College of Veterinary Medicine, University of Florida, Gainesville, FL, USA; Department of Environmental and Global Health, College of Public Health and Health Professions, University of Florida, Gainesville, FL, USA. Electronic address: lstuchal@ufl.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Lynn M. Grattan</Name>
        <Affiliation>Department of Neurology, Neuropsychology Program, University of Maryland School of Medicine, Baltimore, MD, USA. Electronic address: LGrattan@som.umaryland.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Kenneth M. Portier</Name>
        <Affiliation>Center for Environmental and Human Toxicology, College of Veterinary Medicine, University of Florida, Gainesville, FL, USA. Electronic address: kenneth.portier@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Kelsey A. Kilmon</Name>
        <Affiliation>Department of Neurology, Neuropsychology Program, University of Maryland School of Medicine, Baltimore, MD, USA. Electronic address: Kelsey.Roberts@som.umaryland.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Lillian Morris Manahan</Name>
        <Affiliation>Washington State Department of Health, Olympia, WA, USA. Electronic address: lillian.manahan@doh.wa.gov.</Affiliation>
      </Author>
      <Author>
        <Name>Stephen M. Roberts</Name>
        <Affiliation>Center for Environmental and Human Toxicology, College of Veterinary Medicine, University of Florida, Gainesville, FL, USA; Department of Environmental and Global Health, College of Public Health and Health Professions, University of Florida, Gainesville, FL, USA. Electronic address: smroberts@ufl.edu.</Affiliation>
      </Author>
      <Author>
        <Name>J. Glenn Morris</Name>
        <Affiliation>Emerging Pathogens Institute, University of Florida, and Department of Medicine, College of Medicine, University of Florida, Gainesville, FL, USA. Electronic address: jgmorris@epi.ufl.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Me-too validation study for in vitro skin irritation test with a reconstructed human epidermis model, KeraSkin™ for OECD test guideline 439.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32768665</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(20)30151-3</DOI>
    <KeywordList>
      <Keywords>KeraSkin(TM)</Keywords>
      <Keywords>OECD TG 439</Keywords>
      <Keywords>Predictive capacity</Keywords>
      <Keywords>Reconstructed human epidermis</Keywords>
      <Keywords>Reproducibility</Keywords>
      <Keywords>Skin irritation</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Juhee Han</Name>
        <Affiliation>College of Pharmacy, Ewha Womans University, Seoul, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Seolyeong Kim</Name>
        <Affiliation>Biosolution Co, Seoul, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Su Hyun Lee</Name>
        <Affiliation>Biosolution Co, Seoul, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Jin Sik Kim</Name>
        <Affiliation>COSMAX Korea, Seongnam-si, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Yu Jin Chang</Name>
        <Affiliation>Korea Conformity Laboratories, Incheon, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Tae Cheon Jeong</Name>
        <Affiliation>College of Pharmacy, Yeungnam University, Gyeongsan, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Mi Jeong Kang</Name>
        <Affiliation>College of Pharmacy, Yeungnam University, Gyeongsan, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Tae Sung Kim</Name>
        <Affiliation>National Institute of Food and Drug Safety Evaluation, Ministry of Food and Drug Safety, Osong, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Hae Seong Yoon</Name>
        <Affiliation>National Institute of Food and Drug Safety Evaluation, Ministry of Food and Drug Safety, Osong, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Ga Young Lee</Name>
        <Affiliation>National Institute of Food and Drug Safety Evaluation, Ministry of Food and Drug Safety, Osong, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>SeungJin Bae</Name>
        <Affiliation>College of Pharmacy, Ewha Womans University, Seoul, Republic of Korea. Electronic address: sjbae@ewha.ac.kr.</Affiliation>
      </Author>
      <Author>
        <Name>Kyung Min Lim</Name>
        <Affiliation>College of Pharmacy, Ewha Womans University, Seoul, Republic of Korea. Electronic address: kmlim@ewha.ac.kr.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Comparison of acute respiratory epithelial toxicity for 4-Methylimidazole and naphthalene administered by oral gavage in B6C3F1 mice.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32768664</pubmedLink>
    <GrantList>
      <Grant>R01 ES020867</Grant>
      <Grant>T32 ES007148</Grant>
      <Grant>T32 HL007013</Grant>
      <Grant>P30 ES023513</Grant>
      <Grant>U54 OH007550</Grant>
      <Grant>U54OH007550</Grant>
    </GrantList>
    <Year>2020</Year>
    <DOI>S0273-2300(20)30187-2</DOI>
    <KeywordList>
      <Keywords>4-Methylimidazole</Keywords>
      <Keywords>Acute toxicity</Keywords>
      <Keywords>Club cell toxicity</Keywords>
      <Keywords>Naphthalene</Keywords>
      <Keywords>Respiratory</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jacklyn S. Kelty</Name>
        <Affiliation>Center for Health and Environment, University of California, Davis, Bldg 3792, Rm 129, 1250 Old Davis Road, Davis, 95616, CA, USA. Electronic address: jkelty@ucdavis.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Chayoung Keum</Name>
        <Affiliation>Center for Health and Environment, University of California, Davis, Bldg 3792, Rm 129, 1250 Old Davis Road, Davis, 95616, CA, USA. Electronic address: ckeum@ucdavis.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Veneese J. Brown</Name>
        <Affiliation>Center for Health and Environment, University of California, Davis, Bldg 3792, Rm 129, 1250 Old Davis Road, Davis, 95616, CA, USA. Electronic address: vjbrown@ucdavis.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Patricia C. Edwards</Name>
        <Affiliation>Center for Health and Environment, University of California, Davis, Bldg 3792, Rm 129, 1250 Old Davis Road, Davis, 95616, CA, USA. Electronic address: pedwards@ucdavis.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Sarah A. Carratt</Name>
        <Affiliation>Center for Health and Environment, University of California, Davis, Bldg 3792, Rm 129, 1250 Old Davis Road, Davis, 95616, CA, USA. Electronic address: sacarratt@ucdavis.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Laura S. Van Winkle</Name>
        <Affiliation>Center for Health and Environment, University of California, Davis, Bldg 3792, Rm 129, 1250 Old Davis Road, Davis, 95616, CA, USA; Department of Anatomy, Physiology and Cell Biology School of Veterinary Medicine, University of California, Davis, One Shields Ave, Davis, 95616, CA, USA. Electronic address: lsvanwinkle@ucdavis.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Can we define a level of protection for allergic consumers that everyone can accept?</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32763252</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(20)30177-X</DOI>
    <KeywordList>
      <Keywords>Decision framework</Keywords>
      <Keywords>Food allergy</Keywords>
      <Keywords>Risk assessment</Keywords>
      <Keywords>Risk management</Keywords>
      <Keywords>Tolerable risk</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Charlotte B. Madsen</Name>
        <Affiliation>Technical University of Denmark, Anker Engelundsvej 1, 2860, Lyngby, Denmark. Electronic address: publications@ilsieurope.be.</Affiliation>
      </Author>
      <Author>
        <Name>Myrthe W. van den Dungen</Name>
        <Affiliation>DSM Food Specialties B.V., Alexander Fleminglaan 1, 2613 AX, Delft, Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Stella Cochrane</Name>
        <Affiliation>Unilever SEAC, Colworth Science Park, Sharnbrook, MK44 1LQ, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Geert F. Houben</Name>
        <Affiliation>The Netherlands Organisation for Applied Scientific Research (TNO), Utrecht, Netherlands; Dept. Dermatology/Allergology and Center for Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Rebecca C. Knibb</Name>
        <Affiliation>School of Psychology, Aston University, Birmingham, B4 7ET, UK.</Affiliation>
      </Author>
      <Author>
        <Name>André C. Knulst</Name>
        <Affiliation>Dept. Dermatology/Allergology and Center for Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Stefan Ronsmans</Name>
        <Affiliation>Coca-Cola Services NV, BE, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Ross A. R. Yarham</Name>
        <Affiliation>Food Standards Agency (FSA), UK.</Affiliation>
      </Author>
      <Author>
        <Name>Sabine Schnadt</Name>
        <Affiliation>German Allergy and Asthma Association (DAAB), Mönchengladbach, DE, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Paul J. Turner</Name>
        <Affiliation>National Heart &amp; Lung Institute, Imperial College London, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Joseph Baumert</Name>
        <Affiliation>University of Nebraska-Lincoln, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Elisa Cavandoli</Name>
        <Affiliation>Barilla G&amp;R Fratelli, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Chun Han Chan</Name>
        <Affiliation>Food Standards Agency (FSA), UK.</Affiliation>
      </Author>
      <Author>
        <Name>Amena Warner</Name>
        <Affiliation>Allergy UK, UK.</Affiliation>
      </Author>
      <Author>
        <Name>René W. R. Crevel</Name>
        <Affiliation>University of Nebraska-Lincoln, USA; René Crevel Consulting Limited, Bedford, MK44 3UE, UK.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Four-week repeated dose oral toxicity study of KDS2010, a novel selective monoamine oxidase B inhibitor, in Sprague Dawley rats.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32758522</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(20)30159-8</DOI>
    <KeywordList>
      <Keywords>4-Week repeated dose oral toxicity test</Keywords>
      <Keywords>KDS2010</Keywords>
      <Keywords>No-observed-adverse-effect level</Keywords>
      <Keywords>Novel selective monoamine oxidase B inhibitor</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Kyung Tai Kim</Name>
        <Affiliation>Jeonbuk Branch Institute, Korea Institute of Toxicology, Jeonbuk, 56212, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Da Hee Kim</Name>
        <Affiliation>Jeonbuk Branch Institute, Korea Institute of Toxicology, Jeonbuk, 56212, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Bo Kyung Kim</Name>
        <Affiliation>Jeonbuk Branch Institute, Korea Institute of Toxicology, Jeonbuk, 56212, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Ji Seok Han</Name>
        <Affiliation>Department of Advanced Toxicology Research, Korea Institute of Toxicology (KIT), 141 Gajeong-ro, Yuseong-gu, Daejeon, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Han Young Eom</Name>
        <Affiliation>Department of Advanced Toxicology Research, Korea Institute of Toxicology (KIT), 141 Gajeong-ro, Yuseong-gu, Daejeon, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Mi Jin Yang</Name>
        <Affiliation>Jeonbuk Branch Institute, Korea Institute of Toxicology, Jeonbuk, 56212, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Seung Hyuk Shin</Name>
        <Affiliation>Jeonbuk Branch Institute, Korea Institute of Toxicology, Jeonbuk, 56212, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Doo Wan Cho</Name>
        <Affiliation>Jeonbuk Branch Institute, Korea Institute of Toxicology, Jeonbuk, 56212, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Bo Ko Jang</Name>
        <Affiliation>Convergence Research Center for Diagnosis, Treatment and Care System of Dementia, Korea Institute of Science and Technology (KIST), Seoul, 02792, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Ki Duk Park</Name>
        <Affiliation>Convergence Research Center for Diagnosis, Treatment and Care System of Dementia, Korea Institute of Science and Technology (KIST), Seoul, 02792, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Young Su Yang</Name>
        <Affiliation>Jeonbuk Branch Institute, Korea Institute of Toxicology, Jeonbuk, 56212, Republic of Korea. Electronic address: ysyang@kitox.re.kr.</Affiliation>
      </Author>
      <Author>
        <Name>Su Cheol Han</Name>
        <Affiliation>Jeonbuk Branch Institute, Korea Institute of Toxicology, Jeonbuk, 56212, Republic of Korea. Electronic address: vethansc@kitox.re.kr.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Advances in selecting appropriate non-rodent species for regulatory toxicology research: Policy, ethical, and experimental considerations.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32758521</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(20)30183-5</DOI>
    <KeywordList>
      <Keywords>Experimental animal</Keywords>
      <Keywords>Non-human primate</Keywords>
      <Keywords>Non-rodent</Keywords>
      <Keywords>Regulatory toxicology</Keywords>
      <Keywords>Safety assessment</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Yong Wook Son</Name>
        <Affiliation>Department of Biotechnology, The Catholic University of Korea, Bucheon, 14662, South Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Ha Ni Choi</Name>
        <Affiliation>Department of Biotechnology, The Catholic University of Korea, Bucheon, 14662, South Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Jeong Hwan Che</Name>
        <Affiliation>Biomedical Center for Animal Resource and Development, Seoul National University College of Medicine, Seoul, 03080, South Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Byeong Cheol Kang</Name>
        <Affiliation>Graduate School of Translational Medicine, Seoul National University College of Medicine, Seoul, 03080, South Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Jun Won Yun</Name>
        <Affiliation>Department of Biotechnology, The Catholic University of Korea, Bucheon, 14662, South Korea. Electronic address: jwyun@catholic.ac.kr.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Metabolic fate in adult and pediatric population of steviol glycosides produced from stevia leaf extract by different production technologies.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32745585</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(20)30153-7</DOI>
    <KeywordList>
      <Keywords>Anaerobic</Keywords>
      <Keywords>Bioconversion</Keywords>
      <Keywords>Extraction</Keywords>
      <Keywords>Glycosylation</Keywords>
      <Keywords>Human</Keywords>
      <Keywords>Safety</Keywords>
      <Keywords>Stevia extract</Keywords>
      <Keywords>Stevia leaf extract</Keywords>
      <Keywords>Steviol glycosides</Keywords>
      <Keywords>in vitro metabolism</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Sidd Purkayastha</Name>
        <Affiliation>PureCircle Limited, 200 W Jackson Blvd, 8th Floor, Chicago, IL, 60606, USA. Electronic address: sidd.purkayastha@purecircle.com.</Affiliation>
      </Author>
      <Author>
        <Name>David Kwok</Name>
        <Affiliation>BRI Biopharmaceutical Research Inc., 101-8898 Heather St., Vancouver, BC V6P 3S8, Canada.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Evaluation of chronic toxicity of cyclocreatine, a creatine analog, in Sprague Dawley rat after oral gavage administration for up to 26 weeks.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32745584</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(20)30176-8</DOI>
    <KeywordList>
      <Keywords>Creatine analog</Keywords>
      <Keywords>Creatine transporter deficiency (CTD)</Keywords>
      <Keywords>Cyclocreatine</Keywords>
      <Keywords>LUM-001</Keywords>
      <Keywords>Nonclinical safety evaluation</Keywords>
      <Keywords>Nonclinical toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Vijay Pralhad Kale</Name>
        <Affiliation>Battelle, Columbus, OH, USA. Electronic address: vetvijay@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Jeffery Wallery</Name>
        <Affiliation>Battelle, Columbus, OH, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Joseph Novak</Name>
        <Affiliation>Battelle, Columbus, OH, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Seth Gibbs</Name>
        <Affiliation>Battelle, Columbus, OH, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Mohammed Bourdi</Name>
        <Affiliation>National Center for Advancing Translational Sciences, National Institute of Health, Bethesda, MD, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Minh Ha T. Do</Name>
        <Affiliation>Lumos Pharma, Austin, TX, USA.</Affiliation>
      </Author>
      <Author>
        <Name>John C. McKew</Name>
        <Affiliation>Lumos Pharma, Austin, TX, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Pramod S. Terse</Name>
        <Affiliation>National Center for Advancing Translational Sciences, National Institute of Health, Bethesda, MD, USA. Electronic address: tersep@mail.nih.gov.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Safety and health risk assessment methodology of dermal and inhalation exposure to formulated products ingredients.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32745583</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(20)30179-3</DOI>
    <KeywordList>
      <Keywords>Dermal</Keywords>
      <Keywords>Formulated product</Keywords>
      <Keywords>Inhalation</Keywords>
      <Keywords>Risk assessment</Keywords>
      <Keywords>Safety and health index</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Rafeqah Raslan</Name>
        <Affiliation>Department of Chemical Engineering, Centre of Hydrogen Energy, School of Chemical and Energy Engineering, Faculty of Engineering, Universiti Teknologi Malaysia, Johor, Malaysia; Department of Chemical Engineering, Universiti Teknologi MARA, Selangor, Malaysia.</Affiliation>
      </Author>
      <Author>
        <Name>Mimi H. Hassim</Name>
        <Affiliation>Department of Chemical Engineering, Centre of Hydrogen Energy, School of Chemical and Energy Engineering, Faculty of Engineering, Universiti Teknologi Malaysia, Johor, Malaysia. Electronic address: mimi@cheme.utm.my.</Affiliation>
      </Author>
      <Author>
        <Name>Nishanth G. Chemmangattuvalappil</Name>
        <Affiliation>Department of Chemical and Environmental Engineering, Centre of Excellence for Green Technologies, The University of Nottingham Malaysia Campus, Selangor, Malaysia.</Affiliation>
      </Author>
      <Author>
        <Name>Denny K. S. Ng</Name>
        <Affiliation>School of Engineering and Physical Sciences, Heriot-Watt University Malaysia, Putrajaya, Malaysia.</Affiliation>
      </Author>
      <Author>
        <Name>Joon Yoon Ten</Name>
        <Affiliation>School of New Energy &amp; Chemical Engineering, Xiamen University Malaysia, Jalan Sunsuria, Bandar Sunsuria, 43900, Sepang, Selangor, Malaysia.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Determination of the stereoisomeric distribution of R-(-)- and S-(+)-methamphetamine in Thai pills in the legal context of "not inconsiderable quantities".</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32730795</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(20)30173-2</DOI>
    <KeywordList>
      <Keywords>Enantiomeric fraction</Keywords>
      <Keywords>Legislation</Keywords>
      <Keywords>Limit quantity</Keywords>
      <Keywords>Methamphetamine</Keywords>
      <Keywords>Potency</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Tim J. Gelmi</Name>
        <Affiliation>Institute of Forensic Medicine, Department of Forensic Toxicology and Chemistry, University of Bern, Bühlstrasse 20, 3012, Bern, Switzerland. Electronic address: tim.gelmi@irm.unibe.ch.</Affiliation>
      </Author>
      <Author>
        <Name>Marlies Verrijken</Name>
        <Affiliation>Faculty of Pharmaceutical Sciences, Ghent University, Sint-Pietersnieuwstraat 25, 9000, Ghent, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Wolfgang Weinmann</Name>
        <Affiliation>Institute of Forensic Medicine, Department of Forensic Toxicology and Chemistry, University of Bern, Bühlstrasse 20, 3012, Bern, Switzerland.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Association of dietary intake and urinary excretion of inorganic arsenic in the Japanese subjects.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32712302</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(20)30171-9</DOI>
    <KeywordList>
      <Keywords>Arsenic speciation analysis</Keywords>
      <Keywords>Duplicate diet</Keywords>
      <Keywords>Inorganic arsenic</Keywords>
      <Keywords>Regression equation</Keywords>
      <Keywords>Urinary excretion</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jun Yoshinaga</Name>
        <Affiliation>Faculty of Life Sciences, Toyo University, 1-1-1 Izumino, Itakura, Oura, Gunma, 374-0193, Japan. Electronic address: yoshinaga@toyo.jp.</Affiliation>
      </Author>
      <Author>
        <Name>Tomohiro Narukawa</Name>
        <Affiliation>National Metrology Institute of Japan, National Institute of Advanced Industrial Sciences and Technology, 1-1-1 Umezono, Tsukuba, Ibaraki, 305-8563, Japan.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Use of the kinetically-derived maximum dose: Opportunities for delivering 3Rs benefits.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32679052</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(20)30160-4</DOI>
    <KeywordList>
      <Keywords>3Rs</Keywords>
      <Keywords>Dose selection</Keywords>
      <Keywords>Kinetically-derived Maximum Dose (KMD)</Keywords>
      <Keywords>Limit dose</Keywords>
      <Keywords>Maximum Tolerated Dose (MTD)</Keywords>
      <Keywords>Reduction</Keywords>
      <Keywords>Refinement</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Fiona Sewell</Name>
        <Affiliation>The National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs), Gibbs Building, 215 Euston Road, London, NW1 2BE, UK. Electronic address: fiona.sewell@nc3rs.org.uk.</Affiliation>
      </Author>
      <Author>
        <Name>Ian Kimber</Name>
        <Affiliation>Faculty of Biology, Medicine and Health, University of Manchester, Manchester, M20 9BX, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Alan R. Boobis</Name>
        <Affiliation>National Heart &amp; Lung Institute, Imperial College London, London, W12 0NN, UK.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The genotoxicity of an organic solvent mixture: A human biomonitoring study and translation of a real-scenario exposure to in vitro.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32659246</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(20)30152-5</DOI>
    <KeywordList>
      <Keywords>In vitro</Keywords>
      <Keywords>Mixtures</Keywords>
      <Keywords>Monitoring</Keywords>
      <Keywords>Occupational exposure</Keywords>
      <Keywords>Styrene</Keywords>
      <Keywords>Xylene</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Carina Ladeira</Name>
        <Affiliation>H&amp;TRC-Health &amp; Technology Research Center, ESTeSL-Escola Superior de Tecnologia da Saúde, Instituto Politécnico de Lisboa, 1990-096, Lisbon, Portugal; NOVA National School of Public Health, Public Health Research Centre, Universidade NOVA de Lisboa, Lisbon, Portugal. Electronic address: carina.ladeira@estesl.ipl.pt.</Affiliation>
      </Author>
      <Author>
        <Name>Goran Gajski</Name>
        <Affiliation>Mutagenesis Unit, Institute for Medical Research and Occupational Health, 10000, Zagreb, Croatia.</Affiliation>
      </Author>
      <Author>
        <Name>Márcia Meneses</Name>
        <Affiliation>Instituto Superior de Engenharia de Lisboa, Instituto Politécnico de Lisboa, 1959-007, Lisbon, Portugal.</Affiliation>
      </Author>
      <Author>
        <Name>Marko Gerić</Name>
        <Affiliation>Mutagenesis Unit, Institute for Medical Research and Occupational Health, 10000, Zagreb, Croatia.</Affiliation>
      </Author>
      <Author>
        <Name>Susana Viegas</Name>
        <Affiliation>H&amp;TRC-Health &amp; Technology Research Center, ESTeSL-Escola Superior de Tecnologia da Saúde, Instituto Politécnico de Lisboa, 1990-096, Lisbon, Portugal; NOVA National School of Public Health, Public Health Research Centre, Universidade NOVA de Lisboa, Lisbon, Portugal; Comprehensive Health Research Center (CHRC), 1600-560, Lisbon, Portugal.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Exposure to environmentally-relevant concentrations of hexavalent chromium does not induce ovarian toxicity in mice.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32652207</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(20)30155-0</DOI>
    <KeywordList>
      <Keywords>Hexavalent chromium [Cr(VI)]</Keywords>
      <Keywords>Maximum allowable dose level (MADL)</Keywords>
      <Keywords>Ovarian follicle</Keywords>
      <Keywords>Risk assessment</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Chad M. Thompson</Name>
        <Affiliation>ToxStrategies Inc., Katy, TX, 77494, USA. Electronic address: cthompson@toxstrategies.com.</Affiliation>
      </Author>
      <Author>
        <Name>Douglas A. Donahue</Name>
        <Affiliation>Integrated Laboratory Systems Inc., Research Triangle Park, NC, 27709, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Cheryl Hobbs</Name>
        <Affiliation>Integrated Laboratory Systems Inc., Research Triangle Park, NC, 27709, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Yanina Costecalde</Name>
        <Affiliation>Integrated Laboratory Systems Inc., Research Triangle Park, NC, 27709, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Allison Franzen</Name>
        <Affiliation>ToxStrategies Inc., Monroe, LA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Mina Suh</Name>
        <Affiliation>ToxStrategies Inc., Mission Viejo, CA, 92692, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Deborah M. Proctor</Name>
        <Affiliation>ToxStrategies Inc., Mission Viejo, CA, 92692, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Mark A. Harris</Name>
        <Affiliation>ToxStrategies Inc., Katy, TX, 77494, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Read-across: Principle, case study and its potential regulatory application in China.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32649957</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(20)30154-9</DOI>
    <KeywordList>
      <Keywords>Case study</Keywords>
      <Keywords>China</Keywords>
      <Keywords>Read-across</Keywords>
      <Keywords>Regulatory application</Keywords>
      <Keywords>Uncertainty</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Renjun Gao</Name>
        <Affiliation>Dow Chemical (China) Investment Company Limited, Beijing, 100738, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Na Guan</Name>
        <Affiliation>Givaudan Fragrances (Shanghai) Limited, Shanghai, 200123, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Mei Huang</Name>
        <Affiliation>BASF (China) Company Ltd., 333 Jiangxinsha Road, Shanghai, 200137, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Jennifer Foreman</Name>
        <Affiliation>ExxonMobil Chemical Company, 22777 Springwoods Village Parkway, Spring, TX, 77389, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Ming Kung</Name>
        <Affiliation>ExxonMobil Biomedical Sciences, Inc, 1545 US Highway 22 East, Annandale, NJ, 08801, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Zhiyi Rong</Name>
        <Affiliation>Lubrizol Management (Shanghai) Co. Ltd, 10F, Park Center International, 2088 Fang Dian Road, SH, 201204, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Yi Su</Name>
        <Affiliation>Symrise AG, Holzminden, 37603, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Len Sweet</Name>
        <Affiliation>Lubrizol Corporation, 29400 Lakeland Blvd, Wickliffe, OH, 44092, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Bin Zhu</Name>
        <Affiliation>DuPont China Holding Company Ltd, 600, Cailun Road, Shanghai, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Hao Zhu</Name>
        <Affiliation>The Rutgers Center for Computational and Integrative Biology, Camden, NJ, 08102, USA; Department of Chemistry, Rutgers University, Camden, NJ, 08102, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Hanjun Zou</Name>
        <Affiliation>ExxonMobil (China) Investment Co., Ltd., 1099 Zixing Road, Shanghai, 200241, PR China. Electronic address: steven.hj.zou@exxonmobil.com.</Affiliation>
      </Author>
      <Author>
        <Name>Bin Li</Name>
        <Affiliation>Department of Toxicology, National Institute of Occupational Health and Poison Control, Chinese Centre for Disease Control and Prevention, Beijing, 100050, PR China. Electronic address: libin@niohp.chinacdc.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Ying Wang</Name>
        <Affiliation>P&amp;G Technology (Beijing) Co., Ltd., No. 35 Yu'an Road, Shunyi District, Beijing, 101312, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Haowen Yin</Name>
        <Affiliation>Shanghai Academy of Public Measurement, 1500 Zhangheng Road, Shanghai, 201203, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhengyu Yin</Name>
        <Affiliation>DuPont de Nemours, Inc, 974 Centre Road, Wilmington, DE, 19805, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Xia Zhang</Name>
        <Affiliation>Intertek Testing Services Ltd, 1198 Qinzhou Road (North), Caohejing Development Zone, Shanghai, 200233, PR China.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>An analysis of skin lightening products' violations reported in four U.S. databases in 2002-2020: In hunt of surveillance quality enhancement, not just an assessment of the magnitude of the problem.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32649956</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(20)30157-4</DOI>
    <KeywordList>
      <Keywords>Cosmetics</Keywords>
      <Keywords>Product recalls and withdrawals</Keywords>
      <Keywords>Skin lightening preparations</Keywords>
      <Keywords>Skin pigmentation</Keywords>
      <Keywords>Vulnerable populations</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Irmina Maria Michalek</Name>
        <Affiliation>Women-Mother-Child Department, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Kedie Pintro</Name>
        <Affiliation>The City University of New York, Medgar Evers College, New York, NY, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Emma K. T. Benn</Name>
        <Affiliation>Institute for Translational Epidemiology, Center for Biostatistics, and Department of Population Health Science &amp; Policy, Icahn School of Medicine at Mount Sinai, New York, NY, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Bian Liu</Name>
        <Affiliation>Institute for Translational Epidemiology, Center for Biostatistics, and Department of Population Health Science &amp; Policy, Icahn School of Medicine at Mount Sinai, New York, NY, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Florentino Luciano Caetano Dos Santos</Name>
        <Affiliation>Institute for Research in Biomedicine, Università della Svizzera Italiana, Bellinzona, Switzerland. Electronic address: florentino.l.c.santos@ieee.org.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Use compatibility intervals in regulatory toxicology.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32645430</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(20)30146-X</DOI>
    <KeywordList>
      <Keywords>Compatibility intervals</Keywords>
      <Keywords>Statistics</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Ludwig A. Hothorn</Name>
        <Affiliation>Leibniz University Hannover, Working Group Biostatistics, D-30167, Hannover, Germany. Electronic address: ludwig@hothorn.de.</Affiliation>
      </Author>
      <Author>
        <Name> Ralph Pirow</Name>
        <Affiliation>German Federal Institute for Risk Assessment (BfR), Department of Chemicals and Product Safety, Max-Dohrn-Straße 8-10, 10589 Berlin, Germany.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Development of a next generation risk assessment framework for the evaluation of skin sensitisation of cosmetic ingredients.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32645429</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(20)30147-1</DOI>
    <AuthorList>
      <Author>
        <Name>Nicola Gilmour</Name>
        <Affiliation>Unilever, Colworth Science Park, Bedford, MK44 1LQ, United Kingdom. Electronic address: Nicola.Gilmour@Unilever.com.</Affiliation>
      </Author>
      <Author>
        <Name>Petra S. Kern</Name>
        <Affiliation>Procter &amp; Gamble Services NV/SA, Temselaan/ Boechoutlaan, 1853, Strombeek-Bever, Belgium. Electronic address: kern.ps@pg.com.</Affiliation>
      </Author>
      <Author>
        <Name>Nathalie Alépée</Name>
        <Affiliation>L'Oréal, Research &amp; Innovation, Aulnay-sous-Bois, Clichy, France. Electronic address: nathalie.alepee@rd.loreal.com.</Affiliation>
      </Author>
      <Author>
        <Name>Fanny Boislève</Name>
        <Affiliation>Chanel, 135 Avenue Charles de Gaulle, 92521, Neuilly, France. Electronic address: fanny.boisleve@chanel.com.</Affiliation>
      </Author>
      <Author>
        <Name>Dagmar Bury</Name>
        <Affiliation>L'Oréal, Research &amp; Innovation, Aulnay-sous-Bois, Clichy, France. Electronic address: dagmar.bury@rd.loreal.com.</Affiliation>
      </Author>
      <Author>
        <Name>Elodie Clouet</Name>
        <Affiliation>Pierre Fabre, 3 Avenue Hubert Curien, 31100, Toulouse, France. Electronic address: http://elodie.clouet@piere_fabre.com.</Affiliation>
      </Author>
      <Author>
        <Name>Morihiko Hirota</Name>
        <Affiliation>Shiseido Global Innovation Centre, 1-2-11, Takashima, Nishi-ku, Yokohama-shi, Kanagawa, 220-0011, Japan. Electronic address: morihiko.hirota@shiseido.com.</Affiliation>
      </Author>
      <Author>
        <Name>Sebastian Hoffmann</Name>
        <Affiliation>Seh Consulting + Services, Stembergring 15, 33106, Paderborn, Germany. Electronic address: sebastian.hoffmann@seh-cs.com.</Affiliation>
      </Author>
      <Author>
        <Name>Jochen Kühnl</Name>
        <Affiliation>Beiersdorf AG, Unnastraße 48, 20245, Hamburg, Germany. Electronic address: Jochen.Kuehnl@Beiersdorf.com.</Affiliation>
      </Author>
      <Author>
        <Name>Jon F. Lalko</Name>
        <Affiliation>Estee Lauder Companies, 155 Pinelawn Road, Suite 300 South, Melville, NY, 11747, USA. Electronic address: jlalko@estee.com.</Affiliation>
      </Author>
      <Author>
        <Name>Karsten Mewes</Name>
        <Affiliation>Henkel AG &amp; Co. KGaA, Henkelstraße 67, 40589, Düsseldorf, Germany. Electronic address: Karsten.Mewes@henkel.com.</Affiliation>
      </Author>
      <Author>
        <Name>Masaaki Miyazawa</Name>
        <Affiliation>Kao Corporation, 2606 Akabane, Ichikai, Haga, Tochigi, 321-3497, Japan. Electronic address: miyazawa.masaaki@kao.com.</Affiliation>
      </Author>
      <Author>
        <Name>Hayato Nishida</Name>
        <Affiliation>Shiseido Global Innovation Centre, 1-2-11, Takashima, Nishi-ku, Yokohama-shi, Kanagawa, 220-0011, Japan. Electronic address: hayato.nishida@shiseido.com.</Affiliation>
      </Author>
      <Author>
        <Name>Anne Osmani</Name>
        <Affiliation>LVMH Recherche, 185 Avenue de Verdun, 45804, St Jean de Braye, France. Electronic address: aosmani@research.lvmh-pc.com.</Affiliation>
      </Author>
      <Author>
        <Name>Dirk Petersohn</Name>
        <Affiliation>Kao Corporation, 2606 Akabane, Ichikai, Haga, Tochigi, 321-3497, Japan. Electronic address: Dirk.Petersohn@henkel.com.</Affiliation>
      </Author>
      <Author>
        <Name>Shuichi Sekine</Name>
        <Affiliation>Shiseido Global Innovation Centre, 1-2-11, Takashima, Nishi-ku, Yokohama-shi, Kanagawa, 220-0011, Japan. Electronic address: shuichi.sekine@shiseido.com.</Affiliation>
      </Author>
      <Author>
        <Name>Erwin van Vliet</Name>
        <Affiliation>Innovitox Consulting &amp; Services, Regentenland 35, 3994TZ, Houten, the Netherlands. Electronic address: vanvliete@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Martina Klaric</Name>
        <Affiliation>Cosmetics Europe, Avenue Herrmann Debroux 40, 1160, Brussels, Belgium. Electronic address: martina_klaric@huntsman.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Letter to the editors regarding Heringa et al. (2020).</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32645428</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(20)30148-3</DOI>
    <AuthorList>
      <Author>
        <Name>Carr J. Smith</Name>
        <Affiliation>Albemarle Corporation, USA. Electronic address: carr.smith@albemarle.com.</Affiliation>
      </Author>
      <Author>
        <Name>Thomas A. Perfetti</Name>
        <Affiliation>Perfetti &amp; Perfetti, LLC, 2116 New Castle Drive, Winston-Salem, NC, 27103, USA. Electronic address: tperfetti@triad.rr.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Heavy metal contamination in recorded and unrecorded spirits. Should we worry?</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32645427</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(20)30149-5</DOI>
    <KeywordList>
      <Keywords>Alcohol consumption</Keywords>
      <Keywords>Hazard index</Keywords>
      <Keywords>Heavy metals</Keywords>
      <Keywords>Recorded and unrecorded spirits</Keywords>
      <Keywords>Target hazard quotient</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>László Pál</Name>
        <Affiliation>Department of Preventive Medicine, Faculty of Public Health, University of Debrecen, Debrecen, Hungary. Electronic address: pal.laszlo@sph.unideb.hu.</Affiliation>
      </Author>
      <Author>
        <Name>Teuta Muhollari</Name>
        <Affiliation>Department of Preventive Medicine, Faculty of Public Health, University of Debrecen, Debrecen, Hungary. Electronic address: muhollari.teuta@sph.unideb.hu.</Affiliation>
      </Author>
      <Author>
        <Name>Orsolya Bujdosó</Name>
        <Affiliation>Department of Preventive Medicine, Faculty of Public Health, University of Debrecen, Debrecen, Hungary. Electronic address: bujdoso.orsolya@sph.unideb.hu.</Affiliation>
      </Author>
      <Author>
        <Name>Edina Baranyai</Name>
        <Affiliation>Department of Inorganic and Analytical Chemistry, Faculty of Science, University of Debrecen, Hungary. Electronic address: baranyai.edina@science.unideb.hu.</Affiliation>
      </Author>
      <Author>
        <Name>Attila Nagy</Name>
        <Affiliation>Department of Preventive Medicine, Faculty of Public Health, University of Debrecen, Debrecen, Hungary. Electronic address: nagy.attila@sph.unideb.hu.</Affiliation>
      </Author>
      <Author>
        <Name>Ervin Árnyas</Name>
        <Affiliation>Department of Preventive Medicine, Faculty of Public Health, University of Debrecen, Debrecen, Hungary. Electronic address: arnyaser@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Róza Ádány</Name>
        <Affiliation>MTA-DE Public Health Research Group, Public Health Research Institute, University of Debrecen, Debrecen, Hungary; WHO Collaborating Centre on Vulnerability and Health, University of Debrecen, Debrecen, Hungary. Electronic address: adany.roza@sph.unideb.hu.</Affiliation>
      </Author>
      <Author>
        <Name>János Sándor</Name>
        <Affiliation>Department of Preventive Medicine, Faculty of Public Health, University of Debrecen, Debrecen, Hungary. Electronic address: sandor.janos@sph.unideb.hu.</Affiliation>
      </Author>
      <Author>
        <Name>Martin McKee</Name>
        <Affiliation>European Centre on Health of Societies in Transition, London School of Hygiene and Tropical Medicine, London, United Kingdom. Electronic address: martin.mckee@lshtm.ac.uk.</Affiliation>
      </Author>
      <Author>
        <Name>Sándor Szűcs</Name>
        <Affiliation>Department of Preventive Medicine, Faculty of Public Health, University of Debrecen, Debrecen, Hungary. Electronic address: szucs.sandor@sph.unideb.hu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Review of the pharmacokinetics and metabolism of triclopyr herbicide in mammals: Impact on safety assessments.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32640299</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(20)30140-9</DOI>
    <KeywordList>
      <Keywords>Metabolism</Keywords>
      <Keywords>Pharmacokinetics</Keywords>
      <Keywords>Protein binding</Keywords>
      <Keywords>Risk assessment</Keywords>
      <Keywords>Transporters</Keywords>
      <Keywords>Triclopyr</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Michael Bartels</Name>
        <Affiliation>ToxMetrics.com, LLC, Midland, MI, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Colin Brown</Name>
        <Affiliation>Newcells Biotech, Newcastle Upon Tyne, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Git Chung</Name>
        <Affiliation>Newcells Biotech, Newcastle Upon Tyne, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Melissa Chan</Name>
        <Affiliation>Corteva Agriscience™, Wilmington, DE, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Claire Terry</Name>
        <Affiliation>Corteva Agriscience™, Indianapolis, IN, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Sean Gehen</Name>
        <Affiliation>Corteva Agriscience™, Indianapolis, IN, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Marco Corvaro</Name>
        <Affiliation>Corteva Agriscience™, Rome, Italy. Electronic address: marco.corvaro@corteva.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Rebuttal to the letter to the editors regarding Heringa et al. (2020).</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32640298</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(20)30156-2</DOI>
    <AuthorList>
      <Author>
        <Name>Minne B. Heringa</Name>
        <Affiliation>National Institute for Public Health and the Environment (RIVM), Centre for Safety of Substances and Products (VSP), Bilthoven, the Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Nicole H. P. Cnubben</Name>
        <Affiliation>National Institute for Public Health and the Environment (RIVM), Centre for Safety of Substances and Products (VSP), Bilthoven, the Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Wout Slob</Name>
        <Affiliation>National Institute for Public Health and the Environment (RIVM), Centre for Safety of Substances and Products (VSP), Bilthoven, the Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Marja E. J. Pronk</Name>
        <Affiliation>National Institute for Public Health and the Environment (RIVM), Centre for Safety of Substances and Products (VSP), Bilthoven, the Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Andre Muller</Name>
        <Affiliation>National Institute for Public Health and the Environment (RIVM), Centre for Safety of Substances and Products (VSP), Bilthoven, the Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Marjolijn Woutersen</Name>
        <Affiliation>National Institute for Public Health and the Environment (RIVM), Centre for Safety of Substances and Products (VSP), Bilthoven, the Netherlands. Electronic address: Marjolijn.woutersen@rivm.nl.</Affiliation>
      </Author>
      <Author>
        <Name>Betty C. Hakkert</Name>
        <Affiliation>National Institute for Public Health and the Environment (RIVM), Centre for Safety of Substances and Products (VSP), Bilthoven, the Netherlands.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Human health hazard assessment of quaternary ammonium compounds: Didecyl dimethyl ammonium chloride and alkyl (C12-C16) dimethyl benzyl ammonium chloride.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32640297</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(20)30143-4</DOI>
    <KeywordList>
      <Keywords>ADBAC</Keywords>
      <Keywords>DDAC</Keywords>
      <Keywords>Human health hazard assessment</Keywords>
      <Keywords>Quaternary ammonium compounds</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Anthony Luz</Name>
        <Affiliation>Integral Consulting Inc, 200 Harry S, Truman Parkway, Suite 330, Annapolis, MD, 21401, USA. Electronic address: aluz@integral-corp.com.</Affiliation>
      </Author>
      <Author>
        <Name>Paul DeLeo</Name>
        <Affiliation>Integral Consulting Inc, 200 Harry S, Truman Parkway, Suite 330, Annapolis, MD, 21401, USA. Electronic address: pdeleo@integral-corp.com.</Affiliation>
      </Author>
      <Author>
        <Name>Nathan Pechacek</Name>
        <Affiliation>Ecolab, 655 Lone Oak Drive, Mailstop F6, Eagan, MN, 55121, USA. Electronic address: nathan.pechacek@ecolab.com.</Affiliation>
      </Author>
      <Author>
        <Name>Mike Freemantle</Name>
        <Affiliation>Lonza, Wheldon Road, Castleford, WF10 2JT, UK. Electronic address: mike.freemantle@lonza.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Use of computational toxicology (CompTox) tools to predict in vivo toxicity for risk assessment.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32640296</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(20)30150-1</DOI>
    <KeywordList>
      <Keywords>Carbaryl</Keywords>
      <Keywords>Chlorpyrifos</Keywords>
      <Keywords>HTTK-Pop</Keywords>
      <Keywords>IVIVE</Keywords>
      <Keywords>Propyzamide</Keywords>
      <Keywords>Risk assessment</Keywords>
      <Keywords>ToxCast/Tox21</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>M. H. Silva</Name>
        <Affiliation>Retired from a Career in Regulatory Toxicology and Risk Assessment, Davis, CA, 95616, USA. Electronic address: marilynhelensilva@gmail.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A flow scheme for cumulative assessment of pesticides for adverse liver effects.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32621977</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(20)30120-3</DOI>
    <KeywordList>
      <Keywords>Common toxic effect (CTE)</Keywords>
      <Keywords>Cumulative assessment groups (CAGs)</Keywords>
      <Keywords>Cumulative risk assessment</Keywords>
      <Keywords>Human relevance</Keywords>
      <Keywords>Liver toxicity</Keywords>
      <Keywords>Pesticides</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Thomas Colnot</Name>
        <Affiliation>CiS Toxicology, Osorno, Chile.</Affiliation>
      </Author>
      <Author>
        <Name>Stephanie Melching-Kollmuß</Name>
        <Affiliation>BASF SE, GUP/PP - Z470, 67056, Ludwigshafen, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Giovanna Semino</Name>
        <Affiliation>Bayer CropScience F-06560, Sophia Antipolis, France.</Affiliation>
      </Author>
      <Author>
        <Name>Wolfgang Dekant</Name>
        <Affiliation>Department of Toxicology, University of Würzburg, Versbacher Strasse 9, 97078, Würzburg, Germany. Electronic address: dekant@toxi.uni-wuerzburg.de.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Skin sensitization in silico protocol.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32621976</pubmedLink>
    <GrantList>
      <Grant>R43 ES026909</Grant>
      <Grant>R44 ES026909</Grant>
    </GrantList>
    <Year>2020</Year>
    <DOI>S0273-2300(20)30114-8</DOI>
    <KeywordList>
      <Keywords>(Q)SAR</Keywords>
      <Keywords>Computational toxicology</Keywords>
      <Keywords>Computational toxicology protocols</Keywords>
      <Keywords>Defined approach</Keywords>
      <Keywords>Expert alerts</Keywords>
      <Keywords>Expert review</Keywords>
      <Keywords>Extractables and leachables</Keywords>
      <Keywords>In silico</Keywords>
      <Keywords>In silico toxicology</Keywords>
      <Keywords>Integrated approaches to testing and assessment (IATA)</Keywords>
      <Keywords>Skin sensitization</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Candice Johnson</Name>
        <Affiliation>Leadscope, Inc, 1393 Dublin Rd, Columbus, OH, 43215, USA. Electronic address: cjohnson@leadscope.com.</Affiliation>
      </Author>
      <Author>
        <Name>Ernst Ahlberg</Name>
        <Affiliation>Bioinformatics Department, The University of Uppsala, 752 36, Uppsala, Sweden.</Affiliation>
      </Author>
      <Author>
        <Name>Lennart T. Anger</Name>
        <Affiliation>Genentech, Inc., 1 DNA Way, South San Francisco, CA, 94080, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Lisa Beilke</Name>
        <Affiliation>Toxicology Solutions Inc., San Diego, CA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Romualdo Benigni</Name>
        <Affiliation>Alpha-PreTox, Via G.Pascoli 1, 00184, Roma, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Joel Bercu</Name>
        <Affiliation>Gilead Sciences, 333 Lakeside Drive, Foster City, CA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Sol Bobst</Name>
        <Affiliation>Toxsci Advisors LLC, 2016 Main Suite 1901, Houston, TX, USA.</Affiliation>
      </Author>
      <Author>
        <Name>David Bower</Name>
        <Affiliation>Leadscope, Inc, 1393 Dublin Rd, Columbus, OH, 43215, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Alessandro Brigo</Name>
        <Affiliation>Roche Pharmaceutical Research &amp; Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd, Grenzacherstrasse 124, 4070, Basel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Sarah Campbell</Name>
        <Affiliation>Nelson Laboratories, LLC, 6280 South Redwood Road, Salt Lake City, UT, 84123, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Mark T. D. Cronin</Name>
        <Affiliation>School of Pharmacy and Biomolecular Sciences, Liverpool John Moores University, Liverpool, L3 3AF, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Ian Crooks</Name>
        <Affiliation>British American Tobacco, Research and Development, Regents Park Road, Southampton, Hampshire, SO15 8TL, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Kevin P. Cross</Name>
        <Affiliation>Leadscope, Inc, 1393 Dublin Rd, Columbus, OH, 43215, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Tatyana Doktorova</Name>
        <Affiliation>Edelweiss Connect GmbH, Technology Park Basel, Hochbergerstrasse 60C, CH-4057, Basel / Basel-Stadt, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Thomas Exner</Name>
        <Affiliation>Edelweiss Connect GmbH, Technology Park Basel, Hochbergerstrasse 60C, CH-4057, Basel / Basel-Stadt, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>David Faulkner</Name>
        <Affiliation>Chemical Sciences Division, Lawrence Berkeley National Lab, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Ian M. Fearon</Name>
        <Affiliation>whatIF? Consulting Ltd, The Crispin Burr Street, Harwell, OX11 0DT, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Markus Fehr</Name>
        <Affiliation>DSM Nutritional Products, Kaiseraugst, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Shayne C. Gad</Name>
        <Affiliation>Gad Consulting Services, 4008 Barrett Drive, Suite 201, Raleigh, NC, 27609, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Véronique Gervais</Name>
        <Affiliation>Servier Group, 905 Route de Saran, 45520, Gidy, France.</Affiliation>
      </Author>
      <Author>
        <Name>Amanda Giddings</Name>
        <Affiliation>GlaxoSmithKline, Park Road, Ware, Hertfordshire, SG12 0DP, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Susanne Glowienke</Name>
        <Affiliation>Novartis Pharma AG, Pre-Clinical Safety, Werk Klybeck, CH-4057, Basel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Barry Hardy</Name>
        <Affiliation>Edelweiss Connect GmbH, Technology Park Basel, Hochbergerstrasse 60C, CH-4057, Basel / Basel-Stadt, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Catrin Hasselgren</Name>
        <Affiliation>Genentech, Inc., 1 DNA Way, South San Francisco, CA, 94080, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jedd Hillegass</Name>
        <Affiliation>Bristol-Myers Squibb, Drug Safety Evaluation, 1 Squibb Dr, New Brunswick, NJ, 08903, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Robert Jolly</Name>
        <Affiliation>Toxicology Division, Eli Lilly and Company, Indianapolis, IN, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Eckart Krupp</Name>
        <Affiliation>Sanofi, Corporate HSE, Global Product Steweardship, Industriepark Hoechst, D-65926, Frankfurt Am Main, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Liat Lomnitski</Name>
        <Affiliation>Perrigo Israel Pharmaceuticals Ltd, Shoham, Israel.</Affiliation>
      </Author>
      <Author>
        <Name>Jason Magby</Name>
        <Affiliation>Colgate-Palmolive Technology Center, 909 River Road, Piscataway, NJ, 08855, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jordi Mestres</Name>
        <Affiliation>IMIM Hospital Del Mar Institute of Medical Research and University Pompeu Fabra, Doctor Aiguader 88, Parc de Recerca Biomèdica, 08003 Barcelona, Spain; and Chemotargets SL, Baldiri Reixac 4, Parc Científic de Barcelona, 08028, Barcelona, Spain.</Affiliation>
      </Author>
      <Author>
        <Name>Lawrence Milchak</Name>
        <Affiliation>3M Company, St. Paul, MN, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Scott Miller</Name>
        <Affiliation>Leadscope, Inc, 1393 Dublin Rd, Columbus, OH, 43215, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Wolfgang Muster</Name>
        <Affiliation>Roche Pharmaceutical Research &amp; Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd, Grenzacherstrasse 124, 4070, Basel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Louise Neilson</Name>
        <Affiliation>Broughton Nicotine Services, Oak Tree House, West Craven Drive, Earby, Lancashire, BB18 6JZ, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Rahul Parakhia</Name>
        <Affiliation>Church &amp; Dwight Co., Inc, 469 North Harrison Street, Princeton, NJ, 08543, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Alexis Parenty</Name>
        <Affiliation>Novartis Pharma AG, Pre-Clinical Safety, Werk Klybeck, CH-4057, Basel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Patricia Parris</Name>
        <Affiliation>Pfizer Worldwide Research and Development, Sandwich, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Alexandre Paulino</Name>
        <Affiliation>ORO AGRI Europe, S.A, Palmela, Portugal.</Affiliation>
      </Author>
      <Author>
        <Name>Ana Theresa Paulino</Name>
        <Affiliation>ORO AGRI Europe, S.A, Palmela, Portugal.</Affiliation>
      </Author>
      <Author>
        <Name>David W. Roberts</Name>
        <Affiliation>Nelson Laboratories, LLC, 6280 South Redwood Road, Salt Lake City, UT, 84123, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Harald Schlecker</Name>
        <Affiliation>Bayer AG, Research &amp; Development, Pharmaceuticals, Industrial Chemicals Toxicology &amp; Genetic Toxicology, 42096, Wuppertal, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Reinhard Stidl</Name>
        <Affiliation>Safetree Consulting e.U, Vienna, Austria.</Affiliation>
      </Author>
      <Author>
        <Name>Diana Suarez-Rodrigez</Name>
        <Affiliation>FStox Consulting LTD, 2 Brooks Road, Raunds, Wellingborough, NN9 6NS, UK.</Affiliation>
      </Author>
      <Author>
        <Name>David T. Szabo</Name>
        <Affiliation>PPG Industries, Pittsburgh, PA, 15146, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Raymond R. Tice</Name>
        <Affiliation>RTice Consulting, Hillsborough, NC, 27278, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Daniel Urbisch</Name>
        <Affiliation>BASF SE, Product Safety, Carl-Bosch-Strasse 38, 67056, Ludwigshafen Am Rhein, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Anna Vuorinen</Name>
        <Affiliation>DSM Nutritional Products, Kaiseraugst, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Brian Wall</Name>
        <Affiliation>Colgate-Palmolive Technology Center, 909 River Road, Piscataway, NJ, 08855, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Thibaud Weiler</Name>
        <Affiliation>Servier Group, 905 Route de Saran, 45520, Gidy, France.</Affiliation>
      </Author>
      <Author>
        <Name>Angela T. White</Name>
        <Affiliation>GlaxoSmithKline, Park Road, Ware, Hertfordshire, SG12 0DP, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Jessica Whritenour</Name>
        <Affiliation>Pfizer Inc., Drug Safety Research and Development, Eastern Point Road, Groton, CT, 06340, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Joerg Wichard</Name>
        <Affiliation>Bayer AG, Research &amp; Development, Pharmaceuticals, Industrial Chemicals Toxicology &amp; Genetic Toxicology, 42096, Wuppertal, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>David Woolley</Name>
        <Affiliation>ForthTox Limited, PO Box 13550, Linlithgow, EH49 7YU, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Craig Zwickl</Name>
        <Affiliation>Transendix LLC, 1407 Moores Manor, Indianapolis, IN, 46229, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Glenn J. Myatt</Name>
        <Affiliation>Leadscope, Inc, 1393 Dublin Rd, Columbus, OH, 43215, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Template-based peptide modeling for celiac risk assessment of newly expressed proteins in GM crops.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32619636</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(20)30141-0</DOI>
    <KeywordList>
      <Keywords>Celiac disease</Keywords>
      <Keywords>GM crops</Keywords>
      <Keywords>Peptide modeling</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Ping Song</Name>
        <Affiliation>Corteva Agriscience™, 9330 Zionsville Rd., Indianapolis, IN 46268, United States. Electronic address: ping.song@corteva.com.</Affiliation>
      </Author>
      <Author>
        <Name>Zhenglin Hou</Name>
        <Affiliation>Corteva Agriscience™, 8325 NW 62nd Avenue, Johnston, IA 50131, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Shravan Sukumar</Name>
        <Affiliation>Corteva Agriscience™, 9330 Zionsville Rd., Indianapolis, IN 46268, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Rod A. Herman</Name>
        <Affiliation>Corteva Agriscience™, 9330 Zionsville Rd., Indianapolis, IN 46268, United States.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Safety assessment of metarrestin in dogs: A clinical candidate targeting a subnuclear structure unique to metastatic cancer cells.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32619635</pubmedLink>
    <GrantList>
      <Grant>HHSN261200800001C</Grant>
      <Grant>HHSN261200800001E</Grant>
      <Grant>ZIA BC011267</Grant>
    </GrantList>
    <Year>2020</Year>
    <DOI>S0273-2300(20)30142-2</DOI>
    <KeywordList>
      <Keywords>Metarrestin</Keywords>
      <Keywords>Metastatic Cancer</Keywords>
      <Keywords>Pancreatic cancer</Keywords>
      <Keywords>Perinucleolar compartment</Keywords>
      <Keywords>Preclinical toxicity</Keywords>
      <Keywords>Safety Assessment</Keywords>
      <Keywords>Safetypharmacology</Keywords>
      <Keywords>Toxicokinetics</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Mohammed Bourdi</Name>
        <Affiliation>National Center for Advancing Translational Sciences, NIH, Rockville, Maryland, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Udo Rudloff</Name>
        <Affiliation>Rare Tumor Initiative, Pediatric Oncology Branch, National Cancer Institute, NIH, Bethesda, Maryland, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Samarjit Patnaik</Name>
        <Affiliation>National Center for Advancing Translational Sciences, NIH, Rockville, Maryland, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Juan Marugan</Name>
        <Affiliation>National Center for Advancing Translational Sciences, NIH, Rockville, Maryland, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Pramod S. Terse</Name>
        <Affiliation>National Center for Advancing Translational Sciences, NIH, Rockville, Maryland, USA. Electronic address: tersep@mail.nih.gov.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Bolstering the existing database supporting the non-cancer Threshold of Toxicological Concern values with toxicity data on fragrance-related materials.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32603678</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(20)30144-6</DOI>
    <KeywordList>
      <Keywords>Cramer classification</Keywords>
      <Keywords>Research institute of fragrance materials</Keywords>
      <Keywords>Threshold of toxicological concern</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Atish Patel</Name>
        <Affiliation>Research Institute for Fragrance Materials, Inc., Woodcliff Lake, NJ, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Kaushal Joshi</Name>
        <Affiliation>Research Institute for Fragrance Materials, Inc., Woodcliff Lake, NJ, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jane Rose</Name>
        <Affiliation>Procter &amp; Gamble, Mason, OH, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Michael Laufersweiler</Name>
        <Affiliation>Procter &amp; Gamble, Mason, OH, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Susan P. Felter</Name>
        <Affiliation>Procter &amp; Gamble, Mason, OH, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Anne Marie Api</Name>
        <Affiliation>Research Institute for Fragrance Materials, Inc., Woodcliff Lake, NJ, USA. Electronic address: amapi@rifm.org.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Clinical epidemiology studies on potential effects of endocrine disrupting chemicals (EDCs) should exclude subjects with obesity as determined by BMI.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32598900</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(20)30137-9</DOI>
    <KeywordList>
      <Keywords>Clinical epidemiology studies</Keywords>
      <Keywords>Endocrine disrupting chemicals (EDC)</Keywords>
      <Keywords>Obese</Keywords>
      <Keywords>Obesity</Keywords>
      <Keywords>Validated regulatory tests on EDCs</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Carr J. Smith</Name>
        <Affiliation>Albemarle Corporation, USA. Electronic address: carr.smith@albemarle.com.</Affiliation>
      </Author>
      <Author>
        <Name>Thomas A. Perfetti</Name>
        <Affiliation>Perfetti &amp; Perfetti, LLC, Winston-Salem, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>A. Wallace Hayes</Name>
        <Affiliation>A. Wallace Hayes, University of South Florida College of Public Health and Institute for Integrative Toxicology, Michigan State University, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Sir Colin Berry</Name>
        <Affiliation>Sir Colin Berry, Professor Emeritus, Queen Mary University, London, UK.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Nonclinical cardiovascular safety evaluation of romosozumab, an inhibitor of sclerostin for the treatment of osteoporosis in postmenopausal women at high risk of fracture.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32590049</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(20)30123-9</DOI>
    <KeywordList>
      <Keywords>ApoE knockout mouse</Keywords>
      <Keywords>Atherosclerosis</Keywords>
      <Keywords>Cardiovascular safety</Keywords>
      <Keywords>Risk assessment</Keywords>
      <Keywords>Romosozumab</Keywords>
      <Keywords>Sclerostin antibody</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>James R. Turk</Name>
        <Affiliation>Translational Safety and Bioanalytical Sciences, Amgen Research, Thousand Oaks, CA, USA. Electronic address: jturk@amgen.com.</Affiliation>
      </Author>
      <Author>
        <Name>Aimee M. Deaton</Name>
        <Affiliation>Translational Safety and Bioanalytical Sciences, Amgen Research, Cambridge, MA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jun Yin</Name>
        <Affiliation>Genome Analysis Unit, Amgen Research, South San Francisco, CA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Marina Stolina</Name>
        <Affiliation>Cardiometabolic Disorders Research, Amgen Research, Thousand Oaks, CA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Melanie Felx</Name>
        <Affiliation>Charles River Laboratories Montreal ULC, Senneville, QC, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Gabrielle Boyd</Name>
        <Affiliation>Charles River Laboratories Montreal ULC, Senneville, QC, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Jean Guy Bienvenu</Name>
        <Affiliation>Charles River Laboratories Montreal ULC, Senneville, QC, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Aurore Varela</Name>
        <Affiliation>Charles River Laboratories Montreal ULC, Senneville, QC, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Martin Guillot</Name>
        <Affiliation>Charles River Laboratories Montreal ULC, Senneville, QC, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Gill Holdsworth</Name>
        <Affiliation>UCB Pharma, Slough, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Alison Wolfreys</Name>
        <Affiliation>UCB Pharma, Slough, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Denise Dwyer</Name>
        <Affiliation>Cardiometabolic Disorders Research, Amgen Research, Thousand Oaks, CA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Sheetal V. Kumar</Name>
        <Affiliation>Translational Safety and Bioanalytical Sciences, Amgen Research, Cambridge, MA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Emily M. de Koning</Name>
        <Affiliation>Translational Safety and Bioanalytical Sciences, Amgen Research, Cambridge, MA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Yusheng Qu</Name>
        <Affiliation>Translational Safety and Bioanalytical Sciences, Amgen Research, Thousand Oaks, CA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Michael Engwall</Name>
        <Affiliation>Translational Safety and Bioanalytical Sciences, Amgen Research, Thousand Oaks, CA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Kathrin Locher</Name>
        <Affiliation>Translational Safety and Bioanalytical Sciences, Amgen Research, South San Francisco, CA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Lucas D. Ward</Name>
        <Affiliation>Translational Safety and Bioanalytical Sciences, Amgen Research, Cambridge, MA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Charles Glaus</Name>
        <Affiliation>Cardiometabolic Disorders Research, Amgen Research, Thousand Oaks, CA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Yudong D. He</Name>
        <Affiliation>Translational Safety and Bioanalytical Sciences, Amgen Research, Thousand Oaks, CA, USA; Genome Analysis Unit, Amgen Research, South San Francisco, CA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Rogely Waite Boyce</Name>
        <Affiliation>Translational Safety and Bioanalytical Sciences, Amgen Research, Thousand Oaks, CA, USA.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: James R Turk, Marina Stolina, Denise Dwyer, Sheetal V Kumar, Emily M de Koning, Yusheng Qu, and Michael Engwall are employees and stockholders of Amgen Inc. Aimee M. Deaton, Jun Yin, Kathrin Locher, Lucas D. Ward, Charles Glaus, Yudong D. He, and Rogely Waite Boyce are former Amgen employees.. Melanie Felx, Gabrielle Boyd, Jean-Guy Bienvenu, Aurore Varela, and Martin Guillot are employees of Charles River Laboratories Montreal ULC, which received funding from Amgen Inc., Astellas, and UCB Pharma to conduct this research. Gill Holdsworth and Alison Wolfreys are employees and stockholders of UCB Pharma.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Indicators for lack of systemic availability of organic pigments.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32565410</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(20)30145-8</DOI>
    <KeywordList>
      <Keywords>Bioavailability</Keywords>
      <Keywords>ECHA</Keywords>
      <Keywords>Low toxicity</Keywords>
      <Keywords>Non-polar</Keywords>
      <Keywords>Organic pigments</Keywords>
      <Keywords>Planar</Keywords>
      <Keywords>REACH</Keywords>
      <Keywords>Solubility</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Heidi Stratmann</Name>
        <Affiliation>Department of Product Safety, BASF Schweiz AG, Basel, Switzerland. Electronic address: heidi.stratmann@basf.com.</Affiliation>
      </Author>
      <Author>
        <Name>Maria Hellmund</Name>
        <Affiliation>Department of Product Safety Services, BASF Services Europe GmbH, Berlin, Germany. Electronic address: maria.hellmund@basf.com.</Affiliation>
      </Author>
      <Author>
        <Name>Ulrich Veith</Name>
        <Affiliation>Department of Product Stewardship, BASF Colors &amp; Effects Switzerland AG, Basel, Switzerland. Electronic address: ulrich.veith@basf.com.</Affiliation>
      </Author>
      <Author>
        <Name>Nicole End</Name>
        <Affiliation>Department of Product Stewardship, BASF Colors &amp; Effects Switzerland AG, Basel, Switzerland. Electronic address: nicole.end@basf.com.</Affiliation>
      </Author>
      <Author>
        <Name>Wera Teubner</Name>
        <Affiliation>Department of Product Safety Services, BASF Services Europe GmbH, Berlin, Germany. Electronic address: wera.teubner@basf.com.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Ulrich Veith and Nicole End are employees of BASF Colors &amp; Effects, a company producing organic pigments.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Corrigendum to "Assessment of the skin sensitisation hazard of functional polysiloxanes and silanes in the SENS-IS assay" [Regul. Toxicol. Pharmacol. 98 (2018) 209-214].</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32564919</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(20)30136-7</DOI>
    <AuthorList>
      <Author>
        <Name>Thomas Petry</Name>
        <Affiliation>ToxMinds BVBA, Product Safety &amp; Regulatory Affairs, B-1200, Brussels, Belgium. Electronic address: thomas.petry@toxminds.com.</Affiliation>
      </Author>
      <Author>
        <Name>Axel Bosch</Name>
        <Affiliation>Wacker Chemie AG, Corporate Product Safety, D-84489, Burghausen, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Farah Koraïchi-Emeriau</Name>
        <Affiliation>EquiTox for Elkem Silicones, F-69191, Saint Fons Cedex, France.</Affiliation>
      </Author>
      <Author>
        <Name>Dorothea Eigler</Name>
        <Affiliation>Evonik Nutrition&amp; Care GmbH, D-45127, Essen, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Pierre Germain</Name>
        <Affiliation>CES, Silicones Europe, CEFIC, B-1040, Brussels, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Shawn Seidel</Name>
        <Affiliation>The Dow Chemical Company, Toxicology &amp; Environmental Research and Consulting, Midland, MI, 48674, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Yellow-colored extract from cashew byproduct - Nonclinical safety assessment.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32562761</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(20)30125-2</DOI>
    <KeywordList>
      <Keywords>Carotenoids</Keywords>
      <Keywords>Cashew</Keywords>
      <Keywords>Food byproduct</Keywords>
      <Keywords>Food coloring agents</Keywords>
      <Keywords>Toxicity test</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Gisele Goulart da Silva</Name>
        <Affiliation>Chemical, Biological and Agricultural Pluridisciplinary Research Center, University of Campinas, CPQBA/UNICAMP, 13148-218, Paulínia, SP, Brazil; Posgraduate Program in Dentistry, Piracicaba Dental School, University of Campinas, FOP/UNICAMP, 13414-903, Piracicaba, SP, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Adriana Della Torre</Name>
        <Affiliation>Chemical, Biological and Agricultural Pluridisciplinary Research Center, University of Campinas, CPQBA/UNICAMP, 13148-218, Paulínia, SP, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Lucia Elaine de Oliveira Braga</Name>
        <Affiliation>Chemical, Biological and Agricultural Pluridisciplinary Research Center, University of Campinas, CPQBA/UNICAMP, 13148-218, Paulínia, SP, Brazil; Posgraduate Program in Dentistry, Piracicaba Dental School, University of Campinas, FOP/UNICAMP, 13414-903, Piracicaba, SP, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Patrícia Bachiega</Name>
        <Affiliation>Department of Agri-food Industry, Foods and Nutrition, Luiz de Queiroz College of Agriculture, University of São Paulo, ESALQ/USP, 13418-900, Piracicaba, SP, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Sirlene Valério Tinti</Name>
        <Affiliation>Chemical, Biological and Agricultural Pluridisciplinary Research Center, University of Campinas, CPQBA/UNICAMP, 13148-218, Paulínia, SP, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>João Ernesto de Carvalho</Name>
        <Affiliation>Faculty of Pharmaceutical Sciences, University of Campinas, FCF/UNICAMP, 13081-970, Campinas, SP, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Ana Paula Dionísio</Name>
        <Affiliation>Embrapa Tropical Agroindustry, 60511-110, Fortaleza, CE, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Ana Lucia Tasca Gois Ruiz</Name>
        <Affiliation>Posgraduate Program in Dentistry, Piracicaba Dental School, University of Campinas, FOP/UNICAMP, 13414-903, Piracicaba, SP, Brazil; Faculty of Pharmaceutical Sciences, University of Campinas, FCF/UNICAMP, 13081-970, Campinas, SP, Brazil. Electronic address: ana.ruiz@fcf.unicamp.br.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Replacing the refinement for skin sensitization testing: Considerations to the implementation of adverse outcome pathway (AOP)-based defined approaches (DA) in OECD guidelines.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32562760</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(20)30139-2</DOI>
    <KeywordList>
      <Keywords>Adverse outcome pathway(AOP)</Keywords>
      <Keywords>Defined approach (DA)</Keywords>
      <Keywords>Integrated Approach for Testing and Assessment (IATA)</Keywords>
      <Keywords>Non-animal methods</Keywords>
      <Keywords>OECD test guideline</Keywords>
      <Keywords>Skin sensitization</Keywords>
      <Keywords>Validation</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Susanne N. Kolle</Name>
        <Affiliation>BASF SE, Experimental Toxicology and Ecology, 67056, Ludwigshafen am Rhein, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Robert Landsiedel</Name>
        <Affiliation>BASF SE, Experimental Toxicology and Ecology, 67056, Ludwigshafen am Rhein, Germany. Electronic address: robert.landsiedel@basf.com.</Affiliation>
      </Author>
      <Author>
        <Name>Andreas Natsch</Name>
        <Affiliation>Givaudan Schweiz AG, Kemptpark 50, 8310, Kemptthal, Switzerland.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Susanne N. Kolle and Robert Landsiedel are employees of BASF SE and Andreas Natsch is employee of Givaudan SA, both companies use the described DA to develop and register substances.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Calculating safety margins using total plasma concentration versus unbound plasma concentration - does it make a difference?</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32553751</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(20)30135-5</DOI>
    <KeywordList>
      <Keywords>Area under the curve (AUC)</Keywords>
      <Keywords>Plasma protein binding (PPB)</Keywords>
      <Keywords>Safety margin</Keywords>
      <Keywords>Total plasma concentration (C(p))</Keywords>
      <Keywords>Unbound fraction in plasma (fu(p))</Keywords>
      <Keywords>Unbound plasma concentration (C(up))</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Suman K. Mukherjee</Name>
        <Affiliation>Safety Assessment and Laboratory Animal Resources, Merck &amp; Co, Inc, West Point, PA, 19486, USA. Electronic address: Suman_Mukherjee@merck.com.</Affiliation>
      </Author>
      <Author>
        <Name>James B. Ferry</Name>
        <Affiliation>Safety Assessment and Laboratory Animal Resources, Merck &amp; Co, Inc, West Point, PA, 19486, USA.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Establishing health-based biological exposure limits for pesticides: A proof of principle study using mancozeb.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32544413</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(20)30115-X</DOI>
    <KeywordList>
      <Keywords>Biological limit values</Keywords>
      <Keywords>ETU</Keywords>
      <Keywords>Exposure assessment</Keywords>
      <Keywords>Health risk assessment</Keywords>
      <Keywords>Mancozeb</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Stefan Mandić-Rajčević</Name>
        <Affiliation>Department of Health Sciences of the University of Milan and International Centre for Rural Health of the San Paolo Hospital, Via San Vigilio 43, 20142, Milan, Italy. Electronic address: stefan.mandic-rajcevic@unimi.it.</Affiliation>
      </Author>
      <Author>
        <Name>Federico Maria Rubino</Name>
        <Affiliation>Department of Health Sciences of the University of Milan and International Centre for Rural Health of the San Paolo Hospital, Via San Vigilio 43, 20142, Milan, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Claudio Colosio</Name>
        <Affiliation>Department of Health Sciences of the University of Milan and International Centre for Rural Health of the San Paolo Hospital, Via San Vigilio 43, 20142, Milan, Italy.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Safety evaluation of E12, W8, X17, and Y9 potatoes: Nutritional evaluation and 90-day subchronic feeding study in rats.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32540328</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(20)30138-0</DOI>
    <KeywordList>
      <Keywords>Animal feeding trial</Keywords>
      <Keywords>Biotechnology</Keywords>
      <Keywords>Food safety assessment</Keywords>
      <Keywords>Risk assessment</Keywords>
      <Keywords>Solanum tuberosum L</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Pushkor Mukerji</Name>
        <Affiliation>Corteva™ Agriscience, Newark, DE, 19711, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Gary W. Rudgers</Name>
        <Affiliation>J.R. Simplot Company, Plant Sciences, 5369 West Irving Street, Boise, ID, 83706, USA. Electronic address: gary.rudgers@simplot.com.</Affiliation>
      </Author>
      <Author>
        <Name>Christopher Gibson</Name>
        <Affiliation>Total Pathology Solutions, LLC, Kennett Square, PA, 19348, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jason M. Roper</Name>
        <Affiliation>Corteva™ Agriscience, Newark, DE, 19711, USA.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Gary W. Rudgers is employed by the Jason M. Roper Simplot Company that funded the research and developed E12, W8, X17, and Y9 potatoes. This study was conducted Corteva™ Agriscience, previous DuPont Haskell Global Centers, and was sponsored by the Jason M. Roper Simplot Company.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Assessment of lead exposure controls on bridge painting projects using worker blood lead levels.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32534069</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(20)30124-0</DOI>
    <KeywordList>
      <Keywords>Blood lead level</Keywords>
      <Keywords>Industrial contractor</Keywords>
      <Keywords>Lead exposure assessment</Keywords>
      <Keywords>OSHA</Keywords>
      <Keywords>Painter</Keywords>
      <Keywords>Prevention and control</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Kevin Guth</Name>
        <Affiliation>Center for Environmental and Occupational Risk Analysis and Management, College of Public Health, University of South Florida, Tampa, FL, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Marie Bourgeois</Name>
        <Affiliation>Center for Environmental and Occupational Risk Analysis and Management, College of Public Health, University of South Florida, Tampa, FL, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Giffe Johnson</Name>
        <Affiliation>Center for Environmental and Occupational Risk Analysis and Management, College of Public Health, University of South Florida, Tampa, FL, USA. Electronic address: gtjohnso@mail.usf.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Raymond Harbison</Name>
        <Affiliation>Center for Environmental and Occupational Risk Analysis and Management, College of Public Health, University of South Florida, Tampa, FL, USA. Electronic address: rharbiso@usf.edu.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Safety evaluation of Ochratoxin A and Citrinin after 28 days repeated dose oral exposure to Wistar rats.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32525063</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(20)30126-4</DOI>
    <KeywordList>
      <Keywords>Citrinin</Keywords>
      <Keywords>Clinico-pathology</Keywords>
      <Keywords>Histopathology</Keywords>
      <Keywords>OECD 407</Keywords>
      <Keywords>Ochratoxin A</Keywords>
      <Keywords>Oral toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Pankaj Ramji Jagdale</Name>
        <Affiliation>Food Toxicology Laboratory, Food, Drug, and Chemical Toxicology Group, CSIR-Indian Institute of Toxicology Research, Vishvigyan Bhawan, 31, Mahatma Gandhi Marg, Lucknow 226001, Uttar Pradesh, India.; Pathology Laboratory, Regulatory Toxicology Group, CSIR-Indian Institute of Toxicology Research, Vishvigyan Bhawan, 31, Mahatma Gandhi Marg, Lucknow 226001, Uttar Pradesh, India.; Department of Zoology, University of Lucknow, Lucknow, 226007, Uttar Pradesh, India.</Affiliation>
      </Author>
      <Author>
        <Name>Indra Dev</Name>
        <Affiliation>Food Toxicology Laboratory, Food, Drug, and Chemical Toxicology Group, CSIR-Indian Institute of Toxicology Research, Vishvigyan Bhawan, 31, Mahatma Gandhi Marg, Lucknow 226001, Uttar Pradesh, India.; Academy of Scientific and Innovation Research, CSIR-Indian Institute of Toxicology Research, Vishvigyan Bhawan, 31, Mahatma Gandhi Marg, Lucknow 226001, Uttar Pradesh, India.</Affiliation>
      </Author>
      <Author>
        <Name>Anjaneya Ayanur</Name>
        <Affiliation>Pathology Laboratory, Regulatory Toxicology Group, CSIR-Indian Institute of Toxicology Research, Vishvigyan Bhawan, 31, Mahatma Gandhi Marg, Lucknow 226001, Uttar Pradesh, India.</Affiliation>
      </Author>
      <Author>
        <Name>Dhirendra Singh</Name>
        <Affiliation>Pathology Laboratory, Regulatory Toxicology Group, CSIR-Indian Institute of Toxicology Research, Vishvigyan Bhawan, 31, Mahatma Gandhi Marg, Lucknow 226001, Uttar Pradesh, India.</Affiliation>
      </Author>
      <Author>
        <Name>Md Arshad</Name>
        <Affiliation>Department of Zoology, University of Lucknow, Lucknow, 226007, Uttar Pradesh, India; Department of Zoology, Aligarh Muslim University, Aligarh, 202002, Uttar Pradesh, India.</Affiliation>
      </Author>
      <Author>
        <Name>Kausar Mahmood Ansari</Name>
        <Affiliation>Food Toxicology Laboratory, Food, Drug, and Chemical Toxicology Group, CSIR-Indian Institute of Toxicology Research, Vishvigyan Bhawan, 31, Mahatma Gandhi Marg, Lucknow 226001, Uttar Pradesh, India.. Electronic address: kmansari@iitr.res.in.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>How the 62-year old Delaney Clause continues to thwart science: Case study of the flavor substance β-myrcene.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32522581</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(20)30134-3</DOI>
    <KeywordList>
      <Keywords>Carcinogen</Keywords>
      <Keywords>Delaney clause</Keywords>
      <Keywords>Flavor chemical</Keywords>
      <Keywords>Nongenotoxic</Keywords>
      <Keywords>β-Myrcene</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Susan P. Felter</Name>
        <Affiliation>Procter &amp; Gamble, Central Product Safety, Mason, OH, USA. Electronic address: Felter.sp@pg.com.</Affiliation>
      </Author>
      <Author>
        <Name>Craig Llewelyn</Name>
        <Affiliation>Toxicology Regulatory Services, Charlottesville, VA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Lisa Navarro</Name>
        <Affiliation>Flavor Producers, LLC, Sharonville, OH, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaoling Zhang</Name>
        <Affiliation>Procter &amp; Gamble, Central Product Safety, Mason, OH, USA.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests:Susan P. Felter and Xiaoling Zhang are employed by Procter &amp; Gamble, a company that uses flavor and fragrance substances in a variety of consumer products. Craig Llewelyn is employed by Toxicology Regulatory Services, a consulting company, whose clients come from a broad range of industries, including companies that manufacture and/or use flavorings. Lisa Navarro is employed by Flavor Producers, a company that uses flavor substances to make flavorings for the food and beverage product industry.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Deriving harmonised permitted daily exposures (PDEs) for paracetamol (acetaminophen) CAS #: 103-90-2.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32522580</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(20)30118-5</DOI>
    <KeywordList>
      <Keywords>Acceptable daily exposure (ADE)</Keywords>
      <Keywords>CAS RN 103-90-2</Keywords>
      <Keywords>Cleaning validation</Keywords>
      <Keywords>Cross contamination</Keywords>
      <Keywords>Health-based exposure limit (HBEL)</Keywords>
      <Keywords>Multipurpose manufacturing facility</Keywords>
      <Keywords>Paracetamol (acetaminophen)</Keywords>
      <Keywords>Permitted daily exposure (PDE)</Keywords>
      <Keywords>Residual carry-over</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Kamila Gromek</Name>
        <Affiliation>GlaxoSmithKline, United Kingdom. Electronic address: kamila.x.gromek@gsk.com.</Affiliation>
      </Author>
      <Author>
        <Name>William Hawkins</Name>
        <Affiliation>GlaxoSmithKline, United Kingdom. Electronic address: william.a.hawkins@gsk.com.</Affiliation>
      </Author>
      <Author>
        <Name>Tanja Bernier</Name>
        <Affiliation>Abbott, United States. Electronic address: tanja.bernier@abbott.com.</Affiliation>
      </Author>
      <Author>
        <Name>Claudia Sehner</Name>
        <Affiliation>Boehringer Ingelheim, Germany. Electronic address: claudia.sehner@boehringer-ingelheim.com.</Affiliation>
      </Author>
      <Author>
        <Name>Eva Zeller</Name>
        <Affiliation>Boehringer Ingelheim, Germany. Electronic address: eva_2.zeller@boehringer-ingelheim.com.</Affiliation>
      </Author>
      <Author>
        <Name>Markus Schwind</Name>
        <Affiliation>Sanofi, France. Electronic address: markus.Schwind@sanofi.com.</Affiliation>
      </Author>
      <Author>
        <Name>Thomas Pfister</Name>
        <Affiliation>Roche, Switzerland. Electronic address: thomas.pfister.tp1@roche.com.</Affiliation>
      </Author>
      <Author>
        <Name>Martin Kohan</Name>
        <Affiliation>Astra Zeneca, United Kingdom. Electronic address: martin.kohan@astrazeneca.com.</Affiliation>
      </Author>
      <Author>
        <Name>Osahon Osadolor</Name>
        <Affiliation>Novartis, Switzerland. Electronic address: osahon.osadolor@novartis.com.</Affiliation>
      </Author>
      <Author>
        <Name>Milica Glogovac</Name>
        <Affiliation>Novartis, Switzerland. Electronic address: milica.glogovac@novartis.com.</Affiliation>
      </Author>
      <Author>
        <Name>Gregor Tuschl</Name>
        <Affiliation>Merck Healthcare KGaA, Germany. Electronic address: gregor.tuschl@merckgroup.com.</Affiliation>
      </Author>
      <Author>
        <Name>David G. Dolan</Name>
        <Affiliation>Amgen Inc., United States. Electronic address: ddolan@amgen.com.</Affiliation>
      </Author>
      <Author>
        <Name>Ester Lovsin Barle</Name>
        <Affiliation>Takeda, Switzerland. Electronic address: ester.lovsin-barle@takeda.com.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Safety assessment of astaxanthin from Haematococcus pluvialis: Acute toxicity, genotoxicity, distribution and repeat-dose toxicity studies in gestation mice.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32512118</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(20)30121-5</DOI>
    <KeywordList>
      <Keywords>Astaxanthin</Keywords>
      <Keywords>Distribution</Keywords>
      <Keywords>Pregnant mice</Keywords>
      <Keywords>Toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Tingting Niu</Name>
        <Affiliation>State Key Laboratory for Managing Biotic and Chemical Threats to the Quality and Safety of Agro-products, Ningbo University, Ningbo, Zhejiang, 315211, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jiawei Zhou</Name>
        <Affiliation>State Key Laboratory for Managing Biotic and Chemical Threats to the Quality and Safety of Agro-products, Ningbo University, Ningbo, Zhejiang, 315211, China.</Affiliation>
      </Author>
      <Author>
        <Name>Feng Wang</Name>
        <Affiliation>Department of Laboratory Medicine, Ningbo Medical Center Lihuili Hospital, Ningbo, 315040, Zhejiang, China; Department of Laboratory Medicine, Taipei Medical University Ningbo Medical Center, Ningbo, 315040, Zhejiang, China.</Affiliation>
      </Author>
      <Author>
        <Name>Rongrong Xuan</Name>
        <Affiliation>Department of Gynecology and Obstetrics, the Affiliated Hospital of Medical College of Ningbo University, Ningbo, Zhejiang, 315211, China. Electronic address: fyxuanrongrong@nbu.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Juanjuan Chen</Name>
        <Affiliation>State Key Laboratory for Managing Biotic and Chemical Threats to the Quality and Safety of Agro-products, Ningbo University, Ningbo, Zhejiang, 315211, China.</Affiliation>
      </Author>
      <Author>
        <Name>Wei Wu</Name>
        <Affiliation>State Key Laboratory for Managing Biotic and Chemical Threats to the Quality and Safety of Agro-products, Ningbo University, Ningbo, Zhejiang, 315211, China.</Affiliation>
      </Author>
      <Author>
        <Name>Haimin Chen</Name>
        <Affiliation>State Key Laboratory for Managing Biotic and Chemical Threats to the Quality and Safety of Agro-products, Ningbo University, Ningbo, Zhejiang, 315211, China. Electronic address: chenhaimin@nbu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Response to "OECD 428 in vitro dermal absorption mass balance performance based on our in-house database of pesticide studies".</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32512117</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(20)30133-1</DOI>
    <KeywordList>
      <Keywords>Data-driven assessment</Keywords>
      <Keywords>Dermal absorption</Keywords>
      <Keywords>In vitro</Keywords>
      <Keywords>Mass balance</Keywords>
      <Keywords>Pesticides</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Felix M. Kluxen</Name>
        <Affiliation>ADAMA Deutschland GmbH, Edmund-Rumpler-Str. 6, 51149, Cologne, Germany. Electronic address: Felix.Kluxen@adama.com.</Affiliation>
      </Author>
      <Author>
        <Name>Sébastien Grégoire</Name>
        <Affiliation>L'Oreal Research &amp; Innovation, 1 Avenue Eugène Schueller, 93600, Aulnay-Sous-Bois, France. Electronic address: sebastien.gregoire@rd.loreal.com.</Affiliation>
      </Author>
      <Author>
        <Name>Andreas Schepky</Name>
        <Affiliation>Beiersdorf AG, Unnastraße 48, 20253, Hamburg, Germany. Electronic address: Andreas.Schepky@Beiersdorf.com.</Affiliation>
      </Author>
      <Author>
        <Name>Nicky J. Hewitt</Name>
        <Affiliation>Cosmetics Europe, Avenue Herrmann-Debroux 40, 1160, Brussels, Belgium. Electronic address: nickyhewittltd@yahoo.co.uk.</Affiliation>
      </Author>
      <Author>
        <Name>Martina Klaric</Name>
        <Affiliation>Cosmetics Europe, Avenue Herrmann-Debroux 40, 1160, Brussels, Belgium. Electronic address: mklaric@cosmeticseurope.eu.</Affiliation>
      </Author>
      <Author>
        <Name>Jeanne Y. Domoradzki</Name>
        <Affiliation>Corteva Agriscience, 9330 Zionsville Road, Indianapolis, IN, 46238, USA. Electronic address: jeanne.domoradzki@corteva.com.</Affiliation>
      </Author>
      <Author>
        <Name>Edgars Felkers</Name>
        <Affiliation>ADAMA Deutschland GmbH, Edmund-Rumpler-Str. 6, 51149, Cologne, Germany. Electronic address: edgars.felkers@adama.com.</Affiliation>
      </Author>
      <Author>
        <Name>Philip Fisher</Name>
        <Affiliation>Bayer SAS, Crop Science Division, 16 Rue Jean-Marie Leclair, 69266, Lyon, France. Electronic address: philip.fisher@bayer.com.</Affiliation>
      </Author>
      <Author>
        <Name>Steven F. McEuen</Name>
        <Affiliation>FMC Corporation, Stine Research Center, S300/427, P.O. Box 30, Newark, DE, 19714-0030, USA. Electronic address: Steven.Mceuen@fmc.com.</Affiliation>
      </Author>
      <Author>
        <Name>Robert Parr-Dobrzanski</Name>
        <Affiliation>Syngenta Ltd., Jealotts Hill Research Station, Warfield, Bracknell, RG42 6EY, UK. Electronic address: bob.parr-dobrzanski@syngenta.com.</Affiliation>
      </Author>
      <Author>
        <Name>Eric Fabian</Name>
        <Affiliation>BASF SE, Carl-Bosch-Str. 38, 67056, Ludwigshafen am Rhein, Germany. Electronic address: eric.fabian@basf.com.</Affiliation>
      </Author>
      <Author>
        <Name>Christiane Wiemann</Name>
        <Affiliation>BASF Oesterreich GmbH, Handelskai 94-96, 1200, Vienna, Austria. Electronic address: christiane.wiemann@basf.com.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests. Christiane Wiemann, Felix M. Kluxen, Jeanne Y. Domoradzki, Edgars Felkers, Philip Fisher, Eric Fabian, Steven McEuen and Bob Parr-Dobrzanski are employees of (agro)chemical companies and Andreas Schepky, Sebastien Grégoire are employees of cosmetics companies that conduct and evaluate dermal absorption studies in vitro through human skin for regulatory purposes in the context of authorization and marketing of their companie's products. They contribute as scientific experts to the respective industry associations for evaluation and development of the state of the art methodology.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A novel approach to monitor skin permeation of metals in vitro.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32505642</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(20)30119-7</DOI>
    <KeywordList>
      <Keywords>Chromium</Keywords>
      <Keywords>Cobalt</Keywords>
      <Keywords>Dermal exposure</Keywords>
      <Keywords>Diffusion cell</Keywords>
      <Keywords>ICP-MS</Keywords>
      <Keywords>Mixed exposure</Keywords>
      <Keywords>Mixtures of metals</Keywords>
      <Keywords>Nickel</Keywords>
      <Keywords>Risk assessment</Keywords>
      <Keywords>Sensitizing metals</Keywords>
      <Keywords>Skin penetration</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Klara Midander</Name>
        <Affiliation>Integrative Toxicology, Institute of Environmental Medicine IMM, Karolinska Institutet, Stockholm, Sweden. Electronic address: klara.midander@ki.se.</Affiliation>
      </Author>
      <Author>
        <Name>Linda Schenk</Name>
        <Affiliation>Integrative Toxicology, Institute of Environmental Medicine IMM, Karolinska Institutet, Stockholm, Sweden.</Affiliation>
      </Author>
      <Author>
        <Name>Anneli Julander</Name>
        <Affiliation>Integrative Toxicology, Institute of Environmental Medicine IMM, Karolinska Institutet, Stockholm, Sweden.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Meta-analysis of animal studies applied to short-term inhalation exposure levels of hazardous chemicals.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32504649</pubmedLink>
    <GrantList>
      <Grant>CC999999</Grant>
    </GrantList>
    <Year>2020</Year>
    <DOI>S0273-2300(20)30108-2</DOI>
    <KeywordList>
      <Keywords>Acute exposure guideline levels (AEGLs)</Keywords>
      <Keywords>Categorical regression</Keywords>
      <Keywords>General linear model</Keywords>
      <Keywords>Meta-analysis</Keywords>
      <Keywords>Probit</Keywords>
      <Keywords>Risk assessment</Keywords>
      <Keywords>Short-term inhalation exposure</Keywords>
      <Keywords>Ten Berge equation</Keywords>
      <Keywords>Toxic load</Keywords>
      <Keywords>Toxic load exponent (TLE)</Keywords>
      <Keywords>n-value</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Andrew J. Prussia</Name>
        <Affiliation>Agency for Toxic Substances and Disease Registry, Atlanta, GA, USA. Electronic address: aprussia@cdc.gov.</Affiliation>
      </Author>
      <Author>
        <Name>Joshua Hill</Name>
        <Affiliation>Agency for Toxic Substances and Disease Registry, Atlanta, GA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Cheryl R. Cornwell</Name>
        <Affiliation>Agency for Toxic Substances and Disease Registry, Atlanta, GA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Ram C. Siwakoti</Name>
        <Affiliation>Agency for Toxic Substances and Disease Registry, Atlanta, GA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Eugene Demchuk</Name>
        <Affiliation>Agency for Toxic Substances and Disease Registry, Atlanta, GA, USA.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>PBPK model reporting template for chemical risk assessment applications.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32502513</pubmedLink>
    <GrantList>
      <Grant>CC999999</Grant>
    </GrantList>
    <Year>2020</Year>
    <DOI>S0273-2300(20)30117-3</DOI>
    <KeywordList>
      <Keywords>Documentation</Keywords>
      <Keywords>Harmonized report</Keywords>
      <Keywords>Pharmacokinetics</Keywords>
      <Keywords>Physiologically-based pharmacokinetic (PBPK) model</Keywords>
      <Keywords>Regulatory review</Keywords>
      <Keywords>Regulatory risk assessment</Keywords>
      <Keywords>Regulatory submission</Keywords>
      <Keywords>Reporting template</Keywords>
      <Keywords>Standardized report</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Yu Mei Tan</Name>
        <Affiliation>U.S. Environmental Protection Agency, Office of Pesticide Programs, Health Effects Division, 109 TW Alexander Dr, Research Triangle Park, NC, 27709, USA. Electronic address: tan.cecilia@epa.gov.</Affiliation>
      </Author>
      <Author>
        <Name>Melissa Chan</Name>
        <Affiliation>Corteva Agriscience, Haskell R&amp;D Center, 1090 Elkton Road, Newark, DE, 19714, USA. Electronic address: melissa.chan@corteva.com.</Affiliation>
      </Author>
      <Author>
        <Name>Amechi Chukwudebe</Name>
        <Affiliation>BASF Corporation, 26 Davis Drive, Research Triangle Park, NC, 27709, USA. Electronic address: amechi.chukwudebe@basf.com.</Affiliation>
      </Author>
      <Author>
        <Name>Jeanne Domoradzki</Name>
        <Affiliation>Corteva Agriscience, Haskell R&amp;D Center, 1090 Elkton Road, Newark, DE, 19714, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jeffrey Fisher</Name>
        <Affiliation>National Center for Toxicological Research, US Food and Drug Administration, 3900 NCTR Rd, Jefferson, AR, 72079, USA. Electronic address: Jeffrey.Fisher@fda.hhs.gov.</Affiliation>
      </Author>
      <Author>
        <Name>C. Eric Hack</Name>
        <Affiliation>ScitoVation, 100 Capitola Drive, Durham, NC, 27713, USA. Electronic address: ehack@scitovation.com.</Affiliation>
      </Author>
      <Author>
        <Name>Paul Hinderliter</Name>
        <Affiliation>Syngenta Crop Protection, LLC, 410 Swing Rd, Greensboro, NC, 27409, USA. Electronic address: paul.hinderliter@alexion.com.</Affiliation>
      </Author>
      <Author>
        <Name>Kota Hirasawa</Name>
        <Affiliation>Sumitomo Chemical Co, Ltd, 1-98, Kasugadenaka 3-chome, Konohana-ku, Osaka, 554-8558, Japan. Electronic address: hirasawak@sc.sumitomo-chem.co.jp.</Affiliation>
      </Author>
      <Author>
        <Name>Jeremy Leonard</Name>
        <Affiliation>Oak Ridge Institute for Science and Education, 100 ORAU Way, Oak Ridge, TN, 37830, USA. Electronic address: Leonard.Jeremy@epa.gov.</Affiliation>
      </Author>
      <Author>
        <Name>Annie Lumen</Name>
        <Affiliation>National Center for Toxicological Research, US Food and Drug Administration, 3900 NCTR Rd, Jefferson, AR, 72079, USA. Electronic address: Annie.Lumen@fda.hhs.gov.</Affiliation>
      </Author>
      <Author>
        <Name>Alicia Paini</Name>
        <Affiliation>European Commission Joint Research Centre, Via E. Fermi 2749, Ispra I, 21027, Italy. Electronic address: alicia.paini@ec.europa.eu.</Affiliation>
      </Author>
      <Author>
        <Name>Hua Qian</Name>
        <Affiliation>ExxonMobil Biomedical Sciences, Inc, 1545 US Hwy 22 East, Annandale, NJ, 08801, USA. Electronic address: hua.qian@exxonmobil.com.</Affiliation>
      </Author>
      <Author>
        <Name>Patricia Ruiz</Name>
        <Affiliation>CDC-ATSDR, 4770 Buford Hwy, Mailstop S102-1, Chamblee, GA, 3034, USA. Electronic address: pruiz@cdc.gov.</Affiliation>
      </Author>
      <Author>
        <Name>John Wambaugh</Name>
        <Affiliation>US Environmental Protection Agency, Center for Computational Toxicology and Exposure, 109 TW Alexander Dr, Research Triangle Park, NC, 27711, USA. Electronic address: wambaugh.john@epa.gov.</Affiliation>
      </Author>
      <Author>
        <Name>Fagen Zhang</Name>
        <Affiliation>The Dow Chemical Company, 1803 Building, Midland, MI, 48674, USA. Electronic address: FZZhang@dow.com.</Affiliation>
      </Author>
      <Author>
        <Name>Michelle Embry</Name>
        <Affiliation>Health and Environmental Sciences Institute, 740 15th Street, NW, Suite 600, Washington, DC, 20005, USA. Electronic address: membry@hesiglobal.org.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Confidence interval function analysis to evaluate the risk of mesothelioma among an expanded international cohort of cosmetic talc miners and millers.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32492522</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(20)30122-7</DOI>
    <KeywordList>
      <Keywords>Asbestos</Keywords>
      <Keywords>Confidence interval function analysis</Keywords>
      <Keywords>Cosmetic talc</Keywords>
      <Keywords>Mesothelioma</Keywords>
      <Keywords>Millers</Keywords>
      <Keywords>Miners</Keywords>
      <Keywords>Mortality</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Gary M. Marsh</Name>
        <Affiliation>Cardno ChemRisk, Pittsburgh, PA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>A. Michael Ierardi</Name>
        <Affiliation>Cardno ChemRisk, Brooklyn, NY, USA. Electronic address: Michael.Ierardi@cardno.com.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Both of the authors are employed by Cardno ChemRisk, a consulting firm that provides scientific advice to the government, corporations, law firms, and various scientific/professional organizations. Gary M. Marsh is also Professor of Biostatistics and Director and Founder, Center for Occupational Biostatistics and Epidemiology at the University of Pittsburgh, Graduate School of Public Health. A. Michael Ierardi is also a student in the Department of Environmental, Occupational, and Geospatial Health Sciences at CUNY Graduate School of Public Health and Health Policy. This manuscript was prepared and written exclusively by the authors, and no external funding was received for this study. No organizations other than Cardno ChemRisk were aware of the preparation of this manuscript, and no other organizations other than Cardno ChemRisk reviewed any part of this manuscript prior to its submission for publication. Both Gary M. Marsh and A. Michael Ierardi have been retained as defense experts in cosmetic talc-related litigation.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Risk assessment of unintentional phthalates contaminants in cosmetics.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32474072</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(20)30113-6</DOI>
    <KeywordList>
      <Keywords>Benzyl butyl phthalate (BBP)</Keywords>
      <Keywords>Cosmetics</Keywords>
      <Keywords>Di(2-ethylhexyl)phthalate (DEHP)</Keywords>
      <Keywords>Dibutyl phthalate (DBP)</Keywords>
      <Keywords>Risk assessment</Keywords>
      <Keywords>Unintentional phthalates contaminants</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Min Kook Kim</Name>
        <Affiliation>Division of Toxicology, College of Pharmacy, Sungkyunkwan University, Suwon, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Kyu Bong Kim</Name>
        <Affiliation>Division of Toxicology, College of Pharmacy, Dankook University, Cheonan, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Sungpil Yoon</Name>
        <Affiliation>Division of Toxicology, College of Pharmacy, Sungkyunkwan University, Suwon, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Hyung Sik Kim</Name>
        <Affiliation>Division of Toxicology, College of Pharmacy, Sungkyunkwan University, Suwon, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Byung Mu Lee</Name>
        <Affiliation>Division of Toxicology, College of Pharmacy, Sungkyunkwan University, Suwon, Republic of Korea. Electronic address: bmlee@skku.edu.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Pulmonary toxicity of silver vapours, nanoparticles and fine dusts: A review.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32474071</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(20)30116-1</DOI>
    <KeywordList>
      <Keywords>Aerosol</Keywords>
      <Keywords>Ag</Keywords>
      <Keywords>Argyria</Keywords>
      <Keywords>Biodistribution</Keywords>
      <Keywords>Biokinetics</Keywords>
      <Keywords>Chronic</Keywords>
      <Keywords>Dental</Keywords>
      <Keywords>Genotoxicity</Keywords>
      <Keywords>Inhalation</Keywords>
      <Keywords>Intratracheal instillation</Keywords>
      <Keywords>Ions</Keywords>
      <Keywords>Mouse</Keywords>
      <Keywords>Nanoparticle</Keywords>
      <Keywords>Occupational</Keywords>
      <Keywords>Rat</Keywords>
      <Keywords>Subacute</Keywords>
      <Keywords>Subchronic</Keywords>
      <Keywords>Translocation</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Niels Hadrup</Name>
        <Affiliation>National Research Centre for the Working Environment, DK, 2100, Copenhagen, Denmark. Electronic address: nih@nfa.dk.</Affiliation>
      </Author>
      <Author>
        <Name>Anoop K. Sharma</Name>
        <Affiliation>Division for Risk Assessment and Nutrition, Group for Chemical Risk Assessment and GMO, National Food Institute, Technical University of Denmark, Denmark.</Affiliation>
      </Author>
      <Author>
        <Name>Katrin Loeschner</Name>
        <Affiliation>Division for Food Technology, Research Group for Nano-Bio Science, National Food Institute, Technical University of Denmark, Denmark.</Affiliation>
      </Author>
      <Author>
        <Name>Nicklas R. Jacobsen</Name>
        <Affiliation>National Research Centre for the Working Environment, DK, 2100, Copenhagen, Denmark. Electronic address: nrj@nfa.dk.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Toxicological testing of a photoactive phthalocyanine-based antimicrobial substance.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32454236</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(20)30111-2</DOI>
    <KeywordList>
      <Keywords>Aluminium phthalocyanine</Keywords>
      <Keywords>Local toxicity</Keywords>
      <Keywords>Phototoxicity</Keywords>
      <Keywords>Skin penetration</Keywords>
      <Keywords>Systemic toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Kristina Kejlová</Name>
        <Affiliation>National Institute of Public Health, Centre of Toxicology and Health Safety, Šrobárova 49/48, 100 00, Prague, Czech Republic. Electronic address: kristina.kejlova@szu.cz.</Affiliation>
      </Author>
      <Author>
        <Name>Hana Bendová</Name>
        <Affiliation>National Institute of Public Health, Centre of Toxicology and Health Safety, Šrobárova 49/48, 100 00, Prague, Czech Republic.</Affiliation>
      </Author>
      <Author>
        <Name>Jan Chrz</Name>
        <Affiliation>National Institute of Public Health, Centre of Toxicology and Health Safety, Šrobárova 49/48, 100 00, Prague, Czech Republic; Department of Medical Biophysics, Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacký University, Hněvotínská 3, 775 15, Olomouc, Czech Republic.</Affiliation>
      </Author>
      <Author>
        <Name>Markéta Dvořáková</Name>
        <Affiliation>National Institute of Public Health, Centre of Toxicology and Health Safety, Šrobárova 49/48, 100 00, Prague, Czech Republic.</Affiliation>
      </Author>
      <Author>
        <Name>Lada Svobodová</Name>
        <Affiliation>National Institute of Public Health, Centre of Toxicology and Health Safety, Šrobárova 49/48, 100 00, Prague, Czech Republic; Department of Medical Biophysics, Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacký University, Hněvotínská 3, 775 15, Olomouc, Czech Republic.</Affiliation>
      </Author>
      <Author>
        <Name>Alena Vlková</Name>
        <Affiliation>National Institute of Public Health, Centre of Toxicology and Health Safety, Šrobárova 49/48, 100 00, Prague, Czech Republic.</Affiliation>
      </Author>
      <Author>
        <Name>Lubomír Kubáč</Name>
        <Affiliation>Center of Organic Chemistry, Rybitví č.p. 296, 533 54, Rybitví, Czech Republic.</Affiliation>
      </Author>
      <Author>
        <Name>Radka Kořínková</Name>
        <Affiliation>Center of Organic Chemistry, Rybitví č.p. 296, 533 54, Rybitví, Czech Republic.</Affiliation>
      </Author>
      <Author>
        <Name>Jiří Černý</Name>
        <Affiliation>Center of Organic Chemistry, Rybitví č.p. 296, 533 54, Rybitví, Czech Republic.</Affiliation>
      </Author>
      <Author>
        <Name>Danuše Očadlíková</Name>
        <Affiliation>National Institute of Public Health, Centre of Toxicology and Health Safety, Šrobárova 49/48, 100 00, Prague, Czech Republic.</Affiliation>
      </Author>
      <Author>
        <Name>Marian Rucki</Name>
        <Affiliation>National Institute of Public Health, Centre of Toxicology and Health Safety, Šrobárova 49/48, 100 00, Prague, Czech Republic.</Affiliation>
      </Author>
      <Author>
        <Name>Tuula Heinonen</Name>
        <Affiliation>FICAM, Faculty of Medicine and Health Technology, FI-33014, Tampere University, Tampere, Finland.</Affiliation>
      </Author>
      <Author>
        <Name>Dagmar Jírová</Name>
        <Affiliation>National Institute of Public Health, Centre of Toxicology and Health Safety, Šrobárova 49/48, 100 00, Prague, Czech Republic.</Affiliation>
      </Author>
      <Author>
        <Name>Silvia Letašiová</Name>
        <Affiliation>MatTek in Vitro Life Science Laboratories, Mlynské Nivy 73, 82 105, Bratislava, Slovakia.</Affiliation>
      </Author>
      <Author>
        <Name>Helena Kandarova</Name>
        <Affiliation>Institute of Experimental Pharmacology and Toxicology, Centre of Experimental Medicine, Slovak Academy of Sciences, Dúbravská Cesta 9, 841 04, Bratislava, Slovakia. Electronic address: helena.kandarova@savba.sk.</Affiliation>
      </Author>
      <Author>
        <Name>Hana Kolářová</Name>
        <Affiliation>Department of Medical Biophysics, Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacký University, Hněvotínská 3, 775 15, Olomouc, Czech Republic.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Effect of low- and high-level groundwater arsenic on peripheral blood and lung function of exposed rural women.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32454235</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(20)30110-0</DOI>
    <KeywordList>
      <Keywords>CD56+NK cells</Keywords>
      <Keywords>CD8+T-cells</Keywords>
      <Keywords>High-level arsenic</Keywords>
      <Keywords>Low-level arsenic</Keywords>
      <Keywords>Lung function</Keywords>
      <Keywords>RBC</Keywords>
      <Keywords>WBC</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Priyanka Prasad</Name>
        <Affiliation>Department of Receptor Biology and Tumor Metastasis, Chittaranjan National Cancer Institute, 37, S.P. Mukherjee Road, Kolkata 700026, India.</Affiliation>
      </Author>
      <Author>
        <Name>Nivedita Sarkar</Name>
        <Affiliation>Department of Receptor Biology and Tumor Metastasis, Chittaranjan National Cancer Institute, 37, S.P. Mukherjee Road, Kolkata 700026, India.</Affiliation>
      </Author>
      <Author>
        <Name>Dona Sinha</Name>
        <Affiliation>Department of Receptor Biology and Tumor Metastasis, Chittaranjan National Cancer Institute, 37, S.P. Mukherjee Road, Kolkata 700026, India. Electronic address: dona.sinha@cnci.org.in.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Toxicological evaluation of exosomes derived from human adipose tissue-derived mesenchymal stem/stromal cells.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32450131</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(20)30112-4</DOI>
    <KeywordList>
      <Keywords>Adipose tissue-derived mesenchymal stem cells (ASCs)</Keywords>
      <Keywords>Exosomes</Keywords>
      <Keywords>Safety</Keywords>
      <Keywords>Skin</Keywords>
      <Keywords>Toxicology</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Dae Hyun Ha</Name>
        <Affiliation>ExoCoBio Exosome Institute (EEI), ExoCoBio Inc., Seoul, 08594, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Sun Don Kim</Name>
        <Affiliation>Nonclinical Research Institute, ChemOn Inc., Yongin-si, Gyeonggi-do, 17162, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Joon Lee</Name>
        <Affiliation>School of Chemical and Biological Engineering, Seoul National University, Seoul, 08826, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Hyuck Hoon Kwon</Name>
        <Affiliation>Oaro Dermatology Clinic, Seoul, 01695, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Gyeong Hun Park</Name>
        <Affiliation>Department of Dermatology, Dongtan Sacred Heart Hospital, College of Medicine, Hallym University, Hwaseong-si, Gyeonggi-do, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Steve Hoseong Yang</Name>
        <Affiliation>Guam Dermatology Institute, Tamuning, GU 96913, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jae Yoon Jung</Name>
        <Affiliation>Oaro Dermatology Clinic, Seoul, 01695, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Jun Ho Lee</Name>
        <Affiliation>ExoCoBio Exosome Institute (EEI), ExoCoBio Inc., Seoul, 08594, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Sang Rae Park</Name>
        <Affiliation>ExoCoBio Exosome Institute (EEI), ExoCoBio Inc., Seoul, 08594, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Jinkwon Youn</Name>
        <Affiliation>ExoCoBio Exosome Institute (EEI), ExoCoBio Inc., Seoul, 08594, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Sang Hee Lee</Name>
        <Affiliation>ExoCoBio Exosome Institute (EEI), ExoCoBio Inc., Seoul, 08594, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Ji Eun Kim</Name>
        <Affiliation>ExoCoBio Exosome Institute (EEI), ExoCoBio Inc., Seoul, 08594, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Jihye Lim</Name>
        <Affiliation>ExoCoBio Exosome Institute (EEI), ExoCoBio Inc., Seoul, 08594, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Hyun Kul Lee</Name>
        <Affiliation>Nonclinical Research Institute, ChemOn Inc., Yongin-si, Gyeonggi-do, 17162, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Byong Seung Cho</Name>
        <Affiliation>ExoCoBio Exosome Institute (EEI), ExoCoBio Inc., Seoul, 08594, Republic of Korea. Electronic address: ceo@exocobio.com.</Affiliation>
      </Author>
      <Author>
        <Name>Yong Weon Yi</Name>
        <Affiliation>ExoCoBio Exosome Institute (EEI), ExoCoBio Inc., Seoul, 08594, Republic of Korea. Electronic address: yongweon.yi@exocobio.com.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Byong Seung Cho and Yong Weon Yi are founders and stockholders of ExoCoBio Inc. Dae Hyun Ha, Jun Ho Lee, Sang Rae Park, Jinkwon Youn, Sang Hee Lee, Ji Eun Kim, Joon Lee, Byong Seung Cho, and Yong Weon Yi are employees of ExoCoBio Inc. Sun Don Kim and HL are employees of ChemOn Inc. Other authors declare no conflict of interest.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>An interim internal Threshold of Toxicologic Concern (iTTC) for chemicals in consumer products, with support from an automated assessment of ToxCast™ dose response data.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32437818</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(20)30082-9</DOI>
    <KeywordList>
      <Keywords>High throughput screening data analysis</Keywords>
      <Keywords>Risk assessment</Keywords>
      <Keywords>SAR</Keywords>
      <Keywords>Structure activity relationships</Keywords>
      <Keywords>TTC</Keywords>
      <Keywords>Threshold of toxicological concern</Keywords>
      <Keywords>ToxCast</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Karen L. Blackburn</Name>
        <Affiliation>The Procter &amp; Gamble Company, Mason Business Center, 8700 Mason Montgomery Road, Cincinnati, OH, 45040, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Gregory Carr</Name>
        <Affiliation>The Procter &amp; Gamble Company, Mason Business Center, 8700 Mason Montgomery Road, Cincinnati, OH, 45040, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Jane L. Rose</Name>
        <Affiliation>The Procter &amp; Gamble Company, Mason Business Center, 8700 Mason Montgomery Road, Cincinnati, OH, 45040, United States. Electronic address: rose.jl@pg.com.</Affiliation>
      </Author>
      <Author>
        <Name>Bastian G. Selman</Name>
        <Affiliation>The Procter &amp; Gamble Company, Mason Business Center, 8700 Mason Montgomery Road, Cincinnati, OH, 45040, United States.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Derivation of biomonitoring equivalents (BE values) for bismuth.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32418918</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(20)30098-2</DOI>
    <KeywordList>
      <Keywords>Biomarkers of exposure</Keywords>
      <Keywords>Biomonitoring</Keywords>
      <Keywords>Biomonitoring equivalents</Keywords>
      <Keywords>Bismuth</Keywords>
      <Keywords>Encephalopathy</Keywords>
      <Keywords>Exposure guidance values</Keywords>
      <Keywords>Human health risk assessment</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Devika Poddalgoda</Name>
        <Affiliation>Health Canada, Ottawa, ON, Canada. Electronic address: devika.poddalgoda@canada.ca.</Affiliation>
      </Author>
      <Author>
        <Name>Sean M. Hays</Name>
        <Affiliation>Summit Toxicology, LLP, Montana, USA. Electronic address: shays@summittoxicology.com.</Affiliation>
      </Author>
      <Author>
        <Name>Andy Nong</Name>
        <Affiliation>Health Canada, Ottawa, ON, Canada. Electronic address: Andy.nong@canada.ca.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Hydroalcoholic extract of leaf of Arachis hypogaea L. (Fabaceae) did not induce toxic effects in the repeated-dose toxicity study in rats.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32416109</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(20)30109-4</DOI>
    <KeywordList>
      <Keywords>Fabaceae</Keywords>
      <Keywords>Hydroalcoholic extract</Keywords>
      <Keywords>Oxidative stress</Keywords>
      <Keywords>Peanut leaves</Keywords>
      <Keywords>Repeated dosage toxicity</Keywords>
      <Keywords>dsDNA levels</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jocelene Filippin Cossetin</Name>
        <Affiliation>Graduate Program in Pharmacology, Federal University of Santa Maria, 97105-900, Santa Maria, RS, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Amanda Spring de Almeida</Name>
        <Affiliation>Graduate Program in Pharmacology, Federal University of Santa Maria, 97105-900, Santa Maria, RS, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Caren Tatiane de David Antoniazzi</Name>
        <Affiliation>Graduate Program in Pharmacology, Federal University of Santa Maria, 97105-900, Santa Maria, RS, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Sabrina Qader Kudsi</Name>
        <Affiliation>Graduate Program in Pharmacology, Federal University of Santa Maria, 97105-900, Santa Maria, RS, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Ana Martiele Engelmann</Name>
        <Affiliation>Veterinary Hospital, Federal University of Santa Maria (UFSM), 97105-900, Santa Maria, RS, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Camille Gaube Guex</Name>
        <Affiliation>Graduate Program in Pharmacology, Federal University of Santa Maria, 97105-900, Santa Maria, RS, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Juliana Sorraila de Oliveira</Name>
        <Affiliation>Graduate Program in Biological Sciences: Toxicological Biochemistry, Federal University of Santa Maria (UFSM), 97105-900, Santa Maria, RS, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Maria Carolina Theisen</Name>
        <Affiliation>Graduate Program in Pharmacology, Federal University of Santa Maria, 97105-900, Santa Maria, RS, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Camila Santos Ritter</Name>
        <Affiliation>Graduate Program in Pharmacology, Federal University of Santa Maria, 97105-900, Santa Maria, RS, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Pedro Henrique Doleski</Name>
        <Affiliation>Graduate Program in Biological Sciences: Toxicological Biochemistry, Federal University of Santa Maria (UFSM), 97105-900, Santa Maria, RS, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Evelyne da Silva Brum</Name>
        <Affiliation>Graduate Program in Biological Sciences: Toxicological Biochemistry, Federal University of Santa Maria (UFSM), 97105-900, Santa Maria, RS, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Diéssica Padilha Dalenogare</Name>
        <Affiliation>Graduate Program in Pharmacology, Federal University of Santa Maria, 97105-900, Santa Maria, RS, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Diulle Spat Peres</Name>
        <Affiliation>Graduate Program in Pharmacology, Federal University of Santa Maria, 97105-900, Santa Maria, RS, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Francieli Guedes Pintos</Name>
        <Affiliation>Graduate Program in Nanoscience, Franciscan University Center (UFN), 97010-032, Santa Maria, RS, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Cinthia Melazzo de Andrade</Name>
        <Affiliation>Graduate Program in Biological Sciences: Toxicological Biochemistry, Federal University of Santa Maria (UFSM), 97105-900, Santa Maria, RS, Brazil; Veterinary Hospital, Federal University of Santa Maria (UFSM), 97105-900, Santa Maria, RS, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Daniela Bitencourt Rosa Leal</Name>
        <Affiliation>Graduate Program in Biological Sciences: Toxicological Biochemistry, Federal University of Santa Maria (UFSM), 97105-900, Santa Maria, RS, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Sara Marchesan Oliveira</Name>
        <Affiliation>Graduate Program in Biological Sciences: Toxicological Biochemistry, Federal University of Santa Maria (UFSM), 97105-900, Santa Maria, RS, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Liliane de Freitas Bauermann</Name>
        <Affiliation>Graduate Program in Pharmacology, Federal University of Santa Maria, 97105-900, Santa Maria, RS, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Roberta Cougo Riéffel</Name>
        <Affiliation>Graduate Program in Nanoscience, Franciscan University Center (UFN), 97010-032, Santa Maria, RS, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Michele Rorato Sagrillo</Name>
        <Affiliation>Graduate Program in Nanoscience, Franciscan University Center (UFN), 97010-032, Santa Maria, RS, Brazil; Laboratory of Cell Culture and Genetics, Franciscan University (UFN), 97010-032, Santa Maria, RS, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Alencar Kolinski Machado</Name>
        <Affiliation>Laboratory of Cell Culture and Genetics, Franciscan University (UFN), 97010-032, Santa Maria, RS, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Adair Roberto Soares Santos</Name>
        <Affiliation>Graduate Program in Pharmacology, Federal University of Santa Maria, 97105-900, Santa Maria, RS, Brazil; Graduate Program in Neuroscience, Laboratory of Neurobiology of Pain and Inflammation, Federal University of Santa Catarina (UFSC), 88040-900, Florianópolis, SC, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Gabriela Trevisan</Name>
        <Affiliation>Graduate Program in Pharmacology, Federal University of Santa Maria, 97105-900, Santa Maria, RS, Brazil. Electronic address: gabriela.trevisan-santos@ufsm.br.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of competing interest The authors declare that they have no known competing for financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Application of structural and functional pharmacokinetic analogs for physiologically based pharmacokinetic model development and evaluation.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32387187</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(20)30093-3</DOI>
    <KeywordList>
      <Keywords>Analog</Keywords>
      <Keywords>Biokinetics</Keywords>
      <Keywords>IVIVE</Keywords>
      <Keywords>Modeling</Keywords>
      <Keywords>Pharmacokinetics</Keywords>
      <Keywords>Physiologically based pharmacokinetics</Keywords>
      <Keywords>Read across</Keywords>
      <Keywords>Structural activity relationship</Keywords>
      <Keywords>Toxicokinetics</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Corie A. Ellison</Name>
        <Affiliation>The Procter &amp; Gamble Company, Cincinnati, OH, 45040, USA. Electronic address: Ellison.ca@pg.com.</Affiliation>
      </Author>
      <Author>
        <Name>Shengde Wu</Name>
        <Affiliation>The Procter &amp; Gamble Company, Cincinnati, OH, 45040, USA.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>An evaluation of the genotoxicity and subchronic toxicity of the peel extract of Ponkan cultivar 'Ohta ponkan' (Citrus reticulata Blanco) that is rich in nobiletin and tangeretin with anti-dementia activity.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32371103</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(20)30096-9</DOI>
    <KeywordList>
      <Keywords>Citrus reticulata peel</Keywords>
      <Keywords>Genotoxicity</Keywords>
      <Keywords>Subchronic toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Akira Nakajima</Name>
        <Affiliation>Department of Applied Biology and Food Sciences, Faculty of Agriculture and Life Science, Hirosaki University, 3 Bunkyo-cho, Hirosaki, Aomori, 036-8561, Japan; Kansei Fukushi Research Institute, Tohoku Fukushi University, 6-149-1 Kunimigaoka, Aoba-ku, Sendai, Miyagi, 989-3201, Japan. Electronic address: anakajim@hirosaki-u.ac.jp.</Affiliation>
      </Author>
      <Author>
        <Name>Kiyomitsu Nemoto</Name>
        <Affiliation>Department of Molecular Toxicology, Faculty of Pharmaceutical Sciences, Toho University, Miyama 2-2-1, Funabashi, Chiba, 274-8510, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Yasushi Ohizumi</Name>
        <Affiliation>Kansei Fukushi Research Institute, Tohoku Fukushi University, 6-149-1 Kunimigaoka, Aoba-ku, Sendai, Miyagi, 989-3201, Japan. Electronic address: ohizumi@tfu-mail.tfu.ac.jp.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Dietary pectin at 0.2% in milk replacer did not inhibit growth, feed intake, or nutrient digestibility in a 3-week neonatal pig study.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32360443</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(20)30095-7</DOI>
    <KeywordList>
      <Keywords>Digestibility</Keywords>
      <Keywords>Fiber</Keywords>
      <Keywords>Formula</Keywords>
      <Keywords>Infant</Keywords>
      <Keywords>Nutrition</Keywords>
      <Keywords>Pectin</Keywords>
      <Keywords>Pig</Keywords>
      <Keywords>Safety</Keywords>
      <Keywords>Thickeners</Keywords>
      <Keywords>Tolerance</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>S. A. Fleming</Name>
        <Affiliation>Traverse Science, Inc, 60 Hazelwood Dr, Champaign, IL, 61820, USA. Electronic address: stephen@traversescience.com.</Affiliation>
      </Author>
      <Author>
        <Name>J. D. Richards</Name>
        <Affiliation>RB Mead Johnson Nutrition, 2400 West Lloyd Expressway, Evansville, IN, 47721, USA. Electronic address: richardsjim01@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>C. L. Bradley</Name>
        <Affiliation>RB Mead Johnson Nutrition, 2400 West Lloyd Expressway, Evansville, IN, 47721, USA. Electronic address: cris.bradley@rb.com.</Affiliation>
      </Author>
      <Author>
        <Name>X. Pan</Name>
        <Affiliation>RB Mead Johnson Nutrition, 2400 West Lloyd Expressway, Evansville, IN, 47721, USA. Electronic address: daxiaopenny@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Q. Li</Name>
        <Affiliation>RB Mead Johnson Nutrition, 2400 West Lloyd Expressway, Evansville, IN, 47721, USA. Electronic address: qian.li2@rb.com.</Affiliation>
      </Author>
      <Author>
        <Name>R. N. Dilger</Name>
        <Affiliation>Traverse Science, Inc, 60 Hazelwood Dr, Champaign, IL, 61820, USA; Piglet Nutrition and Cognition Laboratory, Department of Animal Sciences, University of Illinois, Urbana, IL, USA; Division of Nutritional Sciences, University of Illinois, Urbana, IL, USA. Electronic address: rdilger2@illinois.edu.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: This study was funded by RB Mead Johnson Nutrition. Authors Jim Richards, Cristine Bradley, Xiao Pan, and Qian Li were employees of RB Mead Johnson Nutrition at the time the work was conducted. Jim Richards, Xiao Pan, and Ryan Dilger contributed to project conceptualization. Ryan Dilger provided project administration and completed all statistical analyses. Stephen Fleming and Ryan Dilger contributed to the original manuscript draft. All authors contributed to the review and editing of the final manuscript. Stephen Fleming and Ryan Dilger have consulted for and received grant funding from RB Mead Johnson Nutrition. In addition, both Stephen Fleming and Ryan Dilger both share ownership in Traverse Science, a consulting firm.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Derivation of whole blood biomonitoring equivalents for titanium for the interpretation of biomonitoring data.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32360442</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(20)30097-0</DOI>
    <KeywordList>
      <Keywords>BE</Keywords>
      <Keywords>Biomonitoring</Keywords>
      <Keywords>Biomonitoring equivalents</Keywords>
      <Keywords>Exposure guidance value</Keywords>
      <Keywords>Titanium</Keywords>
      <Keywords>Toxicokinetics</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>S. Ramoju</Name>
        <Affiliation>Risk Sciences International, Ottawa, ON, Canada. Electronic address: SRamoju@Risksciences.com.</Affiliation>
      </Author>
      <Author>
        <Name>M. E. Andersen</Name>
        <Affiliation>Risk Sciences International, Ottawa, ON, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>A. Nong</Name>
        <Affiliation>Health Canada, Ottawa, ON, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>N. Karyakina</Name>
        <Affiliation>Risk Sciences International, Ottawa, ON, Canada; University of Ottawa, Ottawa, ON, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>N. Shilnikova</Name>
        <Affiliation>Risk Sciences International, Ottawa, ON, Canada; University of Ottawa, Ottawa, ON, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>K. Krishnan</Name>
        <Affiliation>Risk Sciences International, Ottawa, ON, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>D. Krewski</Name>
        <Affiliation>Risk Sciences International, Ottawa, ON, Canada; University of Ottawa, Ottawa, ON, Canada.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A 90-day repeated oral dose toxicity study of four stereoisomers of 2,4-dimethyl-4-phenyltetrahydrofuran, a synthetic flavoring substance, in F344 rats.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32353473</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(20)30090-8</DOI>
    <KeywordList>
      <Keywords>2,4-Dimethyl-4-phenyltetrahydrofuran</Keywords>
      <Keywords>F344 rats</Keywords>
      <Keywords>Flavoring substance</Keywords>
      <Keywords>Food additive</Keywords>
      <Keywords>Subchronic toxicity test</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Tetsuya Ide</Name>
        <Affiliation>Division of Pathology, National Institute of Health Sciences, Kanagawa, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Yasuko Mizuta</Name>
        <Affiliation>Division of Pathology, National Institute of Health Sciences, Kanagawa, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Jun Ichi Akagi</Name>
        <Affiliation>Division of Pathology, National Institute of Health Sciences, Kanagawa, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Naoko Masumoto</Name>
        <Affiliation>Division of Food Additives, National Institute of Health Sciences, Kanagawa, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Naoki Sugimoto</Name>
        <Affiliation>Division of Food Additives, National Institute of Health Sciences, Kanagawa, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Kyoko Sato</Name>
        <Affiliation>Division of Food Additives, National Institute of Health Sciences, Kanagawa, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Kumiko Ogawa</Name>
        <Affiliation>Division of Pathology, National Institute of Health Sciences, Kanagawa, Japan. Electronic address: ogawa93@nihs.go.jp.</Affiliation>
      </Author>
      <Author>
        <Name>Young Man Cho</Name>
        <Affiliation>Division of Pathology, National Institute of Health Sciences, Kanagawa, Japan.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: This work was supported by the Ministry of Health, Labour, and Welfare, Japan.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>New ideas for non-animal approaches to predict repeated-dose systemic toxicity: Report from an EPAA Blue Sky Workshop.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32335207</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(20)30094-5</DOI>
    <KeywordList>
      <Keywords>Alternatives</Keywords>
      <Keywords>Chemical legislation</Keywords>
      <Keywords>Read-across</Keywords>
      <Keywords>Repeated dose toxicity testing</Keywords>
      <Keywords>Safety assessment</Keywords>
      <Keywords>ab initio</Keywords>
      <Keywords>in silico</Keywords>
      <Keywords>in vitro</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Catherine Mahony</Name>
        <Affiliation>Procter &amp; Gamble, Egham, Surrey, UK. Electronic address: mahony.c@pg.com.</Affiliation>
      </Author>
      <Author>
        <Name>Randolph S. Ashton</Name>
        <Affiliation>Department of Biomedical Engineering &amp; Wisconsin Institute for Discovery, University of Wisconsin-Madison, Madison, 53715, USA. Electronic address: rashton2@wisc.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Barbara Birk</Name>
        <Affiliation>BASF SE, Experimental Toxicology and Ecology, Carl-Bosch-Straβe 38, 67056, Ludwigshafen, Germany. Electronic address: barbara.birk@basf.com.</Affiliation>
      </Author>
      <Author>
        <Name>Alan R. Boobis</Name>
        <Affiliation>National Heart &amp; Lung Institute, Imperial College London, London, W12 0NN, UK. Electronic address: a.boobis@imperial.ac.uk.</Affiliation>
      </Author>
      <Author>
        <Name>Tom Cull</Name>
        <Affiliation>Unilever, Colworth Science Park, Sharnbrook, Bedford, MK44 1LQ, UK. Electronic address: tom.cull@unilever.com.</Affiliation>
      </Author>
      <Author>
        <Name>George P. Daston</Name>
        <Affiliation>Mason Business Center, The Procter &amp; Gamble Company, Cincinnati, OH, 45040, USA. Electronic address: daston.gp@pg.com.</Affiliation>
      </Author>
      <Author>
        <Name>Lorna Ewart</Name>
        <Affiliation>Veroli Consulting Limited, Cambridge, UK; Emulate Inc, 27 Dry Dock Avenue, Boston, MA, 02210, USA. Electronic address: lorna.ewart@emulatebio.com.</Affiliation>
      </Author>
      <Author>
        <Name>Thomas B. Knudsen</Name>
        <Affiliation>U.S. Environmental Protection Agency, Office of Research and Development, Center for Computational Toxicology and Exposure, Research Triangle Park, NC, 27711, USA. Electronic address: knudsen.thomas@epa.gov.</Affiliation>
      </Author>
      <Author>
        <Name>Irene Manou</Name>
        <Affiliation>European Partnership for Alternative Approaches to Animal Testing (EPAA) Industry Secretariat, Belgium. Electronic address: irene.manou@epaaind.eu.</Affiliation>
      </Author>
      <Author>
        <Name>Sebastian Maurer-Stroh</Name>
        <Affiliation>Innovations in Chemical and Food Safety, Bioinformatics Institute, Agency for Science, Technology and Research (A*STAR), 30 Biopolis Street #07-01 Matrix, Singapore, 138671, Singapore; Department of Biological Sciences, National University of Singapore, 14 Science Drive 4, Singapore, 117543, Singapore. Electronic address: sebastianms@bii.a-star.edu.sg.</Affiliation>
      </Author>
      <Author>
        <Name>Luigi Margiotta-Casaluci</Name>
        <Affiliation>College of Health and Life Sciences, Brunel University London, London, UB8 3PH, UK. Electronic address: luigi.margiotta-casaluci@brunel.ac.uk.</Affiliation>
      </Author>
      <Author>
        <Name>Boris P. Müller</Name>
        <Affiliation>Symrise AG, Holzminden, Germany. Electronic address: boris.mueller@symrise.com.</Affiliation>
      </Author>
      <Author>
        <Name>Pär Nordlund</Name>
        <Affiliation>Department of Oncology and Pathology, Karolinska Institutet, 17177, Stockholm, Sweden; Institute of Molecular and Cellular Biology, A*STAR, 61 Biopolis Drive, 138673, Singapore. Electronic address: par.nordlund@ki.se.</Affiliation>
      </Author>
      <Author>
        <Name>Ruth A. Roberts</Name>
        <Affiliation>School of Chemistry, University of Birmingham, Birmingham, B15 2TT, UK. Electronic address: r.roberts.4@bham.ac.uk.</Affiliation>
      </Author>
      <Author>
        <Name>Thomas Steger-Hartmann</Name>
        <Affiliation>Investigational Toxicology, Bayer AG, Pharmaceuticals, Müllerstraβe 178, 13353, Berlin, Germany. Electronic address: thomas.steger-hartmann@bayer.com.</Affiliation>
      </Author>
      <Author>
        <Name>Evita Vandenbossche</Name>
        <Affiliation>Unilever, Colworth Science Park, Sharnbrook, Bedford, MK44 1LQ, UK. Electronic address: evita.vandenbossche@unilever.com.</Affiliation>
      </Author>
      <Author>
        <Name>Mark R. Viant</Name>
        <Affiliation>School of Biosciences, University of Birmingham, Birmingham, B15 2TT, UK. Electronic address: m.viant@bham.ac.uk.</Affiliation>
      </Author>
      <Author>
        <Name>Mathieu Vinken</Name>
        <Affiliation>Department of In Vitro Toxicology and Dermato-Cosmetology, Vrije Universiteit Brussel, Laarbeeklaan 103, 1090, Brussels, Belgium. Electronic address: mathieu.vinken@vub.be.</Affiliation>
      </Author>
      <Author>
        <Name>Maurice Whelan</Name>
        <Affiliation>European Commission, Joint Research Centre (JRC), Italy. Electronic address: maurice.whelan@ec.europa.eu.</Affiliation>
      </Author>
      <Author>
        <Name>Zvonar Zvonimir</Name>
        <Affiliation>European Partnership for Alternative Approaches to Animal Testing (EPAA) Industry Secretariat, Belgium. Electronic address: zvonimir.zvonar@epaaind.eu.</Affiliation>
      </Author>
      <Author>
        <Name>Mark T. D. Cronin</Name>
        <Affiliation>School of Pharmacy and Biomolecular Sciences, Liverpool John Moores University, Byrom Street, Liverpool, L3 3AF, UK. Electronic address: m.t.cronin@ljmu.ac.uk.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Some of the authors received reimbursement of their travel expenses by the EPAA to make their participation in the workshop possible. If deemed necessary, a list of those people who received travel expenses support can be provided.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Acute toxicity "six-pack" studies supporting approved new drug applications in the U.S., 2015-2018.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32335206</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(20)30092-1</DOI>
    <KeywordList>
      <Keywords>Acute</Keywords>
      <Keywords>Animal testing alternatives</Keywords>
      <Keywords>Animal use alternatives</Keywords>
      <Keywords>In silico</Keywords>
      <Keywords>Investigational new drug application</Keywords>
      <Keywords>Lethal dose 50</Keywords>
      <Keywords>Local lymph node assay</Keywords>
      <Keywords>New approach methodology (NAM)</Keywords>
      <Keywords>Toxicity tests</Keywords>
      <Keywords>United States Food and drug administration</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Joseph Manuppello</Name>
        <Affiliation>Physicians Committee for Responsible Medicine, 5100 Wisconsin Ave., NW, Suite 400, Washington, DC, 20016-4131, USA. Electronic address: jmanuppello@pcrm.org.</Affiliation>
      </Author>
      <Author>
        <Name>Kristie Sullivan</Name>
        <Affiliation>Physicians Committee for Responsible Medicine, 5100 Wisconsin Ave., NW, Suite 400, Washington, DC, 20016-4131, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Elizabeth Baker</Name>
        <Affiliation>Physicians Committee for Responsible Medicine, 5100 Wisconsin Ave., NW, Suite 400, Washington, DC, 20016-4131, USA.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Regulating human safety: How dose selection in toxicity studies impacts human health hazard assessment and subsequent risk management options.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32334039</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(20)30086-6</DOI>
    <KeywordList>
      <Keywords>Classification</Keywords>
      <Keywords>Human health</Keywords>
      <Keywords>Low dosing</Keywords>
      <Keywords>Regulatory impact</Keywords>
      <Keywords>Toxicity studies</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Marjolijn Woutersen</Name>
        <Affiliation>National Institute for Public Health and the Environment (RIVM), Centre for Safety of Substances and Products (VSP), Bilthoven, the Netherlands. Electronic address: marjolijn.woutersen@rivm.nl.</Affiliation>
      </Author>
      <Author>
        <Name>Andre Muller</Name>
        <Affiliation>National Institute for Public Health and the Environment (RIVM), Centre for Safety of Substances and Products (VSP), Bilthoven, the Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Marja E. J. Pronk</Name>
        <Affiliation>National Institute for Public Health and the Environment (RIVM), Centre for Safety of Substances and Products (VSP), Bilthoven, the Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Nicole H. P. Cnubben</Name>
        <Affiliation>National Institute for Public Health and the Environment (RIVM), Centre for Safety of Substances and Products (VSP), Bilthoven, the Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Betty C. Hakkert</Name>
        <Affiliation>National Institute for Public Health and the Environment (RIVM), Centre for Safety of Substances and Products (VSP), Bilthoven, the Netherlands.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Use of the kinetically-derived maximum dose concept in selection of top doses for toxicity studies hampers proper hazard assessment and risk management.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32334038</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(20)30085-4</DOI>
    <KeywordList>
      <Keywords>3Rs</Keywords>
      <Keywords>Classification</Keywords>
      <Keywords>Hazard and risk assessment</Keywords>
      <Keywords>Inflection point</Keywords>
      <Keywords>KMD</Keywords>
      <Keywords>Kinetically derived maximum dose</Keywords>
      <Keywords>Top dose selection</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Minne B. Heringa</Name>
        <Affiliation>National Institute for Public Health and the Environment (RIVM), Centre for Safety of Substances and Products (VSP), Bilthoven, the Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Nicole H. P. Cnubben</Name>
        <Affiliation>National Institute for Public Health and the Environment (RIVM), Centre for Safety of Substances and Products (VSP), Bilthoven, the Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Wout Slob</Name>
        <Affiliation>National Institute for Public Health and the Environment (RIVM), Centre for Safety of Substances and Products (VSP), Bilthoven, the Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Marja E. J. Pronk</Name>
        <Affiliation>National Institute for Public Health and the Environment (RIVM), Centre for Safety of Substances and Products (VSP), Bilthoven, the Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Andre Muller</Name>
        <Affiliation>National Institute for Public Health and the Environment (RIVM), Centre for Safety of Substances and Products (VSP), Bilthoven, the Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Marjolijn Woutersen</Name>
        <Affiliation>National Institute for Public Health and the Environment (RIVM), Centre for Safety of Substances and Products (VSP), Bilthoven, the Netherlands. Electronic address: Marjolijn.woutersen@rivm.nl.</Affiliation>
      </Author>
      <Author>
        <Name>Betty C. Hakkert</Name>
        <Affiliation>National Institute for Public Health and the Environment (RIVM), Centre for Safety of Substances and Products (VSP), Bilthoven, the Netherlands.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Evaluation of the applicability of existing (Q)SAR models for predicting the genotoxicity of pesticides and similarity analysis related with genotoxicity of pesticides for facilitating of grouping and read across: An EFSA funded project.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32334037</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(20)30084-2</DOI>
    <KeywordList>
      <Keywords>(Q)SAR</Keywords>
      <Keywords>Dietary risk assessment</Keywords>
      <Keywords>Genotoxicity</Keywords>
      <Keywords>In silico</Keywords>
      <Keywords>Metabolite</Keywords>
      <Keywords>Pesticide active substance</Keywords>
      <Keywords>Read across</Keywords>
      <Keywords>Structural changes</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Romualdo Benigni</Name>
        <Affiliation>Alpha-Pretox, Rome, Italy. Electronic address: romualdo.benigni@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Rositsa Serafimova</Name>
        <Affiliation>European Food Safety Authority, Parma, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Juan Manuel Parra Morte</Name>
        <Affiliation>European Food Safety Authority, Parma, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Chiara Laura Battistelli</Name>
        <Affiliation>Istituto Superiore di Sanità (ISS), Environmental and Health Department, Rome, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Cecilia Bossa</Name>
        <Affiliation>Istituto Superiore di Sanità (ISS), Environmental and Health Department, Rome, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Alessandro Giuliani</Name>
        <Affiliation>Istituto Superiore di Sanità (ISS), Environmental and Health Department, Rome, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Elena Fioravanzo</Name>
        <Affiliation>S-IN Soluzioni Informatiche Srl, Vicenza, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Arianna Bassan</Name>
        <Affiliation>S-IN Soluzioni Informatiche Srl, Vicenza, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Mojca Fuart Gatnik</Name>
        <Affiliation>S-IN Soluzioni Informatiche Srl, Vicenza, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>James Rathman</Name>
        <Affiliation>Altamira, LLC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Chihae Yang</Name>
        <Affiliation>Altamira, LLC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Aleksandra Mostrag-Szlichtyng</Name>
        <Affiliation>Altamira, LLC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Oliver Sacher</Name>
        <Affiliation>Altamira, LLC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Olga Tcheremenskaia</Name>
        <Affiliation>Istituto Superiore di Sanità (ISS), Environmental and Health Department, Rome, Italy.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Preclinical safety evaluation of body protective compound-157, a potential drug for treating various wounds.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32334036</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(20)30091-X</DOI>
    <KeywordList>
      <Keywords>BPC157</Keywords>
      <Keywords>Preclinical evaluation</Keywords>
      <Keywords>Repeated-dose toxicity study</Keywords>
      <Keywords>Safety</Keywords>
      <Keywords>Single-dose toxicity study</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Chuanyang Xu</Name>
        <Affiliation>State Key Laboratory of Cancer Biology, Biotechnology Center, School of Pharmacy, Fourth Military Medical University, Xi'an, 710032, China.</Affiliation>
      </Author>
      <Author>
        <Name>Lijuan Sun</Name>
        <Affiliation>Department of Ophthalmology, Eye Institute of Chinese PLA, Xijing Hospital, Fourth Military Medical University, Xi'an, 710032, China.</Affiliation>
      </Author>
      <Author>
        <Name>FengLing Ren</Name>
        <Affiliation>School of Public Health, Health Science Center, Xi'an Jiaotong University, Xi'an, 710061, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ping Huang</Name>
        <Affiliation>The Brigade of Undergraduates, The Fourth Military Medical University, Xi'an, 710032, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhuang Tian</Name>
        <Affiliation>The Brigade of Undergraduates, The Fourth Military Medical University, Xi'an, 710032, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jiazhen Cui</Name>
        <Affiliation>The Brigade of Undergraduates, The Fourth Military Medical University, Xi'an, 710032, China.</Affiliation>
      </Author>
      <Author>
        <Name>Wangqian Zhang</Name>
        <Affiliation>State Key Laboratory of Cancer Biology, Biotechnology Center, School of Pharmacy, Fourth Military Medical University, Xi'an, 710032, China.</Affiliation>
      </Author>
      <Author>
        <Name>Shuning Wang</Name>
        <Affiliation>State Key Laboratory of Cancer Biology, Biotechnology Center, School of Pharmacy, Fourth Military Medical University, Xi'an, 710032, China.</Affiliation>
      </Author>
      <Author>
        <Name>Kuo Zhang</Name>
        <Affiliation>State Key Laboratory of Cancer Biology, Biotechnology Center, School of Pharmacy, Fourth Military Medical University, Xi'an, 710032, China.</Affiliation>
      </Author>
      <Author>
        <Name>Lei He</Name>
        <Affiliation>State Key Laboratory of Cancer Biology, Biotechnology Center, School of Pharmacy, Fourth Military Medical University, Xi'an, 710032, China.</Affiliation>
      </Author>
      <Author>
        <Name>Wei Zhang</Name>
        <Affiliation>State Key Laboratory of Cancer Biology, Biotechnology Center, School of Pharmacy, Fourth Military Medical University, Xi'an, 710032, China.</Affiliation>
      </Author>
      <Author>
        <Name>Cun Zhang</Name>
        <Affiliation>State Key Laboratory of Cancer Biology, Biotechnology Center, School of Pharmacy, Fourth Military Medical University, Xi'an, 710032, China.</Affiliation>
      </Author>
      <Author>
        <Name>Qiang Hao</Name>
        <Affiliation>State Key Laboratory of Cancer Biology, Biotechnology Center, School of Pharmacy, Fourth Military Medical University, Xi'an, 710032, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yingqi Zhang</Name>
        <Affiliation>State Key Laboratory of Cancer Biology, Biotechnology Center, School of Pharmacy, Fourth Military Medical University, Xi'an, 710032, China.</Affiliation>
      </Author>
      <Author>
        <Name>Meng Li</Name>
        <Affiliation>State Key Laboratory of Cancer Biology, Biotechnology Center, School of Pharmacy, Fourth Military Medical University, Xi'an, 710032, China. Electronic address: limeng@fmmu.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Weina Li</Name>
        <Affiliation>State Key Laboratory of Cancer Biology, Biotechnology Center, School of Pharmacy, Fourth Military Medical University, Xi'an, 710032, China. Electronic address: liweina@fmmu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Chronic inflammation, Adverse Outcome Pathways, and risk assessment: A diagrammatic exposition.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32330641</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(20)30089-1</DOI>
    <KeywordList>
      <Keywords>Acute inflammation</Keywords>
      <Keywords>Adverse outcome pathway</Keywords>
      <Keywords>Chronic inflammation</Keywords>
      <Keywords>Inflammasome</Keywords>
      <Keywords>Mode of action</Keywords>
      <Keywords>Risk analysis</Keywords>
      <Keywords>Threshold</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Louis Anthony Cox</Name>
        <Affiliation>Cox Associates and University of Colorado, 503 N. Franklin Street, Denver, CO, 80218, USA. Electronic address: tcoxdenver@aol.com.</Affiliation>
      </Author>
      <Author>
        <Name>Julie E. Goodman</Name>
        <Affiliation>Gradient, One Beacon Street, 17th Floor, Boston, MA, 02108, USA. Electronic address: jgoodman@gradientcorp.com.</Affiliation>
      </Author>
      <Author>
        <Name>Anna M. Engel</Name>
        <Affiliation>Gradient, One Beacon Street, 17th Floor, Boston, MA, 02108, USA. Electronic address: aengel@gradientcorp.com.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: The authors had complete control over the design, conduct, interpretation, and composition of this manuscript. The contents of this manuscript are solely the responsibility of the authors and do not necessarily reflect the views or policies of their employers. Julie E. Goodman and Anna M. Engel received support from the George Washington University (GWU) for developing this manuscript. Julie E. Goodman has served as an expert in multiple litigation matters involving asbestos-containing products. None of the underlying research or analysis for this paper was performed during the context of those engagements or was sponsored by any of the defendants. Louis Anthony Cox's work on the risk modeling approach reported here was supported by his employer, Cox Associates LLC, which has received research funding in 2018–2020 from the following sources: (1) a research contract from the National Stone, Sand, and Gravel Association to develop and apply risk models and machine learning methods and causal analytics to risk assessment for mineral dusts and fibers; (2) a research project with the GWU Regulatory Studies Center to investigate and explain the role of the NLRP3 inflammasome in risk analysis.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>An FDA/CDER perspective on nonclinical testing strategies: Classical toxicology approaches and new approach methodologies (NAMs).</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32325112</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(20)30088-X</DOI>
    <KeywordList>
      <Keywords>Alternative</Keywords>
      <Keywords>Approach</Keywords>
      <Keywords>Drug development</Keywords>
      <Keywords>FDA</Keywords>
      <Keywords>In vitro</Keywords>
      <Keywords>Methodology</Keywords>
      <Keywords>Regulatory</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Amy M. Avila</Name>
        <Affiliation>Center for Drug Evaluation and Research, US Food and Drug Administration, 10903 New Hampshire Ave., Silver Spring, MD, 20903, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Ilona Bebenek</Name>
        <Affiliation>Center for Drug Evaluation and Research, US Food and Drug Administration, 10903 New Hampshire Ave., Silver Spring, MD, 20903, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Jessica A. Bonzo</Name>
        <Affiliation>Center for Drug Evaluation and Research, US Food and Drug Administration, 10903 New Hampshire Ave., Silver Spring, MD, 20903, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Todd Bourcier</Name>
        <Affiliation>Center for Drug Evaluation and Research, US Food and Drug Administration, 10903 New Hampshire Ave., Silver Spring, MD, 20903, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Karen L. Davis Bruno</Name>
        <Affiliation>Center for Drug Evaluation and Research, US Food and Drug Administration, 10903 New Hampshire Ave., Silver Spring, MD, 20903, United States.</Affiliation>
      </Author>
      <Author>
        <Name>David B. Carlson</Name>
        <Affiliation>Center for Drug Evaluation and Research, US Food and Drug Administration, 10903 New Hampshire Ave., Silver Spring, MD, 20903, United States.</Affiliation>
      </Author>
      <Author>
        <Name>John Dubinion</Name>
        <Affiliation>Center for Drug Evaluation and Research, US Food and Drug Administration, 10903 New Hampshire Ave., Silver Spring, MD, 20903, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Ikram Elayan</Name>
        <Affiliation>Center for Drug Evaluation and Research, US Food and Drug Administration, 10903 New Hampshire Ave., Silver Spring, MD, 20903, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Wafa Harrouk</Name>
        <Affiliation>Center for Drug Evaluation and Research, US Food and Drug Administration, 10903 New Hampshire Ave., Silver Spring, MD, 20903, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Shwu Luan Lee</Name>
        <Affiliation>Center for Drug Evaluation and Research, US Food and Drug Administration, 10903 New Hampshire Ave., Silver Spring, MD, 20903, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Donna L. Mendrick</Name>
        <Affiliation>National Center for Toxicological Research, US Food and Drug Administration, 10903 New Hampshire Ave., Silver Spring, MD, 20903, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Jill C. Merrill</Name>
        <Affiliation>Center for Drug Evaluation and Research, US Food and Drug Administration, 10903 New Hampshire Ave., Silver Spring, MD, 20903, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Jackye Peretz</Name>
        <Affiliation>Center for Drug Evaluation and Research, US Food and Drug Administration, 10903 New Hampshire Ave., Silver Spring, MD, 20903, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Emily Place</Name>
        <Affiliation>Center for Drug Evaluation and Research, US Food and Drug Administration, 10903 New Hampshire Ave., Silver Spring, MD, 20903, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Muriel Saulnier</Name>
        <Affiliation>Center for Drug Evaluation and Research, US Food and Drug Administration, 10903 New Hampshire Ave., Silver Spring, MD, 20903, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Ronald L. Wange</Name>
        <Affiliation>Center for Drug Evaluation and Research, US Food and Drug Administration, 10903 New Hampshire Ave., Silver Spring, MD, 20903, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Jia Yao</Name>
        <Affiliation>Center for Drug Evaluation and Research, US Food and Drug Administration, 10903 New Hampshire Ave., Silver Spring, MD, 20903, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Dong Zhao</Name>
        <Affiliation>Center for Drug Evaluation and Research, US Food and Drug Administration, 10903 New Hampshire Ave., Silver Spring, MD, 20903, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Paul C. Brown</Name>
        <Affiliation>Center for Drug Evaluation and Research, US Food and Drug Administration, 10903 New Hampshire Ave., Silver Spring, MD, 20903, United States. Electronic address: Paul.Brown@fda.hhs.gov.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Integration of in vitro data from three dimensionally cultured HepaRG cells and physiologically based pharmacokinetic modeling for assessment of acetaminophen hepatotoxicity.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32315674</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(20)30087-8</DOI>
    <KeywordList>
      <Keywords>Acetaminophen (APAP)</Keywords>
      <Keywords>Hepatotoxicity</Keywords>
      <Keywords>Mitochondrial injury</Keywords>
      <Keywords>PBPK modeling</Keywords>
      <Keywords>Three-dimensional (3D)</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Chi Zhang</Name>
        <Affiliation>Academy of Military Medical Sciences, Beijing, PR China; Center of Disease Control and Prevention, PLA, Beijing, PR China; Military Hospital of the 73rd Army Group, Xiamen, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Qiang Zhang</Name>
        <Affiliation>Department of Environmental Health, Rollins School of Public Health, Emory University, Atlanta, GA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jin Li</Name>
        <Affiliation>Unilever Safety and Environmental Assurance Center, Colworth Science Park, Bedfordshire, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Lin Yu</Name>
        <Affiliation>Academy of Military Medical Sciences, Beijing, PR China; Center of Disease Control and Prevention, PLA, Beijing, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Fengxiang Li</Name>
        <Affiliation>Center of Disease Control and Prevention, PLA, Beijing, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Weiwei Li</Name>
        <Affiliation>State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Yujie Li</Name>
        <Affiliation>Center of Disease Control and Prevention, PLA, Beijing, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Hui Peng</Name>
        <Affiliation>Center of Disease Control and Prevention, PLA, Beijing, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Jun Zhao</Name>
        <Affiliation>Center of Disease Control and Prevention, PLA, Beijing, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Paul L. Carmichael</Name>
        <Affiliation>Unilever Safety and Environmental Assurance Center, Colworth Science Park, Bedfordshire, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Yunfang Wang</Name>
        <Affiliation>Academy of Military Medical Sciences, Beijing, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Shuangqing Peng</Name>
        <Affiliation>Academy of Military Medical Sciences, Beijing, PR China; Center of Disease Control and Prevention, PLA, Beijing, PR China. Electronic address: pengsq@hotmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Jiabin Guo</Name>
        <Affiliation>Academy of Military Medical Sciences, Beijing, PR China; Center of Disease Control and Prevention, PLA, Beijing, PR China. Electronic address: gjb321@163.com.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Regulatory landscape of dietary supplements and herbal medicines from a global perspective.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32305367</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(20)30073-8</DOI>
    <KeywordList>
      <Keywords>Dietary supplements</Keywords>
      <Keywords>Emerging technology</Keywords>
      <Keywords>GSRS</Keywords>
      <Keywords>Harmonization</Keywords>
      <Keywords>Herbal medicine</Keywords>
      <Keywords>Regulatory science</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Shraddha Thakkar</Name>
        <Affiliation>National Center for Toxicological Research (NCTR), Food and Drug Administration (FDA), USA.</Affiliation>
      </Author>
      <Author>
        <Name>Elke Anklam</Name>
        <Affiliation>European Commission, Joint Research Centre (JRC), Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Alex Xu</Name>
        <Affiliation>Center of Drug Evaluation (CDE), National Medical Products Administration (NMPA), China.</Affiliation>
      </Author>
      <Author>
        <Name>Franz Ulberth</Name>
        <Affiliation>European Commission, Joint Research Centre (JRC), Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Jing Li</Name>
        <Affiliation>Center for Drug Evaluation and Research (CDER), Food and Drug Administration (FDA), USA.</Affiliation>
      </Author>
      <Author>
        <Name>Bo Li</Name>
        <Affiliation>National Institutes for Food and Drug Control (NIFDC), National Medical Products Administration (NMPA), China.</Affiliation>
      </Author>
      <Author>
        <Name>Marta Hugas</Name>
        <Affiliation>European Food Safety Authority (EFSA), EU, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Nandakumara Sarma</Name>
        <Affiliation>US Pharmacopeia (USP), USA.</Affiliation>
      </Author>
      <Author>
        <Name>Scott Crerar</Name>
        <Affiliation>Food Standards Australia New Zealand (FSANZ), Australia.</Affiliation>
      </Author>
      <Author>
        <Name>Sibyl Swift</Name>
        <Affiliation>Center for Food Safety and Applied Nutrition (CFSAN), Food and Drug Administration (FDA), USA.</Affiliation>
      </Author>
      <Author>
        <Name>Takashi Hakamatsuka</Name>
        <Affiliation>National Institute of Health Sciences (NIHS), Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Valeriu Curtui</Name>
        <Affiliation>European Food Safety Authority (EFSA), EU, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>William Yan</Name>
        <Affiliation>Health Canada (HC), Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Xingchao Geng</Name>
        <Affiliation>National Institutes for Food and Drug Control (NIFDC), National Medical Products Administration (NMPA), China.</Affiliation>
      </Author>
      <Author>
        <Name>William Slikker</Name>
        <Affiliation>National Center for Toxicological Research (NCTR), Food and Drug Administration (FDA), USA. Electronic address: william.slikker@fda.hhs.gov.</Affiliation>
      </Author>
      <Author>
        <Name>Weida Tong</Name>
        <Affiliation>National Center for Toxicological Research (NCTR), Food and Drug Administration (FDA), USA. Electronic address: weida.tong@fda.hhs.gov.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Safety evaluation of water extract of Gastrodia elata Blume: Genotoxicity and 28-day oral toxicity studies.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32278877</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(20)30083-0</DOI>
    <KeywordList>
      <Keywords>Gastrodia elata Blume</Keywords>
      <Keywords>Genotoxicity</Keywords>
      <Keywords>NOAEL</Keywords>
      <Keywords>Safety evaluation</Keywords>
      <Keywords>Subacute toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Kuan Hung Lu</Name>
        <Affiliation>Institute of Food Safety and Health, National Taiwan University, Taipei, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Guan Ling Ou</Name>
        <Affiliation>Institute of Food Science and Technology, National Taiwan University, Taipei, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Hui Ping Chang</Name>
        <Affiliation>Institute of Food Science and Technology, National Taiwan University, Taipei, Taiwan; Department of Dietetics and Nutrition, Taipei City Hospital, Taipei, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Wei Cheng Chen</Name>
        <Affiliation>Institute of Food Science and Technology, National Taiwan University, Taipei, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Shing Hwa Liu</Name>
        <Affiliation>Institute of Toxicology, College of Medicine, National Taiwan University, Taipei, Taiwan; Department of Pediatrics, College of Medicine, National Taiwan University &amp; Hospital, Taipei, Taiwan; Department of Medical Research, China Medical University Hospital, China Medical University, Taichung, Taiwan. Electronic address: shinghwaliu@ntu.edu.tw.</Affiliation>
      </Author>
      <Author>
        <Name>Lee Yan Sheen</Name>
        <Affiliation>Institute of Food Science and Technology, National Taiwan University, Taipei, Taiwan; Center for Food and Biomolecules, National Taiwan University, Taipei, Taiwan; National Center for Food Safety Education and Research, National Taiwan University, Taipei, Taiwan. Electronic address: lysheen@ntu.edu.tw.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Safety evaluation of collagenase from Streptomyces violaceoruber.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32278234</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(20)30071-4</DOI>
    <KeywordList>
      <Keywords>Collagenase</Keywords>
      <Keywords>Genotoxicity</Keywords>
      <Keywords>Microbial enzyme</Keywords>
      <Keywords>Safety</Keywords>
      <Keywords>Streptomyces violaceoruber</Keywords>
      <Keywords>Subchronic oral toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Koichi Harazono</Name>
        <Affiliation>Nagase ChemteX Corporation, Bio Chemicals Department, Development Division, 1-52, Osadanocho, Fukuchiyama, Kyoto, 620-0853, Japan. Electronic address: koichi.harazono@ncx.nagase.co.jp.</Affiliation>
      </Author>
      <Author>
        <Name>Yuta Atsumi</Name>
        <Affiliation>Nagase ChemteX Corporation, Bio Chemicals Department, Development Division, 1-52, Osadanocho, Fukuchiyama, Kyoto, 620-0853, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Naoki Shirasaka</Name>
        <Affiliation>Nagase ChemteX Corporation, Bio Chemicals Department, Development Division, 1-52, Osadanocho, Fukuchiyama, Kyoto, 620-0853, Japan.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of competing interest The authers declare the following financial interests/personal relationships which may be considered as potential competing interests: Koichi Harazono, Yuta Atsumi and Naoki Shirasaka are employees of Nagase ChemteX Corporation. Nagase ChemteX Corporation provided the funding for this study.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Toxicological evaluation of, red rice yeast extract, Xuezhikang: Acute, 26-week chronic and genotoxicity studies.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32278069</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(20)30080-5</DOI>
    <KeywordList>
      <Keywords>Acute toxicity</Keywords>
      <Keywords>Chronic oral toxicity</Keywords>
      <Keywords>Genotoxicity</Keywords>
      <Keywords>Lovastatin</Keywords>
      <Keywords>Red rice yeast extract</Keywords>
      <Keywords>Xuezhikang (XZK)</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Yonglin Gao</Name>
        <Affiliation>School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University, Yantai, 264005, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiao Chen</Name>
        <Affiliation>School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University, Yantai, 264005, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Chunmei Li</Name>
        <Affiliation>School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University, Yantai, 264005, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Hongbo Wang</Name>
        <Affiliation>School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University, Yantai, 264005, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Jingwei Tian</Name>
        <Affiliation>School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University, Yantai, 264005, PR China. Electronic address: tianjingwei@luye.com.</Affiliation>
      </Author>
      <Author>
        <Name>Fenghua Fu</Name>
        <Affiliation>School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University, Yantai, 264005, PR China. Electronic address: fenghua@luye.com.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Cyto-genotoxic evaluation of novel anti-tubercular copper (II) complexes containing isoniazid-based ligands.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32268159</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(20)30079-9</DOI>
    <KeywordList>
      <Keywords>Ames test</Keywords>
      <Keywords>Citotoxicity</Keywords>
      <Keywords>Comet assay</Keywords>
      <Keywords>Copper(II) complexes</Keywords>
      <Keywords>Micronucleus-cytome assay</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Nathália Ferreira Fregonezi</Name>
        <Affiliation>UNIARA- University of Araraquara, Department of Biological Sciences and Health, CEP 14801-340, Araraquara, São Paulo, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Fabiana Aparecida de Souza</Name>
        <Affiliation>UNIARA- University of Araraquara, Department of Biological Sciences and Health, CEP 14801-340, Araraquara, São Paulo, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Nadia Andrade Aleixo</Name>
        <Affiliation>UNIARA- University of Araraquara, Department of Biological Sciences and Health, CEP 14801-340, Araraquara, São Paulo, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Pietra Stefany da Silva Gomes</Name>
        <Affiliation>UNIARA- University of Araraquara, Department of Biological Sciences and Health, CEP 14801-340, Araraquara, São Paulo, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Rafaela Baldassari Silvestre</Name>
        <Affiliation>UNIARA- University of Araraquara, Department of Biological Sciences and Health, CEP 14801-340, Araraquara, São Paulo, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Rone Aparecido De Grandis</Name>
        <Affiliation>UNIARA- University of Araraquara, Department of Biological Sciences and Health, CEP 14801-340, Araraquara, São Paulo, Brazil; UNESP-São Paulo State University, Faculty of Pharmaceutical Sciences of Araraquara- Department of Biological Sciences, 14801-902, Araraquara, São Paulo, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Patricia Bento da Silva</Name>
        <Affiliation>UNESP-São Paulo State University, Faculty of Pharmaceutical Sciences of Araraquara- Department of Biological Sciences, 14801-902, Araraquara, São Paulo, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Fernando Rogério Pavan</Name>
        <Affiliation>UNESP-São Paulo State University, Faculty of Pharmaceutical Sciences of Araraquara- Department of Biological Sciences, 14801-902, Araraquara, São Paulo, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Marlus Chorilli</Name>
        <Affiliation>UNESP-São Paulo State University, Faculty of Pharmaceutical Sciences of Araraquara- Department of Biological Sciences, 14801-902, Araraquara, São Paulo, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Flavia Aparecida Resende</Name>
        <Affiliation>UNIARA- University of Araraquara, Department of Biological Sciences and Health, CEP 14801-340, Araraquara, São Paulo, Brazil. Electronic address: farnogueira@uniara.edu.br.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Short-term toxicogenomics as an alternative approach to chronic in vivo studies for derivation of points of departure: A case study in the rat with a triazole fungicide.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32268158</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(20)30081-7</DOI>
    <KeywordList>
      <Keywords>Benchmark dose</Keywords>
      <Keywords>Pesticide</Keywords>
      <Keywords>Point of departure</Keywords>
      <Keywords>Toxicogenomics</Keywords>
      <Keywords>Triazole</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jessica LaRocca</Name>
        <Affiliation>Corteva Agriscience, Indianapolis, IN, USA. Electronic address: Jessica.larocca@corteva.com.</Affiliation>
      </Author>
      <Author>
        <Name>Eduardo Costa</Name>
        <Affiliation>Corteva Agriscience, Indianapolis, IN, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Shreedharan Sriram</Name>
        <Affiliation>Corteva Agriscience, Indianapolis, IN, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Bethany R. Hannas</Name>
        <Affiliation>Corteva Agriscience, Indianapolis, IN, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Kamin J. Johnson</Name>
        <Affiliation>Corteva Agriscience, Indianapolis, IN, USA.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A semi-automated workflow for adverse outcome pathway hypothesis generation: The use case of non-genotoxic induced hepatocellular carcinoma.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32251711</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(20)30078-7</DOI>
    <KeywordList>
      <Keywords>Automated workflow</Keywords>
      <Keywords>Computationally predicted adverse outcome pathway</Keywords>
      <Keywords>Hypothesis-generation</Keywords>
      <Keywords>Non-genotoxic-induced hepatocellular carcinoma</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Tatyana Y. Doktorova</Name>
        <Affiliation>Edelweiss Connect GmbH, Hochbergerstrasse 60C, Technology Park Basel, Basel, Switzerland. Electronic address: tatyana.doktorova@edelweissconnect.com.</Affiliation>
      </Author>
      <Author>
        <Name>Noffisat O. Oki</Name>
        <Affiliation>American Association for the Advancement of Science, Science &amp; Technology Policy Fellow, USA; National Institutes of Health, Rockville, MD, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Tomaž Mohorič</Name>
        <Affiliation>Edelweiss Connect GmbH, Hochbergerstrasse 60C, Technology Park Basel, Basel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Thomas E. Exner</Name>
        <Affiliation>Edelweiss Connect GmbH, Hochbergerstrasse 60C, Technology Park Basel, Basel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Barry Hardy</Name>
        <Affiliation>Edelweiss Connect GmbH, Hochbergerstrasse 60C, Technology Park Basel, Basel, Switzerland.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The limitations of using the NTP chronic bioassay on vanadium pentoxide in risk assessments.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32246946</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(20)30076-3</DOI>
    <KeywordList>
      <Keywords>Carcinogenicity</Keywords>
      <Keywords>Chronic bioassay</Keywords>
      <Keywords>Inhalation</Keywords>
      <Keywords>Lung tumors</Keywords>
      <Keywords>Risk</Keywords>
      <Keywords>Vanadium pentoxide</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Judith A. MacGregor</Name>
        <Affiliation>Toxicology Consulting Services, Bonita Springs, FL, USA.</Affiliation>
      </Author>
      <Author>
        <Name>David J. White</Name>
        <Affiliation>David White Chemical and Metallurgical Consulting, Apex, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Amy Lavin Williams</Name>
        <Affiliation>Exponent, Inc., Alexandria, VA, USA. Electronic address: awilliams@exponent.com.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: This work was sponsored/funded by the Vanadium Producers &amp; Reclaimers Association (VPRA). Judith A. MacGregor also reports consulting fees from VPRA &amp; VANITEC in other matters. However, the analysis and conclusions presented herein are those of the authors and not of their employers or the sponsor.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Nonclinical safety assessment of repeated administration and biodistribution of a novel rabies self-amplifying mRNA vaccine in rats.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32240713</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(20)30074-X</DOI>
    <KeywordList>
      <Keywords>Biodistribution</Keywords>
      <Keywords>Rabies</Keywords>
      <Keywords>SAM</Keywords>
      <Keywords>Toxicity</Keywords>
      <Keywords>Vaccine</Keywords>
      <Keywords>mRNA</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Alan Stokes</Name>
        <Affiliation>GSK, Rockville, MD, USA. Electronic address: Alan.H.Stokes@gsk.com.</Affiliation>
      </Author>
      <Author>
        <Name>Johanne Pion</Name>
        <Affiliation>Citoxlab (A Charles River Company), Laval (Québec), Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Ornella Binazon</Name>
        <Affiliation>GSK, Wavre, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Benoit Laffont</Name>
        <Affiliation>Citoxlab (A Charles River Company), Laval (Québec), Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Maude Bigras</Name>
        <Affiliation>Citoxlab (A Charles River Company), Laval (Québec), Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Guillaume Dubois</Name>
        <Affiliation>Citoxlab (A Charles River Company), Laval (Québec), Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Karine Blouin</Name>
        <Affiliation>Citoxlab (A Charles River Company), Laval (Québec), Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Jamie K. Young</Name>
        <Affiliation>StageBio, Mason, OH, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Michael A. Ringenberg</Name>
        <Affiliation>GSK, Collegeville, PA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Nawel Ben Abdeljelil</Name>
        <Affiliation>Citoxlab (A Charles River Company), Laval (Québec), Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Julius Haruna</Name>
        <Affiliation>Citoxlab (A Charles River Company), Laval (Québec), Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Luis Alexander Rodriguez</Name>
        <Affiliation>GSK, Wavre, Belgium.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Alan Stokes, Ornella Binazon, Michael Ringenberg and Luis-Alexander Rodriguez are employees of the GSK group of companies. Alan Stokes, Luis Alexander Rodriguez and Michael A. Ringenberg report ownership of GSK shares and/or restricted shares. Johanne Pion, Julius Haruna, Maude Bigras, Benoit Laffont, Guillaume Dubois, Karine Blouin and Nawel Ben Abdeljelil, are employees of Citoxlab, a Contract Research Organization contracted by GSK in the context of this study. Jamie Young is an employee of StageBio, a company subcontracted by Citoxlab for this study.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Risk assessment implications of site-specific oral relative bioavailability factors and dermal absorption fractions for polycyclic aromatic hydrocarbons in surface soils impacted by clay skeet target fragments.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32234330</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(20)30075-1</DOI>
    <KeywordList>
      <Keywords>Clay skeet</Keywords>
      <Keywords>Dermal absorption fraction</Keywords>
      <Keywords>Oral relative bioavailability</Keywords>
      <Keywords>PAHs</Keywords>
      <Keywords>Polycyclic aromatic hydrocarbons</Keywords>
      <Keywords>Risk assessment</Keywords>
      <Keywords>Screening values</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Joseph T. Haney</Name>
        <Affiliation>Texas Commission on Environmental Quality (TCEQ), Toxicology Division, MC-168, P.O. Box 13087, Austin, TX, 78711, United States. Electronic address: Joseph.Haney@tceq.texas.gov.</Affiliation>
      </Author>
      <Author>
        <Name>Norman D. Forsberg</Name>
        <Affiliation>Arcadis U.S., Inc., One Executive Drive, Suite 303, Chelmsford, MA, 01824, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Glenn C. Hoeger</Name>
        <Affiliation>Carollo Engineers, Inc., One South Church Avenue, Suite 2130, Tucson, AZ, 85701, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Brian H. Magee</Name>
        <Affiliation>Arcadis U.S., Inc., One Executive Drive, Suite 303, Chelmsford, MA, 01824, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Anita K. Meyer</Name>
        <Affiliation>Army Corps of Engineers, Huntsville Center, Environmental and Munitions Center of Expertise, 1616 Capitol Avenue, Omaha, NE, 68102, United States.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Comparison of threshold of toxicological concern (TTC) values to oral reference dose (RfD) values.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32229245</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(20)30077-5</DOI>
    <KeywordList>
      <Keywords>Reference value</Keywords>
      <Keywords>Threshold of toxicological concern</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Ly L. Pham</Name>
        <Affiliation>ToxStrategies, Asheville, NC, USA. Electronic address: lpham@toxstrategies.com.</Affiliation>
      </Author>
      <Author>
        <Name>Susan J. Borghoff</Name>
        <Affiliation>ToxStrategies, Cary, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Chad M. Thompson</Name>
        <Affiliation>ToxStrategies, Katy, TX, USA.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: This work was funded by Chemours Chemical Company.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Cell proliferation analysis is a reliable predictor of lack of carcinogenicity: Case study using the pyrethroid imiprothrin on lung tumorigenesis in mice.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32229244</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(20)30072-6</DOI>
    <KeywordList>
      <Keywords>Carcinogenicity</Keywords>
      <Keywords>Club cells</Keywords>
      <Keywords>Isoniazid</Keywords>
      <Keywords>Pyrethroid</Keywords>
      <Keywords>Replicative DNA synthesis</Keywords>
      <Keywords>Short-term bioassays</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Kensuke Kawamoto</Name>
        <Affiliation>Environmental Health Science Laboratory, Sumitomo Chemical Company, Ltd., 3-1-98 Kasugade-naka, Konohana-ku, Osaka, 554-8558, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Keiko Ogata</Name>
        <Affiliation>Environmental Health Science Laboratory, Sumitomo Chemical Company, Ltd., 3-1-98 Kasugade-naka, Konohana-ku, Osaka, 554-8558, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Hiroyuki Asano</Name>
        <Affiliation>Environmental Health Science Laboratory, Sumitomo Chemical Company, Ltd., 3-1-98 Kasugade-naka, Konohana-ku, Osaka, 554-8558, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Kaori Miyata</Name>
        <Affiliation>Environmental Health Science Laboratory, Sumitomo Chemical Company, Ltd., 3-1-98 Kasugade-naka, Konohana-ku, Osaka, 554-8558, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Tokuo Sukata</Name>
        <Affiliation>Environmental Health Science Laboratory, Sumitomo Chemical Company, Ltd., 3-1-98 Kasugade-naka, Konohana-ku, Osaka, 554-8558, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Tooru Utsumi</Name>
        <Affiliation>Environmental Health Science Laboratory, Sumitomo Chemical Company, Ltd., 3-1-98 Kasugade-naka, Konohana-ku, Osaka, 554-8558, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Samuel M. Cohen</Name>
        <Affiliation>Havlik-Wall Professor of Oncology, Department of Pathology and Microbiology, University of Nebraska Medical Center, 983135 Omaha, Nebraska, 68198-3135, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Tomoya Yamada</Name>
        <Affiliation>Environmental Health Science Laboratory, Sumitomo Chemical Company, Ltd., 3-1-98 Kasugade-naka, Konohana-ku, Osaka, 554-8558, Japan. Electronic address: yamadat8@sc.sumitomo-chem.co.jp.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Prof. Samuel M. Cohen consults for Sumitomo Chemical Company, Ltd. The other authors are employed by Sumitomo Chemical Company, Ltd.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Acute and repeated dose 28-day oral toxicity of Chrysobalanusicaco L. leaf aqueous extract.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32199870</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(20)30069-6</DOI>
    <KeywordList>
      <Keywords>Chrysobalanaceae</Keywords>
      <Keywords>Histopathological assessment</Keywords>
      <Keywords>Phytochemical analysis</Keywords>
      <Keywords>Saponins</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Natalie Emanuelle Ribeiro</Name>
        <Affiliation>Laboratory of Pharmacological Prospecting of Bioactive Products (BIOFARMATOX), Department of Antibiotics, Federal University of Pernambuco, Recife, Pernambuco, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Pedro Silvino Pereira</Name>
        <Affiliation>Laboratory of Pharmacological Prospecting of Bioactive Products (BIOFARMATOX), Department of Antibiotics, Federal University of Pernambuco, Recife, Pernambuco, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Tatiane Bezerra de Oliveira</Name>
        <Affiliation>Laboratory of Pharmacological Prospecting of Bioactive Products (BIOFARMATOX), Department of Antibiotics, Federal University of Pernambuco, Recife, Pernambuco, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Sandrine Maria de Arruda Lima</Name>
        <Affiliation>Laboratory of Pharmacological Prospecting of Bioactive Products (BIOFARMATOX), Department of Antibiotics, Federal University of Pernambuco, Recife, Pernambuco, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Tania Maria Sarmento Silva</Name>
        <Affiliation>Department of Chemistry, Rural Federal University of Pernambuco, Av. Manuel de Medeiros, 96, Dois Irmãos, 52171-900, Recife, PE, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Andréa Lopes Bandeira Delmiro Santana</Name>
        <Affiliation>Laboratory of Pharmacological Prospecting of Bioactive Products (BIOFARMATOX), Department of Antibiotics, Federal University of Pernambuco, Recife, Pernambuco, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Márcia Silva do Nascimento</Name>
        <Affiliation>Laboratory of Pharmacological Prospecting of Bioactive Products (BIOFARMATOX), Department of Antibiotics, Federal University of Pernambuco, Recife, Pernambuco, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Rogelio Moreno Santisteban</Name>
        <Affiliation>Department of Chemistry, Rural Federal University of Pernambuco, Av. Manuel de Medeiros, 96, Dois Irmãos, 52171-900, Recife, PE, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Álvaro Aguiar Coelho Teixeira</Name>
        <Affiliation>Department of Morphology and Animal Physiology, Federal Rural University of Pernambuco, Recife, Pernambuco, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Teresinha Gonçalves da Silva</Name>
        <Affiliation>Laboratory of Pharmacological Prospecting of Bioactive Products (BIOFARMATOX), Department of Antibiotics, Federal University of Pernambuco, Recife, Pernambuco, Brazil. Electronic address: teresinha.goncalves@ufpe.br.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>"Natural" is not synonymous with "Safe": Toxicity of natural products alone and in combination with pharmaceutical agents.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32197968</pubmedLink>
    <GrantList>
      <Grant>R01 GM121354</Grant>
      <Grant>U54 AT008909</Grant>
    </GrantList>
    <Year>2020</Year>
    <DOI>S0273-2300(20)30068-4</DOI>
    <KeywordList>
      <Keywords>Cannabis</Keywords>
      <Keywords>Drug interactions</Keywords>
      <Keywords>Medication safety</Keywords>
      <Keywords>Natural products</Keywords>
      <Keywords>Regulatory guidance</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Tyler E. Gaston</Name>
        <Affiliation>Department of Neurology, University of Alabama at Birmingham, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Donna L. Mendrick</Name>
        <Affiliation>National Center for Toxicological Research, United States Food and Drug Administration, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Mary F. Paine</Name>
        <Affiliation>Department of Pharmaceutical Sciences, Washington State University, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Amy L. Roe</Name>
        <Affiliation>The Procter &amp; Gamble Company, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Catherine K. Yeung</Name>
        <Affiliation>Department of Pharmacy, University of Washington, United States. Electronic address: cathyy@uw.edu.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Use of toxicokinetic data for afidopyropen to determine the dose levels in developmental toxicity studies.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32194133</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(20)30070-2</DOI>
    <KeywordList>
      <Keywords>KMD</Keywords>
      <Keywords>Kinetically derived maximum dose</Keywords>
      <Keywords>MTD</Keywords>
      <Keywords>Pharmacokinetics</Keywords>
      <Keywords>Rabbit</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Anne E. Loccisano</Name>
        <Affiliation>Exponent Inc, Alexandria, VA, 22314, USA.</Affiliation>
      </Author>
      <Author>
        <Name>James Bus</Name>
        <Affiliation>Exponent Inc, Alexandria, VA, 22314, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Bhaskar Gollapudi</Name>
        <Affiliation>Exponent Inc, Alexandria, VA, 22314, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Brandy Riffle</Name>
        <Affiliation>BASF Corporation, Research Triangle Park, NC, 27709, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Markus Frericks</Name>
        <Affiliation>BASF SE Experimental Toxicology and Ecology, Ludwigshafen, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Ivana Fegert</Name>
        <Affiliation>BASF SE Experimental Toxicology and Ecology, Ludwigshafen, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Eric Fabian</Name>
        <Affiliation>BASF SE Experimental Toxicology and Ecology, Ludwigshafen, Germany. Electronic address: eric.fabian@basf.com.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Evaluation of the sub-acute toxicity of Acacia catechu Willd seed extract in a Wistar albino rat model.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32169672</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(20)30066-0</DOI>
    <KeywordList>
      <Keywords>Acacia catechu</Keywords>
      <Keywords>Albino rats</Keywords>
      <Keywords>Biochemical parameters</Keywords>
      <Keywords>GGT</Keywords>
      <Keywords>Gastrointestinal</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Lakshmi Thangavelu</Name>
        <Affiliation>Department of Pharmacology, Saveetha Dental College &amp; Hospitals, Saveetha Institute of Medical and Technical Sciences (SIMATS), Saveetha Univeristy, Chennai, Tamilnadu, India.</Affiliation>
      </Author>
      <Author>
        <Name>Sri Renukadevi Balusamy</Name>
        <Affiliation>Department of Food Science and Biotechnology, Sejong University, Gwangjin-gu, Seoul, 05006, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Rajeshkumar Shanmugam</Name>
        <Affiliation>Department of Pharmacology, Saveetha Dental College &amp; Hospitals, Saveetha Institute of Medical and Technical Sciences (SIMATS), Saveetha Univeristy, Chennai, Tamilnadu, India.</Affiliation>
      </Author>
      <Author>
        <Name>Senthilkumar Sivanesan</Name>
        <Affiliation>Department of Research &amp; Development, Saveetha Institute of Medical and Technical Sciences (SIMATS), Chennai, Tamilnadu, India.</Affiliation>
      </Author>
      <Author>
        <Name>Ezhilarasan Devaraj</Name>
        <Affiliation>Department of Pharmacology, Saveetha Dental College &amp; Hospitals, Saveetha Institute of Medical and Technical Sciences (SIMATS), Saveetha Univeristy, Chennai, Tamilnadu, India.</Affiliation>
      </Author>
      <Author>
        <Name>Vijayaraghavan Rajagopalan</Name>
        <Affiliation>Department of Research &amp; Development, Saveetha Institute of Medical and Technical Sciences (SIMATS), Chennai, Tamilnadu, India.</Affiliation>
      </Author>
      <Author>
        <Name>Deepak Nallaswamy Veeraiyan</Name>
        <Affiliation>Department of Prosthodontics, Saveetha Dental College &amp; Hospitals, Saveetha Institute of Medical and Technical Sciences (SIMATS), Saveetha Univeristy, Chennai, Tamilnadu, India.</Affiliation>
      </Author>
      <Author>
        <Name>Dinesh Kumar Chellappan</Name>
        <Affiliation>Department of Life Sciences, School of Pharmacy, International Medical University, Bukit Jalil, Kuala Lumpur, 57000, Malaysia.</Affiliation>
      </Author>
      <Author>
        <Name>Kamal Dua</Name>
        <Affiliation>Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney (UTS), Ultimo, NSW, 2007, Australia.</Affiliation>
      </Author>
      <Author>
        <Name>Yeon Ju Kim</Name>
        <Affiliation>Graduate School of Biotechnology, College of Life Science, Kyung Hee University, Yongin, 446- 701, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Haribalan Perumalsamy</Name>
        <Affiliation>Graduate School of Biotechnology, College of Life Science, Kyung Hee University, Yongin, 446- 701, Republic of Korea. Electronic address: harijai2004@gmail.com.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Is there a rationale for direct dosing of chemicals to nursing pups in the EOGRTS (OECD 443)?</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32165176</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(20)30067-2</DOI>
    <KeywordList>
      <Keywords>Direct dosing of nursing pups</Keywords>
      <Keywords>EOGRTS</Keywords>
      <Keywords>OECD 443</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Josje Arts</Name>
        <Affiliation>Nouryon Chemicals BV, Velperweg 76, 6824 BM, Arnhem, Netherlands. Electronic address: josje.arts@nouryon.com.</Affiliation>
      </Author>
      <Author>
        <Name>Manon Beekhuijzen</Name>
        <Affiliation>Charles River, Hambakenwetering 7, 5231 DD, 's-Hertogenbosch, Netherlands.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>An analysis of the setting of the acute reference dose (ARfD) for pesticides in Europe.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32160954</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(20)30064-7</DOI>
    <KeywordList>
      <Keywords>ARfD</Keywords>
      <Keywords>Acute reference dose</Keywords>
      <Keywords>Pesticides</Keywords>
      <Keywords>Rabbit</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Mary Moxon</Name>
        <Affiliation>MMTGS Limited, Congleton, United Kingdom. Electronic address: marymoxon.tgs@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Christian Strupp</Name>
        <Affiliation>Gowan Crop Protection, Reading, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Manoj Aggarwal</Name>
        <Affiliation>Corteva Agriscience, Newark, DE, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Jenny Odum</Name>
        <Affiliation>Regulatory Science Associates, Inverkip, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Richard Lewis</Name>
        <Affiliation>Syngenta, Bracknell, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Stéphanie Zedet</Name>
        <Affiliation>Albaugh Europe Sàrl, Lausanne, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Jyotigna Mehta</Name>
        <Affiliation>Adama Agricultural Solutions UK Ltd, Reading, United Kingdom.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Recommendations for further revisions to improve the International Agency for Research on Cancer (IARC) Monograph program.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32147291</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(20)30065-9</DOI>
    <KeywordList>
      <Keywords>Carcinogen</Keywords>
      <Keywords>Evidence integration, mode of action</Keywords>
      <Keywords>IARC</Keywords>
      <Keywords>Monograph</Keywords>
      <Keywords>Systematic review</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Julie E. Goodman</Name>
        <Affiliation>Gradient, One Beacon Street, 17th Floor, Boston, MA, 02108, USA. Electronic address: jgoodman@gradientcorp.com.</Affiliation>
      </Author>
      <Author>
        <Name>David B. Mayfield</Name>
        <Affiliation>Gradient, 600 Stewart Street, Suite 1900, Seattle, WA, 98101, USA. Electronic address: dmayfield@gradientcorp.com.</Affiliation>
      </Author>
      <Author>
        <Name>Richard A. Becker</Name>
        <Affiliation>American Chemistry Council, 700 2nd Street NE, Washington, DC, 20002, USA. Electronic address: rick_becker@americanchemistry.com.</Affiliation>
      </Author>
      <Author>
        <Name>Suzanne B. Hartigan</Name>
        <Affiliation>American Chemistry Council, 700 2nd Street NE, Washington, DC, 20002, USA. Electronic address: suzanne_hartigan@americanchemistry.com.</Affiliation>
      </Author>
      <Author>
        <Name>Neeraja K. Erraguntla</Name>
        <Affiliation>American Chemistry Council, 700 2nd Street NE, Washington, DC, 20002, USA. Electronic address: neeraja_erraguntla@americanchemistry.com.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: The authors had complete control over the design, conduct, interpretation, and composition of this manuscript. The contents of this manuscript are solely the responsibility of the authors and do not necessarily reflect the views or policies of their employers. Julie E. Goodman and David B. Mayfield received support from the American Chemistry Council (ACC) for developing this manuscript. Richard A. Becker, Suzanne B. Hartigan, and Neeraja K. Erraguntla are employed by the ACC, a trade association of chemical manufacturers. This work was supported by funding from the ACC.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Assessment of the inhibition risk of paris saponins, bioactive compounds from Paris polyphylla, on CYP and UGT enzymes via cocktail inhibition assays.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32145316</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(20)30063-5</DOI>
    <KeywordList>
      <Keywords>Cytochrome P450 (CYP)</Keywords>
      <Keywords>Paris saponins</Keywords>
      <Keywords>Polyphyllin</Keywords>
      <Keywords>Risk evaluation</Keywords>
      <Keywords>UDP-Glucuronosyltransferases (UGT)</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Han Luo</Name>
        <Affiliation>Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences and School of Life Sciences, East China Normal University, Shanghai, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yuan Xu</Name>
        <Affiliation>Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences and School of Life Sciences, East China Normal University, Shanghai, China.</Affiliation>
      </Author>
      <Author>
        <Name>Dongyi Sun</Name>
        <Affiliation>Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences and School of Life Sciences, East China Normal University, Shanghai, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yi Cheng</Name>
        <Affiliation>Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences and School of Life Sciences, East China Normal University, Shanghai, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhenliang Sun</Name>
        <Affiliation>Southern Medical University Affiliated Fengxian Hospital, Shanghai, China. Electronic address: zhenliang6@126.com.</Affiliation>
      </Author>
      <Author>
        <Name>Jing Gao</Name>
        <Affiliation>College of Life Sciences, Northwest University, Xi'an, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yuanjin Zhang</Name>
        <Affiliation>Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences and School of Life Sciences, East China Normal University, Shanghai, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xin Wang</Name>
        <Affiliation>Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences and School of Life Sciences, East China Normal University, Shanghai, China. Electronic address: xwang@bio.ecnu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Opportunities for use of one species for longer-term toxicology testing during drug development: A cross-industry evaluation.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32126256</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(20)30050-7</DOI>
    <KeywordList>
      <Keywords>3Rs</Keywords>
      <Keywords>Biologics</Keywords>
      <Keywords>Drug development</Keywords>
      <Keywords>ICHS6(R1)</Keywords>
      <Keywords>Non-rodent</Keywords>
      <Keywords>Nonclinical</Keywords>
      <Keywords>Rodent</Keywords>
      <Keywords>Small molecules</Keywords>
      <Keywords>Species selection</Keywords>
      <Keywords>Toxicology</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Helen Prior</Name>
        <Affiliation>National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs), Gibbs Building, 215 Euston Road, London, NW1 2BE, UK. Electronic address: helen.prior@nc3rs.org.uk.</Affiliation>
      </Author>
      <Author>
        <Name>Paul Baldrick</Name>
        <Affiliation>Covance Laboratories Ltd, Otley Road, Harrogate, HG3 1PY, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Sonja Beken</Name>
        <Affiliation>Federal Agency for Medicines and Health Products (FAMHP), Victor Hortaplace 40/40, Brussels, 1060, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Helen Booler</Name>
        <Affiliation>Genentech, Inc, 1 DNA Way, South San Francisco, CA, 94080, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Nancy Bower</Name>
        <Affiliation>Eisai Inc, 155 Tice Blvd, Woodcliff Lake, NJ, 07677, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Paul Brooker</Name>
        <Affiliation>Board member, NC3Rs, Gibbs Building, 215 Euston Road, London, NW1 2BE, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Paul Brown</Name>
        <Affiliation>Food and Drug Administration (FDA), 10903 New Hampshire Avenue, Silver Spring, MD, 20993, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Brian Burlinson</Name>
        <Affiliation>Covance, Huntingdon, Cambridgeshire, PE28 4HS, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Leigh Ann Burns-Naas</Name>
        <Affiliation>Gilead Sciences, Inc, 333 Lakeside Drive, Foster City, CA, 94404, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Warren Casey</Name>
        <Affiliation>National Toxicology Program Interagency Center for the Evaluation of Alternative Toxicological Methods (NICEATM), National Institute of Environmental Health Sciences, P.O. Box 12233, Research Triangle Park, NC, 27709, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Melissa Chapman</Name>
        <Affiliation>Oncology Safety, Clinical Pharmacology and Safety Sciences,R&amp;D, AstraZeneca, Cambridge, UK.</Affiliation>
      </Author>
      <Author>
        <Name>David Clarke</Name>
        <Affiliation>Lilly Research Laboratories, Indianapolis, IN, 46285, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Lolke de Haan</Name>
        <Affiliation>Biologics and Advanced Therapeutics Safety, Clinical Pharmacology and Safety Sciences, R&amp;D, AstraZeneca, Cambridge, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Olaf Doehr</Name>
        <Affiliation>Bayer Pharma AG, Müllerstrasse 170, 13353, Berlin, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Noel Downes</Name>
        <Affiliation>Sequani Limited, Bromyard Rd, Ledbury, Herefordshire, HR8 1LH, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Meghan Flaherty</Name>
        <Affiliation>Takeda Pharmaceuticals, 300 Massachusetts Ave, Cambridge, MA, 02139, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Nichola Gellatly</Name>
        <Affiliation>National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs), Gibbs Building, 215 Euston Road, London, NW1 2BE, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Sophia Gry Moesgaard</Name>
        <Affiliation>Novo Nordisk A/S, Novo Nordisk Park, Maaloev, Denmark.</Affiliation>
      </Author>
      <Author>
        <Name>Jennifer Harris</Name>
        <Affiliation>Association of British Pharmaceutical Industry (ABPI), 105 Victoria Street, London, SW1E 6QT, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Mark Holbrook</Name>
        <Affiliation>VAST Pharma Solutions Ltd, Harrogate, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Julia Hui</Name>
        <Affiliation>Celgene, 86 Morris Avenue, Summit, NJ, 07901, USA.</Affiliation>
      </Author>
      <Author>
        <Name>David Jones</Name>
        <Affiliation>Medicines Healthcare products Regulatory Agency (MHRA) 10 South Colonnade, Canary Wharf, London, E14 4PU, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Keith Jones</Name>
        <Affiliation>CFMD Ltd, Peterborough, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Hilla Kedar</Name>
        <Affiliation>Teva Pharmaceuticals, Netanya Area, Israel.</Affiliation>
      </Author>
      <Author>
        <Name>Andreas Mahl</Name>
        <Affiliation>Novartis Institutes for BioMedical Research (NIBR), Basel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Alli Manninen</Name>
        <Affiliation>Prekliniska Byran Sweden AB, Stockholm, Sweden.</Affiliation>
      </Author>
      <Author>
        <Name>Aidan McGuire</Name>
        <Affiliation>Charles River Laboratories, Preclinical Services, Tranent, Edinburgh, EH33 2NE, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Elisabeth Mortimer-Cassen</Name>
        <Affiliation>Regulatory Safety Centre of Excellence, Clinical Pharmacology and Safety Sciences, R&amp;D, AstraZeneca, Cambridge, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Marjorie Peraza</Name>
        <Affiliation>Pfizer Drug Safety Research and Development, 300 Technology Square, Cambridge, MA, 02139, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Michael K. Pugsley</Name>
        <Affiliation>Cytokinetics, South San Francisco, CA, 94080, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jacques Richard</Name>
        <Affiliation>Sanofi, 371 Rue du Professeur Blayac, Montpellier, 34000, France.</Affiliation>
      </Author>
      <Author>
        <Name>Ruth Roberts</Name>
        <Affiliation>ApconiX, Alderley Park, Alderley Edge, Cheshire, SK10 4TG, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Wendy Roosen</Name>
        <Affiliation>Janssen Research &amp; Development, Turnhoutseweg 30, 2340, Beerse, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Andreas Rothfuss</Name>
        <Affiliation>Roche Pharmaceutical Research and Early Development, Roche Innovation Center Basel, CH - 4070, Basel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Ankie Schoenmakers</Name>
        <Affiliation>Charles River Laboratories, Den Bosch B.V, the Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Fiona Sewell</Name>
        <Affiliation>National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs), Gibbs Building, 215 Euston Road, London, NW1 2BE, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Richard Weaver</Name>
        <Affiliation>Institut de Recherches Internationales Servier, Biopharmacy, 92284, Suresnes, Cedex, France.</Affiliation>
      </Author>
      <Author>
        <Name>Lucinda Weir</Name>
        <Affiliation>GlaxoSmithKline, Park Road, Ware, Hertfordshire, SG12 0DP, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Alison Wolfreys</Name>
        <Affiliation>UCB Biopharma, Bath Rd, Slough, SL1 3WE, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Ian Kimber</Name>
        <Affiliation>University of Manchester, Faculty of Biology, Medicine and Health, Oxford Rd, Manchester, M13 9PL, UK.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. The authors declare the following financial interests/personal relationships which may be considered as potential competing interests:</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A commentary on some epidemiology data for chlorpyrifos.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32119975</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(20)30042-8</DOI>
    <KeywordList>
      <Keywords>Chlorpyrifos</Keywords>
      <Keywords>Chlorpyrifos-oxon</Keywords>
      <Keywords>Cholinesterase inhibition</Keywords>
      <Keywords>Full-scale IQ scores</Keywords>
      <Keywords>Science transparency</Keywords>
      <Keywords>Working memory index</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Michael Dourson</Name>
        <Affiliation>Toxicology Excellence for Risk Assessment (TERA), 1250 Ohio Pike, Suite 197, Amelia, OH, 45102, United States. Electronic address: dourson@tera.org.</Affiliation>
      </Author>
      <Author>
        <Name>Bernard Gadagbui</Name>
        <Affiliation>Toxicology Excellence for Risk Assessment (TERA), 1250 Ohio Pike, Suite 197, Amelia, OH, 45102, United States. Electronic address: gadagbui@tera.org.</Affiliation>
      </Author>
      <Author>
        <Name>Chijioke Onyema</Name>
        <Affiliation>Toxicology Excellence for Risk Assessment (TERA), 1250 Ohio Pike, Suite 197, Amelia, OH, 45102, United States. Electronic address: chijiokeonyema@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Patricia McGinnis</Name>
        <Affiliation>Toxicology Excellence for Risk Assessment (TERA), 1250 Ohio Pike, Suite 197, Amelia, OH, 45102, United States. Electronic address: mcginnis@tera.org.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: The origin of this work came about from briefings of Michael Dourson as a U.S. Environmental Protection Agency senior advisor in 2017. Afterwards, DowAgro Sciences funded, in part, an independently developed report by Toxicology Excellence for Risk Assessment (TERA), which confirmed the findings of EPA staff. The development of this manuscript has been supported by the Internal Development Reserve funds of TERA.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Chimeric hemagglutinin supra-seasonal universal influenza vaccine candidates administered sequentially by the intramuscular route are locally and systemically well-tolerated in rabbits.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32119974</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(20)30051-9</DOI>
    <KeywordList>
      <Keywords>Chimeric hemagglutinin</Keywords>
      <Keywords>Influenza</Keywords>
      <Keywords>Rabbit</Keywords>
      <Keywords>Supra-seasonal</Keywords>
      <Keywords>Toxicity</Keywords>
      <Keywords>Universal</Keywords>
      <Keywords>Vaccine</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Éric Destexhe</Name>
        <Affiliation>GSK, Rixensart, Belgium. Electronic address: eric.x.destexhe@gsk.com.</Affiliation>
      </Author>
      <Author>
        <Name>Émilie Grosdidier</Name>
        <Affiliation>Charles River Laboratories Évreux, France.</Affiliation>
      </Author>
      <Author>
        <Name>Adèle Bouhraoua</Name>
        <Affiliation>Charles River Laboratories Évreux, France.</Affiliation>
      </Author>
      <Author>
        <Name>Catherine Thirion-Delalande</Name>
        <Affiliation>Charles River Laboratories Évreux, France.</Affiliation>
      </Author>
      <Author>
        <Name>Badiaa Bouzya</Name>
        <Affiliation>GSK, Rixensart, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Ronan N. Rouxel</Name>
        <Affiliation>GSK, Rixensart, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Corey P. Mallett</Name>
        <Affiliation>GSK, Rockville, MD, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Judith Baumeister</Name>
        <Affiliation>GSK, Wavre, Belgium.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Badiaa Bouzya, Corey P. Mallett, ED, Judith Baumeister and Ronan N. Rouxel are, or were at the time of the study, employees of the GSK group of companies. ED and Corey P. Mallett report ownership of GSK shares and/or restricted shares. Corey P. Mallett is listed as inventor on patents owned by GSK. Adèle Bouhraoua, Catherine Thirion-Delalande and EG are, or were at the time of the study employees of Charles River Laboratories Evreux, a Contract Research Organization contracted by GSK in the context of this study.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Development of improved QSAR models for predicting the outcome of the in vivo micronucleus genetic toxicity assay.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32092371</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(20)30046-5</DOI>
    <KeywordList>
      <Keywords>(Q)SAR</Keywords>
      <Keywords>Computational toxicology</Keywords>
      <Keywords>Genetic toxicity</Keywords>
      <Keywords>In vivo micronucleus assay</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jae Wook Yoo</Name>
        <Affiliation>US Food and Drug Administration, Center for Drug Evaluation and Research, 10903 New Hampshire Ave, Silver Spring, MD, 20993, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Naomi L. Kruhlak</Name>
        <Affiliation>US Food and Drug Administration, Center for Drug Evaluation and Research, 10903 New Hampshire Ave, Silver Spring, MD, 20993, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Curran Landry</Name>
        <Affiliation>US Food and Drug Administration, Center for Drug Evaluation and Research, 10903 New Hampshire Ave, Silver Spring, MD, 20993, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Kevin P. Cross</Name>
        <Affiliation>Leadscope Inc., 1393 Dublin Road, Columbus, OH, 43215, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Alexander Sedykh</Name>
        <Affiliation>Multicase Inc., 23811 Chagrin Boulevard, Suite 305, Beachwood, OH, 44122, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Lidiya Stavitskaya</Name>
        <Affiliation>US Food and Drug Administration, Center for Drug Evaluation and Research, 10903 New Hampshire Ave, Silver Spring, MD, 20993, USA. Electronic address: lidiya.stavitskaya@fda.hhs.gov.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Phototoxic risk assessment of dermally-applied chemicals with structural variety based on photoreactivity and skin deposition.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32088184</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(20)30045-3</DOI>
    <KeywordList>
      <Keywords>Cassette-dosing pharmacokinetics</Keywords>
      <Keywords>Photosafety</Keywords>
      <Keywords>Phototoxicity</Keywords>
      <Keywords>Reactive oxygen species</Keywords>
      <Keywords>Structural diversity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Yoshiki Seto</Name>
        <Affiliation>Laboratory of Biopharmacy, School of Pharmaceutical Sciences, University of Shizuoka, 52-1 Yada, Suruga-ku, Shizuoka, 422-8526, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Hiroto Ohtake</Name>
        <Affiliation>Laboratory of Biopharmacy, School of Pharmaceutical Sciences, University of Shizuoka, 52-1 Yada, Suruga-ku, Shizuoka, 422-8526, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Hideyuki Sato</Name>
        <Affiliation>Laboratory of Biopharmacy, School of Pharmaceutical Sciences, University of Shizuoka, 52-1 Yada, Suruga-ku, Shizuoka, 422-8526, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Satomi Onoue</Name>
        <Affiliation>Laboratory of Biopharmacy, School of Pharmaceutical Sciences, University of Shizuoka, 52-1 Yada, Suruga-ku, Shizuoka, 422-8526, Japan. Electronic address: onoue@u-shizuoka-ken.ac.jp.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Rat two-generation reproductive toxicity and teratogenicity studies of a novel coccidiostat - Ethanamizuril.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32088183</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(20)30049-0</DOI>
    <KeywordList>
      <Keywords>Ethanamizuril</Keywords>
      <Keywords>Novel triazine coccidiostats</Keywords>
      <Keywords>Reproductive toxicity</Keywords>
      <Keywords>Sprague-dawley rats</Keywords>
      <Keywords>Teratogenicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Keyu Zhang</Name>
        <Affiliation>Key Laboratory of Veterinary Chemical Drugs and Pharmaceutics, Ministry of Agriculture and Rural Affairs, Shanghai Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Shanghai, 200241, PR China. Electronic address: z_cole@sina.com.</Affiliation>
      </Author>
      <Author>
        <Name>Chunmei Wang</Name>
        <Affiliation>Key Laboratory of Veterinary Chemical Drugs and Pharmaceutics, Ministry of Agriculture and Rural Affairs, Shanghai Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Shanghai, 200241, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Yang Li</Name>
        <Affiliation>Centre for New Drug Safety Evaluation and Research, Institute of Laboratory Animal Sciences, Chinese Academy of Medical Sciences, Beijing, 100021, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Jun He</Name>
        <Affiliation>Centre for New Drug Safety Evaluation and Research, Institute of Laboratory Animal Sciences, Chinese Academy of Medical Sciences, Beijing, 100021, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Mi Wang</Name>
        <Affiliation>Key Laboratory of Veterinary Chemical Drugs and Pharmaceutics, Ministry of Agriculture and Rural Affairs, Shanghai Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Shanghai, 200241, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaoyang Wang</Name>
        <Affiliation>Key Laboratory of Veterinary Chemical Drugs and Pharmaceutics, Ministry of Agriculture and Rural Affairs, Shanghai Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Shanghai, 200241, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Lifang Zhang</Name>
        <Affiliation>Key Laboratory of Veterinary Chemical Drugs and Pharmaceutics, Ministry of Agriculture and Rural Affairs, Shanghai Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Shanghai, 200241, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Chenzhong Fei</Name>
        <Affiliation>Key Laboratory of Veterinary Chemical Drugs and Pharmaceutics, Ministry of Agriculture and Rural Affairs, Shanghai Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Shanghai, 200241, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Haihong Zheng</Name>
        <Affiliation>Key Laboratory of Veterinary Chemical Drugs and Pharmaceutics, Ministry of Agriculture and Rural Affairs, Shanghai Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Shanghai, 200241, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Yingchun Liu</Name>
        <Affiliation>Key Laboratory of Veterinary Chemical Drugs and Pharmaceutics, Ministry of Agriculture and Rural Affairs, Shanghai Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Shanghai, 200241, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Feiqun Xue</Name>
        <Affiliation>Key Laboratory of Veterinary Chemical Drugs and Pharmaceutics, Ministry of Agriculture and Rural Affairs, Shanghai Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Shanghai, 200241, PR China.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Towards the development of an omics data analysis framework.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32087354</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(20)30047-7</DOI>
    <KeywordList>
      <Keywords>Data-analysis framework</Keywords>
      <Keywords>Regulatory agencies</Keywords>
      <Keywords>Toxicogenomics</Keywords>
      <Keywords>Toxicology</Keywords>
      <Keywords>Transcriptomics</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Marcha Verheijen</Name>
        <Affiliation>Maastricht University, Maastricht, the Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Weida Tong</Name>
        <Affiliation>National Center for Toxicological Research, U.S. Food and Drug Administration (FDA), Jefferson, AR, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Leming Shi</Name>
        <Affiliation>Fudan University (FU), Yangpu District, Shanghai, China.</Affiliation>
      </Author>
      <Author>
        <Name>Timothy W. Gant</Name>
        <Affiliation>Public Health England (PHE), Harwell Science and Innovation Campus, Oxfordshire, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Bruce Seligman</Name>
        <Affiliation>Biospyder, Tucson, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Florian Caiment</Name>
        <Affiliation>Maastricht University, Maastricht, the Netherlands. Electronic address: florian.caiment@maastichtuniversity.nl.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of competing interest The authors declare that they have no known competing interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Role of Diosmin in protection against the oxidative stress induced damage by gamma-radiation in Wistar albino rats.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32087353</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(20)30048-9</DOI>
    <KeywordList>
      <Keywords>Apoptosis</Keywords>
      <Keywords>DNA damage</Keywords>
      <Keywords>Diosmin</Keywords>
      <Keywords>Gamma radiation</Keywords>
      <Keywords>Radioprotection</Keywords>
      <Keywords>Reactive oxygen species</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Shahenda Mahgoub</Name>
        <Affiliation>Biochemistry and Molecular Biology Department, Faculty of Pharmacy, Helwan University, Ein-Helwan, Helwan, Cairo, 11795, Egypt. Electronic address: shahenda.mahgoub@pharm.helwan.edu.eg.</Affiliation>
      </Author>
      <Author>
        <Name>Anas O. Sallam</Name>
        <Affiliation>Medical Department, Nuclear Material Authority, Cairo, Egypt. Electronic address: Anas.sallam11@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Hazem K. A. Sarhan</Name>
        <Affiliation>Medical and Radiation Research Department, Research Sector, Nuclear Material Authority, Cairo, Egypt. Electronic address: Hazem_Kamel1980@yahoo.com.</Affiliation>
      </Author>
      <Author>
        <Name>Amal A. A. Ammar</Name>
        <Affiliation>Medical and Radiation Research Department, Research Sector, Nuclear Material Authority, Cairo, Egypt. Electronic address: amalammar2016@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Sameh H. Soror</Name>
        <Affiliation>Biochemistry and Molecular Biology Department, Faculty of Pharmacy, Helwan University, Ein-Helwan, Helwan, Cairo, 11795, Egypt. Electronic address: sameh_soror@pharm.helwan.edu.eg.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Silica dioxide nanoparticles aggravate airway inflammation in an asthmatic mouse model via NLRP3 inflammasome activation.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32087352</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(20)30044-1</DOI>
    <KeywordList>
      <Keywords>Asthma</Keywords>
      <Keywords>IL-1β</Keywords>
      <Keywords>Inflammation</Keywords>
      <Keywords>NLRP3 inflammasome</Keywords>
      <Keywords>Silica nanoparticle</Keywords>
      <Keywords>TXNIP</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Je Won Ko</Name>
        <Affiliation>College of Veterinary Medicine (BK21 Plus Project Team), Chonnam National University, Gwangju, 61186, Republic of Korea; College of Veterinary Medicine, Chungnam National University, Daejeon, 34134, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Na Rae Shin</Name>
        <Affiliation>College of Veterinary Medicine (BK21 Plus Project Team), Chonnam National University, Gwangju, 61186, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Lim Je-Oh</Name>
        <Affiliation>College of Veterinary Medicine (BK21 Plus Project Team), Chonnam National University, Gwangju, 61186, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Tae Yang Jung</Name>
        <Affiliation>College of Veterinary Medicine (BK21 Plus Project Team), Chonnam National University, Gwangju, 61186, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Changjong Moon</Name>
        <Affiliation>College of Veterinary Medicine (BK21 Plus Project Team), Chonnam National University, Gwangju, 61186, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Tae Won Kim</Name>
        <Affiliation>College of Veterinary Medicine, Chungnam National University, Daejeon, 34134, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Jungil Choi</Name>
        <Affiliation>Gyeongnam Department of Environment and Toxicology, Korea Institute of Toxicology, Gyeongnam, 52834, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>In Sik Shin</Name>
        <Affiliation>College of Veterinary Medicine (BK21 Plus Project Team), Chonnam National University, Gwangju, 61186, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Jeong Doo Heo</Name>
        <Affiliation>Gyeongnam Department of Environment and Toxicology, Korea Institute of Toxicology, Gyeongnam, 52834, Republic of Korea. Electronic address: jdher@kitox.re.kr.</Affiliation>
      </Author>
      <Author>
        <Name>Jong Choon Kim</Name>
        <Affiliation>College of Veterinary Medicine (BK21 Plus Project Team), Chonnam National University, Gwangju, 61186, Republic of Korea. Electronic address: toxkim@jnu.ac.kr.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Comparison of the potential mechanisms for hepatotoxicity of p-dialkoxy chlorobenzenes in rat primary hepatocytes for read-across.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32087351</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(20)30043-X</DOI>
    <KeywordList>
      <Keywords>Hepatotoxicity</Keywords>
      <Keywords>IATA</Keywords>
      <Keywords>Read-across</Keywords>
      <Keywords>Toxicogenomics</Keywords>
      <Keywords>p-dialkoxy chlorobenzenes</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Shota Nakagawa</Name>
        <Affiliation>Kao Corporation, Safety Science Research, 2606, Akabane, Ichikai-Machi, Haga-Gun Tochigi, 321-3497, Japan. Electronic address: nakagawa.shouta@kao.com.</Affiliation>
      </Author>
      <Author>
        <Name>Maiko Okamoto</Name>
        <Affiliation>Kao Corporation, Safety Science Research, 2606, Akabane, Ichikai-Machi, Haga-Gun Tochigi, 321-3497, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Yuko Nukada</Name>
        <Affiliation>Kao Corporation, Safety Science Research, 2606, Akabane, Ichikai-Machi, Haga-Gun Tochigi, 321-3497, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Osamu Morita</Name>
        <Affiliation>Kao Corporation, Safety Science Research, 2606, Akabane, Ichikai-Machi, Haga-Gun Tochigi, 321-3497, Japan.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>OECD 428 in vitro dermal absorption mass balance performance based on our in-house database of pesticide studies.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32061759</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(20)30038-6</DOI>
    <AuthorList>
      <Author>
        <Name>Jon Heylings</Name>
        <Affiliation>Dermal Technology Laboratory Ltd, Med IC4, Keele University Science and Business Park, ST5 5NL, United Kingdom.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of competing interest The author declares that he has no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The SCCS guidance on the safety assessment of nanomaterials in cosmetics.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32061657</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(20)30037-4</DOI>
    <KeywordList>
      <Keywords>Cosmetics</Keywords>
      <Keywords>Guidance</Keywords>
      <Keywords>Nanomaterials</Keywords>
      <Keywords>SCCS</Keywords>
      <Keywords>Safety assessment</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name> </Name>
      </Author>
      <Author>
        <Name> </Name>
      </Author>
      <Author>
        <Name> </Name>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Echocardiography in nonclinical studies: Where are we?</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32057774</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(20)30041-6</DOI>
    <KeywordList>
      <Keywords>Cardiovascular</Keywords>
      <Keywords>Echocardiography</Keywords>
      <Keywords>Nonclinical</Keywords>
      <Keywords>Regulatory</Keywords>
      <Keywords>Reproducibility</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Elizabeth A. Hausner</Name>
        <Affiliation>Division of Cardiovascular and Renal Products, Center for Drug Evaluation and Research (CDER), United States Food and Drug Administration (FDA), USA. Electronic address: Elizabeth.hausner@fda.hhs.gov.</Affiliation>
      </Author>
      <Author>
        <Name>Xuan Chi</Name>
        <Affiliation>Division of Cardiovascular and Renal Products, Center for Drug Evaluation and Research (CDER), United States Food and Drug Administration (FDA), USA.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A TRPV1 antagonist, PAC-14028 does not increase the risk of tumorigenesis in chemically induced mouse skin carcinogenesis.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32044384</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(20)30039-8</DOI>
    <KeywordList>
      <Keywords>Atopic dermatitis</Keywords>
      <Keywords>EGFR/Akt/mTOR</Keywords>
      <Keywords>PAC-14028</Keywords>
      <Keywords>Skin tumor</Keywords>
      <Keywords>TRPV1</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jin Kyu Choi</Name>
        <Affiliation>Medical Beauty QA Team, Aestura Corporation, Anseong, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Wonkyung Cho</Name>
        <Affiliation>Vital Beautie Research Institute, AmorePacific Corporation R&amp;D Center, Yongin, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Ji Hae Lee</Name>
        <Affiliation>Vital Beautie Research Institute, AmorePacific Corporation R&amp;D Center, Yongin, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Gyeyoung Choi</Name>
        <Affiliation>Vital Beautie Research Institute, AmorePacific Corporation R&amp;D Center, Yongin, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Miyoung Park</Name>
        <Affiliation>Vital Beautie Research Institute, AmorePacific Corporation R&amp;D Center, Yongin, Republic of Korea. Electronic address: mypark@amorepacific.com.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Wonkyung Cho, Ji-Hae Lee, Gyeyoung Choi and Miyoung Park declare employment with AmorePacific corporation, the manufacturer of a compound tested for safety in this study. Jin Kyu Choi is an employee of Aestura Corporation, which conducted the research under contract with AmorePacific corporation.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Organic compounds percutaneous penetration in vivo in man: Relationship to mathematical predictive model.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32044383</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(20)30040-4</DOI>
    <KeywordList>
      <Keywords>Aqueous solubility</Keywords>
      <Keywords>Human</Keywords>
      <Keywords>Hydrogen bonds</Keywords>
      <Keywords>In vivo</Keywords>
      <Keywords>Octanol water partition coefficient</Keywords>
      <Keywords>Organic compounds</Keywords>
      <Keywords>Percutaneous penetration</Keywords>
      <Keywords>Permeability constant</Keywords>
      <Keywords>Pesticides</Keywords>
      <Keywords>Potts and Guy model</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Anuk Burli</Name>
        <Affiliation>Department of Dermatology, University of California, San Francisco, 2340 Sutter Street N461, San Francisco, CA, 94115, USA; University of Rochester School of Medicine and Dentistry, 601 Elmwood Ave, Rochester, NY, 14642, USA. Electronic address: burlianuk@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Rebecca M. Law</Name>
        <Affiliation>Department of Dermatology, University of California, San Francisco, 2340 Sutter Street N461, San Francisco, CA, 94115, USA; Memorial University of Newfoundland School of Pharmacy H3440, 300 Prince Phillip Drive, St. John's, NL, A1B 3V6, Canada. Electronic address: rlaw@mun.ca.</Affiliation>
      </Author>
      <Author>
        <Name>Jocelyn Rodriguez</Name>
        <Affiliation>Department of Dermatology, University of California, San Francisco, 2340 Sutter Street N461, San Francisco, CA, 94115, USA; Washington University in St Louis School of Medicine, 660 S Euclid Ave, St. Louis, MO, 63110, USA. Electronic address: jocelyn.rodriguez@ucsf.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Howard I. Maibach</Name>
        <Affiliation>Department of Dermatology, University of California, San Francisco, 2340 Sutter Street N461, San Francisco, CA, 94115, USA. Electronic address: howard.maibach@ucsf.edu.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Initial hazard assessment of 1,4-dichlorobutane: Genotoxicity tests, 28-day repeated-dose toxicity test, and reproductive/developmental toxicity screening test in rats.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32032664</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(20)30036-2</DOI>
    <KeywordList>
      <Keywords>CAS no. 110-56-5</Keywords>
      <Keywords>Chemical substances control low</Keywords>
      <Keywords>D-value</Keywords>
      <Keywords>Existing chemical substance</Keywords>
      <Keywords>Halogenated hydrocarbon</Keywords>
      <Keywords>Hazard class</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Toshime Igarashi</Name>
        <Affiliation>Division of Risk Assessment, Center for Biological Safety &amp; Research, National Institute of Health Sciences, 3-25-26 Tonomachi, Kawasaki-ku, Kawasaki-shi, Kanagawa, 210-9501, Japan; Division of Cellular &amp; Molecular Toxicology, Center for Biological Safety &amp; Research, National Institute of Health Sciences, 3-25-26 Tonomachi, Kawasaki-ku, Kawasaki-shi, Kanagawa, 210-9501, Japan. Electronic address: toshime.igarashi@nihs.go.jp.</Affiliation>
      </Author>
      <Author>
        <Name>Hiroshi Suzuki</Name>
        <Affiliation>Division of Risk Assessment, Center for Biological Safety &amp; Research, National Institute of Health Sciences, 3-25-26 Tonomachi, Kawasaki-ku, Kawasaki-shi, Kanagawa, 210-9501, Japan. Electronic address: hsuzuki@nihs.go.jp.</Affiliation>
      </Author>
      <Author>
        <Name>Kazuo Ushida</Name>
        <Affiliation>Division of Risk Assessment, Center for Biological Safety &amp; Research, National Institute of Health Sciences, 3-25-26 Tonomachi, Kawasaki-ku, Kawasaki-shi, Kanagawa, 210-9501, Japan. Electronic address: k-ushida@nihs.go.jp.</Affiliation>
      </Author>
      <Author>
        <Name>Mariko Matsumoto</Name>
        <Affiliation>Division of Risk Assessment, Center for Biological Safety &amp; Research, National Institute of Health Sciences, 3-25-26 Tonomachi, Kawasaki-ku, Kawasaki-shi, Kanagawa, 210-9501, Japan. Electronic address: mariko@nihs.go.jp.</Affiliation>
      </Author>
      <Author>
        <Name>Kaoru Inoue</Name>
        <Affiliation>Division of Risk Assessment, Center for Biological Safety &amp; Research, National Institute of Health Sciences, 3-25-26 Tonomachi, Kawasaki-ku, Kawasaki-shi, Kanagawa, 210-9501, Japan. Electronic address: k-inoue@nihs.go.jp.</Affiliation>
      </Author>
      <Author>
        <Name>Takuya Kanno</Name>
        <Affiliation>CMIC Pharma Science Co., Ltd., CMIC Bioresearch Center, 10221 Kobuchizawa-cho, Hokuto-shi, Yamanashi, 408-0044, Japan. Electronic address: takuya-kanno.hg@cmic.co.jp.</Affiliation>
      </Author>
      <Author>
        <Name>Yoshihisa Miwa</Name>
        <Affiliation>Nihon Bioresearch Inc., 6-104 Majima, Fukuju-cho, Hashima-shi, Gifu, 501-6251, Japan. Electronic address: miwa.yoshihisa@nisshin.com.</Affiliation>
      </Author>
      <Author>
        <Name>Takahiro Ishii</Name>
        <Affiliation>BoZo Research Center Inc., 1284 Kamado, Gotennba-shi, Shizuoka, 412-0039, Japan. Electronic address: ishii-t@bozo.co.jp.</Affiliation>
      </Author>
      <Author>
        <Name>Takahiko Nagase</Name>
        <Affiliation>Nihon Bioresearch Inc., 6-104 Majima, Fukuju-cho, Hashima-shi, Gifu, 501-6251, Japan. Electronic address: nagase.takahiko@nisshin.com.</Affiliation>
      </Author>
      <Author>
        <Name>Yoshihiro Katsumata</Name>
        <Affiliation>BoZo Research Center Inc., 1284 Kamado, Gotennba-shi, Shizuoka, 412-0039, Japan. Electronic address: katsumatayoshihiro@outlook.jp.</Affiliation>
      </Author>
      <Author>
        <Name>Akihiko Hirose</Name>
        <Affiliation>Division of Risk Assessment, Center for Biological Safety &amp; Research, National Institute of Health Sciences, 3-25-26 Tonomachi, Kawasaki-ku, Kawasaki-shi, Kanagawa, 210-9501, Japan. Electronic address: hirose@nihs.go.jp.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Chronic oral toxicity of 3-nitro-1,2,4-triazol-5-one (NTO) in rats.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32027946</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(20)30035-0</DOI>
    <KeywordList>
      <Keywords>Chronic</Keywords>
      <Keywords>Insensitive munition</Keywords>
      <Keywords>Nitrotriazolone</Keywords>
      <Keywords>Testicular toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Emily May Lent</Name>
        <Affiliation>Toxicology Directorate. Army Public Health Center, Aberdeen Proving Ground, MD, USA. Electronic address: usarmy.apg.medcom-phc.mbx.tox-info@mail.mil.</Affiliation>
      </Author>
      <Author>
        <Name>Allison M. Narizzano</Name>
        <Affiliation>Toxicology Directorate. Army Public Health Center, Aberdeen Proving Ground, MD, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Keith A. Koistinen</Name>
        <Affiliation>Toxicology Directorate. Army Public Health Center, Aberdeen Proving Ground, MD, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Mark S. Johnson</Name>
        <Affiliation>Toxicology Directorate. Army Public Health Center, Aberdeen Proving Ground, MD, USA.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>An evaluation framework for new approach methodologies (NAMs) for human health safety assessment.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32017962</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(20)30018-0</DOI>
    <KeywordList>
      <Keywords>Evaluation framework</Keywords>
      <Keywords>Human health</Keywords>
      <Keywords>New approach methodologies</Keywords>
      <Keywords>Risk assessment</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Stanley T. Parish</Name>
        <Affiliation>Health and Environmental Sciences Institute, Washington, DC, USA. Electronic address: sparish@hesiglobal.org.</Affiliation>
      </Author>
      <Author>
        <Name>Michael Aschner</Name>
        <Affiliation>Albert Einstein College of Medicine, Bronx, NY, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Warren Casey</Name>
        <Affiliation>National Institute of Environmental Health Sciences, National Toxicology Program Interagency Center for the Evaluation of Alternative Toxicological Methods, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Marco Corvaro</Name>
        <Affiliation>Corteva Agriscience™, Rome, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Michelle R. Embry</Name>
        <Affiliation>Health and Environmental Sciences Institute, Washington, DC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Suzanne Fitzpatrick</Name>
        <Affiliation>US Food and Drug Administration, Center for Food Safety and Applied Nutrition, Silver Spring, MD, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Darren Kidd</Name>
        <Affiliation>Department of Genetic Toxicology, Covance Laboratories Ltd, Harrogate, North Yorkshire, HG3 1PY, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Nicole C. Kleinstreuer</Name>
        <Affiliation>National Institute of Environmental Health Sciences, National Toxicology Program Interagency Center for the Evaluation of Alternative Toxicological Methods, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Beatriz Silva Lima</Name>
        <Affiliation>Universidade de Lisboa and iMED.IL, Portugal.</Affiliation>
      </Author>
      <Author>
        <Name>Raja S. Settivari</Name>
        <Affiliation>Corteva Agriscience™, Newark, DE, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Douglas C. Wolf</Name>
        <Affiliation>Syngenta, Raleigh-Durham, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Daiju Yamazaki</Name>
        <Affiliation>National Institutes of Health Sciences, Kanagawa, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Alan Boobis</Name>
        <Affiliation>Imperial College London, London, UK.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Pulmonary toxicity in rats following inhalation exposure to poorly soluble particles of low toxicity: Testing at excessive concentrations overwhelming lung clearance?</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32014485</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(20)30016-7</DOI>
    <KeywordList>
      <Keywords>Impaired lung clearance</Keywords>
      <Keywords>Lung overload</Keywords>
      <Keywords>Poorly soluble particles</Keywords>
      <Keywords>Poorly soluble particles of low toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Josje Arts</Name>
        <Affiliation>Nouryon Chemicals bv, Velperweg 76, 6824 BM, Arnhem, the Netherlands. Electronic address: josje.arts@nouryon.com.</Affiliation>
      </Author>
      <Author>
        <Name>Marco Kellert</Name>
        <Affiliation>Wacker Chemie AG, Johannes-Hess-Strasse 24, 84489, Burghausen, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Nils Krueger</Name>
        <Affiliation>Evonik Resource Efficiency GmbH, Rodenbacher Chaussee 4, 63457, Hanau, Wolfgang, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Juergen Nolde</Name>
        <Affiliation>Grace Europe Holding GmbH, In der Hollerhecke 1, 67547, Worms, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Tobias Schuster</Name>
        <Affiliation>Evonik Resource Efficiency GmbH, Rodenbacher Chaussee 4, 63457, Hanau, Wolfgang, Germany.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. We are working at companies that produce synthetic amorphous silica.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Response to letter to editor "Pulmonary toxicity in rats following inhalation exposure to poorly soluble particles of low toxicity: Testing at excessive concentrations overwhelming lung clearance"?</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32007437</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(20)30019-2</DOI>
    <AuthorList>
      <Author>
        <Name>Peter M. J. Bos</Name>
        <Affiliation>National Institute for Public Health and the Environment, Bilthoven, the Netherlands. Electronic address: peter.bos@rivm.nl.</Affiliation>
      </Author>
      <Author>
        <Name>Ilse Gosens</Name>
        <Affiliation>National Institute for Public Health and the Environment, Bilthoven, the Netherlands. Electronic address: ilse.gosens@rivm.nl.</Affiliation>
      </Author>
      <Author>
        <Name>Liesbeth Geraets</Name>
        <Affiliation>National Institute for Public Health and the Environment, Bilthoven, the Netherlands. Electronic address: liesbeth.geraets@rivm.nl.</Affiliation>
      </Author>
      <Author>
        <Name>Christiaan Delmaar</Name>
        <Affiliation>National Institute for Public Health and the Environment, Bilthoven, the Netherlands. Electronic address: Christiaan.Delmaar@rivm.nl.</Affiliation>
      </Author>
      <Author>
        <Name>Flemming R. Cassee</Name>
        <Affiliation>National Institute for Public Health and the Environment, Bilthoven, the Netherlands; Institute for Risk Assessment Sciences, Utrecht University, Utrecht, the Netherlands. Electronic address: Flemming.Cassee@rivm.nl.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Regulations for calcium, magnesium or hardness in drinking water in the European Union member states.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32007436</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(20)30015-5</DOI>
    <KeywordList>
      <Keywords>Calcium</Keywords>
      <Keywords>Drinking water</Keywords>
      <Keywords>Magnesium</Keywords>
      <Keywords>Regulation</Keywords>
      <Keywords>Water hardness</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Frantisek Kozisek</Name>
        <Affiliation>National Institute of Public Health, Srobarova 48, Prague, CZ, 10000, Czech Republic. Electronic address: frantisek.kozisek@szu.cz.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of competing interest The author declares that he has no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Preclinical pharmacokinetic, biodistribution, radiation dosimetry, and toxicity studies of </ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32006673</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(20)30017-9</DOI>
    <KeywordList>
      <Keywords>HER2 receptor</Keywords>
      <Keywords>LTVPWY</Keywords>
      <Keywords>Peptide</Keywords>
      <Keywords>Pharmacokinetics</Keywords>
      <Keywords>Technetium-99m</Keywords>
      <Keywords>Toxicology</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Javad Biabani Ardakani</Name>
        <Affiliation>Department of Radiopharmacy, Faculty of Pharmacy, Pharmaceutical Sciences Research Center, Mazandaran University of Medical Sciences, Sari, Iran; Student Research Committee, Mazandaran University of Medical Sciences, Sari, Iran.</Affiliation>
      </Author>
      <Author>
        <Name>Fereshteh Talebpour Amiri</Name>
        <Affiliation>Department of Anatomy, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.</Affiliation>
      </Author>
      <Author>
        <Name>Alireza Khorramimoghaddam</Name>
        <Affiliation>Department of Radiology, Faculty of Allied Medicine, Mazandaran University of Medical Sciences, Sari, Iran.</Affiliation>
      </Author>
      <Author>
        <Name>Ali Abbasi</Name>
        <Affiliation>Department of Community Medicine, Sari Branch, Islamic Azad University, Sari, Iran.</Affiliation>
      </Author>
      <Author>
        <Name>Sajjad Molavipordanjani</Name>
        <Affiliation>Department of Radiopharmacy, Faculty of Pharmacy, Pharmaceutical Sciences Research Center, Mazandaran University of Medical Sciences, Sari, Iran.</Affiliation>
      </Author>
      <Author>
        <Name>Seyed Jalal Hosseinimehr</Name>
        <Affiliation>Department of Radiopharmacy, Faculty of Pharmacy, Pharmaceutical Sciences Research Center, Mazandaran University of Medical Sciences, Sari, Iran. Electronic address: sjhosseinim@mazums.ac.ir.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Time extrapolation in regulatory risk assessment: The impact of study differences on the extrapolation factors.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32006672</pubmedLink>
    <GrantList>
      <Grant>MR/S003991/1</Grant>
    </GrantList>
    <Year>2020</Year>
    <DOI>S0273-2300(20)30010-6</DOI>
    <KeywordList>
      <Keywords>Chronic</Keywords>
      <Keywords>Data variance</Keywords>
      <Keywords>EF distribution</Keywords>
      <Keywords>Risk assessment</Keywords>
      <Keywords>Subacute</Keywords>
      <Keywords>Subchronic</Keywords>
      <Keywords>Time extrapolation</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>S. E. Escher</Name>
        <Affiliation>Fraunhofer Institute for Toxicology and Experimental Medicine, Nikolai-Fuchs-Str. 1, Hannover, Germany. Electronic address: sylvia.escher@item.fraunhofer.de.</Affiliation>
      </Author>
      <Author>
        <Name>I. Mangelsdorf</Name>
        <Affiliation>Fraunhofer Institute for Toxicology and Experimental Medicine, Nikolai-Fuchs-Str. 1, Hannover, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>S. Hoffmann-Doerr</Name>
        <Affiliation>Henkel AG &amp; Co. KGaA, Henkelstraße 67, Düsseldorf, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>F. Partosch</Name>
        <Affiliation>Institut für Arbeits, Sozial- und Umweltmedizin, Georg-August-Universität Göttingen, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>A. Karwath</Name>
        <Affiliation>Centre for Computational Biology, University of Birmingham, UK.</Affiliation>
      </Author>
      <Author>
        <Name>K. Schroeder</Name>
        <Affiliation>Fraunhofer Institute for Toxicology and Experimental Medicine, Nikolai-Fuchs-Str. 1, Hannover, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>A. Zapf</Name>
        <Affiliation>Department of Medical Biometry and Epidemiology, University Medical Center Hamburg-Eppendorf, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>M. Batke</Name>
        <Affiliation>Fraunhofer Institute for Toxicology and Experimental Medicine, Nikolai-Fuchs-Str. 1, Hannover, Germany.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Comparative nonclinical assessments of the biosimilar PF-06410293 and originator adalimumab.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32006671</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(20)30013-1</DOI>
    <KeywordList>
      <Keywords>Adalimumab</Keywords>
      <Keywords>Adalimumab-afzb</Keywords>
      <Keywords>Biosimilar</Keywords>
      <Keywords>Cynomolgus monkey</Keywords>
      <Keywords>Nonclinical</Keywords>
      <Keywords>PF-06410293</Keywords>
      <Keywords>Tumor necrosis factor</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Mazin Derzi</Name>
        <Affiliation>Drug Safety Research and Development, Pfizer Inc., 300 Technology Square Drive, Cambridge, MA, USA. Electronic address: mazin.derzi@pfizer.com.</Affiliation>
      </Author>
      <Author>
        <Name>Ahmed M. Shoieb</Name>
        <Affiliation>Drug Safety Research and Development, Pfizer Inc., Eastern Point Rd, Groton, CT, USA. Electronic address: ahmed.shoieb@pfizer.com.</Affiliation>
      </Author>
      <Author>
        <Name>Sharon L. Ripp</Name>
        <Affiliation>Pharmacokinetics, Dynamics &amp; Metabolism, Pfizer Inc., Eastern Point Rd, Groton, CT, USA. Electronic address: sharon.l.ripp@pfizer.com.</Affiliation>
      </Author>
      <Author>
        <Name>Gregory L. Finch</Name>
        <Affiliation>Drug Safety Research and Development, Pfizer Inc., Eastern Point Rd, Groton, CT, USA. Electronic address: gtafinch@yahoo.com.</Affiliation>
      </Author>
      <Author>
        <Name>Leslie G. Lorello</Name>
        <Affiliation>Pharmacokinetics, Dynamics &amp; Metabolism, Pfizer Inc., Eastern Point Rd, Groton, CT, USA. Electronic address: leslie.g.lorello@pfizer.com.</Affiliation>
      </Author>
      <Author>
        <Name>Shawn P. O'Neil</Name>
        <Affiliation>Drug Safety Research and Development, Pfizer Inc., 300 Technology Square Drive, Cambridge, MA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Zaher Radi</Name>
        <Affiliation>Drug Safety Research and Development, Pfizer Inc., 1 Portland Street, Cambridge, MA, USA. Electronic address: zaher.radi@pfizer.com.</Affiliation>
      </Author>
      <Author>
        <Name>Jameel Syed</Name>
        <Affiliation>Drug Safety Research and Development, Pfizer Inc., Eastern Point Rd, Groton, CT, USA. Electronic address: jameel.syed@pfizer.com.</Affiliation>
      </Author>
      <Author>
        <Name>Matthew S. Thompson</Name>
        <Affiliation>Analytical Research and Development, Pfizer Inc., 1 Burtt Rd, Andover, MA, USA. Electronic address: matthew.thompson@pfizer.com.</Affiliation>
      </Author>
      <Author>
        <Name>Michael W. Leach</Name>
        <Affiliation>Drug Safety Research and Development, Pfizer Inc., 300 Technology Square Drive, Cambridge, MA, USA. Electronic address: michael.leach@pfizer.com.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Mazin Derzi, Ahmed M. Shoieb, Sharon L. Ripp, Leslie G. Lorello, Shawn P. O'Neil, Zaher Radi, Jameel Syed, Matthew S. Thompson, and Michael W. Leach are full-time employees and shareholders of Pfizer Inc. Gregory L. Finch was a full-time employee of Pfizer at the time of these studies and is a shareholder of Pfizer Inc.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Determining the impact of flavored e-liquids on aldehyde production during Vaping.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/32001280</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(20)30014-3</DOI>
    <KeywordList>
      <Keywords>Acetaldehyde</Keywords>
      <Keywords>Acrolein</Keywords>
      <Keywords>E-cigarettes</Keywords>
      <Keywords>ENDS</Keywords>
      <Keywords>Formaldehyde</Keywords>
      <Keywords>Formation of aldehydes</Keywords>
      <Keywords>Impact of flavor compounds</Keywords>
      <Keywords>Standardized testing protocols</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>I. Gene Gillman</Name>
        <Affiliation>Enthalpy Analytical, Durham, NC, USA. Electronic address: gene.gillman@enthalpy.com.</Affiliation>
      </Author>
      <Author>
        <Name>Alexander S. C. Pennington</Name>
        <Affiliation>Enthalpy Analytical, Durham, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Kathy E. Humphries</Name>
        <Affiliation>Enthalpy Analytical, Durham, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Michael J. Oldham</Name>
        <Affiliation>Oldham Associates LLC, Manakin Sabot, VA, USA.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: I. Gene Gillman, Kathy E. Humphries and SECP have no competing interests to disclose. Their employer, Enthalpy Analytical is a CRO that provides testing services on tobacco containing products. Michael J. Oldham started and completed this work as founder of Oldham Associates LLC. Prior to commencing and completion of this work Michael J. Oldham was employed by Altria Client Services. Subsequent to completion of this work, Michael J. Oldham is currently employed by JUUL Labs, Inc. No tobacco industry funding was accepted in return for preparation of this manuscript.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Systematic review and meta-analysis of epidemiological literature evaluating the association between exposure to man-made vitreous fibers and respiratory tract cancers.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31991162</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(20)30011-8</DOI>
    <KeywordList>
      <Keywords>Man-made vitreous fibers</Keywords>
      <Keywords>Meta-analysis</Keywords>
      <Keywords>Respiratory tract cancer</Keywords>
      <Keywords>Systematic review</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Natalie Suder Egnot</Name>
        <Affiliation>Cardno ChemRisk, Pittsburgh, PA, USA. Electronic address: natalie.egnot@cardno.com.</Affiliation>
      </Author>
      <Author>
        <Name>Stacey M. Benson</Name>
        <Affiliation>Cardno ChemRisk, Pittsburgh, PA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Mark F. Vater</Name>
        <Affiliation>Cardno ChemRisk, Pittsburgh, PA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Rebecca Hazan</Name>
        <Affiliation>Cardno ChemRisk, Brooklyn, NY, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Opal Patel</Name>
        <Affiliation>Cardno ChemRisk, San Francisco, CA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Gary M. Marsh</Name>
        <Affiliation>Cardno ChemRisk, Pittsburgh, PA, USA.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: All the authors are employed by Cardno ChemRisk, a consulting firm that provides scientific advice to the government, corporations, law firms and various scientific/professional organizations. Gary M. Marsh is also Professor of Biostatistics and Director and Founder of the Center for Occupational Biostatistics and Epidemiology at the University of Pittsburgh Graduate School of Public Health. Financial support for the research described in the manuscript was provided by the North American Insulation Manufacturers Association (NAIMA). The funding association had no involvement or influence in the analysis, writing or conclusions of this review. This article was prepared and written exclusively by the authors without review or comment by any outside entity.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The value of avian gross pathology in identifying endocrine disrupting properties.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31978447</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(20)30003-9</DOI>
    <KeywordList>
      <Keywords>Avian reproduction test</Keywords>
      <Keywords>Endocrine disruption</Keywords>
      <Keywords>Gross pathology</Keywords>
      <Keywords>Necropsy</Keywords>
      <Keywords>Regulatory toxicology</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Diana Temple</Name>
        <Affiliation>Eurofins EAG Agrosciences, LLC, 8598 Commerce Drive, Easton, MD, 21601, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Timothy Springer</Name>
        <Affiliation>Springer Consulting, 29371 Stoney Ridge Circle, Easton, MD, 2160, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Sean Gallagher</Name>
        <Affiliation>Eurofins EAG Agrosciences, LLC, 8598 Commerce Drive, Easton, MD, 21601, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Gunther du Hoffmann</Name>
        <Affiliation>Eurofins EAG Agrosciences, LLC, 8598 Commerce Drive, Easton, MD, 21601, USA. Electronic address: GuntherduHoffmann@eurofinsUS.com.</Affiliation>
      </Author>
      <Author>
        <Name>James R. Wheeler</Name>
        <Affiliation>Corteva Agriscience, 3b Park Square, Milton Park, Abingdon, Oxfordshire, OX14 4RN, United Kingdom.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Data utilized for evaluation of avian gross pathological findings was obtained from the Eurofins Agroscience Services historical control database. Funding for the statistical analysis of the historical control data and preparation of this publication was funded by Corteva Agriscience.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Genotoxicity and carcinogenicity risk assessment of prucalopride, a selective 5-hydroxytryptamine 4 receptor agonist.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31972188</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(20)30012-X</DOI>
    <KeywordList>
      <Keywords>Carcinogenicity</Keywords>
      <Keywords>Constitutive androstane receptor-mediated liver enzyme induction</Keywords>
      <Keywords>Epigenetic mechanisms</Keywords>
      <Keywords>Human relevance</Keywords>
      <Keywords>Prucalopride</Keywords>
      <Keywords>Prucalopride-mediated neoplasia</Keywords>
      <Keywords>Rodent</Keywords>
      <Keywords>Rodent-specific neoplasia</Keywords>
      <Keywords>Serotonin type 4 (5-HT(4)) receptor agonist</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Hong Wang</Name>
        <Affiliation>Global Nonclinical Development, Shire, a Takeda Company, 125 Binney St, Cambridge, MA, 02142, USA. Electronic address: wanghon4@hotmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Kate Lane</Name>
        <Affiliation>Global Nonclinical Development, Shire, a Takeda Company, 125 Binney St, Cambridge, MA, 02142, USA; Translate Bio, 29 Hartwell Ave., Lexington, MA, 02421, USA. Electronic address: klane@translate.bio.</Affiliation>
      </Author>
      <Author>
        <Name>Zhen Lou</Name>
        <Affiliation>Global Nonclinical Development, Shire, a Takeda Company, 125 Binney St, Cambridge, MA, 02142, USA. Electronic address: zhen.lou@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Suezanne Parker</Name>
        <Affiliation>Global Nonclinical Development, Shire, a Takeda Company, 125 Binney St, Cambridge, MA, 02142, USA; Arcturus Therapeutics, 10628 Science Center Drive, Suite 250, San Diego, CA, 92121, USA. Electronic address: suezanne.parker@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Michael Placke</Name>
        <Affiliation>Global Nonclinical Development, Shire, a Takeda Company, 125 Binney St, Cambridge, MA, 02142, USA. Electronic address: michaelplacke@yahoo.com.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Hong Wang was an employee of Shire, a member of the Takeda group of companies, at the time of this analysis and is now an employee of Pfizer. Zhen Lou was an employee of Shire, a member of the Takeda group of companies, at the time of this analysis and is now an employee of H3 Biomedicine. Kate Lane was an employee of Shire, a member of the Takeda group of companies, at the time of this analysis and is now an employee of Translate Bio. Suezanne Parker was an employee of Shire, a member of the Takeda group of companies, at the time of this analysis and is now an employee of Arcturus Therapeutics. Michael Placke was an employee of Shire, a member of the Takeda group of companies, at the time of this analysis. These studies were funded by Johnson &amp; Johnson. Writing support was provided by Anja Becher, PhD, of PharmaGenesis London, London, UK, and funded by Shire, a member of the Takeda group of companies.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Toxicological evaluation of naringin: Acute, subchronic, and chronic toxicity in Beagle dogs.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31954754</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(20)30006-4</DOI>
    <KeywordList>
      <Keywords>Acute</Keywords>
      <Keywords>Beagle dogs</Keywords>
      <Keywords>Chronic</Keywords>
      <Keywords>Naringin</Keywords>
      <Keywords>Subchronic</Keywords>
      <Keywords>Toxicological evaluation</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Peibo Li</Name>
        <Affiliation>Guangdong Engineering and Technology Research Center for Quality and Efficacy Re-evaluation of Post-marketed TCM, Guangdong Key Laboratory of Plant Resources, School of Life Sciences, Sun Yat-sen University, Guangzhou, 510275, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Hao Wu</Name>
        <Affiliation>Guangdong Engineering and Technology Research Center for Quality and Efficacy Re-evaluation of Post-marketed TCM, Guangdong Key Laboratory of Plant Resources, School of Life Sciences, Sun Yat-sen University, Guangzhou, 510275, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Yonggang Wang</Name>
        <Affiliation>Guangdong Engineering and Technology Research Center for Quality and Efficacy Re-evaluation of Post-marketed TCM, Guangdong Key Laboratory of Plant Resources, School of Life Sciences, Sun Yat-sen University, Guangzhou, 510275, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Wei Peng</Name>
        <Affiliation>Guangdong Engineering and Technology Research Center for Quality and Efficacy Re-evaluation of Post-marketed TCM, Guangdong Key Laboratory of Plant Resources, School of Life Sciences, Sun Yat-sen University, Guangzhou, 510275, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Weiwei Su</Name>
        <Affiliation>Guangdong Engineering and Technology Research Center for Quality and Efficacy Re-evaluation of Post-marketed TCM, Guangdong Key Laboratory of Plant Resources, School of Life Sciences, Sun Yat-sen University, Guangzhou, 510275, PR China. Electronic address: lsssww@126.com.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Estimation of time to compromised tenability in fires: is it time to change paradigms?</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31953227</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(20)30008-8</DOI>
    <KeywordList>
      <Keywords>And effect</Keywords>
      <Keywords>Biomarkers of exposure</Keywords>
      <Keywords>Carbon monoxide</Keywords>
      <Keywords>Carboxyhemoglobin</Keywords>
      <Keywords>Combustion toxicology</Keywords>
      <Keywords>Haber's rule</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Juergen Pauluhn</Name>
        <Affiliation>Hanover Medical School, Hannover, Germany. Electronic address: juergen.pauluhn@iCLOUD.com.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A bioinformatics workflow for the evaluation of RT-qPCR primer specificity: Application for the assessment of gene expression data reliability in toxicological studies.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31945455</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(20)30001-5</DOI>
    <KeywordList>
      <Keywords>Gene expression</Keywords>
      <Keywords>Gene family</Keywords>
      <Keywords>Genomic databases</Keywords>
      <Keywords>Primer specificity</Keywords>
      <Keywords>Pseudogene</Keywords>
      <Keywords>Rat</Keywords>
      <Keywords>Splice variant</Keywords>
      <Keywords>Toxicology</Keywords>
      <Keywords>gDNA contamination</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Bhaja K. Padhi</Name>
        <Affiliation>Hazard Identification Division, Environmental Health Science and Research Bureau, HECSB, Health Canada, Tunney's Pasture, Ottawa, Ontario, K1A 0K9, Canada. Electronic address: bhajakrushna.padhi@canada.ca.</Affiliation>
      </Author>
      <Author>
        <Name>Guillaume Pelletier</Name>
        <Affiliation>Hazard Identification Division, Environmental Health Science and Research Bureau, HECSB, Health Canada, Tunney's Pasture, Ottawa, Ontario, K1A 0K9, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Philip S. Shwed</Name>
        <Affiliation>Mechanistic Studies Division, Environmental Health Science and Research Bureau, HECSB, Health Canada, Tunney's Pasture, Ottawa, Ontario, K1A 0K9, Canada.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A review of the evidence to support interim reference level for dietary lead exposure in adults.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31945454</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(20)30005-2</DOI>
    <KeywordList>
      <Keywords>Adult</Keywords>
      <Keywords>Adverse</Keywords>
      <Keywords>Blood</Keywords>
      <Keywords>Food</Keywords>
      <Keywords>IRL</Keywords>
      <Keywords>Interim reference level</Keywords>
      <Keywords>Lead</Keywords>
      <Keywords>Pb</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Laurie C. Dolan</Name>
        <Affiliation>US Food and Drug Administration, Center for Food Safety and Applied Nutrition, College Park, MD, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Brenna M. Flannery</Name>
        <Affiliation>US Food and Drug Administration, Center for Food Safety and Applied Nutrition, College Park, MD, USA. Electronic address: Brenna.flannery@fda.hhs.gov.</Affiliation>
      </Author>
      <Author>
        <Name>Dana Hoffman-Pennesi</Name>
        <Affiliation>US Food and Drug Administration, Center for Food Safety and Applied Nutrition, College Park, MD, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Alexandra Gavelek</Name>
        <Affiliation>US Food and Drug Administration, Center for Food Safety and Applied Nutrition, College Park, MD, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Olivia E. Jones</Name>
        <Affiliation>US Food and Drug Administration, Center for Food Safety and Applied Nutrition, College Park, MD, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Richard Kanwal</Name>
        <Affiliation>US Food and Drug Administration, Center for Food Safety and Applied Nutrition, College Park, MD, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Beverly Wolpert</Name>
        <Affiliation>US Food and Drug Administration, Center for Food Safety and Applied Nutrition, College Park, MD, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Kathleen Gensheimer</Name>
        <Affiliation>US Food and Drug Administration, Center for Food Safety and Applied Nutrition, College Park, MD, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Sherri Dennis</Name>
        <Affiliation>US Food and Drug Administration, Center for Food Safety and Applied Nutrition, College Park, MD, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Suzanne Fitzpatrick</Name>
        <Affiliation>US Food and Drug Administration, Center for Food Safety and Applied Nutrition, College Park, MD, USA.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>21</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31935484</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(20)30009-X</DOI>
    <KeywordList>
      <Keywords>Adverse outcome pathway (AOP)</Keywords>
      <Keywords>Combined exposure</Keywords>
      <Keywords>Exposure assessment</Keywords>
      <Keywords>Integrated approach to testing and assessment (IATA)</Keywords>
      <Keywords>Mode-of-action (MoA)</Keywords>
      <Keywords>Multi-constituent substances</Keywords>
      <Keywords>New approach methodologies (NAMs)</Keywords>
      <Keywords>UVCBs (substances of unknown or variable compositions, complex reaction products and biological substances)</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Ursula G. Sauer</Name>
        <Affiliation>Scientific Consultancy - Animal Welfare, Neubiberg, Germany. Electronic address: ursula.sauer@sauerug.de.</Affiliation>
      </Author>
      <Author>
        <Name>Robert A. Barter</Name>
        <Affiliation>ExxonMobil Biomedical Sciences, Inc., Annandale, NJ, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Richard A. Becker</Name>
        <Affiliation>American Chemistry Council, Washington DC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Emilio Benfenati</Name>
        <Affiliation>Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Elisabet Berggren</Name>
        <Affiliation>European Commission, Joint Research Centre, Ispra, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Bruno Hubesch</Name>
        <Affiliation>European Chemical Industry Council (Cefic), Brussels, Belgium; Hubesch Consult BVBA, Sint-Pieters-Leeuw, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Heli M. Hollnagel</Name>
        <Affiliation>Dow Europe GmbH, Horgen, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Kunifumi Inawaka</Name>
        <Affiliation>Japan Chemical Industry Association, Tokyo, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Athena M. Keene</Name>
        <Affiliation>Afton Chemical Corporation, Richmond, VA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Philipp Mayer</Name>
        <Affiliation>Technical University of Denmark, Kongens Lyngby, Denmark.</Affiliation>
      </Author>
      <Author>
        <Name>Kathleen Plotzke</Name>
        <Affiliation>Dow, Midland, MI, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Robert Skoglund</Name>
        <Affiliation>Covestro LLC, Pittsburgh, PA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Océane Albert</Name>
        <Affiliation>European Chemical Industry Council (Cefic), Brussels, Belgium.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: The authors had complete control over the design, conduct, interpretation, and composition of this manuscript. The contents of this manuscript are solely the responsibility of the authors and do not necessarily reflect the views or policies of their employers. The workshop was supported by the International Council of Chemical Associations (ICCA) Long Range Research Initiative (LRI) (https://www.icca-chem.org/icca-long-range-research-initiative/) with funding jointly provided by the LRI programs of the American Chemistry Council, the European Chemical Industry Council (Cefic) and the Japan Chemical Industry Association. The affiliations of the authors are provided; a number of authors have worked on hazard, exposure and risk assessment issues related to complex substances as part of their work-related scientific activities. U. G. Sauer received support for manuscript development from Cefic.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Derivation of whole blood biomonitoring equivalents for lithium for the interpretation of biomonitoring data.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31935483</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(20)30007-6</DOI>
    <KeywordList>
      <Keywords>BE</Keywords>
      <Keywords>Biomonitoring</Keywords>
      <Keywords>Biomonitoring equivalents</Keywords>
      <Keywords>Exposure guidance values</Keywords>
      <Keywords>Lithium</Keywords>
      <Keywords>Toxicokinetics</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>S. Ramoju</Name>
        <Affiliation>Risk Sciences International, Ottawa, ON, Canada. Electronic address: sramoju@risksciences.com.</Affiliation>
      </Author>
      <Author>
        <Name>M. Andersen</Name>
        <Affiliation>Risk Sciences International, Ottawa, ON, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>D. Poddalgoda</Name>
        <Affiliation>Health Canada, Ottawa, ON, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>A. Nong</Name>
        <Affiliation>Health Canada, Ottawa, ON, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>N. Karyakina</Name>
        <Affiliation>Risk Sciences International, Ottawa, ON, Canada; University of Ottawa, Ottawa, ON, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>N. Shilnikova</Name>
        <Affiliation>Risk Sciences International, Ottawa, ON, Canada; University of Ottawa, Ottawa, ON, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>K. Krishnan</Name>
        <Affiliation>Risk Sciences International, Ottawa, ON, Canada. Electronic address: kannan.krishnan@irsst.qc.ca.</Affiliation>
      </Author>
      <Author>
        <Name>D. Krewski</Name>
        <Affiliation>Risk Sciences International, Ottawa, ON, Canada; University of Ottawa, Ottawa, ON, Canada.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Target-specific micronucleus induction by colon carcinogens: 2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and 1,2-dimethylhydrazine.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31935482</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(20)30004-0</DOI>
    <KeywordList>
      <Keywords>Bone marrow</Keywords>
      <Keywords>Colon</Keywords>
      <Keywords>DMH</Keywords>
      <Keywords>F344 rats</Keywords>
      <Keywords>Liver</Keywords>
      <Keywords>Micronucleus</Keywords>
      <Keywords>Multiple treatments</Keywords>
      <Keywords>PhIP</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Hisako Hori</Name>
        <Affiliation>Suntory MONOZUKURI Expert Limited, 8-1-1 Seikadai, Seika-cho, Soraku-gun, Kyoto, 619-0284, Japan. Electronic address: Hisako_Hori@suntory.co.jp.</Affiliation>
      </Author>
      <Author>
        <Name>Satomi Shimoyoshi</Name>
        <Affiliation>Suntory Wellness Limited, 8-1-1 Seikadai, Seika-cho, Soraku-gun, Kyoto, 619-0284, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Yasuhiro Tanaka</Name>
        <Affiliation>Suntory MONOZUKURI Expert Limited, 8-1-1 Seikadai, Seika-cho, Soraku-gun, Kyoto, 619-0284, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Wataru Fujii</Name>
        <Affiliation>Suntory MONOZUKURI Expert Limited, 8-1-1 Seikadai, Seika-cho, Soraku-gun, Kyoto, 619-0284, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Yoshinori Kitagawa</Name>
        <Affiliation>Suntory Wellness Limited, 8-1-1 Seikadai, Seika-cho, Soraku-gun, Kyoto, 619-0284, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Makoto Hayashi</Name>
        <Affiliation>Makoto International Consulting, 23-3-1, 4-chome, Kami-imaizumi, Ebina, 243-0431, Japan.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Pharmacokinetics of oseltamivir phosphate and oseltamivir carboxylate in non-pregnant and pregnant rhesus monkeys.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31927005</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(19)30333-2</DOI>
    <KeywordList>
      <Keywords>Oseltamivir</Keywords>
      <Keywords>Pharmacokinetics</Keywords>
      <Keywords>Pregnancy</Keywords>
      <Keywords>Rhesus monkeys</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Lucie Loukotková</Name>
        <Affiliation>FDA National Center for Toxicological Research, Jefferson, AR, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Mallikarjuna Basavarajappa</Name>
        <Affiliation>FDA National Center for Toxicological Research, Jefferson, AR, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Annie Lumen</Name>
        <Affiliation>FDA National Center for Toxicological Research, Jefferson, AR, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Rosemary Roberts</Name>
        <Affiliation>FDA Center for Drug Evaluation and Research, Silver Spring, MD, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Donald Mattison</Name>
        <Affiliation>Risk Sciences International, Ottawa, Ontario, Canada and Hilton Head Island, SC USA and University of Ottawa, Ontario, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Suzanne M. Morris</Name>
        <Affiliation>FDA National Center for Toxicological Research, Jefferson, AR, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jeffrey Fisher</Name>
        <Affiliation>FDA National Center for Toxicological Research, Jefferson, AR, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Frederick A. Beland</Name>
        <Affiliation>FDA National Center for Toxicological Research, Jefferson, AR, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Gonçalo Gamboa da Costa</Name>
        <Affiliation>FDA National Center for Toxicological Research, Jefferson, AR, USA. Electronic address: goncalo.gamboa@fda.hhs.gov.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Plasticizer migration from children's toys, child care articles, art materials, and school supplies.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31917999</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(19)30338-1</DOI>
    <KeywordList>
      <Keywords>Children</Keywords>
      <Keywords>Exposure</Keywords>
      <Keywords>Migration</Keywords>
      <Keywords>Plasticizer</Keywords>
      <Keywords>Polyvinyl chloride</Keywords>
      <Keywords>Toys</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Michael A. Babich</Name>
        <Affiliation>Directorate for Health Sciences, U.S. Consumer Product Safety Commission, 5 Research Place, Rockville, MD, 20850, USA. Electronic address: mbabich@cpsc.gov.</Affiliation>
      </Author>
      <Author>
        <Name>Charles Bevington</Name>
        <Affiliation>Directorate for Health Sciences, U.S. Consumer Product Safety Commission, 5 Research Place, Rockville, MD, 20850, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Matthew A. Dreyfus</Name>
        <Affiliation>Directorate for Laboratory Sciences, U.S. Consumer Product Safety Commission, 5 Research Place, Rockville, MD, 20850, USA.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Maternal exposure to ibuprofen can affect the programming of the hypothalamus of the male offspring.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31911196</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(20)30002-7</DOI>
    <KeywordList>
      <Keywords>Brain sexual differentiation</Keywords>
      <Keywords>Preoptic area</Keywords>
      <Keywords>Prostaglandins</Keywords>
      <Keywords>Sexual behavior</Keywords>
      <Keywords>Sexually dimorphic nucleus</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Paola da Silva Balin</Name>
        <Affiliation>Department of Morphology, Institute of Biosciences of Botucatu, Univ. Estadual Paulista, Botucatu (UNESP), São Paulo State, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Bárbara Campos Jorge</Name>
        <Affiliation>Department of Morphology, Institute of Biosciences of Botucatu, Univ. Estadual Paulista, Botucatu (UNESP), São Paulo State, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Andressa Rejani Ribeiro Leite</Name>
        <Affiliation>Department of Morphology, Institute of Biosciences of Botucatu, Univ. Estadual Paulista, Botucatu (UNESP), São Paulo State, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Cibele Santos Borges</Name>
        <Affiliation>Department of Morphology, Institute of Biosciences of Botucatu, Univ. Estadual Paulista, Botucatu (UNESP), São Paulo State, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Eunice Oba</Name>
        <Affiliation>Department of Animal Reproduction, Faculty of Veterinary Medicine, Univ. Estadual Paulista (UNESP), Botucatu, São Paulo State, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Erick José Ramo Silva</Name>
        <Affiliation>Department of Pharmacology, Institute of Biosciences of Botucatu, Univ. Estadual Paulista (UNESP), Botucatu, São Paulo State, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Aline Lima de Barros</Name>
        <Affiliation>Department of Morphology, Institute of Biosciences of Botucatu, Univ. Estadual Paulista, Botucatu (UNESP), São Paulo State, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>José de Anchieta Castro Horta-Júnior</Name>
        <Affiliation>Department of Anatomy, Institute of Biosciences of Botucatu, Univ. Estadual Paulista (UNESP), Botucatu, São Paulo State, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Arielle Cristina Arena</Name>
        <Affiliation>Department of Morphology, Institute of Biosciences of Botucatu, Univ. Estadual Paulista, Botucatu (UNESP), São Paulo State, Brazil; Center of Toxicological Assistance (CEATOX), Institute of Biosciences of Botucatu, Univ. Estadual Paulista, Botucatu (UNESP), São Paulo State, Brazil. Electronic address: arielle.arena@unesp.br.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Letter to the editor - Factual inaccuracies of the article Causes of drug shortages in the legal pharmaceutical framework.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31899277</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(19)30315-0</DOI>
    <AuthorList>
      <Author>
        <Name>Esco Aguiar</Name>
        <Affiliation>EAEPC, Rue des Deux Eglises 26, 1000, Brussels, Belgium. Electronic address: ea@eaepc.org.</Affiliation>
      </Author>
      <Author>
        <Name>Kasper Ernest</Name>
        <Affiliation>EAEPC, Rue des Deux Eglises 26, 1000, Brussels, Belgium. Electronic address: ke@eaepc.org.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: This paper has been written on behalf of the EAEPC, the European Association of Euro-Pharmaceutical Companies. EAEPC is the voice of parallel distribution of medicines in Europe, and it represents over 120 companies in 23 EEA countries, accounting for 80-85% of the industry.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The accessibility of data on environmental risk assessment of pharmaceuticals - are environmental risk assessments information on emissions with respect to international and European environmental information law?</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31893528</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(19)30335-6</DOI>
    <KeywordList>
      <Keywords>Aarhus convention</Keywords>
      <Keywords>Access to environmental information</Keywords>
      <Keywords>Emission</Keywords>
      <Keywords>Environmental risk assessment</Keywords>
      <Keywords>Pharmaceuticals</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Kim Oelkers</Name>
        <Affiliation>Department Environmental Engineering, Faculty Life Sciences, Hamburg University of Applied Sciences (HAW Hamburg), Ulmenliet 20, 21033, Hamburg, Germany. Electronic address: Kim-Kristin.Oelkers@haw-hamburg.de.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Safety evaluation and protective effects of ethanolic extract from maca (Lepidium meyenii Walp.) against corticosterone and H</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31884156</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(19)30334-4</DOI>
    <KeywordList>
      <Keywords>Corticosterone</Keywords>
      <Keywords>Ethanolic extract from maca</Keywords>
      <Keywords>Macamides</Keywords>
      <Keywords>Neuroprotective effects</Keywords>
      <Keywords>Pro-inflammatory cytokines</Keywords>
      <Keywords>Safety evaluation</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Zejun Yu</Name>
        <Affiliation>Institute of Resource Biology and Biotechnology, Department of Biotechnology, College of Life Science and Technology, Huazhong University of Science and Technology, Wuhan, 430074, PR China; Key Laboratory of Molecular Biophysics, Ministry of Education, Wuhan, 430074, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Wenwen Jin</Name>
        <Affiliation>Institute of Resource Biology and Biotechnology, Department of Biotechnology, College of Life Science and Technology, Huazhong University of Science and Technology, Wuhan, 430074, PR China; Key Laboratory of Molecular Biophysics, Ministry of Education, Wuhan, 430074, PR China. Electronic address: jww@hust.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Xuhui Dong</Name>
        <Affiliation>Institute of Resource Biology and Biotechnology, Department of Biotechnology, College of Life Science and Technology, Huazhong University of Science and Technology, Wuhan, 430074, PR China; Key Laboratory of Molecular Biophysics, Ministry of Education, Wuhan, 430074, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Mingzhang Ao</Name>
        <Affiliation>Institute of Resource Biology and Biotechnology, Department of Biotechnology, College of Life Science and Technology, Huazhong University of Science and Technology, Wuhan, 430074, PR China; Key Laboratory of Molecular Biophysics, Ministry of Education, Wuhan, 430074, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Hao Liu</Name>
        <Affiliation>Institute of Resource Biology and Biotechnology, Department of Biotechnology, College of Life Science and Technology, Huazhong University of Science and Technology, Wuhan, 430074, PR China; Key Laboratory of Molecular Biophysics, Ministry of Education, Wuhan, 430074, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Longjiang Yu</Name>
        <Affiliation>Institute of Resource Biology and Biotechnology, Department of Biotechnology, College of Life Science and Technology, Huazhong University of Science and Technology, Wuhan, 430074, PR China; Key Laboratory of Molecular Biophysics, Ministry of Education, Wuhan, 430074, PR China. Electronic address: yulongjiang@hust.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>In vitro and in vivo effects of 5-aminotetrazole (5-AT), an energetic compound.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31884155</pubmedLink>
    <GrantList>
      <Grant>EPA999999</Grant>
    </GrantList>
    <Year>2020</Year>
    <DOI>S0273-2300(19)30337-X</DOI>
    <KeywordList>
      <Keywords>14-Day sub-acute</Keywords>
      <Keywords>5-AT</Keywords>
      <Keywords>Ames</Keywords>
      <Keywords>Oral</Keywords>
      <Keywords>Rat</Keywords>
      <Keywords>Tetrazole</Keywords>
      <Keywords>Thyroid</Keywords>
      <Keywords>Toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Valerie H. Adams</Name>
        <Affiliation>U.S. Army Public Health Center, Toxicology Directorate, 8252 Blackhawk Rd, ATTN: MCHB-PH-HEF, Aberdeen Proving Ground, MD, 21010, USA. Electronic address: Usarmy.apg.medcom-phc.mbx.tox-info@mail.mil.</Affiliation>
      </Author>
      <Author>
        <Name>Matthew A. Bazar</Name>
        <Affiliation>U.S. Army Public Health Center, Toxicology Directorate, 8252 Blackhawk Rd, ATTN: MCHB-PH-HEF, Aberdeen Proving Ground, MD, 21010, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Emily N. Reinke</Name>
        <Affiliation>U.S. Army Public Health Center, Toxicology Directorate, 8252 Blackhawk Rd, ATTN: MCHB-PH-HEF, Aberdeen Proving Ground, MD, 21010, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Angela R. Buckalew</Name>
        <Affiliation>Endocrine Toxicology Branch, Toxicity Assessment Division, National Health and Environmental Effects Research Laboratory, Office of Research &amp; Development, U.S. Environmental Protection Agency, Research Triangle Park, NC, 27713, USA.</Affiliation>
      </Author>
      <Author>
        <Name>William S. Eck</Name>
        <Affiliation>U.S. Army Public Health Center, Toxicology Directorate, 8252 Blackhawk Rd, ATTN: MCHB-PH-HEF, Aberdeen Proving Ground, MD, 21010, USA.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Transgene expression in sprayed and non-sprayed herbicide-tolerant genetically engineered crops is equivalent.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31884154</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(19)30336-8</DOI>
    <KeywordList>
      <Keywords>Coefficient of identity</Keywords>
      <Keywords>Genetically engineered (GE) breeding stacks</Keywords>
      <Keywords>Herbicide-tolerant crops</Keywords>
      <Keywords>Safety assessment</Keywords>
      <Keywords>Transgene expression</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Brandon J. Fast</Name>
        <Affiliation>Corteva Agriscience™, Johnston, IA, USA. Electronic address: brandon.fast@corteva.com.</Affiliation>
      </Author>
      <Author>
        <Name>Guomin Shan</Name>
        <Affiliation>Corteva Agriscience™, Indianapolis, IN, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Satyalinga Srinivas Gampala</Name>
        <Affiliation>Corteva Agriscience™, Johnston, IA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Rod A. Herman</Name>
        <Affiliation>Corteva Agriscience™, Indianapolis, IN, USA.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: The authors work for a company that develops and markets GE seed.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Oral repeated-dose toxicity studies of BIA 10-2474 in beagle dogs.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31874201</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(19)30319-8</DOI>
    <KeywordList>
      <Keywords>BIA 10–2474</Keywords>
      <Keywords>Beagle dogs</Keywords>
      <Keywords>Endocannabinoid system</Keywords>
      <Keywords>Endogenous anandamide</Keywords>
      <Keywords>Toxicology</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jerry F. Hardisty</Name>
        <Affiliation>EPL Inc., North Carolina, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Stephen B. Harris</Name>
        <Affiliation>Stephen B. Harris Group, San Diego, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Wallace A. Hayes</Name>
        <Affiliation>University of South Florida College and Michigan State University, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Klaus Weber</Name>
        <Affiliation>AnaPath GmbH, 4625, Oberbuchsiten, Switzerland. Electronic address: kweber@anapath.ch.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: The study was funded by Bial Portela &amp; Companhia S.A. (São Mamede do Coronado, Portugal). Stephen B. Harris, Jerry F. Hardisty, A. Wallace Hayes, and Klaus Weber were paid consultants of Bial. Furthermore, one of the authors (Klaus Weber) was the study pathologist on all of the studies. The manuscript was written by the authors and reviewed by Bial; however, the work product and conclusions are those of the authors.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The absence of genotoxicity of a novel fatty acid amide hydrolase inhibitor, BIA 10-2474.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31866344</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(19)30320-4</DOI>
    <KeywordList>
      <Keywords>BIA 10–2474</Keywords>
      <Keywords>Chromosome aberration</Keywords>
      <Keywords>Erythrocyte micronucleus</Keywords>
      <Keywords>Genotoxicity</Keywords>
      <Keywords>Mutation systems</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>A. Wallace Hayes</Name>
        <Affiliation>University of South Florida College, Tampa, FL, USA; Michigan State University, East Lansing, MI, USA. Electronic address: awallacehayes@comcast.net.</Affiliation>
      </Author>
      <Author>
        <Name>Jerry F. Hardisty</Name>
        <Affiliation>EPL Inc., North Carolina, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Stephen B. Harris</Name>
        <Affiliation>Stephen B. Harris Group, San Diego, CA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Klaus Weber</Name>
        <Affiliation>AnaPath GmbH, 4625, Oberbuchsiten, Switzerland.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests. The study was funded by Bial Portela &amp; Companhia S.A. (São Mamede do Coronado, Portugal). Stephen B. Harris, Jerry F. Hardisty, A. Wallace Hayes, and Klaus Weber were paid consultants of Bial. Furthermore, one of the authors (Klaus Weber) was the study pathologist on all of the studies. The manuscript was written by the authors and reviewed by Bial; however, the work product and conclusions are those of the authors.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Oral repeated-dose toxicity studies of BIA 10-2474 in CD-1 mice.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31866343</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(19)30321-6</DOI>
    <KeywordList>
      <Keywords>BIA 10–2474</Keywords>
      <Keywords>CD-1 mice</Keywords>
      <Keywords>Endocannabinoid system</Keywords>
      <Keywords>Endogenous anandamide</Keywords>
      <Keywords>Toxicology</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>A. Wallace Hayes</Name>
        <Affiliation>University of South Florida College and Michigan State University, Andover, USA. Electronic address: awallacehayes@comcast.net.</Affiliation>
      </Author>
      <Author>
        <Name>Peter Pressman</Name>
        <Affiliation>The Daedalus Foundation, San Clemente, CA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jerry F. Hardisty</Name>
        <Affiliation>EPL Inc., North Carolina, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Stephen B. Harris</Name>
        <Affiliation>Stephen B. Harris Group, San Diego, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Klaus Weber</Name>
        <Affiliation>AnaPath GmbH, 4625, Oberbuchsiten, Switzerland.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests. The study was funded by Bial Portela &amp; Companhia S.A. (São Mamede do Coronado, Portugal). Stephen B. Harris, Jerold F. Hardisty, A. Wallace Hayes, and Klaus Weber were paid consultants of Bial. Furthermore, one of the authors (Klaus Weber) was the study pathologist on all of the studies. The manuscript was written by the authors and reviewed by Bial; however, the work product and conclusions are those of the authors.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Genotoxic potential of cellobiose.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31846711</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(19)30318-6</DOI>
    <KeywordList>
      <Keywords>Ames test</Keywords>
      <Keywords>Cellobiose</Keywords>
      <Keywords>Genotoxicity</Keywords>
      <Keywords>In-vitro micronucleus test</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Horst Messinger</Name>
        <Affiliation>Bioresco Ltd., 4054, Basel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Andreas Winkler</Name>
        <Affiliation>LPT Laboratory of Pharmacology and Toxicology GmbH &amp; Co. KG, 21147, Hamburg, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Albert Bär</Name>
        <Affiliation>Bioresco Ltd., 4054, Basel, Switzerland. Electronic address: contact@bioresco.ch.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Nonclinical evaluation of IQG-607, an anti-tuberculosis candidate with potential use in combination drug therapy.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31843592</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(19)30317-4</DOI>
    <KeywordList>
      <Keywords>Combination drug therapy</Keywords>
      <Keywords>Drug development</Keywords>
      <Keywords>IQG-607</Keywords>
      <Keywords>Nonclinical toxicology</Keywords>
      <Keywords>Tuberculosis</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Valnês S. Rodrigues-Junior</Name>
        <Affiliation>Instituto Nacional de Ciência e Tecnologia em Tuberculose (INCT-TB), Brazil; Programa de Pós-Graduação em Biotecnologia, Centro de Biotecnologia, Universidade Federal da Paraíba, João Pessoa, Brazil. Electronic address: valnesjunior@yahoo.com.br.</Affiliation>
      </Author>
      <Author>
        <Name>Anne D. Villela</Name>
        <Affiliation>Instituto Nacional de Ciência e Tecnologia em Tuberculose (INCT-TB), Brazil; Centro de Pesquisas em Biologia Molecular e Funcional (CPBMF), Pontifícia Universidade Católica do Rio Grande do Sul (PUCRS), Porto Alegre, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Bruno L. Abbadi</Name>
        <Affiliation>Instituto Nacional de Ciência e Tecnologia em Tuberculose (INCT-TB), Brazil; Centro de Pesquisas em Biologia Molecular e Funcional (CPBMF), Pontifícia Universidade Católica do Rio Grande do Sul (PUCRS), Porto Alegre, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Nathalia D. M. Sperotto</Name>
        <Affiliation>Instituto Nacional de Ciência e Tecnologia em Tuberculose (INCT-TB), Brazil; Centro de Pesquisas em Biologia Molecular e Funcional (CPBMF), Pontifícia Universidade Católica do Rio Grande do Sul (PUCRS), Porto Alegre, Brazil; Programa de Pós-Graduação em Medicina e Ciências da Saúde, PUCRS, Porto Alegre, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Kenia Pissinate</Name>
        <Affiliation>Instituto Nacional de Ciência e Tecnologia em Tuberculose (INCT-TB), Brazil; Centro de Pesquisas em Biologia Molecular e Funcional (CPBMF), Pontifícia Universidade Católica do Rio Grande do Sul (PUCRS), Porto Alegre, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Jaqueline N. Picada</Name>
        <Affiliation>Laboratório de Genética Toxicológica, Universidade Luterana do Brasil, Canoas, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Juliana Bondan da Silva</Name>
        <Affiliation>Laboratório de Genética Toxicológica, Universidade Luterana do Brasil, Canoas, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Cristiano V. Bizarro</Name>
        <Affiliation>Instituto Nacional de Ciência e Tecnologia em Tuberculose (INCT-TB), Brazil; Centro de Pesquisas em Biologia Molecular e Funcional (CPBMF), Pontifícia Universidade Católica do Rio Grande do Sul (PUCRS), Porto Alegre, Brazil; Programa de Pós-Graduação em Biologia Celular e Molecular, PUCRS, Porto Alegre, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Pablo Machado</Name>
        <Affiliation>Instituto Nacional de Ciência e Tecnologia em Tuberculose (INCT-TB), Brazil; Centro de Pesquisas em Biologia Molecular e Funcional (CPBMF), Pontifícia Universidade Católica do Rio Grande do Sul (PUCRS), Porto Alegre, Brazil; Programa de Pós-Graduação em Biologia Celular e Molecular, PUCRS, Porto Alegre, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Luiz A. Basso</Name>
        <Affiliation>Instituto Nacional de Ciência e Tecnologia em Tuberculose (INCT-TB), Brazil; Centro de Pesquisas em Biologia Molecular e Funcional (CPBMF), Pontifícia Universidade Católica do Rio Grande do Sul (PUCRS), Porto Alegre, Brazil; Programa de Pós-Graduação em Medicina e Ciências da Saúde, PUCRS, Porto Alegre, Brazil; Programa de Pós-Graduação em Biologia Celular e Molecular, PUCRS, Porto Alegre, Brazil. Electronic address: luiz.basso@pucrs.br.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Rat 90-day oral toxicity study of a novel coccidiostat - Ethanamizuril.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31843591</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(19)30314-9</DOI>
    <KeywordList>
      <Keywords>90-Day</Keywords>
      <Keywords>Ethanamizuril</Keywords>
      <Keywords>SD rats</Keywords>
      <Keywords>Subchronic oral toxicity</Keywords>
      <Keywords>Triazine coccidiostats</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Keyu Zhang</Name>
        <Affiliation>Key Laboratory of Veterinary Chemical Drugs and Pharmaceutics, Ministry of Agriculture and Rural Affairs, Shanghai Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Shanghai, 200241, PR China. Electronic address: z_cole@sina.com.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaoyang Wang</Name>
        <Affiliation>Key Laboratory of Veterinary Chemical Drugs and Pharmaceutics, Ministry of Agriculture and Rural Affairs, Shanghai Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Shanghai, 200241, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Mi Wang</Name>
        <Affiliation>Key Laboratory of Veterinary Chemical Drugs and Pharmaceutics, Ministry of Agriculture and Rural Affairs, Shanghai Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Shanghai, 200241, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Yingchun Liu</Name>
        <Affiliation>Key Laboratory of Veterinary Chemical Drugs and Pharmaceutics, Ministry of Agriculture and Rural Affairs, Shanghai Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Shanghai, 200241, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Lifang Zhang</Name>
        <Affiliation>Key Laboratory of Veterinary Chemical Drugs and Pharmaceutics, Ministry of Agriculture and Rural Affairs, Shanghai Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Shanghai, 200241, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Chunmei Wang</Name>
        <Affiliation>Key Laboratory of Veterinary Chemical Drugs and Pharmaceutics, Ministry of Agriculture and Rural Affairs, Shanghai Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Shanghai, 200241, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Chenzhong Fei</Name>
        <Affiliation>Key Laboratory of Veterinary Chemical Drugs and Pharmaceutics, Ministry of Agriculture and Rural Affairs, Shanghai Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Shanghai, 200241, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Juan Li</Name>
        <Affiliation>College of Chemistry, Xiangtan University, Yuhu District, Xiangtan, 411100, Hunan, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Feiqun Xue</Name>
        <Affiliation>Key Laboratory of Veterinary Chemical Drugs and Pharmaceutics, Ministry of Agriculture and Rural Affairs, Shanghai Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Shanghai, 200241, PR China.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Toxicokinetic testing strategies to demonstrate bone marrow exposure in in vivo micronucleus study for genotoxicity assessment of agrochemicals.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31836537</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(19)30316-2</DOI>
    <KeywordList>
      <Keywords>Bone marrow</Keywords>
      <Keywords>Genotoxicity</Keywords>
      <Keywords>In vivo micronucleus</Keywords>
      <Keywords>Target tissue exposure</Keywords>
      <Keywords>Toxicokinetics</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Gopinath C. Nallani</Name>
        <Affiliation>Global Regulatory Sciences, FMC Corporation, 1090 Elkton Rd, Newark, DE, 19711, USA. Electronic address: Gopinath.Nallani@fmc.com.</Affiliation>
      </Author>
      <Author>
        <Name>Zhiwei Liu</Name>
        <Affiliation>Global Regulatory Sciences, FMC Corporation, 1090 Elkton Rd, Newark, DE, 19711, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Appavu Chandrasekaran</Name>
        <Affiliation>Global Regulatory Sciences, FMC Corporation, 1090 Elkton Rd, Newark, DE, 19711, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Guidelines on the benefit-risk assessment of the presence of phthalates in certain medical devices covering phthalates which are carcinogenic, mutagenic, toxic to reproduction (CMR) or have endocrine-disrupting (ED) properties.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31830500</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(19)30310-1</DOI>
    <KeywordList>
      <Keywords>Benefit-risk assessment</Keywords>
      <Keywords>CMR/ED phthalates</Keywords>
      <Keywords>Guidelines</Keywords>
      <Keywords>Medical devices</Keywords>
      <Keywords>SCHEER</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>W. H. De Jong</Name>
      </Author>
      <Author>
        <Name> </Name>
      </Author>
      <Author>
        <Name> </Name>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Oral repeated-dose toxicity studies of BIA 10-2474 in cynomolgus monkeys.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31816339</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(19)30311-3</DOI>
    <KeywordList>
      <Keywords>BIA 10–2474</Keywords>
      <Keywords>Cynomolgus</Keywords>
      <Keywords>Endocannabinoid system</Keywords>
      <Keywords>Endogenous anandamide</Keywords>
      <Keywords>Toxicology</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Klaus Weber</Name>
        <Affiliation>AnaPath GmbH, Oberbuchsiten, Switzerland. Electronic address: kweber@anapath.ch.</Affiliation>
      </Author>
      <Author>
        <Name>Rüdiger Häcker</Name>
        <Affiliation>Medicons GmbH, Beckenried, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Jerry F. Hardisty</Name>
        <Affiliation>EPL Inc., North Carolina, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Stephen B. Harris</Name>
        <Affiliation>Stephen B. Harris Group, San Diego, USA.</Affiliation>
      </Author>
      <Author>
        <Name>A. Wallace Hayes</Name>
        <Affiliation>University of South Florida College and Michigan State University, Tampa, USA.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: The study was funded by Bial Portela &amp; Companhia S.A. (São Mamede do Coronado, Portugal). Stephen B. Harris, Jerry F. Hardisty, A. Wallace Hayes, Yoshimasa Okazaki(,) and Klaus Weber were paid consultants of Bial. Furthermore, one of the authors (Klaus Weber) was the study pathologist on all of the studies. The manuscript was written by the authors and reviewed by Bial; however, the work product and conclusions are those of the authors.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Bioaccessibility of nickel and cobalt in synthetic gastric and lung fluids and its potential use in alloy classification.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31811877</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(19)30313-7</DOI>
    <KeywordList>
      <Keywords>Alloys</Keywords>
      <Keywords>Bioaccessibility</Keywords>
      <Keywords>Bioelution</Keywords>
      <Keywords>Classification</Keywords>
      <Keywords>Cobalt</Keywords>
      <Keywords>Metal</Keywords>
      <Keywords>Nickel</Keywords>
      <Keywords>Relative bioaccessible concentration</Keywords>
      <Keywords>Stainless steel</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Katherine E. Heim</Name>
        <Affiliation>NiPERA Inc., 2525 Meridian Parkway, Suite 240, Durham, NC, 27713, USA. Electronic address: kheim@nipera.org.</Affiliation>
      </Author>
      <Author>
        <Name>Ruth Danzeisen</Name>
        <Affiliation>Cobalt Institute, 18 Jeffries Passage, Guildford, GU1 4AP, UK. Electronic address: RDanzeisen@cobaltinstitute.org.</Affiliation>
      </Author>
      <Author>
        <Name>Violaine Verougstraete</Name>
        <Affiliation>Eurometaux, 168, Avenue de Tervuren, 1150, Brussels, Belgium. Electronic address: verougstraete@eurometaux.be.</Affiliation>
      </Author>
      <Author>
        <Name>Frédéric Gaidou</Name>
        <Affiliation>Environment Department, ERAMET S.A, 75015, Paris, France. Electronic address: frederic.gaidou@eramet.com.</Affiliation>
      </Author>
      <Author>
        <Name>Tony Brouwers</Name>
        <Affiliation>ECTX Bvba, Havenstraat 46/0.01, 3500, Hasselt, Belgium. Electronic address: tony.brouwers@ectx.be.</Affiliation>
      </Author>
      <Author>
        <Name>Adriana R. Oller</Name>
        <Affiliation>NiPERA Inc., 2525 Meridian Parkway, Suite 240, Durham, NC, 27713, USA. Electronic address: aoller@nipera.org.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Chemistry, metabolism and pharmacology of carcinogenic alkaloids present in areca nut and factors affecting their concentration.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31805361</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(19)30312-5</DOI>
    <KeywordList>
      <Keywords>Alkaloids</Keywords>
      <Keywords>Areca Nut (AN)</Keywords>
      <Keywords>Arecoline</Keywords>
      <Keywords>Cancer</Keywords>
      <Keywords>Metabolism</Keywords>
      <Keywords>Pharmacology</Keywords>
      <Keywords>Toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Alpana K. Gupta</Name>
        <Affiliation>Division of Preventive Oncology, ICMR-National Institute of Cancer Prevention and Research, Department of Health Research (Govt. of India), I-7, Sector-39, Noida, G.B. Nagar, 201301, U.P, India.</Affiliation>
      </Author>
      <Author>
        <Name>Sonam Tulsyan</Name>
        <Affiliation>Division of Preventive Oncology, ICMR-National Institute of Cancer Prevention and Research, Department of Health Research (Govt. of India), I-7, Sector-39, Noida, G.B. Nagar, 201301, U.P, India.</Affiliation>
      </Author>
      <Author>
        <Name>Nisha Thakur</Name>
        <Affiliation>Division of Molecular Diagnostics, ICMR-National Institute of Cancer Prevention and Research, Department of Health Research (Govt. of India), I-7, Sector-39, Noida, G.B. Nagar, 201301, U.P, India.</Affiliation>
      </Author>
      <Author>
        <Name>Vishwas Sharma</Name>
        <Affiliation>Division of Preventive Oncology, ICMR-National Institute of Cancer Prevention and Research, Department of Health Research (Govt. of India), I-7, Sector-39, Noida, G.B. Nagar, 201301, U.P, India.</Affiliation>
      </Author>
      <Author>
        <Name>Dhirendra N. Sinha</Name>
        <Affiliation>School of Preventive Oncology, Patna, India.</Affiliation>
      </Author>
      <Author>
        <Name>Ravi Mehrotra</Name>
        <Affiliation>ICMR- India Cancer Research Consortium, Department of Health Research (Govt. of India), 1- Red Cross Road, New Delhi, 110001, India. Electronic address: ravi.mehrotra@gov.in.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Berberine decreases insulin resistance in a PCOS rats by improving GLUT4: Dual regulation of the PI3K/AKT and MAPK pathways.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31778716</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(19)30308-3</DOI>
    <KeywordList>
      <Keywords>Berberine</Keywords>
      <Keywords>Glucose transporter 4 (GLUT4)</Keywords>
      <Keywords>Insulin resistance (IR)</Keywords>
      <Keywords>MAPK pathway</Keywords>
      <Keywords>PI3K/AKT pathway</Keywords>
      <Keywords>Polycystic ovary syndrome (PCOS)</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Ning Zhang</Name>
        <Affiliation>Reproductive Medicine Center, Yantai Yuhuangding Hospital, Yantai, 264000, China. Electronic address: yyyzhangning@126.com.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaoyan Liu</Name>
        <Affiliation>Reproductive Medicine Center, Yantai Yuhuangding Hospital, Yantai, 264000, China.</Affiliation>
      </Author>
      <Author>
        <Name>Lili Zhuang</Name>
        <Affiliation>Reproductive Medicine Center, Yantai Yuhuangding Hospital, Yantai, 264000, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xuemei Liu</Name>
        <Affiliation>Reproductive Medicine Center, Yantai Yuhuangding Hospital, Yantai, 264000, China.</Affiliation>
      </Author>
      <Author>
        <Name>Huishan Zhao</Name>
        <Affiliation>Reproductive Medicine Center, Yantai Yuhuangding Hospital, Yantai, 264000, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yinghua Shan</Name>
        <Affiliation>Reproductive Medicine Center, Yantai Yuhuangding Hospital, Yantai, 264000, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhenteng Liu</Name>
        <Affiliation>Reproductive Medicine Center, Yantai Yuhuangding Hospital, Yantai, 264000, China.</Affiliation>
      </Author>
      <Author>
        <Name>Fenghua Li</Name>
        <Affiliation>Reproductive Medicine Center, Yantai Yuhuangding Hospital, Yantai, 264000, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yilin Wang</Name>
        <Affiliation>Reproductive Medicine Center, Yantai Yuhuangding Hospital, Yantai, 264000, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jianye Fang</Name>
        <Affiliation>Reproductive Medicine Center, Yantai Yuhuangding Hospital, Yantai, 264000, China.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Deriving safe short-term chemical exposure values (STEV) for drinking water.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31778715</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(19)30309-5</DOI>
    <KeywordList>
      <Keywords>Cyanotoxins</Keywords>
      <Keywords>Disinfection by-products</Keywords>
      <Keywords>Pesticides</Keywords>
      <Keywords>Short-term guideline values</Keywords>
      <Keywords>Water quality</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Frederic D. L. Leusch</Name>
        <Affiliation>Australian Rivers Institute, School of Environment and Science, Griffith University, Southport, Qld, 4222, Australia. Electronic address: f.leusch@griffith.edu.au.</Affiliation>
      </Author>
      <Author>
        <Name>Stuart J. Khan</Name>
        <Affiliation>School of Civil &amp; Environmental Engineering, University of New South Wales, Sydney, NSW, Australia.</Affiliation>
      </Author>
      <Author>
        <Name>Daniel Deere</Name>
        <Affiliation>Water Futures, NSW, Australia.</Affiliation>
      </Author>
      <Author>
        <Name>David Cunliffe</Name>
        <Affiliation>Department of Health South Australia, Adelaide, SA, Australia.</Affiliation>
      </Author>
      <Author>
        <Name>Peta A. Neale</Name>
        <Affiliation>Australian Rivers Institute, School of Environment and Science, Griffith University, Southport, Qld, 4222, Australia.</Affiliation>
      </Author>
      <Author>
        <Name>Andrew Humpage</Name>
        <Affiliation>Department of Health Sciences, University of Adelaide, Adelaide, SA, Australia.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Arsenic exposure: A public health problem leading to several cancers.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31765675</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(19)30303-4</DOI>
    <KeywordList>
      <Keywords>Arsenic</Keywords>
      <Keywords>Bladder</Keywords>
      <Keywords>Molecular mechanism</Keywords>
      <Keywords>Skin and lung cancer</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>I. Palma-Lara</Name>
        <Affiliation>Laboratorio de Morfología Celular, Sección de Estudios de Posgrado e Investigación, Escuela Superior de Medicina, Instituto Politécnico Nacional, Plan de San Luis y Díaz Mirón, Casco de Santo Tomas, Ciudad de México, 11340, Mexico.</Affiliation>
      </Author>
      <Author>
        <Name>M. Martínez-Castillo</Name>
        <Affiliation>Laboratorio de Morfología Celular, Sección de Estudios de Posgrado e Investigación, Escuela Superior de Medicina, Instituto Politécnico Nacional, Plan de San Luis y Díaz Mirón, Casco de Santo Tomas, Ciudad de México, 11340, Mexico.</Affiliation>
      </Author>
      <Author>
        <Name>J. C. Quintana-Pérez</Name>
        <Affiliation>Laboratorio de Investigación en Enfermedades Crónico Degenerativas, Sección de Estudios de Posgrado e Investigación, Escuela Superior de Medicina, Instituto Politécnico Nacional, Plan de San Luis y Díaz Mirón, Casco de Santo Tomas, Miguel Hidalgo, Ciudad de México, 11340, Mexico.</Affiliation>
      </Author>
      <Author>
        <Name>M. G. Arellano-Mendoza</Name>
        <Affiliation>Laboratorio de Investigación en Enfermedades Crónico Degenerativas, Sección de Estudios de Posgrado e Investigación, Escuela Superior de Medicina, Instituto Politécnico Nacional, Plan de San Luis y Díaz Mirón, Casco de Santo Tomas, Miguel Hidalgo, Ciudad de México, 11340, Mexico.</Affiliation>
      </Author>
      <Author>
        <Name>F. Tamay-Cach</Name>
        <Affiliation>Laboratorio de Investigación en Enfermedades Crónico Degenerativas, Sección de Estudios de Posgrado e Investigación, Escuela Superior de Medicina, Instituto Politécnico Nacional, Plan de San Luis y Díaz Mirón, Casco de Santo Tomas, Miguel Hidalgo, Ciudad de México, 11340, Mexico.</Affiliation>
      </Author>
      <Author>
        <Name>O. L. Valenzuela-Limón</Name>
        <Affiliation>Facultad de Ciencias Químicas, Universidad Veracruzana, Prolongación de Oriente 6 #1009, Col. Rafael Alvarado, 94340, Orizaba, Veracruz, Mexico.</Affiliation>
      </Author>
      <Author>
        <Name>E. A. García-Montalvo</Name>
        <Affiliation>Facultad de Ciencias Químicas, Universidad Veracruzana, Prolongación de Oriente 6 #1009, Col. Rafael Alvarado, 94340, Orizaba, Veracruz, Mexico.</Affiliation>
      </Author>
      <Author>
        <Name>A. Hernández-Zavala</Name>
        <Affiliation>Laboratorio de Morfología Celular, Sección de Estudios de Posgrado e Investigación, Escuela Superior de Medicina, Instituto Politécnico Nacional, Plan de San Luis y Díaz Mirón, Casco de Santo Tomas, Ciudad de México, 11340, Mexico. Electronic address: arhernandezz@ipn.mx.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Commentary on BIA 10-2474.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31759139</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(19)30305-8</DOI>
    <KeywordList>
      <Keywords>BIA 10–2474</Keywords>
      <Keywords>Clinical trial</Keywords>
      <Keywords>Commentary</Keywords>
      <Keywords>FAAH inhibitors</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>A. Wallace Hayes</Name>
        <Affiliation>University of South Florida College of Public Health, Tampa, FL, USA. Electronic address: awallacehayes@comcast.net.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of competing interest The author declares the following financial interests/personal relationships which may be considered as potential competing interests: The study was funded by Bial Portela &amp; Companhia S.A. (São Mamede do Coronado, Portugal). A. Wallace Hayes was a paid consultants of Bial. The manuscript was written by the author and reviewed by Bial; however, the work product and conclusions are those of the author.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Oral repeated-dose toxicity studies of BIA 10-2474 in Wistar rat.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31759138</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(19)30304-6</DOI>
    <KeywordList>
      <Keywords>BIA 10–2474</Keywords>
      <Keywords>Endocannabinoid system</Keywords>
      <Keywords>Endogenous anandamide</Keywords>
      <Keywords>Toxicology</Keywords>
      <Keywords>Wistar rat</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>A. Wallace Hayes</Name>
        <Affiliation>University of South Florida College and Michigan State University, Tampa, FL, USA. Electronic address: awallacehayes@comcast.net.</Affiliation>
      </Author>
      <Author>
        <Name>Jerry F. Hardisty</Name>
        <Affiliation>EPL Inc., North Carolina, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Stephen B. Harris</Name>
        <Affiliation>Stephen B. Harris Group, San Diego, CA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Yoshimasa Okazaki</Name>
        <Affiliation>AnaPath GmbH, 4625, Oberbuchsiten, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Klaus Weber</Name>
        <Affiliation>AnaPath GmbH, 4625, Oberbuchsiten, Switzerland.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: The study was funded by Bial Portela &amp; Companhia S.A. (São Mamede do Coronado, Portugal). Stephen B. Harris, Jerry F. Hardisty, A. Wallace Hayes, Yoshimasa Okazaki(,) and Klaus Weber were paid consultants of Bial. Furthermore, one of the authors (Klaus Weber) was the study pathologist on all of the studies. The manuscript was written by the authors and reviewed by Bial; however, the work product and conclusions are those of the authors.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Developmental and reproductive toxicity studies of BIA 10-2474.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31759137</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(19)30307-1</DOI>
    <KeywordList>
      <Keywords>BIA 10–2474</Keywords>
      <Keywords>Endocannabinoid system</Keywords>
      <Keywords>Endogenous anandamide</Keywords>
      <Keywords>Rabbit</Keywords>
      <Keywords>Rat</Keywords>
      <Keywords>Reproductive toxicology</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Stephen B. Harris</Name>
        <Affiliation>Stephen B. Harris Group, San Diego, CA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jerry F. Hardisty</Name>
        <Affiliation>Experimental Pathology Laboratories, Inc, PO Box 12766, Research Triangle Park, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>A. Wallace Hayes</Name>
        <Affiliation>University of South Florida College of Public Health, Tampa, FL, USA. Electronic address: awallacehayes@comcast.net.</Affiliation>
      </Author>
      <Author>
        <Name>Klaus Weber</Name>
        <Affiliation>AnaPath GmbH, 4625, Oberbuchsiten, Switzerland.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests:The studies were funded by Bial Portela &amp; Companhia S.A. (São Mamede do Coronado, Portugal). Stephen B. Harris, Jerold F. Hardisty, A. Wallace Hayes, and Klaus Weber were paid consultants of Bial. The manuscript was written by the authors and reviewed by Bial; however, the work product and conclusions are those of the authors.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>SEND harmonization &amp; cross-study analysis: A proposal to better harvest the value from SEND data.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31756353</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(19)30306-X</DOI>
    <KeywordList>
      <Keywords>BioCelerate</Keywords>
      <Keywords>Cross-study analysis</Keywords>
      <Keywords>SEND</Keywords>
      <Keywords>Toxicology data</Keywords>
      <Keywords>US FDA</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Mark A. Carfagna</Name>
        <Affiliation>Eli Lilly and Company, Indianapolis, IN, USA. Electronic address: carfagna_mark_a@lilly.com.</Affiliation>
      </Author>
      <Author>
        <Name>Thomas G. Bjerregaard</Name>
        <Affiliation>Novo Nordisk, Copenhagen, Denmark.</Affiliation>
      </Author>
      <Author>
        <Name>Tamio Fukushima</Name>
        <Affiliation>Shionogi &amp; Co., Ltd., Osaka, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>William Houser</Name>
        <Affiliation>Bristol-Myers Squibb, New Brunswick, NJ, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Cheryl Sloan</Name>
        <Affiliation>Bristol-Myers Squibb, New Brunswick, NJ, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Kevin Snyder</Name>
        <Affiliation>Center for Drug Evaluation and Research, United States Food and Drug Administration, White Oak, MD, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jesse Anderson</Name>
        <Affiliation>Center for Drug Evaluation and Research, United States Food and Drug Administration, White Oak, MD, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Todd Page</Name>
        <Affiliation>Eli Lilly and Company, Indianapolis, IN, USA.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Toxicity of orange peel-originated hesperidin in Sprague Dawley rats.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31751641</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(19)30284-3</DOI>
    <KeywordList>
      <Keywords>Acute toxicity test</Keywords>
      <Keywords>Hesperidin</Keywords>
      <Keywords>LD50</Keywords>
      <Keywords>OECD</Keywords>
      <Keywords>Orange peel</Keywords>
      <Keywords>Subchronic</Keywords>
      <Keywords>Toxicity tests</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Y. Li</Name>
        <Affiliation>Pharmacy Department, Honghui Hospital, Xi'an Jiaotong University, Shaanxi Province, 710054, China.</Affiliation>
      </Author>
      <Author>
        <Name>A. D. Kandhare</Name>
        <Affiliation>Department of Pharmacology, Poona College of Pharmacy, Bharati Vidyapeeth Deemed University, Erandwane, Paud Road, Pune, 411038, India.</Affiliation>
      </Author>
      <Author>
        <Name>A. A. Mukherjee</Name>
        <Affiliation>Department of Pharmacology, Poona College of Pharmacy, Bharati Vidyapeeth Deemed University, Erandwane, Paud Road, Pune, 411038, India.</Affiliation>
      </Author>
      <Author>
        <Name>S. L. Bodhankar</Name>
        <Affiliation>Department of Pharmacology, Poona College of Pharmacy, Bharati Vidyapeeth Deemed University, Erandwane, Paud Road, Pune, 411038, India. Electronic address: drslbodh@gmail.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Safety evaluation of Bacillus coagulans SNZ 1969 in Wistar rats.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31751640</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(19)30302-2</DOI>
    <KeywordList>
      <Keywords>Acute toxicity</Keywords>
      <Keywords>Bacillus coagulans</Keywords>
      <Keywords>Probiotic safety study</Keywords>
      <Keywords>Repeated dose toxicity</Keywords>
      <Keywords>SNZ 1969</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Anantha Samwarnarao Metlakunta</Name>
        <Affiliation>Sanzyme Bio-Analytical Laboratory, Sanzyme Private Limited, Hyderabad, India.</Affiliation>
      </Author>
      <Author>
        <Name>Raunak Jay Soman</Name>
        <Affiliation>Sanzyme Biologics, Hyderabad, India. Electronic address: info@sanzymebiologics.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Biosimilars in Developed Economies: Overview, Status, and Regulatory Considerations.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31743691</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(19)30289-2</DOI>
    <KeywordList>
      <Keywords>Affordable biotherapeutics</Keywords>
      <Keywords>Biosimilars</Keywords>
      <Keywords>Developed economies</Keywords>
      <Keywords>Regulatory framework</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Anurag S. Rathore</Name>
        <Affiliation>Department of Chemical Engineering, Indian Institute of Technology, Delhi, New Delhi, India. Electronic address: asrathore@biotechcmz.com.</Affiliation>
      </Author>
      <Author>
        <Name>Ankita Bhargava</Name>
        <Affiliation>Department of Chemical Engineering, Indian Institute of Technology, Delhi, New Delhi, India.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Qualification of impurities based on metabolite data.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31734179</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(19)30288-0</DOI>
    <KeywordList>
      <Keywords>3R</Keywords>
      <Keywords>Degradation product</Keywords>
      <Keywords>Drug metabolite</Keywords>
      <Keywords>ICH Q3A(R2)</Keywords>
      <Keywords>ICH Q3B(R2)</Keywords>
      <Keywords>Impurity</Keywords>
      <Keywords>Maximum theoretical concentration</Keywords>
      <Keywords>Qualification</Keywords>
      <Keywords>Significant metabolite</Keywords>
      <Keywords>Specification limit</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Lars Weidolf</Name>
        <Affiliation>DMPK, Research and Early Development Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&amp;D, AstraZeneca, Gothenburg, Sweden. Electronic address: Lars.Weidolf@astrazeneca.com.</Affiliation>
      </Author>
      <Author>
        <Name>Thomas Andersson</Name>
        <Affiliation>Pharmaceutical Technology and Development, AstraZeneca, SE-43183, Mölndal, Sweden. Electronic address: Thomas.Andersson@astrazeneca.com.</Affiliation>
      </Author>
      <Author>
        <Name>Joel P. Bercu</Name>
        <Affiliation>Gilead Sciences, Nonclinical Safety and Pathobiology, 333 Lakeside Drive, Foster City, CA, USA. Electronic address: Joel.Bercu@gilead.com.</Affiliation>
      </Author>
      <Author>
        <Name>Andreas Brink</Name>
        <Affiliation>Pharmaceutical Sciences, Roche Pharma Research and Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd, Grenzacherstrasse 124, CH-4070, Basel, Switzerland. Electronic address: Andreas.Brink@roche.com.</Affiliation>
      </Author>
      <Author>
        <Name>Susanne Glowienke</Name>
        <Affiliation>NIBR Pre-clinical Safety, Novartis AG, Klybeckstrasse, 4057, Basel, Switzerland. Electronic address: Susanne.Glowienke@novartis.com.</Affiliation>
      </Author>
      <Author>
        <Name>James Harvey</Name>
        <Affiliation>GSK R&amp;D, Park Road, Ware, Hertfordshire, SG120DP, United Kingdom. Electronic address: James.S.Harvey@gsk.com.</Affiliation>
      </Author>
      <Author>
        <Name>Martin A. Hayes</Name>
        <Affiliation>Hit Discovery, Discovery Sciences, BioPharmaceuticals R&amp;D, AstraZeneca, Gothenburg, Sweden. Electronic address: Martin.Hayes@astrazeneca.com.</Affiliation>
      </Author>
      <Author>
        <Name>Pascale Jacques</Name>
        <Affiliation>UCB Pharma Sprl, Braine-l'Alleud, Belgium. Electronic address: Pascale.Jacques@ucb.com.</Affiliation>
      </Author>
      <Author>
        <Name>Chuang Lu</Name>
        <Affiliation>DMPK, Sanofi, 153 Second Avenue, Waltham, MA, 02451, USA. Electronic address: Chuang.Lu@sanofi.com.</Affiliation>
      </Author>
      <Author>
        <Name>Nenad Manevski</Name>
        <Affiliation>UCB Celltech, SL13WE, Slough, United Kingdom. Electronic address: Nenad.Manevski@ucb.com.</Affiliation>
      </Author>
      <Author>
        <Name>Wolfgang Muster</Name>
        <Affiliation>Pharmaceutical Sciences, Roche Pharma Research and Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd, Grenzacherstrasse 124, CH-4070, Basel, Switzerland. Electronic address: Wolfgang.Muster@roche.com.</Affiliation>
      </Author>
      <Author>
        <Name>Raphael Nudelman</Name>
        <Affiliation>Chemical &amp; Computational Toxicology, Teva Pharmaceutical Industries Ltd., Israel. Electronic address: Raphael.Nudelman@teva.co.il.</Affiliation>
      </Author>
      <Author>
        <Name>Ron Ogilvie</Name>
        <Affiliation>Global Regulatory CMC, Pfizer R&amp;D, United Kingdom. Electronic address: Ron.Ogilvie@pfizer.com.</Affiliation>
      </Author>
      <Author>
        <Name>Jenny Ottosson</Name>
        <Affiliation>Early Product Development, Pharmaceutical Sciences, R&amp;D, AstraZeneca, Gothenburg, Sweden. Electronic address: Jenny.Ottosson@astrazeneca.com.</Affiliation>
      </Author>
      <Author>
        <Name>Andrew Teasdale</Name>
        <Affiliation>Chemical Development, Pharmaceutical Technology &amp; Development, AstraZeneca, Macclesfield Campus, SK102NA, United Kingdom. Electronic address: Andrew.Teasdale@astrazeneca.com.</Affiliation>
      </Author>
      <Author>
        <Name>Bruce Trela</Name>
        <Affiliation>Preclinical Safety, AbbVie, North Chicago, IL, 60064, USA. Electronic address: Bruce.A.Trela@abbvie.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Chemical compounds causing severe acute toxicity in heavy liquids used for intraocular surgery.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31733229</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(19)30291-0</DOI>
    <KeywordList>
      <Keywords>ARPE-19</Keywords>
      <Keywords>Cytotoxicity</Keywords>
      <Keywords>FTIR</Keywords>
      <Keywords>Gas-chromatography</Keywords>
      <Keywords>Mass spectrometry</Keywords>
      <Keywords>Perfluorohexyl-octane</Keywords>
      <Keywords>Perfluorooctane</Keywords>
      <Keywords>Perfluorooctanoic acid</Keywords>
      <Keywords>Retina</Keywords>
      <Keywords>Tributyltin bromide</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Girish K. Srivastava</Name>
        <Affiliation>Instituto Universitario de Oftalmobiología Aplicada (IOBA), Eye Institute, Universidad de Valladolid, Valladolid, Spain; Centro en Red de Medicina Regenerativa y Terapia Celular, Junta de Castilla y León, Valladolid, Spain; Red Temática de Investigación Cooperativa en Salud (RETICS), OftaRed, Instituto de Salud Carlos III, Valladolid, Spain.</Affiliation>
      </Author>
      <Author>
        <Name>Cristina Andrés-Iglesias</Name>
        <Affiliation>Instituto Universitario de Oftalmobiología Aplicada (IOBA), Eye Institute, Universidad de Valladolid, Valladolid, Spain. Electronic address: candresi@ioba.med.uva.es.</Affiliation>
      </Author>
      <Author>
        <Name>Rosa M. Coco</Name>
        <Affiliation>Instituto Universitario de Oftalmobiología Aplicada (IOBA), Eye Institute, Universidad de Valladolid, Valladolid, Spain; Red Temática de Investigación Cooperativa en Salud (RETICS), OftaRed, Instituto de Salud Carlos III, Valladolid, Spain.</Affiliation>
      </Author>
      <Author>
        <Name>Ivan Fernandez-Bueno</Name>
        <Affiliation>Instituto Universitario de Oftalmobiología Aplicada (IOBA), Eye Institute, Universidad de Valladolid, Valladolid, Spain; Centro en Red de Medicina Regenerativa y Terapia Celular, Junta de Castilla y León, Valladolid, Spain; Red Temática de Investigación Cooperativa en Salud (RETICS), OftaRed, Instituto de Salud Carlos III, Valladolid, Spain.</Affiliation>
      </Author>
      <Author>
        <Name>Jesús Medina</Name>
        <Affiliation>Department of Physics of Condensed Matter, Crystallography and Mineralogy, Universidad de Valladolid, Valladolid, Spain.</Affiliation>
      </Author>
      <Author>
        <Name>Juan García-Serna</Name>
        <Affiliation>High Pressure Processes Group, Instituto de Bioeconomía, Departamento de Ingeniería Química y Tecnologías del Medio Ambiente, Universidad de Valladolid, Valladolid, Spain.</Affiliation>
      </Author>
      <Author>
        <Name>Antonio Dueñas</Name>
        <Affiliation>Instituto Universitario de Oftalmobiología Aplicada (IOBA), Eye Institute, Universidad de Valladolid, Valladolid, Spain; Toxicology Department, Universidad de Valladolid, Valladolid, Spain.</Affiliation>
      </Author>
      <Author>
        <Name>Fernando Rull</Name>
        <Affiliation>Department of Physics of Condensed Matter, Crystallography and Mineralogy, Universidad de Valladolid, Valladolid, Spain.</Affiliation>
      </Author>
      <Author>
        <Name>J. Carlos Pastor</Name>
        <Affiliation>Instituto Universitario de Oftalmobiología Aplicada (IOBA), Eye Institute, Universidad de Valladolid, Valladolid, Spain; Centro en Red de Medicina Regenerativa y Terapia Celular, Junta de Castilla y León, Valladolid, Spain; Red Temática de Investigación Cooperativa en Salud (RETICS), OftaRed, Instituto de Salud Carlos III, Valladolid, Spain; Department of Ophthalmology, Hospital Clínico Universitario de Valladolid, Valladolid, Spain.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Preclinical safety evaluation of triacylglycerol lipase QLM from Burkholderia ubonensis.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31726192</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(19)30287-9</DOI>
    <KeywordList>
      <Keywords>Enzyme</Keywords>
      <Keywords>Food</Keywords>
      <Keywords>Genotoxicity</Keywords>
      <Keywords>NOAEL</Keywords>
      <Keywords>Rat</Keywords>
      <Keywords>Safety</Keywords>
      <Keywords>Subchronic toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Alastair Mak</Name>
        <Affiliation>Intertek Scientific and Regulatory Consultancy, 2233, Argentia Road, Suite 201, Mississauga, L5N 2X7, ON, Canada. Electronic address: Alastair.mak@intertek.com.</Affiliation>
      </Author>
      <Author>
        <Name>Ryan R. Simon</Name>
        <Affiliation>Intertek Scientific and Regulatory Consultancy, 2233, Argentia Road, Suite 201, Mississauga, L5N 2X7, ON, Canada.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A 26-week 20(S)-ginsenoside Rg3 oral toxicity study in Beagle dogs.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31726191</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(19)30286-7</DOI>
    <KeywordList>
      <Keywords>20(S)-ginsenoside Rg3</Keywords>
      <Keywords>Beagle dogs</Keywords>
      <Keywords>Oral toxicity study</Keywords>
      <Keywords>Preclinical safety assessment</Keywords>
      <Keywords>Red ginseng</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Yonglin Gao</Name>
        <Affiliation>School of Life Science, Yantai University, Yantai, 264005, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Guangfei Wang</Name>
        <Affiliation>School of Life Science, Yantai University, Yantai, 264005, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Tong Wang</Name>
        <Affiliation>School of Life Science, Yantai University, Yantai, 264005, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Guisheng Li</Name>
        <Affiliation>School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University, Yantai, 264005, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Jian Lin</Name>
        <Affiliation>School of Life Science, Yantai University, Yantai, 264005, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Liqin Sun</Name>
        <Affiliation>School of Life Science, Yantai University, Yantai, 264005, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Xuran Wu</Name>
        <Affiliation>School of Life Science, Yantai University, Yantai, 264005, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Xilin Sun</Name>
        <Affiliation>Yantai Laishan Changen Hospital, Yantai, 264005, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Hongbo Wang</Name>
        <Affiliation>School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University, Yantai, 264005, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Chunmei Li</Name>
        <Affiliation>School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University, Yantai, 264005, PR China. Electronic address: gylbill@163.com.</Affiliation>
      </Author>
      <Author>
        <Name>Jingwei Tian</Name>
        <Affiliation>School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University, Yantai, 264005, PR China. Electronic address: tianjingwei@luye.com.</Affiliation>
      </Author>
      <Author>
        <Name>Jing Zhu</Name>
        <Affiliation>Shandong Provincial Laboratory Animal Center of Shandong Academy of Medical Sciences, Jinan, 250002, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Kezhou Wang</Name>
        <Affiliation>Shandong Provincial Laboratory Animal Center of Shandong Academy of Medical Sciences, Jinan, 250002, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Susan Cho</Name>
        <Affiliation>NutraSource, Inc., Clarksville, MD, 21029, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A cross-sector call to improve carcinogenicity risk assessment through use of genomic methodologies.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31726190</pubmedLink>
    <GrantList>
      <Grant>Z99 ES999999</Grant>
    </GrantList>
    <Year>2020</Year>
    <DOI>S0273-2300(19)30290-9</DOI>
    <KeywordList>
      <Keywords>Cancer</Keywords>
      <Keywords>Cancer risk assessment</Keywords>
      <Keywords>Carcinogenicity</Keywords>
      <Keywords>Genomics</Keywords>
      <Keywords>Risk assessment</Keywords>
      <Keywords>Toxicogenomics</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Carole L. Yauk</Name>
        <Affiliation>Health Canada, Ontario, K1A 0K9, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Alison H. Harrill</Name>
        <Affiliation>National Institute of Environmental Health Sciences, Research Triangle, Park, NC, 27709, USA. Electronic address: alison.harrill@nih.gov.</Affiliation>
      </Author>
      <Author>
        <Name>Heidrun Ellinger-Ziegelbauer</Name>
        <Affiliation>Bayer AG, Wuppertal, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Jan Willem van der Laan</Name>
        <Affiliation>Medicines Evaluation Board Netherlands, Utrecht, Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Jonathan Moggs</Name>
        <Affiliation>Novartis Pharma AG, Basel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Roland Froetschl</Name>
        <Affiliation>BfArM Federal Institute for Drugs and Medical Devices, Bonn, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Frank Sistare</Name>
        <Affiliation>Merck, Kenilworth, NJ, 07033, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Syril Pettit</Name>
        <Affiliation>Health and Environmental Sciences Institute, Washington, DC, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Toxicity of orange peel-originated hesperidin in Sprague Dawley rats.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31715200</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(19)30283-1</DOI>
    <AuthorList>
      <Author>
        <Name>Liping Wei</Name>
        <Affiliation>Innostar Bio-tech Haimen Site, Shanghai Innostar Bio-tech Co., Ltd, 100 Dongtinghu Road, Linjiang, Haimen, Jiangsu, 226133, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yimei Wang</Name>
        <Affiliation>Innostar Bio-tech Haimen Site, Shanghai Innostar Bio-tech Co., Ltd, 100 Dongtinghu Road, Linjiang, Haimen, Jiangsu, 226133, China.</Affiliation>
      </Author>
      <Author>
        <Name>Hua Li</Name>
        <Affiliation>Innostar Bio-tech Haimen Site, Shanghai Innostar Bio-tech Co., Ltd, 100 Dongtinghu Road, Linjiang, Haimen, Jiangsu, 226133, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yan Chang</Name>
        <Affiliation>Innostar Bio-tech Haimen Site, Shanghai Innostar Bio-tech Co., Ltd, 100 Dongtinghu Road, Linjiang, Haimen, Jiangsu, 226133, China.</Affiliation>
      </Author>
      <Author>
        <Name>Min Hong</Name>
        <Affiliation>Innostar Bio-tech Haimen Site, Shanghai Innostar Bio-tech Co., Ltd, 100 Dongtinghu Road, Linjiang, Haimen, Jiangsu, 226133, China. Electronic address: mhong@ncdser.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>U.S. Food and Drug Administration's interim reference levels for dietary lead exposure in children and women of childbearing age.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31707132</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(19)30280-6</DOI>
    <KeywordList>
      <Keywords>Adverse</Keywords>
      <Keywords>Children</Keywords>
      <Keywords>IRL</Keywords>
      <Keywords>Infant</Keywords>
      <Keywords>Interim reference level</Keywords>
      <Keywords>Lead</Keywords>
      <Keywords>Pb</Keywords>
      <Keywords>Pregnant</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Brenna M. Flannery</Name>
        <Affiliation>US Food and Drug Administration, Center for Food Safety and Applied Nutrition, College Park, MD, USA. Electronic address: Brenna.flannery@fda.hhs.gov.</Affiliation>
      </Author>
      <Author>
        <Name>Laurie C. Dolan</Name>
        <Affiliation>US Food and Drug Administration, Center for Food Safety and Applied Nutrition, College Park, MD, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Dana Hoffman-Pennesi</Name>
        <Affiliation>US Food and Drug Administration, Center for Food Safety and Applied Nutrition, College Park, MD, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Alexandra Gavelek</Name>
        <Affiliation>US Food and Drug Administration, Center for Food Safety and Applied Nutrition, College Park, MD, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Olivia E. Jones</Name>
        <Affiliation>US Food and Drug Administration, Center for Food Safety and Applied Nutrition, College Park, MD, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Richard Kanwal</Name>
        <Affiliation>US Food and Drug Administration, Center for Food Safety and Applied Nutrition, College Park, MD, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Beverly Wolpert</Name>
        <Affiliation>US Food and Drug Administration, Center for Food Safety and Applied Nutrition, College Park, MD, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Kathleen Gensheimer</Name>
        <Affiliation>US Food and Drug Administration, Center for Food Safety and Applied Nutrition, College Park, MD, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Sherri Dennis</Name>
        <Affiliation>US Food and Drug Administration, Center for Food Safety and Applied Nutrition, College Park, MD, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Suzanne Fitzpatrick</Name>
        <Affiliation>US Food and Drug Administration, Center for Food Safety and Applied Nutrition, College Park, MD, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Acute and subacute (28 days) toxicity of green coffee oil enriched with diterpenes cafestol and kahweol in rats.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31707131</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(19)30281-8</DOI>
    <KeywordList>
      <Keywords>Diterpenes</Keywords>
      <Keywords>Green coffee oil</Keywords>
      <Keywords>Preclinical studies</Keywords>
      <Keywords>Rodents</Keywords>
      <Keywords>Toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Naila Albertina de Oliveira</Name>
        <Affiliation>LTAPPN, Faculty of Animal Science and Food Engineering, University of São Paulo, Department of Food Engineering, Pirassununga, São Paulo, Brazil. Electronic address: nailaa.oliveira@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Thaisa Meira Sandini</Name>
        <Affiliation>Department of Clinical and Toxicological Analyses, Faculty of Pharmaceutical Sciences, University of São Paulo, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Heber Peleg Cornelio-Santiago</Name>
        <Affiliation>LTAPPN, Faculty of Animal Science and Food Engineering, University of São Paulo, Department of Food Engineering, Pirassununga, São Paulo, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Elaine Cristina Lanzoni Martinelli</Name>
        <Affiliation>Department of Pathology, School of Veterinary Medicine and Animal Sciences, Research Centre for Veterinary Toxicology (CEPTOX), University of São Paulo, Pirassununga, São Paulo, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Leonila Ester Reinert Raspantini</Name>
        <Affiliation>Department of Pathology, School of Veterinary Medicine and Animal Sciences, Research Centre for Veterinary Toxicology (CEPTOX), University of São Paulo, Pirassununga, São Paulo, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Paulo Cesar Raspantini</Name>
        <Affiliation>Department of Pathology, School of Veterinary Medicine and Animal Sciences, Research Centre for Veterinary Toxicology (CEPTOX), University of São Paulo, Pirassununga, São Paulo, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Cláudia Momo</Name>
        <Affiliation>Department of Pathology, School of Veterinary Medicine and Animal Sciences, Research Centre for Veterinary Toxicology (CEPTOX), University of São Paulo, Pirassununga, São Paulo, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Alessandra Lopes de Oliveira</Name>
        <Affiliation>LTAPPN, Faculty of Animal Science and Food Engineering, University of São Paulo, Department of Food Engineering, Pirassununga, São Paulo, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Heidge Fukumasu</Name>
        <Affiliation>Department of Veterinary Medicine, Faculty of Animal Science and Food Engineering, University of São Paulo, Pirassununga, São Paulo, Brazil. Electronic address: fukumasu@usp.br.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>State of the science on alternatives to animal testing and integration of testing strategies for food safety assessments: Workshop proceedings.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31705943</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(19)30279-X</DOI>
    <KeywordList>
      <Keywords>Alternatives</Keywords>
      <Keywords>Food safety assessment</Keywords>
      <Keywords>Read-across</Keywords>
      <Keywords>Safety evaluation</Keywords>
      <Keywords>TTC</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Agnes L. Karmaus</Name>
        <Affiliation>Integrated Laboratory Systems, Inc, 601 Keystone Park Drive, Suite 200, Morrisville, NC, USA. Electronic address: agnes.karmaus@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Heidi Bialk</Name>
        <Affiliation>PepsiCo Inc, 700 Anderson Hill Road, Purchase, NY, 10577, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Suzanne Fitzpatrick</Name>
        <Affiliation>US Food and Drug Administration Center for Food Safety and Applied Nutrition, College Park, MD, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Mansi Krishan</Name>
        <Affiliation>ILSI North America, 740 15th Street NW, Suite 600, Washington, DC, 20005, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Residue analysis of gibberellic acid isomer (iso-GA3) in brewing process and its toxicity evaluation in mice.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31705942</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(19)30278-8</DOI>
    <KeywordList>
      <Keywords>Brewing</Keywords>
      <Keywords>Gibberellic acid</Keywords>
      <Keywords>Toxicity</Keywords>
      <Keywords>iso-GA3</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Weikang Sun</Name>
        <Affiliation>Key Laboratory of Industrial Biotechnology, Ministry of Education, School of Biotechnology, Jiangnan University, Wuxi, 214122, China; Synergetic Innovation Center of Food Safety and Nutrition, School of Biotechnology, Jiangnan University, Wuxi, 214122, China.</Affiliation>
      </Author>
      <Author>
        <Name>Chunfeng Liu</Name>
        <Affiliation>Key Laboratory of Industrial Biotechnology, Ministry of Education, School of Biotechnology, Jiangnan University, Wuxi, 214122, China; Synergetic Innovation Center of Food Safety and Nutrition, School of Biotechnology, Jiangnan University, Wuxi, 214122, China. Electronic address: liuchunfeng@jiangnan.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Jiaoyang Luo</Name>
        <Affiliation>School of Biotechnology, Jiangnan University, Wuxi, 214122, China.</Affiliation>
      </Author>
      <Author>
        <Name>Chengtuo Niu</Name>
        <Affiliation>Key Laboratory of Industrial Biotechnology, Ministry of Education, School of Biotechnology, Jiangnan University, Wuxi, 214122, China; Synergetic Innovation Center of Food Safety and Nutrition, School of Biotechnology, Jiangnan University, Wuxi, 214122, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jinjing Wang</Name>
        <Affiliation>Key Laboratory of Industrial Biotechnology, Ministry of Education, School of Biotechnology, Jiangnan University, Wuxi, 214122, China; Synergetic Innovation Center of Food Safety and Nutrition, School of Biotechnology, Jiangnan University, Wuxi, 214122, China.</Affiliation>
      </Author>
      <Author>
        <Name>Feiyun Zheng</Name>
        <Affiliation>Key Laboratory of Industrial Biotechnology, Ministry of Education, School of Biotechnology, Jiangnan University, Wuxi, 214122, China; Synergetic Innovation Center of Food Safety and Nutrition, School of Biotechnology, Jiangnan University, Wuxi, 214122, China.</Affiliation>
      </Author>
      <Author>
        <Name>Qi Li</Name>
        <Affiliation>Key Laboratory of Industrial Biotechnology, Ministry of Education, School of Biotechnology, Jiangnan University, Wuxi, 214122, China; Synergetic Innovation Center of Food Safety and Nutrition, School of Biotechnology, Jiangnan University, Wuxi, 214122, China. Electronic address: liqi@jiangnan.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The urinary metabolic profile of diethylene glycol methyl ether and triethylene glycol methyl ether in Sprague-Dawley rats and the role of the metabolite methoxyacetic acid in their toxicity.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31704259</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(19)30276-4</DOI>
    <KeywordList>
      <Keywords>2-(2-(2-methoxyethoxy)ethoxy)ethanol</Keywords>
      <Keywords>2-(2-methoxyethoxy)ethanol</Keywords>
      <Keywords>2-Methoxyacetic acid</Keywords>
      <Keywords>DEGME</Keywords>
      <Keywords>Glycol ethers</Keywords>
      <Keywords>Metabolism</Keywords>
      <Keywords>TEGME</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jeffrey R. Kelsey</Name>
        <Affiliation>Chemsage Ltd, PO Box 431, Fleet, Hampshire, GU51 9BP, UK. Electronic address: kelseyjr@chemsage.co.uk.</Affiliation>
      </Author>
      <Author>
        <Name>Nicole H. P. Cnubben</Name>
        <Affiliation>Triskelion BV, Postal Address: P.O. Box 844, 3700 AV, Zeist, the Netherlands. Electronic address: nicole.cnubben@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Jan J. P. Bogaards</Name>
        <Affiliation>Triskelion BV, Postal Address: P.O. Box 844, 3700 AV, Zeist, the Netherlands. Electronic address: jan.bogaards@triskelion.nl.</Affiliation>
      </Author>
      <Author>
        <Name>René B. H. Braakman</Name>
        <Affiliation>Triskelion BV, Postal Address: P.O. Box 844, 3700 AV, Zeist, the Netherlands. Electronic address: rene.braakman@tno.nl.</Affiliation>
      </Author>
      <Author>
        <Name>Leo L. P. van Stee</Name>
        <Affiliation>Triskelion BV, Postal Address: P.O. Box 844, 3700 AV, Zeist, the Netherlands. Electronic address: leo.vanstee@triskelion.nl.</Affiliation>
      </Author>
      <Author>
        <Name>Karen Smet</Name>
        <Affiliation>Ineos Oxide, Safety, Health and Environment, Nieuwe Weg 1, 2070, Zwijndrecht, Belgium. Electronic address: karen.smet@ineos.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Subchronic (91-day) oral toxicity study of cellobiose in rats.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31704258</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(19)30282-X</DOI>
    <KeywordList>
      <Keywords>13-week subchronic toxicity</Keywords>
      <Keywords>Cellobiose</Keywords>
      <Keywords>Novel food ingredient</Keywords>
      <Keywords>Safety evaluation</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Andreas Winkler</Name>
        <Affiliation>LPT Laboratory of Pharmacology and Toxicology GmbH &amp; Co. KG, 21147, Hamburg, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Horst Messinger</Name>
        <Affiliation>Bioresco Ltd., 4054, Basel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Albert Bär</Name>
        <Affiliation>Bioresco Ltd., 4054, Basel, Switzerland. Electronic address: contact@bioresco.ch.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Letter.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31704257</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(19)30267-3</DOI>
    <AuthorList>
      <Author>
        <Name>Keith R. Cooper</Name>
        <Affiliation>Rutgers University, USA. Electronic address: cooper@sebs.rutgers.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Jessie A. Gleason</Name>
        <Affiliation>New Jersey Department of Health, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Gloria B. Post</Name>
        <Affiliation>New Jersey Department of Environmental Protection, USA.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Characteristics of exposure factors and inhalation exposure to selected spray consumer products in Korean population.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31697979</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(19)30277-6</DOI>
    <KeywordList>
      <Keywords>Consumer products</Keywords>
      <Keywords>Exposure assessment</Keywords>
      <Keywords>Exposure factor</Keywords>
      <Keywords>Spray type</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Hyerin Shin</Name>
        <Affiliation>Department of Environmental Health Sciences, Graduate School of Public Health, Seoul National University, Seoul, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Yelim Jang</Name>
        <Affiliation>Department of Environmental Health Sciences, Graduate School of Public Health, Seoul National University, Seoul, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Miyoung Lim</Name>
        <Affiliation>Department of Environmental Health Sciences, Graduate School of Public Health, Seoul National University, Seoul, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Ji Young Park</Name>
        <Affiliation>Institute of Health and Environment, Seoul National University, Seoul, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Wonho Yang</Name>
        <Affiliation>Department of Occupational Health, Daegu Catholic University, Daegu, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Kiyoung Lee</Name>
        <Affiliation>Department of Environmental Health Sciences, Graduate School of Public Health, Seoul National University, Seoul, Republic of Korea; Institute of Health and Environment, Seoul National University, Seoul, Republic of Korea. Electronic address: cleanair@snu.ac.kr.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>An FDA analysis of clinical hold deficiencies affecting investigational new drug applications for oncology products.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31678263</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(19)30275-2</DOI>
    <KeywordList>
      <Keywords>Clinical hold</Keywords>
      <Keywords>Drug development</Keywords>
      <Keywords>FDA</Keywords>
      <Keywords>IND</Keywords>
      <Keywords>Oncology</Keywords>
      <Keywords>Pre-IND meeting</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Michael L. Manning</Name>
        <Affiliation>Office of Hematology and Oncology Products, Center for Drug Evaluation and Research, US Food and Drug Administration, 10903 New Hampshire Ave, Silver Spring, MD, 20903, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Matthew D. Thompson</Name>
        <Affiliation>Office of Hematology and Oncology Products, Center for Drug Evaluation and Research, US Food and Drug Administration, 10903 New Hampshire Ave, Silver Spring, MD, 20903, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Haleh Saber</Name>
        <Affiliation>Office of Hematology and Oncology Products, Center for Drug Evaluation and Research, US Food and Drug Administration, 10903 New Hampshire Ave, Silver Spring, MD, 20903, United States. Electronic address: haleh.saber@fda.hhs.gov.</Affiliation>
      </Author>
      <Author>
        <Name>Virginia E. Maher</Name>
        <Affiliation>Office of Hematology and Oncology Products, Center for Drug Evaluation and Research, US Food and Drug Administration, 10903 New Hampshire Ave, Silver Spring, MD, 20903, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Joyce Z. Crich</Name>
        <Affiliation>Office of Pharmaceutical Quality, Center for Drug Evaluation and Research, US Food and Drug Administration, 10903 New Hampshire Ave, Silver Spring, MD, 20903, United States.</Affiliation>
      </Author>
      <Author>
        <Name>John K. Leighton</Name>
        <Affiliation>Office of Hematology and Oncology Products, Center for Drug Evaluation and Research, US Food and Drug Administration, 10903 New Hampshire Ave, Silver Spring, MD, 20903, United States.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Development of a prioritization method for chemical-mediated effects on steroidogenesis using an integrated statistical analysis of high-throughput H295R data.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31676319</pubmedLink>
    <GrantList>
      <Grant>EPA999999</Grant>
    </GrantList>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30274-0</DOI>
    <KeywordList>
      <Keywords>Endocrine disruption</Keywords>
      <Keywords>Prioritization</Keywords>
      <Keywords>Steroidogenesis</Keywords>
      <Keywords>ToxCast</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Derik E. Haggard</Name>
        <Affiliation>Oak Ridge Institute for Science and Education, 100 ORAU Way, Oak Ridge, TN, 37830, USA; National Center for Computational Toxicology, Office of Research and Development, U.S. Environmental Protection Agency, Research Triangle Park, NC, 27711, USA.</Affiliation>
      </Author>
      <Author>
        <Name>R. Woodrow Setzer</Name>
        <Affiliation>National Center for Computational Toxicology, Office of Research and Development, U.S. Environmental Protection Agency, Research Triangle Park, NC, 27711, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Richard S. Judson</Name>
        <Affiliation>National Center for Computational Toxicology, Office of Research and Development, U.S. Environmental Protection Agency, Research Triangle Park, NC, 27711, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Katie Paul Friedman</Name>
        <Affiliation>National Center for Computational Toxicology, Office of Research and Development, U.S. Environmental Protection Agency, Research Triangle Park, NC, 27711, USA. Electronic address: paul-friedman.katie@epa.gov.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>In vitro and in vivo toxicity evaluation of non-neuroleptic phenothiazines, antitubercular drug candidates.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31672509</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30272-7</DOI>
    <KeywordList>
      <Keywords>Cytotoxicity</Keywords>
      <Keywords>Drug development</Keywords>
      <Keywords>Pharmacokinetics</Keywords>
      <Keywords>Phenothiazines</Keywords>
      <Keywords>Thioridazine</Keywords>
      <Keywords>Toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Sumayah Salie</Name>
        <Affiliation>Division of Immunology, Department of Pathology and Institute of Infectious Disease and Molecular Medicine, Faculty of Health Sciences, University of Cape Town, South Africa.</Affiliation>
      </Author>
      <Author>
        <Name>Antoinette Labuschagné</Name>
        <Affiliation>Division of Immunology, Department of Pathology and Institute of Infectious Disease and Molecular Medicine, Faculty of Health Sciences, University of Cape Town, South Africa.</Affiliation>
      </Author>
      <Author>
        <Name>Avril Walters</Name>
        <Affiliation>Division of Immunology, Department of Pathology and Institute of Infectious Disease and Molecular Medicine, Faculty of Health Sciences, University of Cape Town, South Africa.</Affiliation>
      </Author>
      <Author>
        <Name>Sohair Geyer</Name>
        <Affiliation>Division of Immunology, Department of Pathology and Institute of Infectious Disease and Molecular Medicine, Faculty of Health Sciences, University of Cape Town, South Africa.</Affiliation>
      </Author>
      <Author>
        <Name>Anwar Jardine</Name>
        <Affiliation>Department of Chemistry, Faculty of Sciences, University of Cape Town, South Africa.</Affiliation>
      </Author>
      <Author>
        <Name>Muazzam Jacobs</Name>
        <Affiliation>Division of Immunology, Department of Pathology and Institute of Infectious Disease and Molecular Medicine, Faculty of Health Sciences, University of Cape Town, South Africa; National Health Laboratory Service, Johannesburg, South Africa; Immunology of Infectious Disease Research Unit, South African Medical Research Council, Cape Town, South Africa. Electronic address: Muazzam.Jacobs@uct.ac.za.</Affiliation>
      </Author>
      <Author>
        <Name>Nai Jen Hsu</Name>
        <Affiliation>Division of Immunology, Department of Pathology and Institute of Infectious Disease and Molecular Medicine, Faculty of Health Sciences, University of Cape Town, South Africa.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Cataracts and statins. A disproportionality analysis using data from VigiBase.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31669197</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30273-9</DOI>
    <KeywordList>
      <Keywords>Anticholesteremic agents</Keywords>
      <Keywords>Cataract</Keywords>
      <Keywords>Hydroxymethylglutaryl-CoA reductase inhibitors</Keywords>
      <Keywords>Pharmacovigilance</Keywords>
      <Keywords>Statins</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Diego Macías Saint-Gerons</Name>
        <Affiliation>Department of Medicine, University of Valencia, INCLIVA Health Research Institute and CIBERSAM, Valencia, Spain; Unit of Medicines and Health Technologies (MT), Dep. of Health Systems and Services (HSS), Pan American Health Organization (PAHO/WHO), United States. Electronic address: dmacias.sg@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Francisco Bosco Cortez</Name>
        <Affiliation>Dirección Nacional de Medicamentos. Gobierno de El Salvador, Cd Merliot, El Salvador.</Affiliation>
      </Author>
      <Author>
        <Name>Giset Jiménez López</Name>
        <Affiliation>CECMED Departamento de Vigilancia Postcomercialización, La Habana, Cuba.</Affiliation>
      </Author>
      <Author>
        <Name>José Luis Castro</Name>
        <Affiliation>Unit of Medicines and Health Technologies (MT), Dep. of Health Systems and Services (HSS), Pan American Health Organization (PAHO/WHO), United States.</Affiliation>
      </Author>
      <Author>
        <Name>Rafael Tabarés-Seisdedos</Name>
        <Affiliation>Department of Medicine, University of Valencia, INCLIVA Health Research Institute and CIBERSAM, Valencia, Spain.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Data derived extrapolation factors for developmental toxicity: A preliminary research case study with perfluorooctanoate (PFOA).</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31669196</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(19)30266-1</DOI>
    <AuthorList>
      <Author>
        <Name>Michael L. Dourson</Name>
        <Affiliation>Toxicology Excellence for Risk Assessment, Cincinnati, OH, USA. Electronic address: dourson@tera.org.</Affiliation>
      </Author>
      <Author>
        <Name>Bernard Gadagbui</Name>
        <Affiliation>Toxicology Excellence for Risk Assessment, Cincinnati, OH, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Chijioke Onyema</Name>
        <Affiliation>Toxicology Excellence for Risk Assessment, Cincinnati, OH, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Patricia M. McGinnis</Name>
        <Affiliation>Toxicology Excellence for Risk Assessment, Cincinnati, OH, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Raymond G. York</Name>
        <Affiliation>RG York and Associates, LLC, Cincinnati, OH, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Linking internal dosimetries of the propyl metabolic series in rats and humans using physiologically based pharmacokinetic (PBPK) modeling.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31669189</pubmedLink>
    <Year>2020</Year>
    <DOI>S0273-2300(19)30271-5</DOI>
    <KeywordList>
      <Keywords>1-Propanol</Keywords>
      <Keywords>Propanol</Keywords>
      <Keywords>Propionate</Keywords>
      <Keywords>Propionic acid</Keywords>
      <Keywords>Propyl acetate</Keywords>
      <Keywords>n-Propanol</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jordan N. Smith</Name>
        <Affiliation>Pacific Northwest National Laboratory (PNNL), Richland, WA, 99354, USA. Electronic address: jordan.smith@pnnl.gov.</Affiliation>
      </Author>
      <Author>
        <Name>Kimberly J. Tyrrell</Name>
        <Affiliation>Pacific Northwest National Laboratory (PNNL), Richland, WA, 99354, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jeremy P. Smith</Name>
        <Affiliation>Battelle Memorial Institute, Columbus, OH, 43201, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Karl K. Weitz</Name>
        <Affiliation>Pacific Northwest National Laboratory (PNNL), Richland, WA, 99354, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Willem Faber</Name>
        <Affiliation>Willem Faber Toxicology Consulting, LLC, 1338 Strong Rd., Victor, NY, 14564, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Safety and tolerability of sustained exogenous ketosis using ketone monoester drinks for 28 days in healthy adults.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31655093</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30270-3</DOI>
    <KeywordList>
      <Keywords>Ketone bodies</Keywords>
      <Keywords>Ketone monoester</Keywords>
      <Keywords>Safety</Keywords>
      <Keywords>Tolerability</Keywords>
      <Keywords>Toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Adrian Soto-Mota</Name>
        <Affiliation>Department of Physiology, Anatomy and Genetics, University of Oxford, Oxford, United Kingdom. Electronic address: adrian.soto@dpag.ox.ac.uk.</Affiliation>
      </Author>
      <Author>
        <Name>Hannah Vansant</Name>
        <Affiliation>Department of Physiology, Anatomy and Genetics, University of Oxford, Oxford, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Rhys D. Evans</Name>
        <Affiliation>Department of Physiology, Anatomy and Genetics, University of Oxford, Oxford, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Kieran Clarke</Name>
        <Affiliation>Department of Physiology, Anatomy and Genetics, University of Oxford, Oxford, United Kingdom.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Use of benchmark dose models in risk assessment for occupational handlers of eight pesticides used in pome fruit production.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31655092</pubmedLink>
    <GrantList>
      <Grant>T32 ES007032</Grant>
      <Grant>U54 OH007544</Grant>
    </GrantList>
    <Year>2020</Year>
    <DOI>S0273-2300(19)30268-5</DOI>
    <KeywordList>
      <Keywords>Benchmark dose modeling</Keywords>
      <Keywords>Margin of exposure</Keywords>
      <Keywords>NOAEL</Keywords>
      <Keywords>Occupational exposure</Keywords>
      <Keywords>Pesticides</Keywords>
      <Keywords>Risk analysis</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jane Gurnick Pouzou</Name>
        <Affiliation>EpiX Analytics, LLC, United States. Electronic address: jpouzou@epixanalytics.com.</Affiliation>
      </Author>
      <Author>
        <Name>John Kissel</Name>
        <Affiliation>University of Washington, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Michael G. Yost</Name>
        <Affiliation>University of Washington, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Richard A. Fenske</Name>
        <Affiliation>University of Washington, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Alison C. Cullen</Name>
        <Affiliation>University of Washington, United States.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Evaluating potential refinements to existing Threshold of Toxicological Concern (TTC) values for environmentally-relevant compounds.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31639428</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30269-7</DOI>
    <KeywordList>
      <Keywords>Risk-based prioritisation</Keywords>
      <Keywords>TTC</Keywords>
      <Keywords>Threshold of toxicological concern</Keywords>
      <Keywords>ToxValDB</Keywords>
      <Keywords>Toxicity values database</Keywords>
      <Keywords>Toxtree</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Mark D. Nelms</Name>
        <Affiliation>Oak Ridge Institute for Science and Education, Oak Ridge, TN, 37830, USA; Center for Computational Toxicology &amp; Exposure (CCTE), U.S. Environmental Protection Agency, Research Triangle Park, Durham, NC, 27709, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Prachi Pradeep</Name>
        <Affiliation>Oak Ridge Institute for Science and Education, Oak Ridge, TN, 37830, USA; Center for Computational Toxicology &amp; Exposure (CCTE), U.S. Environmental Protection Agency, Research Triangle Park, Durham, NC, 27709, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Grace Patlewicz</Name>
        <Affiliation>Center for Computational Toxicology &amp; Exposure (CCTE), U.S. Environmental Protection Agency, Research Triangle Park, Durham, NC, 27709, USA. Electronic address: patlewicz.grace@epa.gov.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The Grouping and Assessment Strategy for Organic Pigments (GRAPE): Scientific evidence to facilitate regulatory decision-making.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31629781</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30265-X</DOI>
    <KeywordList>
      <Keywords>(bio)dissolution</Keywords>
      <Keywords>3Rs principle (replace</Keywords>
      <Keywords>Alveolar macrophages</Keywords>
      <Keywords>Bioavailability</Keywords>
      <Keywords>Caco-2 cell line</Keywords>
      <Keywords>EU REACH regulation</Keywords>
      <Keywords>Human health protection</Keywords>
      <Keywords>Inhalation exposure</Keywords>
      <Keywords>Oral exposure</Keywords>
      <Keywords>Reduce</Keywords>
      <Keywords>Refine animal testing)</Keywords>
      <Keywords>Regulatory toxicology</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Ursula G. Sauer</Name>
        <Affiliation>Scientific Consultancy - Animal Welfare, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Reinhard Kreiling</Name>
        <Affiliation>Clariant Produkte (Deutschland) GmbH, Germany. Electronic address: reinhard.kreiling@clariant.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Impact of electronic cigarette heating coil resistance on the production of reactive carbonyls, reactive oxygen species and induction of cytotoxicity in human lung cancer cells in vitro.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31629780</pubmedLink>
    <GrantList>
      <Grant>P50 DA036107</Grant>
    </GrantList>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30264-8</DOI>
    <KeywordList>
      <Keywords>Carbonyl compounds</Keywords>
      <Keywords>E-cig</Keywords>
      <Keywords>Lung cancer cells</Keywords>
      <Keywords>Oxidative stress</Keywords>
      <Keywords>Resistance</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Silvia Cirillo</Name>
        <Affiliation>Department of Pharmacy and Biotechnology, Alma Mater Studiorum-University of Bologna, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Jose F. Urena</Name>
        <Affiliation>Department of Food Science, The Pennsylvania State University, College of Agricultural Sciences, University Park, PA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Joshua D. Lambert</Name>
        <Affiliation>Department of Food Science, The Pennsylvania State University, College of Agricultural Sciences, University Park, PA, USA; Center for Molecular Carcinogenesis and Toxicology, The Pennsylvania State University, University Park, PA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Fabio Vivarelli</Name>
        <Affiliation>Department of Pharmacy and Biotechnology, Alma Mater Studiorum-University of Bologna, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Donatella Canistro</Name>
        <Affiliation>Department of Pharmacy and Biotechnology, Alma Mater Studiorum-University of Bologna, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Moreno Paolini</Name>
        <Affiliation>Department of Pharmacy and Biotechnology, Alma Mater Studiorum-University of Bologna, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Vladimiro Cardenia</Name>
        <Affiliation>Department of Agricultural, Forest and Food Sciences, University of Turin, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Maria Teresa Rodriguez-Estrada</Name>
        <Affiliation>Department of Agricultural and Food Sciences, Alma Mater Studiorum-University of Bologna, Italy; Interdepartmental Centre for Industrial Agrofood Research, Alma Mater Studiorum-University of Bologna, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>John P. Richie</Name>
        <Affiliation>Department of Public Health Sciences, Pennsylvania State University Tobacco Center of Regulatory Science (TCORS), The Pennsylvania State University, College of Medicine, Hershey, PA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Ryan J. Elias</Name>
        <Affiliation>Department of Food Science, The Pennsylvania State University, College of Agricultural Sciences, University Park, PA, USA. Electronic address: elias@psu.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Tetrahydrofuran-induced tumors in rodents are not relevant to humans: Quantitative weight of evidence analysis of mode of action information does not support classification of tetrahydrofuran as a possible human carcinogen.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31626827</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30263-6</DOI>
    <KeywordList>
      <Keywords>Carcinogenesis</Keywords>
      <Keywords>Liver toxicity</Keywords>
      <Keywords>Mode of action</Keywords>
      <Keywords>Renal toxicity</Keywords>
      <Keywords>Tetrahydrofuran</Keywords>
      <Keywords>Weight of evidence</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Wolfgang Dekant</Name>
        <Affiliation>Department of Pharmacology and Toxicology, University of Würzburg, 97078, Würzburg, Germany. Electronic address: dekant@toxi.uni-wuerzburg.de.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Comparison of metabolic and mitogenic response in vitro of the rapid-acting insulin lispro product SAR342434, and US- and EU-approved Humalog®.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31610222</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30261-2</DOI>
    <KeywordList>
      <Keywords>Adipocyte lipolysis</Keywords>
      <Keywords>Hepatocyte glucose-6-phosphatase gene expression</Keywords>
      <Keywords>Insulin lispro</Keywords>
      <Keywords>Insulin receptor</Keywords>
      <Keywords>Insulin-like growth factor receptor-1</Keywords>
      <Keywords>L6 myocyte glucose uptake</Keywords>
      <Keywords>MCF-7 cell proliferation</Keywords>
      <Keywords>Receptor binding/autophosphorylation</Keywords>
      <Keywords>SAR342434</Keywords>
      <Keywords>Surface plasmon resonance</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Marcus Korn</Name>
        <Affiliation>Sanofi-Aventis Deutschland GmbH, Industriepark Höchst, 65926, Frankfurt am Main, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Paulus Wohlfart</Name>
        <Affiliation>Sanofi-Aventis Deutschland GmbH, Industriepark Höchst, 65926, Frankfurt am Main, Germany. Electronic address: paulus.wohlfart@sanofi.com.</Affiliation>
      </Author>
      <Author>
        <Name>Thomas Gossas</Name>
        <Affiliation>Beactica AB, Virdings allé 2, 754 50, Uppsala, Sweden.</Affiliation>
      </Author>
      <Author>
        <Name>Mari Kullman-Magnusson</Name>
        <Affiliation>Beactica AB, Virdings allé 2, 754 50, Uppsala, Sweden.</Affiliation>
      </Author>
      <Author>
        <Name>Birgit Niederhaus</Name>
        <Affiliation>Sanofi-Aventis Deutschland GmbH, Industriepark Höchst, 65926, Frankfurt am Main, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Juergen Dedio</Name>
        <Affiliation>Sanofi-Aventis Deutschland GmbH, Industriepark Höchst, 65926, Frankfurt am Main, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Norbert Tennagels</Name>
        <Affiliation>Sanofi-Aventis Deutschland GmbH, Industriepark Höchst, 65926, Frankfurt am Main, Germany.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Antineoplastic properties of zafirlukast against hepatocellular carcinoma via activation of mitochondrial mediated apoptosis.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31605713</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30253-3</DOI>
    <KeywordList>
      <Keywords>(1)H-NMR based metabolomics</Keywords>
      <Keywords>Apoptosis</Keywords>
      <Keywords>Bcl-2 and BAX proteins</Keywords>
      <Keywords>Hepatocellular carcinoma</Keywords>
      <Keywords>Zafirlukast</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Pranesh Kumar</Name>
        <Affiliation>Department of Pharmaceutical Sciences, Babasaheb Bhimrao Ambedkar University, Vidya Vihar, Raibareli Road, Lucknow, 226025, India.</Affiliation>
      </Author>
      <Author>
        <Name>Aakriti Agarwal</Name>
        <Affiliation>Department of Pharmaceutical Sciences, Babasaheb Bhimrao Ambedkar University, Vidya Vihar, Raibareli Road, Lucknow, 226025, India.</Affiliation>
      </Author>
      <Author>
        <Name>Ashok K. Singh</Name>
        <Affiliation>Department of Pharmaceutical Sciences, Babasaheb Bhimrao Ambedkar University, Vidya Vihar, Raibareli Road, Lucknow, 226025, India.</Affiliation>
      </Author>
      <Author>
        <Name>Anurag Kumar Gautam</Name>
        <Affiliation>Department of Pharmaceutical Sciences, Babasaheb Bhimrao Ambedkar University, Vidya Vihar, Raibareli Road, Lucknow, 226025, India.</Affiliation>
      </Author>
      <Author>
        <Name>Sreemoyee Chakraborti</Name>
        <Affiliation>Centre of Biomedical Research, SGPGIMS Campus, Raebareli Road, Lucknow, 226014, Uttar Pradesh, India.</Affiliation>
      </Author>
      <Author>
        <Name>Umesh Kumar</Name>
        <Affiliation>Centre of Biomedical Research, SGPGIMS Campus, Raebareli Road, Lucknow, 226014, Uttar Pradesh, India.</Affiliation>
      </Author>
      <Author>
        <Name>Dinesh Kumar</Name>
        <Affiliation>Centre of Biomedical Research, SGPGIMS Campus, Raebareli Road, Lucknow, 226014, Uttar Pradesh, India.</Affiliation>
      </Author>
      <Author>
        <Name>Bolay Bhattacharya</Name>
        <Affiliation>Gethanjali College of Pharmacy, Cheeryal, Keesara, Hyderabad, 501301, India.</Affiliation>
      </Author>
      <Author>
        <Name>Parthasarathi Panda</Name>
        <Affiliation>Dr. B.C. Roy College of Pharmacy &amp; Allied Health Sciences, Dr. Meghnad Saha Sarani, Bidhan Nagar, Durgapur, 713206, WB, India.</Affiliation>
      </Author>
      <Author>
        <Name>Biswajit Saha</Name>
        <Affiliation>Department of Chemical Engineering, National Institute of Technology, Rourkela, Odisha, 769008, India.</Affiliation>
      </Author>
      <Author>
        <Name>Tabish Qidwai</Name>
        <Affiliation>Faculty of Biotechnology, IBST, Shri Ramswaroop Memorial University Lucknow, Deva Road, UP, 225003, India.</Affiliation>
      </Author>
      <Author>
        <Name>Biswanath Maity</Name>
        <Affiliation>Centre of Biomedical Research, SGPGIMS Campus, Raebareli Road, Lucknow, 226014, Uttar Pradesh, India.</Affiliation>
      </Author>
      <Author>
        <Name>Sudipta Saha</Name>
        <Affiliation>Department of Pharmaceutical Sciences, Babasaheb Bhimrao Ambedkar University, Vidya Vihar, Raibareli Road, Lucknow, 226025, India. Electronic address: sudiptapharm@gmail.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Pulmonary toxicity in rats following inhalation exposure to poorly soluble particles: The issue of impaired clearance and the relevance for human health hazard and risk assessment.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31604110</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30262-4</DOI>
    <KeywordList>
      <Keywords>Hazard assessment</Keywords>
      <Keywords>Human relevance</Keywords>
      <Keywords>Impaired lung clearance</Keywords>
      <Keywords>Inhalation exposure</Keywords>
      <Keywords>PSPs</Keywords>
      <Keywords>Poorly soluble particles</Keywords>
      <Keywords>Rat pulmonary toxicity</Keywords>
      <Keywords>Risk assessment</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Peter M. J. Bos</Name>
        <Affiliation>National Institute for Public Health and the Environment, Bilthoven, the Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Ilse Gosens</Name>
        <Affiliation>National Institute for Public Health and the Environment, Bilthoven, the Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Liesbeth Geraets</Name>
        <Affiliation>National Institute for Public Health and the Environment, Bilthoven, the Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Christiaan Delmaar</Name>
        <Affiliation>National Institute for Public Health and the Environment, Bilthoven, the Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Flemming R. Cassee</Name>
        <Affiliation>National Institute for Public Health and the Environment, Bilthoven, the Netherlands; Institute for Risk Assessment Sciences, Utrecht University, Utrecht, the Netherlands. Electronic address: Flemming.Cassee@rivm.nl.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Transitioning to composite bacterial mutagenicity models in ICH M7 (Q)SAR analyses.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31586682</pubmedLink>
    <GrantList>
      <Grant>FD999999</Grant>
      <Grant>R44 ES026909</Grant>
    </GrantList>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30252-1</DOI>
    <KeywordList>
      <Keywords>Ames</Keywords>
      <Keywords>Bacterial mutagenicity</Keywords>
      <Keywords>Computational toxicology</Keywords>
      <Keywords>Drug</Keywords>
      <Keywords>Genotoxicity</Keywords>
      <Keywords>ICH M7</Keywords>
      <Keywords>In vitro</Keywords>
      <Keywords>QSAR</Keywords>
      <Keywords>Regulatory review</Keywords>
      <Keywords>Structure-activity relationship</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Curran Landry</Name>
        <Affiliation>US Food and Drug Administration, Center for Drug Evaluation and Research, 10903 New Hampshire Ave, Silver Spring, MD, 20993, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Marlene T. Kim</Name>
        <Affiliation>US Food and Drug Administration, Center for Drug Evaluation and Research, 10903 New Hampshire Ave, Silver Spring, MD, 20993, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Naomi L. Kruhlak</Name>
        <Affiliation>US Food and Drug Administration, Center for Drug Evaluation and Research, 10903 New Hampshire Ave, Silver Spring, MD, 20993, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Kevin P. Cross</Name>
        <Affiliation>Leadscope Inc., 1393 Dublin Road, Columbus, OH, 43215, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Roustem Saiakhov</Name>
        <Affiliation>Multicase Inc., 23811 Chagrin Boulevard, Suite 305, Beachwood, OH, 44122, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Suman Chakravarti</Name>
        <Affiliation>Multicase Inc., 23811 Chagrin Boulevard, Suite 305, Beachwood, OH, 44122, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Lidiya Stavitskaya</Name>
        <Affiliation>US Food and Drug Administration, Center for Drug Evaluation and Research, 10903 New Hampshire Ave, Silver Spring, MD, 20993, USA. Electronic address: Lidiya.Stavitskaya@fda.hhs.gov.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Applying non-animal strategies for assessing skin sensitisation report from an EPAA/cefic-LRI/IFRA Europe cross sector workshop, ECHA helsinki, February 7th and 8th 2019.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31586681</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30241-7</DOI>
    <KeywordList>
      <Keywords>Defined approaches</Keywords>
      <Keywords>Hazard classification</Keywords>
      <Keywords>In vitro alternatives</Keywords>
      <Keywords>Integrated approaches to testing and assessment</Keywords>
      <Keywords>Integrated testing strategies</Keywords>
      <Keywords>Potency sub-categorisation</Keywords>
      <Keywords>Skin sensitisation</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>David Basketter</Name>
        <Affiliation>DABMEB Consultancy Ltd, Sharnbrook, UK. Electronic address: dabmebconsultancyltd@me.com.</Affiliation>
      </Author>
      <Author>
        <Name>Philippe Azam</Name>
        <Affiliation>Solvay, Saint-Fons, France.</Affiliation>
      </Author>
      <Author>
        <Name>Silvia Casati</Name>
        <Affiliation>European Commission, Joint Research Centre (JRC), Ispra, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Marco Corvaro</Name>
        <Affiliation>Corteva AgriSciences, Rome, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Janine Ezendam</Name>
        <Affiliation>National Institute for Public Health and the Environment, Centre for Health Protection, Bilthoven, the Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Peter Griem</Name>
        <Affiliation>Symrise AG, Holzminden, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Bruno Hubesch</Name>
        <Affiliation>Hubesch Consult BVBA, Sint-Pieters-Leeuw, Belgium; European Chemical Industry Council (Cefic), Brussels, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Amaia Irizar</Name>
        <Affiliation>The International Fragrance Association (IFRA), Geneva, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Petra Kern</Name>
        <Affiliation>Procter &amp; Gamble, Strombeek-Bever, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Irene Manou</Name>
        <Affiliation>European Partnership for Alternative Approaches to Animal Testing (EPAA), Brussels, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Annette Mehling</Name>
        <Affiliation>BASF Personal Care and Nutrition GmbH, Duesseldorf, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Laura H. Rossi</Name>
        <Affiliation>European Chemicals Agency (ECHA), Helsinki, Finland.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Evaluation of preclinical safety profile of SPH3127, a direct renin inhibitor, after 28-day repeated oral administration in Sprague-Dawley rats and cynomolgus monkeys.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31585137</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30248-X</DOI>
    <KeywordList>
      <Keywords>Direct renin inhibitor</Keywords>
      <Keywords>Preclinical</Keywords>
      <Keywords>SPH3127</Keywords>
      <Keywords>Subchronic toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Yu Mao</Name>
        <Affiliation>Central Research Institute, Shanghai Pharmaceutical Holding Co. Ltd, Shanghai, 201203, China. Electronic address: maoy@sphchina.com.</Affiliation>
      </Author>
      <Author>
        <Name>Leduo Zhang</Name>
        <Affiliation>Central Research Institute, Shanghai Pharmaceutical Holding Co. Ltd, Shanghai, 201203, China.</Affiliation>
      </Author>
      <Author>
        <Name>Hua Li</Name>
        <Affiliation>National Shanghai Center for New Drug Safety Evaluation and Research, Shanghai, 201203, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xin Li</Name>
        <Affiliation>Shanghai Pharma Biotherapeutics USA Inc., San Diego, CA, 92121, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Yanjun Liu</Name>
        <Affiliation>Central Research Institute, Shanghai Pharmaceutical Holding Co. Ltd, Shanghai, 201203, China.</Affiliation>
      </Author>
      <Author>
        <Name>Guangxin Xia</Name>
        <Affiliation>Central Research Institute, Shanghai Pharmaceutical Holding Co. Ltd, Shanghai, 201203, China. Electronic address: xiagx@sphchina.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Subchronic toxicity evaluation of ethanol extract of Cassia tora L. seeds in rats.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31585136</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30251-X</DOI>
    <KeywordList>
      <Keywords>Cassia tora L. seed</Keywords>
      <Keywords>Herbal medicine</Keywords>
      <Keywords>No-observed-adverse-effect level</Keywords>
      <Keywords>Repeated oral dose toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Mu Jin Lee</Name>
        <Affiliation>Division of Tradition Korean Medicine Research, National Institute for Korean Medicine Development, Jangheung, Jeonnam, 59338, Republic of Korea; College of Veterinary Medicine BK21 Plus Project Team, Chonnam National University, Gwangju, 61186, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Jong Hyun Nho</Name>
        <Affiliation>Division of Tradition Korean Medicine Research, National Institute for Korean Medicine Development, Jangheung, Jeonnam, 59338, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Beo Deul Yang</Name>
        <Affiliation>Division of Tradition Korean Medicine Research, National Institute for Korean Medicine Development, Jangheung, Jeonnam, 59338, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Ho Park</Name>
        <Affiliation>Division of Tradition Korean Medicine Research, National Institute for Korean Medicine Development, Jangheung, Jeonnam, 59338, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Hyun Joo Lee</Name>
        <Affiliation>Division of Tradition Korean Medicine Research, National Institute for Korean Medicine Development, Jangheung, Jeonnam, 59338, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Ki Ho Lee</Name>
        <Affiliation>Division of Tradition Korean Medicine Research, National Institute for Korean Medicine Development, Jangheung, Jeonnam, 59338, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Ji Hun Jang</Name>
        <Affiliation>Division of Tradition Korean Medicine Research, National Institute for Korean Medicine Development, Jangheung, Jeonnam, 59338, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Ho Kyung Jung</Name>
        <Affiliation>Division of Tradition Korean Medicine Research, National Institute for Korean Medicine Development, Jangheung, Jeonnam, 59338, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Sun Ra Kim</Name>
        <Affiliation>Division of Tradition Korean Medicine Research, National Institute for Korean Medicine Development, Jangheung, Jeonnam, 59338, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Hyun Woo Cho</Name>
        <Affiliation>Division of Tradition Korean Medicine Research, National Institute for Korean Medicine Development, Jangheung, Jeonnam, 59338, Republic of Korea. Electronic address: johw7@nikom.or.kr.</Affiliation>
      </Author>
      <Author>
        <Name>Hae Sung Park</Name>
        <Affiliation>Health Care Institute, Korea Testing and Research Institute, Hwasun, Jeonnam, 58141, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Je Oh Lim</Name>
        <Affiliation>College of Veterinary Medicine BK21 Plus Project Team, Chonnam National University, Gwangju, 61186, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Jong Choon Kim</Name>
        <Affiliation>College of Veterinary Medicine BK21 Plus Project Team, Chonnam National University, Gwangju, 61186, Republic of Korea. Electronic address: toxkim@jnu.ac.kr.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Sub-acute toxicological study of artemisinin-piperaquine tablets in rhesus monkeys.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31580888</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30250-8</DOI>
    <KeywordList>
      <Keywords>Artemisinin-piperaquine tablets</Keywords>
      <Keywords>Artequick</Keywords>
      <Keywords>Rhesus monkey</Keywords>
      <Keywords>Safety</Keywords>
      <Keywords>Toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Xiaobo Li</Name>
        <Affiliation>Artemisinin Research Center, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China; Sci-tech Industrial Park, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhiyong Xu</Name>
        <Affiliation>Sci-tech Industrial Park, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yueming Yuan</Name>
        <Affiliation>Sci-tech Industrial Park, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China.</Affiliation>
      </Author>
      <Author>
        <Name>Li Ru</Name>
        <Affiliation>Sci-tech Industrial Park, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zheng Yuan</Name>
        <Affiliation>Sci-tech Industrial Park, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China.</Affiliation>
      </Author>
      <Author>
        <Name>Shouya Zhang</Name>
        <Affiliation>Sci-tech Industrial Park, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China.</Affiliation>
      </Author>
      <Author>
        <Name>Qi Wang</Name>
        <Affiliation>Artemisinin Research Center, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China; Artepharm, Co., Ltd., Guangzhou, Guangdong, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jianping Song</Name>
        <Affiliation>Artemisinin Research Center, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China.</Affiliation>
      </Author>
      <Author>
        <Name>Qin Xu</Name>
        <Affiliation>Artemisinin Research Center, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China. Electronic address: xuqin@163.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Preclinical toxicity evaluation of JD5037, a peripherally restricted CB</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31580887</pubmedLink>
    <GrantList>
      <Grant>HHSN261200800001C</Grant>
      <Grant>HHSN261200800001E</Grant>
    </GrantList>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30247-8</DOI>
    <KeywordList>
      <Keywords>Inverse agonist</Keywords>
      <Keywords>JD5037</Keywords>
      <Keywords>Nonalcoholic steatohepatitis (NASH)</Keywords>
      <Keywords>Obesity</Keywords>
      <Keywords>Peripheral cannabinoid receptor 1 (CB(1)R)</Keywords>
      <Keywords>Preclinical safety</Keywords>
      <Keywords>Toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Vijay Pralhad Kale</Name>
        <Affiliation>Battelle, Columbus, OH, USA. Electronic address: kale@battelle.org.</Affiliation>
      </Author>
      <Author>
        <Name>Seth Gibbs</Name>
        <Affiliation>Battelle, Columbus, OH, USA.</Affiliation>
      </Author>
      <Author>
        <Name>John A. Taylor</Name>
        <Affiliation>Battelle, Columbus, OH, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Amy Zmarowski</Name>
        <Affiliation>Battelle, Columbus, OH, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Joseph Novak</Name>
        <Affiliation>Battelle, Columbus, OH, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Kristin Patton</Name>
        <Affiliation>Battelle, Columbus, OH, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Barney Sparrow</Name>
        <Affiliation>Battelle, Columbus, OH, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jenni Gorospe</Name>
        <Affiliation>Battelle, Columbus, OH, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Satheesh Anand</Name>
        <Affiliation>Battelle, Columbus, OH, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Resat Cinar</Name>
        <Affiliation>National Institute on Alcohol Abuse and Alcoholism, Bethesda, MD, USA.</Affiliation>
      </Author>
      <Author>
        <Name>George Kunos</Name>
        <Affiliation>National Institute on Alcohol Abuse and Alcoholism, Bethesda, MD, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Robert J. Chorvat</Name>
        <Affiliation>Jenrin Discovery, LLC, Wilmington, DE, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Pramod S. Terse</Name>
        <Affiliation>National Center for Advancing Translational Sciences, National Institute of Health, Bethesda, MD, USA. Electronic address: tersep@mail.nih.gov.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>90-Day repeated oral toxicity test of D-allulose produced from Microbacterium foliorum.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31568817</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30249-1</DOI>
    <KeywordList>
      <Keywords>90-Day toxicity test</Keywords>
      <Keywords>D-allulose</Keywords>
      <Keywords>D-psicose</Keywords>
      <Keywords>No-observed-adverse-effect-level (NOAEL)</Keywords>
      <Keywords>Repeated dose</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>MinJi An</Name>
        <Affiliation>GLP Center &amp; Dept. of Toxicity Assessment, Daegu Catholic University, Gyeongsan, 38430, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>JiSun Lee</Name>
        <Affiliation>GLP Center &amp; Dept. of Toxicity Assessment, Daegu Catholic University, Gyeongsan, 38430, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Yeong Chul Park</Name>
        <Affiliation>GLP Center &amp; Dept. of Toxicity Assessment, Daegu Catholic University, Gyeongsan, 38430, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>ChongJin Park</Name>
        <Affiliation>Samyang Corp, 295 Pangyo-ro, Bundang-gu, Seongnam-si, Gyeonggi-do, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Hye Jung Kim</Name>
        <Affiliation>Samyang Corp, 295 Pangyo-ro, Bundang-gu, Seongnam-si, Gyeonggi-do, Republic of Korea. Electronic address: hyejung.kim@samyang.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Toxicological significance of increased serum alkaline phosphatase activity in dog studies of pesticides: Analysis of toxicological data evaluated in Japan.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31568816</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30246-6</DOI>
    <KeywordList>
      <Keywords>Alkaline phosphatase</Keywords>
      <Keywords>Dog</Keywords>
      <Keywords>Hepatotoxicity</Keywords>
      <Keywords>Pesticide</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Yoko Yokoyama</Name>
        <Affiliation>Food Safety Commission of Japan, Minato-ku, Tokyo, 107-6122, Japan; Tokyo University of Agriculture and Technology, Koganei, Tokyo, 184-8588, Japan. Electronic address: yoko.yokoyama.h8w@cao.go.jp.</Affiliation>
      </Author>
      <Author>
        <Name>Atsushi Ono</Name>
        <Affiliation>Okayama University, Kita-ku, Okayama, 700-8530, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Midori Yoshida</Name>
        <Affiliation>Food Safety Commission of Japan, Minato-ku, Tokyo, 107-6122, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Kiyoshi Matsumoto</Name>
        <Affiliation>Shinshu University, Matsumoto, Nagano, 390-8621, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Mikako Saito</Name>
        <Affiliation>Tokyo University of Agriculture and Technology, Koganei, Tokyo, 184-8588, Japan. Electronic address: mikako@cc.tuat.ac.jp.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Quantitative prediction of repeat dose toxicity values using GenRA.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31550520</pubmedLink>
    <GrantList>
      <Grant>EPA999999</Grant>
    </GrantList>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30244-2</DOI>
    <KeywordList>
      <Keywords>Cheminformatics</Keywords>
      <Keywords>Computational toxicology</Keywords>
      <Keywords>Generalized read-across</Keywords>
      <Keywords>Point of departure</Keywords>
      <Keywords>Repeat-dose toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>G. Helman</Name>
        <Affiliation>Oak Ridge Institute for Science and Education (ORISE), Oak Ridge, TN, USA; National Center for Computational Toxicology, Office of Research and Development, U.S. Environmental Protection Agency, Research Triangle Park, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>G. Patlewicz</Name>
        <Affiliation>National Center for Computational Toxicology, Office of Research and Development, U.S. Environmental Protection Agency, Research Triangle Park, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>I. Shah</Name>
        <Affiliation>National Center for Computational Toxicology, Office of Research and Development, U.S. Environmental Protection Agency, Research Triangle Park, NC, USA. Electronic address: shah.Imran@epa.gov.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Reducing the need for animal testing while increasing efficiency in a pesticide regulatory setting: Lessons from the EPA Office of Pesticide Programs' Hazard and Science Policy Council.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31546018</pubmedLink>
    <GrantList>
      <Grant>EPA999999</Grant>
    </GrantList>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30245-4</DOI>
    <KeywordList>
      <Keywords>3Rs</Keywords>
      <Keywords>HASPOC</Keywords>
      <Keywords>Pesticides</Keywords>
      <Keywords>Risk assessment</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Evisabel Craig</Name>
        <Affiliation>United States Environmental Protection Agency, Office of Pesticide Programs, 1200 Pennsylvania Ave NW, Washington D.C, 20460, USA. Electronic address: craig.evisabel@epa.gov.</Affiliation>
      </Author>
      <Author>
        <Name>Kelly Lowe</Name>
        <Affiliation>United States Environmental Protection Agency, Office of Pesticide Programs, 1200 Pennsylvania Ave NW, Washington D.C, 20460, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Gregory Akerman</Name>
        <Affiliation>United States Environmental Protection Agency, Office of Pesticide Programs, 1200 Pennsylvania Ave NW, Washington D.C, 20460, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jeffrey Dawson</Name>
        <Affiliation>United States Environmental Protection Agency, Office of Pesticide Programs, 1200 Pennsylvania Ave NW, Washington D.C, 20460, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Brenda May</Name>
        <Affiliation>United States Environmental Protection Agency, Office of Pesticide Programs, 1200 Pennsylvania Ave NW, Washington D.C, 20460, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Elissa Reaves</Name>
        <Affiliation>United States Environmental Protection Agency, Office of Pesticide Programs, 1200 Pennsylvania Ave NW, Washington D.C, 20460, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Anna Lowit</Name>
        <Affiliation>United States Environmental Protection Agency, Office of Pesticide Programs, 1200 Pennsylvania Ave NW, Washington D.C, 20460, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>MRI-based preclinical discovery of DILI: A lesson from paracetamol-induced hepatotoxicity.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31539568</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30242-9</DOI>
    <KeywordList>
      <Keywords>Hepatotoxicity</Keywords>
      <Keywords>Liver</Keywords>
      <Keywords>Magnetic resonance imaging</Keywords>
      <Keywords>Paracetamol</Keywords>
      <Keywords>Rat</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Ireneusz P. Grudzinski</Name>
        <Affiliation>Department of Applied Toxicology, Medical University of Warsaw, Banacha 1 Str., 02-097, Warsaw, Poland. Electronic address: ireneusz.grudzinski@wum.edu.pl.</Affiliation>
      </Author>
      <Author>
        <Name>Monika Ruzycka</Name>
        <Affiliation>Department of Applied Toxicology, Medical University of Warsaw, Banacha 1 Str., 02-097, Warsaw, Poland.</Affiliation>
      </Author>
      <Author>
        <Name>Andrzej Cieszanowski</Name>
        <Affiliation>Department of Radiology I, Maria Sklodowska - Curie Memorial Cancer Center and Institute of Oncology, Roentgena 5 Str., 02-781, Warsaw, Poland.</Affiliation>
      </Author>
      <Author>
        <Name>Wojciech Szeszkowski</Name>
        <Affiliation>2nd Department of Clinical Radiology, Medical University of Warsaw, Banacha 1A Str., 02-097, Warsaw, Poland.</Affiliation>
      </Author>
      <Author>
        <Name>Iwona Badurek</Name>
        <Affiliation>Department of Pathology, Medical University of Warsaw, Center for Biostructure Research, Chalubinskiego 5 Str., 02-004, Warsaw, Poland.</Affiliation>
      </Author>
      <Author>
        <Name>Anna Malkowska</Name>
        <Affiliation>Department of Applied Toxicology, Medical University of Warsaw, Banacha 1 Str., 02-097, Warsaw, Poland.</Affiliation>
      </Author>
      <Author>
        <Name>Magdalena Bamburowicz-Klimkowska</Name>
        <Affiliation>Department of Applied Toxicology, Medical University of Warsaw, Banacha 1 Str., 02-097, Warsaw, Poland.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Dermal absorption study OECD TG 428 mass balance recommendations based on the EFSA database.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31539567</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30239-9</DOI>
    <KeywordList>
      <Keywords>Agrochemicals</Keywords>
      <Keywords>Cosmetics</Keywords>
      <Keywords>Dermal absorption</Keywords>
      <Keywords>Exploratory data analysis</Keywords>
      <Keywords>Human skin</Keywords>
      <Keywords>Pesticides</Keywords>
      <Keywords>Plant protection products</Keywords>
      <Keywords>Risk assessment</Keywords>
      <Keywords>in vitro</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Felix M. Kluxen</Name>
        <Affiliation>ADAMA Deutschland GmbH, Edmund-Rumpler-Str. 6, 51149, Cologne, Germany. Electronic address: Felix.Kluxen@adama.com.</Affiliation>
      </Author>
      <Author>
        <Name>Sébastien Grégoire</Name>
        <Affiliation>L'Oreal Research &amp; Innovation, 1 Avenue Eugène Schueller, 93600, Aulnay-Sous-Bois, France. Electronic address: sebastien.gregoire@rd.loreal.com.</Affiliation>
      </Author>
      <Author>
        <Name>Andreas Schepky</Name>
        <Affiliation>Beiersdorf AG, Unnastraße 48, 20253, Hamburg, Germany. Electronic address: Andreas.Schepky@beiersdorf.com.</Affiliation>
      </Author>
      <Author>
        <Name>Nicky J. Hewitt</Name>
        <Affiliation>Cosmetics Europe, Avenue Herrmann-Debroux 40, 1160, Brussels, Belgium. Electronic address: nickyhewittltd@yahoo.co.uk.</Affiliation>
      </Author>
      <Author>
        <Name>Martina Klaric</Name>
        <Affiliation>Cosmetics Europe, Avenue Herrmann-Debroux 40, 1160, Brussels, Belgium. Electronic address: mklaric@cosmeticseurope.eu.</Affiliation>
      </Author>
      <Author>
        <Name>Jeanne Y. Domoradzki</Name>
        <Affiliation>Corteva Agriscience, 9330 Zionsville Road, Indianapolis, IN, 46238, USA. Electronic address: jeanne.domoradzki@corteva.com.</Affiliation>
      </Author>
      <Author>
        <Name>Edgars Felkers</Name>
        <Affiliation>ADAMA Deutschland GmbH, Edmund-Rumpler-Str. 6, 51149, Cologne, Germany. Electronic address: edgars.felkers@adama.com.</Affiliation>
      </Author>
      <Author>
        <Name>Joshua Fernandes</Name>
        <Affiliation>Syngenta Ltd., Jealotts Hill Research Station, Warfield, Bracknell, RG42 6EY, UK. Electronic address: Joshua.Fernandes@syngenta.com.</Affiliation>
      </Author>
      <Author>
        <Name>Philip Fisher</Name>
        <Affiliation>Bayer SAS, Crop Science Division, 16 Rue Jean-Marie Leclair, 69266, Lyon, France. Electronic address: philip.fisher@bayer.com.</Affiliation>
      </Author>
      <Author>
        <Name>Steven F. McEuen</Name>
        <Affiliation>FMC Corporation, Stine Research Center, S300/427, P.O. Box 30, Newark, DE, 19714-0030, USA. Electronic address: Steven.Mceuen@fmc.com.</Affiliation>
      </Author>
      <Author>
        <Name>Robert Parr-Dobrzanski</Name>
        <Affiliation>Syngenta Ltd., Jealotts Hill Research Station, Warfield, Bracknell, RG42 6EY, UK. Electronic address: bob.parr-dobrzanski@syngenta.com.</Affiliation>
      </Author>
      <Author>
        <Name>Christiane Wiemann</Name>
        <Affiliation>BASF Oesterreich GmbH, Handelskai 94-96, 1200, Vienna, Austria. Electronic address: christiane.wiemann@basf.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Assessment of FD&amp;C Yellow No. 6 (Sunset Yellow FCF) effects on sperm count, motility and viability in the rat in a 28-day toxicity study.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31539566</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30243-0</DOI>
    <KeywordList>
      <Keywords>FD&amp;C yellow no. 6</Keywords>
      <Keywords>Food color</Keywords>
      <Keywords>Rat</Keywords>
      <Keywords>Safety</Keywords>
      <Keywords>Sperm</Keywords>
      <Keywords>Sunset yellow FCF</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Maria Bastaki</Name>
        <Affiliation>International Association of Color Manufacturers (IACM), 1101 17th St, Suite 700, Washington, DC, 20036, USA. Electronic address: mbastaki@iacmcolor.org.</Affiliation>
      </Author>
      <Author>
        <Name>Odete R. Mendes</Name>
        <Affiliation>Charles River, 4025 Stirrup Creek Drive, Suite 150, Durham, NC, 27703, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Mark R. Bauter</Name>
        <Affiliation>Product Safety Labs, 2394 US Highway 130, Dayton, NJ, 08810, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Sean V. Taylor</Name>
        <Affiliation>International Association of Color Manufacturers (IACM), 1101 17th St, Suite 700, Washington, DC, 20036, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Nonclinical safety of tildrakizumab, a humanized anti-IL-23p19 monoclonal antibody, in nonhuman primates.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31536773</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30240-5</DOI>
    <KeywordList>
      <Keywords>Animal model</Keywords>
      <Keywords>Interleukin-23</Keywords>
      <Keywords>Monoclonal antibody</Keywords>
      <Keywords>Pre- and postnatal development</Keywords>
      <Keywords>Psoriasis</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Michael Santostefano</Name>
        <Affiliation>Safety Assessment and Laboratory Animal Resources, Merck &amp; Co., Inc., 33 Avenue Louis Pasteur, Boston, MA, 02115-5727, United States. Electronic address: michael.santostefano@merck.com.</Affiliation>
      </Author>
      <Author>
        <Name>Danuta Herzyk</Name>
        <Affiliation>Safety Assessment and Laboratory Animal Resources, Merck &amp; Co., Inc., 770 Sumneytown Pike, West Point, PA, 19486, United States. Electronic address: danuta_herzyk@merck.com.</Affiliation>
      </Author>
      <Author>
        <Name>Diana Montgomery</Name>
        <Affiliation>Pharmacokinetics, Predictive and Clinical Immunogenicity, Merck &amp; Co., Inc., 770 Sumneytown Pike, West Point, PA, 19486, United States. Electronic address: diana.montgomery@merck.com.</Affiliation>
      </Author>
      <Author>
        <Name>Jayanthi Wolf</Name>
        <Affiliation>Global Regulatory Affairs, Merck &amp; Co., Inc., 351 N. Sumneytown Pike, North Wales, PA, 19454-2505, United States. Electronic address: jayanthi.wolf@merck.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Subchronic toxicity of cerium nitrate by 90-day oral exposure in wistar rats.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31494192</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30238-7</DOI>
    <KeywordList>
      <Keywords>Cerium nitrate</Keywords>
      <Keywords>No observed adverse effect level</Keywords>
      <Keywords>Rare earth element</Keywords>
      <Keywords>Subchronic toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Yu Wu</Name>
        <Affiliation>Hubei Provincial Key Laboratory for Applied Toxicology, Hubei Provincial Center for Disease Control and Prevention, Wuhan, 430079, China; Renmin Hospital of Wuhan University, Wuhan, 430060, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaoqiao Tang</Name>
        <Affiliation>Hubei Provincial Key Laboratory for Applied Toxicology, Hubei Provincial Center for Disease Control and Prevention, Wuhan, 430079, China.</Affiliation>
      </Author>
      <Author>
        <Name>Wenxiang Yang</Name>
        <Affiliation>Hubei Provincial Key Laboratory for Applied Toxicology, Hubei Provincial Center for Disease Control and Prevention, Wuhan, 430079, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jun Fan</Name>
        <Affiliation>Hubei Provincial Key Laboratory for Applied Toxicology, Hubei Provincial Center for Disease Control and Prevention, Wuhan, 430079, China.</Affiliation>
      </Author>
      <Author>
        <Name>Lijun Tang</Name>
        <Affiliation>Hubei Provincial Key Laboratory for Applied Toxicology, Hubei Provincial Center for Disease Control and Prevention, Wuhan, 430079, China.</Affiliation>
      </Author>
      <Author>
        <Name>Chunhong Wang</Name>
        <Affiliation>Renmin Hospital of Wuhan University, Wuhan, 430060, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhou Yu</Name>
        <Affiliation>Key Laboratory of Food Safety Risk Assessment of Ministry of Health, China National Center for Food Safety Risk Assessment, Beijing, 100021, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xu Dong Jia</Name>
        <Affiliation>Key Laboratory of Food Safety Risk Assessment of Ministry of Health, China National Center for Food Safety Risk Assessment, Beijing, 100021, China.</Affiliation>
      </Author>
      <Author>
        <Name>Bolin Fan</Name>
        <Affiliation>Hubei Provincial Key Laboratory for Applied Toxicology, Hubei Provincial Center for Disease Control and Prevention, Wuhan, 430079, China. Electronic address: vanbolin@163.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Variance of body and organ weights in 28-day studies in mice.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31494191</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30236-3</DOI>
    <KeywordList>
      <Keywords>Endocrine disruptor effects</Keywords>
      <Keywords>Immune system</Keywords>
      <Keywords>Mouse</Keywords>
      <Keywords>Organ weight</Keywords>
      <Keywords>Toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Heike Antje Marxfeld</Name>
        <Affiliation>Experimental Toxicology and Ecotoxicology, BASF SE, 67056, Ludwigshafen, Germany. Electronic address: heike-antje.marxfeld@basf.com.</Affiliation>
      </Author>
      <Author>
        <Name>Karin Küttler</Name>
        <Affiliation>Experimental Toxicology and Ecotoxicology, BASF SE, 67056, Ludwigshafen, Germany. Electronic address: karin.kuettler@basf.com.</Affiliation>
      </Author>
      <Author>
        <Name>Martina Dammann</Name>
        <Affiliation>Experimental Toxicology and Ecotoxicology, BASF SE, 67056, Ludwigshafen, Germany. Electronic address: martina.dammann@basf.com.</Affiliation>
      </Author>
      <Author>
        <Name>Sibylle Gröters</Name>
        <Affiliation>Experimental Toxicology and Ecotoxicology, BASF SE, 67056, Ludwigshafen, Germany. Electronic address: sibylle.groeters@basf.com.</Affiliation>
      </Author>
      <Author>
        <Name>Bennard van Ravenzwaay</Name>
        <Affiliation>Experimental Toxicology and Ecotoxicology, BASF SE, 67056, Ludwigshafen, Germany. Electronic address: bennard.ravenzwaay@basf.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>In vitro RHE skin sensitisation assays: Applicability to challenging substances.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31494190</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30237-5</DOI>
    <KeywordList>
      <Keywords>Hazard identification</Keywords>
      <Keywords>In vitro alternatives</Keywords>
      <Keywords>Reconstructed human epidermis</Keywords>
      <Keywords>Skin sensitisation</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>A. Mehling</Name>
        <Affiliation>BASF Personal Care and Nutrition GmbH, Duesseldorf, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>E. Adriaens</Name>
        <Affiliation>Adriaens Consulting BVBA, Aalter, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>S. Casati</Name>
        <Affiliation>European Commission, Joint Research Centre (JRC), Ispra, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>B. Hubesch</Name>
        <Affiliation>Hubesch Consult BVBA, Sint-Pieters-Leeuw, Belgium, European Chemical Industry Council (Cefic), Brussels, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>A. Irizar</Name>
        <Affiliation>The International Fragrance Association (IFRA), Geneva, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>M. Klaric</Name>
        <Affiliation>Cosmetics Europe, Brussels, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>S. Letasiova</Name>
        <Affiliation>MatTek In Vitro Life Science Laboratories, Bratislava, Slovakia.</Affiliation>
      </Author>
      <Author>
        <Name>I. Manou</Name>
        <Affiliation>European Partnership for Alternative Approaches to Animal Testing (EPAA), Brussels, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>B. P. Müller</Name>
        <Affiliation>Symrise AG, Holzminden, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>E. Roggen</Name>
        <Affiliation>3Rs Management and Consulting ApS, Kongens Lydngby, Denmark.</Affiliation>
      </Author>
      <Author>
        <Name>E. van Vliet</Name>
        <Affiliation>Cosmetics Europe, Brussels, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>D. Basketter</Name>
        <Affiliation>DABMEB Consultancy Ltd, Sharnbrook, UK. Electronic address: dabmebconsultancyltd@me.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Persistence, dissipation, and risk assessment of a combination formulation of trifloxystrobin and tebuconazole fungicides in/on tomato.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31493441</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30235-1</DOI>
    <KeywordList>
      <Keywords>Consumer risk assessment</Keywords>
      <Keywords>OECD MRL calculator</Keywords>
      <Keywords>Pesticide residues</Keywords>
      <Keywords>Tebuconazole</Keywords>
      <Keywords>Tomato</Keywords>
      <Keywords>Trifloxystrobin</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Krishan Kumar Sharma</Name>
        <Affiliation>Project Coordinating Cell, Pesticide Residue Laboratory, All India Network Project on Pesticide Residues, ICAR-Indian Agricultural Research Institute, New Delhi, India. Electronic address: kksaicrp@yahoo.co.in.</Affiliation>
      </Author>
      <Author>
        <Name>Vandana Tripathy</Name>
        <Affiliation>Project Coordinating Cell, Pesticide Residue Laboratory, All India Network Project on Pesticide Residues, ICAR-Indian Agricultural Research Institute, New Delhi, India.</Affiliation>
      </Author>
      <Author>
        <Name>Cherkuri Sreenivasa Rao</Name>
        <Affiliation>Professor Jayashankar Telangana State Agricultural University, All India Network Project on Pesticide Residues, Hyderabad, Telangana, India.</Affiliation>
      </Author>
      <Author>
        <Name>Vemuri Shashi Bhushan</Name>
        <Affiliation>Professor Jayashankar Telangana State Agricultural University, All India Network Project on Pesticide Residues, Hyderabad, Telangana, India.</Affiliation>
      </Author>
      <Author>
        <Name>Karthika Narasimha Reddy</Name>
        <Affiliation>Professor Jayashankar Telangana State Agricultural University, All India Network Project on Pesticide Residues, Hyderabad, Telangana, India.</Affiliation>
      </Author>
      <Author>
        <Name>Gagan Jyot</Name>
        <Affiliation>Punjab Agricultural University, All India Network Project on Pesticide Residues, Ludhiana, Punjab, India.</Affiliation>
      </Author>
      <Author>
        <Name>Sanjay Kumar Sahoo</Name>
        <Affiliation>Punjab Agricultural University, All India Network Project on Pesticide Residues, Ludhiana, Punjab, India.</Affiliation>
      </Author>
      <Author>
        <Name>Balwinder Singh</Name>
        <Affiliation>Punjab Agricultural University, All India Network Project on Pesticide Residues, Ludhiana, Punjab, India.</Affiliation>
      </Author>
      <Author>
        <Name>Kaushik Mandal</Name>
        <Affiliation>Punjab Agricultural University, All India Network Project on Pesticide Residues, Ludhiana, Punjab, India.</Affiliation>
      </Author>
      <Author>
        <Name>Hemanta Banerjee</Name>
        <Affiliation>Bidhan Chandra Krishi Vishwavidyalaya, All India Network Project on Pesticide Residues, Kalyani, West Bengal, India.</Affiliation>
      </Author>
      <Author>
        <Name>Tirthankar Banerjee</Name>
        <Affiliation>Bidhan Chandra Krishi Vishwavidyalaya, All India Network Project on Pesticide Residues, Kalyani, West Bengal, India.</Affiliation>
      </Author>
      <Author>
        <Name>Sudip Bhattacharya</Name>
        <Affiliation>Bidhan Chandra Krishi Vishwavidyalaya, All India Network Project on Pesticide Residues, Kalyani, West Bengal, India.</Affiliation>
      </Author>
      <Author>
        <Name>Thomas George</Name>
        <Affiliation>Kerala Agricultural University, All India Network Project on Pesticide Residues, Vellayani, Kerala, India.</Affiliation>
      </Author>
      <Author>
        <Name>Naseema Beevi</Name>
        <Affiliation>Kerala Agricultural University, All India Network Project on Pesticide Residues, Vellayani, Kerala, India.</Affiliation>
      </Author>
      <Author>
        <Name>Khushbu Sharma</Name>
        <Affiliation>Project Coordinating Cell, Pesticide Residue Laboratory, All India Network Project on Pesticide Residues, ICAR-Indian Agricultural Research Institute, New Delhi, India.</Affiliation>
      </Author>
      <Author>
        <Name>Amol Tayade</Name>
        <Affiliation>Project Coordinating Cell, Pesticide Residue Laboratory, All India Network Project on Pesticide Residues, ICAR-Indian Agricultural Research Institute, New Delhi, India.</Affiliation>
      </Author>
      <Author>
        <Name>Madhuban Gopal</Name>
        <Affiliation>Project Coordinating Cell, Pesticide Residue Laboratory, All India Network Project on Pesticide Residues, ICAR-Indian Agricultural Research Institute, New Delhi, India.</Affiliation>
      </Author>
      <Author>
        <Name>Suresh Walia</Name>
        <Affiliation>Project Coordinating Cell, Pesticide Residue Laboratory, All India Network Project on Pesticide Residues, ICAR-Indian Agricultural Research Institute, New Delhi, India.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Derivation of a chronic reference dose for perfluorohexane sulfonate (PFHxS) for reproductive toxicity in mice.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31487490</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30216-8</DOI>
    <KeywordList>
      <Keywords>Perfluorohexane sulfonate</Keywords>
      <Keywords>Perfluorohexane-1-sulfonic acid</Keywords>
      <Keywords>Point of departure</Keywords>
      <Keywords>Reference dose</Keywords>
      <Keywords>Reproductive toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jonathan M. Ali</Name>
        <Affiliation>Permitting and Environmental Health Bureau, New Hampshire Department of Environmental Services, Concord, NH, 03302, USA. Electronic address: jonathan.ali@des.nh.gov.</Affiliation>
      </Author>
      <Author>
        <Name>Stephen M. Roberts</Name>
        <Affiliation>Center for Environmental and Human Toxicology, Department of Physiological Sciences, College of Veterinary Medicine, University of Florida, Gainesville, FL, 32611, USA; Department of Environmental and Global Health, College of Public Health and Health Professions, University of Florida, Gainesville, FL, 32611, USA.</Affiliation>
      </Author>
      <Author>
        <Name>David S. Gordon</Name>
        <Affiliation>Permitting and Environmental Health Bureau, New Hampshire Department of Environmental Services, Concord, NH, 03302, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Leah D. Stuchal</Name>
        <Affiliation>Center for Environmental and Human Toxicology, Department of Physiological Sciences, College of Veterinary Medicine, University of Florida, Gainesville, FL, 32611, USA; Department of Environmental and Global Health, College of Public Health and Health Professions, University of Florida, Gainesville, FL, 32611, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Finding synergies for the 3Rs - Repeated Dose Toxicity testing: Report from an EPAA Partners' Forum.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31479718</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30234-X</DOI>
    <KeywordList>
      <Keywords>Alternatives</Keywords>
      <Keywords>Chemical legislation</Keywords>
      <Keywords>Cross-sector</Keywords>
      <Keywords>In silico</Keywords>
      <Keywords>In vitro</Keywords>
      <Keywords>Integrated Approaches for Testing and Assessment (IATA)</Keywords>
      <Keywords>Repeated dose toxicity testing</Keywords>
      <Keywords>Safety assessment</Keywords>
      <Keywords>Threshold of Toxicological Concern (TTC)</Keywords>
      <Keywords>Weight of Evidence (WoE)</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Charles Laroche</Name>
        <Affiliation>The International Fragrance Association (IFRA) Europe, Geneva, Switzerland; European Partnership for Alternative Approaches to Animal Testing (EPAA), Industry Secretariat, Belgium. Electronic address: charles.laroche@skynet.be.</Affiliation>
      </Author>
      <Author>
        <Name>Erwin Annys</Name>
        <Affiliation>The European Chemical Industry Council (Cefic), Belgium. Electronic address: ean@cefic.be.</Affiliation>
      </Author>
      <Author>
        <Name>Hans Bender</Name>
        <Affiliation>Bonn, Germany. Electronic address: bender.hj@hotmail.de.</Affiliation>
      </Author>
      <Author>
        <Name>Danielle Botelho</Name>
        <Affiliation>RIFM Research Institute for Fragrance Materials (RIFM) Inc., New Jersey, USA. Electronic address: dbotelho@rifm.org.</Affiliation>
      </Author>
      <Author>
        <Name>Phil Botham</Name>
        <Affiliation>Syngenta, Jealott's Hill, Bracknell, Berkshire, RG42 6EY, United Kingdom. Electronic address: phil.botham@syngenta.com.</Affiliation>
      </Author>
      <Author>
        <Name>Susanne Brendler-Schwaab</Name>
        <Affiliation>Federal Institute for Drugs and Medical Devices, Kurt-Georg-Kiesinger-Allee 3, 53175, Bonn, Germany. Electronic address: Susanne.Brendler-Schwaab@bfarm.de.</Affiliation>
      </Author>
      <Author>
        <Name>Rick Clayton</Name>
        <Affiliation>AnimalhealthEurope, Belgium. Electronic address: r.clayton@animalhealtheurope.eu.</Affiliation>
      </Author>
      <Author>
        <Name>Marco Corvaro</Name>
        <Affiliation>Corteva Agriscience, 3B Milton Park Square, Abingdon, Oxfordshire, OX14 4RN, United Kingdom. Electronic address: marco.corvaro@corteva.com.</Affiliation>
      </Author>
      <Author>
        <Name>Gianni Dal Negro</Name>
        <Affiliation>GlaxoSmithKline, United Kingdom. Electronic address: gianni.a.dal-negro@gsk.com.</Affiliation>
      </Author>
      <Author>
        <Name>Frédérique Delannois</Name>
        <Affiliation>GlaxoSmithKline, United Kingdom. Electronic address: frederique.x.delannois@gsk.com.</Affiliation>
      </Author>
      <Author>
        <Name>Matt Dent</Name>
        <Affiliation>SEAC, Unilever, Colworth Science Park, Bedford, MK44 1LQ, United Kingdom. Electronic address: Matthew.dent@unilever.com.</Affiliation>
      </Author>
      <Author>
        <Name>Christian Desaintes</Name>
        <Affiliation>European Commission, The Directorate-General (DG) for Research and Innovation (RTD), Belgium. Electronic address: christian.desaintes@ec.europa.eu.</Affiliation>
      </Author>
      <Author>
        <Name>Bertrand Desprez</Name>
        <Affiliation>Cosmetics Europe - The Personal Care Association, Belgium. Electronic address: BDesprez@cosmeticseurope.eu.</Affiliation>
      </Author>
      <Author>
        <Name>Stephane Dhalluin</Name>
        <Affiliation>L'Oréal Research &amp; Innovation, France. Electronic address: stephane.dhalluin@rd.loreal.com.</Affiliation>
      </Author>
      <Author>
        <Name>Andreas Hartmann</Name>
        <Affiliation>Novartis, Switzerland. Electronic address: andreas.hartmann@novartis.com.</Affiliation>
      </Author>
      <Author>
        <Name>Simone Hoffmann-Doerr</Name>
        <Affiliation>Henkel AG &amp; Co KGaA, Germany. Electronic address: Simone.Hoffmann-Doerr@henkel.com.</Affiliation>
      </Author>
      <Author>
        <Name>Bruno Hubesch</Name>
        <Affiliation>Hubesch Consult BVBA, Belgium. Electronic address: bhu@cefic.be.</Affiliation>
      </Author>
      <Author>
        <Name>Amaia Irizar</Name>
        <Affiliation>The International Fragrance Association (IFRA) Europe, Geneva, Switzerland. Electronic address: airizar@ifraorg.org.</Affiliation>
      </Author>
      <Author>
        <Name>Irene Manou</Name>
        <Affiliation>European Partnership for Alternative Approaches to Animal Testing (EPAA), Industry Secretariat, Belgium. Electronic address: irene.manou@epaaind.eu.</Affiliation>
      </Author>
      <Author>
        <Name>Boris P. Müller</Name>
        <Affiliation>Symrise AG, Mühlenfeldstr. 1, 37603, Holzminden, Germany. Electronic address: boris.mueller@symrise.com.</Affiliation>
      </Author>
      <Author>
        <Name>Stephanie Nadzialek</Name>
        <Affiliation>ECPA - the European Crop Protection Association, Belgium. Electronic address: stephanie.nadzialek@ecpa.eu.</Affiliation>
      </Author>
      <Author>
        <Name>Pilar Prieto</Name>
        <Affiliation>European Commission, Joint Research Centre (JRC), Italy. Electronic address: Pilar.Prieto-Peraita@ec.europa.eu.</Affiliation>
      </Author>
      <Author>
        <Name>Mike Rasenberg</Name>
        <Affiliation>European Chemicals Agency (ECHA), Finland. Electronic address: Mike.RASENBERG@echa.europa.eu.</Affiliation>
      </Author>
      <Author>
        <Name>Rob Roggeband</Name>
        <Affiliation>Procter &amp; Gamble Services NV/SA, Temselaan 100, 1853, Strombeek-Bever, Belgium. Electronic address: roggeband.r@pg.com.</Affiliation>
      </Author>
      <Author>
        <Name>Tim G. Rowan</Name>
        <Affiliation>EPAA Consultant, Cawton, York, United Kingdom. Electronic address: tim_g_rowan@hotmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Katrin Schutte</Name>
        <Affiliation>European Commission, The Directorate-General (DG) Environment (ENV), Belgium. Electronic address: Katrin.SCHUTTE@ec.europa.eu.</Affiliation>
      </Author>
      <Author>
        <Name>Bob van de Water</Name>
        <Affiliation>Division of Drug Discovery and Safety, Leiden Academic Centre for Drug Research (LACDR), Leiden University, the Netherlands. Electronic address: water_b@lacdr.leidenuniv.nl.</Affiliation>
      </Author>
      <Author>
        <Name>Carl Westmoreland</Name>
        <Affiliation>SEAC, Unilever, Colworth Science Park, Bedford, MK44 1LQ, United Kingdom. Electronic address: Carl.Westmoreland@unilever.com.</Affiliation>
      </Author>
      <Author>
        <Name>Maurice Whelan</Name>
        <Affiliation>European Commission, Joint Research Centre (JRC), Italy. Electronic address: Maurice.WHELAN@ec.europa.eu.</Affiliation>
      </Author>
      <Author>
        <Name>Annette Wilschut</Name>
        <Affiliation>Royal DSM N.V., P.O. Box 6500, 6401 JH, Heerlen, the Netherlands. Electronic address: annette.wilschut@dsm.com.</Affiliation>
      </Author>
      <Author>
        <Name>Zvonar Zvonimir</Name>
        <Affiliation>European Partnership for Alternative Approaches to Animal Testing (EPAA), Industry Secretariat, Belgium. Electronic address: zvonar.zvonimir@epaaind.eu.</Affiliation>
      </Author>
      <Author>
        <Name>Mark T. D. Cronin</Name>
        <Affiliation>School of Pharmacy and Biomolecular Sciences, Liverpool John Moores University, Byrom Street, Liverpool, L3 3AF, United Kingdom. Electronic address: m.t.cronin@ljmu.ac.uk.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Comparative levels of carbonyl delivery between mass-market cigars and cigarettes.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31473262</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30217-X</DOI>
    <KeywordList>
      <Keywords>Acetaldehyde</Keywords>
      <Keywords>Acrolein</Keywords>
      <Keywords>Aldehydes</Keywords>
      <Keywords>CORESTA CRM 64</Keywords>
      <Keywords>Cigar</Keywords>
      <Keywords>Cigarillo</Keywords>
      <Keywords>Formaldehyde</Keywords>
      <Keywords>Machine Smoking</Keywords>
      <Keywords>Market Map</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Joseph J. Jablonski</Name>
        <Affiliation>Enthalpy Analytical LLC., Richmond, VA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>J. Hunter Maines</Name>
        <Affiliation>Enthalpy Analytical LLC., Richmond, VA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Andrew G. Cheetham</Name>
        <Affiliation>Enthalpy Analytical LLC., Richmond, VA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>I. Gene Gillman</Name>
        <Affiliation>Enthalpy Analytical LLC., Richmond, VA, USA. Electronic address: gene.gillman@enthalpy.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The food contaminant acetamide is not an in vivo clastogen, aneugen, or mutagen in rodent hematopoietic tissue.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31470077</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30215-6</DOI>
    <KeywordList>
      <Keywords>Genotoxicity</Keywords>
      <Keywords>In vivo micronucleus test</Keywords>
      <Keywords>In vivoPig-A gene mutation assay</Keywords>
      <Keywords>Mutagenicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Martha M. Moore</Name>
        <Affiliation>Ramboll, 23 Alban Lane, Little Rock, AR, 72223, USA. Electronic address: mmmoore@ramboll.com.</Affiliation>
      </Author>
      <Author>
        <Name>Bhaskar Gollapudi</Name>
        <Affiliation>Exponent, 1800 Diagonal Rd Suite 500, Alexandria, VA, 22314, USA. Electronic address: bgollapudi@exponent.com.</Affiliation>
      </Author>
      <Author>
        <Name>Rajendra Nagane</Name>
        <Affiliation>Jai Research Foundation India, NH-8 Near Daman Ganga Bridge Valvada, Vapi, Gujarat, 396 105, India. Electronic address: rajendra.nagane@jrfonline.com.</Affiliation>
      </Author>
      <Author>
        <Name>Nadeem Khan</Name>
        <Affiliation>Jai Research Foundation India, NH-8 Near Daman Ganga Bridge Valvada, Vapi, Gujarat, 396 105, India. Electronic address: Nadeem.khan@jrfonline.com.</Affiliation>
      </Author>
      <Author>
        <Name>Manish Patel</Name>
        <Affiliation>Jai Research Foundation India, NH-8 Near Daman Ganga Bridge Valvada, Vapi, Gujarat, 396 105, India. Electronic address: patelmv@jrfonline.com.</Affiliation>
      </Author>
      <Author>
        <Name>Tushar Khanvilkar</Name>
        <Affiliation>Jai Research Foundation India, NH-8 Near Daman Ganga Bridge Valvada, Vapi, Gujarat, 396 105, India. Electronic address: tushar.khanvilkar@jrfonline.com.</Affiliation>
      </Author>
      <Author>
        <Name>Avani M. Roy</Name>
        <Affiliation>Jai Research Foundation India, NH-8 Near Daman Ganga Bridge Valvada, Vapi, Gujarat, 396 105, India.</Affiliation>
      </Author>
      <Author>
        <Name>E. Ramesh</Name>
        <Affiliation>Eurofins Advinus Limited, Peenya II Phase, Bangalore, 560 058, India. Electronic address: ramesh.e@advinus.com.</Affiliation>
      </Author>
      <Author>
        <Name>Bryan Bals</Name>
        <Affiliation>MBI International, 3815 Technology Blvd, Lansing, MI, 48910, USA. Electronic address: bals@mbi.org.</Affiliation>
      </Author>
      <Author>
        <Name>Farzaneh Teymouri</Name>
        <Affiliation>MBI International, 3815 Technology Blvd, Lansing, MI, 48910, USA. Electronic address: teymouri@mbi.org.</Affiliation>
      </Author>
      <Author>
        <Name>Rance Nault</Name>
        <Affiliation>Department of Biochemistry and Molecular Biology, Institute for Integrative Toxicology, Michigan State University, 1129 Farm Lane Rm 248, East Lansing, MI, 48824, USA. Electronic address: naultran@msu.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Venkataraman Bringi</Name>
        <Affiliation>Department of Chemical Engineering and Materials Science, Michigan State University, 428 S Shaw Lane Rm 2100, East Lansing, MI, 48824, USA. Electronic address: bringi@msu.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Time to first cigarette of the day and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in adult regular and non-daily smokers: (NHANES) 2007-10.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31470076</pubmedLink>
    <GrantList>
      <Grant>R01 CA169070</Grant>
      <Grant>R01 DA026815</Grant>
      <Grant>R01 MD013338</Grant>
    </GrantList>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30218-1</DOI>
    <KeywordList>
      <Keywords>Intermittent smoker</Keywords>
      <Keywords>Multiple mediation</Keywords>
      <Keywords>NHANES</Keywords>
      <Keywords>NNAL</Keywords>
      <Keywords>Nicotine dependence</Keywords>
      <Keywords>Time to first cigarette</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Steven A. Branstetter</Name>
        <Affiliation>Department of Biobehavioral Health, Pennsylvania State University, 219 BBH Bldg., University Park, PA, 16802, USA. Electronic address: sab57@psu.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Russell T. Nye</Name>
        <Affiliation>Department of Biobehavioral Health, Pennsylvania State University, 219 BBH Bldg., University Park, PA, 16802, USA. Electronic address: rtn111@psu.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Joshua E. Muscat</Name>
        <Affiliation>Department of Public Health Sciences, Pennsylvania State University College of Medicine, Hershey, PA, USA. Electronic address: jmuscat@psu.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The ADME profile of the fungicide tricyclazole in rodent via the oral route: A critical review for human health safety assessment.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31461669</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30202-8</DOI>
    <KeywordList>
      <Keywords>ADME</Keywords>
      <Keywords>Comparative metabolism</Keywords>
      <Keywords>Safety assessment</Keywords>
      <Keywords>Tricyclazole</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Marco Corvaro</Name>
        <Affiliation>Dow AgroSciences Ltd - European Development Centre, Milton Park, Abingdon, OX14 4RN, UK. Electronic address: marco.corvaro@corteva.com.</Affiliation>
      </Author>
      <Author>
        <Name>Michael Bartels</Name>
        <Affiliation>ToxMetrics.com LLC, Midland, MI, USA, 48642.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Consumer safety evaluation of pyraclostrobin residues in strawberry using liquid chromatography tandem mass spectrometry (LC-MS/MS): An Egyptian profile.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31449917</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30214-4</DOI>
    <KeywordList>
      <Keywords>Dietary exposure</Keywords>
      <Keywords>LC-MS/MS</Keywords>
      <Keywords>Pyraclostrobin</Keywords>
      <Keywords>Residues</Keywords>
      <Keywords>Strawberry</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Farag Malhat</Name>
        <Affiliation>Pesticide Residues and Environmental Pollution Department, Central Agricultural Pesticide Laboratory, Agricultural Research Center, Dokki, Giza, 12618, Egypt. Electronic address: farag_malhat@yahoo.com.</Affiliation>
      </Author>
      <Author>
        <Name>El Sayed Saber</Name>
        <Affiliation>Pesticide Residues and Environmental Pollution Department, Central Agricultural Pesticide Laboratory, Agricultural Research Center, Dokki, Giza, 12618, Egypt.</Affiliation>
      </Author>
      <Author>
        <Name>Shokr Abd Elsalam Shokr</Name>
        <Affiliation>Pesticide Residues and Environmental Pollution Department, Central Agricultural Pesticide Laboratory, Agricultural Research Center, Dokki, Giza, 12618, Egypt.</Affiliation>
      </Author>
      <Author>
        <Name>Mohamed Tawfic Ahmed</Name>
        <Affiliation>Plant Protection Department, Faculty of Agriculture, Suez Canal University, Ismailia, 41522, Egypt.</Affiliation>
      </Author>
      <Author>
        <Name>Alaa El-Sayed Amin</Name>
        <Affiliation>Chemistry Department, Faculty of Science, Benha University, Benha, Egypt.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Characterization of in vitro Mrp2 transporter model based on intestinal organoids.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31449916</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30213-2</DOI>
    <KeywordList>
      <Keywords>Drug transport</Keywords>
      <Keywords>Intestinal organoids</Keywords>
      <Keywords>Mouse</Keywords>
      <Keywords>Multidrug resistance-associated protein 2 (Mrp2)</Keywords>
      <Keywords>Transporter model</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Lei Zhang</Name>
        <Affiliation>East China Normal University and Shanghai Fengxian District Central Hospital Joint Research Center for Translational Medicine, Shanghai Key laboratory of Regulatory Biology, Institute of Biomedical Sciences and School of Life Sciences, East China Normal University, Shanghai, China; Department of Pharmacy, Shanghai Fengxian District Central Hospital, Shanghai, China.</Affiliation>
      </Author>
      <Author>
        <Name>Chenmeizi Liang</Name>
        <Affiliation>East China Normal University and Shanghai Fengxian District Central Hospital Joint Research Center for Translational Medicine, Shanghai Key laboratory of Regulatory Biology, Institute of Biomedical Sciences and School of Life Sciences, East China Normal University, Shanghai, China.</Affiliation>
      </Author>
      <Author>
        <Name>Peipei Xu</Name>
        <Affiliation>East China Normal University and Shanghai Fengxian District Central Hospital Joint Research Center for Translational Medicine, Shanghai Key laboratory of Regulatory Biology, Institute of Biomedical Sciences and School of Life Sciences, East China Normal University, Shanghai, China.</Affiliation>
      </Author>
      <Author>
        <Name>Mingyao Liu</Name>
        <Affiliation>East China Normal University and Shanghai Fengxian District Central Hospital Joint Research Center for Translational Medicine, Shanghai Key laboratory of Regulatory Biology, Institute of Biomedical Sciences and School of Life Sciences, East China Normal University, Shanghai, China; Department of Molecular and Cellular Medicine, Institute of Biosciences and Technology, Texas A&amp;M University Health Science Center, Houston, TX, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Feng Xu</Name>
        <Affiliation>East China Normal University and Shanghai Fengxian District Central Hospital Joint Research Center for Translational Medicine, Shanghai Key laboratory of Regulatory Biology, Institute of Biomedical Sciences and School of Life Sciences, East China Normal University, Shanghai, China; Department of Pharmacy, Shanghai Fengxian District Central Hospital, Shanghai, China. Electronic address: andrewfxu@sina.com.</Affiliation>
      </Author>
      <Author>
        <Name>Xin Wang</Name>
        <Affiliation>East China Normal University and Shanghai Fengxian District Central Hospital Joint Research Center for Translational Medicine, Shanghai Key laboratory of Regulatory Biology, Institute of Biomedical Sciences and School of Life Sciences, East China Normal University, Shanghai, China. Electronic address: xwang@bio.ecnu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Investigation of quality review issues and the association with application characteristics for new drug applications in first-cycle reviews.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31446093</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30212-0</DOI>
    <KeywordList>
      <Keywords>Food and Drug Administration</Keywords>
      <Keywords>New Drug Applications</Keywords>
      <Keywords>Quality</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jhih Siang Liou</Name>
        <Affiliation>School of Pharmacy, College of Medicine, National Taiwan University, Taipei, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Lin Chau Chang</Name>
        <Affiliation>School of Pharmacy, College of Medicine, National Taiwan University, Taipei, Taiwan. Electronic address: linchauchang@ntu.edu.tw.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Acute and sub-acute oral toxicity studies of standardized extract of Nasturtium officinale in Wistar rats.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31437473</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30207-7</DOI>
    <KeywordList>
      <Keywords>Nasturtium officinale</Keywords>
      <Keywords>Standardized extract</Keywords>
      <Keywords>Watercress</Keywords>
      <Keywords>Wistar rats and toxicological evaluation</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>M. Clemente</Name>
        <Affiliation>Federal University of Parana (UFPR), Brazil. Electronic address: mirnaclemente@yahoo.com.</Affiliation>
      </Author>
      <Author>
        <Name>M. D. Miguel</Name>
        <Affiliation>Federal University of Parana (UFPR), Brazil. Electronic address: dallarmi@ufpr.br.</Affiliation>
      </Author>
      <Author>
        <Name>K. B. Felipe</Name>
        <Affiliation>Federal University of Parana (UFPR), Brazil. Electronic address: karinabettega@ufpr.br.</Affiliation>
      </Author>
      <Author>
        <Name>C. Gribner</Name>
        <Affiliation>Federal University of Parana (UFPR), Brazil. Electronic address: carol_gribner@yhaoo.com.br.</Affiliation>
      </Author>
      <Author>
        <Name>P. F. Moura</Name>
        <Affiliation>Federal University of Parana (UFPR), Brazil. Electronic address: paulafrancislaine19@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>A. G. R. Rigoni</Name>
        <Affiliation>Federal University of Parana (UFPR), Brazil. Electronic address: ana.angelica@ufpr.br.</Affiliation>
      </Author>
      <Author>
        <Name>L. C. Fernandes</Name>
        <Affiliation>Federal University of Parana (UFPR), Brazil. Electronic address: lcfer@ufpr.br.</Affiliation>
      </Author>
      <Author>
        <Name>J. L. S. Carvalho</Name>
        <Affiliation>Federal University of Parana (UFPR), Brazil. Electronic address: fitoanalitica@hotmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>I. Hartmann</Name>
        <Affiliation>Federal University of Parana (UFPR), Brazil. Electronic address: ivo.hartmann@ufpr.br.</Affiliation>
      </Author>
      <Author>
        <Name>M. T. Piltz</Name>
        <Affiliation>Federal University of Parana (UFPR), Brazil. Electronic address: marinapiltz@yahoo.com.br.</Affiliation>
      </Author>
      <Author>
        <Name>R. Henneberg</Name>
        <Affiliation>Federal University of Parana (UFPR), Brazil. Electronic address: railson@ufpr.br.</Affiliation>
      </Author>
      <Author>
        <Name>D. P. Montrucchio</Name>
        <Affiliation>Federal University of Parana (UFPR), Brazil. Electronic address: deisepm@yahoo.com.br.</Affiliation>
      </Author>
      <Author>
        <Name>O. G. Miguel</Name>
        <Affiliation>Federal University of Parana (UFPR), Brazil. Electronic address: obdulio@ufpr.br.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Classification or non-classification of substances with positive tumor findings in animal studies: Guidance by the German MAK commission.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31433998</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30208-9</DOI>
    <KeywordList>
      <Keywords>Abbreviations: CC</Keywords>
      <Keywords>Animal tumor studies</Keywords>
      <Keywords>Carcinogen category</Keywords>
      <Keywords>Carcinogenicity</Keywords>
      <Keywords>Human relevance</Keywords>
      <Keywords>MTD</Keywords>
      <Keywords>Maximally tolerated dose</Keywords>
      <Keywords>Mechanism of tumorigenesis</Keywords>
      <Keywords>Organ-specific tumors</Keywords>
      <Keywords>PPARα</Keywords>
      <Keywords>Peroxisome proliferator activated receptor α</Keywords>
      <Keywords>ROS</Keywords>
      <Keywords>Reactive nitrogen species</Keywords>
      <Keywords>Reactive oxygen species</Keywords>
      <Keywords>Species-specific tumors</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Britta Laube</Name>
        <Affiliation>Scientific Secretariat of the Senate Commission on the Investigation of Health Hazards of Chemical Compounds in the Work Area (MAK Commission), Institute for Applied Biosciences, Karlsruhe Institute of Technology (KIT), Department of Food Chemistry and Toxicology, Karlsruhe, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Sandra Michaelsen</Name>
        <Affiliation>Scientific Secretariat of the Senate Commission on the Investigation of Health Hazards of Chemical Compounds in the Work Area (MAK Commission), Institute for Applied Biosciences, Karlsruhe Institute of Technology (KIT), Department of Food Chemistry and Toxicology, Karlsruhe, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Veronika Meischner</Name>
        <Affiliation>Scientific Secretariat of the Senate Commission on the Investigation of Health Hazards of Chemical Compounds in the Work Area (MAK Commission), Institute for Applied Biosciences, Karlsruhe Institute of Technology (KIT), Department of Food Chemistry and Toxicology, Karlsruhe, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Andrea Hartwig</Name>
        <Affiliation>Food Chemistry and Toxicology, Institute of Applied Bioscience, Karlsruhe Institute of Technology (KIT), Adenauerring 20a, 76131, Karlsruhe, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Bernd Epe</Name>
        <Affiliation>Institute of Pharmacy and Biochemistry, University of Mainz, Staudingerweg 5, D-55099, Mainz, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Michael Schwarz</Name>
        <Affiliation>Dept. of Experimental and Clinical Pharmacology and Toxicology, Dept. Toxicology, Eberhard Karls University, Wilhelmstr. 56, 72074, Tübingen, Germany. Electronic address: michael.schwarz@uni-tuebingen.de.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The 21st Century movement within the area of skin sensitization assessment: From the animal context towards current human-relevant in vitro solutions.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31430506</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30209-0</DOI>
    <KeywordList>
      <Keywords>Adverse outcome pathway</Keywords>
      <Keywords>Hazard assessment</Keywords>
      <Keywords>Human-relevant methods</Keywords>
      <Keywords>Non-animal testing</Keywords>
      <Keywords>Skin safety</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Renato Ivan de Ávila</Name>
        <Affiliation>Laboratory of Education and Research in In Vitro Toxicology (Tox In), Faculty of Pharmacy, Universidade Federal de Goiás, Goiânia, Goiás State, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Malin Lindstedt</Name>
        <Affiliation>Department of Immunotechnology, Medicon Village, Lund University, Lund, Sweden.</Affiliation>
      </Author>
      <Author>
        <Name>Marize Campos Valadares</Name>
        <Affiliation>Laboratory of Education and Research in In Vitro Toxicology (Tox In), Faculty of Pharmacy, Universidade Federal de Goiás, Goiânia, Goiás State, Brazil. Electronic address: marizecv@ufg.br.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Dissipation rates and residue levels of diflubenzuron and difenoconazole on peaches and dietary risk assessment.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31430505</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30211-9</DOI>
    <KeywordList>
      <Keywords>Dietary risk assessment</Keywords>
      <Keywords>Difenoconazole</Keywords>
      <Keywords>Diflubenzuron</Keywords>
      <Keywords>Peach</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Maofeng Dong</Name>
        <Affiliation>Pesticide Safety Evaluation Research Center, Institute for Agro-food Standards and Testing Technology, Shanghai Academy of Agricultural Sciences, Shanghai, 201106, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Lin Ma</Name>
        <Affiliation>Shanghai Agriculture Technical Extension Service Center, Shanghai, 201103, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiuping Zhan</Name>
        <Affiliation>Shanghai Agriculture Technical Extension Service Center, Shanghai, 201103, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Jianbo Chen</Name>
        <Affiliation>Shanghai Agriculture Technical Extension Service Center, Shanghai, 201103, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Lanqi Huang</Name>
        <Affiliation>Shanghai Agriculture Technical Extension Service Center, Shanghai, 201103, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Weimin Wang</Name>
        <Affiliation>Pesticide Safety Evaluation Research Center, Institute for Agro-food Standards and Testing Technology, Shanghai Academy of Agricultural Sciences, Shanghai, 201106, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Li Zhao</Name>
        <Affiliation>Shanghai Agriculture Technical Extension Service Center, Shanghai, 201103, PR China. Electronic address: zhaoli5741@aliyun.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Safety Evaluation of PQ Birch Allergy Immunotherapy to Support Product Development.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31425728</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30205-3</DOI>
    <KeywordList>
      <Keywords>Allergy vaccine</Keywords>
      <Keywords>Birch pollen</Keywords>
      <Keywords>Genotoxicity</Keywords>
      <Keywords>PQ birch</Keywords>
      <Keywords>Toxicology study</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Paul Baldrick</Name>
        <Affiliation>Nonclinical Strategic Product Development, Covance Laboratories Ltd, Otley Road, Harrogate, North Yorkshire, HG3 1PY, England, UK. Electronic address: paul.baldrick@covance.com.</Affiliation>
      </Author>
      <Author>
        <Name>James W. Hutchings</Name>
        <Affiliation>Allergy Therapeutics (UK) Ltd, Dominion Way, Worthing, West Sussex, BN14 8SA, England, UK. Electronic address: James.Hutchings@AllergyTherapeutics.com.</Affiliation>
      </Author>
      <Author>
        <Name>Matthew D. Heath</Name>
        <Affiliation>Allergy Therapeutics (UK) Ltd, Dominion Way, Worthing, West Sussex, BN14 8SA, England, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Murray A. Skinner</Name>
        <Affiliation>Allergy Therapeutics (UK) Ltd, Dominion Way, Worthing, West Sussex, BN14 8SA, England, UK.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Data derived Extrapolation Factors for developmental toxicity: A preliminary research case study with perfluorooctanoate (PFOA).</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31425727</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30210-7</DOI>
    <AuthorList>
      <Author>
        <Name>Michael L. Dourson</Name>
        <Affiliation>Toxicology Excellence for Risk Assessment, Cincinnati, Ohio, USA. Electronic address: dourson@tera.org.</Affiliation>
      </Author>
      <Author>
        <Name>Bernard Gadagbui</Name>
        <Affiliation>Toxicology Excellence for Risk Assessment, Cincinnati, Ohio, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Chijioke Onyema</Name>
        <Affiliation>Toxicology Excellence for Risk Assessment, Cincinnati, Ohio, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Patricia M. McGinnis</Name>
        <Affiliation>Toxicology Excellence for Risk Assessment, Cincinnati, Ohio, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Raymond G. York</Name>
        <Affiliation>RG York and Associates, LLC, Cincinnati, Ohio, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Metabolomics as read-across tool: An example with 3-aminopropanol and 2-aminoethanol.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31421187</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30206-5</DOI>
    <KeywordList>
      <Keywords>Metabolomics</Keywords>
      <Keywords>Read across</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>S. Sperber</Name>
        <Affiliation>BASF SE, Ludwigshafen, Germany. Electronic address: Saskia.sperber@basf.com.</Affiliation>
      </Author>
      <Author>
        <Name>M. Wahl</Name>
        <Affiliation>BASF SE, Ludwigshafen, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>F. Berger</Name>
        <Affiliation>BASF SE, Ludwigshafen, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>H. Kamp</Name>
        <Affiliation>BASF SE, Ludwigshafen, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>O. Lemke</Name>
        <Affiliation>BASF SE, Ludwigshafen, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>V. Starck</Name>
        <Affiliation>BASF SE, Ludwigshafen, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>T. Walk</Name>
        <Affiliation>BASF Metabolome Solutions GmbH, Berlin, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>M. Spitzer</Name>
        <Affiliation>BASF Metabolome Solutions GmbH, Berlin, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>B. V. Ravenzwaay</Name>
        <Affiliation>BASF SE, Ludwigshafen, Germany.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Opinion of the Scientific Committee on Consumer safety (SCCS) - Opinion on the safety of cosmetic ingredient salicylic acid (CAS 69-72-7).</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31401081</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30123-0</DOI>
    <KeywordList>
      <Keywords>CAS 69-72-7</Keywords>
      <Keywords>EC 200-712-3</Keywords>
      <Keywords>Regulation 1223/2009</Keywords>
      <Keywords>SCCS</Keywords>
      <Keywords>SCCS/1601/18</Keywords>
      <Keywords>Salicylic acid</Keywords>
      <Keywords>Scientific opinion</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name> Sccs</Name>
        <Affiliation>SCCS Secretariat at the European Commission, Directorate General for Health and Food Safety, 11, rue E. Ruppert, L-2920, Luxembourg. Electronic address: SANTE-C2-SCCS@ec.europa.eu.</Affiliation>
      </Author>
      <Author>
        <Name>Eirini Panteri</Name>
        <Affiliation>National and Kapodistrian University of Athens, School of Pharmacy, Division of Pharmaceutical Chemistry, Athens, Greece.</Affiliation>
      </Author>
      <Author>
        <Name> </Name>
      </Author>
      <Author>
        <Name> </Name>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Reproductive and developmental toxicity screening of polyhexamethylene guanidine phosphate by oral gavage in rats.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31398363</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30204-1</DOI>
    <KeywordList>
      <Keywords>Humidifier disinfectant</Keywords>
      <Keywords>OECD 421</Keywords>
      <Keywords>Polyhexamethylene guanidine phosphate (PHMG-P)</Keywords>
      <Keywords>Rat</Keywords>
      <Keywords>Repro screening</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jinsoo Lee</Name>
        <Affiliation>Developmental and Reproductive Toxicology Research Group, Korea Institute of Toxicology, Daejeon, Republic of Korea; College of Veterinary Medicine, Chungbuk National University, Cheongju, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Ji Seong Jeong</Name>
        <Affiliation>Developmental and Reproductive Toxicology Research Group, Korea Institute of Toxicology, Daejeon, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Sang Yun Kim</Name>
        <Affiliation>Developmental and Reproductive Toxicology Research Group, Korea Institute of Toxicology, Daejeon, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Wan Jung Im</Name>
        <Affiliation>Toxicological Pathology Research Group, Korea Institute of Toxicology, Daejeon, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Young Jun Shin</Name>
        <Affiliation>Developmental and Reproductive Toxicology Research Group, Korea Institute of Toxicology, Daejeon, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Kyuhong Lee</Name>
        <Affiliation>Inhalation Toxicology Research Group, Korea Institute of Toxicology, Jeongeup, Republic of Korea; Department of Human and Environmental Toxicology, University of Science &amp; Technology, Daejeon, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Seong Jin Choi</Name>
        <Affiliation>Inhalation Toxicology Research Group, Korea Institute of Toxicology, Jeongeup, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Yongju Heo</Name>
        <Affiliation>Inhalation Toxicology Research Group, Korea Institute of Toxicology, Jeongeup, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Eun Ju Jeong</Name>
        <Affiliation>Developmental and Reproductive Toxicology Research Group, Korea Institute of Toxicology, Daejeon, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Sang Yoon Nam</Name>
        <Affiliation>College of Veterinary Medicine, Chungbuk National University, Cheongju, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Wook Joon Yu</Name>
        <Affiliation>Developmental and Reproductive Toxicology Research Group, Korea Institute of Toxicology, Daejeon, Republic of Korea. Electronic address: yuwj@kitox.re.kr.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Letter to the editor regarding the article "Is a combination of assays really needed for non-animal prediction of skin sensitization potential? Performance of the GARD™ (Genomic Allergen Rapid Detection) assay in comparison with OECD guideline assays alone and in combination."</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31394151</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30203-X</DOI>
    <AuthorList>
      <Author>
        <Name>Andy Forreryd</Name>
        <Affiliation>SenzaGen AB, Medicon Village Bldg 401, Scheelevägen 2, 22381, Lund, Sweden. Electronic address: andy.forreryd@senzagen.com.</Affiliation>
      </Author>
      <Author>
        <Name>Henrik Johansson</Name>
        <Affiliation>SenzaGen AB, Medicon Village Bldg 401, Scheelevägen 2, 22381, Lund, Sweden. Electronic address: henrik.johansson@senzagen.com.</Affiliation>
      </Author>
      <Author>
        <Name>Tim Lindberg</Name>
        <Affiliation>Department of Immunotechnology, Lund University, Medicon Village Bldg 406, Scheelevägen 2, 22381, Lund, Sweden. Electronic address: tim.lindberg@immun.lth.se.</Affiliation>
      </Author>
      <Author>
        <Name>Kathrin S. Zeller</Name>
        <Affiliation>Department of Immunotechnology, Lund University, Medicon Village Bldg 406, Scheelevägen 2, 22381, Lund, Sweden. Electronic address: kathrin.zeller@immun.lth.se.</Affiliation>
      </Author>
      <Author>
        <Name>Malin Lindstedt</Name>
        <Affiliation>Department of Immunotechnology, Lund University, Medicon Village Bldg 406, Scheelevägen 2, 22381, Lund, Sweden. Electronic address: malin.lindstedt@immun.lth.se.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Scientific assessments in European food law: Making it future-proof.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31386882</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30201-6</DOI>
    <KeywordList>
      <Keywords>EFSA</Keywords>
      <Keywords>Nutrition</Keywords>
      <Keywords>Nutritional sciences</Keywords>
      <Keywords>Risk assessment</Keywords>
      <Keywords>Risk management</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Alie de Boer</Name>
        <Affiliation>Food Claims Centre Venlo, Campus Venlo, Faculty of Sciences and Engineering, Maastricht University, P.O. Box 8, 5900 AA, Venlo, the Netherlands. Electronic address: a.deboer@maastrichtuniversity.nl.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Comparative pharmacokinetic and biodistribution study of two distinct squalene-containing oil-in-water emulsion adjuvants in H5N1 influenza vaccines.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31381939</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30200-4</DOI>
    <KeywordList>
      <Keywords>AS03</Keywords>
      <Keywords>Lymphatics</Keywords>
      <Keywords>MF59</Keywords>
      <Keywords>Pharmacokinetics</Keywords>
      <Keywords>Pre-pandemic</Keywords>
      <Keywords>Safety</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Million A. Tegenge</Name>
        <Affiliation>Office of Biostatistics &amp; Epidemiology, Center for Biologics Evaluation and Research, FDA, Silver Spring, MD, 20993, USA. Electronic address: million.tegenge@fda.hhs.gov.</Affiliation>
      </Author>
      <Author>
        <Name>Linda S. Von Tungeln</Name>
        <Affiliation>Division of Biochemical Toxicology, National Center for Toxicological Research, FDA, Jefferson, AR, 72079, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Steven A. Anderson</Name>
        <Affiliation>Office of Biostatistics &amp; Epidemiology, Center for Biologics Evaluation and Research, FDA, Silver Spring, MD, 20993, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Robert J. Mitkus</Name>
        <Affiliation>Office of Biostatistics &amp; Epidemiology, Center for Biologics Evaluation and Research, FDA, Silver Spring, MD, 20993, USA; Current Address: BASF Corporation, 26 Davis Drive, Durham, NC, 27709, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Michelle M. Vanlandingham</Name>
        <Affiliation>Division of Biochemical Toxicology, National Center for Toxicological Research, FDA, Jefferson, AR, 72079, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Richard A. Forshee</Name>
        <Affiliation>Office of Biostatistics &amp; Epidemiology, Center for Biologics Evaluation and Research, FDA, Silver Spring, MD, 20993, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Frederick A. Beland</Name>
        <Affiliation>Division of Biochemical Toxicology, National Center for Toxicological Research, FDA, Jefferson, AR, 72079, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Elemental impurities in pharmaceutical products adding fuel to the fire.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31376414</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30199-0</DOI>
    <KeywordList>
      <Keywords>Analytical method</Keywords>
      <Keywords>Elemental impurities</Keywords>
      <Keywords>Formulations</Keywords>
      <Keywords>Guidelines</Keywords>
      <Keywords>Pharmaceutical</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>M. Maithani</Name>
        <Affiliation>Multidisciplinary Research Unit, University Centre of Excellence in Research, Baba Farid University of Health Sciences, Faridkot, 151203, Punjab, India.</Affiliation>
      </Author>
      <Author>
        <Name>R. Raturi</Name>
        <Affiliation>Multidisciplinary Research Unit, University Centre of Excellence in Research, Baba Farid University of Health Sciences, Faridkot, 151203, Punjab, India.</Affiliation>
      </Author>
      <Author>
        <Name>P. Sharma</Name>
        <Affiliation>Multidisciplinary Research Unit, University Centre of Excellence in Research, Baba Farid University of Health Sciences, Faridkot, 151203, Punjab, India.</Affiliation>
      </Author>
      <Author>
        <Name>V. Gupta</Name>
        <Affiliation>Multidisciplinary Research Unit, University Centre of Excellence in Research, Baba Farid University of Health Sciences, Faridkot, 151203, Punjab, India.</Affiliation>
      </Author>
      <Author>
        <Name>P. Bansal</Name>
        <Affiliation>Multidisciplinary Research Unit, University Centre of Excellence in Research, Baba Farid University of Health Sciences, Faridkot, 151203, Punjab, India. Electronic address: ucer_bfuhs@rediffmail.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Towards quantitative read across: Prediction of Ames mutagenicity in a large database.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31374229</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30198-9</DOI>
    <KeywordList>
      <Keywords>Alternative methods</Keywords>
      <Keywords>Ames test</Keywords>
      <Keywords>Computational toxicology</Keywords>
      <Keywords>Human health</Keywords>
      <Keywords>In silico</Keywords>
      <Keywords>Mutagenicity</Keywords>
      <Keywords>Predictive toxicology</Keywords>
      <Keywords>QSAR</Keywords>
      <Keywords>Read across</Keywords>
      <Keywords>Regulation</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Romualdo Benigni</Name>
        <Affiliation>Alpha-Pretox, Via Giovanni Pascoli 1, 00184, Rome, Italy. Electronic address: romualdo.benigni@gmail.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Nonclinical safety assessment of PF614: A novel TAAP prodrug of oxycodone for chronic pain indication.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31362032</pubmedLink>
    <GrantList>
      <Grant>HHSN261200800001C</Grant>
      <Grant>HHSN261200800001E</Grant>
    </GrantList>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30197-7</DOI>
    <KeywordList>
      <Keywords>Oxycodone</Keywords>
      <Keywords>PF614</Keywords>
      <Keywords>Prodrug</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>P. S. Joshi</Name>
        <Affiliation>National Center for Advancing Translational Sciences, Bethesda, MD, United States.</Affiliation>
      </Author>
      <Author>
        <Name>N. Sanakkayala</Name>
        <Affiliation>Covance Laboratories, Inc., 3301 Kinsman Blvd., Madison, WI, United States.</Affiliation>
      </Author>
      <Author>
        <Name>L. Kirkpatrick</Name>
        <Affiliation>Ensysce Biosciences Inc., San Diego, CA, United States.</Affiliation>
      </Author>
      <Author>
        <Name>P. S. Terse</Name>
        <Affiliation>National Center for Advancing Translational Sciences, Bethesda, MD, United States. Electronic address: tersep@mail.nih.gov.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Can be the health risk from consumption of unrecorded fruit spirits containing alcohols other than ethanol ruled out?</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31336129</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30195-3</DOI>
    <KeywordList>
      <Keywords>Heavy episodic drinking</Keywords>
      <Keywords>Higher alcohols</Keywords>
      <Keywords>Margin of exposure risk assessment</Keywords>
      <Keywords>Methanol</Keywords>
      <Keywords>Unrecorded fruit spirits</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Orsolya Bujdosó</Name>
        <Affiliation>Department of Preventive Medicine, Faculty of Public Health, University of Debrecen, Debrecen, Hungary. Electronic address: bujdoso.orsolya@sph.unideb.hu.</Affiliation>
      </Author>
      <Author>
        <Name>László Pál</Name>
        <Affiliation>Department of Preventive Medicine, Faculty of Public Health, University of Debrecen, Debrecen, Hungary. Electronic address: pal.laszlo@sph.unideb.hu.</Affiliation>
      </Author>
      <Author>
        <Name>Attila Nagy</Name>
        <Affiliation>Department of Preventive Medicine, Faculty of Public Health, University of Debrecen, Debrecen, Hungary. Electronic address: nagy.attila@sph.unideb.hu.</Affiliation>
      </Author>
      <Author>
        <Name>Ervin Árnyas</Name>
        <Affiliation>Department of Preventive Medicine, Faculty of Public Health, University of Debrecen, Debrecen, Hungary. Electronic address: arnyaser@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Róza Ádány</Name>
        <Affiliation>Department of Preventive Medicine, Faculty of Public Health, University of Debrecen, Debrecen, Hungary; MTA-DE Public Health Research Group of Hungarian Academy of Sciences, University of Debrecen, Debrecen, Hungary. Electronic address: adany.roza@sph.unideb.hu.</Affiliation>
      </Author>
      <Author>
        <Name>János Sándor</Name>
        <Affiliation>Department of Preventive Medicine, Faculty of Public Health, University of Debrecen, Debrecen, Hungary. Electronic address: sandor.janos@sph.unideb.hu.</Affiliation>
      </Author>
      <Author>
        <Name>Martin McKee</Name>
        <Affiliation>European Centre on Health of Societies in Transition, London School of Hygiene and Tropical Medicine, London, United Kingdom. Electronic address: martin.mckee@lshtm.ac.uk.</Affiliation>
      </Author>
      <Author>
        <Name>Sándor Szűcs</Name>
        <Affiliation>Department of Preventive Medicine, Faculty of Public Health, University of Debrecen, Debrecen, Hungary. Electronic address: szucs.sandor@sph.unideb.hu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Exaggeration of health risk of congener alcohols in unrecorded alcohol: does this mislead alcohol policy efforts?</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31336128</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30196-5</DOI>
    <KeywordList>
      <Keywords>Alcohol consumption</Keywords>
      <Keywords>Higher alcohols</Keywords>
      <Keywords>Methanol</Keywords>
      <Keywords>Risk assessment</Keywords>
      <Keywords>Unrecorded alcohol</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Dirk W. Lachenmeier</Name>
        <Affiliation>Chemisches und Veterinäruntersuchungsamt (CVUA) Karlsruhe, Weissenburger Strasse 3, 76187, Karlsruhe, Germany. Electronic address: Lachenmeier@web.de.</Affiliation>
      </Author>
      <Author>
        <Name>Stephan G. Walch</Name>
        <Affiliation>Chemisches und Veterinäruntersuchungsamt (CVUA) Karlsruhe, Weissenburger Strasse 3, 76187, Karlsruhe, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Jürgen Rehm</Name>
        <Affiliation>Institute for Mental Health Policy Research, Centre for Addiction and Mental Health, 33 Russell Street, Toronto, Ontario, Canada, M5S 2S1; Department of Psychiatry, University of Toronto, 250 College Street, Toronto, Ontario, M5T 1R8, Canada; Dalla Lana School of Public Health, University of Toronto, 155 College St, Toronto, Ontario, M5T 3M7, Canada; Institute of Medical Science, University of Toronto, 1 King's College Circle, Toronto, Ontario, M5S 1A8, Canada; Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, 33 Russell Street, Toronto, Ontario, M5S 2S1, Canada; Institute of Clinical Psychology and Psychotherapy &amp; Center for Clinical Epidemiology and Longitudinal Studies, Technische Universität Dresden, Chemnitzer Str. 46, D-01187, Dresden, Germany; Department of International Health Projects, Institute for Leadership and Health Management, I.M. Sechenov First Moscow State Medical University, Trubetskaya Str., 8, b. 2, 119992, Moscow, Russian Federation.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Integrated in silico and in vitro genotoxicity assessment of thirteen data-poor substances.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31336127</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30191-6</DOI>
    <KeywordList>
      <Keywords>Ames assay</Keywords>
      <Keywords>Anthraquinones</Keywords>
      <Keywords>Benchmark dose</Keywords>
      <Keywords>Genetic toxicology</Keywords>
      <Keywords>Micronucleus assay</Keywords>
      <Keywords>QSAR</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Yen K. Tran</Name>
        <Affiliation>Environmental Health Science and Research Bureau, Health Canada, Ottawa, Ontario, K1A 0K9, Canada; Department of Biology, Carleton University, Ottawa, Ontario, K1S 5B6, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Julie K. Buick</Name>
        <Affiliation>Environmental Health Science and Research Bureau, Health Canada, Ottawa, Ontario, K1A 0K9, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Jennifer L. A. Keir</Name>
        <Affiliation>Environmental Health Science and Research Bureau, Health Canada, Ottawa, Ontario, K1A 0K9, Canada; Department of Biology, University of Ottawa, Ottawa, Ontario, K1N 6N5, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Andrew Williams</Name>
        <Affiliation>Environmental Health Science and Research Bureau, Health Canada, Ottawa, Ontario, K1A 0K9, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Carol D. Swartz</Name>
        <Affiliation>Integrated Laboratory Systems Inc., Research Triangle Park, Durham, NC, 27709, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Leslie Recio</Name>
        <Affiliation>Integrated Laboratory Systems Inc., Research Triangle Park, Durham, NC, 27709, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Paul A. White</Name>
        <Affiliation>Environmental Health Science and Research Bureau, Health Canada, Ottawa, Ontario, K1A 0K9, Canada; Department of Biology, University of Ottawa, Ottawa, Ontario, K1N 6N5, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Iain B. Lambert</Name>
        <Affiliation>Department of Biology, Carleton University, Ottawa, Ontario, K1S 5B6, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Carole L. Yauk</Name>
        <Affiliation>Environmental Health Science and Research Bureau, Health Canada, Ottawa, Ontario, K1A 0K9, Canada; Department of Biology, Carleton University, Ottawa, Ontario, K1S 5B6, Canada. Electronic address: carole.yauk@canada.ca.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Control performance of fish short term reproduction assays with fathead minnow (Pimephales promelas).</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31330157</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30188-6</DOI>
    <KeywordList>
      <Keywords>Fathead minnow</Keywords>
      <Keywords>Fish short-term reproduction assay</Keywords>
      <Keywords>Historical control data</Keywords>
      <Keywords>Statistical power</Keywords>
      <Keywords>Variability</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>James R. Wheeler</Name>
        <Affiliation>Corteva Agriscience™, Agriculture Division of DowDuPont™, 3B Park Square, Milton Park, Abingdon, Oxfordshire, OX14 4RN, UK. Electronic address: James.Wheeler2@shell.com.</Affiliation>
      </Author>
      <Author>
        <Name>Pablo Valverde-Garcia</Name>
        <Affiliation>Corteva Agriscience™, Agriculture Division of DowDuPont™, 9330 Zionsville Road, Indianapolis, IN, 46268, USA. Electronic address: ppvalverde@dow.com.</Affiliation>
      </Author>
      <Author>
        <Name>Mark Crane</Name>
        <Affiliation>AG-HERA, 23 London Street, Faringdon, SN7 7AG, UK. Electronic address: mark.crane@ag-hera.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Percutaneous penetration of drugs applied in transdermal delivery systems: an in vivo based approach for evaluating computer generated penetration models.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31326435</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30192-8</DOI>
    <KeywordList>
      <Keywords>Human</Keywords>
      <Keywords>In vivo</Keywords>
      <Keywords>Mathematical models</Keywords>
      <Keywords>Percutaneous penetration</Keywords>
      <Keywords>QSAR</Keywords>
      <Keywords>Skin absorption</Keywords>
      <Keywords>Transdermal delivery system</Keywords>
      <Keywords>Transdermal patches</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Anne J. Keurentjes</Name>
        <Affiliation>Department of Dermatology, Maibach Laboratory, University of California, San Francisco, 2340 Sutter Street, San Francisco, CA, 94115, USA. Electronic address: ajkeurentjes@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Howard I. Maibach</Name>
        <Affiliation>Department of Dermatology, Maibach Laboratory, University of California, San Francisco, 2340 Sutter Street, San Francisco, CA, 94115, USA. Electronic address: Howard.Maibach@ucsf.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Determination of offspring NOAEL for zeta-cypermethrin using internal exposure data from rat developmental neurotoxicity studies.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31325535</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30189-8</DOI>
    <KeywordList>
      <Keywords>Developmental neurotoxicity</Keywords>
      <Keywords>No-observed-adverse-effect level</Keywords>
      <Keywords>Pyrethroids</Keywords>
      <Keywords>Toxicokinetics</Keywords>
      <Keywords>Zeta-cypermethrin</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Zhiwei Liu</Name>
        <Affiliation>FMC Corporation, Stine Research Center, 1090 Elkton Rd, Newark, DE, 19711, USA. Electronic address: zhiwei.liu@fmc.com.</Affiliation>
      </Author>
      <Author>
        <Name>Appavu Chandrasekaran</Name>
        <Affiliation>FMC Corporation, Stine Research Center, 1090 Elkton Rd, Newark, DE, 19711, USA.</Affiliation>
      </Author>
      <Author>
        <Name>John M. Becker</Name>
        <Affiliation>FMC Corporation, Stine Research Center, 1090 Elkton Rd, Newark, DE, 19711, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Acute oral toxicity and repeated dose 28-day oral toxicity studies of MIL-101 nanoparticles.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31325534</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30190-4</DOI>
    <KeywordList>
      <Keywords>28-Day oral toxicity</Keywords>
      <Keywords>Acute oral toxicity</Keywords>
      <Keywords>Evaluation</Keywords>
      <Keywords>Nanoparticle</Keywords>
      <Keywords>Safety</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Chia Hung Liu</Name>
        <Affiliation>Institute of Toxicology, College of Medicine, National Taiwan University, Taipei, Taiwan; Department of Urology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan; Department of Urology, Shuang Ho Hospital, Taipei Medical University, New Taipei City, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Hsien Chun Chiu</Name>
        <Affiliation>Institute of Toxicology, College of Medicine, National Taiwan University, Taipei, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Hsiang Ling Sung</Name>
        <Affiliation>Department of Chemical Engineering, National Taiwan University, Taipei, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Jyun Yi Yeh</Name>
        <Affiliation>Department of Chemical Engineering, National Taiwan University, Taipei, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Kevin C. W. Wu</Name>
        <Affiliation>Department of Chemical Engineering, National Taiwan University, Taipei, Taiwan; Division of Medical Engineering Research, National Health Research Institutes, Miaoli County, Taiwan; Center of Atomic Initiative for New Materials (AI-MAT), National Taiwan University, Taipei, Taiwan; International Graduate Program of Molecular Science and Technology, National Taiwan University (NTU-MST), Taipei, Taiwan. Electronic address: kevinwu@ntu.edu.tw.</Affiliation>
      </Author>
      <Author>
        <Name>Shing Hwa Liu</Name>
        <Affiliation>Institute of Toxicology, College of Medicine, National Taiwan University, Taipei, Taiwan; Department of Medical Research, China Medical University Hospital, China Medical University, Taichung, Taiwan; Department of Pediatrics, College of Medicine, National Taiwan University, Taipei, Taiwan. Electronic address: shinghwaliu@ntu.edu.tw.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Statistical analysis of the reproducibility and predictive capacity of MCTT HCE™ eye irritation test, a me-too test method for OECD TG 492.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31325533</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30194-1</DOI>
    <KeywordList>
      <Keywords>Bland-Altman</Keywords>
      <Keywords>Bootstrapping resampling</Keywords>
      <Keywords>Intra-class correlation coefficient</Keywords>
      <Keywords>MCTT HCE™ eye irritation test</Keywords>
      <Keywords>OECD TG 492</Keywords>
      <Keywords>Predictive capacity</Keywords>
      <Keywords>Reproducibility</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Song E. Lim</Name>
        <Affiliation>College of Pharmacy, Ewha Womans University, Seoul, 03760, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Donghwan Lee</Name>
        <Affiliation>Department of Statistics, Ewha Womans University, Seoul, 03760, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>SeungJin Bae</Name>
        <Affiliation>College of Pharmacy, Ewha Womans University, Seoul, 03760, Republic of Korea. Electronic address: sjbae@ewha.ac.kr.</Affiliation>
      </Author>
      <Author>
        <Name>Kyung Min Lim</Name>
        <Affiliation>College of Pharmacy, Ewha Womans University, Seoul, 03760, Republic of Korea. Electronic address: kmlim@ewha.ac.kr.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>An FDA oncology analysis of toxicities associated with PBD-containing antibody-drug conjugates.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31325532</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30193-X</DOI>
    <KeywordList>
      <Keywords>Antibody-drug conjugate</Keywords>
      <Keywords>First-in-human dose selection</Keywords>
      <Keywords>Oncology drug development</Keywords>
      <Keywords>Pyrrolobenzodiazepine</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Haleh Saber</Name>
        <Affiliation>US Food and Drug Administration, Center for Drug Evaluation and Research, Office of Hematology and Oncology Products, 10903 New Hampshire Ave, Silver Spring, MD, 20903, United States. Electronic address: haleh.saber@fda.hhs.gov.</Affiliation>
      </Author>
      <Author>
        <Name>Natalie Simpson</Name>
        <Affiliation>US Food and Drug Administration, Center for Drug Evaluation and Research, Office of Hematology and Oncology Products, 10903 New Hampshire Ave, Silver Spring, MD, 20903, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Tiffany K. Ricks</Name>
        <Affiliation>US Food and Drug Administration, Center for Drug Evaluation and Research, Office of Hematology and Oncology Products, 10903 New Hampshire Ave, Silver Spring, MD, 20903, United States.</Affiliation>
      </Author>
      <Author>
        <Name>John K. Leighton</Name>
        <Affiliation>US Food and Drug Administration, Center for Drug Evaluation and Research, Office of Hematology and Oncology Products, 10903 New Hampshire Ave, Silver Spring, MD, 20903, United States.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Allergenicity prediction of novel and modified proteins: Not a mission impossible! Development of a Random Forest allergenicity prediction model.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31310847</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30186-2</DOI>
    <KeywordList>
      <Keywords>Allergenicity assessment</Keywords>
      <Keywords>Allergenicity prediction</Keywords>
      <Keywords>Food allergy</Keywords>
      <Keywords>Novel and modified proteins</Keywords>
      <Keywords>Random forest</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Joost Westerhout</Name>
        <Affiliation>TNO, Utrechtseweg 48, Zeist, the Netherlands. Electronic address: joost.westerhout@tno.nl.</Affiliation>
      </Author>
      <Author>
        <Name>Tanja Krone</Name>
        <Affiliation>TNO, Utrechtseweg 48, Zeist, the Netherlands. Electronic address: Tanja.Krone@tno.nl.</Affiliation>
      </Author>
      <Author>
        <Name>Almar Snippe</Name>
        <Affiliation>TNO, Utrechtseweg 48, Zeist, the Netherlands. Electronic address: Almar.snippe@tno.nl.</Affiliation>
      </Author>
      <Author>
        <Name>Lilia Babé</Name>
        <Affiliation>DuPont Nutrition and Biosciences, Palo Alto, CA, 94304, USA. Electronic address: Lilia.Babe@dupont.com.</Affiliation>
      </Author>
      <Author>
        <Name>Scott McClain</Name>
        <Affiliation>Syngenta Crop Protection, LLC, Research Triangle Park, NC, 27709, USA. Electronic address: scott.mcclain@syngenta.com.</Affiliation>
      </Author>
      <Author>
        <Name>Gregory S. Ladics</Name>
        <Affiliation>DuPont Nutrition and Biosciences, Wilmington, DE, 19880, USA. Electronic address: Gregory.S.Ladics@dupont.com.</Affiliation>
      </Author>
      <Author>
        <Name>Geert F. Houben</Name>
        <Affiliation>TNO, Utrechtseweg 48, Zeist, the Netherlands. Electronic address: Geert.houben@tno.nl.</Affiliation>
      </Author>
      <Author>
        <Name>Kitty Cm Verhoeckx</Name>
        <Affiliation>TNO, Utrechtseweg 48, Zeist, the Netherlands. Electronic address: Kitty.verhoeckx@tno.nl.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Use of social media to establish vapers puffing behaviour: Findings and implications for laboratory evaluation of e-cigarette emissions.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31310846</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30187-4</DOI>
    <KeywordList>
      <Keywords>E-cigarettes</Keywords>
      <Keywords>Laboratory studies</Keywords>
      <Keywords>Puffing behaviour</Keywords>
      <Keywords>Social media</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Kevin McAdam</Name>
        <Affiliation>Research &amp; Development Centre, British American Tobacco, Regents Park Road, Southampton, SO15 8TL, UK. Electronic address: Kevin@mcadamscience.com.</Affiliation>
      </Author>
      <Author>
        <Name>Anna Warrington</Name>
        <Affiliation>Research &amp; Development Centre, British American Tobacco, Regents Park Road, Southampton, SO15 8TL, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Alice Hughes</Name>
        <Affiliation>Research &amp; Development Centre, British American Tobacco, Regents Park Road, Southampton, SO15 8TL, UK.</Affiliation>
      </Author>
      <Author>
        <Name>David Adams</Name>
        <Affiliation>Research &amp; Development Centre, British American Tobacco, Regents Park Road, Southampton, SO15 8TL, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Jennifer Margham</Name>
        <Affiliation>Research &amp; Development Centre, British American Tobacco, Regents Park Road, Southampton, SO15 8TL, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Carl Vas</Name>
        <Affiliation>Research &amp; Development Centre, British American Tobacco, Regents Park Road, Southampton, SO15 8TL, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Pete Davis</Name>
        <Affiliation>Research &amp; Development Centre, British American Tobacco, Regents Park Road, Southampton, SO15 8TL, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Sandra Costigan</Name>
        <Affiliation>Research &amp; Development Centre, British American Tobacco, Regents Park Road, Southampton, SO15 8TL, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Christopher Proctor</Name>
        <Affiliation>Research &amp; Development Centre, British American Tobacco, Regents Park Road, Southampton, SO15 8TL, UK.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A weight of evidence approach to investigate potential common mechanisms in pesticide groups to support cumulative risk assessment: A case study with dinitroaniline pesticides.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31301330</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30183-7</DOI>
    <KeywordList>
      <Keywords>Chemical descriptors</Keywords>
      <Keywords>Chemical structure</Keywords>
      <Keywords>Dinitroaniline</Keywords>
      <Keywords>Fungicide</Keywords>
      <Keywords>Herbicide</Keywords>
      <Keywords>Mode of action</Keywords>
      <Keywords>Weight of evidence</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jeremy A. Leonard</Name>
        <Affiliation>Oak Ridge Institute for Science and Education, Oak Ridge, TN, 37831, United States. Electronic address: leonard.jeremy@epa.gov.</Affiliation>
      </Author>
      <Author>
        <Name>Mark Nelms</Name>
        <Affiliation>Oak Ridge Institute for Science and Education, Oak Ridge, TN, 37831, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Evisabel Craig</Name>
        <Affiliation>Office of Pesticide Programs, United States Environmental Protection Agency, Washington, DC, 20460, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Monique Perron</Name>
        <Affiliation>Office of Pesticide Programs, United States Environmental Protection Agency, Washington, DC, 20460, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Hannah Pope-Varsalona</Name>
        <Affiliation>Office of Pesticide Programs, United States Environmental Protection Agency, Washington, DC, 20460, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Sarah Dobreniecki</Name>
        <Affiliation>Office of Pesticide Programs, United States Environmental Protection Agency, Washington, DC, 20460, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Anna Lowit</Name>
        <Affiliation>Office of Pesticide Programs, United States Environmental Protection Agency, Washington, DC, 20460, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Yu Mei Tan</Name>
        <Affiliation>Office of Pesticide Programs, United States Environmental Protection Agency, Washington, DC, 20460, United States.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>An investigation of the acute central nervous system effects of n-decane.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31299268</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30185-0</DOI>
    <KeywordList>
      <Keywords>Acute toxicity</Keywords>
      <Keywords>Central nervous system effects</Keywords>
      <Keywords>Hydrocarbon solvents</Keywords>
      <Keywords>Occupational exposure limits</Keywords>
      <Keywords>n-Decane</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Richard H. McKee</Name>
        <Affiliation>ExxonMobil Biomedical Sciences, Inc, Annandale, NJ, USA. Electronic address: Richardmckee3@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Craig S. Nessel</Name>
        <Affiliation>ExxonMobil Biomedical Sciences, Inc, Annandale, NJ, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Juan Carlos Carrillo</Name>
        <Affiliation>Shell International, the Hague, the Netherlands.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Comparative pharmacokinetics of tedizolid in rat plasma and cerebrospinal fluid.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31295511</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30184-9</DOI>
    <KeywordList>
      <Keywords>Blood brain barrier (BBB)</Keywords>
      <Keywords>Cerebrospinal fluid (CSF)</Keywords>
      <Keywords>LC-MS/MS</Keywords>
      <Keywords>Plasma</Keywords>
      <Keywords>Tedizolid</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Liqiang Gu</Name>
        <Affiliation>College of Pharmaceutical Science, Zhejiang Chinese Medical University, 548 Binwen Road, Binjiang district, Hangzhou, 310053, China; Center of Safety Evaluation, Zhejiang Academy of Medical Sciences, 587 Binkang Road, Binjiang district, Hangzhou, 310053, China.</Affiliation>
      </Author>
      <Author>
        <Name>Munong Ma</Name>
        <Affiliation>College of Pharmaceutical Science, Zhejiang Chinese Medical University, 548 Binwen Road, Binjiang district, Hangzhou, 310053, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yuan Zhang</Name>
        <Affiliation>Department of Pharmacy, The third people's Hospital of Xiaoshan District, Hangzhou, 311251, China.</Affiliation>
      </Author>
      <Author>
        <Name>Lijiang Zhang</Name>
        <Affiliation>Center of Safety Evaluation, Zhejiang Academy of Medical Sciences, 587 Binkang Road, Binjiang district, Hangzhou, 310053, China.</Affiliation>
      </Author>
      <Author>
        <Name>Sheng Zhang</Name>
        <Affiliation>Center of Safety Evaluation, Zhejiang Academy of Medical Sciences, 587 Binkang Road, Binjiang district, Hangzhou, 310053, China.</Affiliation>
      </Author>
      <Author>
        <Name>Mincong Huang</Name>
        <Affiliation>Center of Safety Evaluation, Zhejiang Academy of Medical Sciences, 587 Binkang Road, Binjiang district, Hangzhou, 310053, China.</Affiliation>
      </Author>
      <Author>
        <Name>Majuan Zhang</Name>
        <Affiliation>Center of Safety Evaluation, Zhejiang Academy of Medical Sciences, 587 Binkang Road, Binjiang district, Hangzhou, 310053, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yanfei Xin</Name>
        <Affiliation>Center of Safety Evaluation, Zhejiang Academy of Medical Sciences, 587 Binkang Road, Binjiang district, Hangzhou, 310053, China.</Affiliation>
      </Author>
      <Author>
        <Name>Gaoli Zheng</Name>
        <Affiliation>Center of Safety Evaluation, Zhejiang Academy of Medical Sciences, 587 Binkang Road, Binjiang district, Hangzhou, 310053, China. Electronic address: 13255810206@163.com.</Affiliation>
      </Author>
      <Author>
        <Name>Suhong Chen</Name>
        <Affiliation>College of Pharmaceutical Science, Zhejiang Chinese Medical University, 548 Binwen Road, Binjiang district, Hangzhou, 310053, China; Collaborative Innovation Center of Yangtze River Delta Region Green Pharmaceuticals, Zhejiang University of Technology, Hangzhou, 310014, China. Electronic address: chensuhong@aliyun.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Low-level radon exposure and lung cancer mortality.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31278959</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30182-5</DOI>
    <KeywordList>
      <Keywords>Causal inference</Keywords>
      <Keywords>Fair comparisons</Keywords>
      <Keywords>Local control strategy</Keywords>
      <Keywords>Observational data</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Robert Obenchain</Name>
        <Affiliation>Risk Benefit Statistics LLC, Indianapolis, IN, 46250, USA.</Affiliation>
      </Author>
      <Author>
        <Name>S. Stanley Young</Name>
        <Affiliation>CGStat, Raleigh, NC, 27607, USA. Electronic address: genetree@bellsouth.net.</Affiliation>
      </Author>
      <Author>
        <Name>Goran Krstic</Name>
        <Affiliation>Fraser Health Authority, New Westminster, BC, Canada.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Next tier in vitro and in vivo nonclinical studies further elucidating the safety and toxicity profile of MB-102, a novel fluorescent tracer agent for measurement of glomerular filtration rate.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31276731</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30181-3</DOI>
    <KeywordList>
      <Keywords>Fluorescence</Keywords>
      <Keywords>Fluorescent tracer agent</Keywords>
      <Keywords>Glomerular filtration rate</Keywords>
      <Keywords>Optical monitoring</Keywords>
      <Keywords>Preclinical evaluation</Keywords>
      <Keywords>Pyrazine</Keywords>
      <Keywords>Renal clearance</Keywords>
      <Keywords>Renal function</Keywords>
      <Keywords>Safety and toxicity profile</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Richard B. Dorshow</Name>
        <Affiliation>MediBeacon Inc., 1100 Corporate Square Drive, St. Louis, Missouri, 63132, USA. Electronic address: rbdorshow@medibeacon.com.</Affiliation>
      </Author>
      <Author>
        <Name>Joseph E. Bugaj</Name>
        <Affiliation>MediBeacon Inc., 1100 Corporate Square Drive, St. Louis, Missouri, 63132, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Residue behavior and dietary risk assessment of chlorothalonil and its metabolite SDS-3701 in water spinach to propose maximum residue limit (MRL).</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31265862</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30180-1</DOI>
    <KeywordList>
      <Keywords>Chlorothalonil</Keywords>
      <Keywords>MRL</Keywords>
      <Keywords>Risk assessment</Keywords>
      <Keywords>SDS-3701</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Hongfang Lin</Name>
        <Affiliation>Laboratory of Pesticide Residues and Environmental Toxicology, School of Chemistry and Biological Engineering School of Chemistry and Biological Engineering, University of Science and Technology Beijing, Beijing, 100083, PR China. Electronic address: hongfanglin1991@163.com.</Affiliation>
      </Author>
      <Author>
        <Name>Shengming Zhao</Name>
        <Affiliation>Laboratory of Pesticide Residues and Environmental Toxicology, School of Chemistry and Biological Engineering School of Chemistry and Biological Engineering, University of Science and Technology Beijing, Beijing, 100083, PR China. Electronic address: ustbzsm@163.com.</Affiliation>
      </Author>
      <Author>
        <Name>Xueqi Fan</Name>
        <Affiliation>Laboratory of Pesticide Residues and Environmental Toxicology, School of Chemistry and Biological Engineering School of Chemistry and Biological Engineering, University of Science and Technology Beijing, Beijing, 100083, PR China. Electronic address: fanxueqi333@163.com.</Affiliation>
      </Author>
      <Author>
        <Name>Yecheng Ma</Name>
        <Affiliation>Laboratory of Pesticide Residues and Environmental Toxicology, School of Chemistry and Biological Engineering School of Chemistry and Biological Engineering, University of Science and Technology Beijing, Beijing, 100083, PR China. Electronic address: myc19930309@163.com.</Affiliation>
      </Author>
      <Author>
        <Name>Xingling Wu</Name>
        <Affiliation>Laboratory of Pesticide Residues and Environmental Toxicology, School of Chemistry and Biological Engineering School of Chemistry and Biological Engineering, University of Science and Technology Beijing, Beijing, 100083, PR China. Electronic address: wxlingd8062@163.com.</Affiliation>
      </Author>
      <Author>
        <Name>Yue Su</Name>
        <Affiliation>Laboratory of Pesticide Residues and Environmental Toxicology, School of Chemistry and Biological Engineering School of Chemistry and Biological Engineering, University of Science and Technology Beijing, Beijing, 100083, PR China. Electronic address: 782952209@qq.com.</Affiliation>
      </Author>
      <Author>
        <Name>Jiye Hu</Name>
        <Affiliation>Laboratory of Pesticide Residues and Environmental Toxicology, School of Chemistry and Biological Engineering School of Chemistry and Biological Engineering, University of Science and Technology Beijing, Beijing, 100083, PR China. Electronic address: jyhu@ustb.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>An update on the animal studies conducted for biosimilar approvals - Regulatory requirement vs actual scenario.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31254556</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30179-5</DOI>
    <KeywordList>
      <Keywords>Biosimilars</Keywords>
      <Keywords>EMA</Keywords>
      <Keywords>FDA</Keywords>
      <Keywords>In vivo animal study</Keywords>
      <Keywords>Nonclinical development</Keywords>
      <Keywords>Pharmacodynamics</Keywords>
      <Keywords>Pharmacokinetics</Keywords>
      <Keywords>Safety</Keywords>
      <Keywords>Toxicology</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Parag Pipalava</Name>
        <Affiliation>Clinical Development &amp; Medical Affairs, Intas Pharmaceuticals Limited (Biopharma), India. Electronic address: parag_pipalava@intaspharma.com.</Affiliation>
      </Author>
      <Author>
        <Name>Ronak Patel</Name>
        <Affiliation>Clinical Development &amp; Medical Affairs, Intas Pharmaceuticals Limited (Biopharma), India.</Affiliation>
      </Author>
      <Author>
        <Name>Miten Mehta</Name>
        <Affiliation>Clinical Development &amp; Medical Affairs, Intas Pharmaceuticals Limited (Biopharma), India.</Affiliation>
      </Author>
      <Author>
        <Name>Meghana Dahiya</Name>
        <Affiliation>Clinical Development &amp; Medical Affairs, Intas Pharmaceuticals Limited (Biopharma), India.</Affiliation>
      </Author>
      <Author>
        <Name>Inderjeet Singh</Name>
        <Affiliation>Clinical Development &amp; Medical Affairs, Intas Pharmaceuticals Limited (Biopharma), India.</Affiliation>
      </Author>
      <Author>
        <Name>Vinu Jose</Name>
        <Affiliation>Clinical Development &amp; Medical Affairs, Intas Pharmaceuticals Limited (Biopharma), India.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Safety assessment of Weissella confusa - A direct-fed microbial candidate.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31254555</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30178-3</DOI>
    <KeywordList>
      <Keywords>Direct-fed microbial product</Keywords>
      <Keywords>Safety</Keywords>
      <Keywords>Toxicity</Keywords>
      <Keywords>Weissella confusa</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Denisa Cupi</Name>
        <Affiliation>Novozymes A/S, Krogshoejvej 36, DK-2880, Bagsvaerd, Denmark. Electronic address: dcu@novozymes.com.</Affiliation>
      </Author>
      <Author>
        <Name>Signe Gry Elvig-Jørgensen</Name>
        <Affiliation>Novozymes A/S, Krogshoejvej 36, DK-2880, Bagsvaerd, Denmark.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Corrigendum to "Is there any difference between the health risk from consumption of recorded and unrecorded spirits containing alcohols other than ethanol? A population-based comparative risk assessment" [Regul. Toxicol. Pharmacol. 106 (2019) 334-345].</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31253374</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30176-X</DOI>
    <AuthorList>
      <Author>
        <Name>Orsolya Bujdosó</Name>
        <Affiliation>Department of Preventive Medicine, Faculty of Public Health, University of Debrecen, Debrecen, Hungary.</Affiliation>
      </Author>
      <Author>
        <Name>László Pál</Name>
        <Affiliation>Department of Preventive Medicine, Faculty of Public Health, University of Debrecen, Debrecen, Hungary.</Affiliation>
      </Author>
      <Author>
        <Name>Attila Nagy</Name>
        <Affiliation>Department of Preventive Medicine, Faculty of Public Health, University of Debrecen, Debrecen, Hungary.</Affiliation>
      </Author>
      <Author>
        <Name>Ervin Árnyas</Name>
        <Affiliation>Department of Preventive Medicine, Faculty of Public Health, University of Debrecen, Debrecen, Hungary.</Affiliation>
      </Author>
      <Author>
        <Name>Róza Ádány</Name>
        <Affiliation>Department of Preventive Medicine, Faculty of Public Health, University of Debrecen, Debrecen, Hungary; MTA-DE Public Health Research Group of Hungarian Academy of Sciences, University of Debrecen, Debrecen, Hungary.</Affiliation>
      </Author>
      <Author>
        <Name>János Sándor</Name>
        <Affiliation>Department of Preventive Medicine, Faculty of Public Health, University of Debrecen, Debrecen, Hungary.</Affiliation>
      </Author>
      <Author>
        <Name>Martin McKee</Name>
        <Affiliation>European Centre on Health of Societies in Transition, London School of Hygiene and Tropical Medicine, London, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Sándor Szűcs</Name>
        <Affiliation>Department of Preventive Medicine, Faculty of Public Health, University of Debrecen, Debrecen, Hungary. Electronic address: szucs.sandor@sph.unideb.hu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Health risk assessment for pediatric population associated with ethanol and selected residual solvents in herbal based products.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31238087</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30170-9</DOI>
    <KeywordList>
      <Keywords>1-Butanol</Keywords>
      <Keywords>1-Propanol</Keywords>
      <Keywords>2-Propanol</Keywords>
      <Keywords>Acetone</Keywords>
      <Keywords>Ethanol</Keywords>
      <Keywords>HSS-GC-MS</Keywords>
      <Keywords>Herbal products</Keywords>
      <Keywords>Methanol</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Branislava Srdjenovic</Name>
        <Affiliation>University of Novi Sad, Faculty of Medicine, Department of Pharmacy, Hajduk Veljkova 3, 21000 Novi Sad, Serbia; University of Novi Sad, Faculty of Medicine, Center for Medical and Pharmaceutical Investigations and Quality Control, Hajduk Veljkova 3, 21000 Novi Sad, Serbia. Electronic address: BRANISLAVA.SRDJENOVIC-CONIC@mf.uns.ac.rs.</Affiliation>
      </Author>
      <Author>
        <Name>Ljilja Torovic</Name>
        <Affiliation>University of Novi Sad, Faculty of Medicine, Department of Pharmacy, Hajduk Veljkova 3, 21000 Novi Sad, Serbia.</Affiliation>
      </Author>
      <Author>
        <Name>Nebojsa Kladar</Name>
        <Affiliation>University of Novi Sad, Faculty of Medicine, Department of Pharmacy, Hajduk Veljkova 3, 21000 Novi Sad, Serbia; University of Novi Sad, Faculty of Medicine, Center for Medical and Pharmaceutical Investigations and Quality Control, Hajduk Veljkova 3, 21000 Novi Sad, Serbia.</Affiliation>
      </Author>
      <Author>
        <Name>Biljana Bozin</Name>
        <Affiliation>University of Novi Sad, Faculty of Medicine, Department of Pharmacy, Hajduk Veljkova 3, 21000 Novi Sad, Serbia; University of Novi Sad, Faculty of Medicine, Center for Medical and Pharmaceutical Investigations and Quality Control, Hajduk Veljkova 3, 21000 Novi Sad, Serbia.</Affiliation>
      </Author>
      <Author>
        <Name>Jan Sudji</Name>
        <Affiliation>University of Novi Sad, Faculty of Medicine, Department of Pharmacy, Hajduk Veljkova 3, 21000 Novi Sad, Serbia; Institute of Occupational Health Novi Sad, Futoska 121, 21000 Novi Sad, Serbia.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Exposure assessments in reproductive and developmental toxicity testing: An IQ-DruSafe industry survey on current practices and experiences in support of exposure-based high dose selection.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31229519</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30177-1</DOI>
    <KeywordList>
      <Keywords>Developmental toxicity</Keywords>
      <Keywords>Embryofetal</Keywords>
      <Keywords>Exposure</Keywords>
      <Keywords>Fertility</Keywords>
      <Keywords>Malformations</Keywords>
      <Keywords>Pharmacokinetics</Keywords>
      <Keywords>Pregnancy</Keywords>
      <Keywords>Risk assessment</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Paul A. Andrews</Name>
        <Affiliation>Eisai Inc, Woodcliff Lake, NJ, USA. Electronic address: pa_pharma@yahoo.com.</Affiliation>
      </Author>
      <Author>
        <Name>Mary Ellen McNerney</Name>
        <Affiliation>Bristol-Myers Squibb, New Brunswick, NJ, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Joseph J. DeGeorge</Name>
        <Affiliation>Merck &amp; Co., Inc, West Point, PA, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Mechanistic relationship between biodegradation and bioaccumulation. Practical outcomes.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31226393</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30175-8</DOI>
    <KeywordList>
      <Keywords>BOD vs. BCF relationship</Keywords>
      <Keywords>Bioaccumulation</Keywords>
      <Keywords>Biodegradation</Keywords>
      <Keywords>CATALOGIC</Keywords>
      <Keywords>PBT screening</Keywords>
      <Keywords>Persistency</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Sabcho D. Dimitrov</Name>
        <Affiliation>Laboratory of Mathematical Chemistry, University "Prof. As. Zlatarov", 8010, Bourgas, Bulgaria.</Affiliation>
      </Author>
      <Author>
        <Name>Irina A. Dermen</Name>
        <Affiliation>Laboratory of Mathematical Chemistry, University "Prof. As. Zlatarov", 8010, Bourgas, Bulgaria. Electronic address: irina_dermen@btu.bg.</Affiliation>
      </Author>
      <Author>
        <Name>Nadezhda H. Dimitrova</Name>
        <Affiliation>Laboratory of Mathematical Chemistry, University "Prof. As. Zlatarov", 8010, Bourgas, Bulgaria. Electronic address: ndimitrova@btu.bg.</Affiliation>
      </Author>
      <Author>
        <Name>Krasimir G. Vasilev</Name>
        <Affiliation>Laboratory of Mathematical Chemistry, University "Prof. As. Zlatarov", 8010, Bourgas, Bulgaria. Electronic address: kvasilev@btu.bg.</Affiliation>
      </Author>
      <Author>
        <Name>Terry W. Schultz</Name>
        <Affiliation>The University of Tennessee, College of Veterinary Medicine, 2407 River Drive, Knoxville, TN, 37996-4500, USA. Electronic address: tschultz@utk.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Ovanes G. Mekenyan</Name>
        <Affiliation>Laboratory of Mathematical Chemistry, University "Prof. As. Zlatarov", 8010, Bourgas, Bulgaria. Electronic address: omekenya@btu.bg.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Peanut leaf extract has antioxidant and anti-inflammatory activity but no acute toxic effects.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31226392</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30171-0</DOI>
    <KeywordList>
      <Keywords>Acute toxicity</Keywords>
      <Keywords>Cytotoxicity</Keywords>
      <Keywords>Interleukin 1β</Keywords>
      <Keywords>Nitric oxide</Keywords>
      <Keywords>Qualitative chemical analysis</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jocelene Filippin Cossetin</Name>
        <Affiliation>Graduate Program in Pharmacology, Federal University of Santa Maria, 97105-900, Santa Maria, RS, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Evelyne da Silva Brum</Name>
        <Affiliation>Graduate Program in Biological Sciences: Toxicological Biochemistry, Federal University of Santa Maria (UFSM), 97105-900, Santa Maria, RS, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Rosana Casoti</Name>
        <Affiliation>Graduate Program in Pharmaceutical Sciences, University of São Paulo (USP), School of Pharmaceutical Sciences of Ribeirão Preto, 14040-903, Ribeirão Preto, SP, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Camila Camponogara</Name>
        <Affiliation>Graduate Program in Biological Sciences: Toxicological Biochemistry, Federal University of Santa Maria (UFSM), 97105-900, Santa Maria, RS, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Rafaela Castro Dornelles</Name>
        <Affiliation>Graduate Program in Pharmacology, Federal University of Santa Maria, 97105-900, Santa Maria, RS, Brazil; Graduate Program in Pharmaceutical Sciences, Federal University of Santa Maria (UFSM), 97105-900, Santa Maria, RS, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Maiara Maziero</Name>
        <Affiliation>Graduate Program in Pharmaceutical Sciences, Federal University of Santa Maria (UFSM), 97105-900, Santa Maria, RS, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Caren Tatiane de David Antoniazzi</Name>
        <Affiliation>Graduate Program in Pharmacology, Federal University of Santa Maria, 97105-900, Santa Maria, RS, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Camille Gaube Guex</Name>
        <Affiliation>Graduate Program in Pharmacology, Federal University of Santa Maria, 97105-900, Santa Maria, RS, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Andiara Prattes Ramos</Name>
        <Affiliation>Graduate Program in Nanoscience, Franciscan University Center (UFN), 97010-032, Santa Maria, RS, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Francielle Guedes Pintos</Name>
        <Affiliation>Graduate Program in Nanoscience, Franciscan University Center (UFN), 97010-032, Santa Maria, RS, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Ana Martiele Engelmann</Name>
        <Affiliation>Veterinary Hospital, Federal University of Santa Maria (UFSM), 97105-900, Santa Maria, RS, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Cinthia Melazzo de Andrade</Name>
        <Affiliation>Veterinary Hospital, Federal University of Santa Maria (UFSM), 97105-900, Santa Maria, RS, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Melânia Palermo Manfron</Name>
        <Affiliation>Graduate Program in Pharmaceutical Sciences, Federal University of Santa Maria (UFSM), 97105-900, Santa Maria, RS, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Sara Marchesan Oliveira</Name>
        <Affiliation>Graduate Program in Biological Sciences: Toxicological Biochemistry, Federal University of Santa Maria (UFSM), 97105-900, Santa Maria, RS, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Liliane de Freitas Bauermann</Name>
        <Affiliation>Graduate Program in Pharmacology, Federal University of Santa Maria, 97105-900, Santa Maria, RS, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Michele Rorato Sagrillo</Name>
        <Affiliation>Graduate Program in Nanoscience, Franciscan University Center (UFN), 97010-032, Santa Maria, RS, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Alencar Kolinski Machado</Name>
        <Affiliation>Laboratory of Cell Culture and Genetics, Franciscan University (UFN), 97010-032, Santa Maria, RS, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Adair Roberto Soares Santos</Name>
        <Affiliation>Graduate Program in Pharmacology, Federal University of Santa Maria, 97105-900, Santa Maria, RS, Brazil; Graduate Program in Neuroscience, Laboratory of Neurobiology of Pain and Inflammation, Federal University of Santa Catarina (UFSC), 88040-900, Florianópolis, SC, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Gabriela Trevisan</Name>
        <Affiliation>Graduate Program in Pharmacology, Federal University of Santa Maria, 97105-900, Santa Maria, RS, Brazil. Electronic address: gabriela.trevisan-santos@ufsm.br.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Distribution of fluoride contamination in drinking water resources and health risk assessment using geographic information system, northwest Iran.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31226391</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30172-2</DOI>
    <KeywordList>
      <Keywords>Drinking water</Keywords>
      <Keywords>Fluoride</Keywords>
      <Keywords>GIS</Keywords>
      <Keywords>Risk assessment</Keywords>
      <Keywords>Showt</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Mahmood Yousefi</Name>
        <Affiliation>Department of Environmental Health Engineering, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.</Affiliation>
      </Author>
      <Author>
        <Name>Sahar Ghalehaskar</Name>
        <Affiliation>Instructor of Environmental Health Engineering, School of Health, Jiroft University of Medcial Sciences, Jiroft, Iran.</Affiliation>
      </Author>
      <Author>
        <Name>Farzaneh Baghal Asghari</Name>
        <Affiliation>Department of Environmental Health Engineering, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.</Affiliation>
      </Author>
      <Author>
        <Name>Afshin Ghaderpoury</Name>
        <Affiliation>Student Research Committee, Shahid Beheshti University of Medical Sciences, Tehran, Iran.</Affiliation>
      </Author>
      <Author>
        <Name>Mohammad Hadi Dehghani</Name>
        <Affiliation>Department of Environmental Health Engineering, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran; Institute for Environmental Research, Center for Solid Waste Research, Tehran University of Medical Sciences, Tehran, Iran.</Affiliation>
      </Author>
      <Author>
        <Name>Mansour Ghaderpoori</Name>
        <Affiliation>Department of Environmental Health Engineering, School of Health and Nutrition, Lorestan University of Medical Sciences, Khorramabad, Iran.</Affiliation>
      </Author>
      <Author>
        <Name>Ali Akbar Mohammadi</Name>
        <Affiliation>Department of Environmental Health Engineering, Neyshabur University of Medical Sciences, Neyshabur, Iran. Electronic address: mohammadi.eng73@gmail.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Testing developmental toxicity in a second species: are the differences due to species or replication error?</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31226390</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30174-6</DOI>
    <KeywordList>
      <Keywords>Developmental toxicity</Keywords>
      <Keywords>LOAEL</Keywords>
      <Keywords>NOAEL</Keywords>
      <Keywords>Replication error</Keywords>
      <Keywords>Reproducibility error</Keywords>
      <Keywords>Residual variance</Keywords>
      <Keywords>Species differences</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Hedwig M. Braakhuis</Name>
        <Affiliation>Centre for Health Protection, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Peter T. Theunissen</Name>
        <Affiliation>Medicines Evaluation Board, Utrecht, the Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Wout Slob</Name>
        <Affiliation>Centre for Nutrition, Prevention and Health Services, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Emiel Rorije</Name>
        <Affiliation>Centre for Safety of Substances and Products, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Aldert H. Piersma</Name>
        <Affiliation>Centre for Health Protection, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands; Institute for Risk Assessment Sciences, Utrecht University, Utrecht, the Netherlands. Electronic address: aldert.piersma@rivm.nl.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Proposal of GHS sub-categorization criteria for LLNA: BrdU-ELISA (OECD TG442B).</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31220472</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30173-4</DOI>
    <KeywordList>
      <Keywords>ELISA</Keywords>
      <Keywords>GHS</Keywords>
      <Keywords>LLNA-BrdU</Keywords>
      <Keywords>OECD TG442B</Keywords>
      <Keywords>Skin sensitization</Keywords>
      <Keywords>Sub-categorization</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Yosuke Maeda</Name>
        <Affiliation>Chemicals Assessment and Research Center, Chemicals Evaluation and Research Institute (CERI), 1600, Shimotakano, Sugito-machi, Kitakatsushika-gun, Saitama, 3450043, Japan; The United Graduate School of Veterinary Science, Yamaguchi University, 1677-1 Yoshida, Yamaguchi-shi, Yamaguchi, 7538511, Japan. Electronic address: maeda-yosuke@ceri.jp.</Affiliation>
      </Author>
      <Author>
        <Name>Masahiro Takeyoshi</Name>
        <Affiliation>Chemicals Assessment and Research Center, Chemicals Evaluation and Research Institute (CERI), 1600, Shimotakano, Sugito-machi, Kitakatsushika-gun, Saitama, 3450043, Japan.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Biosafety of unmodified ultrafine gold particles (AuPs) upon interacting with human blood components before systemic use.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31207267</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30169-2</DOI>
    <KeywordList>
      <Keywords>Aggregation</Keywords>
      <Keywords>C3 complement</Keywords>
      <Keywords>Coagulation</Keywords>
      <Keywords>Hemolysis</Keywords>
      <Keywords>Peripheral blood mononuclear cells (PBMC)</Keywords>
      <Keywords>Ultrafine Gold Particles</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Farhat Naz</Name>
        <Affiliation>Department of Pathology, All India Institute of Medical Sciences, New Delhi, India. Electronic address: nazfrt@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Amit Kumar Dinda</Name>
        <Affiliation>Department of Pathology, All India Institute of Medical Sciences, New Delhi, India. Electronic address: dindaaiims@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Renu Saxena</Name>
        <Affiliation>Department of Pathology, All India Institute of Medical Sciences, New Delhi, India. Electronic address: renusax@hotmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Veena Koul</Name>
        <Affiliation>Centre for Biomedical Engineering, Indian Institute of Technology, New Delhi, India. Electronic address: veenak_iitd@yahoo.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Assessment of hypolipidemic, anti-inflammatory and antioxidant properties of medicinal plant Erica multiflora in triton WR-1339-induced hyperlipidemia and liver function repair in rats: A comparison with fenofibrate.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31199997</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30166-7</DOI>
    <KeywordList>
      <Keywords>Cardiovascular problems</Keywords>
      <Keywords>Erica multiflora</Keywords>
      <Keywords>Lipid profile</Keywords>
      <Keywords>Liver functions</Keywords>
      <Keywords>Triton WR-1339</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Rihab Khlifi</Name>
        <Affiliation>Unity of Bioactive and Natural Substances and Biotechnology UR17ES49, Faculty of Dental Medicine, University of Monastir, Avicenna Street, 5000, Monastir, Tunisia; Higher Institute of Biotechnology of Monastir, University of Monastir, Avenue Tahar Hadded, BP 74, 5000, Monastir, Tunisia. Electronic address: rihabkhlifi@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Aida Lahmar</Name>
        <Affiliation>Unity of Bioactive and Natural Substances and Biotechnology UR17ES49, Faculty of Dental Medicine, University of Monastir, Avicenna Street, 5000, Monastir, Tunisia; Faculty of Pharmacy, University of Monastir, Avicenna Street, 5000, Monastir, Tunisia.</Affiliation>
      </Author>
      <Author>
        <Name>Zaineb Dhaouefi</Name>
        <Affiliation>Unity of Bioactive and Natural Substances and Biotechnology UR17ES49, Faculty of Dental Medicine, University of Monastir, Avicenna Street, 5000, Monastir, Tunisia; Faculty of Sciences of Tunis, University of Tunis El Manar, Tunis, Tunisia.</Affiliation>
      </Author>
      <Author>
        <Name>Zahar Kalboussi</Name>
        <Affiliation>Unity of Bioactive and Natural Substances and Biotechnology UR17ES49, Faculty of Dental Medicine, University of Monastir, Avicenna Street, 5000, Monastir, Tunisia; Faculty of Pharmacy, University of Monastir, Avicenna Street, 5000, Monastir, Tunisia.</Affiliation>
      </Author>
      <Author>
        <Name>Mouna Maatouk</Name>
        <Affiliation>Unity of Bioactive and Natural Substances and Biotechnology UR17ES49, Faculty of Dental Medicine, University of Monastir, Avicenna Street, 5000, Monastir, Tunisia; Faculty of Pharmacy, University of Monastir, Avicenna Street, 5000, Monastir, Tunisia.</Affiliation>
      </Author>
      <Author>
        <Name>Soumaya Kilani-Jaziri</Name>
        <Affiliation>Unity of Bioactive and Natural Substances and Biotechnology UR17ES49, Faculty of Dental Medicine, University of Monastir, Avicenna Street, 5000, Monastir, Tunisia; Faculty of Pharmacy, University of Monastir, Avicenna Street, 5000, Monastir, Tunisia.</Affiliation>
      </Author>
      <Author>
        <Name>Kamel Ghedira</Name>
        <Affiliation>Faculty of Pharmacy, University of Monastir, Avicenna Street, 5000, Monastir, Tunisia.</Affiliation>
      </Author>
      <Author>
        <Name>Leila Chekir-Ghedira</Name>
        <Affiliation>Unity of Bioactive and Natural Substances and Biotechnology UR17ES49, Faculty of Dental Medicine, University of Monastir, Avicenna Street, 5000, Monastir, Tunisia.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Investigation of number of replicate measurements required to meet cigarette smoke chemistry regulatory requirements measured under Canadian intense smoking conditions.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31199996</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30155-2</DOI>
    <KeywordList>
      <Keywords>Analytical replicate numbers</Keywords>
      <Keywords>Cigarette smoke</Keywords>
      <Keywords>Regulation</Keywords>
      <Keywords>Toxicants</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Alison Eldridge</Name>
        <Affiliation>Group Research and Development, British American Tobacco, Regents Park Road, Milbrook, Southampton, SO15 8TL, UK. Electronic address: Alison_Eldridge@bat.com.</Affiliation>
      </Author>
      <Author>
        <Name>Tatiana Betson</Name>
        <Affiliation>Group Research and Development, British American Tobacco, Regents Park Road, Milbrook, Southampton, SO15 8TL, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Marcos Vinicius Gama</Name>
        <Affiliation>Group Research and Development, British American Tobacco, Regents Park Road, Milbrook, Southampton, SO15 8TL, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Graham Errington</Name>
        <Affiliation>Group Research and Development, British American Tobacco, Regents Park Road, Milbrook, Southampton, SO15 8TL, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Kevin McAdam</Name>
        <Affiliation>McAdam Scientific Ltd., 50 Leigh Road, Eastleigh, SO50 9DT, UK.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Genetic toxicology in silico protocol.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31195068</pubmedLink>
    <GrantList>
      <Grant>R43 ES026909</Grant>
      <Grant>R44 ES026909</Grant>
    </GrantList>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30165-5</DOI>
    <KeywordList>
      <Keywords>(Q)SAR</Keywords>
      <Keywords>Computational toxicology protocols</Keywords>
      <Keywords>Expert alerts</Keywords>
      <Keywords>Expert review</Keywords>
      <Keywords>Genetic toxicology</Keywords>
      <Keywords>In silico</Keywords>
      <Keywords>In silico toxicology</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Catrin Hasselgren</Name>
        <Affiliation>Genentech, Inc., 1 DNA Way, South San Francisco, CA, 94080, USA. Electronic address: hasselgren.catrin@gene.com.</Affiliation>
      </Author>
      <Author>
        <Name>Ernst Ahlberg</Name>
        <Affiliation>Predictive Compound ADME &amp; Safety, Drug Safety &amp; Metabolism, AstraZeneca IMED Biotech Unit, Mölndal, Sweden.</Affiliation>
      </Author>
      <Author>
        <Name>Yumi Akahori</Name>
        <Affiliation>Chemicals Evaluation and Research Institute, 1-4-25 Kouraku, Bunkyo-ku, Tokyo, 112-0004, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Alexander Amberg</Name>
        <Affiliation>Sanofi, R&amp;D Preclinical Safety Frankfurt, Industriepark Hoechst, D-65926, Frankfurt am Main, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Lennart T. Anger</Name>
        <Affiliation>Sanofi, R&amp;D Preclinical Safety Frankfurt, Industriepark Hoechst, D-65926, Frankfurt am Main, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Franck Atienzar</Name>
        <Affiliation>UCB BioPharma SPRL, Chemin du Foriest, B-1420 Braine-l'Alleud, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Scott Auerbach</Name>
        <Affiliation>The National Institute of Environmental Health Sciences, Division of the National Toxicology Program, Research Triangle Park, NC, 27709, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Lisa Beilke</Name>
        <Affiliation>Toxicology Solutions Inc., San Diego, CA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Phillip Bellion</Name>
        <Affiliation>DSM Nutritional Products, Kaiseraugst, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Romualdo Benigni</Name>
        <Affiliation>Alpha-PreTox, via G.Pascoli 1, 00184, Roma, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Joel Bercu</Name>
        <Affiliation>Gilead Sciences, 333 Lakeside Drive, Foster City, CA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Ewan D. Booth</Name>
        <Affiliation>Syngenta, Product Safety Department, Jealott's Hill International Research Centre, Bracknell, Berkshire, RG42 6EY, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Dave Bower</Name>
        <Affiliation>Leadscope, Inc, 1393 Dublin Rd, Columbus, OH, 43215, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Alessandro Brigo</Name>
        <Affiliation>Roche Pharmaceutical Research &amp; Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd, Grenzacherstrasse 124, 4070, Basel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Zoryana Cammerer</Name>
        <Affiliation>Janssen Research &amp; Development, 1400 McKean Road, Spring House, PA, 19477, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Mark T. D. Cronin</Name>
        <Affiliation>School of Pharmacy and Biomolecular Sciences, Liverpool John Moores University, Liverpool, L3 3AF, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Ian Crooks</Name>
        <Affiliation>British American Tobacco, Research and Development, Regents Park Road, Southampton, Hampshire, SO15 8TL, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Kevin P. Cross</Name>
        <Affiliation>Leadscope, Inc, 1393 Dublin Rd, Columbus, OH, 43215, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Laura Custer</Name>
        <Affiliation>Bristol-Myers Squibb, Drug Safety Evaluation, 1 Squibb Dr, New Brunswick, NJ, 08903, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Krista Dobo</Name>
        <Affiliation>Pfizer Global Research &amp; Development, 558 Eastern Point Road, Groton, CT, 06340, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Tatyana Doktorova</Name>
        <Affiliation>Douglas Connect GmbH, Technology Park Basel, Hochbergerstrasse 60C, CH-4057, Basel / Basel-Stadt, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>David Faulkner</Name>
        <Affiliation>Lawrence Berkeley National Laboratory, One Cyclotron Road, MS 70A-1161A, Berkeley, CA, 947020, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Kevin A. Ford</Name>
        <Affiliation>Global Blood Therapeutics, 171 Oyster Point Boulevard, South San Francisco, CA, 94080, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Marie C. Fortin</Name>
        <Affiliation>Jazz Pharmaceuticals, Inc., 200 Princeton South Corporate Center, Suite 180, Ewing, NJ, 08628, USA; Department of Pharmacology and Toxicology, Ernest Mario School of Pharmacy, Rutgers University, 170 Frelinghuysen Rd, Piscataway, NJ, 08855, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Markus Frericks</Name>
        <Affiliation>BASF SE, 67056, Ludwigshafen, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Samantha E. Gad-McDonald</Name>
        <Affiliation>Gad Consulting Services, 4008 Barrett Drive, Suite 201, Raleigh, NC, 27609, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Nichola Gellatly</Name>
        <Affiliation>National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs), Gibbs Building, 215 Euston Road, London, NW1 2BE, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Helga Gerets</Name>
        <Affiliation>UCB BioPharma SPRL, Chemin du Foriest, B-1420, Braine-l'Alleud, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Véronique Gervais</Name>
        <Affiliation>Servier Group, 905 route de Saran, 45520, Gidy, France.</Affiliation>
      </Author>
      <Author>
        <Name>Susanne Glowienke</Name>
        <Affiliation>Novartis Pharma AG, Pre-Clinical Safety, Werk Klybeck, CH, 4057, Basel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Jacky Van Gompel</Name>
        <Affiliation>Janssen Pharmaceutical Companies of Johnson &amp; Johnson, 2340, Beerse, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>James S. Harvey</Name>
        <Affiliation>GlaxoSmithKline Pre-Clinical Development, Park Road, Ware, Hertfordshire, SG12 0DP, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Jedd Hillegass</Name>
        <Affiliation>Bristol-Myers Squibb, Drug Safety Evaluation, 1 Squibb Dr, New Brunswick, NJ, 08903, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Masamitsu Honma</Name>
        <Affiliation>Division of Genetics and Mutagenesis, National Institute of Health Sciences, Kanagawa, 210-9501, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Jui Hua Hsieh</Name>
        <Affiliation>Kelly Government Solutions, Research Triangle Park, NC, 27709, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Chia Wen Hsu</Name>
        <Affiliation>FDA Center for Drug Evaluation and Research, Silver Spring, MD, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Tara S. Barton-Maclaren</Name>
        <Affiliation>Existing Substances Risk Assessment Bureau, Health Canada, Ottawa, ON, K1A 0K9, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Candice Johnson</Name>
        <Affiliation>Leadscope, Inc, 1393 Dublin Rd, Columbus, OH, 43215, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Robert Jolly</Name>
        <Affiliation>Toxicology Division, Eli Lilly and Company, Indianapolis, IN, USA.</Affiliation>
      </Author>
      <Author>
        <Name>David Jones</Name>
        <Affiliation>Medicines and Healthcare Products Regulatory Agency, 10 South Colonnade, Canary Wharf, London, E14 4PU, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Ray Kemper</Name>
        <Affiliation>Vertex Pharmaceuticals Inc., Predictive and Investigative Safety Assessment, 50 Northern Ave, Boston, MA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Michelle O. Kenyon</Name>
        <Affiliation>Pfizer Global Research &amp; Development, 558 Eastern Point Road, Groton, CT, 06340, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Naomi L. Kruhlak</Name>
        <Affiliation>FDA Center for Drug Evaluation and Research, Silver Spring, MD, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Sunil A. Kulkarni</Name>
        <Affiliation>Existing Substances Risk Assessment Bureau, Health Canada, Ottawa, ON, K1A 0K9, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Klaus Kümmerer</Name>
        <Affiliation>Institute for Sustainable and Environmental Chemistry, Leuphana University Lüneburg, Scharnhorststraße 1/C13.311b, 21335, Lüneburg, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Penny Leavitt</Name>
        <Affiliation>Bristol-Myers Squibb, Drug Safety Evaluation, 1 Squibb Dr, New Brunswick, NJ, 08903, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Scott Masten</Name>
        <Affiliation>The National Institute of Environmental Health Sciences, Division of the National Toxicology Program, Research Triangle Park, NC, 27709, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Scott Miller</Name>
        <Affiliation>Leadscope, Inc, 1393 Dublin Rd, Columbus, OH, 43215, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Chandrika Moudgal</Name>
        <Affiliation>Genentech, Inc., 1 DNA Way, South San Francisco, CA, 94080, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Wolfgang Muster</Name>
        <Affiliation>Roche Pharmaceutical Research &amp; Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd, Grenzacherstrasse 124, 4070, Basel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Alexandre Paulino</Name>
        <Affiliation>Oro Agri Setúbal, Portugal.</Affiliation>
      </Author>
      <Author>
        <Name>Elena Lo Piparo</Name>
        <Affiliation>Nestlé Research Vers-chez-les-Blanc, Lausanne, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Mark Powley</Name>
        <Affiliation>Merck Research Laboratories, West Point, PA, 19486, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Donald P. Quigley</Name>
        <Affiliation>Leadscope, Inc, 1393 Dublin Rd, Columbus, OH, 43215, USA.</Affiliation>
      </Author>
      <Author>
        <Name>M. Vijayaray Reddy</Name>
        <Affiliation>Merck Research Laboratories, West Point, PA, 19486, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Andrea Nicole Richarz</Name>
        <Affiliation>European Commission, Joint Research Centre (JRC), Ispra, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Benoit Schilter</Name>
        <Affiliation>Nestlé Research Vers-chez-les-Blanc, Lausanne, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Ronald D. Snyder</Name>
        <Affiliation>RDS Consulting Services, 2936 Wooded Vista Ct, Mason, OH, 45040, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Lidiya Stavitskaya</Name>
        <Affiliation>FDA Center for Drug Evaluation and Research, Silver Spring, MD, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Reinhard Stidl</Name>
        <Affiliation>Safetree Consulting e.U, Vienna, Austria.</Affiliation>
      </Author>
      <Author>
        <Name>David T. Szabo</Name>
        <Affiliation>PPG Industries, Pittsburgh, PA, 15146, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Andrew Teasdale</Name>
        <Affiliation>AstraZeneca, Macclesfield, Cheshire, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Raymond R. Tice</Name>
        <Affiliation>RTice Consulting, Hillsborough, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Alejandra Trejo-Martin</Name>
        <Affiliation>Gilead Sciences, 333 Lakeside Drive, Foster City, CA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Anna Vuorinen</Name>
        <Affiliation>DSM Nutritional Products, Kaiseraugst, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Brian A. Wall</Name>
        <Affiliation>Colgate-Palmolive Company, Piscataway, NJ, 08854, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Pete Watts</Name>
        <Affiliation>Bibra, Cantium House, Railway Approach, Wallington, Surrey, SM6 0DZ, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Angela T. White</Name>
        <Affiliation>GlaxoSmithKline Pre-Clinical Development, Park Road, Ware, Hertfordshire, SG12 0DP, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Joerg Wichard</Name>
        <Affiliation>Bayer AG, Pharmaceuticals Division, Investigational Toxicology, Muellerstr. 178, D-13353, Berlin, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Kristine L. Witt</Name>
        <Affiliation>The National Institute of Environmental Health Sciences, Division of the National Toxicology Program, Research Triangle Park, NC, 27709, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Adam Woolley</Name>
        <Affiliation>ForthTox Limited, PO Box 13550, Linlithgow, EH49 7YU, UK.</Affiliation>
      </Author>
      <Author>
        <Name>David Woolley</Name>
        <Affiliation>ForthTox Limited, PO Box 13550, Linlithgow, EH49 7YU, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Craig Zwickl</Name>
        <Affiliation>Transendix LLC, 1407 Moores Manor, Indianapolis, IN, 46229, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Glenn J. Myatt</Name>
        <Affiliation>Leadscope, Inc, 1393 Dublin Rd, Columbus, OH, 43215, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Opinion of the Scientific Committee on consumer safety (SCCS) - Final opinion on the safety of fragrance ingredient Acetylated Vetiver Oil (AVO) - (Vetiveria zizanioides root extract acetylated) - Submission III.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31176744</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30142-4</DOI>
    <KeywordList>
      <Keywords>Acetylated vetiver oil (AVO)</Keywords>
      <Keywords>CAS 84082-84-8</Keywords>
      <Keywords>EC 282-031-1</Keywords>
      <Keywords>Regulation 1223/2009</Keywords>
      <Keywords>SCCS</Keywords>
      <Keywords>SCCS/1599/18</Keywords>
      <Keywords>Scientific opinion</Keywords>
      <Keywords>Vetiveria zizanioides ext. acetylated</Keywords>
      <Keywords>Vetiverol acetate CAS 62563-80-8</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name> </Name>
      </Author>
      <Author>
        <Name> </Name>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Opinion of the Scientific Committee on Consumer safety (SCCS) - Opinion on Ethylzingerone - 'Hydroxyethoxyphenyl Butanone' (HEPB) - Cosmetics Europe No P98 - CAS No 569646-79-3 - Submission II (eye irritation).</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31170420</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30146-1</DOI>
    <KeywordList>
      <Keywords>CAS 569646-79-3</Keywords>
      <Keywords>Cosmetics Europe No P98</Keywords>
      <Keywords>Ethylzingerone</Keywords>
      <Keywords>Regulation 1223/2009</Keywords>
      <Keywords>SCCS</Keywords>
      <Keywords>SCCS/1604/18</Keywords>
      <Keywords>Scientific opinion</Keywords>
      <Keywords>‘Hydroxyethoxyphenyl Butanone’ (HEPB)</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name> </Name>
      </Author>
      <Author>
        <Name> </Name>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Evaluation of skin sensitization potential of chemicals by local lymph node assay using 5-bromo-2-deoxyuridine with flow cytometry.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31158384</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30154-0</DOI>
    <KeywordList>
      <Keywords>BALB/c</Keywords>
      <Keywords>BrdU-FCM</Keywords>
      <Keywords>Flow cytometry</Keywords>
      <Keywords>LLNA</Keywords>
      <Keywords>Local lymph node assay</Keywords>
      <Keywords>Skin sensitization</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Byeol I. Han</Name>
        <Affiliation>Toxicological Screening and Testing Division, National Institute of Food and Drug Safety Evaluation, Ministry of Food and Drug Safety, Cheongju-si, 28159, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Jung Sun Yi</Name>
        <Affiliation>Toxicological Screening and Testing Division, National Institute of Food and Drug Safety Evaluation, Ministry of Food and Drug Safety, Cheongju-si, 28159, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Souk Jin Seo</Name>
        <Affiliation>Toxicological Screening and Testing Division, National Institute of Food and Drug Safety Evaluation, Ministry of Food and Drug Safety, Cheongju-si, 28159, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Tae Sung Kim</Name>
        <Affiliation>Toxicological Screening and Testing Division, National Institute of Food and Drug Safety Evaluation, Ministry of Food and Drug Safety, Cheongju-si, 28159, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Ilyoung Ahn</Name>
        <Affiliation>Toxicological Screening and Testing Division, National Institute of Food and Drug Safety Evaluation, Ministry of Food and Drug Safety, Cheongju-si, 28159, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Kyungyuk Ko</Name>
        <Affiliation>Toxicological Screening and Testing Division, National Institute of Food and Drug Safety Evaluation, Ministry of Food and Drug Safety, Cheongju-si, 28159, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Joo Hwan Kim</Name>
        <Affiliation>Toxicological Screening and Testing Division, National Institute of Food and Drug Safety Evaluation, Ministry of Food and Drug Safety, Cheongju-si, 28159, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>SeungJin Bae</Name>
        <Affiliation>College of Pharmacy, Ewha Womans University, Seoul, 03760, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Jong Kwon Lee</Name>
        <Affiliation>Toxicological Research Division, National Institute of Food and Drug Safety Evaluation, Ministry of Food and Drug Safety, Cheongju-si, 28159, Republic of Korea. Electronic address: jkleest@korea.kr.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Corrigendum to "Prenatal developmental toxicity study of strontium citrate in Sprague Dawley rats" [Regul. Toxicol. Pharmacol. 101 (2019), 196-200].</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31153644</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30151-5</DOI>
    <AuthorList>
      <Author>
        <Name>Chen Yuan Chiu</Name>
        <Affiliation>Institute of Food Safety and Health, College of Public Health, National Taiwan University, Taipei, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Hsien Chun Chiu</Name>
        <Affiliation>Institute of Toxicology, College of Medicine, National Taiwan University, Taipei, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Shing Hwa Liu</Name>
        <Affiliation>Institute of Toxicology, College of Medicine, National Taiwan University, Taipei, Taiwan; Department of Medical Research, China Medical University Hospital, China Medical University, Taichung, Taiwan; Department of Pediatrics, College of Medicine, National Taiwan University &amp; Hospital, Taipei, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Kuo Cheng Lan</Name>
        <Affiliation>Department of Emergency Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan. Electronic address: kclan.tw@yahoo.com.tw.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>In vitro and in vivo genotoxicity studies on monosodium L-glutamate monohydrate.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31152859</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30152-7</DOI>
    <KeywordList>
      <Keywords>Chromosome aberration test</Keywords>
      <Keywords>Genotoxicity</Keywords>
      <Keywords>Micronucleus test</Keywords>
      <Keywords>Monosodium glutamate</Keywords>
      <Keywords>Mutagenicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Asuka Takumi</Name>
        <Affiliation>Product Evaluation Group, Evaluation &amp; Analysis Section, Research Institute for Bioscience Products &amp; Fine Chemicals, Ajinomoto Co., Inc., 1-1, Suzuki-cho, Kawasaki-shi, Kanagawa, 210-8681, Japan. Electronic address: asuka_takumi@ajinomoto.com.</Affiliation>
      </Author>
      <Author>
        <Name>Yasuko Kawamata</Name>
        <Affiliation>Product Evaluation Group, Evaluation &amp; Analysis Section, Research Institute for Bioscience Products &amp; Fine Chemicals, Ajinomoto Co., Inc., 1-1, Suzuki-cho, Kawasaki-shi, Kanagawa, 210-8681, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Ryosei Sakai</Name>
        <Affiliation>Product Evaluation Group, Evaluation &amp; Analysis Section, Research Institute for Bioscience Products &amp; Fine Chemicals, Ajinomoto Co., Inc., 1-1, Suzuki-cho, Kawasaki-shi, Kanagawa, 210-8681, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Takahiro Narita</Name>
        <Affiliation>Product Evaluation Group, Evaluation &amp; Analysis Section, Research Institute for Bioscience Products &amp; Fine Chemicals, Ajinomoto Co., Inc., 1-1, Suzuki-cho, Kawasaki-shi, Kanagawa, 210-8681, Japan.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Garlic and allopurinol attenuate hepatic apoptosis induced by fipronil in male albino rats.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31152858</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30153-9</DOI>
    <KeywordList>
      <Keywords>Allopurinol</Keywords>
      <Keywords>Apoptosis</Keywords>
      <Keywords>Fipronil</Keywords>
      <Keywords>Garlic</Keywords>
      <Keywords>Liver</Keywords>
      <Keywords>Oxidative stress</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Amira A. Sayed</Name>
        <Affiliation>Biochemistry Division, Faculty of Science, Cairo University, Giza, 12613, Egypt.</Affiliation>
      </Author>
      <Author>
        <Name>Mohamed A. El-Desouky</Name>
        <Affiliation>Biochemistry Division, Faculty of Science, Cairo University, Giza, 12613, Egypt.</Affiliation>
      </Author>
      <Author>
        <Name>Khairy A. Ibrahim</Name>
        <Affiliation>Mammalian Toxicology Department, Central Agricultural Pesticides Laboratory, Agricultural Research Center, Dokki, Giza, 12618, Egypt. Electronic address: khairy_moneim@yahoo.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Comparative study of feminine hygiene product regulations in Korea, the European Union, and the United States.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31152857</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30150-3</DOI>
    <KeywordList>
      <Keywords>General products</Keywords>
      <Keywords>Medical devices</Keywords>
      <Keywords>Menstrual pad</Keywords>
      <Keywords>Quasi-drugs</Keywords>
      <Keywords>Sanitary pad</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jin Il Kwak</Name>
        <Affiliation>Department of Environmental Health Science, Konkuk University, 120 Neungdong-ro, Gwangjin-gu, Seoul, 05029, South Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Sun Hwa Nam</Name>
        <Affiliation>Department of Environmental Health Science, Konkuk University, 120 Neungdong-ro, Gwangjin-gu, Seoul, 05029, South Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Dasom Kim</Name>
        <Affiliation>Department of Environmental Health Science, Konkuk University, 120 Neungdong-ro, Gwangjin-gu, Seoul, 05029, South Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Youn Joo An</Name>
        <Affiliation>Department of Environmental Health Science, Konkuk University, 120 Neungdong-ro, Gwangjin-gu, Seoul, 05029, South Korea. Electronic address: anyjoo@konkuk.ac.kr.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Curation and analysis of clinical pathology parameters and histopathologic findings from eTOXsys, a large database project (eTOX) for toxicologic studies.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31128168</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30149-7</DOI>
    <KeywordList>
      <Keywords>Background incidence rates</Keywords>
      <Keywords>Clinical pathology</Keywords>
      <Keywords>Error rates</Keywords>
      <Keywords>Histopathology</Keywords>
      <Keywords>Preclinical studies</Keywords>
      <Keywords>Statistical modelling</Keywords>
      <Keywords>Toxicology</Keywords>
      <Keywords>Treatment-related</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Mark D. Pinches</Name>
        <Affiliation>Lhasa Limited, Granary Wharf House, 2 Canal Wharf, Leeds, LS11 5PS, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Robert Thomas</Name>
        <Affiliation>Lhasa Limited, Granary Wharf House, 2 Canal Wharf, Leeds, LS11 5PS, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Rosemary Porter</Name>
        <Affiliation>Lhasa Limited, Granary Wharf House, 2 Canal Wharf, Leeds, LS11 5PS, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Lucinda Camidge</Name>
        <Affiliation>Lhasa Limited, Granary Wharf House, 2 Canal Wharf, Leeds, LS11 5PS, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Katharine Briggs</Name>
        <Affiliation>Lhasa Limited, Granary Wharf House, 2 Canal Wharf, Leeds, LS11 5PS, UK. Electronic address: katharine.briggs@lhasalimited.org.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Is there any difference between the health risk from consumption of recorded and unrecorded spirits containing alcohols other than ethanol? A population-based comparative risk assessment.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31128167</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30148-5</DOI>
    <KeywordList>
      <Keywords>Alcohol consumption</Keywords>
      <Keywords>Higher alcohols</Keywords>
      <Keywords>Margin of exposure risk assessment</Keywords>
      <Keywords>Recorded spirits</Keywords>
      <Keywords>Unrecorded spirits</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Orsolya Bujdosó</Name>
        <Affiliation>Department of Preventive Medicine, Faculty of Public Health, University of Debrecen, Debrecen, Hungary. Electronic address: bujdoso.orsolya@sph.unideb.hu.</Affiliation>
      </Author>
      <Author>
        <Name>László Pál</Name>
        <Affiliation>Department of Preventive Medicine, Faculty of Public Health, University of Debrecen, Debrecen, Hungary. Electronic address: pal.laszlo@sph.unideb.hu.</Affiliation>
      </Author>
      <Author>
        <Name>Attila Nagy</Name>
        <Affiliation>Department of Preventive Medicine, Faculty of Public Health, University of Debrecen, Debrecen, Hungary. Electronic address: nagy.attila@sph.unideb.hu.</Affiliation>
      </Author>
      <Author>
        <Name>Ervin Árnyas</Name>
        <Affiliation>Department of Preventive Medicine, Faculty of Public Health, University of Debrecen, Debrecen, Hungary. Electronic address: arnyaser@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Róza Ádány</Name>
        <Affiliation>Department of Preventive Medicine, Faculty of Public Health, University of Debrecen, Debrecen, Hungary; MTA-DE Public Health Research Group of Hungarian Academy of Sciences, University of Debrecen, Debrecen, Hungary. Electronic address: adany.roza@sph.unideb.hu.</Affiliation>
      </Author>
      <Author>
        <Name>János Sándor</Name>
        <Affiliation>Department of Preventive Medicine, Faculty of Public Health, University of Debrecen, Debrecen, Hungary. Electronic address: sandor.janos@sph.unideb.hu.</Affiliation>
      </Author>
      <Author>
        <Name>Martin McKee</Name>
        <Affiliation>European Centre on Health of Societies in Transition, London School of Hygiene and Tropical Medicine, London, United Kingdom. Electronic address: martin.mckee@lshtm.ac.uk.</Affiliation>
      </Author>
      <Author>
        <Name>Sándor Szűcs</Name>
        <Affiliation>Department of Preventive Medicine, Faculty of Public Health, University of Debrecen, Debrecen, Hungary. Electronic address: szucs.sandor@sph.unideb.hu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Predicting estrogen receptor activation by a group of substituted phenols: An integrated approach to testing and assessment case study.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31121201</pubmedLink>
    <GrantList>
      <Grant>EPA999999</Grant>
    </GrantList>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30145-X</DOI>
    <KeywordList>
      <Keywords>2,4-Di-tert-butylphenol</Keywords>
      <Keywords>4-Tert-butylphenol</Keywords>
      <Keywords>Administered equivalent dose (AED)</Keywords>
      <Keywords>Bioactivity exposure ratio (BER)</Keywords>
      <Keywords>Endocrine disruption</Keywords>
      <Keywords>Estrogen</Keywords>
      <Keywords>Integrated approach for testing and assessment (IATA)</Keywords>
      <Keywords>New approach methodology (NAM)</Keywords>
      <Keywords>Octabenzone</Keywords>
      <Keywords>Read-across</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Francina Webster</Name>
      </Author>
      <Author>
        <Name>Matthew Gagné</Name>
      </Author>
      <Author>
        <Name>Grace Patlewicz</Name>
      </Author>
      <Author>
        <Name>Prachi Pradeep</Name>
      </Author>
      <Author>
        <Name>Nicholas Trefiak</Name>
      </Author>
      <Author>
        <Name>Richard S. Judson</Name>
      </Author>
      <Author>
        <Name>Tara S. Barton-Maclaren</Name>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A review of substances found positive in 1 of 3 in vitro tests for skin sensitization.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31112722</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30144-8</DOI>
    <KeywordList>
      <Keywords>2 out of 3 approach</Keywords>
      <Keywords>Adverse outcome pathway</Keywords>
      <Keywords>Allergic contact dermatitis</Keywords>
      <Keywords>Applicability domain</Keywords>
      <Keywords>Concordance</Keywords>
      <Keywords>Defined approaches</Keywords>
      <Keywords>Hazard assessment</Keywords>
      <Keywords>Human reference data</Keywords>
      <Keywords>LLNA reference data</Keywords>
      <Keywords>Skin sensitization</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Susanne N. Kolle</Name>
        <Affiliation>BASF SE, Experimental Toxicology and Ecology, Ludwigshafen, Germany. Electronic address: susanne.kolle@basf.com.</Affiliation>
      </Author>
      <Author>
        <Name>Andreas Natsch</Name>
        <Affiliation>Givaudan Schweiz AG, Dübendorf, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>G. Frank Gerberick</Name>
        <Affiliation>GF3 Consultancy, LLC, West Chester, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Robert Landsiedel</Name>
        <Affiliation>BASF SE, Experimental Toxicology and Ecology, Ludwigshafen, Germany.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>REACH alternative testing strategy for skin sensitization in practice: Fact or fiction?</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31112721</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30147-3</DOI>
    <KeywordList>
      <Keywords>AOP</Keywords>
      <Keywords>Alternative test</Keywords>
      <Keywords>Derek</Keywords>
      <Keywords>Direct peptide reactivity assay (DPRA)</Keywords>
      <Keywords>KeratinoSens</Keywords>
      <Keywords>Non-animal test</Keywords>
      <Keywords>REACH</Keywords>
      <Keywords>Skin sensitization</Keywords>
      <Keywords>U-SENS</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Helma M. Barentsen</Name>
        <Affiliation>Charles River Laboratories, Hambakenwetering 7, 5231 DD Den Bosch, the Netherlands. Electronic address: helma.barentsen@crl.com.</Affiliation>
      </Author>
      <Author>
        <Name>Simon U. Jonis</Name>
        <Affiliation>Charles River Laboratories, Hambakenwetering 7, 5231 DD Den Bosch, the Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Sylvia M. G. J. Pelgrom</Name>
        <Affiliation>Charles River Laboratories, Hambakenwetering 7, 5231 DD Den Bosch, the Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Jeroen C. W. Rijk</Name>
        <Affiliation>Charles River Laboratories, Hambakenwetering 7, 5231 DD Den Bosch, the Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Walter M. A. Westerink</Name>
        <Affiliation>Charles River Laboratories, Hambakenwetering 7, 5231 DD Den Bosch, the Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Jeannette J. C. Paulussen</Name>
        <Affiliation>Charles River Laboratories, Hambakenwetering 7, 5231 DD Den Bosch, the Netherlands.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The selective determination of potentially carcinogenic polycyclic aromatic compounds in lubricant base oils by the DMSO extraction method IP346 and its correlation to mouse skin painting carcinogenicity assays.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31103638</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30140-0</DOI>
    <KeywordList>
      <Keywords>Base oil</Keywords>
      <Keywords>Carcinogenicity</Keywords>
      <Keywords>DMSO</Keywords>
      <Keywords>IP346</Keywords>
      <Keywords>Lubricant</Keywords>
      <Keywords>Mineral oil</Keywords>
      <Keywords>Mouse</Keywords>
      <Keywords>PAC</Keywords>
      <Keywords>PAH</Keywords>
      <Keywords>White oil</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Juan Carlos Carrillo</Name>
        <Affiliation>Shell Health, Shell International B.V, the Netherlands. Electronic address: juan-carlos.carrillo@shell.com.</Affiliation>
      </Author>
      <Author>
        <Name>Arnold van der Wiel</Name>
        <Affiliation>Koninklijke Shell Laboratorium Amsterdam (now Shell Technology Centre Amsterdam), the Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Dirk Danneels</Name>
        <Affiliation>European Wax Federation aisbl, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Olaf Kral</Name>
        <Affiliation>Shell Deutschland Oil GmbH, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Peter J. Boogaard</Name>
        <Affiliation>Shell Health, Shell International B.V, the Netherlands.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Development of Biomonitoring Equivalents for chlordane and toxaphene with application to the general Canadian population.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31103637</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30143-6</DOI>
    <KeywordList>
      <Keywords>Biomonitoring</Keywords>
      <Keywords>Chlordane</Keywords>
      <Keywords>Risk assessment</Keywords>
      <Keywords>Toxaphene</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Kavita Singh</Name>
        <Affiliation>Department of Biology, University of Ottawa, ON, K1N 6N5, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Andy Nong</Name>
        <Affiliation>Exposure and Biomonitoring Division, Environmental Health Sciences and Research Bureau, Health Canada, ON, K1A 0K9, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Mark Feeley</Name>
        <Affiliation>Bureau of Chemical Safety, Food Directorate, Health Products and Food Branch, Health Canada, ON, K1A 0K9, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Hing Man Chan</Name>
        <Affiliation>Department of Biology, University of Ottawa, ON, K1N 6N5, Canada. Electronic address: laurie.chan@uottawa.ca.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Response to letter from Dr Oliviera in relation to our publication: A study in a rat initiation-promotion bladder tumour model demonstrated no promoter/progressor potential of dapagliflozin.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31095971</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30137-0</DOI>
    <AuthorList>
      <Author>
        <Name>Martin Billger</Name>
        <Affiliation>Clinical Pharmacology and Safety Sciences, BioPharmaceuticals R&amp;D, AstraZeneca, Gothenburg, Sweden. Electronic address: martin.billger@astrazeneca.com.</Affiliation>
      </Author>
      <Author>
        <Name>Jason Kirk</Name>
        <Affiliation>Clinical Pharmacology and Safety Sciences, BioPharmaceuticals R&amp;D, AstraZeneca, Cambridge, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Jane Chang</Name>
        <Affiliation>Clinical Pharmacology and Safety Sciences, BioPharmaceuticals R&amp;D, AstraZeneca, Waltham, MA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Agathe Bédard</Name>
        <Affiliation>Charles River Laboratories, Montreal, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Bassem Attalla</Name>
        <Affiliation>Charles River Laboratories, Montreal, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Solomon Haile</Name>
        <Affiliation>Charles River Laboratories, Montreal, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Magnus Söderberg</Name>
        <Affiliation>Clinical Pharmacology and Safety Sciences, BioPharmaceuticals R&amp;D, AstraZeneca, Gothenburg, Sweden.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A response to Professor Steinemann.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31085252</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30128-X</DOI>
    <AuthorList>
      <Author>
        <Name>David Basketter</Name>
      </Author>
      <Author>
        <Name>Joe Huggard</Name>
      </Author>
      <Author>
        <Name>Ian Kimber</Name>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Nonclinical safety evaluation of erenumab, a CGRP receptor inhibitor for the prevention of migraine.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31085251</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30141-2</DOI>
    <KeywordList>
      <Keywords>AMG 334</Keywords>
      <Keywords>Cynomolgus monkey</Keywords>
      <Keywords>Erenumab</Keywords>
      <Keywords>Migraine</Keywords>
      <Keywords>Monoclonal antibody</Keywords>
      <Keywords>Nonclinical</Keywords>
      <Keywords>Platelets</Keywords>
      <Keywords>Repeat dose toxicity</Keywords>
      <Keywords>Reproductive toxicity</Keywords>
      <Keywords>Toxicology</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jeanine L. Bussiere</Name>
        <Affiliation>Amgen Research, One Amgen Center Dr., Thousand Oaks, CA, 91320, USA. Electronic address: Jeanine.bussiere@amgen.com.</Affiliation>
      </Author>
      <Author>
        <Name>Rhian Davies</Name>
        <Affiliation>Amgen Research, 1120 Veterans Blvd., South San Francisco, CA, 94080, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Charles Dean</Name>
        <Affiliation>Amgen Research, One Amgen Center Dr., Thousand Oaks, CA, 91320, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Cen Xu</Name>
        <Affiliation>Amgen Research, One Amgen Center Dr., Thousand Oaks, CA, 91320, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Kyung Hoon Kim</Name>
        <Affiliation>Amgen Research, 1120 Veterans Blvd., South San Francisco, CA, 94080, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Hugo M. Vargas</Name>
        <Affiliation>Amgen Research, One Amgen Center Dr., Thousand Oaks, CA, 91320, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Gary J. Chellman</Name>
        <Affiliation>Charles River Laboratories Inc., 6995 Longley Lane, Reno, NV, 89511, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Ganesh Balasubramanian</Name>
        <Affiliation>Amgen Research, One Amgen Center Dr., Thousand Oaks, CA, 91320, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Eloisa Rubio-Beltran</Name>
        <Affiliation>Erasmus MC Rotterdam, PO Box 2040, 3000, CA, Rotterdam, the Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Antoinette MaassenVanDenBrink</Name>
        <Affiliation>Erasmus MC Rotterdam, PO Box 2040, 3000, CA, Rotterdam, the Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Thomas M. Monticello</Name>
        <Affiliation>Amgen Research, One Amgen Center Dr., Thousand Oaks, CA, 91320, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The impact on classifications for carcinogenicity, mutagenicity, reproductive and specific target organ toxicity after repeated exposure in the first ten years of the REACH regulation.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31085250</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30125-4</DOI>
    <KeywordList>
      <Keywords>CLP</Keywords>
      <Keywords>CMR</Keywords>
      <Keywords>Carcinogenic</Keywords>
      <Keywords>Human health</Keywords>
      <Keywords>Mutagenic</Keywords>
      <Keywords>REACH</Keywords>
      <Keywords>Repeated exposure</Keywords>
      <Keywords>Specific target organ toxicity</Keywords>
      <Keywords>Study availability</Keywords>
      <Keywords>Toxic to reproduction</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Panagiotis G. Karamertzanis</Name>
        <Affiliation>Computational Assessment and Dissemination Unit, Registration Directorate, European Chemicals Agency (ECHA), Helsinki, 00120, Finland. Electronic address: panagiotis.karamertzanis@echa.europa.eu.</Affiliation>
      </Author>
      <Author>
        <Name>Palmi Atlason</Name>
        <Affiliation>Classification and Prioritisation Unit, Risk Management Directorate, European Chemicals Agency (ECHA), Helsinki, 00120, Finland.</Affiliation>
      </Author>
      <Author>
        <Name>Alexis V. Nathanail</Name>
        <Affiliation>Classification and Prioritisation Unit, Risk Management Directorate, European Chemicals Agency (ECHA), Helsinki, 00120, Finland.</Affiliation>
      </Author>
      <Author>
        <Name>Jeroen Provoost</Name>
        <Affiliation>Computational Assessment and Dissemination Unit, Registration Directorate, European Chemicals Agency (ECHA), Helsinki, 00120, Finland.</Affiliation>
      </Author>
      <Author>
        <Name>Elina Karhu</Name>
        <Affiliation>Classification and Prioritisation Unit, Risk Management Directorate, European Chemicals Agency (ECHA), Helsinki, 00120, Finland.</Affiliation>
      </Author>
      <Author>
        <Name>Mike Rasenberg</Name>
        <Affiliation>Computational Assessment and Dissemination Unit, Registration Directorate, European Chemicals Agency (ECHA), Helsinki, 00120, Finland.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Re: A study in a rat initiation-promotion bladder tumour model demonstrated no promoter/progressor potential of dapagliflozin.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31085249</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30138-2</DOI>
    <AuthorList>
      <Author>
        <Name>P. A. Oliveira</Name>
        <Affiliation>Department of Veterinary Sciences, School of Agrarian Sciences, University of Trás-os-Montes and Alto Douro, UTAD, 5001-911, Vila Real, Portugal; Center for the Research and Technology of Agro-Environmental and Biological Sciences (CITAB), University of Trás-os-Montes and Alto Douro, UTAD, 5001-911, Vila Real, Portugal. Electronic address: pamo@utad.pt.</Affiliation>
      </Author>
      <Author>
        <Name>F. Seixas</Name>
        <Affiliation>Department of Veterinary Sciences, School of Agrarian Sciences, University of Trás-os-Montes and Alto Douro, UTAD, 5001-911, Vila Real, Portugal; CECAV, University of Trás-os-Montes and Alto Douro, UTAD, 5001-911, Vila Real, Portugal. Electronic address: fseixas@utad.pt.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Fragrance inhalation and adverse health effects.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31085248</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30129-1</DOI>
    <AuthorList>
      <Author>
        <Name>Anne Steinemann</Name>
        <Affiliation>Professor of Civil Engineering, The University of Melbourne, Australia. Electronic address: anne.steinemann@unimelb.edu.au.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Toxicology and human health risk assessment of polyethoxylated tallow amine surfactant used in glyphosate formulations.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31082430</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30086-8</DOI>
    <KeywordList>
      <Keywords>Food risk assessment</Keywords>
      <Keywords>Glyphosate</Keywords>
      <Keywords>Human health risk assessment</Keywords>
      <Keywords>Occupational risk assessment</Keywords>
      <Keywords>POE-T</Keywords>
      <Keywords>POEA</Keywords>
      <Keywords>Polyethoxylated tallow amine</Keywords>
      <Keywords>Roundup</Keywords>
      <Keywords>Surfactants</Keywords>
      <Keywords>Toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Mark A. Martens</Name>
        <Affiliation>MMTA bvba, Consulting in Preclinical Development and Toxicology, Jachthuislaan 26, B-3210, Lubbeek, Belgium. Electronic address: mark.a.martens@skynet.be.</Affiliation>
      </Author>
      <Author>
        <Name>Marian S. Bleeke</Name>
        <Affiliation>Bayer US Crop Science Division, 700 Chesterfield Parkway, St Louis, MO, United States. Electronic address: marian.bleeke@bayer.com.</Affiliation>
      </Author>
      <Author>
        <Name>Vincent A. Leopold</Name>
        <Affiliation>Bayer US Crop Science Division, 700 Chesterfield Parkway, St Louis, MO, United States. Electronic address: vincent.leopold@bayer.com.</Affiliation>
      </Author>
      <Author>
        <Name>Donna R. Farmer</Name>
        <Affiliation>Bayer US Crop Science Division, 700 Chesterfield Parkway, St Louis, MO, United States. Electronic address: donna.farmer@bayer.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Exploring current read-across applications and needs among selected U.S. Federal Agencies.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31078681</pubmedLink>
    <GrantList>
      <Grant>EPA999999</Grant>
      <Grant>HHSN273201500010C</Grant>
    </GrantList>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30139-4</DOI>
    <KeywordList>
      <Keywords>Analog approach</Keywords>
      <Keywords>Category approach</Keywords>
      <Keywords>ICCVAM</Keywords>
      <Keywords>New approach methodology (NAM)</Keywords>
      <Keywords>Read-across</Keywords>
      <Keywords>Regulatory purpose</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Grace Patlewicz</Name>
        <Affiliation>(a)National Center for Computational Toxicology, U.S. Environmental Protection Agency, 109 TW Alexander Dr, Research Triangle Park, NC, 27709, USA. Electronic address: patlewicz.grace@epa.gov.</Affiliation>
      </Author>
      <Author>
        <Name>Lucina E. Lizarraga</Name>
        <Affiliation>(b)National Center for Environmental Assessment, U.S. Environmental Protection Agency, 26 West Martin Luther King Drive, Cincinnati, OH, 45268, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Diego Rua</Name>
        <Affiliation>Center for Devices and Radiological Health, U.S. Food and Drug Administration, 10903 New Hampshire Avenue, Silver Spring, MD, 20993, USA.</Affiliation>
      </Author>
      <Author>
        <Name>David G. Allen</Name>
        <Affiliation>ILS, P.O. Box 13501, Research Triangle Park, NC, 27709, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Amber B. Daniel</Name>
        <Affiliation>ILS, P.O. Box 13501, Research Triangle Park, NC, 27709, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Suzanne C. Fitzpatrick</Name>
        <Affiliation>Center for Food Safety and Applied Nutrition, U.S. Food and Drug Administration, 5100 Paint Branch Parkway, College Park, MD, 20740, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Natàlia Garcia-Reyero</Name>
        <Affiliation>Environmental Laboratory, U.S. Army Engineer Research and Developmental Center, 3909 Halls Ferry Rd., Vicksburg, MS, 39180, USA.</Affiliation>
      </Author>
      <Author>
        <Name>John Gordon</Name>
        <Affiliation>U.S. Consumer Product Safety Commission, 5 Research Place, Rockville, MD, 20850, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Pertti Hakkinen</Name>
        <Affiliation>National Library of Medicine, 6707 Democracy Blvd., Bethesda, MD, 20892, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Angela S. Howard</Name>
        <Affiliation>ILS, P.O. Box 13501, Research Triangle Park, NC, 27709, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Agnes Karmaus</Name>
        <Affiliation>ILS, P.O. Box 13501, Research Triangle Park, NC, 27709, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Joanna Matheson</Name>
        <Affiliation>U.S. Consumer Product Safety Commission, 5 Research Place, Rockville, MD, 20850, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Moiz Mumtaz</Name>
        <Affiliation>Agency for Toxic Substances and Disease Registry, 1600 Clifton Rd., Chamblee, GA, 30341, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Andrea Nicole Richarz</Name>
        <Affiliation>European Commission, Joint Research Centre (JRC), Ispra, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Patricia Ruiz</Name>
        <Affiliation>Agency for Toxic Substances and Disease Registry, 1600 Clifton Rd., Chamblee, GA, 30341, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Louis Scarano</Name>
        <Affiliation>Office of Pollution Prevention and Toxics, U.S. Environmental Protection Agency, 1200 Pennsylvania Ave. NW, Washington, DC, 20460, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Takashi Yamada</Name>
        <Affiliation>Division of Risk Assessment, Biological Safety Research Center, National Institute of Health Sciences, 3-25-26, Tonomachi, Kawasaki-ku, Kawasaki, Kanagawa, 210-9501, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Nicole Kleinstreuer</Name>
        <Affiliation>National Toxicology Program Interagency Center for the Evaluation of Alternative Toxicological Methods, National Institute of Environmental Health Sciences, P.O. Box 12233, Research Triangle Park, NC, 27709, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Interspecies differences in perfluoroalkyl substances (PFAS) toxicokinetics and application to health-based criteria.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31078680</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30130-8</DOI>
    <KeywordList>
      <Keywords>PFAS</Keywords>
      <Keywords>PFBA</Keywords>
      <Keywords>PFBS</Keywords>
      <Keywords>PFHxS</Keywords>
      <Keywords>PFOA</Keywords>
      <Keywords>PFOS</Keywords>
      <Keywords>Perfluorinated</Keywords>
      <Keywords>Toxicokinetics</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Daniella M. Pizzurro</Name>
        <Affiliation>Gradient, Cambridge, MA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Mara Seeley</Name>
        <Affiliation>Gradient, Cambridge, MA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Laura E. Kerper</Name>
        <Affiliation>Gradient, Cambridge, MA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Barbara D. Beck</Name>
        <Affiliation>Gradient, Cambridge, MA, USA. Electronic address: bbeck@gradientcorp.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Mutual recognition in the European system: A blueprint for increasing access to medicines?</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31071381</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30126-6</DOI>
    <KeywordList>
      <Keywords>Access to medicines</Keywords>
      <Keywords>Mutual recognition</Keywords>
      <Keywords>Regulatory harmonisation</Keywords>
      <Keywords>Reliance</Keywords>
      <Keywords>Work-sharing</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Ivana Škrnjug</Name>
        <Affiliation>Paul-Ehrlich-Institut, Paul-Ehrlich Str. 51-59, 63225, Langen, Germany. Electronic address: Ivana.Skrnjug@inforeg.de.</Affiliation>
      </Author>
      <Author>
        <Name>Sabina Uzeirbegović</Name>
        <Affiliation>The Agency for Medicinal Products and Medical Devices of Croatia, Ksaverska cesta 4, 10000, Zagreb, Croatia.</Affiliation>
      </Author>
      <Author>
        <Name>Maja Lovrek Romčević</Name>
        <Affiliation>The Agency for Medicinal Products and Medical Devices of Croatia, Ksaverska cesta 4, 10000, Zagreb, Croatia.</Affiliation>
      </Author>
      <Author>
        <Name>Siniša Tomić</Name>
        <Affiliation>The Agency for Medicinal Products and Medical Devices of Croatia, Ksaverska cesta 4, 10000, Zagreb, Croatia.</Affiliation>
      </Author>
      <Author>
        <Name>Heidi Meyer</Name>
        <Affiliation>Paul-Ehrlich-Institut, Paul-Ehrlich Str. 51-59, 63225, Langen, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Christoph Conrad</Name>
        <Affiliation>Paul-Ehrlich-Institut, Paul-Ehrlich Str. 51-59, 63225, Langen, Germany.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Can sustained exposure to PFAS trigger a genotoxic response? A comprehensive genotoxicity assessment in mice after subacute oral administration of PFOA and PFBA.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31071380</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30127-8</DOI>
    <KeywordList>
      <Keywords>Genotoxicity</Keywords>
      <Keywords>In vivo</Keywords>
      <Keywords>PFAS</Keywords>
      <Keywords>Risk assessment</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Riccardo Crebelli</Name>
        <Affiliation>Istituto Superiore di Sanità, Rome, Italy. Electronic address: riccardo.crebelli@iss.it.</Affiliation>
      </Author>
      <Author>
        <Name>Stefania Caiola</Name>
        <Affiliation>Istituto Superiore di Sanità, Rome, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Luigi Conti</Name>
        <Affiliation>Istituto Superiore di Sanità, Rome, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Eugenia Cordelli</Name>
        <Affiliation>ENEA Casaccia, Laboratory of Biosafety and Risk Assessment, Rome, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Gabriele De Luca</Name>
        <Affiliation>Istituto Superiore di Sanità, Rome, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Elena Dellatte</Name>
        <Affiliation>Istituto Superiore di Sanità, Rome, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Patrizia Eleuteri</Name>
        <Affiliation>ENEA Casaccia, Laboratory of Biosafety and Risk Assessment, Rome, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Nicola Iacovella</Name>
        <Affiliation>Istituto Superiore di Sanità, Rome, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Paola Leopardi</Name>
        <Affiliation>Istituto Superiore di Sanità, Rome, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Francesca Marcon</Name>
        <Affiliation>Istituto Superiore di Sanità, Rome, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Massimo Sanchez</Name>
        <Affiliation>Istituto Superiore di Sanità, Rome, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Paola Sestili</Name>
        <Affiliation>Istituto Superiore di Sanità, Rome, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Ester Siniscalchi</Name>
        <Affiliation>Istituto Superiore di Sanità, Rome, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Paola Villani</Name>
        <Affiliation>ENEA Casaccia, Laboratory of Biosafety and Risk Assessment, Rome, Italy.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Derivation of biomonitoring equivalents (BE values) for zinc.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31063796</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30117-5</DOI>
    <KeywordList>
      <Keywords>Biomarkers of exposure</Keywords>
      <Keywords>Biomonitoring</Keywords>
      <Keywords>Biomonitoring equivalents</Keywords>
      <Keywords>Exposure guidance values</Keywords>
      <Keywords>Homeostasis</Keywords>
      <Keywords>Human health risk assessment</Keywords>
      <Keywords>Zinc</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Devika Poddalgoda</Name>
        <Affiliation>Healthy Environment and Consumer Safety Branch, Health Canada, Government of Canada, Ottawa, ON, Canada. Electronic address: devika.poddalgoda@canada.ca.</Affiliation>
      </Author>
      <Author>
        <Name>Kristin Macey</Name>
        <Affiliation>Healthy Environment and Consumer Safety Branch, Health Canada, Government of Canada, Ottawa, ON, Canada. Electronic address: kristin.macey@canada.ca.</Affiliation>
      </Author>
      <Author>
        <Name>Scott Hancock</Name>
        <Affiliation>Healthy Environment and Consumer Safety Branch, Health Canada, Government of Canada, Ottawa, ON, Canada. Electronic address: scott.hancock@canada.ca.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Lead exposure in common shelduck (Tadorna tadorna): Tracking the success of the Pb shot ban for hunting in Spanish wetlands.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31063795</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30124-2</DOI>
    <KeywordList>
      <Keywords>Common shelduck</Keywords>
      <Keywords>La Albufera Natural Park</Keywords>
      <Keywords>Lead</Keywords>
      <Keywords>Pellet</Keywords>
      <Keywords>Plumbism</Keywords>
      <Keywords>Tadorna tadorna</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Irene Valverde</Name>
        <Affiliation>Area of Toxicology, Department of Health Sciences, University of Murcia, IMIB-Arrixaca, Campus de Espinardo, 30100, Murcia, Spain.</Affiliation>
      </Author>
      <Author>
        <Name>Silvia Espín</Name>
        <Affiliation>Area of Toxicology, Department of Health Sciences, University of Murcia, IMIB-Arrixaca, Campus de Espinardo, 30100, Murcia, Spain; Toxicology and Risk Assessment Group, Biomedical Research Institute of Murcia (IMIB-Arrixaca), University of Murcia, Campus de Espinardo, 30100, Murcia, Spain.</Affiliation>
      </Author>
      <Author>
        <Name>Isabel Navas</Name>
        <Affiliation>Area of Toxicology, Department of Health Sciences, University of Murcia, IMIB-Arrixaca, Campus de Espinardo, 30100, Murcia, Spain; Toxicology and Risk Assessment Group, Biomedical Research Institute of Murcia (IMIB-Arrixaca), University of Murcia, Campus de Espinardo, 30100, Murcia, Spain.</Affiliation>
      </Author>
      <Author>
        <Name>Pedro María-Mojica</Name>
        <Affiliation>Area of Toxicology, Department of Health Sciences, University of Murcia, IMIB-Arrixaca, Campus de Espinardo, 30100, Murcia, Spain; Santa-Faz Wildlife Rehabilitation Center, Conselleria de Agricultura, Medio Ambiente, Cambio Climático y Desarrollo Rural, Alicante, Generalitat Valenciana, Spain.</Affiliation>
      </Author>
      <Author>
        <Name>José M. Gil</Name>
        <Affiliation>La-Granja Wildlife Rehabilitation Center, Conselleria de Agricultura, Medio Ambiente, Cambio Climático y Desarrollo Rural, Valencia, Generalitat, Valenciana, Spain.</Affiliation>
      </Author>
      <Author>
        <Name>Antonio J. García-Fernández</Name>
        <Affiliation>Area of Toxicology, Department of Health Sciences, University of Murcia, IMIB-Arrixaca, Campus de Espinardo, 30100, Murcia, Spain; Toxicology and Risk Assessment Group, Biomedical Research Institute of Murcia (IMIB-Arrixaca), University of Murcia, Campus de Espinardo, 30100, Murcia, Spain. Electronic address: ajgf@um.es.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Considerations for refining the risk assessment process for formaldehyde: Results from an interdisciplinary workshop.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31059732</pubmedLink>
    <GrantList>
      <Grant>MC_PC_15015</Grant>
      <Grant>MC_U147585823</Grant>
      <Grant>MC_UP_A620_1018</Grant>
      <Grant>MC_UU_12011/5</Grant>
    </GrantList>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30114-X</DOI>
    <KeywordList>
      <Keywords>Evidence integration</Keywords>
      <Keywords>Formaldehyde</Keywords>
      <Keywords>Inconsistent human epidemiology</Keywords>
      <Keywords>Integrating data streams</Keywords>
      <Keywords>Mode-of-action in animal studies</Keywords>
      <Keywords>Reconciling conflicting conclusions</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Melvin E. Andersen</Name>
        <Affiliation>ScitoVation LLC, 100 Capitola Drive, Drive 106, Durham, NC, 27713, USA. Electronic address: mandersen@scitovation.com.</Affiliation>
      </Author>
      <Author>
        <Name>P. Robinan Gentry</Name>
        <Affiliation>Ramboll US Corporation, Monroe, LA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>James A. Swenberg</Name>
        <Affiliation>Department of Environmental Sciences and Engineering, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Kenneth A. Mundt</Name>
        <Affiliation>Ramboll US Corporation, Amherst, MA (currently with Cardno Chemrisk, Boston, MA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Kimberly W. White</Name>
        <Affiliation>American Chemistry Council, Washington, DC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Chad Thompson</Name>
        <Affiliation>ToxStrategies, Inc., Katy, TX, USA.</Affiliation>
      </Author>
      <Author>
        <Name>James Bus</Name>
        <Affiliation>Center for Toxicology and Mechanistic Biology, Exponent, Alexandria, VA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>James H. Sherman</Name>
        <Affiliation>Celanese, Irving, TX, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Helmut Greim</Name>
        <Affiliation>Technical University of Munich, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Hermann Bolt</Name>
        <Affiliation>Leibniz Institute for Working Environment and Human Factors (IfADo), Dortmund, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Gary M. Marsh</Name>
        <Affiliation>Department of Biostatistics, Center for Occupational Biostatistics and Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Harvey Checkoway</Name>
        <Affiliation>University of California, San Diego, Department of Family Medicine and Public Health, USA.</Affiliation>
      </Author>
      <Author>
        <Name>David Coggon</Name>
        <Affiliation>MRC Lifecourse Epidemiology Unit, University of Southampton, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Harvey J. Clewell</Name>
        <Affiliation>Ramboll US Corporation, 6 Davis Drive, Suite 13, Research Triangle Park, NC, 27709, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Traumatic acid toxicity mechanisms in human breast cancer MCF-7 cells.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31055047</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30122-9</DOI>
    <KeywordList>
      <Keywords>Apoptosis</Keywords>
      <Keywords>Glutathione</Keywords>
      <Keywords>MCF-7</Keywords>
      <Keywords>Oxidative stress</Keywords>
      <Keywords>Reactive oxygen species</Keywords>
      <Keywords>Traumatic acid</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Agata Jabłońska-Trypuć</Name>
        <Affiliation>Division of Chemistry, Biology and Biotechnology, Białystok University of Technology, Białystok, 15-351, Poland. Electronic address: a.jablonska@pb.edu.pl.</Affiliation>
      </Author>
      <Author>
        <Name>Rafał Krętowski</Name>
        <Affiliation>Department of Pharmaceutical Biochemistry, Medical University of Białystok, Białystok, 15-222, Poland.</Affiliation>
      </Author>
      <Author>
        <Name>Elżbieta Wołejko</Name>
        <Affiliation>Division of Chemistry, Biology and Biotechnology, Białystok University of Technology, Białystok, 15-351, Poland.</Affiliation>
      </Author>
      <Author>
        <Name>Urszula Wydro</Name>
        <Affiliation>Division of Chemistry, Biology and Biotechnology, Białystok University of Technology, Białystok, 15-351, Poland.</Affiliation>
      </Author>
      <Author>
        <Name>Andrzej Butarewicz</Name>
        <Affiliation>Division of Chemistry, Biology and Biotechnology, Białystok University of Technology, Białystok, 15-351, Poland.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Bridging communities in the field of nanomedicine.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31051191</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30110-2</DOI>
    <KeywordList>
      <Keywords>Nanomedicine</Keywords>
      <Keywords>critical quality attributes</Keywords>
      <Keywords>immune effects</Keywords>
      <Keywords>regulatory science</Keywords>
      <Keywords>standardization</Keywords>
      <Keywords>workshop</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Blanka Halamoda-Kenzaoui</Name>
        <Affiliation>European Commission Joint Research Centre (JRC), Ispra, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Simon Baconnier</Name>
        <Affiliation>Université Grenoble Alpes, CEA LETI MlNATEC Campus, Grenoble, France.</Affiliation>
      </Author>
      <Author>
        <Name>Thierry Bastogne</Name>
        <Affiliation>Université de Lorraine, CNRS, CRAN, INRIA BIGS, Nancy, France.</Affiliation>
      </Author>
      <Author>
        <Name>Didier Bazile</Name>
        <Affiliation>CMC External Innovation, Sanofi, Gentilly, France.</Affiliation>
      </Author>
      <Author>
        <Name>Patrick Boisseau</Name>
        <Affiliation>Université Grenoble Alpes, CEA LETI MlNATEC Campus, Grenoble, France.</Affiliation>
      </Author>
      <Author>
        <Name>Gerrit Borchard</Name>
        <Affiliation>Université de Genève, Ecole de Pharmacie Genève-Lausanne, Genève, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Sven Even Borgos</Name>
        <Affiliation>SINTEF Industry, Trondheim, Norway.</Affiliation>
      </Author>
      <Author>
        <Name>Luigi Calzolai</Name>
        <Affiliation>European Commission Joint Research Centre (JRC), Ispra, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Karin Cederbrant</Name>
        <Affiliation>Swedish Toxicology Sciences Research Center (Swetox), Södertälje, Sweden.</Affiliation>
      </Author>
      <Author>
        <Name>Gabriella Di Felice</Name>
        <Affiliation>National Center for Drug Research and Evaluation, Istituto Superiore di Sanità, Roma, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Tiziana Di Francesco</Name>
        <Affiliation>Université de Genève, Ecole de Pharmacie Genève-Lausanne, Genève, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Marina A. Dobrovolskaia</Name>
        <Affiliation>Nanotechnology Characterization Laboratory (NCL), Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Sponsored By the National Cancer Institute, Frederick, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Rogério Gaspar</Name>
        <Affiliation>Faculty of Pharmacy and Institute for Bioengineering and Biosciences of the University of Lisbon, Lisboa Portugal.</Affiliation>
      </Author>
      <Author>
        <Name>Belén Gracia</Name>
        <Affiliation>Department of Medicines for Human Use, Agencia Española de Medicamentos y Productos Sanitarios, Madrid, Spain.</Affiliation>
      </Author>
      <Author>
        <Name>Vincent A. Hackley</Name>
        <Affiliation>National Institute of Standards and Technology (NIST), Materials Measurement Science Division, Gaithersburg, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Lada Leyens</Name>
        <Affiliation>Swissmedic, Swiss Agency for Therapeutic Products, Bern, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Neill Liptrott</Name>
        <Affiliation>Department of Molecular and Clinical Pharmacology, Institute of Translational Medicine, The University of Liverpool, Liverpool, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Margriet Park</Name>
        <Affiliation>RIVM- National Institute for Public Health and the Environment, Bilthoven, Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Anil Patri</Name>
        <Affiliation>U.S. Food &amp; Drug Administration (FDA), Nanotechnology Core Facility, Jefferson, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Gert Roebben</Name>
        <Affiliation>European Commission Joint Research Centre (JRC), Geel, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Matthias Roesslein</Name>
        <Affiliation>Empa - Swiss Federal Laboratories for Materials Science and Technology, St. Gallen, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>René Thürmer</Name>
        <Affiliation>BfArM - Federal Institute for Drugs and Medical Devices, Bonn, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Patricia Urbán</Name>
        <Affiliation>European Commission Joint Research Centre (JRC), Ispra, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Valérie Zuang</Name>
        <Affiliation>European Commission Joint Research Centre (JRC), Ispra, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Susanne Bremer-Hoffmann</Name>
        <Affiliation>European Commission Joint Research Centre (JRC), Ispra, Italy. Electronic address: susanne.bremer-hoffmann@ec.europa.eu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>An occupational exposure limit (OEL) approach to protect home healthcare workers exposed to common nebulized drugs.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31047944</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30120-5</DOI>
    <KeywordList>
      <Keywords>Acceptable daily exposure or OEL</Keywords>
      <Keywords>Albuterol</Keywords>
      <Keywords>Budesonide</Keywords>
      <Keywords>Ipratropium</Keywords>
      <Keywords>Nebulizer</Keywords>
      <Keywords>Pharmaceutical risk assessment</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Evan Frank</Name>
        <Affiliation>University of Cincinnati, College of Medicine, Department of Environmental Health, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Simileoluwa Ishau</Name>
        <Affiliation>University of Cincinnati, College of Medicine, Department of Environmental Health, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Andrew Maier</Name>
        <Affiliation>University of Cincinnati, College of Medicine, Department of Environmental Health, and Cardno ChemRisk, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Susan Reutman</Name>
        <Affiliation>University of Cincinnati, College of Nursing, USA.</Affiliation>
      </Author>
      <Author>
        <Name>John F. Reichard</Name>
        <Affiliation>University of Cincinnati, College of Medicine, Department of Environmental Health, USA. Electronic address: reichajf@ucmail.uc.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Medical devices biocompatibility assessment on HCE: Evidences of delayed cytotoxicity of preserved compared to preservative free eye drops.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31039384</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30121-7</DOI>
    <KeywordList>
      <Keywords>BAK</Keywords>
      <Keywords>Biocompatibility</Keywords>
      <Keywords>HCE</Keywords>
      <Keywords>Medical devices</Keywords>
      <Keywords>Ocular surface</Keywords>
      <Keywords>Preservative free eye drops</Keywords>
      <Keywords>Soft preservatives</Keywords>
      <Keywords>Toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Marisa Meloni</Name>
        <Affiliation>VitroScreen, Via Mosè Bianchi 103, 20149, Milan, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Silvia Balzaretti</Name>
        <Affiliation>VitroScreen, Via Mosè Bianchi 103, 20149, Milan, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Laura Ceriotti</Name>
        <Affiliation>VitroScreen, Via Mosè Bianchi 103, 20149, Milan, Italy. Electronic address: laura.ceriotti@vitroscreen.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Skin lightening products' violations in Europe: An analysis of the rapid alert system for dangerous non-food products 2005-2018.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31029853</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30119-9</DOI>
    <KeywordList>
      <Keywords>Clobetasol</Keywords>
      <Keywords>Heavy metals</Keywords>
      <Keywords>Hydroquinone</Keywords>
      <Keywords>Skin lightening preparations</Keywords>
      <Keywords>Skin pigmentation</Keywords>
      <Keywords>Vulnerable populations</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Irmina Maria Michalek</Name>
        <Affiliation>Faculty of Social Sciences, Tampere University, Tampere, Finland. Electronic address: irmina.michalek@tuni.fi.</Affiliation>
      </Author>
      <Author>
        <Name>Bian Liu</Name>
        <Affiliation>Institute for Translational Epidemiology, Center for Biostatistics, and Department of Population Health Science &amp; Policy, Icahn School of Medicine at Mount Sinai, New York, NY, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Emma K. T. Benn</Name>
        <Affiliation>Institute for Translational Epidemiology, Center for Biostatistics, and Department of Population Health Science &amp; Policy, Icahn School of Medicine at Mount Sinai, New York, NY, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Florentino Luciano Caetano Dos Santos</Name>
        <Affiliation>School of Engineering, École Polytechnique Fédérale de Lausanne, Lausanne, Switzerland.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Human health risk assessment: Study of a population exposed to fluoride through groundwater of Agra city, India.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31028799</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30112-6</DOI>
    <KeywordList>
      <Keywords>Agra</Keywords>
      <Keywords>Cluster analysis</Keywords>
      <Keywords>Fluoride</Keywords>
      <Keywords>Health risk assessment</Keywords>
      <Keywords>Population</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Krishna Kumar Yadav</Name>
        <Affiliation>Institute of Environment and Development Studies, Bundelkhand University, Kanpur Road, Jhansi, 284128, India. Electronic address: envirokrishna@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Vinit Kumar</Name>
        <Affiliation>Institute of Environment and Development Studies, Bundelkhand University, Kanpur Road, Jhansi, 284128, India.</Affiliation>
      </Author>
      <Author>
        <Name>Neha Gupta</Name>
        <Affiliation>Institute of Environment and Development Studies, Bundelkhand University, Kanpur Road, Jhansi, 284128, India.</Affiliation>
      </Author>
      <Author>
        <Name>Sandeep Kumar</Name>
        <Affiliation>Centre for Environment Science and Climate Resilient Agriculture, Indian Agricultural Research Institute, New Delhi, 110012, India.</Affiliation>
      </Author>
      <Author>
        <Name>Shahabaldin Rezania</Name>
        <Affiliation>Department of Civil and Environmental Engineering, Seoul National University, Seoul, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Neeraja Singh</Name>
        <Affiliation>Department of Botany, University of Delhi, New Delhi, 110007, India.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Non-relevance of acute dermal toxicity testing for assessing human health protection in the regulatory decision-making for agrochemical formulated products.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31028798</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30113-8</DOI>
    <KeywordList>
      <Keywords>Acute toxicity tests</Keywords>
      <Keywords>Animal testing reduction</Keywords>
      <Keywords>Classification</Keywords>
      <Keywords>Crop protection</Keywords>
      <Keywords>Dermal toxicity</Keywords>
      <Keywords>LD(50)</Keywords>
      <Keywords>Oral toxicity</Keywords>
      <Keywords>Reduction</Keywords>
      <Keywords>Replacement</Keywords>
      <Keywords>Waiver of data</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Andreia O. Latorre</Name>
        <Affiliation>Bayer S.A., Rua Domingos Jorge, 1100, Sao Paulo, SP, Brazil. Electronic address: andreia.latorre@bayer.com.</Affiliation>
      </Author>
      <Author>
        <Name>Pedro V. M. Floresta</Name>
        <Affiliation>Corteva, Alameda Itapecuru, 506, Alphaville, Barueri, SP, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Marylia M. Boff</Name>
        <Affiliation>IHARABRAS S.A. INDUSTRIAS QUIMICAS, Avenida Liberdade, Sorocaba, SP, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Priscila M. Fagundes</Name>
        <Affiliation>Syngenta Crop Protection, Avenida das Nacoes Unidas, 18001, Sao Paulo, SP, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Ana P. Martins</Name>
        <Affiliation>FMC Química do Brasil LTDA, Av. Dr. Jose Bonifacio Coutinho Nogueira, 150, Campinas, SP, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Shadia M. Ihlaseh-Catalano</Name>
        <Affiliation>BASF S.A., Avenida das Nacoes Unidas, 12997, 17279, Sao Paulo, SP, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Karen C. C. Cazarin</Name>
        <Affiliation>BASF S.A., Avenida das Nacoes Unidas, 12997, 17279, Sao Paulo, SP, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Ligia L. Romeo</Name>
        <Affiliation>Bayer S.A., Rua Domingos Jorge, 1100, Sao Paulo, SP, Brazil.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Assessing in vitro dermal absorption of dry residues of agrochemical sprays using human skin within OECD TG 428.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31028797</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30115-1</DOI>
    <KeywordList>
      <Keywords>Agrochemicals</Keywords>
      <Keywords>DFR</Keywords>
      <Keywords>Dermal absorption</Keywords>
      <Keywords>Dermal exposure</Keywords>
      <Keywords>Dislodgeable foliar residues</Keywords>
      <Keywords>Human skin</Keywords>
      <Keywords>In vitro</Keywords>
      <Keywords>Pesticides</Keywords>
      <Keywords>Plant protection products</Keywords>
      <Keywords>Re-entry worker risk assessment</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>M. Aggarwal</Name>
        <Affiliation>Corteva Agriscience LLC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>P. Fisher</Name>
        <Affiliation>Bayer CropScience, France.</Affiliation>
      </Author>
      <Author>
        <Name>F. M. Kluxen</Name>
        <Affiliation>ADAMA Deutschland GmbH, Germany. Electronic address: felix.kluxen@adama.com.</Affiliation>
      </Author>
      <Author>
        <Name>W. Maas</Name>
        <Affiliation>TNO Triskelion, Netherlands; (h)Charles River Laboratories, Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>N. Morgan</Name>
        <Affiliation>Syngenta Ltd., UK.</Affiliation>
      </Author>
      <Author>
        <Name>R. Parr-Dobrzanski</Name>
        <Affiliation>Syngenta Ltd., UK.</Affiliation>
      </Author>
      <Author>
        <Name>C. Strupp</Name>
        <Affiliation>Gowan Crop Protection Ltd., UK.</Affiliation>
      </Author>
      <Author>
        <Name>C. Wiemann</Name>
        <Affiliation>BASF Oesterreich GmbH, Austria.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Bioaccessibility of nickel and cobalt in powders and massive forms of stainless steel, nickel- or cobalt-based alloys, and nickel and cobalt metals in artificial sweat.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31028796</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30116-3</DOI>
    <KeywordList>
      <Keywords>Artificial sweat</Keywords>
      <Keywords>Classification</Keywords>
      <Keywords>Corrosion</Keywords>
      <Keywords>EN 1811</Keywords>
      <Keywords>Metal release</Keywords>
      <Keywords>Particles</Keywords>
      <Keywords>Regulation</Keywords>
      <Keywords>Skin sensitizer</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Xuying Wang</Name>
        <Affiliation>KTH Royal Institute of Technology, School of Engineering Sciences in Chemistry, Biotechnology and Health, Department of Chemistry, Division of Surface and Corrosion Science, Drottning Kristinas V. 51, SE-10044, Stockholm, Sweden.</Affiliation>
      </Author>
      <Author>
        <Name>Gunilla Herting</Name>
        <Affiliation>KTH Royal Institute of Technology, School of Engineering Sciences in Chemistry, Biotechnology and Health, Department of Chemistry, Division of Surface and Corrosion Science, Drottning Kristinas V. 51, SE-10044, Stockholm, Sweden.</Affiliation>
      </Author>
      <Author>
        <Name>Zheng Wei</Name>
        <Affiliation>KTH Royal Institute of Technology, School of Engineering Sciences in Chemistry, Biotechnology and Health, Department of Chemistry, Division of Surface and Corrosion Science, Drottning Kristinas V. 51, SE-10044, Stockholm, Sweden.</Affiliation>
      </Author>
      <Author>
        <Name>Inger Odnevall Wallinder</Name>
        <Affiliation>KTH Royal Institute of Technology, School of Engineering Sciences in Chemistry, Biotechnology and Health, Department of Chemistry, Division of Surface and Corrosion Science, Drottning Kristinas V. 51, SE-10044, Stockholm, Sweden.</Affiliation>
      </Author>
      <Author>
        <Name>Yolanda Hedberg</Name>
        <Affiliation>KTH Royal Institute of Technology, School of Engineering Sciences in Chemistry, Biotechnology and Health, Department of Chemistry, Division of Surface and Corrosion Science, Drottning Kristinas V. 51, SE-10044, Stockholm, Sweden. Electronic address: yolanda@kth.se.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Innovative selection approach for a new antifungal agent mefentrifluconazole (Revysol</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31026541</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30108-4</DOI>
    <KeywordList>
      <Keywords>Azole</Keywords>
      <Keywords>Endocrine disruption</Keywords>
      <Keywords>High fungal CYP51 inhibition</Keywords>
      <Keywords>Low human CYP19 (aromatase) inhibition</Keywords>
      <Keywords>Reproductive toxicity</Keywords>
      <Keywords>Selectivity factor</Keywords>
      <Keywords>Teratogenicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Sheila A. Tesh</Name>
        <Affiliation>Tesh Consultants International, Sweffling, Saxmundham, Suffolk, IP17 2BA, UK.</Affiliation>
      </Author>
      <Author>
        <Name>John M. Tesh</Name>
        <Affiliation>Tesh Consultants International, Sweffling, Saxmundham, Suffolk, IP17 2BA, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Ivana Fegert</Name>
        <Affiliation>BASF SE, Regulatory Toxicology Agricultural Solutions, Ludwigshafen, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Roland Buesen</Name>
        <Affiliation>BASF SE, Experimental Toxicology and Ecology, Ludwigshafen, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Steffen Schneider</Name>
        <Affiliation>BASF SE, Experimental Toxicology and Ecology, Ludwigshafen, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Tobias Mentzel</Name>
        <Affiliation>BASF SE, Early Fungicide Biology, Limburgerhof, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Bennard van Ravenzwaay</Name>
        <Affiliation>BASF SE, Experimental Toxicology and Ecology, Ludwigshafen, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Stefan Stinchcombe</Name>
        <Affiliation>BASF SE, Regulatory Toxicology Agricultural Solutions, Ludwigshafen, Germany. Electronic address: stefan.stinchcombe@basf.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Identification and description of the uncertainty, variability, bias and influence in quantitative structure-activity relationships (QSARs) for toxicity prediction.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31026540</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30106-0</DOI>
    <KeywordList>
      <Keywords>Assessment criteria</Keywords>
      <Keywords>Barriers</Keywords>
      <Keywords>Bias</Keywords>
      <Keywords>Influence</Keywords>
      <Keywords>QSAR</Keywords>
      <Keywords>Toxicity prediction</Keywords>
      <Keywords>Uncertainty</Keywords>
      <Keywords>Variability</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Mark T. D. Cronin</Name>
        <Affiliation>Liverpool John Moores University, School of Pharmacy and Biomolecular Sciences, Liverpool, England, United Kingdom. Electronic address: m.t.cronin@ljmu.ac.uk.</Affiliation>
      </Author>
      <Author>
        <Name>Andrea Nicole Richarz</Name>
        <Affiliation>European Commission, Joint Research Centre (JRC), Ispra, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Terry W. Schultz</Name>
        <Affiliation>(c)The University of Tennessee, College of Veterinary Medicine, Knoxville, TN, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Assessment of indirect inhalation exposure to formaldehyde evaporated from water.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31026539</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30118-7</DOI>
    <KeywordList>
      <Keywords>Chloroform</Keywords>
      <Keywords>Distribution</Keywords>
      <Keywords>Partition coefficient</Keywords>
      <Keywords>Shower</Keywords>
      <Keywords>Volatility</Keywords>
      <Keywords>Water quality standard</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Shunto Nishikawa</Name>
        <Affiliation>Graduate School of Engineering, Hokkaido University, N13W8, Sapporo, 060-8628, Japan. Electronic address: shunto1103@eis.hokudai.ac.jp.</Affiliation>
      </Author>
      <Author>
        <Name>Yoshihiko Matsui</Name>
        <Affiliation>Faculty of Engineering, Hokkaido University, N13W8, Sapporo, 060-8628, Japan. Electronic address: matsui@eng.hokudai.ac.jp.</Affiliation>
      </Author>
      <Author>
        <Name>Taku Matsushita</Name>
        <Affiliation>Faculty of Engineering, Hokkaido University, N13W8, Sapporo, 060-8628, Japan. Electronic address: taku-m@eng.hokudai.ac.jp.</Affiliation>
      </Author>
      <Author>
        <Name>Nobutaka Shirasaki</Name>
        <Affiliation>Faculty of Engineering, Hokkaido University, N13W8, Sapporo, 060-8628, Japan. Electronic address: nobutaka@eng.hokudai.ac.jp.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Practical considerations for developmental thyroid toxicity assessments: What's working, what's not, and how can we do better?</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31018155</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30109-6</DOI>
    <KeywordList>
      <Keywords>CTA</Keywords>
      <Keywords>Comparative thyroid assay</Keywords>
      <Keywords>Developmental thyroid toxicity</Keywords>
      <Keywords>EOGRTS</Keywords>
      <Keywords>T3</Keywords>
      <Keywords>T4</Keywords>
      <Keywords>TH</Keywords>
      <Keywords>TSH</Keywords>
      <Keywords>Thyroid hormone</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Abby A. Li</Name>
        <Affiliation>Exponent Inc., 1010 14th Street, San Francisco, CA, 94114, USA. Electronic address: abbyli@exponent.com.</Affiliation>
      </Author>
      <Author>
        <Name>Susan L. Makris</Name>
        <Affiliation>US Environmental Protection Agency Office of Research and Development, 1200 Pennsylvania Ave NW 8623R, Washington, DC, 20460, USA. Electronic address: makris.susan@epa.gov.</Affiliation>
      </Author>
      <Author>
        <Name>M. Sue Marty</Name>
        <Affiliation>The Dow Chemical Company, Toxicology &amp; Environmental Research and Consulting, 1803 Building, Midland, MI, 48674, USA. Electronic address: msmarty@dow.com.</Affiliation>
      </Author>
      <Author>
        <Name>Volker Strauss</Name>
        <Affiliation>BASF SE, Experimental Toxicology and Ecology, 67056, Ludwigshafen, Germany. Electronic address: volker.strauss@basf.com.</Affiliation>
      </Author>
      <Author>
        <Name>Mary E. Gilbert</Name>
        <Affiliation>US Environmental Protection Agency, National Health Environmental Effects Research Lab, 109 T.W. Alexander Drive, MD B105 05, Research Triangle Park, NC, 27711, USA. Electronic address: gilbert.mary@epa.gov.</Affiliation>
      </Author>
      <Author>
        <Name>Ann Blacker</Name>
        <Affiliation>Bayer CropScience, P.O. Box 12014, RTP, NC, 27709, USA. Electronic address: ann.blacker@bayer.com.</Affiliation>
      </Author>
      <Author>
        <Name>Leah M. Zorrilla</Name>
        <Affiliation>Bayer CropScience, P.O. Box 12014, RTP, NC, 27709, USA. Electronic address: leah.zorrilla@bayer.com.</Affiliation>
      </Author>
      <Author>
        <Name>Pragati S. Coder</Name>
        <Affiliation>Charles River Laboratories, Developmental and Reproductive Toxicology, 1407 George Road, Ashland, OH, 44805, USA. Electronic address: pragati.coder@crl.com.</Affiliation>
      </Author>
      <Author>
        <Name>Bethany Hannas</Name>
        <Affiliation>The Dow Chemical Company, Toxicology &amp; Environmental Research and Consulting, 1803 Building, Midland, MI, 48674, USA. Electronic address: brhannas@dow.com.</Affiliation>
      </Author>
      <Author>
        <Name>Sheri Lordi</Name>
        <Affiliation>Charles River Laboratories International, 251 Ballardvale Street, Wilmington, MA, 01887, USA. Electronic address: sheri.lordi@crl.com.</Affiliation>
      </Author>
      <Author>
        <Name>Steffen Schneider</Name>
        <Affiliation>BASF SE, Experimental Toxicology and Ecology, 67056, Ludwigshafen, Germany. Electronic address: steffen.schneider@basf.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Mancozeb impaired male fertility in rabbits with trials of glutathione detoxification.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31014950</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30111-4</DOI>
    <KeywordList>
      <Keywords>Glutathione</Keywords>
      <Keywords>Mancozeb</Keywords>
      <Keywords>Rabbits</Keywords>
      <Keywords>Steroidogenic 3β-HSD enzyme</Keywords>
      <Keywords>Testosterone</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Eman E. Elsharkawy</Name>
        <Affiliation>Department of Forensic Medicine and Toxicology, Faculty of Veterinary Medicine, Assiut University, Egypt. Electronic address: medicine1971@yahoo.com.</Affiliation>
      </Author>
      <Author>
        <Name>Mahmoud Abd El-Nasser</Name>
        <Affiliation>Department of Forensic Medicine and Toxicology, Faculty of Veterinary Medicine, Assiut University, Egypt.</Affiliation>
      </Author>
      <Author>
        <Name>Aliaa A. Bakheet</Name>
        <Affiliation>Animal Health Research Institute, Sohage, Egypt.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Dietary risk evaluation of tetraconazole and bifenazate residues in fresh strawberry from protected field in North China.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31009652</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30107-2</DOI>
    <KeywordList>
      <Keywords>Bifenazate</Keywords>
      <Keywords>Dietary risk</Keywords>
      <Keywords>Digestion dynamics</Keywords>
      <Keywords>Process</Keywords>
      <Keywords>Tetraconazole</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Shifeng Liu</Name>
        <Affiliation>Beijing Key Laboratory of New Technology in Agricultural Application, College of Plant Science and Technology, Beijing University of Agriculture, Beijing, 102206, China.</Affiliation>
      </Author>
      <Author>
        <Name>Hongru Kou</Name>
        <Affiliation>Beijing Key Laboratory of New Technology in Agricultural Application, College of Plant Science and Technology, Beijing University of Agriculture, Beijing, 102206, China.</Affiliation>
      </Author>
      <Author>
        <Name>Baofeng Mu</Name>
        <Affiliation>Beijing Key Laboratory of New Technology in Agricultural Application, College of Plant Science and Technology, Beijing University of Agriculture, Beijing, 102206, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jinzhong Wang</Name>
        <Affiliation>Beijing Key Laboratory of New Technology in Agricultural Application, College of Plant Science and Technology, Beijing University of Agriculture, Beijing, 102206, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhiyong Zhang</Name>
        <Affiliation>Beijing Key Laboratory of New Technology in Agricultural Application, College of Plant Science and Technology, Beijing University of Agriculture, Beijing, 102206, China. Electronic address: zzy@bua.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Subretinal transplantation of human embryonic stem cell-derived retinal pigment epithelium (MA09-hRPE): A safety and tolerability evaluation in minipigs.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/31009651</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30105-9</DOI>
    <KeywordList>
      <Keywords>Age-related macular degeneration</Keywords>
      <Keywords>Minipig</Keywords>
      <Keywords>Preclinical study</Keywords>
      <Keywords>Subretinal injection</Keywords>
      <Keywords>hESC-derived RPE cell</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Sung Min Cho</Name>
        <Affiliation>Department of Pathology, Asan Medical Institute of Convergence Science and Technology, Asan Medical Center, University of Ulsan College of Medicine, 88, Olympic-ro 43-gil, Songpa-gu, Seoul, Republic of Korea. Electronic address: somnium14@naver.com.</Affiliation>
      </Author>
      <Author>
        <Name>Junyeop Lee</Name>
        <Affiliation>Department of Ophthalmology, Yeungnam University, College of Medicine, 170, Hyeonchung-ro, Nam-gu, Daegu, Republic of Korea. Electronic address: retina@yu.ac.kr.</Affiliation>
      </Author>
      <Author>
        <Name>Han Byul Lee</Name>
        <Affiliation>Department of Pathology, Asan Medical Institute of Convergence Science and Technology, Asan Medical Center, University of Ulsan College of Medicine, 88, Olympic-ro 43-gil, Songpa-gu, Seoul, Republic of Korea. Electronic address: onestar0620@naver.com.</Affiliation>
      </Author>
      <Author>
        <Name>Hyun Ji Choi</Name>
        <Affiliation>Department of Pathology, Asan Medical Institute of Convergence Science and Technology, Asan Medical Center, University of Ulsan College of Medicine, 88, Olympic-ro 43-gil, Songpa-gu, Seoul, Republic of Korea. Electronic address: snapple08@naver.com.</Affiliation>
      </Author>
      <Author>
        <Name>Jae Eun Ryu</Name>
        <Affiliation>Department of Pathology, Asan Medical Institute of Convergence Science and Technology, Asan Medical Center, University of Ulsan College of Medicine, 88, Olympic-ro 43-gil, Songpa-gu, Seoul, Republic of Korea. Electronic address: bangarje@naver.com.</Affiliation>
      </Author>
      <Author>
        <Name>Hyo Ju Lee</Name>
        <Affiliation>Department of Pathology, Asan Medical Institute of Convergence Science and Technology, Asan Medical Center, University of Ulsan College of Medicine, 88, Olympic-ro 43-gil, Songpa-gu, Seoul, Republic of Korea. Electronic address: hyoju_lee@daum.net.</Affiliation>
      </Author>
      <Author>
        <Name>Hyun Kyu Park</Name>
        <Affiliation>Department of Pathology, Asan Medical Institute of Convergence Science and Technology, Asan Medical Center, University of Ulsan College of Medicine, 88, Olympic-ro 43-gil, Songpa-gu, Seoul, Republic of Korea. Electronic address: nevok@hanmail.net.</Affiliation>
      </Author>
      <Author>
        <Name>Min Ji Lee</Name>
        <Affiliation>CHA Biotech, 335, Pangyo-ro, Bundang-gu, Seongnam, Republic of Korea. Electronic address: minjilee@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Juyoung Lee</Name>
        <Affiliation>CHA Biotech, 335, Pangyo-ro, Bundang-gu, Seongnam, Republic of Korea. Electronic address: suniv84@hanmail.net.</Affiliation>
      </Author>
      <Author>
        <Name>Hyun Jung Lee</Name>
        <Affiliation>CHA Biotech, 335, Pangyo-ro, Bundang-gu, Seongnam, Republic of Korea. Electronic address: hjlee4993@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Hye Sun Kim</Name>
        <Affiliation>CHA Biotech, 335, Pangyo-ro, Bundang-gu, Seongnam, Republic of Korea. Electronic address: hyesunkim98@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Joo Yong Lee</Name>
        <Affiliation>Department of Ophthalmology, Asan Medical Center, University of Ulsan College of Medicine, 88, Olympic-ro 43-gil, Songpa-gu, Seoul, Republic of Korea. Electronic address: ophthalmo@amc.seoul.kr.</Affiliation>
      </Author>
      <Author>
        <Name>Woo Chan Son</Name>
        <Affiliation>Department of Pathology, Asan Medical Institute of Convergence Science and Technology, Asan Medical Center, University of Ulsan College of Medicine, 88, Olympic-ro 43-gil, Songpa-gu, Seoul, Republic of Korea; Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, 88, Olympic-ro 43-gil, Songpa-gu, Seoul, Republic of Korea. Electronic address: wcson@amc.seoul.kr.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Acute and sub-chronic oral toxicity studies of hesperidin isolated from orange peel extract in Sprague Dawley rats.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30991075</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30092-3</DOI>
    <KeywordList>
      <Keywords>Acute toxicity test</Keywords>
      <Keywords>Hesperidin</Keywords>
      <Keywords>LD(50)</Keywords>
      <Keywords>OECD</Keywords>
      <Keywords>Orange peel</Keywords>
      <Keywords>Sub-chronic toxicity tests</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Yongsheng Li</Name>
        <Affiliation>Pharmacy Department, Honghui Hospital, Xi'an Jiaotong University, Shaanxi Province, 710054, China.</Affiliation>
      </Author>
      <Author>
        <Name>Amit D. Kandhare</Name>
        <Affiliation>Department of Pharmacology, Poona College of Pharmacy, Bharati Vidyapeeth Deemed University, Erandwane, Paud Road, Pune, 411038, India.</Affiliation>
      </Author>
      <Author>
        <Name>Anwesha A. Mukherjee</Name>
        <Affiliation>Department of Pharmacology, Poona College of Pharmacy, Bharati Vidyapeeth Deemed University, Erandwane, Paud Road, Pune, 411038, India.</Affiliation>
      </Author>
      <Author>
        <Name>Subhash L. Bodhankar</Name>
        <Affiliation>Department of Pharmacology, Poona College of Pharmacy, Bharati Vidyapeeth Deemed University, Erandwane, Paud Road, Pune, 411038, India. Electronic address: drslbodh@gmail.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Analysis of exposure margins in developmental toxicity studies for detection of human teratogens.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30981719</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30096-0</DOI>
    <KeywordList>
      <Keywords>Developmental toxicity</Keywords>
      <Keywords>Embryofetal</Keywords>
      <Keywords>Exposure margins</Keywords>
      <Keywords>Malformations</Keywords>
      <Keywords>Pregnancy</Keywords>
      <Keywords>Risk assessment</Keywords>
      <Keywords>Teratogenicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Paul A. Andrews</Name>
        <Affiliation>Eisai Inc., Woodcliff Lake, NJ, USA. Electronic address: paul_andrews@eisai.com.</Affiliation>
      </Author>
      <Author>
        <Name>Diann Blanset</Name>
        <Affiliation>Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Priscila Lemos Costa</Name>
        <Affiliation>Agência Nacional de Vigilância Sanitária, Brasília, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Martin Green</Name>
        <Affiliation>US Food and Drug Administration, Silver Spring, MD, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Maia L. Green</Name>
        <Affiliation>Merck &amp; Co, Inc., West Point, PA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Abigail Jacobs</Name>
        <Affiliation>US Food and Drug Administration, Silver Spring, MD, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Rajkumar Kadaba</Name>
        <Affiliation>Health Canada, Ottawa, Ontario, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Jose A. Lebron</Name>
        <Affiliation>Merck &amp; Co, Inc., West Point, PA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Britta Mattson</Name>
        <Affiliation>Merck &amp; Co, Inc., West Point, PA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Mary Ellen McNerney</Name>
        <Affiliation>Bristol-Myers Squibb, New Brunswick, NJ, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Daniel Minck</Name>
        <Affiliation>US Food and Drug Administration, Silver Spring, MD, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Luana de Castro Oliveira</Name>
        <Affiliation>Agência Nacional de Vigilância Sanitária, Brasília, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Peter T. Theunissen</Name>
        <Affiliation>CBG-MEB, Utrecht, the Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Joseph J. DeGeorge</Name>
        <Affiliation>Merck &amp; Co, Inc., West Point, PA, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>User-oriented independent analysis of the toxic load model's ability to predict the effects of time-varying toxic inhalation exposures.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30978368</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30094-7</DOI>
    <KeywordList>
      <Keywords>Carbon monoxide</Keywords>
      <Keywords>Hazard prediction</Keywords>
      <Keywords>Hydrogen cyanide</Keywords>
      <Keywords>Inhalation toxicology</Keywords>
      <Keywords>Rats</Keywords>
      <Keywords>Time-varying exposures</Keywords>
      <Keywords>Toxic load</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Alexander Slawik</Name>
        <Affiliation>Institute for Defense Analyses, 4850 Mark Center Drive, Alexandria, VA, 22311-1882, USA. Electronic address: aslawik@ida.org.</Affiliation>
      </Author>
      <Author>
        <Name>Nathan Platt</Name>
        <Affiliation>Institute for Defense Analyses, 4850 Mark Center Drive, Alexandria, VA, 22311-1882, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jeffry T. Urban</Name>
        <Affiliation>Institute for Defense Analyses, 4850 Mark Center Drive, Alexandria, VA, 22311-1882, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Eye hazard classification according to UN GHS / EU CLP and the severity of eye symptoms caused by accidental exposures to detergents and cleaning products.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30978367</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30095-9</DOI>
    <KeywordList>
      <Keywords>Accidental eye exposure</Keywords>
      <Keywords>Detergents and cleaning products</Keywords>
      <Keywords>EU CLP</Keywords>
      <Keywords>EU DPD</Keywords>
      <Keywords>Eye hazard classification category</Keywords>
      <Keywords>Poisoning severity score (PSS)</Keywords>
      <Keywords>UN GHS</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Roberto Scazzola</Name>
        <Affiliation>A.I.S.E. (International Association for Soaps, Detergents and Maintenance Products), Belgium. Electronic address: roberto.scazzola@aise.eu.</Affiliation>
      </Author>
      <Author>
        <Name>Geert Boeije</Name>
        <Affiliation>Boeije Consulting bvba, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Ellen Bøtker Pedersen</Name>
        <Affiliation>Danish Poisons Centre, Bispebjerg Hospital, København, Denmark.</Affiliation>
      </Author>
      <Author>
        <Name>William Brenneman</Name>
        <Affiliation>Procter &amp; Gamble, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Blažena Cagáňová</Name>
        <Affiliation>National Toxicological Information Centre, University Hospital Bratislava, Slovakia.</Affiliation>
      </Author>
      <Author>
        <Name>Anna Celentano</Name>
        <Affiliation>Centro Antiveleni di Milano, Azienda Ospedaliera Niguarda Ca' Granda, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Els De Coninck</Name>
        <Affiliation>Procter &amp; Gamble, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Herbert Desel</Name>
        <Affiliation>BfR (German Federal Institute for Risk Assessment), Germany, Formerly GIZ-Nord Poisons Center, University Medical Center Göttingen, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Niels Ebbehøj</Name>
        <Affiliation>Danish Poisons Centre, Bispebjerg Hospital, København, Denmark.</Affiliation>
      </Author>
      <Author>
        <Name>Elke Färber</Name>
        <Affiliation>GIZ-Nord Poisons Centre, University Medical Center Göttingen, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Fabrizio Sesana</Name>
        <Affiliation>Centro Antiveleni di Milano, Azienda Ospedaliera Niguarda Ca' Granda, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Sergej Zacharov</Name>
        <Affiliation>Toxicological Information Centre, Department of Occupational Medicine, First Faculty of Medicine, Charles University and General University Hospital Prague, Czech Republic.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The implementation of RAAF in the OECD QSAR Toolbox.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30970268</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30090-X</DOI>
    <KeywordList>
      <Keywords>Assessment elements</Keywords>
      <Keywords>Category elements uncertainty</Keywords>
      <Keywords>OECD QSAR toolbox</Keywords>
      <Keywords>RAAF</Keywords>
      <Keywords>Read-across</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Chanita Kuseva</Name>
        <Affiliation>Laboratory of Mathematical Chemistry (LMC), As. Zlatarov University, Bourgas, Bulgaria.</Affiliation>
      </Author>
      <Author>
        <Name>Terry W. Schultz</Name>
        <Affiliation>The University of Tennessee, College of Veterinary Medicine, 2407 River Drive, Knoxville, TN, 37996-4500, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Darina Yordanova</Name>
        <Affiliation>Laboratory of Mathematical Chemistry (LMC), As. Zlatarov University, Bourgas, Bulgaria.</Affiliation>
      </Author>
      <Author>
        <Name>Ksenia Tankova</Name>
        <Affiliation>Laboratory of Mathematical Chemistry (LMC), As. Zlatarov University, Bourgas, Bulgaria.</Affiliation>
      </Author>
      <Author>
        <Name>Stela Kutsarova</Name>
        <Affiliation>Laboratory of Mathematical Chemistry (LMC), As. Zlatarov University, Bourgas, Bulgaria.</Affiliation>
      </Author>
      <Author>
        <Name>Todor Pavlov</Name>
        <Affiliation>Laboratory of Mathematical Chemistry (LMC), As. Zlatarov University, Bourgas, Bulgaria.</Affiliation>
      </Author>
      <Author>
        <Name>Atanas Chapkanov</Name>
        <Affiliation>Laboratory of Mathematical Chemistry (LMC), As. Zlatarov University, Bourgas, Bulgaria.</Affiliation>
      </Author>
      <Author>
        <Name>Marin Georgiev</Name>
        <Affiliation>Laboratory of Mathematical Chemistry (LMC), As. Zlatarov University, Bourgas, Bulgaria.</Affiliation>
      </Author>
      <Author>
        <Name>Andrea Gissi</Name>
        <Affiliation>European Chemicals Agency, Helsinki, Finland.</Affiliation>
      </Author>
      <Author>
        <Name>Tomasz Sobanski</Name>
        <Affiliation>European Chemicals Agency, Helsinki, Finland.</Affiliation>
      </Author>
      <Author>
        <Name>Ovanes G. Mekenyan</Name>
        <Affiliation>Laboratory of Mathematical Chemistry (LMC), As. Zlatarov University, Bourgas, Bulgaria. Electronic address: omekenya@btu.bg.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Overgeneralization by Anderson et al. and Luz et al. regarding safety of fluorotelomer-based chemistry.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30959083</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30093-5</DOI>
    <AuthorList>
      <Author>
        <Name>Maricel V. Maffini</Name>
        <Affiliation>Germantown, MD, 20874, USA. Electronic address: drmvma@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Thomas G. Neltner</Name>
        <Affiliation>Environmental Defense Fund, Washington, DC, 20009, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Evaluation of toxicokinetics of nonylphenol in the adult female Sprague-Dawley rats using a physiologically based toxicokinetic model.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30954491</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30091-1</DOI>
    <KeywordList>
      <Keywords>Nonylphenol</Keywords>
      <Keywords>Oral exposure</Keywords>
      <Keywords>PBTK</Keywords>
      <Keywords>Physiologically based toxicokinetic model</Keywords>
      <Keywords>Rats</Keywords>
      <Keywords>Risk assessment</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Teng Liu</Name>
        <Affiliation>Key Laboratory of Environmental Medicine Engineering, Ministry of Education, School of Public Health, Southeast University, Nanjing, 210009, China.</Affiliation>
      </Author>
      <Author>
        <Name>Weixin Cao</Name>
        <Affiliation>Key Laboratory of Environmental Medicine Engineering, Ministry of Education, School of Public Health, Southeast University, Nanjing, 210009, China.</Affiliation>
      </Author>
      <Author>
        <Name>Qiannan Di</Name>
        <Affiliation>Key Laboratory of Environmental Medicine Engineering, Ministry of Education, School of Public Health, Southeast University, Nanjing, 210009, China.</Affiliation>
      </Author>
      <Author>
        <Name>Meng Zhao</Name>
        <Affiliation>Key Laboratory of Environmental Medicine Engineering, Ministry of Education, School of Public Health, Southeast University, Nanjing, 210009, China.</Affiliation>
      </Author>
      <Author>
        <Name>Qian Xu</Name>
        <Affiliation>Key Laboratory of Environmental Medicine Engineering, Ministry of Education, School of Public Health, Southeast University, Nanjing, 210009, China. Electronic address: q_xu68@163.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Effect of plant extracts on the genotoxicity of 1'-hydroxy alkenylbenzenes.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30935955</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30089-3</DOI>
    <KeywordList>
      <Keywords>Botanical preparations</Keywords>
      <Keywords>Estragole</Keywords>
      <Keywords>Genotoxicity</Keywords>
      <Keywords>Matrix effect</Keywords>
      <Keywords>Plant food supplements</Keywords>
      <Keywords>Safrole</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Laura Marabini</Name>
        <Affiliation>Department of Environmental Science and Policy, Università degli Studi di Milano, Via Balzaretti 9, 20133, Milan, Italy. Electronic address: laura.marabini@unimi.it.</Affiliation>
      </Author>
      <Author>
        <Name>Corrado L. Galli</Name>
        <Affiliation>Department of Pharmacological and Biomolecular Sciences, Università degli Studi di Milano, Via Balzaretti 9, 20133, Milan, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Pierpaolo La Fauci</Name>
        <Affiliation>Department of Pharmacological and Biomolecular Sciences, Università degli Studi di Milano, Via Balzaretti 9, 20133, Milan, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Marina Marinovich</Name>
        <Affiliation>Department of Pharmacological and Biomolecular Sciences, Università degli Studi di Milano, Via Balzaretti 9, 20133, Milan, Italy.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Use of stem cells as alternative methods to animal experimentation in predictive toxicology.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30930176</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30088-1</DOI>
    <KeywordList>
      <Keywords>Adult stem cell</Keywords>
      <Keywords>Alternative method</Keywords>
      <Keywords>Embryonic stem cell</Keywords>
      <Keywords>Induced pluripotent stem cells</Keywords>
      <Keywords>Mesenchymal stem cell</Keywords>
      <Keywords>Toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Tae Won Kim</Name>
        <Affiliation>Department of Biotechnology, The Catholic University of Korea, Bucheon, 14662, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Jeong Hwan Che</Name>
        <Affiliation>Biomedical Center for Animal Resource and Development, Seoul National University College of Medicine, Seoul, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Jun Won Yun</Name>
        <Affiliation>Department of Biotechnology, The Catholic University of Korea, Bucheon, 14662, Republic of Korea. Electronic address: jwyun@catholic.ac.kr.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Response to "Overgeneralization by Anderson et al. and Luz et al. regarding safety of fluorotelomer-base chemistry".</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30928331</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30087-X</DOI>
    <KeywordList>
      <Keywords>Fluorotelomers</Keywords>
      <Keywords>Human health</Keywords>
      <Keywords>PFHxA</Keywords>
      <Keywords>Perfluorohexanoic acid</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Janet K. Anderson</Name>
        <Affiliation>Integral Consulting Inc, 17806 I-10, Suite 300, San Antonio, TX, 78257, USA. Electronic address: janderson@integral-corp.com.</Affiliation>
      </Author>
      <Author>
        <Name>Anthony L. Luz</Name>
        <Affiliation>Integral Consulting Inc, 200 Harry S. Truman Parkway, Suite 330, Annapolis, MD, 21401, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Philip Goodrum</Name>
        <Affiliation>Integral Consulting Inc, 7030 E Genesee Street, Suite 105, Fayetteville, NY, 13066, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Evaluation of the avian acute oral and sub-acute dietary toxicity test for pesticide registration.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30922892</pubmedLink>
    <GrantList>
      <Grant>EPA999999</Grant>
    </GrantList>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30085-6</DOI>
    <AuthorList>
      <Author>
        <Name>Gina M. Hilton</Name>
        <Affiliation>PETA International Science Consortium Ltd, London, UK. Electronic address: GinaH@piscltd.org.uk.</Affiliation>
      </Author>
      <Author>
        <Name>Edward Odenkirchen</Name>
        <Affiliation>United States Environmental Protection Agency, Washington, DC, USA(1).</Affiliation>
      </Author>
      <Author>
        <Name>Melissa Panger</Name>
        <Affiliation>United States Environmental Protection Agency, Washington, DC, USA(1).</Affiliation>
      </Author>
      <Author>
        <Name>Garland Waleko</Name>
        <Affiliation>United States Environmental Protection Agency, Washington, DC, USA(1).</Affiliation>
      </Author>
      <Author>
        <Name>Anna Lowit</Name>
        <Affiliation>United States Environmental Protection Agency, Washington, DC, USA(1).</Affiliation>
      </Author>
      <Author>
        <Name>Amy J. Clippinger</Name>
        <Affiliation>PETA International Science Consortium Ltd, London, UK.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Toxicological evaluation of carcinogenicity of the pyrethroid imiprothrin in rats and mice.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30905765</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30084-4</DOI>
    <KeywordList>
      <Keywords>Carcinogenicity</Keywords>
      <Keywords>Imiprothrin</Keywords>
      <Keywords>Long-term bioassays</Keywords>
      <Keywords>Lung tumors</Keywords>
      <Keywords>Maximum tolerated dose</Keywords>
      <Keywords>Mouse</Keywords>
      <Keywords>Pyrethroids</Keywords>
      <Keywords>Statistical analysis</Keywords>
      <Keywords>Step section</Keywords>
      <Keywords>Systemic toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Tomoya Yamada</Name>
        <Affiliation>Environmental Health Science Laboratory, Sumitomo Chemical Company, Ltd., 3-1-98 Kasugade-naka, Konohana-ku, Osaka, 554-8558, Japan. Electronic address: yamadat8@sc.sumitomo-chem.co.jp.</Affiliation>
      </Author>
      <Author>
        <Name>Hiroyuki Asano</Name>
        <Affiliation>Environmental Health Science Laboratory, Sumitomo Chemical Company, Ltd., 3-1-98 Kasugade-naka, Konohana-ku, Osaka, 554-8558, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Kaori Miyata</Name>
        <Affiliation>Environmental Health Science Laboratory, Sumitomo Chemical Company, Ltd., 3-1-98 Kasugade-naka, Konohana-ku, Osaka, 554-8558, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Lorenz R. Rhomberg</Name>
        <Affiliation>Gradient, 20 University Road, Cambridge, MA, 02138, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Joseph K. Haseman</Name>
        <Affiliation>J.K. Haseman Consulting, Raleigh, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Peter Greaves</Name>
        <Affiliation>Department of Cancer Studies and Molecular Medicine, University of Leicester, Leicester, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Helmut Greim</Name>
        <Affiliation>Technical University of Munich, Munich, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Colin Berry</Name>
        <Affiliation>Queen Mary University of London, Mile End Rd, London, E1 4NS, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Samuel M. Cohen</Name>
        <Affiliation>Havlik-Wall Professor of Oncology, Department of Pathology and Microbiology, University of Nebraska Medical Center, 983135, Omaha, NE, 68198-3135, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Acute and genetic toxicity of GS-E3D, a new pectin lyase-modified red ginseng extract.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30904430</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30082-0</DOI>
    <KeywordList>
      <Keywords>Acute toxicity</Keywords>
      <Keywords>GS-E3D</Keywords>
      <Keywords>Genotoxic effects</Keywords>
      <Keywords>Pectin lyase-modified red ginseng extract</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Cho Rong Park</Name>
        <Affiliation>Biotoxtech. Co. Ltd, Cheongju, 13000, South Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Mi Kyung Pyo</Name>
        <Affiliation>International Ginseng and Herb Research Institute, Geumsan, 312-804, South Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Hwan Lee</Name>
        <Affiliation>International Ginseng and Herb Research Institute, Geumsan, 312-804, South Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Seung Young Hong</Name>
        <Affiliation>Biotoxtech. Co. Ltd, Cheongju, 13000, South Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Su Hwan Kim</Name>
        <Affiliation>Biotoxtech. Co. Ltd, Cheongju, 13000, South Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Cheol Beom Park</Name>
        <Affiliation>Biotoxtech. Co. Ltd, Cheongju, 13000, South Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Seung Min Oh</Name>
        <Affiliation>Department of Nanofusion Technology, Hoseo University, Asan, 31499, South Korea. Electronic address: ohsm0403@hoseo.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Fragrance inhalation and adverse health effects: The question of causation.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30904429</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30083-2</DOI>
    <KeywordList>
      <Keywords>Fragrances inhalation</Keywords>
      <Keywords>Respiratory allergy</Keywords>
      <Keywords>Respiratory irritation</Keywords>
      <Keywords>Sensory effects</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>David A. Basketter</Name>
        <Affiliation>DABMEB Consultancy Ltd, Sharnbrook, UK. Electronic address: dabmebconsultancyltd@me.com.</Affiliation>
      </Author>
      <Author>
        <Name>Joe Huggard</Name>
        <Affiliation>The Huggard Consulting Group S.A.R.L, Itzig, Luxembourg.</Affiliation>
      </Author>
      <Author>
        <Name>Ian Kimber</Name>
        <Affiliation>Faculty of Biology, Medicine and Health, University of Manchester, Manchester, M13 9PT, UK.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Micronutrient and heavy metal concentrations in basil plant cultivated on irradiated and non-irradiated sewage sludge- treated soil and evaluation of human health risk.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30894305</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30081-9</DOI>
    <KeywordList>
      <Keywords>Gamma irradiation</Keywords>
      <Keywords>Health risk</Keywords>
      <Keywords>Heavy metals</Keywords>
      <Keywords>Medicinal plant</Keywords>
      <Keywords>Sewage sludge</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Behnam Asgari Lajayer</Name>
        <Affiliation>Department of Soil Science, Faculty of Agriculture, University of Tabriz, Tabriz, Iran.</Affiliation>
      </Author>
      <Author>
        <Name>Nosratollah Najafi</Name>
        <Affiliation>Department of Soil Science, Faculty of Agriculture, University of Tabriz, Tabriz, Iran. Electronic address: n-najafi@tabrizu.ac.ir.</Affiliation>
      </Author>
      <Author>
        <Name>Ebrahim Moghiseh</Name>
        <Affiliation>Nuclear Agriculture Research School, Nuclear Science and Technology Research Institute, Karaj, Iran.</Affiliation>
      </Author>
      <Author>
        <Name>Mohammad Mosaferi</Name>
        <Affiliation>Health and Environment Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.</Affiliation>
      </Author>
      <Author>
        <Name>Javad Hadian</Name>
        <Affiliation>Medicinal Plants and Drugs Research Institute, Shahid Beheshti University, G.C., Evin, Tehran, Iran.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Evaluation of behavioral profiles in mice fed with milk supplemented diets derived from human lactoferrin gene-modified cows.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30890338</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30080-7</DOI>
    <KeywordList>
      <Keywords>Behaviour</Keywords>
      <Keywords>Food safety</Keywords>
      <Keywords>Genetically modified animals</Keywords>
      <Keywords>Genetically modified cow</Keywords>
      <Keywords>Human lactoferrin</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Shan Liu</Name>
        <Affiliation>Key Laboratory of Food Safety Risk Assessment of Ministry of Health, China National Center for Food Safety Risk Assessment, Beijing 100021, PR China. Electronic address: liushan@cfsa.net.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Hai Bo Liu</Name>
        <Affiliation>Key Laboratory of Food Safety Risk Assessment of Ministry of Health, China National Center for Food Safety Risk Assessment, Beijing 100021, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Hui Ling Wang</Name>
        <Affiliation>Key Laboratory of Food Safety Risk Assessment of Ministry of Health, China National Center for Food Safety Risk Assessment, Beijing 100021, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Yuan Zhi</Name>
        <Affiliation>Key Laboratory of Food Safety Risk Assessment of Ministry of Health, China National Center for Food Safety Risk Assessment, Beijing 100021, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiao Lian Feng</Name>
        <Affiliation>Key Laboratory of Food Safety Risk Assessment of Ministry of Health, China National Center for Food Safety Risk Assessment, Beijing 100021, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Xu Dong Jia</Name>
        <Affiliation>Key Laboratory of Food Safety Risk Assessment of Ministry of Health, China National Center for Food Safety Risk Assessment, Beijing 100021, PR China. Electronic address: jiaxudong@cfsa.net.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Flavonoids protect colon against radiation induced colitis.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30878575</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30078-9</DOI>
    <KeywordList>
      <Keywords>Caspase</Keywords>
      <Keywords>Flavonoids</Keywords>
      <Keywords>Heat shock protein 70</Keywords>
      <Keywords>Radiation induced colitis</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Berrak Guven</Name>
        <Affiliation>Zonguldak Bulent Ecevit University Faculty of Medicine, Department of Biochemistry, Zonguldak, Turkey. Electronic address: berrak.guven@beun.edu.tr.</Affiliation>
      </Author>
      <Author>
        <Name>Murat Can</Name>
        <Affiliation>Zonguldak Bulent Ecevit University Faculty of Medicine, Department of Biochemistry, Zonguldak, Turkey.</Affiliation>
      </Author>
      <Author>
        <Name>Ozcan Piskin</Name>
        <Affiliation>Zonguldak Bulent Ecevit University Faculty of Medicine, Department of Anesthesiology and Reanimation, Zonguldak, Turkey.</Affiliation>
      </Author>
      <Author>
        <Name>Bengu Gulhan Aydin</Name>
        <Affiliation>Zonguldak Bulent Ecevit University Faculty of Medicine, Department of Anesthesiology and Reanimation, Zonguldak, Turkey.</Affiliation>
      </Author>
      <Author>
        <Name>Kemal Karakaya</Name>
        <Affiliation>Zonguldak Bulent Ecevit University Faculty of Medicine, Department of General Surgery, Zonguldak, Turkey.</Affiliation>
      </Author>
      <Author>
        <Name>Ozlem Elmas</Name>
        <Affiliation>Zonguldak Bulent Ecevit University Faculty of Medicine, Department of Radiation Oncology, Zonguldak, Turkey.</Affiliation>
      </Author>
      <Author>
        <Name>Bilgehan Acikgoz</Name>
        <Affiliation>Zonguldak Bulent Ecevit University Faculty of Medicine, Department of Public Health, Zonguldak, Turkey.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Sex differences in subacute manganese intoxication: Oxidative parameters and metal deposition in peripheral organs of adult Wistar rats.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30878574</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30077-7</DOI>
    <KeywordList>
      <Keywords>Manganese deposition</Keywords>
      <Keywords>Peripheral oxidative stress</Keywords>
      <Keywords>Sex difference</Keywords>
      <Keywords>Subacute intoxication</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Carine Raquel Richter Schmitz</Name>
        <Affiliation>Programa de Pós-Graduação em Biociências e Saúde (PPGBS), Área de Ciências da Vida e Saúde, Universidade do Oeste de Santa Catarina (UNOESC), Campus de Joaçaba, SC, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Tuany Eichwald</Name>
        <Affiliation>Programa de Pós-Graduação em Biociências e Saúde (PPGBS), Área de Ciências da Vida e Saúde, Universidade do Oeste de Santa Catarina (UNOESC), Campus de Joaçaba, SC, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Maria Victória Branco Flores</Name>
        <Affiliation>Graduação em Ciências Biológicas, Área de Ciências da Vida e Saúde, Universidade do Oeste de Santa Catarina (UNOESC), Campus de Joaçaba, SC, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Karina Giacomini Varela</Name>
        <Affiliation>Graduação em Ciências Biológicas, Área de Ciências da Vida e Saúde, Universidade do Oeste de Santa Catarina (UNOESC), Campus de Joaçaba, SC, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Analu Mantovani</Name>
        <Affiliation>Laboratório de Solos, Universidade do Oeste de Santa Catarina (UNOESC), Campus de Campos Novos, SC, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Jovani Antônio Steffani</Name>
        <Affiliation>Programa de Pós-Graduação em Biociências e Saúde (PPGBS), Área de Ciências da Vida e Saúde, Universidade do Oeste de Santa Catarina (UNOESC), Campus de Joaçaba, SC, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Viviane Glaser</Name>
        <Affiliation>Coordenadoria Especial de Ciências Biológicas e Agronômicas, Centro de Ciências Rurais, Universidade Federal de Santa Catarina (UFSC), Campus de Curitibanos, SC, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Diego de Carvalho</Name>
        <Affiliation>Programa de Pós-Graduação em Biociências e Saúde (PPGBS), Área de Ciências da Vida e Saúde, Universidade do Oeste de Santa Catarina (UNOESC), Campus de Joaçaba, SC, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Aline Pertile Remor</Name>
        <Affiliation>Programa de Pós-Graduação em Biociências e Saúde (PPGBS), Área de Ciências da Vida e Saúde, Universidade do Oeste de Santa Catarina (UNOESC), Campus de Joaçaba, SC, Brazil. Electronic address: aline.remor@unoesc.edu.br.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Toxicological assessment of Tobacco Heating System 2.2: Findings from an independent peer review.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30878573</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30079-0</DOI>
    <KeywordList>
      <Keywords>Clinical assessment</Keywords>
      <Keywords>Nonclinical assessment</Keywords>
      <Keywords>Peer review</Keywords>
      <Keywords>Scientific assessment</Keywords>
      <Keywords>Tobacco harm reduction</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Stéphanie Boué</Name>
        <Affiliation>PMI R&amp;D, Philip Morris Products S.A., Quai Jeanrenaud 5, CH-2000, Neuchâtel, Switzerland. Electronic address: stephanie.boue@pmi.com.</Affiliation>
      </Author>
      <Author>
        <Name>Walter K. Schlage</Name>
        <Affiliation>PMI R&amp;D, Philip Morris Products S.A., Quai Jeanrenaud 5, CH-2000, Neuchâtel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>David Page</Name>
        <Affiliation>PMI R&amp;D, Philip Morris Products S.A., Quai Jeanrenaud 5, CH-2000, Neuchâtel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Julia Hoeng</Name>
        <Affiliation>PMI R&amp;D, Philip Morris Products S.A., Quai Jeanrenaud 5, CH-2000, Neuchâtel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Manuel C. Peitsch</Name>
        <Affiliation>PMI R&amp;D, Philip Morris Products S.A., Quai Jeanrenaud 5, CH-2000, Neuchâtel, Switzerland.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Critical issues and alternatives for the establishment of chemical water quality criteria for livestock.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30872016</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30075-3</DOI>
    <KeywordList>
      <Keywords>Animal watering</Keywords>
      <Keywords>Framework</Keywords>
      <Keywords>In silico modeling</Keywords>
      <Keywords>Regulation</Keywords>
      <Keywords>Standards</Keywords>
      <Keywords>Toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Simone Valente-Campos</Name>
        <Affiliation>School of Technology, University of Campinas, Rua Pascoal Marmo 1888, 13484-332, Limeira, SP, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Douglas J. Spry</Name>
        <Affiliation>Environment and Climate Change Canada, 351 Boulevard Saint-Joseph, Gatineau, QC, J8Y 3Z5, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Julio Cesar Pascale Palhares</Name>
        <Affiliation>Embrapa Southeast Livestock - Rod, Washington Luiz, km 234, PBox 339, 13560-970, Sao Carlos, SP, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Luz Marina Jakomin Rudez</Name>
        <Affiliation>Secretary of Infrastructure and Water Policy, Esmeralda 255 P 11 Of. 1106 CABA, C1035ABE, Argentina.</Affiliation>
      </Author>
      <Author>
        <Name>Gisela de Aragão Umbuzeiro</Name>
        <Affiliation>School of Technology, University of Campinas, Rua Pascoal Marmo 1888, 13484-332, Limeira, SP, Brazil. Electronic address: giselau@ft.unicamp.br.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Oxidative stress, DNA damage, and mutagenicity induced by the extractable organic matter of airborne particulates on bacterial models.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30872015</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30076-5</DOI>
    <KeywordList>
      <Keywords>Ames test</Keywords>
      <Keywords>Bacteria</Keywords>
      <Keywords>MDA</Keywords>
      <Keywords>Particulate matter</Keywords>
      <Keywords>ROS</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Ekaterini Velali</Name>
        <Affiliation>Laboratory of Biochemistry, Department of Chemistry, Aristotle University of Thessaloniki, GR-54124, Thessaloniki, Greece.</Affiliation>
      </Author>
      <Author>
        <Name>Anastasia Pantazaki</Name>
        <Affiliation>Laboratory of Biochemistry, Department of Chemistry, Aristotle University of Thessaloniki, GR-54124, Thessaloniki, Greece. Electronic address: natasa@chem.auth.gr.</Affiliation>
      </Author>
      <Author>
        <Name>Athanasios Besis</Name>
        <Affiliation>Environmental Pollution Control Laboratory, Department of Chemistry, Aristotle University of Thessaloniki, GR-54124, Thessaloniki, Greece.</Affiliation>
      </Author>
      <Author>
        <Name>Theodora Choli-Papadopoulou</Name>
        <Affiliation>Laboratory of Biochemistry, Department of Chemistry, Aristotle University of Thessaloniki, GR-54124, Thessaloniki, Greece.</Affiliation>
      </Author>
      <Author>
        <Name>Constantini Samara</Name>
        <Affiliation>Environmental Pollution Control Laboratory, Department of Chemistry, Aristotle University of Thessaloniki, GR-54124, Thessaloniki, Greece. Electronic address: csamara@chem.auth.gr.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Assessment of priority tobacco additives per the requirements in the EU Tobacco Products Directive (2014/40/EU): Part 2: Smoke chemistry and in vitro toxicology.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30858113</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30064-9</DOI>
    <KeywordList>
      <Keywords>Cigarette</Keywords>
      <Keywords>In vitro</Keywords>
      <Keywords>Priority additive</Keywords>
      <Keywords>Smoke chemistry</Keywords>
      <Keywords>Transfer rates</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Regina Stabbert</Name>
        <Affiliation>Philip Morris International, Philip Morris Products SA, Rue des Usines 90, 2000, Neuchâtel, Switzerland. Electronic address: Regina.Stabbert@pmi.com.</Affiliation>
      </Author>
      <Author>
        <Name>David Ghosh</Name>
        <Affiliation>Philip Morris International, Philip Morris International Management SA, Avenue de Rhodanie 50, 1001, Lausanne, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Anna Clarke</Name>
        <Affiliation>Imperial Tobacco, Winterstoke Road, Bristol, BS32LL, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Jacqueline Miller</Name>
        <Affiliation>Japan Tobacco International SA, Rue Kazem Radjavi 8, 1202, Geneva, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Jane Collard</Name>
        <Affiliation>British American Tobacco, Research &amp; Development, Regents Park Road, Southampton, SO158TL, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Ian Crooks</Name>
        <Affiliation>British American Tobacco, Research &amp; Development, Regents Park Road, Southampton, SO158TL, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Donatien Tafin Djoko</Name>
        <Affiliation>Philip Morris International, Philip Morris Products SA, Rue des Usines 90, 2000, Neuchâtel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Sylvain Larroque</Name>
        <Affiliation>Japan Tobacco International SA, Rue Kazem Radjavi 8, 1202, Geneva, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Guy Jaccard</Name>
        <Affiliation>Philip Morris International, Philip Morris Products SA, Rue des Usines 90, 2000, Neuchâtel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Ewald Roemer</Name>
        <Affiliation>TobToxConsulting, Imp. Blanchet-Dailleres 9, 1585, Cotterd, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Chul Hoon Park</Name>
        <Affiliation>KT&amp;G Research Institute, 30, Gajeong-ro, Yuseong-gu, Daejeon, 34128, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Marco Esposito</Name>
        <Affiliation>Philip Morris International, Philip Morris Products SA, Rue des Usines 90, 2000, Neuchâtel, Switzerland.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Evaluation of the efficacy in cosmetic products safety: Comparison with biochemical substrates.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30853485</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30063-7</DOI>
    <KeywordList>
      <Keywords>Biochemical substrate</Keywords>
      <Keywords>Cosmetic</Keywords>
      <Keywords>Enzyme</Keywords>
      <Keywords>HATKO rules</Keywords>
      <Keywords>Safety</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Yaşar Demir</Name>
        <Affiliation>Ataturk University, Faculty of K.K Education, Department of Chemistry Education, 25200, Erzurum, Turkey. Electronic address: yasdemir@atauni.edu.tr.</Affiliation>
      </Author>
      <Author>
        <Name>Meryem Uckaya</Name>
        <Affiliation>Mugla Sitki Kocman University, Faculty of Science, Department of Chemistry, 48000, Kotekli-Mugla, Turkey.</Affiliation>
      </Author>
      <Author>
        <Name>Nazan Demir</Name>
        <Affiliation>Mugla Sitki Kocman University, Faculty of Science, Department of Chemistry, 48000, Kotekli-Mugla, Turkey.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Factors effecting the induction of rat forestomach hyperplasia induced by Swedish oral smokeless tobacco (snus).</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30844416</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30060-1</DOI>
    <KeywordList>
      <Keywords>Bromodeoxyuridine</Keywords>
      <Keywords>Forestomach</Keywords>
      <Keywords>Hyperplasia</Keywords>
      <Keywords>Keratosis</Keywords>
      <Keywords>Nicotine</Keywords>
      <Keywords>Rat</Keywords>
      <Keywords>Smokeless tobacco</Keywords>
      <Keywords>Snus</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Gordana Joksić</Name>
        <Affiliation>Vinča Institute of Nuclear Sciences, Department of Physical Chemistry, University of Belgrade, POB 522, 11000, Belgrade, Serbia.</Affiliation>
      </Author>
      <Author>
        <Name>Lars Erik Rutqvist</Name>
        <Affiliation>Swedish Match AB, Sveavägen 44, SE-11885, Stockholm, Sweden.</Affiliation>
      </Author>
      <Author>
        <Name>Mileva Mićić</Name>
        <Affiliation>Institute for Medical Research, University of Belgrade, POB 49, 11000, Belgrade, Serbia.</Affiliation>
      </Author>
      <Author>
        <Name>Jelena Filipović Tričković</Name>
        <Affiliation>Vinča Institute of Nuclear Sciences, Department of Physical Chemistry, University of Belgrade, POB 522, 11000, Belgrade, Serbia.</Affiliation>
      </Author>
      <Author>
        <Name>Robert Nilsson</Name>
        <Affiliation>Vinča Institute of Nuclear Sciences, Department of Physical Chemistry, University of Belgrade, POB 522, 11000, Belgrade, Serbia. Electronic address: robertn65@telia.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Developing OECD test guidelines for regulatory testing of nanomaterials to ensure mutual acceptance of test data.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30831158</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30053-4</DOI>
    <KeywordList>
      <Keywords>Hazard assessment</Keywords>
      <Keywords>Nanomaterial</Keywords>
      <Keywords>OECD test guidelines</Keywords>
      <Keywords>Test methods</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Kirsten Rasmussen</Name>
        <Affiliation>European Commission, Joint Research Centre, Ispra, via E. Fermi 2749, 21027, Ispra, (VA), Italy. Electronic address: kirsten.rasmussen@ec.europa.eu.</Affiliation>
      </Author>
      <Author>
        <Name>Hubert Rauscher</Name>
        <Affiliation>European Commission, Joint Research Centre, Ispra, via E. Fermi 2749, 21027, Ispra, (VA), Italy. Electronic address: hubert.rauscher@ec.europa.eu.</Affiliation>
      </Author>
      <Author>
        <Name>Peter Kearns</Name>
        <Affiliation>Organisation for Economic Co-operation and Development (OECD), Environment Directorate, 75775, Paris CEDEX 16, France. Electronic address: peter.kearns@oecd.org.</Affiliation>
      </Author>
      <Author>
        <Name>Mar González</Name>
        <Affiliation>Organisation for Economic Co-operation and Development (OECD), Environment Directorate, 75775, Paris CEDEX 16, France. Electronic address: mar.gonzalez@oecd.org.</Affiliation>
      </Author>
      <Author>
        <Name>Juan Riego Sintes</Name>
        <Affiliation>European Commission, Joint Research Centre, Ispra, via E. Fermi 2749, 21027, Ispra, (VA), Italy. Electronic address: juan.riego-sintes@ec.europa.eu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Toxicological evaluations of colostrum ultrafiltrate.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30831157</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30062-5</DOI>
    <KeywordList>
      <Keywords>Colostrum</Keywords>
      <Keywords>Mutagenicity</Keywords>
      <Keywords>NOAEL</Keywords>
      <Keywords>Safety</Keywords>
      <Keywords>Toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Anne Thiel</Name>
        <Affiliation>AIBMR Life Sciences, Inc., 2800 East Madison Street, Suite 202, Seattle, WA 98112, USA. Electronic address: anne@aibmr.com.</Affiliation>
      </Author>
      <Author>
        <Name>Róbert Glávits</Name>
        <Affiliation>Toxi-Coop Zrt, Magyar Jakobinusok Tere 4/B, H-1122 Budapest, Hungary. Electronic address: glavits.robert.dr@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Timothy S. Murbach</Name>
        <Affiliation>AIBMR Life Sciences, Inc., 2800 East Madison Street, Suite 202, Seattle, WA 98112, USA. Electronic address: tim@aibmr.com.</Affiliation>
      </Author>
      <Author>
        <Name>John R. Endres</Name>
        <Affiliation>AIBMR Life Sciences, Inc., 2800 East Madison Street, Suite 202, Seattle, WA 98112, USA. Electronic address: john@aibmr.com.</Affiliation>
      </Author>
      <Author>
        <Name>Robin Reddeman</Name>
        <Affiliation>AIBMR Life Sciences, Inc., 2800 East Madison Street, Suite 202, Seattle, WA 98112, USA. Electronic address: robin@aibmr.com.</Affiliation>
      </Author>
      <Author>
        <Name>Gábor Hirka</Name>
        <Affiliation>Toxi-Coop Zrt, Magyar Jakobinusok Tere 4/B, H-1122 Budapest, Hungary. Electronic address: gabor.hirka@toxicoop.com.</Affiliation>
      </Author>
      <Author>
        <Name>Adél Vértesi</Name>
        <Affiliation>Toxi-Coop Zrt, Magyar Jakobinusok Tere 4/B, H-1122 Budapest, Hungary. Electronic address: adel.vertesi@toxicoop.com.</Affiliation>
      </Author>
      <Author>
        <Name>Erzsébet Béres</Name>
        <Affiliation>Toxi-Coop Zrt, Magyar Jakobinusok Tere 4/B, H-1122 Budapest, Hungary. Electronic address: erzsebet.beres@toxicoop.com.</Affiliation>
      </Author>
      <Author>
        <Name>Ilona Pasics Szakonyiné</Name>
        <Affiliation>Toxi-Coop Zrt, Magyar Jakobinusok Tere 4/B, H-1122 Budapest, Hungary. Electronic address: ilona.pasics@toxicoop.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The activity of methacrylate esters in skin sensitisation test methods: A review.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30826317</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30059-5</DOI>
    <KeywordList>
      <Keywords>In vitro assays</Keywords>
      <Keywords>Local lymph node assay</Keywords>
      <Keywords>Methacrylates</Keywords>
      <Keywords>Predictive test methods</Keywords>
      <Keywords>QSAR</Keywords>
      <Keywords>Risk assessment</Keywords>
      <Keywords>Skin sensitisation</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Ian Kimber</Name>
        <Affiliation>Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK. Electronic address: ian.kimber@manchester.ac.uk.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Systemic toxicity of di (2-ethylhexyl) adipate (DEHA) in rats following 28-day intravenous exposure.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30826316</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30061-3</DOI>
    <KeywordList>
      <Keywords>DEHA</Keywords>
      <Keywords>Intravenous exposure</Keywords>
      <Keywords>NOEL</Keywords>
      <Keywords>Plasticizer</Keywords>
      <Keywords>Rat</Keywords>
      <Keywords>Toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Haiyan Xu</Name>
        <Affiliation>Baxter Healthcare Corporation, Suzhou, China. Electronic address: haiyan_xu@baxter.com.</Affiliation>
      </Author>
      <Author>
        <Name>Barbara Musi</Name>
        <Affiliation>Baxter Healthcare Corporation, PreClinical, Lund, Sweden.</Affiliation>
      </Author>
      <Author>
        <Name>Zhimei Wang</Name>
        <Affiliation>WuXi AppTec (Suzhou) Co., Ltd, Suzhou, China.</Affiliation>
      </Author>
      <Author>
        <Name>Tiansheng Zhou</Name>
        <Affiliation>WuXi AppTec (Suzhou) Co., Ltd, Suzhou, China.</Affiliation>
      </Author>
      <Author>
        <Name>Qihong Huang</Name>
        <Affiliation>Baxter Qiaoguang Healthcare (Guangzhou) Co., Ltd, Guangzhou, China.</Affiliation>
      </Author>
      <Author>
        <Name>Juanhua Liu</Name>
        <Affiliation>Baxter Healthcare Corporation, Suzhou, China.</Affiliation>
      </Author>
      <Author>
        <Name>Tiantian Li</Name>
        <Affiliation>Baxter Healthcare Corporation, Suzhou, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhen Jiang</Name>
        <Affiliation>Baxter Healthcare Corporation, Suzhou, China.</Affiliation>
      </Author>
      <Author>
        <Name>Songping Liao</Name>
        <Affiliation>Baxter Healthcare Corporation, Suzhou, China.</Affiliation>
      </Author>
      <Author>
        <Name>Glosson Jill</Name>
        <Affiliation>Baxter Healthcare Corporation, PreClinical, Roundlake, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Edward Koo</Name>
        <Affiliation>Baxter Healthcare Corporation, PreClinical, Roundlake, United States.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Assessment of priority tobacco additives per the requirements of the EU Tobacco Products Directive (2014/40/EU): Part 3, Smoking behavior and plasma nicotine pharmacokinetics.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30822442</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30057-1</DOI>
    <KeywordList>
      <Keywords>Cigarette</Keywords>
      <Keywords>Clinical</Keywords>
      <Keywords>Nicotine pharmacokinetics</Keywords>
      <Keywords>Priority additive</Keywords>
      <Keywords>Smoking behavior</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Michael McEwan</Name>
        <Affiliation>British American Tobacco, Research &amp; Development, Regents Park Road, Southampton, SO158TL, United Kingdom. Electronic address: mike_mcewan@bat.com.</Affiliation>
      </Author>
      <Author>
        <Name>Steven Coburn</Name>
        <Affiliation>British American Tobacco, Research &amp; Development, Regents Park Road, Southampton, SO158TL, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>David Ghosh</Name>
        <Affiliation>Philip Morris International, Philip Morris International Management SA, Avenue de Rhodanie 50, 1001, Lausanne, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Liam Simms</Name>
        <Affiliation>Imperial Tobacco, Winterstoke Road, Bristol, BS32LL, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Lesley Giles</Name>
        <Affiliation>Japan Tobacco International SA, Rue Kazem Radjavi 8, 1202, Geneva, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Dai Yuki</Name>
        <Affiliation>Japan Tobacco International SA, Rue Kazem Radjavi 8, 1202, Geneva, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Madeleine Ashley</Name>
        <Affiliation>British American Tobacco, Research &amp; Development, Regents Park Road, Southampton, SO158TL, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Ewald Roemer</Name>
        <Affiliation>TobToxConsulting, Imp. Blanchet-Dailleres 9, 1585, Cotterd, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Hyung Ok Sohn</Name>
        <Affiliation>KT&amp;G Research Institute, 30 Gajeong-ro, Yusong-gu, Daejeon, 34128, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Christopher Proctor</Name>
        <Affiliation>British American Tobacco, Research &amp; Development, Regents Park Road, Southampton, SO158TL, United Kingdom.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Toxicity studies for the use of prodrug of voriconazole in rats.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30817970</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30058-3</DOI>
    <KeywordList>
      <Keywords>One-month toxicity study</Keywords>
      <Keywords>POV</Keywords>
      <Keywords>Toxicokinetic</Keywords>
      <Keywords>Voriconazole</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Juemin Chen</Name>
        <Affiliation>School of Biological and Pharmaceutical Engineering, Nanjing Tech University, Nanjing, 210009, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jing Liu</Name>
        <Affiliation>Jiangsu Center for Safety Evaluation of Drugs, School of Pharmaceutical Sciences, Nanjing Tech University, Nanjing, 210009, China.</Affiliation>
      </Author>
      <Author>
        <Name>Bo Zhou</Name>
        <Affiliation>Jiangsu Center for Safety Evaluation of Drugs, School of Pharmaceutical Sciences, Nanjing Tech University, Nanjing, 210009, China. Electronic address: zhoubo_198209@126.com.</Affiliation>
      </Author>
      <Author>
        <Name>Qingqing Song</Name>
        <Affiliation>Jiangsu Center for Safety Evaluation of Drugs, School of Pharmaceutical Sciences, Nanjing Tech University, Nanjing, 210009, China.</Affiliation>
      </Author>
      <Author>
        <Name>Wu Sun</Name>
        <Affiliation>Jiangsu Center for Safety Evaluation of Drugs, School of Pharmaceutical Sciences, Nanjing Tech University, Nanjing, 210009, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yazhi Yuan</Name>
        <Affiliation>China Pharmaceutical University, Nanjing, 210009, China.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Assessment of priority tobacco additives per the requirements of the EU Tobacco Products Directive (2014/40/EU): Part 1: Background, approach, and summary of findings.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30797887</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30056-X</DOI>
    <KeywordList>
      <Keywords>Cigarette</Keywords>
      <Keywords>Clinical</Keywords>
      <Keywords>In-vitro</Keywords>
      <Keywords>Priority additive</Keywords>
      <Keywords>Sensory</Keywords>
      <Keywords>Smoke chemistry</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Liam Simms</Name>
        <Affiliation>Imperial Tobacco, 121 Winterstoke Road, Bristol, BS3 2LL, United Kingdom. Electronic address: liam.simms@uk.imptob.com.</Affiliation>
      </Author>
      <Author>
        <Name>Anna Clarke</Name>
        <Affiliation>Imperial Tobacco, 121 Winterstoke Road, Bristol, BS3 2LL, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Thilo Paschke</Name>
        <Affiliation>Japan Tobacco International SA, Rue Kazem Radjavi 8, 1202, Geneva, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Andrew Manson</Name>
        <Affiliation>British American Tobacco, Globe House, Temple Place, London, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>James Murphy</Name>
        <Affiliation>British American Tobacco, Research &amp; Development, Regents Park Road, Southampton, SO158TL, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Regina Stabbert</Name>
        <Affiliation>Philip Morris International, Philip Morris Products SA, Rue des Usines 90, 2000, Neuchâtel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Marco Esposito</Name>
        <Affiliation>Philip Morris International, Philip Morris Products SA, Rue des Usines 90, 2000, Neuchâtel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>David Ghosh</Name>
        <Affiliation>Philip Morris International, Philip Morris International Management SA, Avenue de Rhodanie 50, 1001, Lausanne, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Ewald Roemer</Name>
        <Affiliation>TobToxConsulting, Imp. Blanchet-Dailleres 9, 1585, Cotterd, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Javier Martinez</Name>
        <Affiliation>Japan Tobacco International SA, Rue Kazem Radjavi 8, 1202, Geneva, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Jarl Freiesleben</Name>
        <Affiliation>Mac Baren Tobacco Company A/S, Porthusvej 100, DK-5700 Svenborg, Denmark.</Affiliation>
      </Author>
      <Author>
        <Name>Hyo Keun Kim</Name>
        <Affiliation>KT&amp;G Research Institute, 30 Gajeong-ro, Yusong-gu, Daejeon, 34128, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Thomas Lindegaard</Name>
        <Affiliation>Scandinavian TobaccoGroup A/S, Sydmarken 42, 2860, Søborg, Denmark.</Affiliation>
      </Author>
      <Author>
        <Name>Marc Scharfe</Name>
        <Affiliation>LandewykTobacco S. A, 31 rue de Hollerich, 1741, Luxembourg B.P, 2202L-1022, Luxembourg.</Affiliation>
      </Author>
      <Author>
        <Name>Istvan Vincze</Name>
        <Affiliation>Continental Tobacco Corporation, Continental Dohányipari Zrt, 1-3, Dohány utca Sátoraljaújhely, 3980, Hungary.</Affiliation>
      </Author>
      <Author>
        <Name>Panagiotis Vlachos</Name>
        <Affiliation>Karelia Tobacco Company Inc., Athinon Str, 241 00, Kalamata, Greece.</Affiliation>
      </Author>
      <Author>
        <Name>Diane Wigotzki</Name>
        <Affiliation>Joh. Wilh. von Eicken GmbH, Drechslerstr. 1 - 3, 23556, Lübeck, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Gwen Pollner</Name>
        <Affiliation>Pöschl Tabak GmbH &amp; Co. KG, Dieselstrasse 1, 84144, Geisenhausen, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Rolf Lutz</Name>
        <Affiliation>Philip Morris International, Philip Morris International Management SA, Avenue de Rhodanie 50, 1001, Lausanne, Switzerland.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A case study on the application of an expert-driven read-across approach in support of quantitative risk assessment of p,p'-dichlorodiphenyldichloroethane.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30794837</pubmedLink>
    <GrantList>
      <Grant>EPA999999</Grant>
    </GrantList>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30055-8</DOI>
    <KeywordList>
      <Keywords>In vitro high-throughput screening</Keywords>
      <Keywords>Quantitative risk assessment</Keywords>
      <Keywords>Read-across</Keywords>
      <Keywords>Toxicokinetics</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Lucina E. Lizarraga</Name>
        <Affiliation>National Center for Environmental Assessment (NCEA), U.S. Environmental Protection Agency, Cincinnati, OH, 45268, USA. Electronic address: Lizarraga.Lucina@epa.gov.</Affiliation>
      </Author>
      <Author>
        <Name>Jeffry L. Dean</Name>
        <Affiliation>National Center for Environmental Assessment (NCEA), U.S. Environmental Protection Agency, Cincinnati, OH, 45268, USA.</Affiliation>
      </Author>
      <Author>
        <Name>J. Phillip Kaiser</Name>
        <Affiliation>National Center for Environmental Assessment (NCEA), U.S. Environmental Protection Agency, Cincinnati, OH, 45268, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Scott C. Wesselkamper</Name>
        <Affiliation>National Center for Environmental Assessment (NCEA), U.S. Environmental Protection Agency, Cincinnati, OH, 45268, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jason C. Lambert</Name>
        <Affiliation>National Center for Environmental Assessment (NCEA), U.S. Environmental Protection Agency, Cincinnati, OH, 45268, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Q. Jay Zhao</Name>
        <Affiliation>National Center for Environmental Assessment (NCEA), U.S. Environmental Protection Agency, Cincinnati, OH, 45268, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Effect of acute exposure in swiss mice (Mus musculus) to a fibrinolytic protease produced by Mucor subtilissimus UCP 1262: An histomorphometric, genotoxic and cytological approach.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30790607</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30054-6</DOI>
    <KeywordList>
      <Keywords>Fibrinogenolytic activity</Keywords>
      <Keywords>Fibrinolytic enzyme</Keywords>
      <Keywords>Hemostasis</Keywords>
      <Keywords>Mucor</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Marllyn Marques da Silva</Name>
        <Affiliation>Laboratory of Biotechnology and Pharmaceuticals, Academic Center of Vitoria, Federal University of Pernambuco, 55608-680, Vitória de Santo Antão, Pernambuco, Brazil. Electronic address: marllynmsilva@yahoo.com.br.</Affiliation>
      </Author>
      <Author>
        <Name>Tamiris Alves Rocha</Name>
        <Affiliation>Laboratory of Natural Products, Department of Biochemistry, Federal University of Pernambuco, 50670-420, Recife, Pernambuco, Brazil. Electronic address: tamialvesinsl@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Danielle Feijó de Moura</Name>
        <Affiliation>Laboratory of Natural Products, Department of Biochemistry, Federal University of Pernambuco, 50670-420, Recife, Pernambuco, Brazil. Electronic address: danielle.feijo@hotmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Cristiano Aparecido Chagas</Name>
        <Affiliation>Laboratory of Biotechnology and Pharmaceuticals, Academic Center of Vitoria, Federal University of Pernambuco, 55608-680, Vitória de Santo Antão, Pernambuco, Brazil. Electronic address: chagas.cris@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Francisco Carlos Amanajás de Aguiar Júnior</Name>
        <Affiliation>Laboratory of Biotechnology and Pharmaceuticals, Academic Center of Vitoria, Federal University of Pernambuco, 55608-680, Vitória de Santo Antão, Pernambuco, Brazil. Electronic address: famanajas@yahoo.com.br.</Affiliation>
      </Author>
      <Author>
        <Name>Noêmia Pereira da Silva Santos</Name>
        <Affiliation>Laboratory of Nanotechnology, Biotechnology and Cell Culture, Academic Center of Vitória, Federal University of Pernambuco, 55608-680, Vitória de Santo Antão, Pernambuco, Brazil. Electronic address: npereiradasilvasantos@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Renata Vitória Da Silva Sobral</Name>
        <Affiliation>Laboratory of Research in Biotechnology and Hemoderivatives, Department of Pharmaceutical Sciences, Federal University of Pernambuco, 50670-420, Recife, Pernambuco, Brazil. Electronic address: renata.sobral002@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Jéssica Miranda do Nascimento</Name>
        <Affiliation>Laboratory of Research in Biotechnology and Hemoderivatives, Department of Pharmaceutical Sciences, Federal University of Pernambuco, 50670-420, Recife, Pernambuco, Brazil. Electronic address: jessicamnascimento@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Ana Cristina Lima Leite</Name>
        <Affiliation>Laboratory of Research in Biotechnology and Hemoderivatives, Department of Pharmaceutical Sciences, Federal University of Pernambuco, 50670-420, Recife, Pernambuco, Brazil. Electronic address: acllb2003@yahoo.com.br.</Affiliation>
      </Author>
      <Author>
        <Name>Lorenzo Pastrana</Name>
        <Affiliation>International Iberian Nanotechnology Laboratory, Av. Mestre José Veiga, Braga, 4715-330, Portugal. Electronic address: lorenzo.pastrana@inl.int.</Affiliation>
      </Author>
      <Author>
        <Name>Romero Marcos Pedrosa Brandão Costa</Name>
        <Affiliation>Laboratory of Bioactive Technology, Department of Morphology and Animal Physiology, Federal Rural University of Pernambuco, Rua Dom Manoel de Medeiros, s / n, Dois Irmãos, 52171-900, Recife, Pernambuco, Brazil. Electronic address: romero_brandao@yahoo.com.br.</Affiliation>
      </Author>
      <Author>
        <Name>Thiago Pajeú Nascimento</Name>
        <Affiliation>Laboratory of Bioactive Technology, Department of Morphology and Animal Physiology, Federal Rural University of Pernambuco, Rua Dom Manoel de Medeiros, s / n, Dois Irmãos, 52171-900, Recife, Pernambuco, Brazil. Electronic address: thiago_pajeu@hotmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Ana Lúcia Figueiredo Porto</Name>
        <Affiliation>Laboratory of Bioactive Technology, Department of Morphology and Animal Physiology, Federal Rural University of Pernambuco, Rua Dom Manoel de Medeiros, s / n, Dois Irmãos, 52171-900, Recife, Pernambuco, Brazil. Electronic address: analuporto@yahoo.com.br.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>28-Day somatic gene mutation study of 1-bromopropane in female Big Blue</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30779931</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30042-X</DOI>
    <KeywordList>
      <Keywords>1-bromopropane</Keywords>
      <Keywords>Carcinogenesis</Keywords>
      <Keywords>In vivo</Keywords>
      <Keywords>Inhalation</Keywords>
      <Keywords>Mutagenesis</Keywords>
      <Keywords>Threshold</Keywords>
      <Keywords>Vapor degreaser</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Mark Stelljes</Name>
        <Affiliation>SLR International Corporation, Martinez, CA, USA. Electronic address: mstelljes@slrconsulting.com.</Affiliation>
      </Author>
      <Author>
        <Name>Robert Young</Name>
        <Affiliation>MilliporeSigma, BioReliance(®) Testing Services, Rockville, MD, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jeff Weinberg</Name>
        <Affiliation>Charles River, Ashland, OH, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Toxicological assessment compilation of selected examples of raw materials for homeopathic medicinal products.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30771368</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30052-2</DOI>
    <KeywordList>
      <Keywords>Acceptable amounts per day (AAD)</Keywords>
      <Keywords>Acceptable/Tolerable daily intake (ADI/TDI)</Keywords>
      <Keywords>Homeopathic medicinal products (HMP)</Keywords>
      <Keywords>Lowest Human Recommended Dose (LHRD)</Keywords>
      <Keywords>Permitted Daily Exposure (PDE)</Keywords>
      <Keywords>Safety assessment</Keywords>
      <Keywords>Threshold of Toxicological Concern (TTC)</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Marie Luise Buchholzer</Name>
        <Affiliation>Federal Institute for Drugs and Medical Devices (Bundesinstitut für Arzneimittel und Medizinprodukte, BfArM), Kurt-Georg-Kiesinger-Allee 3, 53175, Bonn, Germany. Electronic address: Marie-Luise.Buchholzer@bfarm.de.</Affiliation>
      </Author>
      <Author>
        <Name>Marion Kirch</Name>
        <Affiliation>Federal Institute for Drugs and Medical Devices (Bundesinstitut für Arzneimittel und Medizinprodukte, BfArM), Kurt-Georg-Kiesinger-Allee 3, 53175, Bonn, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Christiane Kirchner</Name>
        <Affiliation>Federal Institute for Drugs and Medical Devices (Bundesinstitut für Arzneimittel und Medizinprodukte, BfArM), Kurt-Georg-Kiesinger-Allee 3, 53175, Bonn, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Werner Knoess</Name>
        <Affiliation>Federal Institute for Drugs and Medical Devices (Bundesinstitut für Arzneimittel und Medizinprodukte, BfArM), Kurt-Georg-Kiesinger-Allee 3, 53175, Bonn, Germany.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Evaluation of developmental toxicity of Methyl Chloride (Chloromethane) in rats, mice, and rabbits.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30753850</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30046-7</DOI>
    <KeywordList>
      <Keywords>Chloromethane</Keywords>
      <Keywords>Classification</Keywords>
      <Keywords>Developmental toxicity</Keywords>
      <Keywords>Methyl chloride</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Josje Arts</Name>
        <Affiliation>Nouryon (former AkzoNobel Chemicals), Velperweg 76, 6824, BM, Arnhem, the Netherlands. Electronic address: Josje.arts@nouryon.com.</Affiliation>
      </Author>
      <Author>
        <Name>Marco Kellert</Name>
        <Affiliation>Wacker Chemie AG, Johannes-Hess-Strasse 24, 84489, Burghausen, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Lynn Pottenger</Name>
        <Affiliation>LHP TOX CONSULT, LLC, Midland, MI, 48640, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Josianne Theuns-van Vliet</Name>
        <Affiliation>Triskelion, Utrechtseweg 48, 3704, HE, Zeist, the Netherlands.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Acute toxicity and genotoxicity evaluations of Nattokinase, a promising agent for cardiovascular diseases prevention.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30742876</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30051-0</DOI>
    <KeywordList>
      <Keywords>Acute toxicity</Keywords>
      <Keywords>Ames test</Keywords>
      <Keywords>Chromosome aberration</Keywords>
      <Keywords>Genotoxicity</Keywords>
      <Keywords>Micronucleus</Keywords>
      <Keywords>Nattokinase</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Hao Wu</Name>
        <Affiliation>Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang, Liaoning, 110016, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Huan Wang</Name>
        <Affiliation>Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang, Liaoning, 110016, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Feng Xu</Name>
        <Affiliation>School of Life Sciences and Biopharmaceutics, Shenyang Pharmaceutical University, Shenyang, Liaoning, 110016, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Jiepeng Chen</Name>
        <Affiliation>Sungen Biotech Co., Ltd, Shantou, 515000, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Lili Duan</Name>
        <Affiliation>Sungen Biotech Co., Ltd, Shantou, 515000, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Fengjiao Zhang</Name>
        <Affiliation>Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang, Liaoning, 110016, PR China. Electronic address: zhangfengjiao@syphu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Regulatory effect of decreasing therapeutic duplication of respiratory drugs using a prescription database between 2012 and 2015.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30742875</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30048-0</DOI>
    <KeywordList>
      <Keywords>Drug utilization review</Keywords>
      <Keywords>Duplicative prescriptions</Keywords>
      <Keywords>Medication errors</Keywords>
      <Keywords>Therapeutic duplication</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Hyesung Lee</Name>
        <Affiliation>School of Pharmacy, Sungkyunkwan University, Suwon, Gyeonggi-do, South Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Inmyung Song</Name>
        <Affiliation>School of Pharmacy, Sungkyunkwan University, Suwon, Gyeonggi-do, South Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Sun Mi Shin</Name>
        <Affiliation>School of Pharmacy, Sungkyunkwan University, Suwon, Gyeonggi-do, South Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Han Eol Jeong</Name>
        <Affiliation>School of Pharmacy, Sungkyunkwan University, Suwon, Gyeonggi-do, South Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Eui Kyung Lee</Name>
        <Affiliation>School of Pharmacy, Sungkyunkwan University, Suwon, Gyeonggi-do, South Korea. Electronic address: ekyung@skku.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Ju Young Shin</Name>
        <Affiliation>School of Pharmacy, Sungkyunkwan University, Suwon, Gyeonggi-do, South Korea. Electronic address: shin.jy@skku.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A 90-day subchronic toxicology screen of genetically modified rice Lac-3 and its effects on the gut microbiota in Sprague-Dawley rats.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30738882</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30050-9</DOI>
    <KeywordList>
      <Keywords>Genetically modified rice</Keywords>
      <Keywords>Gut microbiota</Keywords>
      <Keywords>Lactoferrin</Keywords>
      <Keywords>Safety assessment</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Xueqin Zhang</Name>
        <Affiliation>College of Food Science and Nutritional Engineering, China Agricultural University, No.17 Qinghua East Road, Beijing, 100083, China; Key Laboratory of Safety Assessment of Genetically Modified Organism (Food Safety), Ministry of Agriculture, P.R, Beijing, 100083, China.</Affiliation>
      </Author>
      <Author>
        <Name>Tongtong Zhang</Name>
        <Affiliation>Beijing Jintian Mai International Food Co., Ltd, Beijing, 101407, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jingni Shi</Name>
        <Affiliation>College of Life Sciences, Wuhan University, Wuhan, 430072, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Shiying Zou</Name>
        <Affiliation>College of Food Science and Nutritional Engineering, China Agricultural University, No.17 Qinghua East Road, Beijing, 100083, China; Key Laboratory of Safety Assessment of Genetically Modified Organism (Food Safety), Ministry of Agriculture, P.R, Beijing, 100083, China.</Affiliation>
      </Author>
      <Author>
        <Name>Mingzhang Guo</Name>
        <Affiliation>Key Laboratory of Safety Assessment of Genetically Modified Organism (Food Safety), Ministry of Agriculture, P.R, Beijing, 100083, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaoyun He</Name>
        <Affiliation>College of Food Science and Nutritional Engineering, China Agricultural University, No.17 Qinghua East Road, Beijing, 100083, China; Key Laboratory of Safety Assessment of Genetically Modified Organism (Food Safety), Ministry of Agriculture, P.R, Beijing, 100083, China.</Affiliation>
      </Author>
      <Author>
        <Name>Daichang Yang</Name>
        <Affiliation>College of Life Sciences, Wuhan University, Wuhan, 430072, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaohong Mei</Name>
        <Affiliation>College of Food Science and Nutritional Engineering, China Agricultural University, No.17 Qinghua East Road, Beijing, 100083, China; Key Laboratory of Safety Assessment of Genetically Modified Organism (Food Safety), Ministry of Agriculture, P.R, Beijing, 100083, China. Electronic address: mxh@cau.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Subacute toxicity and toxicokinetics study of DHP107, an oral paclitaxel formulation with once-weekly dosing in mice.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30738088</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30049-2</DOI>
    <KeywordList>
      <Keywords>DHP107</Keywords>
      <Keywords>No-observed-adverse-effect level (NOAEL)</Keywords>
      <Keywords>Oral formulated paclitaxel</Keywords>
      <Keywords>Subacute oral toxicity</Keywords>
      <Keywords>Toxicokinetics</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Ji Young Kim</Name>
        <Affiliation>Department of Toxicological Evaluation and Research, Korea Institute of Toxicology (KIT), Daejeon, Republic of Korea; College of Pharmacy, Chungnam National University, Daejeon, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Sunyeong Lee</Name>
        <Affiliation>Department of Toxicological Evaluation and Research, Korea Institute of Toxicology (KIT), Daejeon, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Yongbum Kim</Name>
        <Affiliation>Department of Toxicological Evaluation and Research, Korea Institute of Toxicology (KIT), Daejeon, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Eun Ju Jeong</Name>
        <Affiliation>Department of Toxicological Evaluation and Research, Korea Institute of Toxicology (KIT), Daejeon, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>In Hyun Lee</Name>
        <Affiliation>Central Research Center, Daehwa Pharmaceutical Co. Ltd, Hoengseong-gun, Gangwon-do, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Min Hee Son</Name>
        <Affiliation>Central Research Center, Daehwa Pharmaceutical Co. Ltd, Hoengseong-gun, Gangwon-do, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Jae Young Lee</Name>
        <Affiliation>College of Pharmacy, Chungnam National University, Daejeon, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Sang Kyum Kim</Name>
        <Affiliation>College of Pharmacy, Chungnam National University, Daejeon, Republic of Korea. Electronic address: sangkim@cnu.ac.kr.</Affiliation>
      </Author>
      <Author>
        <Name>Kyoung Sik Moon</Name>
        <Affiliation>Department of Toxicological Evaluation and Research, Korea Institute of Toxicology (KIT), Daejeon, Republic of Korea; Human and Environmental Toxicology, University of Science and Technology, Daejeon, Republic of Korea. Electronic address: ksmoon@kitox.re.kr.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Toxicology study of long-term administration of rhKGF-2 eye drops on rabbit corneas.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30735698</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30047-9</DOI>
    <KeywordList>
      <Keywords>Corneal injury</Keywords>
      <Keywords>Keratinocyte growth factor-2</Keywords>
      <Keywords>Ocular irritation</Keywords>
      <Keywords>Toxic effects</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>JianQiu Cai</Name>
        <Affiliation>Wenzhou Medical University, Chashan University Park, Wenzhou, 325035, China; Department of Ophthalmology, The Affiliated Second Hospital of Wenzhou Medical University, #109 Xueyuan West Road, Wenzhou 325027, China.</Affiliation>
      </Author>
      <Author>
        <Name>Wenqing Li</Name>
        <Affiliation>Wenzhou Medical University, Chashan University Park, Wenzhou, 325035, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jinghang Li</Name>
        <Affiliation>Swanson School of Engimeering University of Pittsburgh Benedum Hall Pittsburgh, PA, 15261, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Qingde Zhou</Name>
        <Affiliation>Wenzhou Medical University, Chashan University Park, Wenzhou, 325035, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yadong Huang</Name>
        <Affiliation>The National Engineering Research Center of Genetic Medicine, Ninan University, #206 Kaiyuan Road, Economic and Technical Development Zone, Guangzhou, 510730, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaokun Li</Name>
        <Affiliation>Wenzhou Medical University, Chashan University Park, Wenzhou, 325035, China.</Affiliation>
      </Author>
      <Author>
        <Name>Qi Hui</Name>
        <Affiliation>Wenzhou Medical University, Chashan University Park, Wenzhou, 325035, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaojie Wang</Name>
        <Affiliation>Wenzhou Medical University, Chashan University Park, Wenzhou, 325035, China. Electronic address: wangxiaojie@keeningbio.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Toxicological comparison of cigarette smoke and e-cigarette aerosol using a 3D in vitro human respiratory model.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30721718</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30044-3</DOI>
    <KeywordList>
      <Keywords>Aerosol</Keywords>
      <Keywords>Air-liquid interface</Keywords>
      <Keywords>Cigarette</Keywords>
      <Keywords>E-cigarette</Keywords>
      <Keywords>Inflammation</Keywords>
      <Keywords>Organotypic tissue model</Keywords>
      <Keywords>Oxidative stress</Keywords>
      <Keywords>Smoke</Keywords>
      <Keywords>Toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Lukasz Czekala</Name>
        <Affiliation>Imperial Brands PLC, 121 Winterstoke Road, Bristol, BS3 2LL, UK. Electronic address: Lukasz.Czekala@uk.imptob.com.</Affiliation>
      </Author>
      <Author>
        <Name>Liam Simms</Name>
        <Affiliation>Imperial Brands PLC, 121 Winterstoke Road, Bristol, BS3 2LL, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Matthew Stevenson</Name>
        <Affiliation>Imperial Brands PLC, 121 Winterstoke Road, Bristol, BS3 2LL, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Nicole Tschierske</Name>
        <Affiliation>Imperial Brands PLC, 121 Winterstoke Road, Bristol, BS3 2LL, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Anna G. Maione</Name>
        <Affiliation>MatTek, 200 Homer Ave., Ashland, MA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Tanvir Walele</Name>
        <Affiliation>Imperial Brands PLC, 121 Winterstoke Road, Bristol, BS3 2LL, UK.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Evaluation of aspartame cancer epidemiology studies based on quality appraisal criteria.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30716379</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30041-8</DOI>
    <KeywordList>
      <Keywords>Aspartame</Keywords>
      <Keywords>Cancer</Keywords>
      <Keywords>Case-control</Keywords>
      <Keywords>Cohort</Keywords>
      <Keywords>Epidemiology</Keywords>
      <Keywords>Quality criteria</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Lois Haighton</Name>
        <Affiliation>Intertek Regulatory &amp; Scientific Consultancy, 2233 Argentia Rd., Suite 201, Mississauga, ON, L5N 2X7, Canada. Electronic address: lois.haighton@intertek.com.</Affiliation>
      </Author>
      <Author>
        <Name>Ashley Roberts</Name>
        <Affiliation>Intertek Regulatory &amp; Scientific Consultancy, 2233 Argentia Rd., Suite 201, Mississauga, ON, L5N 2X7, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Tomas Jonaitis</Name>
        <Affiliation>Intertek Regulatory &amp; Scientific Consultancy, 2233 Argentia Rd., Suite 201, Mississauga, ON, L5N 2X7, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Barry Lynch</Name>
        <Affiliation>Intertek Regulatory &amp; Scientific Consultancy, 2233 Argentia Rd., Suite 201, Mississauga, ON, L5N 2X7, Canada.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Approval of modified-release products by FDA without clinical efficacy/safety studies: A retrospective survey from 2008 to 2017.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30711621</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30045-5</DOI>
    <KeywordList>
      <Keywords>Exposure-response relationship</Keywords>
      <Keywords>Modified-release drug product</Keywords>
      <Keywords>New drug application</Keywords>
      <Keywords>Pharmacokinetic</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Yi Lin Wang</Name>
        <Affiliation>Division of Pharmaceutical Science, Center for Drug Evaluation (CDE), Taipei, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Yi Ting Chang</Name>
        <Affiliation>Division of Pharmaceutical Science, Center for Drug Evaluation (CDE), Taipei, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Shih Ying Yang</Name>
        <Affiliation>Division of Pharmaceutical Science, Center for Drug Evaluation (CDE), Taipei, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Ya Wen Chang</Name>
        <Affiliation>Division of Pharmaceutical Science, Center for Drug Evaluation (CDE), Taipei, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Mei Hsien Kuan</Name>
        <Affiliation>Division of Pharmaceutical Science, Center for Drug Evaluation (CDE), Taipei, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Chien Lung Tu</Name>
        <Affiliation>Division of Pharmaceutical Science, Center for Drug Evaluation (CDE), Taipei, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Hui Chun Hong</Name>
        <Affiliation>Division of Pharmaceutical Science, Center for Drug Evaluation (CDE), Taipei, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>I. Chun Lai</Name>
        <Affiliation>Center of Consultation, Center for Drug Evaluation (CDE), Taipei, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Churn Shiouh Gau</Name>
        <Affiliation>Office of Executive Director, Center for Drug Evaluation (CDE), Taipei, Taiwan; School of Pharmacy, National Taiwan University, Taipei, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Li Feng Hsu</Name>
        <Affiliation>Center of Consultation, Center for Drug Evaluation (CDE), Taipei, Taiwan. Electronic address: Lfhsu@cde.org.tw.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Emission level of seven mainstream smoke toxicants from cigarette with variable tobacco leaf constituents.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30710578</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30040-6</DOI>
    <KeywordList>
      <Keywords>Cigarette</Keywords>
      <Keywords>Environment</Keywords>
      <Keywords>Mainstream smoke</Keywords>
      <Keywords>Stalk position</Keywords>
      <Keywords>Toxicant</Keywords>
      <Keywords>Variety</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Bin Cai</Name>
        <Affiliation>Molecular Genetics Key Laboratory of China Tobacco, Guizhou Academy of Tobacco Science, Guiyang 550081, PR China; Haikou Cigar Research Institute, Hainan Provincial Branch of CNTC, Haikou, 571100, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhitao Li</Name>
        <Affiliation>China Tobacco Guizhou Import and Export Co. Ltd, 334 Wei-Qing Road, Yun-Yan District, Guiyang City 550003, Guizhou Province, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Rengang Wang</Name>
        <Affiliation>Molecular Genetics Key Laboratory of China Tobacco, Guizhou Academy of Tobacco Science, Guiyang 550081, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhaoliang Geng</Name>
        <Affiliation>Molecular Genetics Key Laboratory of China Tobacco, Guizhou Academy of Tobacco Science, Guiyang 550081, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Yuewei Shi</Name>
        <Affiliation>Molecular Genetics Key Laboratory of China Tobacco, Guizhou Academy of Tobacco Science, Guiyang 550081, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Shengdong Xie</Name>
        <Affiliation>Molecular Genetics Key Laboratory of China Tobacco, Guizhou Academy of Tobacco Science, Guiyang 550081, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhihong Wang</Name>
        <Affiliation>Molecular Genetics Key Laboratory of China Tobacco, Guizhou Academy of Tobacco Science, Guiyang 550081, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhixiao Yang</Name>
        <Affiliation>Molecular Genetics Key Laboratory of China Tobacco, Guizhou Academy of Tobacco Science, Guiyang 550081, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Xueliang Ren</Name>
        <Affiliation>Molecular Genetics Key Laboratory of China Tobacco, Guizhou Academy of Tobacco Science, Guiyang 550081, PR China. Electronic address: renxuel@126.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>An evaluation of the USEPA Proposed Approaches for applying a biologically based dose-response model in a risk assessment for perchlorate in drinking water.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30707931</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30036-4</DOI>
    <KeywordList>
      <Keywords>BBDR model</Keywords>
      <Keywords>MCLG</Keywords>
      <Keywords>Perchlorate</Keywords>
      <Keywords>Risk assessment</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Harvey J. Clewell</Name>
        <Affiliation>Ramboll US Corporation, Research Triangle Park, NC, USA. Electronic address: hclewell@ramboll.com.</Affiliation>
      </Author>
      <Author>
        <Name>P. Robinan Gentry</Name>
        <Affiliation>Ramboll US Corporation, Monroe, LA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>C. Eric Hack</Name>
        <Affiliation>ScitoVation, Research Triangle Park, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Tracy Greene</Name>
        <Affiliation>Ramboll US Corporation, Monroe, LA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Rebecca A. Clewell</Name>
        <Affiliation>ToxStrategies, Research Triangle Park, NC, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Acute and sub-chronic 90-day oral toxicity study of Perilla seed oil in rodents and Beagle dogs.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30703409</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30043-1</DOI>
    <KeywordList>
      <Keywords>Acute toxicity</Keywords>
      <Keywords>Beagle dogs</Keywords>
      <Keywords>Perilla seed oil</Keywords>
      <Keywords>Rodents</Keywords>
      <Keywords>Sub-chronic toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Hui Xing Zhang</Name>
        <Affiliation>Shenyang Pharmaceutical University, Shenyang, 110016, People's Republic of China; Liaoning Xinzhong Modern Medicine Co.,Ltd., Shenyang, 110041, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Jian Guan</Name>
        <Affiliation>Liaoning Xinzhong Modern Medicine Co.,Ltd., Shenyang, 110041, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Yi Hong Tian</Name>
        <Affiliation>Tianjin Institute of Pharmaceutical Research, Tianjin, 300193, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Guang Yue Su</Name>
        <Affiliation>Shenyang Pharmaceutical University, Shenyang, 110016, People's Republic of China; Key Laboratory of Structure-based Drug Design and Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang, 110016, China. Electronic address: suggyy@163.com.</Affiliation>
      </Author>
      <Author>
        <Name>Yu Qing Zhao</Name>
        <Affiliation>Shenyang Pharmaceutical University, Shenyang, 110016, People's Republic of China; Key Laboratory of Structure-based Drug Design and Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang, 110016, China. Electronic address: zyq4885@126.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Improving risk assessment approaches for chemicals with both endogenous and exogenous exposures.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30703408</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30037-6</DOI>
    <KeywordList>
      <Keywords>Endogenous exposure</Keywords>
      <Keywords>Problem formulation</Keywords>
      <Keywords>Risk assessment</Keywords>
      <Keywords>Systematic review</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>William H. Farland</Name>
        <Affiliation>William H. Farland Consulting, LLC, Rockport, ME, 04856, USA. Electronic address: William.Farland@Colostate.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Angela Lynch</Name>
        <Affiliation>ToxPlus Consulting, LLC, Oak Brook, IL 60521, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Neeraja K. Erraguntla</Name>
        <Affiliation>American Chemistry Council, Washington, DC, 20002, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Lynn H. Pottenger</Name>
        <Affiliation>Olin Corporation (retired), Midland, MI, 48674, USA; LHP Tox Consult, LLC, Midland, MI, 48640, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A study in a rat initiation-promotion bladder tumour model demonstrated no promoter/progressor potential of dapagliflozin.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30685222</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30039-X</DOI>
    <KeywordList>
      <Keywords>Bladder cancer</Keywords>
      <Keywords>Carcinogenicity</Keywords>
      <Keywords>Dapagliflozin</Keywords>
      <Keywords>N-Butyl-N-(4-hydroxybutyl)-nitrosamine (BBN)</Keywords>
      <Keywords>Rat</Keywords>
      <Keywords>Sodium-glucose cotransporter 2 (SGLT2)</Keywords>
      <Keywords>Transitional cell carcinoma (TCC)</Keywords>
      <Keywords>Tumour initiator</Keywords>
      <Keywords>Tumour progressor</Keywords>
      <Keywords>Tumour promoter</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Martin Billger</Name>
        <Affiliation>Drug Safety and Metabolism, IMED Biotech Unit, AstraZeneca, Gothenburg, Sweden. Electronic address: Martin.Billger@astrazeneca.com.</Affiliation>
      </Author>
      <Author>
        <Name>Jason Kirk</Name>
        <Affiliation>Drug Safety and Metabolism, IMED Biotech Unit, AstraZeneca, Cambridge, UK. Electronic address: Jason.Kirk@astrazeneca.com.</Affiliation>
      </Author>
      <Author>
        <Name>Jane Chang</Name>
        <Affiliation>Drug Safety and Metabolism, IMED Biotech Unit, AstraZeneca, Waltham, MA, USA. Electronic address: Jane.Chang1@astrazeneca.com.</Affiliation>
      </Author>
      <Author>
        <Name>Agathe Bédard</Name>
        <Affiliation>Charles River Laboratories, Montreal, Canada. Electronic address: Agathe.Bedard@crl.com.</Affiliation>
      </Author>
      <Author>
        <Name>Bassem Attalla</Name>
        <Affiliation>Charles River Laboratories, Montreal, Canada. Electronic address: bazatala@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Solomon Haile</Name>
        <Affiliation>Charles River Laboratories, Montreal, Canada. Electronic address: solomon.haile@crl.com.</Affiliation>
      </Author>
      <Author>
        <Name>Magnus Söderberg</Name>
        <Affiliation>Drug Safety and Metabolism, IMED Biotech Unit, AstraZeneca, Gothenburg, Sweden. Electronic address: Magnus.Soderberg@astrazeneca.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A comprehensive toxicological safety assessment of an extract of Ageratum conyzoides.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30684565</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30035-2</DOI>
    <KeywordList>
      <Keywords>Ageratum conyzoides</Keywords>
      <Keywords>GRAS</Keywords>
      <Keywords>Mutagenicity</Keywords>
      <Keywords>NOAEL</Keywords>
      <Keywords>Pyrrolizidine alkaloids</Keywords>
      <Keywords>Safety</Keywords>
      <Keywords>Toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Philip A. Palmer</Name>
        <Affiliation>AIBMR Life Sciences, Inc., 2800 East Madison Street, Suite 202, Seattle, WA, 98112, USA. Electronic address: phil@aibmr.com.</Affiliation>
      </Author>
      <Author>
        <Name>Jessica A. Bryson</Name>
        <Affiliation>AIBMR Life Sciences, Inc., 2800 East Madison Street, Suite 202, Seattle, WA, 98112, USA. Electronic address: amy@aibmr.com.</Affiliation>
      </Author>
      <Author>
        <Name>Amy E. Clewell</Name>
        <Affiliation>AIBMR Life Sciences, Inc., 2800 East Madison Street, Suite 202, Seattle, WA, 98112, USA.</Affiliation>
      </Author>
      <Author>
        <Name>John R. Endres</Name>
        <Affiliation>AIBMR Life Sciences, Inc., 2800 East Madison Street, Suite 202, Seattle, WA, 98112, USA. Electronic address: info@aibmr.com.</Affiliation>
      </Author>
      <Author>
        <Name>Gábor Hirka</Name>
        <Affiliation>Toxi-Coop Zrt., Magyar Jakobinusok tere 4/B, H-1122, Budapest, Hungary. Electronic address: gabor.hirka@toxicoop.com.</Affiliation>
      </Author>
      <Author>
        <Name>Adél Vértesi</Name>
        <Affiliation>Toxi-Coop Zrt., Magyar Jakobinusok tere 4/B, H-1122, Budapest, Hungary. Electronic address: adel.vertesi@toxicoop.com.</Affiliation>
      </Author>
      <Author>
        <Name>Erzsébet Béres</Name>
        <Affiliation>Toxi-Coop Zrt., Magyar Jakobinusok tere 4/B, H-1122, Budapest, Hungary. Electronic address: erzsebet.beres@toxicoop.com.</Affiliation>
      </Author>
      <Author>
        <Name>Róbert Glávits</Name>
        <Affiliation>Toxi-Coop Zrt., Magyar Jakobinusok tere 4/B, H-1122, Budapest, Hungary. Electronic address: glavits.robert.dr@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Ilona Pasics Szakonyiné</Name>
        <Affiliation>Toxi-Coop Zrt., Magyar Jakobinusok tere 4/B, H-1122, Budapest, Hungary. Electronic address: ilona.pasics@toxicoop.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Toxicologic evaluation of repetitive 4-week intravenous injections of midkine antisense oligonucleotide nanoliposomes in rats.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30682377</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30038-8</DOI>
    <KeywordList>
      <Keywords>Antisense oligonucleotide</Keywords>
      <Keywords>Intravenous injection</Keywords>
      <Keywords>Midkine</Keywords>
      <Keywords>Rat</Keywords>
      <Keywords>Subacute toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jing Chen</Name>
        <Affiliation>Huzhou Key Laboratory of Molecular Medicine, Huzhou Central Hospital, 198 Hongqi Road, Huzhou, 313000, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Jing Zhong</Name>
        <Affiliation>Huzhou Key Laboratory of Molecular Medicine, Huzhou Central Hospital, 198 Hongqi Road, Huzhou, 313000, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Pingping Niu</Name>
        <Affiliation>Huzhou Key Laboratory of Molecular Medicine, Huzhou Central Hospital, 198 Hongqi Road, Huzhou, 313000, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Limin Xu</Name>
        <Affiliation>Huzhou Key Laboratory of Molecular Medicine, Huzhou Central Hospital, 198 Hongqi Road, Huzhou, 313000, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Linfu Zhou</Name>
        <Affiliation>Medical Biotechnology Laboratory, Zhejiang University, 388 Yuhangtang Road, Hangzhou, Zhejiang, 310038, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Honghai Wu</Name>
        <Affiliation>Institute of Pharmacology and Toxicology, Zhejiang University, 866 Yuhangtang Road, Hangzhou, Zhejiang, 310058, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Chao Chen</Name>
        <Affiliation>Institute of Pharmacology and Toxicology, Zhejiang University, 866 Yuhangtang Road, Hangzhou, Zhejiang, 310058, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Licheng Dai</Name>
        <Affiliation>Huzhou Key Laboratory of Molecular Medicine, Huzhou Central Hospital, 198 Hongqi Road, Huzhou, 313000, PR China. Electronic address: dlc171@hzhospital.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Human health safety studies of a new insecticide: Dissipation kinetics and dietary risk assessment of afidopyropen and one of its metabolites in cucumber and nectarine.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30664901</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30025-X</DOI>
    <KeywordList>
      <Keywords>Afidopyropen</Keywords>
      <Keywords>Dietary risk assessment</Keywords>
      <Keywords>Dissipation</Keywords>
      <Keywords>Residue</Keywords>
      <Keywords>UHPLC-MS/MS</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jun Xie</Name>
        <Affiliation>Department of Pesticide Science, College of Plant Protection, Shenyang Agricultural University, Shenyang, 110866, PR China; State Key Laboratory for Biology of Plant Diseases and Insect Pests, Institute of Plant Protection, Chinese Academy of Agricultural Sciences, Beijing, 100193, PR China. Electronic address: xxjj2410@foxmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Yunxi Zheng</Name>
        <Affiliation>Beijing Bayi School, No. 29 Suzhou Street, Haidian District, Beijing, 100080, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Xingang Liu</Name>
        <Affiliation>State Key Laboratory for Biology of Plant Diseases and Insect Pests, Institute of Plant Protection, Chinese Academy of Agricultural Sciences, Beijing, 100193, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Fengshou Dong</Name>
        <Affiliation>State Key Laboratory for Biology of Plant Diseases and Insect Pests, Institute of Plant Protection, Chinese Academy of Agricultural Sciences, Beijing, 100193, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Jun Xu</Name>
        <Affiliation>State Key Laboratory for Biology of Plant Diseases and Insect Pests, Institute of Plant Protection, Chinese Academy of Agricultural Sciences, Beijing, 100193, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaohu Wu</Name>
        <Affiliation>State Key Laboratory for Biology of Plant Diseases and Insect Pests, Institute of Plant Protection, Chinese Academy of Agricultural Sciences, Beijing, 100193, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Mingshan Ji</Name>
        <Affiliation>Department of Pesticide Science, College of Plant Protection, Shenyang Agricultural University, Shenyang, 110866, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Yongquan Zheng</Name>
        <Affiliation>State Key Laboratory for Biology of Plant Diseases and Insect Pests, Institute of Plant Protection, Chinese Academy of Agricultural Sciences, Beijing, 100193, PR China. Electronic address: zhengyongquan@ippcaas.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Effective tool for assessment of the quality of barrier creams - relationships between rheological, textural and sensory properties.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30664900</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30026-1</DOI>
    <KeywordList>
      <Keywords>Barrier creams</Keywords>
      <Keywords>In vitro method</Keywords>
      <Keywords>Quality of barrier creams</Keywords>
      <Keywords>Sensory analysis</Keywords>
      <Keywords>Skin barrier</Keywords>
      <Keywords>Texture profile</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Agnieszka Kulawik-Pióro</Name>
        <Affiliation>Institute of Organic Chemistry and Technology, Department of Chemical Engineering and Technology, Cracow University of Technology, Warszawska, 24, 31-155, Cracow, Poland. Electronic address: akulawik@indy.chemia.pk.edu.pl.</Affiliation>
      </Author>
      <Author>
        <Name>Anna Ptaszek</Name>
        <Affiliation>Department of Engineering and Machinery in Food Industry, Faculty of Food Technology, University of Agriculture in Krakow, ul. Balicka 122, 30-149, Krakow, Poland.</Affiliation>
      </Author>
      <Author>
        <Name>Joanna Kruk</Name>
        <Affiliation>Department of Engineering and Machinery in Food Industry, Faculty of Food Technology, University of Agriculture in Krakow, ul. Balicka 122, 30-149, Krakow, Poland.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Chemical carcinogenicity revisited 2: Current knowledge of carcinogenesis shows that categorization as a carcinogen or non-carcinogen is not scientifically credible.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30660801</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30024-8</DOI>
    <KeywordList>
      <Keywords>Carcinogenicity</Keywords>
      <Keywords>Classification</Keywords>
      <Keywords>Long term bioassay</Keywords>
      <Keywords>Mode of action</Keywords>
      <Keywords>Risk assessment</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>John E. Doe</Name>
        <Affiliation>Parker Doe LLP, Carpenter Court, Maple Road, Bramhall, Stockport, Cheshire, SK7 2DH, UK. Electronic address: john.doe@parkerdoe.com.</Affiliation>
      </Author>
      <Author>
        <Name>Alan R. Boobis</Name>
        <Affiliation>Centre for Pharmacology &amp; Therapeutics, Toxicology Unit, Department of Medicine, Hammersmith Campus, Imperial College London, London, W12 0NN, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Vicki Dellarco</Name>
        <Affiliation>Independent Consultant, Silver Spring, MD, 20901, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Penelope A. Fenner-Crisp</Name>
        <Affiliation>Independent Consultant, North Garden, VA, 22959, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Angelo Moretto</Name>
        <Affiliation>Dipartimento di Scienze Biochimiche e Cliniche (Department of Biomedical and Clinical Sciences), Università degli Studi di Milano, Milan, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Timothy P. Pastoor</Name>
        <Affiliation>Pastoor Science Communication, LLC, Greensboro, NC, 27455, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Rita S. Schoeny</Name>
        <Affiliation>Rita Schoeny LLC, Washington DC, 20002, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jennifer G. Seed</Name>
        <Affiliation>Independent Consultant, Alexandria, VA, 22301, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Douglas C. Wolf</Name>
        <Affiliation>Syngenta Crop Protection, LLC, Greensboro, NC, 27419, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Consumer protection provided by the European medical device and cosmetic legislation for condoms and lubricants.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30659873</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30022-4</DOI>
    <KeywordList>
      <Keywords>Allergies</Keywords>
      <Keywords>Condoms</Keywords>
      <Keywords>Cosmetics</Keywords>
      <Keywords>Irritation</Keywords>
      <Keywords>Medical devices</Keywords>
      <Keywords>Personal lubricants</Keywords>
      <Keywords>Risk assessment</Keywords>
      <Keywords>Safety evaluation</Keywords>
      <Keywords>Systemic toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>B. Desmedt</Name>
        <Affiliation>Medicines and Health Products, Sciensano, Juliette Wytsmanstraat 14, 1050, Brussels, Belgium. Electronic address: Bart.desmedt@sciensano.be.</Affiliation>
      </Author>
      <Author>
        <Name>M. Vanhamme</Name>
        <Affiliation>Medicines and Health Products, Sciensano, Juliette Wytsmanstraat 14, 1050, Brussels, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>C. Vanhee</Name>
        <Affiliation>Medicines and Health Products, Sciensano, Juliette Wytsmanstraat 14, 1050, Brussels, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>V. Rogiers</Name>
        <Affiliation>Department of In Vitro Toxicology and Dermato-Cosmetology, Vrije Universiteit Brussel, Laarbeeklaan 103, 1090, Brussels, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>E. Deconinck</Name>
        <Affiliation>Medicines and Health Products, Sciensano, Juliette Wytsmanstraat 14, 1050, Brussels, Belgium.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Measurement uncertainty for the potency estimation by rapid microbiological methods (RMMs) with correlated data.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30653990</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30023-6</DOI>
    <KeywordList>
      <Keywords>Correlated uncertainty components</Keywords>
      <Keywords>Measurement uncertainty</Keywords>
      <Keywords>Rapid microbiological methods</Keywords>
      <Keywords>Risk of false conformity decisions</Keywords>
      <Keywords>Uncertainty factor</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Alessandro Morais Saviano</Name>
        <Affiliation>Departamento de Farmácia, Faculdade de Ciências Farmacêuticas da Universidade de São Paulo, Av. Prof. Lineu Prestes, 580, 05508-000, São Paulo, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Ricardo J. N. Bettencourt da Silva</Name>
        <Affiliation>Centro de Química Estrutural, Faculdade de Ciências da Universidade de Lisboa, Edifício C8, Campo Grande, 1749-016 Lisboa, Portugal.</Affiliation>
      </Author>
      <Author>
        <Name>Felipe Rebello Lourenço</Name>
        <Affiliation>Departamento de Farmácia, Faculdade de Ciências Farmacêuticas da Universidade de São Paulo, Av. Prof. Lineu Prestes, 580, 05508-000, São Paulo, Brazil. Electronic address: feliperl@usp.br.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Challenges in working towards an internal threshold of toxicological concern (iTTC) for use in the safety assessment of cosmetics: Discussions from the Cosmetics Europe iTTC Working Group workshop.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30653989</pubmedLink>
    <GrantList>
      <Grant>EPA999999</Grant>
    </GrantList>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30016-9</DOI>
    <KeywordList>
      <Keywords>Cosmetics</Keywords>
      <Keywords>Cosmetics europe</Keywords>
      <Keywords>PBPK</Keywords>
      <Keywords>Physiologically based pharmacokinetic model</Keywords>
      <Keywords>Risk assessment</Keywords>
      <Keywords>TTC</Keywords>
      <Keywords>Thresholds of toxicological concern</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Corie A. Ellison</Name>
        <Affiliation>The Procter &amp; Gamble Company, Cincinnati, OH, United States. Electronic address: Ellison.ca@pg.com.</Affiliation>
      </Author>
      <Author>
        <Name>Karen L. Blackburn</Name>
        <Affiliation>The Procter &amp; Gamble Company, Cincinnati, OH, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Paul L. Carmichael</Name>
        <Affiliation>Unilever Safety and Environmental Assurance Center, Bedfordshire, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Harvey J. Clewell</Name>
        <Affiliation>ScitoVation, LLC, North Carolina, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Mark T. D. Cronin</Name>
        <Affiliation>School of Pharmacy and Biomolecular Sciences, Liverpool John Moores University, Liverpool, England, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Bertrand Desprez</Name>
        <Affiliation>Cosmetics Europe, Brussels, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Sylvia E. Escher</Name>
        <Affiliation>Fraunhofer Institute for Toxicology and Experimental Medicine, Hannover, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Steve S. Ferguson</Name>
        <Affiliation>National Institute of Environmental Health Sciences, North Carolina, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Sébastien Grégoire</Name>
        <Affiliation>L'Oréal Research &amp; Innovation, Aulnay-sous-Bois, France.</Affiliation>
      </Author>
      <Author>
        <Name>Nicola J. Hewitt</Name>
        <Affiliation>Cosmetics Europe, Brussels, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Heli M. Hollnagel</Name>
        <Affiliation>Dow Europe GmbH, Horgen, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Martina Klaric</Name>
        <Affiliation>Cosmetics Europe, Brussels, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Atish Patel</Name>
        <Affiliation>Research Institute for Fragrance Materials, New Jersey, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Sabrina Salhi</Name>
        <Affiliation>GlaxoSmithKline, Nyon, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Andreas Schepky</Name>
        <Affiliation>Beiersdorf AG, Hamburg, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Barbara G. Schmitt</Name>
        <Affiliation>Dow Silicones Belgium SPRL, Seneffe, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>John F. Wambaugh</Name>
        <Affiliation>United States Environmental Protection Agency, National Center for Computational Toxicology, North Carolina, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Andrew Worth</Name>
        <Affiliation>European Commission, Joint Research Centre, Ispra, Italy.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Editorial.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30642615</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(18)30328-3</DOI>
    <AuthorList>
      <Author>
        <Name>Michael Aschner</Name>
        <Affiliation>Department of Molecular Pharmacology Albert Einstein College of Medicine 1300 Morris Park Avenue, Bronx, NY, USA. Electronic address: Michael.Aschner@einstein.yu.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Herman N. Autrup</Name>
        <Affiliation>Institute of Public Health, University of Aarhus, Aarhus, Denmark. Electronic address: ha@ph.au.dk.</Affiliation>
      </Author>
      <Author>
        <Name>Samuel M. Cohen</Name>
        <Affiliation>Department of Pathology and Microbiology University of Nebraska Medical Center Omaha, NE; USA. Electronic address: scohen@unmc.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Wolfgang Dekant</Name>
        <Affiliation>Department of Toxicology University of Wuerzburg Wuerzburg, Germany. Electronic address: dekant@toxi.uni-wuerzburg.de.</Affiliation>
      </Author>
      <Author>
        <Name>Gerhard Eisenbrand</Name>
        <Affiliation>Food Chemistry &amp; Toxicology University of Heildelberg Heildelberg, Germany. Electronic address: geisenbra@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Corrado L. Galli</Name>
        <Affiliation>Toxicology and Risk Assessment Pharmacological and Biomolecular Sciences University of Milan. Milan, Italy. Electronic address: corrado.galli@unimi.it.</Affiliation>
      </Author>
      <Author>
        <Name>Gio B. Gori</Name>
        <Affiliation>The Health Policy Center Editor, Regulatory Toxicology and Pharmacology Bethesda, MD, USA. Electronic address: gorigb@msn.com.</Affiliation>
      </Author>
      <Author>
        <Name>Norbert E. Kaminski</Name>
        <Affiliation>Pharmacology &amp; Toxicology Director, Institute for Integrative Toxicology Michigan State University, East Lansing, MI, USA. Electronic address: kamins11@msu.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Curtis D. Klaassen</Name>
        <Affiliation>Department of Pharmacology and Toxicology School of Medicine, University of Kansas Kansas City, Kansas, USA. Electronic address: curtisklaassenphd@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>James E. Klaunig</Name>
        <Affiliation>Department of Environmental Health University of Indiana, Ellettsville, IN, USA. Electronic address: jklauni@indiana.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Len Levy</Name>
        <Affiliation>Institute of Environment and Health Cranfield University, Cranfield, UK. Electronic address: len.levy@cranfield.ac.uk.</Affiliation>
      </Author>
      <Author>
        <Name>Marcello Lotti</Name>
        <Affiliation>Department of Cardiology, Thoracic and Vascular Sciences, School of Medicine, University of Padua, Padua, Italy. Electronic address: marcello.lotti@unipd.it.</Affiliation>
      </Author>
      <Author>
        <Name>Hans Wj Marquardt</Name>
        <Affiliation>Experimental and Clinical Toxicology University of Hamburg Medical School Hambug, Germany. Electronic address: marquardt@uke.uni-hamburg.de.</Affiliation>
      </Author>
      <Author>
        <Name>Olavi Pelkonen</Name>
        <Affiliation>Department of Pharmacology and Toxicology Faculty of Medicine University of Oulu, Oulu, Finland. Electronic address: olavi.pelkonen@oulu.fi.</Affiliation>
      </Author>
      <Author>
        <Name>Dieter F. Schrenk</Name>
        <Affiliation>University of Kaiserslautern Kaiserslautern Germany. Electronic address: schrenk@rhrk.uni-kl.de.</Affiliation>
      </Author>
      <Author>
        <Name>Hiroshi Yamazaki</Name>
        <Affiliation>Laboratory of Drug Metabolism and Pharmacokinetics Showa Pharmaceutical University Machida, Tokyo, Japan. Electronic address: hyamazak@ac.shoyaku.ac.jp.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Fitness for purpose and stability assessment of long-chain polyunsaturated fatty acids in chicken tissues.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30639338</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30014-5</DOI>
    <KeywordList>
      <Keywords>Analytical method</Keywords>
      <Keywords>Chicken tissue</Keywords>
      <Keywords>DHA</Keywords>
      <Keywords>GC-FID</Keywords>
      <Keywords>Validation</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Gerald Patrick Dillon</Name>
        <Affiliation>Alltech Ireland, Sarney, Summerhill Road, Dunboyne, Co Meath, Ireland. Electronic address: gdillon@alltech.com.</Affiliation>
      </Author>
      <Author>
        <Name>Alexandros Yiannikouris</Name>
        <Affiliation>Alltech Inc, Nicholasville, KY, USA. Electronic address: ayiannikouris@Alltech.com.</Affiliation>
      </Author>
      <Author>
        <Name>Walter Brandl</Name>
        <Affiliation>Merieux Nutrisciences, 8255 North Fraser Way, Burnaby, BC, V3N 5G4, Canada. Electronic address: walter.brandl@mxns.com.</Affiliation>
      </Author>
      <Author>
        <Name>Cathy Cardinall</Name>
        <Affiliation>Merieux Nutrisciences, 8255 North Fraser Way, Burnaby, BC, V3N 5G4, Canada. Electronic address: cathy.cardinall@mxns.com.</Affiliation>
      </Author>
      <Author>
        <Name>Wendy Yuan</Name>
        <Affiliation>Merieux Nutrisciences, 8255 North Fraser Way, Burnaby, BC, V3N 5G4, Canada. Electronic address: wendy.yuan@mxns.com.</Affiliation>
      </Author>
      <Author>
        <Name>Colm Anthony Moran</Name>
        <Affiliation>Alltech SARL, Rue Charles Amand, 14500, Vire, France. Electronic address: cmoran@alltech.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Perfluorohexanoic acid toxicity, part I: Development of a chronic human health toxicity value for use in risk assessment.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30639337</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30019-4</DOI>
    <KeywordList>
      <Keywords>Benchmark dose</Keywords>
      <Keywords>Fluorotelomers</Keywords>
      <Keywords>Human health</Keywords>
      <Keywords>Oral reference dose</Keywords>
      <Keywords>PFHxA</Keywords>
      <Keywords>Perfluorohexanoic acid</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Anthony L. Luz</Name>
        <Affiliation>Integral Consulting Inc., 200 Harry S. Truman Parkway, Suite 330, Annapolis, MD, 21401, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Janet K. Anderson</Name>
        <Affiliation>Integral Consulting Inc., 17806 I-10, Suite 300, San Antonio, TX, 78257, USA. Electronic address: janderson@integral-corp.com.</Affiliation>
      </Author>
      <Author>
        <Name>Philip Goodrum</Name>
        <Affiliation>Integral Consulting Inc., 7030 E Genesee Street, Suite 105, Fayetteville, NY, 13066, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Judi Durda</Name>
        <Affiliation>Integral Consulting Inc., 200 Harry S. Truman Parkway, Suite 330, Annapolis, MD, 21401, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Preclinical safety assessment of antipyrine combined with lidocaine hydrochloride as ear drops.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30634025</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30018-2</DOI>
    <KeywordList>
      <Keywords>Antipyrine</Keywords>
      <Keywords>Ear drops</Keywords>
      <Keywords>Lidocaine</Keywords>
      <Keywords>Toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Ying Xin Zou</Name>
        <Affiliation>Naval Medical Research Institute, Second Military Medical University, 880 Xiangyin Road, Shanghai, 200433, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xu Feng</Name>
        <Affiliation>Naval Medical Research Institute, Second Military Medical University, 880 Xiangyin Road, Shanghai, 200433, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhi Yong Chu</Name>
        <Affiliation>Naval Medical Research Institute, Second Military Medical University, 880 Xiangyin Road, Shanghai, 200433, China.</Affiliation>
      </Author>
      <Author>
        <Name>Wei Hong Liu</Name>
        <Affiliation>Naval Medical Research Institute, Second Military Medical University, 880 Xiangyin Road, Shanghai, 200433, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiao Dong Zhang</Name>
        <Affiliation>College of Naval Medicine, Second Military Medical University, 800 Xiangyin Road, Shanghai, 200433, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jian Bo Ba</Name>
        <Affiliation>Naval Medical Research Institute, Second Military Medical University, 880 Xiangyin Road, Shanghai, 200433, China. Electronic address: zhiyongchuleader@163.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Science peer review for the 21st century: Assessing scientific consensus for decision-making while managing conflict of interests, reviewer and process bias.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30634024</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30003-0</DOI>
    <KeywordList>
      <Keywords>Anonymity</Keywords>
      <Keywords>Bias</Keywords>
      <Keywords>Delphi</Keywords>
      <Keywords>Independence</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>C. R. Kirman</Name>
        <Affiliation>SciPinion LLC., Bozeman, MT 59715, USA. Electronic address: ckirman@scipinion.com.</Affiliation>
      </Author>
      <Author>
        <Name>T. W. Simon</Name>
        <Affiliation>Ted Simon LLC, Winston, GA 30187, USA.</Affiliation>
      </Author>
      <Author>
        <Name>S. M. Hays</Name>
        <Affiliation>SciPinion LLC., Bozeman, MT 59715, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Chemical carcinogenicity revisited 1: A unified theory of carcinogenicity based on contemporary knowledge.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30634023</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30021-2</DOI>
    <KeywordList>
      <Keywords>Carcinogenicity</Keywords>
      <Keywords>Mode of action</Keywords>
      <Keywords>Risk assessment</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Douglas C. Wolf</Name>
        <Affiliation>Syngenta Crop Protection LLC, Greensboro, NC, 27419, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Samuel M. Cohen</Name>
        <Affiliation>Department of Pathology and Microbiology, Havlik-Wall Professor of Oncology, University of Nebraska Medical Center, Omaha, NE, 68198-3135, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Alan R. Boobis</Name>
        <Affiliation>Centre for Pharmacology &amp; Therapeutics, Toxicology Unit, Department of Medicine, Hammersmith Campus, Imperial College London, London, W12 0NN, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Vicki L. Dellarco</Name>
        <Affiliation>Independent Consultant, Silver Spring, MD, 20901, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Penelope A. Fenner-Crisp</Name>
        <Affiliation>Independent Consultant, North Garden, VA, 22959, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Angelo Moretto</Name>
        <Affiliation>Dipartimento di Scienze Biochimiche e Cliniche (Department of Biomedical and Clinical Sciences), Università degli Studi di Milano, Milan, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Timothy P. Pastoor</Name>
        <Affiliation>Pastoor Science Communication, LLC, Greensboro, NC, 27455, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Rita S. Schoeny</Name>
        <Affiliation>Rita Schoeny LLC, Washington DC, 20002, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jennifer G. Seed</Name>
        <Affiliation>Independent Consultant, Alexandria, VA, 22301, USA.</Affiliation>
      </Author>
      <Author>
        <Name>John E. Doe</Name>
        <Affiliation>Parker Doe LLP, Carpenter Court, Maple Road, Bramhall, Stockport, Cheshire, SK7 2DH, UK. Electronic address: john.doe@parkerdoe.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Target animal safety testing of an oral salicylanilide suspension, oxyclozanide, for the treatment of fascioliasis in bovine in China.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30634022</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30012-1</DOI>
    <KeywordList>
      <Keywords>Bovine</Keywords>
      <Keywords>Oxyclozanide suspension</Keywords>
      <Keywords>Safety</Keywords>
      <Keywords>Target animal</Keywords>
      <Keywords>Toxicity risk</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Zhen Dong</Name>
        <Affiliation>Lanzhou Institute of Husbandry and Pharmaceutical Sciences, Chinese Academy of Agricultural Sciences (CAAS), China; Key Laboratory of Veterinary Pharmaceutical Development, Ministry of Agriculture, Lanzhou, China; Key Laboratory of New Animal Drug Project of Gansu Province, Lanzhou, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jichao Sun</Name>
        <Affiliation>Lanzhou Institute of Husbandry and Pharmaceutical Sciences, Chinese Academy of Agricultural Sciences (CAAS), China; Key Laboratory of Veterinary Pharmaceutical Development, Ministry of Agriculture, Lanzhou, China; Key Laboratory of New Animal Drug Project of Gansu Province, Lanzhou, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yubin Bai</Name>
        <Affiliation>Lanzhou Institute of Husbandry and Pharmaceutical Sciences, Chinese Academy of Agricultural Sciences (CAAS), China; Key Laboratory of Veterinary Pharmaceutical Development, Ministry of Agriculture, Lanzhou, China; Key Laboratory of New Animal Drug Project of Gansu Province, Lanzhou, China.</Affiliation>
      </Author>
      <Author>
        <Name>Weiwei Wang</Name>
        <Affiliation>Lanzhou Institute of Husbandry and Pharmaceutical Sciences, Chinese Academy of Agricultural Sciences (CAAS), China; Key Laboratory of Veterinary Pharmaceutical Development, Ministry of Agriculture, Lanzhou, China; Key Laboratory of New Animal Drug Project of Gansu Province, Lanzhou, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yueming Zhu</Name>
        <Affiliation>Zhang Ye Wan He Grass Planting and Animal Husbandry Science &amp; Technology Development Co., Ltd., China.</Affiliation>
      </Author>
      <Author>
        <Name>Bing Li</Name>
        <Affiliation>Lanzhou Institute of Husbandry and Pharmaceutical Sciences, Chinese Academy of Agricultural Sciences (CAAS), China; Key Laboratory of Veterinary Pharmaceutical Development, Ministry of Agriculture, Lanzhou, China; Key Laboratory of New Animal Drug Project of Gansu Province, Lanzhou, China.</Affiliation>
      </Author>
      <Author>
        <Name>Fusheng Cheng</Name>
        <Affiliation>Lanzhou Institute of Husbandry and Pharmaceutical Sciences, Chinese Academy of Agricultural Sciences (CAAS), China; Lanzhou Institute of Husbandry and Pharmaceutical Sciences, Chinese Academy of Agricultural Sciences (CAAS), China; Lanzhou Institute of Husbandry and Pharmaceutical Sciences, Chinese Academy of Agricultural Sciences (CAAS), China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaojuan Wei</Name>
        <Affiliation>Lanzhou Institute of Husbandry and Pharmaceutical Sciences, Chinese Academy of Agricultural Sciences (CAAS), China; Lanzhou Institute of Husbandry and Pharmaceutical Sciences, Chinese Academy of Agricultural Sciences (CAAS), China; Lanzhou Institute of Husbandry and Pharmaceutical Sciences, Chinese Academy of Agricultural Sciences (CAAS), China.</Affiliation>
      </Author>
      <Author>
        <Name>Enliang Song</Name>
        <Affiliation>Institute of Animal Science and Veterinary Medicine, Shandong Academy of Agricultural Sciences, China.</Affiliation>
      </Author>
      <Author>
        <Name>Haijian Cheng</Name>
        <Affiliation>Institute of Animal Science and Veterinary Medicine, Shandong Academy of Agricultural Sciences, China.</Affiliation>
      </Author>
      <Author>
        <Name>Fugui Jiang</Name>
        <Affiliation>Institute of Animal Science and Veterinary Medicine, Shandong Academy of Agricultural Sciences, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xuzheng Zhou</Name>
        <Affiliation>Lanzhou Institute of Husbandry and Pharmaceutical Sciences, Chinese Academy of Agricultural Sciences (CAAS), China; Key Laboratory of Veterinary Pharmaceutical Development, Ministry of Agriculture, Lanzhou, China; Key Laboratory of New Animal Drug Project of Gansu Province, Lanzhou, China. Electronic address: zhxuzheng@163.com.</Affiliation>
      </Author>
      <Author>
        <Name>Jiyu Zhang</Name>
        <Affiliation>Lanzhou Institute of Husbandry and Pharmaceutical Sciences, Chinese Academy of Agricultural Sciences (CAAS), China; Key Laboratory of Veterinary Pharmaceutical Development, Ministry of Agriculture, Lanzhou, China; Key Laboratory of New Animal Drug Project of Gansu Province, Lanzhou, China. Electronic address: infzjy@sina.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Chemical carcinogenicity revisited 3: Risk assessment of carcinogenic potential based on the current state of knowledge of carcinogenesis in humans.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30634021</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30017-0</DOI>
    <KeywordList>
      <Keywords>Carcinogenicity</Keywords>
      <Keywords>Decision tree-matrix</Keywords>
      <Keywords>Mode of action</Keywords>
      <Keywords>Risk assessment</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Samuel M. Cohen</Name>
        <Affiliation>Department of Pathology and Microbiology, Havlik-Wall Professor of Oncology, University of Nebraska Medical Center, Omaha, NE, 68198-3135, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Alan R. Boobis</Name>
        <Affiliation>Centre for Pharmacology &amp; Therapeutics, Toxicology Unit, Department of Medicine, Hammersmith Campus, Imperial College London, London, W12 0NN, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Vicki L. Dellarco</Name>
        <Affiliation>Independent Consultant, Silver Spring, MD, 20901, USA.</Affiliation>
      </Author>
      <Author>
        <Name>John E. Doe</Name>
        <Affiliation>Parker Doe LLP, Carpenter Court, Maple Road, Bramhall, Stockport, Cheshire, SK7 2DH, UK. Electronic address: john.doe@parkerdoe.com.</Affiliation>
      </Author>
      <Author>
        <Name>Penelope A. Fenner-Crisp</Name>
        <Affiliation>Independent Consultant, North Garden, VA, 22959, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Angelo Moretto</Name>
        <Affiliation>Dipartimento di Scienze Biochimiche e Cliniche, Università degli Studi di Milano, Milan, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Timothy P. Pastoor</Name>
        <Affiliation>Pastoor Science Communication, LLC, Greensboro, NC, 27455, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Rita S. Schoeny</Name>
        <Affiliation>Rita Schoeny LLC, Washington DC, 20002, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jennifer G. Seed</Name>
        <Affiliation>Independent Consultant, Alexandria, VA, 22301, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Douglas C. Wolf</Name>
        <Affiliation>Syngenta Crop Protection, LLC, Greensboro, NC, 27419, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Perfluorohexanoic acid toxicity, part II: Application of human health toxicity value for risk characterization.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30634020</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30020-0</DOI>
    <KeywordList>
      <Keywords>Fluorotelomers</Keywords>
      <Keywords>Human health</Keywords>
      <Keywords>PFHxA</Keywords>
      <Keywords>Perfluorohexanoic acid</Keywords>
      <Keywords>Risk characterization</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Janet K. Anderson</Name>
        <Affiliation>Integral Consulting Inc., 17806 I-10, Suite 300, San Antonio, TX, 78257, USA. Electronic address: janderson@integral-corp.com.</Affiliation>
      </Author>
      <Author>
        <Name>Anthony L. Luz</Name>
        <Affiliation>Integral Consulting Inc., 200 Harry S. Truman Parkway, Suite 330, Annapolis, MD, 21401, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Philip Goodrum</Name>
        <Affiliation>Integral Consulting Inc., 7030 E Genesee Street, Suite 105, Fayetteville, NY, 13066, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Judi Durda</Name>
        <Affiliation>Integral Consulting Inc., 200 Harry S. Truman Parkway, Suite 330, Annapolis, MD, 21401, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Isopsoralen induces different subchronic toxicities and metabolomic outcomes between male and female Wistar rats.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30634019</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30010-8</DOI>
    <KeywordList>
      <Keywords>Fructus psoraleae</Keywords>
      <Keywords>Isopsoralen</Keywords>
      <Keywords>Metabolomics</Keywords>
      <Keywords>Subchronic toxicity</Keywords>
      <Keywords>Wistar rats</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Yue Zhang</Name>
        <Affiliation>Institute of Traditional Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin, 300193, China; Tianjin State Key Laboratory of Modern Chinese Medicine, Tianjin, 300193, China; Ministry of Education Key Laboratory of Traditional Chinese Medical Formulae, Tianjin University of Traditional Chinese Medicine, Tianjin, 300193, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiao Mei Yuan</Name>
        <Affiliation>Institute of Traditional Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin, 300193, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yue Fei Wang</Name>
        <Affiliation>Institute of Traditional Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin, 300193, China; Tianjin State Key Laboratory of Modern Chinese Medicine, Tianjin, 300193, China.</Affiliation>
      </Author>
      <Author>
        <Name>Miao Miao Jiang</Name>
        <Affiliation>Institute of Traditional Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin, 300193, China; Tianjin State Key Laboratory of Modern Chinese Medicine, Tianjin, 300193, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ya Nan Bi</Name>
        <Affiliation>Institute of Traditional Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin, 300193, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ying Liu</Name>
        <Affiliation>College of Veterinary Medicine, Inner Mongolia Agricultural University, Hohhot, 010018, China.</Affiliation>
      </Author>
      <Author>
        <Name>Wei Ling Pu</Name>
        <Affiliation>Institute of Traditional Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin, 300193, China.</Affiliation>
      </Author>
      <Author>
        <Name>Lei Song</Name>
        <Affiliation>Institute of Traditional Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin, 300193, China; Ministry of Education Key Laboratory of Traditional Chinese Medical Formulae, Tianjin University of Traditional Chinese Medicine, Tianjin, 300193, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ju Yang Huang</Name>
        <Affiliation>Institute of Traditional Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin, 300193, China; Ministry of Education Key Laboratory of Traditional Chinese Medical Formulae, Tianjin University of Traditional Chinese Medicine, Tianjin, 300193, China.</Affiliation>
      </Author>
      <Author>
        <Name>Li Kang Sun</Name>
        <Affiliation>Institute of Traditional Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin, 300193, China; Tianjin State Key Laboratory of Modern Chinese Medicine, Tianjin, 300193, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhi Xing Zhou</Name>
        <Affiliation>Tianjin Institute of Pharmaceutical Research, Tianjin, 300193, China.</Affiliation>
      </Author>
      <Author>
        <Name>Kun Zhou</Name>
        <Affiliation>Institute of Traditional Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin, 300193, China; Tianjin State Key Laboratory of Modern Chinese Medicine, Tianjin, 300193, China; Ministry of Education Key Laboratory of Traditional Chinese Medical Formulae, Tianjin University of Traditional Chinese Medicine, Tianjin, 300193, China. Electronic address: z.k.ken@263.net.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Letter to the editor regarding the article by Roberts, 2018.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30629971</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30005-4</DOI>
    <AuthorList>
      <Author>
        <Name>Andreas Natsch</Name>
        <Affiliation>Givaudan Schweiz AG, Ueberlandstrasse 138, CH-8600, Duebendorf, Switzerland. Electronic address: andreas.natsch@givaudan.com.</Affiliation>
      </Author>
      <Author>
        <Name>Robert Landsiedel</Name>
        <Affiliation>BASF SE, RB/TB - Z470, D-67056, Ludwigshafen, Germany.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The use of Genomic Allergen Rapid Detection (GARD) assays to predict the respiratory and skin sensitising potential of e-liquids.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30629970</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30001-7</DOI>
    <KeywordList>
      <Keywords>Alternative methods</Keywords>
      <Keywords>Electronic cigarettes</Keywords>
      <Keywords>In vitro</Keywords>
      <Keywords>Respiratory sensitisation</Keywords>
      <Keywords>Skin sensitisation</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Matthew Stevenson</Name>
        <Affiliation>Imperial Brands PLC, 121 Winterstoke Road, Bristol, BS3 2LL, UK. Electronic address: Matthew.Stevenson@uk.imptob.com.</Affiliation>
      </Author>
      <Author>
        <Name>Lukasz Czekala</Name>
        <Affiliation>Imperial Brands PLC, 121 Winterstoke Road, Bristol, BS3 2LL, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Liam Simms</Name>
        <Affiliation>Imperial Brands PLC, 121 Winterstoke Road, Bristol, BS3 2LL, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Nicole Tschierske</Name>
        <Affiliation>Imperial Brands PLC, 121 Winterstoke Road, Bristol, BS3 2LL, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Olivia Larne</Name>
        <Affiliation>SenzaGen, Scheelevägen 2, 22381, Lund, Sweden.</Affiliation>
      </Author>
      <Author>
        <Name>Tanvir Walele</Name>
        <Affiliation>Imperial Brands PLC, 121 Winterstoke Road, Bristol, BS3 2LL, UK.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Short commentary on NDMA (N-nitrosodimethylamine) contamination of valsartan products.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30629969</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30007-8</DOI>
    <KeywordList>
      <Keywords>Mutagenic carcinogen</Keywords>
      <Keywords>N-nitrosodimethylamine (NDMA)</Keywords>
      <Keywords>Risk assessment</Keywords>
      <Keywords>Valsartan</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>David J. Snodin</Name>
        <Affiliation>Xiphora Biopharma Consulting, Bristol, UK. Electronic address: snodind@xiphora.com.</Affiliation>
      </Author>
      <Author>
        <Name>David P. Elder</Name>
        <Affiliation>David P Elder Consultancy, Hertford, UK. Electronic address: davidelder2110@gmail.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Response to the comments of Natsch and Landsiedel on my paper "Is a combination of assays really needed for non-animal prediction of skin sensitization potential? Performance of the GARD (genomic allergen rapid detection) assay in comparison with OECD guideline assays alone and in combination."</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30629968</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30006-6</DOI>
    <KeywordList>
      <Keywords>Adverse outcome pathway</Keywords>
      <Keywords>GARD assay</Keywords>
      <Keywords>Skin sensitization</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>David W. Roberts</Name>
        <Affiliation>School of Pharmacy and Biomolecular Sciences, Liverpool John Moores University, Liverpool, L3 3AF, United Kingdom. Electronic address: d.w.roberts@ljmu.ac.uk.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Percutaneous permeability of 1-phenoxy-2-propanol, a preservative in cosmetics.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30611821</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30002-9</DOI>
    <KeywordList>
      <Keywords>1-Phenoxy-2-propanol</Keywords>
      <Keywords>Franz diffusion cell</Keywords>
      <Keywords>Percutaneous absorption rates</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jung Dae Lee</Name>
        <Affiliation>College of Pharmacy, Sungkyunkwan University, Sebu-ro 2066, Changan-Ku, Suwon, Gyeonggi, 16419, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Ji Young Kim</Name>
        <Affiliation>College of Pharmacy, Dankook University, 119 Dandae-ro, Cheonan, Chungnam, 31116, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Hyun Jun Jang</Name>
        <Affiliation>Department of Animal Biotechnology, Chonbuk National University, Jeonju, Chonbuk, 54896, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Byung Mu Lee</Name>
        <Affiliation>College of Pharmacy, Sungkyunkwan University, Sebu-ro 2066, Changan-Ku, Suwon, Gyeonggi, 16419, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Kyu Bong Kim</Name>
        <Affiliation>College of Pharmacy, Dankook University, 119 Dandae-ro, Cheonan, Chungnam, 31116, Republic of Korea. Electronic address: kyubong@dankook.ac.kr.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Authors' response to the letter to the editor by Jowsey et al.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30611820</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30008-X</DOI>
    <KeywordList>
      <Keywords>Plant protection products</Keywords>
      <Keywords>Quantitative risk assessment</Keywords>
      <Keywords>Skin sensitization</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Olivier Sanvido</Name>
        <Affiliation>State Secretariat for Economic Affairs, Holzikofenweg 36, CH-3003, Bern, Switzerland. Electronic address: olivier.sanvido@seco.admin.ch.</Affiliation>
      </Author>
      <Author>
        <Name>Kaspar Schmid</Name>
        <Affiliation>State Secretariat for Economic Affairs, Holzikofenweg 36, CH-3003, Bern, Switzerland. Electronic address: kaspar.schmid@seco.admin.ch.</Affiliation>
      </Author>
      <Author>
        <Name>Rex E. FitzGerald</Name>
        <Affiliation>University of Basel, Swiss Centre for Applied Human Toxicology, Missionsstrasse 64, CH-4055, Basel, Switzerland. Electronic address: rex.fitzgerald@scaht.org.</Affiliation>
      </Author>
      <Author>
        <Name>Nicolas Roth</Name>
        <Affiliation>University of Basel, Swiss Centre for Applied Human Toxicology, Missionsstrasse 64, CH-4055, Basel, Switzerland. Electronic address: nicolas.roth@unibas.ch.</Affiliation>
      </Author>
      <Author>
        <Name>Martin F. Wilks</Name>
        <Affiliation>University of Basel, Swiss Centre for Applied Human Toxicology, Missionsstrasse 64, CH-4055, Basel, Switzerland. Electronic address: martin.wilks@scaht.org.</Affiliation>
      </Author>
      <Author>
        <Name>Peter Bormann</Name>
        <Affiliation>Federal Office for Agriculture, Schwarzenburgstrasse 165, CH-3003, Bern, Switzerland. Electronic address: peter.bormann@blw.admin.ch.</Affiliation>
      </Author>
      <Author>
        <Name>Nancy B. Hopf</Name>
        <Affiliation>University of Lausanne, Institute for Work and Health (IST), Route de la Corniche 2, CH-1066, Epalinges-Lausanne, Switzerland. Electronic address: Nancy.Hopf@hospvd.ch.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Pharmacokinetics and four-week repeated-dose toxicity of hyaluronic acid and ketorolac combination following intra-articular administration in normal rats.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30611819</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30011-X</DOI>
    <KeywordList>
      <Keywords>Four-week repeat-dose toxicity</Keywords>
      <Keywords>Hyaluronic acid</Keywords>
      <Keywords>Intra-articular injection</Keywords>
      <Keywords>Ketorolac</Keywords>
      <Keywords>Local tolerance</Keywords>
      <Keywords>Pharmacokinetics</Keywords>
      <Keywords>Toxicokinetics</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Su Hwan Kim</Name>
        <Affiliation>Dongkook Pharmaceuticals, R&amp;D Center, 147 Gwanggyo-ro, Yeongtong-gu, Suwon, Gyeonggi-do, 16229, South Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Ki Wan Park</Name>
        <Affiliation>Dongkook Pharmaceuticals, R&amp;D Center, 147 Gwanggyo-ro, Yeongtong-gu, Suwon, Gyeonggi-do, 16229, South Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Jong Min Kim</Name>
        <Affiliation>Dongkook Pharmaceuticals, R&amp;D Center, 147 Gwanggyo-ro, Yeongtong-gu, Suwon, Gyeonggi-do, 16229, South Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Myoung Jin Ho</Name>
        <Affiliation>College of Pharmacy, Dankook University, 119 Dandae-ro, Dongnam-gu, Cheonan, Chungnam, 330-714, South Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Hyung Tae Kim</Name>
        <Affiliation>College of Pharmacy, Dankook University, 119 Dandae-ro, Dongnam-gu, Cheonan, Chungnam, 330-714, South Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Seh Hyon Song</Name>
        <Affiliation>Dongkook Pharmaceuticals, R&amp;D Center, 147 Gwanggyo-ro, Yeongtong-gu, Suwon, Gyeonggi-do, 16229, South Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Jeong Hoon Kim</Name>
        <Affiliation>Dongkook Pharmaceuticals, R&amp;D Center, 147 Gwanggyo-ro, Yeongtong-gu, Suwon, Gyeonggi-do, 16229, South Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Myung Joo Kang</Name>
        <Affiliation>College of Pharmacy, Dankook University, 119 Dandae-ro, Dongnam-gu, Cheonan, Chungnam, 330-714, South Korea. Electronic address: kangmj@dankook.ac.kr.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Safety evaluation of the oils extracted from edible insects (Tenebrio molitor and Pachymerus nucleorum) as novel food for humans.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30611818</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30013-3</DOI>
    <KeywordList>
      <Keywords>Acute toxicity</Keywords>
      <Keywords>Amino acids</Keywords>
      <Keywords>Entomophagy</Keywords>
      <Keywords>Pachymerus nucleorum</Keywords>
      <Keywords>Subcrhonic toxicity</Keywords>
      <Keywords>Tenebrio molitor</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Ariana Vieira Alves</Name>
        <Affiliation>Faculty of Exact Sciences and Technologies, Federal University of Grande Dourados, Dourados, Mato Grosso do Sul, Brazil. Electronic address: arianavieiralves@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Fernando Freitas de Lima</Name>
        <Affiliation>Institute of Biology, University of Campinas, Campinas, São Paulo, Brazil. Electronic address: flfernando_@hotmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Tânia Granzotti da Silva</Name>
        <Affiliation>Faculty of Exact Sciences and Technologies, Federal University of Grande Dourados, Dourados, Mato Grosso do Sul, Brazil. Electronic address: taniagranzotti@hotmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Vinícius Soares de Oliveira</Name>
        <Affiliation>Faculty of Environmental and Biological Science, Federal University of Grande Dourados, Dourados, Mato Grosso do Sul, Brazil. Electronic address: viniciusbiomed@hotmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Cândida Aparecida Leite Kassuya</Name>
        <Affiliation>Faculty of Health Sciences, Federal University of Grande Dourados, Dourados, Mato Grosso do Sul, Brazil. Electronic address: candidakassuya@ufgd.edu.br.</Affiliation>
      </Author>
      <Author>
        <Name>Eliana Janet Sanjinez-Argandoña</Name>
        <Affiliation>Faculty of Engineering, Federal University of Grande Dourados, Dourados, Mato Grosso do Sul, Brazil. Electronic address: elianaargandona@ufgd.edu.br.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The effect of Cynara scolymus (artichoke) on maternal reproductive outcomes and fetal development in rats.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30611817</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30004-2</DOI>
    <KeywordList>
      <Keywords>Artichoke</Keywords>
      <Keywords>Herbal medicine</Keywords>
      <Keywords>Pregnancy</Keywords>
      <Keywords>Rat</Keywords>
      <Keywords>Teratology</Keywords>
      <Keywords>Toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>André Tadeu Gotardo</Name>
        <Affiliation>Research Centre for Veterinary Toxicology (CEPTOX) - Department of Pathology, School of Veterinary Medicine and Animal Sciences, University of São Paulo, Pirassununga 05508-270, SP, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Maria Izabel da Silva Mattos</Name>
        <Affiliation>Research Centre for Veterinary Toxicology (CEPTOX) - Department of Pathology, School of Veterinary Medicine and Animal Sciences, University of São Paulo, Pirassununga 05508-270, SP, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Isis Machado Hueza</Name>
        <Affiliation>Institute of Environmental, Chemical and Pharmaceutical Sciences, Federal University of São Paulo (ICAQF-UNIFESP), Campus Diadema, Diadema, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Silvana Lima Górniak</Name>
        <Affiliation>Research Centre for Veterinary Toxicology (CEPTOX) - Department of Pathology, School of Veterinary Medicine and Animal Sciences, University of São Paulo, Pirassununga 05508-270, SP, Brazil. Electronic address: gorniak@usp.br.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Skin sensitization risk assessment for plant protection products: The applicability of sensitization assessment factors.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30611816</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(19)30009-1</DOI>
    <KeywordList>
      <Keywords>Plant protection products</Keywords>
      <Keywords>Quantitative risk assessment</Keywords>
      <Keywords>Skin sensitization</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Ian R. Jowsey</Name>
        <Affiliation>Syngenta Product Safety, Jealott's Hill International Research Centre, Bracknell, Berkshire, RG42 6EY, UK. Electronic address: ian.jowsey@syngenta.com.</Affiliation>
      </Author>
      <Author>
        <Name>Leona Merolla</Name>
        <Affiliation>Syngenta Product Safety, Jealott's Hill International Research Centre, Bracknell, Berkshire, RG42 6EY, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Philip A. Botham</Name>
        <Affiliation>Syngenta Product Safety, Jealott's Hill International Research Centre, Bracknell, Berkshire, RG42 6EY, UK.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Biomonitoring Equivalents (BEs) for tetrabromobisphenol A.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30593853</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(18)30321-0</DOI>
    <KeywordList>
      <Keywords>Biomonitoring Equivalents</Keywords>
      <Keywords>Pharmacokinetics</Keywords>
      <Keywords>Risk assessment</Keywords>
      <Keywords>Tetrabromobisphenol A</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Sean M. Hays</Name>
        <Affiliation>Summit Toxicology, L.L.P., Bozeman, MT, USA. Electronic address: shays@summittoxicology.com.</Affiliation>
      </Author>
      <Author>
        <Name>Christopher R. Kirman</Name>
        <Affiliation>Summit Toxicology, L.L.P., Bozeman, MT, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The reliability of an environmental epidemiology meta-analysis, a case study.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30590082</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(18)30320-9</DOI>
    <KeywordList>
      <Keywords>Case study</Keywords>
      <Keywords>Causality</Keywords>
      <Keywords>Heart attacks</Keywords>
      <Keywords>Meta-analysis</Keywords>
      <Keywords>Reliability</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>S. Stanley Young</Name>
      </Author>
      <Author>
        <Name>Mithun Kumar Acharjee</Name>
      </Author>
      <Author>
        <Name>Kumer Das</Name>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Histopathology re-examination of the NTP toxicity/carcinogenicity studies of tert-butyl alcohol to identify renal tumor and toxicity modes of action.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30590081</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(18)30318-0</DOI>
    <KeywordList>
      <Keywords>Chronic progressive nephropathy</Keywords>
      <Keywords>Modes-of-action</Keywords>
      <Keywords>Renal tubule tumors</Keywords>
      <Keywords>alpha2u-globulin nephropathy</Keywords>
      <Keywords>tert-Butyl alcohol</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Gordon C. Hard</Name>
        <Affiliation>Independent Consultant, Tairua, New Zealand.</Affiliation>
      </Author>
      <Author>
        <Name>Samuel M. Cohen</Name>
        <Affiliation>Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE, 68198-3135, USA; Havlik-Wall Professor of Oncology, USA. Electronic address: scohen@unmc.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Jihyun Ma</Name>
        <Affiliation>Department of Biostatistics, College of Public Health, University of Nebraska Medical Center, Omaha, NE, 68198-4375, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Fang Yu</Name>
        <Affiliation>Department of Biostatistics, College of Public Health, University of Nebraska Medical Center, Omaha, NE, 68198-4375, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Lora L. Arnold</Name>
        <Affiliation>Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE, 68198-3135, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Marcy I. Banton</Name>
        <Affiliation>LyondellBasell, Houston, TX, 77010, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Reflections on the progress towards non-animal methods for acute toxicity testing of chemicals.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30578838</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(18)30315-5</DOI>
    <KeywordList>
      <Keywords>Acute toxicity testing</Keywords>
      <Keywords>Alternatives</Keywords>
      <Keywords>Non-animal testing</Keywords>
      <Keywords>Regulation</Keywords>
      <Keywords>Validation and acceptance</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Helen Prior</Name>
        <Affiliation>National Centre for the Replacement, Refinement &amp; Reduction of Animals in Research (NC3Rs), Gibbs Building, 215 Euston Road, London, NW1 2BE, UK. Electronic address: helen.prior@nc3rs.org.uk.</Affiliation>
      </Author>
      <Author>
        <Name>Warren Casey</Name>
        <Affiliation>National Toxicology Program Interagency Center for the Evaluation of Alternative Toxicological Methods, National Institute of Environmental Health Sciences, P.O. Box 12233, Research Triangle Park, NC, 27709, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Ian Kimber</Name>
        <Affiliation>University of Manchester, Faculty of Biology, Medicine and Health, Oxford Rd, Manchester, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Maurice Whelan</Name>
        <Affiliation>European Commission, Joint Research Centre (JRC), Via E. Fermi, 2749, 21027, Ispra, VA, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Fiona Sewell</Name>
        <Affiliation>National Centre for the Replacement, Refinement &amp; Reduction of Animals in Research (NC3Rs), Gibbs Building, 215 Euston Road, London, NW1 2BE, UK.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Pharmaceutical industry perspective on combination toxicity studies: Results from an intra-industry survey conducted by IQ DruSafe Leadership Group.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30576687</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(18)30319-2</DOI>
    <KeywordList>
      <Keywords>Combination toxicity studies</Keywords>
      <Keywords>Drug combinations</Keywords>
      <Keywords>Drug development</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Joanne Birkebak</Name>
        <Affiliation>Gilead Sciences Inc., 333 Lakeside Dr, Foster City, CA, 94404, USA. Electronic address: joanne.birkebak@gilead.com.</Affiliation>
      </Author>
      <Author>
        <Name>Lorrene A. Buckley</Name>
        <Affiliation>Eli Lilly and Co. Inc., Lilly Corporate Center, Indianapolis, IN, 46285, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Donna Dambach</Name>
        <Affiliation>Genentech Inc., 1 DNA Way, South San Francisco, CA, 94080, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Eunice Musvasva</Name>
        <Affiliation>Boehringer Ingelheim Pharmaceuticals Inc., 900 Ridgebury Road, Ridgefield, CT, 06877, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Karen Price</Name>
        <Affiliation>Bristol-Myers Squibb Co., 1 Squibb Drive, New Brunswick, NJ, 08903, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Sherry Ralston</Name>
        <Affiliation>AbbVie Inc., 1 North Waukegan Road, North Chicago, IL, 60064, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Aida Sacaan</Name>
        <Affiliation>Pfizer Inc., 10646 Science Center Drive, San Diego, CA, 92121, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Corrigendum to "Combined effect of benzophenone-2 and ultraviolet radiation promote photogenotoxicity and photocytotoxicity in human keratinocytes". [Regul. Toxicol. Pharmacol. 95 (2018) 298-306].</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30573279</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(18)30312-X</DOI>
    <AuthorList>
      <Author>
        <Name>Saroj Kumar Amar</Name>
        <Affiliation>Department of Forensic Science, School of Bioengineering and Biosciences, Lovely Professional University, Punjab, India; Academy of Scientific and Innovative Research, CSIR-IITR Campus, Lucknow, India. Electronic address: sarojkumaramar@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Shruti Goyal</Name>
        <Affiliation>Photobiology Laboratory, Systems Toxicology and Health Risk Assessment Group, CSIR-Indian Institute of Toxicology Research, Post. Box 80, M.G. Marg, Lucknow 226001, India; Academy of Scientific and Innovative Research, CSIR-IITR Campus, Lucknow, India.</Affiliation>
      </Author>
      <Author>
        <Name>Ajeet K. Srivastav</Name>
        <Affiliation>Photobiology Laboratory, Systems Toxicology and Health Risk Assessment Group, CSIR-Indian Institute of Toxicology Research, Post. Box 80, M.G. Marg, Lucknow 226001, India.</Affiliation>
      </Author>
      <Author>
        <Name>Deepti Chopra</Name>
        <Affiliation>Photobiology Laboratory, Systems Toxicology and Health Risk Assessment Group, CSIR-Indian Institute of Toxicology Research, Post. Box 80, M.G. Marg, Lucknow 226001, India.</Affiliation>
      </Author>
      <Author>
        <Name>Ratan Singh Ray</Name>
        <Affiliation>Photobiology Laboratory, Systems Toxicology and Health Risk Assessment Group, CSIR-Indian Institute of Toxicology Research, Post. Box 80, M.G. Marg, Lucknow 226001, India; Academy of Scientific and Innovative Research, CSIR-IITR Campus, Lucknow, India.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Histological analyses of the Ishii (1981) rat carcinogenicity study of aspartame and comparison with the Ramazzini Institute studies.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30572082</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(18)30317-9</DOI>
    <KeywordList>
      <Keywords>Aspartame</Keywords>
      <Keywords>Carcinogenicity</Keywords>
      <Keywords>Kidney</Keywords>
      <Keywords>Leukemia</Keywords>
      <Keywords>Lymphoma</Keywords>
      <Keywords>Ramazzini</Keywords>
      <Keywords>Rat</Keywords>
      <Keywords>Schwannoma</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Yusuke Shibui</Name>
        <Affiliation>Institute for Innovation, Ajinomoto Co., Inc., 1-1, Suzuki-cho, Kawasaki-ku, Kawasaki-shi, 210-8681, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Shoji Fujitani</Name>
        <Affiliation>Institute for Innovation, Ajinomoto Co., Inc., 1-1, Suzuki-cho, Kawasaki-ku, Kawasaki-shi, 210-8681, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Hijiri Iwata</Name>
        <Affiliation>LunaPath LLC., 3-5-1, Aoihigashi, Naka-ku, Hamamatsu-shi, 433-8114, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Barry Lynch</Name>
        <Affiliation>Intertek Scientific &amp; Regulatory Consultancy, 2233 Argentia Road, Suite 201, Mississauga, Ontario, L5N 2X7, Canada. Electronic address: barry.lynch@intertek.com.</Affiliation>
      </Author>
      <Author>
        <Name>Ashley Roberts</Name>
        <Affiliation>Intertek Scientific &amp; Regulatory Consultancy, 2233 Argentia Road, Suite 201, Mississauga, Ontario, L5N 2X7, Canada.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The rat bone marrow micronucleus test: Statistical considerations on historical negative control data.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30572081</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(18)30316-7</DOI>
    <KeywordList>
      <Keywords>Bone marrow</Keywords>
      <Keywords>Historical negative control data</Keywords>
      <Keywords>Micronucleus test</Keywords>
      <Keywords>Rat</Keywords>
      <Keywords>Statistical analyses</Keywords>
      <Keywords>Stratification parameters</Keywords>
      <Keywords>Tolerance intervals</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Bernd Wolfgang Igl</Name>
        <Affiliation>Bayer AG, Research and Clinical Sciences Statistics, Müllerstr. 178, 13353, Berlin, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Annette Bitsch</Name>
        <Affiliation>Fraunhofer Institute for Toxicology and Experimental Medicine ITEM, Nikolai-Fuchs-Str. 1, 30625, Hannover, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Frank Bringezu</Name>
        <Affiliation>Merck KGaA, Biopharma and Non-Clinical Safety, Frankfurter Str. 250, 64293 Darmstadt, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Steffi Chang</Name>
        <Affiliation>Envigo CRS GmbH, In den Leppsteinswiesen 19, 64380 Rossdorf, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Martina Dammann</Name>
        <Affiliation>BASF SE, RB/TC - Z470, Carl-Bosch-Str. 38, 67056 Ludwigshafen am Rhein, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Roland Frötschl</Name>
        <Affiliation>Federal Institute for Drugs and Medical Devices (BfArM), Kurt-Georg-Kiesinger-Allee 3, 53175, Bonn, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Volker Harm</Name>
        <Affiliation>Bayer AG, Research and Clinical Sciences Statistics, Müllerstr. 178, 13353, Berlin, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Rupert Kellner</Name>
        <Affiliation>Fraunhofer Institute for Toxicology and Experimental Medicine ITEM, Nikolai-Fuchs-Str. 1, 30625, Hannover, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Volker Krzykalla</Name>
        <Affiliation>Boehringer Ingelheim Pharma GmbH &amp; Co. KG, Biostatistics and Data Sciences Europe, Birkendorfer Str. 65, 88397, Biberach an der Riss, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Jasmin Lott</Name>
        <Affiliation>Boehringer Ingelheim Pharma GmbH &amp; Co. KG, Development NCE NDS, Birkendorfer Str. 65, 88397, Biberach an der Riss, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Marlies Nern</Name>
        <Affiliation>Bayer AG, Research &amp; Development, Pharmaceuticals, Genetic Toxicology Wuppertal, Aprather Weg 18a, 42096, Wuppertal, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Stefan Pfuhler</Name>
        <Affiliation>Procter &amp; Gamble, 8700 Mason-Montgomery Rd., Cincinnati, 45040, Ohio, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Nina Queisser</Name>
        <Affiliation>Bayer AG, Research &amp; Development, Pharmaceuticals, Genetic Toxicology, 13342, Berlin, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Markus Schulz</Name>
        <Affiliation>Envigo CRS GmbH, In den Leppsteinswiesen 19, 64380 Rossdorf, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Andreas Sutter</Name>
        <Affiliation>Bayer AG, Research &amp; Development, Pharmaceuticals, Genetic Toxicology, 13342, Berlin, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Lea Vaas</Name>
        <Affiliation>Bayer AG, Research and Clinical Sciences Statistics, Müllerstr. 178, 13353, Berlin, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Richardus Vonk</Name>
        <Affiliation>Bayer AG, Medical Writing and Statistics Oncology, Müllerstr. 178, 13353, Berlin, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Dietmar Zellner</Name>
        <Affiliation>Boehringer Ingelheim Pharma GmbH &amp; Co. KG, Biostatistics and Data Sciences Europe, Birkendorfer Str. 65, 88397, Biberach an der Riss, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Christina Ziemann</Name>
        <Affiliation>Fraunhofer Institute for Toxicology and Experimental Medicine ITEM, Nikolai-Fuchs-Str. 1, 30625, Hannover, Germany. Electronic address: christina.ziemann@item.fraunhofer.de.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Effect of common processing of soybeans on the enzymatic activity and detectability of the protein, Dicamba Mono-Oxygenase (DMO), introduced into dicamba-tolerant MON 87708.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30562601</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(18)30313-1</DOI>
    <KeywordList>
      <Keywords>Dicamba monooxygenase (DMO)</Keywords>
      <Keywords>Food safety risk assessment</Keywords>
      <Keywords>GMO</Keywords>
      <Keywords>Genetically engineered</Keywords>
      <Keywords>Processed fractions</Keywords>
      <Keywords>Soymilk</Keywords>
      <Keywords>Tofu</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Thomas C. Lee</Name>
        <Affiliation>Bayer U.S. - Crop Science, 700 Chesterfield Parkway West., St. Louis, MO, 63017, USA. Electronic address: thomas.lee@bayer.com.</Affiliation>
      </Author>
      <Author>
        <Name>Thomas C. Edrington</Name>
        <Affiliation>Bayer U.S. - Crop Science, 700 Chesterfield Parkway West., St. Louis, MO, 63017, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Erin Bell</Name>
        <Affiliation>Bayer U.S. - Crop Science, 700 Chesterfield Parkway West., St. Louis, MO, 63017, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Luis A. Burzio</Name>
        <Affiliation>Bayer U.S. - Crop Science, 700 Chesterfield Parkway West., St. Louis, MO, 63017, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Kevin C. Glenn</Name>
        <Affiliation>Bayer U.S. - Crop Science, 700 Chesterfield Parkway West., St. Louis, MO, 63017, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Principles and procedures for handling out-of-domain and indeterminate results as part of ICH M7 recommended (Q)SAR analyses.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30562600</pubmedLink>
    <GrantList>
      <Grant>R44 ES026909</Grant>
    </GrantList>
    <Year>2019</Year>
    <DOI>S0273-2300(18)30314-3</DOI>
    <AuthorList>
      <Author>
        <Name>Alexander Amberg</Name>
        <Affiliation>Sanofi, R&amp;D Preclinical Safety Frankfurt, Industriepark Hoechst, D-65926, Frankfurt am Main, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Roxanne V. Andaya</Name>
        <Affiliation>Genentech, Inc., 1 DNA Way, South San Francisco, CA, 94080, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Lennart T. Anger</Name>
        <Affiliation>Sanofi, R&amp;D Preclinical Safety Frankfurt, Industriepark Hoechst, D-65926, Frankfurt am Main, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Chris Barber</Name>
        <Affiliation>Lhasa Limited, Leeds, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Lisa Beilke</Name>
        <Affiliation>Toxicology Solutions Inc., San Diego, CA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Joel Bercu</Name>
        <Affiliation>Gilead Sciences, 333 Lakeside Drive, Foster City, CA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Dave Bower</Name>
        <Affiliation>Leadscope, Inc., 1393 Dublin Rd, Columbus, OH, 43215, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Alessandro Brigo</Name>
        <Affiliation>Roche Pharmaceutical Research &amp; Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Zoryanna Cammerer</Name>
        <Affiliation>Janssen Research &amp; Development, 1400 McKean Road, Spring House, PA, 19477, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Kevin P. Cross</Name>
        <Affiliation>Leadscope, Inc., 1393 Dublin Rd, Columbus, OH, 43215, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Laura Custer</Name>
        <Affiliation>Bristol-Myers Squibb, Drug Safety Evaluation, 1 Squibb Dr, New Brunswick, NJ, 08903, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Krista Dobo</Name>
        <Affiliation>Pfizer Global Research &amp; Development, 558 Eastern Point Road, Groton, CT, 06340, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Helga Gerets</Name>
        <Affiliation>UCB Biopharma SPRL, Chemin du Foriest, B-1420, Braine-l'Alleud, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Véronique Gervais</Name>
        <Affiliation>Servier Group, Gidy, France.</Affiliation>
      </Author>
      <Author>
        <Name>Susanne Glowienke</Name>
        <Affiliation>Novartis Pharma AG, Pre-Clinical Safety, Werk Klybeck, CH-4057, Basel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Stephen Gomez</Name>
        <Affiliation>Consultant to Theravance Biopharma US, Inc., 901 Gateway Blvd, South San Francisco, CA, 94080, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jacky Van Gompel</Name>
        <Affiliation>Janssen Pharmaceutical Companies of Johnson &amp; Johnson, 2340, Beerse, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>James Harvey</Name>
        <Affiliation>GlaxoSmithKline, Park Road, Ware, Hertfordshire, SG12 0DP, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Catrin Hasselgren</Name>
        <Affiliation>Genentech, Inc., 1 DNA Way, South San Francisco, CA, 94080, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Masamitsu Honma</Name>
        <Affiliation>National Institute of Health Sciences, Tokyo, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Candice Johnson</Name>
        <Affiliation>Leadscope, Inc., 1393 Dublin Rd, Columbus, OH, 43215, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Robert Jolly</Name>
        <Affiliation>Toxicology Division, Eli Lilly and Company, Indianapolis, IN, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Raymond Kemper</Name>
        <Affiliation>Vertex Pharmaceuticals Inc., Discovery and Investigative Toxicology, 50 Northern Ave, Boston, MA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Michelle Kenyon</Name>
        <Affiliation>Pfizer Global Research &amp; Development, 558 Eastern Point Road, Groton, CT, 06340, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Naomi Kruhlak</Name>
        <Affiliation>FDA Center for Drug Evaluation and Research, Silver Spring, MD, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Penny Leavitt</Name>
        <Affiliation>Bristol-Myers Squibb, Drug Safety Evaluation, 1 Squibb Dr, New Brunswick, NJ, 08903, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Scott Miller</Name>
        <Affiliation>Leadscope, Inc., 1393 Dublin Rd, Columbus, OH, 43215, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Wolfgang Muster</Name>
        <Affiliation>Roche Pharmaceutical Research &amp; Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Russell Naven</Name>
        <Affiliation>Takeda, Cambridge, MA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>John Nicolette</Name>
        <Affiliation>AbbVie Inc., North Chicago, IL, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Alexis Parenty</Name>
        <Affiliation>Novartis Pharma AG, Pre-Clinical Safety, Werk Klybeck, CH-4057, Basel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Mark Powley</Name>
        <Affiliation>Merck Research Laboratories, West Point, PA, 19486, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Donald P. Quigley</Name>
        <Affiliation>Leadscope, Inc., 1393 Dublin Rd, Columbus, OH, 43215, USA.</Affiliation>
      </Author>
      <Author>
        <Name>M. Vijayaraj Reddy</Name>
        <Affiliation>Merck Research Laboratories, West Point, PA, 19486, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jennifer C. Sasaki</Name>
        <Affiliation>Genentech, Inc., 1 DNA Way, South San Francisco, CA, 94080, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Lidiya Stavitskaya</Name>
        <Affiliation>FDA Center for Drug Evaluation and Research, Silver Spring, MD, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Andrew Teasdale</Name>
        <Affiliation>AstraZeneca, Macclesfield, Cheshire, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Alejandra Trejo-Martin</Name>
        <Affiliation>Gilead Sciences, 333 Lakeside Drive, Foster City, CA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Sandy Weiner</Name>
        <Affiliation>Janssen Research &amp; Development, 1400 McKean Road, Spring House, PA, 19477, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Dennie S. Welch</Name>
        <Affiliation>AbbVie Inc., North Chicago, IL, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Angela White</Name>
        <Affiliation>GlaxoSmithKline, Park Road, Ware, Hertfordshire, SG12 0DP, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Joerg Wichard</Name>
        <Affiliation>Bayer Pharma AG, Investigational Toxicology, Muellerstr. 178, D-13353, Berlin, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>David Woolley</Name>
        <Affiliation>ForthTox Limited, PO Box 13550, Linlithgow, EH49 7YU, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Glenn J. Myatt</Name>
        <Affiliation>Leadscope, Inc., 1393 Dublin Rd, Columbus, OH, 43215, USA. Electronic address: gmyatt@leadscope.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>PBTK model for assessment of operator exposure to haloxyfop using human biomonitoring and toxicokinetic data.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30543831</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(18)30310-6</DOI>
    <KeywordList>
      <Keywords>Bayesian analysis</Keywords>
      <Keywords>Haloxyfop</Keywords>
      <Keywords>PBTK model</Keywords>
      <Keywords>Pesticides</Keywords>
      <Keywords>Risk assessment</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Alexander B. Cooper</Name>
        <Affiliation>Centre for Radiation, Chemical and Environmental Hazards, Public Health England, Harwell Campus, Didcot, OX11 0RQ, UK. Electronic address: Alexander.Cooper@food.gov.uk.</Affiliation>
      </Author>
      <Author>
        <Name>Manoj Aggarwal</Name>
        <Affiliation>Dow AgroSciences, 3B Park Square, Milton Park, Abingdon, Oxfordshire, OX14 4RN, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Michael J. Bartels</Name>
        <Affiliation>Dow AgroSciences, 3B Park Square, Milton Park, Abingdon, Oxfordshire, OX14 4RN, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Alistair Morriss</Name>
        <Affiliation>Dow AgroSciences, 3B Park Square, Milton Park, Abingdon, Oxfordshire, OX14 4RN, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Claire Terry</Name>
        <Affiliation>Dow AgroSciences, 3B Park Square, Milton Park, Abingdon, Oxfordshire, OX14 4RN, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Gwyn A. Lord</Name>
        <Affiliation>Centre for Radiation, Chemical and Environmental Hazards, Public Health England, Harwell Campus, Didcot, OX11 0RQ, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Timothy W. Gant</Name>
        <Affiliation>Centre for Radiation, Chemical and Environmental Hazards, Public Health England, Harwell Campus, Didcot, OX11 0RQ, UK; Kings College London, Department of Analytical, Environmental &amp; Forensic Sciences, James Clerk Maxwell Building 57 Waterloo Road, London, SE1 8WA, UK. Electronic address: Tim.Gant@phe.gov.uk.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Subchronic toxicity evaluation of isoeugenyl methyl ether in F344/DuCrj rats by 13-week oral administration.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30529462</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(18)30308-8</DOI>
    <KeywordList>
      <Keywords>F344/DuCrj rats</Keywords>
      <Keywords>Food additives</Keywords>
      <Keywords>Hepatotoxicity</Keywords>
      <Keywords>Isoeugenyl methyl ether</Keywords>
      <Keywords>Subchronic toxicity test</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jun Ichi Akagi</Name>
        <Affiliation>Division of Pathology, National Institute of Health Sciences, 3-25-26 Tonomachi, Kawasaki-ku, Kawasaki, Kanagawa, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Young Man Cho</Name>
        <Affiliation>Division of Pathology, National Institute of Health Sciences, 3-25-26 Tonomachi, Kawasaki-ku, Kawasaki, Kanagawa, Japan. Electronic address: ymcho@nihs.go.jp.</Affiliation>
      </Author>
      <Author>
        <Name>Yasuko Mizuta</Name>
        <Affiliation>Division of Pathology, National Institute of Health Sciences, 3-25-26 Tonomachi, Kawasaki-ku, Kawasaki, Kanagawa, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Chiye Tatebe</Name>
        <Affiliation>Division of Food Additives, National Institute of Health Sciences, 3-25-26 Tonomachi, Kawasaki-ku, Kawasaki, Kanagawa, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Kyoko Sato</Name>
        <Affiliation>Division of Food Additives, National Institute of Health Sciences, 3-25-26 Tonomachi, Kawasaki-ku, Kawasaki, Kanagawa, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Kumiko Ogawa</Name>
        <Affiliation>Division of Pathology, National Institute of Health Sciences, 3-25-26 Tonomachi, Kawasaki-ku, Kawasaki, Kanagawa, Japan.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Prenatal developmental toxicity study of strontium citrate in Sprague Dawley rats.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30529436</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(18)30311-8</DOI>
    <KeywordList>
      <Keywords>No observable adverse effect level</Keywords>
      <Keywords>Prenatal development toxicity</Keywords>
      <Keywords>Sprague Dawley rats</Keywords>
      <Keywords>Strontium citrate</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Chen Yuan Chiu</Name>
        <Affiliation>Institute of Food Safety and Health, College of Public Health, National Taiwan University, Taipei, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Hsien Chun Chiu</Name>
        <Affiliation>Institute of Toxicology, College of Medicine, National Taiwan University, Taipei, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Shing Hwa Liu</Name>
        <Affiliation>Institute of Toxicology, College of Medicine, National Taiwan University, Taipei, Taiwan; Department of Medical Research, China Medical University Hospital, China Medical University, Taichung, Taiwan; Department of Pediatrics, College of Medicine, National Taiwan University &amp; Hospital, Taipei, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Kuo Cheng Lan</Name>
        <Affiliation>Department of Emergency Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan. Electronic address: kclan.tw@yahoo.com.tw.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Endogenous ionone. Commentary on "Study on the developmental toxicity of β-ionone in the rat".</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30529345</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(18)30309-X</DOI>
    <KeywordList>
      <Keywords>Beta carotene oxygenase</Keywords>
      <Keywords>Carotene metabolism</Keywords>
      <Keywords>Odorant receptor 51E2</Keywords>
      <Keywords>Violet scent</Keywords>
      <Keywords>β-ionone</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Georg A. Petroianu</Name>
        <Affiliation>Department of Pharmacology &amp; Cell Biology, Herbert Wertheim College of Medicine, Florida International University, Miami, FL, USA. Electronic address: georg.petroianu@fiu.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Impact of REACH legislation on the production and importation of CMR (carcinogen, mutagen and reproductive) and explosive chemicals in Italy from 2011 to 2015.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30502361</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(18)30305-2</DOI>
    <KeywordList>
      <Keywords>Carcinogen</Keywords>
      <Keywords>Explosivity</Keywords>
      <Keywords>Italian chemical market</Keywords>
      <Keywords>Mutagen and reproductive toxicity</Keywords>
      <Keywords>REACH regulation</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Marco Marzo</Name>
        <Affiliation>Laboratory of Environmental Chemistry and Toxicology, Department of Environmental Health Sciences, IRCCS-Istituto di Ricerche Farmacologiche Mario Negri, Via La Masa 19, 20156, Milano, Italy. Electronic address: Marco.marzo@marionegri.it.</Affiliation>
      </Author>
      <Author>
        <Name>Caterina Leone</Name>
        <Affiliation>Laboratory of Environmental Chemistry and Toxicology, Department of Environmental Health Sciences, IRCCS-Istituto di Ricerche Farmacologiche Mario Negri, Via La Masa 19, 20156, Milano, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Cosimo Toma</Name>
        <Affiliation>Laboratory of Environmental Chemistry and Toxicology, Department of Environmental Health Sciences, IRCCS-Istituto di Ricerche Farmacologiche Mario Negri, Via La Masa 19, 20156, Milano, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Alessandra Roncaglioni</Name>
        <Affiliation>Laboratory of Environmental Chemistry and Toxicology, Department of Environmental Health Sciences, IRCCS-Istituto di Ricerche Farmacologiche Mario Negri, Via La Masa 19, 20156, Milano, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Stefano Gianazzi</Name>
        <Affiliation>Ticass S.c.r.l., Genova, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Ralf Knauf</Name>
        <Affiliation>Centro REACH S.r.l., Milano, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Emilio Benfenati</Name>
        <Affiliation>Laboratory of Environmental Chemistry and Toxicology, Department of Environmental Health Sciences, IRCCS-Istituto di Ricerche Farmacologiche Mario Negri, Via La Masa 19, 20156, Milano, Italy.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A simple problem formulation framework to create the right solution to the right problem.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30513358</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(18)30307-6</DOI>
    <KeywordList>
      <Keywords>Chemical</Keywords>
      <Keywords>Pesticide</Keywords>
      <Keywords>Problem formulation</Keywords>
      <Keywords>Risk assessment</Keywords>
      <Keywords>Solution</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Alaina Sauve-Ciencewicki</Name>
        <Affiliation>Syngenta Crop Protection, Research Triangle Park, NC, 27709, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Kathryn P. Davis</Name>
        <Affiliation>Syngenta Crop Protection, Research Triangle Park, NC, 27709, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Justin McDonald</Name>
        <Affiliation>Syngenta Crop Protection, Research Triangle Park, NC, 27709, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Tharacad Ramanarayanan</Name>
        <Affiliation>Syngenta Crop Protection, Greensboro, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Alan Raybould</Name>
        <Affiliation>Syngenta Crop Protection, Basel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Douglas C. Wolf</Name>
        <Affiliation>Syngenta Crop Protection, Research Triangle Park, NC, 27709, USA. Electronic address: doug.wolf@syngenta.com.</Affiliation>
      </Author>
      <Author>
        <Name>Ted Valenti</Name>
        <Affiliation>Syngenta Crop Protection, Greensboro, NC, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Updating the evidence relating smoking bans to incidence of heart disease.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30500390</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(18)30306-4</DOI>
    <KeywordList>
      <Keywords>Cessation</Keywords>
      <Keywords>Heart disease</Keywords>
      <Keywords>Smoking bans</Keywords>
      <Keywords>Tobacco</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Peter N. Lee</Name>
        <Affiliation>P.N. Lee Statistics and Computing Ltd, 17 Cedar Road, Sutton, Surrey, SM2 5DA, UK. Electronic address: PeterLee@pnlee.co.uk.</Affiliation>
      </Author>
      <Author>
        <Name>John S. Fry</Name>
        <Affiliation>ROELEE Statistics Ltd, 17 Cedar Road, Sutton, Surrey, SM2 5DA, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Alison J. Thornton</Name>
        <Affiliation>Independent Consultant, Oak Cottage, Beer Farm, Okehampton, Devon, EX20 1SG, UK.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Assessment of the approved Risk Evaluation and Mitigation Strategy programs for New Drug Applications and Biologics Licensing Applications.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30473489</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(18)30279-4</DOI>
    <AuthorList>
      <Author>
        <Name>Nina A. Johnson</Name>
        <Affiliation>Western New England University, Springfield, MA, 01119, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Ronny Priefer</Name>
        <Affiliation>Western New England University, Springfield, MA, 01119, United States. Electronic address: ronny.priefer@wne.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Multi-dimensional in vitro bioactivity profiling for grouping of glycol ethers.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30471335</pubmedLink>
    <GrantList>
      <Grant>P42 ES027704</Grant>
    </GrantList>
    <Year>2019</Year>
    <DOI>S0273-2300(18)30303-9</DOI>
    <KeywordList>
      <Keywords>Glycol ethers</Keywords>
      <Keywords>In vitro</Keywords>
      <Keywords>New assessment methodologies</Keywords>
      <Keywords>Read-across</Keywords>
      <Keywords>Safety assessment</Keywords>
      <Keywords>ToxPi</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Fabian A. Grimm</Name>
        <Affiliation>Department of Veterinary Integrative Biosciences, Texas A&amp;M University, College Station, TX, 77843, USA.</Affiliation>
      </Author>
      <Author>
        <Name>John S. House</Name>
        <Affiliation>Bioinformatics Research Center, North Carolina State University, Raleigh, NC 27695, USA; Center for Human Health and the Environment, North Carolina State University, Raleigh, NC 27695, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Melinda R. Wilson</Name>
        <Affiliation>Department of Veterinary Integrative Biosciences, Texas A&amp;M University, College Station, TX, 77843, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Oksana Sirenko</Name>
        <Affiliation>Molecular Devices, LLC, San Jose, CA, 95134, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Yasuhiro Iwata</Name>
        <Affiliation>Department of Veterinary Integrative Biosciences, Texas A&amp;M University, College Station, TX, 77843, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Fred A. Wright</Name>
        <Affiliation>Bioinformatics Research Center, North Carolina State University, Raleigh, NC 27695, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Nicholas Ball</Name>
        <Affiliation>Toxicology and Environmental Research and Consulting (TERC), Environment, Health and Safety (EH&amp;S), The Dow Chemical Company, Horgen, Zurich, 8810, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Ivan Rusyn</Name>
        <Affiliation>Department of Veterinary Integrative Biosciences, Texas A&amp;M University, College Station, TX, 77843, USA. Electronic address: irusyn@tamu.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A comparative assessment of the CLP calculation method and in vivo testing for the classification of plant protection products.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30471334</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(18)30304-0</DOI>
    <KeywordList>
      <Keywords>Additivity approach</Keywords>
      <Keywords>CLP calculation method</Keywords>
      <Keywords>Hazard assessment</Keywords>
      <Keywords>Pesticides</Keywords>
      <Keywords>Plant protection products</Keywords>
      <Keywords>Weight of evidence approach</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Denise Kurth</Name>
        <Affiliation>Federal Institute for Risk Assessment, Max-Dohrn-Str. 8-10, 10589, Berlin, Germany. Electronic address: denise.kurth@bfr.bund.de.</Affiliation>
      </Author>
      <Author>
        <Name>Korinna Wend</Name>
        <Affiliation>Federal Institute for Risk Assessment, Max-Dohrn-Str. 8-10, 10589, Berlin, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Sarah Adler-Flindt</Name>
        <Affiliation>Federal Institute for Risk Assessment, Max-Dohrn-Str. 8-10, 10589, Berlin, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Sabine Martin</Name>
        <Affiliation>Federal Institute for Risk Assessment, Max-Dohrn-Str. 8-10, 10589, Berlin, Germany.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Molecular fingerprint-derived similarity measures for toxicological read-across: Recommendations for optimal use.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30468762</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(18)30294-0</DOI>
    <KeywordList>
      <Keywords>In silico</Keywords>
      <Keywords>Molecular fingerprint</Keywords>
      <Keywords>Molecular similarity</Keywords>
      <Keywords>Read-across</Keywords>
      <Keywords>Regulatory acceptance</Keywords>
      <Keywords>Tanimoto coefficient</Keywords>
      <Keywords>Toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>C. L. Mellor</Name>
        <Affiliation>School of Pharmacy and Biomolecular Sciences, Liverpool John Moores University, Byrom Street, Liverpool, L3 3AF, England, UK.</Affiliation>
      </Author>
      <Author>
        <Name>R. L. Marchese Robinson</Name>
        <Affiliation>School of Pharmacy and Biomolecular Sciences, Liverpool John Moores University, Byrom Street, Liverpool, L3 3AF, England, UK.</Affiliation>
      </Author>
      <Author>
        <Name>R. Benigni</Name>
        <Affiliation>Alpha-Pretox, Via G. Pascoli 1, 00184, Rome, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>D. Ebbrell</Name>
        <Affiliation>School of Pharmacy and Biomolecular Sciences, Liverpool John Moores University, Byrom Street, Liverpool, L3 3AF, England, UK.</Affiliation>
      </Author>
      <Author>
        <Name>S. J. Enoch</Name>
        <Affiliation>School of Pharmacy and Biomolecular Sciences, Liverpool John Moores University, Byrom Street, Liverpool, L3 3AF, England, UK.</Affiliation>
      </Author>
      <Author>
        <Name>J. W. Firman</Name>
        <Affiliation>School of Pharmacy and Biomolecular Sciences, Liverpool John Moores University, Byrom Street, Liverpool, L3 3AF, England, UK.</Affiliation>
      </Author>
      <Author>
        <Name>J. C. Madden</Name>
        <Affiliation>School of Pharmacy and Biomolecular Sciences, Liverpool John Moores University, Byrom Street, Liverpool, L3 3AF, England, UK.</Affiliation>
      </Author>
      <Author>
        <Name>G. Pawar</Name>
        <Affiliation>School of Pharmacy and Biomolecular Sciences, Liverpool John Moores University, Byrom Street, Liverpool, L3 3AF, England, UK.</Affiliation>
      </Author>
      <Author>
        <Name>C. Yang</Name>
        <Affiliation>Molecular Networks GmbH, Neumeyerstraße 28, 90411, Nürnberg, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>M. T. D. Cronin</Name>
        <Affiliation>School of Pharmacy and Biomolecular Sciences, Liverpool John Moores University, Byrom Street, Liverpool, L3 3AF, England, UK. Electronic address: M.T.Cronin@ljmu.ac.uk.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>In further defense of nonclinical abuse liability testing of biologics.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30465804</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(18)30301-5</DOI>
    <KeywordList>
      <Keywords>Biologics</Keywords>
      <Keywords>Controlled substances act</Keywords>
      <Keywords>Drug</Keywords>
      <Keywords>Drug abuse liability testing</Keywords>
      <Keywords>Drug control</Keywords>
      <Keywords>FD&amp;CA</Keywords>
      <Keywords>Risk assessment</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>David V. Gauvin</Name>
        <Affiliation>MPI Research (A Charles River Company), USA. Electronic address: david.gauvin@crl.com.</Affiliation>
      </Author>
      <Author>
        <Name>Zachary J. Zimmermann</Name>
        <Affiliation>MPI Research (A Charles River Company), USA.</Affiliation>
      </Author>
      <Author>
        <Name>Theodore J. Baird</Name>
        <Affiliation>MPI Research (A Charles River Company), USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Acute and 28-days repeated dose sub-acute toxicity study of gallic acid in albino mice.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30465803</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(18)30302-7</DOI>
    <KeywordList>
      <Keywords>Gallic acid</Keywords>
      <Keywords>Gross histopathology</Keywords>
      <Keywords>Gross necropsy</Keywords>
      <Keywords>OECD 407</Keywords>
      <Keywords>Oral toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Bhavesh C. Variya</Name>
        <Affiliation>Department of Pharmacology, Institute of Pharmacy, Nirma University, Ahmedabad, Gujarat, 382 481, India.</Affiliation>
      </Author>
      <Author>
        <Name>Anita K. Bakrania</Name>
        <Affiliation>Department of Pharmacology, Institute of Pharmacy, Nirma University, Ahmedabad, Gujarat, 382 481, India.</Affiliation>
      </Author>
      <Author>
        <Name>Prem Madan</Name>
        <Affiliation>MD-Pathologist, Sukoon Pathology Laboratory, Ahmedabad, Gujarat, 380052, India.</Affiliation>
      </Author>
      <Author>
        <Name>Snehal S. Patel</Name>
        <Affiliation>Department of Pharmacology, Institute of Pharmacy, Nirma University, Ahmedabad, Gujarat, 382 481, India. Electronic address: snehal.patel@nirmauni.ac.in.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Safety evaluation of β-agarase preparations from Streptomyces coelicolor A3(2).</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30453009</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(18)30297-6</DOI>
    <KeywordList>
      <Keywords>Agarase</Keywords>
      <Keywords>DagA</Keywords>
      <Keywords>Safety</Keywords>
      <Keywords>Streptomyces coelicolor</Keywords>
      <Keywords>Toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Sun Joo Hong</Name>
        <Affiliation>Department of Biological Science and Bioinformatics, Myongji University, 116 Myongji-Ro, Cheoin-gu, Yongin, Gyeonggido, 17058, Republic of Korea; Dynebio Inc, B-B205 Woolimlions Valley II, 146-8, Sangdaewon-Dong, Jungwon-Gu, Seongnam-Si, Gyeonggi-Do, 462-807, South Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Je Hyeon Lee</Name>
        <Affiliation>Dynebio Inc, B-B205 Woolimlions Valley II, 146-8, Sangdaewon-Dong, Jungwon-Gu, Seongnam-Si, Gyeonggi-Do, 462-807, South Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Eun Joo Kim</Name>
        <Affiliation>Dynebio Inc, B-B205 Woolimlions Valley II, 146-8, Sangdaewon-Dong, Jungwon-Gu, Seongnam-Si, Gyeonggi-Do, 462-807, South Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Yeon Hee Lee</Name>
        <Affiliation>Dynebio Inc, B-B205 Woolimlions Valley II, 146-8, Sangdaewon-Dong, Jungwon-Gu, Seongnam-Si, Gyeonggi-Do, 462-807, South Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Hoe Myung Jung</Name>
        <Affiliation>Dynebio Inc, B-B205 Woolimlions Valley II, 146-8, Sangdaewon-Dong, Jungwon-Gu, Seongnam-Si, Gyeonggi-Do, 462-807, South Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Soon Kwang Hong</Name>
        <Affiliation>Department of Biological Science and Bioinformatics, Myongji University, 116 Myongji-Ro, Cheoin-gu, Yongin, Gyeonggido, 17058, Republic of Korea. Electronic address: ookane@nate.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Safety evaluation of 3'-siallylactose sodium salt supplementation on growth and clinical parameters in neonatal piglets.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30453008</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(18)30300-3</DOI>
    <KeywordList>
      <Keywords>3′-sialyllactose</Keywords>
      <Keywords>Human milk oligosaccharide</Keywords>
      <Keywords>Infant formula</Keywords>
      <Keywords>Infant nutrition</Keywords>
      <Keywords>Piglet</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Marcia H. Monaco</Name>
        <Affiliation>Department of Food Science and Human Nutrition, University of Illinois, Urbana, IL, 61801, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Rit Bahadur Gurung</Name>
        <Affiliation>GeneChem Inc, Daejeon, 34025, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Sharon M. Donovan</Name>
        <Affiliation>Department of Food Science and Human Nutrition, University of Illinois, Urbana, IL, 61801, USA. Electronic address: sdonovan@illinois.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Legal aspects of zebrafish neuropharmacology and neurotoxicology research.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30453007</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(18)30299-X</DOI>
    <KeywordList>
      <Keywords>3Rs</Keywords>
      <Keywords>Animal welfare regulations</Keywords>
      <Keywords>Pharmacology</Keywords>
      <Keywords>Toxicology</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Murilo S. de Abreu</Name>
        <Affiliation>Bioscience Institute, University of Passo Fundo (UPF), Passo Fundo, RS, Brazil; The International Zebrafish Neuroscience Research Consortium (ZNRC), Slidell, LA, USA. Electronic address: abreu_murilo@hotmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Ana C. V. V. Giacomini</Name>
        <Affiliation>Bioscience Institute, University of Passo Fundo (UPF), Passo Fundo, RS, Brazil; Postgraduate Program in Environmental Sciences, University of Passo Fundo (UPF), Passo Fundo, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>David J. Echevarria</Name>
        <Affiliation>The International Zebrafish Neuroscience Research Consortium (ZNRC), Slidell, LA, USA; ZENEREI Research Center, Slidell, LA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Allan V. Kalueff</Name>
        <Affiliation>School of Pharmacy, Southwest University, Chongqing, China; Scientific Research Institute of Physiology and Basic Medicine, Novosibirsk, Russia; Ural Federal University, Ekaterinburg, Russia; Institute of Translational Biomedicine, St. Petersburg State University, St. Petersburg, Russia; Institute of Experimental Medicine, Almazov National Medical Research Centre, Ministry of Healthcare of Russian Federation, St. Petersburg, Russia; Granov Russian Scientific Center of Radiology and Surgical Technologies, Ministry of Healthcare of Russian Federation, St. Petersburg, Russia. Electronic address: avkalueff@gmail.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Investigation of menthol content and transfer rates in cigarettes and Tobacco Heating System 2.2.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30445138</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(18)30296-4</DOI>
    <AuthorList>
      <Author>
        <Name>Guy Jaccard</Name>
        <Affiliation>PMI R&amp;D, Philip Morris Products S.A., Quai Jeanrenaud 5, CH-2000, Neuchâtel, Switzerland. Electronic address: Guy.Jaccard@pmi.com.</Affiliation>
      </Author>
      <Author>
        <Name>Maxim Belushkin</Name>
        <Affiliation>PMI R&amp;D, Philip Morris Products S.A., Quai Jeanrenaud 5, CH-2000, Neuchâtel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Cyril Jeannet</Name>
        <Affiliation>PMI R&amp;D, Philip Morris Products S.A., Quai Jeanrenaud 5, CH-2000, Neuchâtel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Evi Nurlaili Aldilla</Name>
        <Affiliation>PT HM Sampoerna Tbk. Scientific Technical Services Laboratories, Jl. Raya Surabaya Malang Km 51.4, 67161, Pasuruan, Indonesia.</Affiliation>
      </Author>
      <Author>
        <Name>Andry Ongko Wijoyo</Name>
        <Affiliation>PT HM Sampoerna Tbk. Scientific Technical Services Laboratories, Jl. Raya Surabaya Malang Km 51.4, 67161, Pasuruan, Indonesia.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Dissipation behavior and dietary risk assessment of lambda-cyhalothrin, thiamethoxam and its metabolite clothianidin in apple after open field application.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30445137</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(18)30295-2</DOI>
    <KeywordList>
      <Keywords>Apple</Keywords>
      <Keywords>Clothianidin</Keywords>
      <Keywords>Dietary risk assessment</Keywords>
      <Keywords>Dissipation</Keywords>
      <Keywords>Lambda-cyhalothrin</Keywords>
      <Keywords>Thiamethoxam</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Xueqi Fan</Name>
        <Affiliation>College of Chemistry and Biological Engineering, University of Science and Technology Beijing, Beijing, 100083, PR China. Electronic address: fanxueqi333@163.com.</Affiliation>
      </Author>
      <Author>
        <Name>Shengming Zhao</Name>
        <Affiliation>College of Chemistry and Biological Engineering, University of Science and Technology Beijing, Beijing, 100083, PR China. Electronic address: ustbzsm@163.com.</Affiliation>
      </Author>
      <Author>
        <Name>Jiye Hu</Name>
        <Affiliation>College of Chemistry and Biological Engineering, University of Science and Technology Beijing, Beijing, 100083, PR China. Electronic address: jyhu@ustb.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Influence of machine-based puffing parameters on aerosol and smoke emissions from next generation nicotine inhalation products.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30445136</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(18)30298-8</DOI>
    <KeywordList>
      <Keywords>Behaviour</Keywords>
      <Keywords>Nicotine</Keywords>
      <Keywords>Parameters</Keywords>
      <Keywords>Puffing</Keywords>
      <Keywords>Standards</Keywords>
      <Keywords>Tobacco</Keywords>
      <Keywords>Topography</Keywords>
      <Keywords>e-cigarettes</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>K. McAdam</Name>
        <Affiliation>British American Tobacco, Regents Park Road, Southampton, SO15 8TL, UK. Electronic address: kevin@mcadamscience.com.</Affiliation>
      </Author>
      <Author>
        <Name>P. Davis</Name>
        <Affiliation>British American Tobacco, Regents Park Road, Southampton, SO15 8TL, UK.</Affiliation>
      </Author>
      <Author>
        <Name>L. Ashmore</Name>
        <Affiliation>British American Tobacco, Regents Park Road, Southampton, SO15 8TL, UK.</Affiliation>
      </Author>
      <Author>
        <Name>D. Eaton</Name>
        <Affiliation>British American Tobacco, Regents Park Road, Southampton, SO15 8TL, UK.</Affiliation>
      </Author>
      <Author>
        <Name>B. Jakaj</Name>
        <Affiliation>British American Tobacco, Regents Park Road, Southampton, SO15 8TL, UK.</Affiliation>
      </Author>
      <Author>
        <Name>A. Eldridge</Name>
        <Affiliation>British American Tobacco, Regents Park Road, Southampton, SO15 8TL, UK.</Affiliation>
      </Author>
      <Author>
        <Name>C. Liu</Name>
        <Affiliation>British American Tobacco, Regents Park Road, Southampton, SO15 8TL, UK.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A defined approach for predicting skin sensitisation hazard and potency based on the guided integration of in silico, in chemico and in vitro data using exclusion criteria.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30439387</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(18)30285-X</DOI>
    <KeywordList>
      <Keywords>(Q)SAR</Keywords>
      <Keywords>Defined approach</Keywords>
      <Keywords>Expert system</Keywords>
      <Keywords>Hazard</Keywords>
      <Keywords>In silico toxicology</Keywords>
      <Keywords>Integrated testing strategy</Keywords>
      <Keywords>Negative predictions</Keywords>
      <Keywords>Potency</Keywords>
      <Keywords>Risk</Keywords>
      <Keywords>Skin sensitisation</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Donna S. Macmillan</Name>
        <Affiliation>Lhasa Limited, Granary Wharf House, 2 Canal Wharf, Leeds, LS11 5PS, UK. Electronic address: donna.macmillan@lhasalimited.org.</Affiliation>
      </Author>
      <Author>
        <Name>Martyn L. Chilton</Name>
        <Affiliation>Lhasa Limited, Granary Wharf House, 2 Canal Wharf, Leeds, LS11 5PS, UK.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A comparison of 24 chemicals in the six-well bacterial reverse mutation assay to the standard 100-mm Petri plate bacterial reverse mutation assay in two laboratories.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30401633</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30270-8</DOI>
    <KeywordList>
      <Keywords>100-Mm plates</Keywords>
      <Keywords>Ames test</Keywords>
      <Keywords>Bacterial mutation</Keywords>
      <Keywords>Inter-laboratory evaluation</Keywords>
      <Keywords>Miniaturized</Keywords>
      <Keywords>Six-well plates</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>J. Nicolette</Name>
        <Affiliation>AbbVie, Inc., 1 North Waukegan Road, North Chicago, IL, USA. Electronic address: john.nicolette@abbvie.com.</Affiliation>
      </Author>
      <Author>
        <Name>E. Dakoulas</Name>
        <Affiliation>MilliporeSigma BioReliance(®) Toxicology Services, 9630, Medical Center Drive, Rockville, MD, USA.</Affiliation>
      </Author>
      <Author>
        <Name>K. Pant</Name>
        <Affiliation>MilliporeSigma BioReliance(®) Toxicology Services, 9630, Medical Center Drive, Rockville, MD, USA.</Affiliation>
      </Author>
      <Author>
        <Name>M. Crosby</Name>
        <Affiliation>AbbVie, Inc., 1 North Waukegan Road, North Chicago, IL, USA.</Affiliation>
      </Author>
      <Author>
        <Name>A. Kondratiuk</Name>
        <Affiliation>AbbVie, Inc., 1 North Waukegan Road, North Chicago, IL, USA.</Affiliation>
      </Author>
      <Author>
        <Name>J. Murray</Name>
        <Affiliation>AbbVie, Inc., 1 North Waukegan Road, North Chicago, IL, USA.</Affiliation>
      </Author>
      <Author>
        <Name>P. Sonders</Name>
        <Affiliation>AbbVie, Inc., 1 North Waukegan Road, North Chicago, IL, USA.</Affiliation>
      </Author>
      <Author>
        <Name>R. Kulkarni</Name>
        <Affiliation>MilliporeSigma BioReliance(®) Toxicology Services, 9630, Medical Center Drive, Rockville, MD, USA.</Affiliation>
      </Author>
      <Author>
        <Name>G. Jayakumar</Name>
        <Affiliation>MilliporeSigma BioReliance(®) Toxicology Services, 9630, Medical Center Drive, Rockville, MD, USA.</Affiliation>
      </Author>
      <Author>
        <Name>M. Mathur</Name>
        <Affiliation>MilliporeSigma BioReliance(®) Toxicology Services, 9630, Medical Center Drive, Rockville, MD, USA.</Affiliation>
      </Author>
      <Author>
        <Name>A. Patel</Name>
        <Affiliation>MilliporeSigma BioReliance(®) Toxicology Services, 9630, Medical Center Drive, Rockville, MD, USA.</Affiliation>
      </Author>
      <Author>
        <Name>R. Vicente</Name>
        <Affiliation>MilliporeSigma BioReliance(®) Toxicology Services, 9630, Medical Center Drive, Rockville, MD, USA.</Affiliation>
      </Author>
      <Author>
        <Name>K. Datta</Name>
        <Affiliation>Celgene Corporation, 556 Morris Avenue, Summit, NJ, USA.</Affiliation>
      </Author>
      <Author>
        <Name>K. Kolaja</Name>
        <Affiliation>Celgene Corporation, 556 Morris Avenue, Summit, NJ, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Toxicity assessment of cypermethrin nanoparticles in Channa punctatus: Behavioural response, micronuclei induction and enzyme alteration.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30393047</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30269-1</DOI>
    <KeywordList>
      <Keywords>Cypermethrin</Keywords>
      <Keywords>Enzyme activity</Keywords>
      <Keywords>LC(50)</Keywords>
      <Keywords>Micronucleus</Keywords>
      <Keywords>Murrel</Keywords>
      <Keywords>Nanoparticles</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Saima Amjad</Name>
        <Affiliation>Department of Zoology, University of Lucknow, Lucknow, 226007, UP, India. Electronic address: saimaamjadlko@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>A. K. Sharma</Name>
        <Affiliation>Department of Zoology, University of Lucknow, Lucknow, 226007, UP, India. Electronic address: draksharma57@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>M. Serajuddin</Name>
        <Affiliation>Department of Zoology, University of Lucknow, Lucknow, 226007, UP, India. Electronic address: lu.fisheries@gmail.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Comparison of numbers and timing of new medication regulatory approvals in Canada and New Zealand.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30391284</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(18)30284-8</DOI>
    <KeywordList>
      <Keywords>Canada</Keywords>
      <Keywords>New Zealand</Keywords>
      <Keywords>New drugs</Keywords>
      <Keywords>Regulatory approval</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Nigel S. B. Rawson</Name>
        <Affiliation>Eastlake Research Group, Oakville, Ontario, Canada; Canadian Health Policy Institute, Toronto, Ontario, Canada; Fraser Institute, Vancouver, British Columbia, Canada. Electronic address: EastlakeRG@gmail.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Assessing safety of Lactobacillus plantarum MTCC 5690 and Lactobacillus fermentum MTCC 5689 using in vitro approaches and an in vivo murine model.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30367905</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(18)30276-9</DOI>
    <KeywordList>
      <Keywords>Genotoxicity</Keywords>
      <Keywords>Lactobacilli</Keywords>
      <Keywords>Mice model</Keywords>
      <Keywords>Oral toxicity</Keywords>
      <Keywords>Probiotics</Keywords>
      <Keywords>Safety</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Diwas Pradhan</Name>
        <Affiliation>Molecular Biology Unit, Dairy Microbiology Division, ICAR-National Dairy Research Institute, Karnal, 132001, Haryana, India.</Affiliation>
      </Author>
      <Author>
        <Name>Rajbir Singh</Name>
        <Affiliation>University of Louisville, 505 South Hancock Street # 323, Clinical Translational Research Bldg, Louisville, KY, 40202, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Ashish Tyagi</Name>
        <Affiliation>Molecular Biology Unit, Dairy Microbiology Division, ICAR-National Dairy Research Institute, Karnal, 132001, Haryana, India; University of Louisville, 505 South Hancock Street # 323, Clinical Translational Research Bldg, Louisville, KY, 40202, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Rashmi H M</Name>
        <Affiliation>Molecular Biology Unit, Dairy Microbiology Division, ICAR-National Dairy Research Institute, Karnal, 132001, Haryana, India.</Affiliation>
      </Author>
      <Author>
        <Name>V. K. Batish</Name>
        <Affiliation>Molecular Biology Unit, Dairy Microbiology Division, ICAR-National Dairy Research Institute, Karnal, 132001, Haryana, India.</Affiliation>
      </Author>
      <Author>
        <Name>Sunita Grover</Name>
        <Affiliation>Molecular Biology Unit, Dairy Microbiology Division, ICAR-National Dairy Research Institute, Karnal, 132001, Haryana, India. Electronic address: sungro@gmail.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Estimating the population health impact of introducing a reduced-risk tobacco product into Japan. The effect of differing assumptions, and some comparisons with the U.S.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30367904</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30275-7</DOI>
    <KeywordList>
      <Keywords>Attributable risk</Keywords>
      <Keywords>Harm reduction</Keywords>
      <Keywords>Modelling</Keywords>
      <Keywords>Reduced-risk tobacco product</Keywords>
      <Keywords>Smoking</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Peter N. Lee</Name>
        <Affiliation>P.N. Lee Statistics and Computing Ltd., 17 Cedar Road, Sutton, Surrey, SM2 5DA, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Smilja Djurdjevic</Name>
        <Affiliation>PMI R&amp;D, Philip Morris Products S.A., Quai Jeanrenaud 5, CH-2000, Neuchâtel, Switzerland. Electronic address: Smilja.Djurdjevic@pmi.com.</Affiliation>
      </Author>
      <Author>
        <Name>Rolf Weitkunat</Name>
        <Affiliation>PMI R&amp;D, Philip Morris Products S.A., Quai Jeanrenaud 5, CH-2000, Neuchâtel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Gizelle Baker</Name>
        <Affiliation>PMI R&amp;D, Philip Morris Products S.A., Quai Jeanrenaud 5, CH-2000, Neuchâtel, Switzerland.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Use of the permitted daily exposure (PDE) concept for contaminants of intravitreal (IVT) drugs in multipurpose manufacturing facilities.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30367903</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(18)30272-1</DOI>
    <KeywordList>
      <Keywords>Carry-over</Keywords>
      <Keywords>Cleaning validation</Keywords>
      <Keywords>Cross contamination</Keywords>
      <Keywords>Intravitreal (IVT) drug</Keywords>
      <Keywords>Multipurpose manufacturing facility</Keywords>
      <Keywords>Permitted daily exposure (PDE)</Keywords>
      <Keywords>Risk assessment</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Ester Lovsin Barle</Name>
        <Affiliation>Lonza AG, CH-4002, Basel, Switzerland. Electronic address: ester.lovsinbarle@lonza.com.</Affiliation>
      </Author>
      <Author>
        <Name>Thomas Pfister</Name>
        <Affiliation>Hoffman la Roche GmbH, CH-4002, Basel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Cornelia Fux</Name>
        <Affiliation>Lonza AG, CH-4002, Basel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Dieter Röthlisberger</Name>
        <Affiliation>Lonza AG, CH-4002, Basel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Dhananjay Jere</Name>
        <Affiliation>Lonza AG, CH-4002, Basel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Hanns Christian Mahler</Name>
        <Affiliation>Lonza AG, CH-4002, Basel, Switzerland.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Toxicity testing of poorly soluble particles, lung overload and lung cancer.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30366008</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30271-X</DOI>
    <KeywordList>
      <Keywords>ECETOC</Keywords>
      <Keywords>Inflammation</Keywords>
      <Keywords>Interstitialisation</Keywords>
      <Keywords>Lung overload</Keywords>
      <Keywords>Lung tumours</Keywords>
      <Keywords>Non-neoplastic events</Keywords>
      <Keywords>Poorly soluble particles</Keywords>
      <Keywords>Risk assessment</Keywords>
      <Keywords>Species-differences</Keywords>
      <Keywords>Toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Ruth J. Bevan</Name>
        <Affiliation>IEH Consulting Ltd., West Bridgford, Nottingham, UK. Electronic address: ruth@iehconsulting.co.uk.</Affiliation>
      </Author>
      <Author>
        <Name>Reinhard Kreiling</Name>
        <Affiliation>Clariant Produkte (DE) GmbH, Sulzbach, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Leonard S. Levy</Name>
        <Affiliation>Cranfield University, Cranfield, Bedfordshire, UK.</Affiliation>
      </Author>
      <Author>
        <Name>David B. Warheit</Name>
        <Affiliation>Chemours Company, Wilmington, DE, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Subchronic (90-day) repeated dose oral toxicity study of 2-hydroxybenzylamine acetate in rabbit.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30359704</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30282-4</DOI>
    <KeywordList>
      <Keywords>Preclinical</Keywords>
      <Keywords>Rabbit</Keywords>
      <Keywords>Safety</Keywords>
      <Keywords>Salicylamine</Keywords>
      <Keywords>γ-Ketoaldehydes</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>John C. Fuller</Name>
        <Affiliation>Metabolic Technologies, Inc., Ames, IA, 50010, USA. Electronic address: fuller@mti-hmb.com.</Affiliation>
      </Author>
      <Author>
        <Name>Lisa M. Pitchford</Name>
        <Affiliation>Metabolic Technologies, Inc., Ames, IA, 50010, USA. Electronic address: pitchford@mti-hmb.com.</Affiliation>
      </Author>
      <Author>
        <Name>Naji N. Abumrad</Name>
        <Affiliation>Department of Surgery, Vanderbilt University Medical Center, Nashville, TN, 37232, USA. Electronic address: naji.abumrad@vanderbilt.edu.</Affiliation>
      </Author>
      <Author>
        <Name>John A. Rathmacher</Name>
        <Affiliation>Metabolic Technologies, Inc., Ames, IA, 50010, USA; Department of Animal Science, Iowa State University, Ames, IA, 50010, USA. Electronic address: rathmacher@mti-hmb.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A 13-week subchronic toxicity study of 2-ethylbutanal in F344 rats.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30359703</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30277-0</DOI>
    <KeywordList>
      <Keywords>2-Ethylbutanal</Keywords>
      <Keywords>F344 rats</Keywords>
      <Keywords>Flavoring agent</Keywords>
      <Keywords>Hepatocellular hypertrophy</Keywords>
      <Keywords>Renal tubular necrosis</Keywords>
      <Keywords>Subchronic toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Kohei Matsushita</Name>
        <Affiliation>Division of Pathology, National Institute of Health Sciences, 3-25-26 Tonomachi, Kawasaki, Kanagawa 210-9501, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Takeshi Toyoda</Name>
        <Affiliation>Division of Pathology, National Institute of Health Sciences, 3-25-26 Tonomachi, Kawasaki, Kanagawa 210-9501, Japan. Electronic address: t-toyoda@nihs.go.jp.</Affiliation>
      </Author>
      <Author>
        <Name>Tomomi Morikawa</Name>
        <Affiliation>Division of Pathology, National Institute of Health Sciences, 3-25-26 Tonomachi, Kawasaki, Kanagawa 210-9501, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Miwa Takahashi</Name>
        <Affiliation>Division of Pathology, National Institute of Health Sciences, 3-25-26 Tonomachi, Kawasaki, Kanagawa 210-9501, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Kaoru Inoue</Name>
        <Affiliation>Division of Pathology, National Institute of Health Sciences, 3-25-26 Tonomachi, Kawasaki, Kanagawa 210-9501, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Kumiko Ogawa</Name>
        <Affiliation>Division of Pathology, National Institute of Health Sciences, 3-25-26 Tonomachi, Kawasaki, Kanagawa 210-9501, Japan.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Residues, dissipation kinetics, and dietary intake risk assessment of two fungicides in grape and soil.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30359702</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30280-0</DOI>
    <KeywordList>
      <Keywords>Dietary risk assessment</Keywords>
      <Keywords>Dimethomorph</Keywords>
      <Keywords>Grape</Keywords>
      <Keywords>Pyraclostrobin</Keywords>
      <Keywords>Residue dynamics</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Shouyi Wang</Name>
        <Affiliation>Key Laboratory of Green Pesticide and Agricultural Bioengineering, Ministry of Education, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Qingtao Zhang</Name>
        <Affiliation>Center for Research and Development of Fine Chemicals, Guizhou University, Guiyang, 550025, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Yurong Yu</Name>
        <Affiliation>Center for Research and Development of Fine Chemicals, Guizhou University, Guiyang, 550025, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Ya Chen</Name>
        <Affiliation>Center for Research and Development of Fine Chemicals, Guizhou University, Guiyang, 550025, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Song Zeng</Name>
        <Affiliation>Center for Research and Development of Fine Chemicals, Guizhou University, Guiyang, 550025, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Ping Lu</Name>
        <Affiliation>Key Laboratory of Green Pesticide and Agricultural Bioengineering, Ministry of Education, PR China. Electronic address: plu@gzu.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Deyu Hu</Name>
        <Affiliation>Key Laboratory of Green Pesticide and Agricultural Bioengineering, Ministry of Education, PR China. Electronic address: gzu_dyhu@126.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Initial hazard assessment of benzyl salicylate: In vitro genotoxicity test and combined repeated-dose and reproductive/developmental toxicity screening test in rats.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30359701</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30283-6</DOI>
    <KeywordList>
      <Keywords>CAS No. 118-58-1</Keywords>
      <Keywords>Chemical substances control low</Keywords>
      <Keywords>D-value</Keywords>
      <Keywords>Embryonic resorption</Keywords>
      <Keywords>Existing chemical substance</Keywords>
      <Keywords>Hazard class</Keywords>
      <Keywords>Low body weight</Keywords>
      <Keywords>Neural tube defect</Keywords>
      <Keywords>Salicylic acid</Keywords>
      <Keywords>Teratogenic potential</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Toshime Igarashi</Name>
        <Affiliation>Division of Risk Assessment, Center for Biological Safety and Research, National Institute of Health Sciences, 3-25-26 Tonomachi, Kawasaki-ku, Kawasaki, Kanagawa, 210-9501, Japan. Electronic address: toshime.igarashi@nihs.go.jp.</Affiliation>
      </Author>
      <Author>
        <Name>Hiromasa Takashima</Name>
        <Affiliation>BoZo Research Center Inc., 1284 Kamado, Gotennba, Shizuoka, 412-0039, Japan. Electronic address: takashima-hiromasa@bozo.co.jp.</Affiliation>
      </Author>
      <Author>
        <Name>Michihito Takabe</Name>
        <Affiliation>BoZo Research Center Inc., 1284 Kamado, Gotennba, Shizuoka, 412-0039, Japan. Electronic address: takabe-michihito@bozo.co.jp.</Affiliation>
      </Author>
      <Author>
        <Name>Hiroshi Suzuki</Name>
        <Affiliation>Division of Risk Assessment, Center for Biological Safety and Research, National Institute of Health Sciences, 3-25-26 Tonomachi, Kawasaki-ku, Kawasaki, Kanagawa, 210-9501, Japan. Electronic address: hsuzuki@nihs.go.jp.</Affiliation>
      </Author>
      <Author>
        <Name>Kazuo Ushida</Name>
        <Affiliation>Division of Risk Assessment, Center for Biological Safety and Research, National Institute of Health Sciences, 3-25-26 Tonomachi, Kawasaki-ku, Kawasaki, Kanagawa, 210-9501, Japan. Electronic address: k-ushida@nihs.go.jp.</Affiliation>
      </Author>
      <Author>
        <Name>Tomoko Kawamura</Name>
        <Affiliation>Division of Risk Assessment, Center for Biological Safety and Research, National Institute of Health Sciences, 3-25-26 Tonomachi, Kawasaki-ku, Kawasaki, Kanagawa, 210-9501, Japan. Electronic address: tomoko@nihs.go.jp.</Affiliation>
      </Author>
      <Author>
        <Name>Mariko Matsumoto</Name>
        <Affiliation>Division of Risk Assessment, Center for Biological Safety and Research, National Institute of Health Sciences, 3-25-26 Tonomachi, Kawasaki-ku, Kawasaki, Kanagawa, 210-9501, Japan. Electronic address: mariko@nihs.go.jp.</Affiliation>
      </Author>
      <Author>
        <Name>Takako Iso</Name>
        <Affiliation>Division of Risk Assessment, Center for Biological Safety and Research, National Institute of Health Sciences, 3-25-26 Tonomachi, Kawasaki-ku, Kawasaki, Kanagawa, 210-9501, Japan. Electronic address: takako.iso@nihs.go.jp.</Affiliation>
      </Author>
      <Author>
        <Name>Shihori Tanabe</Name>
        <Affiliation>Division of Risk Assessment, Center for Biological Safety and Research, National Institute of Health Sciences, 3-25-26 Tonomachi, Kawasaki-ku, Kawasaki, Kanagawa, 210-9501, Japan. Electronic address: stanabe@nihs.go.jp.</Affiliation>
      </Author>
      <Author>
        <Name>Kaoru Inoue</Name>
        <Affiliation>Division of Risk Assessment, Center for Biological Safety and Research, National Institute of Health Sciences, 3-25-26 Tonomachi, Kawasaki-ku, Kawasaki, Kanagawa, 210-9501, Japan. Electronic address: k-inoue@nihs.go.jp.</Affiliation>
      </Author>
      <Author>
        <Name>Atsushi Ono</Name>
        <Affiliation>Division of Pharmaceutical, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, 2-5-1 Shikata-cho, Kita-ku, Okayama, 700-8530, Japan. Electronic address: atsushiono3@okayama-u.ac.jp.</Affiliation>
      </Author>
      <Author>
        <Name>Takashi Yamada</Name>
        <Affiliation>Division of Risk Assessment, Center for Biological Safety and Research, National Institute of Health Sciences, 3-25-26 Tonomachi, Kawasaki-ku, Kawasaki, Kanagawa, 210-9501, Japan. Electronic address: t-yamada@nihs.go.jp.</Affiliation>
      </Author>
      <Author>
        <Name>Akihiko Hirose</Name>
        <Affiliation>Division of Risk Assessment, Center for Biological Safety and Research, National Institute of Health Sciences, 3-25-26 Tonomachi, Kawasaki-ku, Kawasaki, Kanagawa, 210-9501, Japan. Electronic address: hirose@nihs.go.jp.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Genotoxicity assessment of calcium β-hydroxy-β-methylbutyrate.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30359700</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30281-2</DOI>
    <KeywordList>
      <Keywords>In vitro</Keywords>
      <Keywords>Mutagenicity</Keywords>
      <Keywords>Rodent</Keywords>
      <Keywords>Safety</Keywords>
      <Keywords>Toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Lisa M. Pitchford</Name>
        <Affiliation>Metabolic Technologies, Inc., Ames, IA, 50010, USA. Electronic address: pitchford@mti-hmb.com.</Affiliation>
      </Author>
      <Author>
        <Name>John C. Fuller</Name>
        <Affiliation>Metabolic Technologies, Inc., Ames, IA, 50010, USA. Electronic address: fuller@mti-hmb.com.</Affiliation>
      </Author>
      <Author>
        <Name>John A. Rathmacher</Name>
        <Affiliation>Metabolic Technologies, Inc., Ames, IA, 50010, USA; Department of Animal Science, Iowa State University, Ames, IA, 50010, USA. Electronic address: rathmacher@mti-hmb.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Toxicity effects of a novel potent triple reuptake inhibitor, LPM570065, on the fertility and early embryonic development in Sprague-Dawley rats.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30359699</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30273-3</DOI>
    <KeywordList>
      <Keywords>Early development</Keywords>
      <Keywords>Estrus cycle</Keywords>
      <Keywords>Fertility</Keywords>
      <Keywords>LPM570065</Keywords>
      <Keywords>Triple reuptake inhibitor (TRI)</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Wei Guo</Name>
        <Affiliation>School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation, Yantai University, Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University, Yantai, 264005, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Yonglin Gao</Name>
        <Affiliation>School of Life Sciences, Yantai University, Yantai, 264005, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Wanglin Jiang</Name>
        <Affiliation>School of Pharmacy, Binzhou Medical University, Yantai, 264003, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Chunmei Li</Name>
        <Affiliation>School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation, Yantai University, Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University, Yantai, 264005, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Fei Lin</Name>
        <Affiliation>State Key Laboratory of Long-acting Targeting Drug Delivery Technologies, Luye Pharma Group Ltd., Yantai, 264003, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Haibo Zhu</Name>
        <Affiliation>School of Public Health and Management, Binzhou Medical University, Yantai, 264003, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Hongbo Wang</Name>
        <Affiliation>School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation, Yantai University, Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University, Yantai, 264005, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Liang Ye</Name>
        <Affiliation>School of Public Health and Management, Binzhou Medical University, Yantai, 264003, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Jia Grace Qi</Name>
        <Affiliation>School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation, Yantai University, Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University, Yantai, 264005, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaobo Cen</Name>
        <Affiliation>National Chengdu Center for Safety Evaluation of Drugs, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Collaborative Innovation Center for Biotherapy, Chengdu, 610041, PR China. Electronic address: xbcen@scu.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Jingwei Tian</Name>
        <Affiliation>School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation, Yantai University, Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University, Yantai, 264005, PR China. Electronic address: tianjingwei@luye.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Integrating data gap filling techniques: A case study predicting TEFs for neurotoxicity TEQs to facilitate the hazard assessment of polychlorinated biphenyls.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30359698</pubmedLink>
    <GrantList>
      <Grant>EPA999999</Grant>
    </GrantList>
    <Year>2019</Year>
    <DOI>S0273-2300(18)30278-2</DOI>
    <KeywordList>
      <Keywords>Neurotoxic equivalent factor (NEF)</Keywords>
      <Keywords>Neurotoxicity</Keywords>
      <Keywords>PCB congeners</Keywords>
      <Keywords>QSAR</Keywords>
      <Keywords>Toxic equivalency factors (TEFs)</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Prachi Pradeep</Name>
        <Affiliation>Oak Ridge Institute for Science and Education, Oak Ridge, TN, USA; National Center for Computational Toxicology, Office of Research and Development, U.S. Environmental Protection Agency, Research Triangle Park, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Laura M. Carlson</Name>
        <Affiliation>National Center for Environmental Assessment, Office of Research and Development, U.S. Environmental Protection Agency, Research Triangle Park, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Richard Judson</Name>
        <Affiliation>National Center for Computational Toxicology, Office of Research and Development, U.S. Environmental Protection Agency, Research Triangle Park, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Geniece M. Lehmann</Name>
        <Affiliation>National Center for Environmental Assessment, Office of Research and Development, U.S. Environmental Protection Agency, Research Triangle Park, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Grace Patlewicz</Name>
        <Affiliation>National Center for Computational Toxicology, Office of Research and Development, U.S. Environmental Protection Agency, Research Triangle Park, NC, USA. Electronic address: patlewicz.grace@epa.gov.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Intravenous toxicity and toxicokinetics of an HDL mimetic, Fx-5A peptide complex, in cynomolgus monkeys.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30359697</pubmedLink>
    <GrantList>
      <Grant>HHSN261200800001C</Grant>
      <Grant>HHSN261200800001E</Grant>
    </GrantList>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30274-5</DOI>
    <KeywordList>
      <Keywords>Atherosclerosis</Keywords>
      <Keywords>Cynomolgus monkeys</Keywords>
      <Keywords>Fx-5A peptide complex</Keywords>
      <Keywords>HDL mimetic</Keywords>
      <Keywords>Safety</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Mohammed Bourdi</Name>
        <Affiliation>National Center for Advancing Translational Sciences, NIH, Rockville, MD, 20850, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Marcelo Amar</Name>
        <Affiliation>National Heart, Lung, and Blood Institute, NIH, Bethesda, MD, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Alan T. Remaley</Name>
        <Affiliation>National Heart, Lung, and Blood Institute, NIH, Bethesda, MD, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Pramod S. Terse</Name>
        <Affiliation>National Center for Advancing Translational Sciences, NIH, Rockville, MD, 20850, USA. Electronic address: tersep@mail.nih.gov.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Toxicological evaluation of Microbacterium foliorum SYG27B-MF.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30308225</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30244-7</DOI>
    <KeywordList>
      <Keywords>Acute toxicity</Keywords>
      <Keywords>Clastogenicity</Keywords>
      <Keywords>M. foliorum SYG27B-MF</Keywords>
      <Keywords>Mutagenicity</Keywords>
      <Keywords>Safety</Keywords>
      <Keywords>Subchronic toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Hye Jung Kim</Name>
        <Affiliation>Samyang Corp, Sungnam-si, Kyunggi-do, Republic of Korea. Electronic address: hyejung.kim@samyang.com.</Affiliation>
      </Author>
      <Author>
        <Name>Albert W. Lee</Name>
        <Affiliation>NutraSource, Clarksville, MD, 21029, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Chongjin Park</Name>
        <Affiliation>Samyang Corp, Sungnam-si, Kyunggi-do, Republic of Korea.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Use and handling safety of Mini-Spike 2</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30296468</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30253-8</DOI>
    <KeywordList>
      <Keywords>Chemotherapy</Keywords>
      <Keywords>Compounding</Keywords>
      <Keywords>Drug transfer device</Keywords>
      <Keywords>Occupational health</Keywords>
      <Keywords>Pharmacy</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Silvia Valero García</Name>
        <Affiliation>Instituto de Investigación Sanitaria La Fe, Avenida Fernando Abril Martorell, 106 Torre A 7(a) planta, 46026, Valencia, Spain. Electronic address: valero_sil@gva.es.</Affiliation>
      </Author>
      <Author>
        <Name>Nieves Vila Clérigues</Name>
        <Affiliation>Pharmacy Department, Hospital Universitario y Politécnico La Fe, Valencia, Spain.</Affiliation>
      </Author>
      <Author>
        <Name>Victoria Fornés Ferrer</Name>
        <Affiliation>Data Science, Biostatistics and Bioinformatics Platform, Instituto de Investicación Sanitaria La Fe, Valencia, Spain.</Affiliation>
      </Author>
      <Author>
        <Name>Eduardo López Briz</Name>
        <Affiliation>Pharmacy Department, Hospital Universitario y Politécnico La Fe, Valencia, Spain.</Affiliation>
      </Author>
      <Author>
        <Name>Jose Luis Poveda Andrés</Name>
        <Affiliation>Pharmacy Department, Hospital Universitario y Politécnico La Fe, Valencia, Spain.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The regulatory challenge of chemicals in the environment: Toxicity testing, risk assessment, and decision-making models.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30291878</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30252-6</DOI>
    <KeywordList>
      <Keywords>Complexity</Keywords>
      <Keywords>Decision-making</Keywords>
      <Keywords>Environmental risk assessment</Keywords>
      <Keywords>Models</Keywords>
      <Keywords>Regulations</Keywords>
      <Keywords>Toxicity</Keywords>
      <Keywords>Validation</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>L. S. McCarty</Name>
        <Affiliation>Scientific Research &amp; Consulting, Newmarket, ON, L3X 3E2, Canada. Electronic address: lsmccarty@rogers.com.</Affiliation>
      </Author>
      <Author>
        <Name>C. J. Borgert</Name>
        <Affiliation>Applied Pharmacology and Toxicology, Inc., Gainesville, FL, 32605, USA. Electronic address: cjborgert@apt-pharmatox.com.</Affiliation>
      </Author>
      <Author>
        <Name>L. Posthuma</Name>
        <Affiliation>National Institute of Public Health and the Environment (RIVM), NL-3720, BA, Bilthoven, the Netherlands; Radboud University Nijmegen, Department of Environmental Science, Nijmegen, the Netherlands. Electronic address: leo.posthuma@rivm.nl.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Bioavailability of protein therapeutics in rats following inhalation exposure: Relevance to occupational exposure limit calculations.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30291877</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30254-X</DOI>
    <KeywordList>
      <Keywords>Antibody</Keywords>
      <Keywords>Bioavailability</Keywords>
      <Keywords>Inhalation</Keywords>
      <Keywords>Occupational exposure limit</Keywords>
      <Keywords>Pharmacokinetics</Keywords>
      <Keywords>Protein therapeutic</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Janet C. Gould</Name>
        <Affiliation>SafeBridge Consultants, Inc, 330 Seventh Avenue - Suite 1101, New York, NY, 10001, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Irvith Carvajal</Name>
        <Affiliation>Bristol-Myers Squibb, 1 Squibb Drive, New Brunswick, NJ, 08903, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Todd Davidson</Name>
        <Affiliation>Bristol-Myers Squibb, 1 Squibb Drive, New Brunswick, NJ, 08903, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jessica Graham</Name>
        <Affiliation>Bristol-Myers Squibb, 1 Squibb Drive, New Brunswick, NJ, 08903, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jedd Hillegass</Name>
        <Affiliation>Bristol-Myers Squibb, 1 Squibb Drive, New Brunswick, NJ, 08903, USA. Electronic address: jedd.hillegass@bms.com.</Affiliation>
      </Author>
      <Author>
        <Name>Susan Julien</Name>
        <Affiliation>Bristol-Myers Squibb, 1 Squibb Drive, New Brunswick, NJ, 08903, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Alex Kozhich</Name>
        <Affiliation>Bristol-Myers Squibb, 1 Squibb Drive, New Brunswick, NJ, 08903, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Bonnie Wang</Name>
        <Affiliation>Bristol-Myers Squibb, 1 Squibb Drive, New Brunswick, NJ, 08903, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Hui Wei</Name>
        <Affiliation>Bristol-Myers Squibb, 1 Squibb Drive, New Brunswick, NJ, 08903, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Aaron P. Yamniuk</Name>
        <Affiliation>Bristol-Myers Squibb, 1 Squibb Drive, New Brunswick, NJ, 08903, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Neil Mathias</Name>
        <Affiliation>Bristol-Myers Squibb, 1 Squibb Drive, New Brunswick, NJ, 08903, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Helen G. Haggerty</Name>
        <Affiliation>Bristol-Myers Squibb, 1 Squibb Drive, New Brunswick, NJ, 08903, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Michael Graziano</Name>
        <Affiliation>Bristol-Myers Squibb, 1 Squibb Drive, New Brunswick, NJ, 08903, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Construction and application of (Q)SAR models to predict chemical-induced in vitro chromosome aberrations.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30278198</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30248-4</DOI>
    <KeywordList>
      <Keywords>(Q)SAR</Keywords>
      <Keywords>Chromosome aberration</Keywords>
      <Keywords>Computational toxicology</Keywords>
      <Keywords>Drug</Keywords>
      <Keywords>Genetic toxicity</Keywords>
      <Keywords>Genotoxicity</Keywords>
      <Keywords>In vitro</Keywords>
      <Keywords>QSAR</Keywords>
      <Keywords>Regulatory review</Keywords>
      <Keywords>Structure-activity relationship</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Chia Wen Hsu</Name>
        <Affiliation>US Food and Drug Administration, Center for Drug Evaluation and Research, Silver Spring, MD, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Kurt P. Hewes</Name>
        <Affiliation>US Food and Drug Administration, Center for Drug Evaluation and Research, Silver Spring, MD, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Lidiya Stavitskaya</Name>
        <Affiliation>US Food and Drug Administration, Center for Drug Evaluation and Research, Silver Spring, MD, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Naomi L. Kruhlak</Name>
        <Affiliation>US Food and Drug Administration, Center for Drug Evaluation and Research, Silver Spring, MD, USA. Electronic address: Naomi.Kruhlak@fda.hhs.gov.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Hypothesis-driven weight-of-evidence analysis for the endocrine disruption potential of benzene.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30273620</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30249-6</DOI>
    <KeywordList>
      <Keywords>Androgen</Keywords>
      <Keywords>Benzene</Keywords>
      <Keywords>Data quality</Keywords>
      <Keywords>Endocrine disruptor screening program</Keywords>
      <Keywords>Endocrine screening</Keywords>
      <Keywords>Estrogen</Keywords>
      <Keywords>Regulatory toxicology</Keywords>
      <Keywords>Steroidogenesis</Keywords>
      <Keywords>Thyroid</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Ellen M. Mihaich</Name>
        <Affiliation>Environmental and Regulatory Resources, LLC, Durham, NC, USA. Electronic address: emihaich@nc.rr.com.</Affiliation>
      </Author>
      <Author>
        <Name>Christopher J. Borgert</Name>
        <Affiliation>Applied Pharmacology and Toxicology, Inc., 2250 NW 24th, Avenue, Gainesville, FL, 32605, USA. Electronic address: cjborgert@apt-pharmatox.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Are skin sensitisation test methods relevant for proteins?</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30268830</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30250-2</DOI>
    <KeywordList>
      <Keywords>Enzymes</Keywords>
      <Keywords>Hazard identification</Keywords>
      <Keywords>Proteins</Keywords>
      <Keywords>Skin sensitisation</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>David A. Basketter</Name>
        <Affiliation>DABMEB Consultancy Ltd, Sharnbrook, MK44 1PR, UK. Electronic address: dabmebconsultancyltd@me.com.</Affiliation>
      </Author>
      <Author>
        <Name>Ian Kimber</Name>
        <Affiliation>Faculty of Biology, Medicine and Health, University of Manchester, Manchester, M13 9PT, UK.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>In vitro and in vivo evaluation of the genotoxicity of Eriobotrya japonica leaf extract.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30268829</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30251-4</DOI>
    <KeywordList>
      <Keywords>Bacterial reverse mutation test</Keywords>
      <Keywords>Chromosome aberration test</Keywords>
      <Keywords>Eriobotrya japonica leaf extract</Keywords>
      <Keywords>Genotoxicity</Keywords>
      <Keywords>Micronucleus test</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Myung Hwan Jeong</Name>
        <Affiliation>Health Care Institute, Korea Testing and Research Institute, Hwasun, Jeonnam, 58141, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Nak Won Seong</Name>
        <Affiliation>Health Care Institute, Korea Testing and Research Institute, Hwasun, Jeonnam, 58141, Republic of Korea; College of Veterinary Medicine BK21 Plus Project Team, Chonnam National University, Gwangju, 61186, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Jong Yun Lee</Name>
        <Affiliation>Health Care Institute, Korea Testing and Research Institute, Hwasun, Jeonnam, 58141, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Yong Jae Kim</Name>
        <Affiliation>Korea INS Pharm Research Institute, Hwasun, Jeonnam, 58143, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Na Rae Shin</Name>
        <Affiliation>College of Veterinary Medicine BK21 Plus Project Team, Chonnam National University, Gwangju, 61186, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Jong Choon Kim</Name>
        <Affiliation>College of Veterinary Medicine BK21 Plus Project Team, Chonnam National University, Gwangju, 61186, Republic of Korea. Electronic address: toxkim@jnu.ac.kr.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Opinion of the Scientific Committee on Consumer safety (SCCS) - Final opinion on water-soluble zinc salts used in oral hygiene products.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30267827</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30228-9</DOI>
    <KeywordList>
      <Keywords>Oral hygiene products</Keywords>
      <Keywords>Regulation 1223/2009</Keywords>
      <Keywords>SCCS</Keywords>
      <Keywords>SCCS/1586/17</Keywords>
      <Keywords>Scientific opinion</Keywords>
      <Keywords>Water-soluble zinc salts</Keywords>
      <Keywords>Zinc acetate CAS: 557-34-6 EC: 209-170-2</Keywords>
      <Keywords>Zinc chloride CAS: 7646-85-7 EC: 231-592-0</Keywords>
      <Keywords>Zinc citrate CAS: 546-46-3 EC:/</Keywords>
      <Keywords>Zinc gluconate CAS: 4468-02-4 EC:/</Keywords>
      <Keywords>Zinc sulphate/zinc sulphate monohydrate/zinc sulphate heptahydrate CAS: 7733-02-0/7446-19-7/7446-20-0 EC:/</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name> </Name>
        <Affiliation>SCCS Secretariat at the European Commission, Directorate General for Health and Food Safety, 11, rue E. Ruppert, L-2920, Luxembourg, Luxembourg.</Affiliation>
      </Author>
      <Author>
        <Name>Berit Granum</Name>
        <Affiliation>Norwegian Institute of Public Health, Oslo, Norway.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A novel glucuronoxylan hydrolase produced by fermentation is safe as feed additive: toxicology and tolerance in broiler chickens.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30266242</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30246-0</DOI>
    <KeywordList>
      <Keywords>Bacillus licheniformis</Keywords>
      <Keywords>Broilers</Keywords>
      <Keywords>Feed additive</Keywords>
      <Keywords>Glucuronoxylan hydrolase</Keywords>
      <Keywords>Safety</Keywords>
      <Keywords>Toxicology</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Raffaella Aureli</Name>
        <Affiliation>Research Center for Animal Nutrition and Health, DSM Nutritional Products, F-68128, Village-Neuf, France.</Affiliation>
      </Author>
      <Author>
        <Name>James La-Marta</Name>
        <Affiliation>Research Center for Animal Nutrition and Health, DSM Nutritional Products, F-68128, Village-Neuf, France.</Affiliation>
      </Author>
      <Author>
        <Name>Alberto Blak Grossi</Name>
        <Affiliation>Novozymes A/S, Krogshoejvej 36, DK-2880, Bagsvaerd, Denmark.</Affiliation>
      </Author>
      <Author>
        <Name>Eduardo Antonio Della Pia</Name>
        <Affiliation>Novozymes A/S, Krogshoejvej 36, DK-2880, Bagsvaerd, Denmark.</Affiliation>
      </Author>
      <Author>
        <Name>Enric Esteve-Garcia</Name>
        <Affiliation>Institute of Agriculture and Food Research and Technology, Animal Nutrition, Mas de Bover, E-43120, Constantí, Tarragona, Spain.</Affiliation>
      </Author>
      <Author>
        <Name>Linda Wulf-Andersen</Name>
        <Affiliation>Novozymes A/S, Krogshoejvej 36, DK-2880, Bagsvaerd, Denmark.</Affiliation>
      </Author>
      <Author>
        <Name>Michael Thorsen</Name>
        <Affiliation>Novozymes A/S, Krogshoejvej 36, DK-2880, Bagsvaerd, Denmark. Electronic address: mith@novozymes.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Efficacy of metformin in mediating cellular uptake and inducing apoptosis activity of doxorubicin.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30266241</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30245-9</DOI>
    <KeywordList>
      <Keywords>Apoptosis</Keywords>
      <Keywords>Caspase-3</Keywords>
      <Keywords>Cell cycle arrest</Keywords>
      <Keywords>Doxorubicin</Keywords>
      <Keywords>Metformin</Keywords>
      <Keywords>p21 expression</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Maryam Hoseini Shafa</Name>
        <Affiliation>Department of Chemistry, Faculty of Science, Ferdowsi University of Mashhad, Mashhad, Iran.</Affiliation>
      </Author>
      <Author>
        <Name>Razieh Jalal</Name>
        <Affiliation>Department of Chemistry, Faculty of Science, Ferdowsi University of Mashhad, Mashhad, Iran; Cell and Molecular Biotechnology Research Group, Institute of Biotechnology, Ferdowsi University of Mashhad, Mashhad, Iran. Electronic address: razieh@um.ac.ir.</Affiliation>
      </Author>
      <Author>
        <Name>Negin Kosari</Name>
        <Affiliation>Department of Chemistry, Faculty of Science, Ferdowsi University of Mashhad, Mashhad, Iran.</Affiliation>
      </Author>
      <Author>
        <Name>Farzad Rahmani</Name>
        <Affiliation>Department of Medical Biochemistry, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Q-X1-P-X2 motif search for potential celiac disease risk has poor selectivity.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30266240</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30243-5</DOI>
    <KeywordList>
      <Keywords>Bioinformatics</Keywords>
      <Keywords>Celiac disease</Keywords>
      <Keywords>GM crops</Keywords>
      <Keywords>Motif</Keywords>
      <Keywords>Selectivity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Ping Song</Name>
        <Affiliation>Corteva Agriscience™, Agriculture Division of DowDuPont™, Indianapolis, IN, USA. Electronic address: psong@dow.com.</Affiliation>
      </Author>
      <Author>
        <Name>Nancy Podevin</Name>
        <Affiliation>Corteva Agriscience™, Agriculture Division of DowDuPont™, Johnston, IA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Henry Mirsky</Name>
        <Affiliation>Corteva Agriscience™, Agriculture Division of DowDuPont™, Johnston, IA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jennifer Anderson</Name>
        <Affiliation>Corteva Agriscience™, Agriculture Division of DowDuPont™, Johnston, IA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Bryan Delaney</Name>
        <Affiliation>Corteva Agriscience™, Agriculture Division of DowDuPont™, Johnston, IA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Carey Mathesius</Name>
        <Affiliation>Corteva Agriscience™, Agriculture Division of DowDuPont™, Johnston, IA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Laura Rowe</Name>
        <Affiliation>Corteva Agriscience™, Agriculture Division of DowDuPont™, Johnston, IA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Rod A. Herman</Name>
        <Affiliation>Corteva Agriscience™, Agriculture Division of DowDuPont™, Indianapolis, IN, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Subchronic (90-day) repeated dose toxicity study of 2-hydroxybenzylamine acetate in rats.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30266239</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30247-2</DOI>
    <KeywordList>
      <Keywords>Preclinical</Keywords>
      <Keywords>Rodent</Keywords>
      <Keywords>Safety</Keywords>
      <Keywords>Salicylamine</Keywords>
      <Keywords>γ-Ketoaldehydes</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>John C. Fuller</Name>
        <Affiliation>Metabolic Technologies, Inc, Ames, IA 50010, USA. Electronic address: fuller@mti-hmb.com.</Affiliation>
      </Author>
      <Author>
        <Name>Lisa M. Pitchford</Name>
        <Affiliation>Metabolic Technologies, Inc, Ames, IA 50010, USA. Electronic address: pitchford@mti-hmb.com.</Affiliation>
      </Author>
      <Author>
        <Name>Naji N. Abumrad</Name>
        <Affiliation>Department of Surgery, Vanderbilt University Medical Center, Nashville, TN, 37232, USA. Electronic address: naji.abumrad@vanderbilt.edu.</Affiliation>
      </Author>
      <Author>
        <Name>John A. Rathmacher</Name>
        <Affiliation>Metabolic Technologies, Inc, Ames, IA 50010, USA; Department of Animal Science, Iowa State University, Ames, IA, 50010, USA. Electronic address: rathmacher@mti-hmb.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Tree nut allergy and anxiety related factors modulate food consumption behaviour in peanut-allergic patients: Results of the MIRABEL survey.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30253193</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30242-3</DOI>
    <KeywordList>
      <Keywords>Allergy</Keywords>
      <Keywords>Food behaviour</Keywords>
      <Keywords>Food factors</Keywords>
      <Keywords>Peanut</Keywords>
      <Keywords>Precautionary allergen labelling</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Alexandra Papadopoulos</Name>
        <Affiliation>Risk Assessment Department (DER), French Agency for Food, Environmental and Occupational Health &amp; Safety (ANSES), 94701, Maisons-Alfort, France. Electronic address: alexandra.papadopoulos@anses.fr.</Affiliation>
      </Author>
      <Author>
        <Name>Chabi Fabrice Elegbede</Name>
        <Affiliation>Risk Assessment Department (DER), French Agency for Food, Environmental and Occupational Health &amp; Safety (ANSES), 94701, Maisons-Alfort, France.</Affiliation>
      </Author>
      <Author>
        <Name>Sarra Ait-Dahmane</Name>
        <Affiliation>Risk Assessment Department (DER), French Agency for Food, Environmental and Occupational Health &amp; Safety (ANSES), 94701, Maisons-Alfort, France.</Affiliation>
      </Author>
      <Author>
        <Name>Carine Dubuisson</Name>
        <Affiliation>Risk Assessment Department (DER), French Agency for Food, Environmental and Occupational Health &amp; Safety (ANSES), 94701, Maisons-Alfort, France.</Affiliation>
      </Author>
      <Author>
        <Name>Antoine Deschildre</Name>
        <Affiliation>CHU Lille, Pediatric Pulmonology and Allergy Department, Jeanne de Flandre Hospital, 59000, Lille, France; Allergy Vigilance Network, 15, rue du bois de la Champelle, 54500, Vandoeuvre les Nancy, France.</Affiliation>
      </Author>
      <Author>
        <Name>Amélie Crépet</Name>
        <Affiliation>Risk Assessment Department (DER), French Agency for Food, Environmental and Occupational Health &amp; Safety (ANSES), 94701, Maisons-Alfort, France.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Dose related effects of buspirone on pain, learning / memory and food intake.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30244043</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30239-3</DOI>
    <KeywordList>
      <Keywords>Analgesia</Keywords>
      <Keywords>Buspirone</Keywords>
      <Keywords>Hyperphagia</Keywords>
      <Keywords>Learning and memory</Keywords>
      <Keywords>Serotonin 1A receptors</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Darakhshan Jabeen Haleem</Name>
        <Affiliation>Neuroscience Research Laboratory, Dr Panjwani Center for Molecular Medicine &amp; Drug Research (PCMD), International Center for Chemical and Biological Science (ICCBS), University of Karachi, Karachi, 75270, Pakistan. Electronic address: darakhshan_haleem@yahoo.com.</Affiliation>
      </Author>
      <Author>
        <Name>Shazia Nawaz</Name>
        <Affiliation>Neuroscience Research Laboratory, Dr Panjwani Center for Molecular Medicine &amp; Drug Research (PCMD), International Center for Chemical and Biological Science (ICCBS), University of Karachi, Karachi, 75270, Pakistan.</Affiliation>
      </Author>
      <Author>
        <Name>Tabinda Salman</Name>
        <Affiliation>Neuroscience Research Laboratory, Dr Panjwani Center for Molecular Medicine &amp; Drug Research (PCMD), International Center for Chemical and Biological Science (ICCBS), University of Karachi, Karachi, 75270, Pakistan.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Preclinical safety evaluation of the human-identical milk oligosaccharide lacto-N-tetraose.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30244042</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30240-X</DOI>
    <KeywordList>
      <Keywords>Genotoxicity</Keywords>
      <Keywords>Human-identical milk oligosaccharide</Keywords>
      <Keywords>Infant formula</Keywords>
      <Keywords>LNT</Keywords>
      <Keywords>Lacto-N-tetraose</Keywords>
      <Keywords>Safety’</Keywords>
      <Keywords>Subchronic toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Kirt R. Phipps</Name>
        <Affiliation>Intertek Scientific &amp; Regulatory Consultancy, Room 1036, Building A8, Cody Technology Park, Ively Road, Farnborough, Hampshire, GU14 0LX, UK. Electronic address: kirt.phipps@intertek.com.</Affiliation>
      </Author>
      <Author>
        <Name>Nigel Baldwin</Name>
        <Affiliation>Intertek Scientific &amp; Regulatory Consultancy, Room 1036, Building A8, Cody Technology Park, Ively Road, Farnborough, Hampshire, GU14 0LX, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Barry Lynch</Name>
        <Affiliation>Intertek Scientific &amp; Regulatory Consultancy, 2233 Argentia Road, Suite 201, Mississauga, Ontario, L5N 2X7, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Diane R. Stannard</Name>
        <Affiliation>Envigo CRS Limited, Eye, Suffolk, IP23 7PX, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Alica Šoltesová</Name>
        <Affiliation>Envigo CRS Limited, Woolley Road, Alconbury, Huntingdon, Cambridgeshire, PE28 4HS, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Ben Gilby</Name>
        <Affiliation>Envigo CRS Limited, Woolley Road, Alconbury, Huntingdon, Cambridgeshire, PE28 4HS, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Marta H. Mikš</Name>
        <Affiliation>Glycom A/S, Kogle Allé 4, Hørsholm, DK-2970, Denmark; University of Warmia and Mazury in Olsztyn, Faculty of Food Science, Plac Cieszynski 1, 10-726, Olsztyn, Poland.</Affiliation>
      </Author>
      <Author>
        <Name>Christoph H. Röhrig</Name>
        <Affiliation>Glycom A/S, Kogle Allé 4, Hørsholm, DK-2970, Denmark.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Accurate measurement of main aerosol constituents from heated tobacco products (HTPs): Implications for a fundamentally different aerosol.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30244041</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30238-1</DOI>
    <KeywordList>
      <Keywords>Aerosol</Keywords>
      <Keywords>Collection</Keywords>
      <Keywords>Formation</Keywords>
      <Keywords>Heated tobacco product</Keywords>
      <Keywords>ISO 4387</Keywords>
      <Keywords>Nicotine free dry particulate matter</Keywords>
      <Keywords>Total particulate matter</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>H. Gasparyan</Name>
        <Affiliation>R&amp;D Centre, British American Tobacco Investments Ltd., Regents Park Road, Southampton, SO15 8TL, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Derek Mariner</Name>
        <Affiliation>R&amp;D Centre, British American Tobacco Investments Ltd., Regents Park Road, Southampton, SO15 8TL, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Christopher Wright</Name>
        <Affiliation>R&amp;D Centre, British American Tobacco Investments Ltd., Regents Park Road, Southampton, SO15 8TL, UK.</Affiliation>
      </Author>
      <Author>
        <Name>James Nicol</Name>
        <Affiliation>JTN Consulting Limited, 272 Bath Street, Glasgow, Scotland, G2 4JR, UK.</Affiliation>
      </Author>
      <Author>
        <Name>James Murphy</Name>
        <Affiliation>R&amp;D Centre, British American Tobacco Investments Ltd., Regents Park Road, Southampton, SO15 8TL, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Chuan Liu</Name>
        <Affiliation>R&amp;D Centre, British American Tobacco Investments Ltd., Regents Park Road, Southampton, SO15 8TL, UK. Electronic address: chuan_liu@bat.com.</Affiliation>
      </Author>
      <Author>
        <Name>Christopher Proctor</Name>
        <Affiliation>R&amp;D Centre, British American Tobacco Investments Ltd., Regents Park Road, Southampton, SO15 8TL, UK.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Allergic contact dermatitis: Adequacy of the default 10X assessment factor for human variability to protect infants and children.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30240832</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30233-2</DOI>
    <KeywordList>
      <Keywords>Allergic contact dermatitis</Keywords>
      <Keywords>Children</Keywords>
      <Keywords>Early life susceptibility</Keywords>
      <Keywords>Human heterogeneity</Keywords>
      <Keywords>Infants</Keywords>
      <Keywords>Sensitization assessment factor</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Susan Felter</Name>
        <Affiliation>Procter and Gamble, Central Product Safety, Mason, OH, USA. Electronic address: Felter.sp@pg.com.</Affiliation>
      </Author>
      <Author>
        <Name>Petra Kern</Name>
        <Affiliation>Procter and Gamble, Central Product Safety, Brussels, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Cindy Ryan</Name>
        <Affiliation>Procter and Gamble, Central Product Safety, Brussels, Belgium.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Toxicological safety evaluation of 3,3'-diselenodipropionic acid (DSePA), a pharmacologically important derivative of selenocystine.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30240831</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30241-1</DOI>
    <KeywordList>
      <Keywords>Acute toxicity</Keywords>
      <Keywords>Ames test</Keywords>
      <Keywords>Cytotoxicity</Keywords>
      <Keywords>Metabolic stability</Keywords>
      <Keywords>Mutagenicity</Keywords>
      <Keywords>S9 liver fraction</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Amit Kunwar</Name>
        <Affiliation>Radiation and Photochemistry Division, Bhabha Atomic Research Centre, Mumbai, 400085, India; Homi Bhabha National Institute, Anushaktinagar, Mumbai, 400 094, India. Electronic address: kamit@barc.gov.in.</Affiliation>
      </Author>
      <Author>
        <Name>Anand Patil</Name>
        <Affiliation>Department of Clinical Pharmacology, Advanced Centre for Treatment, Research and Education in Cancer (ACTREC), Tata Memorial Centre, Navi Mumbai, India.</Affiliation>
      </Author>
      <Author>
        <Name>Sanjeev Kumar</Name>
        <Affiliation>Food Technology Division, Bhabha Atomic Research Centre, Mumbai 400085, India.</Affiliation>
      </Author>
      <Author>
        <Name>Raviraj Deshpande</Name>
        <Affiliation>Department of Clinical Pharmacology, Advanced Centre for Treatment, Research and Education in Cancer (ACTREC), Tata Memorial Centre, Navi Mumbai, India.</Affiliation>
      </Author>
      <Author>
        <Name>V. Gota</Name>
        <Affiliation>Department of Clinical Pharmacology, Advanced Centre for Treatment, Research and Education in Cancer (ACTREC), Tata Memorial Centre, Navi Mumbai, India.</Affiliation>
      </Author>
      <Author>
        <Name>Jayant S. Goda</Name>
        <Affiliation>Department of Radiation Oncology, Advanced Centre for Treatment, Research and Education in Cancer (ACTREC), Tata Memorial Centre, Navi Mumbai, India.</Affiliation>
      </Author>
      <Author>
        <Name>V. K. Jain</Name>
        <Affiliation>UM-DAE Centre for Excellence in Basic Sciences, Health Centre Building, University of Mumbai, Kalina Campus, Santacruz (E), Mumbai, 400098, India.</Affiliation>
      </Author>
      <Author>
        <Name>K. Indira Priyadarsini</Name>
        <Affiliation>Chemistry Division, Bhabha Atomic Research Centre, Mumbai, 400085, India; Homi Bhabha National Institute, Anushaktinagar, Mumbai, 400 094, India.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A hypothesis-driven weight-of-evidence analysis to evaluate potential endocrine activity of perfluorohexanoic acid.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30240830</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30223-X</DOI>
    <KeywordList>
      <Keywords>Androgen</Keywords>
      <Keywords>Endocrine</Keywords>
      <Keywords>Estrogen</Keywords>
      <Keywords>PFHxA</Keywords>
      <Keywords>Steroidogenesis</Keywords>
      <Keywords>Thyroid</Keywords>
      <Keywords>Weight-of-evidence</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>S. J. Borghoff</Name>
        <Affiliation>ToxStrategies, Cary, NC, USA. Electronic address: sborghoff@toxstrategies.com.</Affiliation>
      </Author>
      <Author>
        <Name>S. Fitch</Name>
        <Affiliation>ToxStrategies, Katy, TX, USA.</Affiliation>
      </Author>
      <Author>
        <Name>J. E. Rager</Name>
        <Affiliation>ToxStrategies, Austin, TX, USA.</Affiliation>
      </Author>
      <Author>
        <Name>D. Huggett</Name>
        <Affiliation>EAG Laboratories, Easton, MD, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Opinion of the scientific committee on consumer safety (SCCS) - Opinion on the safety of cosmetic ingredient phenylene bis-diphenyltriazine (CAS No 55514-22-2) - S86.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30237057</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30229-0</DOI>
    <KeywordList>
      <Keywords>CAS 55514-22-2</Keywords>
      <Keywords>Cosmetic ingredient phenylene bis-diphenyltriazine (CAS No 55514-22-2)</Keywords>
      <Keywords>EC 700-823-1</Keywords>
      <Keywords>Regulation 1223/2009</Keywords>
      <Keywords>S86</Keywords>
      <Keywords>SCCS</Keywords>
      <Keywords>Scientific opinion</Keywords>
      <Keywords>Submission II</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name> </Name>
        <Affiliation>French Agency for Food, Environmental and Occupational Health &amp; Safety (ANSES), Maisons-Alfort, France.</Affiliation>
      </Author>
      <Author>
        <Name> </Name>
        <Affiliation>French Agency for Food, Environmental and Occupational Health &amp; Safety (ANSES), Maisons-Alfort, France.</Affiliation>
      </Author>
      <Author>
        <Name>Christophe Rousselle</Name>
        <Affiliation>French Agency for Food, Environmental and Occupational Health &amp; Safety (ANSES), Maisons-Alfort, France.</Affiliation>
      </Author>
      <Author>
        <Name> </Name>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Oxidative stress responses in human bronchial epithelial cells exposed to cigarette smoke and vapor from tobacco- and nicotine-containing products.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30227175</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30231-9</DOI>
    <KeywordList>
      <Keywords>Bronchial epithelial cells</Keywords>
      <Keywords>Cigarette smoke</Keywords>
      <Keywords>In vitro</Keywords>
      <Keywords>Inflammation</Keywords>
      <Keywords>Oxidative stress</Keywords>
      <Keywords>Tobacco vapor</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Satoru Munakata</Name>
        <Affiliation>Scientific Product Assessment Center, R&amp;D Group, Japan Tobacco Inc., 6-2 Umegaoka, Aoba-ku, Yokohama, Kanagawa, 227-8512, Japan. Electronic address: satoru.munakata@jt.com.</Affiliation>
      </Author>
      <Author>
        <Name>Kanae Ishimori</Name>
        <Affiliation>Scientific Product Assessment Center, R&amp;D Group, Japan Tobacco Inc., 6-2 Umegaoka, Aoba-ku, Yokohama, Kanagawa, 227-8512, Japan. Electronic address: kanae.ishimori@jt.com.</Affiliation>
      </Author>
      <Author>
        <Name>Nobumasa Kitamura</Name>
        <Affiliation>Scientific Product Assessment Center, R&amp;D Group, Japan Tobacco Inc., 6-2 Umegaoka, Aoba-ku, Yokohama, Kanagawa, 227-8512, Japan. Electronic address: nobumasa.kitamura@jt.com.</Affiliation>
      </Author>
      <Author>
        <Name>Shinkichi Ishikawa</Name>
        <Affiliation>Scientific Product Assessment Center, R&amp;D Group, Japan Tobacco Inc., 6-2 Umegaoka, Aoba-ku, Yokohama, Kanagawa, 227-8512, Japan. Electronic address: shinkichi.ishikawa@jt.com.</Affiliation>
      </Author>
      <Author>
        <Name>Yuichiro Takanami</Name>
        <Affiliation>Scientific Product Assessment Center, R&amp;D Group, Japan Tobacco Inc., 6-2 Umegaoka, Aoba-ku, Yokohama, Kanagawa, 227-8512, Japan. Electronic address: yuichiro.takanami@jt.com.</Affiliation>
      </Author>
      <Author>
        <Name>Shigeaki Ito</Name>
        <Affiliation>Scientific Product Assessment Center, R&amp;D Group, Japan Tobacco Inc., 6-2 Umegaoka, Aoba-ku, Yokohama, Kanagawa, 227-8512, Japan. Electronic address: shigeaki.ito@jt.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>In vitro test systems to determine tetracycline residue binding to human feces.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30227174</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30235-6</DOI>
    <KeywordList>
      <Keywords>Binding</Keywords>
      <Keywords>Human fecal slurries</Keywords>
      <Keywords>In vitro test systems</Keywords>
      <Keywords>Tetracycline</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Youngbeom Ahn</Name>
        <Affiliation>Division of Microbiology, National Center for Toxicological Research, U.S. Food and Drug Administration, Jefferson, AR, USA. Electronic address: young.ahn@fda.hhs.gov.</Affiliation>
      </Author>
      <Author>
        <Name>Ji Young Jung</Name>
        <Affiliation>Division of Microbiology, National Center for Toxicological Research, U.S. Food and Drug Administration, Jefferson, AR, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Brian T. Veach</Name>
        <Affiliation>Arkansas Regional Laboratory, Office of Regulatory Affairs, U.S. Food and Drug Administration, Jefferson, AR, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Sangeeta Khare</Name>
        <Affiliation>Division of Microbiology, National Center for Toxicological Research, U.S. Food and Drug Administration, Jefferson, AR, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Kuppan Gokulan</Name>
        <Affiliation>Division of Microbiology, National Center for Toxicological Research, U.S. Food and Drug Administration, Jefferson, AR, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Silvia A. Piñeiro</Name>
        <Affiliation>Division of Human Food Safety, Center for Veterinary Medicine, U.S. Food and Drug Administration, Rockville, MD, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Carl E. Cerniglia</Name>
        <Affiliation>Division of Microbiology, National Center for Toxicological Research, U.S. Food and Drug Administration, Jefferson, AR, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Modeling of cigarette smoke constituents - From intense to less intense smoking regime.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30227173</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30237-X</DOI>
    <KeywordList>
      <Keywords>Computational process</Keywords>
      <Keywords>Mainstream cigarette smoke</Keywords>
      <Keywords>Multiple linear regressions</Keywords>
      <Keywords>Smoking regimes</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Thomas Verron</Name>
        <Affiliation>SEITA, Imperial Brands, 143 Boulevard Romain Rolland, 75685, Paris, France. Electronic address: thomas.verron@fr.imptob.com.</Affiliation>
      </Author>
      <Author>
        <Name>Rémi Julien</Name>
        <Affiliation>SEITA, Imperial Brands, 143 Boulevard Romain Rolland, 75685, Paris, France.</Affiliation>
      </Author>
      <Author>
        <Name>Xavier Cahours</Name>
        <Affiliation>SEITA, Imperial Brands, 143 Boulevard Romain Rolland, 75685, Paris, France.</Affiliation>
      </Author>
      <Author>
        <Name>Stéphane Colard</Name>
        <Affiliation>SEITA, Imperial Brands, 143 Boulevard Romain Rolland, 75685, Paris, France.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Sensory irritation of vapours of formic, acetic, propionic and butyric acid.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30223073</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30234-4</DOI>
    <KeywordList>
      <Keywords>Acetic acid</Keywords>
      <Keywords>Butyric acid</Keywords>
      <Keywords>Formic acid</Keywords>
      <Keywords>Humans</Keywords>
      <Keywords>Mice</Keywords>
      <Keywords>Propionic acid</Keywords>
      <Keywords>Receptor activation mechanisms</Keywords>
      <Keywords>Sensory irritation</Keywords>
      <Keywords>Threshold limit values</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Gunnar Damgaard Nielsen</Name>
        <Affiliation>National Research Centre for the Working Environment, Lersø Parkallé 105, DK-2100, Copenhagen Ø, Denmark. Electronic address: gdn@nrcwe.dk.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A review on arsenic carcinogenesis: Epidemiology, metabolism, genotoxicity and epigenetic changes.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30223072</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30232-0</DOI>
    <KeywordList>
      <Keywords>Arsenic</Keywords>
      <Keywords>Carcinogenesis</Keywords>
      <Keywords>Epidemiology</Keywords>
      <Keywords>Inorganic arsenic</Keywords>
      <Keywords>Methylation</Keywords>
      <Keywords>Signal transduction</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Qing Zhou</Name>
        <Affiliation>Department of Environmental and Occupational Health, Liaoning Provincial Key Laboratory of Arsenic Biological Effect and Poisoning, School of Public Health, China Medical University, No.77 Puhe Road, Shenyang North New Area, Shenyang 110122, Liaoning Province, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Shuhua Xi</Name>
        <Affiliation>Department of Environmental and Occupational Health, Liaoning Provincial Key Laboratory of Arsenic Biological Effect and Poisoning, School of Public Health, China Medical University, No.77 Puhe Road, Shenyang North New Area, Shenyang 110122, Liaoning Province, People's Republic of China. Electronic address: Shxi@cmu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Estimation of total prescription weights of active pharmaceutical ingredients in human medicines based on a public database for environmental risk assessment in Japan.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30223071</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30236-8</DOI>
    <KeywordList>
      <Keywords>Active pharmaceutical ingredient</Keywords>
      <Keywords>Environmental risk assessment</Keywords>
      <Keywords>Environmental risk ranking</Keywords>
      <Keywords>Human medicine</Keywords>
      <Keywords>NDB</Keywords>
      <Keywords>Pharmaceuticals</Keywords>
      <Keywords>Prescription</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Keiichiro Sato</Name>
        <Affiliation>Non-Clinical Evaluation Expert Committee ERA Team, Drug Evaluation Committee, The Japan Pharmaceutical Manufacturers Association (JPMA), Tokyo, Japan; Drug Safety Research and Evaluation, Takeda Pharmaceutical Co., Ltd., 26-1-2, Muraoka-Higashi, Fujisawa, Kanagawa, 251-8555, Japan. Electronic address: keiichiro.sato@takeda.com.</Affiliation>
      </Author>
      <Author>
        <Name>Hidenori Watanabe</Name>
        <Affiliation>Non-Clinical Evaluation Expert Committee ERA Team, Drug Evaluation Committee, The Japan Pharmaceutical Manufacturers Association (JPMA), Tokyo, Japan; Central Pharmaceutical Research Institute, Japan Tobacco Inc., Murasakicho 1-1, Takatsuki, Osaka, 569-1125, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Takanori Ikeda</Name>
        <Affiliation>Non-Clinical Evaluation Expert Committee ERA Team, Drug Evaluation Committee, The Japan Pharmaceutical Manufacturers Association (JPMA), Tokyo, Japan; Safety Assessment, MSD K.K., Kitanomaru Square, 1-13-12, Kudan-kita, Chiyoda-ku, Tokyo, 102-8667, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Hiroaki Miida</Name>
        <Affiliation>Non-Clinical Evaluation Expert Committee ERA Team, Drug Evaluation Committee, The Japan Pharmaceutical Manufacturers Association (JPMA), Tokyo, Japan; Medicinal Safety Research Laboratories, Daiichi-Sankyo Co., Ltd., 1-16-13, Kita-kasai, Edogawa-ku, Tokyo, 134-8630, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Kiyoshi Ohtaki</Name>
        <Affiliation>Non-Clinical Evaluation Expert Committee ERA Team, Drug Evaluation Committee, The Japan Pharmaceutical Manufacturers Association (JPMA), Tokyo, Japan; Quality &amp; Regulatory Compliance Unit, Chugai Pharmaceutical Co., Ltd., 1-135, Komakado, Gotemba, Shizuoka, 412-8513, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Kazuto Watanabe</Name>
        <Affiliation>Non-Clinical Evaluation Expert Committee ERA Team, Drug Evaluation Committee, The Japan Pharmaceutical Manufacturers Association (JPMA), Tokyo, Japan; Research Division, Chugai Pharmaceutical Co., Ltd., 1-135, Komakado, Gotemba, Shizuoka, 412-8513, Japan.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Distinguishing between endocrine disruption and non-specific effects on endocrine systems.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30217484</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30224-1</DOI>
    <KeywordList>
      <Keywords>Endocrine disruption</Keywords>
      <Keywords>Endocrine screening</Keywords>
      <Keywords>Endocrine system</Keywords>
      <Keywords>Maximum tolerated dose</Keywords>
      <Keywords>Stress</Keywords>
      <Keywords>Systemic toxicity</Keywords>
      <Keywords>Weight of evidence</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>M. Sue Marty</Name>
        <Affiliation>The Dow Chemical Company, Toxicology &amp; Environmental Research and Consulting, 1803 Building, Midland, MI, 48674, USA. Electronic address: msmarty@dow.com.</Affiliation>
      </Author>
      <Author>
        <Name>Chris Borgert</Name>
        <Affiliation>Applied Pharmacology and Toxicology, Inc., C.E.H.T. Dept. Physiological Sciences, University of FL College of Veterinary Medicine, 2250 NW 24th Avenue, Gainesville, FL, 32605, USA. Electronic address: cjborgert@apt-pharmatox.com.</Affiliation>
      </Author>
      <Author>
        <Name>Katie Coady</Name>
        <Affiliation>The Dow Chemical Company, Toxicology &amp; Environmental Research and Consulting, 1803 Building, Midland, MI, 48674, USA. Electronic address: kcoady@dow.com.</Affiliation>
      </Author>
      <Author>
        <Name>Richard Green</Name>
        <Affiliation>Dow AgroSciences, 3b Park Square, Milton Park, Abingdon, Oxfordshire, OX14 4RN, United Kingdom. Electronic address: Richard_Green@vrtx.com.</Affiliation>
      </Author>
      <Author>
        <Name>Steven L. Levine</Name>
        <Affiliation>Monsanto Company, Global Regulatory Science, 700 Chesterfield Parkway W, Chesterfield, MO, 63017, USA. Electronic address: steven.l.levine@monsanto.com.</Affiliation>
      </Author>
      <Author>
        <Name>Ellen Mihaich</Name>
        <Affiliation>Environmental and Regulatory Resources, LLC, 6807 Lipscomb Drive, Durham, NC, 27712, USA. Electronic address: emihaich@nc.rr.com.</Affiliation>
      </Author>
      <Author>
        <Name>Lisa Ortego</Name>
        <Affiliation>Bayer CropScience, 2 TW Alexander Dr, Research Triangle Park, NC, 27709, USA. Electronic address: lisa.ortego@bayer.com.</Affiliation>
      </Author>
      <Author>
        <Name>James R. Wheeler</Name>
        <Affiliation>Dow AgroSciences, 3b Park Square, Milton Park, Abingdon, Oxfordshire, OX14 4RN, United Kingdom. Electronic address: jrwheeler@dow.com.</Affiliation>
      </Author>
      <Author>
        <Name>Kun Don Yi</Name>
        <Affiliation>Syngenta Crop Protection, LLC, 410 S Wing Rd, Greensboro, NC, 27409, USA. Electronic address: sue.yi@syngenta.com.</Affiliation>
      </Author>
      <Author>
        <Name>Leah M. Zorrilla</Name>
        <Affiliation>Bayer CropScience, 2 TW Alexander Dr, Research Triangle Park, NC, 27709, USA. Electronic address: leah.zorrilla@bayer.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Structural and functional pharmacokinetic analogs for physiologically based pharmacokinetic (PBPK) model evaluation.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30201539</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30230-7</DOI>
    <KeywordList>
      <Keywords>Analog</Keywords>
      <Keywords>Modeling</Keywords>
      <Keywords>Pharmacokinetics</Keywords>
      <Keywords>Physiologically based pharmacokinetics</Keywords>
      <Keywords>Read across</Keywords>
      <Keywords>Structural activity relationship</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Corie A. Ellison</Name>
        <Affiliation>The Procter &amp; Gamble Company, 8700 Mason Montgomery Road, Cincinnati, OH, 45040, USA. Electronic address: Ellison.ca@pg.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Nicotine pharmacokinetics of electronic cigarettes: A review of the literature.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30201538</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30226-5</DOI>
    <KeywordList>
      <Keywords>Clinical studies</Keywords>
      <Keywords>E-cigarette</Keywords>
      <Keywords>Human</Keywords>
      <Keywords>Nicotine</Keywords>
      <Keywords>Pharmacokinetics</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Ian M. Fearon</Name>
        <Affiliation>Celerion, 22-24 Lisburn Road, Belfast, BT9 6AD, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Alison C. Eldridge</Name>
        <Affiliation>British American Tobacco (Investments) Limited, Research and Development, Regents Park Road, Southampton, SO15 8TL, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Nathan Gale</Name>
        <Affiliation>British American Tobacco (Investments) Limited, Research and Development, Regents Park Road, Southampton, SO15 8TL, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Mike McEwan</Name>
        <Affiliation>British American Tobacco (Investments) Limited, Research and Development, Regents Park Road, Southampton, SO15 8TL, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Mitchell F. Stiles</Name>
        <Affiliation>RAI Services Company, Winston-Salem, North Carolina, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Elaine K. Round</Name>
        <Affiliation>RAI Services Company, Winston-Salem, North Carolina, USA. Electronic address: rounde@rjrt.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Safety of the Bacillus thuringiensis-derived Cry1A.105 protein: Evidence that domain exchange preserves mode of action and safety.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30196079</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30225-3</DOI>
    <KeywordList>
      <Keywords>Bacillus thuringiensis</Keywords>
      <Keywords>Chimeric protein</Keywords>
      <Keywords>Cry1A.105</Keywords>
      <Keywords>Domain exchange</Keywords>
      <Keywords>History of safe use</Keywords>
      <Keywords>Safety assessment</Keywords>
      <Keywords>Soybean insect protection</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Cunxi Wang</Name>
        <Affiliation>Bayer U.S., Crop Science Division, 700 Chesterfield Pkwy West, Chesterfield, MO 63017, USA. Electronic address: Cunxi.wang@bayer.com.</Affiliation>
      </Author>
      <Author>
        <Name>Wenze Li</Name>
        <Affiliation>Bayer U.S., Crop Science Division, 700 Chesterfield Pkwy West, Chesterfield, MO 63017, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Colton R. Kessenich</Name>
        <Affiliation>Bayer U.S., Crop Science Division, 700 Chesterfield Pkwy West, Chesterfield, MO 63017, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jay S. Petrick</Name>
        <Affiliation>Bayer U.S., Crop Science Division, 700 Chesterfield Pkwy West, Chesterfield, MO 63017, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Timothy J. Rydel</Name>
        <Affiliation>Bayer U.S., Crop Science Division, 700 Chesterfield Pkwy West, Chesterfield, MO 63017, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Eric J. Sturman</Name>
        <Affiliation>Bayer U.S., Crop Science Division, 700 Chesterfield Pkwy West, Chesterfield, MO 63017, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Thomas C. Lee</Name>
        <Affiliation>Bayer U.S., Crop Science Division, 700 Chesterfield Pkwy West, Chesterfield, MO 63017, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Kevin C. Glenn</Name>
        <Affiliation>Bayer U.S., Crop Science Division, 700 Chesterfield Pkwy West, Chesterfield, MO 63017, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Thomas C. Edrington</Name>
        <Affiliation>Bayer U.S., Crop Science Division, 700 Chesterfield Pkwy West, Chesterfield, MO 63017, USA. Electronic address: thomas.edrington@bayer.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Conflicts of interest, bias, and the IARC Monographs Program.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30194952</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30227-7</DOI>
    <KeywordList>
      <Keywords>Conflicts of interest</Keywords>
      <Keywords>Glyphosate</Keywords>
      <Keywords>IARC Monographs Program</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Robert E. Tarone</Name>
        <Affiliation>14 Chantilly Ct., Rockville, MD, 20850, United States. Electronic address: robertotarone@gmail.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Finding synergies for 3Rs - Toxicokinetics and read-across: Report from an EPAA partners' Forum.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30144470</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30218-6</DOI>
    <KeywordList>
      <Keywords>Absorption</Keywords>
      <Keywords>And elimination</Keywords>
      <Keywords>Distribution</Keywords>
      <Keywords>Excretion (ADME)</Keywords>
      <Keywords>Hazard and risk assessment</Keywords>
      <Keywords>In vitro to in vivo extrapolation (IVIVE)</Keywords>
      <Keywords>Integrated approach for testing and assessment (IATA)</Keywords>
      <Keywords>Metabolism</Keywords>
      <Keywords>Physiologically-based kinetic (PBK) modelling</Keywords>
      <Keywords>Threshold of toxicological concern (TTC)</Keywords>
      <Keywords>Weight-of-evidence (WoE)</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Charles Laroche</Name>
        <Affiliation>The International Fragrance Association (IFRA), Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Manoj Aggarwal</Name>
        <Affiliation>Dow AgroSciences, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Hans Bender</Name>
        <Affiliation>Bonn, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Paul Benndorf</Name>
        <Affiliation>Henkel AG &amp; Co KGaA, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Barbara Birk</Name>
        <Affiliation>BASF SE, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Jonathan Crozier</Name>
        <Affiliation>European Partnership for Alternative Approaches to Animal Testing (EPAA) Industry Secretariat, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Gianni Dal Negro</Name>
        <Affiliation>GlaxoSmithKline, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Federica De Gaetano</Name>
        <Affiliation>European Commission, the Directorate-General (DG) for Internal Market, Industry, Entrepreneurship and SMEs (GROW), Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Christian Desaintes</Name>
        <Affiliation>European Commission, The Directorate-General (DG) for Research and Innovation (RTD), Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Iain Gardner</Name>
        <Affiliation>SIMCYP, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Bruno Hubesch</Name>
        <Affiliation>Hubesch Consult BVBA, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Amaia Irizar</Name>
        <Affiliation>The International Fragrance Association (IFRA), Belgium. Electronic address: airizar@ifraorg.org.</Affiliation>
      </Author>
      <Author>
        <Name>David John</Name>
        <Affiliation>Animal Health Europe, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Vikas Kumar</Name>
        <Affiliation>University of Rovira i Virgili, Spain.</Affiliation>
      </Author>
      <Author>
        <Name>Alfonso Lostia</Name>
        <Affiliation>European Commission, The Directorate-General (DG) Joint Research Centre (JRC), Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Irene Manou</Name>
        <Affiliation>European Partnership for Alternative Approaches to Animal Testing (EPAA) Industry Secretariat, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Mario Monshouwer</Name>
        <Affiliation>Janssen Pharmaceuticals, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Boris P. Müller</Name>
        <Affiliation>Symrise AG Holzminden, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Alicia Paini</Name>
        <Affiliation>European Commission, The Directorate-General (DG) Joint Research Centre (JRC), Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Kirsty Reid</Name>
        <Affiliation>European Federation of Pharmaceutical Industries and Associations (EFPIA), Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Timothy Rowan</Name>
        <Affiliation>EPAA Consultant, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Magdalini Sachana</Name>
        <Affiliation>Organisation for Economic Cooperation and Development (OECD), France.</Affiliation>
      </Author>
      <Author>
        <Name>Katrin Schutte</Name>
        <Affiliation>European Commission, the Directorate-General (DG) Environment (ENV), Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Catrina Stirling</Name>
        <Affiliation>Zoetis Ltd, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Rob Taalman</Name>
        <Affiliation>Cosmetics Europe, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Leon van Aerts</Name>
        <Affiliation>Medicines Evaluation Board, the Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Renate Weissenhorn</Name>
        <Affiliation>European Commission, the Directorate-General (DG) for Internal Market, Industry, Entrepreneurship and SMEs (GROW), Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Ursula G. Sauer</Name>
        <Affiliation>Scientific Consultancy - Animal Welfare, Germany.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Beta-cypermethrin exposure affects female reproduction by enhancing oxidative stress in mice uterine tissue.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30138661</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30222-8</DOI>
    <KeywordList>
      <Keywords>Beta-cypermethrin</Keywords>
      <Keywords>Mouse</Keywords>
      <Keywords>Oxidative stress</Keywords>
      <Keywords>Uterus</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Yong Jiang Zhou</Name>
        <Affiliation>Maternal, Child and Adolescent Health, School of Public Health, Hainan Medical University, No.3 Yixueyuan Road, Longhua District, Hainan Province, 571199, PR China. Electronic address: hy0208033@hainmc.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Hai Rong Huang</Name>
        <Affiliation>School of Public Health, Hainan Medical University, Yixueyuan Road, Longhua District, Hainan Province, 571199, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Jing Zhou</Name>
        <Affiliation>School of Public Health, Hainan Medical University, Yixueyuan Road, Longhua District, Hainan Province, 571199, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Li Qing Wang</Name>
        <Affiliation>Maternal, Child and Adolescent Health, School of Public Health, Hainan Medical University, No.3 Yixueyuan Road, Longhua District, Hainan Province, 571199, PR China.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Evaluation of skin irritation potentials of different cosmetic products in Turkish market by reconstructed human epidermis model.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30138660</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30221-6</DOI>
    <KeywordList>
      <Keywords>Cosmetics</Keywords>
      <Keywords>EpiDerm</Keywords>
      <Keywords>In vitro toxicity test</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Ozge Kose</Name>
        <Affiliation>Hacettepe University, Faculty of Pharmacy, Department of Toxicology, Sıhhiye, Ankara, Turkey.</Affiliation>
      </Author>
      <Author>
        <Name>Pinar Erkekoglu</Name>
        <Affiliation>Hacettepe University, Faculty of Pharmacy, Department of Toxicology, Sıhhiye, Ankara, Turkey. Electronic address: erkekp@yahoo.com.</Affiliation>
      </Author>
      <Author>
        <Name>Suna Sabuncuoglu</Name>
        <Affiliation>Hacettepe University, Faculty of Pharmacy, Department of Toxicology, Sıhhiye, Ankara, Turkey.</Affiliation>
      </Author>
      <Author>
        <Name>Belma Kocer-Gumusel</Name>
        <Affiliation>Hacettepe University, Faculty of Pharmacy, Department of Toxicology, Sıhhiye, Ankara, Turkey; Lokman Hekim University, Faculty of Pharmacy, Department of Toxicology, Çankaya, Ankara, Turkey. Electronic address: belmagumusel@yahoo.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Risk assessment of occupational pesticide exposure: Use of endpoints and surrogates.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30130552</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30219-8</DOI>
    <KeywordList>
      <Keywords>Endpoints and surrogates</Keywords>
      <Keywords>Occupational exposure</Keywords>
      <Keywords>Pesticides</Keywords>
      <Keywords>Risk assessment</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Simone Caetani Machado</Name>
        <Affiliation>Laboratory of Toxicants and Drugs Analysis - LATF, Faculty of Pharmaceutical Sciences, Federal University of Alfenas - UNIFAL-MG, 700 Gabriel Monteiro da Silva Street, 37130-000, Alfenas, MG, Brazil. Electronic address: simonecaetani@uol.com.br.</Affiliation>
      </Author>
      <Author>
        <Name>Isarita Martins</Name>
        <Affiliation>Laboratory of Toxicants and Drugs Analysis - LATF, Faculty of Pharmaceutical Sciences, Federal University of Alfenas - UNIFAL-MG, 700 Gabriel Monteiro da Silva Street, 37130-000, Alfenas, MG, Brazil. Electronic address: isarita.sakakibara@unifal-mg.edu.br.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Quality control programmes for veterinary antimicrobial medicines.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30130551</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30220-4</DOI>
    <KeywordList>
      <Keywords>Antimicrobial resistance</Keywords>
      <Keywords>Food-producing animals</Keywords>
      <Keywords>Medicated feed</Keywords>
      <Keywords>Medicines quality</Keywords>
      <Keywords>One health</Keywords>
      <Keywords>Veterinary antimicrobial medicines</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Helena Ponte</Name>
        <Affiliation>INFARMED - Portuguese National Authority of Medicines and Health Products, IP Parque de Saúde de Lisboa, Av. do Brasil, 53, 1749-004, Lisboa, Portugal.</Affiliation>
      </Author>
      <Author>
        <Name>Rui Santos Ivo</Name>
        <Affiliation>INFARMED - Portuguese National Authority of Medicines and Health Products, IP Parque de Saúde de Lisboa, Av. do Brasil, 53, 1749-004, Lisboa, Portugal.</Affiliation>
      </Author>
      <Author>
        <Name>Beatriz Silva-Lima</Name>
        <Affiliation>iMed.UL - Research Institute for Medicines and Pharmaceutical Sciences, Faculty of Pharmacy, University of Lisbon, Av. Prof. Gama Pinto, 1649-003, Lisboa, Portugal.</Affiliation>
      </Author>
      <Author>
        <Name>Fernando Ramos</Name>
        <Affiliation>REQUIMTE/LAQV - Faculty of Pharmacy, University of Coimbra, Azinhaga de Santa Comba, 3000-548, Coimbra, Portugal. Electronic address: fjramos@ci.uc.pt.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Opinion of the Scientific Committee on Consumer Safety (SCCS) - Revision of the Opinion on hydroxyapatite (nano) in cosmetic products.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30125613</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30201-0</DOI>
    <KeywordList>
      <Keywords>CAS 1306-06-5</Keywords>
      <Keywords>EC 215-145-7</Keywords>
      <Keywords>Hydroxyapatite</Keywords>
      <Keywords>Nano</Keywords>
      <Keywords>Regulation 1223/2009</Keywords>
      <Keywords>SCCS</Keywords>
      <Keywords>Scientific Opinion</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name> </Name>
        <Affiliation>SCCS Secretariat at the European Commission, Directorate General for Health and Food Safety, 11, rue E. Ruppert, L-2920, Luxembourg, Luxembourg.</Affiliation>
      </Author>
      <Author>
        <Name>Ulrike Bernauer</Name>
        <Affiliation>Federal Institute for Risk Assessment (BfR), Berlin, Germany.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Toxicity of silver ions, metallic silver, and silver nanoparticle materials after in vivo dermal and mucosal surface exposure: A review.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30125612</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30217-4</DOI>
    <KeywordList>
      <Keywords>Acticoat</Keywords>
      <Keywords>Dermal</Keywords>
      <Keywords>Eye</Keywords>
      <Keywords>Genotoxicity</Keywords>
      <Keywords>Metallic</Keywords>
      <Keywords>Nanocrystalline</Keywords>
      <Keywords>Nanoparticle</Keywords>
      <Keywords>Silver</Keywords>
      <Keywords>Silver sulfadiazine</Keywords>
      <Keywords>Toxicology</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Niels Hadrup</Name>
        <Affiliation>National Research Centre for the Working Environment, DK-2100, Copenhagen, Denmark. Electronic address: nih@nfa.dk.</Affiliation>
      </Author>
      <Author>
        <Name>Anoop K. Sharma</Name>
        <Affiliation>Division for Risk Assessment and Nutrition, National Food Institute, Technical University of Denmark, Søborg, Denmark. Electronic address: aksha@food.dtu.dk.</Affiliation>
      </Author>
      <Author>
        <Name>Katrin Loeschner</Name>
        <Affiliation>Division for Food Technology, National Food Institute, Technical University of Denmark, Søborg, Denmark. Electronic address: kals@food.dtu.dk.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Managing emerging mutagenicity risks: Late stage mutagenic impurity control within the atovaquone second generation synthesis.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30118726</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30215-0</DOI>
    <KeywordList>
      <Keywords>Atovaquone</Keywords>
      <Keywords>Fate and effects</Keywords>
      <Keywords>ICH M7 option 4</Keywords>
      <Keywords>Mutagenic impurities</Keywords>
      <Keywords>Selective excitation</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Michael W. J. Urquhart</Name>
        <Affiliation>GlaxoSmithKline, Medicines Research Centre, Gunnels Wood Road, Stevenage, Hertfordshire, SG1 2NY, United Kingdom. Electronic address: Michael.W.Urquhart@gsk.com.</Affiliation>
      </Author>
      <Author>
        <Name>Ben Bardsley</Name>
        <Affiliation>GlaxoSmithKline, Medicines Research Centre, Gunnels Wood Road, Stevenage, Hertfordshire, SG1 2NY, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Andrew J. Edwards</Name>
        <Affiliation>GlaxoSmithKline, Medicines Research Centre, Gunnels Wood Road, Stevenage, Hertfordshire, SG1 2NY, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Amanda Giddings</Name>
        <Affiliation>GlaxoSmithKline, David Jack Centre for Research and Development, Park Road, Ware, Hertfordshire, SG12 0DP, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Emma Griva</Name>
        <Affiliation>GlaxoSmithKline, Medicines Research Centre, Gunnels Wood Road, Stevenage, Hertfordshire, SG1 2NY, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Jim Harvey</Name>
        <Affiliation>GlaxoSmithKline, David Jack Centre for Research and Development, Park Road, Ware, Hertfordshire, SG12 0DP, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Stephen Hermitage</Name>
        <Affiliation>GlaxoSmithKline, Medicines Research Centre, Gunnels Wood Road, Stevenage, Hertfordshire, SG1 2NY, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Fiona King</Name>
        <Affiliation>GlaxoSmithKline, Medicines Research Centre, Gunnels Wood Road, Stevenage, Hertfordshire, SG1 2NY, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Stuart Leach</Name>
        <Affiliation>GlaxoSmithKline, Medicines Research Centre, Gunnels Wood Road, Stevenage, Hertfordshire, SG1 2NY, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Claire Lesurf</Name>
        <Affiliation>GlaxoSmithKline, Medicines Research Centre, Gunnels Wood Road, Stevenage, Hertfordshire, SG1 2NY, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Clare McKinlay</Name>
        <Affiliation>GlaxoSmithKline, Medicines Research Centre, Gunnels Wood Road, Stevenage, Hertfordshire, SG1 2NY, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Paul Oxley</Name>
        <Affiliation>Formerly at GlaxoSmithKline, Medicines Research Centre, Gunnels Wood Road, Stevenage, Hertfordshire, SG1 2NY, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Tran N. Pham</Name>
        <Affiliation>GlaxoSmithKline, Medicines Research Centre, Gunnels Wood Road, Stevenage, Hertfordshire, SG1 2NY, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Alec Simpson</Name>
        <Affiliation>GlaxoSmithKline, Medicines Research Centre, Gunnels Wood Road, Stevenage, Hertfordshire, SG1 2NY, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Elaine Smith</Name>
        <Affiliation>GlaxoSmithKline, Medicines Research Centre, Gunnels Wood Road, Stevenage, Hertfordshire, SG1 2NY, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Neil Stevenson</Name>
        <Affiliation>GlaxoSmithKline, Medicines Research Centre, Gunnels Wood Road, Stevenage, Hertfordshire, SG1 2NY, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Charles Wade</Name>
        <Affiliation>GlaxoSmithKline, Medicines Research Centre, Gunnels Wood Road, Stevenage, Hertfordshire, SG1 2NY, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Angela White</Name>
        <Affiliation>GlaxoSmithKline, David Jack Centre for Research and Development, Park Road, Ware, Hertfordshire, SG12 0DP, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Nick Wooster</Name>
        <Affiliation>Formerly at GlaxoSmithKline, Medicines Research Centre, Gunnels Wood Road, Stevenage, Hertfordshire, SG1 2NY, United Kingdom.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Protection of manganese oxide nanoparticles-induced liver and kidney damage by vitamin D.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30102957</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30216-2</DOI>
    <KeywordList>
      <Keywords>Kidney</Keywords>
      <Keywords>Liver</Keywords>
      <Keywords>Manganese oxide-nanoparticles</Keywords>
      <Keywords>Nanoparticles</Keywords>
      <Keywords>Vitamin D</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Asghar Ashrafi Hafez</Name>
        <Affiliation>Cancer Research Center, Student Research Committee, Shahid Beheshti University of Medical Sciences, Tehran, Iran.</Affiliation>
      </Author>
      <Author>
        <Name>Parvaneh Naserzadeh</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Faculty of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran.</Affiliation>
      </Author>
      <Author>
        <Name>Khadijeh Ashtari</Name>
        <Affiliation>Radiation Biology Research Center, Iran University of Medical Sciences, Tehran, Iran; Department of Medical Nanotechnology. Faculty of Advanced Technology in Medicine, Iran University of Medical Sciences, Tehran, Iran.</Affiliation>
      </Author>
      <Author>
        <Name>Amir Mohammad Mortazavian</Name>
        <Affiliation>Department of Food Science and Technology, Faculty of Nutrition Sciences and Food Technology, Shahid Beheshti University of Medical Sciences, Tehran, Iran. Electronic address: Mortazn@sbmu.ac.ir.</Affiliation>
      </Author>
      <Author>
        <Name>Ahmad Salimi</Name>
        <Affiliation>Department of Pharmacology and Toxicology, School of Pharmacy, Ardabil University of Medical Sciences, Ardabil, Iran. Electronic address: salimikd@yahoo.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>One science-driven approach for the regulatory implementation of alternative methods: A multi-sector perspective.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30098372</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30213-7</DOI>
    <AuthorList>
      <Author>
        <Name>Gianni Dal Negro</Name>
        <Affiliation>GlaxoSmithKline, Gunnels Wood Road, Stevenage, Hertfordshire, SG1 2NY, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Chantra Eskes</Name>
        <Affiliation>SeCAM Services and Consultation on Alternative Methods, Via Campagnora 1, 6983, Magliaso, Switzerland. Electronic address: chantra.eskes@secam-ce.eu.</Affiliation>
      </Author>
      <Author>
        <Name>Susanne Belz</Name>
        <Affiliation>European Commission, Joint Research Centre (JRC), Via E. Fermi 2749, 21017, Ispra, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Caroline Bertein</Name>
        <Affiliation>A.I.S.E, Boulevard du Souverain 164, 1160, Brussels, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Magda Chlebus</Name>
        <Affiliation>European Federation of Pharmaceutical Industries and Associations (EFPIA), Rue du Trône 108, 1050, Brussels, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Marco Corvaro</Name>
        <Affiliation>ECPA - the European Crop Protection Association, 6 Avenue E. Van Nieuwenhuyse, 1160, Brussels, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Raffaella Corvi</Name>
        <Affiliation>European Commission, Joint Research Centre (JRC), Via E. Fermi 2749, 21017, Ispra, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Stephane Dhalluin</Name>
        <Affiliation>L'Oréal Research &amp; Innovation, 9 rue Pierre Dreyfus, 92110, Clichy, France.</Affiliation>
      </Author>
      <Author>
        <Name>Marlies Halder</Name>
        <Affiliation>European Commission, Joint Research Centre (JRC), Via E. Fermi 2749, 21017, Ispra, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Jim Harvey</Name>
        <Affiliation>GlaxoSmithKline, Gunnels Wood Road, Stevenage, Hertfordshire, SG1 2NY, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Martina Hermann</Name>
        <Affiliation>Henkel AG &amp; Co. KGaA, Henkelstr. 67, 40589, Duesseldorf, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Simone Hoffmann-Dörr</Name>
        <Affiliation>Henkel AG &amp; Co. KGaA, Henkelstr. 67, 40589, Duesseldorf, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Karin Kilian</Name>
        <Affiliation>European Commission, Directorate General for the Environment (DG ENV), Brussels, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Denis Lambrigts</Name>
        <Affiliation>GlaxoSmithKline Vaccines, 20 Avenue Fleming, 1300, Wavre, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Charles Laroche</Name>
        <Affiliation>European Partnership for Alternative Approaches to Animal Testing (EPAA), Av. Herrmann-Debroux 40, 1160, Brussels, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Susanna Louhimies</Name>
        <Affiliation>European Commission, Directorate General for the Environment (DG ENV), Brussels, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Catherine Mahony</Name>
        <Affiliation>The Procter &amp; Gamble Company, Whitehall Lane, Egham, Surrey TW20 9NW, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Irene Manou</Name>
        <Affiliation>European Partnership for Alternative Approaches to Animal Testing (EPAA), Av. Herrmann-Debroux 40, 1160, Brussels, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Pauline McNamee</Name>
        <Affiliation>The Procter &amp; Gamble Company, Whitehall Lane, Egham, Surrey TW20 9NW, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Pilar Prieto</Name>
        <Affiliation>European Commission, Joint Research Centre (JRC), Via E. Fermi 2749, 21017, Ispra, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Kirsty Reid</Name>
        <Affiliation>European Federation of Pharmaceutical Industries and Associations (EFPIA), Rue du Trône 108, 1050, Brussels, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Erwin Roggen</Name>
        <Affiliation>3Rs Management and Consulting, Asavænget 14, 2800, Kongens Lyngby, Denmark.</Affiliation>
      </Author>
      <Author>
        <Name>Katrin Schutte</Name>
        <Affiliation>European Commission, Directorate General for the Environment (DG ENV), Brussels, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Catrina Stirling</Name>
        <Affiliation>Zoetis Ltd, Kent, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Sylvie Uhlrich</Name>
        <Affiliation>Sanofi Pasteur, 1541 Av. Marcel Merieux, 69280, Marcy l'Etoile, France.</Affiliation>
      </Author>
      <Author>
        <Name>Renate Weissenhorn</Name>
        <Affiliation>European Commission, Directorate General for Internal Market, Industry, Enterpreneurship and SME, Brussels, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Maurice Whelan</Name>
        <Affiliation>European Commission, Joint Research Centre (JRC), Via E. Fermi 2749, 21017, Ispra, Italy.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A review on silver nanoparticles-induced ecotoxicity and the underlying toxicity mechanisms.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30096342</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30214-9</DOI>
    <KeywordList>
      <Keywords>In vitro toxicity</Keywords>
      <Keywords>In vivo toxicity</Keywords>
      <Keywords>Mechanism</Keywords>
      <Keywords>Physicochemical properties</Keywords>
      <Keywords>Silver nanoparticles</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jia Du</Name>
        <Affiliation>Institute of Environmental Science and Engineering, College of Materials and Environmental Engineering, Hangzhou Dianzi University, 1158, Baiyang Rd, Hangzhou, 310018, PR China. Electronic address: djhd@hdu.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Junhong Tang</Name>
        <Affiliation>Institute of Environmental Science and Engineering, College of Materials and Environmental Engineering, Hangzhou Dianzi University, 1158, Baiyang Rd, Hangzhou, 310018, PR China. Electronic address: tangjunhong@hdu.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Shaodan Xu</Name>
        <Affiliation>Institute of Environmental Science and Engineering, College of Materials and Environmental Engineering, Hangzhou Dianzi University, 1158, Baiyang Rd, Hangzhou, 310018, PR China. Electronic address: xusd@hdu.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Jingyuan Ge</Name>
        <Affiliation>Institute of Environmental Science and Engineering, College of Materials and Environmental Engineering, Hangzhou Dianzi University, 1158, Baiyang Rd, Hangzhou, 310018, PR China. Electronic address: gejingyuan@hdu.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Yuwei Dong</Name>
        <Affiliation>Institute of Environmental Science and Engineering, College of Materials and Environmental Engineering, Hangzhou Dianzi University, 1158, Baiyang Rd, Hangzhou, 310018, PR China. Electronic address: ywdong@hdu.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Huanxuan Li</Name>
        <Affiliation>Institute of Environmental Science and Engineering, College of Materials and Environmental Engineering, Hangzhou Dianzi University, 1158, Baiyang Rd, Hangzhou, 310018, PR China. Electronic address: hxlee@hdu.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Meiqing Jin</Name>
        <Affiliation>Institute of Environmental Science and Engineering, College of Materials and Environmental Engineering, Hangzhou Dianzi University, 1158, Baiyang Rd, Hangzhou, 310018, PR China. Electronic address: jmq@hdu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Molybdenum bupropion combined neurotoxicity in rats.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30081056</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30212-5</DOI>
    <KeywordList>
      <Keywords>Antidepressant</Keywords>
      <Keywords>Brain</Keywords>
      <Keywords>Bupropion</Keywords>
      <Keywords>Inflammatory response</Keywords>
      <Keywords>Molybdenum</Keywords>
      <Keywords>Nrf2</Keywords>
      <Keywords>Oxidative stress</Keywords>
      <Keywords>TNF-α</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>A. M. Helaly</Name>
        <Affiliation>Forensic and Clinical Toxicology Department, Egypt; Faculty of Medicine, Yarmouk University, Jordan.</Affiliation>
      </Author>
      <Author>
        <Name>Naglaa Mokhtar</Name>
        <Affiliation>Medical Biochemistry Department, Egypt; Faculty of Medicine, Mansoura University, Egypt.</Affiliation>
      </Author>
      <Author>
        <Name>Alaa El Din L. Firgany</Name>
        <Affiliation>Department of Histology and Cell Biology, Egypt; Faculty of Medicine, Mansoura University, Egypt.</Affiliation>
      </Author>
      <Author>
        <Name>Noha M. Hazem</Name>
        <Affiliation>Medical Biochemistry Department, Egypt; Faculty of Medicine, Mansoura University, Egypt. Electronic address: nohadata@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>E. El Morsi</Name>
        <Affiliation>Forensic and Clinical Toxicology Department, Egypt; Faculty of Medicine, Mansoura University, Egypt.</Affiliation>
      </Author>
      <Author>
        <Name>D. Ghorab</Name>
        <Affiliation>Pathology Department, Egypt; Faculty of Medicine, Mansoura University, Egypt.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Human relevance of follicular thyroid tumors in rodents caused by non-genotoxic substances.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30076866</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30209-5</DOI>
    <KeywordList>
      <Keywords>Carcinogen classification</Keywords>
      <Keywords>Follicular thyroid tumors</Keywords>
      <Keywords>Human relevance</Keywords>
      <Keywords>Non-genotoxic chemicals</Keywords>
      <Keywords>Rodent tumors</Keywords>
      <Keywords>Species differences</Keywords>
      <Keywords>Thyroid hormones</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Ruediger Bartsch</Name>
        <Affiliation>Institute for Applied Biosciences, Karlsruhe Institute of Technology (KIT), Department of Food Chemistry and Toxicology, Karlsruhe, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Britta Brinkmann</Name>
        <Affiliation>Institute for Applied Biosciences, Karlsruhe Institute of Technology (KIT), Department of Food Chemistry and Toxicology, Karlsruhe, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Gunnar Jahnke</Name>
        <Affiliation>Institute for Applied Biosciences, Karlsruhe Institute of Technology (KIT), Department of Food Chemistry and Toxicology, Karlsruhe, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Britta Laube</Name>
        <Affiliation>Institute for Applied Biosciences, Karlsruhe Institute of Technology (KIT), Department of Food Chemistry and Toxicology, Karlsruhe, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Ruth Lohmann</Name>
        <Affiliation>Institute for Applied Biosciences, Karlsruhe Institute of Technology (KIT), Department of Food Chemistry and Toxicology, Karlsruhe, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Sandra Michaelsen</Name>
        <Affiliation>Institute for Applied Biosciences, Karlsruhe Institute of Technology (KIT), Department of Food Chemistry and Toxicology, Karlsruhe, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Ingrid Neumann</Name>
        <Affiliation>Institute for Applied Biosciences, Karlsruhe Institute of Technology (KIT), Department of Food Chemistry and Toxicology, Karlsruhe, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Helmut Greim</Name>
        <Affiliation>Institute for Applied Biosciences, Karlsruhe Institute of Technology (KIT), Department of Food Chemistry and Toxicology, Karlsruhe, Germany. Electronic address: helmut.greim@lrz.tum.de.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Acute and 28-day repeated dose toxicity evaluations of 2-hydroxybenzylamine acetate in mice and rats.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30075181</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30210-1</DOI>
    <KeywordList>
      <Keywords>Preclinical</Keywords>
      <Keywords>Rodent</Keywords>
      <Keywords>Safety</Keywords>
      <Keywords>Salicylamine</Keywords>
      <Keywords>γ-Ketoaldehydes</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Lisa M. Pitchford</Name>
        <Affiliation>Metabolic Technologies, Inc, Ames, IA 50010, USA. Electronic address: pitchford@mti-hmb.com.</Affiliation>
      </Author>
      <Author>
        <Name>Jodi D. Smith</Name>
        <Affiliation>Department of Veterinary Pathology, Iowa State University College of Veterinary Medicine, Ames, IA 50010, USA. Electronic address: jdismith@iastate.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Naji N. Abumrad</Name>
        <Affiliation>Department of Surgery, Vanderbilt University Medical Center, Nashville, TN 37232, USA. Electronic address: naji.abumrad@vanderbilt.edu.</Affiliation>
      </Author>
      <Author>
        <Name>John A. Rathmacher</Name>
        <Affiliation>Metabolic Technologies, Inc, Ames, IA 50010, USA; Department of Animal Science, Iowa State University, Ames, IA 50010, USA. Electronic address: rathmacher@mti-hmb.com.</Affiliation>
      </Author>
      <Author>
        <Name>John C. Fuller</Name>
        <Affiliation>Metabolic Technologies, Inc, Ames, IA 50010, USA. Electronic address: fuller@mti-hmb.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Screening of acute and sub-chronic dermal toxicity of Calendula officinalis L essential oil.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30075180</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30211-3</DOI>
    <KeywordList>
      <Keywords>Acute toxicity</Keywords>
      <Keywords>Calendula officinalis essential oil</Keywords>
      <Keywords>Dermal toxicity</Keywords>
      <Keywords>OECD</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Arun K. Mishra</Name>
        <Affiliation>Central Facility of Instrumentation, Faculty of Pharmacy, IFTM University, Lodipur-Rajput, Moradabad, 244001, India. Electronic address: arun_azam@rediffmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Amrita Mishra</Name>
        <Affiliation>Central Facility of Instrumentation, Faculty of Pharmacy, IFTM University, Lodipur-Rajput, Moradabad, 244001, India.</Affiliation>
      </Author>
      <Author>
        <Name> Pragya</Name>
        <Affiliation>Central Facility of Instrumentation, Faculty of Pharmacy, IFTM University, Lodipur-Rajput, Moradabad, 244001, India.</Affiliation>
      </Author>
      <Author>
        <Name>Pronobesh Chattopadhyay</Name>
        <Affiliation>Pharmaceutical Technology Division, Defense Research Laboratory, DRDO, Tezpur, 784001, India.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Regulatory status of N-alkylamide containing health products.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30071240</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30181-8</DOI>
    <KeywordList>
      <Keywords>Biocidal products</Keywords>
      <Keywords>Cosmetic</Keywords>
      <Keywords>Food</Keywords>
      <Keywords>Legal-regulatory classification</Keywords>
      <Keywords>Medical device</Keywords>
      <Keywords>Medicine</Keywords>
      <Keywords>N-alkylamide-containing health products</Keywords>
      <Keywords>Plants</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Evelien Wynendaele</Name>
        <Affiliation>Drug Quality and Registration (DruQuaR) Group, Faculty of Pharmaceutical Sciences, Ghent University, Ottergemsesteenweg 460, B-9000 Ghent, Belgium. Electronic address: Ejwynend.Wynendaele@UGent.be.</Affiliation>
      </Author>
      <Author>
        <Name>Bart De Spiegeleer</Name>
        <Affiliation>Drug Quality and Registration (DruQuaR) Group, Faculty of Pharmaceutical Sciences, Ghent University, Ottergemsesteenweg 460, B-9000 Ghent, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Bert Gevaert</Name>
        <Affiliation>Drug Quality and Registration (DruQuaR) Group, Faculty of Pharmaceutical Sciences, Ghent University, Ottergemsesteenweg 460, B-9000 Ghent, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Yorick Janssens</Name>
        <Affiliation>Drug Quality and Registration (DruQuaR) Group, Faculty of Pharmaceutical Sciences, Ghent University, Ottergemsesteenweg 460, B-9000 Ghent, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Sultan Suleman</Name>
        <Affiliation>School of Pharmacy, Jimma University, PO. Box 378, Jimma, Ethiopia.</Affiliation>
      </Author>
      <Author>
        <Name>Steven Cattoor</Name>
        <Affiliation>Hoyng Rokh Monegier LLP, Nerviërslaan 9-31, B-1040 Brussels, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Jimmy H. Saunders</Name>
        <Affiliation>Department of Medical Imaging and Small Animal Orthopedics, Faculty of Veterinary Medicine, Ghent University, Salisburylaan 133, B-9820 Merelbeke, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Lieselotte Veryser</Name>
        <Affiliation>Drug Quality and Registration (DruQuaR) Group, Faculty of Pharmaceutical Sciences, Ghent University, Ottergemsesteenweg 460, B-9000 Ghent, Belgium.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A quantitative risk assessment for skin sensitizing plant protection products: Linking derived No-Effect levels (DNELs) with agricultural exposure models.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30063949</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30206-X</DOI>
    <KeywordList>
      <Keywords>Agricultural operator exposure model</Keywords>
      <Keywords>Allergic contact dermatitis</Keywords>
      <Keywords>Chemical skin sensitizers</Keywords>
      <Keywords>Derived No-Effect level (DNEL)</Keywords>
      <Keywords>Plant protection products</Keywords>
      <Keywords>Quantitative risk assessment</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Olivier Sanvido</Name>
        <Affiliation>State Secretariat for Economic Affairs, Holzikofenweg 36, CH-3003, Bern, Switzerland. Electronic address: olivier.sanvido@seco.admin.ch.</Affiliation>
      </Author>
      <Author>
        <Name>Kaspar Schmid</Name>
        <Affiliation>State Secretariat for Economic Affairs, Holzikofenweg 36, CH-3003, Bern, Switzerland. Electronic address: kaspar.schmid@seco.admin.ch.</Affiliation>
      </Author>
      <Author>
        <Name>Rex E. FitzGerald</Name>
        <Affiliation>University of Basel, Swiss Centre for Applied Human Toxicology, Missionsstrasse 64, CH-4055, Basel, Switzerland. Electronic address: rex.fitzgerald@unibas.ch.</Affiliation>
      </Author>
      <Author>
        <Name>Nicolas Roth</Name>
        <Affiliation>University of Basel, Swiss Centre for Applied Human Toxicology, Missionsstrasse 64, CH-4055, Basel, Switzerland. Electronic address: nicolas.roth@unibas.ch.</Affiliation>
      </Author>
      <Author>
        <Name>Martin F. Wilks</Name>
        <Affiliation>University of Basel, Swiss Centre for Applied Human Toxicology, Missionsstrasse 64, CH-4055, Basel, Switzerland. Electronic address: martin.wilks@unibas.ch.</Affiliation>
      </Author>
      <Author>
        <Name>Peter Bormann</Name>
        <Affiliation>Federal Office for Agriculture, Schwarzenburgstrasse 165, CH-3003, Bern, Switzerland. Electronic address: peter.bormann@blw.admin.ch.</Affiliation>
      </Author>
      <Author>
        <Name>Nancy B. Hopf</Name>
        <Affiliation>University of Lausanne, Institute for Work and Health (IST) , Route de la Corniche 2, CH-1066, Epalinges-Lausanne, Switzerland. Electronic address: Nancy.Hopf@hospvd.ch.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Assessment of the skin sensitisation hazard of functional polysiloxanes and silanes in the SENS-IS assay.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30056248</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30204-6</DOI>
    <KeywordList>
      <Keywords>DPRA</Keywords>
      <Keywords>Functional polysiloxanes and silanes</Keywords>
      <Keywords>GPMT</Keywords>
      <Keywords>In chemico</Keywords>
      <Keywords>In vitro</Keywords>
      <Keywords>KeratinoSens™</Keywords>
      <Keywords>LLNA</Keywords>
      <Keywords>SENS-IS</Keywords>
      <Keywords>Skin sensitisation</Keywords>
      <Keywords>h-CLAT</Keywords>
      <Keywords>mMUSST</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Thomas Petry</Name>
        <Affiliation>ToxMinds BVBA, Product Safety &amp; Regulatory Affairs, Brussels, B-1200, Belgium. Electronic address: thomas.petry@toxminds.com.</Affiliation>
      </Author>
      <Author>
        <Name>Axel Bosch</Name>
        <Affiliation>Wacker Chemie AG, Corporate Product Safety, Burghausen, D-84489, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Farah Koraïchi-Emeriau</Name>
        <Affiliation>EquiTox for Elkem Silicones, Saint Fons Cedex, F-69191, France.</Affiliation>
      </Author>
      <Author>
        <Name>Dorothea Eigler</Name>
        <Affiliation>Evonik Nutrition&amp; Care GmbH, Essen, D-45127, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Pierre Germain</Name>
        <Affiliation>CES - Silicones Europe, CEFIC, Brussels, B-1160, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Shawn Seidel</Name>
        <Affiliation>The Dow Chemical Company, Toxicology &amp; Environmental Research and Consulting, Midland, MI, 48674, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>In vivo toxicity study of quatro stimuli nanocontainers in pregnant rats: Gestation, parturition and offspring evaluation.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30056247</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30207-1</DOI>
    <KeywordList>
      <Keywords>Histopathology</Keywords>
      <Keywords>Nanocontainers</Keywords>
      <Keywords>Pregnancy</Keywords>
      <Keywords>Rat</Keywords>
      <Keywords>Toxicity</Keywords>
      <Keywords>Ultrasonography</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>P. Lelovas</Name>
        <Affiliation>Clinical, Experimental Surgery, &amp; Translational Research, Biomedical Research Foundation Academy of Athens (BRFAA), Athens, 115 27, Greece. Electronic address: paulveterin@yahoo.com.</Affiliation>
      </Author>
      <Author>
        <Name>E. K. Efthimiadou</Name>
        <Affiliation>Laboratory for Sol-Gel, Institute of Nanoscience and Nanotechnology, NCSR "Demokritos", 153 10, Ag.Paraskevi Attikis, Greece; Laboratory of Inorganic Chemistry, Chemistry Department, National and Kapodistrian University of Athens, Panepistimioupolis, Zografou, 157 71, Greece.</Affiliation>
      </Author>
      <Author>
        <Name>G. Mantziaras</Name>
        <Affiliation>Clinical, Experimental Surgery, &amp; Translational Research, Biomedical Research Foundation Academy of Athens (BRFAA), Athens, 115 27, Greece.</Affiliation>
      </Author>
      <Author>
        <Name>N. Siskos</Name>
        <Affiliation>Clinical, Experimental Surgery, &amp; Translational Research, Biomedical Research Foundation Academy of Athens (BRFAA), Athens, 115 27, Greece.</Affiliation>
      </Author>
      <Author>
        <Name>G. Kordas</Name>
        <Affiliation>Laboratory for Sol-Gel, Institute of Nanoscience and Nanotechnology, NCSR "Demokritos", 153 10, Ag.Paraskevi Attikis, Greece.</Affiliation>
      </Author>
      <Author>
        <Name>N. Kostomitsopoulos</Name>
        <Affiliation>Clinical, Experimental Surgery, &amp; Translational Research, Biomedical Research Foundation Academy of Athens (BRFAA), Athens, 115 27, Greece.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A 28-day subchronic feeding study of chicken injected by genetically modified DNA-vaccine of avian influenzas in Sprague-Dawley rats.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30056246</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30205-8</DOI>
    <KeywordList>
      <Keywords>Avian influenza</Keywords>
      <Keywords>Food safety</Keywords>
      <Keywords>Genetically modified</Keywords>
      <Keywords>Oral ingestion</Keywords>
      <Keywords>Vaccine</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Yuan Cao</Name>
        <Affiliation>College of Food Science and Nutritional Engineering, China Agricultural University, Beijing, 100083, China; Beijing Science and Technology Information Research Institute, Beijing, 100044, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaoyun He</Name>
        <Affiliation>Beijing Advanced Innovation Center for Food Nutrition and Human Health, College of Food Science and Nutritional Engineering, China Agricultural University, Beijing, 100083, China; Key Laboratory of Safety Assessment of Genetically Modified Organism (Food Safety), Ministry of Agriculture, 100083, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Wentao Xu</Name>
        <Affiliation>Beijing Advanced Innovation Center for Food Nutrition and Human Health, College of Food Science and Nutritional Engineering, China Agricultural University, Beijing, 100083, China; Key Laboratory of Safety Assessment of Genetically Modified Organism (Food Safety), Ministry of Agriculture, 100083, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Kunlun Huang</Name>
        <Affiliation>Beijing Advanced Innovation Center for Food Nutrition and Human Health, College of Food Science and Nutritional Engineering, China Agricultural University, Beijing, 100083, China; Key Laboratory of Safety Assessment of Genetically Modified Organism (Food Safety), Ministry of Agriculture, 100083, PR China. Electronic address: hkl009@163.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Consistency of listed indications and contraindications between the U.S., the U.K., Japan, and Korea on prescription drug labels.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30056245</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30208-3</DOI>
    <KeywordList>
      <Keywords>Contraindication</Keywords>
      <Keywords>Indication</Keywords>
      <Keywords>Label</Keywords>
      <Keywords>New drugs</Keywords>
      <Keywords>Safety</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Dongwon Yoon</Name>
        <Affiliation>School of Pharmacy, Sungkyunkwan University, Suwon, South Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Inmyung Song</Name>
        <Affiliation>School of Pharmacy, Sungkyunkwan University, Suwon, South Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Yunha Noh</Name>
        <Affiliation>School of Pharmacy, Sungkyunkwan University, Suwon, South Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Junqing Li</Name>
        <Affiliation>School of Pharmacy, Sungkyunkwan University, Suwon, South Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Ju Young Shin</Name>
        <Affiliation>School of Pharmacy, Sungkyunkwan University, Suwon, South Korea. Electronic address: shin.jy@skku.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Characterization of puff topography of a prototype electronic cigarette in adult exclusive cigarette smokers and adult exclusive electronic cigarette users.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30053435</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30203-4</DOI>
    <KeywordList>
      <Keywords>Cartridge-based</Keywords>
      <Keywords>E-cigarette users</Keywords>
      <Keywords>E-cigarettes</Keywords>
      <Keywords>E-vapor products</Keywords>
      <Keywords>Puff parameters</Keywords>
      <Keywords>Puff volume</Keywords>
      <Keywords>Smokers</Keywords>
      <Keywords>Topography</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Andrea Rae Vansickel</Name>
        <Affiliation>Altria Client Services LLC, Center for Research and Technology, 601 E. Jackson Street, Richmond, VA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jeffery S. Edmiston</Name>
        <Affiliation>Altria Client Services LLC, Center for Research and Technology, 601 E. Jackson Street, Richmond, VA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Qiwei Liang</Name>
        <Affiliation>Altria Client Services LLC, Center for Research and Technology, 601 E. Jackson Street, Richmond, VA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Cheryl Duhon</Name>
        <Affiliation>Altria Client Services LLC, Center for Research and Technology, 601 E. Jackson Street, Richmond, VA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Chris Connell</Name>
        <Affiliation>Altria Client Services LLC, Center for Research and Technology, 601 E. Jackson Street, Richmond, VA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>David Bennett</Name>
        <Affiliation>Altria Client Services LLC, Center for Research and Technology, 601 E. Jackson Street, Richmond, VA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Mohamadi Sarkar</Name>
        <Affiliation>Altria Client Services LLC, Center for Research and Technology, 601 E. Jackson Street, Richmond, VA, USA. Electronic address: Mohamadi.Sarkar@altria.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Industrial microbial enzyme safety: What does the weight-of-evidence indicate?</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30053434</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30200-9</DOI>
    <KeywordList>
      <Keywords>Decision tree</Keywords>
      <Keywords>Genotoxicity</Keywords>
      <Keywords>Health-based guidance values</Keywords>
      <Keywords>Microbial enzymes</Keywords>
      <Keywords>Safe strain lineage</Keywords>
      <Keywords>Safety</Keywords>
      <Keywords>Subchronic oral toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Gregory S. Ladics</Name>
        <Affiliation>DuPont Industrial Biosciences, Wilmington, DE, USA. Electronic address: gregory.s.ladics@dupont.com.</Affiliation>
      </Author>
      <Author>
        <Name>Vincent Sewalt</Name>
        <Affiliation>DuPont Industrial Biosciences, Palo Alto, CA, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Safety evaluation of two α-amylase enzyme preparations derived from Bacillus licheniformis expressing an α-amylase gene from Cytophaga species.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30048706</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30199-5</DOI>
    <KeywordList>
      <Keywords>Bacillus licheniformis</Keywords>
      <Keywords>Carbohydrate processing</Keywords>
      <Keywords>Cytophaga sp.</Keywords>
      <Keywords>Fermentation</Keywords>
      <Keywords>Safe strain lineage</Keywords>
      <Keywords>Safety studies</Keywords>
      <Keywords>Whole broth</Keywords>
      <Keywords>α-Amylase</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Vincent J. Sewalt</Name>
        <Affiliation>DuPont Industrial Biosciences, 925 Page Mill Road, Palo Alto, CA, 94304, USA. Electronic address: vincent.sewalt@dupont.com.</Affiliation>
      </Author>
      <Author>
        <Name>Teresa F. Reyes</Name>
        <Affiliation>DuPont Industrial Biosciences, 925 Page Mill Road, Palo Alto, CA, 94304, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Quang Bui</Name>
        <Affiliation>DuPont Industrial Biosciences, 925 Page Mill Road, Palo Alto, CA, 94304, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Is a combination of assays really needed for non-animal prediction of skin sensitization potential? Performance of the GARD™ (Genomic Allergen Rapid Detection) assay in comparison with OECD guideline assays alone and in combination.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30048705</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30198-3</DOI>
    <KeywordList>
      <Keywords>GARD™</Keywords>
      <Keywords>Integrated testing strategies</Keywords>
      <Keywords>Non-animal assays</Keywords>
      <Keywords>Skin sensitization potential</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>David W. Roberts</Name>
        <Affiliation>School of Pharmacy and Biomolecular Sciences, Liverpool John Moores University, Liverpool, L3 3AF, United Kingdom. Electronic address: d.w.roberts@ljmu.ac.uk.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Emerging technologies for food and drug safety.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30048704</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30197-1</DOI>
    <KeywordList>
      <Keywords>Alternative methods</Keywords>
      <Keywords>Best practices</Keywords>
      <Keywords>Cross-training</Keywords>
      <Keywords>Drug safety</Keywords>
      <Keywords>Emerging technologies</Keywords>
      <Keywords>Food safety</Keywords>
      <Keywords>Global coalition</Keywords>
      <Keywords>Regulatory agencies</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>William Slikker</Name>
        <Affiliation>U.S. Food and Drug Administration, United States. Electronic address: william.slikker@fda.hhs.gov.</Affiliation>
      </Author>
      <Author>
        <Name>Thalita Antony de Souza Lima</Name>
        <Affiliation>Brazilian Health Surveillance Agency (ANVISA), Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Davide Archella</Name>
        <Affiliation>European Food Safety Authority (EFSA), Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Jarbas Barbosa de Silva</Name>
        <Affiliation>Brazilian Health Surveillance Agency (ANVISA), Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Tara Barton-Maclaren</Name>
        <Affiliation>Existing Substances Risk Assessment Bureau, Health Canada, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Li Bo</Name>
        <Affiliation>National Institutes for Food and Drug Control (NIFDC), China Food and Drug Administration (CFDA), China.</Affiliation>
      </Author>
      <Author>
        <Name>Danitza Buvinich</Name>
        <Affiliation>Brazilian Health Surveillance Agency (ANVISA), Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Qasim Chaudhry</Name>
        <Affiliation>University of Chester, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Peiying Chuan</Name>
        <Affiliation>Agency for Science, Technology of Research (A*STAR), Singapore.</Affiliation>
      </Author>
      <Author>
        <Name>Hubert Deluyker</Name>
        <Affiliation>European Food Safety Authority (EFSA), Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Gary Domselaar</Name>
        <Affiliation>Public Health Agency of Canada, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Meiruze Freitas</Name>
        <Affiliation>Brazilian Health Surveillance Agency (ANVISA), Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Barry Hardy</Name>
        <Affiliation>Douglas Connect, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Hans Georg Eichler</Name>
        <Affiliation>European Medicines Agency (EMA), United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Marta Hugas</Name>
        <Affiliation>European Food Safety Authority (EFSA), Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Kenneth Lee</Name>
        <Affiliation>Agency for Science, Technology of Research (A*STAR), Singapore.</Affiliation>
      </Author>
      <Author>
        <Name>Chia Ding Liao</Name>
        <Affiliation>Food and Drug Administration, Ministry of Health and Welfare (MHW), Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Lit Hsin Loo</Name>
        <Affiliation>Agency for Science, Technology of Research (A*STAR), Singapore.</Affiliation>
      </Author>
      <Author>
        <Name>Haruhiro Okuda</Name>
        <Affiliation>National Institute of Health Sciences, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Orish Ebere Orisakwe</Name>
        <Affiliation>University of Port Harcourt, Nigeria.</Affiliation>
      </Author>
      <Author>
        <Name>Anil Patri</Name>
        <Affiliation>U.S. Food and Drug Administration, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Carl Sactitono</Name>
        <Affiliation>U.S. Food and Drug Administration, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Leming Shi</Name>
        <Affiliation>Fudan University in Shanghai, China.</Affiliation>
      </Author>
      <Author>
        <Name>Primal Silva</Name>
        <Affiliation>Canadian Food Inspection Agency (CFIA), Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Frank Sistare</Name>
        <Affiliation>Safety Assessment and Laboratory Animal Resources, Merck &amp; Co., Inc., West Point, PA, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Shraddha Thakkar</Name>
        <Affiliation>U.S. Food and Drug Administration, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Weida Tong</Name>
        <Affiliation>U.S. Food and Drug Administration, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Mary Lou Valdez</Name>
        <Affiliation>U.S. Food and Drug Administration, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Maurice Whelan</Name>
        <Affiliation>European Commission, Joint Research Centre, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Anna Zhao-Wong</Name>
        <Affiliation>MedDRA Maintenance and Support Services Organization (MSSO), United States.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Scientific advances and challenges in safety evaluation of food packaging materials: Workshop proceedings.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30048703</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30202-2</DOI>
    <KeywordList>
      <Keywords>Analytical methods</Keywords>
      <Keywords>Exposure</Keywords>
      <Keywords>Food packaging</Keywords>
      <Keywords>Risk assessment</Keywords>
      <Keywords>Toxicology</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Agnes L. Karmaus</Name>
        <Affiliation>Integrated Laboratory Systems, Inc., 601 Keystone Park Drive, Suite 200, Morrisville, NC, 27560, USA. Electronic address: agnes.karmaus@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Ron Osborn</Name>
        <Affiliation>Mars Wrigley Confectionery, Global Innovation Center, Chicago, IL, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Mansi Krishan</Name>
        <Affiliation>North American Branch of the International Life Sciences Institute (ILSI North America), 740 15th Street NW, Suite 600, Washington, DC, 20005, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Acute, subchronic oral toxicity, and genotoxicity evaluations of LPM570065, a new potent triple reuptake inhibitor.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30030102</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30189-2</DOI>
    <KeywordList>
      <Keywords>LPM570065</Keywords>
      <Keywords>Toxicity</Keywords>
      <Keywords>Triple reuptake inhibitor (TRI)</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Chunmei Li</Name>
        <Affiliation>School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University, Yantai, 264005, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Wanglin Jiang</Name>
        <Affiliation>School of Pharmacy, Binzhou Medical University, Yantai, 264003, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Yonglin Gao</Name>
        <Affiliation>School of Life Sciences, Yantai University, Yantai, 264005, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Fei Lin</Name>
        <Affiliation>State Key Laboratory of Long-acting Targeting Drug Delivery Technologies (Luye Pharma Group Ltd.), Yantai, 264003, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Haibo Zhu</Name>
        <Affiliation>School of Public Health and Management, Binzhou Medical University, Yantai, 264003, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Hongbo Wang</Name>
        <Affiliation>School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University, Yantai, 264005, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Liang Ye</Name>
        <Affiliation>School of Public Health and Management, Binzhou Medical University, Yantai, 264003, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Jia Grace Qi</Name>
        <Affiliation>School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University, Yantai, 264005, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Jingwei Tian</Name>
        <Affiliation>School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University, Yantai, 264005, PR China. Electronic address: tianjingwei@luye.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Ginsenoside Rg1 protects against acetaminophen-induced liver injury via activating Nrf2 signaling pathway in vivo and in vitro.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30030101</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30190-9</DOI>
    <KeywordList>
      <Keywords>Acetaminophen (APAP)</Keywords>
      <Keywords>Acute liver injury</Keywords>
      <Keywords>Ginsenoside Rg1</Keywords>
      <Keywords>Nuclear factor erythroid-2-related factor 2 (Nrf2)</Keywords>
      <Keywords>Oxidative stress</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Chenqing Ning</Name>
        <Affiliation>Department of Clinical Pharmacology, College of Pharmacy, Dalian Medical University, Dalian, 116044, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaoguang Gao</Name>
        <Affiliation>Department of Clinical Pharmacology, College of Pharmacy, Dalian Medical University, Dalian, 116044, China.</Affiliation>
      </Author>
      <Author>
        <Name>Changyuan Wang</Name>
        <Affiliation>Department of Clinical Pharmacology, College of Pharmacy, Dalian Medical University, Dalian, 116044, China; Key Laboratory of Pharmacokinetics and Transport of Liaoning Province, Dalian Medical University, Dalian, 116044, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yulong Kong</Name>
        <Affiliation>Department of Clinical Pharmacology, College of Pharmacy, Dalian Medical University, Dalian, 116044, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhihao Liu</Name>
        <Affiliation>Department of Clinical Pharmacology, College of Pharmacy, Dalian Medical University, Dalian, 116044, China; Key Laboratory of Pharmacokinetics and Transport of Liaoning Province, Dalian Medical University, Dalian, 116044, China.</Affiliation>
      </Author>
      <Author>
        <Name>Huijun Sun</Name>
        <Affiliation>Department of Clinical Pharmacology, College of Pharmacy, Dalian Medical University, Dalian, 116044, China; Key Laboratory of Pharmacokinetics and Transport of Liaoning Province, Dalian Medical University, Dalian, 116044, China.</Affiliation>
      </Author>
      <Author>
        <Name>Pengyuan Sun</Name>
        <Affiliation>Department of Clinical Pharmacology, College of Pharmacy, Dalian Medical University, Dalian, 116044, China; Key Laboratory of Pharmacokinetics and Transport of Liaoning Province, Dalian Medical University, Dalian, 116044, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaokui Huo</Name>
        <Affiliation>Department of Clinical Pharmacology, College of Pharmacy, Dalian Medical University, Dalian, 116044, China; Key Laboratory of Pharmacokinetics and Transport of Liaoning Province, Dalian Medical University, Dalian, 116044, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaodong Ma</Name>
        <Affiliation>Department of Clinical Pharmacology, College of Pharmacy, Dalian Medical University, Dalian, 116044, China; Key Laboratory of Pharmacokinetics and Transport of Liaoning Province, Dalian Medical University, Dalian, 116044, China.</Affiliation>
      </Author>
      <Author>
        <Name>Qiang Meng</Name>
        <Affiliation>Department of Clinical Pharmacology, College of Pharmacy, Dalian Medical University, Dalian, 116044, China; Key Laboratory of Pharmacokinetics and Transport of Liaoning Province, Dalian Medical University, Dalian, 116044, China. Electronic address: qiangmeng@dlmedu.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Kexin Liu</Name>
        <Affiliation>Department of Clinical Pharmacology, College of Pharmacy, Dalian Medical University, Dalian, 116044, China; Key Laboratory of Pharmacokinetics and Transport of Liaoning Province, Dalian Medical University, Dalian, 116044, China. Electronic address: kexinliu@dlmedu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Safety assessment of Oryeong-san, a traditional herbal formula: Study of subacute toxicity and influence of cytochrome P450s and UDP-glucuronosyltransferases.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30026136</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30188-0</DOI>
    <KeywordList>
      <Keywords>Cytochrome P450s</Keywords>
      <Keywords>Herbal formula</Keywords>
      <Keywords>Oryeong-san</Keywords>
      <Keywords>Subacute toxicity</Keywords>
      <Keywords>UDP-glucuronosyltransferase</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Woo Young Jeon</Name>
        <Affiliation>Clinical Medicine Division, Korea Institute of Oriental Medicine, 1672 Yuseong-daero, Yuseong-gu, Daejeon, 34054, Republic of Korea. Electronic address: ssamggun85@kiom.re.kr.</Affiliation>
      </Author>
      <Author>
        <Name>Seong Eun Jin</Name>
        <Affiliation>Herbal Medicine Research Division, Korea Institute of Oriental Medicine, 1672 Yuseong-daero, Yuseong-gu, Daejeon, 34054, Republic of Korea. Electronic address: noellajin@kiom.re.kr.</Affiliation>
      </Author>
      <Author>
        <Name>Mee Young Lee</Name>
        <Affiliation>Clinical Medicine Division, Korea Institute of Oriental Medicine, 1672 Yuseong-daero, Yuseong-gu, Daejeon, 34054, Republic of Korea. Electronic address: cozy11@kiom.re.kr.</Affiliation>
      </Author>
      <Author>
        <Name>Chang Seob Seo</Name>
        <Affiliation>Herbal Medicine Research Division, Korea Institute of Oriental Medicine, 1672 Yuseong-daero, Yuseong-gu, Daejeon, 34054, Republic of Korea. Electronic address: csseo0914@kiom.re.kr.</Affiliation>
      </Author>
      <Author>
        <Name>Hyeun Kyoo Shin</Name>
        <Affiliation>Herbal Medicine Research Division, Korea Institute of Oriental Medicine, 1672 Yuseong-daero, Yuseong-gu, Daejeon, 34054, Republic of Korea. Electronic address: hkshin@kiom.re.kr.</Affiliation>
      </Author>
      <Author>
        <Name>Yong Bum Kim</Name>
        <Affiliation>Korea Institute of Toxicology, 141 Gajeong-ro, Yuseong-gu, Daejeon, 34114, Republic of Korea. Electronic address: ybkim@kitox.re.kr.</Affiliation>
      </Author>
      <Author>
        <Name>Hyekyung Ha</Name>
        <Affiliation>Herbal Medicine Research Division, Korea Institute of Oriental Medicine, 1672 Yuseong-daero, Yuseong-gu, Daejeon, 34054, Republic of Korea. Electronic address: hkha@kiom.re.kr.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Current strategies in the non-clinical safety assessment of biologics: New targets, new molecules, new challenges.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30026135</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30187-9</DOI>
    <KeywordList>
      <Keywords>Adversity</Keywords>
      <Keywords>Biopharmaceuticals</Keywords>
      <Keywords>Bispecifics</Keywords>
      <Keywords>Cytokine release</Keywords>
      <Keywords>Emerging therapies</Keywords>
      <Keywords>Gene and cell therapies</Keywords>
      <Keywords>Gene editing</Keywords>
      <Keywords>Immune-oncology</Keywords>
      <Keywords>Immunomodulation</Keywords>
      <Keywords>Microbiome</Keywords>
      <Keywords>Minimum anticipated biological effect level (MABEL)</Keywords>
      <Keywords>Monoclonal antibodies</Keywords>
      <Keywords>No observed adverse effect level (NOAEL)</Keywords>
      <Keywords>Nonclinical safety</Keywords>
      <Keywords>Nonclinical species selection</Keywords>
      <Keywords>Oligonucleotide</Keywords>
      <Keywords>Orphan drug</Keywords>
      <Keywords>Pharmacodynamics (PD)</Keywords>
      <Keywords>Pharmacokinetics (PK)</Keywords>
      <Keywords>Recombinant proteins</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Frank R. Brennan</Name>
        <Affiliation>UCB Pharma, Slough, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Laura Andrews</Name>
        <Affiliation>Abbvie, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Antonio R. Arulanandam</Name>
        <Affiliation>Agilis Biotherapeutics Inc., USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jorg Blumel</Name>
        <Affiliation>Genentech, Inc, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jim Fikes</Name>
        <Affiliation>Biogen-Idec, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Christine Grimaldi</Name>
        <Affiliation>Boehringer-Ingelheim, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Janice Lansita</Name>
        <Affiliation>ToxStrategies Inc., USA.</Affiliation>
      </Author>
      <Author>
        <Name>Lise I. Loberg</Name>
        <Affiliation>Abbvie, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Tim MacLachlan</Name>
        <Affiliation>Novartis Pharma, Boston, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Mark Milton</Name>
        <Affiliation>Novartis Pharma, Boston, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Suezanne Parker</Name>
        <Affiliation>Shire Pharmaceutical Inc, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jay Tibbitts</Name>
        <Affiliation>Abbvie, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jayanthi Wolf</Name>
        <Affiliation>Merck &amp; Co., Inc, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Krishna P. Allamneni</Name>
        <Affiliation>Jazz Pharmaceuticals, USA. Electronic address: krishna.allamneni@jazzpharma.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Taurine treatment decreases inflammation and oxidative stress in lungs of adult mice exposed to cigarette smoke.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30026134</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30186-7</DOI>
    <KeywordList>
      <Keywords>Antioxidant</Keywords>
      <Keywords>Cigarette smoke</Keywords>
      <Keywords>Inflammation</Keywords>
      <Keywords>Oxidative stress</Keywords>
      <Keywords>Taurine</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Camila de Oliveira Ramos</Name>
        <Affiliation>Laboratory of Experimental Pathophysiology (LAFEx), Department of Biological Sciences (DECBI), Center of Research in Biological Sciences (NUPEB), Federal University of Ouro Preto (UFOP), Ouro Preto, MG, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Keila Karine Duarte Campos</Name>
        <Affiliation>Laboratory of Experimental Pathophysiology (LAFEx), Department of Biological Sciences (DECBI), Center of Research in Biological Sciences (NUPEB), Federal University of Ouro Preto (UFOP), Ouro Preto, MG, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Guilherme de Paula Costa</Name>
        <Affiliation>Laboratory of Immunobiology of Inflammation (LABIIN), Department of Biological Sciences (DECBI), Center of Research in Biological Sciences(NUPEB), Federal University of Ouro Preto (UFOP), Ouro Preto, MG, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Sílvia Dantas Cangussú</Name>
        <Affiliation>Laboratory of Experimental Pathophysiology (LAFEx), Department of Biological Sciences (DECBI), Center of Research in Biological Sciences (NUPEB), Federal University of Ouro Preto (UFOP), Ouro Preto, MG, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>André Talvani</Name>
        <Affiliation>Laboratory of Immunobiology of Inflammation (LABIIN), Department of Biological Sciences (DECBI), Center of Research in Biological Sciences(NUPEB), Federal University of Ouro Preto (UFOP), Ouro Preto, MG, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Frank Silva Bezerra</Name>
        <Affiliation>Laboratory of Experimental Pathophysiology (LAFEx), Department of Biological Sciences (DECBI), Center of Research in Biological Sciences (NUPEB), Federal University of Ouro Preto (UFOP), Ouro Preto, MG, Brazil. Electronic address: franksbezerra@hotmail.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Obfuscating transparency?</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30017904</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30182-X</DOI>
    <AuthorList>
      <Author>
        <Name>Michael Aschner</Name>
        <Affiliation>Department of Molecular Pharmacology, Albert Einstein College of Medicine, Bronx, NY, USA. Electronic address: Michael.Aschner@einstein.yu.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Herman Autrup</Name>
        <Affiliation>Institute of Public Health, University of Aarhus, Aarhus, Denmark. Electronic address: ha@ph.au.dk.</Affiliation>
      </Author>
      <Author>
        <Name>Colin L. Berry</Name>
        <Affiliation>Emeritus of Pathology, Queen Mary, London, UK. Electronic address: colin@sircolinberry.co.uk.</Affiliation>
      </Author>
      <Author>
        <Name>Alan R. Boobis</Name>
        <Affiliation>Department of Medicine, Imperial College London, London, UK. Electronic address: a.boobis@imperial.ac.uk.</Affiliation>
      </Author>
      <Author>
        <Name>Samuel M. Cohen</Name>
        <Affiliation>Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE, USA. Electronic address: scohen@unmc.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Wolfgang Dekant</Name>
        <Affiliation>Department of Toxicology, University of Wuerzburg, Wuerzburg, Germany. Electronic address: dekant@toxi.uni-wuerzburg.de.</Affiliation>
      </Author>
      <Author>
        <Name>Corrado L. Galli</Name>
        <Affiliation>Toxicology and Risk Assessment, Pharmacological and Biomolecular Sciences, University of Milan, Milan, Italy. Electronic address: corrado.galli@unimi.it.</Affiliation>
      </Author>
      <Author>
        <Name>Jay I. Goodman</Name>
        <Affiliation>Pharmacology &amp; Toxicology Department, Michigan State University East Lansing, MI, USA. Electronic address: goodman3@msu.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Gio B. Gori</Name>
        <Affiliation>The Health Policy Center, Editor, Regulatory Toxicology and Pharmacology, Bethesda, MD, USA. Electronic address: gorigb@msn.com.</Affiliation>
      </Author>
      <Author>
        <Name>Helmut A. Greim</Name>
        <Affiliation>Technical University of Munich, Munich, Germany. Electronic address: helmut.greim@lrz.tum.de.</Affiliation>
      </Author>
      <Author>
        <Name>Norbert E. Kaminski</Name>
        <Affiliation>Pharmacology &amp; Toxicology, Director, Institute for Integrative Toxicology, Michigan State University, East Lansing, MI, USA. Electronic address: kamins11@msu.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Curtis D. Klaassen</Name>
        <Affiliation>Department of Pharmacology, Toxicology and Therapeutics, College of Medicine, University of Kansas, Kansas City, KS, USA. Electronic address: curtisklaassenphd@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>James E. Klaunig</Name>
        <Affiliation>Department of Environmental Health, School of Public Health, Indiana University Bloomington, IN, USA. Electronic address: jklauni@indiana.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Marcello Lotti</Name>
        <Affiliation>Department of Cardiology, Thoracic and Vascular Sciences, School of Medicine, University of Padua, Padua, Italy. Electronic address: marcello.lotti@unipd.it.</Affiliation>
      </Author>
      <Author>
        <Name>Hans Wj Marquardt</Name>
        <Affiliation>Experimental and Clinical Toxicology, University of Hamburg Medical School, Hambug, Germany. Electronic address: marquardt@uke.uni-hamburg.de.</Affiliation>
      </Author>
      <Author>
        <Name>Angelo Moretto</Name>
        <Affiliation>Department of, Biomedical and Clinical Sciences, University of Milan, Milan, Italy. Electronic address: angelo.moretto@unimi.it.</Affiliation>
      </Author>
      <Author>
        <Name>Olavi Pelkonen</Name>
        <Affiliation>Pharmacology and Toxicology, University of Oulu, Oulu, Finland. Electronic address: olavi.pelkonen@oulu.fi.</Affiliation>
      </Author>
      <Author>
        <Name>I. Glenn Sipes</Name>
        <Affiliation>Pharmacology, University of Arizona, Tucson, AZ, USA. Electronic address: Sipes@email.arizona.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Kendall B. Wallace</Name>
        <Affiliation>Biochemistry &amp; Molecular Biology, University of Minnesota Medical School, Duluth, MN, USA. Electronic address: kwallace@d.umn.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Hiroshi Yamazaki</Name>
        <Affiliation>The Japanese Society for the Study of Xenobiotics, Showa Pharmaceutical University, Machida, Tokyo, Japan. Electronic address: hyamazak@ac.shoyaku.ac.jp.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Parental transfer of perfluorooctane sulfonate and ZnO nanoparticles chronic co-exposure and inhibition of growth in F1 offspring.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30017903</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30183-1</DOI>
    <KeywordList>
      <Keywords>F1 generation</Keywords>
      <Keywords>HPG axis</Keywords>
      <Keywords>Nano-ZnO</Keywords>
      <Keywords>PFOS</Keywords>
      <Keywords>Parental transfer</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jia Du</Name>
        <Affiliation>Institute of Environmental Science and Engineering, College of Materials and Environmental Engineering, Hangzhou Dianzi University, 1158, Baiyang Rd, Hangzhou, 310018, PR China. Electronic address: djhd@hdu.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Junhong Tang</Name>
        <Affiliation>Institute of Environmental Science and Engineering, College of Materials and Environmental Engineering, Hangzhou Dianzi University, 1158, Baiyang Rd, Hangzhou, 310018, PR China. Electronic address: Tang_jhjh@tom.com.</Affiliation>
      </Author>
      <Author>
        <Name>Shaodan Xu</Name>
        <Affiliation>Institute of Environmental Science and Engineering, College of Materials and Environmental Engineering, Hangzhou Dianzi University, 1158, Baiyang Rd, Hangzhou, 310018, PR China. Electronic address: xusd@hdu.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Jingyuan Ge</Name>
        <Affiliation>Institute of Environmental Science and Engineering, College of Materials and Environmental Engineering, Hangzhou Dianzi University, 1158, Baiyang Rd, Hangzhou, 310018, PR China. Electronic address: gejingyuan@hdu.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Yuwei Dong</Name>
        <Affiliation>Institute of Environmental Science and Engineering, College of Materials and Environmental Engineering, Hangzhou Dianzi University, 1158, Baiyang Rd, Hangzhou, 310018, PR China. Electronic address: ywdong@hdu.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Huanxuan Li</Name>
        <Affiliation>Institute of Environmental Science and Engineering, College of Materials and Environmental Engineering, Hangzhou Dianzi University, 1158, Baiyang Rd, Hangzhou, 310018, PR China. Electronic address: hxlee@hdu.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Meiqing Jin</Name>
        <Affiliation>Institute of Environmental Science and Engineering, College of Materials and Environmental Engineering, Hangzhou Dianzi University, 1158, Baiyang Rd, Hangzhou, 310018, PR China. Electronic address: jmq@hdu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Applying a weight of evidence approach to the evaluation of developmental toxicity of biopharmaceuticals.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30009863</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30184-3</DOI>
    <KeywordList>
      <Keywords>Biopharmaceutical</Keywords>
      <Keywords>Developmental toxicity</Keywords>
      <Keywords>Embryo-fetal development</Keywords>
      <Keywords>Pregnancy</Keywords>
      <Keywords>Teratogen</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Meredith Rocca</Name>
        <Affiliation>Janssen R&amp;D LLC, Spring House, PA, United States. Electronic address: mrocca@its.jnj.com.</Affiliation>
      </Author>
      <Author>
        <Name>LaRonda L. Morford</Name>
        <Affiliation>Lilly Research Laboratories, Indianapolis, IN, United States. Electronic address: lmorford@lilly.com.</Affiliation>
      </Author>
      <Author>
        <Name>Diann L. Blanset</Name>
        <Affiliation>Boehringer Ingelheim, Ridgefield, CT, United States. Electronic address: diann.blanset@boehringer-ingelheim.com.</Affiliation>
      </Author>
      <Author>
        <Name>Wendy G. Halpern</Name>
        <Affiliation>Genentech, A Member of the Roche Group, South San Francisco, CA, United States. Electronic address: halpern.wendy@gene.com.</Affiliation>
      </Author>
      <Author>
        <Name>Joy Cavagnaro</Name>
        <Affiliation>Access BIO, LC, Boyce, VA, United States. Electronic address: jcavagnaro@accessbio.com.</Affiliation>
      </Author>
      <Author>
        <Name>Christopher J. Bowman</Name>
        <Affiliation>Pfizer, Inc, Drug Safety Research &amp; Development, Groton, CT, United States. Electronic address: christopher.j.bowman@pfizer.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Effects of dietary alpha-linolenic acid-enriched diacylglycerol oil on embryo/fetal development in rats.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30009862</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30185-5</DOI>
    <KeywordList>
      <Keywords>Alpha linolenic acid</Keywords>
      <Keywords>Developmental toxicity</Keywords>
      <Keywords>Diacylglycerol oil</Keywords>
      <Keywords>Flaxseed oil</Keywords>
      <Keywords>Food ingredient</Keywords>
      <Keywords>Teratology</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Hiroto Bushita</Name>
        <Affiliation>R&amp;D Safety Science Research, Kao Corporation, 2-1-3, Bunka, Sumida-ku, Tokyo, 131-8501, Japan. Electronic address: bushita.hiroto@kao.com.</Affiliation>
      </Author>
      <Author>
        <Name>Shujie Liu</Name>
        <Affiliation>R&amp;D Safety Science Research, Kao Corporation, 2606, Akabane, Ichikai-machi, Haga-gun, Tochigi, 321-3497, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Takafumi Ohta</Name>
        <Affiliation>Kumamoto Safety Assessment Department, Nonclinical Research Center, Drug Development Service Segment, LSI Medience Corporation, 1285, Kurisaki-machi, Uto-shi, Kumamoto, 869-0425, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Yuichi Ito</Name>
        <Affiliation>R&amp;D Safety Science Research, Kao Corporation, 2-1-3, Bunka, Sumida-ku, Tokyo, 131-8501, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Kazutoshi Saito</Name>
        <Affiliation>R&amp;D Safety Science Research, Kao Corporation, 2606, Akabane, Ichikai-machi, Haga-gun, Tochigi, 321-3497, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Yuko Nukada</Name>
        <Affiliation>R&amp;D Safety Science Research, Kao Corporation, 2606, Akabane, Ichikai-machi, Haga-gun, Tochigi, 321-3497, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Naohiro Ikeda</Name>
        <Affiliation>R&amp;D Safety Science Research, Kao Corporation, 2606, Akabane, Ichikai-machi, Haga-gun, Tochigi, 321-3497, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Osamu Morita</Name>
        <Affiliation>R&amp;D Safety Science Research, Kao Corporation, 2606, Akabane, Ichikai-machi, Haga-gun, Tochigi, 321-3497, Japan.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Determination of chidamide in rat plasma and cerebrospinal fluid.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30008379</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30179-X</DOI>
    <KeywordList>
      <Keywords>Blood brain barrier (BBB)</Keywords>
      <Keywords>Cerebrospinal fluid (CSF)</Keywords>
      <Keywords>Chidamide</Keywords>
      <Keywords>HPLC-MS/MS</Keywords>
      <Keywords>Plasma</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Haiyan Yang</Name>
        <Affiliation>Chemotherapy Center, Zhejiang Province Cancer Hospital, 1 Banshandong Road, Gongshu District, Hangzhou, 310012, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Cong Li</Name>
        <Affiliation>Chemotherapy Center, Zhejiang Province Cancer Hospital, 1 Banshandong Road, Gongshu District, Hangzhou, 310012, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhongjian Chen</Name>
        <Affiliation>Zhejiang Cancer Research Institute, Zhejiang Province Cancer Hospital, 1 Banshandong Road, Gongshu District, Hangzhou, 310012, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Hanzhou Mou</Name>
        <Affiliation>Zhejiang Cancer Research Institute, Zhejiang Province Cancer Hospital, 1 Banshandong Road, Gongshu District, Hangzhou, 310012, PR China. Electronic address: mouhz@zjcc.org.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Liqiang Gu</Name>
        <Affiliation>Center of Safety Evaluation, Zhejiang Academy of Medical Sciences, 587 Binkang Road, Binjiang District, Hangzhou, 310053, PR China; College of Pharmaceutical Science, Zhejiang Chinese Medical University, 548 Binwen Road, Binjiang District, Hangzhou, 310053, PR China. Electronic address: xiaoguddy@163.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Investigation on the relationship between critical body residue and bioconcentration in zebrafish based on bio-uptake kinetics for five nitro-aromatics.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30008378</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30180-6</DOI>
    <KeywordList>
      <Keywords>Bio-uptake kinetics</Keywords>
      <Keywords>Bioconcentration</Keywords>
      <Keywords>Critical body residue</Keywords>
      <Keywords>Hydrophobicity</Keywords>
      <Keywords>Nitrobenzenes</Keywords>
      <Keywords>Toxicity ratio</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Yi Yang</Name>
        <Affiliation>State Environmental Protection Key Laboratory of Wetland Ecology and Vegetation Restoration, School of Environment, Northeast Normal University, Changchun, Jilin 130117, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Tiantian Li</Name>
        <Affiliation>State Environmental Protection Key Laboratory of Wetland Ecology and Vegetation Restoration, School of Environment, Northeast Normal University, Changchun, Jilin 130117, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Lichen Yan</Name>
        <Affiliation>State Environmental Protection Key Laboratory of Wetland Ecology and Vegetation Restoration, School of Environment, Northeast Normal University, Changchun, Jilin 130117, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Yang Yu</Name>
        <Affiliation>State Environmental Protection Key Laboratory of Wetland Ecology and Vegetation Restoration, School of Environment, Northeast Normal University, Changchun, Jilin 130117, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Shuo Wang</Name>
        <Affiliation>State Environmental Protection Key Laboratory of Wetland Ecology and Vegetation Restoration, School of Environment, Northeast Normal University, Changchun, Jilin 130117, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Chao Li</Name>
        <Affiliation>State Environmental Protection Key Laboratory of Wetland Ecology and Vegetation Restoration, School of Environment, Northeast Normal University, Changchun, Jilin 130117, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Yang Wen</Name>
        <Affiliation>Key Laboratory of Environmental Materials and Pollution Control, The Education Department of Jilin Province, School of Environmental Science and Engineering, Jilin Normal University, Siping, Jilin 136000, PR China. Electronic address: weny501@126.com.</Affiliation>
      </Author>
      <Author>
        <Name>Yuanhui Zhao</Name>
        <Affiliation>State Environmental Protection Key Laboratory of Wetland Ecology and Vegetation Restoration, School of Environment, Northeast Normal University, Changchun, Jilin 130117, PR China. Electronic address: zhaoyh@nenu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Development of nutritional risk assessment platform in Korea.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29983384</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30178-8</DOI>
    <KeywordList>
      <Keywords>Dietary modeling</Keywords>
      <Keywords>Integrated database</Keywords>
      <Keywords>Nutritional fortification and reduction</Keywords>
      <Keywords>Nutritional risk assessment</Keywords>
      <Keywords>Simulation</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Hunjoo Lee</Name>
        <Affiliation>CHEM.I.NET Ltd., Room 302, 773-3, Mok-dong, Yangcheon-gu, Seoul, South Korea. Electronic address: adstar@cheminet.kr.</Affiliation>
      </Author>
      <Author>
        <Name>Nam Ji Kwon</Name>
        <Affiliation>CHEM.I.NET Ltd., Room 302, 773-3, Mok-dong, Yangcheon-gu, Seoul, South Korea; College of Pharmacy, Duksung Women's University, Seoul, South Korea. Electronic address: njkwon@cheminet.kr.</Affiliation>
      </Author>
      <Author>
        <Name>Yongsoo Kim</Name>
        <Affiliation>Korea Health Industry Development Institute, 187 Osongsaengmyeong2(i)-ro, Gangoe-myeon, Cheongwon-gun, Chungcheongbuk-do, 363-951, South Korea. Electronic address: kimys@khidi.or.kr.</Affiliation>
      </Author>
      <Author>
        <Name>Eunyoung Han</Name>
        <Affiliation>College of Pharmacy, Duksung Women's University, Seoul, South Korea; Innovative Drug Center, Duksung Women's University, 33, Samyangro 144-gil, DobongGu, Seoul, South Korea. Electronic address: homepage2600@duksung.ac.kr.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Role of testing standards in smoke-free product assessments.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29983383</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30177-6</DOI>
    <AuthorList>
      <Author>
        <Name>M. Belushkin</Name>
        <Affiliation>PMI R&amp;D, Philip Morris Products S.A (Part of Philip Morris International Group of Companies), Quai Jeanrenaud 5, CH-2000, Neuchâtel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>M. Esposito</Name>
        <Affiliation>PMI R&amp;D, Philip Morris Products S.A (Part of Philip Morris International Group of Companies), Quai Jeanrenaud 5, CH-2000, Neuchâtel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>G. Jaccard</Name>
        <Affiliation>PMI R&amp;D, Philip Morris Products S.A (Part of Philip Morris International Group of Companies), Quai Jeanrenaud 5, CH-2000, Neuchâtel, Switzerland. Electronic address: Guy.Jaccard@pmi.com.</Affiliation>
      </Author>
      <Author>
        <Name>C. Jeannet</Name>
        <Affiliation>PMI R&amp;D, Philip Morris Products S.A (Part of Philip Morris International Group of Companies), Quai Jeanrenaud 5, CH-2000, Neuchâtel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>A. Korneliou</Name>
        <Affiliation>PMI R&amp;D, Philip Morris Products S.A (Part of Philip Morris International Group of Companies), Quai Jeanrenaud 5, CH-2000, Neuchâtel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>D. Tafin Djoko</Name>
        <Affiliation>PMI R&amp;D, Philip Morris Products S.A (Part of Philip Morris International Group of Companies), Quai Jeanrenaud 5, CH-2000, Neuchâtel, Switzerland.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Exploration of toxicological impacts following acute and sub-chronic exposure to ethyl anthranilate-loaded mosquito repellent patch.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29969653</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30176-4</DOI>
    <KeywordList>
      <Keywords>Acute exposure</Keywords>
      <Keywords>Dermal toxicity</Keywords>
      <Keywords>Ethyl anthranilate</Keywords>
      <Keywords>Mosquito</Keywords>
      <Keywords>Patch</Keywords>
      <Keywords>Penh</Keywords>
      <Keywords>Pulmonary toxicity</Keywords>
      <Keywords>Repellents</Keywords>
      <Keywords>Sub-chronic exposure</Keywords>
      <Keywords>Whole body plethysmograph</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Johirul Islam</Name>
        <Affiliation>Defence Research Laboratory, Tezpur, Assam, 784001, India; Department of Pharmaceutical Sciences, Dibrugarh University, Dibrugarh, Assam, 786004, India.</Affiliation>
      </Author>
      <Author>
        <Name>Kamaruz Zaman</Name>
        <Affiliation>Department of Pharmaceutical Sciences, Dibrugarh University, Dibrugarh, Assam, 786004, India.</Affiliation>
      </Author>
      <Author>
        <Name>Srijita Chakrabarti</Name>
        <Affiliation>Defence Research Laboratory, Tezpur, Assam, 784001, India.</Affiliation>
      </Author>
      <Author>
        <Name>Pronobesh Chattopadhyay</Name>
        <Affiliation>Defence Research Laboratory, Tezpur, Assam, 784001, India. Electronic address: chattopadhyay.drl@gmail.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Should DTPA, an Aminocarboxylic acid (ethylenediamine-based) chelating agent, be considered a developmental toxicant?</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29964121</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30175-2</DOI>
    <KeywordList>
      <Keywords>Bioavailability</Keywords>
      <Keywords>Chelating agents</Keywords>
      <Keywords>Developmental toxicity</Keywords>
      <Keywords>Zinc depletion</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Josje Arts</Name>
        <Affiliation>AkzoNobel Chemicals, Velperweg 76, 6824 BM, Arnhem, the Netherlands. Electronic address: josje.arts@akzonobel.com.</Affiliation>
      </Author>
      <Author>
        <Name>Steffen Bade</Name>
        <Affiliation>BASF SE, Carl-Bosch-Strasse 38, 67056, Ludwigshafen am Rhein, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Marta Badrinas</Name>
        <Affiliation>S.A. Dabeer, Pje. Arrahona 18, 2º Polígono Industrial Santiga, 08210, Barberà del Vallès, Barcelona, Spain.</Affiliation>
      </Author>
      <Author>
        <Name>Nicholas Ball</Name>
        <Affiliation>Dow Europe GmbH, Bachtobelstrasse 3, CH-8810, Horgen, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Stuart Hindle</Name>
        <Affiliation>Dow Europe GmbH, Bachtobelstrasse 3, CH-8810, Horgen, Switzerland.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Critique of the ACGIH 2016 derivation of toluene diisocyanate Threshold Limit Values.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29964120</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30173-9</DOI>
    <KeywordList>
      <Keywords>Industrial hygiene</Keywords>
      <Keywords>Lung function</Keywords>
      <Keywords>Occupational asthma</Keywords>
      <Keywords>Occupational exposure limits</Keywords>
      <Keywords>Toluene diisocyanate</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Heather N. Lynch</Name>
        <Affiliation>Gradient, Cambridge, MA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Robyn L. Prueitt</Name>
        <Affiliation>Gradient, Seattle, WA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Julie E. Goodman</Name>
        <Affiliation>Gradient, Cambridge, MA, USA. Electronic address: jgoodman@gradientcorp.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Interspecies assessment factors and skin sensitization risk assessment.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29964119</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30174-0</DOI>
    <AuthorList>
      <Author>
        <Name>D. A. Basketter</Name>
        <Affiliation>DABMEB Consultancy Ltd, Sharnbrook, Bedfordshire, UK. Electronic address: dabmebconsultancyltd@me.com.</Affiliation>
      </Author>
      <Author>
        <Name>A. Natsch</Name>
        <Affiliation>Fragrances S&amp;T, Ingredients Research, Givaudan Schweiz AG, Duebendorf, CH-8600, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>G. Ellis</Name>
        <Affiliation>Regulatory Affairs and Product Safety, Givaudan International SA, Vernier, CH-1214, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>A. M. Api</Name>
        <Affiliation>Research Institute for Fragrance Materials Inc., 50 Tice Boulevard, Woodcliff Lake, NJ, USA.</Affiliation>
      </Author>
      <Author>
        <Name>A. Irizar</Name>
        <Affiliation>The International Fragrance Association, Avenue des Arts 6, Brussels, 1210, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>B. Safford</Name>
        <Affiliation>B-Safe Toxicology Consulting, Rushden, Northamptonshire, UK.</Affiliation>
      </Author>
      <Author>
        <Name>C. Ryan</Name>
        <Affiliation>The Procter &amp; Gamble Company, Mason Business Center, 8700 Mason Montgomery Rd., Mason, OH, 45040, USA.</Affiliation>
      </Author>
      <Author>
        <Name>P. Kern</Name>
        <Affiliation>Procter &amp; Gamble Services Company NV, Temselaan 100, Strombeek-Bever, B-1853, Belgium.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Fragrance allergens in household detergents.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29940212</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30171-5</DOI>
    <KeywordList>
      <Keywords>Aggregated exposure</Keywords>
      <Keywords>Co-exposure</Keywords>
      <Keywords>Contact allergy</Keywords>
      <Keywords>Detergents</Keywords>
      <Keywords>Fragrance allergens</Keywords>
      <Keywords>Product inventory</Keywords>
      <Keywords>Washing and cleaning agents</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Stefanie Wieck</Name>
        <Affiliation>Institute for Sustainable and Environmental Chemistry, Leuphana University of Lüneburg, Universitätsallee 1, 21335 Lüneburg, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Oliver Olsson</Name>
        <Affiliation>Institute for Sustainable and Environmental Chemistry, Leuphana University of Lüneburg, Universitätsallee 1, 21335 Lüneburg, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Klaus Kümmerer</Name>
        <Affiliation>Institute for Sustainable and Environmental Chemistry, Leuphana University of Lüneburg, Universitätsallee 1, 21335 Lüneburg, Germany. Electronic address: klaus.kuemmerer@uni.leuphana.de.</Affiliation>
      </Author>
      <Author>
        <Name>Ursula Klaschka</Name>
        <Affiliation>Institute for Applied Research, University of Applied Sciences Ulm, Prittwitzstr. 10, 89075 Ulm, Germany.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The food safety of DP-356Ø43 soybeans on SD rats reflected by physiological variables and fecal microbiota during a 90-day feeding study.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29940211</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30172-7</DOI>
    <KeywordList>
      <Keywords>90-Day</Keywords>
      <Keywords>Microbiota</Keywords>
      <Keywords>Toxicology</Keywords>
      <Keywords>Transgenic</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Shiying Zou</Name>
        <Affiliation>Beijing Advanced Innovation Center for Food Nutrition and Human Health, College of Food Science ＆, Nutritional Engineering, China Agricultural University, Beijing, 100083, China; Key Laboratory of Safety Assessment of Genetically modified Organism(Food Safety), Ministry of Agriculture, Beijing, 100083, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jiao Lu</Name>
        <Affiliation>School of Management, Shanxi Medical University, Taiyuan, Shanxi, 030001, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yunbo Luo</Name>
        <Affiliation>Beijing Advanced Innovation Center for Food Nutrition and Human Health, College of Food Science ＆, Nutritional Engineering, China Agricultural University, Beijing, 100083, China; Key Laboratory of Safety Assessment of Genetically modified Organism(Food Safety), Ministry of Agriculture, Beijing, 100083, China; The Supervision, Inspection and Testing Center of Genetically Modified Organisms, Ministry of Agriculture, Beijing, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaozhe Qi</Name>
        <Affiliation>Beijing Advanced Innovation Center for Food Nutrition and Human Health, College of Food Science ＆, Nutritional Engineering, China Agricultural University, Beijing, 100083, China; Key Laboratory of Safety Assessment of Genetically modified Organism(Food Safety), Ministry of Agriculture, Beijing, 100083, China.</Affiliation>
      </Author>
      <Author>
        <Name>Bryan Delaney</Name>
        <Affiliation>Pioneer, A DuPont Company, Johnston, IA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Wentao Xu</Name>
        <Affiliation>Beijing Advanced Innovation Center for Food Nutrition and Human Health, College of Food Science ＆, Nutritional Engineering, China Agricultural University, Beijing, 100083, China; Key Laboratory of Safety Assessment of Genetically modified Organism(Food Safety), Ministry of Agriculture, Beijing, 100083, China; School of Management, Shanxi Medical University, Taiyuan, Shanxi, 030001, China.</Affiliation>
      </Author>
      <Author>
        <Name>Kunlun Huang</Name>
        <Affiliation>Beijing Advanced Innovation Center for Food Nutrition and Human Health, College of Food Science ＆, Nutritional Engineering, China Agricultural University, Beijing, 100083, China; Key Laboratory of Safety Assessment of Genetically modified Organism(Food Safety), Ministry of Agriculture, Beijing, 100083, China; The Supervision, Inspection and Testing Center of Genetically Modified Organisms, Ministry of Agriculture, Beijing, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaoyun He</Name>
        <Affiliation>Beijing Advanced Innovation Center for Food Nutrition and Human Health, College of Food Science ＆, Nutritional Engineering, China Agricultural University, Beijing, 100083, China; Key Laboratory of Safety Assessment of Genetically modified Organism(Food Safety), Ministry of Agriculture, Beijing, 100083, China; The Supervision, Inspection and Testing Center of Genetically Modified Organisms, Ministry of Agriculture, Beijing, China. Electronic address: raininghe@163.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Prioritization before risk assessment: The viability of uncertain data on food contact materials.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29932981</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30168-5</DOI>
    <KeywordList>
      <Keywords>Exposure assessment</Keywords>
      <Keywords>FCM</Keywords>
      <Keywords>Hazard assessment</Keywords>
      <Keywords>Risk prioritization</Keywords>
      <Keywords>Semi-quantification</Keywords>
      <Keywords>Structure assessment</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Eelco N. Pieke</Name>
        <Affiliation>Technical University of Denmark, National Food Institute, Research Group for Analytical Food Chemistry, Kemitorvet Building 202, 2800, Kgs. Lyngby, Denmark. Electronic address: eelco.pieke@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Kit Granby</Name>
        <Affiliation>Technical University of Denmark, National Food Institute, Research Group for Analytical Food Chemistry, Kemitorvet Building 202, 2800, Kgs. Lyngby, Denmark. Electronic address: kgra@food.dtu.dk.</Affiliation>
      </Author>
      <Author>
        <Name>Bruno Teste</Name>
        <Affiliation>French Agency for Food, Environmental and Occupational Health &amp; Safety (ANSES), 14 rue Pierre et Marie Curie, 94701, Maisons-Alfort Cedex, France. Electronic address: bruno.teste@anses.fr.</Affiliation>
      </Author>
      <Author>
        <Name>Jørn Smedsgaard</Name>
        <Affiliation>Technical University of Denmark, National Food Institute, Research Group for Analytical Food Chemistry, Kemitorvet Building 202, 2800, Kgs. Lyngby, Denmark. Electronic address: smeds@dtu.dk.</Affiliation>
      </Author>
      <Author>
        <Name>Gilles Rivière</Name>
        <Affiliation>French Agency for Food, Environmental and Occupational Health &amp; Safety (ANSES), 14 rue Pierre et Marie Curie, 94701, Maisons-Alfort Cedex, France. Electronic address: gilles.riviere@anses.fr.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Drug adulteration of food supplements: A threat to public health in the European Union?</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29932980</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30170-3</DOI>
    <KeywordList>
      <Keywords>Dietary supplement</Keywords>
      <Keywords>Drug adulteration</Keywords>
      <Keywords>Food supplement</Keywords>
      <Keywords>RASFF</Keywords>
      <Keywords>Regulation</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Edyta Czepielewska</Name>
        <Affiliation>Department of Clinical Pharmacy and Pharmaceutical Care, Faculty of Pharmacy with the Laboratory Medicine Division, Medical University of Warsaw, Poland. Electronic address: edyta.czepielewska@wum.edu.pl.</Affiliation>
      </Author>
      <Author>
        <Name>Magdalena Makarewicz-Wujec</Name>
        <Affiliation>Department of Clinical Pharmacy and Pharmaceutical Care, Faculty of Pharmacy with the Laboratory Medicine Division, Medical University of Warsaw, Poland.</Affiliation>
      </Author>
      <Author>
        <Name>Filip Różewski</Name>
        <Affiliation>Department of Clinical Pharmacy and Pharmaceutical Care, Faculty of Pharmacy with the Laboratory Medicine Division, Medical University of Warsaw, Poland.</Affiliation>
      </Author>
      <Author>
        <Name>Elżbieta Wojtasik</Name>
        <Affiliation>Department of Clinical Pharmacy and Pharmaceutical Care, Faculty of Pharmacy with the Laboratory Medicine Division, Medical University of Warsaw, Poland.</Affiliation>
      </Author>
      <Author>
        <Name>Małgorzata Kozłowska-Wojciechowska</Name>
        <Affiliation>Department of Clinical Pharmacy and Pharmaceutical Care, Faculty of Pharmacy with the Laboratory Medicine Division, Medical University of Warsaw, Poland.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Assessment of structurally modified plant virus as a novel adjuvant in toxicity studies.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29932979</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30166-1</DOI>
    <KeywordList>
      <Keywords>Adjuvant</Keywords>
      <Keywords>Plant virus</Keywords>
      <Keywords>Spherical particles</Keywords>
      <Keywords>Structurally modified virus</Keywords>
      <Keywords>Tobacco mosaic virus</Keywords>
      <Keywords>Toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>N. A. Nikitin</Name>
        <Affiliation>Department of Virology, Faculty of Biology, Lomonosov Moscow State University, 1-12 Leninskie Gory, Moscow, 119234, Russian Federation. Electronic address: nikitin@mail.bio.msu.ru.</Affiliation>
      </Author>
      <Author>
        <Name>V. A. Zenin</Name>
        <Affiliation>Group of Molecular Biotechnology, Federal State Institution «Federal Research Centre «Fundamentals of Biotechnology» of the Russian Academy of Sciences», 33-2 Leninsky pr., Moscow, 119071, Russian Federation.</Affiliation>
      </Author>
      <Author>
        <Name>E. A. Trifonova</Name>
        <Affiliation>Department of Virology, Faculty of Biology, Lomonosov Moscow State University, 1-12 Leninskie Gory, Moscow, 119234, Russian Federation.</Affiliation>
      </Author>
      <Author>
        <Name>E. M. Ryabchevskaya</Name>
        <Affiliation>Department of Virology, Faculty of Biology, Lomonosov Moscow State University, 1-12 Leninskie Gory, Moscow, 119234, Russian Federation.</Affiliation>
      </Author>
      <Author>
        <Name>O. A. Kondakova</Name>
        <Affiliation>Department of Virology, Faculty of Biology, Lomonosov Moscow State University, 1-12 Leninskie Gory, Moscow, 119234, Russian Federation.</Affiliation>
      </Author>
      <Author>
        <Name>A. N. Fedorov</Name>
        <Affiliation>Group of Molecular Biotechnology, Federal State Institution «Federal Research Centre «Fundamentals of Biotechnology» of the Russian Academy of Sciences», 33-2 Leninsky pr., Moscow, 119071, Russian Federation.</Affiliation>
      </Author>
      <Author>
        <Name>J. G. Atabekov</Name>
        <Affiliation>Department of Virology, Faculty of Biology, Lomonosov Moscow State University, 1-12 Leninskie Gory, Moscow, 119234, Russian Federation.</Affiliation>
      </Author>
      <Author>
        <Name>O. V. Karpova</Name>
        <Affiliation>Department of Virology, Faculty of Biology, Lomonosov Moscow State University, 1-12 Leninskie Gory, Moscow, 119234, Russian Federation.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Benchmark dose analysis of multiple thyroid toxicity endpoints in ovariectomized rats exposed to propylthiouracil.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29928935</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30169-7</DOI>
    <KeywordList>
      <Keywords>Benchmark dose</Keywords>
      <Keywords>Endocrine disrupting chemicals</Keywords>
      <Keywords>Ovariectomized rats</Keywords>
      <Keywords>Point of departure</Keywords>
      <Keywords>Propylthiouracil</Keywords>
      <Keywords>Thyroid toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Hao Chen</Name>
        <Affiliation>Key Laboratory of Food Safety Risk Assessment of Ministry of Health, National Center for Food Safety Risk Assessment, Beijing, 100022, China; Department of Environmental and Global Health, Center for Environmental and Human Toxicology, University of Florida, Gainesville, FL, 32611, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaopeng Zhang</Name>
        <Affiliation>Key Laboratory of Food Safety Risk Assessment of Ministry of Health, National Center for Food Safety Risk Assessment, Beijing, 100022, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xudong Jia</Name>
        <Affiliation>Key Laboratory of Food Safety Risk Assessment of Ministry of Health, National Center for Food Safety Risk Assessment, Beijing, 100022, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhaoping Liu</Name>
        <Affiliation>Key Laboratory of Food Safety Risk Assessment of Ministry of Health, National Center for Food Safety Risk Assessment, Beijing, 100022, China. Electronic address: liuzhaoping@cfsa.net.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Study on the developmental toxicity of β-ionone in the rat.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29928934</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30165-X</DOI>
    <KeywordList>
      <Keywords>Embryotoxicity</Keywords>
      <Keywords>Food additives</Keywords>
      <Keywords>Fragrance chemicals</Keywords>
      <Keywords>Reproductive toxicity</Keywords>
      <Keywords>Teratogenicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Flávia C. M. Pinto</Name>
        <Affiliation>Laboratory of Environmental Toxicology, Department of Biological Sciences, National School of Public Health, Rio de Janeiro, RJ, 21040-361, Brazil; National Institute for Health Quality Control, Oswaldo Cruz Foundation, Rio de Janeiro, RJ, 21040-361, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Rosangela R. De-Carvalho</Name>
        <Affiliation>Laboratory of Environmental Toxicology, Department of Biological Sciences, National School of Public Health, Rio de Janeiro, RJ, 21040-361, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Ana Cecilia A. X. De-Oliveira</Name>
        <Affiliation>Laboratory of Environmental Toxicology, Department of Biological Sciences, National School of Public Health, Rio de Janeiro, RJ, 21040-361, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Isabella F. Delgado</Name>
        <Affiliation>National Institute for Health Quality Control, Oswaldo Cruz Foundation, Rio de Janeiro, RJ, 21040-361, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Francisco J. R. Paumgartten</Name>
        <Affiliation>Laboratory of Environmental Toxicology, Department of Biological Sciences, National School of Public Health, Rio de Janeiro, RJ, 21040-361, Brazil. Electronic address: paum@ensp.fiocruz.br.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Investigation and comparison of the transfer of TSNA from tobacco to cigarette mainstream smoke and to the aerosol of a heated tobacco product, THS2.2.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29928933</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30167-3</DOI>
    <AuthorList>
      <Author>
        <Name>Guy Jaccard</Name>
        <Affiliation>PMI R&amp;D, Philip Morris Products S.A., Part of Philip Morris International Group of Companies, Quai Jeanrenaud 5, CH-2000, Neuchâtel, Switzerland. Electronic address: Guy.Jaccard@pmi.com.</Affiliation>
      </Author>
      <Author>
        <Name>Athanasios Kondylis</Name>
        <Affiliation>PMI R&amp;D, Philip Morris Products S.A., Part of Philip Morris International Group of Companies, Quai Jeanrenaud 5, CH-2000, Neuchâtel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Irfan Gunduz</Name>
        <Affiliation>Philip Morris International Management S.A., Part of Philip Morris International Group of Companies, Lausanne, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Johannes Pijnenburg</Name>
        <Affiliation>PMI R&amp;D, Philip Morris Products S.A., Part of Philip Morris International Group of Companies, Quai Jeanrenaud 5, CH-2000, Neuchâtel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Maxim Belushkin</Name>
        <Affiliation>PMI R&amp;D, Philip Morris Products S.A., Part of Philip Morris International Group of Companies, Quai Jeanrenaud 5, CH-2000, Neuchâtel, Switzerland.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A monitoring survey and dietary risk assessment for pesticide residues on peaches in China.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29909271</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30163-6</DOI>
    <KeywordList>
      <Keywords>Peach</Keywords>
      <Keywords>Pesticide residue</Keywords>
      <Keywords>Risk assessment</Keywords>
      <Keywords>Risk scoring</Keywords>
      <Keywords>Use suggestions</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Zhixia Li</Name>
        <Affiliation>Institute of Pomology, Chinese Academy of Agricultural Sciences, 125100 Xingcheng, China; Laboratory of Quality &amp; Safety Risk Assessment for Fruit (Xingcheng), Ministry of Agriculture, 125100 Xingcheng, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jiyun Nie</Name>
        <Affiliation>Institute of Pomology, Chinese Academy of Agricultural Sciences, 125100 Xingcheng, China; Laboratory of Quality &amp; Safety Risk Assessment for Fruit (Xingcheng), Ministry of Agriculture, 125100 Xingcheng, China. Electronic address: niejiyun@caas.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Zhen Yan</Name>
        <Affiliation>Institute of Pomology, Chinese Academy of Agricultural Sciences, 125100 Xingcheng, China; Laboratory of Quality &amp; Safety Risk Assessment for Fruit (Xingcheng), Ministry of Agriculture, 125100 Xingcheng, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yang Cheng</Name>
        <Affiliation>Institute of Pomology, Chinese Academy of Agricultural Sciences, 125100 Xingcheng, China; Laboratory of Quality &amp; Safety Risk Assessment for Fruit (Xingcheng), Ministry of Agriculture, 125100 Xingcheng, China.</Affiliation>
      </Author>
      <Author>
        <Name>Feng Lan</Name>
        <Affiliation>Yantai Academy of Agricultural Sciences, 265500 Yantai, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yunan Huang</Name>
        <Affiliation>Zhengzhou Institute of Pomology, Chinese Academy of Agricultural Sciences, 450009 Zhengzhou, China.</Affiliation>
      </Author>
      <Author>
        <Name>Qiusheng Chen</Name>
        <Affiliation>Institute of Tianjin Agriculture Quality Standard and Testing Technology, 300381 Tianjin, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xubo Zhao</Name>
        <Affiliation>Northwest Agriculture and Forestry University, 712100 Yangling, China.</Affiliation>
      </Author>
      <Author>
        <Name>An Li</Name>
        <Affiliation>Beijing Research Center for Agricultural Standards and Testing, 100097, Beijing, China.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Feasibility of using urinary TDGA as a biomarker for VCM exposures.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29909270</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30164-8</DOI>
    <KeywordList>
      <Keywords>Biomarker</Keywords>
      <Keywords>PBPK</Keywords>
      <Keywords>Risk assessment</Keywords>
      <Keywords>Signal</Keywords>
      <Keywords>TDGA</Keywords>
      <Keywords>VCM</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Chao W. Chen</Name>
        <Affiliation>University of Maryland University College, Adelphi, MD, USA; National Center of Environmental Assessment, US Environmental Protection Agency, Washing, D. C, USA. Electronic address: chao.chen@faculty.umus.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Dennis Hsieh</Name>
        <Affiliation>Department of Environmental Toxicology, University of California, Davis, CA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Fung Chang Sung</Name>
        <Affiliation>Department of Health Service Administration, China Medical University, Taichung, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Shan P. Tsai</Name>
        <Affiliation>Texas A&amp;M, School of Public Health, College Station, TX, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Characterization and safety evaluation of HPPD W336, a modified 4-hydroxyphenylpyruvate dioxygenase protein, and the impact of its expression on plant metabolism in herbicide-tolerant MST-FGØ72-2 soybean.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29894735</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30158-2</DOI>
    <KeywordList>
      <Keywords>4-Hydroxyphenylpyruvate dioxygenase</Keywords>
      <Keywords>Allergenicity assessment</Keywords>
      <Keywords>Characterization</Keywords>
      <Keywords>Functional and structural equivalence</Keywords>
      <Keywords>Genetically modified crop</Keywords>
      <Keywords>HPPD W336</Keywords>
      <Keywords>MST-FGØ72-2 soybean</Keywords>
      <Keywords>Overexpression</Keywords>
      <Keywords>Safety assessment</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Rozemarijn Dreesen</Name>
        <Affiliation>Bayer CropScience N.V. - Innovation Center, Tech Lane Ghent Science Park 38, B-9052, Gent, Belgium. Electronic address: rozemarijn.dreesen@bayer.com.</Affiliation>
      </Author>
      <Author>
        <Name>Annabelle Capt</Name>
        <Affiliation>Bayer S.A.S., Bayer CropScience, 355 rue Dostoïevski, 06903, Sophia Antipolis, France. Electronic address: annabelle.capt@bayer.com.</Affiliation>
      </Author>
      <Author>
        <Name>Regina Oberdoerfer</Name>
        <Affiliation>Bayer A.G., CropScience Division, Alfred-Nobel-Straße 50, 40789, Monheim, Germany. Electronic address: regina.oberdoerfer@bayer.com.</Affiliation>
      </Author>
      <Author>
        <Name>Isabelle Coats</Name>
        <Affiliation>Bayer CropScience L.P., 2 T.W. Alexander Drive, Research Triangle Park, NC, 27709, USA. Electronic address: isabelle.coats@bayer.com.</Affiliation>
      </Author>
      <Author>
        <Name>Kenneth Edward Pallett</Name>
        <Affiliation>Bayer CropScience N.V. - Innovation Center, Tech Lane Ghent Science Park 38, B-9052, Gent, Belgium. Electronic address: ken.pallett@blueyonder.co.uk.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Prediction of tissue concentrations of monoclonal antibodies in mice from plasma concentrations.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29894734</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30160-0</DOI>
    <KeywordList>
      <Keywords>Allometry</Keywords>
      <Keywords>Antibody biodistribution coefficient</Keywords>
      <Keywords>Monoclonal antibodies</Keywords>
      <Keywords>Tissue-to-plasma partition coefficients</Keywords>
      <Keywords>Volume of distribution at steady state</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Iftekhar Mahmood</Name>
        <Affiliation>Office of Tissue &amp; Advanced Therapies (OTAT), Center for Biologics Evaluation and Research, Food &amp; Drug Administration, 10903 New Hampshire Avenue, Silver Spring, MD, 20993-0002, USA. Electronic address: iftekhar.mahmood@fda.hhs.gov.</Affiliation>
      </Author>
      <Author>
        <Name>Million A. Tegenge</Name>
        <Affiliation>Office of Biostatistics &amp; Epidemiology, Center for Biologics Evaluation and Research, Food &amp; Drug Administration, 10903 New Hampshire Avenue, Silver Spring, MD, 20993-0002, USA. Electronic address: million.tegenge@fda.hhs.gov.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Modeling the impact of changes in tobacco use on individual disease risks.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29894733</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30157-0</DOI>
    <KeywordList>
      <Keywords>Population health impact modeling</Keywords>
      <Keywords>Public health</Keywords>
      <Keywords>Reduced risk</Keywords>
      <Keywords>Smoke-free</Keywords>
      <Keywords>Smoking</Keywords>
      <Keywords>Tobacco harm reduction</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>S. Djurdjevic</Name>
        <Affiliation>Philip Morris International R&amp;D, Philip Morris Products S.A, Quai Jeanrenaud 5, 2000, Neuchatel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Z. Sponsiello-Wang</Name>
        <Affiliation>Philip Morris International R&amp;D, Philip Morris Products S.A, Quai Jeanrenaud 5, 2000, Neuchatel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>P. N. Lee</Name>
        <Affiliation>P. N. Lee Statistics and Computing Ltd, 17 Cedar Road, Sutton, SM2 5DA, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>J. S. Fry</Name>
        <Affiliation>RoeLee Statistics Limited, 17 Cedar Road, Sutton, SM2 5DA, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>R. Weitkunat</Name>
        <Affiliation>Philip Morris International R&amp;D, Philip Morris Products S.A, Quai Jeanrenaud 5, 2000, Neuchatel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>F. Lüdicke</Name>
        <Affiliation>Philip Morris International R&amp;D, Philip Morris Products S.A, Quai Jeanrenaud 5, 2000, Neuchatel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>G. Baker</Name>
        <Affiliation>Philip Morris International R&amp;D, Philip Morris Products S.A, Quai Jeanrenaud 5, 2000, Neuchatel, Switzerland. Electronic address: Gizelle.Baker@pmi.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Biomonitoring Equivalents for cyanide.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29885879</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30162-4</DOI>
    <KeywordList>
      <Keywords>Biomonitoring Equivalents</Keywords>
      <Keywords>Plasma</Keywords>
      <Keywords>Thiocyanate</Keywords>
      <Keywords>Urine</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>C. R. Kirman</Name>
        <Affiliation>Summit Toxicology, LLP, Bozeman, MT, USA. Electronic address: ckirman@summittoxicology.com.</Affiliation>
      </Author>
      <Author>
        <Name>A. M. Belknap</Name>
        <Affiliation>Existing Substances Risk Assessment Bureau, Health Canada, Ottawa, Ontario, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>A. F. Webster</Name>
        <Affiliation>Existing Substances Risk Assessment Bureau, Health Canada, Ottawa, Ontario, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>S. M. Hays</Name>
        <Affiliation>Summit Toxicology, LLP, Bozeman, MT, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A comparison of in vitro cytotoxicity assays in medical device regulatory studies.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29885342</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30159-4</DOI>
    <KeywordList>
      <Keywords>Cytotoxicity</Keywords>
      <Keywords>Medical device</Keywords>
      <Keywords>Qualitative and quantitative</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Xuemei Liu</Name>
        <Affiliation>Preclinical Safety, Alcon Research, LTD, Fort Worth, TX, 76134, USA. Electronic address: xuemei.liu@alcon.com.</Affiliation>
      </Author>
      <Author>
        <Name>Denise P. Rodeheaver</Name>
        <Affiliation>Preclinical Safety, Alcon Research, LTD, Fort Worth, TX, 76134, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jeffrey C. White</Name>
        <Affiliation>Preclinical Safety, Alcon Research, LTD, Fort Worth, TX, 76134, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Ann M. Wright</Name>
        <Affiliation>Preclinical Safety, Alcon Research, LTD, Fort Worth, TX, 76134, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Lisa M. Walker</Name>
        <Affiliation>Preclinical Safety, Alcon Research, LTD, Fort Worth, TX, 76134, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Fan Zhang</Name>
        <Affiliation>Preclinical Safety, Alcon Research, LTD, Fort Worth, TX, 76134, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Stephen Shannon</Name>
        <Affiliation>Preclinical Safety, Alcon Research, LTD, Fort Worth, TX, 76134, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Fate of inhaled Nano-CeO2 revisited: Predicting the unpredictable.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29885341</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30161-2</DOI>
    <KeywordList>
      <Keywords>Aggregates</Keywords>
      <Keywords>Disposition</Keywords>
      <Keywords>Nanoparticles</Keywords>
      <Keywords>Repeated inhalation studies</Keywords>
      <Keywords>Volume displacement lung overload</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Juergen Pauluhn</Name>
        <Affiliation>Hannover Medical School, Hannover, Germany; 4thMilitary Medical University, Xi'an, China. Electronic address: juergen.pauluhn@bayer.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A 90-day repeated-dose toxicity study of dietary alpha linolenic acid-enriched diacylglycerol oil in rats.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29859764</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30154-5</DOI>
    <KeywordList>
      <Keywords>Alpha linolenic acid</Keywords>
      <Keywords>Diacylglycerol oil</Keywords>
      <Keywords>Flaxseed oil</Keywords>
      <Keywords>Food ingredient</Keywords>
      <Keywords>Repeated-dose toxicity</Keywords>
      <Keywords>Subchronic toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Hiroto Bushita</Name>
        <Affiliation>R&amp;D Safety Science Research, Kao Corporation, 2-1-3 Bunka, Sumida-ku, Tokyo 131-8501, Japan. Electronic address: bushita.hiroto@kao.com.</Affiliation>
      </Author>
      <Author>
        <Name>Yuichi Ito</Name>
        <Affiliation>R&amp;D Safety Science Research, Kao Corporation, 2-1-3 Bunka, Sumida-ku, Tokyo 131-8501, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Tetsuji Saito</Name>
        <Affiliation>Kumamoto Safety Assessment Department, Nonclinical Research Center, Drug Development Service Segment, LSI Medience Corporation, 1285 Kurisaki-machi, Uto-shi, Kumamoto 869-0425, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Yuko Nukada</Name>
        <Affiliation>R&amp;D Safety Science Research, Kao Corporation, 2606 Akabane, Ichikai-machi, Haga-gun, Tochigi 321-3497, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Naohiro Ikeda</Name>
        <Affiliation>R&amp;D Safety Science Research, Kao Corporation, 2606 Akabane, Ichikai-machi, Haga-gun, Tochigi 321-3497, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Hideaki Nakagiri</Name>
        <Affiliation>R&amp;D Safety Science Research, Kao Corporation, 2606 Akabane, Ichikai-machi, Haga-gun, Tochigi 321-3497, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Kazutoshi Saito</Name>
        <Affiliation>R&amp;D Safety Science Research, Kao Corporation, 2606 Akabane, Ichikai-machi, Haga-gun, Tochigi 321-3497, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Osamu Morita</Name>
        <Affiliation>R&amp;D Safety Science Research, Kao Corporation, 2606 Akabane, Ichikai-machi, Haga-gun, Tochigi 321-3497, Japan.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Risk assessment to human health: Consumer exposure to ingredients in air fresheners.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29857116</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30146-6</DOI>
    <KeywordList>
      <Keywords>Air freshener consumer products</Keywords>
      <Keywords>Fragrance ingredients</Keywords>
      <Keywords>Health risk assessment</Keywords>
      <Keywords>Inhalation and dermal hazard</Keywords>
      <Keywords>Tiered 1 and 2 risk assessment</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Joo Hyon Kim</Name>
        <Affiliation>Division of Risk Assessment, National Institute of Environmental Research, Hwangyeong-ro 42, Seo-gu, Incheon 22689, South Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Daeyeop Lee</Name>
        <Affiliation>Division of Risk Assessment, National Institute of Environmental Research, Hwangyeong-ro 42, Seo-gu, Incheon 22689, South Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Hyunwoo Lim</Name>
        <Affiliation>Division of Risk Assessment, National Institute of Environmental Research, Hwangyeong-ro 42, Seo-gu, Incheon 22689, South Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Taksoo Kim</Name>
        <Affiliation>Division of Risk Assessment, National Institute of Environmental Research, Hwangyeong-ro 42, Seo-gu, Incheon 22689, South Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Kwangsul Suk</Name>
        <Affiliation>Division of Risk Assessment, National Institute of Environmental Research, Hwangyeong-ro 42, Seo-gu, Incheon 22689, South Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Jungkwan Seo</Name>
        <Affiliation>Division of Risk Assessment, National Institute of Environmental Research, Hwangyeong-ro 42, Seo-gu, Incheon 22689, South Korea. Electronic address: jkseo2001@korea.kr.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>In vitro and in vivo DFO-chelatable labile iron release profiles among commercially available intravenous iron nanoparticle formulations.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29857115</pubmedLink>
    <GrantList>
      <Grant>P30 CA046592</Grant>
      <Grant>U01 FD004889</Grant>
    </GrantList>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30145-4</DOI>
    <KeywordList>
      <Keywords>Bioequivalence</Keywords>
      <Keywords>Intravenous iron</Keywords>
      <Keywords>Labile iron</Keywords>
      <Keywords>Pharmacokinetics</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Amy Barton Pai</Name>
        <Affiliation>University of Michigan College of Pharmacy, 428 Church Street, Ann Arbor, MI, 48109, USA. Electronic address: amypai@med.umich.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Manjunath P. Pai</Name>
        <Affiliation>University of Michigan College of Pharmacy, 428 Church Street, Ann Arbor, MI, 48109, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Dan E. Meyer</Name>
        <Affiliation>General Electric Global Research Center, 1 Research Circle, Niskayuna, NY, 12309, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Brian C. Bales</Name>
        <Affiliation>General Electric Global Research Center, 1 Research Circle, Niskayuna, NY, 12309, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Victoria E. Cotero</Name>
        <Affiliation>General Electric Global Research Center, 1 Research Circle, Niskayuna, NY, 12309, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Nan Zheng</Name>
        <Affiliation>Food and Drug Administration, Office of Generic Drugs, 10903 New Hampshire Avenue, Silver Spring, MD, 20903, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Wenlei Jiang</Name>
        <Affiliation>Food and Drug Administration, Office of Generic Drugs, 10903 New Hampshire Avenue, Silver Spring, MD, 20903, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Safety evaluation of xylanase 50316 enzyme preparation (also known as VR007), expressed in Pseudomonas fluorescens, intended for use in animal feed.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29857114</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30147-8</DOI>
    <KeywordList>
      <Keywords>Enzyme</Keywords>
      <Keywords>Poultry</Keywords>
      <Keywords>Pseudomonas fluorescens</Keywords>
      <Keywords>Safety</Keywords>
      <Keywords>Swine</Keywords>
      <Keywords>Toxicology</Keywords>
      <Keywords>Xylanase</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Roxanna Van Dorn</Name>
        <Affiliation>BASF Enzymes LLC, 3550 John Hopkins Court, San Diego, CA 92121, USA. Electronic address: Roxanna.vandorn@basf.com.</Affiliation>
      </Author>
      <Author>
        <Name>Diane Shanahan</Name>
        <Affiliation>BASF Enzymes LLC, 3550 John Hopkins Court, San Diego, CA 92121, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Vince Ciofalo</Name>
        <Affiliation>Shoreline Toxicology, LLC, 53 River Walk, Branford, CT 06405, USA. Electronic address: vbc6@juno.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>High dose targeted delivery on cancer sites and the importance of short-chain fatty acids for metformin's action: Two crucial aspects of the wonder drug.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29857113</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30144-2</DOI>
    <KeywordList>
      <Keywords>Butyrate producing taxa</Keywords>
      <Keywords>Cancer</Keywords>
      <Keywords>Metformin</Keywords>
      <Keywords>Microbiome</Keywords>
      <Keywords>SCFA</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Kunal Maniar</Name>
        <Affiliation>Department of Pharmacology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.</Affiliation>
      </Author>
      <Author>
        <Name>Vandana Singh</Name>
        <Affiliation>Department of Experimental Medicine and Biotechnology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.</Affiliation>
      </Author>
      <Author>
        <Name>Amitava Chakrabarti</Name>
        <Affiliation>Department of Pharmacology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.</Affiliation>
      </Author>
      <Author>
        <Name>Rajasri Bhattacharyya</Name>
        <Affiliation>Department of Experimental Medicine and Biotechnology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.</Affiliation>
      </Author>
      <Author>
        <Name>Dibyajyoti Banerjee</Name>
        <Affiliation>Department of Experimental Medicine and Biotechnology, Postgraduate Institute of Medical Education and Research, Chandigarh, India. Electronic address: dibyajyoti5200@yahoo.co.in.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Energy drink exposures reported to Texas poison centers: Analysis of adverse incidents in relation to total sales, 2010-2014.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29792898</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30139-9</DOI>
    <KeywordList>
      <Keywords>Adverse effects</Keywords>
      <Keywords>Beverages</Keywords>
      <Keywords>Caffeine</Keywords>
      <Keywords>Concentrates</Keywords>
      <Keywords>Energy drinks</Keywords>
      <Keywords>Poison centers</Keywords>
      <Keywords>Shots</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Stephen W. Borron</Name>
        <Affiliation>Texas Tech University Health Sciences Center El Paso, Department of Emergency Medicine, 4801 Alberta Ave., Suite B3200, El Paso, TX 79905, United States; West Texas Regional Poison Center at University Medical Center of El Paso, 4815 Alameda Ave., El Paso, TX 79905, United States; SafetyCall International, PLLC, 3600 American Blvd. W., Suite 725, Bloomington, MN 55431, United States. Electronic address: stephen.borron@ttuhsc.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Susan H. Watts</Name>
        <Affiliation>Texas Tech University Health Sciences Center El Paso, Department of Emergency Medicine, 4801 Alberta Ave., Suite B3200, El Paso, TX 79905, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Jessica Herrera</Name>
        <Affiliation>Texas Tech University Health Sciences Center El Paso, Department of Emergency Medicine, 4801 Alberta Ave., Suite B3200, El Paso, TX 79905, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Joshua Larson</Name>
        <Affiliation>Texas Tech University Health Sciences Center El Paso, Department of Emergency Medicine, 4801 Alberta Ave., Suite B3200, El Paso, TX 79905, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Salvador Baeza</Name>
        <Affiliation>West Texas Regional Poison Center at University Medical Center of El Paso, 4815 Alameda Ave., El Paso, TX 79905, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Richard L. Kingston</Name>
        <Affiliation>University of Minnesota College of Pharmacy, 308 SE. Harvard St., Minneapolis, MN 55455, United States; SafetyCall International, PLLC, 3600 American Blvd. W., Suite 725, Bloomington, MN 55431, United States.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>PM</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29782888</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30143-0</DOI>
    <AuthorList>
      <Author>
        <Name>Cheng You</Name>
        <Affiliation>Pennsylvania State University, United States. Electronic address: cheng1you@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Dennis K. J. Lin</Name>
        <Affiliation>Pennsylvania State University, United States. Electronic address: dkl5@psu.edu.</Affiliation>
      </Author>
      <Author>
        <Name>S. Stanley Young</Name>
        <Affiliation>CGStat, 3401 Caldwell Drive, Raleigh, NC 27607, United States. Electronic address: genetree@bellsouth.net.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Strain-related differences in mouse lung gene expression over a two-year period of inhalation exposure to styrene: Relevance to human risk assessment.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29777725</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30142-9</DOI>
    <KeywordList>
      <Keywords>Gene expression</Keywords>
      <Keywords>Human risk</Keywords>
      <Keywords>Lung</Keywords>
      <Keywords>Mice</Keywords>
      <Keywords>Styrene</Keywords>
      <Keywords>Tumor</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Melvin E. Andersen</Name>
        <Affiliation>ScitoVation LLC, Six Davis Drive PO Box 12878, Research Triangle Park, NC 27709, United States.</Affiliation>
      </Author>
      <Author>
        <Name>George Cruzan</Name>
        <Affiliation>ToxWorks, 1153 Roadstown Road, Bridgeton, NJ 08302, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Michael B. Black</Name>
        <Affiliation>ScitoVation LLC, Six Davis Drive PO Box 12878, Research Triangle Park, NC 27709, United States. Electronic address: correspondingauthor@scitovation.com.</Affiliation>
      </Author>
      <Author>
        <Name>Salil N. Pendse</Name>
        <Affiliation>ScitoVation LLC, Six Davis Drive PO Box 12878, Research Triangle Park, NC 27709, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Darol E. Dodd</Name>
        <Affiliation>Charles River, 640 N. Elizabeth St., Spencerville, OH 45887, United States.</Affiliation>
      </Author>
      <Author>
        <Name>James S. Bus</Name>
        <Affiliation>Exponent Inc., 5806 Woodberry Drive, Midland, MI 48640, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Satinder S. Sarang</Name>
        <Affiliation>Shell International, 150 North Dairy, Houston, TX 77079, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Marcy I. Banton</Name>
        <Affiliation>Lyondell Chemical Company, Houston, TX 77010, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Robbie Waites</Name>
        <Affiliation>SABIC Innovative Plastics US LLC, Mount Vernon, IN 47620, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Debra B. Layko</Name>
        <Affiliation>The Hamner Institutes for Health Sciences, Research Triangle Park, NC, 27709, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Patrick D. McMullen</Name>
        <Affiliation>ScitoVation LLC, Six Davis Drive PO Box 12878, Research Triangle Park, NC 27709, United States.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Lack of value of juvenile animal toxicity studies for supporting the safety of pediatric oncology phase I trials.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29763632</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30140-5</DOI>
    <KeywordList>
      <Keywords>Biologics</Keywords>
      <Keywords>Juvenile animal studies</Keywords>
      <Keywords>Molecularly-targeted agents</Keywords>
      <Keywords>Pediatric oncology</Keywords>
      <Keywords>Phase 1 trials</Keywords>
      <Keywords>Starting dose for pediatric patients</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Thomas Visalli</Name>
        <Affiliation>Eisai Inc., Global Nonclinical Regulatory Affairs, 155 Tice Boulevard, Woodcliff Lake, NJ 07677, United States. Electronic address: thomas_visalli@eisai.com.</Affiliation>
      </Author>
      <Author>
        <Name>Nancy Bower</Name>
        <Affiliation>Eisai Inc., Global Nonclinical Regulatory Affairs, 155 Tice Boulevard, Woodcliff Lake, NJ 07677, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Tushar Kokate</Name>
        <Affiliation>Eisai Inc., Global Nonclinical Regulatory Affairs, 155 Tice Boulevard, Woodcliff Lake, NJ 07677, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Paul A. Andrews</Name>
        <Affiliation>Eisai Inc., Global Nonclinical Regulatory Affairs, 155 Tice Boulevard, Woodcliff Lake, NJ 07677, United States.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Safety evaluation of genetically modified DAS-40278-9 maize in a subchronic rodent feeding study.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29763631</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30141-7</DOI>
    <KeywordList>
      <Keywords>90-Day feeding study</Keywords>
      <Keywords>Genetically modified</Keywords>
      <Keywords>Herbicide tolerance</Keywords>
      <Keywords>Maize</Keywords>
      <Keywords>Safety assessment</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Shiying Zou</Name>
        <Affiliation>Beijing Advanced Innovation Center for Food Nutrition and Human Health, College of Food Science &amp; Nutritional Engineering, China Agricultural University, Beijing, 100083, China; Beijing Laboratory for Food Quality and Safety, College of Food Science and Nutritional Engineering, China Agricultural University, Beijing, 100083, China.</Affiliation>
      </Author>
      <Author>
        <Name>Tianqi Lang</Name>
        <Affiliation>Beijing Advanced Innovation Center for Food Nutrition and Human Health, College of Food Science &amp; Nutritional Engineering, China Agricultural University, Beijing, 100083, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xu Liu</Name>
        <Affiliation>Beijing Laboratory for Food Quality and Safety, College of Food Science and Nutritional Engineering, China Agricultural University, Beijing, 100083, China; Key Laboratory of Safety Assessment of Genetically Modified Organism (Food Safety), Ministry of Agriculture, Beijing, 100083, China.</Affiliation>
      </Author>
      <Author>
        <Name>Kunlun Huang</Name>
        <Affiliation>Beijing Advanced Innovation Center for Food Nutrition and Human Health, College of Food Science &amp; Nutritional Engineering, China Agricultural University, Beijing, 100083, China; Beijing Laboratory for Food Quality and Safety, College of Food Science and Nutritional Engineering, China Agricultural University, Beijing, 100083, China; Key Laboratory of Safety Assessment of Genetically Modified Organism (Food Safety), Ministry of Agriculture, Beijing, 100083, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaoyun He</Name>
        <Affiliation>Beijing Advanced Innovation Center for Food Nutrition and Human Health, College of Food Science &amp; Nutritional Engineering, China Agricultural University, Beijing, 100083, China; Beijing Laboratory for Food Quality and Safety, College of Food Science and Nutritional Engineering, China Agricultural University, Beijing, 100083, China; Key Laboratory of Safety Assessment of Genetically Modified Organism (Food Safety), Ministry of Agriculture, Beijing, 100083, China. Electronic address: raininghe@163.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Cantharides poisoning: A retrospective analysis from 1996 to 2016 in China.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29753762</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30138-7</DOI>
    <KeywordList>
      <Keywords>Autopsy</Keywords>
      <Keywords>Cantharides</Keywords>
      <Keywords>Clinical manifestations</Keywords>
      <Keywords>Posioning</Keywords>
      <Keywords>Prognosis</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Youyou Zhang</Name>
        <Affiliation>Department of Forensic Medicine, Tongji Medical College, Huazhong University of Science and Technology, No. 13 Hangkong Road, Wuhan 430030, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaowei Zhou</Name>
        <Affiliation>Department of Forensic Medicine, Tongji Medical College, Huazhong University of Science and Technology, No. 13 Hangkong Road, Wuhan 430030, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Jie Zhang</Name>
        <Affiliation>Department of Forensic Medicine, Tongji Medical College, Huazhong University of Science and Technology, No. 13 Hangkong Road, Wuhan 430030, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Chuhuai Guan</Name>
        <Affiliation>Department of Forensic Medicine, Tongji Medical College, Huazhong University of Science and Technology, No. 13 Hangkong Road, Wuhan 430030, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Liang Liu</Name>
        <Affiliation>Department of Forensic Medicine, Tongji Medical College, Huazhong University of Science and Technology, No. 13 Hangkong Road, Wuhan 430030, PR China. Electronic address: 869974299@qq.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Assessment of the exposure to harmful and potentially harmful constituents in healthy Japanese smokers using a novel tobacco vapor product compared with conventional cigarettes and smoking abstinence.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29738810</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30132-6</DOI>
    <KeywordList>
      <Keywords>Biomarkers of exposure</Keywords>
      <Keywords>Clinical study</Keywords>
      <Keywords>Harmful and potentially harmful constituents</Keywords>
      <Keywords>Japanese healthy adult smokers</Keywords>
      <Keywords>Novel tobacco vapor product</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Dai Yuki</Name>
        <Affiliation>Scientific Product Assessment Center, R&amp;D Group, Japan Tobacco Inc., Japan. Electronic address: dai.yuki@jti.com.</Affiliation>
      </Author>
      <Author>
        <Name>Yuki Takeshige</Name>
        <Affiliation>Scientific Product Assessment Center, R&amp;D Group, Japan Tobacco Inc., Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Kyoko Nakaya</Name>
        <Affiliation>Scientific Product Assessment Center, R&amp;D Group, Japan Tobacco Inc., Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Yasuyuki Futamura</Name>
        <Affiliation>Scientific Product Assessment Center, R&amp;D Group, Japan Tobacco Inc., Japan.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Assessment of the mode of action underlying development of forestomach tumors in rodents following oral exposure to ethyl acrylate and relevance to humans.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29738809</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30137-5</DOI>
    <KeywordList>
      <Keywords>Carcinogenesis</Keywords>
      <Keywords>Ethyl acrylate</Keywords>
      <Keywords>Forestomach</Keywords>
      <Keywords>Mode of action (MOA)</Keywords>
      <Keywords>Risk assessment</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Chad M. Thompson</Name>
        <Affiliation>ToxStrategies, Inc., Katy, TX 77494, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Mina Suh</Name>
        <Affiliation>ToxStrategies, Inc., Mission Viejo, CA 92692, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Deborah M. Proctor</Name>
        <Affiliation>ToxStrategies, Inc., Mission Viejo, CA 92692, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Grace Chappell</Name>
        <Affiliation>ToxStrategies, Inc., Austin, TX 78731, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Susan Borghoff</Name>
        <Affiliation>ToxStrategies, Inc., Cary, NC 27511, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Robert Ellis-Hutchings</Name>
        <Affiliation>The Dow Chemical Company, Midland, MI 48674, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Karin Wiench</Name>
        <Affiliation>BASF SE, Ludwigshafen am Rhein Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Lavorgie Finch</Name>
        <Affiliation>Arkema Inc., King of Prussia, PA 19406, United States. Electronic address: lavorgie.finch@arkema.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A big data approach to the concordance of the toxicity of pharmaceuticals in animals and humans.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29730448</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30127-2</DOI>
    <KeywordList>
      <Keywords>Adverse event</Keywords>
      <Keywords>Big data</Keywords>
      <Keywords>Concordance</Keywords>
      <Keywords>Predictive value</Keywords>
      <Keywords>Predictivity of animal studies</Keywords>
      <Keywords>Risk assessment</Keywords>
      <Keywords>Signal detection</Keywords>
      <Keywords>Translation</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Matthew Clark</Name>
        <Affiliation>Elsevier R&amp;D Solutions, 1600 JFK Blvd, Philadelphia, PA, 19103, USA. Electronic address: m.clark@elsevier.com.</Affiliation>
      </Author>
      <Author>
        <Name>Thomas Steger-Hartmann</Name>
        <Affiliation>Investigational Toxicology, Bayer AG, 13353, Berlin, Germany.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Application of a direct aerosol exposure system for the assessment of biological effects of cigarette smoke and novel tobacco product vapor on human bronchial epithelial cultures.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29730447</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30135-1</DOI>
    <KeywordList>
      <Keywords>Cigarette smoke</Keywords>
      <Keywords>MucilAir</Keywords>
      <Keywords>Novel tobacco products</Keywords>
      <Keywords>Vitrocell systems</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Shinkichi Ishikawa</Name>
        <Affiliation>Scientific Product Assessment Center, R&amp;D Group, Japan Tobacco Inc., 6-2 Umegaoka, Aoba-ku, Yokohama, Kanagawa 227-8512, Japan. Electronic address: shinkichi.ishikawa@jt.com.</Affiliation>
      </Author>
      <Author>
        <Name>Kazushi Matsumura</Name>
        <Affiliation>Scientific Product Assessment Center, R&amp;D Group, Japan Tobacco Inc., 6-2 Umegaoka, Aoba-ku, Yokohama, Kanagawa 227-8512, Japan. Electronic address: kazushi.matsumura@jt.com.</Affiliation>
      </Author>
      <Author>
        <Name>Nobumasa Kitamura</Name>
        <Affiliation>Scientific Product Assessment Center, R&amp;D Group, Japan Tobacco Inc., 6-2 Umegaoka, Aoba-ku, Yokohama, Kanagawa 227-8512, Japan. Electronic address: nobumasa.kitamura@jt.com.</Affiliation>
      </Author>
      <Author>
        <Name>Kanae Ishimori</Name>
        <Affiliation>Scientific Product Assessment Center, R&amp;D Group, Japan Tobacco Inc., 6-2 Umegaoka, Aoba-ku, Yokohama, Kanagawa 227-8512, Japan. Electronic address: kanaeishimori@jt.com.</Affiliation>
      </Author>
      <Author>
        <Name>Yuichiro Takanami</Name>
        <Affiliation>Scientific Product Assessment Center, R&amp;D Group, Japan Tobacco Inc., 6-2 Umegaoka, Aoba-ku, Yokohama, Kanagawa 227-8512, Japan. Electronic address: yuichiro.takanami@jt.com.</Affiliation>
      </Author>
      <Author>
        <Name>Shigeaki Ito</Name>
        <Affiliation>Scientific Product Assessment Center, R&amp;D Group, Japan Tobacco Inc., 6-2 Umegaoka, Aoba-ku, Yokohama, Kanagawa 227-8512, Japan. Electronic address: shigeaki.ito@jt.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Canadian, European and United States new drug approval times now relatively similar.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29730446</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30133-8</DOI>
    <KeywordList>
      <Keywords>Canada</Keywords>
      <Keywords>Drug approval</Keywords>
      <Keywords>Europe</Keywords>
      <Keywords>Orphan drugs</Keywords>
      <Keywords>United States</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Nigel S. B. Rawson</Name>
        <Affiliation>Eastlake Research Group, Oakville, Ontario, Canada; Canadian Health Policy Institute, Toronto, Ontario, Canada; Fraser Institute, Vancouver, British Columbia, Canada. Electronic address: EastlakeRG@gmail.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Chemical applicability domain of the local lymph node assay (LLNA) for skin sensitisation potency. Part 4. Quantitative correlation of LLNA potency with human potency.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29730445</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30131-4</DOI>
    <KeywordList>
      <Keywords>Applicability domains</Keywords>
      <Keywords>HRIPT</Keywords>
      <Keywords>LLNA</Keywords>
      <Keywords>Quantitative correlation</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>David W. Roberts</Name>
        <Affiliation>School of Pharmacy and Biomolecular Sciences, Liverpool John Moores University, Liverpool L3 3AF, United Kingdom. Electronic address: d.w.roberts@ljmu.ac.uk.</Affiliation>
      </Author>
      <Author>
        <Name>Anne Marie Api</Name>
        <Affiliation>Research Institute for Fragrance Materials, Inc., 50 Tice Boulevard, Woodcliff Lake, NJ 07677, United States.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Pesticide exposure and risk of Parkinson's disease: Dose-response meta-analysis of observational studies.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29729297</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30136-3</DOI>
    <KeywordList>
      <Keywords>Exposure</Keywords>
      <Keywords>Meta-analysis</Keywords>
      <Keywords>Parkinson's disease</Keywords>
      <Keywords>Pesticides</Keywords>
      <Keywords>Risk</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Dandan Yan</Name>
        <Affiliation>Department of Health Toxicology, MOE Key Lab of Environment and Health, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, 13 Hangkong-Road, Wuhan, 430030, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Yunjian Zhang</Name>
        <Affiliation>Department of Huazhong Univ Sci &amp; Technol, Tongji Med Coll, Union Hosp, Dept Neurol, Wuhan 430030, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Liegang Liu</Name>
        <Affiliation>Department of Nutrition and Food Hygiene, Hubei Key Laboratory of Food Nutrition and Safety, Tongji Medical College, Huazhong University of Science and Technology, 13 Hangkong-Road, Wuhan, 430030, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Nian Shi</Name>
        <Affiliation>Department of Health Toxicology, MOE Key Lab of Environment and Health, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, 13 Hangkong-Road, Wuhan, 430030, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Hong Yan</Name>
        <Affiliation>Department of Health Toxicology, MOE Key Lab of Environment and Health, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, 13 Hangkong-Road, Wuhan, 430030, PR China. Electronic address: yanhong@mails.tjmu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Let the IRIS Bloom:Regrowing the integrated risk information system (IRIS) of the U.S. Environmental Protection Agency.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29729296</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30134-X</DOI>
    <AuthorList>
      <Author>
        <Name>Michael L. Dourson</Name>
        <Affiliation>Toxicology Excellence for Risk Assessment (TERA), Cincinnati, OH, USA. Electronic address: dourson@tera.org.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Evaluation of airborne asbestos exposure from routine handling of asbestos-containing wire gauze pads in the research laboratory.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29723551</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30129-6</DOI>
    <KeywordList>
      <Keywords>Asbestos</Keywords>
      <Keywords>Hazard identification</Keywords>
      <Keywords>Laboratory exposure</Keywords>
      <Keywords>Wire gauze pads</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Ediberto Garcia</Name>
        <Affiliation>Center for Environmental and Occupational Risk Analysis and Management, Department of Environmental and Occupational Health, College of Public Health, University of South Florida, 13201 Bruce B. Downs Blvd., Tampa, FL, 33612, USA. Electronic address: edg@mail.usf.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Daniel Newfang</Name>
        <Affiliation>Center for Environmental and Occupational Risk Analysis and Management, Department of Environmental and Occupational Health, College of Public Health, University of South Florida, 13201 Bruce B. Downs Blvd., Tampa, FL, 33612, USA. Electronic address: dnewfang@health.usf.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Jayme P. Coyle</Name>
        <Affiliation>Center for Environmental and Occupational Risk Analysis and Management, Department of Environmental and Occupational Health, College of Public Health, University of South Florida, 13201 Bruce B. Downs Blvd., Tampa, FL, 33612, USA. Electronic address: jcoyle3@health.usf.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Charles L. Blake</Name>
        <Affiliation>Bureau Veritas North America, Inc., 3380 Chastain Meadows Pkwy, Suite 300, Kennesaw, GA, 30144, USA. Electronic address: charlie.blake@us.bureauveritas.com.</Affiliation>
      </Author>
      <Author>
        <Name>John W. Spencer</Name>
        <Affiliation>Environmental Profiles, Inc., 8805 Columbia 100 Pkwy., Ste 100, Columbia, MD, 21045, USA. Electronic address: jspencer@episervices.com.</Affiliation>
      </Author>
      <Author>
        <Name>Leonard G. Burrelli</Name>
        <Affiliation>Environmental Profiles, Inc., 8805 Columbia 100 Pkwy., Ste 100, Columbia, MD, 21045, USA. Electronic address: lburrelli@episervices.com.</Affiliation>
      </Author>
      <Author>
        <Name>Giffe T. Johnson</Name>
        <Affiliation>Center for Environmental and Occupational Risk Analysis and Management, Department of Environmental and Occupational Health, College of Public Health, University of South Florida, 13201 Bruce B. Downs Blvd., Tampa, FL, 33612, USA. Electronic address: gtjohnso@mail.usf.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Raymond D. Harbison</Name>
        <Affiliation>Center for Environmental and Occupational Risk Analysis and Management, Department of Environmental and Occupational Health, College of Public Health, University of South Florida, 13201 Bruce B. Downs Blvd., Tampa, FL, 33612, USA. Electronic address: rharbiso@health.usf.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Subchronic toxicity study in rats evaluating genetically modified DAS-81419-2 soybean.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29715492</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30128-4</DOI>
    <KeywordList>
      <Keywords>90-Day feeding study</Keywords>
      <Keywords>Genetically modified soybean</Keywords>
      <Keywords>Rat</Keywords>
      <Keywords>Subchronic toxicity</Keywords>
      <Keywords>cry1Ac gene</Keywords>
      <Keywords>cry1F gene</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Zhi Yong Qian</Name>
        <Affiliation>Department of Toxicology, Tianjin Centers for Disease Control and Prevention, Tianjin 300011, China. Electronic address: 13323360260@163.com.</Affiliation>
      </Author>
      <Author>
        <Name>Shu Jing Zhang</Name>
        <Affiliation>Department of Toxicology, Tianjin Centers for Disease Control and Prevention, Tianjin 300011, China.</Affiliation>
      </Author>
      <Author>
        <Name>Li Zhang</Name>
        <Affiliation>Department of Toxicology, Tianjin Centers for Disease Control and Prevention, Tianjin 300011, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jing Zhang</Name>
        <Affiliation>Department of Toxicology, Tianjin Centers for Disease Control and Prevention, Tianjin 300011, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ying Hua Liu</Name>
        <Affiliation>Department of Toxicology, Tianjin Centers for Disease Control and Prevention, Tianjin 300011, China.</Affiliation>
      </Author>
      <Author>
        <Name>Qing Hong Zhou</Name>
        <Affiliation>Department of Toxicology, Tianjin Centers for Disease Control and Prevention, Tianjin 300011, China.</Affiliation>
      </Author>
      <Author>
        <Name>Shu Qing Jiang</Name>
        <Affiliation>Department of Toxicology, Tianjin Centers for Disease Control and Prevention, Tianjin 300011, China.</Affiliation>
      </Author>
      <Author>
        <Name>Shu Fei Li</Name>
        <Affiliation>Department of Toxicology, Tianjin Centers for Disease Control and Prevention, Tianjin 300011, China.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Recent updates and challenges on the regulation of precision medicine: The United States in perspective.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29715491</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30130-2</DOI>
    <KeywordList>
      <Keywords>Food and drug administration</Keywords>
      <Keywords>Precision medicine</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Lin Chau Chang</Name>
        <Affiliation>School of Pharmacy, College of Medicine, National Taiwan University, 33 Linsen S. Rd., Zhongzheng Dist., Taipei City 10050, Taiwan. Electronic address: linchauchang@ntu.edu.tw.</Affiliation>
      </Author>
      <Author>
        <Name>Thomas E. Colonna</Name>
        <Affiliation>Regulatory Science and Food Safety Regulation Programs, Johns Hopkins University, Montgomery County Campus, 9601 Medical Center Drive, Rockville, MD 20850, United States.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Initial hazard assessment of 4-benzylphenol, a structural analog of bisphenol F: Genotoxicity tests in vitro and a 28-day repeated-dose toxicity study in rats.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29705401</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30117-X</DOI>
    <KeywordList>
      <Keywords>4-Benzylphenol</Keywords>
      <Keywords>CAS no. 101-53-1</Keywords>
      <Keywords>D-value</Keywords>
      <Keywords>Gavage</Keywords>
      <Keywords>Genotoxicity</Keywords>
      <Keywords>Hazard class</Keywords>
      <Keywords>NOAEL</Keywords>
      <Keywords>Rat</Keywords>
      <Keywords>Repeated-dose toxicity</Keywords>
      <Keywords>Screening risk assessment</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Toshime Igarashi</Name>
        <Affiliation>Division of Risk Assessment, Biological Safety Research Center, National Institute of Health Sciences, 3-25-26 Tonomachi, Kawasaki-ku, Kawasaki, Kanagawa, 210-9501, Japan. Electronic address: toshime.igarashi@nihs.go.jp.</Affiliation>
      </Author>
      <Author>
        <Name>Hideki Serizawa</Name>
        <Affiliation>BoZo Research Center Inc., 1284 Kamado, Gotennba, Shizuoka, 412-0039, Japan. Electronic address: serizawa-hideki@bozo.co.jp.</Affiliation>
      </Author>
      <Author>
        <Name>Katsumi Kobayashi</Name>
        <Affiliation>Division of Risk Assessment, Biological Safety Research Center, National Institute of Health Sciences, 3-25-26 Tonomachi, Kawasaki-ku, Kawasaki, Kanagawa, 210-9501, Japan. Electronic address: student-kobayashi@beige.plala.or.jp.</Affiliation>
      </Author>
      <Author>
        <Name>Hiroshi Suzuki</Name>
        <Affiliation>Division of Risk Assessment, Biological Safety Research Center, National Institute of Health Sciences, 3-25-26 Tonomachi, Kawasaki-ku, Kawasaki, Kanagawa, 210-9501, Japan. Electronic address: hsuzuki@nihs.go.jp.</Affiliation>
      </Author>
      <Author>
        <Name>Mariko Matsumoto</Name>
        <Affiliation>Division of Risk Assessment, Biological Safety Research Center, National Institute of Health Sciences, 3-25-26 Tonomachi, Kawasaki-ku, Kawasaki, Kanagawa, 210-9501, Japan. Electronic address: mariko@nihs.go.jp.</Affiliation>
      </Author>
      <Author>
        <Name>Takako Iso</Name>
        <Affiliation>Division of Risk Assessment, Biological Safety Research Center, National Institute of Health Sciences, 3-25-26 Tonomachi, Kawasaki-ku, Kawasaki, Kanagawa, 210-9501, Japan. Electronic address: takako.iso@nihs.go.jp.</Affiliation>
      </Author>
      <Author>
        <Name>Tomoko Kawamura</Name>
        <Affiliation>Division of Risk Assessment, Biological Safety Research Center, National Institute of Health Sciences, 3-25-26 Tonomachi, Kawasaki-ku, Kawasaki, Kanagawa, 210-9501, Japan. Electronic address: tomoko@nihs.go.jp.</Affiliation>
      </Author>
      <Author>
        <Name>Kaoru Inoue</Name>
        <Affiliation>Division of Risk Assessment, Biological Safety Research Center, National Institute of Health Sciences, 3-25-26 Tonomachi, Kawasaki-ku, Kawasaki, Kanagawa, 210-9501, Japan. Electronic address: k-inoue@nihs.go.jp.</Affiliation>
      </Author>
      <Author>
        <Name>Atsushi Ono</Name>
        <Affiliation>Division of Pharmaceutical, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, 2-5-1 Shikata-cho, Kita-ku, Okayama, 700-8530, Japan. Electronic address: atsushiono3@okayama-u.ac.jp.</Affiliation>
      </Author>
      <Author>
        <Name>Takashi Yamada</Name>
        <Affiliation>Division of Risk Assessment, Biological Safety Research Center, National Institute of Health Sciences, 3-25-26 Tonomachi, Kawasaki-ku, Kawasaki, Kanagawa, 210-9501, Japan. Electronic address: t-yamada@nihs.go.jp.</Affiliation>
      </Author>
      <Author>
        <Name>Akihiko Hirose</Name>
        <Affiliation>Division of Risk Assessment, Biological Safety Research Center, National Institute of Health Sciences, 3-25-26 Tonomachi, Kawasaki-ku, Kawasaki, Kanagawa, 210-9501, Japan. Electronic address: hirose@nihs.go.jp.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>An Adverse Outcome Pathway (AOP) for forestomach tumors induced by non-genotoxic initiating events.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29684431</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30116-8</DOI>
    <KeywordList>
      <Keywords>Adverse outcome pathway (AOP)</Keywords>
      <Keywords>Butylated hydroxyanisole (BHA)</Keywords>
      <Keywords>Cytotoxicity</Keywords>
      <Keywords>Ethyl acrylate</Keywords>
      <Keywords>Forestomach tumors</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Deborah M. Proctor</Name>
        <Affiliation>ToxStrategies, Inc., Mission Viejo, CA 92692, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Mina Suh</Name>
        <Affiliation>ToxStrategies, Inc., Mission Viejo, CA 92692, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Grace Chappell</Name>
        <Affiliation>ToxStrategies, Inc., Austin, TX 78759, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Susan J. Borghoff</Name>
        <Affiliation>ToxStrategies, Inc., Cary, NC 27511, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Chad M. Thompson</Name>
        <Affiliation>ToxStrategies, Inc., Katy, TX 77494, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Karin Wiench</Name>
        <Affiliation>BASF SE, Ludwigshafen Am Rhein, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Lavorgie Finch</Name>
        <Affiliation>Arkema Inc., King of Prussia, PA 19406, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Robert Ellis-Hutchings</Name>
        <Affiliation>The Dow Chemical Company, Midland, MI 48674, USA. Electronic address: REllis-hutchings@dow.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Use of toxicogenomics in drug safety evaluation: Current status and an industry perspective.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29679677</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30111-9</DOI>
    <KeywordList>
      <Keywords>Drug development</Keywords>
      <Keywords>Drug discovery</Keywords>
      <Keywords>Drug safety</Keywords>
      <Keywords>Predictive toxicology</Keywords>
      <Keywords>Toxicogenomics</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>John L. Vahle</Name>
        <Affiliation>Lilly Research Laboratories, Indianapolis, IN, USA. Electronic address: jvahle@lilly.com.</Affiliation>
      </Author>
      <Author>
        <Name>Ulf Anderson</Name>
        <Affiliation>AstraZeneca, Drug Safety &amp; Metabolism, Mölndal, Sweden.</Affiliation>
      </Author>
      <Author>
        <Name>Eric A. G. Blomme</Name>
        <Affiliation>AbbVie, Global Preclinical Safety, North Chicago, IL, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jean Christophe Hoflack</Name>
        <Affiliation>F Hoffmann La Roche, Pharma Research and Early Development, Roche Innovation Center Basel, CH, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Daniel P. Stiehl</Name>
        <Affiliation>Novartis Pharma AG, Translational Medicine at the Novartis Institutes of Biomedical Research, Basel, Switzerland.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Exposure to beta-cypermethrin impairs the reproductive function of female mice.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29678769</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30115-6</DOI>
    <KeywordList>
      <Keywords>Beta-cypermethrin</Keywords>
      <Keywords>Female reproductive function</Keywords>
      <Keywords>Mice</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Yong Jiang Zhou</Name>
        <Affiliation>Maternal, Child and Adolescent Health, School of Public Health, Hainan Medical University, No.3 Yixueyuan Road, Longhua District, Hainan Province, 571199, PR China. Electronic address: hy0208033@hainmc.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Xiao Dan Wang</Name>
        <Affiliation>School of Public Health, Hainan Medical University, Yixueyuan Road, Longhua District, Hainan Province, 571199, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Sha Xiao</Name>
        <Affiliation>School of Public Health, Hainan Medical University, Yixueyuan Road, Longhua District, Hainan Province, 571199, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>De E. Yu</Name>
        <Affiliation>School of Public Health, Hainan Medical University, Yixueyuan Road, Longhua District, Hainan Province, 571199, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Li Qing Wang</Name>
        <Affiliation>Maternal, Child and Adolescent Health, School of Public Health, Hainan Medical University, No.3 Yixueyuan Road, Longhua District, Hainan Province, 571199, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Ji Hong Wang</Name>
        <Affiliation>School of Public Health, Hainan Medical University, Yixueyuan Road, Longhua District, Hainan Province, 571199, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Hui Quan Zhu</Name>
        <Affiliation>Maternal, Child and Adolescent Health, School of Public Health, Hainan Medical University, No.3 Yixueyuan Road, Longhua District, Hainan Province, 571199, PR China.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Safety assessment of ethanolic extract of Olea europaea L. leaves after acute and subacute administration to Wistar rats.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29678768</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30113-2</DOI>
    <KeywordList>
      <Keywords>Acute</Keywords>
      <Keywords>Leaves</Keywords>
      <Keywords>Oleaceae</Keywords>
      <Keywords>Olive</Keywords>
      <Keywords>Safety</Keywords>
      <Keywords>Subacute</Keywords>
      <Keywords>Toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Camille Gaube Guex</Name>
        <Affiliation>Departamento de Fisiologia e Farmacologia, Centro de Ciências da Saúde, Universidade Federal de Santa Maria, Santa Maria, RS, Brazil. Electronic address: camilleguex@yahoo.com.br.</Affiliation>
      </Author>
      <Author>
        <Name>Fernanda Ziegler Reginato</Name>
        <Affiliation>Departamento de Fisiologia e Farmacologia, Centro de Ciências da Saúde, Universidade Federal de Santa Maria, Santa Maria, RS, Brazil. Electronic address: fernanda_zr@yahoo.com.br.</Affiliation>
      </Author>
      <Author>
        <Name>Kássia Caroline Figueredo</Name>
        <Affiliation>Departamento de Fisiologia e Farmacologia, Centro de Ciências da Saúde, Universidade Federal de Santa Maria, Santa Maria, RS, Brazil. Electronic address: kassia.tquimica@yahoo.com.br.</Affiliation>
      </Author>
      <Author>
        <Name>Andreia Regina Haas da da Silva</Name>
        <Affiliation>Departamento de Fisiologia e Farmacologia, Centro de Ciências da Saúde, Universidade Federal de Santa Maria, Santa Maria, RS, Brazil. Electronic address: andreiaregina_silva@yahoo.com.br.</Affiliation>
      </Author>
      <Author>
        <Name>Fernanda Brum Pires</Name>
        <Affiliation>Departamento de Farmácia Industrial, Centro de Ciências da Saúde, Universidade Federal de Santa Maria, Santa Maria, RS, Brazil. Electronic address: fernandabrumpires@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Roberta da Silva Jesus</Name>
        <Affiliation>Departamento de Farmácia Industrial, Centro de Ciências da Saúde, Universidade Federal de Santa Maria, Santa Maria, RS, Brazil. Electronic address: robertasj@hotmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Cibele Lima Lhamas</Name>
        <Affiliation>Departamento de Clínica Médica de Pequenos Animais, Hospital Veterinário Universitário, Universidade Federal de Santa Maria, Santa Maria, RS, Brazil. Electronic address: cibelelhamas@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Gilberti Helena Hübscher Lopes</Name>
        <Affiliation>Departamento de Tecnologia e Ciência dos Alimentos, Centro de Ciências Rurais, Universidade Federal de Santa Maria, Santa Maria, RS, Brazil. Electronic address: gilberti@gilbertinutri.com.br.</Affiliation>
      </Author>
      <Author>
        <Name>Liliane de Freitas Bauermann</Name>
        <Affiliation>Departamento de Fisiologia e Farmacologia, Centro de Ciências da Saúde, Universidade Federal de Santa Maria, Santa Maria, RS, Brazil. Electronic address: lgfbauermann@gmail.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Targeted inhibition of tumor survival, metastasis and angiogenesis by Acacia ferruginea mediated regulation of VEGF, inflammatory mediators, cytokine profile and inhibition of transcription factor activation.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29678767</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30112-0</DOI>
    <KeywordList>
      <Keywords>Acacia ferruginea</Keywords>
      <Keywords>Angiogenesis</Keywords>
      <Keywords>B16F-10 melanoma cells</Keywords>
      <Keywords>Cytokines</Keywords>
      <Keywords>Metastasis</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Kunnathur Murugesan Sakthivel</Name>
        <Affiliation>Department of Biosciences &amp; Technology, Karunya University, Karunya Nagar, Coimbatore 641114, Tamil Nadu, India.</Affiliation>
      </Author>
      <Author>
        <Name>Chandrasekaran Guruvayoorappan</Name>
        <Affiliation>Laboratory of Immunopharmacology and Experimental Therapeutics, Division of Cancer Research, Regional Cancer Centre, Medical College Post, Thiruvananthapuram, 695011, Kerala, India. Electronic address: immunopharmacologyrcc@gmail.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>In silico toxicology protocols.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29678766</pubmedLink>
    <GrantList>
      <Grant>R43 ES026909</Grant>
      <Grant>R44 ES026909</Grant>
      <Grant>Z99 ES999999</Grant>
    </GrantList>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30114-4</DOI>
    <KeywordList>
      <Keywords>Computational toxicology</Keywords>
      <Keywords>Expert alert</Keywords>
      <Keywords>Expert review</Keywords>
      <Keywords>In silico</Keywords>
      <Keywords>In silico toxicology</Keywords>
      <Keywords>Predictive toxicology</Keywords>
      <Keywords>QSAR</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Glenn J. Myatt</Name>
        <Affiliation>Leadscope, Inc., 1393 Dublin Rd, Columbus, OH 43215, USA. Electronic address: gmyatt@leadscope.com.</Affiliation>
      </Author>
      <Author>
        <Name>Ernst Ahlberg</Name>
        <Affiliation>Predictive Compound ADME &amp; Safety, Drug Safety &amp; Metabolism, AstraZeneca IMED Biotech Unit, Mölndal, Sweden.</Affiliation>
      </Author>
      <Author>
        <Name>Yumi Akahori</Name>
        <Affiliation>Chemicals Evaluation and Research Institute, 1-4-25 Kouraku, Bunkyo-ku, Tokyo 112-0004 Japan.</Affiliation>
      </Author>
      <Author>
        <Name>David Allen</Name>
        <Affiliation>Integrated Laboratory Systems, Inc., Research Triangle Park, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Alexander Amberg</Name>
        <Affiliation>Sanofi, R&amp;D Preclinical Safety Frankfurt, Industriepark Hoechst, D-65926 Frankfurt am Main, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Lennart T. Anger</Name>
        <Affiliation>Sanofi, R&amp;D Preclinical Safety Frankfurt, Industriepark Hoechst, D-65926 Frankfurt am Main, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Aynur Aptula</Name>
        <Affiliation>Unilever, Safety and Environmental Assurance Centre, Colworth, Beds, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Scott Auerbach</Name>
        <Affiliation>The National Institute of Environmental Health Sciences, Division of the National Toxicology Program, Research Triangle Park, NC 27709, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Lisa Beilke</Name>
        <Affiliation>Toxicology Solutions Inc., San Diego, CA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Phillip Bellion</Name>
        <Affiliation>DSM Nutritional Products, Kaiseraugst, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Romualdo Benigni</Name>
        <Affiliation>Alpha-PreTox, via G.Pascoli 1, 00184 Roma, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Joel Bercu</Name>
        <Affiliation>Gilead Sciences, 333 Lakeside Drive, Foster City, CA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Ewan D. Booth</Name>
        <Affiliation>Syngenta, Product Safety Department, Jealott's Hill International Research Centre, Bracknell, Berkshire, RG42 6EY, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Dave Bower</Name>
        <Affiliation>Leadscope, Inc., 1393 Dublin Rd, Columbus, OH 43215, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Alessandro Brigo</Name>
        <Affiliation>Roche Pharmaceutical Research &amp; Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Natalie Burden</Name>
        <Affiliation>National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs), Gibbs Building, 215 Euston Road, London NW1 2BE, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Zoryana Cammerer</Name>
        <Affiliation>Janssen Research &amp; Development, 1400 McKean Road, Spring House, PA 19477, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Mark T. D. Cronin</Name>
        <Affiliation>School of Pharmacy and Chemistry, Liverpool John Moores University, Liverpool, L3 3AF, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Kevin P. Cross</Name>
        <Affiliation>Leadscope, Inc., 1393 Dublin Rd, Columbus, OH 43215, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Laura Custer</Name>
        <Affiliation>Bristol-Myers Squibb, Drug Safety Evaluation, 1 Squibb Dr, New Brunswick, NJ 08903, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Magdalena Dettwiler</Name>
        <Affiliation>Elanco Animal Health, Schwarzwaldallee 215, 4058 Basel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Krista Dobo</Name>
        <Affiliation>Pfizer Global Research &amp; Development, 558 Eastern Point Road, Groton, CT 06340, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Kevin A. Ford</Name>
        <Affiliation>Global Blood Therapeutics, South San Francisco, CA 94080, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Marie C. Fortin</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, 170 Frelinghuysen Rd, Piscataway, NJ 08855, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Samantha E. Gad-McDonald</Name>
        <Affiliation>Gad Consulting Services, 4008 Barrett Drive, Suite 201, Raleigh, NC 27609, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Nichola Gellatly</Name>
        <Affiliation>National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs), Gibbs Building, 215 Euston Road, London NW1 2BE, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Véronique Gervais</Name>
        <Affiliation>Biologie Servier, 905 Route de Saran, 45520 Gidy, France.</Affiliation>
      </Author>
      <Author>
        <Name>Kyle P. Glover</Name>
        <Affiliation>Defense Threat Reduction Agency, Edgewood Chemical Biological Center, Aberdeen Proving Ground, MD 21010, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Susanne Glowienke</Name>
        <Affiliation>Novartis Pharma AG, Pre-Clinical Safety, Werk Klybeck, CH-4057, Basel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Jacky Van Gompel</Name>
        <Affiliation>Janssen Pharmaceutical Companies of Johnson &amp; Johnson, 2340 Beerse, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Steve Gutsell</Name>
        <Affiliation>Unilever, Safety and Environmental Assurance Centre, Colworth, Beds, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Barry Hardy</Name>
        <Affiliation>Douglas Connect GmbH, Technology Park Basel, Hochbergerstrasse 60C, CH-4057 Basel / Basel-Stadt, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>James S. Harvey</Name>
        <Affiliation>GlaxoSmithKline Pre-Clinical Development, Park Road, Ware, Hertfordshire, SG12 0DP, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Jedd Hillegass</Name>
        <Affiliation>Bristol-Myers Squibb, Drug Safety Evaluation, 1 Squibb Dr, New Brunswick, NJ 08903, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Masamitsu Honma</Name>
        <Affiliation>National Institute of Health Sciences, Tokyo, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Jui Hua Hsieh</Name>
        <Affiliation>Kelly Government Solutions, Research Triangle Park, NC 27709, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Chia Wen Hsu</Name>
        <Affiliation>FDA Center for Drug Evaluation and Research, Silver Spring, MD 20993, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Kathy Hughes</Name>
        <Affiliation>Existing Substances Risk Assessment Bureau, Health Canada, Ottawa, ON, K1A 0K9, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Candice Johnson</Name>
        <Affiliation>Leadscope, Inc., 1393 Dublin Rd, Columbus, OH 43215, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Robert Jolly</Name>
        <Affiliation>Toxicology Division, Eli Lilly and Company, Indianapolis, IN, USA.</Affiliation>
      </Author>
      <Author>
        <Name>David Jones</Name>
        <Affiliation>Medicines and Healthcare Products Regulatory Agency, 151 Buckingham Palace Road, London, SW1W 9SZ, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Ray Kemper</Name>
        <Affiliation>Vertex Pharmaceuticals Inc., Discovery and Investigative Toxicology, 50 Northern Ave, Boston, MA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Michelle O. Kenyon</Name>
        <Affiliation>Pfizer Global Research &amp; Development, 558 Eastern Point Road, Groton, CT 06340, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Marlene T. Kim</Name>
        <Affiliation>FDA Center for Drug Evaluation and Research, Silver Spring, MD 20993, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Naomi L. Kruhlak</Name>
        <Affiliation>FDA Center for Drug Evaluation and Research, Silver Spring, MD 20993, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Sunil A. Kulkarni</Name>
        <Affiliation>Existing Substances Risk Assessment Bureau, Health Canada, Ottawa, ON, K1A 0K9, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Klaus Kümmerer</Name>
        <Affiliation>Institute for Sustainable and Environmental Chemistry, Leuphana University Lüneburg, Scharnhorststraße 1/C13.311b, 21335 Lüneburg, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Penny Leavitt</Name>
        <Affiliation>Bristol-Myers Squibb, Drug Safety Evaluation, 1 Squibb Dr, New Brunswick, NJ 08903, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Bernhard Majer</Name>
        <Affiliation>Shire, Industriestrasse 20, 1221, Wien, Austria.</Affiliation>
      </Author>
      <Author>
        <Name>Scott Masten</Name>
        <Affiliation>The National Institute of Environmental Health Sciences, Division of the National Toxicology Program, Research Triangle Park, NC 27709, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Scott Miller</Name>
        <Affiliation>Leadscope, Inc., 1393 Dublin Rd, Columbus, OH 43215, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Janet Moser</Name>
        <Affiliation>Chemical Security Analysis Center, Department of Homeland Security, 3401 Ricketts Point Road, Aberdeen Proving Ground, MD 21010-5405, USA; Battelle Memorial Institute, 505 King Avenue, Columbus, OH 43210, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Moiz Mumtaz</Name>
        <Affiliation>Agency for Toxic Substances and Disease Registry, US Department of Health and Human Services, Atlanta, GA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Wolfgang Muster</Name>
        <Affiliation>Roche Pharmaceutical Research &amp; Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Louise Neilson</Name>
        <Affiliation>British American Tobacco, Research and Development, Regents Park Road, Southampton, Hampshire, SO15 8TL, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Tudor I. Oprea</Name>
        <Affiliation>Translational Informatics Division, Department of Internal Medicine, Health Sciences Center, The University of New Mexico, NM, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Grace Patlewicz</Name>
        <Affiliation>U.S. Environmental Protection Agency, National Center for Computational Toxicology, Research Triangle Park, NC 27711, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Alexandre Paulino</Name>
        <Affiliation>SAPEC Agro, S.A., Avenida do Rio Tejo, Herdade das Praias, 2910-440 Setúbal, Portugal.</Affiliation>
      </Author>
      <Author>
        <Name>Elena Lo Piparo</Name>
        <Affiliation>Chemical Food Safety Group, Nestlé Research Center, Lausanne, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Mark Powley</Name>
        <Affiliation>FDA Center for Drug Evaluation and Research, Silver Spring, MD 20993, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Donald P. Quigley</Name>
        <Affiliation>Leadscope, Inc., 1393 Dublin Rd, Columbus, OH 43215, USA.</Affiliation>
      </Author>
      <Author>
        <Name>M. Vijayaraj Reddy</Name>
        <Affiliation>Merck Research Laboratories, West Point, PA 19486, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Andrea Nicole Richarz</Name>
        <Affiliation>European Commission, Joint Research Centre, Directorate for Health, Consumers and Reference Materials, Chemical Safety and Alternative Methods Unit, Via Enrico Fermi 2749, 21027 Ispra, VA, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Patricia Ruiz</Name>
        <Affiliation>Agency for Toxic Substances and Disease Registry, US Department of Health and Human Services, Atlanta, GA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Benoit Schilter</Name>
        <Affiliation>Chemical Food Safety Group, Nestlé Research Center, Lausanne, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Rositsa Serafimova</Name>
        <Affiliation>European Food Safety Authority, Via Carlo Magno 1A, 43126 Parma, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Wendy Simpson</Name>
        <Affiliation>Unilever, Safety and Environmental Assurance Centre, Colworth, Beds, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Lidiya Stavitskaya</Name>
        <Affiliation>FDA Center for Drug Evaluation and Research, Silver Spring, MD 20993, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Reinhard Stidl</Name>
        <Affiliation>Shire, Industriestrasse 20, 1221, Wien, Austria.</Affiliation>
      </Author>
      <Author>
        <Name>Diana Suarez-Rodriguez</Name>
        <Affiliation>Unilever, Safety and Environmental Assurance Centre, Colworth, Beds, UK.</Affiliation>
      </Author>
      <Author>
        <Name>David T. Szabo</Name>
        <Affiliation>RAI Services Company, 950 Reynolds Blvd., Winston-Salem, NC 27105, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Andrew Teasdale</Name>
        <Affiliation>AstraZeneca, Macclesfield, Cheshire, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Alejandra Trejo-Martin</Name>
        <Affiliation>Gilead Sciences, 333 Lakeside Drive, Foster City, CA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jean Pierre Valentin</Name>
        <Affiliation>UCB Biopharma SPRL, Chemin du Foriest, B-1420 Braine-l'Alleud, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Anna Vuorinen</Name>
        <Affiliation>DSM Nutritional Products, Kaiseraugst, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Brian A. Wall</Name>
        <Affiliation>Colgate-Palmolive Company, Piscataway, NJ 08854, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Pete Watts</Name>
        <Affiliation>Bibra, Cantium House, Railway Approach, Wallington, Surrey, SM6 0DZ, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Angela T. White</Name>
        <Affiliation>GlaxoSmithKline Pre-Clinical Development, Park Road, Ware, Hertfordshire, SG12 0DP, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Joerg Wichard</Name>
        <Affiliation>Bayer Pharma AG, Investigational Toxicology, Muellerstr. 178, D-13353 Berlin, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Kristine L. Witt</Name>
        <Affiliation>The National Institute of Environmental Health Sciences, Division of the National Toxicology Program, Research Triangle Park, NC 27709, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Adam Woolley</Name>
        <Affiliation>ForthTox Limited, PO Box 13550, Linlithgow, EH49 7YU, UK.</Affiliation>
      </Author>
      <Author>
        <Name>David Woolley</Name>
        <Affiliation>ForthTox Limited, PO Box 13550, Linlithgow, EH49 7YU, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Craig Zwickl</Name>
        <Affiliation>Transendix LLC, 1407 Moores Manor, Indianapolis, IN 46229, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Catrin Hasselgren</Name>
        <Affiliation>Leadscope, Inc., 1393 Dublin Rd, Columbus, OH 43215, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Minimum datasets to establish a CAR-mediated mode of action for rodent liver tumors.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29673940</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30101-6</DOI>
    <KeywordList>
      <Keywords>CAR</Keywords>
      <Keywords>Constitutive androstane receptor</Keywords>
      <Keywords>Liver</Keywords>
      <Keywords>Metofluthrin</Keywords>
      <Keywords>Minimal dataset</Keywords>
      <Keywords>Mode of action</Keywords>
      <Keywords>Nitrapyrin</Keywords>
      <Keywords>Rodent</Keywords>
      <Keywords>Tumor</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Richard C. Peffer</Name>
        <Affiliation>Syngenta Crop Protection, LLC, P.O. Box 18300, Greensboro, NC, 27419-8300, United States. Electronic address: richard.peffer@syngenta.com.</Affiliation>
      </Author>
      <Author>
        <Name>Matthew J. LeBaron</Name>
        <Affiliation>The Dow Chemical Company, Toxicology &amp; Environmental Research &amp; Consulting, Midland, MI, 48674, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Michael Battalora</Name>
        <Affiliation>DuPont Crop Protection, 1090 Elkton Road, Newark, DE, 19711, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Werner H. Bomann</Name>
        <Affiliation>Tox-Consult LLC for ADAMA MAH BV, Amsterdam NL Schaffhausen Branch, 8200, Schaffhausen, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Christoph Werner</Name>
        <Affiliation>BASF SE, FEP/PP, Z473, 67056, Ludwigshafen, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Manoj Aggarwal</Name>
        <Affiliation>Dow AgroSciences Ltd, 3B Park Square, Milton Park, Abingdon, Oxfordshire, OX14 4RN, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Rocky R. Rowe</Name>
        <Affiliation>European Crop Protection Association (ECPA), Brussels, BE, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Helen Tinwell</Name>
        <Affiliation>Bayer SAS, 16 rue Jean-Marie Leclair, 69009, Lyon, France.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Acute and subchronic toxicities in dogs and genotoxicity of honokiol microemulsion.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29655856</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30110-7</DOI>
    <KeywordList>
      <Keywords>Acute toxicity</Keywords>
      <Keywords>Beagle dog</Keywords>
      <Keywords>Genotoxicity</Keywords>
      <Keywords>Honokiol microemulsion</Keywords>
      <Keywords>Subchronic toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Xiujun Qin</Name>
        <Affiliation>Department of Radiological and Environmental Medicine, China Institute for Radiation Protection, Taiyuan 030006, China; Shanxi Key Laboratory of Drug Toxicology and Drug for Radiation Injury, Taiyuan 030006, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jingjing Yin</Name>
        <Affiliation>Department of Radiological and Environmental Medicine, China Institute for Radiation Protection, Taiyuan 030006, China; Shanxi Key Laboratory of Drug Toxicology and Drug for Radiation Injury, Taiyuan 030006, China.</Affiliation>
      </Author>
      <Author>
        <Name>Wei Zhang</Name>
        <Affiliation>Department of Radiological and Environmental Medicine, China Institute for Radiation Protection, Taiyuan 030006, China; Shanxi Key Laboratory of Drug Toxicology and Drug for Radiation Injury, Taiyuan 030006, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jianguo Li</Name>
        <Affiliation>Department of Radiological and Environmental Medicine, China Institute for Radiation Protection, Taiyuan 030006, China; Shanxi Key Laboratory of Drug Toxicology and Drug for Radiation Injury, Taiyuan 030006, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jianhua Wen</Name>
        <Affiliation>Department of Radiological and Environmental Medicine, China Institute for Radiation Protection, Taiyuan 030006, China; Shanxi Key Laboratory of Drug Toxicology and Drug for Radiation Injury, Taiyuan 030006, China. Electronic address: jianhua570621@163.com.</Affiliation>
      </Author>
      <Author>
        <Name>Shizhong Chen</Name>
        <Affiliation>School of Pharmaceutical Sciences, Peking University, Beijing 100191, China. Electronic address: chenshizhong66@163.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>An open-label, randomized, four-treatment crossover study evaluating the effects of salt form, acetaminophen, and food on the pharmacokinetics of phenylephrine.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29635061</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30108-9</DOI>
    <KeywordList>
      <Keywords>Food effect</Keywords>
      <Keywords>Pharmacokinetics</Keywords>
      <Keywords>Phenylephrine</Keywords>
      <Keywords>Phenylephrine hydrochloride</Keywords>
      <Keywords>Phenylephrine tannate</Keywords>
      <Keywords>Phenylephrine-acetaminophen combination product</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Cathy K. Gelotte</Name>
        <Affiliation>Johnson &amp; Johnson Consumer, Inc, 7050 Camp Hill Road, Fort Washington, PA 19034, USA. Electronic address: cathy.k.gelotte@gmail.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>In vitro percutaneous penetration of silver nanoparticles in pig and human skin.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29635060</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30106-5</DOI>
    <KeywordList>
      <Keywords>AgNPs</Keywords>
      <Keywords>Dermal penetration</Keywords>
      <Keywords>Nanosilver</Keywords>
      <Keywords>Percutaneous penetration</Keywords>
      <Keywords>Silver nanoparticles</Keywords>
      <Keywords>Skin</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Margaret E. K. Kraeling</Name>
        <Affiliation>United States Food and Drug Administration, Center for Food Safety and Applied Nutrition, Office of Applied Research and Safety Assessment, Division of Toxicology, Laurel, MD 20708, USA. Electronic address: Margaret.Kraeling@fda.hhs.gov.</Affiliation>
      </Author>
      <Author>
        <Name>Vanessa D. Topping</Name>
        <Affiliation>United States Food and Drug Administration, Center for Food Safety and Applied Nutrition, Office of Applied Research and Safety Assessment, Division of Toxicology, Laurel, MD 20708, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Zachary M. Keltner</Name>
        <Affiliation>United States Food and Drug Administration, Center for Food Safety and Applied Nutrition, Office of Applied Research and Safety Assessment, Division of Toxicology, Laurel, MD 20708, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Kathleen R. Belgrave</Name>
        <Affiliation>Oak Ridge Institute for Science and Education (ORISE), United States Department of Energy, Oakridge, TN 37837, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Keenan D. Bailey</Name>
        <Affiliation>United States Food and Drug Administration, Center for Food Safety and Applied Nutrition, Office of Applied Research and Safety Assessment, Division of Toxicology, Laurel, MD 20708, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Xiugong Gao</Name>
        <Affiliation>United States Food and Drug Administration, Center for Food Safety and Applied Nutrition, Office of Applied Research and Safety Assessment, Division of Toxicology, Laurel, MD 20708, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jeffrey J. Yourick</Name>
        <Affiliation>United States Food and Drug Administration, Center for Food Safety and Applied Nutrition, Office of Applied Research and Safety Assessment, Division of Toxicology, Laurel, MD 20708, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>An innovative investigative approach to characterize the effects observed in a combined fertility study in male and female rats.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29635059</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30107-7</DOI>
    <KeywordList>
      <Keywords>Fertility and early embryonic development</Keywords>
      <Keywords>ICH S5(R2)</Keywords>
      <Keywords>Postimplantation loss</Keywords>
      <Keywords>Preimplantation loss</Keywords>
      <Keywords>Rat</Keywords>
      <Keywords>Reproductive toxicity</Keywords>
      <Keywords>Sperm</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jianxun Xie</Name>
        <Affiliation>F. Hoffmann-La Roche Ltd., Roche Pharma and Early Development, Pharmaceutical Sciences, Roche Innovation Center, Shanghai 201023, China.</Affiliation>
      </Author>
      <Author>
        <Name>Juergen Funk</Name>
        <Affiliation>F. Hoffmann-La Roche Ltd., Roche Pharma and Early Development, Pharmaceutical Sciences, Roche Innovation Center, Basel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Martin Bopst</Name>
        <Affiliation>F. Hoffmann-La Roche Ltd., Roche Pharma and Early Development, Pharmaceutical Sciences, Roche Innovation Center, Basel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Giorgio Ottaviani</Name>
        <Affiliation>F. Hoffmann-La Roche Ltd., Roche Pharma and Early Development, Pharmaceutical Sciences, Roche Innovation Center, Basel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Noel Downes</Name>
        <Affiliation>Sequani Limited, Bromyard Road, Ledbury, Herefordshire, HR8 1LH, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Scott Hackford</Name>
        <Affiliation>Sequani Limited, Bromyard Road, Ledbury, Herefordshire, HR8 1LH, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Loris Villabruna</Name>
        <Affiliation>F. Hoffmann-La Roche Ltd., Roche Pharma and Early Development, Pharmaceutical Sciences, Roche Innovation Center, Basel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Georg Schmitt</Name>
        <Affiliation>F. Hoffmann-La Roche Ltd., Roche Pharma and Early Development, Pharmaceutical Sciences, Roche Innovation Center, Basel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Paul Barrow</Name>
        <Affiliation>F. Hoffmann-La Roche Ltd., Roche Pharma and Early Development, Pharmaceutical Sciences, Roche Innovation Center, Basel, Switzerland. Electronic address: paul.barrow.pb1@roche.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Elemental impurities in lipsticks: Results from a survey of the Portuguese and Brazilian markets.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29635058</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30109-0</DOI>
    <KeywordList>
      <Keywords>European regulation</Keywords>
      <Keywords>ICP-MS</Keywords>
      <Keywords>Limits</Keywords>
      <Keywords>Lipsticks</Keywords>
      <Keywords>Metals</Keywords>
      <Keywords>Safety assessment</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Edgar Pinto</Name>
        <Affiliation>LAQV, REQUIMTE, Department of Chemical Sciences, Faculty of Pharmacy, University of Porto, Rua de Jorge Viterbo Ferreira 228, 4050-313 Porto, Portugal; Department of Environmental Health, School of Health, Polytechnic Institute of Porto, CISA/Research Center in Environment and Health, R. Dr. António Bernardino de Almeida 400, 4200-072 Porto, Portugal. Electronic address: ecp@ess.ipp.pt.</Affiliation>
      </Author>
      <Author>
        <Name>Kainá Paiva</Name>
        <Affiliation>LAQV, REQUIMTE, Department of Chemical Sciences, Faculty of Pharmacy, University of Porto, Rua de Jorge Viterbo Ferreira 228, 4050-313 Porto, Portugal; Department of Pharmaceutical Sciences, Health Sciences Centre - Vitória, Federal University of Espírito Santo, Avenida Fernando Ferrari 514, 29075-910 Vitória, Espírito Santo, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Ana Carvalhido</Name>
        <Affiliation>LAQV, REQUIMTE, Department of Chemical Sciences, Faculty of Pharmacy, University of Porto, Rua de Jorge Viterbo Ferreira 228, 4050-313 Porto, Portugal.</Affiliation>
      </Author>
      <Author>
        <Name>Agostinho Almeida</Name>
        <Affiliation>LAQV, REQUIMTE, Department of Chemical Sciences, Faculty of Pharmacy, University of Porto, Rua de Jorge Viterbo Ferreira 228, 4050-313 Porto, Portugal.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The sub-chronic toxicity of a naphthenic hydrocarbon solvent in rats.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29630908</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30102-8</DOI>
    <KeywordList>
      <Keywords>Cyclo-alkanes</Keywords>
      <Keywords>Dearomatized white spirit</Keywords>
      <Keywords>Decalin</Keywords>
      <Keywords>Hydrocarbon solvent</Keywords>
      <Keywords>Inhalation toxicity</Keywords>
      <Keywords>Naphthene</Keywords>
      <Keywords>Occupational exposure level</Keywords>
      <Keywords>Sub-chronic toxicity</Keywords>
      <Keywords>UVCB</Keywords>
      <Keywords>α2u-globulin</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Juan Carlos Carrillo</Name>
        <Affiliation>Shell Health, Shell International B.V., P.O. Box 162, 2501 AN, The Hague, The Netherlands. Electronic address: juan-carlos.carrillo@shell.com.</Affiliation>
      </Author>
      <Author>
        <Name>M. David Adenuga</Name>
        <Affiliation>ExxonMobil Biomedical Sciences, Inc., 1545 Route 22 E., Annandale, NJ 08801, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Fayaz Momin</Name>
        <Affiliation>Shell Health, Shell Oil Company, 150 N. Dairy Ashford Road, Woodcreek E276E, Houston, TX 77079, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Richard H. McKee</Name>
        <Affiliation>ExxonMobil Biomedical Sciences, Inc., 1545 Route 22 E., Annandale, NJ 08801, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Combined effect of Benzophenone-2 and ultraviolet radiation promote photogenotoxicity and photocytotoxicity in human keratinocytes.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29626563</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30103-X</DOI>
    <KeywordList>
      <Keywords>Benzophenone-2</Keywords>
      <Keywords>CPDs</Keywords>
      <Keywords>DNA damage</Keywords>
      <Keywords>Photogenotoxicity</Keywords>
      <Keywords>Phototoxicity</Keywords>
      <Keywords>Sunscreens</Keywords>
      <Keywords>UV-radiation</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Saroj Kumar Amar</Name>
        <Affiliation>Department of Forensic Science, School of Bioengineering and Biosciences, Lovely Professional University, Punjab, India; Academy of Scientific and Innovative Research, CSIR-IITR Campus, Lucknow, India. Electronic address: sarojkumaramar@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Shruti Goyal</Name>
        <Affiliation>Photobiology Laboratory, Systems Toxicology and Health Risk Assessment Group, CSIR-Indian Institute of Toxicology Research, Post. Box 80, M.G. Marg, Lucknow 226001, India; Academy of Scientific and Innovative Research, CSIR-IITR Campus, Lucknow, India.</Affiliation>
      </Author>
      <Author>
        <Name>Ajeet K. Srivastav</Name>
        <Affiliation>Photobiology Laboratory, Systems Toxicology and Health Risk Assessment Group, CSIR-Indian Institute of Toxicology Research, Post. Box 80, M.G. Marg, Lucknow 226001, India.</Affiliation>
      </Author>
      <Author>
        <Name>Deepti Chopra</Name>
        <Affiliation>Photobiology Laboratory, Systems Toxicology and Health Risk Assessment Group, CSIR-Indian Institute of Toxicology Research, Post. Box 80, M.G. Marg, Lucknow 226001, India.</Affiliation>
      </Author>
      <Author>
        <Name>Ratan Singh Ray</Name>
        <Affiliation>Photobiology Laboratory, Systems Toxicology and Health Risk Assessment Group, CSIR-Indian Institute of Toxicology Research, Post. Box 80, M.G. Marg, Lucknow 226001, India; Academy of Scientific and Innovative Research, CSIR-IITR Campus, Lucknow, India.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A human relevance investigation of PPARα-mediated key events in the hepatocarcinogenic mode of action of propaquizafop in rats.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29626562</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30105-3</DOI>
    <KeywordList>
      <Keywords>Carcinogenicity</Keywords>
      <Keywords>Enzyme induction</Keywords>
      <Keywords>Human relevance framework</Keywords>
      <Keywords>Liver</Keywords>
      <Keywords>Mode of action</Keywords>
      <Keywords>PPARα</Keywords>
      <Keywords>Peroxisome proliferators</Keywords>
      <Keywords>Propaquizafop</Keywords>
      <Keywords>Rats</Keywords>
      <Keywords>Rodent hepatocarcinogenesis</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Christian Strupp</Name>
        <Affiliation>ADAMA Deutschland GmbH, Edmund-Rumpler-Str. 6, 51149 Cologne, Germany. Electronic address: chr.strupp@web.de.</Affiliation>
      </Author>
      <Author>
        <Name>Werner H. Bomann</Name>
        <Affiliation>ToxConsult(®), 9393 W 110th Street, 51 Corporate Woods, Suite 500, Overland Park, KS 66210, USA. Electronic address: info@tox-consult.com.</Affiliation>
      </Author>
      <Author>
        <Name>François Spézia</Name>
        <Affiliation>Citoxlab, 27005 Evreux Cedex, France. Electronic address: francois.spezia@fr.citoxlab.com.</Affiliation>
      </Author>
      <Author>
        <Name>Frédéric Gervais</Name>
        <Affiliation>Citoxlab, 27005 Evreux Cedex, France. Electronic address: frederic.gervais@fr.citoxlab.com.</Affiliation>
      </Author>
      <Author>
        <Name>Roy Forster</Name>
        <Affiliation>Citoxlab, 27005 Evreux Cedex, France. Electronic address: roy.forster@fr.citoxlab.com.</Affiliation>
      </Author>
      <Author>
        <Name>Lysiane Richert</Name>
        <Affiliation>KaLy-Cell, 67115 Plobsheim, France; Université de Bourgogne Franche-Comté, EA4267, 25030 Besançon, France. Electronic address: l.richert@kaly-cell.com.</Affiliation>
      </Author>
      <Author>
        <Name>Pramila Singh</Name>
        <Affiliation>Citoxlab, 27005 Evreux Cedex, France. Electronic address: pramila.singh@fr.citoxlab.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Saline extract of Pilosocereus gounellei stem has antinociceptive effect in mice without showing acute toxicity and altering motor coordination.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29626561</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30104-1</DOI>
    <KeywordList>
      <Keywords>Cactaceae</Keywords>
      <Keywords>Flavonoids</Keywords>
      <Keywords>Inflammatory pain</Keywords>
      <Keywords>Neurogenic pain</Keywords>
      <Keywords>Toxicological survey</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Alisson Macário de Oliveira</Name>
        <Affiliation>Departamento de Bioquímica, Centro de Biociências, Universidade Federal de Pernambuco, 50670-420, Recife, Pernambuco, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Micaelle Oliveira de Luna Freire</Name>
        <Affiliation>Departamento de Biotecnologia, Centro de Biotecnologia, Universidade Federal da Paraíba, 58051-970, João Pessoa, Paraíba, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Wliana Alves Viturino da Silva</Name>
        <Affiliation>Departamento de Farmácia, Centro de Ciências da Saúde, Universidade Federal de Pernambuco, 50740-520, Recife, Pernambuco, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Magda Rhayanny Assunção Ferreira</Name>
        <Affiliation>Departamento de Farmácia, Centro de Ciências da Saúde, Universidade Federal de Pernambuco, 50740-520, Recife, Pernambuco, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Patrícia Maria Guedes Paiva</Name>
        <Affiliation>Departamento de Bioquímica, Centro de Biociências, Universidade Federal de Pernambuco, 50670-420, Recife, Pernambuco, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Luiz Alberto Lira Soares</Name>
        <Affiliation>Departamento de Farmácia, Centro de Ciências da Saúde, Universidade Federal de Pernambuco, 50740-520, Recife, Pernambuco, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Paloma Lys de Medeiros</Name>
        <Affiliation>Departamento de Histologia e Embriologia, Centro de Biociências, Universidade Federal de Pernambuco, 50670-420, Recife, Pernambuco, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Bruno de Melo Carvalho</Name>
        <Affiliation>Laboratório de Fisiopatologia Experimental, Instituto de Ciências Biológicas, Universidade de Pernambuco, 50100-130, Recife, Pernambuco, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Thiago Henrique Napoleão</Name>
        <Affiliation>Departamento de Bioquímica, Centro de Biociências, Universidade Federal de Pernambuco, 50670-420, Recife, Pernambuco, Brazil. Electronic address: thiago.napoleao@ufpe.br.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Criteria for grouping of manufactured nanomaterials to facilitate hazard and risk assessment, a systematic review of expert opinions.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29614343</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30100-4</DOI>
    <KeywordList>
      <Keywords>Grouping</Keywords>
      <Keywords>Health</Keywords>
      <Keywords>Nanomaterials</Keywords>
      <Keywords>Opinions</Keywords>
      <Keywords>Reviews</Keywords>
      <Keywords>Toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Nina Elisabeth Landvik</Name>
        <Affiliation>National Institute of Occupational Health, Oslo, Norway.</Affiliation>
      </Author>
      <Author>
        <Name>Vidar Skaug</Name>
        <Affiliation>National Institute of Occupational Health, Oslo, Norway.</Affiliation>
      </Author>
      <Author>
        <Name>Benedicte Mohr</Name>
        <Affiliation>National Institute of Occupational Health, Oslo, Norway.</Affiliation>
      </Author>
      <Author>
        <Name>Jos Verbeek</Name>
        <Affiliation>Finnsih Institute of Occupational Health, Helsinki, Finland.</Affiliation>
      </Author>
      <Author>
        <Name>Shanbeh Zienolddiny</Name>
        <Affiliation>National Institute of Occupational Health, Oslo, Norway. Electronic address: shan.zienolddiny@stami.no.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Quantitative risk assessment of tobacco products: A potentially useful component of substantial equivalence evaluations.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29614342</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30099-0</DOI>
    <KeywordList>
      <Keywords>QRA</Keywords>
      <Keywords>Quantitative risk assessment</Keywords>
      <Keywords>Regulation</Keywords>
      <Keywords>Substantial equivalence</Keywords>
      <Keywords>Tobacco products</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Kristin M. Marano</Name>
        <Affiliation>RAI Services Company, 401 North Main Street, Winston-Salem, NC, 27101, USA. Electronic address: maranok@rjrt.com.</Affiliation>
      </Author>
      <Author>
        <Name>Charlene Liu</Name>
        <Affiliation>RAI Services Company, 401 North Main Street, Winston-Salem, NC, 27101, USA. Electronic address: lius1@rjrt.com.</Affiliation>
      </Author>
      <Author>
        <Name>William Fuller</Name>
        <Affiliation>Ramboll, 3107 Armand Street, Monroe, LA, 71201, USA. Electronic address: wfuller@ramboll.com.</Affiliation>
      </Author>
      <Author>
        <Name>P. Robinan Gentry</Name>
        <Affiliation>Ramboll, 3107 Armand Street, Monroe, LA, 71201, USA. Electronic address: rgentry@ramboll.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Residue behavior and dietary intake risk assessment of carbosulfan and its metabolites in cucumber.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29601912</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30096-5</DOI>
    <KeywordList>
      <Keywords>Carbosulfan</Keywords>
      <Keywords>Cucumber</Keywords>
      <Keywords>Dietary intake risk</Keywords>
      <Keywords>Dissipation</Keywords>
      <Keywords>Metabolite</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Wencheng Song</Name>
        <Affiliation>Institute for the Control of Agrochemicals, Ministry of Agriculture, Beijing 100125, China.</Affiliation>
      </Author>
      <Author>
        <Name>Chunhong Jia</Name>
        <Affiliation>Institute of Plant and Environment Protection, Beijing Academy of Agriculture and Forestry Science, Beijing 100097, China.</Affiliation>
      </Author>
      <Author>
        <Name>Junjie Jing</Name>
        <Affiliation>Institute of Plant and Environment Protection, Beijing Academy of Agriculture and Forestry Science, Beijing 100097, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ercheng Zhao</Name>
        <Affiliation>Institute of Plant and Environment Protection, Beijing Academy of Agriculture and Forestry Science, Beijing 100097, China.</Affiliation>
      </Author>
      <Author>
        <Name>Min He</Name>
        <Affiliation>Institute of Plant and Environment Protection, Beijing Academy of Agriculture and Forestry Science, Beijing 100097, China.</Affiliation>
      </Author>
      <Author>
        <Name>Li Chen</Name>
        <Affiliation>Institute of Plant and Environment Protection, Beijing Academy of Agriculture and Forestry Science, Beijing 100097, China.</Affiliation>
      </Author>
      <Author>
        <Name>Pingzhong Yu</Name>
        <Affiliation>Institute of Plant and Environment Protection, Beijing Academy of Agriculture and Forestry Science, Beijing 100097, China. Electronic address: pzhyu@sina.com.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Neuroprotective effect of the carnosine - α-lipoic acid nanomicellar complex in a model of early-stage Parkinson's disease.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29601911</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30098-9</DOI>
    <KeywordList>
      <Keywords>1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine</Keywords>
      <Keywords>Carnosine</Keywords>
      <Keywords>Catecholamines</Keywords>
      <Keywords>Lipid peroxidation</Keywords>
      <Keywords>Nanomicellar complex of carnosine and α-lipoic acid</Keywords>
      <Keywords>Neuroprotection</Keywords>
      <Keywords>Parkinson's disease</Keywords>
      <Keywords>Rat</Keywords>
      <Keywords>α-lipoic acid</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Olga I. Kulikova</Name>
        <Affiliation>Laboratory of Clinical and Experimental Neurochemistry, Research Center of Neurology, Moscow, 125367, Russia; Faculty of Ecology, Peoples' Friendship University of Russia, Moscow, 117198, Russia. Electronic address: posibilidad@mail.ru.</Affiliation>
      </Author>
      <Author>
        <Name>Daniil S. Berezhnoy</Name>
        <Affiliation>Laboratory of Clinical and Experimental Neurochemistry, Research Center of Neurology, Moscow, 125367, Russia; Faculty of Biology, Moscow State University, Moscow, 119234, Russia.</Affiliation>
      </Author>
      <Author>
        <Name>Sergey L. Stvolinsky</Name>
        <Affiliation>Laboratory of Clinical and Experimental Neurochemistry, Research Center of Neurology, Moscow, 125367, Russia.</Affiliation>
      </Author>
      <Author>
        <Name>Alexander V. Lopachev</Name>
        <Affiliation>Laboratory of Clinical and Experimental Neurochemistry, Research Center of Neurology, Moscow, 125367, Russia.</Affiliation>
      </Author>
      <Author>
        <Name>Valentina S. Orlova</Name>
        <Affiliation>Faculty of Ecology, Peoples' Friendship University of Russia, Moscow, 117198, Russia.</Affiliation>
      </Author>
      <Author>
        <Name>Tatiana N. Fedorova</Name>
        <Affiliation>Laboratory of Clinical and Experimental Neurochemistry, Research Center of Neurology, Moscow, 125367, Russia.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Safety assessment of vitacoxib: 180-day chronic oral toxicity studies.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29601910</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30097-7</DOI>
    <KeywordList>
      <Keywords>Coxibs</Keywords>
      <Keywords>NSAIDs</Keywords>
      <Keywords>Safety evaluation</Keywords>
      <Keywords>Toxicity studies</Keywords>
      <Keywords>Vitacoxib</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jianzhong Wang</Name>
        <Affiliation>Department of Veterinary Pharmacology and Toxicology, College of Veterinary Medicine, China Agricultural University, Beijing 100193, People's Republic of China; Laboratory of Quality &amp; Safety Risk Assessment for Animal Products on Chemical Hazards (Beijing), Ministry of Agriculture, Beijing 100193, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Tingting Zhao</Name>
        <Affiliation>Department of Veterinary Pharmacology and Toxicology, College of Veterinary Medicine, China Agricultural University, Beijing 100193, People's Republic of China; Laboratory of Quality &amp; Safety Risk Assessment for Animal Products on Chemical Hazards (Beijing), Ministry of Agriculture, Beijing 100193, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Shusheng Tang</Name>
        <Affiliation>Department of Veterinary Pharmacology and Toxicology, College of Veterinary Medicine, China Agricultural University, Beijing 100193, People's Republic of China; Laboratory of Quality &amp; Safety Risk Assessment for Animal Products on Chemical Hazards (Beijing), Ministry of Agriculture, Beijing 100193, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Suxia Zhang</Name>
        <Affiliation>Department of Veterinary Pharmacology and Toxicology, College of Veterinary Medicine, China Agricultural University, Beijing 100193, People's Republic of China; Laboratory of Quality &amp; Safety Risk Assessment for Animal Products on Chemical Hazards (Beijing), Ministry of Agriculture, Beijing 100193, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Pengyyue Lv</Name>
        <Affiliation>Beijing Orbiepharm Co., Ltd, Beijing 100185, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Jing Li</Name>
        <Affiliation>Beijing Orbiepharm Co., Ltd, Beijing 100185, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Xingyuan Cao</Name>
        <Affiliation>Department of Veterinary Pharmacology and Toxicology, College of Veterinary Medicine, China Agricultural University, Beijing 100193, People's Republic of China; Laboratory of Quality &amp; Safety Risk Assessment for Animal Products on Chemical Hazards (Beijing), Ministry of Agriculture, Beijing 100193, People's Republic of China; Key Laboratory of Detection for Veterinary Drug Residues and Illegal Additives, Ministry of Agriculture, Beijing 100193, People's Republic of China. Electronic address: cxy@cau.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Isoline use in crop composition studies with genetically modified crops under EFSA guidance - Short communication.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29596977</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30095-3</DOI>
    <KeywordList>
      <Keywords>Crop composition</Keywords>
      <Keywords>Equivalence</Keywords>
      <Keywords>Genetically modified</Keywords>
      <Keywords>Isoline</Keywords>
      <Keywords>Risk assessment</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Rod A. Herman</Name>
        <Affiliation>Dow AgroSciences LLC, 9330 Zionsville Road, Indianapolis, IN 46268, United States. Electronic address: raherman@dow.com.</Affiliation>
      </Author>
      <Author>
        <Name>Brandon J. Fast</Name>
        <Affiliation>Dow AgroSciences LLC, 9330 Zionsville Road, Indianapolis, IN 46268, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Carey Mathesius</Name>
        <Affiliation>DuPont Pioneer, 8325 NW 62nd Avenue, Johnston, IA 50131, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Bryan Delaney</Name>
        <Affiliation>DuPont Pioneer, 7100 NW 62nd Avenue, Johnston, IA 50131, United States.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The safety of green tea and green tea extract consumption in adults - Results of a systematic review.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29580974</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30092-8</DOI>
    <KeywordList>
      <Keywords>Catechins</Keywords>
      <Keywords>Epigallocatechingallate (EGCG)</Keywords>
      <Keywords>Green tea</Keywords>
      <Keywords>Green tea extract (GTE)</Keywords>
      <Keywords>Hepatotoxicity</Keywords>
      <Keywords>Safety</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jiang Hu</Name>
        <Affiliation>Worldwide Scientific Affairs, Herbalife Nutrition, Torrance, CA 90502, USA. Electronic address: jianghu@herbalife.com.</Affiliation>
      </Author>
      <Author>
        <Name>Donna Webster</Name>
        <Affiliation>Product Science, Herbalife Nutrition, Torrance, CA 90502, USA. Electronic address: donnawe@herbalife.com.</Affiliation>
      </Author>
      <Author>
        <Name>Joyce Cao</Name>
        <Affiliation>Global Post Market Safety Surveillance, Herbalife Nutrition, Torrance, CA 90502, USA. Electronic address: joyceca@herbalife.com.</Affiliation>
      </Author>
      <Author>
        <Name>Andrew Shao</Name>
        <Affiliation>Independent Consultant, Rancho Palos Verdes, CA 90505, USA. Electronic address: drashao@aol.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A pre-clinical safety study of PEGylated recombinant human endostatin (M</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29580973</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30090-4</DOI>
    <KeywordList>
      <Keywords>M(2)ES</Keywords>
      <Keywords>Pre-clinical</Keywords>
      <Keywords>Rat</Keywords>
      <Keywords>Renal injury</Keywords>
      <Keywords>Safety</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Xingchao Geng</Name>
        <Affiliation>National Center for Safety Evaluation of Drugs, National Institute for Food and Drug Control, Beijing 100176, China.</Affiliation>
      </Author>
      <Author>
        <Name>Lifang Guo</Name>
        <Affiliation>National Engineering Laboratory for Anti-tumor Protein Therapeutics, School of Life Sciences, Tsinghua University, Beijing 100084, China.</Affiliation>
      </Author>
      <Author>
        <Name>Li Liu</Name>
        <Affiliation>National Center for Safety Evaluation of Drugs, National Institute for Food and Drug Control, Beijing 100176, China.</Affiliation>
      </Author>
      <Author>
        <Name>Chao Wang</Name>
        <Affiliation>National Center for Safety Evaluation of Drugs, National Institute for Food and Drug Control, Beijing 100176, China.</Affiliation>
      </Author>
      <Author>
        <Name>Qian Peng</Name>
        <Affiliation>National Center for Safety Evaluation of Drugs, National Institute for Food and Drug Control, Beijing 100176, China.</Affiliation>
      </Author>
      <Author>
        <Name>Weihong Qi</Name>
        <Affiliation>National Center for Safety Evaluation of Drugs, National Institute for Food and Drug Control, Beijing 100176, China.</Affiliation>
      </Author>
      <Author>
        <Name>Li Sun</Name>
        <Affiliation>National Center for Safety Evaluation of Drugs, National Institute for Food and Drug Control, Beijing 100176, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaomeng Liu</Name>
        <Affiliation>National Center for Safety Evaluation of Drugs, National Institute for Food and Drug Control, Beijing 100176, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yufa Miao</Name>
        <Affiliation>National Center for Safety Evaluation of Drugs, National Institute for Food and Drug Control, Beijing 100176, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhi Lin</Name>
        <Affiliation>National Center for Safety Evaluation of Drugs, National Institute for Food and Drug Control, Beijing 100176, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yan Fu</Name>
        <Affiliation>National Engineering Laboratory for Anti-tumor Protein Therapeutics, School of Life Sciences, Tsinghua University, Beijing 100084, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yongzhang Luo</Name>
        <Affiliation>National Engineering Laboratory for Anti-tumor Protein Therapeutics, School of Life Sciences, Tsinghua University, Beijing 100084, China. Electronic address: yluo@mail.tsinghua.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Bo Li</Name>
        <Affiliation>National Center for Safety Evaluation of Drugs, National Institute for Food and Drug Control, Beijing 100176, China. Electronic address: libo@nifdc.org.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Making reliable negative predictions of human skin sensitisation using an in silico fragmentation approach.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29580972</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30088-6</DOI>
    <KeywordList>
      <Keywords>(Q)SAR</Keywords>
      <Keywords>Derek Nexus</Keywords>
      <Keywords>Expert assessment</Keywords>
      <Keywords>Expert knowledge-based system</Keywords>
      <Keywords>Negative predictions</Keywords>
      <Keywords>Skin sensitisation</Keywords>
      <Keywords>in silico toxicology</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Martyn L. Chilton</Name>
        <Affiliation>Lhasa Limited, Granary Wharf House, 2 Canal Wharf, Leeds, LS11 5PS, UK. Electronic address: martyn.chilton@lhasalimited.org.</Affiliation>
      </Author>
      <Author>
        <Name>Donna S. Macmillan</Name>
        <Affiliation>Lhasa Limited, Granary Wharf House, 2 Canal Wharf, Leeds, LS11 5PS, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Thomas Steger-Hartmann</Name>
        <Affiliation>Bayer AG, Pharmaceuticals, Muellerstrasse 178, Berlin, D-13342, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Jedd Hillegass</Name>
        <Affiliation>Bristol-Myers Squibb, 1 Squibb Drive, New Brunswick, NJ 08903, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Phillip Bellion</Name>
        <Affiliation>DSM Nutritional Products Ltd., Wurmisweg 576, CH-4303 Kaiseraugst, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Anna Vuorinen</Name>
        <Affiliation>DSM Nutritional Products Ltd., Wurmisweg 576, CH-4303 Kaiseraugst, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Sylvain Etter</Name>
        <Affiliation>Firmenich S.A., Rue de la Bergère 7, Meyrin 2, CH-1217, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Benjamin P. C. Smith</Name>
        <Affiliation>Firmenich Inc., POB 5880, Princeton, NJ 08543, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Angela White</Name>
        <Affiliation>GlaxoSmithKline, Park Road, Ware, SG12 0DP, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Paul Sterchele</Name>
        <Affiliation>International Flavors &amp; Fragrances Inc., 800 Rose Lane, Union Beach, NJ 07735, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Ann De Smedt</Name>
        <Affiliation>Janssen Research and Development, Turnhoutseweg 30, Beerse, B-2340, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Milica Glogovac</Name>
        <Affiliation>Novartis Pharma AG, Klybeckstrasse 141, CH-4057 Basel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Susanne Glowienke</Name>
        <Affiliation>Novartis Pharma AG, Klybeckstrasse 141, CH-4057 Basel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Devin O'Brien</Name>
        <Affiliation>RIFM, 50 Tice Boulevard, Woodcliff Lake, NJ 07677, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Rahul Parakhia</Name>
        <Affiliation>RIFM, 50 Tice Boulevard, Woodcliff Lake, NJ 07677, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The validation &amp; verification of an LC/MS method for the determination of total docosahexaenoic acid concentrations in canine blood serum.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29577958</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30094-1</DOI>
    <KeywordList>
      <Keywords>Analytical method</Keywords>
      <Keywords>DHA</Keywords>
      <Keywords>Enrichment</Keywords>
      <Keywords>LC/MS</Keywords>
      <Keywords>Serum</Keywords>
      <Keywords>Validation and verification</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Gerald Patrick Dillon</Name>
        <Affiliation>Alltech Ireland, Sarney, Summerhill Road, Dunboyne, Co Meath, Ireland. Electronic address: gdillon@alltech.com.</Affiliation>
      </Author>
      <Author>
        <Name>Jason D. Keegan</Name>
        <Affiliation>Alltech Ireland, Sarney, Summerhill Road, Dunboyne, Co Meath, Ireland.</Affiliation>
      </Author>
      <Author>
        <Name>Geoff Wallace</Name>
        <Affiliation>LGC, Newmarket Road, Fordham, Cambridgeshire, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Alexandros Yiannikouris</Name>
        <Affiliation>Alltech Inc, Nicholasville, KY, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Colm Anthony Moran</Name>
        <Affiliation>Regulatory Affairs Department, Alltech SARL, Rue Charles Amand, 14500 Vire, France.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Characterizing risk assessments for the development of occupational exposure limits for engineered nanomaterials.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29574195</pubmedLink>
    <GrantList>
      <Grant>CC999999</Grant>
    </GrantList>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30091-6</DOI>
    <KeywordList>
      <Keywords>Biomarkers</Keywords>
      <Keywords>Lung disease</Keywords>
      <Keywords>Nanomaterials</Keywords>
      <Keywords>Nanoparticles</Keywords>
      <Keywords>Occupational exposure limits</Keywords>
      <Keywords>Particle overload</Keywords>
      <Keywords>Quantitative risk assessment</Keywords>
      <Keywords>Respiratory effects</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>P. A. Schulte</Name>
        <Affiliation>National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention, United States. Electronic address: PSchulte@cdc.gov.</Affiliation>
      </Author>
      <Author>
        <Name>E. D. Kuempel</Name>
        <Affiliation>National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention, United States.</Affiliation>
      </Author>
      <Author>
        <Name>N. M. Drew</Name>
        <Affiliation>National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention, United States.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Repeated dose 90-day oral toxicity test of G-7% NANA in rats: An application of new criterion for toxicity determination to test article-induced changes.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29574194</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30089-8</DOI>
    <KeywordList>
      <Keywords>Glycomacropeptide</Keywords>
      <Keywords>Immunotoxicity</Keywords>
      <Keywords>LOAEL</Keywords>
      <Keywords>N-acetylneuraminic acid</Keywords>
      <Keywords>NANA</Keywords>
      <Keywords>NOAEL</Keywords>
      <Keywords>NOEL</Keywords>
      <Keywords>Repeated dose,90-daytoxicity test</Keywords>
      <Keywords>Toxicity determination criterion</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Hye Seon Heo</Name>
        <Affiliation>GLP Center, Dept. of Toxicity Assessment, Catholic University of Daegu, Gyeongsan, 38430 Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>MinJi An</Name>
        <Affiliation>GLP Center, Dept. of Toxicity Assessment, Catholic University of Daegu, Gyeongsan, 38430 Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Ji Sun Lee</Name>
        <Affiliation>GLP Center, Dept. of Toxicity Assessment, Catholic University of Daegu, Gyeongsan, 38430 Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Hee Kyong Kim</Name>
        <Affiliation>Hanilbiomed Co., Gwangju 62363, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Yeong Chul Park</Name>
        <Affiliation>GLP Center, Dept. of Toxicity Assessment, Catholic University of Daegu, Gyeongsan, 38430 Republic of Korea. Electronic address: ycpark@cu.ac.kr.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Nonclinical assessments of the potential biosimilar PF-06439535 and bevacizumab.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29574193</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30093-X</DOI>
    <KeywordList>
      <Keywords>Bevacizumab</Keywords>
      <Keywords>Biosimilar</Keywords>
      <Keywords>Cynomolgus monkey</Keywords>
      <Keywords>Nonclinical</Keywords>
      <Keywords>PF-06439535</Keywords>
      <Keywords>Sprague Dawley rat</Keywords>
      <Keywords>Vascular endothelial growth factor</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Marjorie A. Peraza</Name>
        <Affiliation>Drug Safety Research and Development, Pfizer Inc, 610 Main St, Cambridge, MA 02139, USA. Electronic address: marjorie.peraza@pfizer.com.</Affiliation>
      </Author>
      <Author>
        <Name>Karen E. Rule</Name>
        <Affiliation>Analytical Research &amp; Development, Biotherapeutics Pharmaceutical Sciences, Pfizer Inc, 1 Burtt Rd, Andover, MA 01810, USA. Electronic address: karen.rule@pfizer.com.</Affiliation>
      </Author>
      <Author>
        <Name>Michael H. I. Shiue</Name>
        <Affiliation>Pharmacokinetics, Dynamics, and Metabolism, Pfizer Inc, 10646 Science Center Dr, San Diego, CA 92121, USA. Electronic address: dr.shiue@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Gregory L. Finch</Name>
        <Affiliation>Drug Safety Research and Development, Pfizer Inc, Eastern Point Rd, Groton, CT 06340, USA. Electronic address: gtafinch@yahoo.com.</Affiliation>
      </Author>
      <Author>
        <Name>Stéphane Thibault</Name>
        <Affiliation>Drug Safety Research and Development, Pfizer Inc, 10646 Science Center Dr, San Diego, CA 92121, USA. Electronic address: stephane.thibault@pfizer.com.</Affiliation>
      </Author>
      <Author>
        <Name>Paul R. Brown</Name>
        <Affiliation>Pfizer Global Supply, Pfizer Inc, 1 Burtt Rd, Andover, MA 01810, USA. Electronic address: paul.r.brown@pfizer.com.</Affiliation>
      </Author>
      <Author>
        <Name>David W. Clarke</Name>
        <Affiliation>Drug Safety Research and Development, Pfizer Inc, 401 North Middletown Rd, Pearl River, NY 10965, USA. Electronic address: david.w.clarke@pfizer.com.</Affiliation>
      </Author>
      <Author>
        <Name>Michael W. Leach</Name>
        <Affiliation>Drug Safety Research and Development, Pfizer Inc, 610 Main St, Cambridge, MA 02139, USA. Electronic address: michael.leach@pfizer.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>An evaluation of electronic cigarette formulations and aerosols for harmful and potentially harmful constituents (HPHCs) typically derived from combustion.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29567331</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30085-0</DOI>
    <KeywordList>
      <Keywords>Combustion</Keywords>
      <Keywords>E-cigarette</Keywords>
      <Keywords>E-liquid</Keywords>
      <Keywords>ENDS</Keywords>
      <Keywords>HPHC</Keywords>
      <Keywords>Harmful and potentially harmful constituents</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Karl A. Wagner</Name>
        <Affiliation>Altria Client Services LLC, 601 East Jackson Street, Richmond, VA 23219, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jason W. Flora</Name>
        <Affiliation>Altria Client Services LLC, 601 East Jackson Street, Richmond, VA 23219, USA. Electronic address: Jason.W.Flora@altria.com.</Affiliation>
      </Author>
      <Author>
        <Name>Matt S. Melvin</Name>
        <Affiliation>Altria Client Services LLC, 601 East Jackson Street, Richmond, VA 23219, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Karen C. Avery</Name>
        <Affiliation>Altria Client Services LLC, 601 East Jackson Street, Richmond, VA 23219, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Regina M. Ballentine</Name>
        <Affiliation>Altria Client Services LLC, 601 East Jackson Street, Richmond, VA 23219, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Anthony P. Brown</Name>
        <Affiliation>Altria Client Services LLC, 601 East Jackson Street, Richmond, VA 23219, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Willie J. McKinney</Name>
        <Affiliation>Altria Client Services LLC, 601 East Jackson Street, Richmond, VA 23219, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Dietary supplement intake during pregnancy; better safe than sorry?</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29567330</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30087-4</DOI>
    <KeywordList>
      <Keywords>Dietary supplements</Keywords>
      <Keywords>European food law</Keywords>
      <Keywords>Fetal programming</Keywords>
      <Keywords>Food safety</Keywords>
      <Keywords>Novel food</Keywords>
      <Keywords>Nutrivigilance</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Alie de Boer</Name>
        <Affiliation>Food Claims Centre Venlo, Maastricht University Campus Venlo, Faculty of Humanities and Sciences, Venlo, The Netherlands. Electronic address: a.deboer@maastrichtuniversity.nl.</Affiliation>
      </Author>
      <Author>
        <Name>Aalt Bast</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Faculty of Health Medicine and Life Sciences, Maastricht University, Maastricht, The Netherlands; Maastricht University Campus Venlo, Faculty of Humanities and Sciences, Venlo, The Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Roger Godschalk</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Faculty of Health Medicine and Life Sciences, Maastricht University, Maastricht, The Netherlands.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Acute and repeated dose 28-day oral toxicity of poly(3-hydroxybutyrate-co-4-hydroxybutyrate) nanoparticles in Sprague-Dawley rats.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29567329</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30084-9</DOI>
    <KeywordList>
      <Keywords>Acute oral toxicity</Keywords>
      <Keywords>Nanoparticles</Keywords>
      <Keywords>P(3HB-co-4HB)</Keywords>
      <Keywords>Sprague-Dawley rats</Keywords>
      <Keywords>Subacute toxicological evaluation</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Yin Hui Leong</Name>
        <Affiliation>National Poison Centre, Universiti Sains Malaysia, 11800, USM, Penang, Malaysia. Electronic address: yinhui_leong@yahoo.com.</Affiliation>
      </Author>
      <Author>
        <Name>Anis Syaffini Mat Isa</Name>
        <Affiliation>Malaysian Institute of Pharmaceuticals and Nutraceuticals (IPharm), National Institutes of Biotechnology Malaysia, Ministry of Science, Technology and Innovation, Block 5-D, Halaman Bukit Gambir, 11700 Penang, Malaysia.</Affiliation>
      </Author>
      <Author>
        <Name>Mazlianum Mohamed Mahmood</Name>
        <Affiliation>Malaysian Institute of Pharmaceuticals and Nutraceuticals (IPharm), National Institutes of Biotechnology Malaysia, Ministry of Science, Technology and Innovation, Block 5-D, Halaman Bukit Gambir, 11700 Penang, Malaysia.</Affiliation>
      </Author>
      <Author>
        <Name>Chiew Erh Jacqueline Moey</Name>
        <Affiliation>Malaysian Institute of Pharmaceuticals and Nutraceuticals (IPharm), National Institutes of Biotechnology Malaysia, Ministry of Science, Technology and Innovation, Block 5-D, Halaman Bukit Gambir, 11700 Penang, Malaysia.</Affiliation>
      </Author>
      <Author>
        <Name>Zulkhurnain Utar</Name>
        <Affiliation>Malaysian Institute of Pharmaceuticals and Nutraceuticals (IPharm), National Institutes of Biotechnology Malaysia, Ministry of Science, Technology and Innovation, Block 5-D, Halaman Bukit Gambir, 11700 Penang, Malaysia.</Affiliation>
      </Author>
      <Author>
        <Name>Yong Ing Soon</Name>
        <Affiliation>Malaysian Institute of Pharmaceuticals and Nutraceuticals (IPharm), National Institutes of Biotechnology Malaysia, Ministry of Science, Technology and Innovation, Block 5-D, Halaman Bukit Gambir, 11700 Penang, Malaysia.</Affiliation>
      </Author>
      <Author>
        <Name>Mohamed Isa Abd Majid</Name>
        <Affiliation>National Poison Centre, Universiti Sains Malaysia, 11800, USM, Penang, Malaysia.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Literature-based safety assessment of an agriculture- and animal-associated microorganism: Weissella confusa.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29567328</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30086-2</DOI>
    <KeywordList>
      <Keywords>Commensal microbiota</Keywords>
      <Keywords>Direct-fed microbial products</Keywords>
      <Keywords>Lactic acid bacteria</Keywords>
      <Keywords>Safety assessment</Keywords>
      <Keywords>Weissella confusa</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Joseph M. Sturino</Name>
        <Affiliation>Novozymes Incorporated, Durham, NC, United States. Electronic address: joseph.sturino@gmail.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Monte-Carlo and multi-exposure assessment for the derivation of criteria for disinfection byproducts and volatile organic compounds in drinking water: Allocation factors and liter-equivalents per day.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29555557</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30082-5</DOI>
    <KeywordList>
      <Keywords>HAA</Keywords>
      <Keywords>PCE</Keywords>
      <Keywords>TCE</Keywords>
      <Keywords>THM</Keywords>
      <Keywords>Water quality standard</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Megumi Akiyama</Name>
        <Affiliation>Graduate School of Engineering, Hokkaido University, N13W8, Sapporo 060-8628, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Yoshihiko Matsui</Name>
        <Affiliation>Faculty of Engineering, Hokkaido University, N13W8, Sapporo 060-8628, Japan. Electronic address: matsui@eng.hokudai.ac.jp.</Affiliation>
      </Author>
      <Author>
        <Name>Junki Kido</Name>
        <Affiliation>Graduate School of Engineering, Hokkaido University, N13W8, Sapporo 060-8628, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Taku Matsushita</Name>
        <Affiliation>Faculty of Engineering, Hokkaido University, N13W8, Sapporo 060-8628, Japan. Electronic address: taku-m@eng.hokudai.ac.jp.</Affiliation>
      </Author>
      <Author>
        <Name>Nobutaka Shirasaki</Name>
        <Affiliation>Faculty of Engineering, Hokkaido University, N13W8, Sapporo 060-8628, Japan. Electronic address: nobutaka@eng.hokudai.ac.jp.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Toxicological evaluation of 6'-sialyllactose (6'-SL) sodium salt.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29555556</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30083-7</DOI>
    <KeywordList>
      <Keywords>6′-SL sodium salt</Keywords>
      <Keywords>No-observed-adverse-effect level (NOAEL)</Keywords>
      <Keywords>Rat</Keywords>
      <Keywords>Subchronic toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Rit Bahadur Gurung</Name>
        <Affiliation>GeneChem, Inc, Daejeon, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Dae Hee Kim</Name>
        <Affiliation>GeneChem, Inc, Daejeon, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Lila Kim</Name>
        <Affiliation>GeneChem, Inc, Daejeon, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Albert W. Lee</Name>
        <Affiliation>NutraSource, Inc., Clarksville, MD 21029, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Zhenhua Wang</Name>
        <Affiliation>School of Life Science, Center for Mitochondria and Healthy Aging, Yantai University, Yantai, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Yonglin Gao</Name>
        <Affiliation>School of Life Science, Center for Mitochondria and Healthy Aging, Yantai University, Yantai, PR China. Electronic address: gaoyonglin@ytu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Safety evaluation of mulberry leaf extract: Acute, subacute toxicity and genotoxicity studies.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29530616</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30076-X</DOI>
    <KeywordList>
      <Keywords>Ames assay</Keywords>
      <Keywords>Genotoxicity</Keywords>
      <Keywords>Micronucleus</Keywords>
      <Keywords>Mulberry leaf extract</Keywords>
      <Keywords>Rat</Keywords>
      <Keywords>Safety assessment</Keywords>
      <Keywords>Sperm abnormality</Keywords>
      <Keywords>Subacute toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Yuzhe Li</Name>
        <Affiliation>Key Laboratory of Food Safety Risk Assessment, Ministry of Health, China National Center for Food Safety Risk Assessment, Beijing, 100021, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaopeng Zhang</Name>
        <Affiliation>Key Laboratory of Food Safety Risk Assessment, Ministry of Health, China National Center for Food Safety Risk Assessment, Beijing, 100021, China.</Affiliation>
      </Author>
      <Author>
        <Name>Chunlai Liang</Name>
        <Affiliation>Key Laboratory of Food Safety Risk Assessment, Ministry of Health, China National Center for Food Safety Risk Assessment, Beijing, 100021, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jing Hu</Name>
        <Affiliation>Key Laboratory of Food Safety Risk Assessment, Ministry of Health, China National Center for Food Safety Risk Assessment, Beijing, 100021, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhou Yu</Name>
        <Affiliation>Key Laboratory of Food Safety Risk Assessment, Ministry of Health, China National Center for Food Safety Risk Assessment, Beijing, 100021, China. Electronic address: yuzhou@cfsa.net.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Skin sensitization quantitative risk assessment for occupational exposure of hairdressers to hair dye ingredients.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29530615</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30075-8</DOI>
    <KeywordList>
      <Keywords>Allergic contact dermatitis</Keywords>
      <Keywords>Hair dye allergy</Keywords>
      <Keywords>Hairdresser</Keywords>
      <Keywords>Occupational exposure</Keywords>
      <Keywords>Quantitative risk assessment</Keywords>
      <Keywords>Resorcinol</Keywords>
      <Keywords>Skin sensitization</Keywords>
      <Keywords>Toluene-2,5-diamine</Keywords>
      <Keywords>p-Phenylenediamine</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Carsten Goebel</Name>
        <Affiliation>Coty, Toxicology Dept., Berliner Allee 65, 64274 Darmstadt, Germany. Electronic address: carsten_goebel@cotyinc.com.</Affiliation>
      </Author>
      <Author>
        <Name>Thomas L. Diepgen</Name>
        <Affiliation>Dept. of Social Medicine, Occupational and Environmental Dermatology, University Hospital Heidelberg, Heidelberg, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Brunhilde Blömeke</Name>
        <Affiliation>Dept. of Environmental Toxicology, Trier University, Trier, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Anthony A. Gaspari</Name>
        <Affiliation>Department of Dermatology, Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Axel Schnuch</Name>
        <Affiliation>Information Network of Dept. of Dermatology (IVDK) at the University of Göttingen, Göttingen, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Anne Fuchs</Name>
        <Affiliation>Kao Germany GmbH, European Research Center (EURL), Darmstadt, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Kordula Schlotmann</Name>
        <Affiliation>Henkel AG &amp; Co. KGaA, Düsseldorf, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Maya Krasteva</Name>
        <Affiliation>L'Oréal, Research and Innovation, Clichy, France.</Affiliation>
      </Author>
      <Author>
        <Name>Ian Kimber</Name>
        <Affiliation>Faculty of Biology, Medicine and Health, University of Manchester, Manchester M13 9PT, UK.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Food safety evaluation for R-proteins introduced by biotechnology: A case study of VNT1 in late blight protected potatoes.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29530614</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30077-1</DOI>
    <KeywordList>
      <Keywords>Biotechnology</Keywords>
      <Keywords>Food safety assessment</Keywords>
      <Keywords>Resistance protein (R-protein)</Keywords>
      <Keywords>Risk assessment</Keywords>
      <Keywords>VNT1</Keywords>
      <Keywords>Weight-of-evidence</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jeffrey W. Habig</Name>
        <Affiliation>J.R. Simplot Company, Simplot Plant Sciences, 5369 West Irving Street, Boise, ID 83706, USA. Electronic address: jeffrey.habig@simplot.com.</Affiliation>
      </Author>
      <Author>
        <Name>Aaron Rowland</Name>
        <Affiliation>J.R. Simplot Company, Simplot Plant Sciences, 5369 West Irving Street, Boise, ID 83706, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Matthew G. Pence</Name>
        <Affiliation>J.R. Simplot Company, Simplot Plant Sciences, 5369 West Irving Street, Boise, ID 83706, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Cathy X. Zhong</Name>
        <Affiliation>J.R. Simplot Company, Simplot Plant Sciences, 5369 West Irving Street, Boise, ID 83706, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Integrating chemical, toxicological and clinical research to assess the potential of reducing health risks associated with cigarette smoking through reducing toxicant emissions.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29526814</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30074-6</DOI>
    <KeywordList>
      <Keywords>Biomarkers of exposure</Keywords>
      <Keywords>Cigarettes</Keywords>
      <Keywords>Clinical studies</Keywords>
      <Keywords>Product regulation</Keywords>
      <Keywords>Prototype</Keywords>
      <Keywords>Public health</Keywords>
      <Keywords>Tobacco</Keywords>
      <Keywords>Toxicants</Keywords>
      <Keywords>Toxicology</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Kevin McAdam</Name>
        <Affiliation>Research and Development, British American Tobacco, Regents Park Road, Southampton, UK. Electronic address: kevin_mcadam@bat.com.</Affiliation>
      </Author>
      <Author>
        <Name>James Murphy</Name>
        <Affiliation>Research and Development, British American Tobacco, Regents Park Road, Southampton, UK. Electronic address: james_murphy@bat.com.</Affiliation>
      </Author>
      <Author>
        <Name>Alison Eldridge</Name>
        <Affiliation>Research and Development, British American Tobacco, Regents Park Road, Southampton, UK. Electronic address: alison_eldridge@bat.com.</Affiliation>
      </Author>
      <Author>
        <Name>Clive Meredith</Name>
        <Affiliation>Research and Development, British American Tobacco, Regents Park Road, Southampton, UK. Electronic address: clive_meredith@bat.com.</Affiliation>
      </Author>
      <Author>
        <Name>Christopher Proctor</Name>
        <Affiliation>Research and Development, British American Tobacco, Regents Park Road, Southampton, UK. Electronic address: christopher_proctor@bat.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The antithrombotic, anticoagulant activity and toxicity research of ambinine, an alkaloid from the tuber of Corydalis ambigua var. amurensis.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29524465</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30067-9</DOI>
    <KeywordList>
      <Keywords>Ambinine</Keywords>
      <Keywords>Corydalis ambigua var. amurensis</Keywords>
      <Keywords>LD(50)</Keywords>
      <Keywords>Subacute toxicity</Keywords>
      <Keywords>Thrombosis</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Sheng Chang</Name>
        <Affiliation>Development and Utilization Key Laboratory of Northeast Plant Materials, School of Traditional Chinese Materia, Shenyang Pharmaceutical University, Wenhua Road 103, Shenyang 110016, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhiyou Yang</Name>
        <Affiliation>Development and Utilization Key Laboratory of Northeast Plant Materials, School of Traditional Chinese Materia, Shenyang Pharmaceutical University, Wenhua Road 103, Shenyang 110016, China.</Affiliation>
      </Author>
      <Author>
        <Name>Na Han</Name>
        <Affiliation>Development and Utilization Key Laboratory of Northeast Plant Materials, School of Traditional Chinese Materia, Shenyang Pharmaceutical University, Wenhua Road 103, Shenyang 110016, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhihui Liu</Name>
        <Affiliation>Development and Utilization Key Laboratory of Northeast Plant Materials, School of Traditional Chinese Materia, Shenyang Pharmaceutical University, Wenhua Road 103, Shenyang 110016, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jun Yin</Name>
        <Affiliation>Development and Utilization Key Laboratory of Northeast Plant Materials, School of Traditional Chinese Materia, Shenyang Pharmaceutical University, Wenhua Road 103, Shenyang 110016, China. Electronic address: yinjun2002@yahoo.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>International regulatory requirements for skin sensitization testing.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29518484</pubmedLink>
    <GrantList>
      <Grant>HHSN273201500010C</Grant>
    </GrantList>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30066-7</DOI>
    <KeywordList>
      <Keywords>Alternative approaches</Keywords>
      <Keywords>Defined approaches</Keywords>
      <Keywords>Non-animal methods</Keywords>
      <Keywords>Regulatory requirements</Keywords>
      <Keywords>Skin sensitization testing</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Amber B. Daniel</Name>
        <Affiliation>ILS, P.O. Box 13501, Research Triangle Park, NC, 27709, USA. Electronic address: amber.daniel@nih.gov.</Affiliation>
      </Author>
      <Author>
        <Name>Judy Strickland</Name>
        <Affiliation>ILS, P.O. Box 13501, Research Triangle Park, NC, 27709, USA. Electronic address: strickl2@niehs.nih.gov.</Affiliation>
      </Author>
      <Author>
        <Name>David Allen</Name>
        <Affiliation>ILS, P.O. Box 13501, Research Triangle Park, NC, 27709, USA. Electronic address: dallen@ils-inc.com.</Affiliation>
      </Author>
      <Author>
        <Name>Silvia Casati</Name>
        <Affiliation>European Commission, Joint Research Centre (JRC), Via E. Fermi, 2749, 21027, Ispra, VA, Italy. Electronic address: silvia.casati@ec.europa.eu.</Affiliation>
      </Author>
      <Author>
        <Name>Valérie Zuang</Name>
        <Affiliation>European Commission, Joint Research Centre (JRC), Via E. Fermi, 2749, 21027, Ispra, VA, Italy. Electronic address: valerie.zuang@ec.europa.eu.</Affiliation>
      </Author>
      <Author>
        <Name>João Barroso</Name>
        <Affiliation>European Commission, Joint Research Centre (JRC), Via E. Fermi, 2749, 21027, Ispra, VA, Italy. Electronic address: joao.barroso@ec.europa.eu.</Affiliation>
      </Author>
      <Author>
        <Name>Maurice Whelan</Name>
        <Affiliation>European Commission, Joint Research Centre (JRC), Via E. Fermi, 2749, 21027, Ispra, VA, Italy. Electronic address: maurice.whelan@ec.europa.eu.</Affiliation>
      </Author>
      <Author>
        <Name>M. J. Régimbald-Krnel</Name>
        <Affiliation>Environmental Health Science and Research Bureau, Healthy Environments and Consumer Safety Branch, Health Canada, Ottawa, ON, K1A 0K9, Canada. Electronic address: michele.regimbald-krnel@canada.ca.</Affiliation>
      </Author>
      <Author>
        <Name>Hajime Kojima</Name>
        <Affiliation>Japanese Centre for the Validation of Alternative Methods, National Institute of Health Sciences, 3-25-26, Tonomachi, Kawasaki-ku, Kawasaki, Kanagawa, Japan. Electronic address: h-kojima@nihs.go.jp.</Affiliation>
      </Author>
      <Author>
        <Name>Akiyoshi Nishikawa</Name>
        <Affiliation>Japanese Centre for the Validation of Alternative Methods, National Institute of Health Sciences, 3-25-26, Tonomachi, Kawasaki-ku, Kawasaki, Kanagawa, Japan. Electronic address: nishikaw@nihs.go.jp.</Affiliation>
      </Author>
      <Author>
        <Name>Hye Kyung Park</Name>
        <Affiliation>Korean Centre for the Validation of Alternative Methods, National Institute of Food and Drug Safety Evaluation, 187 Osongsaengmyeong 2(i)-ro, Osong-eup, Heungdoek-gu, Cheongju-si, Chungcheongbuk-do, 28159, Republic of Korea. Electronic address: phkfda@korea.kr.</Affiliation>
      </Author>
      <Author>
        <Name>Jong Kwon Lee</Name>
        <Affiliation>Korean Centre for the Validation of Alternative Methods, National Institute of Food and Drug Safety Evaluation, 187 Osongsaengmyeong 2(i)-ro, Osong-eup, Heungdoek-gu, Cheongju-si, Chungcheongbuk-do, 28159, Republic of Korea. Electronic address: jkleest@korea.kr.</Affiliation>
      </Author>
      <Author>
        <Name>Tae Sung Kim</Name>
        <Affiliation>Korean Centre for the Validation of Alternative Methods, National Institute of Food and Drug Safety Evaluation, 187 Osongsaengmyeong 2(i)-ro, Osong-eup, Heungdoek-gu, Cheongju-si, Chungcheongbuk-do, 28159, Republic of Korea. Electronic address: ktsung@korea.kr.</Affiliation>
      </Author>
      <Author>
        <Name>Isabella Delgado</Name>
        <Affiliation>National Institute of Quality Control in Health, Oswaldo Cruz Foundation (Fiocruz), Avenida Brasil, 4365 - Manguinhos, 21045-900, Rio de Janeiro, RJ, Brazil. Electronic address: isabella.delgado@incqs.fiocruz.br.</Affiliation>
      </Author>
      <Author>
        <Name>Ludmila Rios</Name>
        <Affiliation>Brazilian Health Regulatory Agency (ANVISA), Setor de Indústria e Abastecimento (SIA), Trecho 5, Área Especial 57, Lote 200, 71205-050, Guará, DF, Brazil. Electronic address: ludy.rios@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Ying Yang</Name>
        <Affiliation>Guangdong Provincial Center for Disease Control and Prevention, Qunxian Road 160, Panyu Strict, 510430, Guangzhou, China. Electronic address: yang99063@126.com.</Affiliation>
      </Author>
      <Author>
        <Name>Gangli Wang</Name>
        <Affiliation>National Institutes for Food and Drug Control, Tiantan Xili Road 2, 100050, Beijing, China. Electronic address: duneer@163.com.</Affiliation>
      </Author>
      <Author>
        <Name>Nicole Kleinstreuer</Name>
        <Affiliation>National Toxicology Program Interagency Center for the Evaluation of Alternative Toxicological Methods, National Institute of Environmental Health Sciences, P.O. Box 12233, Research Triangle Park, NC, 27709, USA. Electronic address: nicole.kleinstreuer@nih.gov.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Uterine adenocarcinoma in the rat induced by afidopyropen. An analysis of the lesion's induction, progression and its relevance to humans.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29510166</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30063-1</DOI>
    <KeywordList>
      <Keywords>Afidopyropen</Keywords>
      <Keywords>Carcinogenicity</Keywords>
      <Keywords>Dopamine receptor agonism</Keywords>
      <Keywords>Pharmacokinetics</Keywords>
      <Keywords>Uterine adenocarcinoma</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Andrew Van Cott</Name>
        <Affiliation>BASF Corporation, Research Triangle Park, NC 27709, USA. Electronic address: andrew.vancott@basf.com.</Affiliation>
      </Author>
      <Author>
        <Name>Markus Frericks</Name>
        <Affiliation>BASF SE Experimental Toxicology and Ecology, Ludwigshafen, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Charles Hastings</Name>
        <Affiliation>BASF Corporation, Research Triangle Park, NC 27709, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Naveed Honarvar</Name>
        <Affiliation>BASF SE Experimental Toxicology and Ecology, Ludwigshafen, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Burkhard Flick</Name>
        <Affiliation>BASF SE Experimental Toxicology and Ecology, Ludwigshafen, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Eric Fabian</Name>
        <Affiliation>BASF SE Experimental Toxicology and Ecology, Ludwigshafen, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Bennard van Ravenzwaay</Name>
        <Affiliation>BASF SE Experimental Toxicology and Ecology, Ludwigshafen, Germany.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Pre and post intervention study of antiblastic drugs contamination surface levels at a Pharmacy Department Compounding Area using a closed system drug transfer device and a decontamination process.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29510165</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30064-3</DOI>
    <KeywordList>
      <Keywords>Closed system drug transfer device</Keywords>
      <Keywords>Compounding area</Keywords>
      <Keywords>Cytotoxic drugs</Keywords>
      <Keywords>Occupational exposure</Keywords>
      <Keywords>Pharmacy department</Keywords>
      <Keywords>Surface contamination</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Silvia Valero</Name>
        <Affiliation>Instituto de Investigación Sanitaria La Fe, Valencia, Spain. Electronic address: valero_sil@gva.es.</Affiliation>
      </Author>
      <Author>
        <Name>Eduardo López-Briz</Name>
        <Affiliation>Hospital Universitario y Politécnico La Fe, Valencia, Spain.</Affiliation>
      </Author>
      <Author>
        <Name>Nieves Vila</Name>
        <Affiliation>Hospital Universitario y Politécnico La Fe, Valencia, Spain.</Affiliation>
      </Author>
      <Author>
        <Name>Antonio Solana</Name>
        <Affiliation>Hospital Universitario y Politécnico La Fe, Valencia, Spain.</Affiliation>
      </Author>
      <Author>
        <Name>Mar Melero</Name>
        <Affiliation>Instituto de Investigación Sanitaria La Fe, Valencia, Spain.</Affiliation>
      </Author>
      <Author>
        <Name>Jose Luis Poveda</Name>
        <Affiliation>Hospital Universitario y Politécnico La Fe, Valencia, Spain.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>In-silico study of toxicokinetics and disease association of chemicals present in smokeless tobacco products.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29505798</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30065-5</DOI>
    <KeywordList>
      <Keywords>ADMET</Keywords>
      <Keywords>Carcinogen</Keywords>
      <Keywords>Chemical compounds</Keywords>
      <Keywords>Pathway</Keywords>
      <Keywords>Regulation</Keywords>
      <Keywords>Smokeless tobacco</Keywords>
      <Keywords>Toxicity</Keywords>
      <Keywords>Toxicokinetics</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Deeksha Bhartiya</Name>
        <Affiliation>Data Management Laboratory, National Institute of Cancer Prevention and Research, Noida, Uttar Pradesh 201301, India.</Affiliation>
      </Author>
      <Author>
        <Name>Amit Kumar</Name>
        <Affiliation>Data Management Laboratory, National Institute of Cancer Prevention and Research, Noida, Uttar Pradesh 201301, India.</Affiliation>
      </Author>
      <Author>
        <Name>Jasmine Kaur</Name>
        <Affiliation>Informatics, Systems and Research Management, Indian Council of Medical Research, New Delhi 110029, India.</Affiliation>
      </Author>
      <Author>
        <Name>Suchitra Kumari</Name>
        <Affiliation>Data Management Laboratory, National Institute of Cancer Prevention and Research, Noida, Uttar Pradesh 201301, India.</Affiliation>
      </Author>
      <Author>
        <Name>Amitesh Kumar Sharma</Name>
        <Affiliation>Informatics, Systems and Research Management, Indian Council of Medical Research, New Delhi 110029, India.</Affiliation>
      </Author>
      <Author>
        <Name>Dhirendra N. Sinha</Name>
        <Affiliation>WHO FCTC Global Knowledge Hub of Smokeless Tobacco, National Institute of Cancer Prevention and Research, Noida, Uttar Pradesh 201301, India.</Affiliation>
      </Author>
      <Author>
        <Name>Harpreet Singh</Name>
        <Affiliation>Informatics, Systems and Research Management, Indian Council of Medical Research, New Delhi 110029, India. Electronic address: hsingh@bmi.icmr.org.in.</Affiliation>
      </Author>
      <Author>
        <Name>Ravi Mehrotra</Name>
        <Affiliation>WHO FCTC Global Knowledge Hub of Smokeless Tobacco, National Institute of Cancer Prevention and Research, Noida, Uttar Pradesh 201301, India; National Institute of Cancer Prevention and Research, Noida, Uttar Pradesh 201301, India.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>In vitro and in vivo safety studies of cinnamon extract (Cinnamomum cassia) on general and genetic toxicology.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29501463</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30062-X</DOI>
    <KeywordList>
      <Keywords>Cinnamomum cassia</Keywords>
      <Keywords>Cinnamon</Keywords>
      <Keywords>Genotoxicity</Keywords>
      <Keywords>Subchronic</Keywords>
      <Keywords>Toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jun Won Yun</Name>
        <Affiliation>Department of Biotechnology, The Catholic University of Korea, Bucheon, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Ji Ran You</Name>
        <Affiliation>Department of Experimental Animal Research, Biomedical Research Institute, Seoul National University Hospital, Seoul, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Yun Soon Kim</Name>
        <Affiliation>Department of Experimental Animal Research, Biomedical Research Institute, Seoul National University Hospital, Seoul, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Seung Hyun Kim</Name>
        <Affiliation>Department of Experimental Animal Research, Biomedical Research Institute, Seoul National University Hospital, Seoul, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Eun Young Cho</Name>
        <Affiliation>Department of Experimental Animal Research, Biomedical Research Institute, Seoul National University Hospital, Seoul, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Jung Hee Yoon</Name>
        <Affiliation>Department of Experimental Animal Research, Biomedical Research Institute, Seoul National University Hospital, Seoul, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Euna Kwon</Name>
        <Affiliation>Department of Experimental Animal Research, Biomedical Research Institute, Seoul National University Hospital, Seoul, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Ja June Jang</Name>
        <Affiliation>Department of Pathology, Seoul National University College of Medicine, Seoul, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Jin Sung Park</Name>
        <Affiliation>Department of Neurogenetics, Kolling Institute, Royal North Shore Hospital and University of Sydney, St. Leonards, Australia.</Affiliation>
      </Author>
      <Author>
        <Name>Hyoung Chin Kim</Name>
        <Affiliation>Laboratory Animal Resource Center, Korea Research Institute of Bioscience and Biotechnology, Cheongju, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Jeong Hwan Che</Name>
        <Affiliation>Biomedical Center for Animal Resource and Development, Seoul National University College of Medicine, Seoul, Republic of Korea. Electronic address: casache@snu.ac.kr.</Affiliation>
      </Author>
      <Author>
        <Name>Byeong Cheol Kang</Name>
        <Affiliation>Department of Experimental Animal Research, Biomedical Research Institute, Seoul National University Hospital, Seoul, Republic of Korea; Biomedical Center for Animal Resource and Development, Seoul National University College of Medicine, Seoul, Republic of Korea; Graduate School of Translational Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea; Designed Animal and Transplantation Research Institute, Institute of GreenBio Science Technology, Seoul National University, Pyeongchang-gun, Gangwon-do, Republic of Korea. Electronic address: bckang@snu.ac.kr.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Based on an analysis of mode of action, styrene-induced mouse lung tumors are not a human cancer concern.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29496518</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30055-2</DOI>
    <KeywordList>
      <Keywords>Cyp2F2</Keywords>
      <Keywords>Cytotoxicity</Keywords>
      <Keywords>Gene expression</Keywords>
      <Keywords>Mitogenicity</Keywords>
      <Keywords>Mode of action</Keywords>
      <Keywords>Ring oxidized metabolites</Keywords>
      <Keywords>Styrene</Keywords>
      <Keywords>Styrene oxide</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>George Cruzan</Name>
        <Affiliation>ToxWorks, Bridgeton, NJ 08302, United States. Electronic address: toxworks@aol.com.</Affiliation>
      </Author>
      <Author>
        <Name>James S. Bus</Name>
        <Affiliation>Exponent, Midland, MI 48640, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Melvin E. Andersen</Name>
        <Affiliation>ScitoVation, Research Triangle Park, NC 27709, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Gary P. Carlson</Name>
        <Affiliation>Purdue University, West Lafayette, IN 47906, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Marcy I. Banton</Name>
        <Affiliation>Lyondell Chemical Company, Houston, TX 77010, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Satinder S. Sarang</Name>
        <Affiliation>Shell International, Houston, TX 77002, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Robbie Waites</Name>
        <Affiliation>Sabic, Innovative Plastics US LLC, Mount Vernon, IN 47620, United States.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Weight of contribution of in vitro chromosomal aberration assay for evaluation of pesticides: Experience of risk assessment at the Food Safety Commission of Japan.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29486272</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30058-8</DOI>
    <KeywordList>
      <Keywords>Genotoxicity</Keywords>
      <Keywords>Pesticides</Keywords>
      <Keywords>in vitro chromosomal aberration assay</Keywords>
      <Keywords>in vivo micronucleus assay</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Atsuko Horibe</Name>
        <Affiliation>Food Safety Commission Secretariat of Japan, Tokyo, Japan. Electronic address: atsuko_horibe730@maff.go.jp.</Affiliation>
      </Author>
      <Author>
        <Name>Shigenori Odashima</Name>
        <Affiliation>Kyoto Prefectural Government, Kyoto, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Nobuyuki Hamasuna</Name>
        <Affiliation>Food Safety Commission Secretariat of Japan, Tokyo, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Takeshi Morita</Name>
        <Affiliation>National Institute of Health Sciences, Tokyo, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Makoto Hayashi</Name>
        <Affiliation>Public Interest Incorporated Foundation BioSafety Research Center, Iwata, Japan; Makoto International Consulting, Ebina, Japan.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Survival of Escherichia coli harboring nucleic acid-hydrolyzing 3D8 scFv during RNA virus infection.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29486271</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30057-6</DOI>
    <KeywordList>
      <Keywords>3D8 scFv</Keywords>
      <Keywords>Anti-DNA antibody</Keywords>
      <Keywords>Anti-viral</Keywords>
      <Keywords>Escherichia coli</Keywords>
      <Keywords>Gastrointestinal tract</Keywords>
      <Keywords>Mice</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jung Ho Park</Name>
        <Affiliation>Bio-Evaluation Center, Korea Research Institute of Bioscience and Biotechnology, Cheongju, Chungcheongbuk-do 28116, South Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Jae Woo Lee</Name>
        <Affiliation>Bio-Evaluation Center, Korea Research Institute of Bioscience and Biotechnology, Cheongju, Chungcheongbuk-do 28116, South Korea; Department of Food Science and Technology, College of Agriculture and Life Sciences, Chungnam National University, Daejeon 34134, South Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Hoonsung Choi</Name>
        <Affiliation>Animal Biotechnology Division, National Institute of Animal Science, RDA, 1500, Kongjwipatjwi-ro, Iseo-myeon, Wanju-gun, Jeollabuk-do, 55365, South Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Sun Keun Jung</Name>
        <Affiliation>Animal Biotechnology Division, National Institute of Animal Science, RDA, 1500, Kongjwipatjwi-ro, Iseo-myeon, Wanju-gun, Jeollabuk-do, 55365, South Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Jeom Sun Kim</Name>
        <Affiliation>Animal Biotechnology Division, National Institute of Animal Science, RDA, 1500, Kongjwipatjwi-ro, Iseo-myeon, Wanju-gun, Jeollabuk-do, 55365, South Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Kyung Woon Kim</Name>
        <Affiliation>Animal Biotechnology Division, National Institute of Animal Science, RDA, 1500, Kongjwipatjwi-ro, Iseo-myeon, Wanju-gun, Jeollabuk-do, 55365, South Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Keon Bong Oh</Name>
        <Affiliation>Animal Biotechnology Division, National Institute of Animal Science, RDA, 1500, Kongjwipatjwi-ro, Iseo-myeon, Wanju-gun, Jeollabuk-do, 55365, South Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Hyeon Yang</Name>
        <Affiliation>Animal Biotechnology Division, National Institute of Animal Science, RDA, 1500, Kongjwipatjwi-ro, Iseo-myeon, Wanju-gun, Jeollabuk-do, 55365, South Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Sung June Byun</Name>
        <Affiliation>Animal Biotechnology Division, National Institute of Animal Science, RDA, 1500, Kongjwipatjwi-ro, Iseo-myeon, Wanju-gun, Jeollabuk-do, 55365, South Korea. Electronic address: pcs1778@korea.kr.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Mechanism-informed read-across assessment of skin sensitizers based on SkinSensDB.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29486270</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30059-X</DOI>
    <KeywordList>
      <Keywords>Adverse outcome pathway</Keywords>
      <Keywords>Read-across</Keywords>
      <Keywords>Skin sensitizer</Keywords>
      <Keywords>SkinSensDB</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Chun Wei Tung</Name>
        <Affiliation>School of Pharmacy, Kaohsiung Medical University, Kaohsiung 80708, Taiwan; PhD Program in Toxicology, Kaohsiung Medical University, Kaohsiung 80708, Taiwan; Department of Medical Research, Kaohsiung Medical University Hospital, Kaohsiung 80708, Taiwan; National Institute of Environmental Health Sciences, National Health Research Institutes, Miaoli County 35053, Taiwan. Electronic address: cwtung@kmu.edu.tw.</Affiliation>
      </Author>
      <Author>
        <Name>Chia Chi Wang</Name>
        <Affiliation>School of Pharmacy, Kaohsiung Medical University, Kaohsiung 80708, Taiwan; PhD Program in Toxicology, Kaohsiung Medical University, Kaohsiung 80708, Taiwan; Department of Medical Research, Kaohsiung Medical University Hospital, Kaohsiung 80708, Taiwan; National Institute of Environmental Health Sciences, National Health Research Institutes, Miaoli County 35053, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Shan Shan Wang</Name>
        <Affiliation>School of Pharmacy, Kaohsiung Medical University, Kaohsiung 80708, Taiwan.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Allergenic sensitization versus elicitation risk criteria for novel food proteins.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29481837</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30061-8</DOI>
    <KeywordList>
      <Keywords>Allergen</Keywords>
      <Keywords>Elicitation</Keywords>
      <Keywords>Exposure</Keywords>
      <Keywords>Genetically modified crops</Keywords>
      <Keywords>Hazard</Keywords>
      <Keywords>Risk</Keywords>
      <Keywords>Sensitization</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Rod A. Herman</Name>
        <Affiliation>Dow AgroSciences LLC, 9330 Zionsville Road, Indianapolis, IN 46268, United States. Electronic address: raherman@dow.com.</Affiliation>
      </Author>
      <Author>
        <Name>Gregory S. Ladics</Name>
        <Affiliation>DuPont Haskell Global Centers for Health and Environmental Sciences, 1090 Elkton Road, Newark, DE 19711, United States.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Nonclinical evaluation of immunological safety in Göttingen Minipigs: The CONFIRM initiative.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29481836</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30060-6</DOI>
    <KeywordList>
      <Keywords>Biologics</Keywords>
      <Keywords>CONFIRM initiative</Keywords>
      <Keywords>Immunological safety</Keywords>
      <Keywords>Immunotoxicity</Keywords>
      <Keywords>Minipigs</Keywords>
      <Keywords>Nonclinical evaluation</Keywords>
      <Keywords>Pharmaceuticals</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jacques Descotes</Name>
        <Affiliation>ImmunoSafe Consulting &amp; University of Lyon, 38480 Saint Jean d'Avelanne, France. Electronic address: descotes@me.com.</Affiliation>
      </Author>
      <Author>
        <Name>Linda Allais</Name>
        <Affiliation>Charles River Laboratories, 69210 Saint Germain-Nuelles, France.</Affiliation>
      </Author>
      <Author>
        <Name>Philippe Ancian</Name>
        <Affiliation>CiToxLAB Group, 27005 Evreux, France.</Affiliation>
      </Author>
      <Author>
        <Name>Henrik Duelund Pedersen</Name>
        <Affiliation>Ellegaard Göttingen Minipigs, 4261 Dalmose, Denmark.</Affiliation>
      </Author>
      <Author>
        <Name>Claire Friry-Santini</Name>
        <Affiliation>Galderma, 06410 Sophia-Antipolis, France.</Affiliation>
      </Author>
      <Author>
        <Name>Antonio Iglesias</Name>
        <Affiliation>Roche, 4070 Basel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Tina Rubic-Schneider</Name>
        <Affiliation>Novartis, 4056 Basel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Hollie Skaggs</Name>
        <Affiliation>Janssen, 2340 Beerse, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Peter Vestbjerg</Name>
        <Affiliation>Ellegaard Göttingen Minipigs, 4261 Dalmose, Denmark.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Acute, subchronic oral toxicity, toxicokinetics, and genotoxicity studies of DFC-2, an antitubercular drug candidate.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29475068</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30056-4</DOI>
    <KeywordList>
      <Keywords>Chromosomal aberrations</Keywords>
      <Keywords>DFC-2</Keywords>
      <Keywords>Genotoxicity</Keywords>
      <Keywords>M. tuberculosis</Keywords>
      <Keywords>Micronucleus formation test</Keywords>
      <Keywords>Preclinical toxicology</Keywords>
      <Keywords>Reverse mutation test</Keywords>
      <Keywords>Subchronic oral toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Hoonhee Seo</Name>
        <Affiliation>Department of Microbiology and Immunology, School of Medicine, Soonchunhyang University, Cheonan, Chungnam, 31151, South Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Hafij Al Mahmud</Name>
        <Affiliation>Department of Microbiology and Immunology, School of Medicine, Soonchunhyang University, Cheonan, Chungnam, 31151, South Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Sukyung Kim</Name>
        <Affiliation>Department of Microbiology and Immunology, School of Medicine, Soonchunhyang University, Cheonan, Chungnam, 31151, South Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Md Imtiazul Islam</Name>
        <Affiliation>Department of Microbiology and Immunology, School of Medicine, Soonchunhyang University, Cheonan, Chungnam, 31151, South Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Kee In Lee</Name>
        <Affiliation>Green Chemistry Division, Korea Research Institute of Chemical Technology, Taejon, 34114, South Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Young Sig Gil</Name>
        <Affiliation>R&amp;D Center, Kolmarpharma Co., Ltd., Chungbuk, 27159, South Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Ho Yeon Song</Name>
        <Affiliation>Department of Microbiology and Immunology, School of Medicine, Soonchunhyang University, Cheonan, Chungnam, 31151, South Korea. Electronic address: songmic@sch.ac.kr.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Transcriptional profiling of male CD-1 mouse lungs and Harderian glands supports the involvement of calcium signaling in acrylamide-induced tumors.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29475067</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30050-3</DOI>
    <KeywordList>
      <Keywords>Calcium signaling</Keywords>
      <Keywords>Dose-response</Keywords>
      <Keywords>Gene expression</Keywords>
      <Keywords>Harderian gland</Keywords>
      <Keywords>Human health risk assessment</Keywords>
      <Keywords>Lung</Keywords>
      <Keywords>Mode of action</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Nikolai L. Chepelev</Name>
        <Affiliation>Integrated Laboratory Systems Inc., Research Triangle Park, NC 27709, USA; Environmental Health Science and Research Bureau, Environmental and Radiation Health Sciences Directorate, HECSB, Health Canada, Ottawa, ON K1A 0K9, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Rémi Gagné</Name>
        <Affiliation>Environmental Health Science and Research Bureau, Environmental and Radiation Health Sciences Directorate, HECSB, Health Canada, Ottawa, ON K1A 0K9, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Timothy Maynor</Name>
        <Affiliation>Integrated Laboratory Systems Inc., Research Triangle Park, NC 27709, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Byron Kuo</Name>
        <Affiliation>Environmental Health Science and Research Bureau, Environmental and Radiation Health Sciences Directorate, HECSB, Health Canada, Ottawa, ON K1A 0K9, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Cheryl A. Hobbs</Name>
        <Affiliation>Integrated Laboratory Systems Inc., Research Triangle Park, NC 27709, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Leslie Recio</Name>
        <Affiliation>Integrated Laboratory Systems Inc., Research Triangle Park, NC 27709, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Carole L. Yauk</Name>
        <Affiliation>Environmental Health Science and Research Bureau, Environmental and Radiation Health Sciences Directorate, HECSB, Health Canada, Ottawa, ON K1A 0K9, Canada. Electronic address: carole.yauk@canada.ca.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>No subchronic toxicity of multiple herbicide-resistant soybean FG72 in Sprague-Dawley rats by 90-days feeding study.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29462651</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30049-7</DOI>
    <KeywordList>
      <Keywords>Feeding study</Keywords>
      <Keywords>Food safety</Keywords>
      <Keywords>Genetically modified</Keywords>
      <Keywords>Soybean</Keywords>
      <Keywords>Subchronic</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Zixin Xie</Name>
        <Affiliation>Beijing Advanced Innovation Center for Food Nutrition and Human Health, College of Food Science &amp; Nutritional Engineering, China Agricultural University, Beijing 100083, China.</Affiliation>
      </Author>
      <Author>
        <Name>Shiying Zou</Name>
        <Affiliation>Beijing Advanced Innovation Center for Food Nutrition and Human Health, College of Food Science &amp; Nutritional Engineering, China Agricultural University, Beijing 100083, China; Key Laboratory of Safety Assessment of Genetically Modified Organism (Food Safety), Ministry of Agriculture, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Wentao Xu</Name>
        <Affiliation>Beijing Advanced Innovation Center for Food Nutrition and Human Health, College of Food Science &amp; Nutritional Engineering, China Agricultural University, Beijing 100083, China; Beijing Laboratory for Food Quality and Safety, College of Food Science &amp; Nutritional Engineering, China Agricultural University, Beijing 100083, China; Key Laboratory of Safety Assessment of Genetically Modified Organism (Food Safety), Ministry of Agriculture, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Xu Liu</Name>
        <Affiliation>Key Laboratory of Safety Assessment of Genetically Modified Organism (Food Safety), Ministry of Agriculture, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Kunlun Huang</Name>
        <Affiliation>Beijing Advanced Innovation Center for Food Nutrition and Human Health, College of Food Science &amp; Nutritional Engineering, China Agricultural University, Beijing 100083, China; Beijing Laboratory for Food Quality and Safety, College of Food Science &amp; Nutritional Engineering, China Agricultural University, Beijing 100083, China; Key Laboratory of Safety Assessment of Genetically Modified Organism (Food Safety), Ministry of Agriculture, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaoyun He</Name>
        <Affiliation>Beijing Advanced Innovation Center for Food Nutrition and Human Health, College of Food Science &amp; Nutritional Engineering, China Agricultural University, Beijing 100083, China; Beijing Laboratory for Food Quality and Safety, College of Food Science &amp; Nutritional Engineering, China Agricultural University, Beijing 100083, China; Key Laboratory of Safety Assessment of Genetically Modified Organism (Food Safety), Ministry of Agriculture, PR China. Electronic address: raininghe@163.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Bioequivalence decision for nanoparticular iron complex drugs for parenteral administration based on their disposition.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29454888</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30054-0</DOI>
    <KeywordList>
      <Keywords>Bioequivalence</Keywords>
      <Keywords>Essential similarity</Keywords>
      <Keywords>Iron</Keywords>
      <Keywords>Nanomedicine</Keywords>
      <Keywords>Non-biological complex drugs</Keywords>
      <Keywords>Organotropy</Keywords>
      <Keywords>Tissue distribution</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Julia Schnorr</Name>
        <Affiliation>Pharmaceutical Technology and Biopharmaceutics, Johannes Gutenberg University, Mainz, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Sören Fütterer</Name>
        <Affiliation>Pharmaceutical Technology and Biopharmaceutics, Johannes Gutenberg University, Mainz, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Karsten Spicher</Name>
        <Affiliation>Federal Institute for Drugs and Medical Devices (BfArM), Bonn, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Maria Catarinolo</Name>
        <Affiliation>Federal Institute for Drugs and Medical Devices (BfArM), Bonn, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Christoph Schlösser</Name>
        <Affiliation>Federal Institute for Drugs and Medical Devices (BfArM), Bonn, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Harald Enzmann</Name>
        <Affiliation>Federal Institute for Drugs and Medical Devices (BfArM), Bonn, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Peter Langguth</Name>
        <Affiliation>Pharmaceutical Technology and Biopharmaceutics, Johannes Gutenberg University, Mainz, Germany. Electronic address: langguth@uni-mainz.de.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Immunologic effects of chronic administration of tofacitinib, a Janus kinase inhibitor, in cynomolgus monkeys and rats - Comparison of juvenile and adult responses.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29454012</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30051-5</DOI>
    <KeywordList>
      <Keywords>Immune function</Keywords>
      <Keywords>Immunology</Keywords>
      <Keywords>Immunomodulation</Keywords>
      <Keywords>Lymphoma</Keywords>
      <Keywords>Tofacitinib</Keywords>
      <Keywords>Toxicology</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Mark Collinge</Name>
        <Affiliation>Pfizer Worldwide Research and Development, Drug Safety R&amp;D, Eastern Point Road, Groton, CT 06340, USA. Electronic address: mark.collinge@pfizer.com.</Affiliation>
      </Author>
      <Author>
        <Name>Douglas J. Ball</Name>
        <Affiliation>Pfizer Worldwide Research and Development, Drug Safety R&amp;D, Eastern Point Road, Groton, CT 06340, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Christopher J. Bowman</Name>
        <Affiliation>Pfizer Worldwide Research and Development, Drug Safety R&amp;D, Eastern Point Road, Groton, CT 06340, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Andrea L. Nilson</Name>
        <Affiliation>Pfizer Worldwide Research and Development, Drug Safety R&amp;D, Eastern Point Road, Groton, CT 06340, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Zaher A. Radi</Name>
        <Affiliation>Pfizer Worldwide Research and Development, Drug Safety R&amp;D, One Portland Street, Cambridge, MA 02139, USA.</Affiliation>
      </Author>
      <Author>
        <Name>W. Mark Vogel</Name>
        <Affiliation>Pfizer Worldwide Research and Development, Drug Safety R&amp;D, One Portland Street, Cambridge, MA 02139, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Comparative study on some oxidative stress parameters in blood of vitiligo patients before and after combined therapy.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29454011</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30053-9</DOI>
    <KeywordList>
      <Keywords>Ascorbate radicals</Keywords>
      <Keywords>EPR spectroscopy</Keywords>
      <Keywords>Oxidative stress</Keywords>
      <Keywords>ROS</Keywords>
      <Keywords>Vitiligo</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>A. Zheleva</Name>
        <Affiliation>Department of Chemistry and Biochemistry, Medical Faculty, Trakia University, Stara Zagora, Bulgaria. Electronic address: azheleva@mf.uni-sz.bg.</Affiliation>
      </Author>
      <Author>
        <Name>G. Nikolova</Name>
        <Affiliation>Department of Chemistry and Biochemistry, Medical Faculty, Trakia University, Stara Zagora, Bulgaria.</Affiliation>
      </Author>
      <Author>
        <Name>Y. Karamalakova</Name>
        <Affiliation>Department of Chemistry and Biochemistry, Medical Faculty, Trakia University, Stara Zagora, Bulgaria.</Affiliation>
      </Author>
      <Author>
        <Name>E. Hristakieva</Name>
        <Affiliation>Department of Dermatology and Venereology, Medical Faculty, Trakia University, Stara Zagora, Bulgaria.</Affiliation>
      </Author>
      <Author>
        <Name>R. Lavcheva</Name>
        <Affiliation>Department of Dermatology and Venereology, Medical Faculty, Trakia University, Stara Zagora, Bulgaria.</Affiliation>
      </Author>
      <Author>
        <Name>V. Gadjeva</Name>
        <Affiliation>Department of Chemistry and Biochemistry, Medical Faculty, Trakia University, Stara Zagora, Bulgaria.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Corrigendum to "Implementing the D4F in a robust model, allowing for enhanced comparison, prioritisation and grouping of NMs" [Regul. Toxicol. Pharmacol. 92 (2018) 207-212].</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29453136</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30048-5</DOI>
    <AuthorList>
      <Author>
        <Name>J. J. Scott-Fordsmand</Name>
        <Affiliation>Department of Bioscience, Aarhus University, Vejlsovej 25, PO BOX 314, Silkeborg, Denmark. Electronic address: jsf@bios.au.dk.</Affiliation>
      </Author>
      <Author>
        <Name>M. J. B. Amorim</Name>
        <Affiliation>University of Aveiro, Department of Biology &amp; CESAM, Aveiro, Portugal.</Affiliation>
      </Author>
      <Author>
        <Name>P. B. Sørensen</Name>
        <Affiliation>Department of Bioscience, Aarhus University, Vejlsovej 25, PO BOX 314, Silkeborg, Denmark.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Impact of exposure factor selection on deterministic consumer exposure assessment.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29447927</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30052-7</DOI>
    <KeywordList>
      <Keywords>Consumer product</Keywords>
      <Keywords>Deterministic</Keywords>
      <Keywords>Exposure assessment</Keywords>
      <Keywords>Exposure factor</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Hyunkyung Ban</Name>
        <Affiliation>Department of Environmental Health Sciences, Graduate School of Public Health, Seoul National University, Seoul, South Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Ji Young Park</Name>
        <Affiliation>Institute of Health and Environment, Seoul National University, Seoul, South Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Daeyeop Lee</Name>
        <Affiliation>Risk Assessment Division, National Institute of Environmental Research, Incheon, South Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Kiyoung Lee</Name>
        <Affiliation>Department of Environmental Health Sciences, Graduate School of Public Health, Seoul National University, Seoul, South Korea; Institute of Health and Environment, Seoul National University, Seoul, South Korea. Electronic address: cleanair@snu.ac.kr.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Insulation fiber deposition in the airways of men and rats. A review of experimental and computational studies.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29444452</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30037-0</DOI>
    <KeywordList>
      <Keywords>Deposition</Keywords>
      <Keywords>Equivalent dose</Keywords>
      <Keywords>Glass wool</Keywords>
      <Keywords>Humans</Keywords>
      <Keywords>Inhalation</Keywords>
      <Keywords>Man-made mineral fibers</Keywords>
      <Keywords>Rats</Keywords>
      <Keywords>Rock wool</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>G. D. Nielsen</Name>
        <Affiliation>National Research Centre for the Working Environment, Lersø Parkallé, DK-2100 Copenhagen, Denmark. Electronic address: gdn@nrcwe.dk.</Affiliation>
      </Author>
      <Author>
        <Name>I. K. Koponen</Name>
        <Affiliation>National Research Centre for the Working Environment, Lersø Parkallé, DK-2100 Copenhagen, Denmark.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Corrigendum to "Quantitative analysis of menthol and identification of other flavoring ingredients in capsule cigarettes marketed in Korea" [Regul. Toxicol. Pharmacol. 92C (2018) 420-428].</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29429759</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30030-8</DOI>
    <AuthorList>
      <Author>
        <Name>Hyung Soo Kim</Name>
        <Affiliation>Department of Public Health Sciences, Graduate School, Korea University, Seoul, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Eun Chul Pack</Name>
        <Affiliation>Department of Public Health Sciences, Graduate School, Korea University, Seoul, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Ye Ji Koo</Name>
        <Affiliation>Department of Public Health Sciences, Graduate School, Korea University, Seoul, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Ye Jin Lee</Name>
        <Affiliation>Department of Public Health Sciences, Graduate School, Korea University, Seoul, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Dae Kwan Sung</Name>
        <Affiliation>Department of Public Health Sciences, Graduate School, Korea University, Seoul, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Seung Ha Lee</Name>
        <Affiliation>Department of Public Health Sciences, Graduate School, Korea University, Seoul, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Young Soon Kim</Name>
        <Affiliation>School of Biosystem and Biomedical Science, Korea University, Seoul, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Kyeng Hee Kwon</Name>
        <Affiliation>College of Pharmacy, Dongguk University, Goyang-city, Gyeonggi-do, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Kyung Min Lim</Name>
        <Affiliation>College of Pharmacy, Ewha Womans University, Seoul, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Dae Yong Jang</Name>
        <Affiliation>Department of Public Health Sciences, Graduate School, Korea University, Seoul, Republic of Korea. Electronic address: dyjang0803@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Dal Woong Choi</Name>
        <Affiliation>Department of Public Health Sciences, Graduate School, Korea University, Seoul, Republic of Korea. Electronic address: dwlove@korea.ac.kr.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Suitability of biomarkers of biological effects (BOBEs) for assessing the likelihood of reducing the tobacco related disease risk by new and innovative tobacco products: A literature review.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29428304</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30047-3</DOI>
    <KeywordList>
      <Keywords>Biomarkers of biological effect</Keywords>
      <Keywords>Electronic cigarettes</Keywords>
      <Keywords>New and innovative tobacco products</Keywords>
      <Keywords>Non-smokers</Keywords>
      <Keywords>Smokers</Keywords>
      <Keywords>Tobacco harm reduction</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Gerhard Scherer</Name>
        <Affiliation>ABF Analytisch-Biologisches Forschungslabor GmbH, Semmelweisstrasse 5, 82152 Planegg, Germany. Electronic address: gerhard.scherer@abf-lab.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Developmental immunotoxicity is not associated with the consumption of transgenic Bt rice TT51 in rats.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29427604</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30044-8</DOI>
    <KeywordList>
      <Keywords>Developmental immunotoxicity</Keywords>
      <Keywords>Transgenic Bt rice</Keywords>
      <Keywords>Two-generation study</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jing Hu</Name>
        <Affiliation>China National Center for Food Safety Risk Assessment, Beijing, China; Key Laboratory of Food Safety Risk Assessment of Ministry of Health, Beijing, China.</Affiliation>
      </Author>
      <Author>
        <Name>Chunlai Liang</Name>
        <Affiliation>China National Center for Food Safety Risk Assessment, Beijing, China; Key Laboratory of Food Safety Risk Assessment of Ministry of Health, Beijing, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaopeng Zhang</Name>
        <Affiliation>China National Center for Food Safety Risk Assessment, Beijing, China; Key Laboratory of Food Safety Risk Assessment of Ministry of Health, Beijing, China.</Affiliation>
      </Author>
      <Author>
        <Name>Qiannan Zhang</Name>
        <Affiliation>China National Center for Food Safety Risk Assessment, Beijing, China; Key Laboratory of Food Safety Risk Assessment of Ministry of Health, Beijing, China.</Affiliation>
      </Author>
      <Author>
        <Name>Wenming Cui</Name>
        <Affiliation>China National Center for Food Safety Risk Assessment, Beijing, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhou Yu</Name>
        <Affiliation>China National Center for Food Safety Risk Assessment, Beijing, China; Key Laboratory of Food Safety Risk Assessment of Ministry of Health, Beijing, China. Electronic address: yuzhou@cfsa.net.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A kinetic-based safety assessment of consumer exposure to salicylic acid from cosmetic products demonstrates no evidence of a health risk from developmental toxicity.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29410076</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30042-4</DOI>
    <KeywordList>
      <Keywords>Acetylsalicylic acid</Keywords>
      <Keywords>Developmental toxicity</Keywords>
      <Keywords>Hazard identification</Keywords>
      <Keywords>Human data</Keywords>
      <Keywords>Plasma exposure</Keywords>
      <Keywords>Salicylic acid</Keywords>
      <Keywords>Teratogenicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>R. Labib</Name>
        <Affiliation>Johnson &amp; Johnson Consumer Inc., Skillman, NJ, USA. Electronic address: rlabib@its.jnj.com.</Affiliation>
      </Author>
      <Author>
        <Name>D. Bury</Name>
        <Affiliation>L'Oreal Research and Development, Worldwide Safety Evaluation, 9 Rue Pierre Dreyfus, 92110 Clichy, France.</Affiliation>
      </Author>
      <Author>
        <Name>F. Boisleve</Name>
        <Affiliation>Johnson &amp; Johnson Consumer Inc., Campus de Maigremont Chaussée du Vexin, 27100, Val De Reuil, France.</Affiliation>
      </Author>
      <Author>
        <Name>G. Eichenbaum</Name>
        <Affiliation>Johnson &amp; Johnson, Office of the Chief Medical Officer, New Brunswick, NJ, USA.</Affiliation>
      </Author>
      <Author>
        <Name>S. Girard</Name>
        <Affiliation>Novacyl, 21 Chemin de la Sauvegarde, 69130, Écully, France.</Affiliation>
      </Author>
      <Author>
        <Name>J. Naciff</Name>
        <Affiliation>The Procter and Gamble Company, Mason Business Center, Mason, OH, 45040, USA.</Affiliation>
      </Author>
      <Author>
        <Name>M. Leal</Name>
        <Affiliation>KAO USA Inc., Cincinnati, OH, 45214, USA.</Affiliation>
      </Author>
      <Author>
        <Name>J. Wong</Name>
        <Affiliation>The Estée Lauder Companies, Inc., Melville, NY, 11747-3258, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Mixture risk assessment of selected mainstream cigarette smoke constituents generated from low-yield cigarettes in South Korean smokers.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29408505</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30041-2</DOI>
    <KeywordList>
      <Keywords>Low-yield cigarette</Keywords>
      <Keywords>Mainstream smoke chemistry</Keywords>
      <Keywords>Mixture risk assessment</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Eun Chul Pack</Name>
        <Affiliation>Department of Public Health Sciences, Graduate School, Korea University, Seoul, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Dae Yong Jang</Name>
        <Affiliation>Department of Public Health Sciences, Graduate School, Korea University, Seoul, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Hyung Soo Kim</Name>
        <Affiliation>Department of Public Health Sciences, Graduate School, Korea University, Seoul, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Seung Ha Lee</Name>
        <Affiliation>Department of Public Health Sciences, Graduate School, Korea University, Seoul, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Hae Young Kim</Name>
        <Affiliation>Department of Public Health Sciences, Graduate School, Korea University, Seoul, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Seok Ho Song</Name>
        <Affiliation>Korea Conformity Laboratories, Seoul, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Hoon Sik Cho</Name>
        <Affiliation>Korea Conformity Laboratories, Seoul, Republic of Korea. Electronic address: hscho02021004@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Kyeng Hee Kwon</Name>
        <Affiliation>College of Pharmacy, Dongguk University, Goyang-city, Gyeonggi-do, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Kun Ho Park</Name>
        <Affiliation>Korea Chemical Management Association, Seoul, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Kyung Min Lim</Name>
        <Affiliation>College of Pharmacy, Ewha Womans University, Seoul, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Dal Woong Choi</Name>
        <Affiliation>Department of Public Health Sciences, Graduate School, Korea University, Seoul, Republic of Korea. Electronic address: dwlove@korea.ac.kr.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Mutagenicity and genotoxicity studies of aspartame.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29408486</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(18)30039-4</DOI>
    <KeywordList>
      <Keywords>Aspartame</Keywords>
      <Keywords>Genotoxicity</Keywords>
      <Keywords>Micronucleus</Keywords>
      <Keywords>Mutagenicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Akira Otabe</Name>
        <Affiliation>Ajinomoto Co., Inc., 1-15-1 Kyobashi, Tokyo, 104-8315, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Fumio Ohta</Name>
        <Affiliation>Ajinomoto Co., Inc., 1-15-1 Kyobashi, Tokyo, 104-8315, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Asuka Takumi</Name>
        <Affiliation>Ajinomoto Co., Inc., 1-15-1 Kyobashi, Tokyo, 104-8315, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Barry Lynch</Name>
        <Affiliation>Intertek Scientific &amp; Regulatory Consultancy, Suite 201, 2233 Argentia Rd., Mississauga, Ontario, L5N 2X7, Canada. Electronic address: barry.lynch@intertek.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Status of acute systemic toxicity testing requirements and data uses by U.S. regulatory agencies.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29408321</pubmedLink>
    <GrantList>
      <Grant>HHSN273201500010C</Grant>
    </GrantList>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30038-2</DOI>
    <KeywordList>
      <Keywords>Acute systemic toxicity</Keywords>
      <Keywords>Alternative approaches</Keywords>
      <Keywords>In silico</Keywords>
      <Keywords>In vitro</Keywords>
      <Keywords>LC(50)</Keywords>
      <Keywords>LD(50)</Keywords>
      <Keywords>Non-animal methods</Keywords>
      <Keywords>Regulatory requirements</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Judy Strickland</Name>
        <Affiliation>ILS, P.O. Box 13501, Research Triangle Park, NC 27709, USA. Electronic address: strickl2@niehs.nih.gov.</Affiliation>
      </Author>
      <Author>
        <Name>Amy J. Clippinger</Name>
        <Affiliation>PETA International Science Consortium Ltd., Society Building, 8 All Saints Street, London, UK. Electronic address: amyjc@piscltd.org.uk.</Affiliation>
      </Author>
      <Author>
        <Name>Jeffrey Brown</Name>
        <Affiliation>PETA International Science Consortium Ltd., Society Building, 8 All Saints Street, London, UK. Electronic address: jeffreyb@piscltd.org.uk.</Affiliation>
      </Author>
      <Author>
        <Name>David Allen</Name>
        <Affiliation>ILS, P.O. Box 13501, Research Triangle Park, NC 27709, USA. Electronic address: dallen@ils-inc.com.</Affiliation>
      </Author>
      <Author>
        <Name>Abigail Jacobs</Name>
        <Affiliation>Center for Drug Evaluation and Research, U.S. Food and Drug Administration (FDA), White Oak Office Building 22, 10903 New Hampshire Ave., Silver Spring, MD 20993, USA. Electronic address: abbyj96210@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Joanna Matheson</Name>
        <Affiliation>U.S. Consumer Product Safety Commission, 5 Research Place, Rockville, MD 20850, USA. Electronic address: jmatheson@cpsc.gov.</Affiliation>
      </Author>
      <Author>
        <Name>Anna Lowit</Name>
        <Affiliation>Office of Pesticide Programs, U.S. Environmental Protection Agency, 1200 Pennsylvania Ave, NW, Washington, DC 20460, USA. Electronic address: lowit.anna@epa.gov.</Affiliation>
      </Author>
      <Author>
        <Name>Emily N. Reinke</Name>
        <Affiliation>U.S. Army Public Health Center, 5158 Blackhawk Rd., Aberdeen Proving Ground, MD 21010, USA. Electronic address: Emily.n.reinke.civ@mail.mil.</Affiliation>
      </Author>
      <Author>
        <Name>Mark S. Johnson</Name>
        <Affiliation>U.S. Army Public Health Center, 5158 Blackhawk Rd., Aberdeen Proving Ground, MD 21010, USA. Electronic address: mark.s.johnson.civ@mail.mil.</Affiliation>
      </Author>
      <Author>
        <Name>Michael J. Quinn</Name>
        <Affiliation>U.S. Army Public Health Center, 5158 Blackhawk Rd., Aberdeen Proving Ground, MD 21010, USA. Electronic address: michael.j.quinn104.civ@mail.mil.</Affiliation>
      </Author>
      <Author>
        <Name>David Mattie</Name>
        <Affiliation>U.S. Air Force, Air Force Research Laboratory, AFRL/711 HPW RHDJ, 711 Human Performance Wing, Wright-Patterson Air Force Base, OH 45433, USA. Electronic address: david.mattie@us.af.mil.</Affiliation>
      </Author>
      <Author>
        <Name>Suzanne C. Fitzpatrick</Name>
        <Affiliation>Center for Food Safety and Applied Nutrition, FDA, Harvey W. Wiley Building, 5100 Paint Branch Parkway, College Park, MD 20740, USA. Electronic address: Suzanne.fitzpatrick@fda.hhs.gov.</Affiliation>
      </Author>
      <Author>
        <Name>Surender Ahir</Name>
        <Affiliation>U.S. Occupational Safety and Health Administration, 200 Constitution Ave. NW, Washington, DC 20210, USA. Electronic address: ahir.surender@dol.gov.</Affiliation>
      </Author>
      <Author>
        <Name>Nicole Kleinstreuer</Name>
        <Affiliation>National Toxicology Program Interagency Center for the Evaluation of Alternative Toxicological Methods, National Institute of Environmental Health Sciences, P.O. Box 12233, Research Triangle Park, NC 27709, USA. Electronic address: nicole.kleinstreuer@nih.gov.</Affiliation>
      </Author>
      <Author>
        <Name>Warren Casey</Name>
        <Affiliation>National Toxicology Program Interagency Center for the Evaluation of Alternative Toxicological Methods, National Institute of Environmental Health Sciences, P.O. Box 12233, Research Triangle Park, NC 27709, USA. Electronic address: warren.casey@nih.gov.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Potential impurities in drug substances: Compound-specific toxicology limits for 20 synthetic reagents and by-products, and a class-specific toxicology limit for alkyl bromides.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29408293</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30046-1</DOI>
    <KeywordList>
      <Keywords>Acceptable intake (AI)</Keywords>
      <Keywords>Class-specific limit</Keywords>
      <Keywords>Compound-specific limit</Keywords>
      <Keywords>Drug substance</Keywords>
      <Keywords>Impurities</Keywords>
      <Keywords>Monofunctional alkyl bromides</Keywords>
      <Keywords>Permissible daily exposure (PDE)</Keywords>
      <Keywords>Threshold of toxicological concern (TTC)</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>J. P. Bercu</Name>
        <Affiliation>Gilead Sciences, 333 Lakeside Drive, Foster City, CA, USA. Electronic address: jbercu@gilead.com.</Affiliation>
      </Author>
      <Author>
        <Name>S. M. Galloway</Name>
        <Affiliation>MRL, Merck &amp; Co., Inc., W 45-316, West Point, PA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>P. Parris</Name>
        <Affiliation>AstraZeneca, Drug Safety and Metabolism, Innovative Medicines and Early Development, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>A. Teasdale</Name>
        <Affiliation>AstraZeneca, Silk Road Business Park, Macclesfield, Cheshire, SK10 2NX, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>M. Masuda-Herrera</Name>
        <Affiliation>Gilead Sciences, 333 Lakeside Drive, Foster City, CA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>K. Dobo</Name>
        <Affiliation>Pfizer Worldwide Research and Development, Genetic Toxicology, Eastern Point Road, Groton, CT, USA.</Affiliation>
      </Author>
      <Author>
        <Name>P. Heard</Name>
        <Affiliation>Pfizer Worldwide Research and Development, Genetic Toxicology, Eastern Point Road, Groton, CT, USA.</Affiliation>
      </Author>
      <Author>
        <Name>M. Kenyon</Name>
        <Affiliation>Pfizer Worldwide Research and Development, Genetic Toxicology, Eastern Point Road, Groton, CT, USA.</Affiliation>
      </Author>
      <Author>
        <Name>J. Nicolette</Name>
        <Affiliation>AbbVie, Inc., 1 North Waukegan Road, North Chicago, IL, USA.</Affiliation>
      </Author>
      <Author>
        <Name>E. Vock</Name>
        <Affiliation>Boehringer Ingelheim Pharma GmbH &amp; Co. KG, Birkendorfer Str., 88397 Biberach, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>W. Ku</Name>
        <Affiliation>Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, USA.</Affiliation>
      </Author>
      <Author>
        <Name>J. Harvey</Name>
        <Affiliation>GlaxoSmithKline R&amp;D, Park Road, Ware, Hertfordshire, SG12 0DP, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>A. White</Name>
        <Affiliation>GlaxoSmithKline R&amp;D, Park Road, Ware, Hertfordshire, SG12 0DP, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>S. Glowienke</Name>
        <Affiliation>Novartis AG, NIBR, Klybeckstrasse, CH-4057 Basel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>E. A. Martin</Name>
        <Affiliation>AstraZeneca, Drug Safety and Metabolism, Innovative Medicines and Early Development, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>L. Custer</Name>
        <Affiliation>Bristol-Myers Squibb, 1 Squibb Dr, New Brunswick, NJ, USA.</Affiliation>
      </Author>
      <Author>
        <Name>R. A. Jolly</Name>
        <Affiliation>Eli Lilly and Company, Indianapolis, IN, USA.</Affiliation>
      </Author>
      <Author>
        <Name>V. Thybaud</Name>
        <Affiliation>Sanofi, Vitry-sur-Seine, France.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Providing context for phosphatidylethanol as a biomarker of alcohol consumption with a pharmacokinetic model.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29408287</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30045-X</DOI>
    <KeywordList>
      <Keywords>Alcohol consumption</Keywords>
      <Keywords>Blood alcohol concentration</Keywords>
      <Keywords>PEth 16:0/18:1</Keywords>
      <Keywords>Pharmacokinetics</Keywords>
      <Keywords>Phosphatidylethanol</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Ted W. Simon</Name>
        <Affiliation>Ted Simon, LLC, 4184 Johnston Road, Winston, GA, 30187, USA. Electronic address: ted@tedsimon-toxicology.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Toxicological evaluation of 3'-sialyllactose sodium salt.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29407203</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30036-9</DOI>
    <KeywordList>
      <Keywords>3′-sialyllactose sodium salt</Keywords>
      <Keywords>Acute toxicity</Keywords>
      <Keywords>Clastogenicity</Keywords>
      <Keywords>Human milk oligosaccharides</Keywords>
      <Keywords>Mutagenicity</Keywords>
      <Keywords>Subchronic toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Daehee Kim</Name>
        <Affiliation>GeneChem Inc., Daejeon, Republic of Korea. Electronic address: daeheekim@genechem.co.kr.</Affiliation>
      </Author>
      <Author>
        <Name>Rit Bahadur Gurung</Name>
        <Affiliation>GeneChem Inc., Daejeon, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Wonmin Seo</Name>
        <Affiliation>GeneChem Inc., Daejeon, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Albert W. Lee</Name>
        <Affiliation>NutraSource, Clarksville, MD, 21029, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jinsuk Woo</Name>
        <Affiliation>GeneChem Inc., Daejeon, Republic of Korea.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A comparison of fish pesticide metabolic pathways with those of the rat and goat.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29407202</pubmedLink>
    <GrantList>
      <Grant>EPA999999</Grant>
    </GrantList>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30035-7</DOI>
    <KeywordList>
      <Keywords>Biotransformation</Keywords>
      <Keywords>Bluegill sunfish</Keywords>
      <Keywords>Goat</Keywords>
      <Keywords>MetaPath</Keywords>
      <Keywords>Metabolic map</Keywords>
      <Keywords>Metabolism</Keywords>
      <Keywords>Rainbow trout</Keywords>
      <Keywords>Rat</Keywords>
      <Keywords>Risk assessment</Keywords>
      <Keywords>Species extrapolation</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Richard C. Kolanczyk</Name>
        <Affiliation>US Environmental Protection Agency, Office of Research and Development, National Health and Environmental Effects Research Laboratory, Mid-Continent Ecology Division, 6201 Congdon Boulevard, Duluth, MN 55804, USA. Electronic address: kolanczyk.rick@epa.gov.</Affiliation>
      </Author>
      <Author>
        <Name>Jose A. Serrano</Name>
        <Affiliation>US Environmental Protection Agency, Office of Research and Development, National Health and Environmental Effects Research Laboratory, Mid-Continent Ecology Division, 6201 Congdon Boulevard, Duluth, MN 55804, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Mark A. Tapper</Name>
        <Affiliation>US Environmental Protection Agency, Office of Research and Development, National Health and Environmental Effects Research Laboratory, Mid-Continent Ecology Division, 6201 Congdon Boulevard, Duluth, MN 55804, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Patricia K. Schmieder</Name>
        <Affiliation>US Environmental Protection Agency, Office of Research and Development, National Health and Environmental Effects Research Laboratory, Mid-Continent Ecology Division, 6201 Congdon Boulevard, Duluth, MN 55804, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Repeated dose 28-day oral toxicity study of a botanical composition composed of Morus alba and Acacia catechu in rats.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29407201</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30040-0</DOI>
    <KeywordList>
      <Keywords>Acacia catechu</Keywords>
      <Keywords>Morus alba</Keywords>
      <Keywords>Rats</Keywords>
      <Keywords>Safety</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Mesfin Yimam</Name>
        <Affiliation>Unigen Inc., 3005 1st Ave., Seattle, WA 98121, USA. Electronic address: myimam@unigen.net.</Affiliation>
      </Author>
      <Author>
        <Name>Ping Jiao</Name>
        <Affiliation>Unigen Inc., 3005 1st Ave., Seattle, WA 98121, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Mei Hong</Name>
        <Affiliation>Unigen Inc., 3005 1st Ave., Seattle, WA 98121, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Lidia Brownell</Name>
        <Affiliation>Unigen Inc., 3005 1st Ave., Seattle, WA 98121, USA.</Affiliation>
      </Author>
      <Author>
        <Name> Hyun-Jin Kim</Name>
        <Affiliation>Unigen Inc., #450-86, Maebong-Ro, Dongnam-Gu, Cheonan-Si, Chungnam 330-863, South Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Young Chul Lee</Name>
        <Affiliation>Unigen Inc., #450-86, Maebong-Ro, Dongnam-Gu, Cheonan-Si, Chungnam 330-863, South Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Qi Jia</Name>
        <Affiliation>Unigen Inc., 3005 1st Ave., Seattle, WA 98121, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Interplay of gender, age and drug properties on reporting frequency of drug-induced liver injury.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29407200</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30034-5</DOI>
    <KeywordList>
      <Keywords>Drug property</Keywords>
      <Keywords>Drug-induced liver injury</Keywords>
      <Keywords>Gender differences</Keywords>
      <Keywords>Hepatotoxicity</Keywords>
      <Keywords>Liver events, and pharmacovigilance</Keywords>
      <Keywords>Spontaneous adverse event reporting system</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Nayana George</Name>
        <Affiliation>Department of Medicine, University of Arkansas for Medical Sciences, Little Rock, AR, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Minjun Chen</Name>
        <Affiliation>Division of Bioinformatics and Biostatistics, The FDA's National Center for Toxicological Research, Jefferson, AR, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Nancy Yuen</Name>
        <Affiliation>Global Patient Safety, UCB BioSciences Inc., Raleigh, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Christine M. Hunt</Name>
        <Affiliation>Department of Medicine, Duke University, Durham, NC, USA; Department of Medicine, Durham VA Medical Center, Durham, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Ayako Suzuki</Name>
        <Affiliation>Department of Medicine, Duke University, Durham, NC, USA; Department of Medicine, Durham VA Medical Center, Durham, NC, USA. Electronic address: ayako.suzuki@duke.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Assessing the safety of an Ephedrae Herba aqueous extract in rats: A repeat dose toxicity study.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29407176</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30043-6</DOI>
    <KeywordList>
      <Keywords>Ephedrae Herba</Keywords>
      <Keywords>F344 rats</Keywords>
      <Keywords>NOAEL</Keywords>
      <Keywords>Repeated dose toxicity</Keywords>
      <Keywords>Safety assessment</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Hyoung Yun Han</Name>
        <Affiliation>Department of Predictive Toxicology, Korea Institute Toxicology, 141 Gajeong-ro, Yuseong-gu, Daejeon, 34114, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Jung Im Huh</Name>
        <Affiliation>Department of Toxicological Evaluation and Research, Korea Institute Toxicology, 141 Gajeong-ro, Yuseong-gu, Daejeon, 34114, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>So Ri Han</Name>
        <Affiliation>Department of Toxicological Evaluation and Research, Korea Institute Toxicology, 141 Gajeong-ro, Yuseong-gu, Daejeon, 34114, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Myung Gyun Kang</Name>
        <Affiliation>Department of Predictive Toxicology, Korea Institute Toxicology, 141 Gajeong-ro, Yuseong-gu, Daejeon, 34114, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Seokjoo Yoon</Name>
        <Affiliation>Department of Predictive Toxicology, Korea Institute Toxicology, 141 Gajeong-ro, Yuseong-gu, Daejeon, 34114, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Ji Seok Han</Name>
        <Affiliation>Department of Toxicological Evaluation and Research, Korea Institute Toxicology, 141 Gajeong-ro, Yuseong-gu, Daejeon, 34114, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Byoung Seok Lee</Name>
        <Affiliation>Department of Toxicological Evaluation and Research, Korea Institute Toxicology, 141 Gajeong-ro, Yuseong-gu, Daejeon, 34114, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Jeong Ah Kim</Name>
        <Affiliation>College of Pharmacy, Research Institute of Pharmaceutical Sciences, Kyungpook National University, 80 Daehak-ro, Bukgu, Daegu, 41566, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Byung Sun Min</Name>
        <Affiliation>College of Pharmacy, Catholic University of Daegu, 13-13 Hayang-ro, Hayang-eup, Gyeongsan-si, Gyeongsangbuk-do, 38430, Republic of Korea. Electronic address: bsmin@cu.ac.kr.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Letter to the editor: "Evaulation of radioisotopic and non-radioisotopic versions of local lymph node assays for subcategorization of skin sensitiers compliant to UN GHS rev 4" by Ha et al., 2017.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29398199</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30007-2</DOI>
    <KeywordList>
      <Keywords>LLNA</Keywords>
      <Keywords>Non-radioactive variants</Keywords>
      <Keywords>Performance standards</Keywords>
      <Keywords>Validation</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Susanne Noreen Kolle</Name>
        <Affiliation>BASF SE, Experimental Toxicology and Ecology, Ludwigshafen, Germany. Electronic address: susanne.kolle@basf.com.</Affiliation>
      </Author>
      <Author>
        <Name>Robert Landsiedel</Name>
        <Affiliation>BASF SE, Experimental Toxicology and Ecology, Ludwigshafen, Germany.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Food and feed safety of DAS-444Ø6-6 herbicide-tolerant soybean.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29366656</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30032-1</DOI>
    <KeywordList>
      <Keywords>AAD-12</Keywords>
      <Keywords>DAS-444Ø6-6</Keywords>
      <Keywords>Feed</Keywords>
      <Keywords>Food</Keywords>
      <Keywords>Risk</Keywords>
      <Keywords>Safety</Keywords>
      <Keywords>Soybean</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Rod A. Herman</Name>
        <Affiliation>Dow AgroSciences LLC, 9330 Zionsville Road, Indianapolis, IN, 46268, USA. Electronic address: raherman@dow.com.</Affiliation>
      </Author>
      <Author>
        <Name>Ricardo D. Ekmay</Name>
        <Affiliation>Dow AgroSciences LLC, 9330 Zionsville Road, Indianapolis, IN, 46268, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Barry W. Schafer</Name>
        <Affiliation>Dow AgroSciences LLC, 9330 Zionsville Road, Indianapolis, IN, 46268, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Ping Song</Name>
        <Affiliation>Dow AgroSciences LLC, 9330 Zionsville Road, Indianapolis, IN, 46268, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Brandon J. Fast</Name>
        <Affiliation>Dow AgroSciences LLC, 9330 Zionsville Road, Indianapolis, IN, 46268, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Sabitha Papineni</Name>
        <Affiliation>Dow AgroSciences LLC, 9330 Zionsville Road, Indianapolis, IN, 46268, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Guomin Shan</Name>
        <Affiliation>Dow AgroSciences LLC, 9330 Zionsville Road, Indianapolis, IN, 46268, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Daland R. Juberg</Name>
        <Affiliation>Dow AgroSciences LLC, 9330 Zionsville Road, Indianapolis, IN, 46268, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Toxicity assessment of the extractables from multi-layer coextrusion poly ethylene bags exposed to pH=5 solution containing 4% benzyl alcohol and 0.1 M sodium acetate.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29360483</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30031-X</DOI>
    <KeywordList>
      <Keywords>Extractables</Keywords>
      <Keywords>Multi-layer coextrusion poly ethylene bag</Keywords>
      <Keywords>Risk assessment</Keywords>
      <Keywords>UPLC-Q-TOF MS</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jingcong Zhuang</Name>
        <Affiliation>College of Science, Beijing University of Chemical Technology, Beijing 100029, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xuebin Xing</Name>
        <Affiliation>College of Science, Beijing University of Chemical Technology, Beijing 100029, China.</Affiliation>
      </Author>
      <Author>
        <Name>Di Wang</Name>
        <Affiliation>College of Science, Beijing University of Chemical Technology, Beijing 100029, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhenxia Du</Name>
        <Affiliation>College of Science, Beijing University of Chemical Technology, Beijing 100029, China; Beijing Key Laboratory of Environmentally Harmful Chemical Analysis, Beijing University of Chemical Technology, Beijing 100029, China. Electronic address: duzx@mail.buct.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Jianfeng Wang</Name>
        <Affiliation>College of Science, Beijing University of Chemical Technology, Beijing 100029, China; Beijing Engineering Research Center of Food Safety Analysis, Beijing Centre for Physical and Chemical Analysis, Beijing 100089, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yan Dong</Name>
        <Affiliation>Shanghai LePure Biotechnology Company Limited, Shanghai 201600, China.</Affiliation>
      </Author>
      <Author>
        <Name>Wenlian Yu</Name>
        <Affiliation>Chinese Academy of Inspection and Quarantine, Beijing, China.</Affiliation>
      </Author>
      <Author>
        <Name>Sajid Hussain Siyal</Name>
        <Affiliation>State Key Laboratory of Organic-Inorganic Composite, Beijing University of Chemical Technology, Beijing, 100029, China.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Biomonitoring Equivalents for interpretation of urinary iodine.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29360482</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30033-3</DOI>
    <KeywordList>
      <Keywords>Biomonitoring Equivalents</Keywords>
      <Keywords>Biomonitoring risk assessment</Keywords>
      <Keywords>Exposure assessment</Keywords>
      <Keywords>Iodine</Keywords>
      <Keywords>Nutrition</Keywords>
      <Keywords>Toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Sean M. Hays</Name>
        <Affiliation>Summit Toxicology, L.L.P, Bozeman, MT, United States; Summit Toxicology, L.L.P., Falls Church, VA, United States. Electronic address: shays@summittoxicology.com.</Affiliation>
      </Author>
      <Author>
        <Name>Devika Poddalgoda</Name>
        <Affiliation>Health Canada, Ottawa, ON, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Kristin Macey</Name>
        <Affiliation>Health Canada, Ottawa, ON, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Lesa Aylward</Name>
        <Affiliation>Summit Toxicology, L.L.P., Falls Church, VA, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Andy Nong</Name>
        <Affiliation>Health Canada, Ottawa, ON, Canada.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Biotherapeutics in non-clinical development: Strengthening the interface between safety, pharmacokinetics-pharmacodynamics and manufacturing.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29355662</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30025-4</DOI>
    <KeywordList>
      <Keywords>Biotherapeutics</Keywords>
      <Keywords>Cross-reactive species</Keywords>
      <Keywords>Gene and cell therapy</Keywords>
      <Keywords>Immunogenicity</Keywords>
      <Keywords>Non-clinical safety</Keywords>
      <Keywords>Pharmacokinetics</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Peter Ulrich</Name>
        <Affiliation>Novartis Pharma, Basel, Switzerland. Electronic address: peter.ulrich@novartis.com.</Affiliation>
      </Author>
      <Author>
        <Name>Guenter Blaich</Name>
        <Affiliation>AbbVie GmbH, Ludwigshafen, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Andreas Baumann</Name>
        <Affiliation>Bayer AG, Berlin, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Rajni Fagg</Name>
        <Affiliation>GSK, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Adam Hey</Name>
        <Affiliation>Novartis Pharma, Basel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Andrea Kiessling</Name>
        <Affiliation>UCB Celltech, Slough, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Sven Kronenberg</Name>
        <Affiliation>Roche Pharmaceutical Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center, Basel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Rikke Hvid Lindecrona</Name>
        <Affiliation>Novo Nordisk, Denmark.</Affiliation>
      </Author>
      <Author>
        <Name>Silke Mohl</Name>
        <Affiliation>Roche Pharmaceutical Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center, Basel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Wolfgang F. Richter</Name>
        <Affiliation>Roche Pharmaceutical Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center, Basel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Jay Tibbitts</Name>
        <Affiliation>UCB Celltech, Slough, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Flavio Crameri</Name>
        <Affiliation>Roche Pharmaceutical Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center, Basel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Lucinda Weir</Name>
        <Affiliation>GSK, UK.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Response to Letter to the Editor on our paper "Evaluation of radioisotopic and non-radioisotopic versions of local lymph node assays for subcategorization of skin sensitizers compliant to UN GHS rev 4" by Ha et al. (Submitted 25 Jun 2017).</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29355661</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30016-3</DOI>
    <AuthorList>
      <Author>
        <Name>Lim Kyung-Min</Name>
        <Affiliation>College of Pharmacy, Ewha Womans University, Seoul, Republic of Korea. Electronic address: kmlim@ewha.ac.kr.</Affiliation>
      </Author>
      <Author>
        <Name>SeungJin Bae</Name>
        <Affiliation>College of Pharmacy, Ewha Womans University, Seoul, Republic of Korea. Electronic address: sjbae@ewha.ac.kr.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Antinociception of the spirocyclopiperazinium salt compound LXM-15 via activating α7 nAChR and M4 mAChR and inhibiting CaMKIIα/cAMP/CREB/CGRP signalling pathway in mice.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29353067</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30024-2</DOI>
    <KeywordList>
      <Keywords>Antinociception</Keywords>
      <Keywords>CaMKIIα/cAMP/CREB/CGRP signalling pathway</Keywords>
      <Keywords>LXM-15</Keywords>
      <Keywords>M4 muscarine acetylcholine receptor</Keywords>
      <Keywords>Spirocyclopiperazinium salt compound</Keywords>
      <Keywords>α7 nicotinic acetylcholine receptor</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Hua Yang</Name>
        <Affiliation>Department of Molecular and Cellular Pharmacology, School of Pharmaceutical Sciences, Peking University, Beijing, China.</Affiliation>
      </Author>
      <Author>
        <Name>Qi Sun</Name>
        <Affiliation>Department of Chemical Biology, School of Pharmaceutical Sciences, Peking University, Beijing, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yingying Liang</Name>
        <Affiliation>Department of Molecular and Cellular Pharmacology, School of Pharmaceutical Sciences, Peking University, Beijing, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yimin Jiang</Name>
        <Affiliation>Center of Medical and Health Analysis, Peking University, Beijing, China.</Affiliation>
      </Author>
      <Author>
        <Name>Runtao Li</Name>
        <Affiliation>Department of Chemical Biology, School of Pharmaceutical Sciences, Peking University, Beijing, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jia Ye</Name>
        <Affiliation>Department of Molecular and Cellular Pharmacology, School of Pharmaceutical Sciences, Peking University, Beijing, China. Electronic address: yejia@bjmu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Azodicarbonamide (ADCA): A reconsideration of classification as a respiratory sensitiser.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29353066</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30023-0</DOI>
    <AuthorList>
      <Author>
        <Name>Josje Arts</Name>
        <Affiliation>AkzoNobel NV, Velperweg 76, Arnhem 6824 BM, The Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Ian Kimber</Name>
        <Affiliation>Faculty of Biology, Medicine and Health, University of Manchester, Oxford Road, Manchester M13 9PT, UK. Electronic address: ian.kimber@manchester.ac.uk.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Absence of toxicity in Swiss mice following treatment with 7-acetoxy-4-aryl-3,4-dihydrocoumarin: Acute and repeated-dose toxicity study.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29339246</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30003-5</DOI>
    <KeywordList>
      <Keywords>7-acetoxy-4-aryl-3,4-dihydrocoumarin</Keywords>
      <Keywords>Acute toxicity</Keywords>
      <Keywords>Neoflavonoids</Keywords>
      <Keywords>Repeated-dose toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Gláucio Barros Saldanha</Name>
        <Affiliation>Institute of Chemistry, Federal University of Bahia, Salvador, Bahia, 40170-280, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Glaucia Barros Saldanha</Name>
        <Affiliation>Institute of Chemistry, Federal University of Bahia, Salvador, Bahia, 40170-280, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Marina Rebeca Soares Carneiro de Sousa</Name>
        <Affiliation>Department of Veterinary Morphophysiology, Federal University of Piaui, School of Agrarians Sciences, Teresina, Piauí, 64049-550, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>George Laylson da Silva Oliveira</Name>
        <Affiliation>Department of Pharmacy, Federal University of Piauí, Teresina, Piauí, 64049-550, Brazil; Department of Biology, Center for Higher Studies of Coelho Neto, State University of Maranhão, Coelho Neto, Maranhão, 65.620-000, Brazil. Electronic address: georggeoliveira@outlook.com.</Affiliation>
      </Author>
      <Author>
        <Name>Ana Paula Dos Santos C. L. da Silva</Name>
        <Affiliation>Department of Pharmacy, Federal University of Piauí, Teresina, Piauí, 64049-550, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Jorge M. David</Name>
        <Affiliation>Institute of Chemistry, Federal University of Bahia, Salvador, Bahia, 40170-280, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Juceni Pereira David</Name>
        <Affiliation>Institute of Chemistry, Federal University of Bahia, Salvador, Bahia, 40170-280, Brazil.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Systematic review and evaluation of aspartame carcinogenicity bioassays using quality criteria.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29339245</pubmedLink>
    <Year>2019</Year>
    <DOI>S0273-2300(18)30009-6</DOI>
    <KeywordList>
      <Keywords>Aspartame</Keywords>
      <Keywords>Bioassays</Keywords>
      <Keywords>Cancer</Keywords>
      <Keywords>Klimisch rating</Keywords>
      <Keywords>Quality appraisal</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Lois Haighton</Name>
        <Affiliation>Intertek Regulatory &amp; Scientific Consultancy, 2233 Argentia Rd., Suite 201, Mississauga, ON, L5N 2X7, Canada. Electronic address: lois.haighton@intertek.com.</Affiliation>
      </Author>
      <Author>
        <Name>Ashley Roberts</Name>
        <Affiliation>Intertek Regulatory &amp; Scientific Consultancy, 2233 Argentia Rd., Suite 201, Mississauga, ON, L5N 2X7, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Brandon Walters</Name>
        <Affiliation>Intertek Regulatory &amp; Scientific Consultancy, 2233 Argentia Rd., Suite 201, Mississauga, ON, L5N 2X7, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Barry Lynch</Name>
        <Affiliation>Intertek Regulatory &amp; Scientific Consultancy, 2233 Argentia Rd., Suite 201, Mississauga, ON, L5N 2X7, Canada.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Combining machine learning models of in vitro and in vivo bioassays improves rat carcinogenicity prediction.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29337192</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30008-4</DOI>
    <KeywordList>
      <Keywords>Assay</Keywords>
      <Keywords>Cancer</Keywords>
      <Keywords>Carcinogenicity</Keywords>
      <Keywords>Cheminformatics</Keywords>
      <Keywords>Machine learning</Keywords>
      <Keywords>Prediction</Keywords>
      <Keywords>QSAR</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Davy Guan</Name>
        <Affiliation>Sydney Medical School, The University of Sydney, Australia.</Affiliation>
      </Author>
      <Author>
        <Name>Kevin Fan</Name>
        <Affiliation>Sydney Medical School, The University of Sydney, Australia.</Affiliation>
      </Author>
      <Author>
        <Name>Ian Spence</Name>
        <Affiliation>Sydney Medical School, The University of Sydney, Australia.</Affiliation>
      </Author>
      <Author>
        <Name>Slade Matthews</Name>
        <Affiliation>Sydney Medical School, The University of Sydney, Australia. Electronic address: slade.matthews@sydney.edu.au.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The classification of azodicarbonamide (ADCA) as a respiratory sensitiser; adding to the weight of evidence.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29337191</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30006-0</DOI>
    <AuthorList>
      <Author>
        <Name>Hille Suojalehto</Name>
        <Affiliation>Occupational Medicine, Finnish Institute of Occupational Health, P.O Box 40, FI-00032 Työterveyslaitos, Helsinki, Finland. Electronic address: hille.suojalehto@ttl.fi.</Affiliation>
      </Author>
      <Author>
        <Name>Jean Luc Malo</Name>
        <Affiliation>Dept of Chest Medicine, Sacré-Coeur Hospital, 5400 West Gouin Blvd, Montréal H4J 1C5, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Paul Cullinan</Name>
        <Affiliation>Dept Occupational and Environmental Medicine, Royal Brompton Hospital, London, UK.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Analysis of refuse-to-file policy for generic drug application in Taiwan.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29329941</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30004-7</DOI>
    <KeywordList>
      <Keywords>Administrative information</Keywords>
      <Keywords>Bioequivalence</Keywords>
      <Keywords>Chemistry</Keywords>
      <Keywords>Comparative dissolution profile</Keywords>
      <Keywords>Generic drug application</Keywords>
      <Keywords>Manufacturing and controls</Keywords>
      <Keywords>Refuse-to-file</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>I. Chen Sun</Name>
        <Affiliation>Division of Pharmaceutical Science, Center for Drug Evaluation, Taipei, Taiwan, ROC; School of Pharmacy, National Defense Medical Center, Taipei, Taiwan, ROC. Electronic address: icsun@cde.org.tw.</Affiliation>
      </Author>
      <Author>
        <Name>Churn Shiouh Gau</Name>
        <Affiliation>Office of Executive Director, Center for Drug Evaluation, Taipei, Taiwan, ROC; School of Pharmacy, National Taiwan University, Taipei, Taiwan, ROC.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Evaluation of 30% DAS-444Ø6-6 soybean meal in a subchronic rat toxicity study.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29317244</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30005-9</DOI>
    <KeywordList>
      <Keywords>90-Day rat</Keywords>
      <Keywords>Aryloxyalkanoate dioxygenase</Keywords>
      <Keywords>DAS-444Ø6-6</Keywords>
      <Keywords>Genetically-modified soybean</Keywords>
      <Keywords>Herbicide tolerant</Keywords>
      <Keywords>Subchronic rat</Keywords>
      <Keywords>Transgenic soybean</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Sabitha Papineni</Name>
        <Affiliation>Dow AgroSciences LLC, Indianapolis, IN, 46268, USA. Electronic address: SPapineni@dow.com.</Affiliation>
      </Author>
      <Author>
        <Name>Julie K. Passage</Name>
        <Affiliation>Toxicology and Environmental Research and Consulting, The Dow Chemical Company, Midland, MI, 48674, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Ricardo D. Ekmay</Name>
        <Affiliation>Dow AgroSciences LLC, Indianapolis, IN, 46268, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Johnson Thomas</Name>
        <Affiliation>Toxicology and Environmental Research and Consulting, The Dow Chemical Company, Midland, MI, 48674, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>An evaluation of the fixed concentration procedure for assessment of acute inhalation toxicity.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29309809</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30001-1</DOI>
    <KeywordList>
      <Keywords>3Rs</Keywords>
      <Keywords>Acute inhalation studies</Keywords>
      <Keywords>Evident toxicity</Keywords>
      <Keywords>Fixed concentration procedure (FCP)</Keywords>
      <Keywords>Refinement</Keywords>
      <Keywords>Regulatory toxicology</Keywords>
      <Keywords>TG403</Keywords>
      <Keywords>TG433</Keywords>
      <Keywords>TG436</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Fiona Sewell</Name>
        <Affiliation>National Centre for the Replacement, Refinement &amp; Reduction of Animals in Research (NC3Rs), UK. Electronic address: Fiona.Sewell@nc3rs.org.uk.</Affiliation>
      </Author>
      <Author>
        <Name>Ian Ragan</Name>
        <Affiliation>Board Member, NC3Rs, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Ian Indans</Name>
        <Affiliation>Health and Safety Executive, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Tim Marczylo</Name>
        <Affiliation>Public Heath England, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Nigel Stallard</Name>
        <Affiliation>University of Warwick, UK.</Affiliation>
      </Author>
      <Author>
        <Name>David Griffiths</Name>
        <Affiliation>Envigo, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Thomas Holmes</Name>
        <Affiliation>Exponent International Ltd., UK.</Affiliation>
      </Author>
      <Author>
        <Name>Paul Smith</Name>
        <Affiliation>Charles River Laboratories Edinburgh Ltd., UK.</Affiliation>
      </Author>
      <Author>
        <Name>Graham Horgan</Name>
        <Affiliation>Biomathematics &amp; Statistics Scotland (BioSS), UK.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Quantitative analysis of menthol and identification of other flavoring ingredients in capsule cigarettes marketed in Korea.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29309808</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(18)30002-3</DOI>
    <KeywordList>
      <Keywords>Capsule</Keywords>
      <Keywords>Cigarette</Keywords>
      <Keywords>Flavoring</Keywords>
      <Keywords>Menthol</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Hyung Soo Kim</Name>
        <Affiliation>Department of Public Health Sciences, Graduate School, Korea University, Seoul, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Eun Chul Pack</Name>
        <Affiliation>Department of Public Health Sciences, Graduate School, Korea University, Seoul, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Ye Ji Koo</Name>
        <Affiliation>Department of Public Health Sciences, Graduate School, Korea University, Seoul, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Ye Jin Lee</Name>
        <Affiliation>Department of Public Health Sciences, Graduate School, Korea University, Seoul, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Dae Kwan Sung</Name>
        <Affiliation>Department of Public Health Sciences, Graduate School, Korea University, Seoul, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Seung Ha Lee</Name>
        <Affiliation>Department of Public Health Sciences, Graduate School, Korea University, Seoul, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Young Soon Kim</Name>
        <Affiliation>School of Biosystem and Biomedical Science, Korea University, Seoul, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Kyeng Hee Kwon</Name>
        <Affiliation>College of Pharmacy, Dongguk University, Goyang, Gyeonggi-do, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Kyung Min Lim</Name>
        <Affiliation>College of Pharmacy, Ewha Womans University, Seoul, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Dae Yong Jang</Name>
        <Affiliation>Department of Public Health Sciences, Graduate School, Korea University, Seoul, Republic of Korea. Electronic address: dyjang0803@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Dal Woong Choi</Name>
        <Affiliation>Department of Public Health Sciences, Graduate School, Korea University, Seoul, Republic of Korea. Electronic address: dwlove@korea.ac.kr.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Structure activity relationship (SAR) toxicological assessments: The role of expert judgment.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29305951</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(17)30413-0</DOI>
    <KeywordList>
      <Keywords>Analog rating</Keywords>
      <Keywords>Expert judgement</Keywords>
      <Keywords>Read-across</Keywords>
      <Keywords>Similarity</Keywords>
      <Keywords>Structure activity relationship (SAR)</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Cathy Lester</Name>
        <Affiliation>Central Product Safety Department, The Procter &amp; Gamble Company, 8700 Mason Montgomery Rd., Mason, OH 45040, USA. Electronic address: lester.cc@pg.com.</Affiliation>
      </Author>
      <Author>
        <Name>Allison Reis</Name>
        <Affiliation>Central Product Safety Department, The Procter &amp; Gamble Company, 8700 Mason Montgomery Rd., Mason, OH 45040, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Michael Laufersweiler</Name>
        <Affiliation>Central Product Safety Department, The Procter &amp; Gamble Company, 8700 Mason Montgomery Rd., Mason, OH 45040, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Shengde Wu</Name>
        <Affiliation>Central Product Safety Department, The Procter &amp; Gamble Company, 8700 Mason Montgomery Rd., Mason, OH 45040, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Karen Blackburn</Name>
        <Affiliation>Central Product Safety Department, The Procter &amp; Gamble Company, 8700 Mason Montgomery Rd., Mason, OH 45040, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>GHS additivity formula: can it predict the acute systemic toxicity of agrochemical formulations that contain acutely toxic ingredients?</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29305950</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(17)30411-7</DOI>
    <KeywordList>
      <Keywords>Acute toxicity</Keywords>
      <Keywords>Agrochemicals</Keywords>
      <Keywords>Formulations</Keywords>
      <Keywords>GHS additivity formula</Keywords>
      <Keywords>Mixtures</Keywords>
      <Keywords>Selection bias</Keywords>
      <Keywords>Theory of additivity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Andrew Van Cott</Name>
        <Affiliation>BASF Corporation, Research Triangle Park, NC 27709, USA. Electronic address: andrew.vancott@basf.com.</Affiliation>
      </Author>
      <Author>
        <Name>Charles E. Hastings</Name>
        <Affiliation>BASF Corporation, Research Triangle Park, NC 27709, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Robert Landsiedel</Name>
        <Affiliation>BASF SE Experimental Toxicology and Ecology, Ludwigshafen, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Susanne Kolle</Name>
        <Affiliation>BASF SE Experimental Toxicology and Ecology, Ludwigshafen, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Stefan Stinchcombe</Name>
        <Affiliation>BASF SE Experimental Toxicology and Ecology, Ludwigshafen, Germany.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Primary study on the toxic mechanism of vanadyl trehalose in Kunming mice.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29305949</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(17)30412-9</DOI>
    <KeywordList>
      <Keywords>Kunming mice</Keywords>
      <Keywords>Toxic mechanism</Keywords>
      <Keywords>Vanadium</Keywords>
      <Keywords>Vanadyl trehalose</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Pingzhe Jiang</Name>
        <Affiliation>Key Laboratory for Bioactive Materials of the Ministry of Education, Institute of Molecular Biology, College of Life Science, Nankai University, 300071, Tianjin, China; State Key Laboratory of Medicinal Chemical Biology, Nankai University, 300071, Tianjin, China.</Affiliation>
      </Author>
      <Author>
        <Name>Qiqi Liu</Name>
        <Affiliation>Key Laboratory for Bioactive Materials of the Ministry of Education, Institute of Molecular Biology, College of Life Science, Nankai University, 300071, Tianjin, China; State Key Laboratory of Medicinal Chemical Biology, Nankai University, 300071, Tianjin, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zaizhong Ni</Name>
        <Affiliation>Key Laboratory for Bioactive Materials of the Ministry of Education, Institute of Molecular Biology, College of Life Science, Nankai University, 300071, Tianjin, China; State Key Laboratory of Medicinal Chemical Biology, Nankai University, 300071, Tianjin, China.</Affiliation>
      </Author>
      <Author>
        <Name>Qian Wei</Name>
        <Affiliation>Key Laboratory for Bioactive Materials of the Ministry of Education, Institute of Molecular Biology, College of Life Science, Nankai University, 300071, Tianjin, China; State Key Laboratory of Medicinal Chemical Biology, Nankai University, 300071, Tianjin, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaodan Li</Name>
        <Affiliation>Key Laboratory for Bioactive Materials of the Ministry of Education, Institute of Molecular Biology, College of Life Science, Nankai University, 300071, Tianjin, China; State Key Laboratory of Medicinal Chemical Biology, Nankai University, 300071, Tianjin, China.</Affiliation>
      </Author>
      <Author>
        <Name>Shuguang Xing</Name>
        <Affiliation>Key Laboratory for Bioactive Materials of the Ministry of Education, Institute of Molecular Biology, College of Life Science, Nankai University, 300071, Tianjin, China; State Key Laboratory of Medicinal Chemical Biology, Nankai University, 300071, Tianjin, China.</Affiliation>
      </Author>
      <Author>
        <Name>Deling Kong</Name>
        <Affiliation>Key Laboratory for Bioactive Materials of the Ministry of Education, Institute of Molecular Biology, College of Life Science, Nankai University, 300071, Tianjin, China; State Key Laboratory of Medicinal Chemical Biology, Nankai University, 300071, Tianjin, China.</Affiliation>
      </Author>
      <Author>
        <Name>Minggang Li</Name>
        <Affiliation>Key Laboratory for Bioactive Materials of the Ministry of Education, Institute of Molecular Biology, College of Life Science, Nankai University, 300071, Tianjin, China; State Key Laboratory of Medicinal Chemical Biology, Nankai University, 300071, Tianjin, China. Electronic address: mgl@nankai.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Determination of developmental toxicity of zebrafish exposed to propyl gallate dosed lower than ADI (Acceptable Daily Intake).</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29305948</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(17)30414-2</DOI>
    <KeywordList>
      <Keywords>Antioxidant</Keywords>
      <Keywords>Apoptosis</Keywords>
      <Keywords>Developmental toxicity</Keywords>
      <Keywords>Food additives</Keywords>
      <Keywords>ROS</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Alper Baran</Name>
        <Affiliation>Atatürk University, Erzurum Vocational School, Department of Food Quality Control and Analysis, Erzurum, Turkey.</Affiliation>
      </Author>
      <Author>
        <Name>Mine Köktürk</Name>
        <Affiliation>Atatürk University, Fisheries Faculty, Aquaculture Department, Erzurum, Turkey; Atatürk University, Fisheries Faculty, Aquatic Biotechnology Laboratory, Erzurum, Turkey.</Affiliation>
      </Author>
      <Author>
        <Name>Muhammed Atamanalp</Name>
        <Affiliation>Atatürk University, Fisheries Faculty, Aquaculture Department, Erzurum, Turkey.</Affiliation>
      </Author>
      <Author>
        <Name>Saltuk Buğrahan Ceyhun</Name>
        <Affiliation>Atatürk University, Fisheries Faculty, Aquaculture Department, Erzurum, Turkey; Atatürk University, Fisheries Faculty, Aquatic Biotechnology Laboratory, Erzurum, Turkey. Electronic address: saltuk@atauni.edu.tr.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A reappraisal on metformin.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29291990</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(17)30410-5</DOI>
    <KeywordList>
      <Keywords>Alzheimer's disease</Keywords>
      <Keywords>Cancer</Keywords>
      <Keywords>Diabetes</Keywords>
      <Keywords>Metformin</Keywords>
      <Keywords>Mode of action</Keywords>
      <Keywords>Polycystic ovarian syndrome</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Tuğba Adak</Name>
        <Affiliation>Department of Pharmaceutical Toxicology, Hacettepe University, Ankara, Turkey.</Affiliation>
      </Author>
      <Author>
        <Name>Afshin Samadi</Name>
        <Affiliation>Department of Medical Biochemistry, Hacettepe University, Ankara, Turkey.</Affiliation>
      </Author>
      <Author>
        <Name>Ayşe Zeynep Ünal</Name>
        <Affiliation>Department of Pharmaceutical Toxicology, Hacettepe University, Ankara, Turkey.</Affiliation>
      </Author>
      <Author>
        <Name>Suna Sabuncuoğlu</Name>
        <Affiliation>Department of Pharmaceutical Toxicology, Hacettepe University, Ankara, Turkey. Electronic address: suna@hacettepe.edu.tr.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Treatment of β-thujaplicin counteracts di(2-ethylhexyl)phthalate (DEHP)-exposed vascular smooth muscle activation, inflammation and atherosclerosis progression.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29288721</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(17)30408-7</DOI>
    <KeywordList>
      <Keywords>DEHP</Keywords>
      <Keywords>E-selectin</Keywords>
      <Keywords>ICAM-1</Keywords>
      <Keywords>MMP-2</Keywords>
      <Keywords>MMP-9</Keywords>
      <Keywords>Plasticizer</Keywords>
      <Keywords>VCAM-1</Keywords>
      <Keywords>β-thujaplicin</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Mei Fen Shih</Name>
        <Affiliation>Department of Pharmacy, Chia-Nan University of Pharmacy and Science, Tainan, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Kuang Hung Pan</Name>
        <Affiliation>Department of Chemistry and Biochemistry, National Chung-Cheng University, Chia-Yi, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Chia Chyuan Liu</Name>
        <Affiliation>Department and Institute of Cosmetics Science, Chia-Nan University of Pharmacy and Science, Tainan, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Chia Rui Shen</Name>
        <Affiliation>Department of Medical Biotechnology &amp; Lab Sciences, Chang Gung University, Tao-Yuan, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Jong Yuh Cherng</Name>
        <Affiliation>Department of Chemistry and Biochemistry, National Chung-Cheng University, Chia-Yi, Taiwan. Electronic address: chejyc@ccu.edu.tw.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Applicability of surface sampling and calculation of surface limits for pharmaceutical drug substances for occupational health purposes.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29288720</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(17)30407-5</DOI>
    <KeywordList>
      <Keywords>Drug substance</Keywords>
      <Keywords>Occupational health</Keywords>
      <Keywords>PDE</Keywords>
      <Keywords>Surface sampling</Keywords>
      <Keywords>skin absorption</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Camille Jandard</Name>
        <Affiliation>Servier Group, Gidy, France. Electronic address: camille.jandard@servier.com.</Affiliation>
      </Author>
      <Author>
        <Name>Helena Hemming</Name>
        <Affiliation>Astra Zeneca AB, Södertälje, Sweden.</Affiliation>
      </Author>
      <Author>
        <Name>Maarten Prause</Name>
        <Affiliation>Novartis Pharma AG, Postfach, CH-4002 Basel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Claudia Sehner</Name>
        <Affiliation>Boehringer Ingelheim Pharma GmbH &amp; Co. KG, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Markus Schwind</Name>
        <Affiliation>Sanofi-Aventis Deutschland GmbH, Frankfurt am Main, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Marc Abromovitz</Name>
        <Affiliation>Novartis Pharma AG, Postfach, CH-4002 Basel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Ester Lovsin Barle</Name>
        <Affiliation>Novartis Pharma AG, Postfach, CH-4002 Basel, Switzerland.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Safety assessment of methanolic extract of Terminalia chebula fruit, Terminalia arjuna bark and its bioactive constituent 7-methyl gallic acid: In vitro and in vivo studies.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29288719</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(17)30406-3</DOI>
    <KeywordList>
      <Keywords>7-Methyl gallic acid</Keywords>
      <Keywords>Acute toxicity</Keywords>
      <Keywords>Comet assay</Keywords>
      <Keywords>Cytotoxicity</Keywords>
      <Keywords>Hemolytic activity</Keywords>
      <Keywords>Salmonella reversion assay</Keywords>
      <Keywords>Sub acute toxicity</Keywords>
      <Keywords>Terminalia arjuna</Keywords>
      <Keywords>Terminalia chebula</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>N. Suganthy</Name>
        <Affiliation>Department of Nanoscience and Technology, Alagappa University, Karaikudi, Tamil Nadu, India; Centre for Phermone Technology, Department of Animal Science, Bharadhidasan University, Triuchirappalli, Tamil Nadu, India. Electronic address: suganthyn@alagappauniversity.ac.in.</Affiliation>
      </Author>
      <Author>
        <Name>S. Muniasamy</Name>
        <Affiliation>Centre for Phermone Technology, Department of Animal Science, Bharadhidasan University, Triuchirappalli, Tamil Nadu, India; Department of Microbiology, Ayaa Nadar Janaki Ammal College, Sivakasi, Tamil Nadu, India.</Affiliation>
      </Author>
      <Author>
        <Name>G. Archunan</Name>
        <Affiliation>Centre for Phermone Technology, Department of Animal Science, Bharadhidasan University, Triuchirappalli, Tamil Nadu, India. Electronic address: archunan@bdu.ac.in.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Acute and sub-chronic toxicological studies of the iridoid glycosides extract of Lamiophlomis rotata (Benth.) Kudo in rats.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29287802</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(17)30405-1</DOI>
    <KeywordList>
      <Keywords>Acute toxicity</Keywords>
      <Keywords>Hemolytic anemia</Keywords>
      <Keywords>Iridoid glycosides</Keywords>
      <Keywords>Lamiophlomis rotata(Benth.) Kudo</Keywords>
      <Keywords>Sub-chronic toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Quanlong Zhang</Name>
        <Affiliation>School of Pharmacy, Zhejiang Chinese Medical University, Hangzhou, 310053, PR China. Electronic address: zql20161065@zcmu.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Zhujun Mao</Name>
        <Affiliation>School of Pharmacy, Zhejiang Chinese Medical University, Hangzhou, 310053, PR China; Department of Medicine, Zhejiang Academy of Traditional Chinese Medicine, Hangzhou, 310007, Zhejiang, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Qiaoyan Zhang</Name>
        <Affiliation>School of Pharmacy, Zhejiang Chinese Medical University, Hangzhou, 310053, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Jianguo Qiu</Name>
        <Affiliation>Department of Pharmacy, Lanzhou General Hospital of PLA, Lanzhou, 730050, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhengping Jia</Name>
        <Affiliation>Department of Pharmacy, Lanzhou General Hospital of PLA, Lanzhou, 730050, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Luping Qin</Name>
        <Affiliation>School of Pharmacy, Zhejiang Chinese Medical University, Hangzhou, 310053, PR China. Electronic address: qinluping@126.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Subchronic toxicity and genotoxicity studies of Antrodia mushroom β-glucan preparation.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29287801</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(17)30409-9</DOI>
    <KeywordList>
      <Keywords>Food ingredient</Keywords>
      <Keywords>Safety</Keywords>
      <Keywords>Toxicity</Keywords>
      <Keywords>β-Glucan</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>S. N. Chen</Name>
        <Affiliation>Department of Life Science, College of Science, National Taiwan University, Taipei, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>C. S. Chang</Name>
        <Affiliation>Department of Life Science, College of Science, National Taiwan University, Taipei, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>S. Chen</Name>
        <Affiliation>Glytheron Inc., 5 Holland, Unit 109, Irvine, CA 92618, USA. Electronic address: sherwin@superbetaglucan.com.</Affiliation>
      </Author>
      <Author>
        <Name>Madhu Soni</Name>
        <Affiliation>Soni and Associates Inc., 973 37th Place, Vero Beach, FL 32960, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Carcinogenicity assessment of the Hedgehog pathway inhibitor, vismodegib in Tg.rasH2 mice and Sprague-Dawley rats.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29278695</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(17)30402-6</DOI>
    <KeywordList>
      <Keywords>Carcinogenicity</Keywords>
      <Keywords>Hedgehog</Keywords>
      <Keywords>Keratoacanthoma</Keywords>
      <Keywords>Pilomatricoma</Keywords>
      <Keywords>Vismodegib</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jinze Li</Name>
        <Affiliation>Safety Assessment, Genentech Inc., 1 DNA Way, South San Francisco, CA 94080, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Eric Morinello</Name>
        <Affiliation>Safety Assessment, Genentech Inc., 1 DNA Way, South San Francisco, CA 94080, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Thomas Larsen</Name>
        <Affiliation>Pathology Department, Covance Laboratories Inc., Chantilly, VA 20151, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Denzil Frost</Name>
        <Affiliation>Pathology Department, Covance Laboratories Inc., Chantilly, VA 20151, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Ivor Caro</Name>
        <Affiliation>Clinical Sciences, Genentech Inc., 1 DNA Way, South San Francisco, CA 94080, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Stephen Gould</Name>
        <Affiliation>Translational Oncology, Genentech Inc., 1 DNA Way, South San Francisco, CA 94080, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Lisa Wong</Name>
        <Affiliation>Safety Assessment, Genentech Inc., 1 DNA Way, South San Francisco, CA 94080, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Angela Hendricks</Name>
        <Affiliation>Safety Assessment, Genentech Inc., 1 DNA Way, South San Francisco, CA 94080, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Noel Dybdal</Name>
        <Affiliation>Safety Assessment, Genentech Inc., 1 DNA Way, South San Francisco, CA 94080, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Donna Dambach</Name>
        <Affiliation>Safety Assessment, Genentech Inc., 1 DNA Way, South San Francisco, CA 94080, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Melissa Schutten</Name>
        <Affiliation>Safety Assessment, Genentech Inc., 1 DNA Way, South San Francisco, CA 94080, USA. Electronic address: schutten.melissa@gene.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Non-clinical assessment of safety and gadolinium deposition after cumulative administration of gadobenate dimeglumine (MultiHance</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29278694</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(17)30403-8</DOI>
    <KeywordList>
      <Keywords>Behavioral test</Keywords>
      <Keywords>Gadobenate dimeglumine</Keywords>
      <Keywords>Gadolinium</Keywords>
      <Keywords>Juvenile rat</Keywords>
      <Keywords>Magnetic resonance contrast agents</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Simona Bussi</Name>
        <Affiliation>Bracco Imaging Spa, Bracco Research Centre, Via Ribes 5, 10010 Colleretto Giacosa, TO, Italy. Electronic address: simona.bussi@bracco.com.</Affiliation>
      </Author>
      <Author>
        <Name>Laure Penard</Name>
        <Affiliation>Charles River, 329 Impasse du Domaine Rozier, 69210 Saint Germain-Nuelles, Lyon, France. Electronic address: laure.penard@crl.com.</Affiliation>
      </Author>
      <Author>
        <Name>Roberta Bonafè</Name>
        <Affiliation>Bracco Imaging Spa, Bracco Research Centre, Via Ribes 5, 10010 Colleretto Giacosa, TO, Italy. Electronic address: roberta.bonafe@bracco.com.</Affiliation>
      </Author>
      <Author>
        <Name>Catherine Botteron</Name>
        <Affiliation>Bracco Suisse SA, Route de la Galaise 31, 1228 Plan-les-Ouates, Genève, Switzerland. Electronic address: catherine.botteron@bracco.com.</Affiliation>
      </Author>
      <Author>
        <Name>Roberto Celeste</Name>
        <Affiliation>Bracco Imaging Spa, Bracco Research Centre, Via Ribes 5, 10010 Colleretto Giacosa, TO, Italy. Electronic address: roberto.celeste@bracco.com.</Affiliation>
      </Author>
      <Author>
        <Name>Alessandra Coppo</Name>
        <Affiliation>Bracco Imaging Spa, Bracco Research Centre, Via Ribes 5, 10010 Colleretto Giacosa, TO, Italy. Electronic address: alessandra.coppo@bracco.com.</Affiliation>
      </Author>
      <Author>
        <Name>Roberta Queliti</Name>
        <Affiliation>Bracco Imaging Spa, Bracco Research Centre, Via Ribes 5, 10010 Colleretto Giacosa, TO, Italy. Electronic address: roberta.queliti@bracco.com.</Affiliation>
      </Author>
      <Author>
        <Name>Miles A. Kirchin</Name>
        <Affiliation>Bracco Imaging Spa, Via Caduti di Marcinelle 13, 20134 Milano, Italy. Electronic address: miles.kirchin@bracco.com.</Affiliation>
      </Author>
      <Author>
        <Name>Fabio Tedoldi</Name>
        <Affiliation>Bracco Imaging Spa, Bracco Research Centre, Via Ribes 5, 10010 Colleretto Giacosa, TO, Italy. Electronic address: fabio.tedoldi@bracco.com.</Affiliation>
      </Author>
      <Author>
        <Name>Federico Maisano</Name>
        <Affiliation>Bracco Imaging Spa, Bracco Research Centre, Via Ribes 5, 10010 Colleretto Giacosa, TO, Italy. Electronic address: federico.maisano@bracco.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Hazardous parameters associated with natural radioactivity exposure from black sand.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29277438</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(17)30396-3</DOI>
    <KeywordList>
      <Keywords>Baltim</Keywords>
      <Keywords>Black sand deposits</Keywords>
      <Keywords>Health risks</Keywords>
      <Keywords>Natural radionuclides</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>M. A. Hilal</Name>
        <Affiliation>Department of Analytical Chemistry and Control, Hot Laboratories and Waste Management Center (HLWMC), Atomic Energy Authority, 13759 Cairo, Egypt. Electronic address: moustafa_hilal@yahoo.com.</Affiliation>
      </Author>
      <Author>
        <Name>E. H. Borai</Name>
        <Affiliation>Department of Analytical Chemistry and Control, Hot Laboratories and Waste Management Center (HLWMC), Atomic Energy Authority, 13759 Cairo, Egypt.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Indoor air quality (IAQ) evaluation of a Novel Tobacco Vapor (NTV) product.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29277437</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(17)30404-X</DOI>
    <KeywordList>
      <Keywords>Cigarette</Keywords>
      <Keywords>Conference room</Keywords>
      <Keywords>Dining room</Keywords>
      <Keywords>E-cigarette</Keywords>
      <Keywords>Environmental tobacco smoke (ETS)</Keywords>
      <Keywords>Indoor air quality (IAQ)</Keywords>
      <Keywords>Novel tobacco vapor (NTV) product</Keywords>
      <Keywords>Restaurant</Keywords>
      <Keywords>Smoking lounge</Keywords>
      <Keywords>Tobacco</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Hirokazu Ichitsubo</Name>
        <Affiliation>Tobacco Science Research Center, Japan Tobacco Inc., 6-2 Umegaoka, Aoba-ku, Yokohama, Kanagawa 227-8512, Japan. Electronic address: hirokazu.ichitsubo@jt.com.</Affiliation>
      </Author>
      <Author>
        <Name>Misato Kotaki</Name>
        <Affiliation>Corporate, Scientific and Regulatory Affairs Div., Tobacco Business Headquarters, Japan Tobacco Inc., JT Bldg. 2-2-1 Toranomon, Minato-ku, Tokyo, 105-8422, Japan.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Quantifying the risk-reduction potential of new Modified Risk Tobacco Products.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29258927</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(17)30399-9</DOI>
    <KeywordList>
      <Keywords>Biomarker</Keywords>
      <Keywords>Modeling</Keywords>
      <Keywords>Modified risk tobacco product</Keywords>
      <Keywords>Monte Carlo</Keywords>
      <Keywords>Risk assessment</Keywords>
      <Keywords>Smoking</Keywords>
      <Keywords>Translatability</Keywords>
      <Keywords>Uncertainty</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Florian Martin</Name>
        <Affiliation>Philip Morris International Research &amp; Development, Neuchâtel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Gregory Vuillaume</Name>
        <Affiliation>Philip Morris International Research &amp; Development, Neuchâtel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Gizelle Baker</Name>
        <Affiliation>Philip Morris International Research &amp; Development, Neuchâtel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Zheng Sponsiello-Wang</Name>
        <Affiliation>Philip Morris International Research &amp; Development, Neuchâtel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Paolo F. Ricci</Name>
        <Affiliation>University of Bologna, Ravenna, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Frank Lüdicke</Name>
        <Affiliation>Philip Morris International Research &amp; Development, Neuchâtel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Rolf Weitkunat</Name>
        <Affiliation>Philip Morris International Research &amp; Development, Neuchâtel, Switzerland. Electronic address: rolf.weitkunat@pmi.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>No treatment-related effects with aryloxyalkanoate dioxygenase-12 in three 28-day mouse toxicity studies.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29258926</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(17)30400-2</DOI>
    <KeywordList>
      <Keywords>28-Day</Keywords>
      <Keywords>AAD-12</Keywords>
      <Keywords>Mouse</Keywords>
      <Keywords>Toxicology</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Sabitha Papineni</Name>
        <Affiliation>Dow AgroSciences LLC., 9330 Zionsville Road, Indianapolis, IN 46268, USA. Electronic address: spapineni@dow.com.</Affiliation>
      </Author>
      <Author>
        <Name>Johnson Thomas</Name>
        <Affiliation>Toxicology and Environmental Research and Consulting, The Dow Chemical Company, 1803 Building, Washington Street, Midland, MI 48674, USA. Electronic address: jthomas4@dow.com.</Affiliation>
      </Author>
      <Author>
        <Name>Valerie A. Marshall</Name>
        <Affiliation>Toxicology and Environmental Research and Consulting, The Dow Chemical Company, 1803 Building, Washington Street, Midland, MI 48674, USA. Electronic address: vamarshall@dow.com.</Affiliation>
      </Author>
      <Author>
        <Name>Daland R. Juberg</Name>
        <Affiliation>Dow AgroSciences LLC., 9330 Zionsville Road, Indianapolis, IN 46268, USA. Electronic address: drjuberg@dow.com.</Affiliation>
      </Author>
      <Author>
        <Name>Rod A. Herman</Name>
        <Affiliation>Dow AgroSciences LLC., 9330 Zionsville Road, Indianapolis, IN 46268, USA. Electronic address: raherman@dow.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Non-clinical toxicity of β-caryophyllene, a dietary cannabinoid: Absence of adverse effects in female Swiss mice.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29258925</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(17)30401-4</DOI>
    <KeywordList>
      <Keywords>Acute toxicity</Keywords>
      <Keywords>Bicyclic sesquiterpene</Keywords>
      <Keywords>Repeated-dose toxicity</Keywords>
      <Keywords>Swiss mice</Keywords>
      <Keywords>β-caryophyllene</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>George Laylson da Silva Oliveira</Name>
        <Affiliation>Center for Research on Medicinal Plants, Federal University of Piauí, 64049-550 Teresina, Brazil. Electronic address: georggeoliveira@outlook.com.</Affiliation>
      </Author>
      <Author>
        <Name>Keylla Conceição Machado</Name>
        <Affiliation>Department of Pharmacy, Federal University of Piauí, 64049-550, Teresina, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Kátia Conceição Machado</Name>
        <Affiliation>Department of Pharmacy, Federal University of Piauí, 64049-550, Teresina, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Ana Paula Dos Santos C. L. da Silva</Name>
        <Affiliation>Department of Pharmacy, Federal University of Piauí, 64049-550, Teresina, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Chistiane Mendes Feitosa</Name>
        <Affiliation>Department of Chemistry, University Federal of Piauí, 64049-550, Teresina, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Fernanda Regina de Castro Almeida</Name>
        <Affiliation>Center for Research on Medicinal Plants, Federal University of Piauí, 64049-550 Teresina, Brazil.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Implementing the DF4 in a robust model, allowing for enhanced comparison, prioritisation and grouping of Nanomaterials.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29253514</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(17)30395-1</DOI>
    <KeywordList>
      <Keywords>Hazard assessment-</Keywords>
      <Keywords>Nanomaterials</Keywords>
      <Keywords>Partial order</Keywords>
      <Keywords>Ranking</Keywords>
      <Keywords>Regulatory</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Janeck J. Scott-Fordsmand</Name>
        <Affiliation>Department of Bioscience, Aarhus University, Vejlsovej 25, PO BOX 314, Silkeborg, Denmark. Electronic address: jsf@bios.au.dk.</Affiliation>
      </Author>
      <Author>
        <Name>Mónica J. B. Amorim</Name>
        <Affiliation>University of Aveiro, Department of Biology &amp; CESAM, Aveiro, Portugal.</Affiliation>
      </Author>
      <Author>
        <Name>Peter B. Sørensen</Name>
        <Affiliation>Department of Bioscience, Aarhus University, Vejlsovej 25, PO BOX 314, Silkeborg, Denmark.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Safety assessment of propylparaben in juvenile rats.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29248488</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(17)30398-7</DOI>
    <KeywordList>
      <Keywords>Estrogen/estrogenic</Keywords>
      <Keywords>Fertility assessment</Keywords>
      <Keywords>Juvenile rats</Keywords>
      <Keywords>Maturation</Keywords>
      <Keywords>Pediatric</Keywords>
      <Keywords>Propylparaben</Keywords>
      <Keywords>Reproduction</Keywords>
      <Keywords>Reproductive organs</Keywords>
      <Keywords>Sexual maturation</Keywords>
      <Keywords>Uterotrophic assay</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Lakshmi Sivaraman</Name>
        <Affiliation>Research &amp; Development, Bristol-Myers Squibb Company, 1 Squibb Drive, New Brunswick, New Jersey 08903, United States. Electronic address: lakshmi.sivaraman@bms.com.</Affiliation>
      </Author>
      <Author>
        <Name>Louise Pouliot</Name>
        <Affiliation>Charles River Laboratories Montreal ULC 22022 Transcanadienne, Senneville, Quebec H9X.3R3, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Bonnie Wang</Name>
        <Affiliation>Research &amp; Development, Bristol-Myers Squibb Company, 1 Squibb Drive, New Brunswick, New Jersey 08903, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Thomas Brodie</Name>
        <Affiliation>Research &amp; Development, Bristol-Myers Squibb Company, 1 Squibb Drive, New Brunswick, New Jersey 08903, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Michael Graziano</Name>
        <Affiliation>Research &amp; Development, Bristol-Myers Squibb Company, 1 Squibb Drive, New Brunswick, New Jersey 08903, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Mary Ellen McNerney</Name>
        <Affiliation>Research &amp; Development, Bristol-Myers Squibb Company, 1 Squibb Drive, New Brunswick, New Jersey 08903, United States.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Evaluation of the safety profile of an electronic vapour product used for two years by smokers in a real-life setting.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29248487</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(17)30397-5</DOI>
    <KeywordList>
      <Keywords>Adverse events</Keywords>
      <Keywords>Biomarkers of exposure</Keywords>
      <Keywords>Clinical study</Keywords>
      <Keywords>Electronic cigarette</Keywords>
      <Keywords>Electronic vapour product</Keywords>
      <Keywords>Safety</Keywords>
      <Keywords>Subjective effects</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Tanvir Walele</Name>
        <Affiliation>Fontem Ventures, Barbara Strozzilaan 101, 1083 HN Amsterdam, The Netherlands. Electronic address: tanvir.walele@fontemventures.com.</Affiliation>
      </Author>
      <Author>
        <Name>Jim Bush</Name>
        <Affiliation>Covance Clinical Research Unit, Hyde Street, Leeds, LS2 9LH, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Annelize Koch</Name>
        <Affiliation>Simbec Research, Merthyr Tydfil, CF48 4DR, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Rebecca Savioz</Name>
        <Affiliation>Clinopsis S.A., Jardins 6, 1426 Concise, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Claire Martin</Name>
        <Affiliation>Clinopsis S.A., Jardins 6, 1426 Concise, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Grant O'Connell</Name>
        <Affiliation>Fontem Ventures, Barbara Strozzilaan 101, 1083 HN Amsterdam, The Netherlands.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Editorial: Applying 'omics technologies in chemicals risk assessment.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29246668</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30374-4</DOI>
    <AuthorList>
      <Author>
        <Name>Bennard van Ravenzwaay</Name>
        <Affiliation>BASF SE, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Ursula G. Sauer</Name>
        <Affiliation>Scientific Consultancy - Animal Welfare, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Olivier de Matos</Name>
        <Affiliation>ECETOC, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Alan Poole</Name>
        <Affiliation>ECETOC, Belgium.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>An avian reproduction study historical control database: A tool for data interpretation.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29242156</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(17)30391-4</DOI>
    <KeywordList>
      <Keywords>Avian</Keywords>
      <Keywords>Historical control</Keywords>
      <Keywords>Reproduction</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Pablo Valverde-Garcia</Name>
        <Affiliation>Dow AgroSciences, 9330 Zionsville Road, Indianapolis, IN 46268, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Tim Springer</Name>
        <Affiliation>EAG Laboratories - Easton, 8598 Commerce Drive, Easton, MD 21601, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Vince Kramer</Name>
        <Affiliation>Dow AgroSciences, 9330 Zionsville Road, Indianapolis, IN 46268, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Manousos Foudoulakis</Name>
        <Affiliation>Dow AgroSciences, 3B Park Square, Milton Park, Abingdon, Oxfordshire, OX14 4RN, UK.</Affiliation>
      </Author>
      <Author>
        <Name>James R. Wheeler</Name>
        <Affiliation>Dow AgroSciences, 3B Park Square, Milton Park, Abingdon, Oxfordshire, OX14 4RN, UK. Electronic address: jrwheeler@dow.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A quantitative comparison of points of departure between 28-day and 90-day repeated dose studies with a proposed extrapolation factor.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29242155</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(17)30394-X</DOI>
    <KeywordList>
      <Keywords>28-day to 90-day extrapolation</Keywords>
      <Keywords>ATSDR</Keywords>
      <Keywords>Benchmark dose</Keywords>
      <Keywords>ECHA</Keywords>
      <Keywords>NOAEL</Keywords>
      <Keywords>Point of departure</Keywords>
      <Keywords>Risk assessment</Keywords>
      <Keywords>Study duration</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Bradley J. Lampe</Name>
        <Affiliation>NSF International, Ann Arbor, MI, USA. Electronic address: blampe@nsf.org.</Affiliation>
      </Author>
      <Author>
        <Name>Emily Fuller</Name>
        <Affiliation>NSF International, Ann Arbor, MI, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Senthilkumar P. Kuppusamy</Name>
        <Affiliation>Division of Applied Research and Technology, The National Institute for Occupational Safety and Health (NIOSH), Centers for Disease Control and Prevention (CDC), Atlanta, GA, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Repeated oral dose toxicity study on hydrolysable tannin rich fraction isolated from fruit pericarps of Terminalia chebula Retz in Wistar albino rats.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29233773</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(17)30388-4</DOI>
    <KeywordList>
      <Keywords>Acute toxicity</Keywords>
      <Keywords>Hydrolysable tannins</Keywords>
      <Keywords>Repeated dose toxicity</Keywords>
      <Keywords>Terminalia chebula</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Sanmuga Priya Ekambaram</Name>
        <Affiliation>Department of Pharmaceutical Technology, University College of Engineering, Bharathidasan Institute of Technology Campus, Anna University, Tiruchirappalli 620 024, Tamilnadu, India. Electronic address: sanmug77@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Keerthi B. Babu</Name>
        <Affiliation>Department of Pharmaceutical Technology, University College of Engineering, Bharathidasan Institute of Technology Campus, Anna University, Tiruchirappalli 620 024, Tamilnadu, India.</Affiliation>
      </Author>
      <Author>
        <Name>Senthamil Selvan Perumal</Name>
        <Affiliation>Department of Pharmaceutical Technology, University College of Engineering, Bharathidasan Institute of Technology Campus, Anna University, Tiruchirappalli 620 024, Tamilnadu, India.</Affiliation>
      </Author>
      <Author>
        <Name>Durgalakshmi Rajendran</Name>
        <Affiliation>Department of Pharmaceutical Technology, University College of Engineering, Bharathidasan Institute of Technology Campus, Anna University, Tiruchirappalli 620 024, Tamilnadu, India.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Genetic toxicological assessment and anti-arthritic effects of an ethanolic extract obtained from Salvia lachnostachys Benth leaves in mice.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29233772</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(17)30393-8</DOI>
    <KeywordList>
      <Keywords>Arthritis</Keywords>
      <Keywords>Complete Freund's Adjuvant</Keywords>
      <Keywords>Genotoxicity</Keywords>
      <Keywords>Lamiaceae</Keywords>
      <Keywords>Salvia lachnostachys</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Joyce Alencar Santos Radai</Name>
        <Affiliation>Federal University of Grande Dourados, College Exact Sciences and Technology, Dourados, Mato Grosso do Sul, Brazil. Electronic address: joycealencarr@hotmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Fernanda da Silva Graciani</Name>
        <Affiliation>Federal University of Grande Dourados, College of Health Science, Dourados, MS, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Claudia Rodrigues Berno</Name>
        <Affiliation>Federal University of Mato Grosso Do Sul, College of Health Science, Campo Grande, MS, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Maicon Matos Leitão</Name>
        <Affiliation>Federal University of Grande Dourados, College of Health Science, Dourados, MS, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Elide Pereira Dos Santos</Name>
        <Affiliation>Federal University of Paraná, Department of Botanic, Curitiba, PR, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Rodrigo Juliano Oliveira</Name>
        <Affiliation>Federal University of Mato Grosso Do Sul, College of Health Science, Campo Grande, MS, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Cândida Aparecida Leite Kassuya</Name>
        <Affiliation>Federal University of Grande Dourados, College of Health Science, Dourados, MS, Brazil.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Toxicological evaluation of β-Galactosidase enzyme produced by Papiliotrema terrestris.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29233771</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(17)30389-6</DOI>
    <KeywordList>
      <Keywords>Food</Keywords>
      <Keywords>Papiliotrema terrestris</Keywords>
      <Keywords>Safety</Keywords>
      <Keywords>Toxicity</Keywords>
      <Keywords>β-Galactosidase</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Qingdong Ke</Name>
        <Affiliation>Keller and Heckman, LLP, 1001 G Street NW, Suite 500 West, Washington, DC 20001, United States. Electronic address: ke@khlaw.com.</Affiliation>
      </Author>
      <Author>
        <Name>Preston Fulmer</Name>
        <Affiliation>Keller and Heckman, LLP, 1001 G Street NW, Suite 500 West, Washington, DC 20001, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Atsushi Mizutani</Name>
        <Affiliation>Amano Enzyme Inc., 1-2-7 Nishiki, Naka-ku, Nagoya 460-8630, Japan.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Dissipation kinetics, pre-harvest residue limits, and dietary risk assessment of the systemic fungicide metalaxyl in Swiss chard grown under greenhouse conditions.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29233770</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(17)30390-2</DOI>
    <KeywordList>
      <Keywords>HPLC-UVD</Keywords>
      <Keywords>Leafy vegetables</Keywords>
      <Keywords>Metalaxyl</Keywords>
      <Keywords>PHRL</Keywords>
      <Keywords>Risk assessment</Keywords>
      <Keywords>Systemic fungicide</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Md Humayun Kabir</Name>
        <Affiliation>Natural Products Chemistry Laboratory, College of Agriculture and Life Sciences, Chonnam National University, 300 Yongbong-dong, Buk-gu, Gwangju 500-757, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>A. M. Abd El-Aty</Name>
        <Affiliation>Department of Pharmacology, Faculty of Veterinary Medicine, Cairo University, Giza 12211, Egypt; Department of Veterinary Pharmacology and Toxicology, College of Veterinary Medicine, Konkuk University, Seoul 143-701, Republic of Korea. Electronic address: abdelaty44@hotmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Md Musfiqur Rahman</Name>
        <Affiliation>Natural Products Chemistry Laboratory, College of Agriculture and Life Sciences, Chonnam National University, 300 Yongbong-dong, Buk-gu, Gwangju 500-757, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Hyung Suk Chung</Name>
        <Affiliation>Natural Products Chemistry Laboratory, College of Agriculture and Life Sciences, Chonnam National University, 300 Yongbong-dong, Buk-gu, Gwangju 500-757, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Han Sol Lee</Name>
        <Affiliation>Natural Products Chemistry Laboratory, College of Agriculture and Life Sciences, Chonnam National University, 300 Yongbong-dong, Buk-gu, Gwangju 500-757, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Ji Hoon Jeong</Name>
        <Affiliation>Department of Pharmacology, College of Medicine, Chung-Ang University, 221, Heuksuk-dong, Dongjak-gu, Seoul 156-756, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Jing Wang</Name>
        <Affiliation>Key Laboratory for Agro-Products Quality and Safety, Institute of Quality Standards &amp; Testing Technology for Agro-Products, Chinese Academy of Agricultural Sciences, Beijing, China.</Affiliation>
      </Author>
      <Author>
        <Name>SungShik Shin</Name>
        <Affiliation>Laboratory of Parasitology, College of Veterinary Medicine, Chonnam National University, 77 Yongbong-ro, Buk-gu, Gwangju 61186, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Ho Chul Shin</Name>
        <Affiliation>Department of Veterinary Pharmacology and Toxicology, College of Veterinary Medicine, Konkuk University, Seoul 143-701, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Jae Han Shim</Name>
        <Affiliation>Natural Products Chemistry Laboratory, College of Agriculture and Life Sciences, Chonnam National University, 300 Yongbong-dong, Buk-gu, Gwangju 500-757, Republic of Korea. Electronic address: jhshim@chonnam.ac.kr.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Historical evolution of regulatory standards for occupational and consumer exposures to industrial talc.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29233769</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(17)30392-6</DOI>
    <KeywordList>
      <Keywords>ACGIH</Keywords>
      <Keywords>Asbestos</Keywords>
      <Keywords>Bureau of Mines</Keywords>
      <Keywords>Exposure</Keywords>
      <Keywords>Industrial hygiene</Keywords>
      <Keywords>OSHA</Keywords>
      <Keywords>Regulation</Keywords>
      <Keywords>State of the art</Keywords>
      <Keywords>Talc</Keywords>
      <Keywords>Tremolite</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Derek A. Drechsel</Name>
        <Affiliation>Cardno ChemRisk, Boulder, CO, United States. Electronic address: derek.drechsel@cardno.com.</Affiliation>
      </Author>
      <Author>
        <Name>Christy A. Barlow</Name>
        <Affiliation>Cardno ChemRisk, Boulder, CO, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Jennifer L. Bare</Name>
        <Affiliation>Cardno ChemRisk, Arlington, VA, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Neva F. Jacobs</Name>
        <Affiliation>Cardno ChemRisk, Arlington, VA, United States.</Affiliation>
      </Author>
      <Author>
        <Name>John L. Henshaw</Name>
        <Affiliation>John Henshaw &amp; Associates, Sanibel, FL, United States.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Carcinogenicity assessment of baricitinib in Tg.rasH2 mice and Sprague-Dawley (Crl:CD) rats.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29203403</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(17)30377-X</DOI>
    <KeywordList>
      <Keywords>Baricitinib</Keywords>
      <Keywords>Carcinogenicity</Keywords>
      <Keywords>Janus kinase inhibitor</Keywords>
      <Keywords>Rats</Keywords>
      <Keywords>Tg.rasH2 mice</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Mark Carfagna</Name>
        <Affiliation>Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN 46285, USA. Electronic address: carfagna_mark_a@lilly.com.</Affiliation>
      </Author>
      <Author>
        <Name>Ellen Cannady</Name>
        <Affiliation>Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN 46285, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Thomas Ryan</Name>
        <Affiliation>Covance Laboratories Inc., 3301 Kinsman Boulevard, Madison, WI 53704-2595, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jay Herman</Name>
        <Affiliation>Covance Laboratories Inc., 3301 Kinsman Boulevard, Madison, WI 53704-2595, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Lew Truex</Name>
        <Affiliation>Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN 46285, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Kanchan Narwani</Name>
        <Affiliation>Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN 46285, USA.</Affiliation>
      </Author>
      <Author>
        <Name>John Sullivan</Name>
        <Affiliation>Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN 46285, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Abuse liability assessment for biologic drugs - All molecules are not created equal.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29199066</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(17)30376-8</DOI>
    <KeywordList>
      <Keywords>Abuse liability</Keywords>
      <Keywords>Biologic</Keywords>
      <Keywords>Biotherapeutic</Keywords>
      <Keywords>Drug abuse</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Christina L. Zuch de Zafra</Name>
        <Affiliation>Comparative Biology and Safety Sciences, Amgen, Inc., South San Francisco, CA, USA. Electronic address: cdezafra@amgen.com.</Affiliation>
      </Author>
      <Author>
        <Name>Carrie G. Markgraf</Name>
        <Affiliation>Preclinical Safety, Discovery Sciences Support, Merck &amp; Co., Ltd., Kenilworth, NJ, USA.</Affiliation>
      </Author>
      <Author>
        <Name>David R. Compton</Name>
        <Affiliation>Preclinical Safety, Sanofi US, Bridgewater, NJ, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Thomas J. Hudzik</Name>
        <Affiliation>ALA BioPharma Consulting, Chicago, IL, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Safety evaluation of DAS-44406-6 soybeans in Wistar rats.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29199065</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(17)30373-2</DOI>
    <KeywordList>
      <Keywords>90-day rat</Keywords>
      <Keywords>DAS-44406-6</Keywords>
      <Keywords>Genetically-modified soybean</Keywords>
      <Keywords>Herbicide tolerant</Keywords>
      <Keywords>Transgenic soybean</Keywords>
      <Keywords>Wistar rat</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Zhiyong Qian</Name>
        <Affiliation>Tianjin Centers for Disease Control and Prevention, Tianjin, China.</Affiliation>
      </Author>
      <Author>
        <Name>JoAnna Bultman</Name>
        <Affiliation>Charles River Laboratories International, Inc, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Sabitha Papineni</Name>
        <Affiliation>Dow AgroSciences LLC, Indianapolis, IN 46268, United States. Electronic address: SPapineni@dow.com.</Affiliation>
      </Author>
      <Author>
        <Name>Ning He</Name>
        <Affiliation>Tianjin Centers for Disease Control and Prevention, Tianjin, China.</Affiliation>
      </Author>
      <Author>
        <Name>Lisa Lanigan</Name>
        <Affiliation>Charles River Laboratories International, Inc, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Rod A. Herman</Name>
        <Affiliation>Dow AgroSciences LLC, Indianapolis, IN 46268, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Gordon C. Hard</Name>
        <Affiliation>Private Consultant, Tairua, New Zealand.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Subchronic bisphenol S exposure affects liver function in mice involving oxidative damage.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29199064</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(17)30375-6</DOI>
    <KeywordList>
      <Keywords>Bisphenol S</Keywords>
      <Keywords>In vivo</Keywords>
      <Keywords>Liver function</Keywords>
      <Keywords>Mice</Keywords>
      <Keywords>Oxidative stress</Keywords>
      <Keywords>Subchronic exposure</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Zhen Zhang</Name>
        <Affiliation>Department of Pharmacology, Xiamen Institute for Food and Drug Quality Control, Xiamen 361012, Fujian, China. Electronic address: albumen_zz@163.com.</Affiliation>
      </Author>
      <Author>
        <Name>Lihua Lin</Name>
        <Affiliation>Department of Pharmacology, Xiamen Institute for Food and Drug Quality Control, Xiamen 361012, Fujian, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yating Gai</Name>
        <Affiliation>Department of Pharmacology, Xiamen Institute for Food and Drug Quality Control, Xiamen 361012, Fujian, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ying Hong</Name>
        <Affiliation>Department of Pharmacology, Xiamen Institute for Food and Drug Quality Control, Xiamen 361012, Fujian, China.</Affiliation>
      </Author>
      <Author>
        <Name>Lingling Li</Name>
        <Affiliation>Department of Pharmacology, Xiamen Institute for Food and Drug Quality Control, Xiamen 361012, Fujian, China.</Affiliation>
      </Author>
      <Author>
        <Name>Luna Weng</Name>
        <Affiliation>Department of Pharmacology, Xiamen Institute for Food and Drug Quality Control, Xiamen 361012, Fujian, China. Electronic address: lnwyjyl@163.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Expert opinions on the acceptance of alternative methods in food safety evaluations: Formulating recommendations to increase acceptance of non-animal methods for kinetics.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29196030</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(17)30372-0</DOI>
    <KeywordList>
      <Keywords>Alternatives to animal testing</Keywords>
      <Keywords>Drivers and barriers</Keywords>
      <Keywords>Food toxicology</Keywords>
      <Keywords>Multilevel perspective on technology transitions</Keywords>
      <Keywords>QIVIVE</Keywords>
      <Keywords>Regulatory acceptance</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Ans Punt</Name>
        <Affiliation>RIKILT Wageningen University and Research, PO Box 230, 6700 AE Wageningen, The Netherlands. Electronic address: ans.punt@wur.nl.</Affiliation>
      </Author>
      <Author>
        <Name>Hans Bouwmeester</Name>
        <Affiliation>RIKILT Wageningen University and Research, PO Box 230, 6700 AE Wageningen, The Netherlands; Division of Toxicology, Wageningen University and Research, PO Box 8000, 6700 EA Wageningen, The Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Marie Jeanne W. A. Schiffelers</Name>
        <Affiliation>Utrecht University School of Governance (USG), Bijlhouwerstraat 6, 3511 ZC Utrecht, The Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Ad A. C. M. Peijnenburg</Name>
        <Affiliation>RIKILT Wageningen University and Research, PO Box 230, 6700 AE Wageningen, The Netherlands.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Assessment of phototoxicity in pigmented Long-Evans rat: sparfloxacin and 8-methoxypsoralen.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29196029</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(17)30371-9</DOI>
    <KeywordList>
      <Keywords>Melanin-binding</Keywords>
      <Keywords>Photo-activation</Keywords>
      <Keywords>Photosafety</Keywords>
      <Keywords>Pigmentation</Keywords>
      <Keywords>Rats</Keywords>
      <Keywords>UVA/Vis irradiation</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Stephen Turnock</Name>
        <Affiliation>CiToxLAB France, 27005 Evreux, France; Kings College London, London, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Cédric Gerbeix</Name>
        <Affiliation>CiToxLAB France, 27005 Evreux, France.</Affiliation>
      </Author>
      <Author>
        <Name>Catherine Thirion-Delalande</Name>
        <Affiliation>CiToxLAB France, 27005 Evreux, France.</Affiliation>
      </Author>
      <Author>
        <Name>Nick Pearson</Name>
        <Affiliation>CiToxLAB France, 27005 Evreux, France; Pharmaceutical Sciences, pRED, Roche Innovation Center Basel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Roy Forster</Name>
        <Affiliation>CiToxLAB France, 27005 Evreux, France. Electronic address: roy.forster@fr.citoxlab.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The role of ethyl acrylate induced GSH depletion in the rodent forestomach and its impact on MTD and in vivo genotoxicity in developing an adverse outcome pathway (AOP).</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29183839</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(17)30369-0</DOI>
    <KeywordList>
      <Keywords>CAS# 140-88-5</Keywords>
      <Keywords>Ethyl acrylate</Keywords>
      <Keywords>GSH depletion</Keywords>
      <Keywords>Maximum tolerated dose</Keywords>
      <Keywords>Rodent forestomach tumors</Keywords>
      <Keywords>Transgenic mouse assay</Keywords>
      <Keywords>gpt delta mouse</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>R. Ellis-Hutchings</Name>
        <Affiliation>The Dow Chemical Company, Midland, MI, USA. Electronic address: Rellis-hutchings@dow.com.</Affiliation>
      </Author>
      <Author>
        <Name>J. Giuliani</Name>
        <Affiliation>Arkema Inc., King of Prussia, PA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>M. Hayashi</Name>
        <Affiliation>Public Interest Incorporated Foundation, Biosafety Research Center (BSRC) Iwata, Shizuoka, Japan; Makoto International Consulting, Ebina, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>S. Masumori</Name>
        <Affiliation>Public Interest Incorporated Foundation, Biosafety Research Center (BSRC) Iwata, Shizuoka, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>E. L. McClymont</Name>
        <Affiliation>The Dow Chemical Company, Midland, MI, USA.</Affiliation>
      </Author>
      <Author>
        <Name>S. Murphy</Name>
        <Affiliation>Sandra Murphy, Kennett Square, PA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>K. Wiench</Name>
        <Affiliation>BASF SE, Ludwigshafen, Germany.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Toxicological assessment of lower alkyl methacrylate esters by a category approach.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29180022</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(17)30370-7</DOI>
    <KeywordList>
      <Keywords>Category approach</Keywords>
      <Keywords>Fill in data gaps</Keywords>
      <Keywords>Health effects</Keywords>
      <Keywords>Lower methacrylate esters</Keywords>
      <Keywords>Read-across</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Heinz Peter Gelbke</Name>
        <Affiliation>CinTox, F-06100 Nice, France. Electronic address: heinz-peter.gelbke@gmx.de.</Affiliation>
      </Author>
      <Author>
        <Name>Robert Ellis-Hutchings</Name>
        <Affiliation>The Dow Chemical Company, Midland, MI 48674, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Harald Müllerschön</Name>
        <Affiliation>Evonik Röhm GmbH, D-64293 Darmstadt, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Sandra Murphy</Name>
        <Affiliation>Arkema Inc., King of Prussia PA19406-1308, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Mark Pemberton</Name>
        <Affiliation>Systox Limited, Wilmslow, GB-SK9 2QA Cheshire, UK.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Derivation of an oral reference dose (RfD) for di 2-ethylhexyl cyclohexan-1,4-dicarboxylate (DEHCH), an alternative to phthalate plasticizers.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29162533</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(17)30367-7</DOI>
    <KeywordList>
      <Keywords>DEHCH</Keywords>
      <Keywords>Phthalate alternative</Keywords>
      <Keywords>Plasticizer</Keywords>
      <Keywords>Reference dose</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Brian J. Hughes</Name>
        <Affiliation>NSF International, Ann Arbor, MI, United States. Electronic address: bhughes@nsf.org.</Affiliation>
      </Author>
      <Author>
        <Name>Kevin Cox</Name>
        <Affiliation>NSF International, Ann Arbor, MI, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Virunya Bhat</Name>
        <Affiliation>NSF International, Ann Arbor, MI, United States.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Chemical analysis and in vitro toxicological evaluation of aerosol from a novel tobacco vapor product: A comparison with cigarette smoke.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29158044</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(17)30366-5</DOI>
    <KeywordList>
      <Keywords>Cigarette smoke</Keywords>
      <Keywords>Cytotoxicity</Keywords>
      <Keywords>Hoffmann analytes</Keywords>
      <Keywords>In vitro genotoxicity</Keywords>
      <Keywords>Mutagenicity</Keywords>
      <Keywords>Tobacco vapor product</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Yasunori Takahashi</Name>
        <Affiliation>Scientific Product Assessment Center, R&amp;D Group, Japan Tobacco Inc., Kanagawa, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Yuki Kanemaru</Name>
        <Affiliation>Scientific Product Assessment Center, R&amp;D Group, Japan Tobacco Inc., Kanagawa, Japan. Electronic address: yuki.kanemaru@jt.com.</Affiliation>
      </Author>
      <Author>
        <Name>Toshiro Fukushima</Name>
        <Affiliation>Scientific Product Assessment Center, R&amp;D Group, Japan Tobacco Inc., Kanagawa, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Kentaro Eguchi</Name>
        <Affiliation>Product Quality Research Center, R&amp;D Group, Japan Tobacco Inc., Kanagawa, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Shinya Yoshida</Name>
        <Affiliation>Product Technology Development Center, R&amp;D Group, Japan Tobacco Inc., Tokyo, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Jacqueline Miller-Holt</Name>
        <Affiliation>Scientific and Regulatory Affairs, JT International S.A., Geneva, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Ian Jones</Name>
        <Affiliation>Emerging Products, JT International S.A., Geneva, Switzerland.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Six years after the NRC review of EPA's Draft IRIS Toxicological Review of Formaldehyde: Regulatory implications of new science in evaluating formaldehyde leukemogenicity.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29158043</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(17)30363-X</DOI>
    <KeywordList>
      <Keywords>Epidemiology</Keywords>
      <Keywords>Evidence integration</Keywords>
      <Keywords>Hazard evaluation</Keywords>
      <Keywords>Mechanistic studies</Keywords>
      <Keywords>Regulatory science</Keywords>
      <Keywords>Toxicology</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Kenneth A. Mundt</Name>
        <Affiliation>Environment and Health, Ramboll Environ, Amherst MA, United States. Electronic address: kmundt@ramboll.com.</Affiliation>
      </Author>
      <Author>
        <Name>P. Robinan Gentry</Name>
        <Affiliation>Environment and Health, Ramboll Environ, Amherst MA, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Linda D. Dell</Name>
        <Affiliation>Environment and Health, Ramboll Environ, Amherst MA, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Joseph V. Rodricks</Name>
        <Affiliation>Environment and Health, Ramboll Environ, Amherst MA, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Paolo Boffetta</Name>
        <Affiliation>Icahn School of Medicine at Mount Sinai, New York, NY, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Development of an inhalation reference concentration for diethanolamine.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29158042</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(17)30368-9</DOI>
    <KeywordList>
      <Keywords>DEA</Keywords>
      <Keywords>Diethanolamine</Keywords>
      <Keywords>Inhalation</Keywords>
      <Keywords>Laryngeal squamous metaplasia</Keywords>
      <Keywords>Liver</Keywords>
      <Keywords>Regulatory</Keywords>
      <Keywords>Toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Joseph T. Haney</Name>
        <Affiliation>Texas Commission on Environmental Quality (TCEQ), Toxicology Division, MC-168, P.O. Box 13087, Austin, TX, 78711, United States. Electronic address: Joseph.Haney@tceq.texas.gov.</Affiliation>
      </Author>
      <Author>
        <Name>Darrell McCant</Name>
        <Affiliation>Texas Commission on Environmental Quality (TCEQ), Toxicology Division, MC-168, P.O. Box 13087, Austin, TX, 78711, United States. Electronic address: Darrell.McCant@tceq.texas.gov.</Affiliation>
      </Author>
      <Author>
        <Name>Michael E. Honeycutt</Name>
        <Affiliation>Texas Commission on Environmental Quality (TCEQ), Toxicology Division, MC-168, P.O. Box 13087, Austin, TX, 78711, United States. Electronic address: Michael.Honeycutt@tceq.texas.gov.</Affiliation>
      </Author>
      <Author>
        <Name>Sabine Lange</Name>
        <Affiliation>Texas Commission on Environmental Quality (TCEQ), Toxicology Division, MC-168, P.O. Box 13087, Austin, TX, 78711, United States. Electronic address: Sabine.Lange@tceq.texas.gov.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Subchronic oral toxicity study of Korean red ginseng extract in Sprague-Dawley rats with a 4-week recovery period.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29155077</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(17)30364-1</DOI>
    <KeywordList>
      <Keywords>Ginsenoside</Keywords>
      <Keywords>Korean red ginseng extract</Keywords>
      <Keywords>Panax ginseng</Keywords>
      <Keywords>SD rats</Keywords>
      <Keywords>Toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Sang Jin Park</Name>
        <Affiliation>Division of Non-clinical Studies, Korea Institute of Toxicology, 141 Gaejeongro, Yuseong-gu, Daejeon 305-343, South Korea.</Affiliation>
      </Author>
      <Author>
        <Name>JeongHo Noh</Name>
        <Affiliation>Division of Non-clinical Studies, Korea Institute of Toxicology, 141 Gaejeongro, Yuseong-gu, Daejeon 305-343, South Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Eun Ju Jeong</Name>
        <Affiliation>Division of Non-clinical Studies, Korea Institute of Toxicology, 141 Gaejeongro, Yuseong-gu, Daejeon 305-343, South Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Yong Soon Kim</Name>
        <Affiliation>Botanical Drug Laboratory, R&amp;D Headquarters, Korea Ginseng Corp., 30 Gaejeongro, Yuseong-gu, Daejeon 305-805, South Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Byung Cheol Han</Name>
        <Affiliation>Botanical Drug Laboratory, R&amp;D Headquarters, Korea Ginseng Corp., 30 Gaejeongro, Yuseong-gu, Daejeon 305-805, South Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Seung Ho Lee</Name>
        <Affiliation>Botanical Drug Laboratory, R&amp;D Headquarters, Korea Ginseng Corp., 30 Gaejeongro, Yuseong-gu, Daejeon 305-805, South Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Kyoung Sik Moon</Name>
        <Affiliation>Division of Non-clinical Studies, Korea Institute of Toxicology, 141 Gaejeongro, Yuseong-gu, Daejeon 305-343, South Korea. Electronic address: ksmoon@kitox.re.kr.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Genotoxicity and 28-day oral toxicity studies of a functional food mixture containing maltodextrin, white kidney bean extract, mulberry leaf extract, and niacin-bound chromium complex.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29155076</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(17)30365-3</DOI>
    <KeywordList>
      <Keywords>Evaluation</Keywords>
      <Keywords>Food</Keywords>
      <Keywords>Functional</Keywords>
      <Keywords>Genotoxicity</Keywords>
      <Keywords>Safety</Keywords>
      <Keywords>Toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Cheng Tien Wu</Name>
        <Affiliation>Institute of Toxicology, College of Medicine, National Taiwan University, Taipei, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Chen Yuan Chiu</Name>
        <Affiliation>Institute of Toxicology, College of Medicine, National Taiwan University, Taipei, Taiwan; Institute of Food Safety and Health, College of Public Health, National Taiwan University, Taipei, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Chun Fa Huang</Name>
        <Affiliation>School of Chinese Medicine, College of Chinese Medicine, China Medical University, Taichung, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Fu Chuo Peng</Name>
        <Affiliation>Institute of Toxicology, College of Medicine, National Taiwan University, Taipei, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Shing Hwa Liu</Name>
        <Affiliation>Institute of Toxicology, College of Medicine, National Taiwan University, Taipei, Taiwan; Department of Pediatrics, College of Medicine, National Taiwan University &amp; Hospital, Taipei, Taiwan; Department of Medical Research, China Medical University Hospital, China Medical University, Taichung, Taiwan. Electronic address: shinghwaliu@ntu.edu.tw.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>TDCPP protects cardiomyocytes from hypoxia-reoxygenation injury induced apoptosis through mitigating calcium overload and promotion GSK-3β phosphorylation.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29129621</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(17)30354-9</DOI>
    <KeywordList>
      <Keywords>Apoptosis</Keywords>
      <Keywords>Calcium overload</Keywords>
      <Keywords>GSK3β</Keywords>
      <Keywords>Hypoxia/re-oxygenation injury</Keywords>
      <Keywords>Ischemia-reperfusion injury</Keywords>
      <Keywords>TDCPP</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Xiju He</Name>
        <Affiliation>Department of Anatomy, Hubei University of Medicine, Shiyan, Hubei 442000, China; Department of Anatomy, Tongji Medical College of Huazhong University of Science and Technology, Wuhan, Hubei 430030, China. Electronic address: huizi630@163.com.</Affiliation>
      </Author>
      <Author>
        <Name>Shoutian Li</Name>
        <Affiliation>Department of Anatomy, Tongji Medical College of Huazhong University of Science and Technology, Wuhan, Hubei 430030, China. Electronic address: lishoutian2009@126.com.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaoxia Fang</Name>
        <Affiliation>Department of Neurology, Taihe Hospital, Hubei University of Medicine, Shiyan, Hubei, 42000, China. Electronic address: hbsyfxx@21cn.com.</Affiliation>
      </Author>
      <Author>
        <Name>Yanhong Liao</Name>
        <Affiliation>Department of Anatomy, Tongji Medical College of Huazhong University of Science and Technology, Wuhan, Hubei 430030, China. Electronic address: yhliao1@126.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Human adipose-derived stem cells (ADSC) and human periodontal ligament stem cells (PDLSC) as cellular substrates of a toxicity prediction assay.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29129620</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(17)30353-7</DOI>
    <KeywordList>
      <Keywords>Adipose-derived stem cells</Keywords>
      <Keywords>Cytotoxicity</Keywords>
      <Keywords>In vitro toxicity prediction</Keywords>
      <Keywords>Periodontal ligament stem cells</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Natássia Caroline Resende Corrêa</Name>
        <Affiliation>Laboratório de Biologia Básica de Células-tronco, Instituto Carlos Chagas, Fiocruz, Curitiba, PR, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Crisciele Kuligovski</Name>
        <Affiliation>Laboratório de Biologia Básica de Células-tronco, Instituto Carlos Chagas, Fiocruz, Curitiba, PR, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Ariane Caroline Campos Paschoal</Name>
        <Affiliation>Laboratório de Biologia Básica de Células-tronco, Instituto Carlos Chagas, Fiocruz, Curitiba, PR, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Ana Paula Ressetti Abud</Name>
        <Affiliation>Laboratório de Biologia Básica de Células-tronco, Instituto Carlos Chagas, Fiocruz, Curitiba, PR, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Carmen Lucia Kuniyoshi Rebelatto</Name>
        <Affiliation>Núcleo de Tecnologia Celular (NTC), Pontifícia Universidade Católica do Paraná (PUCPR), Curitiba, PR, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Lidiane Maria Boldrini Leite</Name>
        <Affiliation>Núcleo de Tecnologia Celular (NTC), Pontifícia Universidade Católica do Paraná (PUCPR), Curitiba, PR, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Alexandra Cristina Senegaglia</Name>
        <Affiliation>Núcleo de Tecnologia Celular (NTC), Pontifícia Universidade Católica do Paraná (PUCPR), Curitiba, PR, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Bruno Dallagiovanna</Name>
        <Affiliation>Laboratório de Biologia Básica de Células-tronco, Instituto Carlos Chagas, Fiocruz, Curitiba, PR, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Alessandra Melo de Aguiar</Name>
        <Affiliation>Laboratório de Biologia Básica de Células-tronco, Instituto Carlos Chagas, Fiocruz, Curitiba, PR, Brazil. Electronic address: alessandra.aguiar@fiocruz.br.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Human relevance of rodent liver tumors: Key insights from a Toxicology Forum workshop on nongenotoxic modes of action.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29113941</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(17)30352-5</DOI>
    <KeywordList>
      <Keywords>Constitutive Androstane Receptor</Keywords>
      <Keywords>Mode of action</Keywords>
      <Keywords>Nongenotoxic</Keywords>
      <Keywords>Peroxisome proliferator-activated receptor alpha (PPARα)</Keywords>
      <Keywords>Rodent liver tumors</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Susan P. Felter</Name>
        <Affiliation>Procter and Gamble, Central Product Safety, Mason, OH, United States. Electronic address: Felter.sp@pg.com.</Affiliation>
      </Author>
      <Author>
        <Name>Jennifer E. Foreman</Name>
        <Affiliation>ExxonMobil Biomedical Sciences, Inc., Annandale, NJ, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Alan Boobis</Name>
        <Affiliation>Department of Medicine, Imperial College London, London, UK.</Affiliation>
      </Author>
      <Author>
        <Name>J. Christopher Corton</Name>
        <Affiliation>National Health and Environmental Effects Research Lab, US EPA, Durham, NC, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Adriana M. Doi</Name>
        <Affiliation>BASF Corporation, Research Triangle Park, NC, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Lynn Flowers</Name>
        <Affiliation>Office of Science Policy, US EPA, Washington DC, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Jay Goodman</Name>
        <Affiliation>Michigan State University, Dept. Pharmacology and Toxicology, East Lansing, MI, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Lynne T. Haber</Name>
        <Affiliation>Risk Science Center, Dept. of Environmental Health, University of Cincinnati, Cincinnati, OH, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Abigail Jacobs</Name>
        <Affiliation>Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, United States.</Affiliation>
      </Author>
      <Author>
        <Name>James E. Klaunig</Name>
        <Affiliation>Indiana University, Bloomington, IN, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Angela M. Lynch</Name>
        <Affiliation>ToxPlus Consulting, LLC, Haymarket, VA, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Jonathan Moggs</Name>
        <Affiliation>Novartis Institutes for BioMedical Research, Preclinical Safety, Translational Medicine, Basel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Arun Pandiri</Name>
        <Affiliation>National Toxicology Program, National Institute of Environmental Health Sciences, Research Triangle Park, NC, United States.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Screening-level Biomonitoring Equivalents for tiered interpretation of urinary 3-phenoxybenzoic acid (3-PBA) in a risk assessment context.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29113940</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(17)30351-3</DOI>
    <KeywordList>
      <Keywords>Biomonitoring</Keywords>
      <Keywords>Biomonitoring Equivalents</Keywords>
      <Keywords>Pesticides</Keywords>
      <Keywords>Pyrethroids</Keywords>
      <Keywords>Risk assessment</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Lesa L. Aylward</Name>
        <Affiliation>Summit Toxicology, LLP, Falls Church, VA, USA. Electronic address: laylward@summittoxicology.com.</Affiliation>
      </Author>
      <Author>
        <Name>Kim Irwin</Name>
        <Affiliation>Health Canada, Ottawa, Ontario, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Annie St-Amand</Name>
        <Affiliation>Health Canada, Ottawa, Ontario, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Andy Nong</Name>
        <Affiliation>Health Canada, Ottawa, Ontario, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Sean M. Hays</Name>
        <Affiliation>Summit Toxicology, LLP, Allenspark, CO, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A generic Transcriptomics Reporting Framework (TRF) for 'omics data processing and analysis.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29113939</pubmedLink>
    <GrantList>
      <Grant>EPA999999</Grant>
    </GrantList>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30350-1</DOI>
    <KeywordList>
      <Keywords>Bioinformatics</Keywords>
      <Keywords>Differentially expressed genes</Keywords>
      <Keywords>Gene expression</Keywords>
      <Keywords>Normalisation of ‘omics data</Keywords>
      <Keywords>Regulatory toxicology</Keywords>
      <Keywords>Reproducibility</Keywords>
      <Keywords>Statistical analysis</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Timothy W. Gant</Name>
        <Affiliation>Centre for Radiation, Chemical and Environmental Hazards (CRCE), Public Health England (PHE), Harwell Campus, Oxfordshire, UK. Electronic address: tim.gant@phe.gov.uk.</Affiliation>
      </Author>
      <Author>
        <Name>Ursula G. Sauer</Name>
        <Affiliation>Scientific Consultancy - Animal Welfare, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Shu Dong Zhang</Name>
        <Affiliation>Northern Ireland Centre for Stratified Medicine, Biomedical Sciences Research Institute, University of Ulster, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Brian N. Chorley</Name>
        <Affiliation>U.S. Environmental Protection Agency, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jörg Hackermüller</Name>
        <Affiliation>Department of Molecular Systems Biology, Helmholtz Centre for Environmental Research - UFZ, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Stefania Perdichizzi</Name>
        <Affiliation>Center for Environmental Toxicology, Agency for Prevention, Environment and Energy (Arpae), Emilia-Romagna, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Knut E. Tollefsen</Name>
        <Affiliation>Norwegian Institute for Water Research (NIVA), Norway.</Affiliation>
      </Author>
      <Author>
        <Name>Ben van Ravenzwaay</Name>
        <Affiliation>BASF SE, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Carole Yauk</Name>
        <Affiliation>Environmental Health Science and Research Bureau, Health Canada, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Weida Tong</Name>
        <Affiliation>National Center for Toxicological Research (NCTR), U.S. Food and Drug Administration (FDA), USA.</Affiliation>
      </Author>
      <Author>
        <Name>Alan Poole</Name>
        <Affiliation>European Centre for Ecotoxicology and Toxicology of Chemicals (ECETOC), Belgium.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Toxicity assessment of pesticide triclosan by aquatic organisms and degradation studies.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29111444</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30345-8</DOI>
    <KeywordList>
      <Keywords>2,4-Dichlorophenol</Keywords>
      <Keywords>Biodegradation</Keywords>
      <Keywords>Cyanobacteria</Keywords>
      <Keywords>Microalgae</Keywords>
      <Keywords>Toxicity</Keywords>
      <Keywords>Triclosan</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Burcu Ertit Taştan</Name>
        <Affiliation>Polatlı Faculty of Science &amp; Arts, Gazi University, 06900, Polatlı, Ankara, Turkey; Health Services Vocational School, Gazi University, 06830, Gölbaşı, Ankara, Turkey; Life Sciences Application and Research Center, Gazi University, 06830, Gölbaşı, Ankara, Turkey. Electronic address: burcuertit@gazi.edu.tr.</Affiliation>
      </Author>
      <Author>
        <Name>Turgay Tekinay</Name>
        <Affiliation>Life Sciences Application and Research Center, Gazi University, 06830, Gölbaşı, Ankara, Turkey; Department of Medical Biology and Genetics, Faculty of Medicine, Gazi University, 06500, Ankara, Turkey. Electronic address: ttekinay@gazi.edu.tr.</Affiliation>
      </Author>
      <Author>
        <Name>Hatice Sena Çelik</Name>
        <Affiliation>Life Sciences Application and Research Center, Gazi University, 06830, Gölbaşı, Ankara, Turkey; Department of Medical Biology and Genetics, Faculty of Medicine, Gazi University, 06500, Ankara, Turkey.</Affiliation>
      </Author>
      <Author>
        <Name>Caner Özdemir</Name>
        <Affiliation>Department of Biology, Faculty of Science, Ankara University, 06100, Beşevler, Ankara, Turkey.</Affiliation>
      </Author>
      <Author>
        <Name>Dilara Nur Cakir</Name>
        <Affiliation>Department of Biology, Faculty of Science, Ankara University, 06100, Beşevler, Ankara, Turkey.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Derivation of endogenous equivalent values to support risk assessment and risk management decisions for an endogenous carcinogen: Ethylene oxide.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29111443</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30347-1</DOI>
    <KeywordList>
      <Keywords>Biomarkers of exposure</Keywords>
      <Keywords>Endogenous exposure</Keywords>
      <Keywords>Ethylene oxide</Keywords>
      <Keywords>Point of departure</Keywords>
      <Keywords>Risk assessment</Keywords>
      <Keywords>Risk management</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>C. R. Kirman</Name>
        <Affiliation>Summit Toxicology, P.O. Box 3209, Bozeman, MT 59715, United States. Electronic address: ckirman@summittoxicology.com.</Affiliation>
      </Author>
      <Author>
        <Name>S. M. Hays</Name>
        <Affiliation>Summit Toxicology, P.O. Box 3209, Bozeman, MT 59715, United States.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Enzymatic extract from Ecklonia cava: Acute and subchronic oral toxicity and genotoxicity studies.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29108849</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(17)30349-5</DOI>
    <KeywordList>
      <Keywords>Brown alga</Keywords>
      <Keywords>Ecklonia cava</Keywords>
      <Keywords>Genotoxicity</Keywords>
      <Keywords>Subchronic</Keywords>
      <Keywords>Toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jun Won Yun</Name>
        <Affiliation>Department of Biotechnology, The Catholic University of Korea, Bucheon, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Seung Hyun Kim</Name>
        <Affiliation>Department of Experimental Animal Research, Biomedical Research Institute, Seoul National University Hospital, Seoul, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Yun Soon Kim</Name>
        <Affiliation>Department of Experimental Animal Research, Biomedical Research Institute, Seoul National University Hospital, Seoul, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Ji Ran You</Name>
        <Affiliation>Department of Experimental Animal Research, Biomedical Research Institute, Seoul National University Hospital, Seoul, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Eun Young Cho</Name>
        <Affiliation>Department of Experimental Animal Research, Biomedical Research Institute, Seoul National University Hospital, Seoul, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Jung Hee Yoon</Name>
        <Affiliation>Department of Experimental Animal Research, Biomedical Research Institute, Seoul National University Hospital, Seoul, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Euna Kwon</Name>
        <Affiliation>Department of Experimental Animal Research, Biomedical Research Institute, Seoul National University Hospital, Seoul, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>In Jue Yun</Name>
        <Affiliation>Ju Yeong NS Co., Ltd., Chuncheon, Kangwon-do, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Je Hun Oh</Name>
        <Affiliation>Ju Yeong NS Co., Ltd., Chuncheon, Kangwon-do, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Ja June Jang</Name>
        <Affiliation>Department of Pathology, Seoul National University College of Medicine, Seoul, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Jin Sung Park</Name>
        <Affiliation>Department of Neurogenetics, Kolling Institute, Royal North Shore Hospital and University of Sydney, St. Leonards, Australia.</Affiliation>
      </Author>
      <Author>
        <Name>Jeong Hwan Che</Name>
        <Affiliation>Biomedical Center for Animal Resource and Development, Seoul National University College of Medicine, Seoul, Republic of Korea. Electronic address: casache@snu.ac.kr.</Affiliation>
      </Author>
      <Author>
        <Name>Byeong Cheol Kang</Name>
        <Affiliation>Department of Experimental Animal Research, Biomedical Research Institute, Seoul National University Hospital, Seoul, Republic of Korea; Biomedical Center for Animal Resource and Development, Seoul National University College of Medicine, Seoul, Republic of Korea; Graduate School of Translational Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea; Designed Animal and Transplantation Research Institute, Institute of GreenBio Science Technology, Seoul National University, Pyeongchang-gun, Gangwon-do, Republic of Korea. Electronic address: bckang@snu.ac.kr.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Pharmacokinetics, pharmacodynamics and safety profiling of IS01957, a preclinical candidate possessing dual activity against inflammation and nociception.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29108848</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30348-3</DOI>
    <KeywordList>
      <Keywords>IS01957</Keywords>
      <Keywords>Inflammation</Keywords>
      <Keywords>Nociception</Keywords>
      <Keywords>Para-coumaric acid derivative</Keywords>
      <Keywords>Pharmacokinetics</Keywords>
      <Keywords>Safety pharmacology</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Anjna Sharma</Name>
        <Affiliation>PK-PD, Toxicology and Formulation Division, CSIR-Indian Institute of Integrative Medicine, Jammu 180 001, India; Academy of Scientific and Innovative Research (AcSIR), CSIR-Indian Institute of Integrative Medicine, Jammu 180 001, India.</Affiliation>
      </Author>
      <Author>
        <Name>Asmita Magotra</Name>
        <Affiliation>PK-PD, Toxicology and Formulation Division, CSIR-Indian Institute of Integrative Medicine, Jammu 180 001, India; Academy of Scientific and Innovative Research (AcSIR), CSIR-Indian Institute of Integrative Medicine, Jammu 180 001, India.</Affiliation>
      </Author>
      <Author>
        <Name>Ashish Dogra</Name>
        <Affiliation>PK-PD, Toxicology and Formulation Division, CSIR-Indian Institute of Integrative Medicine, Jammu 180 001, India; Academy of Scientific and Innovative Research (AcSIR), CSIR-Indian Institute of Integrative Medicine, Jammu 180 001, India.</Affiliation>
      </Author>
      <Author>
        <Name>Santosh Kumar Rath</Name>
        <Affiliation>Bio-Organic Chemistry Division, CSIR-Indian Institute of Integrative Medicine, Jammu 180 001, India; Academy of Scientific and Innovative Research (AcSIR), CSIR-Indian Institute of Integrative Medicine, Jammu 180 001, India.</Affiliation>
      </Author>
      <Author>
        <Name>Sheikh Rayees</Name>
        <Affiliation>PK-PD, Toxicology and Formulation Division, CSIR-Indian Institute of Integrative Medicine, Jammu 180 001, India.</Affiliation>
      </Author>
      <Author>
        <Name>Priya Wazir</Name>
        <Affiliation>PK-PD, Toxicology and Formulation Division, CSIR-Indian Institute of Integrative Medicine, Jammu 180 001, India.</Affiliation>
      </Author>
      <Author>
        <Name>Sadhana Sharma</Name>
        <Affiliation>PK-PD, Toxicology and Formulation Division, CSIR-Indian Institute of Integrative Medicine, Jammu 180 001, India.</Affiliation>
      </Author>
      <Author>
        <Name>Payare Lal Sangwan</Name>
        <Affiliation>Bio-Organic Chemistry Division, CSIR-Indian Institute of Integrative Medicine, Jammu 180 001, India; Academy of Scientific and Innovative Research (AcSIR), CSIR-Indian Institute of Integrative Medicine, Jammu 180 001, India.</Affiliation>
      </Author>
      <Author>
        <Name>Surjeet Singh</Name>
        <Affiliation>PK-PD, Toxicology and Formulation Division, CSIR-Indian Institute of Integrative Medicine, Jammu 180 001, India.</Affiliation>
      </Author>
      <Author>
        <Name>Gurdarshan Singh</Name>
        <Affiliation>PK-PD, Toxicology and Formulation Division, CSIR-Indian Institute of Integrative Medicine, Jammu 180 001, India; Academy of Scientific and Innovative Research (AcSIR), CSIR-Indian Institute of Integrative Medicine, Jammu 180 001, India. Electronic address: singh_gd@iiim.ac.in.</Affiliation>
      </Author>
      <Author>
        <Name>Utpal Nandi</Name>
        <Affiliation>PK-PD, Toxicology and Formulation Division, CSIR-Indian Institute of Integrative Medicine, Jammu 180 001, India; Academy of Scientific and Innovative Research (AcSIR), CSIR-Indian Institute of Integrative Medicine, Jammu 180 001, India. Electronic address: unandi@iiim.ac.in.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Assessment of preclinical pharmacokinetics and acute toxicity of pioglitazone and telmisartan combination.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29107617</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30344-6</DOI>
    <KeywordList>
      <Keywords>Acute toxicity</Keywords>
      <Keywords>Pharmacokinetics</Keywords>
      <Keywords>Pioglitazone</Keywords>
      <Keywords>Telmisartan</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Pinaki Sengupta</Name>
        <Affiliation>National Institute of Pharmaceutical Education and Research (NIPER), Ahmedabad, Gujrat, India; Department of Pharmaceutical Technology, International Islamic University Malaysia, Malaysia. Electronic address: psg725@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Bappaditya Chatterjee</Name>
        <Affiliation>Department of Pharmaceutical Technology, International Islamic University Malaysia, Malaysia. Electronic address: bdpharmaju@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Tapan Kumar Pal</Name>
        <Affiliation>Bioequivalence Study Centre, Jadavpur University, India. Electronic address: tkpal12@gmail.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Integration of a plasma protein binding factor to the Chemical-Specific Adjustment Factor (CSAF) for facilitating the estimation of uncertainties in interspecies extrapolations when deriving health-based exposure limits for active pharmaceutical ingredients: Investigation of recent drug datasets.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29107009</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30340-9</DOI>
    <KeywordList>
      <Keywords>ADE</Keywords>
      <Keywords>API</Keywords>
      <Keywords>OEL</Keywords>
      <Keywords>Occupational exposure limits</Keywords>
      <Keywords>PBPK modeling</Keywords>
      <Keywords>PDE</Keywords>
      <Keywords>Pharmacokinetics</Keywords>
      <Keywords>Protein binding</Keywords>
      <Keywords>RFD</Keywords>
      <Keywords>Toxicological risk assessment</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Patrick Poulin</Name>
        <Affiliation>Consultant Patrick Poulin Inc., Québec City, Québec, Canada; Department of Occupational and Environmental Health, School of Public Health, IRSPUM, Université de Montréal, Québec, Canada. Electronic address: patrick-poulin@videotron.ca.</Affiliation>
      </Author>
      <Author>
        <Name>Richard Arnett</Name>
        <Affiliation>Industrial Hygiene, Pharmascience Inc., 100, boul. de l'Industrie, Candiac, Québec Canada.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Acute and a 28-day repeated-dose toxicity study of total flavonoids from Clinopodium chinense (Benth.) O. Ktze in mice and rats.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29107008</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30341-0</DOI>
    <KeywordList>
      <Keywords>Acute toxicity</Keywords>
      <Keywords>Mice</Keywords>
      <Keywords>Rats</Keywords>
      <Keywords>Subacute toxicity</Keywords>
      <Keywords>Total flavonoids from Clinopodium chinense (Benth.) O. Ktze (TFCC)</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Yonglin Gao</Name>
        <Affiliation>School of Life Science, Center for Mitochondria and Healthy Aging, Yantai University, Yantai, 264005, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Yunzhi Wang</Name>
        <Affiliation>School of Life Science, Center for Mitochondria and Healthy Aging, Yantai University, Yantai, 264005, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Kezhou Wang</Name>
        <Affiliation>Shandong Provincial Laboratory Animal Center of Shandong Academy of Medical Sciences, Jinan, 250002, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Jing Zhu</Name>
        <Affiliation>Shandong Provincial Laboratory Animal Center of Shandong Academy of Medical Sciences, Jinan, 250002, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Guisheng Li</Name>
        <Affiliation>School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery Systems and Biotech Drugs, Universities of Shandong, Yantai University, Yantai, 264005, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Jingwei Tian</Name>
        <Affiliation>School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery Systems and Biotech Drugs, Universities of Shandong, Yantai University, Yantai, 264005, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Chunmei Li</Name>
        <Affiliation>School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery Systems and Biotech Drugs, Universities of Shandong, Yantai University, Yantai, 264005, PR China. Electronic address: sdlcm1978@163.com.</Affiliation>
      </Author>
      <Author>
        <Name>Zhenhua Wang</Name>
        <Affiliation>School of Life Science, Center for Mitochondria and Healthy Aging, Yantai University, Yantai, 264005, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Ji Li</Name>
        <Affiliation>School of Life Science, Center for Mitochondria and Healthy Aging, Yantai University, Yantai, 264005, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Albert W. Lee</Name>
        <Affiliation>NutraSource, Inc. Clarksville, MD 21029, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Chenghua Guo</Name>
        <Affiliation>School of Life Science, Center for Mitochondria and Healthy Aging, Yantai University, Yantai, 264005, PR China.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Studies on the environmental fate, ecotoxicology and toxicology of 2-methyl 1,3-propanediol.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29097239</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30346-X</DOI>
    <KeywordList>
      <Keywords>2-methyl 1,3-propandiol</Keywords>
      <Keywords>Ecotoxicology</Keywords>
      <Keywords>Environmental fate</Keywords>
      <Keywords>Regulatory toxicology</Keywords>
      <Keywords>Toxicology</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>J. Fowles</Name>
        <Affiliation>Tox-Logic Consulting, Santa Rosa CA, United States. Electronic address: tox-logic@hotmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>C. Lewis</Name>
        <Affiliation>Bootman Chemical Safety, Diss, UK.</Affiliation>
      </Author>
      <Author>
        <Name>E. Rushton</Name>
        <Affiliation>LyondellBasell Industries, Rotterdam, The Netherlands.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Influence of cigarette filter ventilation on smokers' mouth level exposure to tar and nicotine.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29097238</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30343-4</DOI>
    <KeywordList>
      <Keywords>Cigarette</Keywords>
      <Keywords>Filter ventilation</Keywords>
      <Keywords>Mouth level exposure</Keywords>
      <Keywords>Nicotine</Keywords>
      <Keywords>Tar</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>John W. Caraway</Name>
        <Affiliation>RAI Services Company, Winston-Salem, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Madeleine Ashley</Name>
        <Affiliation>British American Tobacco (Investments) Limited, Research and Development, Regents Park Road, Southampton, SO15 8TL, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Sheri A. Bowman</Name>
        <Affiliation>RAI Services Company, Winston-Salem, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Peter Chen</Name>
        <Affiliation>RAI Services Company, Winston-Salem, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Graham Errington</Name>
        <Affiliation>British American Tobacco (Investments) Limited, Research and Development, Regents Park Road, Southampton, SO15 8TL, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Krishna Prasad</Name>
        <Affiliation>British American Tobacco (Investments) Limited, Research and Development, Regents Park Road, Southampton, SO15 8TL, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Paul R. Nelson</Name>
        <Affiliation>RAI Services Company, Winston-Salem, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Christopher J. Shepperd</Name>
        <Affiliation>British American Tobacco (Investments) Limited, Research and Development, Regents Park Road, Southampton, SO15 8TL, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Ian M. Fearon</Name>
        <Affiliation>British American Tobacco (Investments) Limited, Research and Development, Regents Park Road, Southampton, SO15 8TL, UK. Electronic address: ian_fearon@bat.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Guidelines for performing systematic reviews in the development of toxicity factors.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29080853</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30310-0</DOI>
    <KeywordList>
      <Keywords>Regulatory toxicology</Keywords>
      <Keywords>Risk assessment</Keywords>
      <Keywords>Systematic review</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Heather R. Schaefer</Name>
        <Affiliation>Texas Commission on Environmental Quality, Toxicology Division, Austin, TX, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jessica L. Myers</Name>
        <Affiliation>Texas Commission on Environmental Quality, Toxicology Division, Austin, TX, USA. Electronic address: jessica.myers@tceq.texas.gov.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Assessment of tobacco heating product THP1.0. Part 9: The placement of a range of next-generation products on an emissions continuum relative to cigarettes via pre-clinical assessment studies.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29080852</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(17)30303-3</DOI>
    <KeywordList>
      <Keywords>Next-generation products</Keywords>
      <Keywords>Novel tobacco products</Keywords>
      <Keywords>Pre-clinical assessment</Keywords>
      <Keywords>Risk continuum</Keywords>
      <Keywords>electronic cigarettes</Keywords>
      <Keywords>tobacco heating products</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>James Murphy</Name>
        <Affiliation>British American Tobacco, R&amp;D Centre, Southampton, SO15 8TL, United Kingdom. Electronic address: james_murphy@bat.com.</Affiliation>
      </Author>
      <Author>
        <Name>Chuan Liu</Name>
        <Affiliation>British American Tobacco, R&amp;D Centre, Southampton, SO15 8TL, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Kevin McAdam</Name>
        <Affiliation>British American Tobacco, R&amp;D Centre, Southampton, SO15 8TL, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Marianna Gaҫa</Name>
        <Affiliation>British American Tobacco, R&amp;D Centre, Southampton, SO15 8TL, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Krishna Prasad</Name>
        <Affiliation>British American Tobacco, R&amp;D Centre, Southampton, SO15 8TL, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Oscar Camacho</Name>
        <Affiliation>British American Tobacco, R&amp;D Centre, Southampton, SO15 8TL, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>John McAughey</Name>
        <Affiliation>British American Tobacco, R&amp;D Centre, Southampton, SO15 8TL, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Christopher Proctor</Name>
        <Affiliation>British American Tobacco, R&amp;D Centre, Southampton, SO15 8TL, United Kingdom.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Assessment of tobacco heating product THP1.0. Part 2: Product design, operation and thermophysical characterisation.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29080851</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(17)30281-7</DOI>
    <KeywordList>
      <Keywords>Combustion</Keywords>
      <Keywords>Next generation products</Keywords>
      <Keywords>Preclinical assessment</Keywords>
      <Keywords>THP1.0</Keywords>
      <Keywords>Thermophysical assessment</Keywords>
      <Keywords>Tobacco heating product</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Dan Eaton</Name>
        <Affiliation>Research and Development, British American Tobacco Investments Ltd, Regents Park Road, Southampton, Hampshire SO15 8TL, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Blerta Jakaj</Name>
        <Affiliation>Research and Development, British American Tobacco Investments Ltd, Regents Park Road, Southampton, Hampshire SO15 8TL, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Mark Forster</Name>
        <Affiliation>Research and Development, British American Tobacco Investments Ltd, Regents Park Road, Southampton, Hampshire SO15 8TL, UK.</Affiliation>
      </Author>
      <Author>
        <Name>James Nicol</Name>
        <Affiliation>Research and Development, British American Tobacco Investments Ltd, Regents Park Road, Southampton, Hampshire SO15 8TL, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Eleni Mavropoulou</Name>
        <Affiliation>Research and Development, British American Tobacco Investments Ltd, Regents Park Road, Southampton, Hampshire SO15 8TL, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Kenneth Scott</Name>
        <Affiliation>Research and Development, British American Tobacco Investments Ltd, Regents Park Road, Southampton, Hampshire SO15 8TL, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Chuan Liu</Name>
        <Affiliation>Research and Development, British American Tobacco Investments Ltd, Regents Park Road, Southampton, Hampshire SO15 8TL, UK. Electronic address: chuan_liu@bat.com.</Affiliation>
      </Author>
      <Author>
        <Name>Kevin McAdam</Name>
        <Affiliation>Research and Development, British American Tobacco Investments Ltd, Regents Park Road, Southampton, Hampshire SO15 8TL, UK.</Affiliation>
      </Author>
      <Author>
        <Name>James Murphy</Name>
        <Affiliation>Research and Development, British American Tobacco Investments Ltd, Regents Park Road, Southampton, Hampshire SO15 8TL, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Christopher J. Proctor</Name>
        <Affiliation>Research and Development, British American Tobacco Investments Ltd, Regents Park Road, Southampton, Hampshire SO15 8TL, UK.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Assessment of novel tobacco heating product THP1.0. Part 7: Comparative in vitro toxicological evaluation.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29080850</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(17)30267-2</DOI>
    <KeywordList>
      <Keywords>Ames</Keywords>
      <Keywords>Bhas transformation assay</Keywords>
      <Keywords>In vitro</Keywords>
      <Keywords>Mouse lymphoma</Keywords>
      <Keywords>Neutral red uptake</Keywords>
      <Keywords>TPM</Keywords>
      <Keywords>Tobacco heating products</Keywords>
      <Keywords>Whole aerosol</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>David Thorne</Name>
        <Affiliation>British American Tobacco, R&amp;D, Southampton, Hampshire, SO15 8TL, UK. Electronic address: David_Thorne@bat.com.</Affiliation>
      </Author>
      <Author>
        <Name>Damien Breheny</Name>
        <Affiliation>British American Tobacco, R&amp;D, Southampton, Hampshire, SO15 8TL, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Christopher Proctor</Name>
        <Affiliation>British American Tobacco, R&amp;D, Southampton, Hampshire, SO15 8TL, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Marianna Gaca</Name>
        <Affiliation>British American Tobacco, R&amp;D, Southampton, Hampshire, SO15 8TL, UK.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Assessment of novel tobacco heating product THP1.0. Part 6: A comparative in vitro study using contemporary screening approaches.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29080849</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(17)30266-0</DOI>
    <KeywordList>
      <Keywords>Cigarette smoke</Keywords>
      <Keywords>High content screening</Keywords>
      <Keywords>In vitro</Keywords>
      <Keywords>Lung epithelial</Keywords>
      <Keywords>Reporter assay</Keywords>
      <Keywords>Tobacco heating products</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Mark Taylor</Name>
        <Affiliation>British American Tobacco, Research and Development Centre, Southampton, Hampshire, SO15 8TL, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>David Thorne</Name>
        <Affiliation>British American Tobacco, Research and Development Centre, Southampton, Hampshire, SO15 8TL, United Kingdom. Electronic address: David_Thorne@bat.com.</Affiliation>
      </Author>
      <Author>
        <Name>Tony Carr</Name>
        <Affiliation>British American Tobacco, Research and Development Centre, Southampton, Hampshire, SO15 8TL, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Damien Breheny</Name>
        <Affiliation>British American Tobacco, Research and Development Centre, Southampton, Hampshire, SO15 8TL, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Paul Walker</Name>
        <Affiliation>Cyprotex, Alderley Park, Alderley, Cheshire, SK10 4TG, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Christopher Proctor</Name>
        <Affiliation>British American Tobacco, Research and Development Centre, Southampton, Hampshire, SO15 8TL, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Marianna Gaça</Name>
        <Affiliation>British American Tobacco, Research and Development Centre, Southampton, Hampshire, SO15 8TL, United Kingdom.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Assessment of novel tobacco heating product THP1.0. Part 3: Comprehensive chemical characterisation of harmful and potentially harmful aerosol emissions.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29080848</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(17)30308-2</DOI>
    <KeywordList>
      <Keywords>1R6F reference cigarette</Keywords>
      <Keywords>3R4F reference cigarette</Keywords>
      <Keywords>Next-generation products</Keywords>
      <Keywords>Preclinical assessment</Keywords>
      <Keywords>Tobacco heating product</Keywords>
      <Keywords>Toxicant reduction</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Mark Forster</Name>
        <Affiliation>Research and Development, British American Tobacco Investments Ltd, Regents Park Road, Southampton, Hampshire SO15 8TL, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Stacy Fiebelkorn</Name>
        <Affiliation>Research and Development, British American Tobacco Investments Ltd, Regents Park Road, Southampton, Hampshire SO15 8TL, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Caner Yurteri</Name>
        <Affiliation>Research and Development, British American Tobacco Investments Ltd, Regents Park Road, Southampton, Hampshire SO15 8TL, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Derek Mariner</Name>
        <Affiliation>Research and Development, British American Tobacco Investments Ltd, Regents Park Road, Southampton, Hampshire SO15 8TL, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Chuan Liu</Name>
        <Affiliation>Research and Development, British American Tobacco Investments Ltd, Regents Park Road, Southampton, Hampshire SO15 8TL, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Christopher Wright</Name>
        <Affiliation>Research and Development, British American Tobacco Investments Ltd, Regents Park Road, Southampton, Hampshire SO15 8TL, UK. Electronic address: Christopher_Wright@bat.com.</Affiliation>
      </Author>
      <Author>
        <Name>Kevin McAdam</Name>
        <Affiliation>Research and Development, British American Tobacco Investments Ltd, Regents Park Road, Southampton, Hampshire SO15 8TL, UK.</Affiliation>
      </Author>
      <Author>
        <Name>James Murphy</Name>
        <Affiliation>Research and Development, British American Tobacco Investments Ltd, Regents Park Road, Southampton, Hampshire SO15 8TL, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Christopher Proctor</Name>
        <Affiliation>Research and Development, British American Tobacco Investments Ltd, Regents Park Road, Southampton, Hampshire SO15 8TL, UK.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Safety evaluation of auraptene in rats in acute and subacute toxicity studies.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29080847</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30342-2</DOI>
    <KeywordList>
      <Keywords>Acute toxicity</Keywords>
      <Keywords>Auraptene</Keywords>
      <Keywords>Immunotoxicity</Keywords>
      <Keywords>Subacute toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Tooraj Vakili</Name>
        <Affiliation>Resident of Pharmacology, Department of Pharmacology, Faculty of Veterinary Medicine, University of Tehran, Tehran, Iran.</Affiliation>
      </Author>
      <Author>
        <Name>Mehrdad Iranshahi</Name>
        <Affiliation>Biotechnology Research Center, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran.</Affiliation>
      </Author>
      <Author>
        <Name>Hosseinali Arab</Name>
        <Affiliation>Resident of Pharmacology, Department of Pharmacology, Faculty of Veterinary Medicine, University of Tehran, Tehran, Iran.</Affiliation>
      </Author>
      <Author>
        <Name>Bamdad Riahi</Name>
        <Affiliation>Medical Toxicology Research Center, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.</Affiliation>
      </Author>
      <Author>
        <Name>Nama Mohammadian Roshan</Name>
        <Affiliation>Department of Pathology, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.</Affiliation>
      </Author>
      <Author>
        <Name>Gholamreza Karimi</Name>
        <Affiliation>Pharmaceutical Research Center, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran. Electronic address: Karimig@mums.ac.ir.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Safety against nephrotoxicity in paclitaxel treatment: Oral nanocarrier as an effective tool in preclinical evaluation with marked in vivo antitumor activity.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29080846</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30338-0</DOI>
    <KeywordList>
      <Keywords>Antitumor activity</Keywords>
      <Keywords>Hematological analysis</Keywords>
      <Keywords>Histopathology</Keywords>
      <Keywords>Oral nanoemulsion</Keywords>
      <Keywords>Paclitaxel</Keywords>
      <Keywords>Sub-chronic toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Hira Choudhury</Name>
        <Affiliation>Department of Pharmaceutical Technology, Jadavpur University, Kolkata, 700032, India. Electronic address: HiraChoudhury@imu.edu.my.</Affiliation>
      </Author>
      <Author>
        <Name>Bapi Gorain</Name>
        <Affiliation>Department of Pharmaceutical Technology, Jadavpur University, Kolkata, 700032, India; Faculty of Pharmacy, Lincoln University College, Petaling Jaya, Selangor, Kuala Lumpur, 47301, Malaysia.</Affiliation>
      </Author>
      <Author>
        <Name>Rakesh Kumar Tekade</Name>
        <Affiliation>National Institute of Pharmaceutical Education and Research (NIPER) - Ahmedabad, Department of Pharmaceutics, Opposite Air Force Station, Palaj, Gandhinagar, 382355, Gujarat, India.</Affiliation>
      </Author>
      <Author>
        <Name>Manisha Pandey</Name>
        <Affiliation>International Medical University, School of Pharmacy, Department of Pharmaceutical Technology, 57000, Kuala Lumpur, Malaysia.</Affiliation>
      </Author>
      <Author>
        <Name>Sanmoy Karmakar</Name>
        <Affiliation>Department of Pharmaceutical Technology, Jadavpur University, Kolkata, 700032, India.</Affiliation>
      </Author>
      <Author>
        <Name>Tapan Kumar Pal</Name>
        <Affiliation>Department of Pharmaceutical Technology, Jadavpur University, Kolkata, 700032, India. Electronic address: proftkpal@gmail.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Application of in vitro skin penetration measurements to confirm and refine the quantitative skin sensitization risk assessment of methylisothiazolinone.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29080845</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30339-2</DOI>
    <KeywordList>
      <Keywords>Consumer</Keywords>
      <Keywords>Cosmetics</Keywords>
      <Keywords>Household care</Keywords>
      <Keywords>Measured exposure levels</Keywords>
      <Keywords>Methylisothiazolinone</Keywords>
      <Keywords>Quantitative-risk-assessment</Keywords>
      <Keywords>Skin penetration</Keywords>
      <Keywords>Skin sensitization</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Helga Rothe</Name>
        <Affiliation>Coty, Berliner Allee 65, 64295 Darmstadt, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Cindy A. Ryan</Name>
        <Affiliation>The Procter &amp; Gamble Company, Mason Business Center, 8700 Mason Montgomery Rd., Mason, OH 45040, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Leanne Page</Name>
        <Affiliation>Charles River Laboratories Edinburgh Ltd, Elphinstone Research Centre, Tranent, East Lothian, EH33 2NE, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Joanne Vinall</Name>
        <Affiliation>Charles River Laboratories Edinburgh Ltd, Elphinstone Research Centre, Tranent, East Lothian, EH33 2NE, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Carsten Goebel</Name>
        <Affiliation>Coty, Berliner Allee 65, 64295 Darmstadt, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Heike Scheffler</Name>
        <Affiliation>Procter &amp; Gamble Service GmbH, Frankfurter Strasse 145, 61476 Kronberg, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Frank Toner</Name>
        <Affiliation>Charles River Laboratories Edinburgh Ltd, Elphinstone Research Centre, Tranent, East Lothian, EH33 2NE, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Clive Roper</Name>
        <Affiliation>Charles River Laboratories Edinburgh Ltd, Elphinstone Research Centre, Tranent, East Lothian, EH33 2NE, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Petra S. Kern</Name>
        <Affiliation>Procter &amp; Gamble Services Company NV, Temselaan 100, B-1853 Strombeek-Bever, Belgium. Electronic address: kern.ps@pg.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A new approach for risk assessment of aggregate dermal exposure to banned azo dyes in textiles.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29080844</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30337-9</DOI>
    <KeywordList>
      <Keywords>Aromatic amines</Keywords>
      <Keywords>Azo dyes</Keywords>
      <Keywords>Risk assessment</Keywords>
      <Keywords>Textile</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Xuezhang Chen</Name>
        <Affiliation>Guangdong Institute of Standardization, 563 Nantian Road, Haizhu District, Guangzhou, 510220, China. Electronic address: chen.xz@gdis.org.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Qixi Deng</Name>
        <Affiliation>Guangdong Institute of Standardization, 563 Nantian Road, Haizhu District, Guangzhou, 510220, China.</Affiliation>
      </Author>
      <Author>
        <Name>Shubao Lin</Name>
        <Affiliation>Guangdong Institute of Standardization, 563 Nantian Road, Haizhu District, Guangzhou, 510220, China.</Affiliation>
      </Author>
      <Author>
        <Name>Chao Du</Name>
        <Affiliation>Guangdong Testing Institute of Product Quality Supervision, No.10 Science Avenue, Huangpu District, Guangzhou, 510663, China.</Affiliation>
      </Author>
      <Author>
        <Name>Shengqiao Zhao</Name>
        <Affiliation>Guangdong Institute of Standardization, 563 Nantian Road, Haizhu District, Guangzhou, 510220, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yongjie Hu</Name>
        <Affiliation>Guangdong Testing Institute of Product Quality Supervision, No.10 Science Avenue, Huangpu District, Guangzhou, 510663, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhongguo Yang</Name>
        <Affiliation>Guangdong Institute of Standardization, 563 Nantian Road, Haizhu District, Guangzhou, 510220, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yanhui Lyu</Name>
        <Affiliation>Guangdong Testing Institute of Product Quality Supervision, No.10 Science Avenue, Huangpu District, Guangzhou, 510663, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jianjian Han</Name>
        <Affiliation>Guangdong Testing Institute of Product Quality Supervision, No.10 Science Avenue, Huangpu District, Guangzhou, 510663, China.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Physico-chemical properties of manufactured nanomaterials - Characterisation and relevant methods. An outlook based on the OECD Testing Programme.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29074277</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(17)30334-3</DOI>
    <KeywordList>
      <Keywords>Characterisation</Keywords>
      <Keywords>Manufactured nanomaterials</Keywords>
      <Keywords>OECD test guidelines</Keywords>
      <Keywords>Physico-chemical properties</Keywords>
      <Keywords>Working party on manufactured nanomaterials</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Kirsten Rasmussen</Name>
        <Affiliation>European Commission, Joint Research Centre, Ispra, Via E. Fermi 2749, 21027 Ispra, VA, Italy. Electronic address: kirsten.rasmussen@ec.europa.eu.</Affiliation>
      </Author>
      <Author>
        <Name>Hubert Rauscher</Name>
        <Affiliation>European Commission, Joint Research Centre, Ispra, Via E. Fermi 2749, 21027 Ispra, VA, Italy. Electronic address: hubert.rauscher@ec.europa.eu.</Affiliation>
      </Author>
      <Author>
        <Name>Agnieszka Mech</Name>
        <Affiliation>European Commission, Joint Research Centre, Ispra, Via E. Fermi 2749, 21027 Ispra, VA, Italy. Electronic address: agnieszka.mech@ec.europa.eu.</Affiliation>
      </Author>
      <Author>
        <Name>Juan Riego Sintes</Name>
        <Affiliation>European Commission, Joint Research Centre, Ispra, Via E. Fermi 2749, 21027 Ispra, VA, Italy. Electronic address: juan.riego-sintes@ec.europa.eu.</Affiliation>
      </Author>
      <Author>
        <Name>Douglas Gilliland</Name>
        <Affiliation>European Commission, Joint Research Centre, Ispra, Via E. Fermi 2749, 21027 Ispra, VA, Italy. Electronic address: douglas.gilliland@ec.europa.eu.</Affiliation>
      </Author>
      <Author>
        <Name>Mar González</Name>
        <Affiliation>Organisation for Economic Co-operation and Development (OECD), Environment Directorate, 75775 Paris CEDEX 16, France. Electronic address: mar.gonzalez@oecd.org.</Affiliation>
      </Author>
      <Author>
        <Name>Peter Kearns</Name>
        <Affiliation>Organisation for Economic Co-operation and Development (OECD), Environment Directorate, 75775 Paris CEDEX 16, France. Electronic address: peter.kearns@oecd.org.</Affiliation>
      </Author>
      <Author>
        <Name>Kenneth Moss</Name>
        <Affiliation>United States Environmental Protection Agency (US-EPA), Office of Pollution Prevention and Toxics (7405M), 1200 Pennsylvania Avenue, NW, Washington DC, 20460 United States. Electronic address: moss.kenneth@epa.gov.</Affiliation>
      </Author>
      <Author>
        <Name>Maaike Visser</Name>
        <Affiliation>National Institute for Public Health and the Environment (RIVM), PO Box 1, 3720 BA Bilthoven, The Netherlands. Electronic address: maaike.visser@rivm.nl.</Affiliation>
      </Author>
      <Author>
        <Name>Monique Groenewold</Name>
        <Affiliation>National Institute for Public Health and the Environment (RIVM), PO Box 1, 3720 BA Bilthoven, The Netherlands. Electronic address: monique.groenewold@rivm.nl.</Affiliation>
      </Author>
      <Author>
        <Name>Eric A. J. Bleeker</Name>
        <Affiliation>National Institute for Public Health and the Environment (RIVM), PO Box 1, 3720 BA Bilthoven, The Netherlands. Electronic address: eric.bleeker@rivm.nl.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Safety assessment of transgenic canola RF3 with bar and barstar gene on Sprague-Dawley (SD) rats by 90-day feeding test.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29074276</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30333-1</DOI>
    <KeywordList>
      <Keywords>90-Day feeding test</Keywords>
      <Keywords>Gut microbiota</Keywords>
      <Keywords>Safety assessment</Keywords>
      <Keywords>Transgenic canola</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Tianqi Lang</Name>
        <Affiliation>Beijing Advanced Innovation Center for Food Nutrition and Human Health, College of Food Science and Nutritional Engineering, China Agricultural University, Beijing, 100083, China.</Affiliation>
      </Author>
      <Author>
        <Name>Shiying Zou</Name>
        <Affiliation>Beijing Advanced Innovation Center for Food Nutrition and Human Health, College of Food Science and Nutritional Engineering, China Agricultural University, Beijing, 100083, China.</Affiliation>
      </Author>
      <Author>
        <Name>Kunlun Huang</Name>
        <Affiliation>Beijing Advanced Innovation Center for Food Nutrition and Human Health, College of Food Science and Nutritional Engineering, China Agricultural University, Beijing, 100083, China; Key Laboratory of Safety Assessment of Genetically Modified Organism (Food Safety), Ministry of Agriculture, 100083, China; Beijing Laboratory for Food Quality and Safety, College of Food Science &amp; Nutritional Engineering, China Agricultural University, Beijing, 100083, China.</Affiliation>
      </Author>
      <Author>
        <Name>Mingzhang Guo</Name>
        <Affiliation>Beijing Advanced Innovation Center for Food Nutrition and Human Health, College of Food Science and Nutritional Engineering, China Agricultural University, Beijing, 100083, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xu Liu</Name>
        <Affiliation>Beijing Advanced Innovation Center for Food Nutrition and Human Health, College of Food Science and Nutritional Engineering, China Agricultural University, Beijing, 100083, China; Key Laboratory of Safety Assessment of Genetically Modified Organism (Food Safety), Ministry of Agriculture, 100083, China; Beijing Laboratory for Food Quality and Safety, College of Food Science &amp; Nutritional Engineering, China Agricultural University, Beijing, 100083, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaoyun He</Name>
        <Affiliation>Beijing Advanced Innovation Center for Food Nutrition and Human Health, College of Food Science and Nutritional Engineering, China Agricultural University, Beijing, 100083, China; Key Laboratory of Safety Assessment of Genetically Modified Organism (Food Safety), Ministry of Agriculture, 100083, China; Beijing Laboratory for Food Quality and Safety, College of Food Science &amp; Nutritional Engineering, China Agricultural University, Beijing, 100083, China. Electronic address: raininghe@163.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Cigar burning under different smoking intensities and effects on emissions.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29074275</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30328-8</DOI>
    <KeywordList>
      <Keywords>Cigar</Keywords>
      <Keywords>Cigar burning</Keywords>
      <Keywords>Cigar emissions</Keywords>
      <Keywords>Cigar smoking</Keywords>
      <Keywords>Product comparison</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Ole Dethloff</Name>
        <Affiliation>Reemtsma Cigarettenfabriken GmbH, Imperial Tobacco Limited, Albert-Einstein-Ring 7, D-22761 Hamburg, Germany. Electronic address: Ole.dethloff@reemtsma.de.</Affiliation>
      </Author>
      <Author>
        <Name>Christian Mueller</Name>
        <Affiliation>Reemtsma Cigarettenfabriken GmbH, Imperial Tobacco Limited, Albert-Einstein-Ring 7, D-22761 Hamburg, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Xavier Cahours</Name>
        <Affiliation>SEITA, Imperial Tobacco Limited, 48, rue Danton, 45404 Fleury-les-Aubrais, France.</Affiliation>
      </Author>
      <Author>
        <Name>Stéphane Colard</Name>
        <Affiliation>SEITA, Imperial Tobacco Limited, 48, rue Danton, 45404 Fleury-les-Aubrais, France.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
</PubmedArticleSet>
